Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989942|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14989943|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14989944|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14989945|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
14989946|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
14989947|NCT01723150|Ertapenem|ertapenem|mesh-list
14989948|NCT01723150|Trimethoprim|trimethoprim|mesh-list
14989949|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
14989950|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14989951|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989952|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14989953|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14989954|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14989955|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989956|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14989957|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14989958|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14989959|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14989960|NCT01723150|Renal Agents|renal agents|mesh-ancestor
14989961|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
14989962|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14989963|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14989964|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14801345|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14989965|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14989966|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14989967|NCT01723371|Carvedilol|carvedilol|mesh-list
14989968|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14989969|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14989970|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
14989971|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14989972|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14989973|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989974|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14989975|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
14989976|NCT01723371|Protective Agents|protective agents|mesh-ancestor
14989977|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14989978|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14989979|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14989980|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
14989981|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14989982|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14989983|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
14989984|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14989985|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14989986|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
14989987|NCT01723527|Buprenorphine|buprenorphine|mesh-list
14989988|NCT01723527|Methadone|methadone|mesh-list
14989989|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14989990|NCT01723527|Narcotics|narcotics|mesh-ancestor
14989991|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14989992|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14989993|NCT01723527|Analgesics|analgesics|mesh-ancestor
14989994|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
14989995|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14989996|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14989997|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
14989998|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
14989999|NCT01723553|Corticosterone|corticosterone|mesh-list
14990000|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14990001|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
14990002|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14990003|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990004|NCT01723670|Flurbiprofen|flurbiprofen|mesh-list
14990005|NCT01723670|Analgesics|analgesics|mesh-ancestor
14801346|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14801347|NCT00792025|Growth Substances|growth substances|mesh-ancestor
14801348|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801349|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
14801350|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14801351|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801352|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801353|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14990006|NCT01723670|Sensory System Agents|sensory system agents|mesh-ancestor
14990007|NCT01723670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990008|NCT01723670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990009|NCT01723670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14990010|NCT01723670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14990011|NCT01723670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14990012|NCT01723670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14990013|NCT01723670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14990014|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990015|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990016|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14990017|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
14990018|NCT01723735|Ezetimibe|ezetimibe|mesh-list
14990019|NCT01723735|Fenofibrate|fenofibrate|mesh-list
14990020|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14990021|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14990022|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
14990023|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990024|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14990025|NCT01723748|Hormones|hormones|mesh-list
14990026|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14990027|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990028|NCT01723774|Anastrozole|anastrozole|mesh-list
14990029|NCT01723774|Goserelin|goserelin|mesh-list
14990030|NCT01723774|Palbociclib|palbociclib|mesh-list
14990031|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14990032|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990033|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14990034|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14990035|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990036|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990037|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14990038|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
14990039|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14990040|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990041|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14990042|NCT01723800|Carboplatin|carboplatin|mesh-list
14990043|NCT01723800|Pemetrexed|pemetrexed|mesh-list
14990044|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990045|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990046|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990047|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14990048|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14990049|NCT01723852|Vitamin D|vitamin d|mesh-list
14990050|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
14990051|NCT01723852|Vitamins|vitamins|mesh-list
14990052|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
14990053|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990054|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14990055|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14990056|NCT01724086|Interferons|interferons|mesh-list
14990057|NCT01724086|Ritonavir|ritonavir|mesh-list
14990058|NCT01724086|Ribavirin|ribavirin|mesh-list
14990059|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
14990060|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
14990061|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14990062|NCT01724086|Simeprevir|simeprevir|mesh-list
14990063|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990064|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
14990065|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990066|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14990067|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14990068|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
14990069|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990070|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990071|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14990072|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14990073|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14990074|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14990075|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
14990076|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
14990077|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990078|NCT01724138|Deferasirox|deferasirox|mesh-list
14990079|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14990080|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
14990081|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
14990082|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990083|NCT01724190|Vitamin D|vitamin d|mesh-list
14990084|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
14990085|NCT01724190|Vitamins|vitamins|mesh-ancestor
14990086|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
14990087|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990088|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14990089|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14990090|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
14990091|NCT01724229|Clotrimazole|clotrimazole|mesh-list
14990092|NCT01724229|Miconazole|miconazole|mesh-list
14990093|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990094|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14990095|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14990096|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14990097|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990098|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990099|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14990100|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
14990101|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14990102|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990103|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14990104|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14990105|NCT01724268|Prednisolone|prednisolone|mesh-list
14990106|NCT01724268|Methotrexate|methotrexate|mesh-list
14990107|NCT01724268|Methamphetamine|methamphetamine|mesh-list
14990108|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14990109|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
14990110|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14990111|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990112|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14990113|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
14990114|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990115|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990116|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
14990117|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990118|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14990119|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14990120|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
14990121|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14990122|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14990123|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14990124|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
14990125|NCT01724268|Hormones|hormones|mesh-ancestor
14990126|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14990127|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14990128|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
14990129|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990130|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14990131|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
14990132|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
14990133|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14990134|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
14990135|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14990136|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14990137|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14990138|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14990139|NCT01724346|Chlorambucil|chlorambucil|mesh-list
14990140|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14990141|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
14990142|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990143|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031212|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031213|NCT01973101|Antiviral Agents|antiviral agents|mesh-ancestor
15031214|NCT01973101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031215|NCT01973101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031216|NCT01973101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15031217|NCT01973101|Immunologic Factors|immunologic factors|mesh-ancestor
15031218|NCT01973101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031219|NCT01973114|Latanoprost|latanoprost|mesh-list
15031220|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15031221|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15031222|NCT01973140|Tolvaptan|tolvaptan|mesh-list
15031223|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15031224|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031225|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
15031226|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031227|NCT01973309|Paclitaxel|paclitaxel|mesh-list
15031228|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15031229|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031230|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
15031231|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
15031232|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
15031233|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031234|NCT01973322|Vaccines|vaccines|mesh-list
15031235|NCT01973322|Complement Factor H|complement factor h|mesh-list
15031236|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
15031237|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031238|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15031239|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15031240|NCT01973400|Tocotrienols|tocotrienols|mesh-list
15031241|NCT01973400|Vitamin E|vitamin e|mesh-list
15031242|NCT01973400|Tocopherols|tocopherols|mesh-list
15031243|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
15031244|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031245|NCT01973400|Protective Agents|protective agents|mesh-ancestor
15031246|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031247|NCT01973400|Vitamins|vitamins|mesh-ancestor
15031248|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
15031249|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15031250|NCT01973517|Hematinics|hematinics|mesh-ancestor
15031251|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15031252|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15031253|NCT01973660|Tamoxifen|tamoxifen|mesh-list
15031254|NCT01973660|Paclitaxel|paclitaxel|mesh-list
15031255|NCT01973660|Trastuzumab|trastuzumab|mesh-list
15031256|NCT01973660|Letrozole|letrozole|mesh-list
15031257|NCT01973660|Lapatinib|lapatinib|mesh-list
15031258|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15031259|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031260|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
15031261|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
15031262|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
15031263|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031264|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15031265|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15031266|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15031267|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031268|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15031269|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
15031270|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031271|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031272|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15031273|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15031274|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15031275|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15031276|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15031277|NCT01973751|Budesonide|budesonide|mesh-list
15031278|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15031279|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15031280|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
15031281|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990144|NCT01724372|Aripiprazole|aripiprazole|mesh-list
14990145|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
14990146|NCT01724372|Fluoxetine|fluoxetine|mesh-list
14990147|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
14990148|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14990149|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14990150|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14990151|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990152|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
14990153|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
14990154|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14990155|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990156|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14990157|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14990158|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
14990159|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14990160|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14990161|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14990162|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14990163|NCT01724372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14990164|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14990165|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14990166|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14990167|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14990168|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14990169|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990170|NCT01724385|Bevacizumab|bevacizumab|mesh-list
14990171|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14990172|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990173|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14990174|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14990175|NCT01724385|Growth Substances|growth substances|mesh-ancestor
14523475|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
14523476|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
14523477|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14523478|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990176|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990177|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
14990178|NCT01724424|Melatonin|melatonin|mesh-list
14990179|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
14990180|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990181|NCT01724424|Protective Agents|protective agents|mesh-ancestor
14990182|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990183|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14990184|NCT01724450|Carvedilol|carvedilol|mesh-list
14990185|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14801354|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14801355|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14801356|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14801357|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801358|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523479|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
14523480|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523481|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14523482|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14801359|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801360|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14801361|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
14801362|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14801363|NCT00792181|Midazolam|midazolam|mesh-list
14801364|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14801365|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14801366|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801367|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801368|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14801369|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14801370|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14801371|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14801372|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
14801373|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
14801374|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
14801375|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
14801376|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801377|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801378|NCT00792246|Voriconazole|voriconazole|mesh-list
14801379|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
14801380|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990186|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14990187|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
14990188|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14990189|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990190|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801381|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14801382|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14801383|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990191|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14990192|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
14990193|NCT01724450|Protective Agents|protective agents|mesh-ancestor
14990194|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14990195|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14990196|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14990197|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
14990198|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14990199|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14990200|NCT01724554|Aflibercept|aflibercept|mesh-list
14801384|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801385|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14801386|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
14801387|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14801388|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801389|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14801390|NCT00792324|Efavirenz|efavirenz|mesh-list
14801391|NCT00792324|Etravirine|etravirine|mesh-list
14801392|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14801393|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14801394|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801395|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801396|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
14801397|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14801398|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14801399|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14801400|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14801401|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14801402|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14801403|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14801404|NCT00792337|Simvastatin|simvastatin|mesh-list
14801405|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14801406|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14801407|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
14801408|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801409|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14801410|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14801411|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801412|NCT00792350|Sorafenib|sorafenib|mesh-list
14801413|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990201|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14990202|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14990203|NCT01724554|Growth Substances|growth substances|mesh-ancestor
14990204|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990205|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
14990206|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990207|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
14990208|NCT01724619|Androgens|androgens|mesh-ancestor
14990209|NCT01724619|Hormones|hormones|mesh-ancestor
14990210|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14990211|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990212|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
14990213|NCT01724658|Testosterone|testosterone|mesh-list
14990214|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
14990215|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
14990216|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14990217|NCT01724658|Androgens|androgens|mesh-ancestor
14990218|NCT01724658|Hormones|hormones|mesh-ancestor
14990219|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14990220|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990221|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14990222|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990223|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
14990224|NCT01724723|Entecavir|entecavir|mesh-list
14990225|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
14990226|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990227|NCT01724788|Furosemide|furosemide|mesh-list
14990228|NCT01724788|Diuretics|diuretics|mesh-ancestor
14990229|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
14990230|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990231|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14990232|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14990233|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990234|NCT01724814|Insulin|insulin|mesh-list
14990235|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14990236|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990237|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14990238|NCT01724892|Dexamethasone|dexamethasone|mesh-list
14990239|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14990240|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
14990241|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
14990242|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990243|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990244|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14990245|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
14990246|NCT01724892|Hormones|hormones|mesh-ancestor
14990247|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14990248|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14990249|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990250|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14990251|NCT01724918|Lacosamide|lacosamide|mesh-list
14990252|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
14990253|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14990254|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14990255|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14990256|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990257|NCT01724931|Aminopterin|aminopterin|mesh-list
14990258|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14990259|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990260|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990261|NCT01724983|Fentanyl|fentanyl|mesh-list
14990262|NCT01724983|Ketamine|ketamine|mesh-list
14990263|NCT01724983|Analgesics|analgesics|mesh-ancestor
14990264|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
14990265|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990266|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990267|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14990268|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14990269|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
14990270|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
14990271|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14990272|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14990273|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14990274|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14990275|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990276|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14990277|NCT01724983|Narcotics|narcotics|mesh-ancestor
14990278|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14990279|NCT01725009|Levetiracetam|levetiracetam|mesh-list
14990280|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
14990281|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
14990282|NCT01725048|Mirtazapine|mirtazapine|mesh-list
14990283|NCT01725048|Citalopram|citalopram|mesh-list
14990284|NCT01725048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14990285|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14990286|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14990287|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990288|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14990289|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
14990290|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990291|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14990292|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
14990293|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14990294|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14990295|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
14990296|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
14990297|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14990298|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14990299|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14990300|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14990301|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14990302|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14990303|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
14990304|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14990305|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14990306|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14990307|NCT01725087|Tapentadol|tapentadol|mesh-list
14990308|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14990309|NCT01725087|Narcotics|narcotics|mesh-ancestor
14990310|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14990311|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990312|NCT01725087|Analgesics|analgesics|mesh-ancestor
14990313|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
14990314|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990315|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14990316|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14990317|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14990318|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990319|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
14990320|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14990321|NCT01725100|Trametinib|trametinib|mesh-list
14990322|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
14990323|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990324|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14990325|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990326|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990327|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14990328|NCT01725100|Protective Agents|protective agents|mesh-ancestor
14990329|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990330|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14990331|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
14990332|NCT01725113|Calcitriol|calcitriol|mesh-list
14990333|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14990334|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990335|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14990336|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14990337|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990338|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14990339|NCT01725113|Vitamins|vitamins|mesh-ancestor
14990340|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
14990341|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14990342|NCT01725204|Dasatinib|dasatinib|mesh-list
14990343|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990344|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14990345|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990346|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990347|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14990348|NCT01725230|Simvastatin|simvastatin|mesh-list
14990349|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14990350|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14990351|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
14990352|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990353|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14990354|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14990355|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990356|NCT01725243|Carbetocin|carbetocin|mesh-list
14990357|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
14990358|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14990359|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990360|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14801414|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14801415|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801416|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990361|NCT01725360|Montelukast|montelukast|mesh-list
14990362|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14990363|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
14990364|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14990365|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
14990366|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14990367|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990368|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14990369|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14990370|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990371|NCT01725412|Thiamine|thiamine|mesh-list
14990372|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
14990373|NCT01725412|Vitamins|vitamins|mesh-ancestor
14990374|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
14990375|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990376|NCT01725477|Methylene Blue|methylene blue|mesh-list
14990377|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990378|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990379|NCT01725490|Metformin|metformin|mesh-list
14990380|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14990381|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990382|NCT01725542|Ribavirin|ribavirin|mesh-list
14990383|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14990384|NCT01725542|Asunaprevir|asunaprevir|mesh-list
14990385|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
14990386|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990387|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
14990388|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990389|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
14990390|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990391|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
14990392|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14990393|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990394|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
14990395|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
14990396|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
14990397|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
14990398|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
14990399|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990400|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
14990401|NCT01725607|Anesthetics|anesthetics|mesh-list
14990402|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14990403|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990404|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14990405|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14990406|NCT01725607|Analgesics|analgesics|mesh-ancestor
14990407|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
14990408|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990409|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14990410|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14990411|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14801417|NCT00792363|Irinotecan|irinotecan|mesh-list
14801418|NCT00792363|Panitumumab|panitumumab|mesh-list
14801419|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14801420|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14801421|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801422|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990412|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
14990413|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14990414|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990415|NCT01725620|Etanercept|etanercept|mesh-list
14990416|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14990417|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14990418|NCT01725620|Analgesics|analgesics|mesh-ancestor
14990419|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
14990420|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990421|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990422|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14990423|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14990424|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14990425|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14990426|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
14990427|NCT01725672|Metformin|metformin|mesh-list
14990428|NCT01725672|Glimepiride|glimepiride|mesh-list
14990429|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14990430|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990431|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14990432|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14990433|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
14990434|NCT01725776|Milrinone|milrinone|mesh-list
14990435|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14990436|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14990437|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
14990438|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14990439|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14990440|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990441|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990442|NCT01725776|Protective Agents|protective agents|mesh-ancestor
14990443|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990444|NCT01725802|Levodopa|levodopa|mesh-list
14990445|NCT01725802|Carbidopa|carbidopa|mesh-list
14990446|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14990447|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14990448|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
14990449|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14990450|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990451|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990452|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14990453|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990454|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14990455|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14990456|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990457|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
15031282|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031283|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15031284|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
15031285|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
15031286|NCT01973751|Hormones|hormones|mesh-ancestor
15031287|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031288|NCT01973790|Z 338|z 338|mesh-list
15031289|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15031290|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031291|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031292|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
15031293|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15031294|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031295|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15031296|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
15031297|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15031298|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15031299|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15031300|NCT01973816|Estradiol|estradiol|mesh-list
14990458|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14990459|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14990460|NCT01726075|Somatostatin|somatostatin|mesh-list
14990461|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14990462|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14990463|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14990464|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14990465|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14990466|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
14990467|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14990468|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990469|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990470|NCT01726075|Hormones|hormones|mesh-ancestor
14990471|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14990472|NCT01726088|Modafinil|modafinil|mesh-list
14990473|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14990474|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990475|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14990476|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14990477|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14990478|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990479|NCT01726192|Ropivacaine|ropivacaine|mesh-list
14990480|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
14990481|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
14990482|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14990483|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990484|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
14990485|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990486|NCT01726205|Pregabalin|pregabalin|mesh-list
14990487|NCT01726205|Ropivacaine|ropivacaine|mesh-list
14990488|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
14990489|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
14990490|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14990491|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990492|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
14990493|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990494|NCT01726205|Analgesics|analgesics|mesh-ancestor
14990495|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
14990496|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14990497|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14990498|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990499|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14990500|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14990501|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14990502|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14990503|NCT01726283|Riboflavin|riboflavin|mesh-list
14990504|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
14990505|NCT01726283|Vitamins|vitamins|mesh-ancestor
14990506|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
14990507|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990508|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14990509|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
14990510|NCT01726400|Interferons|interferons|mesh-list
14990511|NCT01726400|Ribavirin|ribavirin|mesh-list
14990512|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
14990513|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990514|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
14990515|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990516|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
14990517|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990518|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
14990519|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990520|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
14990521|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
14990522|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14990523|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14990524|NCT01726465|Prednisolone|prednisolone|mesh-list
14990525|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
14990526|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14990527|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
14990528|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14990529|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14990530|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
14990531|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
14990532|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990533|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990534|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14990535|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
14990536|NCT01726465|Hormones|hormones|mesh-ancestor
14990537|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14990538|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14990539|NCT01726465|Protective Agents|protective agents|mesh-ancestor
14990540|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14990541|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990542|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
14990543|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990544|NCT01726465|Expectorants|expectorants|mesh-ancestor
14990545|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
14990546|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14990547|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
14990548|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990549|NCT01726465|Antidotes|antidotes|mesh-ancestor
14990550|NCT01726478|Oxytocin|oxytocin|mesh-list
14990551|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
14990552|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14990553|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990554|NCT01726530|Fentanyl|fentanyl|mesh-list
14801423|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801424|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14801425|NCT00792376|Diclofenac|diclofenac|mesh-list
14801426|NCT00792376|Etoricoxib|etoricoxib|mesh-list
14801427|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14801428|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14801429|NCT00792376|Analgesics|analgesics|mesh-ancestor
14801430|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
14990555|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14990556|NCT01726530|Narcotics|narcotics|mesh-ancestor
14990557|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14990558|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990559|NCT01726530|Analgesics|analgesics|mesh-ancestor
14990560|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
14990561|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990562|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14990563|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14990564|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
14990565|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
14990566|NCT01726582|Leucovorin|leucovorin|mesh-list
14990567|NCT01726582|Gemcitabine|gemcitabine|mesh-list
14990568|NCT01726582|Paclitaxel|paclitaxel|mesh-list
14990569|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14990570|NCT01726582|Capecitabine|capecitabine|mesh-list
14990571|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
14990572|NCT01726582|Irinotecan|irinotecan|mesh-list
14990573|NCT01726582|Cisplatin|cisplatin|mesh-list
14990574|NCT01726582|Folfirinox|folfirinox|mesh-list
14990575|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14990576|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801431|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990577|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
14990578|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
14990579|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
14990580|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990581|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14990582|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
14523483|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14523484|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14523485|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523486|NCT03595579|Bupropion|bupropion|mesh-list
14523487|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14523488|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
14523489|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14523490|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14801432|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801433|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14801434|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14801435|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14801436|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801437|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801438|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14801439|NCT00792584|Efavirenz|efavirenz|mesh-list
14801440|NCT00792584|Etravirine|etravirine|mesh-list
14801441|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14801442|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14801443|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801444|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801445|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
14801446|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14801447|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14801448|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14801449|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14990583|NCT01726582|Antiviral Agents|antiviral agents|mesh-ancestor
14990584|NCT01726582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990585|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990586|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14990587|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
14990588|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990589|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14990590|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14990591|NCT01726582|Antidotes|antidotes|mesh-ancestor
14990592|NCT01726582|Protective Agents|protective agents|mesh-ancestor
14990593|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
14801450|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14801451|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14801452|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14801453|NCT00792662|Methylphenidate|methylphenidate|mesh-list
14801454|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14801455|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990594|NCT01726582|Vitamins|vitamins|mesh-ancestor
14990595|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
14990596|NCT01726686|Ropivacaine|ropivacaine|mesh-list
14990597|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
14990598|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
14990599|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14990600|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990601|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
14990602|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990603|NCT01726725|Desflurane|desflurane|mesh-list
14990604|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14990605|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
14990606|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
14990607|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14990608|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990609|NCT01726764|Metformin|metformin|mesh-list
14990610|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14990611|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990612|NCT01726777|Vitamin D|vitamin d|mesh-list
14990613|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
14990614|NCT01726777|Vitamins|vitamins|mesh-list
14990615|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
14990616|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990617|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14990618|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14990619|NCT01726816|Probucol|probucol|mesh-list
14990620|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14990621|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14990622|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
14990623|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990624|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14990625|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
14990626|NCT01726816|Protective Agents|protective agents|mesh-ancestor
14990627|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990628|NCT01726829|Pancrelipase|pancrelipase|mesh-list
14990629|NCT01726829|Pancreatin|pancreatin|mesh-list
14990630|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14990631|NCT01726920|Naproxen|naproxen|mesh-list
14990632|NCT01726920|Naratriptan|naratriptan|mesh-list
14990633|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14990634|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14990635|NCT01726920|Analgesics|analgesics|mesh-ancestor
14990636|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
14990637|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990638|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990639|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14990640|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14801456|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14990641|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
14990642|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14801457|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14801458|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14801459|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801460|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
14801461|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801462|NCT00792714|Mannitol|mannitol|mesh-list
14801463|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14801464|NCT00792714|Diuretics|diuretics|mesh-ancestor
14801465|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
14990643|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990644|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990645|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14990646|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14990647|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14990648|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
14990649|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14990650|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14990651|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
14990652|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14990653|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
14990654|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990655|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14990656|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
14990657|NCT01727050|Coagulants|coagulants|mesh-ancestor
14990658|NCT01727271|Interferons|interferons|mesh-list
14990659|NCT01727271|Tenofovir|tenofovir|mesh-list
14990660|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
14990661|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
14990662|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14990663|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990664|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
14990665|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990666|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14990667|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14990668|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990669|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990670|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14990671|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14990672|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
14990673|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990674|NCT01727401|PENTA|penta|mesh-list
14990675|NCT01727401|Fondaparinux|fondaparinux|mesh-list
14990676|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14990677|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
14990678|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14990679|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
14990680|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990681|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801466|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801467|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
14801468|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14801469|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801470|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801471|NCT00792766|Everolimus|everolimus|mesh-list
14801472|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801473|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14801474|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
14801475|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801476|NCT00792779|Propofol|propofol|mesh-list
14801477|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14801478|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801479|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801480|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14801481|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
14990682|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
14990683|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14990684|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14990685|NCT01727427|Aspirin|aspirin|mesh-list
14990686|NCT01727427|Vitamin K|vitamin k|mesh-list
14990687|NCT01727427|Heparin|heparin|mesh-list
14990688|NCT01727427|Enoxaparin|enoxaparin|mesh-list
14990689|NCT01727427|Dalteparin|dalteparin|mesh-list
14990690|NCT01727427|Tinzaparin|tinzaparin|mesh-list
14990691|NCT01727427|PENTA|penta|mesh-list
14990692|NCT01727427|Nadroparin|nadroparin|mesh-list
14990693|NCT01727427|Warfarin|warfarin|mesh-list
14990694|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
14990695|NCT01727427|Dabigatran|dabigatran|mesh-list
14990696|NCT01727427|Apixaban|apixaban|mesh-list
14990697|NCT01727427|Fondaparinux|fondaparinux|mesh-list
14990698|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
14990699|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
14990700|NCT01727427|Bemiparin|bemiparin|mesh-list
14990701|NCT01727427|Vitamins|vitamins|mesh-ancestor
14990702|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
14990703|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990704|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14990705|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14990706|NCT01727427|Analgesics|analgesics|mesh-ancestor
14990707|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
14990708|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990709|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14990710|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14990711|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14990712|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14990713|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990714|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14990715|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14990716|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990717|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
14990718|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
14990719|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14990720|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
14990721|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14990722|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
14990723|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14990724|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
14990725|NCT01727427|Coagulants|coagulants|mesh-ancestor
14990726|NCT01727453|Warfarin|warfarin|mesh-list
14990727|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
14990728|NCT01727531|Chloroquine|chloroquine|mesh-list
14990729|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14990730|NCT01727531|Amebicides|amebicides|mesh-ancestor
14990731|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14990732|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14990733|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990734|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
14990735|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14990736|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14990737|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14990738|NCT01727531|Analgesics|analgesics|mesh-ancestor
14990739|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
14990740|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990741|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990742|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14990743|NCT01727531|Filaricides|filaricides|mesh-ancestor
14990744|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
14990745|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
14990746|NCT01727557|Anesthetics|anesthetics|mesh-list
14990747|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14990748|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990749|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14990750|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14990751|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031301|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15031302|NCT01973816|Cyproterone|cyproterone|mesh-list
15031303|NCT01973816|Estrogens|estrogens|mesh-ancestor
15031304|NCT01973816|Hormones|hormones|mesh-ancestor
15031305|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031306|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031307|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15031308|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
15031309|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15031310|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15031311|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
15031312|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
15031313|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031314|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15031315|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
15031316|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15031317|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15031318|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
15031319|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15031320|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
15031321|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15031322|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031323|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15031324|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15031325|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031326|NCT01973855|Ribavirin|ribavirin|mesh-list
15031327|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
14990752|NCT01727778|Antibodies|antibodies|mesh-list
14990753|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
14990754|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
14990755|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990756|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
14990757|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14990758|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14990759|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990760|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
14990761|NCT01727843|Coagulants|coagulants|mesh-ancestor
14990762|NCT01727869|Cetuximab|cetuximab|mesh-list
14990763|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14990764|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14990765|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990766|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14990767|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990768|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990769|NCT01727973|Doxycycline|doxycycline|mesh-list
14990770|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14990771|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990772|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
14990773|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14990774|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14990775|NCT01728025|Ranolazine|ranolazine|mesh-list
14990776|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14990777|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14990778|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990779|NCT01728051|Melphalan|melphalan|mesh-list
14990780|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14990781|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
14990782|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990783|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990784|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14990785|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14990786|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
14990787|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990788|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
14990789|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14990790|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990791|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
14990792|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14990793|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990794|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14990795|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990796|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990797|NCT01728272|Metoprolol|metoprolol|mesh-list
14990798|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14990799|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14990800|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
14990801|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
14990802|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990803|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990804|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14990805|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14990806|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14990807|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
14990808|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14990809|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990810|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14990811|NCT01728363|Rifampin|rifampin|mesh-list
14990812|NCT01728363|Clindamycin|clindamycin|mesh-list
14990813|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
14990814|NCT01728363|Ticarcillin|ticarcillin|mesh-list
14990815|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
14990816|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990817|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14990818|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
14990819|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
14990820|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14990821|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990822|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990823|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14990824|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14990825|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14990826|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14990827|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14990828|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14990829|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14990830|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14990831|NCT01728441|Paclitaxel|paclitaxel|mesh-list
14990832|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14990833|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14990834|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990835|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
14990836|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
14990837|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
14990838|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990839|NCT01728480|Cisplatin|cisplatin|mesh-list
14990840|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990841|NCT01728571|Vitamin D|vitamin d|mesh-list
14990842|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
14990843|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
14990844|NCT01728571|Vitamins|vitamins|mesh-list
14990845|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
14990846|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990847|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14990848|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14990849|NCT01728740|Metformin|metformin|mesh-list
14990850|NCT01728740|Acarbose|acarbose|mesh-list
14990851|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14990852|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990853|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14990854|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990855|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990856|NCT01728818|Gemcitabine|gemcitabine|mesh-list
14990857|NCT01728818|Afatinib|afatinib|mesh-list
14990858|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14990859|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
14990860|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990861|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990862|NCT01728818|Antiviral Agents|antiviral agents|mesh-ancestor
14990863|NCT01728818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990864|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990865|NCT01728818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14990866|NCT01728818|Immunologic Factors|immunologic factors|mesh-ancestor
14990867|NCT01728818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990868|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14990869|NCT01728909|Oxytocin|oxytocin|mesh-list
14990870|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
14990871|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14990872|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990873|NCT01728922|Vitamin D|vitamin d|mesh-list
14990874|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
14990875|NCT01728922|Vitamins|vitamins|mesh-list
14990876|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
14990877|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990878|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14990879|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14990880|NCT01728935|Tenofovir|tenofovir|mesh-list
14990881|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
14990882|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990883|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14990884|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14990885|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990886|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990887|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14990888|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14990889|NCT01728948|Sorafenib|sorafenib|mesh-list
14990890|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990891|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14990892|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990893|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990894|NCT01728961|Lumefantrine|lumefantrine|mesh-list
14990895|NCT01728961|Artemether|artemether|mesh-list
14990896|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14990897|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
14990898|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14990899|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14990900|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990901|NCT01728974|Anesthetics|anesthetics|mesh-list
14990902|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14990903|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990904|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
14990905|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14990906|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990907|NCT01728987|Vitamins|vitamins|mesh-ancestor
14990908|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
14990909|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14990910|NCT01729104|Rituximab|rituximab|mesh-list
14990911|NCT01729104|Lenalidomide|lenalidomide|mesh-list
14990912|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14990913|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990914|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
14990915|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990916|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14990917|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14990918|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14990919|NCT01729104|Growth Substances|growth substances|mesh-ancestor
14990920|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
14990921|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
14990922|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14990923|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990924|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14990925|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14990926|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990927|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990928|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990929|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14990930|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14990931|NCT01729260|Mebendazole|mebendazole|mesh-list
14990932|NCT01729260|Piperazine|piperazine|mesh-list
14990933|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
14990934|NCT01729260|DMP 777|dmp 777|mesh-list
14990935|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
14990936|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
14990937|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14990938|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990939|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
14990940|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
14990941|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
14990942|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990943|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990944|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031328|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031329|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
15031330|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031331|NCT01973868|Cetuximab|cetuximab|mesh-list
15031332|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15031333|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031334|NCT01973920|Insulin|insulin|mesh-list
15031335|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15031336|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031337|NCT01973933|Metformin|metformin|mesh-list
15031338|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
15031339|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15031340|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031341|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
15031342|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15031343|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15031344|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031345|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15031346|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031347|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031348|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
15031349|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14523491|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14523492|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14523493|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523494|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
14523495|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523496|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523497|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14801482|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
14801483|NCT00792818|Ibuprofen|ibuprofen|mesh-list
14801484|NCT00792818|Curcumin|curcumin|mesh-list
14801485|NCT00792818|Turmeric extract|turmeric extract|mesh-list
14801486|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14801487|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14801488|NCT00792818|Analgesics|analgesics|mesh-ancestor
14801489|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
14801490|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801491|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801492|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14801493|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14801494|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14801495|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990945|NCT01729468|Aspirin|aspirin|mesh-list
14990946|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14990947|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14990948|NCT01729468|Analgesics|analgesics|mesh-ancestor
14990949|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
14990950|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14990951|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801496|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801497|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801498|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
14801499|NCT00792818|Protective Agents|protective agents|mesh-ancestor
14801500|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14801501|NCT00792857|Vitamins|vitamins|mesh-ancestor
14801502|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
14801503|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801504|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14801505|NCT00793052|Dexamethasone|dexamethasone|mesh-list
14990952|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14990953|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14990954|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14990955|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14990956|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990957|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14990958|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14990959|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990960|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
14990961|NCT01729481|Leucovorin|leucovorin|mesh-list
14990962|NCT01729481|Folic Acid|folic acid|mesh-list
14990963|NCT01729481|Gemcitabine|gemcitabine|mesh-list
14990964|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
14990965|NCT01729481|Irinotecan|irinotecan|mesh-list
14990966|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
14990967|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14990968|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
14990969|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14990970|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990971|NCT01729481|Antiviral Agents|antiviral agents|mesh-ancestor
14990972|NCT01729481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990973|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14990974|NCT01729481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14990975|NCT01729481|Immunologic Factors|immunologic factors|mesh-ancestor
14990976|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990977|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14990978|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14990979|NCT01729481|Antidotes|antidotes|mesh-ancestor
14990980|NCT01729481|Protective Agents|protective agents|mesh-ancestor
14990981|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
14990982|NCT01729481|Vitamins|vitamins|mesh-ancestor
14990983|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
14990984|NCT01729481|Hematinics|hematinics|mesh-ancestor
14990985|NCT01729663|Interferons|interferons|mesh-list
14990986|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
14990987|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
14990988|NCT01729663|Molgramostim|molgramostim|mesh-list
14990989|NCT01729663|Sargramostim|sargramostim|mesh-list
14990990|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
14990991|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14990992|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
14990993|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14990994|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
14990995|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14990996|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14801506|NCT00793052|Etoricoxib|etoricoxib|mesh-list
14990997|NCT01729767|Acyclovir|acyclovir|mesh-list
14990998|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
14990999|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991000|NCT01729806|Rituximab|rituximab|mesh-list
14991001|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14991002|NCT01729806|Ipilimumab|ipilimumab|mesh-list
14991003|NCT01729806|Antibodies|antibodies|mesh-list
14991004|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
14991005|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14991006|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
14991007|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991008|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801507|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991009|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991010|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14991011|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991012|NCT01729897|Fentanyl|fentanyl|mesh-list
14801508|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
14801509|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
14991013|NCT01729897|Propofol|propofol|mesh-list
14991014|NCT01729897|Etomidate|etomidate|mesh-list
14991015|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14991016|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991017|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991018|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14991019|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
14991020|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
14991021|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14991022|NCT01729897|Narcotics|narcotics|mesh-ancestor
14991023|NCT01729897|Analgesics|analgesics|mesh-ancestor
14991024|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
14991025|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991026|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14991027|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
14991028|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14991029|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991030|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14991031|NCT01730157|Ipilimumab|ipilimumab|mesh-list
14991032|NCT01730157|Antibodies|antibodies|mesh-list
14991033|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
14991034|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14991035|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
14991036|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991037|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991038|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14991039|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991040|NCT01730209|Everolimus|everolimus|mesh-list
14991041|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991042|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14991043|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
14991044|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991045|NCT01730222|Gemcitabine|gemcitabine|mesh-list
14991046|NCT01730222|Paclitaxel|paclitaxel|mesh-list
14991047|NCT01730222|Capecitabine|capecitabine|mesh-list
14991048|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14991049|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991050|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
14991051|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
14991052|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
14991053|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991054|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14991055|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
14991056|NCT01730222|Antiviral Agents|antiviral agents|mesh-ancestor
14991057|NCT01730222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991058|NCT01730222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991059|NCT01730222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14991060|NCT01730222|Immunologic Factors|immunologic factors|mesh-ancestor
14991061|NCT01730222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991062|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
14991063|NCT01730287|Calcium|calcium|mesh-list
14991064|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14991065|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991066|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14991067|NCT01730313|Pyridoxine|pyridoxine|mesh-list
14991068|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
14991069|NCT01730313|Phenytoin|phenytoin|mesh-list
14991070|NCT01730313|Valproic Acid|valproic acid|mesh-list
14991071|NCT01730313|Vitamins|vitamins|mesh-ancestor
14991072|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
14991073|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801510|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801511|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801512|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14801513|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
14801514|NCT00793052|Hormones|hormones|mesh-ancestor
14801515|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14801516|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14801517|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801518|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14991074|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
14991075|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
14991076|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991077|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991078|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
14991079|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14991080|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
14991081|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14991082|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991083|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14991084|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14991085|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14991086|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14991087|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14991088|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14991089|NCT01730326|Acetaminophen|acetaminophen|mesh-list
14991090|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14991091|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14991092|NCT01730326|Analgesics|analgesics|mesh-ancestor
14991093|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
14991094|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991095|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991096|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
14991097|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14991098|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991099|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991100|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
14991101|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991102|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991103|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991104|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14991105|NCT01730495|Etanercept|etanercept|mesh-list
14991106|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14991107|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14991108|NCT01730495|Analgesics|analgesics|mesh-ancestor
14991109|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
14991110|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991111|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991112|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991113|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991114|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14991115|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14991116|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
14991117|NCT01730508|Interferons|interferons|mesh-list
14991118|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
14991119|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991120|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
14991121|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991122|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
14991123|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991124|NCT01730612|Histamine|histamine|mesh-list
14991125|NCT01730612|Glycine|glycine|mesh-list
14991126|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
14991127|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
14991128|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14991129|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991130|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991131|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
14991132|NCT01730638|Histamine|histamine|mesh-list
14991133|NCT01730638|Glycine|glycine|mesh-list
14991134|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
14991135|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
14991136|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14991137|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991138|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991139|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
14991140|NCT01730664|Ertapenem|ertapenem|mesh-list
14991141|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14991142|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991143|NCT01730677|Vinorelbine|vinorelbine|mesh-list
14991144|NCT01730677|Lapatinib|lapatinib|mesh-list
14991145|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14991146|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991147|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
14991148|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
14991149|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
14991150|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991151|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14991152|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991153|NCT01730976|Vitamin D|vitamin d|mesh-list
14991154|NCT01730976|Vitamins|vitamins|mesh-list
14991155|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
14991156|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991157|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14991158|NCT01731067|Fexofenadine|fexofenadine|mesh-list
14991159|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
14991160|NCT01731067|Midazolam|midazolam|mesh-list
14991161|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
14991162|NCT01731067|Caffeine|caffeine|mesh-list
14991163|NCT01731067|Bupropion|bupropion|mesh-list
14991164|NCT01731067|Omeprazole|omeprazole|mesh-list
14991165|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14991166|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14991167|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991168|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991169|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14991170|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14991171|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14991172|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14991173|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
14991174|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
14991175|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
14991176|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
14991177|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14991178|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991179|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14991180|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14991181|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14991182|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991183|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14991184|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14991185|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14991186|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14991187|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
14991188|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14991189|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
14991190|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14991191|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14991192|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14991193|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
14991194|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14991195|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14991196|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
14991197|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
14991198|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14991199|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14991200|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14991201|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14991202|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14991203|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
14991204|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
14991205|NCT01731067|Analgesics|analgesics|mesh-ancestor
14991206|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
14991207|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991208|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14991209|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14991210|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991211|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991212|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14991213|NCT01731132|Copper|copper|mesh-list
14991214|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
14991215|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14991216|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
14991217|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14991218|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991219|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14991220|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14991221|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14991222|NCT01731132|Trace Elements|trace elements|mesh-ancestor
14991223|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
15031350|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15031351|NCT01974024|Prednisolone|prednisolone|mesh-list
15031352|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
15031353|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15031354|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
15031355|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15031356|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
15031357|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
15031358|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031359|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031360|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15031361|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
15031362|NCT01974024|Hormones|hormones|mesh-ancestor
15031363|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031364|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15031365|NCT01974024|Protective Agents|protective agents|mesh-ancestor
15031366|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15031367|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031368|NCT01974037|Capsaicin|capsaicin|mesh-list
15031369|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
15031370|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
15031371|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
15031372|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031373|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031374|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
15031375|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
15031376|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
15031377|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15031378|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031379|NCT01974167|Vitamins|vitamins|mesh-ancestor
15031380|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
15035336|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15035337|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15035338|NCT02001012|Analgesics|analgesics|mesh-ancestor
15035339|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
15035340|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035341|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035342|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15035343|NCT02001012|Filaricides|filaricides|mesh-ancestor
15035344|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
15035345|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
15035346|NCT02001103|Memantine|memantine|mesh-list
15035347|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15035348|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15035349|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
15035350|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035351|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035352|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035353|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15035354|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15035355|NCT02001168|Docetaxel|docetaxel|mesh-list
15035356|NCT02001168|Pemetrexed|pemetrexed|mesh-list
15035357|NCT02001168|Cisplatin|cisplatin|mesh-list
15035358|NCT02001168|Endostatins|endostatins|mesh-list
15035359|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035360|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
15035361|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
15035362|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
15035363|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035364|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035365|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15035366|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15035367|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15035368|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15035369|NCT02001168|Growth Substances|growth substances|mesh-ancestor
15035370|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035371|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
15035372|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
15035373|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15035374|NCT02001259|Lidocaine|lidocaine|mesh-list
15035375|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
15035376|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
15035377|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991224|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
14991225|NCT01731158|Bevacizumab|bevacizumab|mesh-list
14991226|NCT01731158|Sunitinib|sunitinib|mesh-list
14991227|NCT01731158|Everolimus|everolimus|mesh-list
14991228|NCT01731158|Sorafenib|sorafenib|mesh-list
14991229|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14991230|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991231|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14991232|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14991233|NCT01731158|Growth Substances|growth substances|mesh-ancestor
14991234|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991235|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
14991236|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14991237|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
14991238|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14991239|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991240|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991241|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
14991242|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991243|NCT01731184|Midazolam|midazolam|mesh-list
14991244|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14991245|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14991246|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991247|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991248|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14991249|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14991250|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14991251|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14991252|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
14991253|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
14991254|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
14991255|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
14991256|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14991257|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991258|NCT01731236|Aspirin|aspirin|mesh-list
14991259|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14991260|NCT01731236|Vancomycin|vancomycin|mesh-list
14991261|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
14991262|NCT01731236|Neomycin|neomycin|mesh-list
14991263|NCT01731236|Choline|choline|mesh-list
14991264|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14991265|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14991266|NCT01731236|Analgesics|analgesics|mesh-ancestor
14991267|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
14991268|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991269|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991270|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991271|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991272|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14991273|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14991274|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991275|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14991276|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14991277|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991278|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
14991279|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991280|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14991281|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14991282|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991283|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14991284|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14991285|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
14991286|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14991287|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
14991288|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14991289|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14991290|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
14991291|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14991292|NCT01731275|Quetmolimab|quetmolimab|mesh-list
14991293|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14991294|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991295|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
14991296|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801519|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14801520|NCT00793052|Analgesics|analgesics|mesh-ancestor
14801521|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
14801522|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14801523|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14801524|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14801525|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801526|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801527|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14801528|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14801529|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14801530|NCT00793195|SMOFlipid|smoflipid|mesh-list
14991297|NCT01731301|Ribavirin|ribavirin|mesh-list
14991298|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
14801531|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14801532|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14801533|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14801534|NCT00793221|Sirolimus|sirolimus|mesh-list
14801535|NCT00793221|Everolimus|everolimus|mesh-list
14801536|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801537|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14801538|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
14801539|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801540|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14801541|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14801542|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14991299|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991300|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
14991301|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991302|NCT01731327|Tofacitinib|tofacitinib|mesh-list
14991303|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14991304|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991305|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801543|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
14991306|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
14991307|NCT01731340|Calcium|calcium|mesh-list
14991308|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14801544|NCT00793234|Enoxaparin|enoxaparin|mesh-list
14801545|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
14991309|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991310|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14991311|NCT01731431|Glyburide|glyburide|mesh-list
14991312|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14991313|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991314|NCT01731444|Phenylephrine|phenylephrine|mesh-list
14991315|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
14991316|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14991317|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
14991318|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
14991319|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991320|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991321|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
14991322|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14991323|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
14991324|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
14991325|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14991326|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14991327|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14991328|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
14991329|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14991330|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991331|NCT01731444|Protective Agents|protective agents|mesh-ancestor
14991332|NCT01731457|Etanercept|etanercept|mesh-list
14991333|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14991334|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14991335|NCT01731457|Analgesics|analgesics|mesh-ancestor
14991336|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
14991337|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991338|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991339|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991340|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991341|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14991342|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14801546|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14801547|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14801548|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801549|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
14801550|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14801551|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801552|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
14801553|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
14991343|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
14991344|NCT01731561|Rituximab|rituximab|mesh-list
14523498|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14523499|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523500|NCT03596723|Prednisolone|prednisolone|mesh-list
14523501|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14523502|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
14523503|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14523504|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
14523505|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14523506|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
14523507|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14523508|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
14523509|NCT03596723|Hormones|hormones|mesh-ancestor
14523510|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14523511|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523512|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14523513|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523514|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
14523515|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
14523516|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523517|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14523518|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14523519|NCT03596723|Protective Agents|protective agents|mesh-ancestor
14523520|NCT03597009|Nivolumab|nivolumab|mesh-list
14523521|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14523522|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14523523|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523524|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14523525|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523526|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
14523527|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
14523528|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
14523529|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
14523530|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523531|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
14523532|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14523533|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14523534|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031381|NCT01974258|Vemurafenib|vemurafenib|mesh-list
14991345|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14991346|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991347|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
14991348|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991349|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991350|NCT01731574|Dapivirine|dapivirine|mesh-list
14991351|NCT01731574|Miconazole|miconazole|mesh-list
14991352|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14991353|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14991354|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
14991355|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991356|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
14991357|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14991358|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14991359|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991360|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991361|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14991362|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
14991363|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14991364|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991365|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14991366|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14991367|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
14991368|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14991369|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
14991370|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991371|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991372|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14991373|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
14991374|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991375|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991376|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14991377|NCT01731652|Imiquimod|imiquimod|mesh-list
14991378|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14991379|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
14991380|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991381|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991382|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
14991383|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
14991384|NCT01731756|Salicylates|salicylates|mesh-list
14991385|NCT01731756|Petrolatum|petrolatum|mesh-list
14991386|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991387|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
14991388|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
14991389|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
14991390|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14991391|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14991392|NCT01731756|Analgesics|analgesics|mesh-ancestor
14991393|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
14991394|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991395|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991396|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991397|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991398|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14991399|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991400|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991401|NCT01731756|Emollients|emollients|mesh-ancestor
14991402|NCT01731782|Bupivacaine|bupivacaine|mesh-list
14991403|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
14991404|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
14991405|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991406|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991407|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
14991408|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991409|NCT01731795|Dexamethasone|dexamethasone|mesh-list
14991410|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
14991411|NCT01731795|BB 1101|bb 1101|mesh-list
14991412|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991413|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
14991414|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
14991415|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991416|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991417|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14991418|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
14991419|NCT01731795|Hormones|hormones|mesh-ancestor
14991420|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14991421|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14991422|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991423|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
14991424|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991425|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991426|NCT01731899|S 20098|s 20098|mesh-list
14991427|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14991428|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991429|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991430|NCT01731925|Sunitinib|sunitinib|mesh-list
14991431|NCT01731925|Lanreotide|lanreotide|mesh-list
14991432|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991433|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14991434|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14991435|NCT01731925|Growth Substances|growth substances|mesh-ancestor
14991436|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991437|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
14991438|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14991439|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991440|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991441|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
14991442|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14991443|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14991444|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
14991445|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14991446|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
14991447|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14991448|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991449|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14991450|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14991451|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991452|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14991453|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
14991454|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14991455|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
14991456|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14991457|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991458|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14991459|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14991460|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991461|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
14991462|NCT01732146|Hematinics|hematinics|mesh-ancestor
14991463|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14991464|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
14991465|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991466|NCT01732224|Tenofovir|tenofovir|mesh-list
14991467|NCT01732224|Telbivudine|telbivudine|mesh-list
14991468|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
14991469|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991470|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14991471|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14991472|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991473|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991474|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14991475|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14991476|NCT01732250|Meropenem|meropenem|mesh-list
14991477|NCT01732250|Colistin|colistin|mesh-list
14991478|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14991479|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991480|NCT01732276|Gefitinib|gefitinib|mesh-list
14991481|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991482|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14991483|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991484|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991485|NCT01732328|Vitamin D|vitamin d|mesh-list
14991486|NCT01732328|Calcium|calcium|mesh-list
14991487|NCT01732328|Vitamins|vitamins|mesh-ancestor
14991488|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
14991489|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991490|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14991491|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14991492|NCT01732367|Tenofovir|tenofovir|mesh-list
14991493|NCT01732367|Lamivudine|lamivudine|mesh-list
14991494|NCT01732367|Adefovir|adefovir|mesh-list
14991495|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
14991496|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991497|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14991498|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14991499|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991500|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991501|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14991502|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14991503|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
14991504|NCT01732380|Raltitrexed|raltitrexed|mesh-list
14991505|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991506|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14991507|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
14991508|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991509|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14991510|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991511|NCT01732393|Quercetin|quercetin|mesh-list
14991512|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
14991513|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991514|NCT01732393|Protective Agents|protective agents|mesh-ancestor
14991515|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991516|NCT01732666|Remifentanil|remifentanil|mesh-list
14991517|NCT01732666|Nefopam|nefopam|mesh-list
14991518|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14991519|NCT01732666|Narcotics|narcotics|mesh-ancestor
14991520|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991521|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991522|NCT01732666|Analgesics|analgesics|mesh-ancestor
14991523|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
14991524|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991525|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14991526|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
14991527|NCT01732744|Eusol|eusol|mesh-list
14991528|NCT01732744|Castor Oil|castor oil|mesh-list
14991529|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14991530|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
14991531|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991532|NCT01732744|Cathartics|cathartics|mesh-ancestor
14991533|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14991534|NCT01732861|Lenalidomide|lenalidomide|mesh-list
14991535|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
14991536|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991537|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14991538|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14991539|NCT01732861|Growth Substances|growth substances|mesh-ancestor
14991540|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
14991541|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031382|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031383|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15031384|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031385|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031386|NCT01974297|Atorvastatin|atorvastatin|mesh-list
15031387|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
15031388|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15031389|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15031390|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
15031391|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031392|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15031393|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15031394|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031395|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
15031396|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15031397|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15031398|NCT01974375|Fluconazole|fluconazole|mesh-list
15031399|NCT01974375|Micafungin|micafungin|mesh-list
15031400|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
15031401|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031402|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15031403|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15031404|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035378|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991542|NCT01733017|Lycopene|lycopene|mesh-list
14991543|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991544|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
14991545|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991546|NCT01733017|Protective Agents|protective agents|mesh-ancestor
14991547|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991548|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14991549|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14991550|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991551|NCT01733030|Cycloserine|cycloserine|mesh-list
14801554|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14801555|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14801556|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801557|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991552|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14801558|NCT00793338|Urological Agents|urological agents|mesh-ancestor
14801559|NCT00793377|Tamoxifen|tamoxifen|mesh-list
14801560|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
14801561|NCT00793377|Docetaxel|docetaxel|mesh-list
14801562|NCT00793377|Doxorubicin|doxorubicin|mesh-list
14801563|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14991553|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991554|NCT01733030|Renal Agents|renal agents|mesh-ancestor
14991555|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14991556|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
14991557|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14991558|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
14991559|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991560|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
14991561|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14991562|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991563|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991564|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14991565|NCT01733043|Analgesics|analgesics|mesh-ancestor
14991566|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
14991567|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991568|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14991569|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14991570|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14991571|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
14991572|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14991573|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991574|NCT01733095|Ambrisentan|ambrisentan|mesh-list
14991575|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14991576|NCT01733108|Canagliflozin|canagliflozin|mesh-list
14991577|NCT01733108|Glyburide|glyburide|mesh-list
14991578|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14991579|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991580|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14991581|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991582|NCT01733134|Tolvaptan|tolvaptan|mesh-list
14991583|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14991584|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991585|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
14991586|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991587|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
14991588|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14991589|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14991590|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14991591|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14991592|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991593|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
14991594|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14991595|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991596|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14991597|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991598|NCT01733342|Anesthetics|anesthetics|mesh-list
14991599|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991600|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991601|NCT01733394|Lamotrigine|lamotrigine|mesh-list
14991602|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
14991603|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14991604|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14991605|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991606|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14991607|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991608|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14991609|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14991610|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991611|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14991612|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14991613|NCT01733459|Metformin|metformin|mesh-list
14991614|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14991615|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991616|NCT01733485|Aspirin|aspirin|mesh-list
14991617|NCT01733485|Indomethacin|indomethacin|mesh-list
14991618|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14991619|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14991620|NCT01733485|Analgesics|analgesics|mesh-ancestor
14991621|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
14991622|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991623|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991624|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991625|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991626|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14991627|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14991628|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991629|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14991630|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14991631|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991632|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
14991633|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
14991634|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
14991635|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14801564|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14801565|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
14801566|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801567|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14801568|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14991636|NCT01733589|Etoposide|etoposide|mesh-list
14991637|NCT01733589|Cisplatin|cisplatin|mesh-list
14991638|NCT01733589|Endostatins|endostatins|mesh-list
14991639|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14991640|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991641|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14991642|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14991643|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991644|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991645|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14991646|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14991647|NCT01733589|Growth Substances|growth substances|mesh-ancestor
14991648|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991649|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
14991650|NCT01733706|Nicotine|nicotine|mesh-list
14991651|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14991652|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
14991653|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991654|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991655|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14991656|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14991657|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
14991658|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14991659|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991660|NCT01733823|Nimorazole|nimorazole|mesh-list
14991661|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14991662|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14991663|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14991664|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991665|NCT01733836|Metformin|metformin|mesh-list
14991666|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14991667|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991668|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14991669|NCT01733888|Immunoconjugates|immunoconjugates|mesh-list
14991670|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14991671|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991672|NCT01733888|Immunologic Factors|immunologic factors|mesh-ancestor
14991673|NCT01733888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991674|NCT01733966|Amoxicillin|amoxicillin|mesh-list
14991675|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
14991676|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
14991677|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14991678|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
14991679|NCT01733966|Secnidazole|secnidazole|mesh-list
14991680|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14991681|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991682|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991683|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991684|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14991685|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14991686|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14801569|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
14801570|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801571|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801572|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14801573|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
14801574|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
14801575|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
14801576|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14991687|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14991688|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14991689|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991690|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14991691|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14991692|NCT01733979|Iron|iron|mesh-list
14991693|NCT01733979|Trace Elements|trace elements|mesh-ancestor
14991694|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
14991695|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991696|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14991697|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14991698|NCT01734044|Dexamethasone|dexamethasone|mesh-list
14991699|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
14991700|NCT01734044|BB 1101|bb 1101|mesh-list
14991701|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991702|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
14991703|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
14991704|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991705|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991706|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14991707|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
14991708|NCT01734044|Hormones|hormones|mesh-ancestor
14991709|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14991710|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14991711|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991712|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
14991713|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991714|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991715|NCT01734057|Dexamethasone|dexamethasone|mesh-list
14991716|NCT01734057|Rituximab|rituximab|mesh-list
14991717|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991718|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
14991719|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
14991720|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991721|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991722|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14991723|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
14991724|NCT01734057|Hormones|hormones|mesh-ancestor
14991725|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14991726|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14991727|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991728|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14991729|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
14991730|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991731|NCT01734096|Candesartan|candesartan|mesh-list
14991732|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
14991733|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14991734|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14991735|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14991736|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991737|NCT01734252|Argatroban|argatroban|mesh-list
14991738|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
14991739|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14991740|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
14991741|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991742|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991743|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
14991744|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14991745|NCT01734304|Vaccines|vaccines|mesh-list
14991746|NCT01734304|Immunologic Factors|immunologic factors|mesh-ancestor
14523535|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14523536|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
14523537|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523538|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14523539|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
14523540|NCT03597139|Cyclosporine|cyclosporine|mesh-list
14523541|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14523542|NCT03597139|Cyclosporins|cyclosporins|mesh-list
14523543|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523544|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523545|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14523546|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
14523547|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523548|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
14523549|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991747|NCT01734304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991748|NCT01734330|Nicotine|nicotine|mesh-list
14991749|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14991750|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
14991751|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991752|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991753|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14991754|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14991755|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
14991756|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14991757|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991758|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14991759|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
14991760|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14991761|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
14991762|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991763|NCT01734408|Antacids|antacids|mesh-ancestor
14991764|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991765|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14991766|NCT01734473|Caseins|caseins|mesh-list
14991767|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
14991768|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
14991769|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991770|NCT01734564|Poly I-C|poly i-c|mesh-list
14991771|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14991772|NCT01734564|Poly ICLC|poly iclc|mesh-list
14991773|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
14991774|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
14991775|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991776|NCT01734564|Laxatives|laxatives|mesh-ancestor
14991777|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14991778|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
14991779|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991780|NCT01734694|Vancomycin|vancomycin|mesh-list
14991781|NCT01734694|Linezolid|linezolid|mesh-list
14991782|NCT01734694|Daptomycin|daptomycin|mesh-list
14991783|NCT01734694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
14991784|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14991785|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991786|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14991787|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991788|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031405|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031406|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15031407|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
15031408|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031409|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031410|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15031411|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15031412|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
15031413|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15031414|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031415|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
15031416|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
15031417|NCT01974518|Rituximab|rituximab|mesh-list
15031418|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15031419|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
15031420|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031421|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15031422|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15031423|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
15031424|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031425|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031426|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15031427|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15031428|NCT01974622|Verteporfin|verteporfin|mesh-list
15031429|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15031430|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
15031431|NCT01974648|Remifentanil|remifentanil|mesh-list
15031432|NCT01974648|Propofol|propofol|mesh-list
15031433|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15031434|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031435|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031436|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15031437|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
14991789|NCT01734798|Gemcitabine|gemcitabine|mesh-list
14801577|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14801578|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14801579|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801580|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14801581|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
14801582|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14801583|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14801584|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14801585|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14801586|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14801587|NCT00793429|Prucalopride|prucalopride|mesh-list
14801588|NCT00793429|Laxatives|laxatives|mesh-ancestor
14801589|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14801590|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
14801591|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14991790|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991791|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14991792|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
14991793|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991794|NCT01734798|Antiviral Agents|antiviral agents|mesh-ancestor
14991795|NCT01734798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991796|NCT01734798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991797|NCT01734798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14991798|NCT01734798|Immunologic Factors|immunologic factors|mesh-ancestor
14991799|NCT01734798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991800|NCT01734824|Denosumab|denosumab|mesh-list
14991801|NCT01734824|Teriparatide|teriparatide|mesh-list
14991802|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
14991803|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14991804|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991805|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14991806|NCT01734915|Iproplatin|iproplatin|mesh-list
14991807|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991808|NCT01734954|Midazolam|midazolam|mesh-list
14991809|NCT01734954|Analgesics|analgesics|mesh-list
14991810|NCT01734954|Anesthetics|anesthetics|mesh-list
14991811|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
14991812|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
14991813|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991814|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991815|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14991816|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14991817|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14991818|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14991819|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14991820|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14991821|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
14991822|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
14991823|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
14991824|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14991825|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991826|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
14991827|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991828|NCT01735006|Vaccines|vaccines|mesh-list
14991829|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
14991830|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991831|NCT01735019|Remifentanil|remifentanil|mesh-list
14991832|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14991833|NCT01735019|Narcotics|narcotics|mesh-ancestor
14991834|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991835|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991836|NCT01735019|Analgesics|analgesics|mesh-ancestor
14991837|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
14991838|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991839|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
14991840|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14991841|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
14991842|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991843|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
14991844|NCT01735058|Protective Agents|protective agents|mesh-ancestor
14991845|NCT01735071|Bevacizumab|bevacizumab|mesh-list
14991846|NCT01735071|Carboplatin|carboplatin|mesh-list
14991847|NCT01735071|Trabectedin|trabectedin|mesh-list
14991848|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14991849|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991850|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14991851|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14991852|NCT01735071|Growth Substances|growth substances|mesh-ancestor
14991853|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991854|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
14991855|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14991856|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
14991857|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991858|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14991859|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
14991860|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991861|NCT01735097|Vitamin E|vitamin e|mesh-list
14991862|NCT01735097|Vitamins|vitamins|mesh-ancestor
14991863|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
14991864|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991865|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
14991866|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991867|NCT01735097|Protective Agents|protective agents|mesh-ancestor
14991868|NCT01735123|Caseins|caseins|mesh-list
14991869|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
14991870|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
14991871|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991872|NCT01735227|Omeprazole|omeprazole|mesh-list
14991873|NCT01735227|Pantoprazole|pantoprazole|mesh-list
14991874|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14991875|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14991876|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14991877|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991878|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991879|NCT01735240|Ketoconazole|ketoconazole|mesh-list
14523550|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
14523551|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14523552|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14523553|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14523554|NCT03597347|Molgramostim|molgramostim|mesh-list
14523555|NCT03597347|Sargramostim|sargramostim|mesh-list
14523556|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523557|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
14991880|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
14523558|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523559|NCT03597529|Melatonin|melatonin|mesh-list
14523560|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
14991881|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14991882|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14991883|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14991884|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991885|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991886|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14991887|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
14991888|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14991889|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991890|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14991891|NCT01735318|Lisinopril|lisinopril|mesh-list
14991892|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14991893|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
14991894|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991895|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991896|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14991897|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14991898|NCT01735318|Protective Agents|protective agents|mesh-ancestor
14991899|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991900|NCT01735344|Lisinopril|lisinopril|mesh-list
14991901|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14991902|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
14991903|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991904|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991905|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14991906|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14991907|NCT01735344|Protective Agents|protective agents|mesh-ancestor
14991908|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991909|NCT01735370|Etodolac|etodolac|mesh-list
14991910|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14991911|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14991912|NCT01735370|Analgesics|analgesics|mesh-ancestor
14801592|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
14801593|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801594|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801595|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801596|NCT00793468|Nicotine|nicotine|mesh-list
14801597|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14801598|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
14801599|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801600|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801601|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14801602|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14801603|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
14801604|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801605|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801606|NCT00793559|Terlipressin|terlipressin|mesh-list
14801607|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14801608|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14801609|NCT00793663|Dexamethasone|dexamethasone|mesh-list
14801610|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
14991913|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
14991914|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991915|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991916|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991917|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991918|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14801611|NCT00793663|Ondansetron|ondansetron|mesh-list
14801612|NCT00793663|Sevoflurane|sevoflurane|mesh-list
14801613|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14801614|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
14801615|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
14801616|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801617|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801618|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14801619|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
14801620|NCT00793663|Hormones|hormones|mesh-ancestor
14801621|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14801622|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14801623|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801624|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14801625|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14801626|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
14801627|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
14801628|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801629|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
14801630|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
14801631|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14801632|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
14801633|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801634|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801635|NCT00793663|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14801636|NCT00793663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14801637|NCT00793663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14991919|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14991920|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991921|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991922|NCT01735383|Etodolac|etodolac|mesh-list
14991923|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14991924|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14991925|NCT01735383|Analgesics|analgesics|mesh-ancestor
14991926|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
14801638|NCT00793663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14801639|NCT00793741|Somatostatin|somatostatin|mesh-list
14991927|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991928|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991929|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14991930|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14991931|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14991932|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14991933|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14991934|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991935|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
14991936|NCT01735461|Calcium|calcium|mesh-list
14991937|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14991938|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991939|NCT01735461|Antacids|antacids|mesh-ancestor
14991940|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991941|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14991942|NCT01735487|Nicotine|nicotine|mesh-list
14991943|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14991944|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
14991945|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991946|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991947|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14991948|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14991949|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
14991950|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14991951|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991952|NCT01735669|Remifentanil|remifentanil|mesh-list
14991953|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
14991954|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14991955|NCT01735669|Narcotics|narcotics|mesh-ancestor
14991956|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14991957|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991958|NCT01735669|Analgesics|analgesics|mesh-ancestor
14991959|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
14991960|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14991961|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14991962|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
14991963|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
14991964|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14991965|NCT01735747|Vincristine|vincristine|mesh-list
14991966|NCT01735747|Temozolomide|temozolomide|mesh-list
14991967|NCT01735747|Nedaplatin|nedaplatin|mesh-list
14991968|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14991969|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801640|NCT00793741|Hormones|hormones|mesh-ancestor
14991970|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
14991971|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
14991972|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
14991973|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991974|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14991975|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
14991976|NCT01735825|Paclitaxel|paclitaxel|mesh-list
14991977|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14991978|NCT01735825|Everolimus|everolimus|mesh-list
14991979|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14991980|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991981|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
14991982|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
14991983|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
14991984|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991985|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14991986|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
14991987|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14991988|NCT01735864|Indirubin|indirubin|mesh-list
14991989|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14991990|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14991991|NCT01735890|Amlodipine|amlodipine|mesh-list
14991992|NCT01735890|Valsartan|valsartan|mesh-list
14991993|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
14991994|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14991995|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14991996|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14991997|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14991998|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14991999|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992000|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
14801641|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14801642|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992001|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14992002|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14992003|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
14992004|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
14992005|NCT01736020|Ketamine|ketamine|mesh-list
14992006|NCT01736020|Propofol|propofol|mesh-list
14992007|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14992008|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992009|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992010|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14992011|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
14992012|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
14992013|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14992014|NCT01736020|Analgesics|analgesics|mesh-ancestor
14992015|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
14992016|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992017|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14992018|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14992019|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14992020|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
14992021|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992022|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992023|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14801643|NCT00793754|Aspirin|aspirin|mesh-list
14801644|NCT00793754|Atorvastatin|atorvastatin|mesh-list
14801645|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14801646|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14801647|NCT00793754|Analgesics|analgesics|mesh-ancestor
14801648|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
14801649|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992024|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15031438|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
14992025|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14992026|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14992027|NCT01736033|Tamsulosin|tamsulosin|mesh-list
14992028|NCT01736033|Finasteride|finasteride|mesh-list
14992029|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14992030|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14992031|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14992032|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
14992033|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992034|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992035|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992036|NCT01736033|Urological Agents|urological agents|mesh-ancestor
14992037|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14992038|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14992039|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992040|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
14992041|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992042|NCT01736150|Sevelamer|sevelamer|mesh-list
14992043|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
14992044|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
14992045|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992046|NCT01736163|Hormones|hormones|mesh-list
14992047|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992048|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992049|NCT01736371|Propofol|propofol|mesh-list
14992050|NCT01736371|Sevoflurane|sevoflurane|mesh-list
14992051|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
14992052|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992053|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992054|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14992055|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14992056|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
14992057|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14992058|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14992059|NCT01736410|Trastuzumab|trastuzumab|mesh-list
14992060|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992061|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14992062|NCT01736423|Ramosetron|ramosetron|mesh-list
14992063|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
14992064|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
14992065|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992066|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992067|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14992068|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14992069|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
14992070|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992071|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992072|NCT01736449|Bevacizumab|bevacizumab|mesh-list
14992073|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14992074|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992075|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14992076|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14992077|NCT01736449|Growth Substances|growth substances|mesh-ancestor
14992078|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992079|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
14992080|NCT01736488|Atenolol|atenolol|mesh-list
14992081|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14992082|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14992083|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
14992084|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
14992085|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992086|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992087|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14992088|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14992089|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14992090|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
14992091|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992092|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031439|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15031440|NCT01974648|Narcotics|narcotics|mesh-ancestor
15031441|NCT01974648|Analgesics|analgesics|mesh-ancestor
15031442|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
15031443|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031444|NCT01974843|Bupivacaine|bupivacaine|mesh-list
15031445|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
15031446|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
15031447|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
15031448|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031449|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031450|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
15031451|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031452|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15031453|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15031454|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15031455|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15031456|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031457|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15031458|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031459|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
15031460|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15031461|NCT01975012|Rilpivirine|rilpivirine|mesh-list
15031462|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15031463|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15031464|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031465|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031466|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
14992093|NCT01736514|Allopurinol|allopurinol|mesh-list
14523561|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523562|NCT03597529|Protective Agents|protective agents|mesh-ancestor
14523563|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523564|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14523565|NCT03599089|Acetaminophen|acetaminophen|mesh-list
14523566|NCT03599089|Ketorolac|ketorolac|mesh-list
14523567|NCT03599089|Oxycodone|oxycodone|mesh-list
14523568|NCT03599089|Bupivacaine|bupivacaine|mesh-list
14992094|NCT01736514|Febuxostat|febuxostat|mesh-list
14992095|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
14992096|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992097|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992098|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
14992099|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14992100|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14992101|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
14992102|NCT01736514|Protective Agents|protective agents|mesh-ancestor
14992103|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992104|NCT01736670|Triamcinolone|triamcinolone|mesh-list
14992105|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14992106|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14992107|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14992108|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14992109|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
14992110|NCT01736670|Hormones|hormones|mesh-ancestor
14992111|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992112|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992113|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14992114|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
14992115|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992116|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992117|NCT01736761|Ritonavir|ritonavir|mesh-list
14992118|NCT01736761|Darunavir|darunavir|mesh-list
14992119|NCT01736761|Rilpivirine|rilpivirine|mesh-list
14992120|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14992121|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14992122|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
14992123|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992124|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992125|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14992126|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14992127|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
14992128|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14992129|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14992130|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14992131|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14992132|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14992133|NCT01736800|Temozolomide|temozolomide|mesh-list
14992134|NCT01736800|Topotecan|topotecan|mesh-list
14992135|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14992136|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
14992137|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992138|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992139|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14992140|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14992141|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992142|NCT01736813|Maraviroc|maraviroc|mesh-list
14992143|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14992144|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14992145|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992146|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14992147|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14992148|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
14992149|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14992150|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14992151|NCT01736878|Sorafenib|sorafenib|mesh-list
14992152|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992153|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14992154|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992155|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992156|NCT01736891|Rasagiline|rasagiline|mesh-list
14992157|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14992158|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992159|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992160|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14992161|NCT01736891|Protective Agents|protective agents|mesh-ancestor
14992162|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992163|NCT01737008|Cisplatin|cisplatin|mesh-list
14992164|NCT01737008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992165|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
14992166|NCT01737073|Narcotics|narcotics|mesh-ancestor
14992167|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992168|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992169|NCT01737073|Analgesics|analgesics|mesh-ancestor
14992170|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
14992171|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992172|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
14992173|NCT01737086|Astringents|astringents|mesh-ancestor
14992174|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992175|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
14992176|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
14992177|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14992178|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992179|NCT01737177|Rituximab|rituximab|mesh-list
14992180|NCT01737177|Lenalidomide|lenalidomide|mesh-list
14992181|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14992182|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14992183|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992184|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
14992185|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992186|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14992187|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14992188|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14992189|NCT01737177|Growth Substances|growth substances|mesh-ancestor
14992190|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
14992191|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14992192|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
14992193|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992194|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
14992195|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992196|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
14992197|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14992198|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14992199|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992200|NCT01737203|Urological Agents|urological agents|mesh-ancestor
14992201|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
14992202|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14992203|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992204|NCT01737294|Capsaicin|capsaicin|mesh-list
14992205|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
14992206|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
14992207|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
14992208|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992209|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992210|NCT01737307|Fluorides|fluorides|mesh-list
14992211|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
14992212|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
14992213|NCT01737307|Protective Agents|protective agents|mesh-ancestor
14992214|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992215|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14992216|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14992217|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14992218|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
14992219|NCT01737346|Lomustine|lomustine|mesh-list
14992220|NCT01737346|Procarbazine|procarbazine|mesh-list
14992221|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14992222|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
14992223|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992224|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992225|NCT01737359|Tenofovir|tenofovir|mesh-list
14992226|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
14992227|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14992228|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14992229|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14992230|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992231|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992232|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14992233|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14992234|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
14992235|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14992236|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14992237|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
14992238|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992239|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992240|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992241|NCT01737411|Urological Agents|urological agents|mesh-ancestor
14992242|NCT01737541|Fluoxetine|fluoxetine|mesh-list
14992243|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14992244|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14992245|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14992246|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523569|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
14523570|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
14523571|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14523572|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523573|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
14523574|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523575|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14523576|NCT03599089|Analgesics|analgesics|mesh-ancestor
14523577|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
14523578|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14523579|NCT03599089|Narcotics|narcotics|mesh-ancestor
14523580|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14992247|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992248|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
14992249|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992250|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14992251|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
14992252|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14992253|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14992254|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14992255|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992256|NCT01737671|Leucovorin|leucovorin|mesh-list
14992257|NCT01737671|Methotrexate|methotrexate|mesh-list
14992258|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14992259|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
14992260|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14992261|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992262|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14992263|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
14992264|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523581|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14523582|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14523583|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14523584|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523585|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992265|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992266|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
14992267|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992268|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14992269|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14992270|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
14992271|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14992272|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14992273|NCT01737671|Antidotes|antidotes|mesh-ancestor
14992274|NCT01737671|Protective Agents|protective agents|mesh-ancestor
14992275|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
14992276|NCT01737671|Vitamins|vitamins|mesh-ancestor
14992277|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
14992278|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
14992279|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14992280|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14992281|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
14992282|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992283|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992284|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992285|NCT01737918|Urological Agents|urological agents|mesh-ancestor
14523586|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
14523587|NCT03599193|Tazarotene|tazarotene|mesh-list
14992286|NCT01738035|Budesonide|budesonide|mesh-list
14992287|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14992288|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14992289|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
14992290|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992291|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992292|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14992293|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
14992294|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
14992295|NCT01738035|Hormones|hormones|mesh-ancestor
14992296|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992297|NCT01738087|Fluticasone|fluticasone|mesh-list
14992298|NCT01738087|Xhance|xhance|mesh-list
14992299|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
14992300|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14992301|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14992302|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
14992303|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992304|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992305|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14992306|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
14992307|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
14992308|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14992309|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14992310|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14992311|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14992312|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
14992313|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992314|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992315|NCT01738100|Morphine|morphine|mesh-list
14992316|NCT01738100|Clopidogrel|clopidogrel|mesh-list
14992317|NCT01738100|Ticagrelor|ticagrelor|mesh-list
14992318|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14992319|NCT01738100|Narcotics|narcotics|mesh-ancestor
14992320|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992321|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992322|NCT01738100|Analgesics|analgesics|mesh-ancestor
14992323|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
14992324|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992325|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14992326|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14992327|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14992328|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14992329|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
14992330|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992331|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992332|NCT01738139|Ipilimumab|ipilimumab|mesh-list
14992333|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
14992334|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14992335|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992336|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14992337|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992338|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14992339|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992340|NCT01738178|Caffeine|caffeine|mesh-list
14992341|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14992342|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992343|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14992344|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992345|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992346|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14992347|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14992348|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
14801650|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801651|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14801652|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14801653|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14992349|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992350|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
14992351|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14992352|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
14992353|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992354|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
14992355|NCT01738243|Protective Agents|protective agents|mesh-ancestor
14992356|NCT01738282|Baclofen|baclofen|mesh-list
14992357|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14992358|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992359|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14992360|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992361|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14992362|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
14992363|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
14992364|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992365|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801654|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14801655|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801656|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14801657|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14801658|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801659|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
14801660|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14801661|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14801662|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
14801663|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14801664|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14801665|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
14992366|NCT01738295|Donepezil|donepezil|mesh-list
14992367|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14992368|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992369|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992370|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
14992371|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992372|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992373|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
15031467|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031468|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15031469|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15031470|NCT01975051|Miltefosine|miltefosine|mesh-list
15031471|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
15031472|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031473|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031474|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15031475|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15031476|NCT01975064|Propofol|propofol|mesh-list
15031477|NCT01975064|Sevoflurane|sevoflurane|mesh-list
15031478|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15031479|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031480|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031481|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15031482|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
15031483|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
15031484|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15031485|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15031486|NCT01975129|Oxytocin|oxytocin|mesh-list
15031487|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
15031488|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15031489|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031490|NCT01975142|Trastuzumab|trastuzumab|mesh-list
15031491|NCT01975142|Maytansine|maytansine|mesh-list
15031492|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15031493|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031494|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15031495|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
15031496|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
15031497|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
15031498|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031499|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15031500|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15031501|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15031502|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
15031503|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031504|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15031505|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14523588|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
15031506|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031507|NCT01975259|Glucagon|glucagon|mesh-list
15031508|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
15031509|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15031510|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15031511|NCT01975259|Hormones|hormones|mesh-ancestor
15031512|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031513|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031514|NCT01975259|Incretins|incretins|mesh-ancestor
14801666|NCT00793767|Hematinics|hematinics|mesh-ancestor
14992374|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
14992375|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992376|NCT01738373|Plerixafor|plerixafor|mesh-list
14992377|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14992378|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14992379|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
14992380|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14992381|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
14992382|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
14992383|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992384|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992385|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992386|NCT01738451|Dabrafenib|dabrafenib|mesh-list
14992387|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992388|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14992389|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992390|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992391|NCT01738542|Bosentan|bosentan|mesh-list
14992392|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
14992393|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14992394|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992395|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14992396|NCT01738607|Psyllium|psyllium|mesh-list
14992397|NCT01738607|Laxatives|laxatives|mesh-ancestor
14992398|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14992399|NCT01738607|Cathartics|cathartics|mesh-ancestor
14992400|NCT01738724|Goserelin|goserelin|mesh-list
14992401|NCT01738724|Dienogest|dienogest|mesh-list
14992402|NCT01738724|Desogestrel|desogestrel|mesh-list
14992403|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14992404|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992405|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14992406|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
14992407|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14992408|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992409|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14992410|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14992411|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14992412|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14992413|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
14992414|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992415|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14992416|NCT01738724|Progestins|progestins|mesh-ancestor
14992417|NCT01738724|Hormones|hormones|mesh-ancestor
14992418|NCT01738763|Inositol|inositol|mesh-list
14992419|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
14992420|NCT01738763|Vitamins|vitamins|mesh-ancestor
14992421|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
14992422|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992423|NCT01738802|Micronutrients|micronutrients|mesh-list
14992424|NCT01738802|Trace Elements|trace elements|mesh-list
14992425|NCT01738802|Antioxidants|antioxidants|mesh-list
14992426|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992427|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992428|NCT01738802|Protective Agents|protective agents|mesh-ancestor
14992429|NCT01738815|Valproic Acid|valproic acid|mesh-list
14992430|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
15031515|NCT01975272|Iron|iron|mesh-list
14992431|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992432|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992433|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
14992434|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992435|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992436|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
14992437|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14992438|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992439|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14992440|NCT01738867|Naltrexone|naltrexone|mesh-list
14992441|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14992442|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14992443|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992444|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
14992445|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992446|NCT01738893|Gabapentin|gabapentin|mesh-list
14992447|NCT01738893|Analgesics|analgesics|mesh-ancestor
14992448|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
14992449|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992450|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992451|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
14992452|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14992453|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14992454|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992455|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14992456|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14992457|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14992458|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992459|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992460|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
14992461|NCT01738945|Amlodipine|amlodipine|mesh-list
14992462|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14992463|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14992464|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14992465|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992466|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14992467|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992468|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
14992469|NCT01739049|Liraglutide|liraglutide|mesh-list
14992470|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14992471|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992472|NCT01739049|Incretins|incretins|mesh-ancestor
14992473|NCT01739049|Hormones|hormones|mesh-ancestor
14992474|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992475|NCT01739127|Risperidone|risperidone|mesh-list
14992476|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14992477|NCT01739127|Aripiprazole|aripiprazole|mesh-list
14992478|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14992479|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
14992480|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992481|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992482|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992483|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14992484|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14992485|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992486|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14992487|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14992488|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
14992489|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
14992490|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
14992491|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14992492|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14992493|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14992494|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14801667|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
14801668|NCT00793845|Melphalan|melphalan|mesh-list
14801669|NCT00793845|Thiotepa|thiotepa|mesh-list
14801670|NCT00793845|Carboplatin|carboplatin|mesh-list
14801671|NCT00793845|Etoposide|etoposide|mesh-list
14801672|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14992495|NCT01739192|Bupropion|bupropion|mesh-list
14801673|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
14801674|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801675|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14801676|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14801677|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
14801678|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801679|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801680|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14801681|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14801682|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14992496|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14992497|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
14992498|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14992499|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14992500|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14992501|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14992502|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992503|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
14992504|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992505|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992506|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14992507|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14992508|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992509|NCT01739218|Paclitaxel|paclitaxel|mesh-list
14992510|NCT01739218|Bevacizumab|bevacizumab|mesh-list
14992511|NCT01739218|Carboplatin|carboplatin|mesh-list
14992512|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14992513|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992514|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
14992515|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
14992516|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
14992517|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992518|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14992519|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14992520|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14992521|NCT01739218|Growth Substances|growth substances|mesh-ancestor
14992522|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992523|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
14992524|NCT01739413|Anesthetics|anesthetics|mesh-list
14992525|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992526|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992527|NCT01739439|Gemcitabine|gemcitabine|mesh-list
14992528|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14992529|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
14992530|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992531|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992532|NCT01739439|Antiviral Agents|antiviral agents|mesh-ancestor
14992533|NCT01739439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14992534|NCT01739439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992535|NCT01739439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14992536|NCT01739439|Immunologic Factors|immunologic factors|mesh-ancestor
14992537|NCT01739439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992538|NCT01739504|Anesthetics|anesthetics|mesh-list
14992539|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992540|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992541|NCT01739556|Aspirin|aspirin|mesh-list
14992542|NCT01739556|Ticagrelor|ticagrelor|mesh-list
14992543|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14992544|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14992545|NCT01739556|Analgesics|analgesics|mesh-ancestor
14992546|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
14992547|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992548|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992549|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14992550|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14992551|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14992552|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14801683|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14801684|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801685|NCT00793858|Ciclesonide|ciclesonide|mesh-list
14801686|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
14801687|NCT00793858|Hormones|hormones|mesh-ancestor
14801688|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14801689|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801690|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14801691|NCT00793897|Paclitaxel|paclitaxel|mesh-list
14801692|NCT00793897|Carboplatin|carboplatin|mesh-list
14801693|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14801694|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801695|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
14801696|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
14801697|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
14801698|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992553|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992554|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14992555|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14992556|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992557|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
14992558|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14992559|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14992560|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14992561|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
14992562|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992563|NCT01739582|Enclomiphene|enclomiphene|mesh-list
14992564|NCT01739582|Clomiphene|clomiphene|mesh-list
14992565|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
14992566|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14992567|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
14992568|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14523589|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
14523590|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
14523591|NCT03599193|Vitamins|vitamins|mesh-ancestor
14523592|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
14523593|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523594|NCT03599362|Nivolumab|nivolumab|mesh-list
14523595|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14523596|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523597|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14523598|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523599|NCT03600376|Dantrolene|dantrolene|mesh-list
14801699|NCT00793923|Dexamethasone|dexamethasone|mesh-list
14801700|NCT00793923|Ranibizumab|ranibizumab|mesh-list
14801701|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14801702|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
14801703|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
14801704|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801705|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801706|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14801707|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
14801708|NCT00793923|Hormones|hormones|mesh-ancestor
14992569|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992570|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14992571|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
14992572|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14992573|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14801709|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14801710|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14801711|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992574|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14992575|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
14801712|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14801713|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14801714|NCT00793923|Growth Substances|growth substances|mesh-ancestor
14801715|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
14801716|NCT00793975|Ramucirumab|ramucirumab|mesh-list
14801717|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801718|NCT00793988|Anesthetics|anesthetics|mesh-list
14801719|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992576|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
14992577|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14992578|NCT01739673|Riboflavin|riboflavin|mesh-list
14992579|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
14992580|NCT01739673|Vitamins|vitamins|mesh-ancestor
14992581|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
14992582|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992583|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14992584|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
14992585|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
14992586|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
14992587|NCT01739855|Calcium|calcium|mesh-list
14992588|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14992589|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992590|NCT01739855|Antacids|antacids|mesh-ancestor
14992591|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992592|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14992593|NCT01739855|Vitamins|vitamins|mesh-ancestor
14992594|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
14992595|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14992596|NCT01739894|Paclitaxel|paclitaxel|mesh-list
14992597|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14992598|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992599|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
14992600|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
14992601|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
14992602|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992603|NCT01739907|Vitamin D|vitamin d|mesh-list
14992604|NCT01739907|Vitamins|vitamins|mesh-ancestor
14992605|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
14992606|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992607|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14992608|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
14992609|NCT01739920|Povidone|povidone|mesh-list
14992610|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
14992611|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
14992612|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14992613|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031516|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
15031517|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
15031518|NCT01975272|Trace Elements|trace elements|mesh-ancestor
15031519|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
15031520|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031521|NCT01975272|Hematinics|hematinics|mesh-ancestor
15031522|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
15031523|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15031524|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15031525|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031526|NCT01975363|Curcumin|curcumin|mesh-list
15031527|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15031528|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15031529|NCT01975363|Analgesics|analgesics|mesh-ancestor
15031530|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
15031531|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031532|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031533|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15031534|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15031535|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031536|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523600|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15031537|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031538|NCT01975441|Ivermectin|ivermectin|mesh-list
15031539|NCT01975441|Albendazole|albendazole|mesh-list
15031540|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
15031541|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15031542|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031543|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
15031544|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
15031545|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15031546|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15031547|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
15031548|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
15031549|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
15031550|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031551|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031552|NCT01975441|Filaricides|filaricides|mesh-ancestor
15031553|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
15031554|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14992614|NCT01739985|Dexamethasone|dexamethasone|mesh-list
14992615|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
14992616|NCT01739985|Droperidol|droperidol|mesh-list
14992617|NCT01739985|Ondansetron|ondansetron|mesh-list
14992618|NCT01739985|BB 1101|bb 1101|mesh-list
14992619|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14992620|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
14992621|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
14992622|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992623|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992624|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14992625|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
14992626|NCT01739985|Hormones|hormones|mesh-ancestor
14992627|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992628|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14992629|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992630|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
14992631|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992632|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992633|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
14992634|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
14992635|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14992636|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
14992637|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992638|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14992639|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14992640|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992641|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14992642|NCT01739985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14992643|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14992644|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14992645|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14992646|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
14992647|NCT01740245|Biguanides|biguanides|mesh-list
14992648|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
14992649|NCT01740245|Polihexanide|polihexanide|mesh-list
14992650|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14992651|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14992652|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
14992653|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14992654|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992655|NCT01740271|Epirubicin|epirubicin|mesh-list
14992656|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14992657|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992658|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14992659|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14992660|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992661|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992662|NCT01740336|Paclitaxel|paclitaxel|mesh-list
14992663|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14992664|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992665|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
14992666|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
14992667|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
14992668|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992669|NCT01740453|Ropivacaine|ropivacaine|mesh-list
14992670|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
14992671|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
14523601|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523602|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14523603|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523604|NCT03600428|Vaccines|vaccines|mesh-list
14523605|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
14523606|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523607|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
14523608|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
14523609|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
14523610|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523611|NCT03604341|Dronabinol|dronabinol|mesh-list
14523612|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
14523613|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523614|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14523615|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14523616|NCT03604341|Analgesics|analgesics|mesh-ancestor
14523617|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
14523618|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523619|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14523620|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14992672|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992673|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992674|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
14992675|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992676|NCT01740492|Ketamine|ketamine|mesh-list
14992677|NCT01740492|Analgesics|analgesics|mesh-ancestor
14992678|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
14992679|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992680|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992681|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14992682|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14992683|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
14992684|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
14992685|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992686|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14992687|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14992688|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992689|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992690|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
14992691|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
14992692|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992693|NCT01740518|Protective Agents|protective agents|mesh-ancestor
14992694|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992695|NCT01740518|Vitamins|vitamins|mesh-ancestor
14992696|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
14992697|NCT01740921|Aspirin|aspirin|mesh-list
14992698|NCT01740921|Liraglutide|liraglutide|mesh-list
14992699|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14992700|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14992701|NCT01740921|Analgesics|analgesics|mesh-ancestor
14992702|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
14992703|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992704|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992705|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14992706|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14992707|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14992708|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14992709|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992710|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14992711|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14992712|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992713|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
14992714|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14992715|NCT01740921|Incretins|incretins|mesh-ancestor
14992716|NCT01740921|Hormones|hormones|mesh-ancestor
14992717|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992718|NCT01740947|Amphotericin B|amphotericin b|mesh-list
14992719|NCT01740947|Tobramycin|tobramycin|mesh-list
14992720|NCT01740947|Colistin|colistin|mesh-list
14992721|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14992722|NCT01740947|Amebicides|amebicides|mesh-ancestor
14992723|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14992724|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14992725|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14992726|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14992727|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
14992728|NCT01740960|Dronabinol|dronabinol|mesh-list
14992729|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
14992730|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992731|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14992732|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14992733|NCT01740960|Analgesics|analgesics|mesh-ancestor
14992734|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
14992735|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992736|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14992737|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14992738|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992739|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992740|NCT01740960|Hormones|hormones|mesh-ancestor
14992741|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992742|NCT01741038|Cetuximab|cetuximab|mesh-list
14992743|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14992744|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992745|NCT01741077|Folic Acid|folic acid|mesh-list
14992746|NCT01741077|Hematinics|hematinics|mesh-ancestor
14992747|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
14992748|NCT01741077|Vitamins|vitamins|mesh-ancestor
14992749|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
14992750|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992751|NCT01741142|Citalopram|citalopram|mesh-list
14992752|NCT01741142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14992753|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14992754|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14992755|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992756|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992757|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
14992758|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031555|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992759|NCT01741142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14992760|NCT01741142|Antidepressive Agents|antidepressive agents|mesh-ancestor
14992761|NCT01741142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14992762|NCT01741181|Vitamin D|vitamin d|mesh-list
14992763|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
14992764|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
14992765|NCT01741181|Vitamins|vitamins|mesh-list
14992766|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
14992767|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992768|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14992769|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14992770|NCT01741285|Fluticasone|fluticasone|mesh-list
14992771|NCT01741285|Beclomethasone|beclomethasone|mesh-list
14992772|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14992773|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14992774|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
14992775|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992776|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992777|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14992778|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
14992779|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
14992780|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14992781|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
14992782|NCT01741285|Hormones|hormones|mesh-ancestor
14992783|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992784|NCT01741324|Vitamin D|vitamin d|mesh-list
14992785|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
14992786|NCT01741324|Vitamins|vitamins|mesh-list
14992787|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
14992788|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992789|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14992790|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14992791|NCT01741376|Progesterone|progesterone|mesh-list
14992792|NCT01741376|Progestins|progestins|mesh-ancestor
14992793|NCT01741376|Hormones|hormones|mesh-ancestor
14992794|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992795|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992796|NCT01741389|Melatonin|melatonin|mesh-list
14992797|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
14992798|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992799|NCT01741389|Protective Agents|protective agents|mesh-ancestor
14992800|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992801|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992802|NCT01741493|Upadacitinib|upadacitinib|mesh-list
14992803|NCT01741493|Tofacitinib|tofacitinib|mesh-list
14992804|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14992805|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992806|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992807|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14992808|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14992809|NCT01741506|Dalteparin|dalteparin|mesh-list
14992810|NCT01741506|Tinzaparin|tinzaparin|mesh-list
14992811|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14992812|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
14992813|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14992814|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14992815|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992816|NCT01741519|Landiolol|landiolol|mesh-list
14992817|NCT01741519|Esmolol|esmolol|mesh-list
14992818|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14992819|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14992820|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14992821|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
14992822|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992823|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992824|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992825|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14992826|NCT01741558|Riboflavin|riboflavin|mesh-list
14992827|NCT01741558|Methotrexate|methotrexate|mesh-list
14992828|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14992829|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
14992830|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14992831|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992832|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14992833|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
14992834|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992835|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992836|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
14992837|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992838|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14992839|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14992840|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
14992841|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14992842|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14992843|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
14992844|NCT01741558|Vitamins|vitamins|mesh-ancestor
14992845|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
14992846|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14992847|NCT01741623|Bisoprolol|bisoprolol|mesh-list
14992848|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14992849|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
14992850|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
14992851|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992852|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992853|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14992854|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14992855|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14992856|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
14992857|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992858|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992859|NCT01741649|Povidone|povidone|mesh-list
14992860|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
14992861|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
15031556|NCT01975454|Capecitabine|capecitabine|mesh-list
15031557|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
15031558|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15031559|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
15031560|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031561|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031562|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15031563|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15031564|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15031565|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15031566|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031567|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15031568|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031569|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
15031570|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15031571|NCT01975662|Vancomycin|vancomycin|mesh-list
15031572|NCT01975662|Daptomycin|daptomycin|mesh-list
15031573|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15031574|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031575|NCT01975688|Nabiximols|nabiximols|mesh-list
15031576|NCT01975688|Analgesics|analgesics|mesh-ancestor
15031577|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
15031578|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031579|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031580|NCT01975714|Bimatoprost|bimatoprost|mesh-list
15031581|NCT01975714|Latanoprost|latanoprost|mesh-list
15031582|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15031583|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14992862|NCT01741753|Prednisone|prednisone|mesh-list
14992863|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14992864|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
14992865|NCT01741753|Hormones|hormones|mesh-ancestor
14992866|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992867|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992868|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14992869|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992870|NCT01741831|Darunavir|darunavir|mesh-list
14992871|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14992872|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14992873|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
14992874|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992875|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992876|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14992877|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14992878|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
14992879|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14992880|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
14992881|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14992882|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992883|NCT01742247|Palmidrol|palmidrol|mesh-list
14992884|NCT01742247|Analgesics|analgesics|mesh-ancestor
14992885|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
14992886|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992887|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992888|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14992889|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14992890|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14992891|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14992892|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
14992893|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14992894|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14992895|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14992896|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992897|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992898|NCT01742247|Hormones|hormones|mesh-ancestor
14992899|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992900|NCT01742273|Vitamin K|vitamin k|mesh-list
14992901|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
14992902|NCT01742273|Vitamins|vitamins|mesh-ancestor
14992903|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
14992904|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992905|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14992906|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14992907|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992908|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
14992909|NCT01742273|Coagulants|coagulants|mesh-ancestor
14992910|NCT01742338|Prednisone|prednisone|mesh-list
14992911|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
14992912|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14992913|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14992914|NCT01742338|Prednisolone|prednisolone|mesh-list
14992915|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
14992916|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14992917|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
14992918|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14992919|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
14992920|NCT01742338|Hormones|hormones|mesh-ancestor
14992921|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992922|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992923|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14992924|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992925|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
14992926|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
14992927|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14992928|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14992929|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14992930|NCT01742338|Protective Agents|protective agents|mesh-ancestor
14992931|NCT01742390|Risperidone|risperidone|mesh-list
14992932|NCT01742390|Aripiprazole|aripiprazole|mesh-list
14992933|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14992934|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14992935|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
14992936|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14992937|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992938|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992939|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14992940|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14992941|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14992942|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14992943|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14992944|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
14992945|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
14992946|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
14992947|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14992948|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14992949|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14992950|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14992951|NCT01742429|Amoxicillin|amoxicillin|mesh-list
14992952|NCT01742429|Metronidazole|metronidazole|mesh-list
14992953|NCT01742429|Levofloxacin|levofloxacin|mesh-list
14992954|NCT01742429|Ofloxacin|ofloxacin|mesh-list
14992955|NCT01742429|Tetracycline|tetracycline|mesh-list
14992956|NCT01742429|Bismuth|bismuth|mesh-list
14992957|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
14992958|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
14992959|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14992960|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14992961|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14992962|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14992963|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14992964|NCT01742429|Renal Agents|renal agents|mesh-ancestor
14992965|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14992966|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14992967|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992968|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992969|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992970|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14992971|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14992972|NCT01742429|Antacids|antacids|mesh-ancestor
14992973|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14992974|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14992975|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
14992976|NCT01742533|Hormones|hormones|mesh-list
14992977|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14992978|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992979|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
14992980|NCT01742624|Tacrolimus|tacrolimus|mesh-list
14992981|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14992982|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
14992983|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14992984|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14992985|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14992986|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14992987|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14992988|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14992989|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14992990|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
14992991|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14992992|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14992993|NCT01742637|Adapalene|adapalene|mesh-list
14992994|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14992995|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
14992996|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14992997|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14992998|NCT01742637|Analgesics|analgesics|mesh-ancestor
14992999|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
14993000|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993001|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993002|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14993003|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993004|NCT01742663|Diclofenac|diclofenac|mesh-list
14993005|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14993006|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14993007|NCT01742663|Analgesics|analgesics|mesh-ancestor
14993008|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
14993009|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993010|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993011|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14993012|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993013|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14993014|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523621|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523622|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523623|NCT03604341|Hormones|hormones|mesh-ancestor
14529791|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
14993015|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993016|NCT01742676|Tacrolimus|tacrolimus|mesh-list
14993017|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14993018|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
14993019|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993020|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14993021|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993022|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993023|NCT01742689|Indomethacin|indomethacin|mesh-list
14993024|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14993025|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14993026|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14993027|NCT01742689|Analgesics|analgesics|mesh-ancestor
14993028|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
14993029|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993030|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993031|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14993032|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993033|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
14993034|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
14993035|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14993036|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14993037|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993038|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993039|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
14993040|NCT01742689|Coagulants|coagulants|mesh-ancestor
14993041|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14993042|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
14993043|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
14993044|NCT01742702|Bisoprolol|bisoprolol|mesh-list
14993045|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
14993046|NCT01742702|Albuterol|albuterol|mesh-list
14993047|NCT01742702|Caseins|caseins|mesh-list
14993048|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14993049|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
14993050|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993051|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993052|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14993053|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
14993054|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
14993055|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14993056|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14993057|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14993058|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14993059|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
14993060|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993061|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993062|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
14993063|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
14993064|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
14993065|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14993066|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
14993067|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14993068|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14993069|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14993070|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14993071|NCT01742767|Pemetrexed|pemetrexed|mesh-list
14993072|NCT01742767|Cisplatin|cisplatin|mesh-list
14993073|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993074|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993075|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993076|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14993077|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14993078|NCT01742793|Lenalidomide|lenalidomide|mesh-list
14993079|NCT01742793|Romidepsin|romidepsin|mesh-list
14993080|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
14993081|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993082|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14993083|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14993084|NCT01742793|Growth Substances|growth substances|mesh-ancestor
14993085|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
14993086|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993087|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14993088|NCT01742845|Ropivacaine|ropivacaine|mesh-list
14993089|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
14993090|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
14993091|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993092|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993093|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
14993094|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993095|NCT01742988|Rituximab|rituximab|mesh-list
14993096|NCT01742988|Venetoclax|venetoclax|mesh-list
14993097|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14993098|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993099|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
14993100|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993101|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993102|NCT01743014|Ramipril|ramipril|mesh-list
14993103|NCT01743014|Clopidogrel|clopidogrel|mesh-list
14993104|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14993105|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14993106|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14993107|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14993108|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
14993109|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993110|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993111|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993112|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14993113|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
14993114|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993115|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14993116|NCT01743066|Vitamin E|vitamin e|mesh-list
14993117|NCT01743066|Vitamins|vitamins|mesh-ancestor
14993118|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
14993119|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993120|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
14993121|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993122|NCT01743066|Protective Agents|protective agents|mesh-ancestor
14993123|NCT01743079|Lamivudine|lamivudine|mesh-list
14993124|NCT01743079|Telbivudine|telbivudine|mesh-list
14993125|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14993126|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14993127|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993128|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993129|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
14993130|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14993131|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14993132|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14993133|NCT01743118|Calcipotriene|calcipotriene|mesh-list
14993134|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
14993135|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
14993136|NCT01743144|Analgesics|analgesics|mesh-ancestor
14993137|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
14993138|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993139|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993140|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
14993141|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993142|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14993143|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
14993144|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14993145|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14993146|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993147|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14993148|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
14993149|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14993150|NCT01743157|Bevacizumab|bevacizumab|mesh-list
14993151|NCT01743157|Ipilimumab|ipilimumab|mesh-list
14993152|NCT01743157|Interleukin-2|interleukin-2|mesh-list
14801720|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801721|NCT00794209|Fentanyl|fentanyl|mesh-list
14801722|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14801723|NCT00794209|Narcotics|narcotics|mesh-ancestor
14801724|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801725|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801726|NCT00794209|Analgesics|analgesics|mesh-ancestor
14801727|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
14801728|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801729|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14801730|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14801731|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
14801732|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
14993153|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14993154|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993155|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14993156|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14993157|NCT01743157|Growth Substances|growth substances|mesh-ancestor
14993158|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993159|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
14993160|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14993161|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993162|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14993163|NCT01743157|Analgesics|analgesics|mesh-ancestor
14993164|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
14801733|NCT00794235|Sorafenib|sorafenib|mesh-list
14801734|NCT00794235|Dacarbazine|dacarbazine|mesh-list
14993165|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993166|NCT01743235|Buspirone|buspirone|mesh-list
14993167|NCT01743235|Testosterone|testosterone|mesh-list
14993168|NCT01743235|Androgens|androgens|mesh-ancestor
14993169|NCT01743235|Hormones|hormones|mesh-ancestor
14993170|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14993171|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993172|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14993173|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14993174|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993175|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14993176|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14993177|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
14993178|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993179|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031584|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15031585|NCT01975727|Dexamethasone|dexamethasone|mesh-list
15031586|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
15031587|NCT01975727|BB 1101|bb 1101|mesh-list
15031588|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15031589|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
15031590|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
15031591|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031592|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031593|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15031594|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
15031595|NCT01975727|Hormones|hormones|mesh-ancestor
15031596|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031597|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15031598|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031599|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
15031600|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031601|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031602|NCT01975753|Fentanyl|fentanyl|mesh-list
15031603|NCT01975753|Morphine|morphine|mesh-list
15031604|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15031605|NCT01975753|Narcotics|narcotics|mesh-ancestor
15031606|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031607|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031608|NCT01975753|Analgesics|analgesics|mesh-ancestor
15031609|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
15031610|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031611|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15031612|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15031613|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
15031614|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
15031615|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
15031616|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15031617|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
15031618|NCT01975805|Povidone|povidone|mesh-list
15031619|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15031620|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031621|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
15031622|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
15031623|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
15031624|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
15035379|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
15035380|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035381|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15035382|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15035383|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15035384|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15035385|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035386|NCT02001272|Paclitaxel|paclitaxel|mesh-list
15035387|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15035388|NCT02001272|Carboplatin|carboplatin|mesh-list
15035389|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15035390|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035391|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
15035392|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
15035393|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
15035394|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035395|NCT02001285|Remifentanil|remifentanil|mesh-list
15035396|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14993180|NCT01743300|Sunitinib|sunitinib|mesh-list
14993181|NCT01743300|Midazolam|midazolam|mesh-list
14993182|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14993183|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14993184|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993185|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993186|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14993187|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14993188|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14993189|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14993190|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
14993191|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
14993192|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
14993193|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
14993194|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993195|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993196|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993197|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14993198|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14993199|NCT01743300|Growth Substances|growth substances|mesh-ancestor
14993200|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
14993201|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14993202|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993203|NCT01743326|Anesthetics|anesthetics|mesh-list
14993204|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993205|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993206|NCT01743365|Afatinib|afatinib|mesh-list
14993207|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993208|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14993209|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993210|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993211|NCT01743378|Ropivacaine|ropivacaine|mesh-list
14993212|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
14993213|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
14993214|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993215|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993216|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
14993217|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993218|NCT01743456|Anesthetics|anesthetics|mesh-list
14993219|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993220|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993221|NCT01743508|Misoprostol|misoprostol|mesh-list
14993222|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14993223|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
14993224|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14993225|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993226|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14993227|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14993228|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
14993229|NCT01743690|Nystatin|nystatin|mesh-list
14993230|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14993231|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14993232|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
14993233|NCT01743690|Hormones|hormones|mesh-ancestor
14993234|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14993235|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993236|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14993237|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14993238|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
14993239|NCT01743690|Ionophores|ionophores|mesh-ancestor
14993240|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14993241|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993242|NCT01743742|Vitamins|vitamins|mesh-list
14993243|NCT01743742|Ascorbic Acid|ascorbic acid|mesh-list
14993244|NCT01743742|Vitamin E|vitamin e|mesh-list
14993245|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
14993246|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993247|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
14993248|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993249|NCT01743742|Protective Agents|protective agents|mesh-ancestor
14993250|NCT01743755|Dexamethasone|dexamethasone|mesh-list
14993251|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14993252|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
14993253|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
14993254|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993255|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993256|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14993257|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
14993258|NCT01743755|Hormones|hormones|mesh-ancestor
14993259|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14993260|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14993261|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993262|NCT01743794|Ropivacaine|ropivacaine|mesh-list
14993263|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
14993264|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
14993265|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993266|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993267|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
14993268|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993269|NCT01743820|Piperaquine|piperaquine|mesh-list
14993270|NCT01743820|Primaquine|primaquine|mesh-list
14993271|NCT01743820|Artenimol|artenimol|mesh-list
14993272|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
14993273|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14993274|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14993275|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14993276|NCT01743885|Propranolol|propranolol|mesh-list
14993277|NCT01743885|Acebutolol|acebutolol|mesh-list
14993278|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14993279|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14993280|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
14993281|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993282|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993283|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993284|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14993285|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14993286|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
14993287|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
14993288|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
14993289|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993290|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14993291|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
14993292|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14993293|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
14993294|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14993295|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
14993296|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993297|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993298|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
14993299|NCT01743911|Tadalafil|tadalafil|mesh-list
14993300|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
14993301|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14993302|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14993303|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993304|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993305|NCT01743911|Urological Agents|urological agents|mesh-ancestor
14993306|NCT01743950|Bevacizumab|bevacizumab|mesh-list
14993307|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14993308|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993309|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14993310|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14993311|NCT01743950|Growth Substances|growth substances|mesh-ancestor
14993312|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993313|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
14993314|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
14993315|NCT01744106|Ephedrine|ephedrine|mesh-list
14993316|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14993317|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
14993318|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993319|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993320|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14993321|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
14993322|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
14993323|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14993324|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14993325|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
14993326|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
14993327|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993328|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993329|NCT01744184|Midazolam|midazolam|mesh-list
14993330|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
14993331|NCT01744184|Entonox|entonox|mesh-list
14993332|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14993333|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14993334|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993335|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993336|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14993337|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14993338|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14993339|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14993340|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
14993341|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
14993342|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
14993343|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
14993344|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993345|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993346|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14993347|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14993348|NCT01744184|Analgesics|analgesics|mesh-ancestor
14993349|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
14993350|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993351|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14993352|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14993353|NCT01744236|Liraglutide|liraglutide|mesh-list
14993354|NCT01744236|Exenatide|exenatide|mesh-list
14993355|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14993356|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993357|NCT01744236|Incretins|incretins|mesh-ancestor
14993358|NCT01744236|Hormones|hormones|mesh-ancestor
14993359|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14993360|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14993361|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
14993362|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993363|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993364|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14993365|NCT01744249|Axitinib|axitinib|mesh-list
14993366|NCT01744249|Octreotide|octreotide|mesh-list
14993367|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993368|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14993369|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993370|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993371|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14993372|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14993373|NCT01744262|Anesthetics|anesthetics|mesh-list
14993374|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993375|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993376|NCT01744288|Clopidogrel|clopidogrel|mesh-list
14993377|NCT01744288|Ticagrelor|ticagrelor|mesh-list
14993378|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14993379|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14993380|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14993381|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14993382|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
14993383|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993384|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993385|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993386|NCT01744314|Indomethacin|indomethacin|mesh-list
14993387|NCT01744314|Pantoprazole|pantoprazole|mesh-list
14993388|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14993389|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14993390|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14993391|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993392|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993393|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14993394|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14993395|NCT01744314|Analgesics|analgesics|mesh-ancestor
14993396|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
14993397|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993398|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993399|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14993400|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993401|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
14993402|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
14993403|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14993404|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14523624|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14523625|NCT03605212|Febuxostat|febuxostat|mesh-list
14523626|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
14523627|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14523628|NCT03605914|Acetaminophen|acetaminophen|mesh-list
14523629|NCT03605914|Diclofenac|diclofenac|mesh-list
14523630|NCT03605914|Hydrocodone|hydrocodone|mesh-list
14523631|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14993405|NCT01744366|Goserelin|goserelin|mesh-list
14993406|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14993407|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993408|NCT01744379|Lesinurad|lesinurad|mesh-list
14993409|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
14993410|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993411|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
14993412|NCT01744379|Renal Agents|renal agents|mesh-ancestor
14993413|NCT01744444|Gabapentin|gabapentin|mesh-list
14993414|NCT01744444|Memantine|memantine|mesh-list
14993415|NCT01744444|Analgesics|analgesics|mesh-ancestor
14993416|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
14993417|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993418|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993419|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
14993420|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14993421|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14993422|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993423|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14993424|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14993425|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14993426|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993427|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993428|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
14993429|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14993430|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14993431|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
14993432|NCT01744470|Tacrolimus|tacrolimus|mesh-list
14993433|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14993434|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
14993435|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993436|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14993437|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993438|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993439|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14993440|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
14993441|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993442|NCT01744587|Protective Agents|protective agents|mesh-ancestor
14993443|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993444|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14993445|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14993446|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993447|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14993448|NCT01744626|Rituximab|rituximab|mesh-list
14993449|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14993450|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993451|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
14993452|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993453|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993454|NCT01744652|Dasatinib|dasatinib|mesh-list
14993455|NCT01744652|Crizotinib|crizotinib|mesh-list
14993456|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993457|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14993458|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993459|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993460|NCT01744678|Immunoconjugates|immunoconjugates|mesh-list
14993461|NCT01744678|Immunologic Factors|immunologic factors|mesh-ancestor
14993462|NCT01744678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993463|NCT01744756|Bevacizumab|bevacizumab|mesh-list
14993464|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14993465|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993466|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14993467|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14993468|NCT01744756|Growth Substances|growth substances|mesh-ancestor
14993469|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993470|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
14993471|NCT01744873|Bisoprolol|bisoprolol|mesh-list
14993472|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14993473|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
14993474|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
14993475|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993476|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993477|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14993478|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14993479|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14993480|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
14993481|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993482|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993483|NCT01744886|Benzocaine|benzocaine|mesh-list
14993484|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
14993485|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
14993486|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993487|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993488|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
14993489|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993490|NCT01744912|Lenalidomide|lenalidomide|mesh-list
14993491|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
14993492|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993493|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14993494|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14993495|NCT01744912|Growth Substances|growth substances|mesh-ancestor
14993496|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
14993497|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031625|NCT01975961|Telmisartan|telmisartan|mesh-list
15031626|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15031627|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15031628|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15031629|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
15031630|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031631|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15031632|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15031633|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031634|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15031635|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15031636|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15031637|NCT01976078|Midazolam|midazolam|mesh-list
15031638|NCT01976078|Esomeprazole|esomeprazole|mesh-list
15031639|NCT01976078|Ranitidine|ranitidine|mesh-list
15031640|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
15031641|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15031642|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15031643|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031644|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031645|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15031646|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15031647|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15031648|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15031649|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
15031650|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
15031651|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
15031652|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
15031653|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15031654|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993498|NCT01744964|Apomorphine|apomorphine|mesh-list
14993499|NCT01744964|Emetics|emetics|mesh-ancestor
14993500|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993501|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
14993502|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993503|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14993504|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
14993505|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
14993506|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993507|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993508|NCT01745081|Mannitol|mannitol|mesh-list
14993509|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14993510|NCT01745081|Diuretics|diuretics|mesh-ancestor
14993511|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
14993512|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993513|NCT01745159|Tacrolimus|tacrolimus|mesh-list
14993514|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14993515|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
14993516|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993517|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14993518|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993519|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993520|NCT01745263|Vitamin D|vitamin d|mesh-list
14993521|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
14993522|NCT01745263|Vitamins|vitamins|mesh-ancestor
14993523|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
14993524|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993525|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14993526|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14993527|NCT01745302|Gefitinib|gefitinib|mesh-list
14993528|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523632|NCT03605914|Analgesics|analgesics|mesh-ancestor
14993529|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14993530|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993531|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993532|NCT01745328|Amoxicillin|amoxicillin|mesh-list
14993533|NCT01745328|Levofloxacin|levofloxacin|mesh-list
14993534|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14993535|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14993536|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14993537|NCT01745328|Renal Agents|renal agents|mesh-ancestor
14993538|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14993539|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14993540|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993541|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993542|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993543|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14993544|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14993545|NCT01745549|Insulin|insulin|mesh-list
14993546|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14993547|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14993548|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993549|NCT01745562|Alprazolam|alprazolam|mesh-list
14993550|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14993551|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993552|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993553|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14993554|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14993555|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14993556|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
14993557|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
14993558|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993559|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993560|NCT01745575|Alprazolam|alprazolam|mesh-list
14993561|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14993562|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993563|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993564|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14993565|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14993566|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14993567|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
14993568|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
14993569|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993570|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993571|NCT01745601|Dexetimide|dexetimide|mesh-list
14993572|NCT01745601|Citalopram|citalopram|mesh-list
14993573|NCT01745601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14993574|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14993575|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14993576|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993577|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993578|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
14993579|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993580|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14993581|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
14993582|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14993583|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14993584|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14993585|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
14993586|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
14993587|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993588|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14993589|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14993590|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
14993591|NCT01745614|Nimesulide|nimesulide|mesh-list
14993592|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14993593|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14993594|NCT01745614|Analgesics|analgesics|mesh-ancestor
14993595|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
14993596|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993597|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993598|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14993599|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993600|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14993601|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993602|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993603|NCT01745640|Dexamethasone|dexamethasone|mesh-list
14993604|NCT01745640|Pomalidomide|pomalidomide|mesh-list
14993605|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14993606|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
14993607|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
14993608|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993609|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993610|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14993611|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
14993612|NCT01745640|Hormones|hormones|mesh-ancestor
14993613|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14993614|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14993615|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993616|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
14993617|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14993618|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14993619|NCT01745640|Growth Substances|growth substances|mesh-ancestor
14993620|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
14993621|NCT01745666|Epinephrine|epinephrine|mesh-list
14993622|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14993623|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14993624|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
14993625|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993626|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993627|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993628|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14993629|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14993630|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
14993631|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993632|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14993633|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
14993634|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
14993635|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
14993636|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14993637|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
14993638|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14993639|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14993640|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14993641|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14993642|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14993643|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993644|NCT01745770|Mesalamine|mesalamine|mesh-list
14993645|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14993646|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14993647|NCT01745770|Analgesics|analgesics|mesh-ancestor
14993648|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
14993649|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993650|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993651|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14993652|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993653|NCT01745835|Bisacodyl|bisacodyl|mesh-list
14993654|NCT01745835|Cathartics|cathartics|mesh-ancestor
14993655|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14993656|NCT01745835|Laxatives|laxatives|mesh-ancestor
14993657|NCT01745965|Trastuzumab|trastuzumab|mesh-list
14993658|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14993659|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993660|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
14993661|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
14993662|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14993663|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14993664|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
14993665|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
14993666|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14993667|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14993668|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14993669|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14993670|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523633|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
14523634|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523635|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523636|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
14993671|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993672|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14993673|NCT01746199|Renal Agents|renal agents|mesh-ancestor
14993674|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14993675|NCT01746251|Afatinib|afatinib|mesh-list
14993676|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993677|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14993678|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993679|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993680|NCT01746277|Docetaxel|docetaxel|mesh-list
14993681|NCT01746277|Pemetrexed|pemetrexed|mesh-list
14993682|NCT01746277|Gefitinib|gefitinib|mesh-list
14993683|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993684|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
14993685|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
14993686|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
14993687|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993688|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993689|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14993690|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14993691|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14993692|NCT01746485|Treprostinil|treprostinil|mesh-list
14993693|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14993694|NCT01746563|Ranibizumab|ranibizumab|mesh-list
14801735|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801736|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14801737|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801738|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801739|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14801740|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
14801741|NCT00794261|Lenograstim|lenograstim|mesh-list
14801742|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14801743|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
14801744|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801745|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
14801746|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14801747|NCT00794443|Diphosphonates|diphosphonates|mesh-list
14801748|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14801749|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801750|NCT00794625|Valproic Acid|valproic acid|mesh-list
14993695|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14993696|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14993697|NCT01746563|Growth Substances|growth substances|mesh-ancestor
14993698|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993699|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
14993700|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993701|NCT01746602|Timolol|timolol|mesh-list
14993702|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14993703|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14993704|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
14993705|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993706|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993707|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993708|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14993709|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14993710|NCT01746641|Remifentanil|remifentanil|mesh-list
14801751|NCT00794625|Risperidone|risperidone|mesh-list
14993711|NCT01746641|Propofol|propofol|mesh-list
14993712|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14993713|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993714|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993715|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14993716|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
14993717|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
14993718|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14993719|NCT01746641|Narcotics|narcotics|mesh-ancestor
14993720|NCT01746641|Analgesics|analgesics|mesh-ancestor
14993721|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
14993722|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993723|NCT01746680|Methotrexate|methotrexate|mesh-list
14993724|NCT01746680|Tacrolimus|tacrolimus|mesh-list
14993725|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14993726|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
14993727|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14993728|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993729|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14993730|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
14993731|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993732|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993733|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
14993734|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993735|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14993736|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14993737|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
14801752|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
14801753|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14801754|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
14801755|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801756|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801757|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801758|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14801759|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14801760|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801761|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14801762|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14801763|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
14801764|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
14993738|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993739|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14993740|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15031655|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15031656|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15031657|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15031658|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031659|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15031660|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
15031661|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
15031662|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
15031663|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031664|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15031665|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15031666|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031667|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031668|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
15031669|NCT01976182|Methotrexate|methotrexate|mesh-list
15031670|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15031671|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
15031672|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031673|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15031674|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15031675|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
15031676|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031677|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031678|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15031679|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15031680|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
15031681|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15031682|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15031683|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
15031684|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
15031685|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031686|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15031687|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15031688|NCT01976195|Thalidomide|thalidomide|mesh-list
15031689|NCT01976195|Dexamethasone|dexamethasone|mesh-list
15031690|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15031691|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
15031692|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
15031693|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031694|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031695|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15031696|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
15031697|NCT01976195|Hormones|hormones|mesh-ancestor
15031698|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031699|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15031700|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031701|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15031702|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
15031703|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
15031704|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15031705|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031706|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15031707|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15031708|NCT01976195|Growth Substances|growth substances|mesh-ancestor
15031709|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
15031710|NCT01976208|Omalizumab|omalizumab|mesh-list
15031711|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15031712|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15031713|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
15031714|NCT01976520|Vaccines|vaccines|mesh-list
15031715|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
15031716|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031717|NCT01976585|Poly ICLC|poly iclc|mesh-list
15031718|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
15031719|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
15031720|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031721|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
15031722|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15031723|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15031724|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15031725|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15031726|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993741|NCT01746719|Etodolac|etodolac|mesh-list
14993742|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14993743|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14993744|NCT01746719|Analgesics|analgesics|mesh-ancestor
14993745|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
14993746|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993747|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993748|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14993749|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993750|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14993751|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14993752|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993753|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993754|NCT01746771|Paclitaxel|paclitaxel|mesh-list
14993755|NCT01746771|Trastuzumab|trastuzumab|mesh-list
14993756|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14993757|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993758|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
14993759|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
14993760|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
14993761|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993762|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14993763|NCT01746823|Cyclosporine|cyclosporine|mesh-list
14993764|NCT01746823|Cyclosporins|cyclosporins|mesh-list
14993765|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993766|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993767|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14993768|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
14993769|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993770|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
14993771|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14993772|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
14993773|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993774|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14993775|NCT01746875|Aflibercept|aflibercept|mesh-list
14993776|NCT01746875|Verteporfin|verteporfin|mesh-list
14993777|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14993778|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14993779|NCT01746875|Growth Substances|growth substances|mesh-ancestor
14993780|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993781|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
14993782|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993783|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14993784|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
14993785|NCT01746992|Prednisone|prednisone|mesh-list
14993786|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
14993787|NCT01746992|Ifosfamide|ifosfamide|mesh-list
14993788|NCT01746992|Doxorubicin|doxorubicin|mesh-list
14523637|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14523638|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14523639|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14523640|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14523641|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523642|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523643|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14523644|NCT03605914|Narcotics|narcotics|mesh-ancestor
14523645|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14523646|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
14523647|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
14523648|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
14523649|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
14523650|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523651|NCT03607539|Pemetrexed|pemetrexed|mesh-list
14523652|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993789|NCT01746992|Methotrexate|methotrexate|mesh-list
14993790|NCT01746992|Etoposide|etoposide|mesh-list
14523653|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523654|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523655|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14523656|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14523657|NCT03608488|Vitamin D|vitamin d|mesh-list
14993791|NCT01746992|Vincristine|vincristine|mesh-list
14993792|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
14993793|NCT01746992|Pirarubicin|pirarubicin|mesh-list
14993794|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14993795|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
14993796|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993797|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993798|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14993799|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
14993800|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993801|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993802|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14993803|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14993804|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14993805|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14993806|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993807|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14993808|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
14993809|NCT01746992|Hormones|hormones|mesh-ancestor
14993810|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14993811|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14993812|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14993813|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
14993814|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14993815|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14993816|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
14993817|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
14993818|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14993819|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14993820|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14993821|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
14993822|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
14993823|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
14993824|NCT01747044|Milnacipran|milnacipran|mesh-list
14993825|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
14993826|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14993827|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14993828|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14993829|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993830|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993831|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993832|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14993833|NCT01747044|Analgesics|analgesics|mesh-ancestor
14993834|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
14993835|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993836|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
14993837|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14993838|NCT01747083|Metformin|metformin|mesh-list
14993839|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14993840|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993841|NCT01747135|Betadex|betadex|mesh-list
14993842|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
14993843|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993844|NCT01747148|Radavirsen|radavirsen|mesh-list
14993845|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
14993846|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14993847|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
14993848|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14993849|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14993850|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993851|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
14993852|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15031727|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
14993853|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993854|NCT01747174|Adenosine|adenosine|mesh-list
14993855|NCT01747174|Nitroprusside|nitroprusside|mesh-list
14993856|NCT01747174|Analgesics|analgesics|mesh-ancestor
14993857|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
14993858|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14993859|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993860|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14993861|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
14993862|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14993863|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
14993864|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
14993865|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993866|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993867|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14993868|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14993869|NCT01747226|Fluorides|fluorides|mesh-list
14993870|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
14993871|NCT01747226|Protective Agents|protective agents|mesh-ancestor
14993872|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993873|NCT01747252|Resveratrol|resveratrol|mesh-list
14993874|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
14993875|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993876|NCT01747252|Protective Agents|protective agents|mesh-ancestor
14993877|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993878|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993879|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14993880|NCT01747278|Trimethoprim|trimethoprim|mesh-list
14993881|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
14993882|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14993883|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14993884|NCT01747278|Renal Agents|renal agents|mesh-ancestor
14993885|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
14993886|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14993887|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14993888|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14993889|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993890|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993891|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14993892|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14993893|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14993894|NCT01747564|Mirabegron|mirabegron|mesh-list
14993895|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14993896|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14993897|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14993898|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
14993899|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993900|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993901|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993902|NCT01747564|Urological Agents|urological agents|mesh-ancestor
14993903|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
14993904|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14993905|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14993906|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
14993907|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993908|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993909|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993910|NCT01747577|Urological Agents|urological agents|mesh-ancestor
14993911|NCT01747590|Zolpidem|zolpidem|mesh-list
14993912|NCT01747590|Alprazolam|alprazolam|mesh-list
14993913|NCT01747590|Caffeine|caffeine|mesh-list
14993914|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14993915|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993916|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14993917|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993918|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993919|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14993920|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14993921|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
14993922|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14993923|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14993924|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14993925|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14993926|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14993927|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
14993928|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
14993929|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14993930|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14993931|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14993932|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
14993933|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
14993934|NCT01747616|Chitosan|chitosan|mesh-list
14993935|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14993936|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14993937|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14993938|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
14993939|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14993940|NCT01747616|Expectorants|expectorants|mesh-ancestor
14993941|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
14993942|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14993943|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
14993944|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993945|NCT01747616|Protective Agents|protective agents|mesh-ancestor
14993946|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993947|NCT01747616|Antidotes|antidotes|mesh-ancestor
14993948|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14993949|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14993950|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
14993951|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14993952|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
14993953|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
14993954|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
14993955|NCT01747616|Coagulants|coagulants|mesh-ancestor
14993956|NCT01747642|Sorafenib|sorafenib|mesh-list
14993957|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993958|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14993959|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993960|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993961|NCT01747668|Tocopherols|tocopherols|mesh-list
14993962|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
14993963|NCT01747668|Vitamin E|vitamin e|mesh-list
14993964|NCT01747668|Vitamins|vitamins|mesh-ancestor
14993965|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
14993966|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993967|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
14993968|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993969|NCT01747668|Protective Agents|protective agents|mesh-ancestor
14993970|NCT01747707|Docetaxel|docetaxel|mesh-list
14993971|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14993972|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
14993973|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
14993974|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
14993975|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993976|NCT01747720|Vitamin D|vitamin d|mesh-list
14993977|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
14993978|NCT01747720|Vitamins|vitamins|mesh-ancestor
14993979|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
14993980|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14993981|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14993982|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14993983|NCT01747746|Enoxaparin|enoxaparin|mesh-list
14993984|NCT01747746|Warfarin|warfarin|mesh-list
14993985|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
14993986|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
14993987|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14993988|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
14993989|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14993990|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
14993991|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14993992|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14993993|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14993994|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14993995|NCT01747798|Auranofin|auranofin|mesh-list
14993996|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14993997|NCT01747993|Tamsulosin|tamsulosin|mesh-list
14993998|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14993999|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14994000|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14994001|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
14994002|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994003|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994004|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994005|NCT01747993|Urological Agents|urological agents|mesh-ancestor
14994006|NCT01748019|Namitecan|namitecan|mesh-list
14994007|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14994008|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994009|NCT01748084|Rituximab|rituximab|mesh-list
14994010|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14994011|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994012|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
14994013|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994014|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14994015|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14994016|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
14994017|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14994018|NCT01748123|Diuretics|diuretics|mesh-ancestor
14994019|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
14994020|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994021|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14994022|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14994023|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994024|NCT01748253|Amlodipine|amlodipine|mesh-list
14994025|NCT01748253|Telmisartan|telmisartan|mesh-list
14994026|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
14994027|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14994028|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14994029|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14994030|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994031|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14994032|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994033|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
14994034|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14994035|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14994036|NCT01748279|Atorvastatin|atorvastatin|mesh-list
14994037|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
14994038|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14994039|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14994040|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
14994041|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994042|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14994043|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14994044|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994045|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14994046|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
14994047|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994048|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994049|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14994050|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
14994051|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14994052|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14994053|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14994054|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
14994055|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994056|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14994057|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14994058|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14994059|NCT01748318|Renal Agents|renal agents|mesh-ancestor
14994060|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14994061|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
14994062|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14994063|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14994064|NCT01748344|Cetirizine|cetirizine|mesh-list
14994065|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14994066|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14994067|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14994068|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
14994069|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
14994070|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994071|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994072|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994073|NCT01748370|Vitamin D|vitamin d|mesh-list
14523658|NCT03608488|Vitamins|vitamins|mesh-ancestor
14523659|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
14523660|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523661|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14523662|NCT03608774|Azithromycin|azithromycin|mesh-list
14523663|NCT03608774|Doxycycline|doxycycline|mesh-list
14523664|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14523665|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523666|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
14523667|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14523668|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14523669|NCT03608839|Dexamethasone|dexamethasone|mesh-list
14523670|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
14523671|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14523672|NCT03608839|BB 1101|bb 1101|mesh-list
14523673|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14523674|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
14523675|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
14523676|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523677|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523678|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14523679|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
14523680|NCT03608839|Hormones|hormones|mesh-ancestor
14994074|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
14994075|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
14994076|NCT01748370|Vitamins|vitamins|mesh-list
14994077|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
14994078|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994079|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14994080|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14994081|NCT01748396|Calcitriol|calcitriol|mesh-list
14994082|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
14994083|NCT01748396|Calcium|calcium|mesh-list
14994084|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14994085|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994086|NCT01748396|Antacids|antacids|mesh-ancestor
14994087|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994088|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14994089|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14994090|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14994091|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14994092|NCT01748396|Vitamins|vitamins|mesh-ancestor
14994093|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
14994094|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14994095|NCT01748422|Capsaicin|capsaicin|mesh-list
14994096|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
14994097|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
14994098|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
14994099|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994100|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994101|NCT01748435|Capsaicin|capsaicin|mesh-list
14994102|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
14994103|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
14994104|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
14994105|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994106|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994107|NCT01748448|Vitamin D|vitamin d|mesh-list
14994108|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
14994109|NCT01748448|Vitamins|vitamins|mesh-ancestor
14994110|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
14994111|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994112|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14994113|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15031728|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15031729|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031730|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15031731|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031732|NCT01976676|Folic Acid|folic acid|mesh-list
15031733|NCT01976676|Hematinics|hematinics|mesh-ancestor
15031734|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
15031735|NCT01976676|Vitamins|vitamins|mesh-ancestor
15031736|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
15031737|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031738|NCT01976780|Artesunate|artesunate|mesh-list
15031739|NCT01976780|Lumefantrine|lumefantrine|mesh-list
15031740|NCT01976780|Artemether|artemether|mesh-list
15031741|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15031742|NCT01976780|Mefloquine|mefloquine|mesh-list
15031743|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
15031744|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15031745|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15031746|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031747|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031748|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
15031749|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
15031750|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15031751|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
15031752|NCT01976923|Bevacizumab|bevacizumab|mesh-list
15031753|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15031754|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031755|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15031756|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15031757|NCT01976923|Growth Substances|growth substances|mesh-ancestor
15031758|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031759|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
15031760|NCT01976936|Lovastatin|lovastatin|mesh-list
15031761|NCT01976936|L 647318|l 647318|mesh-list
15031762|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
15031763|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15031764|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15031765|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
15031766|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994114|NCT01748487|Dexamethasone|dexamethasone|mesh-list
14994115|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
14994116|NCT01748487|BB 1101|bb 1101|mesh-list
14994117|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14994118|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
14994119|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
14994120|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994121|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994122|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14994123|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
14994124|NCT01748487|Hormones|hormones|mesh-ancestor
14994125|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14994126|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14994127|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994128|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
14994129|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994130|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994131|NCT01748500|Pantoprazole|pantoprazole|mesh-list
14994132|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14994133|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14994134|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14994135|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994136|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994137|NCT01748526|Canagliflozin|canagliflozin|mesh-list
14994138|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14994139|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994140|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14994141|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994142|NCT01748539|Brodalumab|brodalumab|mesh-list
14994143|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
14994144|NCT01748630|Fentanyl|fentanyl|mesh-list
14994145|NCT01748630|Midazolam|midazolam|mesh-list
14994146|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
14994147|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14994148|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994149|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994150|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14994151|NCT01748630|Analgesics|analgesics|mesh-ancestor
14994152|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
14994153|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994154|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14994155|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14994156|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14994157|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
14994158|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994159|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994160|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14994161|NCT01748630|Narcotics|narcotics|mesh-ancestor
14994162|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14994163|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14994164|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
14994165|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
14994166|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14994167|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14994168|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14994169|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
14994170|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
14994171|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
14994172|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
14994173|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994174|NCT01748669|Protective Agents|protective agents|mesh-ancestor
14994175|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994176|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14994177|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994178|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14994179|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994180|NCT01748721|Antibodies|antibodies|mesh-list
14994181|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14994182|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
14994183|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994184|NCT01748773|Capecitabine|capecitabine|mesh-list
14994185|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
14994186|NCT01748773|Trastuzumab|trastuzumab|mesh-list
14994187|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14994188|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
14994189|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994190|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994191|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14994192|NCT01748838|Mannitol|mannitol|mesh-list
14994193|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14994194|NCT01748838|Diuretics|diuretics|mesh-ancestor
14994195|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
14994196|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994197|NCT01748929|Albendazole|albendazole|mesh-list
14994198|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
14994199|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14994200|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14994201|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
14994202|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14523681|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14523682|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14523683|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523684|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
14523685|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523686|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529792|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14529793|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
14529794|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994203|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14994204|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
14994205|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
14994206|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
14994207|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994208|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994209|NCT01749072|Vinorelbine|vinorelbine|mesh-list
14994210|NCT01749072|Ifosfamide|ifosfamide|mesh-list
14994211|NCT01749072|Gefitinib|gefitinib|mesh-list
14994212|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14994213|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994214|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
14994215|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
14994216|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
14994217|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994218|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14994219|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
14994220|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14994221|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994222|NCT01749085|Ketoconazole|ketoconazole|mesh-list
14994223|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
14994224|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14994225|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14994226|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14994227|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994228|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994229|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14994230|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
14994231|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14994232|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994233|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14994234|NCT01749098|Ketamine|ketamine|mesh-list
14994235|NCT01749098|Analgesics|analgesics|mesh-ancestor
14994236|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
14994237|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994238|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994239|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14994240|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14994241|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
14994242|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
14994243|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994244|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14994245|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14994246|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994247|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994248|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
14994249|NCT01749111|Methotrexate|methotrexate|mesh-list
14994250|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14994251|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14994252|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
14994253|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994254|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14994255|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14994256|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
14994257|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994258|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994259|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14994260|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14994261|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
14994262|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14994263|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14994264|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
14994265|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
14994266|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994267|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14994268|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14994269|NCT01749150|Ritonavir|ritonavir|mesh-list
14994270|NCT01749150|Ribavirin|ribavirin|mesh-list
14994271|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14994272|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
14994273|NCT01749150|Lactams|lactams|mesh-list
14994274|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14994275|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14994276|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
14801765|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801766|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
14994277|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994278|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994279|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14994280|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14994281|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
14994282|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14994283|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14994284|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14994285|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
14994286|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
14994287|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994288|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14994289|NCT01749228|Etodolac|etodolac|mesh-list
14994290|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14994291|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14994292|NCT01749228|Analgesics|analgesics|mesh-ancestor
14994293|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
14994294|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994295|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994296|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14994297|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14994298|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14994299|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14994300|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994301|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994302|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14994303|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14994304|NCT01749319|Baclofen|baclofen|mesh-list
14994305|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14994306|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994307|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14994308|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994309|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14994310|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
14801767|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
14801768|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14801769|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14801770|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14801771|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14801772|NCT00794638|Rituximab|rituximab|mesh-list
14801773|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14801774|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14801775|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801776|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
14801777|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994311|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
14994312|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994313|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994314|NCT01749371|Vitamins|vitamins|mesh-list
14994315|NCT01749371|Vitamin E|vitamin e|mesh-list
14994316|NCT01749371|Tocopherols|tocopherols|mesh-list
14994317|NCT01749371|Tocotrienols|tocotrienols|mesh-list
14994318|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
14994319|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
14994320|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994321|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
14994322|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994323|NCT01749371|Protective Agents|protective agents|mesh-ancestor
14994324|NCT01749384|Bevacizumab|bevacizumab|mesh-list
14994325|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14994326|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
14994327|NCT01749384|Antibodies|antibodies|mesh-list
14994328|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
14994329|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14994330|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
14994331|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994332|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14994333|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14994334|NCT01749384|Growth Substances|growth substances|mesh-ancestor
14994335|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994336|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
14994337|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
14994338|NCT01749397|Fluorouracil|fluorouracil|mesh-list
14994339|NCT01749397|Floxuridine|floxuridine|mesh-list
14994340|NCT01749397|Veliparib|veliparib|mesh-list
14994341|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
14994342|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
14994343|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994344|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14994345|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994346|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14994347|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
14994348|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994349|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14994350|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994351|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
14994352|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14994353|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14994354|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14994355|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14994356|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994357|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
14994358|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994359|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994360|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14994361|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994362|NCT01749475|Midazolam|midazolam|mesh-list
14994363|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14994364|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14994365|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994366|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994367|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14994368|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14994369|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14994370|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14994371|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
14994372|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
14994373|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
14994374|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
14994375|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994376|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994377|NCT01749514|Luspatercept|luspatercept|mesh-list
14994378|NCT01749514|Hematinics|hematinics|mesh-ancestor
14994379|NCT01749540|Luspatercept|luspatercept|mesh-list
14994380|NCT01749540|Hematinics|hematinics|mesh-ancestor
14994381|NCT01749566|Maraviroc|maraviroc|mesh-list
14994382|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14994383|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15031767|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14994384|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994385|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14994386|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14994387|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
14994388|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14994389|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14994390|NCT01749579|Fentanyl|fentanyl|mesh-list
14994391|NCT01749579|Midazolam|midazolam|mesh-list
14994392|NCT01749579|Propofol|propofol|mesh-list
14994393|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14994394|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994395|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994396|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14994397|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
14994398|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
14994399|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14994400|NCT01749579|Narcotics|narcotics|mesh-ancestor
14994401|NCT01749579|Analgesics|analgesics|mesh-ancestor
14994402|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
14994403|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994404|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14994405|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14994406|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14994407|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14994408|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
14994409|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
14994410|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994411|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994412|NCT01750060|Fentanyl|fentanyl|mesh-list
14994413|NCT01750060|Naltrexone|naltrexone|mesh-list
14994414|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14994415|NCT01750060|Narcotics|narcotics|mesh-ancestor
14994416|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994417|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994418|NCT01750060|Analgesics|analgesics|mesh-ancestor
14994419|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
14994420|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994421|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14994422|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14994423|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
14994424|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
14994425|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14994426|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14994427|NCT01750099|Lidocaine|lidocaine|mesh-list
14994428|NCT01750099|Epinephrine|epinephrine|mesh-list
14994429|NCT01750099|Fentanyl|fentanyl|mesh-list
14994430|NCT01750099|Bupivacaine|bupivacaine|mesh-list
14994431|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
14523687|NCT03610399|Primaquine|primaquine|mesh-list
14994432|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
14994433|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994434|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994435|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
14994436|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994437|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14994438|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14994439|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14994440|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14994441|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994442|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14994443|NCT01750099|Narcotics|narcotics|mesh-ancestor
14994444|NCT01750099|Analgesics|analgesics|mesh-ancestor
14994445|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14994446|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14994447|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
14994448|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14994449|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14994450|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
14994451|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994452|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14994453|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14994454|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
14994455|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14994456|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
14994457|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
14994458|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
14994459|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15031768|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15031769|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031770|NCT01977118|Streptokinase|streptokinase|mesh-list
15031771|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15031772|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15031773|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031774|NCT01977209|Gossypol|gossypol|mesh-list
15031775|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15031776|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
15031777|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15031778|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031779|NCT01977235|Irinotecan|irinotecan|mesh-list
15031780|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031781|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15031782|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15031783|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031784|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031785|NCT01977300|Valproic Acid|valproic acid|mesh-list
15031786|NCT01977300|Olanzapine|olanzapine|mesh-list
15031787|NCT01977300|Risperidone|risperidone|mesh-list
15031788|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
15031789|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15031790|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
15031791|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15031792|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031793|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031794|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15031795|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15031796|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031797|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15031798|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15031799|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
15031800|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
15031801|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
15031802|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031803|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15031804|NCT01977300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15031805|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15031806|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15031807|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
15031808|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031809|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
15031810|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
15031811|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
15031812|NCT01977339|Bupivacaine|bupivacaine|mesh-list
15031813|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
15031814|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
15031815|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994460|NCT01750359|Curcumin|curcumin|mesh-list
14994461|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14994462|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14994463|NCT01750359|Analgesics|analgesics|mesh-ancestor
14994464|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
14994465|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994466|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994467|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14994468|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14994469|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994470|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994471|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994472|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14994473|NCT01750385|Cephalosporins|cephalosporins|mesh-list
14994474|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14994475|NCT01750437|Esomeprazole|esomeprazole|mesh-list
14994476|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14994477|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14994478|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14994479|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994480|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994481|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14994482|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
14994483|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14994484|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
14994485|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14994486|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994487|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14994488|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14994489|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14994490|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14994491|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14994492|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994493|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14994494|NCT01750541|Valproic Acid|valproic acid|mesh-list
14994495|NCT01750541|Haloperidol|haloperidol|mesh-list
14994496|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
14994497|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
14994498|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
14994499|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994500|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994501|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14994502|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14994503|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14994504|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994505|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14994506|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14994507|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
14994508|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994509|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994510|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14994511|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
14994512|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994513|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
14994514|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
14994515|NCT01750580|Ipilimumab|ipilimumab|mesh-list
14994516|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14994517|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994518|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14994519|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994520|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
14994521|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14994522|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15031816|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994523|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994524|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
14994525|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994526|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994527|NCT01750723|Acetazolamide|acetazolamide|mesh-list
14994528|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
14994529|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14994530|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994531|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994532|NCT01750723|Diuretics|diuretics|mesh-ancestor
14994533|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
14994534|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994535|NCT01750762|Lenalidomide|lenalidomide|mesh-list
14994536|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
14994537|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994538|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14994539|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14994540|NCT01750762|Growth Substances|growth substances|mesh-ancestor
14994541|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
14994542|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994543|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
14994544|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14994545|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
14994546|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14994547|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
14994548|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994549|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994550|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
14994551|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
14994552|NCT01750801|Propolis|propolis|mesh-list
14994553|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14994554|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14994555|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
14994556|NCT01750866|Prednisone|prednisone|mesh-list
14994557|NCT01750866|Sargramostim|sargramostim|mesh-list
14994558|NCT01750866|Lenograstim|lenograstim|mesh-list
14994559|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14994560|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
14994561|NCT01750866|Hormones|hormones|mesh-ancestor
14994562|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14994563|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994564|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14994565|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994566|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
14994567|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14994568|NCT01750983|Lenalidomide|lenalidomide|mesh-list
14994569|NCT01750983|Ipilimumab|ipilimumab|mesh-list
14994570|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
14994571|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994572|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14994573|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14994574|NCT01750983|Growth Substances|growth substances|mesh-ancestor
14994575|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
14994576|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994577|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14994578|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14994579|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994580|NCT01751009|Vitamins|vitamins|mesh-list
14994581|NCT01751009|Vitamin A|vitamin a|mesh-list
14801778|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14801779|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14994582|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
14994583|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
14994584|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994585|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
14994586|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994587|NCT01751009|Protective Agents|protective agents|mesh-ancestor
14994588|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14994589|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994590|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14994591|NCT01751074|Darapladib|darapladib|mesh-list
14994592|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14994593|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14994594|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
14994595|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994596|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14994597|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14994598|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994599|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
14994600|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
14994601|NCT01751204|Calcium|calcium|mesh-list
14994602|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14994603|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994604|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14994605|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
14994606|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994607|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801780|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
14801781|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801782|NCT00794703|Itraconazole|itraconazole|mesh-list
14801783|NCT00794703|Micafungin|micafungin|mesh-list
14801784|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
14801785|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14801786|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14801787|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14801788|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801789|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801790|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14801791|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
14801792|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14801793|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801794|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14801795|NCT00794755|Vitamin K|vitamin k|mesh-list
14994608|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14994609|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14994610|NCT01751295|Atorvastatin|atorvastatin|mesh-list
14994611|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14994612|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14994613|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
14994614|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994615|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14994616|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14994617|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994618|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14994619|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14994620|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994621|NCT01751321|Incretins|incretins|mesh-ancestor
14994622|NCT01751321|Hormones|hormones|mesh-ancestor
14994623|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14994624|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14994625|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
14994626|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994627|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994628|NCT01751347|Lidocaine|lidocaine|mesh-list
14994629|NCT01751347|Bupivacaine|bupivacaine|mesh-list
14994630|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
14994631|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
14994632|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994633|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994634|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
14994635|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994636|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14994637|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14994638|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14994639|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14994640|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994641|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
14994642|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14994643|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14994644|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14994645|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994646|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
14994647|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994648|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994649|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14994650|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994651|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
14994652|NCT01751425|Dasatinib|dasatinib|mesh-list
14994653|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
14994654|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994655|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14994656|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994657|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994658|NCT01751763|Sorafenib|sorafenib|mesh-list
14994659|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994660|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14994661|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994662|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994663|NCT01751828|Sertraline|sertraline|mesh-list
14994664|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
14994665|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14994666|NCT01751828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14994667|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14994668|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14994669|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994670|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994671|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
14994672|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994673|NCT01751854|Citalopram|citalopram|mesh-list
14994674|NCT01751854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14994675|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14994676|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14994677|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994678|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994679|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
14994680|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994681|NCT01751854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14994682|NCT01751854|Antidepressive Agents|antidepressive agents|mesh-ancestor
14994683|NCT01751854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14994684|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
14994685|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994686|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14994687|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994688|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994689|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
14994690|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994691|NCT01752075|Lenalidomide|lenalidomide|mesh-list
14994692|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
14994693|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994694|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14994695|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14994696|NCT01752075|Growth Substances|growth substances|mesh-ancestor
14994697|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
14994698|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031817|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
15031818|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031819|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15031820|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15031821|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15031822|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14523688|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
14994699|NCT01752153|Silymarin|silymarin|mesh-list
14994700|NCT01752153|Deferoxamine|deferoxamine|mesh-list
14994701|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
14994702|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994703|NCT01752153|Protective Agents|protective agents|mesh-ancestor
14994704|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994705|NCT01752153|Siderophores|siderophores|mesh-ancestor
14994706|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14994707|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
14994708|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
14994709|NCT01752205|Paclitaxel|paclitaxel|mesh-list
14994710|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14994711|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14994712|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994713|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
14994714|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
14994715|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
14994716|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994717|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14994718|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994719|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
14994720|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14994721|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14994722|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994723|NCT01752244|Vitamins|vitamins|mesh-ancestor
14994724|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
14994725|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
14994726|NCT01752270|Cyproterone|cyproterone|mesh-list
14994727|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
14994728|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
14994729|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
14994730|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14994731|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994732|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994733|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14994734|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
14994735|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14994736|NCT01752322|Lidocaine|lidocaine|mesh-list
14994737|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
14994738|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
14994739|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994740|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994741|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
14994742|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994743|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14994744|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14994745|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14994746|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14994747|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994748|NCT01752517|Vinorelbine|vinorelbine|mesh-list
14994749|NCT01752517|Ifosfamide|ifosfamide|mesh-list
14994750|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14994751|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994752|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
14994753|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
14994754|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
14994755|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994756|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14994757|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
14994758|NCT01752543|Conivaptan|conivaptan|mesh-list
14994759|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14994760|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994761|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
14994762|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994763|NCT01752686|Carboplatin|carboplatin|mesh-list
14994764|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994765|NCT01752699|Methadone|methadone|mesh-list
14994766|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14994767|NCT01752699|Narcotics|narcotics|mesh-ancestor
14994768|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994769|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994770|NCT01752699|Analgesics|analgesics|mesh-ancestor
14994771|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
14994772|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994773|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
14523689|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14994774|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
14994775|NCT01752790|Azathioprine|azathioprine|mesh-list
14994776|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14994777|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
14994778|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994779|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14994780|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994781|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14994782|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
14994783|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994784|NCT01752881|Vaccines|vaccines|mesh-list
14994785|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
14994786|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994787|NCT01752959|Remifentanil|remifentanil|mesh-list
14994788|NCT01752959|Esmolol|esmolol|mesh-list
14994789|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14994790|NCT01752959|Narcotics|narcotics|mesh-ancestor
14994791|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994792|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994793|NCT01752959|Analgesics|analgesics|mesh-ancestor
14994794|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
14994795|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994796|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14994797|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14994798|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14994799|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
14994800|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994801|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994802|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
14994803|NCT01752998|Narcotics|narcotics|mesh-ancestor
14994804|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994805|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994806|NCT01752998|Analgesics|analgesics|mesh-ancestor
14994807|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
14994808|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994809|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14994810|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14994811|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
14994812|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994813|NCT01753102|Estradiol|estradiol|mesh-list
14994814|NCT01753102|Estrogens|estrogens|mesh-ancestor
14994815|NCT01753102|Hormones|hormones|mesh-ancestor
14994816|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14994817|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994818|NCT01753128|Imipramine|imipramine|mesh-list
15035397|NCT02001285|Narcotics|narcotics|mesh-ancestor
14994819|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14994820|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
14994821|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14994822|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14994823|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14994824|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14994825|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994826|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
14994827|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994828|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994829|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14994830|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
14994831|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14994832|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14994833|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14994834|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14994835|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994836|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
14994837|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994838|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994839|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14994840|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994841|NCT01753375|Vitamin D|vitamin d|mesh-list
14994842|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
14994843|NCT01753375|Vitamins|vitamins|mesh-ancestor
14994844|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
14994845|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994846|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14994847|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14994848|NCT01753453|Plerixafor|plerixafor|mesh-list
14994849|NCT01753453|Sargramostim|sargramostim|mesh-list
14994850|NCT01753453|Lenograstim|lenograstim|mesh-list
14994851|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
14994852|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994853|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14994854|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14994855|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14994856|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
14994857|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14994858|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14994859|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14994860|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
14994861|NCT01753752|Chitosan|chitosan|mesh-list
14994862|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14994863|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14994864|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14994865|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
14994866|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14994867|NCT01753752|Expectorants|expectorants|mesh-ancestor
14994868|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
14994869|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14994870|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
14994871|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994872|NCT01753752|Protective Agents|protective agents|mesh-ancestor
14994873|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994874|NCT01753752|Antidotes|antidotes|mesh-ancestor
14994875|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14994876|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14994877|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
14994878|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14994879|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
14994880|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
14994881|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
14994882|NCT01753752|Coagulants|coagulants|mesh-ancestor
15031823|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15031824|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031825|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15031826|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031827|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15031828|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
15031829|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15031830|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
15031831|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15031832|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15031833|NCT01977417|Analgesics|analgesics|mesh-ancestor
14523690|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14523691|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523692|NCT03610464|Amphetamine|amphetamine|mesh-list
14523693|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14523694|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523695|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
14523696|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
14523697|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523698|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
14523699|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801796|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
14801797|NCT00794755|Vitamins|vitamins|mesh-ancestor
14801798|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
14801799|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801800|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14801801|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14801802|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801803|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
14801804|NCT00794755|Coagulants|coagulants|mesh-ancestor
14801805|NCT00794807|Alefacept|alefacept|mesh-list
14801806|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
14801807|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
14801808|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801809|NCT00794859|Sorafenib|sorafenib|mesh-list
14801810|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801811|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14801812|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801813|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801814|NCT00794885|Folic Acid|folic acid|mesh-list
14801815|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
14801816|NCT00794885|Enalapril|enalapril|mesh-list
14801817|NCT00794885|Enalaprilat|enalaprilat|mesh-list
14801818|NCT00794885|Maleic acid|maleic acid|mesh-list
14801819|NCT00794885|Hematinics|hematinics|mesh-ancestor
14801820|NCT00794885|Vitamins|vitamins|mesh-ancestor
14801821|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
14801822|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801823|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801824|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529795|NCT03680911|Protective Agents|protective agents|mesh-ancestor
15031834|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
15031835|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994883|NCT01753882|Citalopram|citalopram|mesh-list
14994884|NCT01753882|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14994885|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14994886|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14994887|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994888|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994889|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
14994890|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994891|NCT01753882|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14994892|NCT01753882|Antidepressive Agents|antidepressive agents|mesh-ancestor
14994893|NCT01753882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14994894|NCT01754116|Cabotegravir|cabotegravir|mesh-list
14994895|NCT01754116|Midazolam|midazolam|mesh-list
14994896|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14994897|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14994898|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994899|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994900|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14994901|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14994902|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14994903|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14994904|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
14994905|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
14994906|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
14994907|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
14994908|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14994909|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994910|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14994911|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14994912|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994913|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14994914|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14994915|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
14994916|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14994917|NCT01754181|Insulin|insulin|mesh-list
14994918|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14994919|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994920|NCT01754220|Montelukast|montelukast|mesh-list
14994921|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14994922|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
14994923|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14994924|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
14994925|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14994926|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994927|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14994928|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14994929|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994930|NCT01754285|Octreotide|octreotide|mesh-list
14994931|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14994932|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14994933|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994934|NCT01754324|Methadone|methadone|mesh-list
14994935|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14994936|NCT01754324|Narcotics|narcotics|mesh-ancestor
14994937|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14994938|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994939|NCT01754324|Analgesics|analgesics|mesh-ancestor
14994940|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
14994941|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14994942|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
14994943|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
14994944|NCT01754649|Misoprostol|misoprostol|mesh-list
14994945|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14994946|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
14994947|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14994948|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994949|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14994950|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14994951|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
14994952|NCT01754701|Iron|iron|mesh-list
14994953|NCT01754701|Trace Elements|trace elements|mesh-ancestor
14994954|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
14994955|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994956|NCT01754792|Inositol|inositol|mesh-list
14994957|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
14994958|NCT01754792|Vitamins|vitamins|mesh-ancestor
14994959|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
14994960|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994961|NCT01754805|Methotrexate|methotrexate|mesh-list
14994962|NCT01754805|Peficitinib|peficitinib|mesh-list
14994963|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14994964|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
14994965|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14994966|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994967|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14994968|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
14994969|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994970|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994971|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
14994972|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994973|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14994974|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14994975|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
14994976|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14994977|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14994978|NCT01754831|Fluorides|fluorides|mesh-list
14994979|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
14994980|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
14994981|NCT01754831|Protective Agents|protective agents|mesh-ancestor
14994982|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994983|NCT01754844|AZD7624|azd7624|mesh-list
14994984|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14994985|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14994986|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14994987|NCT01754870|Rituximab|rituximab|mesh-list
14994988|NCT01754870|Lenalidomide|lenalidomide|mesh-list
14994989|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14994990|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14994991|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14994992|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
14994993|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14994994|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14994995|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14994996|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14994997|NCT01754870|Growth Substances|growth substances|mesh-ancestor
14994998|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
14994999|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14995000|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
14995001|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995002|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
14995003|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
14995004|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14995005|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995006|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995007|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
14995008|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14995009|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995010|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995011|NCT01754961|Vitamin D|vitamin d|mesh-list
14995012|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
14995013|NCT01754961|Vitamins|vitamins|mesh-list
14995014|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
14995015|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995016|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14995017|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14995018|NCT01754974|Ribavirin|ribavirin|mesh-list
14995019|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14995020|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
14995021|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995022|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
14995023|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14995024|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
14995025|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
14995026|NCT01755078|Calcium|calcium|mesh-list
14995027|NCT01755078|Sevelamer|sevelamer|mesh-list
14995028|NCT01755078|Calcium acetate|calcium acetate|mesh-list
14995029|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14995030|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995031|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14995032|NCT01755078|Antacids|antacids|mesh-ancestor
14995033|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995034|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14995035|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
14995036|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
14995037|NCT01755117|Ropivacaine|ropivacaine|mesh-list
14995038|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
14995039|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
14995040|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995041|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995042|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
14995043|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995044|NCT01755182|Somatostatin|somatostatin|mesh-list
14995045|NCT01755182|Hormones|hormones|mesh-ancestor
14995046|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14995047|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995048|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
14995049|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14995050|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14995051|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14995052|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14995053|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995054|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995055|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995056|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14995057|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14995058|NCT01755299|Caffeine|caffeine|mesh-list
14995059|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14995060|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995061|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14995062|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995063|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995064|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14995065|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14995066|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
14995067|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14995068|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
14995069|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14995070|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14995071|NCT01755338|Prednisolone|prednisolone|mesh-list
14995072|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
14995073|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14995074|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
14995075|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14995076|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
14995077|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
14995078|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995079|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995080|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14995081|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
14995082|NCT01755338|Hormones|hormones|mesh-ancestor
14995083|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14995084|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14995085|NCT01755338|Protective Agents|protective agents|mesh-ancestor
14995086|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14995087|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995088|NCT01755377|Benzonidazole|benzonidazole|mesh-list
14995089|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14995090|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
14995091|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995092|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14995093|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14995094|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14995095|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14995096|NCT01755403|Benzonidazole|benzonidazole|mesh-list
14995097|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14995098|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
14995099|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995100|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14995101|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14995102|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14995103|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14995104|NCT01755468|Insulin|insulin|mesh-list
14995105|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14995106|NCT01755468|Metformin|metformin|mesh-list
14995107|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
14995108|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
14995109|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14995110|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995111|NCT01755494|Metformin|metformin|mesh-list
14995112|NCT01755494|Saxagliptin|saxagliptin|mesh-list
14995113|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14995114|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995115|NCT01755494|Incretins|incretins|mesh-ancestor
14995116|NCT01755494|Hormones|hormones|mesh-ancestor
14995117|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14995118|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14995119|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
14995120|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995121|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995122|NCT01755520|Aspirin|aspirin|mesh-list
14995123|NCT01755520|Ticagrelor|ticagrelor|mesh-list
14995124|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14995125|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14995126|NCT01755520|Analgesics|analgesics|mesh-ancestor
14995127|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
14995128|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995129|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995130|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14995131|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14995132|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14995133|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14995134|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995135|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14995136|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14995137|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995138|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
14995139|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14995140|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14995141|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14995142|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
14995143|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14995144|NCT01755559|Artesunate|artesunate|mesh-list
14995145|NCT01755559|Lumefantrine|lumefantrine|mesh-list
14995146|NCT01755559|Artemether|artemether|mesh-list
14995147|NCT01755559|Piperaquine|piperaquine|mesh-list
14995148|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14995149|NCT01755559|Amodiaquine|amodiaquine|mesh-list
14995150|NCT01755559|Artenimol|artenimol|mesh-list
14995151|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
14995152|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14995153|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14995154|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14995155|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995156|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
14995157|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
14995158|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14995159|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
14995160|NCT01755572|Liraglutide|liraglutide|mesh-list
14995161|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14995162|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995163|NCT01755572|Incretins|incretins|mesh-ancestor
14995164|NCT01755572|Hormones|hormones|mesh-ancestor
14995165|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031836|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031837|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15031838|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15031839|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15031840|NCT01977430|Furosemide|furosemide|mesh-list
15031841|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15031842|NCT01977430|Diuretics|diuretics|mesh-ancestor
15031843|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
15031844|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995166|NCT01755611|Minocycline|minocycline|mesh-list
14995167|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14995168|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14995169|NCT01755663|Metoprolol|metoprolol|mesh-list
14995170|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14995171|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14995172|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
14995173|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
14995174|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995175|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995176|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14995177|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14995178|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14995179|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
14995180|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14995181|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995182|NCT01755676|Orlistat|orlistat|mesh-list
14995183|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995184|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995185|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14995186|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14995187|NCT01755728|Acetaminophen|acetaminophen|mesh-list
14995188|NCT01755728|Ibuprofen|ibuprofen|mesh-list
14995189|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14995190|NCT01755728|Analgesics|analgesics|mesh-ancestor
14995191|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
14995192|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995193|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995194|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
14995195|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14995196|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14995197|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14995198|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14995199|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995200|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995201|NCT01755845|Paclitaxel|paclitaxel|mesh-list
14995202|NCT01755845|Cisplatin|cisplatin|mesh-list
14995203|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14995204|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995205|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
14995206|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
14995207|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
14995208|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995209|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14995210|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14995211|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995212|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14995213|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
14995214|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995215|NCT01755897|Paclitaxel|paclitaxel|mesh-list
14995216|NCT01755897|Cisplatin|cisplatin|mesh-list
14995217|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14995218|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995219|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
14995220|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
14995221|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
14995222|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995223|NCT01755923|Docetaxel|docetaxel|mesh-list
14995224|NCT01755923|Gefitinib|gefitinib|mesh-list
14995225|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995226|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
14995227|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
14995228|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
14995229|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995230|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14995231|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995232|NCT01756040|Lactulose|lactulose|mesh-list
14995233|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14995234|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14995235|NCT01756105|Insulin|insulin|mesh-list
14995236|NCT01756105|Metformin|metformin|mesh-list
14995237|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
14995238|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
14995239|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
14995240|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14995241|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995242|NCT01756118|Dactolisib|dactolisib|mesh-list
14995243|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995244|NCT01756131|Cabotegravir|cabotegravir|mesh-list
14995245|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14995246|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14995247|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995248|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995249|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14995250|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14523700|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523701|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
14523702|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14523703|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14523704|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14523705|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14523706|NCT03610633|Oxytocin|oxytocin|mesh-list
14523707|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
14523708|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14523709|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523710|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
14995251|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
14995252|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14995253|NCT01756170|Paclitaxel|paclitaxel|mesh-list
14995254|NCT01756170|Cisplatin|cisplatin|mesh-list
14995255|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14995256|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995257|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
14995258|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
14995259|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
14995260|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995261|NCT01756183|Paclitaxel|paclitaxel|mesh-list
14995262|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14995263|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995264|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
14995265|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
14995266|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
14995267|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995268|NCT01756248|Aflibercept|aflibercept|mesh-list
14995269|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14995270|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14995271|NCT01756248|Growth Substances|growth substances|mesh-ancestor
14995272|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995273|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
14995274|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995275|NCT01756261|Aflibercept|aflibercept|mesh-list
14995276|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14995277|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14995278|NCT01756261|Growth Substances|growth substances|mesh-ancestor
14995279|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995280|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
14995281|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995282|NCT01756404|Canagliflozin|canagliflozin|mesh-list
14995283|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14995284|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995285|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14995286|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995287|NCT01756417|Metformin|metformin|mesh-list
14995288|NCT01756417|Canagliflozin|canagliflozin|mesh-list
14995289|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14995290|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995291|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14995292|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995293|NCT01756430|Carvedilol|carvedilol|mesh-list
14995294|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14995295|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14995296|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
14995297|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14995298|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995299|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995300|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14995301|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
14995302|NCT01756430|Protective Agents|protective agents|mesh-ancestor
14995303|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14995304|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14995305|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14995306|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
14995307|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14995308|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14995309|NCT01756443|Lidocaine|lidocaine|mesh-list
14995310|NCT01756443|Epinephrine|epinephrine|mesh-list
14995311|NCT01756443|Racepinephrine|racepinephrine|mesh-list
14995312|NCT01756443|Bupivacaine|bupivacaine|mesh-list
14995313|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
14995314|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
14995315|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
14995316|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995317|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995318|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
14995319|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995320|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14995321|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14995322|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14995323|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14995324|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995325|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14995326|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14995327|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
14995328|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14995329|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14995330|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14995331|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
14995332|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14995333|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
14995334|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
14995335|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
14995336|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14995337|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
14995338|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14995339|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14995340|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14995341|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14995342|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14995343|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995344|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995345|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995346|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14995347|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
14995348|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14995349|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995350|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14995351|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14995352|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14995353|NCT01756508|Eculizumab|eculizumab|mesh-list
14995354|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14995355|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14995356|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
14995357|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995358|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
14995359|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14995360|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14995361|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14995362|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14995363|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995364|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995365|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995366|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
14995367|NCT01756547|Diuretics|diuretics|mesh-ancestor
14995368|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
14995369|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995370|NCT01756547|Expectorants|expectorants|mesh-ancestor
14995371|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
14995372|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
14995373|NCT01756612|Hematinics|hematinics|mesh-ancestor
14995374|NCT01756638|Prednisolone|prednisolone|mesh-list
14995375|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14995376|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
14995377|NCT01756638|Hormones|hormones|mesh-ancestor
14995378|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14995379|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995380|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14995381|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995382|NCT01756651|Fentanyl|fentanyl|mesh-list
14995383|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14995384|NCT01756651|Narcotics|narcotics|mesh-ancestor
14995385|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995386|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995387|NCT01756651|Analgesics|analgesics|mesh-ancestor
14995388|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
14995389|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995390|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14995391|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14995392|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
14995393|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
14995394|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
14995395|NCT01756664|Petrolatum|petrolatum|mesh-list
14995396|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14995397|NCT01756664|Protective Agents|protective agents|mesh-ancestor
14995398|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995399|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
14995400|NCT01756664|Emollients|emollients|mesh-ancestor
14995401|NCT01756768|Palbociclib|palbociclib|mesh-list
14995402|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995403|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14995404|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995405|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995406|NCT01756781|Palbociclib|palbociclib|mesh-list
14995407|NCT01756781|Midazolam|midazolam|mesh-list
14523711|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14523712|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523713|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14523714|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14523715|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523716|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995408|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14995409|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14995410|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995411|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995412|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14995413|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14995414|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14995415|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14995416|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
14995417|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
14995418|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
14995419|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
14995420|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14995421|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995422|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995423|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14995424|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995425|NCT01756989|Thalidomide|thalidomide|mesh-list
14995426|NCT01756989|Celecoxib|celecoxib|mesh-list
14995427|NCT01756989|Etoposide|etoposide|mesh-list
14995428|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
14995429|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14995430|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995431|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14995432|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14995433|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995434|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995435|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14995436|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14995437|NCT01756989|Analgesics|analgesics|mesh-ancestor
14995438|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
14995439|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995440|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995441|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14995442|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14995443|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14995444|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14995445|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14995446|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
14995447|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
14995448|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14995449|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14995450|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14995451|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14995452|NCT01756989|Growth Substances|growth substances|mesh-ancestor
14995453|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
14995454|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
14995455|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14995456|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14995457|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14995458|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
14995459|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14995460|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995461|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995462|NCT01757106|Sevoflurane|sevoflurane|mesh-list
14995463|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14995464|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14995465|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
14995466|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
14995467|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995468|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995469|NCT01757236|Vancomycin|vancomycin|mesh-list
14995470|NCT01757236|Rifampin|rifampin|mesh-list
14995471|NCT01757236|Clindamycin|clindamycin|mesh-list
14995472|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
14995473|NCT01757236|Linezolid|linezolid|mesh-list
14995474|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14995475|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
14995476|NCT01757236|Trimethoprim|trimethoprim|mesh-list
14995477|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
14995478|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14995479|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14995480|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14995481|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
14995482|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
14995483|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14995484|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995485|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995486|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14995487|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14995488|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14995489|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14995490|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14995491|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14995492|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14995493|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14995494|NCT01757236|Renal Agents|renal agents|mesh-ancestor
14995495|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
14995496|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14995497|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14995498|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14995499|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14995500|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14995501|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14995502|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
14995503|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14995504|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14995505|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
14995506|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14995507|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14995508|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995509|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14995510|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14995511|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14995512|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14995513|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14995514|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14995515|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14995516|NCT01757262|Clopidogrel|clopidogrel|mesh-list
14995517|NCT01757262|Ticagrelor|ticagrelor|mesh-list
14995518|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14995519|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14995520|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14995521|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14995522|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
14995523|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14995524|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995525|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995526|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
14995527|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14995528|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031845|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15031846|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15031847|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031848|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15031849|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15031850|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15031851|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
15031852|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
15031853|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035398|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15035399|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035400|NCT02001285|Analgesics|analgesics|mesh-ancestor
15035401|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
15035402|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035403|NCT02001298|Nitroprusside|nitroprusside|mesh-list
14523717|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995529|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
14995530|NCT01757418|Antibodies|antibodies|mesh-list
14995531|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
14995532|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14995533|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14995534|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
14995535|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995536|NCT01757431|Eculizumab|eculizumab|mesh-list
14995537|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14995538|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14995539|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
14995540|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995541|NCT01757457|Abciximab|abciximab|mesh-list
14995542|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
14995543|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14995544|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
14995545|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14995546|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995547|NCT01757587|Insulin|insulin|mesh-list
14995548|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14995549|NCT01757587|Metformin|metformin|mesh-list
14995550|NCT01757587|Vildagliptin|vildagliptin|mesh-list
14995551|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14995552|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995553|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14995554|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
14995555|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995556|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995557|NCT01757626|Molgramostim|molgramostim|mesh-list
14995558|NCT01757626|Sargramostim|sargramostim|mesh-list
14995559|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
14995560|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995561|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995562|NCT01757639|Ipilimumab|ipilimumab|mesh-list
14995563|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14995564|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995565|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14995566|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995567|NCT01757756|Midazolam|midazolam|mesh-list
14995568|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14995569|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14995570|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995571|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995572|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14995573|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14995574|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14995575|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14995576|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
14995577|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
14995578|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
14995579|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
14995580|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14995581|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995582|NCT01757769|Silodosin|silodosin|mesh-list
14995583|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14995584|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14995585|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14995586|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
14995587|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14995588|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995589|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995590|NCT01757769|Urological Agents|urological agents|mesh-ancestor
14995591|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
14995592|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
14995593|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14995594|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14995595|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995596|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995597|NCT01757782|Urological Agents|urological agents|mesh-ancestor
14995598|NCT01757795|Otaplimastat|otaplimastat|mesh-list
14995599|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14995600|NCT01757795|Protective Agents|protective agents|mesh-ancestor
14995601|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995602|NCT01757808|Ranolazine|ranolazine|mesh-list
14995603|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14995604|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14995605|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995606|NCT01757860|Vitamin D|vitamin d|mesh-list
14995607|NCT01757860|Vitamins|vitamins|mesh-ancestor
14995608|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
14995609|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995610|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14995611|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
14995612|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14995613|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14995614|NCT01757899|Prednisolone|prednisolone|mesh-list
14995615|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
14995616|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14995617|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
14995618|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14995619|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
14995620|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
14995621|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995622|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995623|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14995624|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
14995625|NCT01757899|Hormones|hormones|mesh-ancestor
14995626|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14995627|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14995628|NCT01757899|Protective Agents|protective agents|mesh-ancestor
14995629|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14995630|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995631|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
14995632|NCT01758029|Testosterone|testosterone|mesh-list
14995633|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
14995634|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
14995635|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14995636|NCT01758029|Androgens|androgens|mesh-ancestor
14995637|NCT01758029|Hormones|hormones|mesh-ancestor
14995638|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14995639|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995640|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14995641|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995642|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
14995643|NCT01758094|Testosterone|testosterone|mesh-list
14995644|NCT01758094|Androgens|androgens|mesh-ancestor
14995645|NCT01758094|Hormones|hormones|mesh-ancestor
14995646|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14995647|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995648|NCT01758107|Cyclosporine|cyclosporine|mesh-list
14995649|NCT01758107|Cyclosporins|cyclosporins|mesh-list
14995650|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995651|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995652|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14995653|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
14995654|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995655|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
14995656|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14995657|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
14995658|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14995659|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14995660|NCT01758120|Prednisone|prednisone|mesh-list
14995661|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
14995662|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14995663|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
14995664|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995665|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14995666|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14995667|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
14995668|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995669|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995670|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14995671|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14995672|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
14995673|NCT01758120|Hormones|hormones|mesh-ancestor
14995674|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14995675|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14995676|NCT01758146|Tamoxifen|tamoxifen|mesh-list
14995677|NCT01758146|Letrozole|letrozole|mesh-list
14995678|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995679|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14995680|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14995681|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995682|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995683|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14995684|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
14995685|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14995686|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995687|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14995688|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14995689|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14995690|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14995691|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
14995692|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
14995693|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
14995694|NCT01758185|Vaccines|vaccines|mesh-list
14995695|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
14995696|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995697|NCT01758198|Methotrexate|methotrexate|mesh-list
14995698|NCT01758198|Abatacept|abatacept|mesh-list
14995699|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14995700|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
14995701|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14995702|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995703|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14995704|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
14995705|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995706|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995707|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
14995708|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995709|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14995710|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14995711|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
14995712|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14995713|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14995714|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14995715|NCT01758263|Metoprolol|metoprolol|mesh-list
14995716|NCT01758263|Nebivolol|nebivolol|mesh-list
14995717|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14995718|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14995719|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
14995720|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
14995721|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995722|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995723|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14995724|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14995725|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14995726|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
14995727|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14995728|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995729|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
14995730|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14995731|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14995732|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14995733|NCT01758367|Decitabine|decitabine|mesh-list
14995734|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14995735|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
14995736|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995737|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995738|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995739|NCT01758380|Metformin|metformin|mesh-list
14995740|NCT01758380|Vildagliptin|vildagliptin|mesh-list
14995741|NCT01758380|Gliclazide|gliclazide|mesh-list
14995742|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14995743|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995744|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14995745|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
14995746|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995747|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995748|NCT01758393|Prednisone|prednisone|mesh-list
14995749|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14995750|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
14995751|NCT01758393|Hormones|hormones|mesh-ancestor
14995752|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14995753|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995754|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14995755|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995756|NCT01758471|Acarbose|acarbose|mesh-list
14995757|NCT01758471|Glipizide|glipizide|mesh-list
14995758|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14995759|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995760|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995761|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14995762|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995763|NCT01758627|Icodextrin|icodextrin|mesh-list
14995764|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
14995765|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14995766|NCT01758640|Warfarin|warfarin|mesh-list
14995767|NCT01758640|Phenindione|phenindione|mesh-list
14995768|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
14995769|NCT01758666|Leucovorin|leucovorin|mesh-list
14995770|NCT01758666|Methotrexate|methotrexate|mesh-list
14995771|NCT01758666|Calcium|calcium|mesh-list
14995772|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
14995773|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14995774|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995775|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14995776|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
14995777|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14995778|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14995779|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
14995780|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995781|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995782|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
14995783|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995784|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14995785|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14995786|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
14995787|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14995788|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14995789|NCT01758666|Antidotes|antidotes|mesh-ancestor
14995790|NCT01758666|Protective Agents|protective agents|mesh-ancestor
14995791|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
14995792|NCT01758666|Vitamins|vitamins|mesh-ancestor
14995793|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
14995794|NCT01758744|Treprostinil|treprostinil|mesh-list
14995795|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14995796|NCT01758809|Bupivacaine|bupivacaine|mesh-list
14995797|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
14995798|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
14995799|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995800|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995801|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
14995802|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995803|NCT01758835|Calpastatin|calpastatin|mesh-list
14995804|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
14995805|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
14995806|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995807|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995808|NCT01758861|Anesthetics|anesthetics|mesh-list
14995809|NCT01758861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995810|NCT01758861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995811|NCT01758913|Ibuprofen|ibuprofen|mesh-list
14995812|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14995813|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14995814|NCT01758913|Analgesics|analgesics|mesh-ancestor
14995815|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
14995816|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995817|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995818|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14995819|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14995820|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14995821|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995822|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995823|NCT01758978|Hydrocodone|hydrocodone|mesh-list
14995824|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14995825|NCT01758978|Narcotics|narcotics|mesh-ancestor
14995826|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995827|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995828|NCT01758978|Analgesics|analgesics|mesh-ancestor
14995829|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
14995830|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995831|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
14995832|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
15031854|NCT01977989|Vancomycin|vancomycin|mesh-list
15031855|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15031856|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031857|NCT01978015|Timolol|timolol|mesh-list
15031858|NCT01978015|Bimatoprost|bimatoprost|mesh-list
15031859|NCT01978015|Travoprost|travoprost|mesh-list
15031860|NCT01978015|Dextrans|dextrans|mesh-list
15031861|NCT01978015|Latanoprost|latanoprost|mesh-list
15031862|NCT01978015|Maleic acid|maleic acid|mesh-list
15031863|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15031864|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15031865|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
15031866|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15031867|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031868|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031869|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15031870|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15031871|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031872|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15031873|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15031874|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
15031875|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
15031876|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
15031877|NCT01978041|Fluorides|fluorides|mesh-list
15031878|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
15031879|NCT01978041|Protective Agents|protective agents|mesh-ancestor
15031880|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031881|NCT01978301|Triamcinolone|triamcinolone|mesh-list
15031882|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15031883|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15031884|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15031885|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15031886|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
15031887|NCT01978301|Hormones|hormones|mesh-ancestor
15031888|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031889|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031890|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15031891|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
15031892|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031893|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031894|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
15031895|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
15031896|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031897|NCT01978405|Protective Agents|protective agents|mesh-ancestor
15031898|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031899|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
15031900|NCT01978405|Vitamins|vitamins|mesh-ancestor
15031901|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
15031902|NCT01978418|Albuterol|albuterol|mesh-list
15031903|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15031904|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
15031905|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031906|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031907|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15031908|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
15031909|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
15031910|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15031911|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15031912|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15031913|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15031914|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
15031915|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15031916|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031917|NCT01978431|Cocaine|cocaine|mesh-list
15031918|NCT01978431|Methylphenidate|methylphenidate|mesh-list
14995833|NCT01759030|Rituximab|rituximab|mesh-list
14995834|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14995835|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995836|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
14995837|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995838|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14995839|NCT01759108|Rebamipide|rebamipide|mesh-list
14995840|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14995841|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14995842|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
14995843|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995844|NCT01759108|Protective Agents|protective agents|mesh-ancestor
14995845|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995846|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995847|NCT01759238|Bevacizumab|bevacizumab|mesh-list
14995848|NCT01759238|Capecitabine|capecitabine|mesh-list
14995849|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14995850|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995851|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14995852|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14995853|NCT01759238|Growth Substances|growth substances|mesh-ancestor
14995854|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995855|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
14995856|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14995857|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
14995858|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995859|NCT01759394|Maleic acid|maleic acid|mesh-list
14995860|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14995861|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995862|NCT01759459|Lidocaine|lidocaine|mesh-list
14995863|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
14995864|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
14995865|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995866|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995867|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
14995868|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995869|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14995870|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14995871|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14995872|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14995873|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995874|NCT01759485|Vitamin D|vitamin d|mesh-list
14995875|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
14995876|NCT01759485|Vitamins|vitamins|mesh-ancestor
14995877|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
14995878|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995879|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14995880|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14995881|NCT01759524|Lidocaine|lidocaine|mesh-list
14995882|NCT01759524|Clonidine|clonidine|mesh-list
14995883|NCT01759524|Bupivacaine|bupivacaine|mesh-list
14995884|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
14995885|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
14995886|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995887|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995888|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
14995889|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995890|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14995891|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14995892|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14995893|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15035404|NCT02001298|Remifentanil|remifentanil|mesh-list
14995894|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995895|NCT01759524|Analgesics|analgesics|mesh-ancestor
14995896|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14995897|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
14995898|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
14995899|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14995900|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14995901|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14995902|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
14995903|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14995904|NCT01759576|Canagliflozin|canagliflozin|mesh-list
14995905|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14995906|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995907|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14995908|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995909|NCT01759589|Remifentanil|remifentanil|mesh-list
14995910|NCT01759589|Propofol|propofol|mesh-list
14995911|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
14995912|NCT01759589|Sevoflurane|sevoflurane|mesh-list
14995913|NCT01759589|Anesthetics|anesthetics|mesh-list
14995914|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14995915|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995916|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995917|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
14995918|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14995919|NCT01759589|Narcotics|narcotics|mesh-ancestor
14995920|NCT01759589|Analgesics|analgesics|mesh-ancestor
14995921|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
14995922|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995923|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14995924|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14995925|NCT01759706|Dexamethasone|dexamethasone|mesh-list
14995926|NCT01759706|Sufentanil|sufentanil|mesh-list
14995927|NCT01759706|Diazepam|diazepam|mesh-list
14995928|NCT01759706|Ondansetron|ondansetron|mesh-list
14995929|NCT01759706|Anesthetics|anesthetics|mesh-list
14995930|NCT01759706|Ropivacaine|ropivacaine|mesh-list
14995931|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14995932|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
14995933|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
14995934|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14995935|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995936|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14995937|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
14995938|NCT01759706|Hormones|hormones|mesh-ancestor
14995939|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14995940|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14995941|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995942|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14995943|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
14995944|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
14995945|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14995946|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
14995947|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14995948|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995949|NCT01759706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14995950|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14995951|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14995952|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14995953|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14995954|NCT01759706|Narcotics|narcotics|mesh-ancestor
14995955|NCT01759706|Analgesics|analgesics|mesh-ancestor
14995956|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
14995957|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14995958|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14995959|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
14995960|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
14995961|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
14995962|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14995963|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14995964|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14995965|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
14995966|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
14995967|NCT01759719|Chromium|chromium|mesh-list
14995968|NCT01759719|Trace Elements|trace elements|mesh-ancestor
14995969|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
14995970|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995971|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
14995972|NCT01759732|Fludarabine|fludarabine|mesh-list
14995973|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14995974|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14995975|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
14995976|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995977|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14995978|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14995979|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
14995980|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14995981|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14995982|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14995983|NCT01759771|Vitamin D|vitamin d|mesh-list
14995984|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
14995985|NCT01759771|Vitamins|vitamins|mesh-ancestor
14995986|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
14995987|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995988|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14995989|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14995990|NCT01759810|Vaccines|vaccines|mesh-list
14995991|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
14995992|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14995993|NCT01759875|Ritonavir|ritonavir|mesh-list
14995994|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14995995|NCT01759875|Rabeprazole|rabeprazole|mesh-list
14995996|NCT01759875|Betaine|betaine|mesh-list
14995997|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14995998|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14995999|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
14996000|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996001|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996002|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14996003|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14996004|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
14996005|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996006|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14996007|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14996008|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14996009|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14996010|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14996011|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
14996012|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14996013|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
14996014|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14996015|NCT01759940|Ropivacaine|ropivacaine|mesh-list
14996016|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
14996017|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
14996018|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14996019|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996020|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
14996021|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996022|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14996023|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
14996024|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996025|NCT01760018|Desflurane|desflurane|mesh-list
14996026|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14996027|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
14996028|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
14996029|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14996030|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996031|NCT01760096|Cyclosporine|cyclosporine|mesh-list
14996032|NCT01760096|Levamisole|levamisole|mesh-list
14996033|NCT01760096|Cyclosporins|cyclosporins|mesh-list
14996034|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
14996035|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996036|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996037|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14996038|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
14996039|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996040|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
14996041|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996042|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
14996043|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996044|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14996045|NCT01760096|Hormones|hormones|mesh-ancestor
14996046|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14996047|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14996048|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
14996049|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
14996050|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14996051|NCT01760109|Piperacillin|piperacillin|mesh-list
14996052|NCT01760109|Sulbactam|sulbactam|mesh-list
14996053|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14996054|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996055|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14996056|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996057|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996058|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14996059|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
14996060|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996061|NCT01760148|Interferons|interferons|mesh-list
14996062|NCT01760148|Ribavirin|ribavirin|mesh-list
14996063|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
14996064|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
14996065|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996066|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
14996067|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996068|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
14996069|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996070|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
14996071|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996072|NCT01760161|Ropivacaine|ropivacaine|mesh-list
14996073|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
14996074|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
14996075|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14996076|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996077|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
14996078|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996079|NCT01760174|Bupivacaine|bupivacaine|mesh-list
14996080|NCT01760174|Ropivacaine|ropivacaine|mesh-list
14996081|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
14996082|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
14996083|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14996084|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996085|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
14996086|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996087|NCT01760226|Prednisone|prednisone|mesh-list
14996088|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
14996089|NCT01760226|Rituximab|rituximab|mesh-list
14996090|NCT01760226|Doxorubicin|doxorubicin|mesh-list
14996091|NCT01760226|Methotrexate|methotrexate|mesh-list
14996092|NCT01760226|Etoposide|etoposide|mesh-list
14996093|NCT01760226|Vincristine|vincristine|mesh-list
14996094|NCT01760226|Sargramostim|sargramostim|mesh-list
14996095|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14996096|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
14996097|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996098|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996099|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14996100|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
14996101|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996102|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996103|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14996104|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14996105|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14996106|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14996107|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14996108|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996109|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996110|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
14996111|NCT01760226|Hormones|hormones|mesh-ancestor
14996112|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14996113|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14996114|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14996115|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
14996116|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14996117|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14996118|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
14996119|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
14996120|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14996121|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14996122|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14996123|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
14996124|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
14996125|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
14996126|NCT01760252|Capecitabine|capecitabine|mesh-list
14996127|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
14996128|NCT01760252|Irinotecan|irinotecan|mesh-list
14996129|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14996130|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
14996131|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996132|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996133|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14996134|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14996135|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996136|NCT01760278|Cetrorelix|cetrorelix|mesh-list
14996137|NCT01760278|Hormones|hormones|mesh-list
14996138|NCT01760278|Progesterone|progesterone|mesh-list
14996139|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14996140|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14996141|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996142|NCT01760278|Progestins|progestins|mesh-ancestor
14996143|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14996144|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
14996145|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14996146|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
14996147|NCT01760330|Acetaminophen|acetaminophen|mesh-list
14996148|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14996149|NCT01760330|Analgesics|analgesics|mesh-ancestor
14996150|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
14996151|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996152|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996153|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
14996154|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
14996155|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
14996156|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14996157|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14996158|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996159|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996160|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996161|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996162|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
14996163|NCT01760460|Anacetrapib|anacetrapib|mesh-list
14996164|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14996165|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14996166|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
14996167|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996168|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14996169|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996170|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14996171|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996172|NCT01760564|Miglustat|miglustat|mesh-list
14996173|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996174|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996175|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14996176|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14996177|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
14996178|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996179|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14996180|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14996181|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996182|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
14996183|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14996184|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14996185|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
14996186|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14996187|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14996188|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996189|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
14996190|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14996191|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996192|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14996193|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996194|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14996195|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
14996196|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
14996197|NCT01760577|Protective Agents|protective agents|mesh-ancestor
15031919|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15031920|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031921|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15031922|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15031923|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15031924|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031925|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
15031926|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14996198|NCT01760642|Rifampin|rifampin|mesh-list
14996199|NCT01760642|Ketoconazole|ketoconazole|mesh-list
14996200|NCT01760642|Midazolam|midazolam|mesh-list
14996201|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14996202|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14996203|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14996204|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996205|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14996206|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14996207|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14996208|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14996209|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
14996210|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
14996211|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
14996212|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
14996213|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14996214|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996215|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14996216|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
14996217|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14996218|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996219|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
14996220|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14996221|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996222|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14996223|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14996224|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14996225|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14996226|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14996227|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14996228|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
14996229|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14996230|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14996231|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14996232|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
14996233|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14996234|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14996235|NCT01760655|Vidarabine|vidarabine|mesh-list
14996236|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
14996237|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
14996238|NCT01760655|Thiotepa|thiotepa|mesh-list
14996239|NCT01760655|Fludarabine|fludarabine|mesh-list
14996240|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
14996241|NCT01760655|Tacrolimus|tacrolimus|mesh-list
14996242|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14996243|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
14996244|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996245|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996246|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14996247|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
14996248|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996249|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996250|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14996251|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14996252|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
14996253|NCT01760655|Antiviral Agents|antiviral agents|mesh-ancestor
14996254|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996255|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14996256|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996257|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14996258|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14996259|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
14996260|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14996261|NCT01760694|Leucovorin|leucovorin|mesh-list
14996262|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
14996263|NCT01760694|Irinotecan|irinotecan|mesh-list
14996264|NCT01760694|Folfirinox|folfirinox|mesh-list
14996265|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996266|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14996267|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14996268|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996269|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996270|NCT01760694|Antidotes|antidotes|mesh-ancestor
14996271|NCT01760694|Protective Agents|protective agents|mesh-ancestor
14996272|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996273|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
14996274|NCT01760694|Vitamins|vitamins|mesh-ancestor
14996275|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
14996276|NCT01760746|Bevacizumab|bevacizumab|mesh-list
14996277|NCT01760746|Ranibizumab|ranibizumab|mesh-list
14996278|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14996279|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996280|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14996281|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14996282|NCT01760746|Growth Substances|growth substances|mesh-ancestor
14996283|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996284|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
14996285|NCT01760798|Teriparatide|teriparatide|mesh-list
14996286|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14996287|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996288|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14996289|NCT01760811|Cetuximab|cetuximab|mesh-list
14996290|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14996291|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996292|NCT01760824|Amoxicillin|amoxicillin|mesh-list
14996293|NCT01760824|Metronidazole|metronidazole|mesh-list
14996294|NCT01760824|Clarithromycin|clarithromycin|mesh-list
14996295|NCT01760824|Tetracycline|tetracycline|mesh-list
14996296|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
14996297|NCT01760824|Esomeprazole|esomeprazole|mesh-list
14996298|NCT01760824|Bismuth|bismuth|mesh-list
14996299|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14996300|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996301|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14996302|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14996303|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14996304|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14996305|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14996306|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996307|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996308|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14996309|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14996310|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14996311|NCT01760824|Antacids|antacids|mesh-ancestor
14996312|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14996313|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996314|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
14996315|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14996316|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14996317|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996318|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14996319|NCT01760967|Analgesics|analgesics|mesh-ancestor
14996320|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
14996321|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996322|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14996323|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14996324|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14996325|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
14996326|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14996327|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996328|NCT01760980|Exemestane|exemestane|mesh-list
14996329|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996330|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14996331|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14996332|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996333|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996334|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14996335|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
14996336|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14996337|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996338|NCT01761071|Diclofenac|diclofenac|mesh-list
14996339|NCT01761071|Ketorolac|ketorolac|mesh-list
14996340|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14996341|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14996342|NCT01761071|Analgesics|analgesics|mesh-ancestor
14996343|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
14996344|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996345|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996346|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996347|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996348|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14996349|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996350|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996351|NCT01761110|Buprenorphine|buprenorphine|mesh-list
14996352|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14996353|NCT01761110|Narcotics|narcotics|mesh-ancestor
14996354|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14996355|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996356|NCT01761110|Analgesics|analgesics|mesh-ancestor
14996357|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
14996358|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996359|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14996360|NCT01761136|Vaccines|vaccines|mesh-list
14996361|NCT01761136|Immunologic Factors|immunologic factors|mesh-ancestor
14996362|NCT01761136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996363|NCT01761149|Remifentanil|remifentanil|mesh-list
14996364|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14996365|NCT01761149|Narcotics|narcotics|mesh-ancestor
14996366|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14996367|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996368|NCT01761149|Analgesics|analgesics|mesh-ancestor
14996369|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
14996370|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996371|NCT01761201|Levofloxacin|levofloxacin|mesh-list
14996372|NCT01761201|Ofloxacin|ofloxacin|mesh-list
14996373|NCT01761201|Isoniazid|isoniazid|mesh-list
14996374|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14996375|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996376|NCT01761201|Renal Agents|renal agents|mesh-ancestor
14996377|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14996378|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14996379|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14996380|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996381|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996382|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996383|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14996384|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14996385|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
14996386|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14996387|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14996388|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
14996389|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14996390|NCT01761214|Amoxicillin|amoxicillin|mesh-list
14996391|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
14996392|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
14996393|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
14996394|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14996395|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
14996396|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14996397|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996398|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14996399|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14996400|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996401|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996402|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996403|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14996404|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14996405|NCT01761318|Liraglutide|liraglutide|mesh-list
14996406|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14996407|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996408|NCT01761318|Incretins|incretins|mesh-ancestor
14996409|NCT01761318|Hormones|hormones|mesh-ancestor
14996410|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14996411|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
14996412|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996413|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
14996414|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996415|NCT01761487|Gentamicins|gentamicins|mesh-list
14996416|NCT01761487|Polymyxins|polymyxins|mesh-list
14996417|NCT01761487|Colistin|colistin|mesh-list
14996418|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14996419|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996420|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14996421|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996422|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996423|NCT01761513|Esomeprazole|esomeprazole|mesh-list
14996424|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14996425|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14996426|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14996427|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996428|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996429|NCT01761526|Rotigotine|rotigotine|mesh-list
14996430|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
14996431|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
14996432|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14996433|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996434|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996435|NCT01761552|Atropine|atropine|mesh-list
14996436|NCT01761552|Neostigmine|neostigmine|mesh-list
14996437|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14996438|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14996439|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14996440|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
14996441|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996442|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996443|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14996444|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
14996445|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
14996446|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
14996447|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14996448|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14996449|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
14996450|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14996451|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996452|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14996453|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996454|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14996455|NCT01761656|Atorvastatin|atorvastatin|mesh-list
14996456|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14996457|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14996458|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
14996459|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996460|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14996461|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14996462|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996463|NCT01761669|Vitamin D|vitamin d|mesh-list
14996464|NCT01761669|Vitamins|vitamins|mesh-ancestor
14996465|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
14996466|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996467|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14996468|NCT01761877|Sulindac|sulindac|mesh-list
14996469|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14996470|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14996471|NCT01761877|Analgesics|analgesics|mesh-ancestor
14996472|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
14996473|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996474|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996475|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996476|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996477|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996478|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14996479|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996480|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996481|NCT01761916|Clonidine|clonidine|mesh-list
14996482|NCT01761916|Captopril|captopril|mesh-list
14996483|NCT01761916|Analgesics|analgesics|mesh-ancestor
14996484|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
14996485|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996486|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996487|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14996488|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
14996489|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
14996490|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14996491|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14996492|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14996493|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
14996494|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14996495|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996496|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14996497|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
14996498|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996499|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
14996500|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14996501|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996502|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996503|NCT01761994|Nafamostat|nafamostat|mesh-list
14996504|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14996505|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14996506|NCT01761994|Analgesics|analgesics|mesh-ancestor
14996507|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
14996508|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996509|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996510|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996511|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996512|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
14996513|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
14996514|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996515|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996516|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14996517|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14996518|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14996519|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14996520|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
14996521|NCT01762046|Metformin|metformin|mesh-list
14996522|NCT01762046|Glipizide|glipizide|mesh-list
14996523|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14996524|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996525|NCT01762150|Gemcitabine|gemcitabine|mesh-list
14996526|NCT01762150|Sorafenib|sorafenib|mesh-list
14996527|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996528|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14996529|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
14996530|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996531|NCT01762150|Antiviral Agents|antiviral agents|mesh-ancestor
14996532|NCT01762150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996533|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996534|NCT01762150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14996535|NCT01762150|Immunologic Factors|immunologic factors|mesh-ancestor
14996536|NCT01762150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996537|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14996538|NCT01762163|Aspirin|aspirin|mesh-list
14996539|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14996540|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14996541|NCT01762163|Analgesics|analgesics|mesh-ancestor
14996542|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
14996543|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996544|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996545|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996546|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996547|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14996548|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14996549|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996550|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14996551|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14996552|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996553|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
15031927|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
15031928|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
15031929|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031930|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
15031931|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031932|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15031933|NCT01978457|Propranolol|propranolol|mesh-list
15031934|NCT01978457|Cocaine|cocaine|mesh-list
15031935|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14996554|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
14996555|NCT01762202|Fludarabine|fludarabine|mesh-list
14996556|NCT01762202|Ofatumumab|ofatumumab|mesh-list
14996557|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14996558|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
14996559|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996560|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996561|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14996562|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
14996563|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996564|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996565|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14996566|NCT01762306|Folic Acid|folic acid|mesh-list
14996567|NCT01762306|Diclofenac|diclofenac|mesh-list
14996568|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14996569|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14996570|NCT01762306|Analgesics|analgesics|mesh-ancestor
14996571|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
14996572|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996573|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996574|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996575|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996576|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14996577|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996578|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996579|NCT01762306|Hematinics|hematinics|mesh-ancestor
14996580|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
14996581|NCT01762306|Vitamins|vitamins|mesh-ancestor
14996582|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
14996583|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
14996584|NCT01762319|Pyridoxal|pyridoxal|mesh-list
14996585|NCT01762319|Pyridoxine|pyridoxine|mesh-list
14996586|NCT01762319|Misoprostol|misoprostol|mesh-list
14996587|NCT01762319|Vitamins|vitamins|mesh-ancestor
14996588|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
14996589|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996590|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14996591|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
14996592|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14996593|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14996594|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14996595|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
14996596|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
14996597|NCT01762332|Remifentanil|remifentanil|mesh-list
14996598|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14996599|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14996600|NCT01762332|Narcotics|narcotics|mesh-ancestor
14996601|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14996602|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996603|NCT01762332|Analgesics|analgesics|mesh-ancestor
14996604|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
14996605|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996606|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14996607|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
14996608|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14996609|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996610|NCT01762436|Atenolol|atenolol|mesh-list
14996611|NCT01762436|Bisoprolol|bisoprolol|mesh-list
14996612|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14996613|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14996614|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
14996615|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
14996616|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996617|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996618|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14996619|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14996620|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14996621|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
14996622|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14996623|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996624|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
14996625|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
14996626|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14996627|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14996628|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996629|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996630|NCT01762475|Urological Agents|urological agents|mesh-ancestor
14996631|NCT01762514|Amifostine|amifostine|mesh-list
14996632|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14996633|NCT01762514|Protective Agents|protective agents|mesh-ancestor
14996634|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996635|NCT01762540|Prednisolone|prednisolone|mesh-list
14996636|NCT01762540|Calcium|calcium|mesh-list
14996637|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
14996638|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14996639|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996640|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996641|NCT01762540|Hormones|hormones|mesh-ancestor
14996642|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14996643|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14996644|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996645|NCT01762644|Cyclosporine|cyclosporine|mesh-list
14996646|NCT01762644|Omeprazole|omeprazole|mesh-list
14996647|NCT01762644|Cyclosporins|cyclosporins|mesh-list
14996648|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996649|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996650|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14996651|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
14996652|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996653|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
14996654|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996655|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
14996656|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996657|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14996658|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14996659|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14996660|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14996661|NCT01762657|Cyclosporine|cyclosporine|mesh-list
14996662|NCT01762657|Lansoprazole|lansoprazole|mesh-list
14996663|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
14996664|NCT01762657|Cyclosporins|cyclosporins|mesh-list
14996665|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996666|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996667|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14996668|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
14996669|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996670|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
14996671|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996672|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
14996673|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996674|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14996675|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14996676|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14996677|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14996678|NCT01762670|Metronidazole|metronidazole|mesh-list
14996679|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996680|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14996681|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14996682|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14996683|NCT01762787|Aspirin|aspirin|mesh-list
14996684|NCT01762787|Prednisolone|prednisolone|mesh-list
14996685|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14996686|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
14996687|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14996688|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
14996689|NCT01762787|Cantharidin|cantharidin|mesh-list
14996690|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14996691|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
14996692|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14996693|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14996694|NCT01762787|Analgesics|analgesics|mesh-ancestor
14996695|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
14996696|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996697|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996698|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996699|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996700|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14996701|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14996702|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996703|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14996704|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14996705|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996706|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
14996707|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
14996708|NCT01762787|Hormones|hormones|mesh-ancestor
14996709|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14996710|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14996711|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996712|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
14996713|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
14996714|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14996715|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14996716|NCT01762787|Protective Agents|protective agents|mesh-ancestor
14996717|NCT01762826|Inositol|inositol|mesh-list
14996718|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
14996719|NCT01762826|Vitamins|vitamins|mesh-ancestor
14996720|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
14996721|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996722|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
14996723|NCT01762839|Oritavancin|oritavancin|mesh-list
14996724|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14996725|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996726|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14996727|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14996728|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996729|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996730|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996731|NCT01762852|Belimumab|belimumab|mesh-list
14996732|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14996733|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
14996734|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996735|NCT01762878|Nemiralisib|nemiralisib|mesh-list
14996736|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14996737|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996738|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996739|NCT01762891|Acetaminophen|acetaminophen|mesh-list
14996740|NCT01762891|Celecoxib|celecoxib|mesh-list
14996741|NCT01762891|Rofecoxib|rofecoxib|mesh-list
14996742|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14996743|NCT01762891|Analgesics|analgesics|mesh-ancestor
14996744|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
14996745|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996746|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996747|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
14996748|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14996749|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996750|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14996751|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14996752|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14996753|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996754|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996755|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
14996756|NCT01762995|Dolutegravir|dolutegravir|mesh-list
14996757|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
14996758|NCT01762995|Calcium|calcium|mesh-list
14996759|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14996760|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996761|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14996762|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14996763|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996764|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996765|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14996766|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14996767|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
14996768|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996769|NCT01762995|Antacids|antacids|mesh-ancestor
14996770|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14996771|NCT01762995|Trace Elements|trace elements|mesh-ancestor
14996772|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
14996773|NCT01763021|Rifampin|rifampin|mesh-list
14996774|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14996775|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
14996776|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14996777|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996778|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
14996779|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14996780|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996781|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996782|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14996783|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14996784|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14996785|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14996786|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14996787|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14996788|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
14996789|NCT01763281|Hormones|hormones|mesh-ancestor
14996790|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14996791|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996792|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14996793|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996794|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14996795|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996796|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996797|NCT01763424|Calcitriol|calcitriol|mesh-list
14996798|NCT01763424|Niacinamide|niacinamide|mesh-list
14996799|NCT01763424|Niacin|niacin|mesh-list
14996800|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
14996801|NCT01763424|Calcipotriene|calcipotriene|mesh-list
14996802|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
14996803|NCT01763424|Vitamins|vitamins|mesh-ancestor
14996804|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
14996805|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996806|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14996807|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
14996808|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996809|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14996810|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
14996811|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
14996812|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14996813|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14996814|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14996815|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14996816|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14996817|NCT01763437|Tetracycline|tetracycline|mesh-list
14996818|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14996819|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996820|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14996821|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996822|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996823|NCT01763450|Bevacizumab|bevacizumab|mesh-list
14996824|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14996825|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996826|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14996827|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14996828|NCT01763450|Growth Substances|growth substances|mesh-ancestor
14996829|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996830|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
14996831|NCT01763463|Fluticasone|fluticasone|mesh-list
14996832|NCT01763463|Xhance|xhance|mesh-list
14996833|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14996834|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14996835|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
14996836|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996837|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
14996838|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996839|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996840|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14996841|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
14996842|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
14996843|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14996844|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14996845|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14996846|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14996847|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
14996848|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14996849|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996850|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
14996851|NCT01763463|Hormones|hormones|mesh-ancestor
14996852|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14996853|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
14996854|NCT01763476|Paclitaxel|paclitaxel|mesh-list
14996855|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14996856|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996857|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
14996858|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
14996859|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
14996860|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996861|NCT01763541|Anastrozole|anastrozole|mesh-list
14996862|NCT01763541|Leuprolide|leuprolide|mesh-list
14996863|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14996864|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996865|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14996866|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14996867|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996868|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996869|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14996870|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
14996871|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14996872|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996873|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14996874|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
14996875|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14996876|NCT01763580|Prednisolone|prednisolone|mesh-list
14996877|NCT01763580|Tacrolimus|tacrolimus|mesh-list
14996878|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14996879|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
14996880|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996881|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14996882|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996883|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996884|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996885|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
14996886|NCT01763580|Hormones|hormones|mesh-ancestor
14996887|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14996888|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14996889|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996890|NCT01763658|Dexamethasone|dexamethasone|mesh-list
14996891|NCT01763658|Prednisolone|prednisolone|mesh-list
14996892|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14996893|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
14996894|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14996895|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
14996896|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14996897|NCT01763658|Antioxidants|antioxidants|mesh-list
14996898|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996899|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
14996900|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
14996901|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14996902|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996903|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14996904|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
14996905|NCT01763658|Hormones|hormones|mesh-ancestor
14996906|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14996907|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14996908|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996909|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996910|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14996911|NCT01763658|Protective Agents|protective agents|mesh-ancestor
14996912|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
14996913|NCT01763671|Paclitaxel|paclitaxel|mesh-list
14996914|NCT01763671|Docetaxel|docetaxel|mesh-list
14996915|NCT01763671|Bevacizumab|bevacizumab|mesh-list
14996916|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14996917|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996918|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
14996919|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
14996920|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
14996921|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996922|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14996923|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14996924|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14996925|NCT01763671|Growth Substances|growth substances|mesh-ancestor
14996926|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996927|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
14996928|NCT01763710|Paclitaxel|paclitaxel|mesh-list
14996929|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14996930|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14996931|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996932|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
14996933|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
14996934|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
14996935|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031936|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15031937|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
15031938|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15031939|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031940|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031941|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15031942|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15031943|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
15031944|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
15031945|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
15031946|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031947|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
15031948|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031949|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15031950|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15031951|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15031952|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15031953|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
15031954|NCT01978483|Denosumab|denosumab|mesh-list
15031955|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15031956|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031957|NCT01978496|Eletriptan|eletriptan|mesh-list
15031958|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15031959|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
15031960|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15031961|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031962|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031963|NCT01978665|Prednisone|prednisone|mesh-list
15031964|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14996936|NCT01763749|Clopidogrel|clopidogrel|mesh-list
14996937|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14996938|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14996939|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14996940|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14996941|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
14996942|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14996943|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996944|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996945|NCT01763788|Gemcitabine|gemcitabine|mesh-list
14996946|NCT01763788|Necitumumab|necitumumab|mesh-list
14996947|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996948|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14996949|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
14996950|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996951|NCT01763788|Antiviral Agents|antiviral agents|mesh-ancestor
14996952|NCT01763788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14996953|NCT01763788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996954|NCT01763788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14996955|NCT01763788|Immunologic Factors|immunologic factors|mesh-ancestor
14996956|NCT01763788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996957|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14996958|NCT01764087|Paclitaxel|paclitaxel|mesh-list
14996959|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
14996960|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14996961|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996962|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
14996963|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
14996964|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
14996965|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996966|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996967|NCT01764126|Vaccines|vaccines|mesh-list
14996968|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
14996969|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996970|NCT01764139|Vitamin D|vitamin d|mesh-list
14996971|NCT01764139|Vitamins|vitamins|mesh-ancestor
14996972|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
14996973|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996974|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14996975|NCT01764178|Valsartan|valsartan|mesh-list
14996976|NCT01764178|Pitavastatin|pitavastatin|mesh-list
14996977|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14996978|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14996979|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14996980|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14996981|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14996982|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14996983|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14996984|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
14996985|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14996986|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14996987|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
14996988|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
14996989|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14996990|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
14996991|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14996992|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14996993|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14996994|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14996995|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14996996|NCT01764295|Olmesartan|olmesartan|mesh-list
14996997|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14996998|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14996999|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14997000|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
14997001|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997002|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14997003|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14997004|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997005|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14997006|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14997007|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14997008|NCT01764451|Simvastatin|simvastatin|mesh-list
14997009|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14997010|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14997011|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
14997012|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997013|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14997014|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14997015|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997016|NCT01764555|Acetaminophen|acetaminophen|mesh-list
14997017|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14997018|NCT01764555|Analgesics|analgesics|mesh-ancestor
14997019|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
14997020|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997021|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997022|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
14997023|NCT01764581|Tacrolimus|tacrolimus|mesh-list
14997024|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14997025|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
14997026|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997027|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14997028|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997029|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997030|NCT01764672|Methylphenidate|methylphenidate|mesh-list
14997031|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14997032|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997033|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14997034|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14997035|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14997036|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997037|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
14997038|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997039|NCT01764750|Vancomycin|vancomycin|mesh-list
14997040|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14997041|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997042|NCT01764828|Gemcitabine|gemcitabine|mesh-list
15031965|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
14997043|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14997044|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
14997045|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997046|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997047|NCT01764828|Antiviral Agents|antiviral agents|mesh-ancestor
14997048|NCT01764828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997049|NCT01764828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997050|NCT01764828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14997051|NCT01764828|Immunologic Factors|immunologic factors|mesh-ancestor
14997052|NCT01764828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997053|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14997054|NCT01764867|Dexetimide|dexetimide|mesh-list
14997055|NCT01764867|Mirtazapine|mirtazapine|mesh-list
14997056|NCT01764867|Trazodone|trazodone|mesh-list
14997057|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
14997058|NCT01764867|Citalopram|citalopram|mesh-list
14997059|NCT01764867|Bupropion|bupropion|mesh-list
14997060|NCT01764867|Fluoxetine|fluoxetine|mesh-list
14997061|NCT01764867|Paroxetine|paroxetine|mesh-list
14997062|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14997063|NCT01764867|Sertraline|sertraline|mesh-list
14997064|NCT01764867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14997065|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14997066|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14997067|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997068|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997069|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
14997070|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997071|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14997072|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
14997073|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14997074|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14997075|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14997076|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
14997077|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
14997078|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997079|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14997080|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14997081|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
14997082|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14997083|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
14997084|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14997085|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14997086|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997087|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14997088|NCT01764867|Analgesics|analgesics|mesh-ancestor
14997089|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
14997090|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14997091|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
14997092|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
14997093|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14997094|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14997095|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14997096|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14997097|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14997098|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14997099|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
14997100|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14997101|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14997102|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14997103|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14997104|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14997105|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
14997106|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14997107|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14997108|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
14997109|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997110|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997111|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997112|NCT01764893|Urological Agents|urological agents|mesh-ancestor
14997113|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
14997114|NCT01765010|Calcitriol|calcitriol|mesh-list
14997115|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
14997116|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14997117|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14997118|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997119|NCT01765010|Vitamins|vitamins|mesh-ancestor
14997120|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
14997121|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14997122|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14997123|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14997124|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997125|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14997126|NCT01765023|Metformin|metformin|mesh-list
14997127|NCT01765023|Atorvastatin|atorvastatin|mesh-list
14997128|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14997129|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997130|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14997131|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14997132|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
14997133|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997134|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14997135|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14997136|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997137|NCT01765088|Temozolomide|temozolomide|mesh-list
14997138|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14997139|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
14997140|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997141|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997142|NCT01765231|Entecavir|entecavir|mesh-list
14997143|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
14997144|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997145|NCT01765257|Rasagiline|rasagiline|mesh-list
14997146|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14997147|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997148|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997149|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14997150|NCT01765257|Protective Agents|protective agents|mesh-ancestor
14997151|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997152|NCT01765296|Celecoxib|celecoxib|mesh-list
14997153|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14997154|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14997155|NCT01765296|Analgesics|analgesics|mesh-ancestor
14997156|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
14997157|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997158|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997159|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14997160|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14997161|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14997162|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14997163|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997164|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997165|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
14997166|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14997167|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14997168|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997169|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
14997170|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997171|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997172|NCT01765374|Rituximab|rituximab|mesh-list
14997173|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14997174|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997175|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
14997176|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997177|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14997178|NCT01765400|Clopidogrel|clopidogrel|mesh-list
14997179|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14997180|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14997181|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14997182|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14997183|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14997184|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
14997185|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997186|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997187|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031966|NCT01978665|Hormones|hormones|mesh-ancestor
15031967|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031968|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031969|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15031970|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15031971|NCT01978678|Budesonide|budesonide|mesh-list
15031972|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15031973|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15031974|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
15031975|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15031976|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031977|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15031978|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
15031979|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
15031980|NCT01978678|Hormones|hormones|mesh-ancestor
15031981|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031982|NCT01978704|Insulin|insulin|mesh-list
15031983|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15031984|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15031985|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031986|NCT01978717|Anesthetics|anesthetics|mesh-list
15031987|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15031988|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15031989|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
15031990|NCT01978782|Citalopram|citalopram|mesh-list
15031991|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15031992|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14801825|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14801826|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
14801827|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14801828|NCT00794898|Infliximab|infliximab|mesh-list
14801829|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
14801830|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14801831|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14801832|NCT00794976|Dexamethasone|dexamethasone|mesh-list
14801833|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
14801834|NCT00794976|BB 1101|bb 1101|mesh-list
14801835|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14801836|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
14801837|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
14801838|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801839|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801840|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14801841|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
14801842|NCT00794976|Hormones|hormones|mesh-ancestor
14801843|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15031993|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
14801844|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14997188|NCT01765452|Clopidogrel|clopidogrel|mesh-list
14997189|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14997190|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14997191|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14997192|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14997193|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
14997194|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997195|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997196|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997197|NCT01765556|Ketoconazole|ketoconazole|mesh-list
14997198|NCT01765556|Vemurafenib|vemurafenib|mesh-list
14997199|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
14997200|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997201|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14997202|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14997203|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997204|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997205|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14997206|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
14997207|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14997208|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997209|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14997210|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997211|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14997212|NCT01765608|Zonisamide|zonisamide|mesh-list
14997213|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
14997214|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14997215|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14997216|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997217|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14997218|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997219|NCT01765738|Minocycline|minocycline|mesh-list
14997220|NCT01765738|Rifampin|rifampin|mesh-list
14997221|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14997222|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997223|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14997224|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
14997225|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
14997226|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14997227|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997228|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997229|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14997230|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14997231|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14997232|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14997233|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14997234|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14997235|NCT01765790|Antibodies|antibodies|mesh-list
14997236|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
14997237|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
14997238|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997239|NCT01765829|Droperidol|droperidol|mesh-list
14997240|NCT01765829|Haloperidol|haloperidol|mesh-list
14997241|NCT01765829|Pimozide|pimozide|mesh-list
14997242|NCT01765829|Olanzapine|olanzapine|mesh-list
14997243|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
14997244|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
14997245|NCT01765829|Risperidone|risperidone|mesh-list
14997246|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14997247|NCT01765829|Aripiprazole|aripiprazole|mesh-list
14997248|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14801845|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801846|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
14801847|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801848|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801849|NCT00795015|Insulin|insulin|mesh-list
14801850|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14801851|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14801852|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801853|NCT00795106|Capsaicin|capsaicin|mesh-list
14801854|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
14801855|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
14801856|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
14801857|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997249|NCT01765829|Ziprasidone|ziprasidone|mesh-list
14997250|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
14997251|NCT01765829|Clozapine|clozapine|mesh-list
14997252|NCT01765829|Asenapine|asenapine|mesh-list
14997253|NCT01765829|Amisulpride|amisulpride|mesh-list
14997254|NCT01765829|Perphenazine|perphenazine|mesh-list
14997255|NCT01765829|Sertindole|sertindole|mesh-list
14997256|NCT01765829|Sulpiride|sulpiride|mesh-list
14997257|NCT01765829|Clopenthixol|clopenthixol|mesh-list
14997258|NCT01765829|Clothiapine|clothiapine|mesh-list
14997259|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14997260|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
14997261|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997262|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997263|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997264|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14997265|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14997266|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14997267|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14997268|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
14997269|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
14997270|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
14997271|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997272|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14997273|NCT01765829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14997274|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14997275|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14997276|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
14997277|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
14997278|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14997279|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14997280|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14997281|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14997282|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14997283|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
14997284|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
14997285|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14997286|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14997287|NCT01765842|Rituximab|rituximab|mesh-list
14997288|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14997289|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997290|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
14997291|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997292|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14997293|NCT01765855|Betrixaban|betrixaban|mesh-list
14997294|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14997295|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
14997296|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14997297|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
14997298|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997299|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997300|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
14997301|NCT01765868|Betrixaban|betrixaban|mesh-list
14997302|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14997303|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
14997304|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14997305|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
14997306|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997307|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997308|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
14997309|NCT01765881|Misoprostol|misoprostol|mesh-list
14997310|NCT01765881|Dinoprostone|dinoprostone|mesh-list
14997311|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14997312|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
14997313|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14997314|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997315|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14997316|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14997317|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
14997318|NCT01765946|Metformin|metformin|mesh-list
14997319|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14997320|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997321|NCT01766063|Interferons|interferons|mesh-list
14997322|NCT01766063|Interferon-beta|interferon-beta|mesh-list
14997323|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
14997324|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997325|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
14997326|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997327|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
14997328|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997329|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14997330|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
14997331|NCT01766089|Remifentanil|remifentanil|mesh-list
14997332|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14997333|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14997334|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997335|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14997336|NCT01766089|Analgesics|analgesics|mesh-ancestor
14801858|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801859|NCT00795171|Docetaxel|docetaxel|mesh-list
14801860|NCT00795171|Sunitinib|sunitinib|mesh-list
14801861|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801862|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
14801863|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
14801864|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
14801865|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801866|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14801867|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14801868|NCT00795171|Growth Substances|growth substances|mesh-ancestor
14801869|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801870|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
14801871|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14801872|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997337|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
14997338|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997339|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14997340|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14997341|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14997342|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
14997343|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997344|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801873|NCT00795223|Morphine|morphine|mesh-list
14801874|NCT00795223|Bupivacaine|bupivacaine|mesh-list
14801875|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
14801876|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
14801877|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801878|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801879|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
14801880|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801881|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14801882|NCT00795223|Narcotics|narcotics|mesh-ancestor
14801883|NCT00795223|Analgesics|analgesics|mesh-ancestor
14801884|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
14801885|NCT00795262|Quinapril|quinapril|mesh-list
14801886|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
14801887|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801888|NCT00795262|Protective Agents|protective agents|mesh-ancestor
14801889|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801890|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
14801891|NCT00795262|Vitamins|vitamins|mesh-ancestor
14801892|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
14801893|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14801894|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
14997345|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14997346|NCT01766089|Narcotics|narcotics|mesh-ancestor
14997347|NCT01766154|Tirofiban|tirofiban|mesh-list
14997348|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14997349|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14997350|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997351|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14997352|NCT01766180|Resveratrol|resveratrol|mesh-list
14997353|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
14997354|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997355|NCT01766180|Protective Agents|protective agents|mesh-ancestor
14997356|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997357|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997358|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14997359|NCT01766258|Carbidopa|carbidopa|mesh-list
14997360|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14997361|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14997362|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
14997363|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997364|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997365|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997366|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14997367|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997368|NCT01766323|Modafinil|modafinil|mesh-list
14997369|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14997370|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997371|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14997372|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14997373|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14997374|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997375|NCT01766375|Cyclosporine|cyclosporine|mesh-list
14997376|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
14997377|NCT01766375|Methotrexate|methotrexate|mesh-list
14997378|NCT01766375|Cyclosporins|cyclosporins|mesh-list
14997379|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14997380|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
14997381|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14997382|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997383|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14997384|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
14997385|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997386|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997387|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
14997388|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997389|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14997390|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14997391|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
14997392|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14997393|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14997394|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
14997395|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997396|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14997397|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14997398|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14997399|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
14997400|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14997401|NCT01766414|Complement C1s|complement c1s|mesh-list
14997402|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14997403|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14997404|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
14997405|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997406|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14997407|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14997408|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
15035405|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14801895|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801896|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14801897|NCT00795301|Capecitabine|capecitabine|mesh-list
14801898|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
14801899|NCT00795301|Cetuximab|cetuximab|mesh-list
14801900|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14801901|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
14801902|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801903|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801904|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14997409|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14997410|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997411|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14997412|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
14997413|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14997414|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997415|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997416|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997417|NCT01766583|Lenalidomide|lenalidomide|mesh-list
14997418|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
14997419|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997420|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14997421|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14997422|NCT01766583|Growth Substances|growth substances|mesh-ancestor
14997423|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
14997424|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997425|NCT01766609|Triamcinolone|triamcinolone|mesh-list
14997426|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14997427|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14997428|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14997429|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14997430|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
14997431|NCT01766609|Hormones|hormones|mesh-ancestor
14997432|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14997433|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997434|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14997435|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
14997436|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997437|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997438|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
14997439|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
14997440|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
14997441|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997442|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14997443|NCT01766843|Charcoal|charcoal|mesh-list
14997444|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14997445|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
14997446|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997447|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997448|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14997449|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
14997450|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
14997451|NCT01766843|Hormones|hormones|mesh-ancestor
14997452|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14997453|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
14997454|NCT01766843|Antidotes|antidotes|mesh-ancestor
14997455|NCT01766843|Protective Agents|protective agents|mesh-ancestor
14997456|NCT01766960|Morphine|morphine|mesh-list
14997457|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14997458|NCT01766960|Narcotics|narcotics|mesh-ancestor
14997459|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14997460|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997461|NCT01766960|Analgesics|analgesics|mesh-ancestor
14997462|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
14997463|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997464|NCT01767025|Oxytocin|oxytocin|mesh-list
14997465|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
14997466|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14997467|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997468|NCT01767090|Leuprolide|leuprolide|mesh-list
14997469|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14997470|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
14997471|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14997472|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997473|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14997474|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997475|NCT01767259|Valsartan|valsartan|mesh-list
14997476|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14997477|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14997478|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14997479|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14997480|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997481|NCT01767259|Diuretics|diuretics|mesh-ancestor
14997482|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
14997483|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997484|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14997485|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15031994|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15031995|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15031996|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15031997|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15031998|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15031999|NCT01978782|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15032000|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15032001|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15032002|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032003|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
15032004|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032005|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15032006|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
15032007|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15032008|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
15032009|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
15032010|NCT01978873|Androgens|androgens|mesh-list
15032011|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15032012|NCT01978873|Hormones|hormones|mesh-ancestor
15032013|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15032014|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032015|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
15032016|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032017|NCT01978873|Protective Agents|protective agents|mesh-ancestor
15032018|NCT01978873|Vitamins|vitamins|mesh-ancestor
15032019|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
15032020|NCT01978873|Estrogens|estrogens|mesh-ancestor
15032021|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14997486|NCT01767272|Fexofenadine|fexofenadine|mesh-list
14997487|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14997488|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14997489|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14997490|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
14997491|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
14997492|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997493|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997494|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997495|NCT01767298|Valsartan|valsartan|mesh-list
14997496|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14997497|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14997498|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14997499|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14997500|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997501|NCT01767298|Diuretics|diuretics|mesh-ancestor
14997502|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
14997503|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997504|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14997505|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14997506|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
14997507|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
14997508|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14997509|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
14997510|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997511|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997512|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997513|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14997514|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997515|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
14997516|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14997517|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14997518|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
14997519|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997520|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997521|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14997522|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523718|NCT03614975|Vaccines|vaccines|mesh-list
14523719|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
14523720|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523721|NCT03615404|Molgramostim|molgramostim|mesh-list
14523722|NCT03615404|Sargramostim|sargramostim|mesh-list
14523723|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
14523724|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523725|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523726|NCT03615482|Vaccines|vaccines|mesh-list
14523727|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
14523728|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523729|NCT03615534|Niacin|niacin|mesh-list
14523730|NCT03615534|Fenofibrate|fenofibrate|mesh-list
14523731|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14523732|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
14523733|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523734|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14523735|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
14523736|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
14523737|NCT03615534|Vitamins|vitamins|mesh-ancestor
14997523|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14997524|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
14997525|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997526|NCT01767428|Acetaminophen|acetaminophen|mesh-list
14997527|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14997528|NCT01767428|Analgesics|analgesics|mesh-ancestor
14997529|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
14997530|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997531|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997532|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
14997533|NCT01767454|Ipilimumab|ipilimumab|mesh-list
14997534|NCT01767454|Trametinib|trametinib|mesh-list
14997535|NCT01767454|Dabrafenib|dabrafenib|mesh-list
14997536|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14997537|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997538|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14997539|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997540|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14997541|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997542|NCT01767532|Cephalexin|cephalexin|mesh-list
14997543|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14523738|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
14523739|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523740|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14997544|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997545|NCT01767545|Dexamethasone|dexamethasone|mesh-list
14997546|NCT01767545|Bevacizumab|bevacizumab|mesh-list
14997547|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14997548|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997549|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14997550|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14997551|NCT01767545|Growth Substances|growth substances|mesh-ancestor
14997552|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997553|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
14997554|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14997555|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
14997556|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
14997557|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997558|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14997559|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
14997560|NCT01767545|Hormones|hormones|mesh-ancestor
14997561|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14997562|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14997563|NCT01767571|Cephalexin|cephalexin|mesh-list
14997564|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14997565|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997566|NCT01767584|Cephalexin|cephalexin|mesh-list
14997567|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14997568|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997569|NCT01767610|Infliximab|infliximab|mesh-list
14997570|NCT01767610|Fenofibrate|fenofibrate|mesh-list
14997571|NCT01767610|Pitavastatin|pitavastatin|mesh-list
14997572|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14997573|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
14997574|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997575|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14997576|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14997577|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14997578|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997579|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
14997580|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14997581|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14997582|NCT01767623|Vemurafenib|vemurafenib|mesh-list
14997583|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997584|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14997585|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997586|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997587|NCT01767714|Plerixafor|plerixafor|mesh-list
14997588|NCT01767714|Sargramostim|sargramostim|mesh-list
14997589|NCT01767714|Lenograstim|lenograstim|mesh-list
14997590|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
14997591|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997592|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14997593|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14997594|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14997595|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
14997596|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997597|NCT01767896|Vaccines|vaccines|mesh-list
14997598|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
14997599|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997600|NCT01768039|Vitamin D|vitamin d|mesh-list
14997601|NCT01768039|Vitamins|vitamins|mesh-ancestor
14997602|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
14997603|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997604|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14997605|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14997606|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14997607|NCT01768078|Betamethasone|betamethasone|mesh-list
14997608|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997609|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
14997610|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14997611|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
14997612|NCT01768078|Hormones|hormones|mesh-ancestor
14997613|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14997614|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997615|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14997616|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
14997617|NCT01768182|Leucovorin|leucovorin|mesh-list
14997618|NCT01768182|Folic Acid|folic acid|mesh-list
14997619|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
14997620|NCT01768182|Antidotes|antidotes|mesh-ancestor
14997621|NCT01768182|Protective Agents|protective agents|mesh-ancestor
14997622|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997623|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
14997624|NCT01768182|Vitamins|vitamins|mesh-ancestor
14997625|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
14997626|NCT01768182|Hematinics|hematinics|mesh-ancestor
14997627|NCT01768195|Entecavir|entecavir|mesh-list
14997628|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
14997629|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997630|NCT01768208|Saxagliptin|saxagliptin|mesh-list
14997631|NCT01768208|Incretins|incretins|mesh-ancestor
14997632|NCT01768208|Hormones|hormones|mesh-ancestor
14997633|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14997634|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997635|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14997636|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
14997637|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997638|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997639|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14997640|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14997641|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14997642|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997643|NCT01768260|Aspirin|aspirin|mesh-list
14997644|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14997645|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14997646|NCT01768260|Analgesics|analgesics|mesh-ancestor
14997647|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
14997648|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997649|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997650|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14997651|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14997652|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14997653|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14997654|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997655|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14997656|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14997657|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997658|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
14997659|NCT01768273|Midazolam|midazolam|mesh-list
14997660|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14997661|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14997662|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14997663|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997664|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14997665|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14997666|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14997667|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14997668|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
14997669|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
14997670|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
14997671|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
14997672|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997673|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997674|NCT01768299|Misoprostol|misoprostol|mesh-list
14997675|NCT01768299|Mifepristone|mifepristone|mesh-list
14997676|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14997677|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
14997678|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14997679|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997680|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14997681|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14997682|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
14997683|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14997684|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14997685|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14997686|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14997687|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
14523741|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523742|NCT03615924|Ticagrelor|ticagrelor|mesh-list
14523743|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14523744|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14523745|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14523746|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14523747|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
14523748|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523749|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523750|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523751|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
14523752|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14523753|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523754|NCT03617861|Secretin|secretin|mesh-list
14523755|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14523756|NCT03617861|Hormones|hormones|mesh-ancestor
14523757|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14523758|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523759|NCT03617913|Cisplatin|cisplatin|mesh-list
14523760|NCT03617913|Fluorouracil|fluorouracil|mesh-list
14523761|NCT03617913|Mitomycins|mitomycins|mesh-list
14523762|NCT03617913|Mitomycin|mitomycin|mesh-list
14523763|NCT03617913|Avelumab|avelumab|mesh-list
14523764|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14523765|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523766|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
14523767|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523768|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14523769|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14523770|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
14523771|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523772|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14523773|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
14523774|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14523775|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523776|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14523777|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
14523778|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14523779|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523780|NCT03618823|Acetaminophen|acetaminophen|mesh-list
14523781|NCT03618823|Ibuprofen|ibuprofen|mesh-list
14523782|NCT03618823|Oxycodone|oxycodone|mesh-list
14523783|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14523784|NCT03618823|Analgesics|analgesics|mesh-ancestor
14997688|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14997689|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14997690|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
14997691|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14997692|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
14997693|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14997694|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14997695|NCT01768312|Cyclosporine|cyclosporine|mesh-list
14997696|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14997697|NCT01768312|Cyclosporins|cyclosporins|mesh-list
14997698|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997699|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997700|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14997701|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
14997702|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997703|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
14997704|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997705|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
14997706|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14997707|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14997708|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14997709|NCT01768338|Ofatumumab|ofatumumab|mesh-list
14997710|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997711|NCT01768351|Calcitriol|calcitriol|mesh-list
14997712|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14997713|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997714|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14997715|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14997716|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997717|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14997718|NCT01768351|Vitamins|vitamins|mesh-ancestor
14997719|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
14997720|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14997721|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14997722|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14997723|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997724|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14997725|NCT01768364|Renal Agents|renal agents|mesh-ancestor
14997726|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
14997727|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14997728|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14997729|NCT01768377|Lidocaine|lidocaine|mesh-list
14997730|NCT01768377|Fentanyl|fentanyl|mesh-list
14997731|NCT01768377|Midazolam|midazolam|mesh-list
14997732|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
14997733|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
14997734|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14997735|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997736|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
14997737|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997738|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14997739|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14997740|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14997741|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14997742|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997743|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14997744|NCT01768377|Narcotics|narcotics|mesh-ancestor
14997745|NCT01768377|Analgesics|analgesics|mesh-ancestor
14997746|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14997747|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14997748|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
14997749|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14997750|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14997751|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14997752|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14997753|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
14997754|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
14997755|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997756|NCT01768390|Fluorides|fluorides|mesh-list
14997757|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
14997758|NCT01768390|Protective Agents|protective agents|mesh-ancestor
14997759|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997760|NCT01768455|Glimepiride|glimepiride|mesh-list
14997761|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14997762|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14997763|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997764|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14997765|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
14997766|NCT01768481|Atorvastatin|atorvastatin|mesh-list
14997767|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14997768|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14997769|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
14997770|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997771|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14997772|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14997773|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997774|NCT01768507|Resveratrol|resveratrol|mesh-list
14997775|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
14997776|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997777|NCT01768507|Protective Agents|protective agents|mesh-ancestor
14997778|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997779|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997780|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14997781|NCT01768663|Itraconazole|itraconazole|mesh-list
14997782|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
14997783|NCT01768663|Rifampin|rifampin|mesh-list
14997784|NCT01768663|Ivacaftor|ivacaftor|mesh-list
14997785|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
14997786|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997787|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14997788|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14997789|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997790|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997791|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14997792|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
14997793|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14997794|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997795|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14997796|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14997797|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14997798|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14997799|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997800|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14997801|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14997802|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
14997803|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
14997804|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14997805|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14997806|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14997807|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14997808|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14997809|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14997810|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14997811|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14997812|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14997813|NCT01768741|Liver Extracts|liver extracts|mesh-list
14997814|NCT01768741|Hematinics|hematinics|mesh-ancestor
14997815|NCT01768767|Ketamine|ketamine|mesh-list
14997816|NCT01768767|Analgesics|analgesics|mesh-ancestor
14997817|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
14997818|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997819|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997820|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14997821|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14997822|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
14997823|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
14997824|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14997825|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14997826|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14997827|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997828|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997829|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
14997830|NCT01768780|Bupivacaine|bupivacaine|mesh-list
14997831|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
14997832|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
14997833|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
14997834|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14997835|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997836|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
14997837|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997838|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14997839|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14997840|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
14997841|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997842|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997843|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
14997844|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14997845|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
14997846|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997847|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997848|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14997849|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
14997850|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14997851|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
14997852|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997853|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997854|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14997855|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
14997856|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
14997857|NCT01768884|Protective Agents|protective agents|mesh-ancestor
14997858|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
14997859|NCT01768897|Cytarabine|cytarabine|mesh-list
14997860|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
14997861|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14997862|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
14997863|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997864|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997865|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
14997866|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997867|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14997868|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
14997869|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997870|NCT01768897|Analgesics|analgesics|mesh-ancestor
14997871|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
14997872|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997873|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14997874|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14997875|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997876|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
14997877|NCT01768897|Protective Agents|protective agents|mesh-ancestor
14997878|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
14997879|NCT01768897|Vitamins|vitamins|mesh-ancestor
14997880|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
15032022|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032023|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
15032024|NCT01979211|Cetuximab|cetuximab|mesh-list
15032025|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15032026|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032027|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15032028|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15032029|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032030|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
15032031|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15032032|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
15032033|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15032034|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15032035|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15032036|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032037|NCT01979354|Morphine|morphine|mesh-list
15032038|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15032039|NCT01979354|Narcotics|narcotics|mesh-ancestor
15032040|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032041|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032042|NCT01979354|Analgesics|analgesics|mesh-ancestor
15032043|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
15032044|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032045|NCT01979406|Vaccines|vaccines|mesh-list
15032046|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
15032047|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032048|NCT01979510|Acetaminophen|acetaminophen|mesh-list
15032049|NCT01979510|Etoricoxib|etoricoxib|mesh-list
15032050|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15032051|NCT01979510|Analgesics|analgesics|mesh-ancestor
15032052|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
15032053|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032054|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032055|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
15032056|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15032057|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15032058|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15032059|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15032060|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15032061|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032062|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032063|NCT01979653|Midazolam|midazolam|mesh-list
15032064|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
15032065|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15032066|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032067|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032068|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15032069|NCT01979653|Analgesics|analgesics|mesh-ancestor
15032070|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
15032071|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032072|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15032073|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15032074|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15032075|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
15032076|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032077|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032078|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15032079|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15032080|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15032081|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15032082|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15032083|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
15032084|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
15032085|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
15032086|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
14997881|NCT01768988|Pregabalin|pregabalin|mesh-list
14997882|NCT01768988|Analgesics|analgesics|mesh-ancestor
14997883|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
14997884|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997885|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997886|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
14997887|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14997888|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14997889|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997890|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14997891|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14997892|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14997893|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14997894|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14997895|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14997896|NCT01769027|Azithromycin|azithromycin|mesh-list
14997897|NCT01769027|Penicillins|penicillins|mesh-list
14997898|NCT01769027|Penicillin G Benzathine|penicillin g benzathine|mesh-list
14997899|NCT01769027|Sertraline|sertraline|mesh-list
14997900|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14997901|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997902|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
14997903|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14997904|NCT01769027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14997905|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14997906|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14997907|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997908|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997909|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
14997910|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997911|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
14997912|NCT01769040|Rifaximin|rifaximin|mesh-list
14997913|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14997914|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997915|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14997916|NCT01769066|Pemetrexed|pemetrexed|mesh-list
14997917|NCT01769066|Gefitinib|gefitinib|mesh-list
14997918|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997919|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997920|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997921|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14997922|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14997923|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14997924|NCT01769079|Isosorbide|isosorbide|mesh-list
14997925|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14997926|NCT01769079|Diuretics|diuretics|mesh-ancestor
14997927|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
14997928|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997929|NCT01769118|Caffeine|caffeine|mesh-list
14997930|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14997931|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997932|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14997933|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997934|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997935|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14997936|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14997937|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
14997938|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14997939|NCT01769183|Squalamine|squalamine|mesh-list
14997940|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14997941|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14997942|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14997943|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997944|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14997945|NCT01769183|Protective Agents|protective agents|mesh-ancestor
14997946|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997947|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14997948|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14997949|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14997950|NCT01769183|Growth Substances|growth substances|mesh-ancestor
14997951|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
14997952|NCT01769235|Clindamycin|clindamycin|mesh-list
14997953|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
14997954|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
14997955|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14997956|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14997957|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14997958|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14997959|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997960|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997961|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
14997962|NCT01769482|Udenafil|udenafil|mesh-list
14997963|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14997964|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14997965|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997966|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997967|NCT01769625|Vitamin D|vitamin d|mesh-list
14997968|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
14997969|NCT01769625|Celecoxib|celecoxib|mesh-list
14997970|NCT01769625|Vitamins|vitamins|mesh-ancestor
14997971|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
14997972|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997973|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14997974|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14997975|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14997976|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14997977|NCT01769625|Analgesics|analgesics|mesh-ancestor
14997978|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
14997979|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997980|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14997981|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14997982|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14997983|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14997984|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14997985|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14997986|NCT01769651|Methadone|methadone|mesh-list
14997987|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14997988|NCT01769651|Narcotics|narcotics|mesh-ancestor
14997989|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14997990|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14997991|NCT01769651|Analgesics|analgesics|mesh-ancestor
14997992|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
14997993|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14997994|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
14997995|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
14997996|NCT01769664|Clindamycin|clindamycin|mesh-list
14997997|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
14997998|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
14997999|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
14998000|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14998001|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998002|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14998003|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998004|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998005|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
14998006|NCT01769677|Hydrocodone|hydrocodone|mesh-list
14998007|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14998008|NCT01769677|Narcotics|narcotics|mesh-ancestor
14998009|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14998010|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998011|NCT01769677|Analgesics|analgesics|mesh-ancestor
14998012|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
14998013|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998014|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
14998015|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
14998016|NCT01769703|Dabigatran|dabigatran|mesh-list
14998017|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
14998018|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14998019|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
14998020|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998021|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998022|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
14998023|NCT01769768|Bupropion|bupropion|mesh-list
14998024|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14998025|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
14998026|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14998027|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14998028|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14998029|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14998030|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998031|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
14998032|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14998033|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998034|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14998035|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14998036|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998037|NCT01769781|Anastrozole|anastrozole|mesh-list
14998038|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14998039|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998040|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14998041|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14998042|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998043|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998044|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14998045|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
14998046|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14998047|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998048|NCT01769820|Dexamethasone|dexamethasone|mesh-list
14998049|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14998050|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
14998051|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
14998052|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998053|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998054|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14998055|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
14998056|NCT01769820|Hormones|hormones|mesh-ancestor
14998057|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14998058|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14998059|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998060|NCT01769833|Interferons|interferons|mesh-list
14998061|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
14998062|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
14998063|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14998064|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998065|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
14998066|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998067|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
14998068|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998069|NCT01769898|Budesonide|budesonide|mesh-list
14998070|NCT01769898|Theophylline|theophylline|mesh-list
14998071|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
14998072|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14998073|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14998074|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
14998075|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998076|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998077|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14998078|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
14998079|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
14998080|NCT01769898|Hormones|hormones|mesh-ancestor
14998081|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14998082|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14998083|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14998084|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14998085|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
14998086|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14998087|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998088|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14998089|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998090|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
14998091|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14998092|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14998093|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
14998094|NCT01769911|Cytarabine|cytarabine|mesh-list
14998095|NCT01769911|Etoposide|etoposide|mesh-list
14998096|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
14998097|NCT01769911|Melphalan|melphalan|mesh-list
14998098|NCT01769911|Carmustine|carmustine|mesh-list
14998099|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14998100|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14523785|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
14523786|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523787|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523788|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
14523789|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14998101|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998102|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14998103|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14998104|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998105|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998106|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14998107|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
14998108|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
14998109|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998110|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14998111|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
14998112|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998113|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14998114|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
14998115|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14998116|NCT01769950|Choline|choline|mesh-list
14998117|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
14998118|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14998119|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
14998120|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998121|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14998122|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14998123|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
14998124|NCT01770041|Acetaminophen|acetaminophen|mesh-list
14998125|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14998126|NCT01770041|Analgesics|analgesics|mesh-ancestor
14998127|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
14998128|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998129|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998130|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
14998131|NCT01770080|Peppermint oil|peppermint oil|mesh-list
14998132|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14998133|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
14998134|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
14998135|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998136|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998137|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14998138|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
14998139|NCT01770106|Denosumab|denosumab|mesh-list
14998140|NCT01770106|Alendronate|alendronate|mesh-list
14998141|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14998142|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998143|NCT01770119|Vaccines|vaccines|mesh-list
14998144|NCT01770119|Immunologic Factors|immunologic factors|mesh-ancestor
14998145|NCT01770119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998146|NCT01770132|Gemcitabine|gemcitabine|mesh-list
14998147|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14998148|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
14998149|NCT01770132|Trioxsalen|trioxsalen|mesh-list
14998150|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14998151|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
14998152|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998153|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998154|NCT01770132|Antiviral Agents|antiviral agents|mesh-ancestor
14998155|NCT01770132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998156|NCT01770132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998157|NCT01770132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14998158|NCT01770132|Immunologic Factors|immunologic factors|mesh-ancestor
14998159|NCT01770132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998160|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
14998161|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14998162|NCT01770171|Paclitaxel|paclitaxel|mesh-list
14998163|NCT01770171|Bevacizumab|bevacizumab|mesh-list
14998164|NCT01770171|Carboplatin|carboplatin|mesh-list
14998165|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14998166|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998167|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
14998168|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
14998169|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
14998170|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998171|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14998172|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14998173|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14998174|NCT01770171|Growth Substances|growth substances|mesh-ancestor
14998175|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998176|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
14998177|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14998178|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14998179|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14998180|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998181|NCT01770210|Atorvastatin|atorvastatin|mesh-list
14998182|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14998183|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14998184|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
14998185|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998186|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14998187|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14998188|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998189|NCT01770223|Ribavirin|ribavirin|mesh-list
14998190|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14998191|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
14998192|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998193|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
14998194|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998195|NCT01770236|Acetaminophen|acetaminophen|mesh-list
14998196|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14998197|NCT01770236|Analgesics|analgesics|mesh-ancestor
14998198|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
14998199|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998200|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998201|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
14998202|NCT01770301|Paclitaxel|paclitaxel|mesh-list
14998203|NCT01770301|Bevacizumab|bevacizumab|mesh-list
14998204|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14998205|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998206|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
14998207|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
14998208|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
14998209|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998210|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14998211|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14998212|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14998213|NCT01770301|Growth Substances|growth substances|mesh-ancestor
14998214|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998215|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
14998216|NCT01770444|Cytarabine|cytarabine|mesh-list
14998217|NCT01770444|Thioguanine|thioguanine|mesh-list
14998218|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14998219|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
14998220|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998221|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998222|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
14998223|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998224|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14998225|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
14998226|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998227|NCT01770470|Chitosan|chitosan|mesh-list
14998228|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14998229|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14998230|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
14998231|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998232|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14998233|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
14998234|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
14998235|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
14998236|NCT01770470|Coagulants|coagulants|mesh-ancestor
14998237|NCT01770496|Vaccines|vaccines|mesh-list
14998238|NCT01770496|Immunologic Factors|immunologic factors|mesh-ancestor
14998239|NCT01770496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998240|NCT01770600|Risperidone|risperidone|mesh-list
14998241|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14998242|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
14998243|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14998244|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998245|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998246|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14998247|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14998248|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14998249|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14998250|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14998251|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
15032087|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
15032088|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15032089|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15032090|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032091|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032092|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15032093|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15032094|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15032095|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15032096|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
15032097|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032098|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032099|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15032100|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15032101|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
15032102|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15032103|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15032104|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
15032105|NCT01979796|Nicotine|nicotine|mesh-list
15032106|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15032107|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
15032108|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032109|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032110|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15032111|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15032112|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
15032113|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032114|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032115|NCT01979965|Ranolazine|ranolazine|mesh-list
15032116|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15032117|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15032118|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032119|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
15032120|NCT01980004|Diuretics|diuretics|mesh-ancestor
15032121|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
15032122|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032123|NCT01980004|Expectorants|expectorants|mesh-ancestor
15032124|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
15032125|NCT01980069|Neostigmine|neostigmine|mesh-list
15032126|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15032127|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032128|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032129|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
15032130|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032131|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032132|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15032133|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
14998252|NCT01770769|Cloxacillin|cloxacillin|mesh-list
14998253|NCT01770769|Cephalothin|cephalothin|mesh-list
14998254|NCT01770769|Dalteparin|dalteparin|mesh-list
14998255|NCT01770769|Tinzaparin|tinzaparin|mesh-list
14998256|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14998257|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
14998258|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14998259|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14998260|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998261|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14998262|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998263|NCT01770795|Gemcitabine|gemcitabine|mesh-list
14998264|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14998265|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
14998266|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998267|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998268|NCT01770795|Antiviral Agents|antiviral agents|mesh-ancestor
14998269|NCT01770795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998270|NCT01770795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998271|NCT01770795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14998272|NCT01770795|Immunologic Factors|immunologic factors|mesh-ancestor
14998273|NCT01770795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998274|NCT01770899|Montelukast|montelukast|mesh-list
14998275|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14998276|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
14998277|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14998278|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
14998279|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14998280|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998281|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14998282|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14998283|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998284|NCT01770964|Pregabalin|pregabalin|mesh-list
14998285|NCT01770964|Analgesics|analgesics|mesh-ancestor
14998286|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
14998287|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998288|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998289|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
14998290|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14998291|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14998292|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998293|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14998294|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14998295|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14998296|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14998297|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14998298|NCT01771081|Ranibizumab|ranibizumab|mesh-list
14998299|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14998300|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14998301|NCT01771081|Growth Substances|growth substances|mesh-ancestor
14998302|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998303|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
14998304|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998305|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
14998306|NCT01771146|Irinotecan|irinotecan|mesh-list
14998307|NCT01771146|Folfirinox|folfirinox|mesh-list
14998308|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998309|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14998310|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14998311|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998312|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998313|NCT01771185|Metformin|metformin|mesh-list
14998314|NCT01771185|Gliclazide|gliclazide|mesh-list
14998315|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14998316|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998317|NCT01771198|Simvastatin|simvastatin|mesh-list
14998318|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14998319|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14998320|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
14998321|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998322|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14998323|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14998324|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998325|NCT01771289|Docetaxel|docetaxel|mesh-list
14998326|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998327|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
14998328|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
14998329|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
14998330|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998331|NCT01771302|Calcium|calcium|mesh-list
14998332|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14998333|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998334|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
14998335|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14998336|NCT01771328|Cortisone|cortisone|mesh-list
14998337|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14998338|NCT01771406|Nebivolol|nebivolol|mesh-list
14998339|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14998340|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
14998341|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14998342|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14998343|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14998344|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
14998345|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14998346|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998347|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998348|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14998349|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998350|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14998351|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14998352|NCT01771458|Tamoxifen|tamoxifen|mesh-list
14998353|NCT01771458|Trastuzumab|trastuzumab|mesh-list
14998354|NCT01771458|Everolimus|everolimus|mesh-list
14998355|NCT01771458|Sorafenib|sorafenib|mesh-list
14998356|NCT01771458|Letrozole|letrozole|mesh-list
14998357|NCT01771458|Dasatinib|dasatinib|mesh-list
14998358|NCT01771458|Lapatinib|lapatinib|mesh-list
14998359|NCT01771458|Vemurafenib|vemurafenib|mesh-list
14998360|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14998361|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998362|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14998363|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
14998364|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998365|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14998366|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998367|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998368|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14998369|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14998370|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14998371|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
14998372|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14998373|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14998374|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14998375|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14998376|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14998377|NCT05318443|Paclitaxel|paclitaxel|mesh-list
14998378|NCT05318443|Carboplatin|carboplatin|mesh-list
14998379|NCT05318443|Bevacizumab|bevacizumab|mesh-list
14998380|NCT05318443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14998381|NCT05318443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998382|NCT05318443|Tubulin Modulators|tubulin modulators|mesh-ancestor
14998383|NCT05318443|Antimitotic Agents|antimitotic agents|mesh-ancestor
14998384|NCT05318443|Mitosis Modulators|mitosis modulators|mesh-ancestor
14998385|NCT05318443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998386|NCT05318443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14998387|NCT05318443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14998388|NCT05318443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14998389|NCT05318443|Growth Substances|growth substances|mesh-ancestor
14998390|NCT05318443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998391|NCT05318443|Growth Inhibitors|growth inhibitors|mesh-ancestor
14998392|NCT05318365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14998393|NCT05318365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14998394|NCT05318365|Laxatives|laxatives|mesh-ancestor
14998395|NCT05318339|Trastuzumab|trastuzumab|mesh-list
14998396|NCT05318339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14998397|NCT05318339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998398|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14998399|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14998400|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14998401|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998402|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
14998403|NCT01771822|Ibuprofen|ibuprofen|mesh-list
14998404|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14998405|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14998406|NCT01771822|Analgesics|analgesics|mesh-ancestor
14998407|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
14998408|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998409|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998410|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14998411|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14998412|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14998413|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998414|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998415|NCT01771874|Bupropion|bupropion|mesh-list
14998416|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14998417|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14998418|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
14998419|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14998420|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14998421|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14998422|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14998423|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998424|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
14998425|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14998426|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998427|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14998428|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14998429|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998430|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
14998431|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
14998432|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14998433|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
14998434|NCT01771978|Diltiazem|diltiazem|mesh-list
14998435|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14998436|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14998437|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14998438|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998439|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14998440|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998441|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
14998442|NCT01772056|Fluticasone|fluticasone|mesh-list
14998443|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14998444|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14998445|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
14998446|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998447|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998448|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14998449|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
14998450|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
14998451|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15032134|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032135|NCT01980082|Cefazolin|cefazolin|mesh-list
15032136|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14998452|NCT01772212|Terbinafine|terbinafine|mesh-list
14998453|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
14998454|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998455|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998456|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998457|NCT01772238|Amoxicillin|amoxicillin|mesh-list
14998458|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14998459|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
14998460|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
14998461|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14998462|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998463|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14998464|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998465|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998466|NCT01772251|Insulin|insulin|mesh-list
14998467|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14998468|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998469|NCT01772290|Itraconazole|itraconazole|mesh-list
14998470|NCT01772290|Fluconazole|fluconazole|mesh-list
14998471|NCT01772290|Rabeprazole|rabeprazole|mesh-list
14998472|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
14998473|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998474|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14998475|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14998476|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998477|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998478|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14998479|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
14998480|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14998481|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998482|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14998483|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14998484|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14998485|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14998486|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14998487|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14998488|NCT01772381|Dexamethasone|dexamethasone|mesh-list
14998489|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14998490|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
14998491|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
14998492|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998493|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998494|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14998495|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
14998496|NCT01772381|Hormones|hormones|mesh-ancestor
14998497|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14998498|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14998499|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998500|NCT01772420|Lenalidomide|lenalidomide|mesh-list
14998501|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
14998502|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998503|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14998504|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14998505|NCT01772420|Growth Substances|growth substances|mesh-ancestor
14998506|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
14998507|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998508|NCT01772563|Itraconazole|itraconazole|mesh-list
14998509|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
14998510|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998511|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14998512|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14998513|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998514|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998515|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14998516|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
14998517|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14998518|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998519|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14998520|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
14998521|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
14998522|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
14998523|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
14998524|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14998525|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998526|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14998527|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14998528|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998529|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998530|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998531|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14998532|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14998533|NCT01772641|Varenicline|varenicline|mesh-list
14998534|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14998535|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14998536|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
14998537|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14998538|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998539|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998540|NCT01772797|Ceritinib|ceritinib|mesh-list
14998541|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998542|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14998543|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998544|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998545|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
14998546|NCT01772836|Biapenem|biapenem|mesh-list
14998547|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998548|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998549|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14998550|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998551|NCT01772940|Ritonavir|ritonavir|mesh-list
14998552|NCT01772940|Lopinavir|lopinavir|mesh-list
14998553|NCT01772940|Tenofovir|tenofovir|mesh-list
14998554|NCT01772940|Lamivudine|lamivudine|mesh-list
14998555|NCT01772940|Zidovudine|zidovudine|mesh-list
14998556|NCT01772940|Emtricitabine|emtricitabine|mesh-list
14998557|NCT01772940|Nevirapine|nevirapine|mesh-list
14998558|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14998559|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14998560|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
14998561|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998562|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998563|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14998564|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14998565|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
14998566|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998567|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14998568|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14998569|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14998570|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14998571|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
14998572|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14998573|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14998574|NCT01772953|Treosulfan|treosulfan|mesh-list
14998575|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14998576|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
14998577|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998578|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998579|NCT01772979|Trabectedin|trabectedin|mesh-list
14998580|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14998581|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
14998582|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998583|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998584|NCT01773005|Acetaminophen|acetaminophen|mesh-list
14998585|NCT01773005|Ibuprofen|ibuprofen|mesh-list
14998586|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14998587|NCT01773005|Analgesics|analgesics|mesh-ancestor
14998588|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
14998589|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998590|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998591|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
14998592|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14998593|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14998594|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14998595|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14998596|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998597|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998598|NCT01773044|Lidocaine|lidocaine|mesh-list
14998599|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
14998600|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
14998601|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14998602|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998603|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
14998604|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998605|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14998606|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14998607|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14998608|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14998609|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998610|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
14998611|NCT01773096|Bisacodyl|bisacodyl|mesh-list
14998612|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
14998613|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
14998614|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
14998615|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14998616|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998617|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
14998618|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998619|NCT01773096|Cathartics|cathartics|mesh-ancestor
14998620|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14998621|NCT01773096|Laxatives|laxatives|mesh-ancestor
14998622|NCT01773096|Antacids|antacids|mesh-ancestor
14998623|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998624|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
14998625|NCT01773174|Dabigatran|dabigatran|mesh-list
14998626|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
14998627|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14998628|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
14998629|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998630|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998631|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
14998632|NCT01773408|Cytarabine|cytarabine|mesh-list
14998633|NCT01773408|Daunorubicin|daunorubicin|mesh-list
14998634|NCT01773408|Idarubicin|idarubicin|mesh-list
14998635|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14998636|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
14998637|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998638|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998639|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
14998640|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998641|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14998642|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
14998643|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998644|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14998645|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14998646|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14998647|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998648|NCT01773460|Everolimus|everolimus|mesh-list
14998649|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998650|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14998651|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
14998652|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998653|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14998654|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14998655|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14998656|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
14998657|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998658|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14998659|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14998660|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998661|NCT01773538|Rifaximin|rifaximin|mesh-list
14998662|NCT01773538|Lactulose|lactulose|mesh-list
14998663|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14998664|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998665|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14998666|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
14998667|NCT01773616|Prednisolone|prednisolone|mesh-list
14998668|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14998669|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
14998670|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14998671|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
14998672|NCT01773616|Rituximab|rituximab|mesh-list
14998673|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14998674|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
14998675|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14998676|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998677|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
14998678|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998679|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14998680|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14998681|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14998682|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
14998683|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14998684|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998685|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998686|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998687|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14998688|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
14998689|NCT01773616|Hormones|hormones|mesh-ancestor
14998690|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14998691|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14998692|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
14998693|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
14998694|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998695|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14998696|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14998697|NCT01773616|Protective Agents|protective agents|mesh-ancestor
14998698|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
14998699|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14998700|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
14998701|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998702|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14998703|NCT01773772|Progesterone|progesterone|mesh-list
14998704|NCT01773772|Progestins|progestins|mesh-ancestor
14998705|NCT01773772|Hormones|hormones|mesh-ancestor
14998706|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14998707|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998708|NCT01773798|Insulin|insulin|mesh-list
14998709|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14998710|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
14998711|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
14998712|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14998713|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14998714|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998715|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14998716|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15032137|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15032138|NCT01980277|Paclitaxel|paclitaxel|mesh-list
15032139|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15032140|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032141|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
15032142|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
15032143|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
15032144|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032145|NCT01980303|Esketamine|esketamine|mesh-list
15032146|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
15032147|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15032148|NCT01980316|Heparin|heparin|mesh-list
15032149|NCT01980316|Calcium heparin|calcium heparin|mesh-list
15032150|NCT01980316|Argatroban|argatroban|mesh-list
15032151|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
15032152|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15032153|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15032154|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032155|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
15032156|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15032157|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
15032158|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032159|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15032160|NCT01980329|Maraviroc|maraviroc|mesh-list
15032161|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15032162|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15032163|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032164|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15032165|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15032166|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
15032167|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15032168|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15032169|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
15032170|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15032171|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15032172|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032173|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
15032174|NCT01980355|Coagulants|coagulants|mesh-ancestor
15032175|NCT01980407|Leucovorin|leucovorin|mesh-list
15032176|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
15032177|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
15032178|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032179|NCT01980407|Antidotes|antidotes|mesh-ancestor
15032180|NCT01980407|Protective Agents|protective agents|mesh-ancestor
15032181|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998717|NCT01773837|Methylphenidate|methylphenidate|mesh-list
14998718|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14998719|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998720|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14998721|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14998722|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14998723|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998724|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
14998725|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14998726|NCT01773876|Micafungin|micafungin|mesh-list
14998727|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
14998728|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998729|NCT01774370|Dabigatran|dabigatran|mesh-list
14998730|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
14998731|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14998732|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
14998733|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998734|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998735|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
14998736|NCT01774396|Lidocaine|lidocaine|mesh-list
14998737|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
14998738|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
14998739|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14998740|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998741|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
14998742|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998743|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14998744|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14998745|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14998746|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14998747|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998748|NCT01774474|Dexamethasone|dexamethasone|mesh-list
14998749|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
14998750|NCT01774474|Triamcinolone|triamcinolone|mesh-list
14998751|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14998752|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14998753|NCT01774474|Bromfenac|bromfenac|mesh-list
14998754|NCT01774474|Bevacizumab|bevacizumab|mesh-list
14998755|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14998756|NCT01774474|BB 1101|bb 1101|mesh-list
14998757|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14998758|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14998759|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998760|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14998761|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14998762|NCT01774474|Growth Substances|growth substances|mesh-ancestor
14998763|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998764|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
14998765|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14998766|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
14998767|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
14998768|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998769|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14998770|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
14998771|NCT01774474|Hormones|hormones|mesh-ancestor
14998772|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14998773|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14998774|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
14998775|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998776|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998777|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14998778|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14998779|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
14998780|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14998781|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14998782|NCT01774474|Analgesics|analgesics|mesh-ancestor
14998783|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
14998784|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14998785|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
14998786|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14998787|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998788|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998789|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14998790|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14998791|NCT01774487|Protective Agents|protective agents|mesh-ancestor
14998792|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998793|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
14998794|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14998795|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
14998796|NCT01774565|Insulin|insulin|mesh-list
14998797|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14998798|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14998799|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998800|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
14998801|NCT01774812|Vitamin D|vitamin d|mesh-list
14998802|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
14998803|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14998804|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14998805|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998806|NCT01774812|Vitamins|vitamins|mesh-ancestor
14998807|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
14998808|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14998809|NCT01774838|Clopidogrel|clopidogrel|mesh-list
14998810|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14998811|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14998812|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14998813|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14998814|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14998815|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
14998816|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14998817|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998818|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998819|NCT01774864|Udenafil|udenafil|mesh-list
14998820|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14998821|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14998822|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998823|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998824|NCT01774877|Leflunomide|leflunomide|mesh-list
14998825|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998826|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998827|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14998828|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
14998829|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998830|NCT01775098|Allopurinol|allopurinol|mesh-list
14998831|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
14998832|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998833|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998834|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
14998835|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14998836|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14998837|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
14998838|NCT01775098|Protective Agents|protective agents|mesh-ancestor
15032182|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
14523790|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14998839|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998840|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14998841|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
14998842|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998843|NCT01775397|Vancomycin|vancomycin|mesh-list
14998844|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
14998845|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14998846|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998847|NCT01775475|Prednisone|prednisone|mesh-list
14998848|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
14998849|NCT01775475|Lomustine|lomustine|mesh-list
14998850|NCT01775475|Doxorubicin|doxorubicin|mesh-list
14998851|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14998852|NCT01775475|Etoposide|etoposide|mesh-list
14998853|NCT01775475|Vincristine|vincristine|mesh-list
14998854|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
14998855|NCT01775475|Procarbazine|procarbazine|mesh-list
14998856|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14998857|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
14998858|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998859|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14998860|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14998861|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
14998862|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998863|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998864|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14998865|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14998866|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14998867|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14998868|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998869|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14998870|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
14998871|NCT01775475|Hormones|hormones|mesh-ancestor
14998872|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14998873|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14998874|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14998875|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
14998876|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
14998877|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
14998878|NCT01775540|Dexamethasone|dexamethasone|mesh-list
14998879|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
14998880|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14998881|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
14998882|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
14998883|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998884|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998885|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14998886|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
14998887|NCT01775540|Hormones|hormones|mesh-ancestor
14998888|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14998889|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14998890|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998891|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14998892|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14998893|NCT01775579|Metformin|metformin|mesh-list
14998894|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14998895|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14998896|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998897|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14998898|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14998899|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
14998900|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998901|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14998902|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14998903|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998904|NCT01775618|Factor VIII|factor viii|mesh-list
14998905|NCT01775618|Coagulants|coagulants|mesh-ancestor
14998906|NCT01775631|Rituximab|rituximab|mesh-list
14998907|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14998908|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998909|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
14998910|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998911|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15032183|NCT01980407|Vitamins|vitamins|mesh-ancestor
15032184|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
15032185|NCT01980472|Paclitaxel|paclitaxel|mesh-list
15032186|NCT01980472|Bevacizumab|bevacizumab|mesh-list
15032187|NCT01980472|Carboplatin|carboplatin|mesh-list
14998912|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
14998913|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14998914|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14998915|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14998916|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14998917|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998918|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998919|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998920|NCT01775839|Aspirin|aspirin|mesh-list
14998921|NCT01775839|Digoxin|digoxin|mesh-list
14998922|NCT01775839|Clopidogrel|clopidogrel|mesh-list
14998923|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14998924|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14998925|NCT01775839|Analgesics|analgesics|mesh-ancestor
14998926|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
14998927|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998928|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998929|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14998930|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14998931|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14998932|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14998933|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998934|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14998935|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14998936|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998937|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
14998938|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14998939|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14998940|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14998941|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
14998942|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14998943|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14998944|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14998945|NCT01775839|Protective Agents|protective agents|mesh-ancestor
14998946|NCT01775891|Flecainide|flecainide|mesh-list
14998947|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14998948|NCT01775891|Propafenone|propafenone|mesh-list
14998949|NCT01775891|Pilsicainide|pilsicainide|mesh-list
14998950|NCT01775891|Lidocaine|lidocaine|mesh-list
14998951|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14998952|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14998953|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14998954|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998955|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
14998956|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
14998957|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14998958|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998959|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
14998960|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998961|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
14998962|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14998963|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14998964|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
14998965|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14998966|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14998967|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14998968|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
14998969|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14998970|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998971|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14998972|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14998973|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14998974|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14998975|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998976|NCT01776320|Alprostadil|alprostadil|mesh-list
14998977|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14998978|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
14998979|NCT01776320|Urological Agents|urological agents|mesh-ancestor
14998980|NCT01776437|Talazoparib|talazoparib|mesh-list
14998981|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14998982|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14998983|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14998984|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998985|NCT01776515|Acetaminophen|acetaminophen|mesh-list
14998986|NCT01776515|Tramadol|tramadol|mesh-list
14998987|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14998988|NCT01776515|Analgesics|analgesics|mesh-ancestor
14998989|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
14998990|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14998991|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14998992|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
14998993|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14998994|NCT01776515|Narcotics|narcotics|mesh-ancestor
14998995|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14998996|NCT01776567|Everolimus|everolimus|mesh-list
14998997|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14998998|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14998999|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
14999000|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999001|NCT01776671|Gabapentin|gabapentin|mesh-list
14999002|NCT01776671|Analgesics|analgesics|mesh-ancestor
14999003|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
14999004|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999005|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999006|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
14999007|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14999008|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14999009|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999010|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14999011|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14999012|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14999013|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999014|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999015|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
14999016|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14999017|NCT01776684|Gefitinib|gefitinib|mesh-list
14999018|NCT01776684|Afatinib|afatinib|mesh-list
14999019|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999020|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14999021|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999022|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999023|NCT01776788|Insulin|insulin|mesh-list
14999024|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14999025|NCT01776788|Exenatide|exenatide|mesh-list
14999026|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
14999027|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14999028|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999029|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14999030|NCT01776788|Incretins|incretins|mesh-ancestor
14999031|NCT01776788|Hormones|hormones|mesh-ancestor
14999032|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14999033|NCT01776853|Levan|levan|mesh-list
14999034|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999035|NCT01776970|Nabiximols|nabiximols|mesh-list
14999036|NCT01776970|Analgesics|analgesics|mesh-ancestor
14999037|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
14999038|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999039|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999040|NCT01777087|Capsaicin|capsaicin|mesh-list
14999041|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
14999042|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
14999043|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
14999044|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999045|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999046|NCT01777100|Sufentanil|sufentanil|mesh-list
14999047|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14999048|NCT01777100|Narcotics|narcotics|mesh-ancestor
14999049|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999050|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999051|NCT01777100|Analgesics|analgesics|mesh-ancestor
14999052|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
14999053|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999054|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14999055|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14999056|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
14999057|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
14999058|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14999059|NCT01777464|Histamine|histamine|mesh-list
14999060|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
14999061|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
14999062|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999063|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999064|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999065|NCT01777477|Gemcitabine|gemcitabine|mesh-list
14999066|NCT01777477|Chloroquine|chloroquine|mesh-list
14999067|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14999068|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
14999069|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999070|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999071|NCT01777477|Antiviral Agents|antiviral agents|mesh-ancestor
14999072|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999073|NCT01777477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999074|NCT01777477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14999075|NCT01777477|Immunologic Factors|immunologic factors|mesh-ancestor
14999076|NCT01777477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999077|NCT01777477|Amebicides|amebicides|mesh-ancestor
14999078|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14999079|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14999080|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
14999081|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14999082|NCT01777503|Clopidogrel|clopidogrel|mesh-list
14999083|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14999084|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14999085|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14999086|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14999087|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14999088|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
14999089|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999090|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999091|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032188|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15032189|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032190|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
15032191|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
15032192|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
15032193|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032194|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15032195|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15032196|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15032197|NCT01980472|Growth Substances|growth substances|mesh-ancestor
15032198|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032199|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
15032200|NCT01980498|Fentanyl|fentanyl|mesh-list
15032201|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15032202|NCT01980498|Narcotics|narcotics|mesh-ancestor
15032203|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032204|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032205|NCT01980498|Analgesics|analgesics|mesh-ancestor
15032206|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
15032207|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032208|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15032209|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15032210|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
15032211|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
15032212|NCT01980550|Nicotine|nicotine|mesh-list
15032213|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15032214|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
15032215|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032216|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032217|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15032218|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15032219|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
15032220|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032221|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032222|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15032223|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15032224|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
15032225|NCT01980667|Cisplatin|cisplatin|mesh-list
15032226|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032227|NCT01980680|Estradiol|estradiol|mesh-list
15032228|NCT01980680|Progesterone|progesterone|mesh-list
15032229|NCT01980680|Estrogens|estrogens|mesh-ancestor
15032230|NCT01980680|Hormones|hormones|mesh-ancestor
15032231|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15032232|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032233|NCT01980680|Progestins|progestins|mesh-ancestor
15032234|NCT01980745|Chloroquine|chloroquine|mesh-list
15032235|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15032236|NCT01980745|Amebicides|amebicides|mesh-ancestor
15032237|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15032238|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15032239|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15032240|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
15032241|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15032242|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15032243|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15032244|NCT01980745|Analgesics|analgesics|mesh-ancestor
15032245|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
15032246|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032247|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032248|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15032249|NCT01980745|Filaricides|filaricides|mesh-ancestor
15032250|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
15032251|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
15032252|NCT01980810|Paclitaxel|paclitaxel|mesh-list
15032253|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14523791|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15032254|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15032255|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523792|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14523793|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523794|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523795|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14801905|NCT00795314|Fentanyl|fentanyl|mesh-list
14801906|NCT00795314|Butorphanol|butorphanol|mesh-list
14801907|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14801908|NCT00795314|Narcotics|narcotics|mesh-ancestor
14801909|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14801910|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999092|NCT01777685|Sulpiride|sulpiride|mesh-list
14999093|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14999094|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14999095|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999096|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999097|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14999098|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14999099|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
14999100|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999101|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999102|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14999103|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
14999104|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
14999105|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14999106|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999107|NCT01777737|Renal Agents|renal agents|mesh-ancestor
14999108|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14999109|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
14999110|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14999111|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14999112|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
14999113|NCT01777867|Miotics|miotics|mesh-ancestor
14999114|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
14999115|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999116|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999117|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14999118|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
14999119|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
14999120|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14999121|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14999122|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
14999123|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999124|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999125|NCT01777919|Copper|copper|mesh-list
14999126|NCT01777919|Temozolomide|temozolomide|mesh-list
14999127|NCT01777919|Disulfiram|disulfiram|mesh-list
14999128|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14999129|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
14999130|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999131|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999132|NCT01777919|Trace Elements|trace elements|mesh-ancestor
14999133|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
14523796|NCT03618823|Narcotics|narcotics|mesh-ancestor
14523797|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14523798|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
14523799|NCT03619837|Velpatasvir|velpatasvir|mesh-list
14523800|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
14801911|NCT00795314|Analgesics|analgesics|mesh-ancestor
14801912|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
14801913|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801914|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14801915|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14801916|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
14801917|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
14801918|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
14801919|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
14801920|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14801921|NCT00795353|Alefacept|alefacept|mesh-list
14801922|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
14801923|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
14801924|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801925|NCT00795444|Maraviroc|maraviroc|mesh-list
14801926|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14999134|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999135|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14999136|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14999137|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999138|NCT01778075|Acetaminophen|acetaminophen|mesh-list
14999139|NCT01778075|Tramadol|tramadol|mesh-list
14999140|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14999141|NCT01778075|Analgesics|analgesics|mesh-ancestor
14999142|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
14999143|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999144|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999145|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
14999146|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14999147|NCT01778075|Narcotics|narcotics|mesh-ancestor
14999148|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999149|NCT01778101|Lansoprazole|lansoprazole|mesh-list
14999150|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
14999151|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14999152|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14999153|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14999154|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999155|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999156|NCT01778114|Vitamin D|vitamin d|mesh-list
14999157|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
14999158|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
14999159|NCT01778114|Vitamins|vitamins|mesh-list
14999160|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
14999161|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999162|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14999163|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14999164|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
14999165|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
14999166|NCT01778192|Citric Acid|citric acid|mesh-list
14999167|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
14999168|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
14999169|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14999170|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
14999171|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
14999172|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999173|NCT01778192|Cathartics|cathartics|mesh-ancestor
14999174|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14999175|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
14999176|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
14999177|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999178|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
14999179|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999180|NCT01778244|Metformin|metformin|mesh-list
14999181|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14999182|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999183|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
14999184|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14999185|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
14999186|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14999187|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
14999188|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999189|NCT01778309|Expectorants|expectorants|mesh-ancestor
14999190|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
14999191|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14999192|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
14999193|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999194|NCT01778309|Protective Agents|protective agents|mesh-ancestor
14999195|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999196|NCT01778309|Antidotes|antidotes|mesh-ancestor
14999197|NCT01778400|Ethanol|ethanol|mesh-list
14999198|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14999199|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999200|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999201|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999202|NCT01778413|Tenofovir|tenofovir|mesh-list
14999203|NCT01778413|Emtricitabine|emtricitabine|mesh-list
14999204|NCT01778413|Efavirenz|efavirenz|mesh-list
14999205|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14999206|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
14999207|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999208|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14999209|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14999210|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999211|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999212|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14999213|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14999214|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14999215|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14999216|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14999217|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14999218|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14999219|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14999220|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
14999221|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999222|NCT01778686|Pindolol|pindolol|mesh-list
14999223|NCT01778686|Citalopram|citalopram|mesh-list
14999224|NCT01778686|Tryptophan|tryptophan|mesh-list
14999225|NCT01778686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14999226|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14999227|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14999228|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999229|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999230|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
14999231|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999232|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14999233|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
14999234|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14999235|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14999236|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14999237|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
14999238|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14999239|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14999240|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
14999241|NCT01778803|Paclitaxel|paclitaxel|mesh-list
14999242|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14999243|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999244|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
14999245|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
14999246|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
14999247|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999248|NCT01778842|Clopidogrel|clopidogrel|mesh-list
14999249|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14999250|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14999251|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14999252|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14999253|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14999254|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
14999255|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999256|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999257|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999258|NCT01778946|Nicotine|nicotine|mesh-list
14999259|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14999260|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
14999261|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999262|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999263|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14999264|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14999265|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
14999266|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999267|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999268|NCT01779089|Minocycline|minocycline|mesh-list
14999269|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14999270|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999271|NCT01779206|Paclitaxel|paclitaxel|mesh-list
14999272|NCT01779206|Docetaxel|docetaxel|mesh-list
14999273|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
14999274|NCT01779206|Epirubicin|epirubicin|mesh-list
14999275|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14999276|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999277|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
14999278|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
14999279|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
14999280|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999281|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14999282|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
14999283|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999284|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14999285|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14999286|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
14999287|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14999288|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14999289|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14999290|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14999291|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999292|NCT01779232|Danazol|danazol|mesh-list
14999293|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14999294|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
14999295|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14999296|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999297|NCT01779245|Calcium|calcium|mesh-list
14999298|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14999299|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999300|NCT01779258|Desonide|desonide|mesh-list
14999301|NCT01779258|Glycerol|glycerol|mesh-list
14999302|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14999303|NCT01779258|Protective Agents|protective agents|mesh-ancestor
14999304|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999305|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14999306|NCT01779271|Loxoprofen|loxoprofen|mesh-list
14999307|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14999308|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14999309|NCT01779271|Analgesics|analgesics|mesh-ancestor
14999310|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
14999311|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999312|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999313|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14999314|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14999315|NCT01779284|Timolol|timolol|mesh-list
14999316|NCT01779284|Travoprost|travoprost|mesh-list
14999317|NCT01779284|Latanoprost|latanoprost|mesh-list
14999318|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14999319|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14999320|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
14999321|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999322|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999323|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999324|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14999325|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14999326|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14999327|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15032256|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
14999328|NCT01779362|Metformin|metformin|mesh-list
14999329|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
14999330|NCT01779362|Liraglutide|liraglutide|mesh-list
14999331|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14999332|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999333|NCT01779362|Incretins|incretins|mesh-ancestor
14999334|NCT01779362|Hormones|hormones|mesh-ancestor
14999335|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14999336|NCT01779401|Aspirin|aspirin|mesh-list
14999337|NCT01779401|Cilostazol|cilostazol|mesh-list
14999338|NCT01779401|Clopidogrel|clopidogrel|mesh-list
14999339|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14999340|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14999341|NCT01779401|Analgesics|analgesics|mesh-ancestor
14999342|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
14999343|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999344|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999345|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14999346|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14999347|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14999348|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14999349|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999350|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14999351|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14999352|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999353|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
14999354|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14999355|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14999356|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14999357|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
14999358|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999359|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14999360|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
14999361|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14999362|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
14999363|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
14999364|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14999365|NCT01779401|Protective Agents|protective agents|mesh-ancestor
14999366|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14999367|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14999368|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14999369|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
14999370|NCT01779466|Coagulants|coagulants|mesh-ancestor
14999371|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14999372|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
14999373|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999374|NCT01779479|Paclitaxel|paclitaxel|mesh-list
14999375|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14999376|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999377|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
14999378|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
14999379|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
14999380|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999381|NCT01779492|Oxycodone|oxycodone|mesh-list
14999382|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14999383|NCT01779492|Narcotics|narcotics|mesh-ancestor
14999384|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999385|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999386|NCT01779492|Analgesics|analgesics|mesh-ancestor
14999387|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
14999388|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999389|NCT01779518|Interferons|interferons|mesh-list
14999390|NCT01779518|Ribavirin|ribavirin|mesh-list
14999391|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
14999392|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999393|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
14999394|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999395|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
14999396|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999397|NCT01779596|Bosentan|bosentan|mesh-list
14999398|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14999399|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14999400|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999401|NCT01779609|Bosentan|bosentan|mesh-list
14999402|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14999403|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15032257|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
14999404|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999405|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
14999406|NCT01779687|Atorvastatin|atorvastatin|mesh-list
14999407|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14999408|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14999409|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
14999410|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999411|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14999412|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14999413|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999414|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14999415|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14999416|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
14999417|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999418|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14999419|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14999420|NCT01779830|Zolpidem|zolpidem|mesh-list
14999421|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14999422|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14999423|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999424|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999425|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14999426|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
14999427|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
14999428|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999429|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999430|NCT01779843|Cytarabine|cytarabine|mesh-list
14999431|NCT01779843|Idarubicin|idarubicin|mesh-list
14999432|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14999433|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
14999434|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999435|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999436|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
14999437|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999438|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14999439|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
14999440|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999441|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14999442|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14999443|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14999444|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999445|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
14999446|NCT01779882|Busulfan|busulfan|mesh-list
14999447|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14999448|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
14999449|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999450|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14999451|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14999452|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
14999453|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999454|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999455|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14999456|NCT01779908|Vitamin D|vitamin d|mesh-list
14999457|NCT01779908|Vitamins|vitamins|mesh-ancestor
14999458|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
14999459|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999460|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14999461|NCT01779921|Thrombin|thrombin|mesh-list
14999462|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
14999463|NCT01779921|Coagulants|coagulants|mesh-ancestor
14999464|NCT01780051|Metformin|metformin|mesh-list
14999465|NCT01780051|Repaglinide|repaglinide|mesh-list
14999466|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14999467|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999468|NCT01780181|Gemcitabine|gemcitabine|mesh-list
14999469|NCT01780181|Docetaxel|docetaxel|mesh-list
14999470|NCT01780181|Vinorelbine|vinorelbine|mesh-list
14999471|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14999472|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
14999473|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999474|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999475|NCT01780181|Antiviral Agents|antiviral agents|mesh-ancestor
14999476|NCT01780181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999477|NCT01780181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999478|NCT01780181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14999479|NCT01780181|Immunologic Factors|immunologic factors|mesh-ancestor
14999480|NCT01780181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999481|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
14999482|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
14999483|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
14999484|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14999485|NCT01780233|Fentanyl|fentanyl|mesh-list
14999486|NCT01780233|Naltrexone|naltrexone|mesh-list
14999487|NCT01780233|Citric Acid|citric acid|mesh-list
14999488|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
14999489|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14999490|NCT01780233|Narcotics|narcotics|mesh-ancestor
14999491|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999492|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999493|NCT01780233|Analgesics|analgesics|mesh-ancestor
14999494|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
14999495|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999496|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14999497|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14999498|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
14999499|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
14999500|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
14999501|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14999502|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
14999503|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
14999504|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999505|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14999506|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14999507|NCT01780259|Triazolam|triazolam|mesh-list
14999508|NCT01780259|Esketamine|esketamine|mesh-list
14999509|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
14999510|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14999511|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14999512|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14999513|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14999514|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999515|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999516|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
14999517|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
14999518|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999519|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999520|NCT01780311|Sotalol|sotalol|mesh-list
14999521|NCT01780311|Flecainide|flecainide|mesh-list
14999522|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14999523|NCT01780311|Propafenone|propafenone|mesh-list
14999524|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14999525|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14999526|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
14999527|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999528|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999529|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999530|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
14999531|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
14999532|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999533|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14999534|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14999535|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14999536|NCT01780467|Dopamine|dopamine|mesh-list
14999537|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14999538|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
14999539|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
14999540|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999541|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999542|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
14999543|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999544|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999545|NCT01780467|Protective Agents|protective agents|mesh-ancestor
14999546|NCT01780519|Lorazepam|lorazepam|mesh-list
14999547|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
14999548|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
14999549|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
14999550|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801927|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14801928|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801929|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14801930|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14801931|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
14801932|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14801933|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14801934|NCT00795457|Poly I-C|poly i-c|mesh-list
14801935|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14801936|NCT00795457|Vaccines|vaccines|mesh-list
14801937|NCT00795457|Poly ICLC|poly iclc|mesh-list
14801938|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
14801939|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801940|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
14801941|NCT00795457|Laxatives|laxatives|mesh-ancestor
14801942|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14999551|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032258|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
14999552|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14999553|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14999554|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999555|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14999556|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14999557|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14999558|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
14999559|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
14999560|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999561|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999562|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14999563|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14999564|NCT01780558|Hormones|hormones|mesh-list
14999565|NCT01780558|Estradiol|estradiol|mesh-list
14999566|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14999567|NCT01780558|Progesterone|progesterone|mesh-list
14999568|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14999569|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999570|NCT01780558|Estrogens|estrogens|mesh-ancestor
14999571|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14999572|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
14999573|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14999574|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14999575|NCT01780558|Progestins|progestins|mesh-ancestor
14999576|NCT01780610|Letrozole|letrozole|mesh-list
14999577|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14999578|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14999579|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14999580|NCT01780610|Hormones|hormones|mesh-list
14999581|NCT01780610|Estradiol|estradiol|mesh-list
14999582|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14999583|NCT01780610|Progesterone|progesterone|mesh-list
14999584|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14999585|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999586|NCT01780610|Estrogens|estrogens|mesh-ancestor
14999587|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14999588|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
14999589|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14999590|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14999591|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999592|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14999593|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14999594|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999595|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999596|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14999597|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
14999598|NCT01780610|Progestins|progestins|mesh-ancestor
14999599|NCT01780740|Atorvastatin|atorvastatin|mesh-list
14999600|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14999601|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14999602|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
14999603|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999604|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14999605|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14999606|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999607|NCT01780753|Primaquine|primaquine|mesh-list
14999608|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
14999609|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14999610|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14999611|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999612|NCT01780883|Melatonin|melatonin|mesh-list
14999613|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
14999614|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999615|NCT01780883|Protective Agents|protective agents|mesh-ancestor
14999616|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999617|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999618|NCT01780909|Paromomycin|paromomycin|mesh-list
14999619|NCT01780909|Domperidone|domperidone|mesh-list
14999620|NCT01780909|Loperamide|loperamide|mesh-list
14999621|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
14999622|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14999623|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
14999624|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
14999625|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999626|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999627|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14999628|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
14999629|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999630|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999631|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14999632|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999633|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14999634|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14999635|NCT01780948|Everolimus|everolimus|mesh-list
14999636|NCT01780948|Atorvastatin|atorvastatin|mesh-list
14999637|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14999638|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14999639|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
14999640|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999641|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14999642|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14999643|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999644|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999645|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14999646|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
14999647|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999648|NCT01781052|Iloprost|iloprost|mesh-list
14999649|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14999650|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
15032259|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032260|NCT01980823|Metformin|metformin|mesh-list
15032261|NCT01980823|Atorvastatin|atorvastatin|mesh-list
15032262|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15032263|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032264|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15032265|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15032266|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
15032267|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032268|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15032269|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15032270|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032271|NCT01980849|Nadroparin|nadroparin|mesh-list
15032272|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
15032273|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15032274|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15032275|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032276|NCT01980966|Oseltamivir|oseltamivir|mesh-list
15032277|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
15032278|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15032279|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032280|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032281|NCT01980979|Treprostinil|treprostinil|mesh-list
15032282|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15032283|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
15032284|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15032285|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032286|NCT01981278|Tapentadol|tapentadol|mesh-list
15032287|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15032288|NCT01981278|Narcotics|narcotics|mesh-ancestor
15032289|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032290|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032291|NCT01981278|Analgesics|analgesics|mesh-ancestor
15032292|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
15032293|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032294|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15032295|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15032296|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15032297|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032298|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
15032299|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032300|NCT01981291|Anesthetics|anesthetics|mesh-list
15032301|NCT01981291|Mepivacaine|mepivacaine|mesh-list
15032302|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
15032303|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032304|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032305|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
15032306|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035406|NCT02001298|Narcotics|narcotics|mesh-ancestor
15035407|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15035408|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035409|NCT02001298|Analgesics|analgesics|mesh-ancestor
14999651|NCT01781273|Ethanol|ethanol|mesh-list
14999652|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14999653|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999654|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999655|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999656|NCT01781377|Metoclopramide|metoclopramide|mesh-list
14999657|NCT01781377|Propofol|propofol|mesh-list
14999658|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14999659|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999660|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999661|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14999662|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
14999663|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
14999664|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
14999665|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
14999666|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999667|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14999668|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14999669|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14999670|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
14999671|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999672|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999673|NCT01781442|Sirolimus|sirolimus|mesh-list
14999674|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14999675|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999676|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14999677|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999678|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
14999679|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14999680|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
14999681|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999682|NCT01781507|Cetirizine|cetirizine|mesh-list
14999683|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14999684|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14999685|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14999686|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
14999687|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
14999688|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999689|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999690|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999691|NCT01781663|Petrolatum|petrolatum|mesh-list
14999692|NCT01781663|Emollients|emollients|mesh-ancestor
14999693|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
14999694|NCT01781702|Celecoxib|celecoxib|mesh-list
14999695|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14999696|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14999697|NCT01781702|Analgesics|analgesics|mesh-ancestor
14999698|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
14999699|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999700|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999701|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14999702|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14999703|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14999704|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14999705|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999706|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999707|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14999708|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
14999709|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999710|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
14999711|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
14999712|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999713|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999714|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999715|NCT01781897|Mosapride|mosapride|mesh-list
14999716|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14999717|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14999718|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
14999719|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999720|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999721|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999722|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14999723|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14999724|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
14999725|NCT01781936|Hormones|hormones|mesh-ancestor
14999726|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14999727|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999728|NCT01781988|Gemcitabine|gemcitabine|mesh-list
14999729|NCT01781988|Carboplatin|carboplatin|mesh-list
14999730|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999731|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14999732|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
14999733|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999734|NCT01781988|Antiviral Agents|antiviral agents|mesh-ancestor
14999735|NCT01781988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999736|NCT01781988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999737|NCT01781988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14999738|NCT01781988|Immunologic Factors|immunologic factors|mesh-ancestor
14999739|NCT01781988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999740|NCT01782001|Vitamins|vitamins|mesh-list
14999741|NCT01782001|Vitamin A|vitamin a|mesh-list
14999742|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
14999743|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
14999744|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999745|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
14999746|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999747|NCT01782001|Protective Agents|protective agents|mesh-ancestor
14999748|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14999749|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999750|NCT01782261|Liraglutide|liraglutide|mesh-list
14999751|NCT01782261|Saxagliptin|saxagliptin|mesh-list
14999752|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14999753|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999754|NCT01782261|Incretins|incretins|mesh-ancestor
14999755|NCT01782261|Hormones|hormones|mesh-ancestor
14999756|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14999757|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14999758|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
14999759|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999760|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999761|NCT01782274|Vaccines|vaccines|mesh-list
14999762|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
14999763|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999764|NCT01782287|Vaccines|vaccines|mesh-list
14999765|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
14999766|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999767|NCT01782300|Vaccines|vaccines|mesh-list
14999768|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
14999769|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999770|NCT01782352|Vitamin D|vitamin d|mesh-list
14999771|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
14999772|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
14999773|NCT01782352|Vitamins|vitamins|mesh-list
14999774|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
14999775|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999776|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14999777|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14999778|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
14999779|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14999780|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999781|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
14999782|NCT01782443|Aflibercept|aflibercept|mesh-list
14999783|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14999784|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14999785|NCT01782443|Growth Substances|growth substances|mesh-ancestor
14999786|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999787|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
14999788|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999789|NCT01782508|Interferons|interferons|mesh-list
14999790|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
14999791|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999792|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
14999793|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999794|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14999795|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999796|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999797|NCT01782560|Omeprazole|omeprazole|mesh-list
14999798|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14999799|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14999800|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14999801|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999802|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999803|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
14999804|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14999805|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14999806|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999807|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
14999808|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
14999809|NCT01782599|Nicotine|nicotine|mesh-list
14999810|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14999811|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
14999812|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999813|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999814|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14999815|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14999816|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
14999817|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999818|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999819|NCT01782612|Analgesics|analgesics|mesh-list
14999820|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
14999821|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999822|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999823|NCT01782651|Capecitabine|capecitabine|mesh-list
14999824|NCT01782651|Lapatinib|lapatinib|mesh-list
14999825|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14999826|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
14999827|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999828|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999829|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14999830|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999831|NCT01782781|Epinephrine|epinephrine|mesh-list
14999832|NCT01782781|Ropivacaine|ropivacaine|mesh-list
14999833|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
14999834|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
14999835|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999836|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999837|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
14999838|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999839|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14999840|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14999841|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
14999842|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14999843|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999844|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14999845|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14999846|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
14999847|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14999848|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
14999849|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
14999850|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
14999851|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15032307|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
15032308|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15032309|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
15032310|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032311|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
15032312|NCT01981330|Protective Agents|protective agents|mesh-ancestor
15032313|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
15032314|NCT01981369|Propofol|propofol|mesh-list
15032315|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15032316|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032317|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032318|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15032319|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
15032320|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
15032321|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15032322|NCT01981369|Analgesics|analgesics|mesh-ancestor
15032323|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
15032324|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032325|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15032326|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15032327|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15032328|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
14999852|NCT01782846|Codeine|codeine|mesh-list
14999853|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14999854|NCT01782846|Narcotics|narcotics|mesh-ancestor
14999855|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14999856|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999857|NCT01782846|Analgesics|analgesics|mesh-ancestor
14999858|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
14999859|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999860|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
14999861|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
14999862|NCT01782911|Resveratrol|resveratrol|mesh-list
14999863|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
14999864|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999865|NCT01782911|Protective Agents|protective agents|mesh-ancestor
14999866|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999867|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999868|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14999869|NCT01782924|Brodalumab|brodalumab|mesh-list
14999870|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
14999871|NCT01782937|Brodalumab|brodalumab|mesh-list
14999872|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
14999873|NCT01782950|Rifampin|rifampin|mesh-list
14999874|NCT01782950|Isoniazid|isoniazid|mesh-list
14999875|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
14999876|NCT01782950|Ethambutol|ethambutol|mesh-list
14999877|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14999878|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
14999879|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14999880|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999881|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
14999882|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14999883|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999884|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999885|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14999886|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14999887|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14999888|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14999889|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14999890|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14999891|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14999892|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14999893|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
14999894|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14999895|NCT01782976|Bevacizumab|bevacizumab|mesh-list
14999896|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14999897|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523801|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
14523802|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523803|NCT03620162|Vaccines|vaccines|mesh-list
14523804|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
14523805|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523806|NCT03620708|Nicotine|nicotine|mesh-list
14523807|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14523808|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
14523809|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14801943|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
14801944|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14801945|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
14801946|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14801947|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
14801948|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14801949|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801950|NCT00795496|Histamine|histamine|mesh-list
14801951|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
14801952|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
14801953|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14801954|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14801955|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801956|NCT00795548|Azacitidine|azacitidine|mesh-list
14801957|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14801958|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
14801959|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999898|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14999899|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14999900|NCT01782976|Growth Substances|growth substances|mesh-ancestor
14999901|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999902|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
14999903|NCT01782989|Doxycycline|doxycycline|mesh-list
14999904|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14999905|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999906|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
14999907|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14999908|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14999909|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
14999910|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14999911|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999912|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
14999913|NCT01783106|Doxycycline|doxycycline|mesh-list
14999914|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
14999915|NCT01783106|Budesonide|budesonide|mesh-list
14999916|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14999917|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14999918|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
14999919|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14999920|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999921|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14999922|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
14999923|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
14999924|NCT01783106|Hormones|hormones|mesh-ancestor
14999925|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14999926|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
14999927|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14999928|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14999929|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999930|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999931|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999932|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14999933|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14999934|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14999935|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14999936|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999937|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14999938|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14999939|NCT01783197|Paclitaxel|paclitaxel|mesh-list
14999940|NCT01783197|Carboplatin|carboplatin|mesh-list
14999941|NCT01783197|Pemetrexed|pemetrexed|mesh-list
14999942|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14999943|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999944|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
14999945|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
14999946|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
14999947|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999948|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999949|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14999950|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14999951|NCT01783340|Azithromycin|azithromycin|mesh-list
14999952|NCT01783340|Vaccines|vaccines|mesh-list
14999953|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14999954|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999955|NCT01783340|Immunologic Factors|immunologic factors|mesh-ancestor
14999956|NCT01783340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999957|NCT01783379|Micafungin|micafungin|mesh-list
14999958|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
14999959|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14999960|NCT01783431|Poly ICLC|poly iclc|mesh-list
14999961|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
14999962|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
14999963|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999964|NCT01783587|Docetaxel|docetaxel|mesh-list
14999965|NCT01783587|Afatinib|afatinib|mesh-list
14999966|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999967|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
14999968|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
14999969|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
14999970|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999971|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14999972|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999973|NCT01783717|Exenatide|exenatide|mesh-list
14999974|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14999975|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999976|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14999977|NCT01783717|Incretins|incretins|mesh-ancestor
14999978|NCT01783717|Hormones|hormones|mesh-ancestor
14999979|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14999980|NCT01783756|Capecitabine|capecitabine|mesh-list
14999981|NCT01783756|Everolimus|everolimus|mesh-list
14999982|NCT01783756|Lapatinib|lapatinib|mesh-list
14999983|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14999984|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
14999985|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999986|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999987|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14999988|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
14999989|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14999990|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14999991|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999992|NCT01783834|Pemetrexed|pemetrexed|mesh-list
14999993|NCT01783834|Gefitinib|gefitinib|mesh-list
14999994|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14999995|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14999996|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14999997|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14999998|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14999999|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15000000|NCT01783925|Aflibercept|aflibercept|mesh-list
15000001|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15000002|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15000003|NCT01783925|Growth Substances|growth substances|mesh-ancestor
15000004|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000005|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
15000006|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000007|NCT01783951|Cisplatin|cisplatin|mesh-list
15000008|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000009|NCT01783964|Cytarabine|cytarabine|mesh-list
15000010|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15000011|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
15000012|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000013|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000014|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
15000015|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000016|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15000017|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
15000018|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000019|NCT01783977|Vaccines|vaccines|mesh-list
15000020|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
15000021|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000022|NCT01784107|Ifosfamide|ifosfamide|mesh-list
15000023|NCT01784107|Belotecan|belotecan|mesh-list
15000024|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15000025|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
15000026|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000027|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000028|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15000029|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15000030|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000031|NCT01784120|Doxorubicin|doxorubicin|mesh-list
15000032|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15000033|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000034|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15000035|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15000036|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000037|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000038|NCT01784250|Propranolol|propranolol|mesh-list
15000039|NCT01784250|Clonidine|clonidine|mesh-list
15000040|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15000041|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15000042|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
15000043|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000044|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000045|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000046|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15000047|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15000048|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
15000049|NCT01784250|Analgesics|analgesics|mesh-ancestor
15000050|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
15000051|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000052|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
15000053|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
15000054|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15000055|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15000056|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15000057|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
15000058|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15000059|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15000060|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
15000061|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000062|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15000063|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15000064|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000065|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000066|NCT01784315|Chloroquine|chloroquine|mesh-list
15000067|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15000068|NCT01784315|Primaquine|primaquine|mesh-list
15000069|NCT01784315|Artemisinins|artemisinins|mesh-list
15000070|NCT01784315|Artemisinin|artemisinin|mesh-list
15000071|NCT01784315|Amebicides|amebicides|mesh-ancestor
15000072|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15000073|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15000074|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000075|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
15000076|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15000077|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15000078|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15000079|NCT01784315|Analgesics|analgesics|mesh-ancestor
15000080|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
15000081|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000082|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000083|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15000084|NCT01784315|Filaricides|filaricides|mesh-ancestor
15000085|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
15000086|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
15000087|NCT01784380|Metformin|metformin|mesh-list
15000088|NCT01784380|Clomiphene|clomiphene|mesh-list
15000089|NCT01784380|Enclomiphene|enclomiphene|mesh-list
15000090|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
15000091|NCT01784380|Menotropins|menotropins|mesh-list
15000092|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
15000093|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15000094|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000095|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15000096|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
15000097|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15000098|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15000099|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
15000100|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15000101|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15000102|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15000103|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
15000104|NCT01784445|Ceftazidime|ceftazidime|mesh-list
15000105|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15000106|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000107|NCT01784536|Oritavancin|oritavancin|mesh-list
15000108|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15000109|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000110|NCT01784549|Gemcitabine|gemcitabine|mesh-list
15000111|NCT01784549|Docetaxel|docetaxel|mesh-list
15000112|NCT01784549|Pemetrexed|pemetrexed|mesh-list
15000113|NCT01784549|Vinorelbine|vinorelbine|mesh-list
15000114|NCT01784549|Gefitinib|gefitinib|mesh-list
15000115|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000116|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15000117|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
15000118|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000119|NCT01784549|Antiviral Agents|antiviral agents|mesh-ancestor
15000120|NCT01784549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000121|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000122|NCT01784549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15000123|NCT01784549|Immunologic Factors|immunologic factors|mesh-ancestor
15000124|NCT01784549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000125|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
15000126|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
15000127|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
15000128|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15000129|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15000130|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15000131|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15000132|NCT01784562|Riociguat|riociguat|mesh-list
15000133|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
15000134|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000135|NCT01784640|Pemetrexed|pemetrexed|mesh-list
15000136|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000137|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000138|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000139|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15000140|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15000141|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
15000142|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032329|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032330|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032331|NCT01981447|Lacosamide|lacosamide|mesh-list
15032332|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
15032333|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15032334|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15032335|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15032336|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000143|NCT01784900|Catumaxomab|catumaxomab|mesh-list
15000144|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15000145|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15000146|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
15000147|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000148|NCT01784913|Sargramostim|sargramostim|mesh-list
15000149|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
15000150|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000151|NCT01784978|Everolimus|everolimus|mesh-list
15000152|NCT01784978|Sunitinib|sunitinib|mesh-list
15000153|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000154|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15000155|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
15000156|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000157|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15000158|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15000159|NCT01784978|Growth Substances|growth substances|mesh-ancestor
15000160|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
15000161|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15000162|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000163|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000164|NCT01785004|Vitamin D|vitamin d|mesh-list
15000165|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
15000166|NCT01785004|Vitamins|vitamins|mesh-ancestor
15000167|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
15000168|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000169|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15000170|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15000171|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
15000172|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15000173|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
15000174|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
15000175|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15000176|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000177|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15000178|NCT01785030|Analgesics|analgesics|mesh-ancestor
15000179|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
15000180|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000181|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15000182|NCT01785043|Liraglutide|liraglutide|mesh-list
15000183|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15000184|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000185|NCT01785043|Incretins|incretins|mesh-ancestor
15000186|NCT01785043|Hormones|hormones|mesh-ancestor
15000187|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15000188|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15000189|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
15000190|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000191|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000192|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15000193|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
15000194|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000195|NCT01785108|Vitamin D|vitamin d|mesh-list
15000196|NCT01785108|Ibuprofen|ibuprofen|mesh-list
15000197|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
15000198|NCT01785108|Vitamins|vitamins|mesh-ancestor
15000199|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
15000200|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000201|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15000202|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15000203|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15000204|NCT01785108|Analgesics|analgesics|mesh-ancestor
15000205|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
15000206|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000207|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15000208|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15000209|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15000210|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000211|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000212|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15000213|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
15000214|NCT01785290|Haloperidol|haloperidol|mesh-list
15000215|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
15000216|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
15000217|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
15000218|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000219|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000220|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15000221|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15000222|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15000223|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15000224|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15000225|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15000226|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
15000227|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000228|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000229|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15000230|NCT01785446|Sufentanil|sufentanil|mesh-list
15000231|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
15000232|NCT01785446|Dsuvia|dsuvia|mesh-list
15000233|NCT01785446|Atracurium|atracurium|mesh-list
15000234|NCT01785446|Cisatracurium|cisatracurium|mesh-list
15000235|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15000236|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15000237|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000238|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15000239|NCT01785446|Analgesics|analgesics|mesh-ancestor
15000240|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
15000241|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000242|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15000243|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15000244|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15000245|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
15000246|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000247|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000248|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15000249|NCT01785446|Narcotics|narcotics|mesh-ancestor
15000250|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15000251|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15000252|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
15000253|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
15000254|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15000255|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15000256|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15000257|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15000258|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15000259|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
15000260|NCT01785589|Adenosine|adenosine|mesh-list
15000261|NCT01785589|Analgesics|analgesics|mesh-ancestor
15000262|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
15000263|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000264|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000265|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15000266|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
15000267|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15000268|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
15000269|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
15000270|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000271|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000272|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15000273|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
15000274|NCT01785641|Gentamicins|gentamicins|mesh-list
15000275|NCT01785641|Cefazolin|cefazolin|mesh-list
15000276|NCT01785641|Ceftazidime|ceftazidime|mesh-list
15000277|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15000278|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000279|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
15000280|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15000281|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15000282|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000283|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000284|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000285|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15000286|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15000287|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15000288|NCT01785693|Clonidine|clonidine|mesh-list
15000289|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
15000290|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
15000291|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
15000292|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15000293|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000294|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
15000295|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000296|NCT01785693|Analgesics|analgesics|mesh-ancestor
15000297|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15000298|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
15000299|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
15000300|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15000301|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15000302|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15000303|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
15000304|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000305|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000306|NCT01785797|Silicon|silicon|mesh-list
15000307|NCT01785797|Trace Elements|trace elements|mesh-ancestor
15000308|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
15000309|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000310|NCT01785836|Dapsone|dapsone|mesh-list
15000311|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000312|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
15000313|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15000314|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15000315|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15000316|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000317|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000318|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
15000319|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15000320|NCT01785862|Ibuprofen|ibuprofen|mesh-list
15000321|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15000322|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15000323|NCT01785862|Analgesics|analgesics|mesh-ancestor
15000324|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
15000325|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000326|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000327|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15000328|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15000329|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15000330|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000331|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000332|NCT01785979|Chloroquine|chloroquine|mesh-list
15000333|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15000334|NCT01785979|Prednisone|prednisone|mesh-list
15000335|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15000336|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
15000337|NCT01785979|Hormones|hormones|mesh-ancestor
15000338|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15000339|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000340|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15000341|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000342|NCT01785979|Amebicides|amebicides|mesh-ancestor
15000343|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15000344|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15000345|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000346|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
15000347|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15000348|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15000349|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15000350|NCT01785979|Analgesics|analgesics|mesh-ancestor
15000351|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
15000352|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000353|NCT01785979|Filaricides|filaricides|mesh-ancestor
15000354|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
15000355|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
15000356|NCT01786018|Cyclosporine|cyclosporine|mesh-list
15000357|NCT01786018|Methotrexate|methotrexate|mesh-list
15000358|NCT01786018|Busulfan|busulfan|mesh-list
15000359|NCT01786018|Thiotepa|thiotepa|mesh-list
15000360|NCT01786018|Cyclosporins|cyclosporins|mesh-list
15000361|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15000362|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
15000363|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15000364|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000365|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15000366|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
15000367|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000368|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000369|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
15000370|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000371|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15000372|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15000373|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
15000374|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15000375|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15000376|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
15000377|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000378|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15000379|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
15000380|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15000381|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15000382|NCT01786070|Budesonide|budesonide|mesh-list
15000383|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15000384|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15000385|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
15000386|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000387|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000388|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15000389|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
15000390|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
15000391|NCT01786070|Hormones|hormones|mesh-ancestor
15000392|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15000393|NCT01786200|Aspirin|aspirin|mesh-list
15000394|NCT01786200|Ibuprofen|ibuprofen|mesh-list
15000395|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15000396|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15000397|NCT01786200|Analgesics|analgesics|mesh-ancestor
15000398|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
15000399|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000400|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000401|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15000402|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15000403|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15000404|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15000405|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000406|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15000407|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15000408|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000409|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
15000410|NCT01786226|Mifepristone|mifepristone|mesh-list
15000411|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15000412|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
15000413|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15032337|NCT01981460|Methylene Blue|methylene blue|mesh-list
15000414|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000415|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15000416|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15000417|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15000418|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
15000419|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15000420|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15000421|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
15000422|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15000423|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
15000424|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15000425|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15000426|NCT01786382|Midazolam|midazolam|mesh-list
15000427|NCT01786382|Omeprazole|omeprazole|mesh-list
15000428|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15000429|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15000430|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15000431|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000432|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15000433|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15000434|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15000435|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15000436|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
15000437|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
15000438|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
15000439|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
15000440|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000441|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000442|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15000443|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15000444|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15000445|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000446|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
15000447|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15032338|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032339|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032340|NCT01981499|Cetirizine|cetirizine|mesh-list
15032341|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15032342|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15032343|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15032344|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
15032345|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
15032346|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032347|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032348|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032349|NCT01981525|Metformin|metformin|mesh-list
15032350|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15032351|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032352|NCT01981707|Choline|choline|mesh-list
15032353|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
15032354|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15032355|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
15032356|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032357|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15032358|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15032359|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
15032360|NCT01981746|Ropivacaine|ropivacaine|mesh-list
15032361|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
15032362|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
15032363|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032364|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032365|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
15032366|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032367|NCT01981811|Aripiprazole|aripiprazole|mesh-list
15000448|NCT01786538|Leucovorin|leucovorin|mesh-list
15000449|NCT01786538|Fluorouracil|fluorouracil|mesh-list
15000450|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
15000451|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
15000452|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000453|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15000454|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000455|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15000456|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
15000457|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000458|NCT01786538|Antidotes|antidotes|mesh-ancestor
15000459|NCT01786538|Protective Agents|protective agents|mesh-ancestor
15000460|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
15000461|NCT01786538|Vitamins|vitamins|mesh-ancestor
15000462|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
15000463|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
15000464|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15000465|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
15000466|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000467|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000468|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15000469|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
15000470|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15000471|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15000472|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15000473|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
15000474|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000475|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000476|NCT01786655|Epinephrine|epinephrine|mesh-list
15000477|NCT01786655|Bupivacaine|bupivacaine|mesh-list
15000478|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
15000479|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
15000480|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
15000481|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15000482|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000483|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
15000484|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000485|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15000486|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15000487|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
15000488|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000489|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000490|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15000491|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15000492|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
15000493|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15000494|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
15000495|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
15000496|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
15000497|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15000498|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15000499|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15000500|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
15000501|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15000502|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15000503|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15000504|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
15000505|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15000506|NCT01787123|Protective Agents|protective agents|mesh-ancestor
15000507|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000508|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
15000509|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
15000510|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
15000511|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
15000512|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15000513|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15000514|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000515|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000516|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000517|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
15000518|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15000519|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15000520|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15000521|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15000522|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000523|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
15000524|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000525|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000526|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15000527|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000528|NCT01787357|Canagliflozin|canagliflozin|mesh-list
15000529|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
15000530|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15000531|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000532|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15000533|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15000534|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000535|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000536|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000537|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000538|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15000539|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15000540|NCT01787396|Metformin|metformin|mesh-list
15000541|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15000542|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000543|NCT01787474|Cytarabine|cytarabine|mesh-list
15000544|NCT01787474|Fludarabine|fludarabine|mesh-list
15000545|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
15000546|NCT01787474|Lenograstim|lenograstim|mesh-list
15000547|NCT01787474|Sargramostim|sargramostim|mesh-list
15000548|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000549|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15000550|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
15000551|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000552|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15000553|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
15000554|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000555|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
15000556|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000557|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15000558|NCT01787487|Azacitidine|azacitidine|mesh-list
15000559|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15000560|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
15000561|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000562|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000563|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000564|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
15000565|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15000566|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
15000567|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000568|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
15000569|NCT01787630|Protective Agents|protective agents|mesh-ancestor
15000570|NCT01787669|Dexamethasone|dexamethasone|mesh-list
15000571|NCT01787669|Bevacizumab|bevacizumab|mesh-list
15000572|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15000573|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000574|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15000575|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15000576|NCT01787669|Growth Substances|growth substances|mesh-ancestor
15000577|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000578|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
15000579|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15000580|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
15000581|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
15000582|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000583|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15000584|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
15000585|NCT01787669|Hormones|hormones|mesh-ancestor
15000586|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15000587|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15000588|NCT01788007|Imiquimod|imiquimod|mesh-list
15000589|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15000590|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
15000591|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000592|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000593|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
15000594|NCT01788020|Dexamethasone|dexamethasone|mesh-list
15000595|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
15000596|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
15000597|NCT01788020|Rituximab|rituximab|mesh-list
15000598|NCT01788020|Bortezomib|bortezomib|mesh-list
15000599|NCT01788020|BB 1101|bb 1101|mesh-list
15000600|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15000601|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
15000602|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000603|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15000604|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15000605|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
15000606|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000607|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000608|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15000609|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15000610|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
15000611|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
15000612|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000613|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15000614|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
15000615|NCT01788020|Hormones|hormones|mesh-ancestor
15000616|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15000617|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15000618|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
15000619|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000620|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15000621|NCT01788072|Oxytocin|oxytocin|mesh-list
15000622|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
15000623|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15000624|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000625|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
15000626|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15000627|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000628|NCT01788189|Lenalidomide|lenalidomide|mesh-list
15000629|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
15000630|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000631|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15000632|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15000633|NCT01788189|Growth Substances|growth substances|mesh-ancestor
15000634|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
15000635|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000636|NCT01788254|Talinolol|talinolol|mesh-list
15000637|NCT01788254|Torsemide|torsemide|mesh-list
15000638|NCT01788254|Midazolam|midazolam|mesh-list
15000639|NCT01788254|Codeine|codeine|mesh-list
15000640|NCT01788254|Pravastatin|pravastatin|mesh-list
15000641|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15000642|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15000643|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15000644|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000645|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15000646|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15000647|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15000648|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15000649|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
15000650|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
15000651|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
15000652|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
15000653|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000654|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000655|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15000656|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15000657|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
15000658|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15000659|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15000660|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000661|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15000662|NCT01788254|Narcotics|narcotics|mesh-ancestor
15000663|NCT01788254|Analgesics|analgesics|mesh-ancestor
15000664|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
15000665|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000666|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
15000667|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
15000668|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15000669|NCT01788254|Diuretics|diuretics|mesh-ancestor
15000670|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
15000671|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15000672|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15000673|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15000674|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15000675|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
15000676|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15000677|NCT01788280|Bevacizumab|bevacizumab|mesh-list
15000678|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15000679|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000680|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15000681|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15000682|NCT01788280|Growth Substances|growth substances|mesh-ancestor
15000683|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000684|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
15000685|NCT01788332|Olaparib|olaparib|mesh-list
15000686|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15000687|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000688|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000689|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000690|NCT01788371|Lamivudine|lamivudine|mesh-list
15000691|NCT01788371|Telbivudine|telbivudine|mesh-list
15000692|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15000693|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15000694|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000695|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000696|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
15000697|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000698|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15000699|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15000700|NCT01788384|Clindamycin|clindamycin|mesh-list
15000701|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
15000702|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
15000703|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
15000704|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15000705|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000706|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15000707|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000708|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000709|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
15000710|NCT01788462|Tesamorelin|tesamorelin|mesh-list
15000711|NCT01788462|Growth Substances|growth substances|mesh-ancestor
15000712|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000713|NCT01788501|Cyclosporine|cyclosporine|mesh-list
15000714|NCT01788501|Methotrexate|methotrexate|mesh-list
15000715|NCT01788501|Tacrolimus|tacrolimus|mesh-list
15000716|NCT01788501|Cyclosporins|cyclosporins|mesh-list
15000717|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15000718|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
15000719|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15000720|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000721|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15000722|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
15000723|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000724|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000725|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
15000726|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000727|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15000728|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15000729|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
15000730|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15000731|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15000732|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15000733|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
15000734|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000735|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
15000736|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15000737|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15000738|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15000739|NCT01788605|Ramosetron|ramosetron|mesh-list
15000740|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
15000741|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
15000742|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000743|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000744|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15000745|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15000746|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
15000747|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000748|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000749|NCT01788670|Ethanol|ethanol|mesh-list
15000750|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15000751|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000752|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15000753|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000754|NCT01788722|Dienogest|dienogest|mesh-list
15000755|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15000756|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
15000757|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15000758|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000759|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15000760|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15000761|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15000762|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15000763|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
15000764|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15000765|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15000766|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801960|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801961|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000767|NCT01788774|Risperidone|risperidone|mesh-list
15000768|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15000769|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
15000770|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032368|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
14801962|NCT00795574|Infliximab|infliximab|mesh-list
14801963|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
14801964|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14801965|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14801966|NCT00795587|Mannitol|mannitol|mesh-list
14801967|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14801968|NCT00795587|Diuretics|diuretics|mesh-ancestor
14801969|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
14801970|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14801971|NCT00795613|Doxorubicin|doxorubicin|mesh-list
14801972|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14801973|NCT00795613|Vincristine|vincristine|mesh-list
15000771|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000772|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000773|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15000774|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15000775|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15000776|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15000777|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15000778|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
15000779|NCT01788969|Citalopram|citalopram|mesh-list
15000780|NCT01788969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15000781|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15000782|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15000783|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000784|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000785|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
15000786|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000787|NCT01788969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15000788|NCT01788969|Antidepressive Agents|antidepressive agents|mesh-ancestor
15000789|NCT01788969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15000790|NCT01788982|Nintedanib|nintedanib|mesh-list
15000791|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000792|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15000793|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000794|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000795|NCT01789086|Liraglutide|liraglutide|mesh-list
15000796|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15000797|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000798|NCT01789086|Incretins|incretins|mesh-ancestor
15000799|NCT01789086|Hormones|hormones|mesh-ancestor
15000800|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15000801|NCT01789099|Sargramostim|sargramostim|mesh-list
15000802|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
15000803|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000804|NCT01789125|Nicotine|nicotine|mesh-list
15000805|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15000806|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
15000807|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000808|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000809|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15000810|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15000811|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
15000812|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000813|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000814|NCT01789216|Ketorolac|ketorolac|mesh-list
15000815|NCT01789216|Meloxicam|meloxicam|mesh-list
15000816|NCT01789216|Pregabalin|pregabalin|mesh-list
15000817|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15000818|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15000819|NCT01789216|Analgesics|analgesics|mesh-ancestor
15000820|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
15000821|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000822|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000823|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15000824|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15000825|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15000826|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000827|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000828|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
15000829|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15000830|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15000831|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15000832|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15000833|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15000834|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15000835|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15000836|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15000837|NCT01789242|Dexamethasone|dexamethasone|mesh-list
15000838|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15000839|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
15000840|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
15000841|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000842|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000843|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15000844|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
15000845|NCT01789242|Hormones|hormones|mesh-ancestor
15000846|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15000847|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15000848|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000849|NCT01789294|Mesalamine|mesalamine|mesh-list
15000850|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15000851|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15000852|NCT01789294|Analgesics|analgesics|mesh-ancestor
15000853|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
15000854|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000855|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000856|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15000857|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15000858|NCT01789333|Riboflavin|riboflavin|mesh-list
15000859|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15000860|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15000861|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
15000862|NCT01789333|Vitamins|vitamins|mesh-ancestor
15000863|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
15000864|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000865|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15000866|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
15000867|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
15000868|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15000869|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15000870|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000871|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15000872|NCT01789385|Analgesics|analgesics|mesh-ancestor
15000873|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
15000874|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000875|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15000876|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15000877|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15000878|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
15000879|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000880|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000881|NCT01789437|Dexamethasone|dexamethasone|mesh-list
15000882|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15000883|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
15000884|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
15000885|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000886|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000887|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15000888|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
15000889|NCT01789437|Hormones|hormones|mesh-ancestor
15000890|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15000891|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15000892|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000893|NCT01789619|Tacrolimus|tacrolimus|mesh-list
15000894|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15000895|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
15000896|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000897|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15000898|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000899|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000900|NCT01789710|Bupropion|bupropion|mesh-list
15000901|NCT01789710|Nicotine|nicotine|mesh-list
15000902|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15000903|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
15000904|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000905|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000906|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15000907|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15000908|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
15000909|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15000910|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000911|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15000912|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
15000913|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15000914|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15000915|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15000916|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15000917|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
15000918|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15000919|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15000920|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000921|NCT01789723|Leucovorin|leucovorin|mesh-list
15000922|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
15000923|NCT01789723|Antidotes|antidotes|mesh-ancestor
15000924|NCT01789723|Protective Agents|protective agents|mesh-ancestor
15000925|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000926|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
15000927|NCT01789723|Vitamins|vitamins|mesh-ancestor
15000928|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
15000929|NCT01789827|Interleukin-2|interleukin-2|mesh-list
14523810|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523811|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14523812|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14523813|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
15000930|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000931|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15000932|NCT01789827|Analgesics|analgesics|mesh-ancestor
15000933|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
15000934|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000935|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000936|NCT01789879|Efavirenz|efavirenz|mesh-list
15000937|NCT01789879|Nevirapine|nevirapine|mesh-list
15000938|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
15000939|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15000940|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15000941|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15000942|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000943|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
15000944|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15000945|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15000946|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15000947|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15000948|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15000949|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15000950|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15000951|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15000952|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
15000953|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15000954|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000955|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15000956|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15000957|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15000958|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15000959|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15000960|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
15000961|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15000962|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15000963|NCT01789892|Prednisolone|prednisolone|mesh-list
15000964|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
15000965|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15000966|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
15000967|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15000968|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15000969|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
15000970|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
15000971|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000972|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000973|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15000974|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
15000975|NCT01789892|Hormones|hormones|mesh-ancestor
15000976|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15000977|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15000978|NCT01789892|Protective Agents|protective agents|mesh-ancestor
15000979|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15000980|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15000981|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15000982|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15000983|NCT01789957|Exenatide|exenatide|mesh-list
15000984|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15000985|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000986|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15000987|NCT01789957|Incretins|incretins|mesh-ancestor
15000988|NCT01789957|Hormones|hormones|mesh-ancestor
15000989|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15000990|NCT01790009|Acetaminophen|acetaminophen|mesh-list
15000991|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15000992|NCT01790009|Analgesics|analgesics|mesh-ancestor
15000993|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
15000994|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15000995|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15000996|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
15000997|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
15000998|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15000999|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15001000|NCT01790022|Prednisolone|prednisolone|mesh-list
15001001|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
15001002|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15001003|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
15001004|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15001005|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
15001006|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
15001007|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001008|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001009|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15001010|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
15001011|NCT01790022|Hormones|hormones|mesh-ancestor
15001012|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001013|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15001014|NCT01790022|Protective Agents|protective agents|mesh-ancestor
15001015|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15001016|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032369|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15032370|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15032371|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15032372|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032373|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032374|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
15032375|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
15032376|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032377|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032378|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15001017|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
15001018|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15001019|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15001020|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15001021|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15001022|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001023|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001024|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001025|NCT01790139|Simethicone|simethicone|mesh-list
15001026|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
15001027|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001028|NCT01790139|Emollients|emollients|mesh-ancestor
15001029|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
15001030|NCT01790165|Terbinafine|terbinafine|mesh-list
15001031|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
15001032|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15001033|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001034|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001035|NCT01790282|Estradiol|estradiol|mesh-list
15001036|NCT01790282|Progesterone|progesterone|mesh-list
15001037|NCT01790282|Estrogens|estrogens|mesh-ancestor
15001038|NCT01790282|Hormones|hormones|mesh-ancestor
15001039|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001040|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001041|NCT01790282|Progestins|progestins|mesh-ancestor
15001042|NCT01790308|Liraglutide|liraglutide|mesh-list
15001043|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15001044|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001045|NCT01790308|Incretins|incretins|mesh-ancestor
15001046|NCT01790308|Hormones|hormones|mesh-ancestor
15001047|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001048|NCT01790464|Lidocaine|lidocaine|mesh-list
15001049|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
15001050|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
15001051|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001052|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001053|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
15001054|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001055|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15001056|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15001057|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15001058|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15001059|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001060|NCT01790529|Metronidazole|metronidazole|mesh-list
15001061|NCT01790529|Cefuroxime|cefuroxime|mesh-list
15001062|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
15001063|NCT01790529|Anesthetics|anesthetics|mesh-list
15001064|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001065|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001066|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15001067|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15001068|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15001069|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15001070|NCT01790542|Iron|iron|mesh-list
15001071|NCT01790542|Trace Elements|trace elements|mesh-ancestor
15001072|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
15001073|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001074|NCT01790555|Diazepam|diazepam|mesh-list
15001075|NCT01790555|Dronabinol|dronabinol|mesh-list
15001076|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15001077|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
15001078|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
15001079|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
15001080|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001081|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001082|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15001083|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15001084|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001085|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15001086|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15001087|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15001088|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15001089|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15001090|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15001091|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
15001092|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
15001093|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
15001094|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
15001095|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001096|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001097|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
15001098|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15001099|NCT01790555|Analgesics|analgesics|mesh-ancestor
15001100|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
15001101|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15001102|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15001103|NCT01790555|Hormones|hormones|mesh-ancestor
15001104|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001105|NCT01790672|Ethanol|ethanol|mesh-list
15001106|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15001107|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15001108|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001109|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001110|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
15001111|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15001112|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
15001113|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001114|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15001115|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15001116|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
15001117|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001118|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001119|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15001120|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15001121|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15001122|NCT01790893|Aflibercept|aflibercept|mesh-list
15001123|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15001124|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15001125|NCT01790893|Growth Substances|growth substances|mesh-ancestor
15001126|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001127|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
15001128|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001129|NCT01790971|Morphine|morphine|mesh-list
15001130|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15001131|NCT01790971|Narcotics|narcotics|mesh-ancestor
15001132|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001133|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001134|NCT01790971|Analgesics|analgesics|mesh-ancestor
15001135|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
15001136|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001137|NCT01790997|Aspirin|aspirin|mesh-list
15001138|NCT01790997|Clopidogrel|clopidogrel|mesh-list
15001139|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15001140|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15001141|NCT01790997|Analgesics|analgesics|mesh-ancestor
15001142|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
15001143|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001144|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001145|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15001146|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15001147|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15001148|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15001149|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001150|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15001151|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15001152|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001153|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
15001154|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15001155|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15001156|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15001157|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
15001158|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001159|NCT01791088|Sirolimus|sirolimus|mesh-list
15001160|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15001161|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15001162|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15001163|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001164|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
15001165|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15001166|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
15001167|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001168|NCT01791114|Propranolol|propranolol|mesh-list
15001169|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15001170|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15001171|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
15001172|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001173|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001174|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001175|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15001176|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15001177|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
15001178|NCT01791166|Antibodies|antibodies|mesh-list
15001179|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
15001180|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001181|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15001182|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15001183|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001184|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15001185|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
15001186|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001187|NCT01791231|Canagliflozin|canagliflozin|mesh-list
15001188|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15001189|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001190|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15001191|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001192|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
15001193|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15001194|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001195|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001196|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15001197|NCT01791296|Analgesics|analgesics|mesh-ancestor
15001198|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
15001199|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001200|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15001201|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15001202|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15001203|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
15001204|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001205|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001206|NCT01791309|Panitumumab|panitumumab|mesh-list
15001207|NCT01791309|Vemurafenib|vemurafenib|mesh-list
15001208|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15001209|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001210|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15001211|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001212|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001213|NCT01791374|Rilotumumab|rilotumumab|mesh-list
15001214|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15001215|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15001216|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001217|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
15001218|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001219|NCT01791400|Sumatriptan|sumatriptan|mesh-list
15001220|NCT01791400|Metoclopramide|metoclopramide|mesh-list
15001221|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
15001222|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
15001223|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001224|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523814|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523815|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523816|NCT03620890|Protamines|protamines|mesh-list
14523817|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
14523818|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523819|NCT03620890|Coagulants|coagulants|mesh-ancestor
14523820|NCT03621085|Ketamine|ketamine|mesh-list
15001225|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15001226|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15001227|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15001228|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
15001229|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001230|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001231|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15001232|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15001233|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15001234|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
15001235|NCT01791439|Lidocaine|lidocaine|mesh-list
15001236|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
14523821|NCT03621085|Analgesics|analgesics|mesh-ancestor
14523822|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
14523823|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523824|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523825|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14523826|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14523827|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
14523828|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
14523829|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14523830|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14523831|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14523832|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523833|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001237|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
15001238|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001239|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001240|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
15001241|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001242|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15001243|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15001244|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15001245|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15001246|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001247|NCT01791608|Zinc|zinc|mesh-list
15001248|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
15001249|NCT01791608|Trace Elements|trace elements|mesh-ancestor
15001250|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
15001251|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001252|NCT01791608|Astringents|astringents|mesh-ancestor
15001253|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
15001254|NCT01791647|Inositol|inositol|mesh-list
15001255|NCT01791647|Metformin|metformin|mesh-list
15001256|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15001257|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001258|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
15001259|NCT01791647|Vitamins|vitamins|mesh-ancestor
15001260|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
15001261|NCT01791699|Moxonidine|moxonidine|mesh-list
15001262|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15001263|NCT01791751|Clomiphene|clomiphene|mesh-list
15001264|NCT01791751|Enclomiphene|enclomiphene|mesh-list
15001265|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
15001266|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15001267|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
15001268|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001269|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001270|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15001271|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
15001272|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15001273|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15001274|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15032379|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15032380|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
15032381|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15032382|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15032383|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15032384|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15032385|NCT01981889|Prednisone|prednisone|mesh-list
15032386|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15032387|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
15032388|NCT01981889|Hormones|hormones|mesh-ancestor
15032389|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15032390|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032391|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15032392|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032393|NCT01981941|Gabapentin|gabapentin|mesh-list
15032394|NCT01981941|Analgesics|analgesics|mesh-ancestor
15032395|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
15032396|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032397|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032398|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
15032399|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15032400|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15032401|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14523834|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15032402|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15032403|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15032404|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15032405|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032406|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032407|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
15032408|NCT01982019|Hormones|hormones|mesh-list
15032409|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15032410|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032411|NCT01982071|Micafungin|micafungin|mesh-list
15032412|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
15032413|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15032414|NCT01982097|Sorafenib|sorafenib|mesh-list
15032415|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032416|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15032417|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032418|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032419|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
15032420|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15032421|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032422|NCT01982201|Lesinurad|lesinurad|mesh-list
15001275|NCT01791868|Valproic Acid|valproic acid|mesh-list
15001276|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
15001277|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001278|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001279|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
15001280|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001281|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001282|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
15001283|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15001284|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001285|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15001286|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
15001287|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15001288|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15001289|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15001290|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15001291|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001292|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
15001293|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001294|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001295|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15001296|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001297|NCT01791985|Letrozole|letrozole|mesh-list
15001298|NCT01791985|Anastrozole|anastrozole|mesh-list
15001299|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001300|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15001301|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15001302|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001303|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001304|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15001305|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
15001306|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001307|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001308|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15001309|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
15001310|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15001311|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15001312|NCT01792037|Prednisolone|prednisolone|mesh-list
15001313|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
15001314|NCT01792037|Midazolam|midazolam|mesh-list
15001315|NCT01792037|Etomidate|etomidate|mesh-list
15001316|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15001317|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
15001318|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15001319|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15001320|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001321|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001322|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15001323|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15001324|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15001325|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15001326|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
15001327|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
15001328|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
15001329|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
15001330|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001331|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001332|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15001333|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
15001334|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
15001335|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001336|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15001337|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
15001338|NCT01792037|Hormones|hormones|mesh-ancestor
15001339|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001340|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15001341|NCT01792037|Protective Agents|protective agents|mesh-ancestor
15001342|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15001343|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001344|NCT01792063|Sevoflurane|sevoflurane|mesh-list
15001345|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15001346|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15001347|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
15001348|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
15001349|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001350|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001351|NCT01792102|Dexamethasone|dexamethasone|mesh-list
15001352|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15001353|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
15001354|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
15001355|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001356|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001357|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15001358|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
15001359|NCT01792102|Hormones|hormones|mesh-ancestor
15001360|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001361|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15001362|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001363|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
15001364|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15001365|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001366|NCT01792375|Dinoprostone|dinoprostone|mesh-list
15001367|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
15001368|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15001369|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001370|NCT01792388|Vitamin D|vitamin d|mesh-list
15001371|NCT01792388|Vitamins|vitamins|mesh-ancestor
15001372|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
15001373|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001374|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15001375|NCT01792505|Imiquimod|imiquimod|mesh-list
15001376|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15001377|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
15001378|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001379|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001380|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
15001381|NCT01792557|Phenol|phenol|mesh-list
15001382|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15001383|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15001384|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
15001385|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15001386|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15001387|NCT01792570|Darunavir|darunavir|mesh-list
15001388|NCT01792570|Rilpivirine|rilpivirine|mesh-list
15001389|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15001390|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15001391|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
15001392|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001393|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001394|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15001395|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15001396|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
15001397|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15001398|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15001399|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15001400|NCT01792700|Amoxicillin|amoxicillin|mesh-list
15001401|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
15001402|NCT01792700|Metronidazole|metronidazole|mesh-list
15001403|NCT01792700|Tetracycline|tetracycline|mesh-list
15001404|NCT01792700|Esomeprazole|esomeprazole|mesh-list
15001405|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15001406|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15001407|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15001408|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15001409|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001410|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001411|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001412|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15001413|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15001414|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15001415|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15001416|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15001417|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15001418|NCT01792713|Sertaconazole|sertaconazole|mesh-list
15001419|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
15001420|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15001421|NCT01792804|Vancomycin|vancomycin|mesh-list
15001422|NCT01792804|Clindamycin|clindamycin|mesh-list
15001423|NCT01792804|Cefazolin|cefazolin|mesh-list
15001424|NCT01792804|Linezolid|linezolid|mesh-list
15001425|NCT01792804|Daptomycin|daptomycin|mesh-list
15001426|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15001427|NCT01792804|Floxacillin|floxacillin|mesh-list
15001428|NCT01792804|Cloxacillin|cloxacillin|mesh-list
15001429|NCT01792804|Trimethoprim|trimethoprim|mesh-list
15001430|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
15001431|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15001432|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15001433|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15001434|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001435|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001436|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15001437|NCT01792804|Renal Agents|renal agents|mesh-ancestor
15001438|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
15001439|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15001440|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15001441|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15001442|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15001443|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15001444|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15001445|NCT01792934|Bevacizumab|bevacizumab|mesh-list
15001446|NCT01792934|Irinotecan|irinotecan|mesh-list
15001447|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15001448|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001449|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15001450|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15001451|NCT01792934|Growth Substances|growth substances|mesh-ancestor
15001452|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001453|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
15001454|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15001455|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15001456|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001457|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001458|NCT01793038|Clomiphene|clomiphene|mesh-list
15001459|NCT01793038|Enclomiphene|enclomiphene|mesh-list
15001460|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
15001461|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15001462|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001463|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15001464|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
15001465|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001466|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001467|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15001468|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
15001469|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15001470|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15001471|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15001472|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15001473|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001474|NCT01793077|Leuprolide|leuprolide|mesh-list
15001475|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15001476|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
15001477|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15001478|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001479|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15001480|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001481|NCT01793259|Methotrexate|methotrexate|mesh-list
15001482|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15001483|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
15001484|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15001485|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001486|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15001487|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
15001488|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001489|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001490|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
15001491|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001492|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15001493|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15001494|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
15001495|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15001496|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15001497|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
15001498|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15001499|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523835|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15001500|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001501|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15001502|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15001503|NCT01793272|Protective Agents|protective agents|mesh-ancestor
15001504|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001505|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
15001506|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15001507|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
15001508|NCT01793350|Benphothiamine|benphothiamine|mesh-list
15001509|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15001510|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
15001511|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001512|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
15001513|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
15001514|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032423|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
15032424|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15032425|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
15032426|NCT01982201|Renal Agents|renal agents|mesh-ancestor
15032427|NCT01982396|Lamivudine|lamivudine|mesh-list
15032428|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15032429|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15032430|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032431|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032432|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
15032433|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15032434|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15001515|NCT01793480|Methadone|methadone|mesh-list
15001516|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15001517|NCT01793480|Narcotics|narcotics|mesh-ancestor
15001518|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001519|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001520|NCT01793480|Analgesics|analgesics|mesh-ancestor
15001521|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
15001522|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001523|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
15001524|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
15001525|NCT01793519|Adalimumab|adalimumab|mesh-list
15001526|NCT01793519|Etanercept|etanercept|mesh-list
15001527|NCT01793519|Infliximab|infliximab|mesh-list
15001528|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15001529|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15001530|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
15001531|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15001532|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15001533|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15001534|NCT01793519|Analgesics|analgesics|mesh-ancestor
15001535|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
15001536|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001537|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001538|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15001539|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
15001540|NCT01793636|Everolimus|everolimus|mesh-list
15001541|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001542|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15001543|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
15001544|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001545|NCT01793753|Propofol|propofol|mesh-list
15001546|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15001547|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001548|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001549|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15001550|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
15001551|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
15001552|NCT01793870|Carvedilol|carvedilol|mesh-list
15001553|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15001554|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15001555|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
15001556|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001557|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001558|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001559|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15001560|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
15001561|NCT01793870|Protective Agents|protective agents|mesh-ancestor
15001562|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15001563|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15001564|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15001565|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
15001566|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15001567|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15001568|NCT01793948|Metformin|metformin|mesh-list
15001569|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15001570|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001571|NCT01794078|Ambrisentan|ambrisentan|mesh-list
15001572|NCT01794078|Aminophylline|aminophylline|mesh-list
15001573|NCT01794078|Theophylline|theophylline|mesh-list
15001574|NCT01794078|Ethylene|ethylene|mesh-list
15001575|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15001576|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
15001577|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001578|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001579|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15001580|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
15001581|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15001582|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001583|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001584|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
15001585|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15001586|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15001587|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
15001588|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001589|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14523836|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
15001590|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15001591|NCT01794078|Protective Agents|protective agents|mesh-ancestor
15001592|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14523837|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15001593|NCT01794078|Growth Substances|growth substances|mesh-ancestor
15001594|NCT01794091|Eplerenone|eplerenone|mesh-list
15001595|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15001596|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
15001597|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001598|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001599|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15001600|NCT01794091|Diuretics|diuretics|mesh-ancestor
15001601|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
15001602|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15001603|NCT01794169|Cytarabine|cytarabine|mesh-list
15001604|NCT01794169|Azacitidine|azacitidine|mesh-list
15001605|NCT01794169|Daunorubicin|daunorubicin|mesh-list
15001606|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15001607|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
15001608|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001609|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001610|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
15001611|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15001612|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15001613|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
15001614|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001615|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001616|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15001617|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15001618|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15001619|NCT01794182|Glyburide|glyburide|mesh-list
15001620|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15001621|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001622|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15001623|NCT01794208|Hormones|hormones|mesh-ancestor
15001624|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001625|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001626|NCT01794247|Lidocaine|lidocaine|mesh-list
15001627|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
15001628|NCT01794247|Fentanyl|fentanyl|mesh-list
15001629|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
15001630|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
15001631|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001632|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001633|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
15001634|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001635|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15001636|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15001637|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15001638|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15001639|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001640|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15001641|NCT01794247|Narcotics|narcotics|mesh-ancestor
15001642|NCT01794247|Analgesics|analgesics|mesh-ancestor
15001643|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15001644|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15001645|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
15001646|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
15001647|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15001648|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15001649|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
15001650|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15001651|NCT01794273|Phenylephrine|phenylephrine|mesh-list
15001652|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
15001653|NCT01794273|Ephedrine|ephedrine|mesh-list
15001654|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15001655|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
15001656|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
15001657|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001658|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001659|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
15001660|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15001661|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
15001662|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
15001663|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15001664|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15001665|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15001666|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
15001667|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001668|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001669|NCT01794273|Protective Agents|protective agents|mesh-ancestor
15001670|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15001671|NCT01794351|Resveratrol|resveratrol|mesh-list
15001672|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
15001673|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001674|NCT01794351|Protective Agents|protective agents|mesh-ancestor
15001675|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001676|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001677|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15001678|NCT01794429|Exenatide|exenatide|mesh-list
15001679|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15001680|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001681|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15001682|NCT01794429|Incretins|incretins|mesh-ancestor
15001683|NCT01794429|Hormones|hormones|mesh-ancestor
15001684|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001685|NCT01794507|Dexamethasone|dexamethasone|mesh-list
15001686|NCT01794507|Bortezomib|bortezomib|mesh-list
15001687|NCT01794507|Venetoclax|venetoclax|mesh-list
15001688|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15001689|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
15001690|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
15001691|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001692|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001693|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15001694|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
15001695|NCT01794507|Hormones|hormones|mesh-ancestor
15001696|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001697|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15001698|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001699|NCT01794533|Lidocaine|lidocaine|mesh-list
15001700|NCT01794533|Epinephrine|epinephrine|mesh-list
15001701|NCT01794533|Racepinephrine|racepinephrine|mesh-list
15001702|NCT01794533|Fentanyl|fentanyl|mesh-list
15001703|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
15001704|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
15001705|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
15001706|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001707|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001708|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
15001709|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001710|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15001711|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15001712|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15001713|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15001714|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001715|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15001716|NCT01794533|Narcotics|narcotics|mesh-ancestor
15001717|NCT01794533|Analgesics|analgesics|mesh-ancestor
15001718|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15001719|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15001720|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
15001721|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15001722|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15001723|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
15001724|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001725|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15001726|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15001727|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
15001728|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15001729|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
15001730|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
15001731|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
15001732|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15001733|NCT01794572|Melphalan|melphalan|mesh-list
15001734|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15001735|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
15001736|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001737|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001738|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15001739|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15001740|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
15001741|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001742|NCT01794767|Heparin|heparin|mesh-list
15001743|NCT01794767|Calcium heparin|calcium heparin|mesh-list
15001744|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
15001745|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15001746|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15001747|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001748|NCT01794793|Cabergoline|cabergoline|mesh-list
15001749|NCT01794793|Pasireotide|pasireotide|mesh-list
15001750|NCT01794793|Somatostatin|somatostatin|mesh-list
15001751|NCT01794793|Hormones|hormones|mesh-ancestor
15001752|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001753|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001754|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15001755|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15001756|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
15001757|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
15001758|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001759|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001760|NCT01794897|Valacyclovir|valacyclovir|mesh-list
15001761|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
15001762|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15001763|NCT01794975|Ketamine|ketamine|mesh-list
15001764|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15001765|NCT01794975|Analgesics|analgesics|mesh-ancestor
15001766|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
15001767|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001768|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001769|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15001770|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15001771|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
15001772|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
15001773|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001774|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15001775|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15001776|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001777|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001778|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15001779|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15001780|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15001781|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
15001782|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
15001783|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001784|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
15001785|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
15001786|NCT01795131|Vitamins|vitamins|mesh-ancestor
15001787|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
15001788|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001789|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
15001790|NCT01795131|Hematinics|hematinics|mesh-ancestor
15001791|NCT01795144|Glucagon|glucagon|mesh-list
15001792|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15001793|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15001794|NCT01795144|Hormones|hormones|mesh-ancestor
15001795|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001796|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001797|NCT01795144|Incretins|incretins|mesh-ancestor
15001798|NCT01795170|Pyridoxine|pyridoxine|mesh-list
15001799|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
15001800|NCT01795170|Vitamins|vitamins|mesh-ancestor
15001801|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
15001802|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032435|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15032436|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15032437|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15032438|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15032439|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
15032440|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032441|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15032442|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15032443|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032444|NCT01982578|Genistein|genistein|mesh-list
15032445|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15032446|NCT01982578|Protective Agents|protective agents|mesh-ancestor
15032447|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032448|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032449|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15032450|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032451|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032452|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
15032453|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15032454|NCT01982578|Estrogens|estrogens|mesh-ancestor
15032455|NCT01982578|Hormones|hormones|mesh-ancestor
15032456|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15032457|NCT01982734|Curcumin|curcumin|mesh-list
15032458|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15032459|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15032460|NCT01982734|Analgesics|analgesics|mesh-ancestor
15032461|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
15032462|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032463|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032464|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15032465|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15032466|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032467|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032468|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032469|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
15032470|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
15032471|NCT01982760|Coagulants|coagulants|mesh-ancestor
15032472|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15001803|NCT01795183|Amisulpride|amisulpride|mesh-list
15001804|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15001805|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15001806|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001807|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001808|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15001809|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15001810|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
15001811|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001812|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001813|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15001814|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
15001815|NCT01795209|Ranibizumab|ranibizumab|mesh-list
15001816|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15001817|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15001818|NCT01795209|Growth Substances|growth substances|mesh-ancestor
15001819|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001820|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
15001821|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001822|NCT01795222|Midazolam|midazolam|mesh-list
15001823|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15001824|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15001825|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001826|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001827|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15001828|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15001829|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15001830|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15001831|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
15001832|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
15001833|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
15001834|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
15001835|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001836|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001837|NCT01795235|Atenolol|atenolol|mesh-list
15001838|NCT01795235|Glucagon|glucagon|mesh-list
15001839|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15001840|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15001841|NCT01795235|Hormones|hormones|mesh-ancestor
15001842|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001843|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001844|NCT01795235|Incretins|incretins|mesh-ancestor
15001845|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15001846|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15001847|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
15001848|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
15001849|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001850|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15001851|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15001852|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15001853|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
15001854|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001855|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001856|NCT01795248|Liraglutide|liraglutide|mesh-list
15001857|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15001858|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001859|NCT01795248|Incretins|incretins|mesh-ancestor
15001860|NCT01795248|Hormones|hormones|mesh-ancestor
15001861|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001862|NCT01795287|Anesthetics|anesthetics|mesh-list
15001863|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15001864|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001865|NCT01795313|Imiquimod|imiquimod|mesh-list
15001866|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15001867|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
15001868|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001869|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001870|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
15001871|NCT01795430|Etoposide|etoposide|mesh-list
15001872|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
15001873|NCT01795430|Melphalan|melphalan|mesh-list
15001874|NCT01795430|Busulfan|busulfan|mesh-list
15001875|NCT01795430|Topotecan|topotecan|mesh-list
15001876|NCT01795430|Ifosfamide|ifosfamide|mesh-list
15001877|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15001878|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001879|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15001880|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15001881|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001882|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001883|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15001884|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
15001885|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15001886|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15001887|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
15001888|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001889|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15001890|NCT01795599|Mifepristone|mifepristone|mesh-list
15001891|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15001892|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
15001893|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15001894|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001895|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15001896|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15001897|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15001898|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
15001899|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15001900|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15001901|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
15001902|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001903|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
15001904|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15001905|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15001906|NCT01795664|Fluticasone|fluticasone|mesh-list
15001907|NCT01795664|Xhance|xhance|mesh-list
15001908|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15001909|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15001910|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15001911|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15001912|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
15001913|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001914|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001915|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15001916|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
15001917|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
15001918|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15001919|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15001920|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15001921|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15001922|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
15001923|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001924|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001925|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
15001926|NCT01795664|Hormones|hormones|mesh-ancestor
15001927|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001928|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
15001929|NCT01795703|Prednisolone|prednisolone|mesh-list
15001930|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15001931|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
15001932|NCT01795703|Hormones|hormones|mesh-ancestor
15001933|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15001934|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001935|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15001936|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001937|NCT01795794|Omeprazole|omeprazole|mesh-list
15001938|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15001939|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15001940|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15001941|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001942|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001943|NCT01795820|Ticagrelor|ticagrelor|mesh-list
15001944|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15001945|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15001946|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15001947|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15001948|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
15001949|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15001950|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001951|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001952|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
15001953|NCT01795976|Fludarabine|fludarabine|mesh-list
15001954|NCT01795976|Interleukin-2|interleukin-2|mesh-list
15001955|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15001956|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
15001957|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001958|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15001959|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15001960|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
15001961|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001962|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001963|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15001964|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15001965|NCT01795976|Analgesics|analgesics|mesh-ancestor
15001966|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
15001967|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15001968|NCT01796002|Romidepsin|romidepsin|mesh-list
15001969|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15001970|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001971|NCT01796028|Metformin|metformin|mesh-list
15001972|NCT01796028|Docetaxel|docetaxel|mesh-list
15001973|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15001974|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001975|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15001976|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
15001977|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
15001978|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
15001979|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001980|NCT01796093|Digoxin|digoxin|mesh-list
15001981|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15001982|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15001983|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15001984|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15001985|NCT01796093|Protective Agents|protective agents|mesh-ancestor
15001986|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001987|NCT01796106|Fluorides|fluorides|mesh-list
15001988|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
15001989|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
15001990|NCT01796106|Protective Agents|protective agents|mesh-ancestor
15001991|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15001992|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15001993|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
15001994|NCT01796132|Citalopram|citalopram|mesh-list
15001995|NCT01796132|Fluoxetine|fluoxetine|mesh-list
15001996|NCT01796132|Paroxetine|paroxetine|mesh-list
15001997|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15001998|NCT01796132|Sertraline|sertraline|mesh-list
15001999|NCT01796132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15002000|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15002001|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15002002|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002003|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15002004|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
15002005|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002006|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15002007|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
15002008|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15002009|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002010|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15002011|NCT01796132|Analgesics|analgesics|mesh-ancestor
15002012|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
15002013|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
15002014|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15002015|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15002016|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002017|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15002018|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15002019|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15002020|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15002021|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15002022|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15002023|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002024|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15002025|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002026|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002027|NCT01796366|Insulin|insulin|mesh-list
15002028|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15002029|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
15002030|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15002031|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002032|NCT01796405|Clofarabine|clofarabine|mesh-list
15002033|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15002034|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
15002035|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002036|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002037|NCT01796418|Beraprost|beraprost|mesh-list
15002038|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15002039|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
15002040|NCT01796444|Hormones|hormones|mesh-list
15002041|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15002042|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002043|NCT01796483|Clonidine|clonidine|mesh-list
15002044|NCT01796483|Analgesics|analgesics|mesh-ancestor
15002045|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
15002046|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002047|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002048|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15002049|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
15002050|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
15002051|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15002052|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14523838|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523839|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
14523840|NCT03624946|Antibodies|antibodies|mesh-list
14523841|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
14523842|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15002053|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15002054|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
15002055|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15002056|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002057|NCT01796522|Nifedipine|nifedipine|mesh-list
15002058|NCT01796522|Progesterone|progesterone|mesh-list
15002059|NCT01796522|Progestins|progestins|mesh-ancestor
15002060|NCT01796522|Hormones|hormones|mesh-ancestor
15002061|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15002062|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002063|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15002064|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15002065|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002066|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15002067|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
15002068|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
15002069|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15002070|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15002071|NCT01796613|Desogestrel|desogestrel|mesh-list
15002072|NCT01796613|Etonogestrel|etonogestrel|mesh-list
15002073|NCT01796613|NuvaRing|nuvaring|mesh-list
15002074|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15002075|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15002076|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15002077|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
15002078|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15002079|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002080|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15002081|NCT01796613|Estrogens|estrogens|mesh-ancestor
15002082|NCT01796613|Hormones|hormones|mesh-ancestor
15002083|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15002084|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15002085|NCT01796613|Progestins|progestins|mesh-ancestor
15002086|NCT01796730|Bambuterol|bambuterol|mesh-list
15002087|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15002088|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
15002089|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002090|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032473|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
14523843|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14523844|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
14523845|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
15002091|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15002092|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
15032474|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032475|NCT01982799|Acetaminophen|acetaminophen|mesh-list
15032476|NCT01982799|Ibuprofen|ibuprofen|mesh-list
15032477|NCT01982799|Naproxen|naproxen|mesh-list
15032478|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15032479|NCT01982799|Hydrocodone|hydrocodone|mesh-list
15032480|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15032481|NCT01982799|Analgesics|analgesics|mesh-ancestor
15032482|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
15032483|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032484|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032485|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
15032486|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15032487|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15032488|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15032489|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15032490|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032491|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032492|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
15032493|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15032494|NCT01982799|Narcotics|narcotics|mesh-ancestor
15032495|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032496|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
15032497|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
15032498|NCT01982864|Gentamicins|gentamicins|mesh-list
15032499|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15032500|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15032501|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15032502|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032503|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032504|NCT01982929|Epinephrine|epinephrine|mesh-list
15032505|NCT01982929|Bupivacaine|bupivacaine|mesh-list
15032506|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
15032507|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
15032508|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032509|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032510|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
15032511|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032512|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15032513|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15032514|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
15032515|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032516|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032517|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15032518|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15032519|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
15032520|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15032521|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
15032522|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
15032523|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
15032524|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15035410|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
15035411|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035412|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15035413|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
15035414|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15035415|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035416|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
15035417|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15035418|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15035419|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15035420|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
15035421|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
15035422|NCT02001363|Liraglutide|liraglutide|mesh-list
15035423|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15035424|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035425|NCT02001363|Incretins|incretins|mesh-ancestor
15035426|NCT02001363|Hormones|hormones|mesh-ancestor
15002093|NCT01796782|Capecitabine|capecitabine|mesh-list
15002094|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15002095|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
15002096|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002097|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002098|NCT01796808|Lidocaine|lidocaine|mesh-list
15002099|NCT01796808|Epinephrine|epinephrine|mesh-list
15002100|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
15002101|NCT01796808|Anesthetics|anesthetics|mesh-list
15002102|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15002103|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002104|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
15002105|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002106|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15002107|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15002108|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15002109|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15002110|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002111|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15002112|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15002113|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
15002114|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15002115|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15002116|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15002117|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
15002118|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15002119|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
15002120|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
15002121|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
15002122|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15002123|NCT01796899|Brivaracetam|brivaracetam|mesh-list
15002124|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
15002125|NCT01796938|Lacosamide|lacosamide|mesh-list
15002126|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
15032525|NCT01983124|Vemurafenib|vemurafenib|mesh-list
15002127|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15002128|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15002129|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15002130|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002131|NCT01796951|Aspirin|aspirin|mesh-list
15002132|NCT01796951|Celecoxib|celecoxib|mesh-list
15002133|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15002134|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15002135|NCT01796951|Analgesics|analgesics|mesh-ancestor
15002136|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
15002137|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002138|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002139|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15002140|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15002141|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15002142|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15002143|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002144|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15002145|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15002146|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002147|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
15002148|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15002149|NCT01797107|Azithromycin|azithromycin|mesh-list
15002150|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15002151|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002152|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15002153|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15002154|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002155|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
15002156|NCT01797198|Repaglinide|repaglinide|mesh-list
15002157|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
15002158|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15002159|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002160|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15002161|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
15002162|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002163|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15002164|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15002165|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15002166|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002167|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
15002168|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15002169|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15002170|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002171|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
15002172|NCT01797289|Coagulants|coagulants|mesh-ancestor
15002173|NCT01797315|Sirolimus|sirolimus|mesh-list
15002174|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15002175|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002176|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15002177|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002178|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
15002179|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15002180|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
15002181|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002182|NCT01797341|Tacrolimus|tacrolimus|mesh-list
15002183|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15002184|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
15002185|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002186|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15002187|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002188|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002189|NCT01797601|Insulin|insulin|mesh-list
15002190|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15002191|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15002192|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002193|NCT01797666|Pioglitazone|pioglitazone|mesh-list
15002194|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15002195|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002196|NCT01797718|Letrozole|letrozole|mesh-list
15002197|NCT01797718|Testosterone|testosterone|mesh-list
15002198|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002199|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15002200|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15002201|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002202|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002203|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15002204|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
15002205|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15002206|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002207|NCT01797718|Androgens|androgens|mesh-ancestor
15002208|NCT01797718|Hormones|hormones|mesh-ancestor
15002209|NCT01797757|Orlistat|orlistat|mesh-list
15002210|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002211|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002212|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15002213|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15002214|NCT01797796|Capsaicin|capsaicin|mesh-list
15002215|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
15002216|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
15002217|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
15002218|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002219|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002220|NCT01797848|Ribavirin|ribavirin|mesh-list
15002221|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15002222|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
15002223|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002224|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
15002225|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002226|NCT01797900|Paclitaxel|paclitaxel|mesh-list
15002227|NCT01797900|Cisplatin|cisplatin|mesh-list
15002228|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15002229|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002230|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
15002231|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
15002232|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
15002233|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002234|NCT01797913|Gemcitabine|gemcitabine|mesh-list
15002235|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15002236|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
15002237|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002238|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002239|NCT01797913|Antiviral Agents|antiviral agents|mesh-ancestor
15002240|NCT01797913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002241|NCT01797913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002242|NCT01797913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15002243|NCT01797913|Immunologic Factors|immunologic factors|mesh-ancestor
15002244|NCT01797913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002245|NCT01797926|Losartan|losartan|mesh-list
15002246|NCT01797926|Amlodipine|amlodipine|mesh-list
15002247|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15002248|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15002249|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15002250|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002251|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15002252|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002253|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
15002254|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15002255|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15002256|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15002257|NCT01797978|Methylene Blue|methylene blue|mesh-list
15002258|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002259|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002260|NCT01797991|Dexamethasone|dexamethasone|mesh-list
15002261|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
15002262|NCT01797991|BB 1101|bb 1101|mesh-list
15002263|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15002264|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
15002265|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
15002266|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002267|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002268|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15002269|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
15002270|NCT01797991|Hormones|hormones|mesh-ancestor
15002271|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15002272|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15002273|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002274|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
15002275|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002276|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002277|NCT01798017|Misoprostol|misoprostol|mesh-list
15002278|NCT01798017|Mifepristone|mifepristone|mesh-list
15002279|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15002280|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
15002281|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15002282|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002283|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15002284|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15002285|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
15002286|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15002287|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15002288|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14523846|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523847|NCT03626415|Abrocitinib|abrocitinib|mesh-list
14523848|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14523849|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523850|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523851|NCT03626714|Tacrolimus|tacrolimus|mesh-list
15002289|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15002290|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
15002291|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15002292|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15002293|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
15002294|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15002295|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
14801974|NCT00795613|Procarbazine|procarbazine|mesh-list
14801975|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14801976|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801977|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14801978|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14801979|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801980|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002296|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15002297|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15002298|NCT01798030|Vitamin D|vitamin d|mesh-list
15002299|NCT01798030|Vitamins|vitamins|mesh-ancestor
15002300|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
15002301|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002302|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15002303|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
15002304|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002305|NCT01798251|Capecitabine|capecitabine|mesh-list
15002306|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
15002307|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15002308|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
15002309|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002310|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002311|NCT01798277|Amiodarone|amiodarone|mesh-list
14523852|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14523853|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
14523854|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523855|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14523856|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14801981|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14801982|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
14801983|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
15002312|NCT01798277|Sotalol|sotalol|mesh-list
15002313|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15002314|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
15002315|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15002316|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15002317|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002318|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15002319|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15002320|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15002321|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002322|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15002323|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15002324|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15002325|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15002326|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15002327|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
15002328|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15002329|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002330|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
15002331|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
15002332|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002333|NCT01798446|Axitinib|axitinib|mesh-list
15002334|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002335|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15002336|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002337|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002338|NCT01798459|Methylphenidate|methylphenidate|mesh-list
15002339|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15002340|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002341|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15002342|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15002343|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15002344|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002345|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
15002346|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15002347|NCT01798472|Cimetidine|cimetidine|mesh-list
15002348|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15002349|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15002350|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15002351|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
15002352|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
15002353|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15002354|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002355|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002356|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15002357|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15002358|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002359|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
15002360|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15002361|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
15002362|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002363|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
15002364|NCT01798498|Protective Agents|protective agents|mesh-ancestor
15002365|NCT01798537|Vancomycin|vancomycin|mesh-list
15002366|NCT01798537|Colistin|colistin|mesh-list
15002367|NCT01798537|Nystatin|nystatin|mesh-list
15002368|NCT01798537|Neomycin|neomycin|mesh-list
15002369|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15002370|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002371|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
15002372|NCT01798537|Ionophores|ionophores|mesh-ancestor
15002373|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15002374|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002375|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15002376|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002377|NCT01798576|Interferons|interferons|mesh-list
15002378|NCT01798576|Ribavirin|ribavirin|mesh-list
15002379|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
15002380|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
15002381|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15002382|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002383|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
15002384|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002385|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
15002386|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002387|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
15002388|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002389|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15002390|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15002391|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15002392|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
15002393|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002394|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15002395|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15002396|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002397|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
15002398|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002399|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15002400|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002401|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002402|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
15002403|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15002404|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002405|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15032526|NCT01983124|Fotemustine|fotemustine|mesh-list
15032527|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032528|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15032529|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032530|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032531|NCT01983137|Oxycodone|oxycodone|mesh-list
15032532|NCT01983137|Naloxone|naloxone|mesh-list
14801984|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
14801985|NCT00795678|Gemcitabine|gemcitabine|mesh-list
14801986|NCT00795678|Paclitaxel|paclitaxel|mesh-list
14801987|NCT00795678|Vinorelbine|vinorelbine|mesh-list
14801988|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14801989|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
14801990|NCT00795678|Doxorubicin|doxorubicin|mesh-list
14801991|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14801992|NCT00795678|Capecitabine|capecitabine|mesh-list
14801993|NCT00795678|Trastuzumab|trastuzumab|mesh-list
14801994|NCT00795678|Lapatinib|lapatinib|mesh-list
14801995|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14801996|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14801997|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
14801998|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
14801999|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
15032533|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15002406|NCT01798680|Vitamin D|vitamin d|mesh-list
15002407|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
15002408|NCT01798680|Vitamins|vitamins|mesh-ancestor
15002409|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
15002410|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002411|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15002412|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15002413|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15002414|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15002415|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
15002416|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15002417|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15002418|NCT01798836|Estradiol|estradiol|mesh-list
15002419|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15002420|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15002421|NCT01798836|Estrogens|estrogens|mesh-ancestor
15002422|NCT01798836|Hormones|hormones|mesh-ancestor
15002423|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15002424|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002425|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15002426|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
15002427|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15002428|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15002429|NCT01798875|Metformin|metformin|mesh-list
15002430|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
15002431|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
15002432|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15002433|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802000|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802001|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802002|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
14802003|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802004|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14802005|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14802006|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
14802007|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15002434|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15002435|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15002436|NCT01798901|Decitabine|decitabine|mesh-list
15002437|NCT01798901|Azacitidine|azacitidine|mesh-list
15002438|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
15002439|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15002440|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
15002441|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002442|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002443|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002444|NCT01798914|Insulin|insulin|mesh-list
15002445|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15002446|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002447|NCT01798940|Pioglitazone|pioglitazone|mesh-list
15002448|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15002449|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002450|NCT01798979|Midazolam|midazolam|mesh-list
15002451|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14523857|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523858|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14523859|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14523860|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14523861|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14523862|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523863|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15002452|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15002453|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032534|NCT01983137|Narcotics|narcotics|mesh-ancestor
15002454|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002455|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15002456|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15002457|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15002458|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15002459|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
15002460|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
15002461|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
15002462|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
15002463|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15002464|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002465|NCT01799005|Micronutrients|micronutrients|mesh-list
15002466|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002467|NCT01799057|Metformin|metformin|mesh-list
15002468|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15002469|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002470|NCT01799083|Decitabine|decitabine|mesh-list
15002471|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15002472|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
15002473|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002474|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002475|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002476|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
15002477|NCT01799109|Albuterol|albuterol|mesh-list
15002478|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15002479|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
15002480|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002481|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002482|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14523864|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14523865|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14523866|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14523867|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
14523868|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523869|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002483|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
15002484|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
15002485|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15002486|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15002487|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15002488|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15002489|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
15002490|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15002491|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002492|NCT01799109|Analgesics|analgesics|mesh-ancestor
15002493|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
15002494|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
15002495|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15002496|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15002497|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
15002498|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15002499|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15002500|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15002501|NCT01799161|Theophylline|theophylline|mesh-list
14523870|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14523871|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14523872|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
15002502|NCT01799161|Vaccines|vaccines|mesh-list
15002503|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
15002504|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002505|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15002506|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
14523873|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14523874|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14523875|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
14523876|NCT03627767|Abrocitinib|abrocitinib|mesh-list
14523877|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14523878|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802008|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15002507|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002508|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15002509|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
15002510|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15002511|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002512|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802009|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
14802010|NCT00795678|Antiviral Agents|antiviral agents|mesh-ancestor
14802011|NCT00795678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802012|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802013|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14802014|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14802015|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14802016|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15002513|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
15002514|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15002515|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15002516|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
15002517|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15002518|NCT01799317|Vitamin D|vitamin d|mesh-list
15002519|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
15002520|NCT01799317|Vitamins|vitamins|mesh-ancestor
15002521|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
15002522|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002523|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15002524|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15002525|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15002526|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
15002527|NCT01799356|Metronidazole|metronidazole|mesh-list
15002528|NCT01799356|Ofloxacin|ofloxacin|mesh-list
15002529|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15002530|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002531|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
15002532|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15002533|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15002534|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002535|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002536|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002537|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15002538|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15002539|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15002540|NCT01799356|Renal Agents|renal agents|mesh-ancestor
14523879|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523880|NCT03628417|Bleomycin|bleomycin|mesh-list
14523881|NCT03628417|Calcium|calcium|mesh-list
14523882|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14523883|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523884|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14523885|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523886|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15002541|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15002542|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15002543|NCT01799460|Cyclosporine|cyclosporine|mesh-list
15002544|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
15002545|NCT01799460|Tacrolimus|tacrolimus|mesh-list
15002546|NCT01799460|Cyclosporins|cyclosporins|mesh-list
15002547|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
15002548|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
15002549|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
15002550|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002551|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15002552|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15002553|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
15032535|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15002554|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002555|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002556|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15002557|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15002558|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002559|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
15002560|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002561|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
15002562|NCT01799460|Hormones|hormones|mesh-ancestor
15002563|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15002564|NCT01799486|Adefovir|adefovir|mesh-list
15002565|NCT01799486|Telbivudine|telbivudine|mesh-list
15002566|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
15002567|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002568|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15002569|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15002570|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002571|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002572|NCT01799603|Simeprevir|simeprevir|mesh-list
15002573|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
15002574|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002575|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
15002576|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002577|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002578|NCT01799616|Pamidronate|pamidronate|mesh-list
15002579|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15002580|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002581|NCT01799798|Denosumab|denosumab|mesh-list
15002582|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15002583|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002584|NCT01799850|Pioglitazone|pioglitazone|mesh-list
15002585|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15002586|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002587|NCT01799863|Ketorolac|ketorolac|mesh-list
15002588|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15002589|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15002590|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
15002591|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15002592|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15002593|NCT01799863|Analgesics|analgesics|mesh-ancestor
15002594|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
15002595|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002596|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002597|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15002598|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15002599|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15002600|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002601|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002602|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15002603|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15002604|NCT01799863|Laxatives|laxatives|mesh-ancestor
15002605|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15002606|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
15002607|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15002608|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15002609|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
15002610|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15002611|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002612|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002613|NCT01799902|Urological Agents|urological agents|mesh-ancestor
15002614|NCT01799954|Vaccines|vaccines|mesh-list
15002615|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
15002616|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002617|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
15002618|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15002619|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
15002620|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15002621|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
15002622|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002623|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002624|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
15002625|NCT01800019|Nicotine|nicotine|mesh-list
15002626|NCT01800019|Varenicline|varenicline|mesh-list
15002627|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15002628|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
15002629|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002630|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002631|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15002632|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15002633|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
15002634|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15002635|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002636|NCT01800097|Modafinil|modafinil|mesh-list
15002637|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15002638|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002639|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15002640|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15002641|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15002642|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002643|NCT01800227|Metformin|metformin|mesh-list
15002644|NCT01800227|Pioglitazone|pioglitazone|mesh-list
15002645|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15002646|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002647|NCT01800240|Metformin|metformin|mesh-list
15002648|NCT01800240|Pioglitazone|pioglitazone|mesh-list
15002649|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15002650|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002651|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
15002652|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002653|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
15002654|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15002655|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15002656|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002657|NCT01800292|Urological Agents|urological agents|mesh-ancestor
15032536|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032537|NCT01983137|Analgesics|analgesics|mesh-ancestor
15032538|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
15032539|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032540|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15032541|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15032542|NCT01983371|Hematinics|hematinics|mesh-ancestor
15002658|NCT01800357|Aspirin|aspirin|mesh-list
15002659|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
15002660|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15002661|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15002662|NCT01800357|Analgesics|analgesics|mesh-ancestor
15002663|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
15002664|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002665|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002666|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15002667|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15002668|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15002669|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15002670|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002671|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15002672|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15002673|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002674|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
15002675|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15002676|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
15002677|NCT01800396|Caseins|caseins|mesh-list
15002678|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
15002679|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
15002680|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002681|NCT01800422|Progesterone|progesterone|mesh-list
15002682|NCT01800422|Progestins|progestins|mesh-ancestor
15002683|NCT01800422|Hormones|hormones|mesh-ancestor
15002684|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15002685|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002686|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
15002687|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
15002688|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15002689|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15002690|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002691|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
15002692|NCT01800435|Coagulants|coagulants|mesh-ancestor
15002693|NCT01800487|Silymarin|silymarin|mesh-list
15002694|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
15002695|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002696|NCT01800487|Protective Agents|protective agents|mesh-ancestor
15002697|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002698|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
15002699|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15002700|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
15002701|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002702|NCT01800526|Expectorants|expectorants|mesh-ancestor
15002703|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
15002704|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15002705|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
15032543|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14802017|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14802018|NCT00795756|Cytarabine|cytarabine|mesh-list
14802019|NCT00795756|Methotrexate|methotrexate|mesh-list
14802020|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15002706|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002707|NCT01800526|Protective Agents|protective agents|mesh-ancestor
15002708|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002709|NCT01800526|Antidotes|antidotes|mesh-ancestor
15002710|NCT01800630|Gemcitabine|gemcitabine|mesh-list
15002711|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15002712|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
15002713|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002714|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002715|NCT01800630|Antiviral Agents|antiviral agents|mesh-ancestor
15002716|NCT01800630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002717|NCT01800630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002718|NCT01800630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15002719|NCT01800630|Immunologic Factors|immunologic factors|mesh-ancestor
15002720|NCT01800630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002721|NCT01800643|Busulfan|busulfan|mesh-list
15002722|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
15002723|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002724|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15002725|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
15002726|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002727|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15002728|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002729|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15002730|NCT01800695|Temozolomide|temozolomide|mesh-list
15002731|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15002732|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
15002733|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002734|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002735|NCT01800708|Prednisolone|prednisolone|mesh-list
15002736|NCT01800708|Triamcinolone|triamcinolone|mesh-list
15002737|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15002738|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15002739|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15002740|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15002741|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
15002742|NCT01800708|Hormones|hormones|mesh-ancestor
15002743|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15002744|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002745|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15002746|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802021|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
14802022|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14802023|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802024|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14802025|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
14802026|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802027|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002747|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15002748|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
15002749|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002750|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002751|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15002752|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002753|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
15002754|NCT01800799|Celecoxib|celecoxib|mesh-list
15002755|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15002756|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15002757|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15002758|NCT01800799|Analgesics|analgesics|mesh-ancestor
15002759|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
15002760|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002761|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002762|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15002763|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15002764|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15002765|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523887|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
14523888|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523889|NCT03629054|Metformin|metformin|mesh-list
14523890|NCT03629054|Empagliflozin|empagliflozin|mesh-list
14523891|NCT03629054|Linagliptin|linagliptin|mesh-list
14523892|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14523893|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523894|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14523895|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523896|NCT03629054|Incretins|incretins|mesh-ancestor
14523897|NCT03629054|Hormones|hormones|mesh-ancestor
14523898|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14523899|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14523900|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
14523901|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523902|NCT03629184|Oseltamivir|oseltamivir|mesh-list
14523903|NCT03629184|Baloxavir|baloxavir|mesh-list
14523904|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
14523905|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523906|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523907|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523908|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
14523909|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14523910|NCT03629249|Growth Substances|growth substances|mesh-ancestor
14523911|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523912|NCT03629925|Gemcitabine|gemcitabine|mesh-list
14523913|NCT03629925|Carboplatin|carboplatin|mesh-list
14523914|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523915|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14523916|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
14523917|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523918|NCT03629925|Antiviral Agents|antiviral agents|mesh-ancestor
14523919|NCT03629925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002766|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002767|NCT01800825|Clindamycin|clindamycin|mesh-list
15002768|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
15002769|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
15002770|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15002771|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002772|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15002773|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002774|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002775|NCT01800942|Azithromycin|azithromycin|mesh-list
15002776|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15002777|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002778|NCT01801046|Cytarabine|cytarabine|mesh-list
15002779|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
15002780|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15002781|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
15002782|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002783|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002784|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
15002785|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002786|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15002787|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
15002788|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002789|NCT01801046|Analgesics|analgesics|mesh-ancestor
15002790|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
15002791|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002792|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15002793|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15002794|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002795|NCT01801072|Levetiracetam|levetiracetam|mesh-list
15002796|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
15002797|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
15002798|NCT01801137|Everolimus|everolimus|mesh-list
15002799|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002800|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15002801|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
15002802|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002803|NCT01801163|Sorafenib|sorafenib|mesh-list
15002804|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002805|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15002806|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002807|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002808|NCT01801189|Pregabalin|pregabalin|mesh-list
15002809|NCT01801189|Analgesics|analgesics|mesh-ancestor
15002810|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
15002811|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002812|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002813|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
15002814|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15002815|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15002816|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002817|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15002818|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15002819|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15002820|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15002821|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15002822|NCT01801228|Eplerenone|eplerenone|mesh-list
15002823|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15002824|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
15002825|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15002826|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002827|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15002828|NCT01801228|Diuretics|diuretics|mesh-ancestor
15002829|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
15002830|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15002831|NCT01801410|Misoprostol|misoprostol|mesh-list
15002832|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15002833|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
15002834|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15002835|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002836|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15002837|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15002838|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
15002839|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
15002840|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002841|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
15002842|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002843|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002844|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15002845|NCT01801644|Gemcitabine|gemcitabine|mesh-list
15002846|NCT01801644|Cisplatin|cisplatin|mesh-list
15002847|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002848|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15002849|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
15002850|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002851|NCT01801644|Antiviral Agents|antiviral agents|mesh-ancestor
15002852|NCT01801644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002853|NCT01801644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002854|NCT01801644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15002855|NCT01801644|Immunologic Factors|immunologic factors|mesh-ancestor
15002856|NCT01801644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002857|NCT01801774|Triamcinolone|triamcinolone|mesh-list
15002858|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15002859|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15002860|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15002861|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15002862|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
15002863|NCT01801774|Hormones|hormones|mesh-ancestor
15002864|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15002865|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002866|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15002867|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
15002868|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002869|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032544|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15032545|NCT01983384|Anesthetics|anesthetics|mesh-list
15032546|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032547|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032548|NCT01983449|Dexamethasone|dexamethasone|mesh-list
15032549|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
15032550|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15032551|NCT01983449|BB 1101|bb 1101|mesh-list
15032552|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15032553|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
15032554|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
15032555|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032556|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032557|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15032558|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
15032559|NCT01983449|Hormones|hormones|mesh-ancestor
15032560|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15032561|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15032562|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032563|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
15032564|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032565|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032566|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15032567|NCT01983462|Clonidine|clonidine|mesh-list
15032568|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15032569|NCT01983462|Diuretics|diuretics|mesh-ancestor
15032570|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
15032571|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032572|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15032573|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15032574|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032575|NCT01983462|Analgesics|analgesics|mesh-ancestor
15032576|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
15032577|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032578|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
15002870|NCT01801904|Panitumumab|panitumumab|mesh-list
15002871|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15002872|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002873|NCT01802255|Midazolam|midazolam|mesh-list
15002874|NCT01802255|Sevoflurane|sevoflurane|mesh-list
15002875|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14523920|NCT03629925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523921|NCT03629925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14523922|NCT03629925|Immunologic Factors|immunologic factors|mesh-ancestor
14523923|NCT03629925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523924|NCT03630198|Lidocaine|lidocaine|mesh-list
14523925|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
14523926|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
14523927|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14523928|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523929|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
14523930|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523931|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14523932|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14523933|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14523934|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14523935|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002876|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15002877|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15002878|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002879|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15002880|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15002881|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15002882|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15002883|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
14529796|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529797|NCT03680911|Antidotes|antidotes|mesh-ancestor
14529798|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14529799|NCT03656692|Hormones|hormones|mesh-ancestor
14529800|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14529801|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529802|NCT03643159|Aripiprazole|aripiprazole|mesh-list
14529803|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
14529804|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
14529805|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14529806|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14529807|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14529808|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529809|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
14529810|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
14529811|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529812|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529813|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15002884|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
15002885|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
15002886|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
15002887|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15002888|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002889|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15002890|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15002891|NCT01802268|Sirolimus|sirolimus|mesh-list
15002892|NCT01802268|Tacrolimus|tacrolimus|mesh-list
15002893|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15002894|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
15002895|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002896|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15002897|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002898|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032579|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
15002899|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15002900|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002901|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15002902|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002903|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
15002904|NCT01802450|Dasatinib|dasatinib|mesh-list
15002905|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002906|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15002907|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002908|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002909|NCT01802476|Palbociclib|palbociclib|mesh-list
15002910|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002911|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15002912|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002913|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002914|NCT01802489|Amiloride|amiloride|mesh-list
15002915|NCT01802489|Diuretics|diuretics|mesh-ancestor
15002916|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
15002917|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523936|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
14523937|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14523938|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14523939|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523940|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
14523941|NCT03631355|Coagulants|coagulants|mesh-ancestor
14523942|NCT03631433|Acetaminophen|acetaminophen|mesh-list
14523943|NCT03631433|Ibuprofen|ibuprofen|mesh-list
14523944|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14523945|NCT03631433|Analgesics|analgesics|mesh-ancestor
14523946|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
14523947|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14523948|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523949|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
14523950|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14523951|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14523952|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14523953|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14523954|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523955|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523956|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
14523957|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14523958|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
14523959|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523960|NCT03632109|Gentamicins|gentamicins|mesh-list
14523961|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14523962|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14523963|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14523964|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523965|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523966|NCT03633331|Letrozole|letrozole|mesh-list
14523967|NCT03633331|Fulvestrant|fulvestrant|mesh-list
14523968|NCT03633331|Palbociclib|palbociclib|mesh-list
14523969|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14523970|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14523971|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14523972|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14523973|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523974|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14523975|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
14523976|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14523977|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523978|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14523979|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14523980|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14523981|NCT03633344|Silicon|silicon|mesh-list
14523982|NCT03633344|Trace Elements|trace elements|mesh-ancestor
14523983|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
14523984|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523985|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
14523986|NCT03633448|Guaifenesin|guaifenesin|mesh-list
14523987|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
15002918|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
15002919|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15002920|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15002921|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002922|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15002923|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15002924|NCT01802502|Rifampin|rifampin|mesh-list
15002925|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15002926|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
15002927|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15002928|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15002929|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
15002930|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15002931|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002932|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002933|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15002934|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15002935|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15002936|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15002937|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15002938|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15002939|NCT01802593|Methotrexate|methotrexate|mesh-list
15002940|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
15002941|NCT01802593|Azathioprine|azathioprine|mesh-list
15002942|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15002943|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
15002944|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15002945|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002946|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15002947|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
15002948|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002949|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002950|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
15002951|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002952|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15002953|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15002954|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
15002955|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15002956|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15002957|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
15002958|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15002959|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
15002960|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15002961|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15002962|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15002963|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
15002964|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15002965|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
15002966|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002967|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15002968|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15002969|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
15002970|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
15002971|NCT01802619|Protective Agents|protective agents|mesh-ancestor
15002972|NCT01802645|Leucovorin|leucovorin|mesh-list
15002973|NCT01802645|Folic Acid|folic acid|mesh-list
15002974|NCT01802645|Bevacizumab|bevacizumab|mesh-list
15002975|NCT01802645|Cetuximab|cetuximab|mesh-list
15002976|NCT01802645|Fluorouracil|fluorouracil|mesh-list
15002977|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
15002978|NCT01802645|Irinotecan|irinotecan|mesh-list
15002979|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
15002980|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15002981|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15002982|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15002983|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15002984|NCT01802645|Growth Substances|growth substances|mesh-ancestor
15002985|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523988|NCT03633448|Expectorants|expectorants|mesh-ancestor
14523989|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
14523990|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14523991|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14523992|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
14523993|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14523994|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14523995|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14523996|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
14523997|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14523998|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
14523999|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
14524000|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524001|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
14524002|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14524003|NCT03633487|Guaifenesin|guaifenesin|mesh-list
14524004|NCT03633487|Expectorants|expectorants|mesh-ancestor
14524005|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
14524006|NCT03633526|Ivacaftor|ivacaftor|mesh-list
14524007|NCT03633526|VX-659|vx-659|mesh-list
14524008|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14524009|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524010|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524011|NCT03634800|Nivolumab|nivolumab|mesh-list
14524012|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14524013|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524014|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14524015|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524016|NCT03635957|Folic Acid|folic acid|mesh-list
14524017|NCT03635957|Methotrexate|methotrexate|mesh-list
14524018|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15002986|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
15002987|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
15002988|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15002989|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15002990|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15002991|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
15002992|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15002993|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15002994|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15002995|NCT01802645|Antidotes|antidotes|mesh-ancestor
15002996|NCT01802645|Protective Agents|protective agents|mesh-ancestor
14524019|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
15002997|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
15002998|NCT01802645|Vitamins|vitamins|mesh-ancestor
15002999|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
15003000|NCT01802645|Hematinics|hematinics|mesh-ancestor
15003001|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
15003002|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15003003|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003004|NCT01802684|Aflibercept|aflibercept|mesh-list
15003005|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15003006|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15003007|NCT01802684|Growth Substances|growth substances|mesh-ancestor
15003008|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003009|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
15003010|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003011|NCT01802749|Gemcitabine|gemcitabine|mesh-list
15003012|NCT01802749|Paclitaxel|paclitaxel|mesh-list
15003013|NCT01802749|Bevacizumab|bevacizumab|mesh-list
15003014|NCT01802749|Carboplatin|carboplatin|mesh-list
15003015|NCT01802749|Doxorubicin|doxorubicin|mesh-list
15003016|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15003017|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15003018|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003019|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
15003020|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
15003021|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
15003022|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003023|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15003024|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15003025|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15003026|NCT01802749|Growth Substances|growth substances|mesh-ancestor
15003027|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003028|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
15003029|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15003030|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
15003031|NCT01802749|Antiviral Agents|antiviral agents|mesh-ancestor
15003032|NCT01802749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003033|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003034|NCT01802749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15003035|NCT01802749|Immunologic Factors|immunologic factors|mesh-ancestor
15003036|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15003037|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15003038|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15003039|NCT01802814|Epratuzumab|epratuzumab|mesh-list
15003040|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15003041|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003042|NCT01802892|Plerixafor|plerixafor|mesh-list
15003043|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15003044|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15003045|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
15003046|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003047|NCT01802918|Ritonavir|ritonavir|mesh-list
15003048|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
15003049|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15003050|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15003051|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
15003052|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003053|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003054|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15003055|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15003056|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
15003057|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003058|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15003059|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15003060|NCT01802931|Ketoconazole|ketoconazole|mesh-list
15003061|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
15003062|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003063|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15003064|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15003065|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003066|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003067|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15003068|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
15003069|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15003070|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003071|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15003072|NCT01802944|Insulin|insulin|mesh-list
15003073|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15003074|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003075|NCT01802970|Paclitaxel|paclitaxel|mesh-list
15003076|NCT01802970|Vinorelbine|vinorelbine|mesh-list
15003077|NCT01802970|Capecitabine|capecitabine|mesh-list
15003078|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15003079|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15003080|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003081|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
15003082|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
15003083|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
15003084|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003085|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15003086|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
15003087|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15003088|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
15003089|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15003090|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
15003091|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003092|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003093|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15003094|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
15003095|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15003096|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15003097|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15003098|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
15003099|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003100|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003101|NCT01803152|Gemcitabine|gemcitabine|mesh-list
15003102|NCT01803152|Imiquimod|imiquimod|mesh-list
15003103|NCT01803152|Vaccines|vaccines|mesh-list
15003104|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
15003105|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003106|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15003107|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
15003108|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003109|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003110|NCT01803152|Antiviral Agents|antiviral agents|mesh-ancestor
15003111|NCT01803152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003112|NCT01803152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003113|NCT01803152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15003114|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15003115|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
15003116|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
15003117|NCT01803191|Fosfomycin|fosfomycin|mesh-list
15003118|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15003119|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003120|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15003121|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15003122|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003123|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003124|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003125|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15003126|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15003127|NCT01803321|Rilonacept|rilonacept|mesh-list
15003128|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15003129|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15003130|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
15003131|NCT01803347|Coagulants|coagulants|mesh-ancestor
15003132|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
15003133|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15003134|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003135|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15003136|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15003137|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003138|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003139|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003140|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
15003141|NCT01803503|Docetaxel|docetaxel|mesh-list
15003142|NCT01803503|Sunitinib|sunitinib|mesh-list
15003143|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003144|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
15003145|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
15003146|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
15003147|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003148|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15003149|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15003150|NCT01803503|Growth Substances|growth substances|mesh-ancestor
15003151|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003152|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
15003153|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15003154|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003155|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
15003156|NCT01803594|Niacin|niacin|mesh-list
15003157|NCT01803594|Niacinamide|niacinamide|mesh-list
15003158|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
15003159|NCT01803594|Vitamins|vitamins|mesh-ancestor
15003160|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
15003161|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003162|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15003163|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
15003164|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003165|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15003166|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
15003167|NCT01803659|Vitamin A|vitamin a|mesh-list
15003168|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
15003169|NCT01803659|Carotenoids|carotenoids|mesh-list
15003170|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
15003171|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003172|NCT01803659|Protective Agents|protective agents|mesh-ancestor
15003173|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003174|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15003175|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003176|NCT01803659|Vitamins|vitamins|mesh-ancestor
15003177|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
15032580|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15032581|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15032582|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15032583|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
15032584|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032585|NCT01983475|Denosumab|denosumab|mesh-list
15032586|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15032587|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032588|NCT01983501|Tucatinib|tucatinib|mesh-list
15032589|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032590|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003178|NCT01803763|Omalizumab|omalizumab|mesh-list
15003179|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15003180|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15003181|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
15003182|NCT01803828|Tadalafil|tadalafil|mesh-list
15003183|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
15003184|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15003185|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15003186|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003187|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003188|NCT01803828|Urological Agents|urological agents|mesh-ancestor
15003189|NCT01804127|Rituximab|rituximab|mesh-list
15003190|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15003191|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003192|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
15003193|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003194|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15003195|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
15003196|NCT01804205|Analgesics|analgesics|mesh-ancestor
15003197|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
15003198|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003199|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003200|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
15003201|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15003202|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15003203|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
15003204|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15003205|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15003206|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003207|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15003208|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
15003209|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15003210|NCT01804218|Nadolol|nadolol|mesh-list
15003211|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15003212|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15003213|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
15003214|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003215|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003216|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003217|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15003218|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15003219|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
15003220|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
15003221|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003222|NCT01804244|Rilpivirine|rilpivirine|mesh-list
15003223|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15003224|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15003225|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003226|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003227|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
15003228|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003229|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15003230|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15003231|NCT01804335|Trifarotene|trifarotene|mesh-list
15003232|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
15003233|NCT01804361|Cyclosporine|cyclosporine|mesh-list
15003234|NCT01804361|Cyclosporins|cyclosporins|mesh-list
15003235|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003236|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003237|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15003238|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
15003239|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003240|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
15003241|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003242|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
15003243|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15003244|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15003245|NCT01804374|Everolimus|everolimus|mesh-list
15003246|NCT01804374|Sorafenib|sorafenib|mesh-list
15003247|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003248|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15003249|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
15003250|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003251|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15003252|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003253|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003254|NCT01804387|Lamivudine|lamivudine|mesh-list
15003255|NCT01804387|Adefovir|adefovir|mesh-list
15003256|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
15003257|NCT01804387|Telbivudine|telbivudine|mesh-list
15003258|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15003259|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15003260|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003261|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003262|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
15003263|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003264|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15003265|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15003266|NCT01804400|Montelukast|montelukast|mesh-list
15003267|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15003268|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
15003269|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15003270|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
15003271|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15003272|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003273|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15003274|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15003275|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003276|NCT01804413|Insulin|insulin|mesh-list
15003277|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15003278|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15003279|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003280|NCT01804543|Ranolazine|ranolazine|mesh-list
15003281|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15003282|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15003283|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003284|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
15003285|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15003286|NCT01804595|Protective Agents|protective agents|mesh-ancestor
15003287|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003288|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
15003289|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
15003290|NCT01804634|Melphalan|melphalan|mesh-list
15003291|NCT01804634|Fludarabine|fludarabine|mesh-list
15003292|NCT01804634|Tacrolimus|tacrolimus|mesh-list
15003293|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15003294|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
15003295|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003296|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15003297|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15003298|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
15003299|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003300|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003301|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15003302|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15003303|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003304|NCT01804712|Rituximab|rituximab|mesh-list
15003305|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15003306|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003307|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
15003308|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003309|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15003310|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15003311|NCT01804777|Amiloride|amiloride|mesh-list
15003312|NCT01804777|Diuretics|diuretics|mesh-ancestor
15003313|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
15003314|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003315|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
15003316|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15003317|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15003318|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003319|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15003320|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15003321|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15003322|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15003323|NCT01804790|Capecitabine|capecitabine|mesh-list
15003324|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15003325|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
15003326|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003327|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003328|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
15003329|NCT01804985|Dasatinib|dasatinib|mesh-list
15003330|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003331|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15003332|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003333|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003334|NCT01805115|Misoprostol|misoprostol|mesh-list
15003335|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15003336|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
15003337|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15003338|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003339|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15003340|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15003341|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
15003342|NCT01805232|Artesunate|artesunate|mesh-list
15003343|NCT01805232|Quinine|quinine|mesh-list
15003344|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
15003345|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15003346|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15003347|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003348|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003349|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
15003350|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
15003351|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15003352|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
15003353|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15003354|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003355|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15003356|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003357|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15003358|NCT01805232|Analgesics|analgesics|mesh-ancestor
15003359|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
15003360|NCT01805258|Efavirenz|efavirenz|mesh-list
15003361|NCT01805258|Nevirapine|nevirapine|mesh-list
15003362|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15003363|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15003364|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003365|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003366|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
15003367|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003368|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15003369|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15003370|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15003371|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15003372|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15003373|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15003374|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15003375|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15003376|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
15003377|NCT01805310|Cathartics|cathartics|mesh-ancestor
15003378|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15003379|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15003380|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003381|NCT01805453|Losartan|losartan|mesh-list
15003382|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15003383|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15003384|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15003385|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15003386|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032591|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15032592|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032593|NCT01983514|Oxytocin|oxytocin|mesh-list
15032594|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
15032595|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15032596|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032597|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
15032598|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15032599|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15032600|NCT01983527|Prednisolone|prednisolone|mesh-list
15032601|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
15032602|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15032603|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
15032604|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15032605|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
15032606|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
15032607|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032608|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032609|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15032610|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
15032611|NCT01983527|Hormones|hormones|mesh-ancestor
15032612|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15032613|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15032614|NCT01983527|Protective Agents|protective agents|mesh-ancestor
15032615|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15032616|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032617|NCT01983540|Vaccines|vaccines|mesh-list
15032618|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15032619|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
15032620|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032621|NCT01983579|Bevacizumab|bevacizumab|mesh-list
15032622|NCT01983579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14524020|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14524021|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032623|NCT01983579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032624|NCT01983579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15032625|NCT01983579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15032626|NCT01983579|Growth Substances|growth substances|mesh-ancestor
15032627|NCT01983579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032628|NCT01983579|Growth Inhibitors|growth inhibitors|mesh-ancestor
15032629|NCT01983657|Molgramostim|molgramostim|mesh-list
15032630|NCT01983657|Sargramostim|sargramostim|mesh-list
15032631|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
15032632|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032633|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032634|NCT01983722|Stiripentol|stiripentol|mesh-list
15032635|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
15032636|NCT01983735|Niacin|niacin|mesh-list
15032637|NCT01983735|Amlodipine|amlodipine|mesh-list
15032638|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15032639|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15032640|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15032641|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032642|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15032643|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032644|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
15032645|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15032646|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
15032647|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15032648|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
15032649|NCT01983735|Vitamins|vitamins|mesh-ancestor
15003387|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
15003388|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15003389|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
15003390|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15003391|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
15003392|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003393|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003394|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
15003395|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
15003396|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15003397|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
15003398|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15003399|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
15003400|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003401|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003402|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
15003403|NCT01805570|Ticagrelor|ticagrelor|mesh-list
15003404|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15003405|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15003406|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15003407|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15003408|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15003409|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
15003410|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003411|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003412|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003413|NCT01805596|Clopidogrel|clopidogrel|mesh-list
15003414|NCT01805596|Ticagrelor|ticagrelor|mesh-list
15003415|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15003416|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15003417|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15003418|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15003419|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
15003420|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003421|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003422|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003423|NCT01805700|Caffeine|caffeine|mesh-list
15003424|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15003425|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003426|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15003427|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003428|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003429|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15003430|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15003431|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
15032650|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
15003432|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003433|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
15003434|NCT01805726|Alfentanil|alfentanil|mesh-list
15003435|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15003436|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15003437|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003438|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15003439|NCT01805726|Analgesics|analgesics|mesh-ancestor
15003440|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
15003441|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003442|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15003443|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15003444|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15003445|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
15003446|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003447|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003448|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15003449|NCT01805726|Narcotics|narcotics|mesh-ancestor
15003450|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15003451|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
15003452|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
15003453|NCT01805804|Valsartan|valsartan|mesh-list
15003454|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15003455|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15003456|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15003457|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003458|NCT01805817|Copper|copper|mesh-list
15003459|NCT01805817|Drospirenone|drospirenone|mesh-list
15003460|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
15003461|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15003462|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
15003463|NCT01805817|Estradiol|estradiol|mesh-list
15003464|NCT01805817|Estrogens|estrogens|mesh-ancestor
15003465|NCT01805817|Hormones|hormones|mesh-ancestor
15003466|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15003467|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802028|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
14802029|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802030|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14802031|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802032|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
14802033|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14802034|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14802035|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
14802036|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802037|NCT00795808|Metformin|metformin|mesh-list
14802038|NCT00795808|Clomiphene|clomiphene|mesh-list
14802039|NCT00795808|Enclomiphene|enclomiphene|mesh-list
15003468|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15003469|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
15003470|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15003471|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15003472|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15003473|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15003474|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15003475|NCT01805817|Trace Elements|trace elements|mesh-ancestor
15003476|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
15003477|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15003478|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
15003479|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15003480|NCT01805817|Diuretics|diuretics|mesh-ancestor
15003481|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
15003482|NCT01805856|Cefazolin|cefazolin|mesh-list
15003483|NCT01805856|Piperacillin|piperacillin|mesh-list
15003484|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15003485|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003486|NCT01805908|Pertuzumab|pertuzumab|mesh-list
15003487|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15003488|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003489|NCT01805999|Psyllium|psyllium|mesh-list
15003490|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
15003491|NCT01805999|Cathartics|cathartics|mesh-ancestor
15003492|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15003493|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
15003494|NCT01806090|Clopidogrel|clopidogrel|mesh-list
15003495|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15003496|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15003497|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15003498|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15003499|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
15003500|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003501|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003502|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003503|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
15003504|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15003505|NCT01806116|Decitabine|decitabine|mesh-list
15003506|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15003507|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
15003508|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003509|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003510|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003511|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
15003512|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
15003513|NCT01806272|Vitamins|vitamins|mesh-ancestor
15003514|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
15003515|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003516|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
15003517|NCT01806272|Hematinics|hematinics|mesh-ancestor
15003518|NCT01806311|Amlodipine|amlodipine|mesh-list
15003519|NCT01806311|Candesartan|candesartan|mesh-list
15003520|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14802040|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
15003521|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15032651|NCT01983761|Vidarabine|vidarabine|mesh-list
15003522|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15003523|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003524|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15003525|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003526|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
15003527|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15003528|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15003529|NCT01806324|Losartan|losartan|mesh-list
15003530|NCT01806324|Atorvastatin|atorvastatin|mesh-list
15003531|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15003532|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15003533|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
15003534|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003535|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15003536|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15003537|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003538|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15003539|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15003540|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15003541|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15003542|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
15003543|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15003544|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003545|NCT01806363|Telmisartan|telmisartan|mesh-list
15003546|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
15003547|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15003548|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15003549|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15003550|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003551|NCT01806363|Diuretics|diuretics|mesh-ancestor
15003552|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
15003553|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003554|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15003555|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15003556|NCT01806376|Maleic acid|maleic acid|mesh-list
15003557|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003558|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003559|NCT01806415|Imidazole|imidazole|mesh-list
15003560|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003561|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003562|NCT01806454|Calcium|calcium|mesh-list
15003563|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15003564|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003565|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15003566|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
15003567|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003568|NCT01806753|Midazolam|midazolam|mesh-list
15003569|NCT01806753|Propofol|propofol|mesh-list
15003570|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15003571|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15003572|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003573|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15003574|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
15003575|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
15003576|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15003577|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15003578|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15003579|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15003580|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
15003581|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
15003582|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003583|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003584|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
15003585|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
15003586|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
15003587|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15003588|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003589|NCT01806792|Vitamins|vitamins|mesh-ancestor
15003590|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
15003591|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15003592|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15003593|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15003594|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003595|NCT01806805|Zonisamide|zonisamide|mesh-list
15003596|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
15003597|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15003598|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15003599|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003600|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15003601|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003602|NCT01806948|Ramosetron|ramosetron|mesh-list
15003603|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
15003604|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
15003605|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003606|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524022|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15003607|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15003608|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15003609|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
15003610|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003611|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003612|NCT01807078|Ezetimibe|ezetimibe|mesh-list
15003613|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15003614|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15003615|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
15003616|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003617|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15003618|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15003619|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15003620|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032652|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
15032653|NCT01983761|Fludarabine|fludarabine|mesh-list
14524023|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
14524024|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524025|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524026|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
14524027|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524028|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15032654|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
15032655|NCT01983761|Melphalan|melphalan|mesh-list
15032656|NCT01983761|Busulfan|busulfan|mesh-list
15032657|NCT01983761|Clofarabine|clofarabine|mesh-list
15032658|NCT01983761|Tacrolimus|tacrolimus|mesh-list
15032659|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032660|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
15032661|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032662|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15032663|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
15032664|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032665|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15032666|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
15032667|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15032668|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15032669|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032670|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15032671|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15032672|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
15032673|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15032674|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15032675|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
15032676|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15032677|NCT01983800|Midazolam|midazolam|mesh-list
15032678|NCT01983800|Propofol|propofol|mesh-list
15032679|NCT01983800|Isoflurane|isoflurane|mesh-list
15032680|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15032681|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032682|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524029|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14524030|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
14524031|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14524032|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14524033|NCT03635957|Hematinics|hematinics|mesh-ancestor
14524034|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
15003621|NCT01807286|Dexamethasone|dexamethasone|mesh-list
15003622|NCT01807286|Melphalan|melphalan|mesh-list
15003623|NCT01807286|Pomalidomide|pomalidomide|mesh-list
15003624|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15003625|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
15003626|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
15003627|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003628|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003629|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15003630|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
15003631|NCT01807286|Hormones|hormones|mesh-ancestor
15003632|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15003633|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15003634|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003635|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15003636|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
15003637|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003638|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15003639|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15003640|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
15003641|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15003642|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15003643|NCT01807286|Growth Substances|growth substances|mesh-ancestor
15003644|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
15003645|NCT01807325|Pancrelipase|pancrelipase|mesh-list
15003646|NCT01807325|Pancreatin|pancreatin|mesh-list
15003647|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15003648|NCT01807377|Midazolam|midazolam|mesh-list
15003649|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15003650|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15003651|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15003652|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003653|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15003654|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15003655|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15003656|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15003657|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
15003658|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
15003659|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
15003660|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
15003661|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003662|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003663|NCT01807429|Midazolam|midazolam|mesh-list
15003664|NCT01807429|Ketamine|ketamine|mesh-list
15003665|NCT01807429|Morphine|morphine|mesh-list
15003666|NCT01807429|Analgesics|analgesics|mesh-ancestor
15003667|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
15003668|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003669|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003670|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15003671|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15003672|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
15003673|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
15003674|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15003675|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15003676|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15003677|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003678|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003679|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15003680|NCT01807429|Narcotics|narcotics|mesh-ancestor
15003681|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15003682|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15003683|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15003684|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15003685|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15003686|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
15003687|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
15003688|NCT01807494|Cimetidine|cimetidine|mesh-list
15003689|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15003690|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15003691|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14524035|NCT03635957|Vitamins|vitamins|mesh-ancestor
14524036|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
14524037|NCT03636061|Varenicline|varenicline|mesh-list
14524038|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15003692|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
15003693|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
15003694|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003695|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003696|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003697|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15003698|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15003699|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003700|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
15003701|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
15003702|NCT01807611|Melphalan|melphalan|mesh-list
15003703|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
15003704|NCT01807611|Thiotepa|thiotepa|mesh-list
15003705|NCT01807611|Fludarabine|fludarabine|mesh-list
15003706|NCT01807611|Sargramostim|sargramostim|mesh-list
15003707|NCT01807611|Lenograstim|lenograstim|mesh-list
15003708|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15003709|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
15003710|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003711|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15003712|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15003713|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
15003714|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003715|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003716|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15003717|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15003718|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15003719|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
15003720|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15003721|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003722|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003723|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15003724|NCT01807741|Asenapine|asenapine|mesh-list
15003725|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15003726|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15003727|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15003728|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524039|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15003729|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15003730|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
15003731|NCT01807767|Everolimus|everolimus|mesh-list
15003732|NCT01807767|Tacrolimus|tacrolimus|mesh-list
15003733|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15003734|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
15003735|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003736|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15003737|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003738|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003739|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003740|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15003741|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15003742|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
15003743|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15003744|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003745|NCT01807832|Capsaicin|capsaicin|mesh-list
15003746|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
15003747|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
15003748|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
15003749|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003750|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003751|NCT01807910|Choline|choline|mesh-list
15003752|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
15003753|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15003754|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
15003755|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003756|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15003757|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15003758|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
15003759|NCT01807962|Lidocaine|lidocaine|mesh-list
15003760|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
15003761|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
15003762|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15003763|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003764|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
15003765|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003766|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15003767|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15003768|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15003769|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15003770|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003771|NCT01808014|Nefopam|nefopam|mesh-list
15003772|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15003773|NCT01808014|Analgesics|analgesics|mesh-ancestor
15003774|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
15003775|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003776|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003777|NCT01808131|Lesinurad|lesinurad|mesh-list
15003778|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
15003779|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15003780|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
15003781|NCT01808131|Renal Agents|renal agents|mesh-ancestor
15003782|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
15003783|NCT01808300|Pregabalin|pregabalin|mesh-list
15003784|NCT01808300|Analgesics|analgesics|mesh-ancestor
15003785|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
15003786|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003787|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003788|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
15003789|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15003790|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15003791|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003792|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15003793|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15003794|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15003795|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15003796|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15003797|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
15003798|NCT01808300|Protective Agents|protective agents|mesh-ancestor
15003799|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
15003800|NCT01808300|Vitamins|vitamins|mesh-ancestor
15003801|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
15003802|NCT01808456|Vaccines|vaccines|mesh-list
15003803|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
15003804|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003805|NCT01808469|Antibodies|antibodies|mesh-list
15003806|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14802041|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14802042|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802043|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14802044|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
14802045|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14802046|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14802047|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
14802048|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15003807|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
15003808|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524040|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
15003809|NCT01808495|Mitomycins|mitomycins|mesh-list
15003810|NCT01808495|Mitomycin|mitomycin|mesh-list
15003811|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15003812|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003813|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
15003814|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003815|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15003816|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003817|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
15003818|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15003819|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
15003820|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802049|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14802050|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14802051|NCT00795847|Losartan|losartan|mesh-list
14802052|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14802053|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14802054|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14802055|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14802056|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14802057|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802058|NCT00795847|Diuretics|diuretics|mesh-ancestor
14802059|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
14802060|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802061|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14802062|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14802063|NCT00795899|Paclitaxel|paclitaxel|mesh-list
15003821|NCT01808521|Expectorants|expectorants|mesh-ancestor
15003822|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
15003823|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15003824|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
15003825|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003826|NCT01808521|Protective Agents|protective agents|mesh-ancestor
15003827|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003828|NCT01808521|Antidotes|antidotes|mesh-ancestor
15003829|NCT01808586|Dexamethasone|dexamethasone|mesh-list
15003830|NCT01808586|Betamethasone|betamethasone|mesh-list
15003831|NCT01808586|Lidocaine|lidocaine|mesh-list
15003832|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15003833|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
15003834|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
15003835|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003836|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003837|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15003838|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
15003839|NCT01808586|Hormones|hormones|mesh-ancestor
15003840|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15003841|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15003842|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003843|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
15003844|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
15003845|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15003846|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
15003847|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15003848|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15003849|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15003850|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15003851|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003852|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15003853|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
15003854|NCT01808599|Rituximab|rituximab|mesh-list
15003855|NCT01808599|Chlorambucil|chlorambucil|mesh-list
15003856|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15003857|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003858|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
15003859|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003860|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15003861|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15003862|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
15003863|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003864|NCT01808638|Gemcitabine|gemcitabine|mesh-list
15003865|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15003866|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
15003867|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003868|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003869|NCT01808638|Antiviral Agents|antiviral agents|mesh-ancestor
15003870|NCT01808638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003871|NCT01808638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003872|NCT01808638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15003873|NCT01808638|Immunologic Factors|immunologic factors|mesh-ancestor
15003874|NCT01808638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003875|NCT01808768|Alcaftadine|alcaftadine|mesh-list
15003876|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15003877|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
15003878|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
15003879|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003880|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003881|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003882|NCT01808898|Bupivacaine|bupivacaine|mesh-list
15003883|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
15003884|NCT01808898|Mepivacaine|mepivacaine|mesh-list
15003885|NCT01808898|Anesthetics|anesthetics|mesh-list
15003886|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15003887|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003888|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
15003889|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003890|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
15003891|NCT01808911|Rituximab|rituximab|mesh-list
15003892|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15003893|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
15003894|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003895|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15003896|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15003897|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
15003898|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003899|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003900|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15003901|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15003902|NCT01809041|Remifentanil|remifentanil|mesh-list
15003903|NCT01809041|Propofol|propofol|mesh-list
15003904|NCT01809041|Sevoflurane|sevoflurane|mesh-list
15003905|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15003906|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15003907|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003908|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15003909|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
15003910|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
15003911|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15003912|NCT01809041|Narcotics|narcotics|mesh-ancestor
15003913|NCT01809041|Analgesics|analgesics|mesh-ancestor
15003914|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
15003915|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003916|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15003917|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15032683|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15032684|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
15032685|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
15032686|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15032687|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15032688|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15032689|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15032690|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
15032691|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
15032692|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032693|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032694|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15032695|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
15032696|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15032697|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
15032698|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032699|NCT01983943|Protective Agents|protective agents|mesh-ancestor
15003918|NCT01809158|Minocycline|minocycline|mesh-list
15003919|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15003920|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003921|NCT01809171|Vitamin D|vitamin d|mesh-list
15003922|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
15003923|NCT01809171|Vitamins|vitamins|mesh-ancestor
15003924|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
15003925|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003926|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15003927|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15003928|NCT01809184|Insulin|insulin|mesh-list
15003929|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15003930|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
15003931|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15003932|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003933|NCT01809301|Niacin|niacin|mesh-list
15003934|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
15003935|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15003936|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
15003937|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003938|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15003939|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
15003940|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
15003941|NCT01809301|Vitamins|vitamins|mesh-ancestor
15003942|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
15003943|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003944|NCT01809340|Minocycline|minocycline|mesh-list
15003945|NCT01809340|Ketamine|ketamine|mesh-list
15003946|NCT01809340|Analgesics|analgesics|mesh-ancestor
15003947|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
15003948|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15003949|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003950|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15003951|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15003952|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
15003953|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
15003954|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15003955|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15003956|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15003957|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003958|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003959|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15003960|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003961|NCT01809379|Cisplatin|cisplatin|mesh-list
15003962|NCT01809379|Doxorubicin|doxorubicin|mesh-list
15003963|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003964|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15003965|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15003966|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15003967|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003968|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003969|NCT01809392|Decitabine|decitabine|mesh-list
15003970|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15003971|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
15003972|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003973|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524041|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524042|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524043|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003974|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15003975|NCT01809444|Doxycycline|doxycycline|mesh-list
15003976|NCT01809444|Prednisone|prednisone|mesh-list
15003977|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15003978|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
15003979|NCT01809444|Hormones|hormones|mesh-ancestor
15003980|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15003981|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003982|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15003983|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15003984|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15003985|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15003986|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
15003987|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15003988|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15003989|NCT01809626|Zolpidem|zolpidem|mesh-list
15003990|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15003991|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15003992|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15003993|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15003994|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15003995|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
15003996|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
15003997|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15003998|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15003999|NCT01809691|Bicalutamide|bicalutamide|mesh-list
15004000|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
15004001|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
15004002|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004003|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004004|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004005|NCT01809743|Adenosine|adenosine|mesh-list
15004006|NCT01809743|Regadenoson|regadenoson|mesh-list
15004007|NCT01809743|Analgesics|analgesics|mesh-ancestor
15004008|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
15004009|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004010|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004011|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15004012|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
15004013|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15004014|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
15004015|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
15004016|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004017|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004018|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
15004019|NCT01809808|Hormones|hormones|mesh-list
15004020|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004021|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004022|NCT01809847|Ofatumumab|ofatumumab|mesh-list
15004023|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004024|NCT01809860|Sirolimus|sirolimus|mesh-list
15004025|NCT01809860|Isavuconazole|isavuconazole|mesh-list
15004026|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15004027|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004028|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15004029|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004030|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
15004031|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15004032|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
15004033|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004034|NCT01809886|Neostigmine|neostigmine|mesh-list
15004035|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15004036|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004037|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004038|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
15004039|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004040|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004041|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15004042|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
15004043|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004044|NCT01809925|Psyllium|psyllium|mesh-list
15004045|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
15004046|NCT01809925|Cathartics|cathartics|mesh-ancestor
15004047|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15004048|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
15004049|NCT01810185|Naltrexone|naltrexone|mesh-list
15004050|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15004051|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15004052|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004053|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
15004054|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004055|NCT01810237|Dabigatran|dabigatran|mesh-list
15004056|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
15004057|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15004058|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
15004059|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004060|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004061|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
15004062|NCT01810315|Estradiol|estradiol|mesh-list
15004063|NCT01810315|Estrogens|estrogens|mesh-ancestor
15004064|NCT01810315|Hormones|hormones|mesh-ancestor
15004065|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004066|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004067|NCT01810354|Cefazolin|cefazolin|mesh-list
15004068|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15004069|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004070|NCT01810367|Gemcitabine|gemcitabine|mesh-list
15004071|NCT01810367|Cisplatin|cisplatin|mesh-list
15004072|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524044|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14524045|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14524046|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
14524047|NCT03638635|Bupivacaine|bupivacaine|mesh-list
14524048|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
14524049|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
14524050|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524051|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524052|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
14524053|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524054|NCT03638908|Fluoxetine|fluoxetine|mesh-list
14524055|NCT03638908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14524056|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14524057|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524058|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524059|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524060|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
14524061|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524062|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14524063|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
14524064|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14524065|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15004073|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15004074|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
15004075|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004076|NCT01810367|Antiviral Agents|antiviral agents|mesh-ancestor
15004077|NCT01810367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004078|NCT01810367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004079|NCT01810367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15004080|NCT01810367|Immunologic Factors|immunologic factors|mesh-ancestor
15004081|NCT01810367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004082|NCT01810393|Trastuzumab|trastuzumab|mesh-list
15004083|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15004084|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004085|NCT01810458|Acetaminophen|acetaminophen|mesh-list
15004086|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15004087|NCT01810458|Lidocaine|lidocaine|mesh-list
15004088|NCT01810458|Fentanyl|fentanyl|mesh-list
15004089|NCT01810458|Midazolam|midazolam|mesh-list
15004090|NCT01810458|Oxycodone|oxycodone|mesh-list
15004091|NCT01810458|Lorazepam|lorazepam|mesh-list
15004092|NCT01810458|Ondansetron|ondansetron|mesh-list
15004093|NCT01810458|Liver Extracts|liver extracts|mesh-list
15004094|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
15004095|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
15004096|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15004097|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004098|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
15004099|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004100|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15004101|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15004102|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15004103|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15004104|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004105|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15004106|NCT01810458|Narcotics|narcotics|mesh-ancestor
15004107|NCT01810458|Analgesics|analgesics|mesh-ancestor
15004108|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15004109|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15004110|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
15004111|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15004112|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15004113|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15004114|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15004115|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
15004116|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
15004117|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004118|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15004119|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
15004120|NCT01810458|Hematinics|hematinics|mesh-ancestor
15004121|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
15004122|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
15004123|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15004124|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
15004125|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
15004126|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15004127|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
15004128|NCT01810458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15004129|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
15004130|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15004131|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15004132|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15004133|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15004134|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15004135|NCT01810588|Vidarabine|vidarabine|mesh-list
15004136|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
15004137|NCT01810588|Rituximab|rituximab|mesh-list
15004138|NCT01810588|Fludarabine|fludarabine|mesh-list
15004139|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
15004140|NCT01810588|Melphalan|melphalan|mesh-list
15004141|NCT01810588|Tacrolimus|tacrolimus|mesh-list
15004142|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15004143|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
15004144|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15004145|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004146|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
15004147|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004148|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15004149|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15004150|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
15004151|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004152|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15004153|NCT01810588|Antiviral Agents|antiviral agents|mesh-ancestor
15004154|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004155|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15004156|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004157|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15004158|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15004159|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
15004160|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15004161|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15004162|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
15004163|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15004164|NCT01810601|Progesterone|progesterone|mesh-list
15004165|NCT01810601|Progestins|progestins|mesh-ancestor
15004166|NCT01810601|Hormones|hormones|mesh-ancestor
15004167|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004168|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004169|NCT01810640|Liver Extracts|liver extracts|mesh-list
15004170|NCT01810640|Hematinics|hematinics|mesh-ancestor
15004171|NCT01810731|Vaccines|vaccines|mesh-list
15004172|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
15004173|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032700|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032701|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15032702|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
15032703|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
15032704|NCT01984008|Citric Acid|citric acid|mesh-list
15032705|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
15032706|NCT01984008|Cathartics|cathartics|mesh-ancestor
15032707|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15032708|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
15032709|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15032710|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
15032711|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
15032712|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032713|NCT01984008|Antacids|antacids|mesh-ancestor
15032714|NCT01984073|Niacin|niacin|mesh-list
15032715|NCT01984073|Niacinamide|niacinamide|mesh-list
15032716|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
15032717|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15032718|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
15032719|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032720|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15032721|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
15032722|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
15032723|NCT01984073|Vitamins|vitamins|mesh-ancestor
15032724|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
15032725|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032726|NCT01984086|Albuterol|albuterol|mesh-list
15032727|NCT01984086|Charcoal|charcoal|mesh-list
15032728|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15032729|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
15032730|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032731|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032732|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15032733|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
15032734|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
15032735|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15032736|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15032737|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15032738|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15032739|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
15032740|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004174|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
15004175|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004176|NCT01810796|Ranolazine|ranolazine|mesh-list
15004177|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15004178|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15004179|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004180|NCT01810809|Hylan|hylan|mesh-list
15004181|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
15004182|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
15004183|NCT01810809|Protective Agents|protective agents|mesh-ancestor
15004184|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004185|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15004186|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
15004187|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
15004188|NCT01810848|Hylan|hylan|mesh-list
15004189|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15004190|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
15004191|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004192|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
15004193|NCT01810848|Protective Agents|protective agents|mesh-ancestor
15004194|NCT01810887|Ritonavir|ritonavir|mesh-list
15004195|NCT01810887|Darunavir|darunavir|mesh-list
15004196|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15004197|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15004198|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
15004199|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004200|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004201|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15004202|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15004203|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
15004204|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004205|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15004206|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15004207|NCT01810926|Cyclosporine|cyclosporine|mesh-list
15004208|NCT01810926|Rituximab|rituximab|mesh-list
15004209|NCT01810926|Methotrexate|methotrexate|mesh-list
15004210|NCT01810926|Fludarabine|fludarabine|mesh-list
15004211|NCT01810926|Thiotepa|thiotepa|mesh-list
15004212|NCT01810926|Treosulfan|treosulfan|mesh-list
15004213|NCT01810926|Antibodies|antibodies|mesh-list
15004214|NCT01810926|Cyclosporins|cyclosporins|mesh-list
15004215|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
15004216|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004217|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15004218|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004219|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15004220|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15004221|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
15004222|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15004223|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15004224|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
15004225|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004226|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
15004227|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004228|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15004229|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15004230|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15004231|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
15004232|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004233|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15004234|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15004235|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
15004236|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15004237|NCT01811056|Mifepristone|mifepristone|mesh-list
15004238|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15004239|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
15004240|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15004241|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004242|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15004243|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15004244|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15004245|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
15004246|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15004247|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15004248|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
15004249|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004250|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
15004251|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15004252|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15004253|NCT01811160|Melatonin|melatonin|mesh-list
15004254|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
15004255|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004256|NCT01811160|Protective Agents|protective agents|mesh-ancestor
15004257|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004258|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15004259|NCT01811251|Dexamethasone|dexamethasone|mesh-list
15004260|NCT01811251|Pregabalin|pregabalin|mesh-list
15004261|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15004262|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
15004263|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
15004264|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004265|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004266|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15004267|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
15004268|NCT01811251|Hormones|hormones|mesh-ancestor
15004269|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004270|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15004271|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004272|NCT01811251|Analgesics|analgesics|mesh-ancestor
15004273|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
15004274|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
15004275|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15004276|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15004277|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004278|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15004279|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15004280|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15004281|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15004282|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15004283|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
15004284|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004285|NCT01811381|Curcumin|curcumin|mesh-list
15004286|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15004287|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15004288|NCT01811381|Analgesics|analgesics|mesh-ancestor
15004289|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
15004290|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004291|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004292|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15004293|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15004294|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004295|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004296|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004297|NCT01811459|Haloperidol|haloperidol|mesh-list
15004298|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15004299|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
15004300|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
15004301|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15004302|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15004303|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15004304|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15004305|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004306|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
15004307|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
15004308|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004309|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15004310|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15004311|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
15004312|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004313|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004314|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15004315|NCT01811498|Bevacizumab|bevacizumab|mesh-list
15004316|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15004317|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004318|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15004319|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15004320|NCT01811498|Growth Substances|growth substances|mesh-ancestor
15004321|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004322|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
15004323|NCT01811615|Ethanol|ethanol|mesh-list
15004324|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15004325|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004326|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15004327|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004328|NCT01811667|Sirolimus|sirolimus|mesh-list
15004329|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15004330|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004331|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15004332|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004333|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
15004334|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15004335|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
15004336|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004337|NCT01811810|Androgens|androgens|mesh-list
15004338|NCT01811810|Hormones|hormones|mesh-ancestor
15004339|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004340|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004341|NCT01811836|Zinc|zinc|mesh-list
15004342|NCT01811836|Trace Elements|trace elements|mesh-ancestor
15004343|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
15004344|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004345|NCT01811849|Insulin|insulin|mesh-list
15004346|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15004347|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
15004348|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15004349|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004350|NCT01812018|Gemcitabine|gemcitabine|mesh-list
15004351|NCT01812018|Docetaxel|docetaxel|mesh-list
15004352|NCT01812018|Endostar protein|endostar protein|mesh-list
15004353|NCT01812018|Endostatins|endostatins|mesh-list
15004354|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15004355|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
15004356|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004357|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004358|NCT01812018|Antiviral Agents|antiviral agents|mesh-ancestor
15004359|NCT01812018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524066|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14524067|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524068|NCT03639675|Aflibercept|aflibercept|mesh-list
14524069|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14524070|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14524071|NCT03639675|Growth Substances|growth substances|mesh-ancestor
14524072|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524073|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
14524074|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524075|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14524076|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14524077|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14524078|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524079|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524080|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
14524081|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802064|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
14802065|NCT00795899|Trastuzumab|trastuzumab|mesh-list
14802066|NCT00795899|Epirubicin|epirubicin|mesh-list
14802067|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14802068|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802069|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
14802070|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
14802071|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
14802072|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004360|NCT01812018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004361|NCT01812018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15004362|NCT01812018|Immunologic Factors|immunologic factors|mesh-ancestor
15004363|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004364|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
15004365|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
15004366|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
15004367|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15004368|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15004369|NCT01812018|Growth Substances|growth substances|mesh-ancestor
15004370|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
15004371|NCT01812096|Bortezomib|bortezomib|mesh-list
15004372|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004373|NCT01812122|Glimepiride|glimepiride|mesh-list
14524082|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524083|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14524084|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524085|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
14524086|NCT03639779|Antidotes|antidotes|mesh-ancestor
14524087|NCT03639779|Protective Agents|protective agents|mesh-ancestor
14524088|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524089|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
14524090|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524091|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
14524092|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14524093|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524094|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
14524095|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
14524096|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
15004374|NCT01812122|Vildagliptin|vildagliptin|mesh-list
15004375|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15004376|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15004377|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004378|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15004379|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
15004380|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15004381|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
15004382|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004383|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004384|NCT01812135|Vaccines|vaccines|mesh-list
15004385|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
15004386|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004387|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
15004388|NCT01812200|Dabigatran|dabigatran|mesh-list
15004389|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
15004390|NCT01812200|Ticagrelor|ticagrelor|mesh-list
15004391|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15004392|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15004393|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15004394|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15004395|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
15004396|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004397|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004398|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004399|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15004400|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
15004401|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15004402|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
15004403|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004404|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
15004405|NCT01812239|Progesterone|progesterone|mesh-list
15004406|NCT01812239|Progestins|progestins|mesh-list
15004407|NCT01812239|Hormones|hormones|mesh-ancestor
15004408|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004409|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004410|NCT01812330|Clopidogrel|clopidogrel|mesh-list
15004411|NCT01812330|Ticagrelor|ticagrelor|mesh-list
15004412|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15004413|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15004414|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15004415|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15004416|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
15004417|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004418|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004419|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802073|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802074|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
14802075|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802076|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14802077|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14802078|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
14802079|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14802080|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14802081|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15004420|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
15004421|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15004422|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
15004423|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
15004424|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15004425|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004426|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15004427|NCT01812356|Analgesics|analgesics|mesh-ancestor
15004428|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
15004429|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004430|NCT01812369|Gemcitabine|gemcitabine|mesh-list
15004431|NCT01812369|Doxorubicin|doxorubicin|mesh-list
15004432|NCT01812369|Vinblastine|vinblastine|mesh-list
15004433|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15004434|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
15004435|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004436|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004437|NCT01812369|Antiviral Agents|antiviral agents|mesh-ancestor
15004438|NCT01812369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004439|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004440|NCT01812369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15004441|NCT01812369|Immunologic Factors|immunologic factors|mesh-ancestor
15004442|NCT01812369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004443|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15004444|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15004445|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15004446|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15004447|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
15004448|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
15004449|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
15004450|NCT01812382|Retapamulin|retapamulin|mesh-list
15004451|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15004452|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004453|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
15004454|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
15004455|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15004456|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15004457|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004458|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004459|NCT01812434|Urological Agents|urological agents|mesh-ancestor
15004460|NCT01812538|Diclofenac|diclofenac|mesh-list
15004461|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15004462|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15004463|NCT01812538|Analgesics|analgesics|mesh-ancestor
15004464|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
15004465|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004466|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004467|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15004468|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15004469|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15004470|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004471|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032741|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032742|NCT01984086|Antidotes|antidotes|mesh-ancestor
15032743|NCT01984086|Protective Agents|protective agents|mesh-ancestor
15032744|NCT01984099|Folic Acid|folic acid|mesh-list
15032745|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
15032746|NCT01984099|Methotrexate|methotrexate|mesh-list
15032747|NCT01984099|Vitamins|vitamins|mesh-ancestor
15032748|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
15032749|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032750|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15032751|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
15032752|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15032753|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15032754|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
15032755|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032756|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032757|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
15032758|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032759|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15032760|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15032761|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
15032762|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15032763|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15032764|NCT01984099|Hematinics|hematinics|mesh-ancestor
15032765|NCT01984138|Estradiol|estradiol|mesh-list
15032766|NCT01984138|Estrogens|estrogens|mesh-ancestor
15032767|NCT01984138|Hormones|hormones|mesh-ancestor
15032768|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15032769|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032770|NCT01984177|Hormones|hormones|mesh-list
15032771|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15032772|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
15032773|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15032774|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032775|NCT01984255|Ipilimumab|ipilimumab|mesh-list
15032776|NCT01984255|Bavituximab|bavituximab|mesh-list
15032777|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15032778|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032779|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15032780|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004472|NCT01812551|Alendronate|alendronate|mesh-list
15004473|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15004474|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004475|NCT01812603|Nabiximols|nabiximols|mesh-list
15004476|NCT01812603|Analgesics|analgesics|mesh-ancestor
15004477|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
15004478|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004479|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004480|NCT01812616|Nabiximols|nabiximols|mesh-list
15004481|NCT01812616|Analgesics|analgesics|mesh-ancestor
15004482|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
15004483|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004484|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004485|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
15004486|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15004487|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15004488|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
15004489|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004490|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004491|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004492|NCT01812720|Dexamethasone|dexamethasone|mesh-list
15004493|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15004494|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
15004495|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
15004496|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004497|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004498|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15004499|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
15004500|NCT01812720|Hormones|hormones|mesh-ancestor
15004501|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004502|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15004503|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004504|NCT01812889|TOL-463|tol-463|mesh-list
15004505|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004506|NCT01812928|Diclofenac|diclofenac|mesh-list
15004507|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15004508|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15004509|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15004510|NCT01812928|Analgesics|analgesics|mesh-ancestor
15004511|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
15004512|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004513|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004514|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15004515|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15004516|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004517|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004518|NCT01812954|Cyclosporine|cyclosporine|mesh-list
15004519|NCT01812954|Adalimumab|adalimumab|mesh-list
15004520|NCT01812954|Etanercept|etanercept|mesh-list
15004521|NCT01812954|Methotrexate|methotrexate|mesh-list
15004522|NCT01812954|Infliximab|infliximab|mesh-list
15004523|NCT01812954|Ustekinumab|ustekinumab|mesh-list
15004524|NCT01812954|Acitretin|acitretin|mesh-list
15004525|NCT01812954|Cyclosporins|cyclosporins|mesh-list
15004526|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15004527|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
15004528|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15004529|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004530|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15004531|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
15004532|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004533|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004534|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
15004535|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004536|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15004537|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15004538|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
15004539|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15004540|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15004541|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
15004542|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004543|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15004544|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15004545|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15004546|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15004547|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15004548|NCT01812954|Analgesics|analgesics|mesh-ancestor
15004549|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
15004550|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004551|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
15004552|NCT01812967|Caseins|caseins|mesh-list
15004553|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
15004554|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
15004555|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004556|NCT01813162|Tenofovir|tenofovir|mesh-list
15004557|NCT01813162|Metronidazole|metronidazole|mesh-list
15004558|NCT01813162|Terconazole|terconazole|mesh-list
15004559|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
15004560|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
15004561|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004562|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15004563|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15004564|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004565|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004566|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15004567|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15004568|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15004569|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15004570|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15004571|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15004572|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004573|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
15004574|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
15004575|NCT01813201|Testosterone|testosterone|mesh-list
15004576|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
15004577|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
15004578|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15004579|NCT01813201|Androgens|androgens|mesh-ancestor
15004580|NCT01813201|Hormones|hormones|mesh-ancestor
15004581|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004582|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004583|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15004584|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004585|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
15004586|NCT01813240|Minocycline|minocycline|mesh-list
15004587|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15004588|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004589|NCT01813253|Irinotecan|irinotecan|mesh-list
15004590|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
15004591|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15004592|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15004593|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004594|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004595|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004596|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15004597|NCT01813318|Acamprosate|acamprosate|mesh-list
15004598|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15004599|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
15004600|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15004601|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004602|NCT01813461|Isavuconazole|isavuconazole|mesh-list
15004603|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
15004604|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004605|NCT01813487|Entecavir|entecavir|mesh-list
15004606|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
15004607|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004608|NCT01813513|Simeprevir|simeprevir|mesh-list
15004609|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
15004610|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004611|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
15004612|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004613|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004614|NCT01813552|Ritonavir|ritonavir|mesh-list
15004615|NCT01813552|Omeprazole|omeprazole|mesh-list
15004616|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15004617|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15004618|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
15004619|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004620|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004621|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15004622|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15004623|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
15004624|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004625|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15004626|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15004627|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15004628|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15004629|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15004630|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
15004631|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15004632|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
15004633|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004634|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
15004635|NCT01813565|Protective Agents|protective agents|mesh-ancestor
15004636|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15004637|NCT01813591|Hormones|hormones|mesh-ancestor
15004638|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004639|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004640|NCT01813604|Vaccines|vaccines|mesh-list
15004641|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
15004642|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004643|NCT01813617|Prednisone|prednisone|mesh-list
15004644|NCT01813617|Methotrexate|methotrexate|mesh-list
15004645|NCT01813617|Azathioprine|azathioprine|mesh-list
15004646|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
15004647|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15004648|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
15004649|NCT01813617|Hormones|hormones|mesh-ancestor
15004650|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004651|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004652|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15004653|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004654|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15004655|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
15004656|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15004657|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15004658|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
15004659|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004660|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
15004661|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004662|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15004663|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
15004664|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15004665|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15004666|NCT01813643|Risperidone|risperidone|mesh-list
15004667|NCT01813643|Aripiprazole|aripiprazole|mesh-list
15004668|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15004669|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
15004670|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004671|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004672|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004673|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15004674|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15004675|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15004676|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15004677|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15004678|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
15004679|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
15004680|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
15004681|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15004682|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15004683|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15004684|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15004685|NCT01813656|Aripiprazole|aripiprazole|mesh-list
15004686|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
15004687|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15004688|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15004689|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15004690|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15004691|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004692|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
15004693|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
15004694|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004695|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004696|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15004697|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15004698|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
15004699|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15004700|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15004701|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15004702|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15004703|NCT01813773|Aflibercept|aflibercept|mesh-list
15004704|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15004705|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15004706|NCT01813773|Growth Substances|growth substances|mesh-ancestor
15004707|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004708|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
15004709|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004710|NCT01813812|Rebamipide|rebamipide|mesh-list
15004711|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15004712|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15004713|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
15004714|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004715|NCT01813812|Protective Agents|protective agents|mesh-ancestor
15004716|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004717|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004718|NCT01813955|Papaverine|papaverine|mesh-list
15004719|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15004720|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004721|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004722|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
15004723|NCT01813955|Urological Agents|urological agents|mesh-ancestor
15004724|NCT01813981|Caffeine|caffeine|mesh-list
15004725|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15004726|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004727|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15004728|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004729|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004730|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15004731|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15004732|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
15004733|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004734|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
15004735|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15004736|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15004737|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
15004738|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004739|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004740|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15004741|NCT01814059|Sirolimus|sirolimus|mesh-list
15004742|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15004743|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004744|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15004745|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004746|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
15004747|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15004748|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
15004749|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004750|NCT01814085|Citalopram|citalopram|mesh-list
15004751|NCT01814085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15004752|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15004753|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15004754|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004755|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004756|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
15004757|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004758|NCT01814085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15004759|NCT01814085|Antidepressive Agents|antidepressive agents|mesh-ancestor
15004760|NCT01814085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15004761|NCT01814098|Citalopram|citalopram|mesh-list
15004762|NCT01814098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15004763|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15004764|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15004765|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004766|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004767|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
15004768|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004769|NCT01814098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15004770|NCT01814098|Antidepressive Agents|antidepressive agents|mesh-ancestor
15004771|NCT01814098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15004772|NCT01814163|Paclitaxel|paclitaxel|mesh-list
15004773|NCT01814163|Bevacizumab|bevacizumab|mesh-list
15004774|NCT01814163|Carboplatin|carboplatin|mesh-list
15004775|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15004776|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004777|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
15004778|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
15004779|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
15004780|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004781|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15004782|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15004783|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15004784|NCT01814163|Growth Substances|growth substances|mesh-ancestor
15004785|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004786|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
15004787|NCT01814189|Promethazine|promethazine|mesh-list
15004788|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
15004789|NCT01814189|Sumatriptan|sumatriptan|mesh-list
15004790|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15004791|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15004792|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15004793|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
15004794|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004795|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004796|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004797|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
15004798|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
15004799|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15004800|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
15004801|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
15004802|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15004803|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15004804|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15004805|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15004806|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
15004807|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
15004808|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
15004809|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004810|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
15004811|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
15004812|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15032781|NCT01984372|Insulin|insulin|mesh-list
15032782|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15032783|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032784|NCT01984463|Fentanyl|fentanyl|mesh-list
15032785|NCT01984463|Morphine|morphine|mesh-list
15032786|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15032787|NCT01984463|Narcotics|narcotics|mesh-ancestor
15004813|NCT01814319|Probenecid|probenecid|mesh-list
15004814|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
15004815|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
15004816|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15004817|NCT01814319|Renal Agents|renal agents|mesh-ancestor
15004818|NCT01814410|Ethanol|ethanol|mesh-list
15004819|NCT01814410|Nicotine|nicotine|mesh-list
15004820|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15004821|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
15004822|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004823|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004824|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15004825|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15004826|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
15004827|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004828|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004829|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15004830|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004831|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15004832|NCT01814423|Chloroquine|chloroquine|mesh-list
15004833|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15004834|NCT01814423|Amebicides|amebicides|mesh-ancestor
15004835|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15004836|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15004837|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004838|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
15004839|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15004840|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15004841|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15004842|NCT01814423|Analgesics|analgesics|mesh-ancestor
15004843|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
15004844|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004845|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004846|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15004847|NCT01814423|Filaricides|filaricides|mesh-ancestor
15004848|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
15004849|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
15004850|NCT01814449|Letrozole|letrozole|mesh-list
15004851|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004852|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15004853|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15004854|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004855|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004856|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15004857|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
15004858|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004859|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004860|NCT01814475|Vidarabine|vidarabine|mesh-list
15004861|NCT01814475|Fludarabine|fludarabine|mesh-list
15004862|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
15004863|NCT01814475|Busulfan|busulfan|mesh-list
15004864|NCT01814475|Thiotepa|thiotepa|mesh-list
15004865|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004866|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15004867|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
15004868|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004869|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15004870|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
15004871|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004872|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
15004873|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004874|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
15004875|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15004876|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15004877|NCT01814501|Leucovorin|leucovorin|mesh-list
15004878|NCT01814501|Fluorouracil|fluorouracil|mesh-list
15004879|NCT01814501|Irinotecan|irinotecan|mesh-list
15004880|NCT01814501|Panitumumab|panitumumab|mesh-list
15004881|NCT01814501|Calcium|calcium|mesh-list
15004882|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
15004883|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15004884|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004885|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
15004886|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004887|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15004888|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004889|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15004890|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
15004891|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15004892|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15004893|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524097|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14524098|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524099|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
14524100|NCT03641508|Dexamethasone|dexamethasone|mesh-list
14524101|NCT03641508|Triamcinolone|triamcinolone|mesh-list
14524102|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14524103|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
14524104|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
15004894|NCT01814501|Antidotes|antidotes|mesh-ancestor
15004895|NCT01814501|Protective Agents|protective agents|mesh-ancestor
15004896|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
15004897|NCT01814501|Vitamins|vitamins|mesh-ancestor
15004898|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
15004899|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15004900|NCT01814514|Timolol|timolol|mesh-list
15004901|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15004902|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15004903|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
15004904|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15004905|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004906|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004907|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15004908|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15004909|NCT01814618|Budesonide|budesonide|mesh-list
15004910|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15004911|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15004912|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
15004913|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004914|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004915|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15004916|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
15004917|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
15004918|NCT01814618|Hormones|hormones|mesh-ancestor
15004919|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004920|NCT01814657|Lidocaine|lidocaine|mesh-list
15004921|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
14802082|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14802083|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14802084|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004922|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
15004923|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15004924|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004925|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
15004926|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15004927|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15004928|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15004929|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15004930|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15004931|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004932|NCT01814683|Primaquine|primaquine|mesh-list
15004933|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
15004934|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15004935|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15004936|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004937|NCT01814709|Itraconazole|itraconazole|mesh-list
15004938|NCT01814709|Rifampin|rifampin|mesh-list
15004939|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
15004940|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15004941|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15004942|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15004943|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524105|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524106|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524107|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14524108|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
14524109|NCT03641508|Hormones|hormones|mesh-ancestor
14524110|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14524111|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14524112|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524113|NCT03642262|Guaifenesin|guaifenesin|mesh-list
14524114|NCT03642262|Expectorants|expectorants|mesh-ancestor
14524115|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
14524116|NCT03642457|Bupivacaine|bupivacaine|mesh-list
14524117|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
14524118|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
14524119|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524120|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524121|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
14524122|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524123|NCT03642717|Empagliflozin|empagliflozin|mesh-list
14524124|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14524125|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524126|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15004944|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004945|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15004946|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
15004947|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004948|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004949|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15004950|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15004951|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
15004952|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15004953|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
15004954|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15004955|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15004956|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15004957|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15004958|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15004959|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15004960|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15004961|NCT01814826|Azacitidine|azacitidine|mesh-list
15004962|NCT01814826|Pevonedistat|pevonedistat|mesh-list
15004963|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15004964|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
15004965|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004966|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004967|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004968|NCT01814865|Prednisone|prednisone|mesh-list
15004969|NCT01814865|Anastrozole|anastrozole|mesh-list
15004970|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
15004971|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15004972|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15004973|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
15004974|NCT01814865|Hormones|hormones|mesh-ancestor
15004975|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15004976|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004977|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15004978|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15004979|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15004980|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15004981|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15004982|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15004983|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
15004984|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15004985|NCT01814891|Vitamin A|vitamin a|mesh-list
15004986|NCT01814891|Vitamins|vitamins|mesh-ancestor
15004987|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
15004988|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004989|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
15004990|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15004991|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
15004992|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15004993|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004994|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
15004995|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
15004996|NCT01815021|Calcium|calcium|mesh-list
15004997|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15004998|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15004999|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15005000|NCT01815021|Antacids|antacids|mesh-ancestor
15005001|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005002|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15005003|NCT01815047|Vitamin D|vitamin d|mesh-list
15005004|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
15005005|NCT01815047|Vitamins|vitamins|mesh-ancestor
15005006|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
15005007|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005008|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15005009|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15005010|NCT01815073|Vaccines|vaccines|mesh-list
15005011|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
15005012|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005013|NCT01815125|Ondansetron|ondansetron|mesh-list
15005014|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
15005015|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
15005016|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005017|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005018|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15005019|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
15005020|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
15005021|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15005022|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
15005023|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005024|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005025|NCT01815125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15005026|NCT01815125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15005027|NCT01815125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15005028|NCT01815125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15005029|NCT01815125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15005030|NCT01815203|Caffeine|caffeine|mesh-list
15005031|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15005032|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005033|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15005034|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005035|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005036|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15005037|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15005038|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
15005039|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005040|NCT01815242|Gemcitabine|gemcitabine|mesh-list
15005041|NCT01815242|Paclitaxel|paclitaxel|mesh-list
15005042|NCT01815242|Carboplatin|carboplatin|mesh-list
15005043|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15005044|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005045|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
15005046|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
15005047|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
15005048|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005049|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15005050|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
15005051|NCT01815242|Antiviral Agents|antiviral agents|mesh-ancestor
15005052|NCT01815242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005053|NCT01815242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005054|NCT01815242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15005055|NCT01815242|Immunologic Factors|immunologic factors|mesh-ancestor
15005056|NCT01815242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005057|NCT01815255|Tenofovir|tenofovir|mesh-list
15005058|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
15005059|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005060|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15005061|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15005062|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005063|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005064|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15005065|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15005066|NCT01815268|Vaccines|vaccines|mesh-list
15005067|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
15005068|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005069|NCT01815294|Doxorubicin|doxorubicin|mesh-list
15005070|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15005071|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15005072|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005073|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15005074|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15005075|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005076|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005077|NCT01815307|Gemcitabine|gemcitabine|mesh-list
15005078|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15005079|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
15005080|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005081|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005082|NCT01815307|Antiviral Agents|antiviral agents|mesh-ancestor
15005083|NCT01815307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005084|NCT01815307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005085|NCT01815307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15005086|NCT01815307|Immunologic Factors|immunologic factors|mesh-ancestor
15005087|NCT01815307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005088|NCT01815359|Leucovorin|leucovorin|mesh-list
15005089|NCT01815359|Mitomycins|mitomycins|mesh-list
15005090|NCT01815359|Mitomycin|mitomycin|mesh-list
15005091|NCT01815359|Antidotes|antidotes|mesh-ancestor
15005092|NCT01815359|Protective Agents|protective agents|mesh-ancestor
15005093|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005094|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
15005095|NCT01815359|Vitamins|vitamins|mesh-ancestor
15005096|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
15005097|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15005098|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005099|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
15005100|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005101|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15005102|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005103|NCT01815437|Vitamin D|vitamin d|mesh-list
15005104|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
15005105|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
15005106|NCT01815437|Vitamins|vitamins|mesh-list
15005107|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
15005108|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005109|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15005110|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15005111|NCT01815528|Catumaxomab|catumaxomab|mesh-list
15005112|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15005113|NCT01815541|Teicoplanin|teicoplanin|mesh-list
15005114|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15005115|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005116|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15005117|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15005118|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15005119|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15005120|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005121|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005122|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
15005123|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802085|NCT00795912|Atorvastatin|atorvastatin|mesh-list
14802086|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14802087|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14802088|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
14802089|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005124|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15005125|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15005126|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
15005127|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15005128|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005129|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15005130|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
15005131|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15005132|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
15005133|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005134|NCT01815892|Furosemide|furosemide|mesh-list
15005135|NCT01815892|Diuretics|diuretics|mesh-ancestor
15005136|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
15005137|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005138|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15005139|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15005140|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005141|NCT01815944|Ropivacaine|ropivacaine|mesh-list
15005142|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
15005143|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
15005144|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15005145|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005146|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
15005147|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032788|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032789|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032790|NCT01984463|Analgesics|analgesics|mesh-ancestor
15032791|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
15032792|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802090|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14802091|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14802092|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802093|NCT00795925|Propiverine|propiverine|mesh-list
14802094|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
14802095|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
14802096|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802097|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802098|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15032793|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15032794|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15032795|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
15032796|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
15032797|NCT01984567|Vitamin E|vitamin e|mesh-list
15032798|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
15005148|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15005149|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005150|NCT01816035|Trastuzumab|trastuzumab|mesh-list
15005151|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15005152|NCT01816035|Maytansine|maytansine|mesh-list
15005153|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
15005154|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15005155|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005156|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15005157|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
15005158|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
15005159|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
15005160|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005161|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
15005162|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005163|NCT01816191|Diltiazem|diltiazem|mesh-list
15005164|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15005165|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15005166|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15005167|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005168|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15005169|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005170|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
15005171|NCT01816321|Ganirelix|ganirelix|mesh-list
15005172|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
15005173|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15005174|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005175|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
15005176|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15005177|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15005178|NCT01816334|Prednisolone|prednisolone|mesh-list
15005179|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
15005180|NCT01816334|Ketoprofen|ketoprofen|mesh-list
15005181|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15005182|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
15005183|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15005184|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
15005185|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
15005186|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005187|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005188|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15005189|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
15005190|NCT01816334|Hormones|hormones|mesh-ancestor
15005191|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15005192|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15005193|NCT01816334|Protective Agents|protective agents|mesh-ancestor
15005194|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15005195|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005196|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15005197|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15005198|NCT01816334|Analgesics|analgesics|mesh-ancestor
15005199|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
15005200|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15005201|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15005202|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005203|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005204|NCT01816412|Paclitaxel|paclitaxel|mesh-list
15005205|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15005206|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005207|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
15005208|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
15005209|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
15005210|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005211|NCT01816490|Silybin|silybin|mesh-list
15005212|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15005213|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005214|NCT01816490|Protective Agents|protective agents|mesh-ancestor
15005215|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005216|NCT01816529|Diltiazem|diltiazem|mesh-list
15005217|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15005218|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15005219|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15005220|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032799|NCT01984567|Vitamins|vitamins|mesh-ancestor
15005221|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15005222|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005223|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
15005224|NCT01816555|Vitamin D|vitamin d|mesh-list
15005225|NCT01816555|Vitamins|vitamins|mesh-ancestor
15005226|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
15005227|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005228|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15005229|NCT01816581|Morphine|morphine|mesh-list
15005230|NCT01816581|Naloxone|naloxone|mesh-list
15005231|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15005232|NCT01816581|Narcotics|narcotics|mesh-ancestor
15005233|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15005234|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005235|NCT01816581|Analgesics|analgesics|mesh-ancestor
15005236|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
15005237|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005238|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15005239|NCT01816620|Dexamethasone|dexamethasone|mesh-list
15005240|NCT01816620|Lenalidomide|lenalidomide|mesh-list
15005241|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15005242|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
15005243|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
15005244|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005245|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005246|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15005247|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
15005248|NCT01816620|Hormones|hormones|mesh-ancestor
15005249|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15005250|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15005251|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005252|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
15005253|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15005254|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15005255|NCT01816620|Growth Substances|growth substances|mesh-ancestor
15005256|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
15005257|NCT01816646|Cidofovir|cidofovir|mesh-list
15005258|NCT01816646|Probenecid|probenecid|mesh-list
15005259|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
15005260|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
15005261|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15005262|NCT01816646|Renal Agents|renal agents|mesh-ancestor
15005263|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
15005264|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005265|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005266|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005267|NCT01816659|Metformin|metformin|mesh-list
15005268|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15005269|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005270|NCT01816789|Buserelin|buserelin|mesh-list
15005271|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15005272|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
15005273|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15005274|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005275|NCT01816958|Ketamine|ketamine|mesh-list
15005276|NCT01816958|Analgesics|analgesics|mesh-ancestor
15005277|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
15005278|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005279|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005280|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15005281|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15005282|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
15005283|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
15005284|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15005285|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15005286|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15005287|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005288|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005289|NCT01816971|Dexamethasone|dexamethasone|mesh-list
15005290|NCT01816971|Lenalidomide|lenalidomide|mesh-list
15005291|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15005292|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
15005293|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
15005294|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005295|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005296|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15005297|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
15005298|NCT01816971|Hormones|hormones|mesh-ancestor
15005299|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15005300|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15005301|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005302|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
15005303|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15005304|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15005305|NCT01816971|Growth Substances|growth substances|mesh-ancestor
15005306|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
15005307|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15005308|NCT01816997|Pravastatin|pravastatin|mesh-list
15005309|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15005310|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15005311|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
15005312|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005313|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15005314|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15005315|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005316|NCT01817023|Cisplatin|cisplatin|mesh-list
15005317|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005318|NCT01817036|Vitamin D|vitamin d|mesh-list
15005319|NCT01817036|Vitamins|vitamins|mesh-ancestor
15005320|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
15005321|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005322|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15005323|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
15005324|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15005325|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14802099|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14802100|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
14802101|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802102|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802103|NCT00795925|Urological Agents|urological agents|mesh-ancestor
14802104|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
14802105|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
14802106|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14802107|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14802108|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802109|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802110|NCT00795938|Urological Agents|urological agents|mesh-ancestor
14802111|NCT00795977|Picibanil|picibanil|mesh-list
14802112|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802113|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14802114|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14802115|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14802116|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802117|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802118|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802119|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14802120|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14802121|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
14802122|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802123|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802124|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14802125|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14802126|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
14802127|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14802128|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14802129|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14802130|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802131|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802132|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802133|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14802134|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14802135|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
14802136|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802137|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802138|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14802139|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14802140|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
14802141|NCT00796159|Olmesartan|olmesartan|mesh-list
15005326|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15005327|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15005328|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
15005329|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15005330|NCT01817257|Heparin|heparin|mesh-list
15005331|NCT01817257|Enoxaparin|enoxaparin|mesh-list
15005332|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15005333|NCT01817257|Tinzaparin|tinzaparin|mesh-list
15005334|NCT01817257|Dalteparin|dalteparin|mesh-list
15005335|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
15005336|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15005337|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15005338|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005339|NCT01817283|Triptolide|triptolide|mesh-list
14802142|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
15005340|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
15005341|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032800|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
15005342|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15005343|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
15005344|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15005345|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15005346|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
15005347|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15005348|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
15005349|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005350|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005351|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
15005352|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
15005353|NCT01817322|Prednisolone|prednisolone|mesh-list
15005354|NCT01817322|Deflazacort|deflazacort|mesh-list
15005355|NCT01817322|Basiliximab|basiliximab|mesh-list
15005356|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15005357|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
15005358|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
15005359|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005360|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005361|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15005362|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
15005363|NCT01817322|Hormones|hormones|mesh-ancestor
15005364|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15005365|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15005366|NCT01817322|Protective Agents|protective agents|mesh-ancestor
15005367|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15005368|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005369|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15005370|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15005371|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
15005372|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15005373|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005374|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005375|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005376|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15005377|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
15005378|NCT01817348|Lidocaine|lidocaine|mesh-list
15005379|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
15005380|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
15005381|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15005382|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005383|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
15005384|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005385|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15005386|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15005387|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15005388|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15005389|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005390|NCT01817400|Aspirin|aspirin|mesh-list
15005391|NCT01817400|Pioglitazone|pioglitazone|mesh-list
15005392|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
15005393|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15005394|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15005395|NCT01817400|Analgesics|analgesics|mesh-ancestor
15005396|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
15005397|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005398|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005399|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15005400|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15005401|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15005402|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15005403|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005404|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15005405|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15005406|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005407|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
15005408|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15005409|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15005410|NCT01817439|Amiodarone|amiodarone|mesh-list
15005411|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15005412|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
15005413|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15005414|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15005415|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005416|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15005417|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15005418|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15005419|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005420|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15005421|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15005422|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15005423|NCT01817452|Paclitaxel|paclitaxel|mesh-list
15005424|NCT01817452|Trastuzumab|trastuzumab|mesh-list
15005425|NCT01817452|Pertuzumab|pertuzumab|mesh-list
15005426|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15005427|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005428|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
15005429|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
15005430|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
15005431|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005432|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15032801|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032802|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
15032803|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032804|NCT01984567|Protective Agents|protective agents|mesh-ancestor
15032805|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
15032806|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15032807|NCT01984606|Empagliflozin|empagliflozin|mesh-list
15032808|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15032809|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032810|NCT01984606|Incretins|incretins|mesh-ancestor
15032811|NCT01984606|Hormones|hormones|mesh-ancestor
15032812|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15032813|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15032814|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
15032815|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032816|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032817|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15032818|NCT01984749|Febuxostat|febuxostat|mesh-list
15032819|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
15032820|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15035427|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035428|NCT02001428|Piperaquine|piperaquine|mesh-list
15035429|NCT02001428|Artenimol|artenimol|mesh-list
15035430|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
15035431|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15035432|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15035433|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15035434|NCT02001506|Docetaxel|docetaxel|mesh-list
15035435|NCT02001506|Epirubicin|epirubicin|mesh-list
15035436|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035437|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
15035438|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
15035439|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
15035440|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035441|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15035442|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15035443|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15035444|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035445|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
15035446|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035447|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15035448|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035449|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035450|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
15035451|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035452|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035453|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15035454|NCT02001584|Memantine|memantine|mesh-list
15035455|NCT02001584|Baclofen|baclofen|mesh-list
15035456|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15035457|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15035458|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
15035459|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035460|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035461|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035462|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15005433|NCT01817699|Vitamin D|vitamin d|mesh-list
15005434|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
15005435|NCT01817699|Vitamins|vitamins|mesh-ancestor
15005436|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
15005437|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005438|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15005439|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15005440|NCT01817803|Metolazone|metolazone|mesh-list
15005441|NCT01817803|Furosemide|furosemide|mesh-list
15005442|NCT01817803|Spironolactone|spironolactone|mesh-list
15005443|NCT01817803|Diuretics|diuretics|mesh-ancestor
15005444|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
15005445|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005446|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15005447|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15005448|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005449|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15005450|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
15005451|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15005452|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15005453|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15005454|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15005455|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15005456|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15005457|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15005458|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005459|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005460|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15005461|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15005462|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005463|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
15005464|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005465|NCT01817829|Acetaminophen|acetaminophen|mesh-list
15005466|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15005467|NCT01817829|Analgesics|analgesics|mesh-ancestor
15005468|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
15005469|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005470|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005471|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
15005472|NCT01817868|Factor VIII|factor viii|mesh-list
15005473|NCT01817868|Coagulants|coagulants|mesh-ancestor
15005474|NCT01817894|Eflornithine|eflornithine|mesh-list
15005475|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005476|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15005477|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15005478|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15005479|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005480|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
15005481|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005482|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005483|NCT01817972|Azathioprine|azathioprine|mesh-list
15005484|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
15005485|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
15005486|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005487|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15005488|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005489|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15005490|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
15005491|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005492|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15005493|NCT01817985|Velpatasvir|velpatasvir|mesh-list
15005494|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
15005495|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005496|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15005497|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
15005498|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005499|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
15005500|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15005501|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005502|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15005503|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005504|NCT01818375|Anesthetics|anesthetics|mesh-list
15005505|NCT01818375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15005506|NCT01818375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005507|NCT01818648|Exenatide|exenatide|mesh-list
15005508|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15032821|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
15005509|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005510|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15005511|NCT01818648|Incretins|incretins|mesh-ancestor
15005512|NCT01818648|Hormones|hormones|mesh-ancestor
15005513|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15005514|NCT01818713|Doxorubicin|doxorubicin|mesh-list
15005515|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15005516|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15005517|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005518|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15005519|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15005520|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005521|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005522|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
15005523|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
15005524|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005525|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
15005526|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005527|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005528|NCT01818856|Ritonavir|ritonavir|mesh-list
15005529|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15005530|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15005531|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14524127|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524128|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
14524129|NCT03642873|Hydrocodone|hydrocodone|mesh-list
14524130|NCT03642873|Guaifenesin|guaifenesin|mesh-list
14524131|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14524132|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14524133|NCT03642873|Narcotics|narcotics|mesh-ancestor
14524134|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524135|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524136|NCT03642873|Analgesics|analgesics|mesh-ancestor
14524137|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
14524138|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524139|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
14524140|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
15005532|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
15005533|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005534|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005535|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15005536|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15005537|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
15005538|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005539|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15005540|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15005541|NCT01818869|Adenosine|adenosine|mesh-list
15005542|NCT01818869|Analgesics|analgesics|mesh-ancestor
15005543|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
15005544|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005545|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005546|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15005547|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
15005548|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15005549|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
15005550|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
15005551|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005552|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005553|NCT01818908|Prednisone|prednisone|mesh-list
15005554|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
15005555|NCT01818908|Doxorubicin|doxorubicin|mesh-list
15005556|NCT01818908|Etoposide|etoposide|mesh-list
15005557|NCT01818908|Vincristine|vincristine|mesh-list
15005558|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15005559|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
15005560|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005561|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15005562|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15005563|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
15005564|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005565|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005566|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15005567|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15005568|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15005569|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15005570|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005571|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15005572|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
15005573|NCT01818908|Hormones|hormones|mesh-ancestor
15005574|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15005575|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15005576|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15005577|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
15005578|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
15005579|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
15005580|NCT01818973|Bevacizumab|bevacizumab|mesh-list
15005581|NCT01818973|Capecitabine|capecitabine|mesh-list
15005582|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
15005583|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15005584|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005585|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15005586|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15005587|NCT01818973|Growth Substances|growth substances|mesh-ancestor
15005588|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005589|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
15005590|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15005591|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
15005592|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005593|NCT01819012|Isoflurane|isoflurane|mesh-list
15005594|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15005595|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
15005596|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
15005597|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15005598|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005599|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
15005600|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15005601|NCT01819064|Atropine|atropine|mesh-list
15005602|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15005603|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15005604|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15005605|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
15005606|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005607|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005608|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15005609|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
15005610|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
15005611|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
15005612|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15005613|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15005614|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
15005615|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005616|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005617|NCT01819155|Vaccines|vaccines|mesh-list
15005618|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
15005619|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005620|NCT01819220|Amlodipine|amlodipine|mesh-list
15005621|NCT01819220|Valsartan|valsartan|mesh-list
15005622|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15005623|NCT01819220|Telmisartan|telmisartan|mesh-list
15005624|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
15005625|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
15005626|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15005627|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15005628|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15005629|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005630|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15005631|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005632|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
15005633|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15005634|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15005635|NCT01819220|Diuretics|diuretics|mesh-ancestor
15005636|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
15005637|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15005638|NCT01819259|Nicotine|nicotine|mesh-list
15005639|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15005640|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
15005641|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005642|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005643|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15005644|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15005645|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
15005646|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005647|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005648|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15005649|NCT01819285|Hormones|hormones|mesh-ancestor
15005650|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15005651|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005652|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
15005653|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005654|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15005655|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005656|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005657|NCT01819402|Pioglitazone|pioglitazone|mesh-list
15005658|NCT01819402|Glimepiride|glimepiride|mesh-list
15005659|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15005660|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005661|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15005662|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15005663|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
15005664|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15005665|NCT01819441|Perindopril|perindopril|mesh-list
15005666|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15005667|NCT01819441|Diuretics|diuretics|mesh-ancestor
15005668|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
15005669|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005670|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15005671|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15005672|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005673|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15005674|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
15005675|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032822|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15032823|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15032824|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15032825|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15032826|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032827|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032828|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032829|NCT01984931|Medazepam|medazepam|mesh-list
15032830|NCT01984931|Metoclopramide|metoclopramide|mesh-list
15032831|NCT01984931|Bromazepam|bromazepam|mesh-list
15032832|NCT01984931|Simethicone|simethicone|mesh-list
15032833|NCT01984931|Trimebutine|trimebutine|mesh-list
15032834|NCT01984931|Mosapride|mosapride|mesh-list
15032835|NCT01984931|Maleic acid|maleic acid|mesh-list
15032836|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032837|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032838|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
15032839|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
15032840|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032841|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032842|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15032843|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15032844|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15032845|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
15032846|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032847|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
15032848|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15032849|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
15032850|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
15032851|NCT01984931|Emollients|emollients|mesh-ancestor
15032852|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
15032853|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15032854|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15032855|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032856|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15032857|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
15032858|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
15032859|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
15032860|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15032861|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15032862|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15032863|NCT01985061|Busulfan|busulfan|mesh-list
15032864|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
15032865|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032866|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15032867|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
15032868|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005676|NCT01819610|Ketorolac|ketorolac|mesh-list
15005677|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15005678|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15005679|NCT01819610|Analgesics|analgesics|mesh-ancestor
15005680|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
15005681|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005682|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005683|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15005684|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15005685|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15005686|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005687|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005688|NCT01819649|Selenium|selenium|mesh-list
15005689|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
15005690|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005691|NCT01819649|Protective Agents|protective agents|mesh-ancestor
15005692|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005693|NCT01819649|Trace Elements|trace elements|mesh-ancestor
15005694|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
15005695|NCT01819701|Ubiquinone|ubiquinone|mesh-list
15005696|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
15005697|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
15005698|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005699|NCT01819701|Vitamins|vitamins|mesh-ancestor
15005700|NCT01819779|Amlodipine|amlodipine|mesh-list
15005701|NCT01819779|Valsartan|valsartan|mesh-list
15005702|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
15005703|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15005704|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15005705|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15005706|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005707|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15005708|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005709|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
15005710|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15005711|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15005712|NCT01819857|Ondansetron|ondansetron|mesh-list
15005713|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
15005714|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
15005715|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005716|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005717|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15005718|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
15005719|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
15005720|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15005721|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
15005722|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005723|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005724|NCT01819857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15005725|NCT01819857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15005726|NCT01819857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15005727|NCT01819857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15005728|NCT01819857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15005729|NCT01819870|Carvedilol|carvedilol|mesh-list
15005730|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15005731|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15005732|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
15005733|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005734|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005735|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005736|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15005737|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
15005738|NCT01819870|Protective Agents|protective agents|mesh-ancestor
15005739|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15005740|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15005741|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15005742|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
15005743|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15005744|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15005745|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
15005746|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15005747|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15005748|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15005749|NCT01820026|Amoxicillin|amoxicillin|mesh-list
15005750|NCT01820026|Azithromycin|azithromycin|mesh-list
15005751|NCT01820026|Vancomycin|vancomycin|mesh-list
15005752|NCT01820026|Imipenem|imipenem|mesh-list
15005753|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15005754|NCT01820026|Cefotaxime|cefotaxime|mesh-list
15005755|NCT01820026|Cefoxitin|cefoxitin|mesh-list
15005756|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15005757|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005758|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15005759|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005760|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005761|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
15005762|NCT01820091|Antidotes|antidotes|mesh-ancestor
15005763|NCT01820091|Protective Agents|protective agents|mesh-ancestor
15005764|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005765|NCT01820104|Lansoprazole|lansoprazole|mesh-list
15005766|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
15005767|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15005768|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15005769|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15005770|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005771|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005772|NCT01820143|Esomeprazole|esomeprazole|mesh-list
15005773|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15005774|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15005775|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15005776|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005777|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005778|NCT01820299|Vitamin D|vitamin d|mesh-list
15005779|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
15005780|NCT01820299|Vitamins|vitamins|mesh-ancestor
15005781|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
15005782|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005783|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15005784|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15005785|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005786|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
15005787|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005788|NCT01820299|Protective Agents|protective agents|mesh-ancestor
15005789|NCT01820312|Paclitaxel|paclitaxel|mesh-list
15005790|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15005791|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005792|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
15005793|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
15005794|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
15005795|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005796|NCT01820325|Paclitaxel|paclitaxel|mesh-list
15005797|NCT01820325|Carboplatin|carboplatin|mesh-list
15005798|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15005799|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005800|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
15005801|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
15005802|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
15005803|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005804|NCT01820442|Lofexidine|lofexidine|mesh-list
15005805|NCT01820442|Clonidine|clonidine|mesh-list
15005806|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15005807|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15005808|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005809|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
15005810|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005811|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15005812|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15005813|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15005814|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
15005815|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005816|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005817|NCT01820442|Analgesics|analgesics|mesh-ancestor
15005818|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
15005819|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
15005820|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
15005821|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15005822|NCT01820455|Mupirocin|mupirocin|mesh-list
15005823|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15005824|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005825|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
15005826|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
15005827|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15005828|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15005829|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005830|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005831|NCT01820624|Tretinoin|tretinoin|mesh-list
15005832|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
15005833|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
15005834|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15005835|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005836|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005837|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
15005838|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15005839|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15005840|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005841|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005842|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
15005843|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
15005844|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
15005845|NCT01820767|Atorvastatin|atorvastatin|mesh-list
15005846|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15005847|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15005848|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
15005849|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005850|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15005851|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15005852|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005853|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15005854|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005855|NCT01820767|Vitamins|vitamins|mesh-ancestor
15005856|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
15005857|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15005858|NCT01820793|Cefoxitin|cefoxitin|mesh-list
15005859|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15005860|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005861|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
15005862|NCT01820832|Calcitriol|calcitriol|mesh-list
15005863|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15005864|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005865|NCT01820832|Vitamins|vitamins|mesh-ancestor
15005866|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
15005867|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15005868|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15005869|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15005870|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005871|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15005872|NCT01820858|Paclitaxel|paclitaxel|mesh-list
15005873|NCT01820858|Carboplatin|carboplatin|mesh-list
15005874|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15005875|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005876|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
15005877|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
15005878|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
15005879|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005880|NCT01820897|Trimethoprim|trimethoprim|mesh-list
15005881|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15005882|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
15005883|NCT01820897|Fosfomycin|fosfomycin|mesh-list
15005884|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15005885|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005886|NCT01820897|Renal Agents|renal agents|mesh-ancestor
15005887|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
15005888|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15005889|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15005890|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15005891|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005892|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005893|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15005894|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15005895|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15005896|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15005897|NCT01820910|Doxycycline|doxycycline|mesh-list
15005898|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15005899|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005900|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
15005901|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15005902|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15005903|NCT01820962|Heparin|heparin|mesh-list
15005904|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
15005905|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005906|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15005907|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15032869|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14524141|NCT03642873|Expectorants|expectorants|mesh-ancestor
14524142|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14524143|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14524144|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
14524145|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524146|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524147|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
14524148|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14524149|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
14524150|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
14524151|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
14524152|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14524153|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
14524154|NCT03643575|Guaifenesin|guaifenesin|mesh-list
14524155|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
14524156|NCT03643575|Expectorants|expectorants|mesh-ancestor
14524157|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
14524158|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15005908|NCT01821001|Bromocriptine|bromocriptine|mesh-list
15005909|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15005910|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15005911|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
15005912|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15005913|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005914|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
15005915|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
15005916|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005917|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005918|NCT01821027|Canagliflozin|canagliflozin|mesh-list
15005919|NCT01821027|Simvastatin|simvastatin|mesh-list
15005920|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15005921|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15005922|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
15005923|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005924|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15005925|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15005926|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005927|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15005928|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15005929|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005930|NCT01821040|Prednisone|prednisone|mesh-list
15005931|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15005932|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
15005933|NCT01821040|Hormones|hormones|mesh-ancestor
15005934|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15005935|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005936|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15005937|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005938|NCT01821066|Tamoxifen|tamoxifen|mesh-list
15005939|NCT01821066|Palbociclib|palbociclib|mesh-list
15005940|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15005941|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
15005942|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15005943|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005944|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15005945|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005946|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15005947|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15005948|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15005949|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15005950|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005951|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005952|NCT01821170|Methylphenidate|methylphenidate|mesh-list
15005953|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15005954|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005955|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15005956|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15005957|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15005958|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005959|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
15005960|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005961|NCT01821235|Gabapentin|gabapentin|mesh-list
15005962|NCT01821235|Analgesics|analgesics|mesh-ancestor
15005963|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
15005964|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15005965|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005966|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
15005967|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15005968|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15005969|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15005970|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15005971|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15005972|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15005973|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15005974|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005975|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
15005976|NCT01821248|Gemcitabine|gemcitabine|mesh-list
15005977|NCT01821248|Cisplatin|cisplatin|mesh-list
15005978|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15005979|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15005980|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
15005981|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15005982|NCT01821248|Antiviral Agents|antiviral agents|mesh-ancestor
15005983|NCT01821248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005984|NCT01821248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15005985|NCT01821248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15005986|NCT01821248|Immunologic Factors|immunologic factors|mesh-ancestor
15005987|NCT01821248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005988|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
15005989|NCT01821261|Fluorides|fluorides|mesh-list
15005990|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
15005991|NCT01821261|Protective Agents|protective agents|mesh-ancestor
15005992|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15005993|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15005994|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15005995|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
15005996|NCT01821274|Diltiazem|diltiazem|mesh-list
15005997|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15005998|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15005999|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15006000|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006001|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15006002|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006003|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
15006004|NCT01821404|Atorvastatin|atorvastatin|mesh-list
15006005|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15006006|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15006007|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
15006008|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006009|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15006010|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15006011|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006012|NCT01821430|Pregabalin|pregabalin|mesh-list
15006013|NCT01821430|Analgesics|analgesics|mesh-ancestor
15006014|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
15006015|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006016|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006017|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
15006018|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15006019|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15006020|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006021|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15006022|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15006023|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15006024|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006025|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15006026|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
15006027|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
15006028|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
15006029|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15006030|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15006031|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15006032|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15006033|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006034|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
15006035|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006036|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006037|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15006038|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006039|NCT01821612|Leucovorin|leucovorin|mesh-list
15006040|NCT01821612|Gemcitabine|gemcitabine|mesh-list
15006041|NCT01821612|Fluorouracil|fluorouracil|mesh-list
15006042|NCT01821612|Capecitabine|capecitabine|mesh-list
15006043|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
15006044|NCT01821612|Irinotecan|irinotecan|mesh-list
15006045|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15006046|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
15006047|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006048|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006049|NCT01821612|Antiviral Agents|antiviral agents|mesh-ancestor
15006050|NCT01821612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006051|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006052|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15006053|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
15006054|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006055|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15006056|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15006057|NCT01821612|Antidotes|antidotes|mesh-ancestor
15006058|NCT01821612|Protective Agents|protective agents|mesh-ancestor
15006059|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
15006060|NCT01821612|Vitamins|vitamins|mesh-ancestor
15006061|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
15006062|NCT01821664|Heparin|heparin|mesh-list
15006063|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
15006064|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15006065|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15006066|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006067|NCT01821677|Danazol|danazol|mesh-list
15006068|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15006069|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
15006070|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15006071|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006072|NCT01821703|Spironolactone|spironolactone|mesh-list
15006073|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15006074|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
15006075|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15006076|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006077|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15006078|NCT01821703|Diuretics|diuretics|mesh-ancestor
15006079|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
15006080|NCT01821846|Liraglutide|liraglutide|mesh-list
15006081|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15006082|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006083|NCT01821846|Incretins|incretins|mesh-ancestor
15006084|NCT01821846|Hormones|hormones|mesh-ancestor
15006085|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15006086|NCT01821872|Acetaminophen|acetaminophen|mesh-list
15006087|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15006088|NCT01821872|Analgesics|analgesics|mesh-ancestor
15006089|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
15006090|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006091|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006092|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
15006093|NCT01821989|Lactoferrin|lactoferrin|mesh-list
15006094|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006095|NCT01822015|Cytarabine|cytarabine|mesh-list
15006096|NCT01822015|Sirolimus|sirolimus|mesh-list
15006097|NCT01822015|Idarubicin|idarubicin|mesh-list
15006098|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15006099|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
15006100|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006101|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006102|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
15006103|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006104|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15006105|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
15006106|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006107|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15006108|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15006109|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
15006110|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15006111|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15006112|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006113|NCT01822028|Miglustat|miglustat|mesh-list
15006114|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
15006115|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006116|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006117|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15006118|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15006119|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
15006120|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006121|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15006122|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15006123|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006124|NCT01822080|Dienogest|dienogest|mesh-list
15006125|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15006126|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
15006127|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15006128|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006129|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15006130|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15006131|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15006132|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15006133|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
15006134|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15006135|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15006136|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006137|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
15006138|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15006139|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15006140|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006141|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
15006142|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524159|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15006143|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006144|NCT01822275|Temozolomide|temozolomide|mesh-list
15006145|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15006146|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
15006147|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006148|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006149|NCT01822314|Paclitaxel|paclitaxel|mesh-list
15006150|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15006151|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15006152|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006153|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
15006154|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
15006155|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
15006156|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006157|NCT01822405|Tocopherols|tocopherols|mesh-list
15006158|NCT01822405|Vitamin E|vitamin e|mesh-list
15006159|NCT01822405|Tocotrienols|tocotrienols|mesh-list
15006160|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
15006161|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
15006162|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15006163|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006164|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006165|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15006166|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15006167|NCT01822405|Protective Agents|protective agents|mesh-ancestor
15006168|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006169|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
15006170|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15006171|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
15006172|NCT01822405|Vitamins|vitamins|mesh-ancestor
15006173|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
15006174|NCT01822418|S 20098|s 20098|mesh-list
15006175|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15006176|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006177|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006178|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
15006179|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006180|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006181|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006182|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15006183|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
15006184|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15006185|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006186|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15006187|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
15006188|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15006189|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006190|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006191|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006192|NCT01822509|Nivolumab|nivolumab|mesh-list
15006193|NCT01822509|Ipilimumab|ipilimumab|mesh-list
15006194|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15006195|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006196|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15006197|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006198|NCT01822600|Omeprazole|omeprazole|mesh-list
15006199|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15006200|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15006201|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15006202|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006203|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006204|NCT01822613|Paclitaxel|paclitaxel|mesh-list
15006205|NCT01822613|Docetaxel|docetaxel|mesh-list
15006206|NCT01822613|Irinotecan|irinotecan|mesh-list
15006207|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15006208|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006209|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
15006210|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
15006211|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
15006212|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006213|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15006214|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15006215|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006216|NCT01822639|Amlodipine|amlodipine|mesh-list
15006217|NCT01822639|Enalapril|enalapril|mesh-list
15006218|NCT01822639|Enalaprilat|enalaprilat|mesh-list
15006219|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15006220|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15006221|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15006222|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006223|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15006224|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006225|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
15006226|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006227|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15006228|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
15006229|NCT01822730|Risperidone|risperidone|mesh-list
15006230|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15006231|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15006232|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
15006233|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006234|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006235|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006236|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15006237|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15006238|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006239|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15006240|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15006241|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
15006242|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15006243|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15006244|NCT01822808|Hydralazine|hydralazine|mesh-list
15006245|NCT01822808|Isosorbide|isosorbide|mesh-list
15006246|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15006247|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15006248|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15006249|NCT01822808|Diuretics|diuretics|mesh-ancestor
15006250|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
15006251|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006252|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
15006253|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15006254|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006255|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15006256|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15006257|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
15006258|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15006259|NCT01822860|Diuretics|diuretics|mesh-ancestor
15006260|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
15006261|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006262|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15006263|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15006264|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032870|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032871|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15032872|NCT01985087|Temozolomide|temozolomide|mesh-list
15032873|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15032874|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
15032875|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032876|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032877|NCT01985152|Choline|choline|mesh-list
15032878|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
15032879|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15032880|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15032881|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032882|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
15032883|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15032884|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
15032885|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15032886|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15032887|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
15032888|NCT01985256|Flucytosine|flucytosine|mesh-list
15032889|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
15032890|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15032891|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
15032892|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032893|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
15032894|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15032895|NCT01985373|Antibodies|antibodies|mesh-list
15032896|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
15032897|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15032898|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
15032899|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032900|NCT01985451|Temozolomide|temozolomide|mesh-list
15032901|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15032902|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
15032903|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032904|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032905|NCT01985477|Dexamethasone|dexamethasone|mesh-list
15032906|NCT01985477|Lenalidomide|lenalidomide|mesh-list
15032907|NCT01985477|Tretinoin|tretinoin|mesh-list
15032908|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15032909|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
15032910|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
15032911|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032912|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032913|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15032914|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
15032915|NCT01985477|Hormones|hormones|mesh-ancestor
15032916|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15032917|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15032918|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032919|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
15032920|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15032921|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15032922|NCT01985477|Growth Substances|growth substances|mesh-ancestor
15032923|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
15032924|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
15032925|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
15032926|NCT01985594|Nifedipine|nifedipine|mesh-list
15032927|NCT01985594|Progesterone|progesterone|mesh-list
15032928|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15032929|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15032930|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032931|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15006265|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
15006266|NCT01822951|Donepezil|donepezil|mesh-list
15006267|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15006268|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006269|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006270|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
15006271|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006272|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006273|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
15006274|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15006275|NCT01822951|Protective Agents|protective agents|mesh-ancestor
15006276|NCT01822977|Omeprazole|omeprazole|mesh-list
15006277|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15006278|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15006279|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15006280|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006281|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006282|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
15006283|NCT01823029|Hematinics|hematinics|mesh-ancestor
15006284|NCT01823042|Azathioprine|azathioprine|mesh-list
15006285|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
15006286|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006287|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15006288|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006289|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15006290|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
15006291|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006292|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15006293|NCT01823081|Bevacizumab|bevacizumab|mesh-list
15006294|NCT01823081|Fasudil|fasudil|mesh-list
15006295|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15006296|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006297|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15006298|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15006299|NCT01823081|Growth Substances|growth substances|mesh-ancestor
15006300|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006301|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
15006302|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15006303|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15006304|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006305|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15006306|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
15006307|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15006308|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006309|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15006310|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15006311|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15006312|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
14524160|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
14524161|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524162|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524163|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524164|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
14524165|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14524166|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
14524167|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
14524168|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524169|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
15006313|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006314|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15006315|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15006316|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006317|NCT01823159|Ezogabine|ezogabine|mesh-list
15006318|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
15006319|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15006320|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006321|NCT01823172|Methylene Blue|methylene blue|mesh-list
15006322|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006323|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006324|NCT01823185|Clopidogrel|clopidogrel|mesh-list
15006325|NCT01823185|Ticagrelor|ticagrelor|mesh-list
15006326|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14524170|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15006327|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15006328|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15006329|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15006330|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15006331|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
15006332|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006333|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006334|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006335|NCT01823198|Aldesleukin|aldesleukin|mesh-list
15006336|NCT01823198|Fludarabine|fludarabine|mesh-list
15006337|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
15006338|NCT01823198|Busulfan|busulfan|mesh-list
15006339|NCT01823198|Interleukin-2|interleukin-2|mesh-list
15006340|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006341|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15006342|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
15006343|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006344|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15006345|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
15006346|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006347|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
15006348|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15006349|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15006350|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15006351|NCT01823198|Analgesics|analgesics|mesh-ancestor
15006352|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
15006353|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006354|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15006355|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15006356|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
15006357|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006358|NCT01823393|Heparin|heparin|mesh-list
15006359|NCT01823393|Calcium heparin|calcium heparin|mesh-list
15006360|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
15006361|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15006362|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15006363|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006364|NCT01823523|Clindamycin|clindamycin|mesh-list
15006365|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
15006366|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
15006367|NCT01823523|Cefazolin|cefazolin|mesh-list
15006368|NCT01823523|Cephalexin|cephalexin|mesh-list
15006369|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15006370|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006371|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15006372|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006373|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006374|NCT01823744|Micronutrients|micronutrients|mesh-list
15006375|NCT01823744|Trace Elements|trace elements|mesh-list
15006376|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006377|NCT01823770|Rotigotine|rotigotine|mesh-list
15006378|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
15006379|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
15006380|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006381|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006382|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006383|NCT01823809|Adenosine|adenosine|mesh-list
15006384|NCT01823809|Analgesics|analgesics|mesh-ancestor
15006385|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
15006386|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006387|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006388|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15006389|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
15006390|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15006391|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
15006392|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
15006393|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006394|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006395|NCT01823848|Mineral Oil|mineral oil|mesh-list
15006396|NCT01823848|Emollients|emollients|mesh-ancestor
15006397|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
15006398|NCT01823965|Ranibizumab|ranibizumab|mesh-list
15006399|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15006400|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15006401|NCT01823965|Growth Substances|growth substances|mesh-ancestor
15006402|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006403|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
15006404|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006405|NCT01824043|Ranibizumab|ranibizumab|mesh-list
15006406|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15006407|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15006408|NCT01824043|Growth Substances|growth substances|mesh-ancestor
15006409|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006410|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
15006411|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006412|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15006413|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15006414|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006415|NCT01824199|Omeprazole|omeprazole|mesh-list
14524171|NCT03643952|Daptomycin|daptomycin|mesh-list
14524172|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14524173|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524174|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
14524175|NCT03644095|Guaifenesin|guaifenesin|mesh-list
14524176|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
15006416|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14524177|NCT03644095|Expectorants|expectorants|mesh-ancestor
15006417|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15006418|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15006419|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006420|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006421|NCT01824225|Aflibercept|aflibercept|mesh-list
15006422|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15006423|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15006424|NCT01824225|Growth Substances|growth substances|mesh-ancestor
15006425|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006426|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
15006427|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006428|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
15006429|NCT01824238|Anacetrapib|anacetrapib|mesh-list
15006430|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15006431|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15006432|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
15006433|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006434|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15006435|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006436|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15006437|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802143|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14802144|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14802145|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14802146|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802147|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14802148|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14802149|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14802150|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802151|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802152|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802153|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14802154|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14802155|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
14802156|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006438|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
15006439|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15006440|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
15006441|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15006442|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
15006443|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006444|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15006445|NCT01824264|Licogliflozin|licogliflozin|mesh-list
15006446|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15006447|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006448|NCT01824264|Incretins|incretins|mesh-ancestor
15006449|NCT01824264|Hormones|hormones|mesh-ancestor
15006450|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15006451|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15006452|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
15006453|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006454|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006455|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15006456|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
15006457|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
15006458|NCT01824420|Oxybutynin|oxybutynin|mesh-list
15006459|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15006460|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15006461|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
15006462|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006463|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006464|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006465|NCT01824420|Urological Agents|urological agents|mesh-ancestor
15006466|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
15006467|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
15006468|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006469|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15006470|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006471|NCT01824420|Renal Agents|renal agents|mesh-ancestor
15006472|NCT01824433|Fluoxetine|fluoxetine|mesh-list
15006473|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15006474|NCT01824433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15006475|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15006476|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15006477|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006478|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006479|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
15006480|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006481|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15006482|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
15006483|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15006484|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15006485|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15006486|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006487|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15006488|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
15006489|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006490|NCT01824524|Hydromorphone|hydromorphone|mesh-list
15006491|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15006492|NCT01824524|Narcotics|narcotics|mesh-ancestor
15006493|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006494|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006495|NCT01824524|Analgesics|analgesics|mesh-ancestor
15006496|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
15006497|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006498|NCT01824615|Sunitinib|sunitinib|mesh-list
15006499|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006500|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15006501|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15006502|NCT01824615|Growth Substances|growth substances|mesh-ancestor
15006503|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006504|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
15006505|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15006506|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006507|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032932|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032933|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
15032934|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
15032935|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15032936|NCT01985594|Progestins|progestins|mesh-ancestor
15032937|NCT01985594|Hormones|hormones|mesh-ancestor
15006508|NCT01824758|Lidocaine|lidocaine|mesh-list
15006509|NCT01824758|Rocuronium|rocuronium|mesh-list
15006510|NCT01824758|Esmolol|esmolol|mesh-list
15006511|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
15006512|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
15006513|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006514|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006515|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
15006516|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006517|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15006518|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15006519|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15006520|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15006521|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006522|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15006523|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15006524|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15006525|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15006526|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15006527|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15006528|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
15006529|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006530|NCT01824836|Anastrozole|anastrozole|mesh-list
15006531|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15006532|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006533|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15006534|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15006535|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006536|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006537|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15006538|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
15006539|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15006540|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006541|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
15006542|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15006543|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15006544|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15006545|NCT01824992|Interferons|interferons|mesh-list
15006546|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006547|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
15006548|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006549|NCT01825031|Azithromycin|azithromycin|mesh-list
15006550|NCT01825031|Isoniazid|isoniazid|mesh-list
15006551|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
15006552|NCT01825031|Fluconazole|fluconazole|mesh-list
15006553|NCT01825031|Albendazole|albendazole|mesh-list
15006554|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15006555|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006556|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15006557|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15006558|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
15006559|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15006560|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15006561|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006562|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006563|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
15006564|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15006565|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15006566|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15006567|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
15006568|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15006569|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006570|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15006571|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15006572|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
15006573|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15006574|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15006575|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
15006576|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15006577|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
15006578|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15006579|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
15006580|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15006581|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15006582|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
15006583|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
15006584|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
15006585|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006586|NCT01825044|Cyclosporine|cyclosporine|mesh-list
15006587|NCT01825044|Cyclosporins|cyclosporins|mesh-list
15006588|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006589|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006590|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15006591|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
15006592|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006593|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
15006594|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006595|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
15006596|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15006597|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15006598|NCT01825083|Ketamine|ketamine|mesh-list
15006599|NCT01825083|Analgesics|analgesics|mesh-ancestor
15006600|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
15006601|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006602|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006603|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15006604|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15006605|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
15006606|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
15006607|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006608|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15006609|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15006610|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006611|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006612|NCT01825109|Vaccines|vaccines|mesh-list
15006613|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
15006614|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006615|NCT01825395|Amifampridine|amifampridine|mesh-list
15006616|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15006617|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006618|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006619|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15006620|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15006621|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006622|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15006623|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006624|NCT01825447|Naltrexone|naltrexone|mesh-list
15006625|NCT01825447|Oxycodone|oxycodone|mesh-list
15006626|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15006627|NCT01825447|Narcotics|narcotics|mesh-ancestor
15006628|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006629|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006630|NCT01825447|Analgesics|analgesics|mesh-ancestor
15006631|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
15006632|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006633|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15006634|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15006635|NCT01825473|Erythromycin|erythromycin|mesh-list
15006636|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
15006637|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15006638|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
15006639|NCT01825473|Phenobarbital|phenobarbital|mesh-list
15006640|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15006641|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006642|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15006643|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15006644|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006645|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006646|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
15006647|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15006648|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006649|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006650|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15006651|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15006652|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006653|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
15006654|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
15006655|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15006656|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15006657|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15006658|NCT01825551|Sargramostim|sargramostim|mesh-list
15006659|NCT01825551|Lenograstim|lenograstim|mesh-list
15006660|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
15006661|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006662|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15006663|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
15006664|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15006665|NCT01825603|Gemcitabine|gemcitabine|mesh-list
14802157|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802158|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14802159|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14802160|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
14802161|NCT00796198|Latanoprost|latanoprost|mesh-list
14802162|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14802163|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14802164|NCT00796211|Nortriptyline|nortriptyline|mesh-list
14802165|NCT00796211|Calcipotriene|calcipotriene|mesh-list
14802166|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
14802167|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14802168|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
14802169|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802170|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14802171|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14802172|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14802173|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802174|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
14802175|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006666|NCT01825603|Cisplatin|cisplatin|mesh-list
15006667|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006668|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15006669|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
15006670|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006671|NCT01825603|Antiviral Agents|antiviral agents|mesh-ancestor
15006672|NCT01825603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006673|NCT01825603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006674|NCT01825603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15006675|NCT01825603|Immunologic Factors|immunologic factors|mesh-ancestor
15006676|NCT01825603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006677|NCT01825616|Vitamin D|vitamin d|mesh-list
15006678|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
15006679|NCT01825616|Vitamins|vitamins|mesh-ancestor
15006680|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
15006681|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006682|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15006683|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15006684|NCT01825720|Insulin|insulin|mesh-list
15006685|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15006686|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006687|NCT01825733|Palonosetron|palonosetron|mesh-list
15006688|NCT01825733|Ramosetron|ramosetron|mesh-list
15006689|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
15006690|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
15006691|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006692|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802176|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802177|NCT00796250|Prednisolone|prednisolone|mesh-list
14802178|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14802179|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
14802180|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14802181|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
14802182|NCT00796250|Azathioprine|azathioprine|mesh-list
14802183|NCT00796250|Infliximab|infliximab|mesh-list
14802184|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14802185|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
14802186|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14802187|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
14802188|NCT00796250|Hormones|hormones|mesh-ancestor
14802189|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14802190|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802191|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14802192|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802193|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
14802194|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
15006693|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15006694|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15006695|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15006696|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
15006697|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006698|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006699|NCT01825850|Irbesartan|irbesartan|mesh-list
15006700|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15006701|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15006702|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15006703|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006704|NCT01825863|Ropivacaine|ropivacaine|mesh-list
15006705|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
15006706|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
15006707|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006708|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006709|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
15006710|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006711|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15006712|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15006713|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006714|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15006715|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15006716|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15006717|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006718|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006719|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15006720|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15006721|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15006722|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
14524178|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
14524179|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14524180|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14524181|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
14524182|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524183|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524184|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524185|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
14524186|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14524187|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
14524188|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
14524189|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524190|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
14524191|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14524192|NCT03644108|Guaifenesin|guaifenesin|mesh-list
14524193|NCT03644108|Expectorants|expectorants|mesh-ancestor
14524194|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
14524195|NCT03644212|Vitamin D|vitamin d|mesh-list
14524196|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
14524197|NCT03644212|Vitamins|vitamins|mesh-list
14524198|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
14524199|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524200|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14524201|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14802195|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006723|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006724|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006725|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15006726|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15006727|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
15006728|NCT01825993|Morphine|morphine|mesh-list
15006729|NCT01825993|Bupivacaine|bupivacaine|mesh-list
15006730|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
15006731|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
15006732|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006733|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006734|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
15006735|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006736|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15006737|NCT01825993|Narcotics|narcotics|mesh-ancestor
15006738|NCT01825993|Analgesics|analgesics|mesh-ancestor
15006739|NCT01826149|Propofol|propofol|mesh-list
15006740|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15006741|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006742|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006743|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15006744|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
15006745|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
15006746|NCT01826175|Clopidogrel|clopidogrel|mesh-list
15006747|NCT01826175|Ticagrelor|ticagrelor|mesh-list
14802196|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14802197|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14802198|NCT00796250|Protective Agents|protective agents|mesh-ancestor
14802199|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
14802200|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14802201|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
15006748|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15006749|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15006750|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15006751|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15006752|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
15006753|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006754|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006755|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006756|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
15006757|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
15006758|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
15006759|NCT01826279|Resveratrol|resveratrol|mesh-list
15006760|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
15006761|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006762|NCT01826279|Protective Agents|protective agents|mesh-ancestor
15006763|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006764|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006765|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15032938|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15032939|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
15032940|NCT01985724|Docetaxel|docetaxel|mesh-list
15032941|NCT01985724|Epirubicin|epirubicin|mesh-list
15032942|NCT01985724|Fluorouracil|fluorouracil|mesh-list
15032943|NCT01985724|Mitogens|mitogens|mesh-list
15032944|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15032945|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
15032946|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032947|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15032948|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15032949|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
15032950|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032951|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15032952|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15032953|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
15032954|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
15032955|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
15032956|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15032957|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15032958|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15032959|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15032960|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
15032961|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15032962|NCT01985750|Cycloserine|cycloserine|mesh-list
15032963|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15032964|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15032965|NCT01985750|Renal Agents|renal agents|mesh-ancestor
15032966|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15032967|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
15032968|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15032969|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
15032970|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032971|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
15032972|NCT01985789|Promethazine|promethazine|mesh-list
14802202|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802203|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15032973|NCT01985789|Cetirizine|cetirizine|mesh-list
15006766|NCT01826396|Irinotecan|irinotecan|mesh-list
15006767|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15006768|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15006769|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006770|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006771|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006772|NCT01826526|Taurolidine|taurolidine|mesh-list
15006773|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006774|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15006775|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006776|NCT01826747|Progesterone|progesterone|mesh-list
15006777|NCT01826747|Progestins|progestins|mesh-ancestor
15006778|NCT01826747|Hormones|hormones|mesh-ancestor
15006779|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15006780|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006781|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
15006782|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006783|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006784|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
15006785|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006786|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006787|NCT01826864|Sargramostim|sargramostim|mesh-list
15006788|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
15006789|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006790|NCT01826916|Ecallantide|ecallantide|mesh-list
15006791|NCT01826916|Analgesics|analgesics|mesh-ancestor
15006792|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
15006793|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006794|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006795|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15006796|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15006797|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15006798|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15006799|NCT01827007|Polygeline|polygeline|mesh-list
15006800|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
15006801|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
15006802|NCT01827020|Lidocaine|lidocaine|mesh-list
15006803|NCT01827020|Ketamine|ketamine|mesh-list
15006804|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
15006805|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
15006806|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006807|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006808|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
15006809|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006810|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15006811|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15006812|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15006813|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15006814|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006815|NCT01827020|Analgesics|analgesics|mesh-ancestor
15006816|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15006817|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15006818|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
15006819|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15006820|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15006821|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006822|NCT01827059|Bosentan|bosentan|mesh-list
15006823|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15006824|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15006825|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006826|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
15006827|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
15006828|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006829|NCT01827124|Oxytocin|oxytocin|mesh-list
15006830|NCT01827124|Carbetocin|carbetocin|mesh-list
15006831|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
15006832|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15006833|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006834|NCT01827137|Lenalidomide|lenalidomide|mesh-list
15006835|NCT01827137|Molgramostim|molgramostim|mesh-list
15006836|NCT01827137|Sargramostim|sargramostim|mesh-list
15006837|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
15006838|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006839|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15006840|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15006841|NCT01827137|Growth Substances|growth substances|mesh-ancestor
15006842|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
15006843|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006844|NCT01827202|Candesartan|candesartan|mesh-list
15006845|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15006846|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15006847|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15006848|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006849|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
15006850|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
15006851|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006852|NCT01827280|Vildagliptin|vildagliptin|mesh-list
15006853|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15006854|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006855|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15006856|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
15006857|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006858|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006859|NCT01827293|Promethazine|promethazine|mesh-list
15006860|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
15006861|NCT01827293|Lorazepam|lorazepam|mesh-list
15006862|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
15006863|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
15006864|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
15006865|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006866|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006867|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15006868|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15006869|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006870|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15006871|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15006872|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15006873|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
15006874|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
15006875|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006876|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006877|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
15006878|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
15006879|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15006880|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
15006881|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
15006882|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15006883|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15006884|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
15006885|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
15006886|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
15006887|NCT01827345|Vitamin D|vitamin d|mesh-list
15006888|NCT01827345|Vitamins|vitamins|mesh-ancestor
14524202|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
15006889|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
15006890|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006891|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15006892|NCT01827384|Carboplatin|carboplatin|mesh-list
15006893|NCT01827384|Everolimus|everolimus|mesh-list
15006894|NCT01827384|Temozolomide|temozolomide|mesh-list
15006895|NCT01827384|Trametinib|trametinib|mesh-list
15006896|NCT01827384|Veliparib|veliparib|mesh-list
14524203|NCT03647709|Narcotics|narcotics|mesh-ancestor
15006897|NCT01827384|Adavosertib|adavosertib|mesh-list
15006898|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006899|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15006900|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
15006901|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006902|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15006903|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
15006904|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006905|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15006906|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006907|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15006908|NCT01827397|Vaccines|vaccines|mesh-list
15006909|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
15006910|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006911|NCT01827540|Dolutegravir|dolutegravir|mesh-list
15006912|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
15006913|NCT01827540|Midazolam|midazolam|mesh-list
15006914|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15006915|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15006916|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15006917|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006918|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15006919|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15006920|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15006921|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15006922|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
15006923|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
15006924|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
15006925|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
15006926|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15006927|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006928|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15006929|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15006930|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006931|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15006932|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15006933|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
15006934|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006935|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15006936|NCT01827553|Gemcitabine|gemcitabine|mesh-list
15006937|NCT01827553|Folfirinox|folfirinox|mesh-list
15006938|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15006939|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
15006940|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006941|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006942|NCT01827553|Antiviral Agents|antiviral agents|mesh-ancestor
15006943|NCT01827553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006944|NCT01827553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006945|NCT01827553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15006946|NCT01827553|Immunologic Factors|immunologic factors|mesh-ancestor
15006947|NCT01827553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006948|NCT01827618|Sirolimus|sirolimus|mesh-list
15006949|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15006950|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006951|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15006952|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006953|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
15006954|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15006955|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
15006956|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006957|NCT01827722|Dexamethasone|dexamethasone|mesh-list
15006958|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
15006959|NCT01827722|Ranibizumab|ranibizumab|mesh-list
15006960|NCT01827722|BB 1101|bb 1101|mesh-list
15006961|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15006962|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
15006963|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
15006964|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006965|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006966|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15006967|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
15006968|NCT01827722|Hormones|hormones|mesh-ancestor
15006969|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15006970|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15006971|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006972|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
15006973|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006974|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006975|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15006976|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15006977|NCT01827722|Growth Substances|growth substances|mesh-ancestor
15006978|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
15006979|NCT01827735|Aldesleukin|aldesleukin|mesh-list
15006980|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15006981|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15006982|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15006983|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
15006984|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15006985|NCT01827865|Etodolac|etodolac|mesh-list
15006986|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15006987|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15006988|NCT01827865|Analgesics|analgesics|mesh-ancestor
15006989|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
15006990|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967932|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13967933|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13967934|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13968247|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13968248|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968249|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
13968250|NCT03112005|Mydriatics|mydriatics|mesh-list
13968251|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
13968252|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15006991|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15006992|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967935|NCT03114215|Biotin|biotin|mesh-list
13967936|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
13967937|NCT03114215|Vitamins|vitamins|mesh-ancestor
13967938|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
13967939|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967940|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13967941|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
13967942|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13967943|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
13967944|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967945|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
13967946|NCT03114020|Protective Agents|protective agents|mesh-ancestor
15006993|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15006994|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15006995|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15006996|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15006997|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15006998|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15006999|NCT01827878|Lisinopril|lisinopril|mesh-list
15007000|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
15007001|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15007002|NCT01827878|Diuretics|diuretics|mesh-ancestor
15007003|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
15007004|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007005|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15007006|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007007|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007008|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15007009|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
15007010|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007011|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15007012|NCT01827878|Protective Agents|protective agents|mesh-ancestor
15032974|NCT01985789|Desloratadine|desloratadine|mesh-list
15032975|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15032976|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15032977|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15032978|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15032979|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
15032980|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
15032981|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
15032982|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15032983|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
15032984|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
15032985|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15032986|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15032987|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
15032988|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
15032989|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15032990|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15032991|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15032992|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
15032993|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
15032994|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15032995|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15032996|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
15032997|NCT01985828|Androgens|androgens|mesh-list
15032998|NCT01985828|Hormones|hormones|mesh-ancestor
15032999|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15033000|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033001|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
15033002|NCT01985841|Docetaxel|docetaxel|mesh-list
15033003|NCT01985841|Fluorouracil|fluorouracil|mesh-list
15033004|NCT01985841|Epirubicin|epirubicin|mesh-list
15033005|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15033006|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
15033007|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033008|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15033009|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15033010|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
15033011|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033012|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033013|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15033014|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
13967947|NCT03113851|Molgramostim|molgramostim|mesh-list
13967948|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007013|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15007014|NCT01828125|Glucagon|glucagon|mesh-list
15007015|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15007016|NCT01828125|Hormones|hormones|mesh-ancestor
15007017|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15007018|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007019|NCT01828203|Minocycline|minocycline|mesh-list
15007020|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15007021|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007022|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
15007023|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15007024|NCT01828294|Antibodies|antibodies|mesh-list
15007025|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
15007026|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007027|NCT01828346|Azacitidine|azacitidine|mesh-list
15007028|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15007029|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
15007030|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007031|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007032|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007033|NCT01828359|Losartan|losartan|mesh-list
15007034|NCT01828359|Amlodipine|amlodipine|mesh-list
15007035|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15007036|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15007037|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007038|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007039|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15007040|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007041|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
15007042|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15007043|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15007044|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15007045|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
15007046|NCT01828385|Analgesics|analgesics|mesh-ancestor
15007047|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
15007048|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007049|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007050|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
15007051|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15007052|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15007053|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
15007054|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15007055|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007056|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007057|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15007058|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
15007059|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15007060|NCT01828437|Pyridoxine|pyridoxine|mesh-list
15007061|NCT01828437|Prednisolone|prednisolone|mesh-list
15007062|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15007063|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
15007064|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15007065|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
15007066|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15007067|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
15007068|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15007069|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
15007070|NCT01828437|Hormones|hormones|mesh-ancestor
15007071|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15007072|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007073|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15007074|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007075|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
15007076|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
15007077|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007078|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15007079|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15007080|NCT01828437|Protective Agents|protective agents|mesh-ancestor
15007081|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
15007082|NCT01828437|Vitamins|vitamins|mesh-ancestor
15007083|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
15007084|NCT01828463|Nitisinone|nitisinone|mesh-list
15007085|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033015|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
15007086|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007087|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
15007088|NCT01828489|Analgesics|analgesics|mesh-ancestor
15007089|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
15007090|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007091|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007092|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007093|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15007094|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15007095|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007096|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007097|NCT01828606|Monensin|monensin|mesh-list
15007098|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
15007099|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007100|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15007101|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15007102|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
15007103|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
15007104|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
15007105|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007106|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007107|NCT01828606|Ionophores|ionophores|mesh-ancestor
15007108|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007109|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
15007110|NCT01828697|Enoxaparin|enoxaparin|mesh-list
15007111|NCT01828697|Dalteparin|dalteparin|mesh-list
15007112|NCT01828697|Tinzaparin|tinzaparin|mesh-list
15007113|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15007114|NCT01828697|Nadroparin|nadroparin|mesh-list
15007115|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
15007116|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
15007117|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15007118|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15007119|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007120|NCT01828710|Folic Acid|folic acid|mesh-list
15007121|NCT01828710|Inositol|inositol|mesh-list
15007122|NCT01828710|Hematinics|hematinics|mesh-ancestor
15007123|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
15007124|NCT01828710|Vitamins|vitamins|mesh-ancestor
15007125|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
15007126|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007127|NCT01828736|Gemcitabine|gemcitabine|mesh-list
15007128|NCT01828736|Cisplatin|cisplatin|mesh-list
15007129|NCT01828736|Carboplatin|carboplatin|mesh-list
15007130|NCT01828736|Trastuzumab|trastuzumab|mesh-list
15007131|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007132|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15007133|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
15007134|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007135|NCT01828736|Antiviral Agents|antiviral agents|mesh-ancestor
15007136|NCT01828736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007137|NCT01828736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007138|NCT01828736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15007139|NCT01828736|Immunologic Factors|immunologic factors|mesh-ancestor
15007140|NCT01828736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524204|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524205|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524206|NCT03647709|Analgesics|analgesics|mesh-ancestor
14524207|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
14524208|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524209|NCT03649477|Carbetocin|carbetocin|mesh-list
14524210|NCT03649477|Oxytocin|oxytocin|mesh-list
14524211|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
14524212|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14524213|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524214|NCT03649750|Guaifenesin|guaifenesin|mesh-list
14524215|NCT03649750|Expectorants|expectorants|mesh-ancestor
14524216|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
15007141|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15007142|NCT01828788|Ropivacaine|ropivacaine|mesh-list
15007143|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
15007144|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
15007145|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15007146|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007147|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
15007148|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007149|NCT01828879|Tacrolimus|tacrolimus|mesh-list
15007150|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15007151|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
15007152|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007153|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15007154|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007155|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007156|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15007157|NCT01828892|Vancomycin|vancomycin|mesh-list
15007158|NCT01828892|Meropenem|meropenem|mesh-list
15007159|NCT01828892|Ceftazidime|ceftazidime|mesh-list
15007160|NCT01828892|Cefotaxime|cefotaxime|mesh-list
15007161|NCT01828892|Cefoxitin|cefoxitin|mesh-list
15007162|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007163|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
15007164|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15007165|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007166|NCT01829178|Cisplatin|cisplatin|mesh-list
15007167|NCT01829178|Docetaxel|docetaxel|mesh-list
15007168|NCT01829178|Fluorouracil|fluorouracil|mesh-list
15007169|NCT01829178|Silymarin|silymarin|mesh-list
15007170|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007171|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
15007172|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
15007173|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
15007174|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007175|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
15007176|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15007177|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15007178|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
15007179|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007180|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
15007181|NCT01829178|Protective Agents|protective agents|mesh-ancestor
15007182|NCT01829334|Listerine|listerine|mesh-list
15007183|NCT01829334|Fluorides|fluorides|mesh-list
15007184|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
15007185|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
15007186|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
15007187|NCT01829334|Protective Agents|protective agents|mesh-ancestor
15007188|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007189|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15007190|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007191|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
15007192|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15007193|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
15007194|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007195|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
15007196|NCT01829451|Protective Agents|protective agents|mesh-ancestor
15007197|NCT01829529|Amoxicillin|amoxicillin|mesh-list
15007198|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15007199|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007200|NCT01829659|Ticagrelor|ticagrelor|mesh-list
15007201|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15007202|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15007203|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15007204|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15007205|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
15007206|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15007207|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007208|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007209|NCT01829685|Entecavir|entecavir|mesh-list
15007210|NCT01829685|Adefovir|adefovir|mesh-list
15007211|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
15007212|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007213|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15007214|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15007215|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007216|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007217|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
15007218|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15007219|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15007220|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
15007221|NCT01829711|Protective Agents|protective agents|mesh-list
15007222|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007223|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007224|NCT01829802|Ritonavir|ritonavir|mesh-list
15007225|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15007226|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
15007227|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15007228|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15007229|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
15007230|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007231|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007232|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15007233|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15007234|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
15007235|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007236|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15007237|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15007238|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15007239|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15007240|NCT01829841|Sunitinib|sunitinib|mesh-list
15007241|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007242|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15007243|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15007244|NCT01829841|Growth Substances|growth substances|mesh-ancestor
15007245|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007246|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
15007247|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15007248|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007249|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033016|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
15033017|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
15033018|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15033019|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15033020|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15033021|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15033022|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033023|NCT01985854|Propofol|propofol|mesh-list
15033024|NCT01985854|Desflurane|desflurane|mesh-list
15033025|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15033026|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15033027|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033028|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15033029|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
15033030|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
15033031|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15033032|NCT01985893|Trastuzumab|trastuzumab|mesh-list
15033033|NCT01985893|Lapatinib|lapatinib|mesh-list
15033034|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15033035|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033036|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15033037|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033038|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033039|NCT01986036|Calcium|calcium|mesh-list
15033040|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15033041|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033042|NCT01986049|Bupivacaine|bupivacaine|mesh-list
15033043|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
15033044|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
15033045|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15033046|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033047|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
15033048|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033049|NCT01986088|Sumatriptan|sumatriptan|mesh-list
15033050|NCT01986088|Eletriptan|eletriptan|mesh-list
15033051|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15033052|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15033053|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15033054|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
15033055|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033056|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033057|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033058|NCT01986127|Adalimumab|adalimumab|mesh-list
15033059|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15033060|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15033061|NCT01986192|Warfarin|warfarin|mesh-list
15033062|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
15033063|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
15033064|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15033065|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
15033066|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15033067|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
15033068|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033069|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033070|NCT01986270|Sumatriptan|sumatriptan|mesh-list
15007250|NCT01829893|Tamsulosin|tamsulosin|mesh-list
15007251|NCT01829893|Finasteride|finasteride|mesh-list
15007252|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15007253|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15007254|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15007255|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
15007256|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15007257|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007258|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007259|NCT01829893|Urological Agents|urological agents|mesh-ancestor
15007260|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15007261|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15007262|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007263|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
15007264|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15007265|NCT01830101|Temozolomide|temozolomide|mesh-list
15007266|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15007267|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
15007268|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007269|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007270|NCT01830153|Everolimus|everolimus|mesh-list
15007271|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007272|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15007273|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
15007274|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007275|NCT01830218|Anesthetics|anesthetics|mesh-list
15007276|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15007277|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007278|NCT01830244|Paclitaxel|paclitaxel|mesh-list
15007279|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15007280|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007281|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
15007282|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
15007283|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
15007284|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007285|NCT01830270|Paclitaxel|paclitaxel|mesh-list
15007286|NCT01830270|Epirubicin|epirubicin|mesh-list
15007287|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15007288|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007289|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
15007290|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
15007291|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
15007292|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007293|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15007294|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15007295|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15007296|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007297|NCT01830296|Morphine|morphine|mesh-list
15007298|NCT01830296|Remifentanil|remifentanil|mesh-list
15007299|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15007300|NCT01830296|Narcotics|narcotics|mesh-ancestor
15007301|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15007302|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007303|NCT01830296|Analgesics|analgesics|mesh-ancestor
15007304|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
15007305|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007306|NCT01830322|Gemcitabine|gemcitabine|mesh-list
15007307|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15007308|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
15007309|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007310|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007311|NCT01830322|Antiviral Agents|antiviral agents|mesh-ancestor
15007312|NCT01830322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007313|NCT01830322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007314|NCT01830322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15007315|NCT01830322|Immunologic Factors|immunologic factors|mesh-ancestor
15033071|NCT01986270|Eletriptan|eletriptan|mesh-list
15007316|NCT01830322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007317|NCT01830335|Indomethacin|indomethacin|mesh-list
15007318|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15007319|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15007320|NCT01830335|Analgesics|analgesics|mesh-ancestor
15007321|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
15007322|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007323|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007324|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15007325|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007326|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
15007327|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
15007328|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15007329|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15007330|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007331|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007332|NCT01830361|Midostaurin|midostaurin|mesh-list
15007333|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007334|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15007335|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007336|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007337|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
15007338|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
15007339|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15007340|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15007341|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007342|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007343|NCT01830465|Rituximab|rituximab|mesh-list
15007344|NCT01830465|Bortezomib|bortezomib|mesh-list
15007345|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15007346|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007347|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
15007348|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007349|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007350|NCT01830478|Rituximab|rituximab|mesh-list
15007351|NCT01830478|Lenalidomide|lenalidomide|mesh-list
15007352|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15007353|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007354|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
15007355|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007356|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007357|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15007358|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15007359|NCT01830478|Growth Substances|growth substances|mesh-ancestor
15007360|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
15007361|NCT01830491|Aspirin|aspirin|mesh-list
15007362|NCT01830491|Clopidogrel|clopidogrel|mesh-list
15007363|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15007364|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15007365|NCT01830491|Analgesics|analgesics|mesh-ancestor
15007366|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
15007367|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007368|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007369|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15007370|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007371|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15007372|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15007373|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007374|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15007375|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15007376|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007377|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
15007378|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15007379|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15007380|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15007381|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
15007382|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15007383|NCT01830517|Losartan|losartan|mesh-list
15007384|NCT01830517|Amlodipine|amlodipine|mesh-list
15007385|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15007386|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15007387|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007388|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007389|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15007390|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007391|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
15007392|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15007393|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15007394|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15007395|NCT01830530|Telmisartan|telmisartan|mesh-list
15007396|NCT01830530|Nifedipine|nifedipine|mesh-list
15007397|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15007398|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15007399|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15007400|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007401|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15007402|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007403|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15007404|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007405|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
15007406|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
15007407|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15007408|NCT01830556|Cetuximab|cetuximab|mesh-list
15007409|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15007410|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007411|NCT01830777|Cytarabine|cytarabine|mesh-list
15007412|NCT01830777|Etoposide|etoposide|mesh-list
15007413|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
15007414|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15007415|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15007416|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007417|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15007418|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15007419|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007420|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007421|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15007422|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
15007423|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
15007424|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007425|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15007426|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
15007427|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007428|NCT01830777|Analgesics|analgesics|mesh-ancestor
15007429|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
15007430|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007431|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15007432|NCT01830829|Tamsulosin|tamsulosin|mesh-list
15007433|NCT01830829|Dutasteride|dutasteride|mesh-list
15007434|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15007435|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15007436|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15007437|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
15007438|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15007439|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007440|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007441|NCT01830829|Urological Agents|urological agents|mesh-ancestor
15007442|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15007443|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15007444|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007445|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
15007446|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15007447|NCT01830868|Zonisamide|zonisamide|mesh-list
15007448|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
15007449|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15007450|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007451|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007452|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15007453|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007454|NCT01830907|Vitamins|vitamins|mesh-list
15007455|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
15007456|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007457|NCT01830946|Caseins|caseins|mesh-list
15007458|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
15007459|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
15007460|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007461|NCT01831011|Aspirin|aspirin|mesh-list
15007462|NCT01831011|Cinepazide|cinepazide|mesh-list
15007463|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
15007464|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15007465|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15007466|NCT01831011|Analgesics|analgesics|mesh-ancestor
15007467|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
15007468|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007469|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007470|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15007471|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007472|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15007473|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15007474|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007475|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15007476|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15007477|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007478|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
15007479|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
15007480|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15007481|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
15007482|NCT01831050|Vaccines|vaccines|mesh-list
15007483|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
15007484|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007485|NCT01831193|Curcumin|curcumin|mesh-list
15007486|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15007487|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15007488|NCT01831193|Analgesics|analgesics|mesh-ancestor
15007489|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
15007490|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007491|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007492|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15007493|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007494|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007495|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007496|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007497|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15007498|NCT01831323|Rifaximin|rifaximin|mesh-list
15007499|NCT01831323|Mesalamine|mesalamine|mesh-list
15007500|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15007501|NCT01831323|Psyllium|psyllium|mesh-list
15007502|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007503|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15007504|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15007505|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15007506|NCT01831323|Analgesics|analgesics|mesh-ancestor
15007507|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
15007508|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007509|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007510|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007511|NCT01831323|Cathartics|cathartics|mesh-ancestor
15007512|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
15007513|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15007514|NCT01831479|Olmesartan|olmesartan|mesh-list
15007515|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
15007516|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15007517|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15007518|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15007519|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
15007520|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007521|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15007522|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15007523|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007524|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15007525|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15007526|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15007527|NCT01831505|Prednisolone|prednisolone|mesh-list
15007528|NCT01831505|Rituximab|rituximab|mesh-list
15007529|NCT01831505|Doxorubicin|doxorubicin|mesh-list
15007530|NCT01831505|Vincristine|vincristine|mesh-list
15007531|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15007532|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15007533|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007534|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
14802204|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802205|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
14802206|NCT00796263|Dolutegravir|dolutegravir|mesh-list
14802207|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14802208|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14802209|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802210|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802211|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14802212|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14802213|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
14802214|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007535|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007536|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007537|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15007538|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15007539|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15007540|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007541|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007542|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15007543|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
15007544|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
15007545|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
15007546|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15007547|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
15007548|NCT01831505|Hormones|hormones|mesh-ancestor
15007549|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15007550|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15007551|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15007552|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
15033072|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15033073|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15033074|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15033075|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
15033076|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033077|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033078|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033079|NCT01986283|Oxycodone|oxycodone|mesh-list
15033080|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15033081|NCT01986283|Narcotics|narcotics|mesh-ancestor
15033082|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15033083|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033084|NCT01986283|Analgesics|analgesics|mesh-ancestor
15033085|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
15033086|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033087|NCT01986309|Lidocaine|lidocaine|mesh-list
15033088|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
15033089|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
15033090|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15033091|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033092|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
15033093|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033094|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15033095|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15033096|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15033097|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15033098|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033099|NCT01986322|Vaccines|vaccines|mesh-list
15033100|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
14524217|NCT03650387|Lidocaine|lidocaine|mesh-list
14524218|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
14524219|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
14524220|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524221|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524222|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
15033101|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035463|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15035464|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15035465|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15035466|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035467|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
15035468|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
15035469|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
15035470|NCT02001740|Lidocaine|lidocaine|mesh-list
15035471|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
15035472|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
15035473|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15035474|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035475|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
15035476|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035477|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15035478|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15035479|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15035480|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15035481|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035482|NCT02001818|Interferons|interferons|mesh-list
15035483|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
15035484|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
15035485|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15035486|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
15035487|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035488|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
15035489|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15035490|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
15035491|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035492|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15007553|NCT01831622|Methylphenidate|methylphenidate|mesh-list
15007554|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15007555|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007556|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15007557|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15007558|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007559|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007560|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
15007561|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15007562|NCT01831661|Metformin|metformin|mesh-list
15007563|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15007564|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007565|NCT01831674|Metformin|metformin|mesh-list
15007566|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15007567|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007568|NCT01831687|Etodolac|etodolac|mesh-list
15007569|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15007570|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15007571|NCT01831687|Analgesics|analgesics|mesh-ancestor
15007572|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
15007573|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007574|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007575|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15007576|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007577|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15007578|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15007579|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007580|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007581|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15007582|NCT01831700|Lisinopril|lisinopril|mesh-list
15007583|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
15007584|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15007585|NCT01831700|Diuretics|diuretics|mesh-ancestor
15007586|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
15007587|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007588|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15007589|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007590|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007591|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15007592|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
15007593|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007594|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15007595|NCT01831700|Protective Agents|protective agents|mesh-ancestor
15007596|NCT01831947|Ranibizumab|ranibizumab|mesh-list
15007597|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15007598|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15007599|NCT01831947|Growth Substances|growth substances|mesh-ancestor
15007600|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007601|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
15007602|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007603|NCT01832051|Trastuzumab|trastuzumab|mesh-list
15007604|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15007605|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007606|NCT01832129|Vitamins|vitamins|mesh-list
15007607|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
15007608|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
15007609|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
15007610|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
15007611|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007612|NCT01832129|Hematinics|hematinics|mesh-ancestor
15007613|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
15007614|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15007615|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15007616|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15007617|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007618|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15007619|NCT01832285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15007620|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15007621|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007622|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007623|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15007624|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
15007625|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15007626|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
15007627|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15007628|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15007629|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007630|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15007631|NCT01832311|Ketorolac|ketorolac|mesh-list
15007632|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15007633|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15007634|NCT01832311|Analgesics|analgesics|mesh-ancestor
15007635|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
15007636|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007637|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007638|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15007639|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007640|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15007641|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007642|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007643|NCT01832350|Quinidine|quinidine|mesh-list
15007644|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
15007645|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
15007646|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
15007647|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15007648|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15007649|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15007650|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007651|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007652|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15007653|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15007654|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
15007655|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15007656|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
15007657|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15007658|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15007659|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007660|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007661|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15007662|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15007663|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
15007664|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15007665|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15007666|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007667|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15007668|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15007669|NCT01832363|Xenon|xenon|mesh-list
15007670|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15007671|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
15007672|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
15007673|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15007674|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007675|NCT01832415|Bevacizumab|bevacizumab|mesh-list
15007676|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15007677|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007678|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15007679|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15007680|NCT01832415|Growth Substances|growth substances|mesh-ancestor
15007681|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007682|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
15007683|NCT01832467|Cetuximab|cetuximab|mesh-list
15007684|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15007685|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007686|NCT01832558|Eplerenone|eplerenone|mesh-list
15007687|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15007688|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
15007689|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15007690|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007691|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15007692|NCT01832558|Diuretics|diuretics|mesh-ancestor
15007693|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
15007694|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15007695|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15007696|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15007697|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15007698|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007699|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007700|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
15007701|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007702|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15007703|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15007704|NCT01832623|Vitamin D|vitamin d|mesh-list
15007705|NCT01832623|Vitamins|vitamins|mesh-ancestor
15007706|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
15007707|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007708|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15007709|NCT01832662|Caffeine|caffeine|mesh-list
15007710|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15007711|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007712|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15007713|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007714|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007715|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15007716|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15007717|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
15007718|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15007719|NCT01832675|Bupivacaine|bupivacaine|mesh-list
15007720|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
15007721|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
15007722|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15007723|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007724|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
15007725|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007726|NCT01832870|Ipilimumab|ipilimumab|mesh-list
15007727|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15007728|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007729|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15007730|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007731|NCT01832896|Ecallantide|ecallantide|mesh-list
15007732|NCT01832896|Analgesics|analgesics|mesh-ancestor
15007733|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
15007734|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007735|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007736|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15007737|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15007738|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15007739|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007740|NCT01832922|Rituximab|rituximab|mesh-list
15007741|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15007742|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15007743|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007744|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
15007745|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007746|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007747|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13967949|NCT03113773|Aldesleukin|aldesleukin|mesh-list
15007748|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
15007749|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007750|NCT01832935|Insulin|insulin|mesh-list
15007751|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15007752|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
15007753|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
15007754|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
15007755|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
15007756|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15007757|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007758|NCT01832948|Leucovorin|leucovorin|mesh-list
15007759|NCT01832948|Folic Acid|folic acid|mesh-list
15007760|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
15007761|NCT01832948|Endostar protein|endostar protein|mesh-list
15007762|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
15007763|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007764|NCT01832948|Antidotes|antidotes|mesh-ancestor
15007765|NCT01832948|Protective Agents|protective agents|mesh-ancestor
15007766|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007767|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
15007768|NCT01832948|Vitamins|vitamins|mesh-ancestor
15007769|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
15007770|NCT01832948|Hematinics|hematinics|mesh-ancestor
15007771|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15007772|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15007773|NCT01832948|Growth Substances|growth substances|mesh-ancestor
15007774|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
15007775|NCT01832987|Trimethoprim|trimethoprim|mesh-list
15007776|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15007777|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
15007778|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15007779|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007780|NCT01832987|Renal Agents|renal agents|mesh-ancestor
15007781|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
15007782|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15007783|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15007784|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15007785|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007786|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007787|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15007788|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15007789|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15007790|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15007791|NCT01833221|Lidocaine|lidocaine|mesh-list
15007792|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
15007793|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
15007794|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15007795|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007796|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
15007797|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007798|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15007799|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15007800|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15007801|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007802|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007803|NCT01833299|Sorafenib|sorafenib|mesh-list
15007804|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
15007805|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007806|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15007807|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007808|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007809|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15007810|NCT01833299|Estrogens|estrogens|mesh-ancestor
15007811|NCT01833299|Hormones|hormones|mesh-ancestor
15007812|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15007813|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007814|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15007815|NCT01833312|Meperidine|meperidine|mesh-list
15007816|NCT01833312|Buspirone|buspirone|mesh-list
15007817|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15007818|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15007819|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15007820|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007821|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15007822|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15007823|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
15007824|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15007825|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007826|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15007827|NCT01833312|Narcotics|narcotics|mesh-ancestor
15007828|NCT01833312|Analgesics|analgesics|mesh-ancestor
15007829|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
15007830|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007831|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15033102|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
15033103|NCT01986426|Ipilimumab|ipilimumab|mesh-list
15033104|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15033105|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033106|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15033107|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033108|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15033109|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
15033110|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15033111|NCT01986465|Prednisolone|prednisolone|mesh-list
15033112|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
15033113|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15033114|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
15033115|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15033116|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
15033117|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
15033118|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033119|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033120|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15033121|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
15033122|NCT01986465|Hormones|hormones|mesh-ancestor
15033123|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15033124|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15033125|NCT01986465|Protective Agents|protective agents|mesh-ancestor
15033126|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15033127|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033128|NCT01986556|Lesinurad|lesinurad|mesh-list
15033129|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
15033130|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15033131|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
15033132|NCT01986556|Renal Agents|renal agents|mesh-ancestor
15033133|NCT01986582|Phenylephrine|phenylephrine|mesh-list
15033134|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
15033135|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15033136|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15033137|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
15033138|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033139|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524223|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033140|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007832|NCT01833351|Vitamins|vitamins|mesh-list
15007833|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
15007834|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
15007835|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007836|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
15007837|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007838|NCT01833351|Protective Agents|protective agents|mesh-ancestor
15007839|NCT01833559|Insulin|insulin|mesh-list
15007840|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15007841|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
15007842|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15007843|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007844|NCT01833572|Gefitinib|gefitinib|mesh-list
15007845|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007846|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15007847|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007848|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007849|NCT01833611|Entecavir|entecavir|mesh-list
15007850|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
15007851|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007852|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
15007853|NCT01833663|Estrogens|estrogens|mesh-list
15007854|NCT01833663|Hormones|hormones|mesh-ancestor
15007855|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15007856|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007857|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15007858|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15007859|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
15007860|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15007861|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007862|NCT01833663|Urological Agents|urological agents|mesh-ancestor
15007863|NCT01833676|Sevoflurane|sevoflurane|mesh-list
15007864|NCT01833676|Desflurane|desflurane|mesh-list
15007865|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15007866|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15007867|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
14524224|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14524225|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14524226|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14524227|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524228|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524229|NCT03652610|Vaccines|vaccines|mesh-list
14524230|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
14524231|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524232|NCT03652818|Acetaminophen|acetaminophen|mesh-list
14524233|NCT03652818|Pregabalin|pregabalin|mesh-list
14524234|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14524235|NCT03652818|Analgesics|analgesics|mesh-ancestor
14524236|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
14524237|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524238|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524239|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
14524240|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
14524241|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14524242|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524243|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524244|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14524245|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15007868|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
15007869|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15007870|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007871|NCT01833715|Morphine|morphine|mesh-list
15007872|NCT01833715|Methadone|methadone|mesh-list
15007873|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15007874|NCT01833715|Narcotics|narcotics|mesh-ancestor
15007875|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15007876|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007877|NCT01833715|Analgesics|analgesics|mesh-ancestor
15007878|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
15007879|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007880|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
15007881|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
15007882|NCT01833728|Acetaminophen|acetaminophen|mesh-list
15007883|NCT01833728|Propacetamol|propacetamol|mesh-list
15007884|NCT01833728|Nefopam|nefopam|mesh-list
15007885|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15007886|NCT01833728|Analgesics|analgesics|mesh-ancestor
15007887|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
15007888|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007889|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007890|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15007891|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15007892|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007893|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
15007894|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
15007895|NCT01833767|Interleukin-2|interleukin-2|mesh-list
15007896|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15007897|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
15007898|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007899|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15007900|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15007901|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
15007902|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007903|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007904|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15007905|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15007906|NCT01833767|Analgesics|analgesics|mesh-ancestor
15007907|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
15007908|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007909|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
15007910|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15007911|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
15007912|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15007913|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007914|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15007915|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15007916|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15007917|NCT01833819|Lidocaine|lidocaine|mesh-list
15007918|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
15007919|NCT01833819|Remifentanil|remifentanil|mesh-list
15007920|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
15007921|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
15007922|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15007923|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007924|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
15007925|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15007926|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15007927|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15007928|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15007929|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15007930|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007931|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15007932|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15007933|NCT01833819|Analgesics|analgesics|mesh-ancestor
15007934|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15007935|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15007936|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15007937|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
15007938|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15007939|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15007940|NCT01833819|Narcotics|narcotics|mesh-ancestor
15007941|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15007942|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15007943|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007944|NCT01834014|Bevacizumab|bevacizumab|mesh-list
15007945|NCT01834014|Cetuximab|cetuximab|mesh-list
15007946|NCT01834014|Fluorouracil|fluorouracil|mesh-list
15007947|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
15007948|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15007949|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007950|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15007951|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15007952|NCT01834014|Growth Substances|growth substances|mesh-ancestor
15007953|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007954|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
15007955|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
15007956|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007957|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15007958|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15007959|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
15007960|NCT01834170|Gemcitabine|gemcitabine|mesh-list
15007961|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15007962|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
15007963|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007964|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007965|NCT01834170|Antiviral Agents|antiviral agents|mesh-ancestor
15007966|NCT01834170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007967|NCT01834170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007968|NCT01834170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15007969|NCT01834170|Immunologic Factors|immunologic factors|mesh-ancestor
15007970|NCT01834170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007971|NCT01834183|Gemcitabine|gemcitabine|mesh-list
15007972|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15007973|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
15007974|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007975|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007976|NCT01834183|Antiviral Agents|antiviral agents|mesh-ancestor
15007977|NCT01834183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15007978|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007979|NCT01834183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15007980|NCT01834183|Immunologic Factors|immunologic factors|mesh-ancestor
15007981|NCT01834183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007982|NCT01834209|Prednisone|prednisone|mesh-list
15007983|NCT01834209|Prednisolone|prednisolone|mesh-list
15007984|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
15007985|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15007986|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
15007987|NCT01834209|Hormones|hormones|mesh-ancestor
15033141|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
15007988|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15007989|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15007990|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15007991|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15007992|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15007993|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15007994|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15007995|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
15007996|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15007997|NCT01834235|Gemcitabine|gemcitabine|mesh-list
15007998|NCT01834235|Paclitaxel|paclitaxel|mesh-list
15007999|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15008000|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008001|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
15008002|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
15008003|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
15008004|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008005|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15008006|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
15008007|NCT01834235|Antiviral Agents|antiviral agents|mesh-ancestor
15008008|NCT01834235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15008009|NCT01834235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008010|NCT01834235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15008011|NCT01834235|Immunologic Factors|immunologic factors|mesh-ancestor
15008012|NCT01834235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008013|NCT01834248|Poly I-C|poly i-c|mesh-list
15008014|NCT01834248|Decitabine|decitabine|mesh-list
15008015|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15008016|NCT01834248|Poly ICLC|poly iclc|mesh-list
15008017|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15008018|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
15008019|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008020|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008021|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008022|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
15008023|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
15008024|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008025|NCT01834248|Laxatives|laxatives|mesh-ancestor
15008026|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15008027|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
15008028|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15008029|NCT01834508|Entecavir|entecavir|mesh-list
15008030|NCT01834508|Adefovir|adefovir|mesh-list
15008031|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
15008032|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15008033|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15008034|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15008035|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008036|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008037|NCT01834547|Methylphenidate|methylphenidate|mesh-list
15008038|NCT01834547|Caffeine|caffeine|mesh-list
15008039|NCT01834547|Modafinil|modafinil|mesh-list
15008040|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15008041|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008042|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15008043|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15008044|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15008045|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008046|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
15008047|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008048|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15008049|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008050|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15008051|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15008052|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
15008053|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15008054|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15008055|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15008056|NCT01834768|Eplerenone|eplerenone|mesh-list
15008057|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15008058|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
15008059|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15008060|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008061|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15008062|NCT01834768|Diuretics|diuretics|mesh-ancestor
15008063|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
15008064|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15008065|NCT01834820|Dexamethasone|dexamethasone|mesh-list
15008066|NCT01834820|Epinephrine|epinephrine|mesh-list
15008067|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15008068|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
15008069|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
15008070|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008071|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008072|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15008073|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
15008074|NCT01834820|Hormones|hormones|mesh-ancestor
15008075|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15008076|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15008077|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008078|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15008079|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15008080|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
15008081|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008082|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008083|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15008084|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15008085|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15008086|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
15008087|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
15008088|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
15008089|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15008090|NCT01834885|Fluticasone|fluticasone|mesh-list
15008091|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15008092|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15008093|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15008094|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15008095|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
15008096|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008097|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008098|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15008099|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
15008100|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
15008101|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15033142|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
14524246|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15008102|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15008103|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15008104|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15008105|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
15008106|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008107|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008108|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
15008109|NCT01834885|Hormones|hormones|mesh-ancestor
15008110|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15008111|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
15008112|NCT01834898|Oxycodone|oxycodone|mesh-list
15008113|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15008114|NCT01834898|Narcotics|narcotics|mesh-ancestor
15008115|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008116|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008117|NCT01834898|Analgesics|analgesics|mesh-ancestor
15008118|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
15008119|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008120|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
15008121|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15008122|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15008123|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15008124|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008125|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
15008126|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008127|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008128|NCT01834963|Interferons|interferons|mesh-list
15008129|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
15008130|NCT01834963|Cisplatin|cisplatin|mesh-list
15008131|NCT01834963|Fluorouracil|fluorouracil|mesh-list
15008132|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008133|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
15008134|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008135|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15008136|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15008137|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
15008138|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008139|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
15008140|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15008141|NCT01834989|Mitogens|mitogens|mesh-list
15008142|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
15008143|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033143|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033144|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
15033145|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15033146|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
15033147|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15033148|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
15033149|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15033150|NCT01986582|Protective Agents|protective agents|mesh-ancestor
15033151|NCT01986608|Lacosamide|lacosamide|mesh-list
15033152|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
15033153|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15033154|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15008144|NCT01835067|Ranibizumab|ranibizumab|mesh-list
15008145|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15008146|NCT01835067|Plasminogen|plasminogen|mesh-list
15008147|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15008148|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15008149|NCT01835067|Growth Substances|growth substances|mesh-ancestor
15008150|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008151|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
15008152|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008153|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15008154|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15008155|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008156|NCT01835184|Vemurafenib|vemurafenib|mesh-list
15008157|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008158|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15008159|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008160|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008161|NCT01835197|Abrocitinib|abrocitinib|mesh-list
15008162|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15008163|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008164|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008165|NCT01835236|Paclitaxel|paclitaxel|mesh-list
15008166|NCT01835236|Vinorelbine|vinorelbine|mesh-list
15008167|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15008168|NCT01835236|Trastuzumab|trastuzumab|mesh-list
15008169|NCT01835236|Pertuzumab|pertuzumab|mesh-list
15008170|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15008171|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008172|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
15008173|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
15008174|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
15008175|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008176|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15008177|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
15008178|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008179|NCT01835314|Stiripentol|stiripentol|mesh-list
15008180|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
15008181|NCT01835340|Anesthetics|anesthetics|mesh-list
15008182|NCT01835340|Propofol|propofol|mesh-list
15008183|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008184|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008185|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15008186|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15008187|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
15008188|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15008189|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15008190|NCT01835418|Amlodipine|amlodipine|mesh-list
15008191|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15008192|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15008193|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15008194|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008195|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15008196|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008197|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
15008198|NCT01835561|Thalidomide|thalidomide|mesh-list
15008199|NCT01835561|Pomalidomide|pomalidomide|mesh-list
15008200|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
15008201|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008202|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15008203|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15008204|NCT01835561|Growth Substances|growth substances|mesh-ancestor
15008205|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
15008206|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008207|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15008208|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
15008209|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15008210|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15008211|NCT01835639|Vitamin D|vitamin d|mesh-list
15008212|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
15008213|NCT01835639|Vitamins|vitamins|mesh-ancestor
15008214|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
15008215|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008216|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15008217|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15008218|NCT01835665|Nimodipine|nimodipine|mesh-list
15008219|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15008220|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15008221|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15008222|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008223|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15008224|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008225|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
15008226|NCT01835678|Linagliptin|linagliptin|mesh-list
15008227|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15008228|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008229|NCT01835678|Incretins|incretins|mesh-ancestor
15008230|NCT01835678|Hormones|hormones|mesh-ancestor
15008231|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15008232|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15008233|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
15008234|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008235|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008236|NCT01835691|Vitamin D|vitamin d|mesh-list
13967950|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008237|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
15008238|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
15008239|NCT01835691|Vitamins|vitamins|mesh-list
15008240|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
15008241|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008242|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15008243|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15008244|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15008245|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008246|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15008247|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008248|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008249|NCT01836016|Fluticasone|fluticasone|mesh-list
15008250|NCT01836016|Xhance|xhance|mesh-list
15008251|NCT01836016|Albuterol|albuterol|mesh-list
15008252|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
15008253|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15008254|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15008255|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15008256|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15008257|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
15008258|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008259|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008260|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15008261|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
15008262|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
15008263|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15008264|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15008265|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15008266|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15008267|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
15008268|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008269|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008270|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
15008271|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15008272|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
15008273|NCT01836016|Hormones|hormones|mesh-ancestor
15008274|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15008275|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
15008276|NCT01836094|Methylene Blue|methylene blue|mesh-list
15008277|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008278|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008279|NCT01836120|Docetaxel|docetaxel|mesh-list
15008280|NCT01836120|Raltitrexed|raltitrexed|mesh-list
15008281|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008282|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
15008283|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
15008284|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
15008285|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008286|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15008287|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
15008288|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15008289|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008290|NCT01836224|Terlipressin|terlipressin|mesh-list
15008291|NCT01836224|Norepinephrine|norepinephrine|mesh-list
15008292|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15008293|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15008294|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15008295|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15008296|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
15008297|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008298|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008299|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008300|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
15008301|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
15008302|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008303|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
15008304|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14524247|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524248|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14524249|NCT03653416|Bupivacaine|bupivacaine|mesh-list
14524250|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
14524251|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
14524252|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524253|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008305|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
15008306|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008307|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15008308|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15008309|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
15008310|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008311|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008312|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15008313|NCT01836328|Methadone|methadone|mesh-list
15008314|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15008315|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15008316|NCT01836328|Narcotics|narcotics|mesh-ancestor
15008317|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008318|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008319|NCT01836328|Analgesics|analgesics|mesh-ancestor
15008320|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
15008321|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008322|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
15008323|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
15008324|NCT01836341|Carboplatin|carboplatin|mesh-list
15008325|NCT01836341|Pemetrexed|pemetrexed|mesh-list
15008326|NCT01836341|Afatinib|afatinib|mesh-list
15008327|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008328|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008329|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008330|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15008331|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15008332|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15008333|NCT01836406|Ketorolac|ketorolac|mesh-list
15008334|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15008335|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15008336|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15008337|NCT01836406|Analgesics|analgesics|mesh-ancestor
15008338|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
15008339|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008340|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008341|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15008342|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15008343|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15008344|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008345|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008346|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15008347|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15008348|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008349|NCT01836536|Bevacizumab|bevacizumab|mesh-list
15008350|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15008351|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008352|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15008353|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15008354|NCT01836536|Growth Substances|growth substances|mesh-ancestor
15008355|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008356|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
15008357|NCT01836575|Carboplatin|carboplatin|mesh-list
15008358|NCT01836575|Pemetrexed|pemetrexed|mesh-list
15008359|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008360|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008361|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008362|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15008363|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15008364|NCT01836614|Lidocaine|lidocaine|mesh-list
15008365|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
15008366|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
15008367|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008368|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008369|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
15008370|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008371|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15008372|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15008373|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15008374|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15008375|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008376|NCT01836653|Bevacizumab|bevacizumab|mesh-list
15008377|NCT01836653|Cetuximab|cetuximab|mesh-list
13967951|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15008378|NCT01836653|Fluorouracil|fluorouracil|mesh-list
15008379|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
15008380|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15008381|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008382|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15008383|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15008384|NCT01836653|Growth Substances|growth substances|mesh-ancestor
15008385|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008386|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
15008387|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
15008388|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008389|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15008390|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15008391|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
15008392|NCT01836679|Paclitaxel|paclitaxel|mesh-list
15008393|NCT01836679|Carboplatin|carboplatin|mesh-list
15008394|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15008395|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008396|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
15008397|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
15008398|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
15008399|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033155|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15033156|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033157|NCT01986660|Ibuprofen|ibuprofen|mesh-list
15033158|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15033159|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15033160|NCT01986660|Analgesics|analgesics|mesh-ancestor
15033161|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
15033162|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033163|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033164|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15033165|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15033166|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15033167|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033168|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033169|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
15033170|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
15033171|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15033172|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15033173|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033174|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033175|NCT01986673|Urological Agents|urological agents|mesh-ancestor
15033176|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15033177|NCT01986764|Estradiol|estradiol|mesh-list
15033178|NCT01986764|Estrogens|estrogens|mesh-list
15033179|NCT01986764|Hormones|hormones|mesh-ancestor
15033180|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15033181|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033182|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15033183|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15033184|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15033185|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15033186|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033187|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
15033188|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033189|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15033190|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15033191|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033192|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15033193|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15033194|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15033195|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033196|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
15033197|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033198|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
15033199|NCT01986894|Thalidomide|thalidomide|mesh-list
15033200|NCT01986894|Pomalidomide|pomalidomide|mesh-list
15033201|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15033202|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15033203|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15008400|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
15008401|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15008402|NCT01836900|Hemostatics|hemostatics|mesh-list
15008403|NCT01836900|Coagulants|coagulants|mesh-ancestor
15008404|NCT01837043|Cyclosporine|cyclosporine|mesh-list
15008405|NCT01837043|Abatacept|abatacept|mesh-list
15008406|NCT01837043|Tacrolimus|tacrolimus|mesh-list
15008407|NCT01837043|Cyclosporins|cyclosporins|mesh-list
15008408|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
15008409|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15008410|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
15008411|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008412|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008413|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008414|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
15008415|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15008416|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
15008417|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15008418|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15008419|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008420|NCT01837108|Eplerenone|eplerenone|mesh-list
15008421|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15008422|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
15008423|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15008424|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008425|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15008426|NCT01837108|Diuretics|diuretics|mesh-ancestor
15008427|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
15008428|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15008429|NCT01837199|Amoxicillin|amoxicillin|mesh-list
15008430|NCT01837199|Metronidazole|metronidazole|mesh-list
15008431|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15008432|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15008433|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15008434|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15008435|NCT01837251|Bevacizumab|bevacizumab|mesh-list
15008436|NCT01837251|Carboplatin|carboplatin|mesh-list
15008437|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15008438|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008439|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15008440|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15008441|NCT01837251|Growth Substances|growth substances|mesh-ancestor
15008442|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008443|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
15008444|NCT01837290|Midazolam|midazolam|mesh-list
15008445|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
15008446|NCT01837290|Bupivacaine|bupivacaine|mesh-list
15008447|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
15008448|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
15008449|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008450|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008451|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
15008452|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008453|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15008454|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15008455|NCT01837290|Analgesics|analgesics|mesh-ancestor
15008456|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15008457|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15008458|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15008459|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
15008460|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008461|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008462|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15008463|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15008464|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15008465|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15008466|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15008467|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
15008468|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
15008469|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
15008470|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
15008471|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
15008472|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
15008473|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008474|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008475|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15008476|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15008477|NCT01837329|Growth Substances|growth substances|mesh-ancestor
15008478|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008479|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
15008480|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008481|NCT01837394|Acetaminophen|acetaminophen|mesh-list
15008482|NCT01837394|Morphine|morphine|mesh-list
15008483|NCT01837394|Ondansetron|ondansetron|mesh-list
15008484|NCT01837394|Metoclopramide|metoclopramide|mesh-list
15008485|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15008486|NCT01837394|Narcotics|narcotics|mesh-ancestor
15008487|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008488|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008489|NCT01837394|Analgesics|analgesics|mesh-ancestor
15008490|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
15008491|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008492|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15008493|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
15008494|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
15008495|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
15008496|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15008497|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
15008498|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
14524254|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
14524255|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524256|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
14524257|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14524258|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15008499|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15008500|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
15008501|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008502|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008503|NCT01837394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15008504|NCT01837394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15008505|NCT01837394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15008506|NCT01837394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15008507|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15008508|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15008509|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
15008510|NCT01837433|Prednisone|prednisone|mesh-list
15008511|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
15008512|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15008513|NCT01837433|Hormones|hormones|mesh-ancestor
15008514|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15008515|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008516|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15008517|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008518|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
15008519|NCT01837446|Promethazine|promethazine|mesh-list
15008520|NCT01837446|Lidocaine|lidocaine|mesh-list
15008521|NCT01837446|Morphine|morphine|mesh-list
15008522|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15008523|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
15008524|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
15008525|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
15008526|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008527|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008528|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
15008529|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008530|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15008531|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15008532|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15008533|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15008534|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008535|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15008536|NCT01837446|Narcotics|narcotics|mesh-ancestor
15008537|NCT01837446|Analgesics|analgesics|mesh-ancestor
15008538|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15008539|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15008540|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
15008541|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
15008542|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15008543|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15008544|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
15008545|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
15008546|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008547|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15008548|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
15008549|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
15008550|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15008551|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
15008552|NCT01837446|Antacids|antacids|mesh-ancestor
15008553|NCT01837498|Neostigmine|neostigmine|mesh-list
15008554|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15008555|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008556|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008557|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
15008558|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008559|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008560|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15008561|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
15008562|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13967952|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15008563|NCT01837576|Calcipotriene|calcipotriene|mesh-list
15008564|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
15008565|NCT01837628|Lidocaine|lidocaine|mesh-list
15008566|NCT01837628|Mineral Oil|mineral oil|mesh-list
15008567|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
15008568|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
15008569|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008570|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008571|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
15008572|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008573|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15008574|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15008575|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15008576|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15008577|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008578|NCT01837628|Emollients|emollients|mesh-ancestor
15008579|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
15008580|NCT01837667|Docetaxel|docetaxel|mesh-list
15008581|NCT01837667|LB100|lb100|mesh-list
15008582|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008583|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
15008584|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
15008585|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
15008586|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008587|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008588|NCT01837810|Ibuprofen|ibuprofen|mesh-list
15008589|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15008590|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15008591|NCT01837810|Analgesics|analgesics|mesh-ancestor
15008592|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
15008593|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008594|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008595|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15008596|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15008597|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15008598|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008599|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008600|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
15008601|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
15008602|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15008603|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
15008604|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008605|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008606|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15008607|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
15008608|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
15008609|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15008610|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
15008611|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008612|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008613|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15008614|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15008615|NCT01837992|Primaquine|primaquine|mesh-list
15008616|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
15008617|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15008618|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15008619|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15008620|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
15008621|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15008622|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008623|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
15008624|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15008625|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
15008626|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008627|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
15008628|NCT01838252|Protective Agents|protective agents|mesh-ancestor
15008629|NCT01838330|Psyllium|psyllium|mesh-list
15008630|NCT01838330|Cathartics|cathartics|mesh-ancestor
15008631|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15033204|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15033205|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033206|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033207|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033208|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033209|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
15033210|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15033211|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15033212|NCT01986894|Growth Substances|growth substances|mesh-ancestor
15033213|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
15033214|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15033215|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
15033216|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
15033217|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15033218|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15033219|NCT01986998|Prednisolone|prednisolone|mesh-list
15033220|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
15033221|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15033222|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
15033223|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15033224|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
15033225|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
15033226|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033227|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033228|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15033229|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
15033230|NCT01986998|Hormones|hormones|mesh-ancestor
15008632|NCT01838395|Cytarabine|cytarabine|mesh-list
15008633|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15008634|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
15008635|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008636|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008637|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
15008638|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15008639|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15008640|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
15008641|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008642|NCT01838434|Lenalidomide|lenalidomide|mesh-list
15008643|NCT01838434|Idelalisib|idelalisib|mesh-list
15008644|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
15008645|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008646|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15008647|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15008648|NCT01838434|Growth Substances|growth substances|mesh-ancestor
15008649|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
15008650|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008651|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008652|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008653|NCT01838460|Lobeline|lobeline|mesh-list
15008654|NCT01838460|Nicotine|nicotine|mesh-list
15008655|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15008656|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
15008657|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008658|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008659|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15008660|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15008661|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
15008662|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008663|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008664|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
15008665|NCT01838473|Lobeline|lobeline|mesh-list
15008666|NCT01838473|Nicotine|nicotine|mesh-list
15008667|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15008668|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
15008669|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008670|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008671|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15008672|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15008673|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
15008674|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008675|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008676|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
15008677|NCT01838538|Paclitaxel|paclitaxel|mesh-list
15008678|NCT01838538|Bevacizumab|bevacizumab|mesh-list
15008679|NCT01838538|Carboplatin|carboplatin|mesh-list
15008680|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15008681|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008682|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
15008683|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
15008684|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
15008685|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008686|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15008687|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15008688|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15008689|NCT01838538|Growth Substances|growth substances|mesh-ancestor
15008690|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008691|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
15008692|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15008693|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
15008694|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15008695|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
15008696|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008697|NCT01838707|Fentanyl|fentanyl|mesh-list
15008698|NCT01838707|Morphine|morphine|mesh-list
15008699|NCT01838707|Bupivacaine|bupivacaine|mesh-list
15008700|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
15008701|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
15008702|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008703|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008704|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
15008705|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008706|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15008707|NCT01838707|Narcotics|narcotics|mesh-ancestor
15008708|NCT01838707|Analgesics|analgesics|mesh-ancestor
15008709|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15008710|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15008711|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
15008712|NCT01838772|Interferons|interferons|mesh-list
15008713|NCT01838772|Ribavirin|ribavirin|mesh-list
15008714|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008715|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
15008716|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15008717|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
15008718|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008719|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
15008720|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15008721|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15008722|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15008723|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008724|NCT01838902|Primaquine|primaquine|mesh-list
15008725|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
15008726|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15008727|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15008728|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15008729|NCT01838928|Bupivacaine|bupivacaine|mesh-list
15008730|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
15008731|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
15008732|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008733|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008734|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
15008735|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008736|NCT01838993|Lidocaine|lidocaine|mesh-list
15008737|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
15008738|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
15008739|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008740|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008741|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
15008742|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008743|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15008744|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15008745|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15008746|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15008747|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008748|NCT01839032|Vinorelbine|vinorelbine|mesh-list
15008749|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008750|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15008751|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
15008752|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
15008753|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
15008754|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008755|NCT01839084|Isoflurane|isoflurane|mesh-list
15008756|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15008757|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
15008758|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
15008759|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008760|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008761|NCT01839097|Prednisone|prednisone|mesh-list
15008762|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
15008763|NCT01839097|Doxorubicin|doxorubicin|mesh-list
15008764|NCT01839097|Vincristine|vincristine|mesh-list
15008765|NCT01839097|Belinostat|belinostat|mesh-list
15008766|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15008767|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
15008768|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008769|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15008770|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15008771|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
15008772|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008773|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008774|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15008775|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15008776|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15008777|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15008778|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008779|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15008780|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
15008781|NCT01839097|Hormones|hormones|mesh-ancestor
15008782|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15008783|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15008784|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15008785|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
15008786|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
15008787|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
15008788|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15008789|NCT01839149|Oxytocin|oxytocin|mesh-list
15008790|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
15008791|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15008792|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008793|NCT01839175|Vaccines|vaccines|mesh-list
15008794|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15008795|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
15008796|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008797|NCT01839240|Cytarabine|cytarabine|mesh-list
15008798|NCT01839240|Azacitidine|azacitidine|mesh-list
15008799|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
15008800|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15008801|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
15008802|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008803|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008804|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
15008805|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15008806|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15008807|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
15008808|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008809|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008810|NCT01839240|Analgesics|analgesics|mesh-ancestor
15008811|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
15008812|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008813|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14802215|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14802216|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14802217|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14802218|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802219|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802220|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802221|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14802222|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14802223|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
14802224|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13967953|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
14802225|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008814|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15008815|NCT01839253|Atenolol|atenolol|mesh-list
15035493|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008816|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15008817|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15008818|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15008819|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
15008820|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
15008821|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008822|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008823|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15008824|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15008825|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15008826|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
15008827|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008828|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008829|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
15008830|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008831|NCT01839344|Acarbose|acarbose|mesh-list
15008832|NCT01839344|Quercetin|quercetin|mesh-list
15008833|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15008834|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008835|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008836|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15008837|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008838|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
15008839|NCT01839344|Protective Agents|protective agents|mesh-ancestor
15008840|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
15008841|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15008842|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
15008843|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15008844|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
15008845|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008846|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008847|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
15008848|NCT01839370|Pramlintide|pramlintide|mesh-list
15008849|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15008850|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008851|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
15008852|NCT01839383|Calcium|calcium|mesh-list
15008853|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15008854|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008855|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15008856|NCT01839500|Trastuzumab|trastuzumab|mesh-list
15008857|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15008858|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008859|NCT01839552|Fentanyl|fentanyl|mesh-list
15008860|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15008861|NCT01839552|Narcotics|narcotics|mesh-ancestor
15008862|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008863|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008864|NCT01839552|Analgesics|analgesics|mesh-ancestor
15008865|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
15008866|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008867|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15008868|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15008869|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
15008870|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
15008871|NCT01839578|Heparin|heparin|mesh-list
15008872|NCT01839578|Calcium heparin|calcium heparin|mesh-list
15008873|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
15008874|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008875|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15008876|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15008877|NCT01839630|Sorafenib|sorafenib|mesh-list
15008878|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008879|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15008880|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008881|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008882|NCT01839643|Meloxicam|meloxicam|mesh-list
15008883|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15008884|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15008885|NCT01839643|Analgesics|analgesics|mesh-ancestor
15008886|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
15008887|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008888|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008889|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15008890|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15008891|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15008892|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15008893|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008894|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008895|NCT01839734|Lubiprostone|lubiprostone|mesh-list
15008896|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15008897|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15008898|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008899|NCT01839773|Paclitaxel|paclitaxel|mesh-list
15008900|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15008901|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15008902|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008903|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
15008904|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
15008905|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
15008906|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008907|NCT01839812|Cosyntropin|cosyntropin|mesh-list
15008908|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15008909|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
15008910|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
15008911|NCT01839812|Hormones|hormones|mesh-ancestor
15008912|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15008913|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008914|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008915|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008916|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
15008917|NCT01839851|Hormones|hormones|mesh-ancestor
15008918|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15008919|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008920|NCT01839890|Paclitaxel|paclitaxel|mesh-list
15008921|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15008922|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008923|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
15008924|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
15008925|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
15008926|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008927|NCT01839929|Tacrolimus|tacrolimus|mesh-list
15008928|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15008929|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
15008930|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008931|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15008932|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008933|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008934|NCT01839955|Quinacrine|quinacrine|mesh-list
15008935|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15008936|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008937|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15008938|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15008939|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008940|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
15008941|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15008942|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
15008943|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15008944|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15008945|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
15008946|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15008947|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
15008948|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15008949|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15008950|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
15008951|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
15008952|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008953|NCT01839981|Protective Agents|protective agents|mesh-ancestor
15008954|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008955|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
15008956|NCT01839981|Vitamins|vitamins|mesh-ancestor
15008957|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
15008958|NCT01839994|Androgens|androgens|mesh-list
15008959|NCT01839994|Hormones|hormones|mesh-ancestor
15008960|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15008961|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008962|NCT01840007|Metformin|metformin|mesh-list
15008963|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15008964|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008965|NCT01840046|Interleukin-2|interleukin-2|mesh-list
15008966|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15008967|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15008968|NCT01840046|Analgesics|analgesics|mesh-ancestor
15008969|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
15008970|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008971|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033231|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15033232|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15033233|NCT01986998|Protective Agents|protective agents|mesh-ancestor
15033234|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15033235|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033236|NCT01987076|Prednisone|prednisone|mesh-list
15033237|NCT01987076|Clobetasol|clobetasol|mesh-list
15033238|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15033239|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
15033240|NCT01987076|Hormones|hormones|mesh-ancestor
15033241|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15033242|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033243|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15033244|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033245|NCT01987128|Ropivacaine|ropivacaine|mesh-list
15033246|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
15033247|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
15033248|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15033249|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008972|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
15008973|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14524259|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524260|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
14524261|NCT03653429|Coagulants|coagulants|mesh-ancestor
14529814|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14529815|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
14529816|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14529817|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14529818|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15008974|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15008975|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15008976|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15008977|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
15008978|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15008979|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15008980|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008981|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15008982|NCT01840254|Analgesics|analgesics|mesh-ancestor
15008983|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
15008984|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15008985|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15008986|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15008987|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15008988|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
15008989|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15008990|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15008991|NCT01840384|Micronutrients|micronutrients|mesh-list
15008992|NCT01840384|Trace Elements|trace elements|mesh-list
15008993|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15008994|NCT01840423|Levodopa|levodopa|mesh-list
15008995|NCT01840423|Carbidopa|carbidopa|mesh-list
15008996|NCT01840423|Entacapone|entacapone|mesh-list
15008997|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15008998|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15008999|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
15009000|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009001|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009002|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009003|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15009004|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009005|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
15009006|NCT01840449|Lanreotide|lanreotide|mesh-list
15009007|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009008|NCT01840592|Doxorubicin|doxorubicin|mesh-list
15009009|NCT01840592|Sorafenib|sorafenib|mesh-list
15009010|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15009011|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009012|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15009013|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15009014|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009015|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009016|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15009017|NCT01840683|Heparin|heparin|mesh-list
15009018|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
15009019|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15009020|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15009021|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009022|NCT01840696|Regadenoson|regadenoson|mesh-list
15009023|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
15009024|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15009025|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
15009026|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
15009027|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009028|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009029|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009030|NCT01840774|Ketamine|ketamine|mesh-list
15009031|NCT01840774|Analgesics|analgesics|mesh-list
15009032|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
15009033|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009034|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009035|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15009036|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14524262|NCT03654326|Naproxen|naproxen|mesh-list
14524263|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14524264|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14524265|NCT03654326|Analgesics|analgesics|mesh-ancestor
15009037|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
15009038|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
15009039|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009040|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15009041|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15009042|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009043|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009044|NCT01840800|Ropivacaine|ropivacaine|mesh-list
15009045|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
15009046|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
15009047|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009048|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009049|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
15009050|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009051|NCT01840813|Misoprostol|misoprostol|mesh-list
15009052|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15009053|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
15009054|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15009055|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009056|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15009057|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15009058|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
15009059|NCT01841008|Tacrolimus|tacrolimus|mesh-list
15009060|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15009061|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
15009062|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009063|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15009064|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009065|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009066|NCT01841099|Mesalamine|mesalamine|mesh-list
15009067|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15009068|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15009069|NCT01841099|Analgesics|analgesics|mesh-ancestor
15009070|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
15009071|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009072|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009073|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15009074|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15009075|NCT01841112|BI 409306|bi 409306|mesh-list
15009076|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15009077|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009078|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009079|NCT01841125|Citalopram|citalopram|mesh-list
15009080|NCT01841125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15009081|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15009082|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15009083|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009084|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009085|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
15009086|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009087|NCT01841125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15009088|NCT01841125|Antidepressive Agents|antidepressive agents|mesh-ancestor
15009089|NCT01841125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15009090|NCT01841164|Montelukast|montelukast|mesh-list
15009091|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15009092|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
15009093|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15009094|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
15009095|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15009096|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009097|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15009098|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15009099|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009100|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
15009101|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
15009102|NCT01841242|Povidone|povidone|mesh-list
15009103|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15009104|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009105|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
15009106|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
15009107|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
15009108|NCT01841294|Lidocaine|lidocaine|mesh-list
15009109|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
15009110|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
15009111|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009112|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009113|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
15009114|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009115|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15009116|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15009117|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15009118|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15009119|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009120|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
15009121|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
15009122|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
15009123|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009124|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15009125|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15009126|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
15009127|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15009128|NCT01841320|Methadone|methadone|mesh-list
15009129|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15009130|NCT01841320|Narcotics|narcotics|mesh-ancestor
15009131|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009132|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009133|NCT01841320|Analgesics|analgesics|mesh-ancestor
15009134|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
15009135|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009136|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
15009137|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
15009138|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
15009139|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009140|NCT01841359|Pramlintide|pramlintide|mesh-list
15009141|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15009142|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009143|NCT01841411|Metronidazole|metronidazole|mesh-list
15009144|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
15009145|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14524266|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
14524267|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524268|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524269|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14524270|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14524271|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
14524272|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14524273|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524274|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524275|NCT03654417|Lidocaine|lidocaine|mesh-list
14524276|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
14524277|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
14524278|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524279|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524280|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
14524281|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009146|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009147|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15009148|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15009149|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15009150|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
15009151|NCT01841411|Expectorants|expectorants|mesh-ancestor
15009152|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
15009153|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15009154|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
15009155|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009156|NCT01841411|Protective Agents|protective agents|mesh-ancestor
15009157|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009158|NCT01841411|Antidotes|antidotes|mesh-ancestor
15009159|NCT01841424|Benzocaine|benzocaine|mesh-list
15009160|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
15009161|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
15009162|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009163|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009164|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
15009165|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009166|NCT01841463|Vemurafenib|vemurafenib|mesh-list
15009167|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009168|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15009169|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009170|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009171|NCT01841502|Paroxetine|paroxetine|mesh-list
15009172|NCT01841502|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15009173|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15009174|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15009175|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009176|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009177|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
15009178|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009179|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15009180|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
15009181|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15009182|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15009183|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15009184|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009185|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
15009186|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
15009187|NCT01841515|Coagulants|coagulants|mesh-ancestor
15009188|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15009189|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
15009190|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009191|NCT01841658|Folic Acid|folic acid|mesh-list
15009192|NCT01841658|Hematinics|hematinics|mesh-ancestor
15009193|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
15009194|NCT01841658|Vitamins|vitamins|mesh-ancestor
15009195|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
15009196|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009197|NCT01841684|Anacetrapib|anacetrapib|mesh-list
15009198|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15009199|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15009200|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
15009201|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009202|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15009203|NCT01841775|Interferons|interferons|mesh-list
15009204|NCT01841775|Ribavirin|ribavirin|mesh-list
15009205|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009206|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
15009207|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009208|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
15009209|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033250|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
15033251|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033252|NCT01987154|Caseins|caseins|mesh-list
15033253|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
15033254|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
15033255|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033256|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15033257|NCT01987167|Hormones|hormones|mesh-ancestor
15033258|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15033259|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033260|NCT01987297|Cytarabine|cytarabine|mesh-list
15033261|NCT01987297|Daunorubicin|daunorubicin|mesh-list
15033262|NCT01987297|Idarubicin|idarubicin|mesh-list
15033263|NCT01987297|Tretinoin|tretinoin|mesh-list
15033264|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
15033265|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15009210|NCT01841827|Cilostazol|cilostazol|mesh-list
15009211|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15009212|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
15009213|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009214|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009215|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15009216|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
15009217|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15009218|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15009219|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009220|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15009221|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
15009222|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15009223|NCT01841827|Protective Agents|protective agents|mesh-ancestor
15009224|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15009225|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15009226|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009227|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15009228|NCT01842074|Bortezomib|bortezomib|mesh-list
15009229|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009230|NCT01842087|Iproplatin|iproplatin|mesh-list
15009231|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009232|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15009233|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009234|NCT01842113|Rifaximin|rifaximin|mesh-list
15009235|NCT01842113|Lactulose|lactulose|mesh-list
15009236|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15009237|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009238|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15009239|NCT01842139|Poly I-C|poly i-c|mesh-list
15009240|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15009241|NCT01842139|Poly ICLC|poly iclc|mesh-list
15009242|NCT01842139|Basiliximab|basiliximab|mesh-list
15009243|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
15009244|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
15009245|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009246|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15009247|NCT01842139|Laxatives|laxatives|mesh-ancestor
15009248|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15009249|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
15009250|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009251|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15009252|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15009253|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009254|NCT01842230|Niacin|niacin|mesh-list
15009255|NCT01842230|Amlodipine|amlodipine|mesh-list
15009256|NCT01842230|Telmisartan|telmisartan|mesh-list
15009257|NCT01842230|Atorvastatin|atorvastatin|mesh-list
15009258|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15009259|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15009260|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
15009261|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009262|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15009263|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15009264|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009265|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15009266|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15009267|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15009268|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15009269|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009270|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
15009271|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15009272|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15009273|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
15009274|NCT01842230|Vitamins|vitamins|mesh-ancestor
15009275|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
15009276|NCT01842256|Amlodipine|amlodipine|mesh-list
15009277|NCT01842256|Telmisartan|telmisartan|mesh-list
15009278|NCT01842256|Atorvastatin|atorvastatin|mesh-list
15009279|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15009280|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15009281|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
15009282|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009283|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15009284|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15009285|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009286|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15009287|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15009288|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15009289|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15009290|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009291|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
15009292|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15009293|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15009294|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
15009295|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15009296|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009297|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15009298|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
15009299|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15009300|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009301|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009302|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009303|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
15009304|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009305|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15009306|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009307|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009308|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
15009309|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15009310|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009311|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15009312|NCT01842373|Lidocaine|lidocaine|mesh-list
15009313|NCT01842373|Tetracaine|tetracaine|mesh-list
15009314|NCT01842373|Benzocaine|benzocaine|mesh-list
15009315|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
15009316|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
15009317|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009318|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009319|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
15009320|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009321|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15009322|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15009323|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15009324|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15009325|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009326|NCT01842516|Delpazolid|delpazolid|mesh-list
15009327|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
15009328|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15009329|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009330|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15009331|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009332|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009333|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
15009334|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15009335|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15009336|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009337|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
15009338|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009339|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009340|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
15009341|NCT01842672|Clofarabine|clofarabine|mesh-list
15009342|NCT01842672|Analgesics|analgesics|mesh-ancestor
15009343|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
15009344|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009345|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009346|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009347|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15009348|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15009349|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009350|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009351|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15009352|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
15009353|NCT01842893|Fentanyl|fentanyl|mesh-list
15009354|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15009355|NCT01842893|Narcotics|narcotics|mesh-ancestor
15009356|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009357|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009358|NCT01842893|Analgesics|analgesics|mesh-ancestor
15009359|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
15009360|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009361|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15009362|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15009363|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
15009364|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
15009365|NCT01842932|Bromides|bromides|mesh-list
15009366|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
15009367|NCT01842932|Cimetropium|cimetropium|mesh-list
15009368|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
15009369|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
15009370|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009371|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009372|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009373|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
15009374|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
15009375|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009376|NCT01843010|Parecoxib|parecoxib|mesh-list
15009377|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15009378|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15009379|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009380|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009381|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15009382|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15009383|NCT01843010|Analgesics|analgesics|mesh-ancestor
15009384|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
15009385|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009386|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009387|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15009388|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15009389|NCT01843075|Liraglutide|liraglutide|mesh-list
15009390|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15009391|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009392|NCT01843075|Incretins|incretins|mesh-ancestor
15009393|NCT01843075|Hormones|hormones|mesh-ancestor
15009394|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15009395|NCT01843088|Mannitol|mannitol|mesh-list
15009396|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15009397|NCT01843088|Diuretics|diuretics|mesh-ancestor
15009398|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
15009399|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009400|NCT01843127|Exenatide|exenatide|mesh-list
15009401|NCT01843127|Ranolazine|ranolazine|mesh-list
15009402|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15009403|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009404|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15009405|NCT01843127|Incretins|incretins|mesh-ancestor
15009406|NCT01843127|Hormones|hormones|mesh-ancestor
15009407|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15009408|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15009409|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15009410|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009411|NCT01843153|Ropivacaine|ropivacaine|mesh-list
15009412|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
15009413|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
15009414|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009415|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009416|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
15009417|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009418|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15009419|NCT01843166|Estrogens|estrogens|mesh-ancestor
15009420|NCT01843166|Hormones|hormones|mesh-ancestor
15009421|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15009422|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009423|NCT01843179|Cytarabine|cytarabine|mesh-list
15009424|NCT01843179|Sulindac|sulindac|mesh-list
15009425|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15009426|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
15009427|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009428|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009429|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
14524282|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14524283|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14524284|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14524285|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524286|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802226|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14802227|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14802228|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
14802229|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14802230|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15009430|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009431|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15009432|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
15009433|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009434|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15009435|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15009436|NCT01843179|Analgesics|analgesics|mesh-ancestor
15009437|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
15009438|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009439|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15009440|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15009441|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15009442|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524287|NCT03655080|Paclitaxel|paclitaxel|mesh-list
14524288|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14524289|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14524290|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524291|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
14524292|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
14524293|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
14524294|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524295|NCT03655301|Metformin|metformin|mesh-list
14524296|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14802231|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14802232|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802233|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802234|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15009443|NCT01843257|Ethanol|ethanol|mesh-list
15009444|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15009445|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009446|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009447|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009448|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
15009449|NCT01843296|Fentanyl|fentanyl|mesh-list
15009450|NCT01843296|Bupivacaine|bupivacaine|mesh-list
15009451|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
15009452|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
15009453|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009454|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009455|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
15009456|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009457|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15009458|NCT01843296|Narcotics|narcotics|mesh-ancestor
15009459|NCT01843296|Analgesics|analgesics|mesh-ancestor
15009460|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15009461|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15009462|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
15009463|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15009464|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
15009465|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15009466|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15009467|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009468|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15009469|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
15009470|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15009471|NCT01843309|Spironolactone|spironolactone|mesh-list
15033266|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
15009472|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15009473|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
15009474|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15009475|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009476|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15009477|NCT01843309|Diuretics|diuretics|mesh-ancestor
15009478|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
15009479|NCT01843439|Pyridoxine|pyridoxine|mesh-list
15009480|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
15009481|NCT01843439|Vitamins|vitamins|mesh-ancestor
15009482|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
15009483|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009484|NCT01843452|Capecitabine|capecitabine|mesh-list
15009485|NCT01843452|Mitomycins|mitomycins|mesh-list
15009486|NCT01843452|Mitomycin|mitomycin|mesh-list
15009487|NCT01843452|Panitumumab|panitumumab|mesh-list
15009488|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15009489|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
15009490|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009491|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009492|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15009493|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
15009494|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15009495|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009496|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15009497|NCT01843530|Cortisone|cortisone|mesh-list
15009498|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15009499|NCT01843556|Donepezil|donepezil|mesh-list
15009500|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15009501|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009502|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009503|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
15009504|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009505|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009506|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
15033267|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033268|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033269|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
15033270|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15033271|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15033272|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
15033273|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033274|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15033275|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15033276|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15033277|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033278|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
15033279|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
15033280|NCT01987310|Atorvastatin|atorvastatin|mesh-list
15033281|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15033282|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15033283|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
15033284|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033285|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15033286|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15033287|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033288|NCT01987323|Latanoprost|latanoprost|mesh-list
15033289|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15033290|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15033291|NCT01987375|Cetuximab|cetuximab|mesh-list
15033292|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15033293|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033294|NCT01987570|Allopurinol|allopurinol|mesh-list
15033295|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
15033296|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033297|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033298|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
15033299|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15033300|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15033301|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
15033302|NCT01987570|Protective Agents|protective agents|mesh-ancestor
15033303|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033304|NCT01987739|Zolpidem|zolpidem|mesh-list
15033305|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15033306|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15009507|NCT01843647|Cisplatin|cisplatin|mesh-list
15009508|NCT01843647|Vinorelbine|vinorelbine|mesh-list
15009509|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009510|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15009511|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
15009512|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
15009513|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
15009514|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009515|NCT01843699|Topiramate|topiramate|mesh-list
15009516|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
15009517|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15009518|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009519|NCT01843725|Capecitabine|capecitabine|mesh-list
15009520|NCT01843725|Aflibercept|aflibercept|mesh-list
15009521|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15009522|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
15009523|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009524|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009525|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15009526|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15009527|NCT01843725|Growth Substances|growth substances|mesh-ancestor
15009528|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009529|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
15009530|NCT01843738|Vemurafenib|vemurafenib|mesh-list
15009531|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009532|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15009533|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009534|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009535|NCT01843829|Paclitaxel|paclitaxel|mesh-list
15009536|NCT01843829|Carboplatin|carboplatin|mesh-list
15009537|NCT01843829|Capecitabine|capecitabine|mesh-list
15009538|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
15009539|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15009540|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009541|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
15009542|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
15009543|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
15009544|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009545|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15009546|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
15009547|NCT01843868|Prednisolone|prednisolone|mesh-list
15009548|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
15009549|NCT01843868|Doxorubicin|doxorubicin|mesh-list
15009550|NCT01843868|Vincristine|vincristine|mesh-list
15009551|NCT01843868|Lorazepam|lorazepam|mesh-list
15009552|NCT01843868|Ondansetron|ondansetron|mesh-list
15009553|NCT01843868|Aprepitant|aprepitant|mesh-list
15009554|NCT01843868|Palonosetron|palonosetron|mesh-list
15009555|NCT01843868|Metoclopramide|metoclopramide|mesh-list
15009556|NCT01843868|Granisetron|granisetron|mesh-list
15009557|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
15009558|NCT01843868|Tropisetron|tropisetron|mesh-list
15009559|NCT01843868|Antiemetics|antiemetics|mesh-list
15009560|NCT01843868|Emetics|emetics|mesh-list
15009561|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15009562|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
15009563|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009564|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15009565|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15009566|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
15009567|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009568|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009569|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15009570|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15009571|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15009572|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15009573|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009574|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15009575|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
15009576|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
15009577|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
15009578|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15009579|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
15009580|NCT01843868|Hormones|hormones|mesh-ancestor
15009581|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15009582|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15009583|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
15009584|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009585|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15009586|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
15009587|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
15009588|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15009589|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
15009590|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009591|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15009592|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15009593|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009594|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15009595|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15009596|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15009597|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15009598|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15009599|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15009600|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
15009601|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
15009602|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15009603|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
15009604|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
15009605|NCT01843998|Sirolimus|sirolimus|mesh-list
15009606|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15009607|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009608|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15009609|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009610|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
15009611|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15009612|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
15009613|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009614|NCT01844024|Misoprostol|misoprostol|mesh-list
15009615|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15009616|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
15009617|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15009618|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009619|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15009620|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15009621|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
15009622|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
15009623|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009624|NCT01844141|Ethanol|ethanol|mesh-list
15009625|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
15009626|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15009627|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15009628|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009629|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009630|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009631|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
15009632|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
15009633|NCT01844323|Palbociclib|palbociclib|mesh-list
15009634|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009635|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15009636|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009637|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009638|NCT01844401|Albuterol|albuterol|mesh-list
15009639|NCT01844401|Procaterol|procaterol|mesh-list
15009640|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15009641|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
15009642|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009643|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009644|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15009645|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
15009646|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
15009647|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15009648|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15009649|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15009650|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15009651|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
15009652|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009653|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009654|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
15009655|NCT01844427|Memantine|memantine|mesh-list
15009656|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15009657|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15009658|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
15009659|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009660|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009661|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009662|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15009663|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15009664|NCT01844622|Domperidone|domperidone|mesh-list
15009665|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
15009666|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
15009667|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009668|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009669|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15009670|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15009671|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
15009672|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009673|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009674|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
15009675|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
15009676|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009677|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15009678|NCT01844648|Tropicamide|tropicamide|mesh-list
14524297|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524298|NCT03655444|Nivolumab|nivolumab|mesh-list
14524299|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14524300|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524301|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14524302|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802235|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14802236|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14802237|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
14802238|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802239|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802240|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14802241|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14802242|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
14802243|NCT00796458|Docetaxel|docetaxel|mesh-list
14802244|NCT00796458|Hormones|hormones|mesh-list
14524303|NCT03657095|Beraprost|beraprost|mesh-list
14524304|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14524305|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
15009679|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
15009680|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
15009681|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009682|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009683|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15009684|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15009685|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
15009686|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009687|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009688|NCT01844674|Vemurafenib|vemurafenib|mesh-list
15009689|NCT01844674|Tizanidine|tizanidine|mesh-list
15009690|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009691|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15009692|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009693|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009694|NCT01844674|Analgesics|analgesics|mesh-ancestor
15009695|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
15009696|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009697|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009698|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
15009699|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15009700|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15009701|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
15009702|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
15009703|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15009704|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15009705|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15009706|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
15009707|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009708|NCT01844791|Gemcitabine|gemcitabine|mesh-list
15009709|NCT01844791|Pentamidine|pentamidine|mesh-list
15009710|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15009711|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
15009712|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009713|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009714|NCT01844791|Antiviral Agents|antiviral agents|mesh-ancestor
15009715|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009716|NCT01844791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009717|NCT01844791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15009718|NCT01844791|Immunologic Factors|immunologic factors|mesh-ancestor
15009719|NCT01844791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009720|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
15009721|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15009722|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15009723|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15009724|NCT01844804|Infliximab|infliximab|mesh-list
15009725|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
15009726|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15009727|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15009728|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
15009729|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15009730|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009731|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15009732|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009733|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009734|NCT01844947|Sorafenib|sorafenib|mesh-list
15009735|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009736|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15009737|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009738|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009739|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
15009740|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15009741|NCT01845038|Timolol|timolol|mesh-list
14802245|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802246|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
14802247|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
14802248|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
14802249|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802250|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14802251|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802252|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14802253|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14802254|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14802255|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009742|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15009743|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15009744|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
15009745|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009746|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009747|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009748|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15009749|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15009750|NCT01845064|Kallikreins|kallikreins|mesh-list
15009751|NCT01845064|Coagulants|coagulants|mesh-ancestor
15009752|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
15009753|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
15009754|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15009755|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009756|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
15009757|NCT01845090|Calcium|calcium|mesh-list
15009758|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15009759|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009760|NCT01845090|Antacids|antacids|mesh-ancestor
15009761|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009762|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15009763|NCT01845142|Vitamin D|vitamin d|mesh-list
15009764|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
15009765|NCT01845142|Vitamins|vitamins|mesh-ancestor
15009766|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
15009767|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009768|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15009769|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15009770|NCT01845194|Metoprolol|metoprolol|mesh-list
15009771|NCT01845194|Talinolol|talinolol|mesh-list
15009772|NCT01845194|Torsemide|torsemide|mesh-list
15009773|NCT01845194|Midazolam|midazolam|mesh-list
15009774|NCT01845194|Codeine|codeine|mesh-list
15009775|NCT01845194|Caffeine|caffeine|mesh-list
15009776|NCT01845194|Pravastatin|pravastatin|mesh-list
15009777|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15009778|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15009779|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009780|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009781|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15009782|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15009783|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14524306|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
14524307|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15009784|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15009785|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
15009786|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
15009787|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
15009788|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
15009789|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15009790|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009791|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15009792|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15009793|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009794|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15009795|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15009796|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
15009797|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15009798|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15009799|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
15009800|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
15009801|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009802|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15009803|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15009804|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15009805|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
15009806|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15009807|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15009808|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
15009809|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15009810|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15009811|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15009812|NCT01845194|Narcotics|narcotics|mesh-ancestor
15009813|NCT01845194|Analgesics|analgesics|mesh-ancestor
15009814|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
15009815|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
15009816|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
15009817|NCT01845194|Diuretics|diuretics|mesh-ancestor
15009818|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
15009819|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15009820|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15009821|NCT01845246|Colistin|colistin|mesh-list
15009822|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15009823|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009824|NCT01845259|Liraglutide|liraglutide|mesh-list
15009825|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15009826|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009827|NCT01845259|Incretins|incretins|mesh-ancestor
15009828|NCT01845259|Hormones|hormones|mesh-ancestor
15009829|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15009830|NCT01845272|Amlodipine|amlodipine|mesh-list
15009831|NCT01845272|Candesartan|candesartan|mesh-list
15009832|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
15009833|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15009834|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15009835|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15009836|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009837|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15009838|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009839|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
15009840|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15009841|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15009842|NCT01845298|Rifampin|rifampin|mesh-list
15009843|NCT01845298|Rifamycins|rifamycins|mesh-list
15009844|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15009845|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
15009846|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15009847|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009848|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
15009849|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15009850|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009851|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009852|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15009853|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15009854|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15009855|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15009856|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15009857|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15009858|NCT01845337|Capecitabine|capecitabine|mesh-list
15009859|NCT01845337|Tegafur|tegafur|mesh-list
15009860|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15009861|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
15009862|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009863|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009864|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
15009865|NCT01845363|Cefazolin|cefazolin|mesh-list
15009866|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15009867|NCT01845376|Anesthetics|anesthetics|mesh-list
15009868|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009869|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033307|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15033308|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033309|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15033310|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
15033311|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
15033312|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033313|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033314|NCT01987804|Oxytocin|oxytocin|mesh-list
15033315|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
15033316|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15033317|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033318|NCT01988077|Ipilimumab|ipilimumab|mesh-list
15033319|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15033320|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033321|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15033322|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033323|NCT01988116|Calcitriol|calcitriol|mesh-list
15033324|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15033325|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033326|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15033327|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15033328|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033329|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15033330|NCT01988116|Vitamins|vitamins|mesh-ancestor
15033331|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
15033332|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15035494|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035495|NCT02001857|Hemostatics|hemostatics|mesh-list
15035496|NCT02001857|Coagulants|coagulants|mesh-ancestor
15035497|NCT02001883|Policosanol|policosanol|mesh-list
15009870|NCT01845428|Pravastatin|pravastatin|mesh-list
15009871|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15009872|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15009873|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
15009874|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009875|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15009876|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15009877|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009878|NCT01845493|Sulforaphane|sulforaphane|mesh-list
15009879|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15009880|NCT01845493|Protective Agents|protective agents|mesh-ancestor
15009881|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009882|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009883|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15009884|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
15009885|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
15009886|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15009887|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009888|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
15009889|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15009890|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15009891|NCT01845558|Wobenzym|wobenzym|mesh-list
15009892|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15009893|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
15009894|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009895|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
15009896|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15009897|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
15009898|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15009899|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
15009900|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009901|NCT01845610|Manganese|manganese|mesh-list
15009902|NCT01845610|Trace Elements|trace elements|mesh-ancestor
15009903|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
15009904|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009905|NCT01845675|Temozolomide|temozolomide|mesh-list
15009906|NCT01845675|Dacarbazine|dacarbazine|mesh-list
14802256|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802257|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802258|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14802259|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14802260|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
14802261|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802262|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802263|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14802264|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14802265|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
14802266|NCT00796497|Ondansetron|ondansetron|mesh-list
14802267|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
14802268|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
14802269|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802270|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802271|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14802272|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
14802273|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
14802274|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14802275|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
14802276|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802277|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802278|NCT00796497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14802279|NCT00796497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14802280|NCT00796497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802281|NCT00796497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802282|NCT00796497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14802283|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14802284|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14802285|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14802286|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802287|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802288|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802289|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14802290|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15009907|NCT01845675|Endostatins|endostatins|mesh-list
15009908|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14802291|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
14802292|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802293|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802294|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14802295|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14802296|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
14802297|NCT00796692|Heparin|heparin|mesh-list
15009909|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
15009910|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009911|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009912|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15009913|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15009914|NCT01845675|Growth Substances|growth substances|mesh-ancestor
15009915|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009916|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
15009917|NCT01845688|Losartan|losartan|mesh-list
15009918|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15009919|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15009920|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15009921|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15009922|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009923|NCT01845701|Artesunate|artesunate|mesh-list
15009924|NCT01845701|Lumefantrine|lumefantrine|mesh-list
15009925|NCT01845701|Artemether|artemether|mesh-list
15009926|NCT01845701|Piperaquine|piperaquine|mesh-list
15009927|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15009928|NCT01845701|Amodiaquine|amodiaquine|mesh-list
15009929|NCT01845701|Artenimol|artenimol|mesh-list
15009930|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
15009931|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15009932|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15009933|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009934|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009935|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
15009936|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
15009937|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15009938|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
15009939|NCT01845727|Amphotericin B|amphotericin b|mesh-list
15009940|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15009941|NCT01845727|Amebicides|amebicides|mesh-ancestor
15009942|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14802298|NCT00796692|Calcium heparin|calcium heparin|mesh-list
14802299|NCT00796692|Nadroparin|nadroparin|mesh-list
14802300|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
14802301|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14802302|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14802303|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802304|NCT00796796|Sirolimus|sirolimus|mesh-list
14802305|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14802306|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802307|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14802308|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802309|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
15009943|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15009944|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009945|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15009946|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
15009947|NCT01845805|Gemcitabine|gemcitabine|mesh-list
15009948|NCT01845805|Azacitidine|azacitidine|mesh-list
15009949|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15009950|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
15009951|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15009952|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009953|NCT01845805|Antiviral Agents|antiviral agents|mesh-ancestor
15009954|NCT01845805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15009955|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15009956|NCT01845805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15009957|NCT01845805|Immunologic Factors|immunologic factors|mesh-ancestor
15009958|NCT01845805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009959|NCT01845844|Ranibizumab|ranibizumab|mesh-list
15009960|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15009961|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15009962|NCT01845844|Growth Substances|growth substances|mesh-ancestor
15009963|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009964|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
15009965|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009966|NCT01846026|Vitamin D|vitamin d|mesh-list
15009967|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
15009968|NCT01846026|Vitamins|vitamins|mesh-ancestor
15009969|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
15009970|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009971|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15009972|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15009973|NCT01846117|Vitamin D|vitamin d|mesh-list
15009974|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
15009975|NCT01846117|Vitamins|vitamins|mesh-ancestor
15009976|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
15009977|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009978|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15009979|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
15009980|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15009981|NCT01846117|Estrogens|estrogens|mesh-ancestor
15009982|NCT01846117|Hormones|hormones|mesh-ancestor
15009983|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15009984|NCT01846143|Poly ICLC|poly iclc|mesh-list
15009985|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
15009986|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009987|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
15009988|NCT01846273|Ranibizumab|ranibizumab|mesh-list
15009989|NCT01846273|Verteporfin|verteporfin|mesh-list
15009990|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15009991|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15009992|NCT01846273|Growth Substances|growth substances|mesh-ancestor
15009993|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15009994|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
15009995|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15009996|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15009997|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
15009998|NCT01846325|Vitamin E|vitamin e|mesh-list
15009999|NCT01846325|Vitamins|vitamins|mesh-ancestor
15010000|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
15010001|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010002|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
15010003|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010004|NCT01846325|Protective Agents|protective agents|mesh-ancestor
15010005|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
15010006|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15010007|NCT01846364|Protective Agents|protective agents|mesh-ancestor
15010008|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010009|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010010|NCT01846390|Gemcitabine|gemcitabine|mesh-list
15010011|NCT01846390|Dexamethasone|dexamethasone|mesh-list
15010012|NCT01846390|Romidepsin|romidepsin|mesh-list
15010013|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010014|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15010015|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
15010016|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
15010017|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010018|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010019|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15010020|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
15010021|NCT01846390|Hormones|hormones|mesh-ancestor
15010022|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15010023|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15010024|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15010025|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
15010026|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010027|NCT01846390|Antiviral Agents|antiviral agents|mesh-ancestor
15010028|NCT01846390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010029|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010030|NCT01846390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15010031|NCT01846390|Immunologic Factors|immunologic factors|mesh-ancestor
15010032|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15010033|NCT01846559|Clopidogrel|clopidogrel|mesh-list
15010034|NCT01846559|Ticagrelor|ticagrelor|mesh-list
15010035|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15010036|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15010037|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15010038|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15010039|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
15010040|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010041|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010042|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010043|NCT01846650|Capecitabine|capecitabine|mesh-list
15010044|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15010045|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
15010046|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010047|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010048|NCT01846806|Rifaximin|rifaximin|mesh-list
15010049|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15010050|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010051|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15010052|NCT01846832|Interferons|interferons|mesh-list
15010053|NCT01846832|Ribavirin|ribavirin|mesh-list
15010054|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
15010055|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
15010056|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15010057|NCT01846832|Simeprevir|simeprevir|mesh-list
15010058|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010059|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
15010060|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010061|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
15010062|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010063|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
15010064|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010065|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
15010066|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010067|NCT01846962|Fluticasone|fluticasone|mesh-list
15010068|NCT01846962|Budesonide|budesonide|mesh-list
15010069|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15010070|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15010071|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
15010072|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010073|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010074|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15010075|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
15010076|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
15010077|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15010078|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
15010079|NCT01846962|Hormones|hormones|mesh-ancestor
15010080|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15010081|NCT01846975|Abatacept|abatacept|mesh-list
15010082|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15010083|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010084|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010085|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15010086|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
15010087|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010088|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15010089|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15010090|NCT01847144|Gliclazide|gliclazide|mesh-list
15010091|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15010092|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15010093|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010094|NCT01847144|Incretins|incretins|mesh-ancestor
15010095|NCT01847144|Hormones|hormones|mesh-ancestor
15033333|NCT01988298|Acetaminophen|acetaminophen|mesh-list
15010096|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15010097|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
15010098|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010099|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010100|NCT01847157|Anesthetics|anesthetics|mesh-list
15010101|NCT01847157|Prilocaine|prilocaine|mesh-list
15010102|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15010103|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010104|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
15010105|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
15010106|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033334|NCT01988298|Ibuprofen|ibuprofen|mesh-list
15033335|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15033336|NCT01988298|Analgesics|analgesics|mesh-ancestor
15033337|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
15033338|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033339|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033340|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
15033341|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15033342|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15033343|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15033344|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15033345|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033346|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033347|NCT01988311|Psilocybin|psilocybin|mesh-list
15033348|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
14802310|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802311|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
14802312|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802313|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14802314|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14802315|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14802316|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802317|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802318|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802319|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14802320|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14802321|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
14802322|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802323|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802324|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14802325|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15033349|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033350|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15033351|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
15033352|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15033353|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15033354|NCT01988506|Interleukin-2|interleukin-2|mesh-list
15033355|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033356|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15033357|NCT01988506|Analgesics|analgesics|mesh-ancestor
15033358|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
15033359|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033360|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033361|NCT01988545|Exenatide|exenatide|mesh-list
15033362|NCT01988545|Glucagon|glucagon|mesh-list
15033363|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15033364|NCT01988545|Incretins|incretins|mesh-ancestor
15033365|NCT01988545|Hormones|hormones|mesh-ancestor
15033366|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15033367|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033368|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15033369|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15033370|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15033371|NCT01988610|Mifepristone|mifepristone|mesh-list
15033372|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15033373|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
15033374|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15033375|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033376|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15033377|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15033378|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15033379|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
15010107|NCT01847235|Temozolomide|temozolomide|mesh-list
15010108|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15010109|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
15010110|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010111|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010112|NCT01847326|Paclitaxel|paclitaxel|mesh-list
15010113|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15010114|NCT01847326|Carboplatin|carboplatin|mesh-list
15010115|NCT01847326|Fluorouracil|fluorouracil|mesh-list
15010116|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
15010117|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15010118|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010119|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
15010120|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
15010121|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
15010122|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010123|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
15010124|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15010125|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15010126|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
15010127|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010128|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
15010129|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010130|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15010131|NCT01847339|Bupivacaine|bupivacaine|mesh-list
15010132|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
15010133|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
15010134|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15010135|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010136|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
15010137|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010138|NCT01847404|Aspirin|aspirin|mesh-list
15010139|NCT01847404|Pantoprazole|pantoprazole|mesh-list
15010140|NCT01847404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15010141|NCT01847404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15010142|NCT01847404|Analgesics|analgesics|mesh-ancestor
15010143|NCT01847404|Sensory System Agents|sensory system agents|mesh-ancestor
15010144|NCT01847404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010145|NCT01847404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010146|NCT01847404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15010147|NCT01847404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15010148|NCT01847404|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15010149|NCT01847404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14802326|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
14802327|NCT00796887|Niacin|niacin|mesh-list
14802328|NCT00796887|Niacinamide|niacinamide|mesh-list
14802329|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
14802330|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14802331|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
14802332|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802333|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14802334|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
14802335|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
14802336|NCT00796887|Vitamins|vitamins|mesh-ancestor
14802337|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
14802338|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802339|NCT00796900|Dantrolene|dantrolene|mesh-list
14802340|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15010150|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010151|NCT01847404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15010152|NCT01847404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15010153|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010154|NCT01847404|Antipyretics|antipyretics|mesh-ancestor
15010155|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15010156|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15010157|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15010158|NCT01847417|Pantoprazole|pantoprazole|mesh-list
15010159|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15010160|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15010161|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15010162|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010163|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010164|NCT01847456|Insulin|insulin|mesh-list
15010165|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15010166|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15010167|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010168|NCT01847495|Irinotecan|irinotecan|mesh-list
15010169|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15010170|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15010171|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010172|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010173|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010174|NCT01847521|Quercetin|quercetin|mesh-list
15010175|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
15010176|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010177|NCT01847521|Protective Agents|protective agents|mesh-ancestor
15010178|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010179|NCT01847599|Capecitabine|capecitabine|mesh-list
15010180|NCT01847599|Lapatinib|lapatinib|mesh-list
15010181|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15010182|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
15010183|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010184|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010185|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15010186|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010187|NCT01847612|Methylene Blue|methylene blue|mesh-list
15010188|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010189|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010190|NCT01847664|Rifamycins|rifamycins|mesh-list
15010191|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
15010192|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15010193|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524308|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524309|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14524310|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14524311|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524312|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010194|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15010195|NCT01847677|Paclitaxel|paclitaxel|mesh-list
15010196|NCT01847677|Bevacizumab|bevacizumab|mesh-list
15010197|NCT01847677|Carboplatin|carboplatin|mesh-list
15010198|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15010199|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010200|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
15010201|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
15010202|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
15010203|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010204|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15010205|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15010206|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15010207|NCT01847677|Growth Substances|growth substances|mesh-ancestor
15010208|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010209|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
15010210|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
15010211|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15010212|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
15010213|NCT01847768|Miotics|miotics|mesh-ancestor
15010214|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
15010215|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010216|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010217|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15010218|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
15010219|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
15010220|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15010221|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15010222|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
15010223|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010224|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010225|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15010226|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
15010227|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010228|NCT01847872|Vaccines|vaccines|mesh-list
15010229|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
15010230|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010231|NCT01847976|Doxycycline|doxycycline|mesh-list
15010232|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15010233|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010234|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
15010235|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15010236|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15010237|NCT01848106|Bivalirudin|bivalirudin|mesh-list
15010238|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
15010239|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15010240|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
15010241|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010242|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010243|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
15010244|NCT01848119|Gabapentin|gabapentin|mesh-list
15010245|NCT01848119|Analgesics|analgesics|mesh-ancestor
15010246|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
15010247|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010248|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010249|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
15010250|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15010251|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15010252|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15010253|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15010254|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15010255|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15010256|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010257|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010258|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
15010259|NCT01848132|Prednisone|prednisone|mesh-list
15010260|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
15010261|NCT01848132|Rituximab|rituximab|mesh-list
15010262|NCT01848132|Doxorubicin|doxorubicin|mesh-list
15010263|NCT01848132|Vincristine|vincristine|mesh-list
15010264|NCT01848132|Bortezomib|bortezomib|mesh-list
15010265|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15010266|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
15010267|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010268|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15010269|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15010270|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
15010271|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010272|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010273|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15010274|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15010275|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15010276|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15010277|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15010278|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010279|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15010280|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
15010281|NCT01848132|Hormones|hormones|mesh-ancestor
15010282|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15010283|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15010284|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15010285|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
15010286|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
15010287|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
15010288|NCT01848197|Paclitaxel|paclitaxel|mesh-list
15010289|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15010290|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010291|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
15010292|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
15010293|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
15010294|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010295|NCT01848236|Vitamin D|vitamin d|mesh-list
15010296|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
15010297|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
15010298|NCT01848236|Vitamins|vitamins|mesh-list
15010299|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
15010300|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010301|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15010302|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15010303|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
15010304|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
15010305|NCT01848301|Acetylcholine|acetylcholine|mesh-list
15010306|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
15010307|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15010308|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
15010309|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010310|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010311|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010312|NCT01848340|Cabotegravir|cabotegravir|mesh-list
15010313|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15010314|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15010315|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802341|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802342|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14802343|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010316|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010317|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15010318|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15010319|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
15010320|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010321|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15010322|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010323|NCT01848613|Vinorelbine|vinorelbine|mesh-list
15010324|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15010325|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010326|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
15010327|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
15010328|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
15010329|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010330|NCT01848639|Spironolactone|spironolactone|mesh-list
15010331|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15010332|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
15010333|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15010334|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010335|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15010336|NCT01848639|Diuretics|diuretics|mesh-ancestor
15010337|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
15010338|NCT01848652|Doxorubicin|doxorubicin|mesh-list
15010339|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15010340|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010341|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15010342|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15010343|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010344|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010345|NCT01848665|Indomethacin|indomethacin|mesh-list
15010346|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15010347|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15010348|NCT01848665|Analgesics|analgesics|mesh-ancestor
15010349|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
15010350|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035498|NCT02001883|Atorvastatin|atorvastatin|mesh-list
14802344|NCT00797017|Fentanyl|fentanyl|mesh-list
14802345|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14802346|NCT00797017|Narcotics|narcotics|mesh-ancestor
14802347|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802348|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802349|NCT00797017|Analgesics|analgesics|mesh-ancestor
15010351|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010352|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15010353|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15010354|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
15010355|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
15010356|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15010357|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15010358|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010359|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010360|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
15010361|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
15010362|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010363|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
15010364|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010365|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010366|NCT01848743|Tenofovir|tenofovir|mesh-list
15010367|NCT01848743|Lamivudine|lamivudine|mesh-list
15010368|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
15010369|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010370|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15010371|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15010372|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010373|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010374|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15010375|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15010376|NCT01848769|Beclomethasone|beclomethasone|mesh-list
15010377|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
15010378|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15010379|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
15010380|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010381|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010382|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15010383|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
15010384|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15010385|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15010386|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15010387|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
15010388|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010389|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010390|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15010391|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
15010392|NCT01848769|Hormones|hormones|mesh-ancestor
15010393|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15010394|NCT01848808|Wobenzym|wobenzym|mesh-list
15010395|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15010396|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
15010397|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010398|NCT01848873|Amlodipine|amlodipine|mesh-list
15010399|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15010400|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15010401|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15010402|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010403|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15010404|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010405|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
15010406|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
15010407|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010408|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
15010409|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010410|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010411|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15033380|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15033381|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15033382|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
15033383|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15033384|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
15033385|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15033386|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15033387|NCT01988649|Oxytocin|oxytocin|mesh-list
15033388|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
15033389|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15033390|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033391|NCT01988831|Propranolol|propranolol|mesh-list
15010412|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
15010413|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15010414|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
15010415|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010416|NCT01849016|Expectorants|expectorants|mesh-ancestor
15010417|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
15010418|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15010419|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
15010420|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010421|NCT01849016|Protective Agents|protective agents|mesh-ancestor
15010422|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010423|NCT01849016|Antidotes|antidotes|mesh-ancestor
15010424|NCT01849042|Donepezil|donepezil|mesh-list
15010425|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15010426|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010427|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010428|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
15010429|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010430|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010431|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
15010432|NCT01849094|Milrinone|milrinone|mesh-list
15010433|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15010434|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15010435|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
15010436|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15010437|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15010438|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010439|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010440|NCT01849094|Protective Agents|protective agents|mesh-ancestor
15010441|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010442|NCT01849211|Rocuronium|rocuronium|mesh-list
15010443|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15010444|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15010445|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15010446|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010447|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010448|NCT01849406|Budesonide|budesonide|mesh-list
15010449|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15010450|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15010451|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
15010452|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010453|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010454|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15010455|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
15010456|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
15010457|NCT01849406|Hormones|hormones|mesh-ancestor
15010458|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15010459|NCT01849640|Piperaquine|piperaquine|mesh-list
15010460|NCT01849640|Primaquine|primaquine|mesh-list
15010461|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
15010462|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15010463|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15010464|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010465|NCT01849666|Vemurafenib|vemurafenib|mesh-list
15010466|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
15010467|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010468|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15010469|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010470|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010471|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
15010472|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
15010473|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15010474|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15010475|NCT01849783|Thalidomide|thalidomide|mesh-list
15010476|NCT01849783|Dexamethasone|dexamethasone|mesh-list
15010477|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
15010478|NCT01849783|Melphalan|melphalan|mesh-list
15010479|NCT01849783|Doxorubicin|doxorubicin|mesh-list
15010480|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15010481|NCT01849783|Etoposide|etoposide|mesh-list
15010482|NCT01849783|Bortezomib|bortezomib|mesh-list
15010483|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
15010484|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15010485|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
15010486|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010487|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15010488|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15010489|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
15010490|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010491|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010492|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15010493|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15010494|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
15010495|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
15010496|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010497|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15010498|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
15010499|NCT01849783|Hormones|hormones|mesh-ancestor
15010500|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15010501|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15010502|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15010503|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15010504|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15010505|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010506|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15010507|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
15010508|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15010509|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010510|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15010511|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15010512|NCT01849783|Growth Substances|growth substances|mesh-ancestor
15010513|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
15010514|NCT01849835|Menthol|menthol|mesh-list
15010515|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
15010516|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
15010517|NCT01849861|Methimazole|methimazole|mesh-list
15010518|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
15010519|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
15010520|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15010521|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010522|NCT01849926|Amdinocillin|amdinocillin|mesh-list
15010523|NCT01849926|Ibuprofen|ibuprofen|mesh-list
15010524|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15010525|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15010526|NCT01849926|Analgesics|analgesics|mesh-ancestor
15010527|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
15010528|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010529|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010530|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15010531|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15010532|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15010533|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010534|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010535|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15010536|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010537|NCT01849926|Renal Agents|renal agents|mesh-ancestor
15010538|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15010539|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
15010540|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
15010541|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010542|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
15010543|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15010544|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15010545|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010546|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15010547|NCT01850017|Analgesics|analgesics|mesh-ancestor
15010548|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
15010549|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010550|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15010551|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15010552|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15010553|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
15010554|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010555|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010556|NCT01850095|Azelaic acid|azelaic acid|mesh-list
15010557|NCT01850095|Estradiol|estradiol|mesh-list
15010558|NCT01850095|Estrogens|estrogens|mesh-ancestor
15010559|NCT01850095|Hormones|hormones|mesh-ancestor
15010560|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15010561|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010562|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010563|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
15010564|NCT01850121|Infliximab|infliximab|mesh-list
15010565|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
15010566|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15010567|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15010568|NCT01850147|Sunitinib|sunitinib|mesh-list
15010569|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010570|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15010571|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15010572|NCT01850147|Growth Substances|growth substances|mesh-ancestor
15010573|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010574|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
15010575|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15010576|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010577|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010578|NCT01850160|Valsartan|valsartan|mesh-list
15010579|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
15010580|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
15010581|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
15010582|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15010583|NCT01850160|Diuretics|diuretics|mesh-list
15010584|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
15010585|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15010586|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524313|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524314|NCT03657407|Glycerol|glycerol|mesh-list
14524315|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14524316|NCT03657407|Protective Agents|protective agents|mesh-ancestor
14524317|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524318|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14524319|NCT03658876|Hematinics|hematinics|mesh-ancestor
14524320|NCT03661346|Labetalol|labetalol|mesh-list
14524321|NCT03661346|Esmolol|esmolol|mesh-list
14524322|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14524323|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14524324|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14524325|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
15010587|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
15010588|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010589|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15010590|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15010591|NCT01850251|Vitamin D|vitamin d|mesh-list
15010592|NCT01850251|Vitamins|vitamins|mesh-ancestor
15010593|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
15010594|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010595|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15010596|NCT01850277|Amiodarone|amiodarone|mesh-list
15010597|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14524326|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010598|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
15010599|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15010600|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15010601|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010602|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15010603|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15010604|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15010605|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010606|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15010607|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15010608|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15010609|NCT01850303|Gemcitabine|gemcitabine|mesh-list
15010610|NCT01850303|Pemetrexed|pemetrexed|mesh-list
15010611|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15010612|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
15010613|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010614|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010615|NCT01850303|Antiviral Agents|antiviral agents|mesh-ancestor
15010616|NCT01850303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010617|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010618|NCT01850303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15010619|NCT01850303|Immunologic Factors|immunologic factors|mesh-ancestor
15010620|NCT01850303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010621|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15010622|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15010623|NCT01850511|Phenylephrine|phenylephrine|mesh-list
15010624|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
15010625|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15010626|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15010627|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
15010628|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010629|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010630|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010631|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
15010632|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
15010633|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010634|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
15010635|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15010636|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
15010637|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15010638|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
15010639|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15010640|NCT01850511|Protective Agents|protective agents|mesh-ancestor
15010641|NCT01850628|Paclitaxel|paclitaxel|mesh-list
15010642|NCT01850628|Trastuzumab|trastuzumab|mesh-list
15010643|NCT01850628|Pertuzumab|pertuzumab|mesh-list
15010644|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15010645|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010646|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
15010647|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
15010648|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
15010649|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010650|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15010651|NCT01850680|Folic Acid|folic acid|mesh-list
15010652|NCT01850680|Methotrexate|methotrexate|mesh-list
15010653|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15010654|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
15010655|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15010656|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010657|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15010658|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
15010659|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010660|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010661|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
15010662|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010663|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15010664|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15010665|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
15010666|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15010667|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15010668|NCT01850680|Hematinics|hematinics|mesh-ancestor
15010669|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
15010670|NCT01850680|Vitamins|vitamins|mesh-ancestor
15010671|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
15010672|NCT01850940|Tolvaptan|tolvaptan|mesh-list
15010673|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15010674|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010675|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
15010676|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010677|NCT01850953|Varenicline|varenicline|mesh-list
15010678|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15010679|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15010680|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
15010681|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010682|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010683|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010684|NCT01850979|Tacrolimus|tacrolimus|mesh-list
15010685|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15010686|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
15010687|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010688|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15010689|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010690|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010691|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
15010692|NCT01851005|Remifentanil|remifentanil|mesh-list
15010693|NCT01851005|Anesthetics|anesthetics|mesh-list
15010694|NCT01851005|Propofol|propofol|mesh-list
15010695|NCT01851005|Sevoflurane|sevoflurane|mesh-list
15010696|NCT01851005|Rocuronium|rocuronium|mesh-list
15010697|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15010698|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010699|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14524327|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524328|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524329|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14524330|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
14524331|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
14524332|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524333|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14524334|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14524335|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
14524336|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14524337|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
14524338|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524339|NCT03661983|Aripiprazole|aripiprazole|mesh-list
14524340|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
15010700|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15010701|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
15010702|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15010703|NCT01851005|Analgesics|analgesics|mesh-ancestor
15010704|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
15010705|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010706|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15010707|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15010708|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15010709|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
15010710|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010711|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010712|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15010713|NCT01851005|Narcotics|narcotics|mesh-ancestor
15010714|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15010715|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15010716|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15010717|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15010718|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15010719|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
15010720|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15010721|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
15010722|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010723|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010724|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010725|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15010726|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15010727|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010728|NCT01851265|Olaparib|olaparib|mesh-list
15010729|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15010730|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010731|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010732|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010733|NCT01851278|Triamcinolone|triamcinolone|mesh-list
15010734|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15010735|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15010736|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15010737|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15010738|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
15010739|NCT01851278|Hormones|hormones|mesh-ancestor
15010740|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15010741|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010742|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15010743|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
15010744|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010745|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010746|NCT01851408|Sirolimus|sirolimus|mesh-list
15010747|NCT01851408|Sorafenib|sorafenib|mesh-list
15010748|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010749|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15010750|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010751|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010752|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15010753|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010754|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15010755|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
15010756|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15010757|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
15010758|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010759|NCT01851473|Quinine|quinine|mesh-list
15010760|NCT01851473|Acetazolamide|acetazolamide|mesh-list
15010761|NCT01851473|Cocaine|cocaine|mesh-list
15010762|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
15010763|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15010764|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010765|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010766|NCT01851473|Diuretics|diuretics|mesh-ancestor
15010767|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
15010768|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010769|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
15010770|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
15010771|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15010772|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
15010773|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035499|NCT02001883|Simvastatin|simvastatin|mesh-list
15010774|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15010775|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15010776|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15010777|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15010778|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
15010779|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010780|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
15010781|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15010782|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15010783|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010784|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15010785|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15010786|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15010787|NCT01851473|Analgesics|analgesics|mesh-ancestor
15010788|NCT01851486|Clonidine|clonidine|mesh-list
15010789|NCT01851486|Naloxone|naloxone|mesh-list
15010790|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15010791|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010792|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
15010793|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010794|NCT01851486|Analgesics|analgesics|mesh-ancestor
15010795|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15010796|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
15010797|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
15010798|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15010799|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15010800|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15010801|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
15010802|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010803|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010804|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15010805|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15010806|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010807|NCT01851551|Rituximab|rituximab|mesh-list
15010808|NCT01851551|Vincristine|vincristine|mesh-list
15010809|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15010810|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010811|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
15010812|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010813|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15010814|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15010815|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
15010816|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
15010817|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
15010818|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010819|NCT01851642|Albuterol|albuterol|mesh-list
15010820|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15010821|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
15010822|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010823|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010824|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15010825|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
15010826|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
15010827|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15010828|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15010829|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15010830|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15010831|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
15010832|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010833|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010834|NCT01851681|Amoxicillin|amoxicillin|mesh-list
15010835|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15010836|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010837|NCT01851733|Doxorubicin|doxorubicin|mesh-list
15010838|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15010839|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010840|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15010841|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15010842|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010843|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010844|NCT01851759|Cinepazide|cinepazide|mesh-list
15010845|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
15010846|NCT01851824|Vemurafenib|vemurafenib|mesh-list
15010847|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
15010848|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010849|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15010850|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010851|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010852|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
15010853|NCT01851850|Opicapone|opicapone|mesh-list
15010854|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
15010855|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010856|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010857|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15010858|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15010859|NCT01851941|Leucovorin|leucovorin|mesh-list
15010860|NCT01851941|Folic Acid|folic acid|mesh-list
15010861|NCT01851941|Fluorouracil|fluorouracil|mesh-list
15010862|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
15010863|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
15010864|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
15010865|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010866|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15010867|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010868|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15010869|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
15010870|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010871|NCT01851941|Antidotes|antidotes|mesh-ancestor
15010872|NCT01851941|Protective Agents|protective agents|mesh-ancestor
15010873|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
15010874|NCT01851941|Vitamins|vitamins|mesh-ancestor
15010875|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
15010876|NCT01851941|Hematinics|hematinics|mesh-ancestor
15010877|NCT01851954|Clarithromycin|clarithromycin|mesh-list
15010878|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15010879|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010880|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15010881|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010882|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010883|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15010884|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15010885|NCT01851980|Furosemide|furosemide|mesh-list
15010886|NCT01851980|Diuretics|diuretics|mesh-ancestor
15010887|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
15010888|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010889|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15010890|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15010891|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010892|NCT01851993|Ondansetron|ondansetron|mesh-list
15010893|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
15010894|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
15010895|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010896|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010897|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15010898|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
15010899|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
15010900|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15010901|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
15010902|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010903|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010904|NCT01851993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15010905|NCT01851993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15010906|NCT01851993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15010907|NCT01851993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15010908|NCT01851993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15010909|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
15010910|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15010911|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15010912|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010913|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
15010914|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
15010915|NCT01852266|Vaccines|vaccines|mesh-list
15010916|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
15010917|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010918|NCT01852318|Fexofenadine|fexofenadine|mesh-list
15010919|NCT01852318|Pregabalin|pregabalin|mesh-list
15010920|NCT01852318|Analgesics|analgesics|mesh-ancestor
15010921|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
15010922|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010923|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010924|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
15010925|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15010926|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15010927|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010928|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15010929|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15010930|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15010931|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15010932|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15010933|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15010934|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15010935|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15010936|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
15010937|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
15010938|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010939|NCT01852409|Bevacizumab|bevacizumab|mesh-list
15010940|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15010941|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010942|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15010943|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15010944|NCT01852409|Growth Substances|growth substances|mesh-ancestor
15010945|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010946|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
15010947|NCT01852461|Poractant alfa|poractant alfa|mesh-list
15010948|NCT01852461|Beractant|beractant|mesh-list
15010949|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
15010950|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
15033392|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15033393|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15033394|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
15033395|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033396|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033397|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033398|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15033399|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15033400|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
15033401|NCT01988896|Atezolizumab|atezolizumab|mesh-list
15033402|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033403|NCT01988961|Golimumab|golimumab|mesh-list
15033404|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15033405|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15033406|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15033407|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
15033408|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033409|NCT01989000|Gemcitabine|gemcitabine|mesh-list
15033410|NCT01989000|Imidazole|imidazole|mesh-list
15033411|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15033412|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
15033413|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033414|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033415|NCT01989000|Antiviral Agents|antiviral agents|mesh-ancestor
15033416|NCT01989000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15033417|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010951|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
15010952|NCT01852539|Propofol|propofol|mesh-list
15010953|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15010954|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15010955|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010956|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15010957|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
15010958|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
15010959|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15010960|NCT01852539|Analgesics|analgesics|mesh-ancestor
15010961|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
15010962|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15010963|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15010964|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15010965|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15010966|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
15010967|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15010968|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010969|NCT01852565|Diltiazem|diltiazem|mesh-list
15010970|NCT01852565|Darapladib|darapladib|mesh-list
15010971|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15010972|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15010973|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15010974|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010975|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15010976|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15010977|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
15010978|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
15010979|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010980|NCT01852604|Interferons|interferons|mesh-list
15010981|NCT01852604|Ritonavir|ritonavir|mesh-list
15010982|NCT01852604|Ribavirin|ribavirin|mesh-list
15010983|NCT01852604|Simeprevir|simeprevir|mesh-list
15010984|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15010985|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
15010986|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15010987|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15010988|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15010989|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
15010990|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15010991|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15010992|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15010993|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15010994|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15010995|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15010996|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
15010997|NCT01852630|Imipenem|imipenem|mesh-list
15010998|NCT01852630|Cefepime|cefepime|mesh-list
15010999|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15011000|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15011001|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
15011002|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
15011003|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
15011004|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15011005|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011006|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15011007|NCT01852903|Vitamins|vitamins|mesh-list
15011008|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
15011009|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
15011010|NCT01852903|Calcium|calcium|mesh-list
15011011|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
15011012|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011013|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15011014|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
15011015|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011016|NCT01852903|Protective Agents|protective agents|mesh-ancestor
14524341|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14524342|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14524343|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14524344|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524345|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524346|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
14524347|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
15011017|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
15011018|NCT01852994|Testosterone|testosterone|mesh-list
15011019|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
15011020|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
15011021|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15011022|NCT01852994|Androgens|androgens|mesh-ancestor
15011023|NCT01852994|Hormones|hormones|mesh-ancestor
15011024|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15011025|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011026|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15011027|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011028|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
15011029|NCT01853111|Aldesleukin|aldesleukin|mesh-list
15011030|NCT01853111|Interleukin-2|interleukin-2|mesh-list
15011031|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011032|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15011033|NCT01853111|Analgesics|analgesics|mesh-ancestor
15011034|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
15011035|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011036|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011037|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15011038|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15011039|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
15011040|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15011041|NCT01853306|Veliparib|veliparib|mesh-list
15011042|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15011043|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011044|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011045|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011046|NCT01853423|Sirolimus|sirolimus|mesh-list
15011047|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15011048|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802350|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
14802351|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802352|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14802353|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14802354|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
14802355|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
14802356|NCT00797030|Cyclosporine|cyclosporine|mesh-list
14802357|NCT00797030|Cyclosporins|cyclosporins|mesh-list
15011049|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15011050|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011051|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
15011052|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15011053|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
15011054|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011055|NCT01853449|Fentanyl|fentanyl|mesh-list
15011056|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15011057|NCT01853449|Narcotics|narcotics|mesh-ancestor
15011058|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011059|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011060|NCT01853449|Analgesics|analgesics|mesh-ancestor
15011061|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
15011062|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011063|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15011064|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15011065|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
15011066|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
15011067|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
15011068|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
15011069|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15011070|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15011071|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011072|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011073|NCT01853540|Urological Agents|urological agents|mesh-ancestor
15011074|NCT01853566|Hormones|hormones|mesh-list
15011075|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15011076|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011077|NCT01853709|Bisacodyl|bisacodyl|mesh-list
15011078|NCT01853709|Cathartics|cathartics|mesh-ancestor
15011079|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15011080|NCT01853709|Laxatives|laxatives|mesh-ancestor
15011081|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
15011082|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15011083|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15011084|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
15011085|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802358|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011086|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011087|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15011088|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
15011089|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15011090|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15011091|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15011092|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
15011093|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011094|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011095|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
15011096|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15011097|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
15011098|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15011099|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
15011100|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033418|NCT01989000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15011101|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011102|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
15011103|NCT01853813|Bevacizumab|bevacizumab|mesh-list
15011104|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15011105|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011106|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15011107|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15011108|NCT01853813|Growth Substances|growth substances|mesh-ancestor
15011109|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011110|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
15011111|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
15011112|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
15011113|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15011114|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011115|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011116|NCT01853956|Alprazolam|alprazolam|mesh-list
15011117|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15011118|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011119|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011120|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15011121|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15011122|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15011123|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
15011124|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
15011125|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011126|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011127|NCT01854021|Anesthetics|anesthetics|mesh-list
15011128|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011129|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011130|NCT01854073|Scopolamine|scopolamine|mesh-list
15011131|NCT01854073|Bromides|bromides|mesh-list
15011132|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15011133|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
15011134|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15011135|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
15011136|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
15011137|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011138|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011139|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15011140|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
15011141|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15011142|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
15011143|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011144|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011145|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15011146|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
15011147|NCT01854086|Diphosphonates|diphosphonates|mesh-list
15011148|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15011149|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011150|NCT01854203|Gemcitabine|gemcitabine|mesh-list
15011151|NCT01854203|Cisplatin|cisplatin|mesh-list
15011152|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011153|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15011154|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
15011155|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011156|NCT01854203|Antiviral Agents|antiviral agents|mesh-ancestor
15011157|NCT01854203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15011158|NCT01854203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011159|NCT01854203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15011160|NCT01854203|Immunologic Factors|immunologic factors|mesh-ancestor
15011161|NCT01854203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011162|NCT01854216|Rotigotine|rotigotine|mesh-list
15011163|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
15011164|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
15011165|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011166|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011167|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011168|NCT01854255|Cisplatin|cisplatin|mesh-list
15011169|NCT01854255|Doxorubicin|doxorubicin|mesh-list
15011170|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15011171|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011172|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15011173|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15011174|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15011175|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011176|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011177|NCT01854411|Analgesics|analgesics|mesh-list
15011178|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
15011179|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011180|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011181|NCT01854463|Vitamin D|vitamin d|mesh-list
15011182|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
15011183|NCT01854463|Vitamins|vitamins|mesh-ancestor
15011184|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
15011185|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011186|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15011187|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15033419|NCT01989000|Immunologic Factors|immunologic factors|mesh-ancestor
15011188|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
15011189|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15011190|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15011191|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011192|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
15011193|NCT01854476|Coagulants|coagulants|mesh-ancestor
15011194|NCT01854489|Rifampin|rifampin|mesh-list
15011195|NCT01854489|Buprenorphine|buprenorphine|mesh-list
15011196|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15011197|NCT01854489|Narcotics|narcotics|mesh-ancestor
15011198|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011199|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011200|NCT01854489|Analgesics|analgesics|mesh-ancestor
15011201|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
15011202|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011203|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15011204|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15011205|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
15011206|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15011207|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15011208|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
15011209|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15011210|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011211|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011212|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15011213|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15011214|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15011215|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15011216|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15011217|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15011218|NCT01854502|Fluorides|fluorides|mesh-list
15011219|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
15011220|NCT01854502|Protective Agents|protective agents|mesh-ancestor
15011221|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011222|NCT01854515|Dexamethasone|dexamethasone|mesh-list
15011223|NCT01854515|Budesonide|budesonide|mesh-list
15011224|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
15011225|NCT01854515|BB 1101|bb 1101|mesh-list
15011226|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15011227|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
15011228|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
15011229|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011230|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011231|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15011232|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
15011233|NCT01854515|Hormones|hormones|mesh-ancestor
15011234|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15011235|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15011236|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011237|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15011238|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15011239|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
15011240|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
15011241|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011242|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011243|NCT01854606|Everolimus|everolimus|mesh-list
15011244|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011245|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15011246|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
15011247|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011248|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
15011249|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15011250|NCT01854684|Temoporfin|temoporfin|mesh-list
15011251|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011252|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15011253|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
15011254|NCT01854723|Insulin|insulin|mesh-list
15011255|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15011256|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
15011257|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
15011258|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
15011259|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
15011260|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15011261|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011262|NCT01854749|Cisplatin|cisplatin|mesh-list
15011263|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011264|NCT01854762|Ritonavir|ritonavir|mesh-list
15011265|NCT01854762|Lopinavir|lopinavir|mesh-list
15011266|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
15011267|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15011268|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15011269|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
15011270|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011271|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011272|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15011273|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15011274|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
15011275|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15011276|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15011277|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15011278|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15011279|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15011280|NCT01854970|Esomeprazole|esomeprazole|mesh-list
15011281|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15011282|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15011283|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15011284|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011285|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011286|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
15011287|NCT01855009|Vitamin D|vitamin d|mesh-list
15011288|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
15011289|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
15011290|NCT01855009|Calcium|calcium|mesh-list
15011291|NCT01855009|Vitamins|vitamins|mesh-ancestor
15011292|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
15011293|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011294|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15011295|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15011296|NCT01855009|Antacids|antacids|mesh-ancestor
15011297|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011298|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15011299|NCT01855061|Midazolam|midazolam|mesh-list
15011300|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15011301|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15011302|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011303|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011304|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15011305|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15011306|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15011307|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15011308|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
15011309|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
15011310|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
15011311|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
15011312|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011313|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011314|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
15011315|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15011316|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
15011317|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15011318|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
15011319|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011320|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011321|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
15011322|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
15011323|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15011324|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
15011325|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15011326|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
15011327|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011328|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011329|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
15011330|NCT01855256|Oxybutynin|oxybutynin|mesh-list
15011331|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
15011332|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
15011333|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011334|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011335|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15011336|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15011337|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
15011338|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011339|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011340|NCT01855256|Urological Agents|urological agents|mesh-ancestor
15011341|NCT01855321|Vitamin D|vitamin d|mesh-list
15011342|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
15011343|NCT01855321|Vitamins|vitamins|mesh-ancestor
15011344|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
15011345|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011346|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15011347|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15011348|NCT01855334|Spironolactone|spironolactone|mesh-list
15011349|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15011350|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
15011351|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15011352|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011353|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15011354|NCT01855334|Diuretics|diuretics|mesh-ancestor
15011355|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
15011356|NCT01855386|Liver Extracts|liver extracts|mesh-list
15011357|NCT01855386|Hematinics|hematinics|mesh-ancestor
15011358|NCT01855451|Cetuximab|cetuximab|mesh-list
15011359|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011360|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15011361|NCT01855490|Exenatide|exenatide|mesh-list
15011362|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15011363|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011364|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15011365|NCT01855490|Incretins|incretins|mesh-ancestor
15011366|NCT01855490|Hormones|hormones|mesh-ancestor
15011367|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15011368|NCT01855516|Heparin|heparin|mesh-list
15011369|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
15011370|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15011371|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15011372|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011373|NCT01855529|Ropivacaine|ropivacaine|mesh-list
15011374|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
15011375|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
15011376|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011377|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011378|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
15011379|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011380|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
15011381|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15011382|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15011383|NCT01855555|Propofol|propofol|mesh-list
15011384|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15011385|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011386|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011387|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15011388|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
15011389|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
15011390|NCT01855568|Methotrexate|methotrexate|mesh-list
15011391|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15011392|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
15011393|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15011394|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011395|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15011396|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
15011397|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011398|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011399|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
15011400|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011401|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15011402|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15011403|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
15011404|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15011405|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15011406|NCT01855581|Ketamine|ketamine|mesh-list
15011407|NCT01855581|Propofol|propofol|mesh-list
15011408|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15011409|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011410|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011411|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15011412|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
15011413|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
15011414|NCT01855581|Analgesics|analgesics|mesh-ancestor
15011415|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
15011416|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011417|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15011418|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15011419|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15011420|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011421|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011422|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
15011423|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
15011424|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15011425|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011426|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011427|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
15011428|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15011429|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011430|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011431|NCT01855607|Menthol|menthol|mesh-list
15011432|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
15011433|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
15011434|NCT01855711|Alosetron|alosetron|mesh-list
15011435|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15011436|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15011437|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
15011438|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011439|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011440|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011441|NCT01855724|Gemcitabine|gemcitabine|mesh-list
15011442|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15011443|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
15011444|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011445|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011446|NCT01855724|Antiviral Agents|antiviral agents|mesh-ancestor
15011447|NCT01855724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15011448|NCT01855724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011449|NCT01855724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15011450|NCT01855724|Immunologic Factors|immunologic factors|mesh-ancestor
15011451|NCT01855724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011452|NCT01855737|Warfarin|warfarin|mesh-list
15011453|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
15011454|NCT01855763|Insulin|insulin|mesh-list
15011455|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15011456|NCT01855763|Metformin|metformin|mesh-list
15011457|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15011458|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011459|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
15011460|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
15011461|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011462|NCT01855971|Protective Agents|protective agents|mesh-ancestor
15011463|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011464|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15011465|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15011466|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011467|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15011468|NCT01855984|Tocotrienols|tocotrienols|mesh-list
15011469|NCT01855984|Vitamin E|vitamin e|mesh-list
15011470|NCT01855984|Tocopherols|tocopherols|mesh-list
15011471|NCT01855984|Tocovid|tocovid|mesh-list
15011472|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
15011473|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011474|NCT01855984|Protective Agents|protective agents|mesh-ancestor
15011475|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011476|NCT01855984|Vitamins|vitamins|mesh-ancestor
15011477|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
15011478|NCT01856023|Aldesleukin|aldesleukin|mesh-list
15011479|NCT01856023|Ipilimumab|ipilimumab|mesh-list
15011480|NCT01856023|Interleukin-2|interleukin-2|mesh-list
15011481|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15011482|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011483|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15011484|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011485|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15011486|NCT01856023|Analgesics|analgesics|mesh-ancestor
15011487|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
15011488|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011489|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011490|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15011491|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15011492|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
15011493|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15011494|NCT01856062|Dexamethasone|dexamethasone|mesh-list
15011495|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15011496|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
15011497|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
15011498|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011499|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011500|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15011501|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
15011502|NCT01856062|Hormones|hormones|mesh-ancestor
15011503|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15011504|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15011505|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011506|NCT01856101|Dactolisib|dactolisib|mesh-list
15011507|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011508|NCT01856127|Sertraline|sertraline|mesh-list
15011509|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
15011510|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
15011511|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15011512|NCT01856127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15011513|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15011514|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15011515|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011516|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011517|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
15011518|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011519|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15011520|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15011521|NCT01856166|Sufentanil|sufentanil|mesh-list
15011522|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
15011523|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
15011524|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
15011525|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011526|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011527|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
15011528|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011529|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15011530|NCT01856166|Narcotics|narcotics|mesh-ancestor
15011531|NCT01856166|Analgesics|analgesics|mesh-ancestor
15011532|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15011533|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15011534|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
15011535|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
15011536|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15011537|NCT01856205|Antibodies|antibodies|mesh-list
15011538|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
15011539|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15011540|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
15011541|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033420|NCT01989000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033421|NCT01989052|Lomustine|lomustine|mesh-list
15033422|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
15033423|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15033424|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
15033425|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524348|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524349|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524350|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14524351|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14524352|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
14524353|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14524354|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14524355|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14524356|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14524357|NCT03662074|Gemcitabine|gemcitabine|mesh-list
14524358|NCT03662074|Nivolumab|nivolumab|mesh-list
14524359|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14524360|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
14524361|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033426|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033427|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15033428|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15033429|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15033430|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033431|NCT01989078|Losartan|losartan|mesh-list
15033432|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15033433|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15033434|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15033435|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15033436|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033437|NCT01989091|Heparin|heparin|mesh-list
15033438|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
15033439|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15033440|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15033441|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033442|NCT01989312|Lidocaine|lidocaine|mesh-list
15033443|NCT01989312|Epinephrine|epinephrine|mesh-list
15033444|NCT01989312|Midazolam|midazolam|mesh-list
15033445|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
15033446|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
15033447|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
15033448|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15033449|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033450|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
15033451|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033452|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15033453|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15033454|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15035500|NCT02001883|Red yeast rice|red yeast rice|mesh-list
15011542|NCT01856348|Vitamin D|vitamin d|mesh-list
15011543|NCT01856348|Vitamins|vitamins|mesh-ancestor
15011544|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
15011545|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011546|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15011547|NCT01856374|Sirolimus|sirolimus|mesh-list
15011548|NCT01856374|Everolimus|everolimus|mesh-list
15011549|NCT01856374|Atorvastatin|atorvastatin|mesh-list
15011550|NCT01856374|Pravastatin|pravastatin|mesh-list
15011551|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15011552|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15011553|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
15011554|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011555|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15011556|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15011557|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011558|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011559|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15011560|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
15011561|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011562|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15011563|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15011564|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15011565|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
15011566|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
15011567|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
15011568|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011569|NCT01856517|Clonidine|clonidine|mesh-list
15011570|NCT01856517|Analgesics|analgesics|mesh-ancestor
15011571|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
15011572|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011573|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011574|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15011575|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
15011576|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
15011577|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15011578|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15011579|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15011580|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
15011581|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011582|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011583|NCT01856556|Glycine|glycine|mesh-list
15011584|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
15011585|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011586|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011587|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011588|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15011589|NCT01856621|Charcoal|charcoal|mesh-list
15011590|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15011591|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
15011592|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011593|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011594|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15011595|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
15011596|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
15011597|NCT01856621|Hormones|hormones|mesh-ancestor
15011598|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15011599|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
15011600|NCT01856621|Antidotes|antidotes|mesh-ancestor
15011601|NCT01856621|Protective Agents|protective agents|mesh-ancestor
15011602|NCT01856738|Rivastigmine|rivastigmine|mesh-list
15011603|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15011604|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011605|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011606|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
15011607|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011608|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011609|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15011610|NCT01856738|Protective Agents|protective agents|mesh-ancestor
15011611|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
15011612|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15011613|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
15011614|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011615|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15011616|NCT01856946|Vitamin D|vitamin d|mesh-list
15011617|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
15011618|NCT01856946|Vitamins|vitamins|mesh-ancestor
15011619|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
15011620|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011621|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15011622|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15011623|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
15011624|NCT01856959|Albuterol|albuterol|mesh-list
15011625|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14802359|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802360|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802361|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
14802362|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802363|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
14802364|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802365|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
14802366|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14802367|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14802368|NCT00797056|Aspirin|aspirin|mesh-list
14802369|NCT00797056|Clopidogrel|clopidogrel|mesh-list
14802370|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15011626|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
15011627|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011628|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011629|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15011630|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
15011631|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
15011632|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15011633|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15011634|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15011635|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15011636|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
15011637|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011638|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011639|NCT01856959|Analgesics|analgesics|mesh-ancestor
15011640|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
15011641|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
15011642|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011643|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15011644|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
15011645|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15011646|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15011647|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15011648|NCT01856985|Misoprostol|misoprostol|mesh-list
15011649|NCT01856985|Mifepristone|mifepristone|mesh-list
15011650|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15011651|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
15011652|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15011653|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011654|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15011655|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15011656|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
15011657|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15011658|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15011659|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15011660|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15011661|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
15011662|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15011663|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15011664|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
15011665|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15011666|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
15011667|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15011668|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15011669|NCT01856998|Propofol|propofol|mesh-list
15011670|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15011671|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011672|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011673|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15011674|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
15011675|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
15011676|NCT01857011|Iron|iron|mesh-list
15011677|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
15011678|NCT01857011|Teferrol|teferrol|mesh-list
15011679|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
15011680|NCT01857011|Trace Elements|trace elements|mesh-ancestor
15011681|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
15011682|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011683|NCT01857011|Hematinics|hematinics|mesh-ancestor
15011684|NCT01857024|Sevelamer|sevelamer|mesh-list
15011685|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
15011686|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
15011687|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011688|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
15011689|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15011690|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011691|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802371|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14802372|NCT00797056|Analgesics|analgesics|mesh-ancestor
14802373|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
14802374|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802375|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802376|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14802377|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15011692|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15011693|NCT01857141|Analgesics|analgesics|mesh-ancestor
15011694|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
15011695|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011696|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15011697|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15011698|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15011699|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
15011700|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011701|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011702|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
15011703|NCT01857154|Vitamin D|vitamin d|mesh-list
15011704|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
15011705|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
15011706|NCT01857154|Calcium|calcium|mesh-list
15011707|NCT01857154|Vitamins|vitamins|mesh-ancestor
15011708|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
15011709|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011710|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15011711|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15011712|NCT01857154|Antacids|antacids|mesh-ancestor
15011713|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011714|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15011715|NCT01857193|Everolimus|everolimus|mesh-list
15011716|NCT01857193|Exemestane|exemestane|mesh-list
15011717|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011718|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15011719|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
15011720|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011721|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15011722|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15011723|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011724|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011725|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15011726|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
15011727|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15011728|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
15011729|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
15011730|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15011731|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15011732|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
15011733|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15011734|NCT01857349|Ethanol|ethanol|mesh-list
15011735|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
15011736|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15011737|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15011738|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15011739|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011740|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011741|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
15011742|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
15011743|NCT01857375|Insulin|insulin|mesh-list
15011744|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15011745|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011746|NCT01857453|Etoposide|etoposide|mesh-list
15011747|NCT01857453|Carboplatin|carboplatin|mesh-list
15011748|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15011749|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011750|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15011751|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15011752|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011753|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011754|NCT01857479|Amphotericin B|amphotericin b|mesh-list
15011755|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15011756|NCT01857479|Budesonide|budesonide|mesh-list
15011757|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15011758|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15011759|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
15011760|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011761|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011762|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15011763|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
15011764|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
15011765|NCT01857479|Hormones|hormones|mesh-ancestor
15011766|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15011767|NCT01857479|Amebicides|amebicides|mesh-ancestor
15011768|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15011769|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15011770|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15011771|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15011772|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
15011773|NCT01857544|Aflibercept|aflibercept|mesh-list
15011774|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15011775|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15011776|NCT01857544|Growth Substances|growth substances|mesh-ancestor
15011777|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011778|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
15011779|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011780|NCT01857596|Trazodone|trazodone|mesh-list
15011781|NCT01857596|Bupropion|bupropion|mesh-list
15011782|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14529819|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15011783|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
15011784|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15011785|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15011786|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15011787|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15011788|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011789|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
15011790|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011791|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011792|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15011793|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15011794|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011795|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15011796|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15011797|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011798|NCT01857596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15011799|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
15011800|NCT01857609|Metformin|metformin|mesh-list
15011801|NCT01857609|Rabeprazole|rabeprazole|mesh-list
15011802|NCT01857609|Pantoprazole|pantoprazole|mesh-list
15011803|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15011804|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011805|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15011806|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15011807|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15011808|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011809|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011810|NCT01857726|Doxorubicin|doxorubicin|mesh-list
15011811|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011812|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15011813|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15011814|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15011815|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011816|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011817|NCT01857752|Temozolomide|temozolomide|mesh-list
15011818|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15011819|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
15011820|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011821|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011822|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15011823|NCT01857804|Amoxicillin|amoxicillin|mesh-list
15011824|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
15011825|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15011826|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15011827|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15011828|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
15011829|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
15011830|NCT01857817|Etodolac|etodolac|mesh-list
15011831|NCT01857817|Propranolol|propranolol|mesh-list
15011832|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15011833|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15011834|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
15011835|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011836|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011837|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011838|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15011839|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15011840|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
15011841|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15011842|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15011843|NCT01857817|Analgesics|analgesics|mesh-ancestor
15011844|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
15011845|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011846|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15011847|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15011848|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15011849|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15011850|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011851|NCT01857843|Everolimus|everolimus|mesh-list
15011852|NCT01857843|Simvastatin|simvastatin|mesh-list
15011853|NCT01857843|Ezetimibe|ezetimibe|mesh-list
15011854|NCT01857843|Pravastatin|pravastatin|mesh-list
15011855|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011856|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15011857|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
15011858|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011859|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15011860|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15011861|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
15011862|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011863|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15011864|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15011865|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011866|NCT01857856|Eplerenone|eplerenone|mesh-list
14529820|NCT03630120|Sorafenib|sorafenib|mesh-list
15011867|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15011868|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
15011869|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15011870|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011871|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15011872|NCT01857856|Diuretics|diuretics|mesh-ancestor
15011873|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
15011874|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15011875|NCT01857895|Exenatide|exenatide|mesh-list
15011876|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15011877|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011878|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15011879|NCT01857895|Incretins|incretins|mesh-ancestor
15011880|NCT01857895|Hormones|hormones|mesh-ancestor
15011881|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15011882|NCT01857921|Trimetazidine|trimetazidine|mesh-list
15011883|NCT01857921|Atorvastatin|atorvastatin|mesh-list
15011884|NCT01857921|Pravastatin|pravastatin|mesh-list
15011885|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15011886|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15011887|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
15011888|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011889|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15011890|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15011891|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011892|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
15011893|NCT01857999|Losartan|losartan|mesh-list
15011894|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15011895|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15011896|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15011897|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15011898|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011899|NCT01858025|Fluorouracil|fluorouracil|mesh-list
15011900|NCT01858025|Mitomycins|mitomycins|mesh-list
15011901|NCT01858025|Mitomycin|mitomycin|mesh-list
15011902|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
15011903|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011904|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15011905|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011906|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15011907|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
15011908|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011909|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15011910|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
15011911|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15011912|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011913|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
15011914|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15011915|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011916|NCT01858051|Vitamins|vitamins|mesh-ancestor
15011917|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
15011918|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15011919|NCT01858077|Everolimus|everolimus|mesh-list
15011920|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011921|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15011922|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
15011923|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011924|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
15011925|NCT01858090|Promethazine|promethazine|mesh-list
15011926|NCT01858090|Diclofenac|diclofenac|mesh-list
15011927|NCT01858090|Atropine|atropine|mesh-list
15011928|NCT01858090|Ephedrine|ephedrine|mesh-list
15011929|NCT01858090|Fentanyl|fentanyl|mesh-list
15011930|NCT01858090|Sufentanil|sufentanil|mesh-list
15011931|NCT01858090|Meperidine|meperidine|mesh-list
15011932|NCT01858090|Metoclopramide|metoclopramide|mesh-list
15011933|NCT01858090|Propofol|propofol|mesh-list
15011934|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
15011935|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15011936|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011937|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011938|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15011939|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
15011940|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
15011941|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15011942|NCT01858090|Narcotics|narcotics|mesh-ancestor
15011943|NCT01858090|Analgesics|analgesics|mesh-ancestor
15011944|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
15011945|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15011946|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15011947|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15011948|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15011949|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15011950|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15011951|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15011952|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011953|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011954|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15011955|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15011956|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
15011957|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15011958|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
15011959|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
15011960|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
15011961|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15011962|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15011963|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
15011964|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15011965|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15011966|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
15011967|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
15011968|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15011969|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15011970|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
15011971|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
15011972|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15011973|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
15011974|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
15011975|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15011976|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15011977|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
15011978|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15011979|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
15011980|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15011981|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
15033455|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15033456|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033457|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15033458|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15033459|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15033460|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15033461|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15033462|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15033463|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
15033464|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
15033465|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
15033466|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033467|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15033468|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15033469|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
15033470|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15033471|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15033472|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
15033473|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15033474|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
15033475|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
15033476|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
15033477|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15033478|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
15033479|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15033480|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15033481|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15033482|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
15033483|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
15033484|NCT01989507|Nicotine|nicotine|mesh-list
15033485|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15033486|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
15033487|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033488|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033489|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15033490|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15033491|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
15033492|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033493|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033494|NCT01989559|Vaccines|vaccines|mesh-list
15033495|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
15033496|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033497|NCT01989611|Tenofovir|tenofovir|mesh-list
15033498|NCT01989611|Emtricitabine|emtricitabine|mesh-list
15033499|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
15033500|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15033501|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15033502|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15033503|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033504|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011982|NCT01858155|Melatonin|melatonin|mesh-list
15011983|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
15011984|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011985|NCT01858155|Protective Agents|protective agents|mesh-ancestor
15011986|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15011987|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15011988|NCT01858168|Irinotecan|irinotecan|mesh-list
15011989|NCT01858168|Temozolomide|temozolomide|mesh-list
15011990|NCT01858168|Olaparib|olaparib|mesh-list
15011991|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15011992|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15011993|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15011994|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15011995|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15011996|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15011997|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
15011998|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15011999|NCT01858207|Doxorubicin|doxorubicin|mesh-list
15012000|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15012001|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012002|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15012003|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15012004|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012005|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012006|NCT01858311|Tocotrienols|tocotrienols|mesh-list
15012007|NCT01858311|Vitamin E|vitamin e|mesh-list
15012008|NCT01858311|Tocopherols|tocopherols|mesh-list
15012009|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
15012010|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012011|NCT01858311|Protective Agents|protective agents|mesh-ancestor
15012012|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012013|NCT01858311|Vitamins|vitamins|mesh-ancestor
15012014|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
15012015|NCT01858402|Acetaminophen|acetaminophen|mesh-list
15012016|NCT01858402|Dipyrone|dipyrone|mesh-list
15012017|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15012018|NCT01858402|Analgesics|analgesics|mesh-ancestor
15012019|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
15012020|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012021|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012022|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
15012023|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15012024|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15012025|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15012026|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
15012027|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012028|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15012029|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012030|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012031|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
15012032|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15012033|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012034|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15012035|NCT01858571|Thalidomide|thalidomide|mesh-list
15012036|NCT01858571|Celecoxib|celecoxib|mesh-list
15012037|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
15012038|NCT01858571|Etoposide|etoposide|mesh-list
15012039|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15012040|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
15012041|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012042|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15012043|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14524362|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524363|NCT03662074|Antiviral Agents|antiviral agents|mesh-ancestor
14524364|NCT03662074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524365|NCT03662074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524366|NCT03662074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14524367|NCT03662074|Immunologic Factors|immunologic factors|mesh-ancestor
14524368|NCT03662074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524369|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14524370|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14524371|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
14524372|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14529821|NCT03630120|Lenvatinib|lenvatinib|mesh-list
15012044|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
15033505|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15012045|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012046|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012047|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15012048|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15012049|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15012050|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15012051|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012052|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15012053|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15012054|NCT01858571|Analgesics|analgesics|mesh-ancestor
15012055|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
15012056|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012057|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15012058|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15012059|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15012060|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
14524373|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524374|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
14524375|NCT03662789|Hematinics|hematinics|mesh-ancestor
14524376|NCT03663101|Lidocaine|lidocaine|mesh-list
14524377|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
14524378|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14524379|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15012061|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15012062|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012063|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15012064|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15012065|NCT01858571|Growth Substances|growth substances|mesh-ancestor
15012066|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
15012067|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15012068|NCT01858610|Irbesartan|irbesartan|mesh-list
14802378|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14802379|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14802380|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802381|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15012069|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15012070|NCT01858610|Diuretics|diuretics|mesh-ancestor
15012071|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
15012072|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012073|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15012074|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15012075|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012076|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15012077|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15012078|NCT01858623|Losartan|losartan|mesh-list
15012079|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15012080|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15012081|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15012082|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15012083|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15012084|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012085|NCT01858623|Diuretics|diuretics|mesh-ancestor
15012086|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
15012087|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012088|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15012089|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15012090|NCT01858649|Bevacizumab|bevacizumab|mesh-list
15012091|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
15012092|NCT01858649|Irinotecan|irinotecan|mesh-list
15012093|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15012094|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012095|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15012096|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15012097|NCT01858649|Growth Substances|growth substances|mesh-ancestor
15012098|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012099|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
15012100|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15012101|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15012102|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012103|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012104|NCT01858662|Leucovorin|leucovorin|mesh-list
15012105|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
15012106|NCT01858662|Irinotecan|irinotecan|mesh-list
15012107|NCT01858662|Cetuximab|cetuximab|mesh-list
15012108|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012109|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15012110|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15012111|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012112|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012113|NCT01858662|Antidotes|antidotes|mesh-ancestor
15012114|NCT01858662|Protective Agents|protective agents|mesh-ancestor
15012115|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012116|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
15012117|NCT01858662|Vitamins|vitamins|mesh-ancestor
15012118|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
15012119|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15012120|NCT01858792|Belimumab|belimumab|mesh-list
15012121|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15012122|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
15012123|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012124|NCT01858831|Atovaquone|atovaquone|mesh-list
15012125|NCT01858831|Proguanil|proguanil|mesh-list
15012126|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
15012127|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012128|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
15012129|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15012130|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15012131|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012132|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012133|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
15012134|NCT01858870|Lacosamide|lacosamide|mesh-list
15012135|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
15012136|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15012137|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15012138|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15012139|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012140|NCT01858909|Melatonin|melatonin|mesh-list
15012141|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
15012142|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012143|NCT01858909|Protective Agents|protective agents|mesh-ancestor
15012144|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012145|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012146|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15012147|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
15012148|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15012149|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15012150|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15012151|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012152|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012153|NCT01858961|Interferons|interferons|mesh-list
15012154|NCT01858961|Ribavirin|ribavirin|mesh-list
15012155|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012156|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
15012157|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012158|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
15012159|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012160|NCT01859234|Bevacizumab|bevacizumab|mesh-list
15012161|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
15012162|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15012163|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012164|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15012165|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15012166|NCT01859234|Growth Substances|growth substances|mesh-ancestor
15012167|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012168|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
15012169|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15012170|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012171|NCT01859377|Ibuprofen|ibuprofen|mesh-list
15012172|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15012173|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15012174|NCT01859377|Analgesics|analgesics|mesh-ancestor
15012175|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
15012176|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012177|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012178|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15012179|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15012180|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15012181|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012182|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012183|NCT01859455|Atorvastatin|atorvastatin|mesh-list
15012184|NCT01859455|Simvastatin|simvastatin|mesh-list
15012185|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15012186|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15012187|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
15012188|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012189|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15012190|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15012191|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012192|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
15012193|NCT01859468|Calcium|calcium|mesh-list
15012194|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15012195|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012196|NCT01859468|Antacids|antacids|mesh-ancestor
15012197|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012198|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15012199|NCT01859481|Eletriptan|eletriptan|mesh-list
15012200|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15012201|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
15012202|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012203|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012204|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012205|NCT01859585|Ketorolac|ketorolac|mesh-list
15012206|NCT01859585|Parecoxib|parecoxib|mesh-list
15012207|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15012208|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15012209|NCT01859585|Analgesics|analgesics|mesh-ancestor
15012210|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
15012211|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012212|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012213|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15012214|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15012215|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15012216|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012217|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012218|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15012219|NCT01859624|Albuterol|albuterol|mesh-list
15012220|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15012221|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
15012222|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012223|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012224|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15012225|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
15012226|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
15012227|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15012228|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15012229|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15012230|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15012231|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
15012232|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012233|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012234|NCT01859728|Gemcitabine|gemcitabine|mesh-list
15012235|NCT01859728|Cisplatin|cisplatin|mesh-list
15012236|NCT01859728|Irinotecan|irinotecan|mesh-list
15012237|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012238|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15012239|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
15012240|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012241|NCT01859728|Antiviral Agents|antiviral agents|mesh-ancestor
15012242|NCT01859728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012243|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012244|NCT01859728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15012245|NCT01859728|Immunologic Factors|immunologic factors|mesh-ancestor
15012246|NCT01859728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012247|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15012248|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15012249|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
15012250|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15012251|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15012252|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
15012253|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012254|NCT01859819|Cytarabine|cytarabine|mesh-list
15012255|NCT01859819|Rituximab|rituximab|mesh-list
15012256|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15012257|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012258|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
15012259|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012260|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15012261|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15012262|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
15012263|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012264|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
15012265|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012266|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15012267|NCT01859858|Curcumin|curcumin|mesh-list
15012268|NCT01859858|Irinotecan|irinotecan|mesh-list
15012269|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15012270|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15012271|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012272|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012273|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012274|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15012275|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15012276|NCT01859858|Analgesics|analgesics|mesh-ancestor
15012277|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
15012278|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012279|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012280|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15012281|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15033506|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15033507|NCT01989663|Tenofovir|tenofovir|mesh-list
15033508|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
15033509|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15033510|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15033511|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15033512|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033513|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033514|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15033515|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15033516|NCT01989676|Paclitaxel|paclitaxel|mesh-list
15033517|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15033518|NCT01989676|Trastuzumab|trastuzumab|mesh-list
15033519|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15033520|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033521|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
15033522|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
15033523|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
15033524|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033525|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15033526|NCT01989780|Paclitaxel|paclitaxel|mesh-list
15033527|NCT01989780|Bevacizumab|bevacizumab|mesh-list
15033528|NCT01989780|Letrozole|letrozole|mesh-list
15033529|NCT01989780|Fulvestrant|fulvestrant|mesh-list
15033530|NCT01989780|Anastrozole|anastrozole|mesh-list
15033531|NCT01989780|Exemestane|exemestane|mesh-list
15033532|NCT01989780|Goserelin|goserelin|mesh-list
15033533|NCT01989780|Leuprolide|leuprolide|mesh-list
15033534|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15033535|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15033536|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033537|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
15033538|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
15033539|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
15033540|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033541|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15033542|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15033543|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15033544|NCT01989780|Growth Substances|growth substances|mesh-ancestor
15033545|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033546|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
15033547|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15033548|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033549|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15033550|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
15033551|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15033552|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15033553|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15033554|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15033555|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
15033556|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15033557|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
15033558|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15033559|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
15033560|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15033561|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
15033562|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033563|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033564|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
15033565|NCT01989884|IDN 5109|idn 5109|mesh-list
15033566|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033567|NCT01989897|Phenol|phenol|mesh-list
15033568|NCT01989897|Histamine|histamine|mesh-list
15033569|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
15033570|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
15033571|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033572|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033573|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033574|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15033575|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15033576|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
15033577|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15033578|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15033579|NCT01989923|Nicotine|nicotine|mesh-list
15012282|NCT01860014|Poractant alfa|poractant alfa|mesh-list
15012283|NCT01860014|Beractant|beractant|mesh-list
15012284|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
15012285|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
15012286|NCT01860066|Fluticasone|fluticasone|mesh-list
15012287|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15012288|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15012289|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15012290|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15012291|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
15012292|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012293|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012294|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15012295|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
15012296|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
15012297|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15012298|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15012299|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14524380|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
14524381|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
14524382|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524383|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012300|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15012301|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
15012302|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012303|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012304|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
15012305|NCT01860066|Hormones|hormones|mesh-ancestor
15012306|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15012307|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
15012308|NCT01860105|Clopidogrel|clopidogrel|mesh-list
15012309|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15012310|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15012311|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15012312|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15012313|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
15012314|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012315|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012316|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012317|NCT01860144|Bevacizumab|bevacizumab|mesh-list
15012318|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15012319|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524384|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
14524385|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524386|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14524387|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14524388|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15012320|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15012321|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15012322|NCT01860144|Growth Substances|growth substances|mesh-ancestor
15012323|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012324|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
15012325|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
15012326|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15012327|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012328|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15012329|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
15012330|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15012331|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012332|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012333|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012334|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15012335|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15012336|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012337|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012338|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15012339|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15012340|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012341|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
15012342|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012343|NCT01860235|Anesthetics|anesthetics|mesh-list
15012344|NCT01860235|Benzocaine|benzocaine|mesh-list
15012345|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
15012346|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012347|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524389|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524390|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012348|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
15012349|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012350|NCT01860300|Amoxicillin|amoxicillin|mesh-list
15012351|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
15012352|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
15012353|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15012354|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15012355|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012356|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15012357|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012358|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012359|NCT01860391|Fluorides|fluorides|mesh-list
15012360|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
15012361|NCT01860391|Protective Agents|protective agents|mesh-ancestor
15012362|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012363|NCT01860417|Mepivacaine|mepivacaine|mesh-list
15012364|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
15012365|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
15012366|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012367|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012368|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
15012369|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012370|NCT01860469|Vancomycin|vancomycin|mesh-list
15012371|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15012372|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012373|NCT01860482|Rabeprazole|rabeprazole|mesh-list
15012374|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15012375|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15012376|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15012377|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012378|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012379|NCT01860508|Carboplatin|carboplatin|mesh-list
15012380|NCT01860508|Pemetrexed|pemetrexed|mesh-list
15012381|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012382|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012383|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012384|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15012385|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15012386|NCT01860625|Donepezil|donepezil|mesh-list
15012387|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15012388|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012389|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012390|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
15012391|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012392|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012393|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
15012394|NCT01860638|Bevacizumab|bevacizumab|mesh-list
14802382|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14802383|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802384|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
14802385|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14802386|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14802387|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15012395|NCT01860638|Temozolomide|temozolomide|mesh-list
15012396|NCT01860638|Lomustine|lomustine|mesh-list
15012397|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15012398|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012399|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15012400|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15012401|NCT01860638|Growth Substances|growth substances|mesh-ancestor
15012402|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012403|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
15012404|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15012405|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
15012406|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012407|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
15012408|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15012409|NCT01860690|Methotrexate|methotrexate|mesh-list
15012410|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15012411|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
15012412|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15012413|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012414|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15012415|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
15012416|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012417|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012418|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
15012419|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012420|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14802388|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
14802389|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802390|NCT00797160|Propofol|propofol|mesh-list
14802391|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15012421|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15012422|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
15012423|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15012424|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15012425|NCT01860716|Melatonin|melatonin|mesh-list
15012426|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
15012427|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012428|NCT01860716|Protective Agents|protective agents|mesh-ancestor
15012429|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012430|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012431|NCT01860729|Anacetrapib|anacetrapib|mesh-list
15012432|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15012433|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15012434|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
15012435|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012436|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15012437|NCT01860742|Interferons|interferons|mesh-list
15012438|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
15012439|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
15012440|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15012441|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012442|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
15012443|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012444|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
15012445|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012446|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15012447|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012448|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15012449|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15012450|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15012451|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012452|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012453|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15012454|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15012455|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15012456|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
15012457|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012458|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012459|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15012460|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15012461|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
15012462|NCT01860833|Ibuprofen|ibuprofen|mesh-list
15012463|NCT01860833|Celecoxib|celecoxib|mesh-list
15012464|NCT01860833|Diclofenac|diclofenac|mesh-list
15012465|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15012466|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15012467|NCT01860833|Analgesics|analgesics|mesh-ancestor
15012468|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
15012469|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012470|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012471|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15012472|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15012473|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15012474|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012475|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012476|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15012477|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
15012478|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012479|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012480|NCT01861015|Vasopressins|vasopressins|mesh-list
15012481|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
15012482|NCT01861015|Epinephrine|epinephrine|mesh-list
15012483|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15012484|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15012485|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
15012486|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012487|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012488|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012489|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15012490|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15012491|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
15012492|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012493|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15012494|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
15012495|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
15012496|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
15012497|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15012498|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
15012499|NCT01861015|Coagulants|coagulants|mesh-ancestor
15012500|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15012501|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
15012502|NCT01861041|Bupivacaine|bupivacaine|mesh-list
15012503|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
15012504|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
15012505|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012506|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012507|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
15012508|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012509|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
15012510|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15012511|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
15012512|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15012513|NCT01861223|Afatinib|afatinib|mesh-list
15012514|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
15012515|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012516|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15012517|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012518|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012519|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15012520|NCT01861340|Dexamethasone|dexamethasone|mesh-list
15012521|NCT01861340|Lenalidomide|lenalidomide|mesh-list
15012522|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15012523|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
15012524|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
15012525|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012526|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012527|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15012528|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
15012529|NCT01861340|Hormones|hormones|mesh-ancestor
15012530|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15012531|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15012532|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012533|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
15012534|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15012535|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15012536|NCT01861340|Growth Substances|growth substances|mesh-ancestor
15012537|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
15012538|NCT01861535|Imiquimod|imiquimod|mesh-list
15012539|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15012540|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
15012541|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012542|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012543|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
15012544|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
15012545|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15012546|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
15012547|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012548|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15012549|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15012550|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
15012551|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012552|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012553|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15012554|NCT01861626|Isotretinoin|isotretinoin|mesh-list
15012555|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
15033580|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15033581|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
15033582|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033583|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033584|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15033585|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15033586|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
15033587|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033588|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033589|NCT01989936|Eletriptan|eletriptan|mesh-list
15033590|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15033591|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
15033592|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033593|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033594|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012556|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
15012557|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
15012558|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012559|NCT01861951|Doxorubicin|doxorubicin|mesh-list
15012560|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14524391|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14524392|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
14524393|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524394|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14524395|NCT03663283|Bupivacaine|bupivacaine|mesh-list
14524396|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
14524397|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
15012561|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012562|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15012563|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15012564|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012565|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012566|NCT01861990|Valproic Acid|valproic acid|mesh-list
15012567|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
15012568|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012569|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012570|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
15012571|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012572|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012573|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
15012574|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15012575|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012576|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15012577|NCT01862003|Leucovorin|leucovorin|mesh-list
15012578|NCT01862003|Folic Acid|folic acid|mesh-list
15012579|NCT01862003|Fluorouracil|fluorouracil|mesh-list
15012580|NCT01862003|Irinotecan|irinotecan|mesh-list
15012581|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
15012582|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
15012583|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012584|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15012585|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012586|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15012587|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
15012588|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012589|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15012590|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15012591|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012592|NCT01862003|Antidotes|antidotes|mesh-ancestor
15012593|NCT01862003|Protective Agents|protective agents|mesh-ancestor
15012594|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
15012595|NCT01862003|Vitamins|vitamins|mesh-ancestor
14802392|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802393|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802394|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14802395|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
14802396|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
14802397|NCT00797264|Ketamine|ketamine|mesh-list
14802398|NCT00797264|Morphine|morphine|mesh-list
14802399|NCT00797264|Analgesics|analgesics|mesh-ancestor
14802400|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
15012596|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
15012597|NCT01862003|Hematinics|hematinics|mesh-ancestor
14802401|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012598|NCT01862081|Paclitaxel|paclitaxel|mesh-list
15012599|NCT01862081|Docetaxel|docetaxel|mesh-list
15012600|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15012601|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012602|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
15012603|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
15012604|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
15012605|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012606|NCT01862120|Interleukin-2|interleukin-2|mesh-list
15012607|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012608|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15012609|NCT01862120|Analgesics|analgesics|mesh-ancestor
15012610|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
15012611|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012612|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012613|NCT01862263|Vildagliptin|vildagliptin|mesh-list
15012614|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15012615|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012616|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15012617|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
15012618|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012619|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012620|NCT01862302|Haloperidol|haloperidol|mesh-list
15012621|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
15012622|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
15012623|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
15012624|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012625|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012626|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15012627|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15012628|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15012629|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012630|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15012631|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15012632|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
15012633|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012634|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012635|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15012636|NCT01862315|Gemcitabine|gemcitabine|mesh-list
15012637|NCT01862315|Dexamethasone|dexamethasone|mesh-list
15012638|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
15012639|NCT01862315|Floxuridine|floxuridine|mesh-list
15012640|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15012641|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
15012642|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
15012643|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012644|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012645|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15012646|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
15012647|NCT01862315|Hormones|hormones|mesh-ancestor
15012648|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15012649|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15012650|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012651|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15012652|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
15012653|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012654|NCT01862315|Antiviral Agents|antiviral agents|mesh-ancestor
15012655|NCT01862315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012656|NCT01862315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012657|NCT01862315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15012658|NCT01862315|Immunologic Factors|immunologic factors|mesh-ancestor
15012659|NCT01862354|Anesthetics|anesthetics|mesh-list
15012660|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012661|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012662|NCT01862497|Carvedilol|carvedilol|mesh-list
15012663|NCT01862497|Prazosin|prazosin|mesh-list
15012664|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15012665|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15012666|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
15012667|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012668|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012669|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012670|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15012671|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
15012672|NCT01862497|Protective Agents|protective agents|mesh-ancestor
15012673|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15012674|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15012675|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15012676|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
15012677|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15012678|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15012679|NCT01862523|Capsaicin|capsaicin|mesh-list
15012680|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
15012681|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
15012682|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
15012683|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012684|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012685|NCT01862835|Anastrozole|anastrozole|mesh-list
15012686|NCT01862835|Testosterone|testosterone|mesh-list
15012687|NCT01862835|Estrogens|estrogens|mesh-list
15012688|NCT01862835|Androgens|androgens|mesh-ancestor
15012689|NCT01862835|Hormones|hormones|mesh-ancestor
15012690|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15012691|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012692|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15012693|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012694|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15012695|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15012696|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012697|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012698|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15012699|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
15012700|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
15012701|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15012702|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012703|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15012704|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15012705|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012706|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012707|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012708|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
15012709|NCT01862926|Rituximab|rituximab|mesh-list
15012710|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15012711|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
15012712|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012713|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15012714|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15012715|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
15012716|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012717|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012718|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15012719|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15012720|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
15012721|NCT01862978|Heparin|heparin|mesh-list
15012722|NCT01862978|Nadroparin|nadroparin|mesh-list
15012723|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
15012724|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15012725|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15012726|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524398|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524399|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524400|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
14524401|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524402|NCT03663582|Teduglutide|teduglutide|mesh-list
14524403|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14524404|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14524405|NCT03663582|Protective Agents|protective agents|mesh-ancestor
14524406|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524407|NCT03664544|Edaravone|edaravone|mesh-list
15012727|NCT01863004|Bortezomib|bortezomib|mesh-list
15012728|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012729|NCT01863069|Interferons|interferons|mesh-list
15012730|NCT01863069|Interferon-beta|interferon-beta|mesh-list
15012731|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
15012732|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012733|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
15012734|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012735|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
15012736|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012737|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15012738|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14524408|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15012739|NCT01863147|Acarbose|acarbose|mesh-list
15012740|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15012741|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012742|NCT01863147|Incretins|incretins|mesh-ancestor
15012743|NCT01863147|Hormones|hormones|mesh-ancestor
15012744|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15012745|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15012746|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
15012747|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012748|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012749|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15012750|NCT01863173|Metoprolol|metoprolol|mesh-list
15012751|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15012752|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15012753|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
15012754|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
15012755|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012756|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012757|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15012758|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15012759|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15012760|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
15012761|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012762|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012763|NCT01863199|Ranibizumab|ranibizumab|mesh-list
15012764|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15012765|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15012766|NCT01863199|Growth Substances|growth substances|mesh-ancestor
15012767|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012768|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
15012769|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012770|NCT01863225|Atorvastatin|atorvastatin|mesh-list
15012771|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15012772|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15012773|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15012774|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
15012775|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012776|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15012777|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15012778|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012779|NCT01863238|Ivacaftor|ivacaftor|mesh-list
15012780|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15012781|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15012782|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012783|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15012784|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15012785|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15012786|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15012787|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012788|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
15012789|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012790|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012791|NCT01863277|Melatonin|melatonin|mesh-list
15012792|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
15012793|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012794|NCT01863277|Protective Agents|protective agents|mesh-ancestor
15012795|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012796|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012797|NCT01863355|Fentanyl|fentanyl|mesh-list
15012798|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15012799|NCT01863355|Narcotics|narcotics|mesh-ancestor
15012800|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012801|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012802|NCT01863355|Analgesics|analgesics|mesh-ancestor
15012803|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
15012804|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012805|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15012806|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15012807|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
15012808|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
15012809|NCT01863407|Metronidazole|metronidazole|mesh-list
15012810|NCT01863407|Dexamethasone|dexamethasone|mesh-list
15012811|NCT01863407|Allantoin|allantoin|mesh-list
15033595|NCT01990079|Bupropion|bupropion|mesh-list
14524409|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
15012812|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15012813|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
15012814|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
15012815|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012816|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012817|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15012818|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
15012819|NCT01863407|Hormones|hormones|mesh-ancestor
15012820|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15012821|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15012822|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012823|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012824|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15012825|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15012826|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15012827|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
15033596|NCT01990079|Nicotine|nicotine|mesh-list
15033597|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15033598|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
15033599|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033600|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033601|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15033602|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15033603|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
15033604|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033605|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033606|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15033607|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
15033608|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15033609|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15033610|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15033611|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15033612|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
15033613|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15033614|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15033615|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033616|NCT01990118|Cyclosporine|cyclosporine|mesh-list
15033617|NCT01990118|Cyclosporins|cyclosporins|mesh-list
15033618|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033619|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033620|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15033621|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
15033622|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033623|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
15033624|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15033625|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
15033626|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15033627|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15033628|NCT01990144|Rituximab|rituximab|mesh-list
15033629|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15033630|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15033631|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033632|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
15033633|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033634|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15033635|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15033636|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
15033637|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012828|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15012829|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15012830|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012831|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15012832|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15012833|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15012834|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012835|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
15012836|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15012837|NCT01863485|Vorolanib|vorolanib|mesh-list
15012838|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15012839|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012840|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012841|NCT01863511|Tolvaptan|tolvaptan|mesh-list
15012842|NCT01863511|Diuretics|diuretics|mesh-list
15012843|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
15012844|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
15012845|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012846|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15012847|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012848|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15012849|NCT01863589|Adefovir|adefovir|mesh-list
15012850|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
15012851|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012852|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15012853|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15012854|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012855|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012856|NCT01863602|Lamotrigine|lamotrigine|mesh-list
15012857|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
15012858|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15012859|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15012860|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012861|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15012862|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012863|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15012864|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15012865|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012866|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15012867|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15012868|NCT01863615|Isotretinoin|isotretinoin|mesh-list
15012869|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
15012870|NCT01863641|Calcitriol|calcitriol|mesh-list
15012871|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15012872|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012873|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15012874|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15012875|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012876|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15012877|NCT01863641|Vitamins|vitamins|mesh-ancestor
15012878|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
15012879|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15012880|NCT01863654|Montelukast|montelukast|mesh-list
15012881|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15012882|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
15012883|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15012884|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
15012885|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15012886|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012887|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15012888|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15012889|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012890|NCT01863706|Misoprostol|misoprostol|mesh-list
15012891|NCT01863706|Oxytocin|oxytocin|mesh-list
15012892|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
15012893|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15012894|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012895|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15012896|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
15012897|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15012898|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15012899|NCT01863719|Colistin|colistin|mesh-list
15012900|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15012901|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012902|NCT01863810|Pregabalin|pregabalin|mesh-list
15012903|NCT01863810|Analgesics|analgesics|mesh-ancestor
15012904|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
15012905|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012906|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012907|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
15012908|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15012909|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15012910|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012911|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15012912|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15012913|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15012914|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15012915|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15012916|NCT01863823|Amoxicillin|amoxicillin|mesh-list
15012917|NCT01863823|Tetracycline|tetracycline|mesh-list
15012918|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15012919|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15012920|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15012921|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012922|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012923|NCT01863888|Teriflunomide|teriflunomide|mesh-list
15012924|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
15012925|NCT01863888|Charcoal|charcoal|mesh-list
15012926|NCT01863888|Antidotes|antidotes|mesh-ancestor
15012927|NCT01863888|Protective Agents|protective agents|mesh-ancestor
15012928|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012929|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15012930|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15012931|NCT01863888|Analgesics|analgesics|mesh-ancestor
15012932|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
15012933|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15012934|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15012935|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15012936|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15012937|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
15012938|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15012939|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15012940|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
15012941|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012942|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15012943|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15012944|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15012945|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15012946|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
15012947|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012948|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15012949|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15012950|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012951|NCT01864057|Thiamine|thiamine|mesh-list
15012952|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
15012953|NCT01864057|Vitamins|vitamins|mesh-ancestor
15012954|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
15012955|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012956|NCT01864070|Everolimus|everolimus|mesh-list
15012957|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012958|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15012959|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
15012960|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012961|NCT01864083|Fluorides|fluorides|mesh-list
15012962|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
15012963|NCT01864083|Protective Agents|protective agents|mesh-ancestor
15012964|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012965|NCT01864096|Metformin|metformin|mesh-list
15012966|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15012967|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012968|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
15012969|NCT01864109|Temozolomide|temozolomide|mesh-list
15012970|NCT01864109|Ifosfamide|ifosfamide|mesh-list
15012971|NCT01864109|Doxorubicin|doxorubicin|mesh-list
15012972|NCT01864109|Irinotecan|irinotecan|mesh-list
15012973|NCT01864109|Etoposide|etoposide|mesh-list
15012974|NCT01864109|Vincristine|vincristine|mesh-list
15012975|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
15012976|NCT01864109|Razoxane|razoxane|mesh-list
15012977|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15012978|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
15012979|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15012980|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15012981|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15012982|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
15012983|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15012984|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012985|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15012986|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15012987|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15012988|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15012989|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15012990|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15012991|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15012992|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
14529822|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15012993|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
15012994|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
15012995|NCT01864109|Protective Agents|protective agents|mesh-ancestor
15012996|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15012997|NCT01864161|Iron|iron|mesh-list
15012998|NCT01864161|Trace Elements|trace elements|mesh-ancestor
15012999|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
15013000|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013001|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
15013002|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15013003|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013004|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013005|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15013006|NCT01864187|Analgesics|analgesics|mesh-ancestor
15013007|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
15013008|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013009|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15013010|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15013011|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15013012|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
15013013|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013014|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013015|NCT01864213|Tetracaine|tetracaine|mesh-list
15013016|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
15013017|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
15013018|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013019|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013020|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
15013021|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013022|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
15013023|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
15013024|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
15013025|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15013026|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
15013027|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013028|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15013029|NCT01864551|Lamotrigine|lamotrigine|mesh-list
15013030|NCT01864551|Olanzapine|olanzapine|mesh-list
15013031|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
15013032|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
15013033|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013034|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013035|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013036|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15013037|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15013038|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013039|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15013040|NCT01864551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15013041|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15013042|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15013043|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013044|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013045|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
15013046|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
15013047|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15013048|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15013049|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15013050|NCT01864616|Vitamin D|vitamin d|mesh-list
15013051|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
15013052|NCT01864616|Vitamins|vitamins|mesh-ancestor
15013053|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
15013054|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013055|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15013056|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15013057|NCT01864655|Saracatinib|saracatinib|mesh-list
15013058|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013059|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013060|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013061|NCT01864681|Metformin|metformin|mesh-list
15013062|NCT01864681|Gefitinib|gefitinib|mesh-list
15013063|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15013064|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013065|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013066|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15013067|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013068|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013069|NCT01864772|Cetuximab|cetuximab|mesh-list
15013070|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14802402|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802403|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14802404|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14802405|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
14802406|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
14802407|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802408|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15013071|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013072|NCT01864798|Denosumab|denosumab|mesh-list
15013073|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15013074|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013075|NCT01864824|Vitamins|vitamins|mesh-list
15013076|NCT01864824|Folic Acid|folic acid|mesh-list
15013077|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
15013078|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
15013079|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
15013080|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
15013081|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013082|NCT01864824|Hematinics|hematinics|mesh-ancestor
15013083|NCT01864863|Bosentan|bosentan|mesh-list
14802409|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14802410|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802411|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802412|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15013084|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15013085|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15013086|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013087|NCT01864915|Prucalopride|prucalopride|mesh-list
15013088|NCT01864915|Laxatives|laxatives|mesh-ancestor
15013089|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013090|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
15013091|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15013092|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
15013093|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013094|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013095|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033638|NCT01990196|Dasatinib|dasatinib|mesh-list
15033639|NCT01990196|Trametinib|trametinib|mesh-list
15033640|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033641|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15033642|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033643|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033644|NCT01990352|Doxorubicin|doxorubicin|mesh-list
15033645|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15033646|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15033647|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033648|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15033649|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15033650|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033651|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033652|NCT01990378|Rabeprazole|rabeprazole|mesh-list
15033653|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15033654|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15033655|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15033656|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033657|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033658|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
15033659|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15033660|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
15033661|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
15033662|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15033663|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033664|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15033665|NCT01990404|Analgesics|analgesics|mesh-ancestor
15033666|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
15033667|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033668|NCT01990443|Reslizumab|reslizumab|mesh-list
15033669|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15033670|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
15033671|NCT01990586|Rabeprazole|rabeprazole|mesh-list
15033672|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15033673|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15033674|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15033675|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033676|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033677|NCT01990690|Antioxidants|antioxidants|mesh-list
15033678|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033679|NCT01990690|Protective Agents|protective agents|mesh-ancestor
15033680|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033681|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
15033682|NCT01990755|Olanzapine|olanzapine|mesh-list
15033683|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
15033684|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
15033685|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033686|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033687|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15033688|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15033689|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15033690|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15033691|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15033692|NCT01990755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15033693|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15033694|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15033695|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033696|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033697|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
15033698|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
15033699|NCT01990781|Dexamethasone|dexamethasone|mesh-list
15033700|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
15033701|NCT01990781|Lidocaine|lidocaine|mesh-list
15033702|NCT01990781|BB 1101|bb 1101|mesh-list
15013096|NCT01865110|Prednisone|prednisone|mesh-list
15013097|NCT01865110|Rituximab|rituximab|mesh-list
15013098|NCT01865110|Lenalidomide|lenalidomide|mesh-list
15013099|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
15013100|NCT01865110|Vincristine|vincristine|mesh-list
15013101|NCT01865110|Doxorubicin|doxorubicin|mesh-list
15013102|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15013103|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013104|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
15013105|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013106|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15013107|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15013108|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15013109|NCT01865110|Growth Substances|growth substances|mesh-ancestor
15013110|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
15013111|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15013112|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15013113|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
15013114|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013115|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15013116|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15013117|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
15013118|NCT01865110|Hormones|hormones|mesh-ancestor
15013119|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15013120|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15013121|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15013122|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
15013123|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
15013124|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
15013125|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15013126|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15013127|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15013128|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013129|NCT01865175|Iron|iron|mesh-list
15013130|NCT01865175|Trace Elements|trace elements|mesh-ancestor
15013131|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
15013132|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013133|NCT01865188|Amlodipine|amlodipine|mesh-list
15013134|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
15013135|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15013136|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15013137|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15013138|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013139|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15013140|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013141|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
15013142|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15013143|NCT01865201|Mannitol|mannitol|mesh-list
15013144|NCT01865201|Edaravone|edaravone|mesh-list
15013145|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15013146|NCT01865201|Diuretics|diuretics|mesh-ancestor
15013147|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
15013148|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013149|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15013150|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
15013151|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013152|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15013153|NCT01865201|Protective Agents|protective agents|mesh-ancestor
15013154|NCT01865279|Insulin|insulin|mesh-list
15013155|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15013156|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
15013157|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
15013158|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
15013159|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
15013160|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15013161|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013162|NCT01865292|Insulin|insulin|mesh-list
15013163|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15013164|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
15013165|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15013166|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013167|NCT01865305|Insulin|insulin|mesh-list
15013168|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15013169|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
15013170|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
15013171|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15013172|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
15013173|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
15013174|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
15013175|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15013176|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013177|NCT01865318|Insulin|insulin|mesh-list
15013178|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15013179|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013180|NCT01865331|Insulin|insulin|mesh-list
15013181|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15013182|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
15013183|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
15013184|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15013185|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013186|NCT01865500|Prednisolone|prednisolone|mesh-list
15013187|NCT01865500|Budesonide|budesonide|mesh-list
15013188|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15013189|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
15013190|NCT01865500|Hormones|hormones|mesh-ancestor
15013191|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15013192|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013193|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15013194|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013195|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
15013196|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013197|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15013198|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15013199|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
15013200|NCT01865630|Etanercept|etanercept|mesh-list
15013201|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15013202|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15013203|NCT01865630|Analgesics|analgesics|mesh-ancestor
15013204|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
15013205|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013206|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013207|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15013208|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15013209|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013210|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15013211|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
15013212|NCT01865669|Oxytocin|oxytocin|mesh-list
15013213|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
15013214|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15013215|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013216|NCT01865721|Entonox|entonox|mesh-list
15013217|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15013218|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
15013219|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013220|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013221|NCT01865760|Octreotide|octreotide|mesh-list
15013222|NCT01865760|Somatostatin|somatostatin|mesh-list
15013223|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013224|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15013225|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013226|NCT01865760|Hormones|hormones|mesh-ancestor
15013227|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15013228|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013229|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
15013230|NCT01865916|Bisacodyl|bisacodyl|mesh-list
15013231|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
15013232|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013233|NCT01865916|Protective Agents|protective agents|mesh-ancestor
15013234|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013235|NCT01865916|Vitamins|vitamins|mesh-ancestor
15013236|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
15013237|NCT01865916|Cathartics|cathartics|mesh-ancestor
15013238|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013239|NCT01865916|Laxatives|laxatives|mesh-ancestor
15013240|NCT01865968|Vaccines|vaccines|mesh-list
15013241|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
15013242|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013243|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15013244|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
15013245|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013246|NCT01866059|Methamphetamine|methamphetamine|mesh-list
15013247|NCT01866059|Calcium|calcium|mesh-list
15013248|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15013249|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013250|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15013251|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
15013252|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
14524410|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524411|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15013253|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013254|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
15013255|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013256|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013257|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
14524412|NCT03664544|Protective Agents|protective agents|mesh-ancestor
14524413|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013258|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15013259|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14524414|NCT03665155|Daratumumab|daratumumab|mesh-list
14524415|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524416|NCT03666663|Lidocaine|lidocaine|mesh-list
14524417|NCT03666663|Bupivacaine|bupivacaine|mesh-list
14524418|NCT03666663|Ropivacaine|ropivacaine|mesh-list
14524419|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
14524420|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
14524421|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524422|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524423|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
14524424|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524425|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14524426|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14524427|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14524428|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524429|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524430|NCT03667053|Glucagon|glucagon|mesh-list
14524431|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013260|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15013261|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15013262|NCT01866241|Misoprostol|misoprostol|mesh-list
15013263|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15013264|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
15013265|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15013266|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013267|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15013268|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013269|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
15013270|NCT01866254|Morphine|morphine|mesh-list
15013271|NCT01866254|Hydromorphone|hydromorphone|mesh-list
15013272|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15013273|NCT01866254|Narcotics|narcotics|mesh-ancestor
15013274|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013275|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013276|NCT01866254|Analgesics|analgesics|mesh-ancestor
15013277|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
15013278|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013279|NCT01866267|Maraviroc|maraviroc|mesh-list
15013280|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15013281|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15013282|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013283|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15013284|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15013285|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
15013286|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013287|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15013288|NCT01866397|Cidofovir|cidofovir|mesh-list
15013289|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
15013290|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013291|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013292|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013293|NCT01866488|Misoprostol|misoprostol|mesh-list
15013294|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15013295|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
15013296|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15013297|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013298|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15013299|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013300|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
15013301|NCT01866514|Lidocaine|lidocaine|mesh-list
15013302|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
15013303|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
15013304|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013305|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013306|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
15013307|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013308|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15013309|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15013310|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15013311|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15013312|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013313|NCT01866553|Interferons|interferons|mesh-list
15013314|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
15013315|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
15013316|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15013317|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013318|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
15013319|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013320|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
15013321|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013322|NCT01866605|Midazolam|midazolam|mesh-list
15013323|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15013324|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15013325|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013326|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013327|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15013328|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15013329|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15013330|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15013331|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
15013332|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
15013333|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
15013334|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
15013335|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013336|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033703|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15033704|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
15033705|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
15033706|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033707|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033708|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15033709|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
15033710|NCT01990781|Hormones|hormones|mesh-ancestor
15033711|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15033712|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15033713|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033714|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
15033715|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033716|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033717|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
15033718|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
15033719|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15033720|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
15033721|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15033722|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15033723|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15033724|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15033725|NCT01990807|Idarubicin|idarubicin|mesh-list
15033726|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15033727|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033728|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15033729|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15033730|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033731|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033732|NCT01990872|Vitamin D|vitamin d|mesh-list
15033733|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
15033734|NCT01990872|Vitamins|vitamins|mesh-ancestor
15033735|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
15033736|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033737|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15033738|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15033739|NCT01990911|Diuretics|diuretics|mesh-list
15033740|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
15033741|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033742|NCT01990937|Midazolam|midazolam|mesh-list
15033743|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15033744|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15033745|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15033746|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033747|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15033748|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15033749|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15013337|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
15013338|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15013339|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
15013340|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013341|NCT01866644|Expectorants|expectorants|mesh-ancestor
15013342|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
15013343|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15013344|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
15013345|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013346|NCT01866644|Protective Agents|protective agents|mesh-ancestor
15013347|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013348|NCT01866644|Antidotes|antidotes|mesh-ancestor
15013349|NCT01866657|Phenylephrine|phenylephrine|mesh-list
15013350|NCT01866657|Dopamine|dopamine|mesh-list
15013351|NCT01866657|Ephedrine|ephedrine|mesh-list
15013352|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
15013353|NCT01866657|Propofol|propofol|mesh-list
15013354|NCT01866657|Sevoflurane|sevoflurane|mesh-list
15013355|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
15013356|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013357|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013358|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15013359|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15013360|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
15013361|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15013362|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15013363|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15013364|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
15013365|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
15013366|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013367|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
15013368|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
15013369|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
15013370|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15013371|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15013372|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15013373|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
15013374|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013375|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013376|NCT01866657|Protective Agents|protective agents|mesh-ancestor
15013377|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15013378|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
15013379|NCT01867138|Vancomycin|vancomycin|mesh-list
15013380|NCT01867138|Cefazolin|cefazolin|mesh-list
15013381|NCT01867138|Amikacin|amikacin|mesh-list
15013382|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15013383|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013384|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15013385|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15013386|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15013387|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15013388|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013389|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013390|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013391|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15013392|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
15013393|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15013394|NCT01867268|Acetazolamide|acetazolamide|mesh-list
15013395|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
15013396|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15013397|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013398|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013399|NCT01867268|Diuretics|diuretics|mesh-ancestor
15013400|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
15013401|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013402|NCT01867281|Aspirin|aspirin|mesh-list
15013403|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15013404|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15013405|NCT01867281|Analgesics|analgesics|mesh-ancestor
15013406|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
15013407|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013408|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013409|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15013410|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15013411|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15013412|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15013413|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013414|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15013415|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15013416|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013417|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
15013418|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15013419|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15013420|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
15013421|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013422|NCT01867463|Antacids|antacids|mesh-ancestor
15013423|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013424|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013425|NCT01867502|Metformin|metformin|mesh-list
15013426|NCT01867502|Vildagliptin|vildagliptin|mesh-list
15013427|NCT01867502|Glyburide|glyburide|mesh-list
15013428|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15013429|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013430|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15013431|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
15013432|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013433|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013434|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
15013435|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15013436|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013437|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
15013438|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15013439|NCT01867645|Antibodies|antibodies|mesh-list
15013440|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
15013441|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15013442|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
15013443|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013444|NCT01867697|Leucovorin|leucovorin|mesh-list
15013445|NCT01867697|Folic Acid|folic acid|mesh-list
15013446|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
15013447|NCT01867697|Irinotecan|irinotecan|mesh-list
15013448|NCT01867697|Cetuximab|cetuximab|mesh-list
15013449|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
15013450|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
15013451|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013452|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013453|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15013454|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15013455|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033750|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15013456|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013457|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15013458|NCT01867697|Antidotes|antidotes|mesh-ancestor
15013459|NCT01867697|Protective Agents|protective agents|mesh-ancestor
15013460|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
15013461|NCT01867697|Vitamins|vitamins|mesh-ancestor
15013462|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
15013463|NCT01867697|Hematinics|hematinics|mesh-ancestor
15013464|NCT01867697|Antacids|antacids|mesh-ancestor
15013465|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013466|NCT01867775|Mirtazapine|mirtazapine|mesh-list
15013467|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
15013468|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15013469|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15013470|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
15013471|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
15013472|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013473|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013474|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013475|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15013476|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15013477|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013478|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15013479|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15013480|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15013481|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
15013482|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15013483|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15013484|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
15013485|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15013486|NCT01867866|Trifluridine|trifluridine|mesh-list
15013487|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
15013488|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013489|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
15013490|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013491|NCT01867892|Leucovorin|leucovorin|mesh-list
15013492|NCT01867892|Gemcitabine|gemcitabine|mesh-list
15013493|NCT01867892|Fluorouracil|fluorouracil|mesh-list
15013494|NCT01867892|Irinotecan|irinotecan|mesh-list
15013495|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
15013496|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15013497|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
15013498|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013499|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013500|NCT01867892|Antiviral Agents|antiviral agents|mesh-ancestor
15013501|NCT01867892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013502|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013503|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15013504|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
15013505|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013506|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15013507|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15013508|NCT01867892|Antidotes|antidotes|mesh-ancestor
15013509|NCT01867892|Protective Agents|protective agents|mesh-ancestor
15013510|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
15013511|NCT01867892|Vitamins|vitamins|mesh-ancestor
15013512|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
15013513|NCT01867957|Vaccines|vaccines|mesh-list
15013514|NCT01867957|Immunologic Factors|immunologic factors|mesh-ancestor
15013515|NCT01867957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013516|NCT01868048|Nabiximols|nabiximols|mesh-list
15013517|NCT01868048|Analgesics|analgesics|mesh-ancestor
15013518|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
15013519|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013520|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013521|NCT01868113|Fluticasone|fluticasone|mesh-list
15013522|NCT01868113|Xhance|xhance|mesh-list
15013523|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15013524|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15013525|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
15013526|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013527|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013528|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14524432|NCT03667053|Hormones|hormones|mesh-ancestor
15013529|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
15013530|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
15013531|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15013532|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15013533|NCT01868126|Latanoprost|latanoprost|mesh-list
15013534|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15013535|NCT01868191|Thiamine|thiamine|mesh-list
15013536|NCT01868191|Benphothiamine|benphothiamine|mesh-list
15013537|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15013538|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
15013539|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013540|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
15013541|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
15013542|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013543|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
15013544|NCT01868191|Vitamins|vitamins|mesh-ancestor
15013545|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
15013546|NCT01868269|Dexamethasone|dexamethasone|mesh-list
15013547|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
15013548|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
15013549|NCT01868269|Rituximab|rituximab|mesh-list
15013550|NCT01868269|BB 1101|bb 1101|mesh-list
15013551|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15013552|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
15013553|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013554|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15013555|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15013556|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
15013557|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013558|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013559|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15013560|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15013561|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
15013562|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
15013563|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013564|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013565|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
15013566|NCT01868269|Hormones|hormones|mesh-ancestor
15013567|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15013568|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15013569|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
15013570|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013571|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15013572|NCT01868360|Aflibercept|aflibercept|mesh-list
15013573|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15013574|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15013575|NCT01868360|Growth Substances|growth substances|mesh-ancestor
15013576|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013577|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
15013578|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033751|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
15033752|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
15033753|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
15033754|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
15033755|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524433|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14524434|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524435|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
14524436|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14524437|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14524438|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
14524439|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802413|NCT00797264|Narcotics|narcotics|mesh-ancestor
14802414|NCT00797303|Bevacizumab|bevacizumab|mesh-list
14802415|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14802416|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802417|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14802418|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14802419|NCT00797303|Growth Substances|growth substances|mesh-ancestor
14802420|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802421|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
14802422|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
14802423|NCT00797394|Urological Agents|urological agents|mesh-ancestor
14802424|NCT00797420|Fluconazole|fluconazole|mesh-list
14802425|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
14802426|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802427|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14802428|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14802429|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802430|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013579|NCT01868438|Artesunate|artesunate|mesh-list
15013580|NCT01868438|Pyronaridine|pyronaridine|mesh-list
15013581|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
15013582|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15013583|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15013584|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013585|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013586|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
15013587|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
15013588|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15013589|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
15013590|NCT01868451|Doxorubicin|doxorubicin|mesh-list
15013591|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15013592|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15013593|NCT01868451|Dacarbazine|dacarbazine|mesh-list
15013594|NCT01868451|Vinblastine|vinblastine|mesh-list
15013595|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15013596|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013597|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15013598|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15013599|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013600|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013601|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15013602|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15013603|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
15013604|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15013605|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
15013606|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
15013607|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
15013608|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
15013609|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15013610|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
15013611|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013612|NCT01868529|Insulin|insulin|mesh-list
15013613|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15013614|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
15013615|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15013616|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013617|NCT01868555|Insulin|insulin|mesh-list
15013618|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15013619|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
15013620|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
15013621|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15013622|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15013623|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013624|NCT01868568|Insulin|insulin|mesh-list
15013625|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15013626|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
15013627|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
15013628|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15013629|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
15013630|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
15013631|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15013632|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013633|NCT01868581|Insulin|insulin|mesh-list
15013634|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15013635|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
15013636|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
15013637|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15013638|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013639|NCT01868750|Calcitriol|calcitriol|mesh-list
15013640|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15013641|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013642|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15013643|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15013644|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013645|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15013646|NCT01868750|Vitamins|vitamins|mesh-ancestor
15013647|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
15013648|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15013649|NCT01868802|Ketamine|ketamine|mesh-list
15013650|NCT01868802|Analgesics|analgesics|mesh-ancestor
15013651|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
14524440|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14524441|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15013652|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013653|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013654|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15013655|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15013656|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
15013657|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
15013658|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013659|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15013660|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15013661|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013662|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013663|NCT01868880|Bisoprolol|bisoprolol|mesh-list
15013664|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15013665|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15013666|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
15013667|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013668|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013669|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013670|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15013671|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
15013672|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
15013673|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013674|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15013675|NCT01868906|Temozolomide|temozolomide|mesh-list
14524442|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013676|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15013677|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
15013678|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013679|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013680|NCT01868945|Vitamin D|vitamin d|mesh-list
15013681|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
15013682|NCT01868945|Calcifediol|calcifediol|mesh-list
15013683|NCT01868945|Vitamins|vitamins|mesh-ancestor
15013684|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
15013685|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013686|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15013687|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15013688|NCT01868984|Paclitaxel|paclitaxel|mesh-list
15013689|NCT01868984|Heparin|heparin|mesh-list
15013690|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15013691|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013692|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
15013693|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
15013694|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
15013695|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013696|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
15013697|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15013698|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15013699|NCT01869010|Tenofovir|tenofovir|mesh-list
15013700|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
15013701|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013702|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15013703|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15013704|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013705|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013706|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15013707|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15013708|NCT01869023|Gemcitabine|gemcitabine|mesh-list
15013709|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013710|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15013711|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
15013712|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013713|NCT01869023|Antiviral Agents|antiviral agents|mesh-ancestor
15013714|NCT01869023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013715|NCT01869023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013716|NCT01869023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15013717|NCT01869023|Immunologic Factors|immunologic factors|mesh-ancestor
15013718|NCT01869023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013719|NCT01869036|Morphine|morphine|mesh-list
15013720|NCT01869036|Anesthetics|anesthetics|mesh-list
15013721|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013722|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013723|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15013724|NCT01869036|Narcotics|narcotics|mesh-ancestor
15013725|NCT01869036|Analgesics|analgesics|mesh-ancestor
15013726|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
15013727|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013728|NCT01869205|Ivermectin|ivermectin|mesh-list
15013729|NCT01869205|Abamectin|abamectin|mesh-list
15013730|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15013731|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013732|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
15013733|NCT01869257|Triclosan|triclosan|mesh-list
15013734|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15013735|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013736|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15013737|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15013738|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
15013739|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013740|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15013741|NCT01869309|Ticagrelor|ticagrelor|mesh-list
15013742|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15013743|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15013744|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15013745|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15013746|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15013747|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
15013748|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013749|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013750|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013751|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
15013752|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15013753|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15013754|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013755|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
15013756|NCT01869413|Coagulants|coagulants|mesh-ancestor
15013757|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
15013758|NCT01869491|Antacids|antacids|mesh-ancestor
15013759|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013760|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013761|NCT01869556|Oxytocin|oxytocin|mesh-list
15013762|NCT01869556|Ergonovine|ergonovine|mesh-list
15013763|NCT01869556|Carboprost|carboprost|mesh-list
15013764|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
15013765|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15013766|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013767|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15013768|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
15013769|NCT01869569|Pregabalin|pregabalin|mesh-list
15013770|NCT01869569|Analgesics|analgesics|mesh-ancestor
15013771|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
15013772|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013773|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013774|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
15013775|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15013776|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15013777|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013778|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15013779|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15013780|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15013781|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013782|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15013783|NCT01869621|Metformin|metformin|mesh-list
15013784|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15013785|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013786|NCT01869673|Anesthetics|anesthetics|mesh-list
15013787|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013788|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013789|NCT01869751|Prucalopride|prucalopride|mesh-list
15013790|NCT01869751|Laxatives|laxatives|mesh-ancestor
15013791|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013792|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
15013793|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15013794|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
15013795|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013796|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013797|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013798|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
15013799|NCT01869803|Calicheamicins|calicheamicins|mesh-list
15013800|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15013801|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013802|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15013803|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
15013804|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15013805|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15013806|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013807|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15013808|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15013809|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
15013810|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013811|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013812|NCT01869907|Minocycline|minocycline|mesh-list
15013813|NCT01869907|Amitriptyline|amitriptyline|mesh-list
15013814|NCT01869907|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15013815|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15013816|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013817|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15013818|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
15013819|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15013820|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15013821|NCT01869907|Analgesics|analgesics|mesh-ancestor
15013822|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
15013823|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013824|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013825|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15013826|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15013827|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15013828|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013829|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
15013830|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013831|NCT01869907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15013832|NCT01869907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14524443|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013833|NCT01869907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013834|NCT01869946|Ropivacaine|ropivacaine|mesh-list
15013835|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
15013836|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
15013837|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013838|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013839|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
15013840|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013841|NCT01870011|Anesthetics|anesthetics|mesh-list
15013842|NCT01870011|Propofol|propofol|mesh-list
15013843|NCT01870011|Desflurane|desflurane|mesh-list
15013844|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524444|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14524445|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
14524446|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524447|NCT03669081|Ketorolac|ketorolac|mesh-list
14524448|NCT03669081|Pregabalin|pregabalin|mesh-list
14524449|NCT03669081|Analgesics|analgesics|mesh-ancestor
14524450|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
15013845|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013846|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15013847|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15013848|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
15013849|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15013850|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
15013851|NCT01870024|Lorazepam|lorazepam|mesh-list
15013852|NCT01870024|Clonazepam|clonazepam|mesh-list
15013853|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
15013854|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
15013855|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
15013856|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013857|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013858|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013859|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15013860|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013861|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15013862|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15013863|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15013864|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
15013865|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
15013866|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013867|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013868|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15013869|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15013870|NCT01870050|Dapsone|dapsone|mesh-list
15013871|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013872|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
15013873|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15013874|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15013875|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15013876|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013877|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013878|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
15013879|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15013880|NCT01870115|Vitamin D|vitamin d|mesh-list
15013881|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
15013882|NCT01870115|Melatonin|melatonin|mesh-list
15013883|NCT01870115|Vitamins|vitamins|mesh-ancestor
15013884|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
15013885|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013886|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15013887|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013888|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15013889|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
15013890|NCT01870115|Protective Agents|protective agents|mesh-ancestor
15013891|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013892|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
15013893|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
15013894|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
15013895|NCT01870128|Methotrexate|methotrexate|mesh-list
15013896|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15013897|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
15013898|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15013899|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013900|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15013901|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
15013902|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013903|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013904|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
15013905|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013906|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15013907|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15013908|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
15013909|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15013910|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15013911|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15013912|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
15013913|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
15013914|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013915|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013916|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
15013917|NCT01870128|Hormones|hormones|mesh-ancestor
15013918|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15013919|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15013920|NCT01870128|Protective Agents|protective agents|mesh-ancestor
15013921|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
15013922|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15013923|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15013924|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013925|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15013926|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15013927|NCT01870128|Analgesics|analgesics|mesh-ancestor
15013928|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
15033756|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033757|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15033758|NCT01991054|Vitamin D|vitamin d|mesh-list
15033759|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
15033760|NCT01991054|Vitamins|vitamins|mesh-ancestor
15033761|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
15033762|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033763|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15033764|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15033765|NCT01991119|Dronedarone|dronedarone|mesh-list
15033766|NCT01991119|Propafenone|propafenone|mesh-list
15033767|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15033768|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15033769|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15033770|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15013929|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15013930|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15013931|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15013932|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15013933|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013934|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013935|NCT01870219|Ketamine|ketamine|mesh-list
15013936|NCT01870219|Sevoflurane|sevoflurane|mesh-list
15013937|NCT01870219|Anesthetics|anesthetics|mesh-list
15013938|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
15013939|NCT01870219|Analgesics|analgesics|mesh-ancestor
15013940|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
15013941|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013942|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013943|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15013944|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
15013945|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15013946|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15013947|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15013948|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15013949|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013950|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15013951|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15013952|NCT01870284|Adalimumab|adalimumab|mesh-list
15013953|NCT01870284|Ixekizumab|ixekizumab|mesh-list
15013954|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15013955|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15013956|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
15013957|NCT01870427|Aflibercept|aflibercept|mesh-list
15013958|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15013959|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15013960|NCT01870427|Growth Substances|growth substances|mesh-ancestor
15013961|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013962|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
15013963|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013964|NCT01870440|Dexamethasone|dexamethasone|mesh-list
15013965|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
15013966|NCT01870440|BB 1101|bb 1101|mesh-list
15013967|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15013968|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
15013969|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
15013970|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013971|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013972|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15013973|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
15013974|NCT01870440|Hormones|hormones|mesh-ancestor
15013975|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15013976|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15013977|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15013978|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
15013979|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013980|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013981|NCT01870466|Cilostazol|cilostazol|mesh-list
15013982|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15013983|NCT01870466|Simvastatin|simvastatin|mesh-list
15013984|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15013985|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15013986|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
15013987|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15013988|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15013989|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15013990|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15013991|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15013992|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
15013993|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15013994|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15013995|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15013996|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
15013997|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15013998|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15013999|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15014000|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
15014001|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15014002|NCT01870466|Protective Agents|protective agents|mesh-ancestor
15014003|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15014004|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15014005|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15014006|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15014007|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15014008|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014009|NCT01870635|Ondansetron|ondansetron|mesh-list
15014010|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
15014011|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
15014012|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014013|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014014|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15014015|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
15014016|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
15014017|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15014018|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
15014019|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014020|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014021|NCT01870635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15014022|NCT01870635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15014023|NCT01870635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014024|NCT01870635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15014025|NCT01870635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15014026|NCT01870648|Ondansetron|ondansetron|mesh-list
15014027|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
15014028|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
15014029|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014030|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014031|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15014032|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
15014033|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
15014034|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15014035|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
15014036|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014037|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014038|NCT01870648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15014039|NCT01870648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15014040|NCT01870648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014041|NCT01870648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802431|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14802432|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
14802433|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14802434|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802435|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14802436|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14802437|NCT00797472|Bleomycin|bleomycin|mesh-list
14802438|NCT00797472|Dacarbazine|dacarbazine|mesh-list
14802439|NCT00797472|Vinblastine|vinblastine|mesh-list
14802440|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14802441|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802442|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802443|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14802444|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
14802445|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14802446|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
14802447|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
14802448|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
14802449|NCT00797485|Leucovorin|leucovorin|mesh-list
14802450|NCT00797485|Bevacizumab|bevacizumab|mesh-list
14802451|NCT00797485|Fluorouracil|fluorouracil|mesh-list
14802452|NCT00797485|Capecitabine|capecitabine|mesh-list
14802453|NCT00797485|Irinotecan|irinotecan|mesh-list
14802454|NCT00797485|Calcium|calcium|mesh-list
14802455|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
14802456|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14802457|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802458|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14802459|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14802460|NCT00797485|Growth Substances|growth substances|mesh-ancestor
14802461|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802462|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
14802463|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14802464|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
15014042|NCT01870648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15014043|NCT01870674|Prucalopride|prucalopride|mesh-list
15014044|NCT01870674|YH12852|yh12852|mesh-list
15014045|NCT01870674|Laxatives|laxatives|mesh-ancestor
15014046|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15014047|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
15014048|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15014049|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
15014050|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014051|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014052|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014053|NCT01870804|Atorvastatin|atorvastatin|mesh-list
15014054|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15014055|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15014056|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15014057|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
15014058|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014059|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14524451|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524452|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014060|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15014061|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014062|NCT01870895|Ramosetron|ramosetron|mesh-list
15014063|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
15014064|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
15014065|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014066|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014067|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15014068|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15014069|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
15014070|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014071|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014072|NCT01870908|Tacrolimus|tacrolimus|mesh-list
15014073|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15014074|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
15014075|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014076|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15014077|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014078|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014079|NCT01870986|Adalimumab|adalimumab|mesh-list
15014080|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15014081|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15014082|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
15014083|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15014084|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014085|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014086|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15014087|NCT01871129|Analgesics|analgesics|mesh-ancestor
15014088|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
15014089|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014090|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15014091|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15014092|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15014093|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
15014094|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014095|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014096|NCT01871311|Cetuximab|cetuximab|mesh-list
14524453|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
14524454|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14524455|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524456|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524457|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14524458|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14524459|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14524460|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524461|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14524462|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14524463|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14524464|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14524465|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14524466|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14524467|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524468|NCT03669861|Abatacept|abatacept|mesh-list
15014097|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15014098|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014099|NCT01871363|Capecitabine|capecitabine|mesh-list
15014100|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014101|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15014102|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
15014103|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014104|NCT01871376|Aflibercept|aflibercept|mesh-list
15014105|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15014106|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15014107|NCT01871376|Growth Substances|growth substances|mesh-ancestor
15014108|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014109|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
15014110|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014111|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
15014112|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15014113|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014114|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014115|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15014116|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15014117|NCT01871454|Protective Agents|protective agents|mesh-ancestor
15014118|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014119|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
15014120|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15014121|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
15014122|NCT01871467|Sargramostim|sargramostim|mesh-list
15014123|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
15014124|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014125|NCT01871480|Gefitinib|gefitinib|mesh-list
15014126|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014127|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15014128|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014129|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014130|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
15014131|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15014132|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014133|NCT01871571|Leucovorin|leucovorin|mesh-list
15014134|NCT01871571|Bevacizumab|bevacizumab|mesh-list
15014135|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15014136|NCT01871571|Fluorouracil|fluorouracil|mesh-list
15014137|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
15014138|NCT01871571|Antibodies|antibodies|mesh-list
15014139|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
15014140|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15014141|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
15014142|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014143|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15014144|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15014145|NCT01871571|Growth Substances|growth substances|mesh-ancestor
15014146|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014147|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
15014148|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
15014149|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
15014150|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014151|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15014152|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15014153|NCT01871571|Antidotes|antidotes|mesh-ancestor
15014154|NCT01871571|Protective Agents|protective agents|mesh-ancestor
15014155|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
15014156|NCT01871571|Vitamins|vitamins|mesh-ancestor
15014157|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
15014158|NCT01871649|Golimumab|golimumab|mesh-list
15014159|NCT01871649|Methotrexate|methotrexate|mesh-list
15014160|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15014161|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
15014162|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15014163|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014164|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15014165|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
15014166|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014167|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014168|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
15014169|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014170|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15014171|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15014172|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
15014173|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15014174|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15014175|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15014176|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15014177|NCT01871662|Interferons|interferons|mesh-list
15014178|NCT01871662|Ribavirin|ribavirin|mesh-list
15014179|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
15014180|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
15014181|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15014182|NCT01871662|Silybin|silybin|mesh-list
15014183|NCT01871662|Silymarin|silymarin|mesh-list
15014184|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014185|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
15014186|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014187|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
15014188|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014189|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
15014190|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014191|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
15014192|NCT01871662|Protective Agents|protective agents|mesh-ancestor
15014193|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15014194|NCT01871675|Rituximab|rituximab|mesh-list
15014195|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15014196|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15014197|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014198|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
15014199|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014200|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15014201|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15014202|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
15014203|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014204|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
15014205|NCT01871701|Dexetimide|dexetimide|mesh-list
15014206|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15014207|NCT01871701|Citalopram|citalopram|mesh-list
15014208|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15014209|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15014210|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014211|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15014212|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15014213|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014214|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014215|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014216|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15014217|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
15014218|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15014219|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014220|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15014221|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15014222|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15014223|NCT01871701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15014224|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15014225|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15014226|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014227|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
15014228|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15014229|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
15014230|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15014231|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15014232|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15014233|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
14524469|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14524470|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524471|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524472|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14524473|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
14524474|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524475|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14524476|NCT03670030|Sirolimus|sirolimus|mesh-list
14524477|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14524478|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524479|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14524480|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524481|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
14524482|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14524483|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
14524484|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014234|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
15014235|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014236|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15014237|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15014238|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
15014239|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15014240|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15014241|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014242|NCT01871740|Folic Acid|folic acid|mesh-list
15014243|NCT01871740|Enalapril|enalapril|mesh-list
15014244|NCT01871740|Enalaprilat|enalaprilat|mesh-list
15014245|NCT01871740|Maleic acid|maleic acid|mesh-list
15014246|NCT01871740|Hematinics|hematinics|mesh-ancestor
14524485|NCT03670160|Clonidine|clonidine|mesh-list
14524486|NCT03670160|Phenobarbital|phenobarbital|mesh-list
14524487|NCT03670160|Analgesics|analgesics|mesh-ancestor
14524488|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
14524489|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524490|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524491|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14524492|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
14524493|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
14524494|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14524495|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14524496|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14524497|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
14524498|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524499|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014247|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
15014248|NCT01871740|Vitamins|vitamins|mesh-ancestor
15014249|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
15014250|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014251|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014252|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014253|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15014254|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
15014255|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15014256|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
15014257|NCT01871766|Dactinomycin|dactinomycin|mesh-list
15014258|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
15014259|NCT01871766|Ifosfamide|ifosfamide|mesh-list
15014260|NCT01871766|Bevacizumab|bevacizumab|mesh-list
15014261|NCT01871766|Doxorubicin|doxorubicin|mesh-list
15014262|NCT01871766|Irinotecan|irinotecan|mesh-list
15014263|NCT01871766|Etoposide|etoposide|mesh-list
15014264|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
15014265|NCT01871766|Vincristine|vincristine|mesh-list
15014266|NCT01871766|Sorafenib|sorafenib|mesh-list
15014267|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
15014268|NCT01871766|Razoxane|razoxane|mesh-list
15014269|NCT01871766|Mitogens|mitogens|mesh-list
15014270|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15014271|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
15014272|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014273|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15014274|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15014275|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
15014276|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014277|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014278|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15014279|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15014280|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15014281|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15014282|NCT01871766|Growth Substances|growth substances|mesh-ancestor
15014283|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
15014284|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15014285|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15014286|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15014287|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014288|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15014289|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15014290|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
15014291|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
15014292|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
15014293|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15014294|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15014295|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014296|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15014297|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15014298|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15014299|NCT01871766|Protective Agents|protective agents|mesh-ancestor
15014300|NCT01871792|Pitavastatin|pitavastatin|mesh-list
15014301|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15014302|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15014303|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15014304|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
15014305|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014306|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524500|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
14524501|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14524502|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014307|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15014308|NCT01871844|Octreotide|octreotide|mesh-list
15014309|NCT01871844|Somatostatin|somatostatin|mesh-list
15014310|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15014311|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15014312|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014313|NCT01871844|Hormones|hormones|mesh-ancestor
15014314|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15014315|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014316|NCT01871857|Epinephrine|epinephrine|mesh-list
15014317|NCT01871857|Racepinephrine|racepinephrine|mesh-list
15014318|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
15014319|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15014320|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15014321|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
15014322|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014323|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014324|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014325|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15014326|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15014327|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
15014328|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014329|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15014330|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
15014331|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
15014332|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
15014333|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15033771|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033772|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
15033773|NCT01991145|Hematinics|hematinics|mesh-ancestor
15033774|NCT01991158|Gemcitabine|gemcitabine|mesh-list
15033775|NCT01991158|Dexamethasone|dexamethasone|mesh-list
15033776|NCT01991158|Methotrexate|methotrexate|mesh-list
15033777|NCT01991158|Pegaspargase|pegaspargase|mesh-list
15033778|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15033779|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
15033780|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
15033781|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033782|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033783|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15033784|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
15033785|NCT01991158|Hormones|hormones|mesh-ancestor
15033786|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15033787|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15033788|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033789|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15033790|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
15033791|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033792|NCT01991158|Antiviral Agents|antiviral agents|mesh-ancestor
15033793|NCT01991158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15033794|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033795|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15033796|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
15033797|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15033798|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
15033799|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15033800|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
15033801|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15033802|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15033803|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15033804|NCT01991275|Morphine|morphine|mesh-list
15033805|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15033806|NCT01991275|Narcotics|narcotics|mesh-ancestor
15033807|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15033808|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033809|NCT01991275|Analgesics|analgesics|mesh-ancestor
15033810|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
15033811|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033812|NCT01991288|Epinephrine|epinephrine|mesh-list
15033813|NCT01991288|Racepinephrine|racepinephrine|mesh-list
15033814|NCT01991288|Bupivacaine|bupivacaine|mesh-list
15033815|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
15033816|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
15033817|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
15033818|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
15033819|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15033820|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033821|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
15033822|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033823|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15033824|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15033825|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
15033826|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033827|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033828|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15033829|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15033830|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
15033831|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15033832|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
15033833|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
15033834|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
15033835|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15014334|NCT01871922|Atropine|atropine|mesh-list
15014335|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15014336|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15014337|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15014338|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
15014339|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014340|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014341|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15014342|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
15014343|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
15014344|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
15014345|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15014346|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15014347|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
15014348|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014349|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014350|NCT01871935|Sufentanil|sufentanil|mesh-list
15014351|NCT01871935|Remifentanil|remifentanil|mesh-list
15014352|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15014353|NCT01871935|Narcotics|narcotics|mesh-ancestor
15014354|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014355|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014356|NCT01871935|Analgesics|analgesics|mesh-ancestor
15014357|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
15014358|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014359|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15014360|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15014361|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
15014362|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
15014363|NCT01871961|Methotrexate|methotrexate|mesh-list
15014364|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15014365|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
15014366|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15014367|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014368|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15014369|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
15014370|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014371|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014372|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
15014373|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014374|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15014375|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15014376|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
15014377|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15014378|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15014379|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15014380|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
15014381|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15014382|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15014383|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15014384|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014385|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014386|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15014387|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
15014388|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15014389|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15014390|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15014391|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014392|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014393|NCT01872013|ASP7991|asp7991|mesh-list
15014394|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
15014395|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
15014396|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15014397|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014398|NCT01872026|ASP7991|asp7991|mesh-list
15014399|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
15014400|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
15014401|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15014402|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014403|NCT01872039|Nicardipine|nicardipine|mesh-list
15014404|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15014405|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15014406|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15014407|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014408|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15014409|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014410|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
15014411|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
15014412|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
15014413|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
15014414|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014415|NCT01872351|Protective Agents|protective agents|mesh-ancestor
15014416|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014417|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
15014418|NCT01872351|Vitamins|vitamins|mesh-ancestor
15014419|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
15014420|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
15014421|NCT01872403|Paclitaxel|paclitaxel|mesh-list
15014422|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15014423|NCT01872403|Carboplatin|carboplatin|mesh-list
15014424|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15014425|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014426|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
15014427|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
15014428|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
15014429|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014430|NCT01872416|Doxorubicin|doxorubicin|mesh-list
15014431|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15014432|NCT01872416|Ifosfamide|ifosfamide|mesh-list
15014433|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15014434|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014435|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15014436|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15014437|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014438|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014439|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15014440|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
15014441|NCT01872442|Interferons|interferons|mesh-list
15014442|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
15014443|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
15014444|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15014445|NCT01872442|Dasatinib|dasatinib|mesh-list
15014446|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014447|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
15014448|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014449|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
15014450|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014451|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15014452|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014453|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014454|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
15014455|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
15014456|NCT01872494|Pentazocine|pentazocine|mesh-list
15014457|NCT01872494|Palonosetron|palonosetron|mesh-list
15014458|NCT01872494|Ropivacaine|ropivacaine|mesh-list
15014459|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
15014460|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
15014461|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014462|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014463|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
15014464|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014465|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
15014466|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
15014467|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15014468|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15014469|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15014470|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
15014471|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014472|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014473|NCT01872494|Analgesics|analgesics|mesh-ancestor
15014474|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15014475|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15014476|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15014477|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15014478|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15014479|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014480|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15014481|NCT01872494|Narcotics|narcotics|mesh-ancestor
15014482|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15014483|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15014484|NCT01872546|Adalimumab|adalimumab|mesh-list
15014485|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15014486|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15014487|NCT01872702|Piperaquine|piperaquine|mesh-list
15014488|NCT01872702|Primaquine|primaquine|mesh-list
15014489|NCT01872702|Artenimol|artenimol|mesh-list
15014490|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
15014491|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15014492|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15014493|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014494|NCT01872728|Anesthetics|anesthetics|mesh-list
15014495|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014496|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014497|NCT01872754|Remifentanil|remifentanil|mesh-list
15014498|NCT01872754|Propofol|propofol|mesh-list
15014499|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15014500|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014501|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014502|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15014503|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
15014504|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
15014505|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15014506|NCT01872754|Narcotics|narcotics|mesh-ancestor
15014507|NCT01872754|Analgesics|analgesics|mesh-ancestor
15014508|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
15014509|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014510|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
15014511|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15014512|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014513|NCT01872832|Verinurad|verinurad|mesh-list
15014514|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
15014515|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15014516|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15014517|NCT01872845|Pravastatin|pravastatin|mesh-list
15014518|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15014519|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15014520|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
15014521|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014522|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15014523|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15014524|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014525|NCT01872858|Aspirin|aspirin|mesh-list
15014526|NCT01872858|Cilostazol|cilostazol|mesh-list
15014527|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15014528|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15014529|NCT01872858|Analgesics|analgesics|mesh-ancestor
15014530|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
15014531|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014532|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014533|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15014534|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15014535|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15014536|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15014537|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014538|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15014539|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15014540|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014541|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
15014542|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15014543|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
15014544|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15014545|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
15014546|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
15014547|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15014548|NCT01872858|Protective Agents|protective agents|mesh-ancestor
15014549|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15014550|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15014551|NCT01872871|Acetaminophen|acetaminophen|mesh-list
15014552|NCT01872871|Anesthetics|anesthetics|mesh-list
15014553|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
15014554|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15014555|NCT01872871|Analgesics|analgesics|mesh-ancestor
15014556|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
15014557|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014558|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014559|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
15014560|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014561|NCT01872884|Remifentanil|remifentanil|mesh-list
15014562|NCT01872884|Sevoflurane|sevoflurane|mesh-list
15014563|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15014564|NCT01872884|Narcotics|narcotics|mesh-ancestor
15014565|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014566|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014567|NCT01872884|Analgesics|analgesics|mesh-ancestor
15014568|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
15014569|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014570|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15014571|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15014572|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
15014573|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
15014574|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
15014575|NCT01872897|Antacids|antacids|mesh-ancestor
15014576|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014577|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15014578|NCT01872923|Bleomycin|bleomycin|mesh-list
15014579|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15014580|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014581|NCT01872936|Ribavirin|ribavirin|mesh-list
15014582|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
15014583|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014584|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
15014585|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524503|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14524504|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14524505|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
14524506|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
14524507|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15014586|NCT01872962|Gemcitabine|gemcitabine|mesh-list
15014587|NCT01872962|Cisplatin|cisplatin|mesh-list
15014588|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014589|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15014590|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
15014591|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014592|NCT01872962|Antiviral Agents|antiviral agents|mesh-ancestor
15014593|NCT01872962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014594|NCT01872962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524508|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14524509|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14524510|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
14524511|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
14524512|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14524513|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524514|NCT03670810|Lasmiditan|lasmiditan|mesh-list
14524515|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14524516|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
14524517|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524518|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524519|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524520|NCT03672006|Heparin|heparin|mesh-list
14524521|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14524522|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
14524523|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14524524|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14524525|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524526|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14524527|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14524528|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
15014595|NCT01872962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15014596|NCT01872962|Immunologic Factors|immunologic factors|mesh-ancestor
15014597|NCT01872962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524529|NCT03673670|Olodaterol|olodaterol|mesh-list
14524530|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14524531|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
14524532|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524533|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524534|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14524535|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
14524536|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
14524537|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14524538|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
14524539|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524540|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014598|NCT01872988|Tenofovir|tenofovir|mesh-list
15014599|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
15014600|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014601|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15014602|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15014603|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014604|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014605|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15014606|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15014607|NCT01873001|Pioglitazone|pioglitazone|mesh-list
15014608|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
15014609|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15014610|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014611|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014612|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15014613|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014614|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014615|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
15014616|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15014617|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15014618|NCT01873027|Sirolimus|sirolimus|mesh-list
15014619|NCT01873027|Umirolimus|umirolimus|mesh-list
15014620|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15014621|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15014622|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
15014623|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014624|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15014625|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014626|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15014627|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014628|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
15014629|NCT01873079|Esomeprazole|esomeprazole|mesh-list
15014630|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15014631|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15014632|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15014633|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014634|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014635|NCT01873131|Timolol|timolol|mesh-list
15014636|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15014637|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15014638|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
15014639|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014640|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014641|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014642|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14802465|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802466|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14802467|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802468|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
14802469|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14802470|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14802471|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802472|NCT00797485|Antidotes|antidotes|mesh-ancestor
14802473|NCT00797485|Protective Agents|protective agents|mesh-ancestor
15014643|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15014644|NCT01873144|Epinephrine|epinephrine|mesh-list
15014645|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15014646|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15014647|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15014648|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
15014649|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014650|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014651|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014652|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15014653|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15014654|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
15014655|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014656|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15014657|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
15014658|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
15014659|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
15014660|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15014661|NCT01873157|Bortezomib|bortezomib|mesh-list
15014662|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014663|NCT01873222|Sirolimus|sirolimus|mesh-list
15014664|NCT01873222|Umirolimus|umirolimus|mesh-list
15014665|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15014666|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15014667|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
15014668|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014669|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15014670|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014671|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15014672|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014673|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
15014674|NCT01873313|Ropivacaine|ropivacaine|mesh-list
15014675|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
15014676|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
15014677|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014678|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014679|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
15014680|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014681|NCT01873326|Paclitaxel|paclitaxel|mesh-list
15014682|NCT01873326|Etoposide|etoposide|mesh-list
15014683|NCT01873326|Ifosfamide|ifosfamide|mesh-list
15014684|NCT01873326|Bleomycin|bleomycin|mesh-list
15014685|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15014686|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014687|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
15014688|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
15014689|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
15014690|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014691|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15014692|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15014693|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014694|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15014695|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
15014696|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15014697|NCT01873339|Midazolam|midazolam|mesh-list
15014698|NCT01873339|Darapladib|darapladib|mesh-list
15014699|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15014700|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15014701|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014702|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014703|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15014704|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15014705|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15014706|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15014707|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
15014708|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
15014709|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
15014710|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
15014711|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014712|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014713|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
15014714|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014715|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15014716|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
15014717|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15014718|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
15014719|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15014720|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014721|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15014722|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15014723|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033836|NCT01991327|Enclomiphene|enclomiphene|mesh-list
15033837|NCT01991327|Clomiphene|clomiphene|mesh-list
15033838|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
15033839|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15033840|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
15033841|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15033842|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033843|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15033844|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
15033845|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15033846|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15033847|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15033848|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
15033849|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033850|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15033851|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033852|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033853|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15033854|NCT01991561|Vaccines|vaccines|mesh-list
15033855|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
15033856|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033857|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15033858|NCT01991561|Antacids|antacids|mesh-ancestor
15033859|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033860|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15033861|NCT01991574|Calcium|calcium|mesh-list
15033862|NCT01991574|Calcium acetate|calcium acetate|mesh-list
15033863|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15033864|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033865|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
15033866|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
15014724|NCT01873430|Melatonin|melatonin|mesh-list
15014725|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
15014726|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014727|NCT01873430|Protective Agents|protective agents|mesh-ancestor
15014728|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014729|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014730|NCT01873443|Folic Acid|folic acid|mesh-list
15014731|NCT01873443|Rituximab|rituximab|mesh-list
15014732|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15014733|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014734|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
15014735|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014736|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15014737|NCT01873443|Hematinics|hematinics|mesh-ancestor
15014738|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
15014739|NCT01873443|Vitamins|vitamins|mesh-ancestor
15014740|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
15014741|NCT01873573|Triamcinolone|triamcinolone|mesh-list
15014742|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15014743|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
15014744|NCT01873573|Hormones|hormones|mesh-ancestor
15014745|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15014746|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014747|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
15014748|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15014749|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014750|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15014751|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15014752|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014753|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014754|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014755|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15014756|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15014757|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
15014758|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
15014759|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15014760|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15014761|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014762|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
15014763|NCT01873768|Coagulants|coagulants|mesh-ancestor
15014764|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
15014765|NCT01873807|Etoposide|etoposide|mesh-list
15014766|NCT01873807|Idarubicin|idarubicin|mesh-list
14524541|NCT03674177|Vaccines|vaccines|mesh-list
14524542|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
14524543|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524544|NCT03674970|Nicotine|nicotine|mesh-list
14524545|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14524546|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
14524547|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524548|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524549|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14524550|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14524551|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
14524552|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802474|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
14802475|NCT00797485|Vitamins|vitamins|mesh-ancestor
14802476|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
14802477|NCT00797693|Misoprostol|misoprostol|mesh-list
14802478|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14802479|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
15014767|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15014768|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
15014769|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014770|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15014771|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15014772|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
15014773|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014774|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014775|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14802480|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14802481|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802482|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14802483|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14802484|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
14802485|NCT00797745|Ritonavir|ritonavir|mesh-list
14802486|NCT00797745|Ribavirin|ribavirin|mesh-list
14802487|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15014776|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15014777|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15014778|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15014779|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014780|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15014781|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
15014782|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
15014783|NCT01873820|Calcium|calcium|mesh-list
15014784|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15014785|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014786|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
15014787|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014788|NCT01873820|Protective Agents|protective agents|mesh-ancestor
15014789|NCT01873820|Vitamins|vitamins|mesh-ancestor
15014790|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
15014791|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
15014792|NCT01873833|Capecitabine|capecitabine|mesh-list
15014793|NCT01873833|Trastuzumab|trastuzumab|mesh-list
15014794|NCT01873833|Lapatinib|lapatinib|mesh-list
15014795|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15014796|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
15014797|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014798|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15014799|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15014800|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
15014801|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014802|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014803|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15014804|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15014805|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
15014806|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15014807|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15014808|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014809|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
15014810|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
15014811|NCT01874002|Sirolimus|sirolimus|mesh-list
15014812|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15014813|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014814|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15014815|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014816|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
15014817|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15014818|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
15014819|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014820|NCT01874028|Trientine|trientine|mesh-list
15014821|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
15014822|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
15014823|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014824|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
15014825|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014826|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
15014827|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
15014828|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
15014829|NCT01874080|Metformin|metformin|mesh-list
15014830|NCT01874080|Saxagliptin|saxagliptin|mesh-list
15014831|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15014832|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014833|NCT01874080|Incretins|incretins|mesh-ancestor
15014834|NCT01874080|Hormones|hormones|mesh-ancestor
15014835|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15014836|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15014837|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
15014838|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014839|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014840|NCT01874171|Cetuximab|cetuximab|mesh-list
15014841|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014842|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15014843|NCT01874236|Bupivacaine|bupivacaine|mesh-list
15014844|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
15014845|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
15014846|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014847|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014848|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
15014849|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014850|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
15014851|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15014852|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014853|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15014854|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15014855|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014856|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014857|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014858|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
15014859|NCT01874470|Diuretics|diuretics|mesh-list
15014860|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
15014861|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014862|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
15014863|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15014864|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014865|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15014866|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15014867|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014868|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014869|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014870|NCT01874574|Triamcinolone|triamcinolone|mesh-list
15014871|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15014872|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15014873|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15014874|NCT01874574|Hylan|hylan|mesh-list
15014875|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15014876|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
15014877|NCT01874574|Hormones|hormones|mesh-ancestor
15014878|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15014879|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014880|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15014881|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
15014882|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014883|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014884|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
15014885|NCT01874574|Protective Agents|protective agents|mesh-ancestor
15014886|NCT01874639|Hemostatics|hemostatics|mesh-list
15014887|NCT01874639|Coagulants|coagulants|mesh-ancestor
15014888|NCT01874678|Cisplatin|cisplatin|mesh-list
15014889|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014890|NCT01874717|Midazolam|midazolam|mesh-list
15014891|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15014892|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15014893|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014894|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014895|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15014896|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15014897|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15014898|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15014899|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
15014900|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
15014901|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
15014902|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
15014903|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014904|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014905|NCT01874730|Anesthetics|anesthetics|mesh-list
15014906|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014907|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014908|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15014909|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15014910|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15014911|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
15014912|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014913|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15014914|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15014915|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014916|NCT01874847|Melatonin|melatonin|mesh-list
15014917|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
15014918|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014919|NCT01874847|Protective Agents|protective agents|mesh-ancestor
15014920|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014921|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014922|NCT01874860|Doxycycline|doxycycline|mesh-list
15014923|NCT01874860|Clindamycin|clindamycin|mesh-list
15014924|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
15014925|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
15014926|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
15014927|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
15014928|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15014929|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15014930|NCT01874860|Prednisolone|prednisolone|mesh-list
15014931|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
15014932|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
15014933|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15014934|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
15014935|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15014936|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15014937|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15014938|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
15014939|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15014940|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15014941|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
15014942|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
15014943|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014944|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014945|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15014946|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
15014947|NCT01874860|Hormones|hormones|mesh-ancestor
15014948|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15014949|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15014950|NCT01874860|Protective Agents|protective agents|mesh-ancestor
15014951|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15014952|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15014953|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15014954|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014955|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014956|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15014957|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
15014958|NCT01874964|Methadone|methadone|mesh-list
15014959|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15014960|NCT01874964|Narcotics|narcotics|mesh-ancestor
15014961|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15014962|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014963|NCT01874964|Analgesics|analgesics|mesh-ancestor
15014964|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
15014965|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014966|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
15014967|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
15033867|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033868|NCT01991587|Vaccines|vaccines|mesh-list
15033869|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
15033870|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033871|NCT01991626|Iron|iron|mesh-list
15033872|NCT01991626|Trace Elements|trace elements|mesh-list
15033873|NCT01991626|Micronutrients|micronutrients|mesh-list
15033874|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033875|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
15033876|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033877|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15033878|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15033879|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033880|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035501|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15035502|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15035503|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
15035504|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035505|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15035506|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15035507|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035508|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15035509|NCT02001896|Gemcitabine|gemcitabine|mesh-list
15035510|NCT02001896|Carboplatin|carboplatin|mesh-list
15035511|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15035512|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035513|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15014968|NCT01875107|Insulin|insulin|mesh-list
15014969|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15014970|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014971|NCT01875172|Bupropion|bupropion|mesh-list
15014972|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15014973|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
15014974|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15014975|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15014976|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15014977|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15014978|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014979|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
15014980|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15014981|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014982|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15014983|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15014984|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15014985|NCT01875185|Aspirin|aspirin|mesh-list
15014986|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15014987|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15014988|NCT01875185|Analgesics|analgesics|mesh-ancestor
15014989|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
15014990|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15014991|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15014992|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15014993|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15014994|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15014995|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15014996|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15014997|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15014998|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15014999|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015000|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
15015001|NCT01875224|Abatacept|abatacept|mesh-list
15015002|NCT01875224|Tacrolimus|tacrolimus|mesh-list
15015003|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15015004|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
15015005|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015006|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15015007|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015008|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015009|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15015010|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015011|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15015012|NCT01875263|Levofloxacin|levofloxacin|mesh-list
15015013|NCT01875263|Ofloxacin|ofloxacin|mesh-list
15015014|NCT01875263|Cloxacillin|cloxacillin|mesh-list
15015015|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15015016|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015017|NCT01875263|Renal Agents|renal agents|mesh-ancestor
15015018|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15015019|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15015020|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15015021|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015022|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015023|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015024|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15015025|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15015026|NCT01875653|Molgramostim|molgramostim|mesh-list
15015027|NCT01875653|Sargramostim|sargramostim|mesh-list
15015028|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
15015029|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015030|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015031|NCT01875666|Trastuzumab|trastuzumab|mesh-list
15015032|NCT01875666|Pertuzumab|pertuzumab|mesh-list
15015033|NCT01875666|Lapatinib|lapatinib|mesh-list
15015034|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15015035|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015036|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15015037|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015038|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015039|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
15015040|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015041|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15015042|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015043|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015044|NCT01875757|Vitamin D|vitamin d|mesh-list
15015045|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
15015046|NCT01875757|Vitamins|vitamins|mesh-ancestor
15015047|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
15015048|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015049|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15015050|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15015051|NCT01875822|Curcumin|curcumin|mesh-list
15015052|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15015053|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15015054|NCT01875822|Analgesics|analgesics|mesh-ancestor
15015055|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
15015056|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015057|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015058|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15015059|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15015060|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015061|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015062|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015063|NCT01875926|Gontivimab|gontivimab|mesh-list
15015064|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
15015065|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015066|NCT01875952|Isoniazid|isoniazid|mesh-list
15015067|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
15015068|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15015069|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015070|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15015071|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15015072|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
15015073|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015074|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15015075|NCT01876004|Methotrexate|methotrexate|mesh-list
15015076|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15015077|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
15015078|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15015079|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015080|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15015081|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
15015082|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015083|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015084|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
15015085|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015086|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15015087|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15015088|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
15015089|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15015090|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15015091|NCT01876108|Amoxicillin|amoxicillin|mesh-list
15015092|NCT01876108|Azithromycin|azithromycin|mesh-list
15015093|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
15015094|NCT01876108|Omeprazole|omeprazole|mesh-list
15015095|NCT01876108|Bismuth|bismuth|mesh-list
15015096|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14524553|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524554|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14524555|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14524556|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524557|NCT03675581|Nintedanib|nintedanib|mesh-list
14524558|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14524559|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14524560|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524561|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14524562|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524563|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524564|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14524565|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
14524566|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14524567|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015097|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015098|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15015099|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15015100|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15015101|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015102|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015103|NCT01876108|Antacids|antacids|mesh-ancestor
15015104|NCT01876121|Celecoxib|celecoxib|mesh-list
15015105|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15015106|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15015107|NCT01876121|Analgesics|analgesics|mesh-ancestor
15015108|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
15015109|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015110|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015111|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15015112|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15015113|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15015114|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15015115|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015116|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015117|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
15015118|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15015119|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15015120|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
15015121|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15015122|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015123|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015124|NCT01876186|Urological Agents|urological agents|mesh-ancestor
15015125|NCT01876290|Dexamethasone|dexamethasone|mesh-list
15015126|NCT01876290|Ondansetron|ondansetron|mesh-list
15015127|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15015128|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
15015129|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
15015130|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015131|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015132|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15015133|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
15015134|NCT01876290|Hormones|hormones|mesh-ancestor
15015135|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15015136|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15015137|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015138|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
15015139|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
15015140|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15015141|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
15015142|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15015143|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015144|NCT01876290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15015145|NCT01876290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15015146|NCT01876290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015147|NCT01876290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15015148|NCT01876290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15015149|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
15015150|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15015151|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015152|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15015153|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15015154|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015155|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015156|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015157|NCT01876355|Clonidine|clonidine|mesh-list
15015158|NCT01876355|Analgesics|analgesics|mesh-ancestor
15015159|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
15015160|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015161|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015162|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15015163|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
15015164|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
15015165|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15015166|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15015167|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15015168|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
15015169|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15015170|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015171|NCT01876433|Mirabegron|mirabegron|mesh-list
15015172|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15015173|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15015174|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15015175|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
15015176|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15015177|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015178|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015179|NCT01876433|Urological Agents|urological agents|mesh-ancestor
15015180|NCT01876550|Mupirocin|mupirocin|mesh-list
15015181|NCT01876550|Calcium|calcium|mesh-list
15015182|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15015183|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015184|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15015185|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015186|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15015187|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015188|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015189|NCT01876563|Vitamin D|vitamin d|mesh-list
15015190|NCT01876563|Vitamins|vitamins|mesh-ancestor
15015191|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
15015192|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015193|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15015194|NCT01876615|Diclofenac|diclofenac|mesh-list
15015195|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15015196|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15015197|NCT01876615|Analgesics|analgesics|mesh-ancestor
15015198|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
15015199|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015200|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015201|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15015202|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15015203|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15015204|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015205|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015206|NCT01876628|Clindamycin|clindamycin|mesh-list
15015207|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
15015208|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
14802488|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14802489|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14802490|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
14802491|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802492|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802493|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14802494|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14802495|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
14802496|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802497|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15015209|NCT01876628|Floxacillin|floxacillin|mesh-list
15015210|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15015211|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015212|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15015213|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015214|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015215|NCT01876641|Decitabine|decitabine|mesh-list
15015216|NCT01876641|Vemurafenib|vemurafenib|mesh-list
15015217|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15015218|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
15015219|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015220|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015221|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015222|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15015223|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15015224|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015225|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15015226|NCT01876797|Ticagrelor|ticagrelor|mesh-list
15015227|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15015228|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15015229|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15015230|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15015231|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15015232|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
15015233|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15015234|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015235|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033881|NCT01991834|Cefazolin|cefazolin|mesh-list
15033882|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15033883|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15033884|NCT01991873|Leucovorin|leucovorin|mesh-list
15033885|NCT01991873|Folic Acid|folic acid|mesh-list
15033886|NCT01991873|Fluorouracil|fluorouracil|mesh-list
15033887|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
15033888|NCT01991873|Panitumumab|panitumumab|mesh-list
15033889|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
15033890|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
15033891|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033892|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15033893|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033894|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15033895|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
15033896|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033897|NCT01991873|Antidotes|antidotes|mesh-ancestor
15033898|NCT01991873|Protective Agents|protective agents|mesh-ancestor
15033899|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
15033900|NCT01991873|Vitamins|vitamins|mesh-ancestor
15033901|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
15033902|NCT01991873|Hematinics|hematinics|mesh-ancestor
15015236|NCT01876849|Exenatide|exenatide|mesh-list
15015237|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15015238|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015239|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15015240|NCT01876849|Incretins|incretins|mesh-ancestor
15015241|NCT01876849|Hormones|hormones|mesh-ancestor
15015242|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15015243|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15015244|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
15015245|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015246|NCT01876966|Ritonavir|ritonavir|mesh-list
15015247|NCT01876966|Darunavir|darunavir|mesh-list
15015248|NCT01876966|Lumefantrine|lumefantrine|mesh-list
14802498|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14802499|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
14802500|NCT00797771|Insulin|insulin|mesh-list
14802501|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14802502|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802503|NCT00797784|Etanercept|etanercept|mesh-list
15015249|NCT01876966|Artemether|artemether|mesh-list
15015250|NCT01876966|Etravirine|etravirine|mesh-list
15015251|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15015252|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15015253|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15015254|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
15015255|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015256|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015257|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15015258|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15015259|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
14802504|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14802505|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14802506|NCT00797784|Analgesics|analgesics|mesh-ancestor
14802507|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
14802508|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015260|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015261|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15015262|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15015263|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
15015264|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15015265|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15015266|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15015267|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15015268|NCT01877122|Ibuprofen|ibuprofen|mesh-list
15015269|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15015270|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15015271|NCT01877122|Analgesics|analgesics|mesh-ancestor
15015272|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
15015273|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015274|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015275|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15015276|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15015277|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15015278|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015279|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015280|NCT01877226|Tapentadol|tapentadol|mesh-list
15015281|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15015282|NCT01877226|Narcotics|narcotics|mesh-ancestor
15015283|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015284|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015285|NCT01877226|Analgesics|analgesics|mesh-ancestor
15015286|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
15015287|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015288|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15015289|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15015290|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15015291|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015292|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
15015293|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15015294|NCT01877356|Anesthetics|anesthetics|mesh-list
15015295|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015296|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015297|NCT01877512|Hormones|hormones|mesh-list
15015298|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15015299|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015300|NCT01877577|Vitamin D|vitamin d|mesh-list
15015301|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
15015302|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
15015303|NCT01877577|Vitamins|vitamins|mesh-list
15015304|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
15015305|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015306|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15015307|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15015308|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
15015309|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
15015310|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015311|NCT01877590|Protective Agents|protective agents|mesh-ancestor
15015312|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015313|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
15015314|NCT01877590|Vitamins|vitamins|mesh-ancestor
15015315|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
15015316|NCT01877746|Prednisone|prednisone|mesh-list
15015317|NCT01877746|Azathioprine|azathioprine|mesh-list
15015318|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15015319|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
15015320|NCT01877746|Hormones|hormones|mesh-ancestor
15015321|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15015322|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015323|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15015324|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015325|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
15015326|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015327|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15015328|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15015329|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
15015330|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15015331|NCT01877811|Agerafenib|agerafenib|mesh-list
15015332|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15015333|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015334|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015335|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
15015336|NCT01877889|Canagliflozin|canagliflozin|mesh-list
15015337|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15015338|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015339|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15015340|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015341|NCT01877954|Fluticasone|fluticasone|mesh-list
15015342|NCT01877954|Xhance|xhance|mesh-list
15015343|NCT01877954|Beclomethasone|beclomethasone|mesh-list
15015344|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15015345|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15015346|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
15015347|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015348|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015349|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15015350|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
15015351|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
15015352|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15015353|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
15015354|NCT01877954|Hormones|hormones|mesh-ancestor
15015355|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15015356|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15015357|NCT01878136|Plasminogen|plasminogen|mesh-list
15015358|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15015359|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15015360|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015361|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
15015362|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15015363|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
15015364|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015365|NCT01878201|Valsartan|valsartan|mesh-list
15015366|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15015367|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15015368|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15015369|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015370|NCT01878227|Fenofibrate|fenofibrate|mesh-list
15015371|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15015372|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
15015373|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015374|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15015375|NCT01878318|Methotrexate|methotrexate|mesh-list
15015376|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15015377|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
15015378|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15015379|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015380|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15015381|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
15015382|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015383|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015384|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
15015385|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015386|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15015387|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15015388|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
15015389|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15015390|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15015391|NCT01878357|Piperaquine|piperaquine|mesh-list
15015392|NCT01878357|Primaquine|primaquine|mesh-list
15015393|NCT01878357|Artenimol|artenimol|mesh-list
15015394|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
15015395|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15015396|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15015397|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015398|NCT01878422|Leucovorin|leucovorin|mesh-list
15015399|NCT01878422|Bevacizumab|bevacizumab|mesh-list
15015400|NCT01878422|Cetuximab|cetuximab|mesh-list
15015401|NCT01878422|Fluorouracil|fluorouracil|mesh-list
15015402|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
15015403|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15015404|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015405|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15015406|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15015407|NCT01878422|Growth Substances|growth substances|mesh-ancestor
15015408|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015409|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
15015410|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
15015411|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015412|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15015413|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15015414|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
15015415|NCT01878422|Antidotes|antidotes|mesh-ancestor
15015416|NCT01878422|Protective Agents|protective agents|mesh-ancestor
15015417|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
15015418|NCT01878422|Vitamins|vitamins|mesh-ancestor
15015419|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
15015420|NCT01878513|Risperidone|risperidone|mesh-list
15015421|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15015422|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
15015423|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15015424|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015425|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015426|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15015427|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15015428|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015429|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15015430|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15015431|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
15015432|NCT01878539|Anticoagulants|anticoagulants|mesh-list
15015433|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
15015434|NCT01878578|Phenytoin|phenytoin|mesh-list
15015435|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
15015436|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15015437|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15015438|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15015439|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015440|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15015441|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15015442|NCT01878643|Vancomycin|vancomycin|mesh-list
15015443|NCT01878643|Gentamicins|gentamicins|mesh-list
15015444|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15015445|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015446|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15015447|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015448|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015449|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
15015450|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15015451|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
15015452|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015453|NCT01878695|Expectorants|expectorants|mesh-ancestor
15015454|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
15015455|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15015456|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
15015457|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015458|NCT01878695|Protective Agents|protective agents|mesh-ancestor
15015459|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015460|NCT01878695|Antidotes|antidotes|mesh-ancestor
15015461|NCT01878708|Dexamethasone|dexamethasone|mesh-list
15015462|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
15015463|NCT01878708|Asparaginase|asparaginase|mesh-list
15015464|NCT01878708|Pegaspargase|pegaspargase|mesh-list
15015465|NCT01878708|BB 1101|bb 1101|mesh-list
15015466|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15015467|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
15015468|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
15015469|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015470|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015471|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15015472|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
15015473|NCT01878708|Hormones|hormones|mesh-ancestor
15015474|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15015475|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15015476|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015477|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
15015478|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015479|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033903|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15033904|NCT01991951|Warfarin|warfarin|mesh-list
15033905|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
15033906|NCT01992133|Vitamin D|vitamin d|mesh-list
15033907|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
15033908|NCT01992133|Vitamins|vitamins|mesh-ancestor
15033909|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
15033910|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033911|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15033912|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15033913|NCT01992146|Naloxone|naloxone|mesh-list
15033914|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15033915|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033916|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
15033917|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033918|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
15033919|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15033920|NCT01992198|Metronidazole|metronidazole|mesh-list
15033921|NCT01992198|Meropenem|meropenem|mesh-list
15033922|NCT01992198|Cefoperazone|cefoperazone|mesh-list
15033923|NCT01992198|Sulperazone|sulperazone|mesh-list
15033924|NCT01992198|Somatostatin|somatostatin|mesh-list
15033925|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15033926|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15033927|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
15033928|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
15033929|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15033930|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15033931|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15033932|NCT01992198|Hormones|hormones|mesh-ancestor
15033933|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15033934|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033935|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15033936|NCT01992198|Renal Agents|renal agents|mesh-ancestor
15033937|NCT01992211|Metformin|metformin|mesh-list
15033938|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15033939|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15033940|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033941|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15033942|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15033943|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
15033944|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033945|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15033946|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15033947|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033948|NCT01992263|Vitamin D|vitamin d|mesh-list
15033949|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
15033950|NCT01992263|Vitamins|vitamins|mesh-list
15033951|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
15033952|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033953|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15033954|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15033955|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
15033956|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15033957|NCT01992328|Antibodies|antibodies|mesh-list
15033958|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
15033959|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
15033960|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15033961|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
15033962|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033963|NCT01992341|Paclitaxel|paclitaxel|mesh-list
15033964|NCT01992341|Trebananib|trebananib|mesh-list
15033965|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15033966|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15033967|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
15015480|NCT01878734|Micronutrients|micronutrients|mesh-list
15015481|NCT01878734|Trace Elements|trace elements|mesh-list
15015482|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015483|NCT01878864|Lidocaine|lidocaine|mesh-list
15015484|NCT01878864|Bupivacaine|bupivacaine|mesh-list
15015485|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
15015486|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
15015487|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015488|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015489|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
15015490|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015491|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15015492|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15015493|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15015494|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15015495|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015496|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
15015497|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
15015498|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015499|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15015500|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15015501|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
15015502|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15015503|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015504|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15015505|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
15015506|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15015507|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015508|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15015509|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15015510|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015511|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015512|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015513|NCT01879033|Insulin|insulin|mesh-list
15015514|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15015515|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015516|NCT01879202|Methylphenidate|methylphenidate|mesh-list
15015517|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15015518|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015519|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15015520|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15015521|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15015522|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015523|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
15015524|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15015525|NCT01879241|Rasagiline|rasagiline|mesh-list
15015526|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15015527|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015528|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015529|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15015530|NCT01879241|Protective Agents|protective agents|mesh-ancestor
15015531|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015532|NCT01879293|Metformin|metformin|mesh-list
15015533|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15015534|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015535|NCT01879358|Sirolimus|sirolimus|mesh-list
15015536|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15015537|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015538|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15015539|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015540|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
15015541|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15015542|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
15015543|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015544|NCT01879423|Lamotrigine|lamotrigine|mesh-list
15015545|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
15015546|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15015547|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15015548|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015549|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15015550|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015551|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15015552|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15015553|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015554|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15015555|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15015556|NCT01879488|Edetic Acid|edetic acid|mesh-list
15015557|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
15015558|NCT01879488|Antidotes|antidotes|mesh-ancestor
15015559|NCT01879488|Protective Agents|protective agents|mesh-ancestor
15015560|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015561|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
15015562|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
15015563|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015564|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15015565|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
15015566|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15015567|NCT01879514|Prednisone|prednisone|mesh-list
15015568|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15015569|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
15015570|NCT01879514|Hormones|hormones|mesh-ancestor
15015571|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15015572|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015573|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15015574|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015575|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15015576|NCT01879527|Amiloride|amiloride|mesh-list
15015577|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
15015578|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15015579|NCT01879527|Diuretics|diuretics|mesh-ancestor
15015580|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
15015581|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015582|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15015583|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15015584|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015585|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
15015586|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15015587|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15015588|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15015589|NCT01879605|Bisacodyl|bisacodyl|mesh-list
15015590|NCT01879605|Sorbitol|sorbitol|mesh-list
15015591|NCT01879605|Cathartics|cathartics|mesh-ancestor
15015592|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15015593|NCT01879605|Laxatives|laxatives|mesh-ancestor
15015594|NCT01879748|Rasagiline|rasagiline|mesh-list
15015595|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15015596|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015597|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015598|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15015599|NCT01879748|Protective Agents|protective agents|mesh-ancestor
15015600|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015601|NCT01879917|Liraglutide|liraglutide|mesh-list
15015602|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15015603|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015604|NCT01879917|Incretins|incretins|mesh-ancestor
15015605|NCT01879917|Hormones|hormones|mesh-ancestor
15015606|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15015607|NCT01879930|Doxycycline|doxycycline|mesh-list
15015608|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15015609|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015610|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
15015611|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15015612|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15015613|NCT01880112|Cefazolin|cefazolin|mesh-list
15015614|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15015615|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015616|NCT01880125|Acetaminophen|acetaminophen|mesh-list
15015617|NCT01880125|Tramadol|tramadol|mesh-list
15015618|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15015619|NCT01880125|Analgesics|analgesics|mesh-ancestor
15015620|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
15015621|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015622|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015623|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
15015624|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15015625|NCT01880125|Narcotics|narcotics|mesh-ancestor
15015626|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015627|NCT01880138|Anesthetics|anesthetics|mesh-list
15015628|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015629|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015630|NCT01880216|Enoxaparin|enoxaparin|mesh-list
15015631|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
15015632|NCT01880216|Bemiparin|bemiparin|mesh-list
15015633|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
15015634|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15015635|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15015636|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015637|NCT01880307|Prednisolone|prednisolone|mesh-list
15015638|NCT01880307|Azathioprine|azathioprine|mesh-list
15015639|NCT01880307|Infliximab|infliximab|mesh-list
15015640|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15015641|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
15015642|NCT01880307|Hormones|hormones|mesh-ancestor
15015643|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15015644|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015645|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15015646|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015647|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15015648|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
15015649|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15015650|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
15015651|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015652|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15015653|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15015654|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
15015655|NCT01880346|Vitamin D|vitamin d|mesh-list
15015656|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
15015657|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
15015658|NCT01880346|Vitamins|vitamins|mesh-list
15015659|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
15015660|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015661|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15015662|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15015663|NCT01880359|Nimorazole|nimorazole|mesh-list
15015664|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
15015665|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15015666|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15015667|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015668|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
15015669|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
15015670|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015671|NCT01880372|Protective Agents|protective agents|mesh-ancestor
15015672|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015673|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
15015674|NCT01880372|Vitamins|vitamins|mesh-ancestor
15015675|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
15015676|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
15015677|NCT01880385|Bevacizumab|bevacizumab|mesh-list
15015678|NCT01880385|Docetaxel|docetaxel|mesh-list
15015679|NCT01880385|Fluorouracil|fluorouracil|mesh-list
15015680|NCT01880385|Trastuzumab|trastuzumab|mesh-list
15015681|NCT01880385|Epirubicin|epirubicin|mesh-list
15015682|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15015683|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
15015684|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015685|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15015686|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15015687|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
15015688|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015689|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015690|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15015691|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15015692|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15015693|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15015694|NCT01880385|Growth Substances|growth substances|mesh-ancestor
15015695|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
15015696|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
15015697|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
15015698|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
15015699|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
15015700|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15015701|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15015702|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15015703|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15015704|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15033968|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
15033969|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
15033970|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033971|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15033972|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15033973|NCT01992341|Growth Substances|growth substances|mesh-ancestor
15033974|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033975|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
15033976|NCT01992562|Ziconotide|ziconotide|mesh-list
15033977|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15033978|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15033979|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15033980|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15033981|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035514|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
15015705|NCT01880463|Vitamin D|vitamin d|mesh-list
15015706|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
15015707|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
15015708|NCT01880463|Vitamins|vitamins|mesh-list
15015709|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
15015710|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015711|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15015712|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15015713|NCT01880619|Tamsulosin|tamsulosin|mesh-list
14524568|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14524569|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14524570|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14524571|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14524572|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14524573|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14524574|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14524575|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14524576|NCT03676725|Lidocaine|lidocaine|mesh-list
14524577|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
14524578|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
14524579|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524580|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524581|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
14524582|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524583|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14524584|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14524585|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14524586|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524587|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524588|NCT03677401|Serlopitant|serlopitant|mesh-list
14524589|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14524590|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524591|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524592|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524593|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
14524594|NCT03678870|Narcotics|narcotics|mesh-ancestor
14524595|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524596|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524597|NCT03678870|Analgesics|analgesics|mesh-ancestor
14524598|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
14524599|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524600|NCT03679975|Riluzole|riluzole|mesh-list
14524601|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
14524602|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14524603|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14524604|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524605|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524606|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524607|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14524608|NCT03679975|Protective Agents|protective agents|mesh-ancestor
14524609|NCT03680521|Nivolumab|nivolumab|mesh-list
14524610|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14524611|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524612|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14524613|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524614|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
14524615|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14524616|NCT03681093|Growth Substances|growth substances|mesh-ancestor
14524617|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529823|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14529824|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529825|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529826|NCT03615144|Fludarabine|fludarabine|mesh-list
14529827|NCT03615144|Melphalan|melphalan|mesh-list
14529828|NCT03615144|Thiotepa|thiotepa|mesh-list
14529829|NCT03615144|Clofarabine|clofarabine|mesh-list
15015714|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
15015715|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15015716|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15015717|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15015718|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
15015719|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15033982|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15015720|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015721|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015722|NCT01880619|Urological Agents|urological agents|mesh-ancestor
15015723|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15015724|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15015725|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
15015726|NCT01880658|Capecitabine|capecitabine|mesh-list
15015727|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15015728|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
15015729|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015730|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015731|NCT01880749|Everolimus|everolimus|mesh-list
15015732|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015733|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15015734|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
15015735|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015736|NCT01880775|Bupivacaine|bupivacaine|mesh-list
15015737|NCT01880775|Prilocaine|prilocaine|mesh-list
15015738|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
15015739|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
15015740|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015741|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015742|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
15015743|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015744|NCT01880931|Remifentanil|remifentanil|mesh-list
15015745|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15015746|NCT01880931|Narcotics|narcotics|mesh-ancestor
15015747|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015748|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015749|NCT01880931|Analgesics|analgesics|mesh-ancestor
15015750|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
15015751|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015752|NCT01880957|Lamotrigine|lamotrigine|mesh-list
15015753|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
15015754|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
15015755|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15015756|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015757|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015758|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
15015759|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15015760|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015761|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015762|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
14802509|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802510|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14802511|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14802512|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14802513|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802514|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
15015763|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15015764|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15015765|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15015766|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15015767|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15015768|NCT01881074|Listerine|listerine|mesh-list
15015769|NCT01881074|Triclosan|triclosan|mesh-list
15015770|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
15015771|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
15015772|NCT01881074|Protective Agents|protective agents|mesh-ancestor
15015773|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015774|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15015775|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015776|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15015777|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15015778|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
15015779|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015780|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15015781|NCT01881100|Listerine|listerine|mesh-list
15015782|NCT01881100|Fluorides|fluorides|mesh-list
15015783|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
15015784|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
15015785|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
15015786|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
15015787|NCT01881100|Protective Agents|protective agents|mesh-ancestor
15015788|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015789|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15015790|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15015791|NCT01881347|Resveratrol|resveratrol|mesh-list
15015792|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
15015793|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015794|NCT01881347|Protective Agents|protective agents|mesh-ancestor
15015795|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015796|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015797|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15015798|NCT01881464|Adalimumab|adalimumab|mesh-list
15015799|NCT01881464|Infliximab|infliximab|mesh-list
15015800|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15015801|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15015802|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
15015803|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15015804|NCT01881503|HBOC 201|hboc 201|mesh-list
15015805|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
15015806|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
15015807|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15015808|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15015809|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015810|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
15015811|NCT01881568|Coagulants|coagulants|mesh-ancestor
15015812|NCT01881763|Ketamine|ketamine|mesh-list
15015813|NCT01881763|Methohexital|methohexital|mesh-list
15015814|NCT01881763|Analgesics|analgesics|mesh-ancestor
15015815|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
15015816|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015817|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015818|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15015819|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15015820|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
15015821|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
15015822|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015823|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15015824|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15015825|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15015826|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015827|NCT01881919|Quercetin|quercetin|mesh-list
15015828|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
15015829|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015830|NCT01881919|Protective Agents|protective agents|mesh-ancestor
15015831|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015832|NCT01881971|Calcium|calcium|mesh-list
15015833|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15015834|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015835|NCT01881997|Fentanyl|fentanyl|mesh-list
15015836|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15015837|NCT01881997|Narcotics|narcotics|mesh-ancestor
15015838|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015839|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015840|NCT01881997|Analgesics|analgesics|mesh-ancestor
15015841|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
15015842|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015843|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15015844|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15015845|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
15015846|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
15015847|NCT01882010|Sargramostim|sargramostim|mesh-list
15015848|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
15015849|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015850|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
15015851|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
15015852|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
15015853|NCT01882127|Dexamethasone|dexamethasone|mesh-list
15015854|NCT01882127|Tretinoin|tretinoin|mesh-list
15015855|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15015856|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
15015857|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
15015858|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015859|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015860|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15015861|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
15015862|NCT01882127|Hormones|hormones|mesh-ancestor
15015863|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15015864|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15015865|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015866|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
15015867|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
15015868|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
15015869|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
15015870|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
15015871|NCT01882179|Hormones|hormones|mesh-ancestor
15015872|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15015873|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015874|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
15015875|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15015876|NCT01882179|Diuretics|diuretics|mesh-ancestor
15015877|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
15015878|NCT01882296|Pantoprazole|pantoprazole|mesh-list
15015879|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15015880|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15015881|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15015882|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015883|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524618|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
14524619|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14524620|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524621|NCT03682302|Bupivacaine|bupivacaine|mesh-list
14524622|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
14524623|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
14524624|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524625|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524626|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
14524627|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524628|NCT03682705|Upadacitinib|upadacitinib|mesh-list
14524629|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
14524630|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14524631|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524632|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524633|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14524634|NCT03684044|Baloxavir|baloxavir|mesh-list
14524635|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
14524636|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524637|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524638|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524639|NCT03684265|Meloxicam|meloxicam|mesh-list
14524640|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14524641|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14524642|NCT03684265|Analgesics|analgesics|mesh-ancestor
14524643|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
14524644|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524645|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015884|NCT01882322|Tacrolimus|tacrolimus|mesh-list
15015885|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15015886|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
15015887|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015888|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15015889|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015890|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015891|NCT01882361|Naltrexone|naltrexone|mesh-list
15015892|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15015893|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15015894|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015895|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
15015896|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015897|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
15015898|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15015899|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
15015900|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
15015901|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15015902|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
15015903|NCT01882400|Alendronate|alendronate|mesh-list
15015904|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
15015905|NCT01882400|Diphosphonates|diphosphonates|mesh-list
15015906|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15015907|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015908|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15015909|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15015910|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015911|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15015912|NCT01882530|Acetaminophen|acetaminophen|mesh-list
15015913|NCT01882530|Ketoprofen|ketoprofen|mesh-list
15015914|NCT01882530|Morphine|morphine|mesh-list
15015915|NCT01882530|Nefopam|nefopam|mesh-list
15015916|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15015917|NCT01882530|Narcotics|narcotics|mesh-ancestor
15015918|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015919|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015920|NCT01882530|Analgesics|analgesics|mesh-ancestor
15015921|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
15015922|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015923|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15015924|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
15015925|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15015926|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15015927|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15015928|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15015929|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015930|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015931|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
15015932|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15015933|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15015934|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15015935|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15015936|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015937|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
15015938|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15015939|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015940|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15015941|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015942|NCT01882660|Decitabine|decitabine|mesh-list
15015943|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15015944|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
15015945|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015946|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15015947|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15015948|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15015949|NCT01883011|Piracetam|piracetam|mesh-list
15015950|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15015951|NCT01883011|Protective Agents|protective agents|mesh-ancestor
15015952|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015953|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
15015954|NCT01883024|Insulin|insulin|mesh-list
15015955|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15015956|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015957|NCT01883102|Capsaicin|capsaicin|mesh-list
15015958|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
15015959|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
15015960|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
15015961|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015962|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015963|NCT01883167|Febuxostat|febuxostat|mesh-list
15015964|NCT01883167|Verinurad|verinurad|mesh-list
15015965|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
15015966|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15015967|NCT01883193|Micronutrients|micronutrients|mesh-list
15015968|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015969|NCT01883232|Lidocaine|lidocaine|mesh-list
15015970|NCT01883232|Epinephrine|epinephrine|mesh-list
15015971|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
15015972|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
15015973|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15015974|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15015975|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
15015976|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15015977|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15015978|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15015979|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15015980|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15015981|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15015982|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15015983|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15015984|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
15015985|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15015986|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15015987|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15015988|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
15015989|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15015990|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
15015991|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
15015992|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
15015993|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15015994|NCT01883297|Aldesleukin|aldesleukin|mesh-list
15015995|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
15015996|NCT01883297|Interleukin-2|interleukin-2|mesh-list
15015997|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15015998|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
15015999|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016000|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15016001|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15016002|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
15016003|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016004|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016005|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15016006|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15016007|NCT01883297|Analgesics|analgesics|mesh-ancestor
15016008|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
15016009|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016010|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15016011|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15016012|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
15016013|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016014|NCT01883323|Aldesleukin|aldesleukin|mesh-list
15016015|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
15016016|NCT01883323|Fludarabine|fludarabine|mesh-list
15016017|NCT01883323|Interleukin-2|interleukin-2|mesh-list
15016018|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15016019|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
15016020|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016021|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15016022|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15016023|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
15016024|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016025|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016026|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15016027|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15016028|NCT01883323|Analgesics|analgesics|mesh-ancestor
15016029|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
15016030|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524646|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14524647|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14524648|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14524649|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14524650|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524651|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524652|NCT03684642|Metformin|metformin|mesh-list
14524653|NCT03684642|Dulaglutide|dulaglutide|mesh-list
14524654|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
14524655|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15016031|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15016032|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15016033|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
15016034|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016035|NCT01883505|Levodopa|levodopa|mesh-list
15016036|NCT01883505|Carbidopa|carbidopa|mesh-list
15016037|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15016038|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15016039|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
15016040|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016041|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016042|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016043|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15016044|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016045|NCT01883518|Vaccines|vaccines|mesh-list
15016046|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
15016047|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016048|NCT01883531|Mannitol|mannitol|mesh-list
15016049|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15016050|NCT01883531|Diuretics|diuretics|mesh-ancestor
15016051|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
15016052|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016053|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
15016054|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15016055|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016056|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
15033983|NCT01992562|Protective Agents|protective agents|mesh-ancestor
15033984|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15033985|NCT01992562|Analgesics|analgesics|mesh-ancestor
15033986|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
15033987|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15033988|NCT01992588|Insulin|insulin|mesh-list
15033989|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15033990|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
15033991|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
15033992|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15033993|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15033994|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15033995|NCT01992601|Telmisartan|telmisartan|mesh-list
15033996|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15033997|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15033998|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15033999|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
15034000|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034001|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15034002|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15034003|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034004|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15034005|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15016057|NCT01883869|Ticagrelor|ticagrelor|mesh-list
15016058|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15016059|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15016060|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15016061|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15016062|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
15016063|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016064|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016065|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016066|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
15016067|NCT01883882|Narcotics|narcotics|mesh-ancestor
15016068|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016069|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016070|NCT01883882|Analgesics|analgesics|mesh-ancestor
15016071|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
15016072|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016073|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
15016074|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15016075|NCT01883921|Antibodies|antibodies|mesh-list
15016076|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
15016077|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016078|NCT01884038|Treprostinil|treprostinil|mesh-list
15016079|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15016080|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15016081|NCT01884116|Capsaicin|capsaicin|mesh-list
15016082|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
15016083|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
15016084|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
15016085|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016086|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016087|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15016088|NCT01884116|Analgesics|analgesics|mesh-ancestor
15016089|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15016090|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15016091|NCT01884259|Docetaxel|docetaxel|mesh-list
15016092|NCT01884259|Fluorouracil|fluorouracil|mesh-list
15016093|NCT01884259|Cetuximab|cetuximab|mesh-list
15016094|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016095|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
15016096|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
15016097|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
15016098|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016099|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
15016100|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15016101|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15016102|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
15016103|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016104|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15016105|NCT01884272|Naproxen|naproxen|mesh-list
15016106|NCT01884272|Indomethacin|indomethacin|mesh-list
15016107|NCT01884272|Lesinurad|lesinurad|mesh-list
15016108|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15016109|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15016110|NCT01884272|Analgesics|analgesics|mesh-ancestor
15016111|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
15016112|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016113|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016114|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15016115|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15016116|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
15016117|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15016118|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016119|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016120|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
15016121|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15016122|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
15016123|NCT01884272|Renal Agents|renal agents|mesh-ancestor
15016124|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
15016125|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016126|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15016127|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016128|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016129|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
15034006|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15016130|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15016131|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016132|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15016133|NCT01884298|Lidocaine|lidocaine|mesh-list
15016134|NCT01884298|Remifentanil|remifentanil|mesh-list
15016135|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
15016136|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
15016137|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016138|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016139|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
15016140|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016141|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15016142|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15016143|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15016144|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15016145|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016146|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15016147|NCT01884298|Narcotics|narcotics|mesh-ancestor
15016148|NCT01884298|Analgesics|analgesics|mesh-ancestor
15016149|NCT01884402|Ribavirin|ribavirin|mesh-list
15016150|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15016151|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
15016152|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016153|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
15016154|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016155|NCT01884415|Vaccines|vaccines|mesh-list
15016156|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
15016157|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016158|NCT01884428|Gemcitabine|gemcitabine|mesh-list
15016159|NCT01884428|Prednisolone|prednisolone|mesh-list
15016160|NCT01884428|Vinorelbine|vinorelbine|mesh-list
15016161|NCT01884428|Ifosfamide|ifosfamide|mesh-list
15016162|NCT01884428|Panobinostat|panobinostat|mesh-list
15016163|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15016164|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
15016165|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016166|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016167|NCT01884428|Antiviral Agents|antiviral agents|mesh-ancestor
15016168|NCT01884428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016169|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016170|NCT01884428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15016171|NCT01884428|Immunologic Factors|immunologic factors|mesh-ancestor
15016172|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016173|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15016174|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
15016175|NCT01884428|Hormones|hormones|mesh-ancestor
15016176|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15016177|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15016178|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15016179|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
15016180|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
15016181|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
15016182|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15016183|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
15016184|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15016185|NCT01884441|Gemcitabine|gemcitabine|mesh-list
15016186|NCT01884441|Vinorelbine|vinorelbine|mesh-list
15016187|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15016188|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15016189|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
15016190|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016191|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016192|NCT01884441|Antiviral Agents|antiviral agents|mesh-ancestor
15016193|NCT01884441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016194|NCT01884441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016195|NCT01884441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15016196|NCT01884441|Immunologic Factors|immunologic factors|mesh-ancestor
15016197|NCT01884441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016198|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15016199|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
15016200|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
15016201|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
15016202|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15016203|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
15016204|NCT01884467|Gentamicins|gentamicins|mesh-list
15016205|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15016206|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016207|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15016208|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016209|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016210|NCT01884506|Iron|iron|mesh-list
15016211|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
15016212|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15016213|NCT01884506|Trace Elements|trace elements|mesh-ancestor
15016214|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
15016215|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016216|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
15016217|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016218|NCT01884506|Protective Agents|protective agents|mesh-ancestor
15016219|NCT01884506|Vitamins|vitamins|mesh-ancestor
15016220|NCT01884558|Metformin|metformin|mesh-list
15016221|NCT01884558|Isavuconazole|isavuconazole|mesh-list
15016222|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15016223|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016224|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
15016225|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016226|NCT01884623|Methotrexate|methotrexate|mesh-list
15016227|NCT01884623|Cetuximab|cetuximab|mesh-list
15016228|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15016229|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
15016230|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15016231|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016232|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15016233|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
15016234|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524656|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524657|NCT03685344|Durvalumab|durvalumab|mesh-list
14524658|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
14524659|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14524660|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14524661|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524662|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
14524663|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524664|NCT03685396|Hemostatics|hemostatics|mesh-list
14524665|NCT03685396|Coagulants|coagulants|mesh-ancestor
14524666|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15016235|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016236|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
15016237|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016238|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15016239|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15016240|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
15016241|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15016242|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15016243|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15016244|NCT01884636|Isavuconazole|isavuconazole|mesh-list
15016245|NCT01884636|Methotrexate|methotrexate|mesh-list
15016246|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15016247|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
15016248|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15016249|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016250|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15016251|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
15016252|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016253|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016254|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
15016255|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034007|NCT01992653|Prednisone|prednisone|mesh-list
15016256|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15016257|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15016258|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
15016259|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15016260|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15016261|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
15016262|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016263|NCT01884740|Bevacizumab|bevacizumab|mesh-list
15016264|NCT01884740|Cetuximab|cetuximab|mesh-list
15016265|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15016266|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016267|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15016268|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15016269|NCT01884740|Growth Substances|growth substances|mesh-ancestor
15016270|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016271|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
15016272|NCT01884857|Metoprolol|metoprolol|mesh-list
15016273|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15016274|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15016275|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
15016276|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
15016277|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016278|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016279|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15016280|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15016281|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15016282|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
15016283|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016284|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016285|NCT01884896|Metoprolol|metoprolol|mesh-list
15016286|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15016287|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15016288|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
15016289|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
15016290|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016291|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016292|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15016293|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15016294|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15016295|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
15016296|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016297|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016298|NCT01884909|Metoprolol|metoprolol|mesh-list
15016299|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15016300|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15016301|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
15016302|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
15016303|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016304|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016305|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15016306|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15016307|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15016308|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
15016309|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016310|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016311|NCT01884922|Vinblastine|vinblastine|mesh-list
15016312|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15016313|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016314|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
15016315|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
15016316|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
15016317|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016318|NCT01884935|Natalizumab|natalizumab|mesh-list
15016319|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
15016320|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016321|NCT01885013|Metformin|metformin|mesh-list
15016322|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
15016323|NCT01885013|Doxorubicin|doxorubicin|mesh-list
15016324|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15016325|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
15016326|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016327|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15016328|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15016329|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
15016330|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016331|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016332|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15016333|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15016334|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15016335|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15016336|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15016337|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016338|NCT01885091|Kinetin|kinetin|mesh-list
15016339|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
15016340|NCT01885091|Growth Substances|growth substances|mesh-ancestor
15016341|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016342|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
15016343|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
15016344|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
15016345|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016346|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016347|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15016348|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15016349|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
15016350|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
15016351|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016352|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016353|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
15016354|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15016355|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
15016356|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016357|NCT01885338|Expectorants|expectorants|mesh-ancestor
15016358|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
15016359|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15016360|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
15016361|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016362|NCT01885338|Protective Agents|protective agents|mesh-ancestor
15016363|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016364|NCT01885338|Antidotes|antidotes|mesh-ancestor
15016365|NCT01885364|Remifentanil|remifentanil|mesh-list
15016366|NCT01885364|Propofol|propofol|mesh-list
15016367|NCT01885364|Esmolol|esmolol|mesh-list
15016368|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15016369|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016370|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016371|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15016372|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
15016373|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
15016374|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15016375|NCT01885364|Narcotics|narcotics|mesh-ancestor
15016376|NCT01885364|Analgesics|analgesics|mesh-ancestor
15016377|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
15016378|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016379|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15016380|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15016381|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15016382|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
15016383|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524667|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14524668|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524669|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14524670|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15016384|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016385|NCT01885481|Dexamethasone|dexamethasone|mesh-list
15016386|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
15016387|NCT01885481|Betamethasone|betamethasone|mesh-list
15016388|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
15016389|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15016390|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
15016391|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15016392|NCT01885481|BB 1101|bb 1101|mesh-list
15016393|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15016394|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
15016395|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
15016396|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016397|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016398|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15016399|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
15016400|NCT01885481|Hormones|hormones|mesh-ancestor
15016401|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15016402|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15016403|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524671|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14524672|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524673|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524674|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
15016404|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
15016405|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016406|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016407|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15034008|NCT01992653|Prednisolone|prednisolone|mesh-list
15016408|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
15034009|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
15034010|NCT01992653|Rituximab|rituximab|mesh-list
15034011|NCT01992653|Doxorubicin|doxorubicin|mesh-list
15034012|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
15034013|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15034014|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
15034015|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034016|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15034017|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15034018|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
15034019|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034020|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034021|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15034022|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15034023|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15034024|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15034025|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15034026|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034027|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15034028|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
15034029|NCT01992653|Hormones|hormones|mesh-ancestor
15034030|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15034031|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15034032|NCT01992705|Fluorouracil|fluorouracil|mesh-list
15034033|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
15034034|NCT01992705|Irinotecan|irinotecan|mesh-list
15034035|NCT01992705|Folfirinox|folfirinox|mesh-list
15034036|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
15034037|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034038|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15034039|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034040|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15034041|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
15034042|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034043|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15034044|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15034045|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034046|NCT01992796|Telmisartan|telmisartan|mesh-list
15034047|NCT01992796|Candesartan|candesartan|mesh-list
15034048|NCT01992796|Olmesartan|olmesartan|mesh-list
15034049|NCT01992796|Irbesartan|irbesartan|mesh-list
15034050|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15034051|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15034052|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15034053|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034054|NCT01992900|Piperaquine|piperaquine|mesh-list
15034055|NCT01992900|Artenimol|artenimol|mesh-list
15034056|NCT01992900|Artemisinins|artemisinins|mesh-list
15034057|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
15034058|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15034059|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15034060|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034061|NCT01992952|Fulvestrant|fulvestrant|mesh-list
15034062|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15034063|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034064|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15034065|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15034066|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
15034067|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15034068|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034069|NCT01993134|Cefazolin|cefazolin|mesh-list
15034070|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15034071|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034072|NCT01993173|Vaccines|vaccines|mesh-list
15034073|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
15034074|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034075|NCT01993212|Enclomiphene|enclomiphene|mesh-list
15034076|NCT01993212|Testosterone|testosterone|mesh-list
14529830|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
15034077|NCT01993212|Androgens|androgens|mesh-ancestor
15034078|NCT01993212|Hormones|hormones|mesh-ancestor
15034079|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15016409|NCT01885585|Apixaban|apixaban|mesh-list
15016410|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15016411|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
15016412|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15016413|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
15016414|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016415|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016416|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
14802515|NCT00797810|Cytarabine|cytarabine|mesh-list
14802516|NCT00797810|Dexamethasone|dexamethasone|mesh-list
14802517|NCT00797810|Prednisone|prednisone|mesh-list
14802518|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
14802519|NCT00797810|Ifosfamide|ifosfamide|mesh-list
14802520|NCT00797810|Rituximab|rituximab|mesh-list
14802521|NCT00797810|Vincristine|vincristine|mesh-list
15016417|NCT01885598|Apixaban|apixaban|mesh-list
15016418|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15016419|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
15016420|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15016421|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
15016422|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016423|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016424|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
15016425|NCT01885715|Neostigmine|neostigmine|mesh-list
15016426|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15016427|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016428|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016429|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
15016430|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016431|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016432|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15016433|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
15016434|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016435|NCT01885988|Nebivolol|nebivolol|mesh-list
15016436|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15016437|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
15016438|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15016439|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15016440|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15016441|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
15016442|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016443|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016444|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016445|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
15016446|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15016447|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
15016448|NCT01886001|Povidone|povidone|mesh-list
15016449|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15016450|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016451|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
15016452|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
15016453|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
15016454|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
15016455|NCT01886014|Oxytocin|oxytocin|mesh-list
15016456|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
15016457|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15016458|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016459|NCT01886053|Ertapenem|ertapenem|mesh-list
15016460|NCT01886053|beta-Lactams|beta-lactams|mesh-list
15016461|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15016462|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016463|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
15016464|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15016465|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016466|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016467|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15016468|NCT01886079|Analgesics|analgesics|mesh-ancestor
15016469|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
15016470|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016471|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15016472|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15016473|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15016474|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
15016475|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016476|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802522|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802523|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
14802524|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016477|NCT01886196|Ibuprofen|ibuprofen|mesh-list
15016478|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15016479|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15016480|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15016481|NCT01886196|Analgesics|analgesics|mesh-ancestor
15016482|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
15016483|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016484|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016485|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15016486|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15016487|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016488|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529831|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14529832|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529833|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14529834|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
14529835|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529836|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14529837|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
14529838|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529839|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15016489|NCT01886209|Prednisone|prednisone|mesh-list
15016490|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
15016491|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15016492|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15016493|NCT01886209|Prednisolone|prednisolone|mesh-list
15016494|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
15016495|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15016496|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
15016497|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15016498|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
15016499|NCT01886209|Hormones|hormones|mesh-ancestor
15016500|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15016501|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016502|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15016503|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016504|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
15016505|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
15016506|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016507|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15016508|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15016509|NCT01886209|Protective Agents|protective agents|mesh-ancestor
15016510|NCT01886248|Antithrombins|antithrombins|mesh-list
15016511|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
15016512|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15016513|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
15016514|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016515|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016516|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
15016517|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
15016518|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
15016519|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
15016520|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016521|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016522|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
15016523|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016524|NCT01886365|Insulin|insulin|mesh-list
15016525|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15016526|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016527|NCT01886404|Efavirenz|efavirenz|mesh-list
15016528|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15016529|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15016530|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016531|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529840|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
14529841|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14529842|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
14529843|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529844|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
14529845|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14529846|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14529847|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529848|NCT03598140|Urological Agents|urological agents|mesh-ancestor
14529849|NCT03591458|Amitriptyline|amitriptyline|mesh-list
14529850|NCT03591458|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14529851|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14529852|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
14529853|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14529854|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14529855|NCT03591458|Analgesics|analgesics|mesh-ancestor
14802525|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14802526|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14802527|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
14802528|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802529|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802530|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14802531|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14802532|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
14802533|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
14802534|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802535|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15016532|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
15016533|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016534|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15016535|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15016536|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15016537|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15016538|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15016539|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15016540|NCT01886443|Tocopherols|tocopherols|mesh-list
15016541|NCT01886443|Vitamin E|vitamin e|mesh-list
15016542|NCT01886443|alpha-Tocopherol|alpha-tocopherol|mesh-list
15016543|NCT01886443|Infliximab|infliximab|mesh-list
15016544|NCT01886443|Epoprostenol|epoprostenol|mesh-list
15016545|NCT01886443|Tezosentan|tezosentan|mesh-list
15016546|NCT01886443|Melatonin|melatonin|mesh-list
15016547|NCT01886443|Antithrombins|antithrombins|mesh-list
15016548|NCT01886443|Antithrombin III|antithrombin iii|mesh-list
15016549|NCT01886443|Epoetin Alfa|epoetin alfa|mesh-list
15016550|NCT01886443|Dermatologic Agents|dermatologic agents|mesh-ancestor
15016551|NCT01886443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15016552|NCT01886443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15016553|NCT01886443|Antioxidants|antioxidants|mesh-ancestor
15016554|NCT01886443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016555|NCT01886443|Protective Agents|protective agents|mesh-ancestor
15016556|NCT01886443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016557|NCT01886443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016558|NCT01886443|Hematinics|hematinics|mesh-ancestor
15016559|NCT01886443|Vitamins|vitamins|mesh-ancestor
15016560|NCT01886443|Micronutrients|micronutrients|mesh-ancestor
15016561|NCT01886443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15016562|NCT01886443|Protease Inhibitors|protease inhibitors|mesh-ancestor
15016563|NCT01886443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016564|NCT01886443|Anticoagulants|anticoagulants|mesh-ancestor
15016565|NCT01886443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15016566|NCT01886443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15016567|NCT01886443|Vasodilator Agents|vasodilator agents|mesh-ancestor
15016568|NCT01886534|Diuretics|diuretics|mesh-list
15016569|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
15016570|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016571|NCT01886560|Doxycycline|doxycycline|mesh-list
15016572|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15016573|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016574|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
15016575|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15016576|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15016577|NCT01886573|Azacitidine|azacitidine|mesh-list
15016578|NCT01886573|Entinostat|entinostat|mesh-list
15016579|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
15016580|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15016581|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
15016582|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016583|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016584|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016585|NCT01886599|Asunaprevir|asunaprevir|mesh-list
15016586|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
15016587|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016588|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016589|NCT01886638|Abacavir|abacavir|mesh-list
15016590|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15016591|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15016592|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802536|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
14802537|NCT00797810|Hormones|hormones|mesh-ancestor
15016593|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016594|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
15016595|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016596|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15016597|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15016598|NCT01886664|Sevoflurane|sevoflurane|mesh-list
15016599|NCT01886664|Desflurane|desflurane|mesh-list
15016600|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15016601|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15016602|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
15016603|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
15016604|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016605|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016606|NCT01886768|Anesthetics|anesthetics|mesh-list
15016607|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016608|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016609|NCT01886794|Estrogens|estrogens|mesh-list
15016610|NCT01886794|Hormones|hormones|mesh-ancestor
15016611|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15016612|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034080|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034081|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15034082|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
15034083|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15034084|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
15034085|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15034086|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15034087|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15034088|NCT01993225|Enclomiphene|enclomiphene|mesh-list
15034089|NCT01993225|Testosterone|testosterone|mesh-list
15034090|NCT01993225|Androgens|androgens|mesh-ancestor
15034091|NCT01993225|Hormones|hormones|mesh-ancestor
15034092|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15034093|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034094|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15034095|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
15034096|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15034097|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
15034098|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15034099|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15034100|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15034101|NCT01993251|Melatonin|melatonin|mesh-list
15034102|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
15034103|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034104|NCT01993251|Protective Agents|protective agents|mesh-ancestor
15034105|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034106|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034107|NCT01993290|Ropivacaine|ropivacaine|mesh-list
15034108|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
15034109|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
15034110|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034111|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034112|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
15034113|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035515|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035516|NCT02001896|Antiviral Agents|antiviral agents|mesh-ancestor
15035517|NCT02001896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15035518|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035519|NCT02001896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15035520|NCT02001896|Immunologic Factors|immunologic factors|mesh-ancestor
15035521|NCT02001896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035522|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15035523|NCT02001909|Neomycin|neomycin|mesh-list
15035524|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15035525|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15035526|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15035527|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035528|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035529|NCT02001935|Theophylline|theophylline|mesh-list
15035530|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15035531|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
15035532|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035533|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035534|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15035535|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
15035536|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15035537|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035538|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016613|NCT01887119|Eplerenone|eplerenone|mesh-list
15016614|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15016615|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
15016616|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15016617|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016618|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15016619|NCT01887119|Diuretics|diuretics|mesh-ancestor
15016620|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
15016621|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15016622|NCT01887158|Bisacodyl|bisacodyl|mesh-list
15016623|NCT01887158|Cathartics|cathartics|mesh-ancestor
15016624|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15016625|NCT01887158|Laxatives|laxatives|mesh-ancestor
15016626|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
15016627|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15016628|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016629|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016630|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15016631|NCT01887184|Analgesics|analgesics|mesh-ancestor
15016632|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
15016633|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016634|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15016635|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15016636|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15016637|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
15016638|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016639|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016640|NCT01887197|Mannitol|mannitol|mesh-list
15016641|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15016642|NCT01887197|Diuretics|diuretics|mesh-ancestor
15016643|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
15016644|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034114|NCT01993459|Midazolam|midazolam|mesh-list
15034115|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15034116|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15034117|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15034118|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034119|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034120|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15034121|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15034122|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15034123|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15034124|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
15034125|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
15034126|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
15034127|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
15034128|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034129|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034130|NCT01993472|Andrographolide|andrographolide|mesh-list
15034131|NCT01993472|Capecitabine|capecitabine|mesh-list
15034132|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15034133|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
15034134|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034135|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034136|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15034137|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15034138|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15034139|NCT01993472|Analgesics|analgesics|mesh-ancestor
15034140|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
15034141|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034142|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034143|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15034144|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15034145|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15034146|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034147|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
14802538|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14802539|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14802540|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14802541|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14802542|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
14802543|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
14802544|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802545|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15016645|NCT01887223|Timolol|timolol|mesh-list
15016646|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15016647|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15016648|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15016649|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15016650|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15016651|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
15016652|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016653|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016654|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016655|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15016656|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15016657|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15016658|NCT01887249|Metronidazole|metronidazole|mesh-list
15016659|NCT01887249|Clarithromycin|clarithromycin|mesh-list
15016660|NCT01887249|Esomeprazole|esomeprazole|mesh-list
15016661|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016662|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15016663|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15016664|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15016665|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15016666|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15016667|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15016668|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016669|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016670|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15016671|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15016672|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15016673|NCT01887275|Interferons|interferons|mesh-list
15016674|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016675|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
15016676|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016677|NCT01887301|Nabiximols|nabiximols|mesh-list
15016678|NCT01887301|Analgesics|analgesics|mesh-ancestor
15016679|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
15016680|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016681|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016682|NCT01887340|Carboplatin|carboplatin|mesh-list
15016683|NCT01887340|Etoposide|etoposide|mesh-list
15016684|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016685|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15016686|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15016687|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15016688|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016689|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016690|NCT01887379|Furosemide|furosemide|mesh-list
15016691|NCT01887379|Diuretics|diuretics|mesh-ancestor
15016692|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
15016693|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016694|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15016695|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15016696|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016697|NCT01887405|Epinephrine|epinephrine|mesh-list
15016698|NCT01887405|Racepinephrine|racepinephrine|mesh-list
15016699|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
15016700|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15016701|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15016702|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
15016703|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016704|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016705|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016706|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15016707|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15016708|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
15016709|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016710|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15016711|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
15016712|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
15016713|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
15016714|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15016715|NCT01887457|Voriconazole|voriconazole|mesh-list
15016716|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
15016717|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016718|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15016719|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15016720|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524675|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016721|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016722|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15016723|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
15016724|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15016725|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016726|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15016727|NCT01887522|Vinblastine|vinblastine|mesh-list
15016728|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15016729|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016730|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
15016731|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
15016732|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
15016733|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016734|NCT01887561|Dasatinib|dasatinib|mesh-list
15016735|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016736|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15016737|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016738|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016739|NCT01887613|Gabapentin|gabapentin|mesh-list
15016740|NCT01887613|Analgesics|analgesics|mesh-ancestor
15016741|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
15016742|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016743|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016744|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
15016745|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15016746|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15016747|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016748|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15016749|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15016750|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15016751|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016752|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016753|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
15016754|NCT01887626|Ticagrelor|ticagrelor|mesh-list
15016755|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15016756|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15016757|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15016758|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15016759|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
15016760|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016761|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016762|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016763|NCT01887691|Eszopiclone|eszopiclone|mesh-list
15016764|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15016765|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016766|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016767|NCT01887704|Aspirin|aspirin|mesh-list
15016768|NCT01887704|Sirolimus|sirolimus|mesh-list
15016769|NCT01887704|Paclitaxel|paclitaxel|mesh-list
15016770|NCT01887704|Everolimus|everolimus|mesh-list
15016771|NCT01887704|Clopidogrel|clopidogrel|mesh-list
15016772|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14524676|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524677|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14524678|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524679|NCT03687827|Insulin|insulin|mesh-list
14524680|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14524681|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
14524682|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14524683|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524684|NCT03691779|Ivacaftor|ivacaftor|mesh-list
14524685|NCT03691779|Elexacaftor|elexacaftor|mesh-list
14524686|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14524687|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524688|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524689|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
14524690|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15016773|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016774|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
15016775|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
15016776|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
15016777|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016778|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15016779|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15016780|NCT01887704|Analgesics|analgesics|mesh-ancestor
15016781|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
15016782|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016783|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016784|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15016785|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15016786|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15016787|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15016788|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15016789|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15016790|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016791|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
15016792|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15016793|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
15016794|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15035539|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
15016795|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15016796|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15016797|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
15016798|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016799|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15016800|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016801|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15016802|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
14802546|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
14802547|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
14802548|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
14802549|NCT00797836|Interferons|interferons|mesh-list
14802550|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802551|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
15016803|NCT01887743|Pantoprazole|pantoprazole|mesh-list
15016804|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15016805|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15016806|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15016807|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016808|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016809|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15016810|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016811|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15016812|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802552|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802553|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14802554|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
14802555|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
14802556|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802557|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14802558|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802559|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802560|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
14802561|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
14802562|NCT00798070|Fluorouracil|fluorouracil|mesh-list
14802563|NCT00798070|Docetaxel|docetaxel|mesh-list
14802564|NCT00798070|Epirubicin|epirubicin|mesh-list
14802565|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802566|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
15016813|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016814|NCT01887821|Chloroquine|chloroquine|mesh-list
15016815|NCT01887821|Piperaquine|piperaquine|mesh-list
15016816|NCT01887821|Artenimol|artenimol|mesh-list
15016817|NCT01887821|Amebicides|amebicides|mesh-ancestor
15016818|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15016819|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15016820|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016821|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
15016822|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15016823|NCT01887847|Nicotine|nicotine|mesh-list
15016824|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15016825|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
15016826|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016827|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016828|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15016829|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15016830|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
15016831|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016832|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016833|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
15016834|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15016835|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
15016836|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016837|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
15016838|NCT01887873|Protective Agents|protective agents|mesh-ancestor
15016839|NCT01887951|Tramadol|tramadol|mesh-list
15016840|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15016841|NCT01887951|Narcotics|narcotics|mesh-ancestor
15016842|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016843|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016844|NCT01887951|Analgesics|analgesics|mesh-ancestor
15016845|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
15016846|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016847|NCT01888042|Everolimus|everolimus|mesh-list
15016848|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016849|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15016850|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
15016851|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016852|NCT01888107|Risperidone|risperidone|mesh-list
15016853|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15016854|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
15016855|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016856|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016857|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016858|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15016859|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15016860|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016861|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15016862|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15016863|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
15016864|NCT01888120|Ziconotide|ziconotide|mesh-list
15016865|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15016866|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15016867|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016868|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15016869|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016870|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15016871|NCT01888120|Protective Agents|protective agents|mesh-ancestor
15016872|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15016873|NCT01888120|Analgesics|analgesics|mesh-ancestor
15016874|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
15016875|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016876|NCT01888224|Isotretinoin|isotretinoin|mesh-list
15016877|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
15016878|NCT01888250|Lamotrigine|lamotrigine|mesh-list
15016879|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
15016880|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15016881|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15016882|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016883|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15016884|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016885|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15016886|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15016887|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016888|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15016889|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15016890|NCT01888263|Lamotrigine|lamotrigine|mesh-list
15016891|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
15016892|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15016893|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15016894|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016895|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15016896|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016897|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15016898|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15016899|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016900|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15016901|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15016902|NCT01888289|Isotretinoin|isotretinoin|mesh-list
15016903|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
15016904|NCT01888302|Gemcitabine|gemcitabine|mesh-list
15016905|NCT01888302|Sirolimus|sirolimus|mesh-list
15016906|NCT01888302|Cisplatin|cisplatin|mesh-list
15016907|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016908|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15016909|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
15016910|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016911|NCT01888302|Antiviral Agents|antiviral agents|mesh-ancestor
15016912|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016913|NCT01888302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016914|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15016915|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
15016916|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016917|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15016918|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15016919|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
15016920|NCT01888328|Isotretinoin|isotretinoin|mesh-list
15016921|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
15016922|NCT01888341|Isotretinoin|isotretinoin|mesh-list
15016923|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
15016924|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15016925|NCT01888354|Hormones|hormones|mesh-ancestor
15016926|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15016927|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016928|NCT01888393|Ivacaftor|ivacaftor|mesh-list
15016929|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15016930|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15016931|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016932|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
15016933|NCT01888445|Hematinics|hematinics|mesh-ancestor
15016934|NCT01888458|Micafungin|micafungin|mesh-list
15016935|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
15016936|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15016937|NCT01888536|Pregabalin|pregabalin|mesh-list
15016938|NCT01888536|Alprostadil|alprostadil|mesh-list
15016939|NCT01888536|Analgesics|analgesics|mesh-ancestor
15016940|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
15016941|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016942|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016943|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
15016944|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15016945|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15016946|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016947|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15016948|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15016949|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15016950|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016951|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15016952|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15016953|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
15016954|NCT01888536|Urological Agents|urological agents|mesh-ancestor
15016955|NCT01888562|Ponatinib|ponatinib|mesh-list
14802567|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802568|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14802569|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15016956|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15016957|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15016958|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016959|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016960|NCT01888575|Aspirin|aspirin|mesh-list
15016961|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15016962|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15016963|NCT01888575|Analgesics|analgesics|mesh-ancestor
15016964|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
15016965|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15016966|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802570|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
14802571|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802572|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802573|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14802574|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
14802575|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14802576|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
14802577|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
14802578|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
14802579|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14802580|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14802581|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14802582|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802583|NCT00798083|Lidocaine|lidocaine|mesh-list
14802584|NCT00798083|Ketamine|ketamine|mesh-list
14802585|NCT00798083|Amitriptyline|amitriptyline|mesh-list
15016967|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15016968|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15016969|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15016970|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15016971|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016972|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15016973|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15016974|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15016975|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
15034148|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15034149|NCT01993537|Vitamin D|vitamin d|mesh-list
15034150|NCT01993537|Vitamins|vitamins|mesh-ancestor
15034151|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
15034152|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034153|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15034154|NCT01993589|Acetaminophen|acetaminophen|mesh-list
15034155|NCT01993589|Analgesics|analgesics|mesh-list
15034156|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15034157|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
15034158|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034159|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034160|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
15034161|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
15034162|NCT01993680|Bromides|bromides|mesh-list
15034163|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
15034164|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
15034165|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15034166|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034167|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034168|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
15034169|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034170|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034171|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15034172|NCT01993771|Anesthetics|anesthetics|mesh-list
15034173|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034174|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034175|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
15016976|NCT01888718|Fexofenadine|fexofenadine|mesh-list
15016977|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15016978|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15016979|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15016980|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
15016981|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
15016982|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15016983|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016984|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016985|NCT01888731|Lamotrigine|lamotrigine|mesh-list
15016986|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
15016987|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15016988|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15016989|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15016990|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15016991|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15016992|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15016993|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15016994|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15016995|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15016996|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15016997|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15016998|NCT01888744|Cetrorelix|cetrorelix|mesh-list
15016999|NCT01888744|Progesterone|progesterone|mesh-list
15017000|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15017001|NCT01888744|Ganirelix|ganirelix|mesh-list
15017002|NCT01888744|Progestins|progestins|mesh-ancestor
15017003|NCT01888744|Hormones|hormones|mesh-ancestor
15017004|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15017005|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017006|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15017007|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15017008|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
15017009|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
15017010|NCT01888757|Lamotrigine|lamotrigine|mesh-list
15017011|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
15017012|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15017013|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15017014|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017015|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15017016|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017017|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15017018|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15017019|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017020|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15017021|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15017022|NCT01888796|Linagliptin|linagliptin|mesh-list
15017023|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15017024|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017025|NCT01888796|Incretins|incretins|mesh-ancestor
15017026|NCT01888796|Hormones|hormones|mesh-ancestor
15017027|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15017028|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15017029|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
15017030|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017031|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017032|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
15017033|NCT01888822|Ampicillin|ampicillin|mesh-list
15017034|NCT01888822|Sulbactam|sulbactam|mesh-list
15017035|NCT01888822|Sultamicillin|sultamicillin|mesh-list
15017036|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15017037|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017038|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15017039|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15017040|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017041|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017042|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017043|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15017044|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15017045|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15017046|NCT01888835|Mirtazapine|mirtazapine|mesh-list
15017047|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
15017048|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15017049|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15017050|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
15017051|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
15017052|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017053|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017054|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017055|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15017056|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15017057|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017058|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15017059|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15017060|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15017061|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
15017062|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15017063|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15017064|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
15017065|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15017066|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
15017067|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
15017068|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017069|NCT01888861|Protective Agents|protective agents|mesh-ancestor
15017070|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017071|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
15017072|NCT01888861|Vitamins|vitamins|mesh-ancestor
15017073|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
15017074|NCT01888978|Leucovorin|leucovorin|mesh-list
15017075|NCT01888978|Gemcitabine|gemcitabine|mesh-list
15017076|NCT01888978|Fluorouracil|fluorouracil|mesh-list
15017077|NCT01888978|Docetaxel|docetaxel|mesh-list
15017078|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
15017079|NCT01888978|Irinotecan|irinotecan|mesh-list
15017080|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
15017081|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15017082|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
15017083|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017084|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017085|NCT01888978|Antiviral Agents|antiviral agents|mesh-ancestor
15017086|NCT01888978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017087|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017088|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15017089|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
15017090|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017091|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
15017092|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
15017093|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
15017094|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15017095|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15017096|NCT01888978|Antidotes|antidotes|mesh-ancestor
15017097|NCT01888978|Protective Agents|protective agents|mesh-ancestor
15017098|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
15017099|NCT01888978|Vitamins|vitamins|mesh-ancestor
15017100|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
15017101|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
15017102|NCT01889004|Propofol|propofol|mesh-list
15017103|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15017104|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017105|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017106|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15017107|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
15017108|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
15017109|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15017110|NCT01889004|Analgesics|analgesics|mesh-ancestor
15017111|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
15017112|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017113|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15017114|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15017115|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15017116|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
15017117|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017118|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017119|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
15017120|NCT01889056|Hematinics|hematinics|mesh-ancestor
15017121|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
15017122|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15017123|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017124|NCT01889134|Alendronate|alendronate|mesh-list
15017125|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15017126|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017127|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
15017128|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15017129|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
15017130|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15017131|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15017132|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017133|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15017134|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017135|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15017136|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017137|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15017138|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017139|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15017140|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017141|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017142|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
15017143|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15017144|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017145|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
15017146|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017147|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
15017148|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15017149|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017150|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
15017151|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017152|NCT01889368|Protective Agents|protective agents|mesh-ancestor
15017153|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017154|NCT01889407|Idarubicin|idarubicin|mesh-list
15017155|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15017156|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017157|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15017158|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15017159|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017160|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017161|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15017162|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
15017163|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017164|NCT01889446|Calcium|calcium|mesh-list
15017165|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15017166|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017167|NCT01889498|Acetazolamide|acetazolamide|mesh-list
15017168|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
15017169|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15017170|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017171|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017172|NCT01889498|Diuretics|diuretics|mesh-ancestor
15017173|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
15017174|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017175|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
15017176|NCT01889576|Antacids|antacids|mesh-ancestor
15017177|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017178|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15017179|NCT01889680|Leucovorin|leucovorin|mesh-list
15017180|NCT01889680|Fluorouracil|fluorouracil|mesh-list
15017181|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
15017182|NCT01889680|Aflibercept|aflibercept|mesh-list
15017183|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
15017184|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
15017185|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017186|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15017187|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017188|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15017189|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
15017190|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017191|NCT01889680|Antidotes|antidotes|mesh-ancestor
15017192|NCT01889680|Protective Agents|protective agents|mesh-ancestor
15017193|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
15017194|NCT01889680|Vitamins|vitamins|mesh-ancestor
15017195|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
15017196|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15017197|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15017198|NCT01889680|Growth Substances|growth substances|mesh-ancestor
15017199|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
15017200|NCT01889758|Tacrolimus|tacrolimus|mesh-list
15017201|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15017202|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
15017203|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017204|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15017205|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017206|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017207|NCT01889771|Nicotine|nicotine|mesh-list
15017208|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15017209|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
15017210|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017211|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017212|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15017213|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15017214|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
15017215|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017216|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017217|NCT01889810|Vitamin D|vitamin d|mesh-list
15017218|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
15017219|NCT01889810|Vitamins|vitamins|mesh-ancestor
15017220|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
15017221|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524691|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524692|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
14524693|NCT03691948|Narcotics|narcotics|mesh-ancestor
14524694|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524695|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524696|NCT03691948|Analgesics|analgesics|mesh-ancestor
14524697|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
14524698|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524699|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
14524700|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14524701|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
14524702|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524703|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524704|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14524705|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
14524706|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
14524707|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14524708|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
14524709|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524710|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524711|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
14524712|NCT03693950|Hematinics|hematinics|mesh-ancestor
14524713|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
14524714|NCT03693989|Difluprednate|difluprednate|mesh-list
14524715|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
14524716|NCT03693989|Hormones|hormones|mesh-ancestor
14524717|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14524718|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524719|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14524720|NCT03695094|Lamotrigine|lamotrigine|mesh-list
15017222|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15017223|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15017224|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15017225|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15017226|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
15017227|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017228|NCT01889914|Insulin|insulin|mesh-list
15017229|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15017230|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15017231|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017232|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
15017233|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
15017234|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15017235|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15017236|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017237|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017238|NCT01889966|Urological Agents|urological agents|mesh-ancestor
15017239|NCT01889979|Tramadol|tramadol|mesh-list
15017240|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15017241|NCT01889979|Narcotics|narcotics|mesh-ancestor
15017242|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017243|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017244|NCT01889979|Analgesics|analgesics|mesh-ancestor
15017245|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
15017246|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017247|NCT01889992|Sirolimus|sirolimus|mesh-list
15017248|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15017249|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017250|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15017251|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017252|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
15017253|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15017254|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
15017255|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017256|NCT01890005|Aspirin|aspirin|mesh-list
15017257|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15017258|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15017259|NCT01890005|Analgesics|analgesics|mesh-ancestor
15017260|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
15017261|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017262|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017263|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15017264|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15017265|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15017266|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15017267|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017268|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15017269|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15017270|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017271|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
15017272|NCT01890200|Ribavirin|ribavirin|mesh-list
15017273|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15017274|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
15017275|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802586|NCT00798083|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14802587|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
14802588|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
14802589|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802590|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802591|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
14802592|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802593|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14802594|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14802595|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14802596|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14802597|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802598|NCT00798083|Analgesics|analgesics|mesh-ancestor
15017276|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
15017277|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034176|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15034177|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034178|NCT01993810|Paclitaxel|paclitaxel|mesh-list
15034179|NCT01993810|Etoposide|etoposide|mesh-list
15034180|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
15034181|NCT01993810|Cisplatin|cisplatin|mesh-list
15034182|NCT01993810|Carboplatin|carboplatin|mesh-list
15034183|NCT01993810|Pemetrexed|pemetrexed|mesh-list
14802599|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14802600|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14802601|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
15034184|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15034185|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
15017278|NCT01890408|Ropivacaine|ropivacaine|mesh-list
15017279|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
15017280|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
15017281|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017282|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017283|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
15017284|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017285|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
15017286|NCT01890538|Piracetam|piracetam|mesh-list
15017287|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15017288|NCT01890538|Protective Agents|protective agents|mesh-ancestor
15017289|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017290|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
15017291|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
15017292|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
15017293|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017294|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15017295|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15017296|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
15017297|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
15017298|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017299|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017300|NCT01890629|Metformin|metformin|mesh-list
15017301|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15017302|NCT01890629|Glimepiride|glimepiride|mesh-list
15017303|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15017304|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017305|NCT01890629|Incretins|incretins|mesh-ancestor
15017306|NCT01890629|Hormones|hormones|mesh-ancestor
15017307|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15017308|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15017309|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
15017310|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017311|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017312|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15017313|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15017314|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
15017315|NCT01890772|Vitamin D|vitamin d|mesh-list
15017316|NCT01890772|Ribavirin|ribavirin|mesh-list
15017317|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15017318|NCT01890772|Vitamins|vitamins|mesh-ancestor
15017319|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
15017320|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017321|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15017322|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
15017323|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017324|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
15017325|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017326|NCT01890863|Fluticasone|fluticasone|mesh-list
15017327|NCT01890863|Xhance|xhance|mesh-list
15017328|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15017329|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15017330|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15017331|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15017332|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
15017333|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017334|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017335|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15017336|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
15017337|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
15017338|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15017339|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15017340|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15017341|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15017342|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
15017343|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017344|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017345|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
15017346|NCT01890863|Hormones|hormones|mesh-ancestor
15017347|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15017348|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
15017349|NCT01890889|Ezetimibe|ezetimibe|mesh-list
15017350|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15017351|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15017352|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
15017353|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017354|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15017355|NCT01890902|Ketoprofen|ketoprofen|mesh-list
15017356|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15017357|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15017358|NCT01890902|Analgesics|analgesics|mesh-ancestor
15017359|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
15017360|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017361|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017362|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15017363|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15017364|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15017365|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017366|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017367|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15017368|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15017369|NCT01890993|Liraglutide|liraglutide|mesh-list
15017370|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15017371|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017372|NCT01890993|Incretins|incretins|mesh-ancestor
15017373|NCT01890993|Hormones|hormones|mesh-ancestor
15017374|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15017375|NCT01891019|Thalidomide|thalidomide|mesh-list
15017376|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15017377|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
15017378|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017379|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
15017380|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15017381|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017382|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15017383|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15017384|NCT01891019|Growth Substances|growth substances|mesh-ancestor
15017385|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
15017386|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017387|NCT01891084|Acetaminophen|acetaminophen|mesh-list
15017388|NCT01891084|Ibuprofen|ibuprofen|mesh-list
15017389|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15017390|NCT01891084|Analgesics|analgesics|mesh-ancestor
15017391|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
15017392|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017393|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017394|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
15017395|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15017396|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15017397|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15017398|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15017399|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017400|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017401|NCT01891175|Anesthetics|anesthetics|mesh-list
15017402|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017403|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017404|NCT01891201|Oxytocin|oxytocin|mesh-list
15017405|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
15017406|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15017407|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017408|NCT01891227|Capecitabine|capecitabine|mesh-list
15017409|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15017410|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15017411|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
15017412|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017413|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017414|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15017415|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
15017416|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
15017417|NCT01891292|Enalapril|enalapril|mesh-list
15017418|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15017419|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
15017420|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017421|NCT01891292|Expectorants|expectorants|mesh-ancestor
15017422|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
15017423|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15017424|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
15017425|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017426|NCT01891292|Protective Agents|protective agents|mesh-ancestor
15034186|NCT01993810|Durvalumab|durvalumab|mesh-list
15017427|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017428|NCT01891292|Antidotes|antidotes|mesh-ancestor
15017429|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15017430|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
15017431|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017432|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15017433|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
15017434|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15017435|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
15017436|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017437|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
15017438|NCT01891396|Protective Agents|protective agents|mesh-ancestor
15017439|NCT01891435|Acetaminophen|acetaminophen|mesh-list
15017440|NCT01891435|Diclofenac|diclofenac|mesh-list
15017441|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15017442|NCT01891435|Analgesics|analgesics|mesh-ancestor
15017443|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
15017444|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017445|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017446|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
15017447|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15017448|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15017449|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15017450|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15017451|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017452|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017453|NCT01891461|Hemostatics|hemostatics|mesh-list
15017454|NCT01891461|Coagulants|coagulants|mesh-ancestor
15017455|NCT01891487|Bimatoprost|bimatoprost|mesh-list
15017456|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15017457|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
15017458|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15017459|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
15017460|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017461|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017462|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15017463|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
15017464|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15017465|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
15017466|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017467|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017468|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15017469|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
15017470|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
15017471|NCT01891500|Protective Agents|protective agents|mesh-ancestor
15017472|NCT01891513|Losartan|losartan|mesh-list
15017473|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15017474|NCT01891513|Perindopril|perindopril|mesh-list
15017475|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15017476|NCT01891513|Diuretics|diuretics|mesh-list
15017477|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
15017478|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15017479|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15017480|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15017481|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15017482|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017483|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
15017484|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017485|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15017486|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
15017487|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017488|NCT01891526|Tretinoin|tretinoin|mesh-list
15017489|NCT01891526|Alitretinoin|alitretinoin|mesh-list
15017490|NCT01891526|Isotretinoin|isotretinoin|mesh-list
15017491|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017492|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
15017493|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
15017494|NCT01891643|Dexamethasone|dexamethasone|mesh-list
15017495|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
15017496|NCT01891643|Lenalidomide|lenalidomide|mesh-list
15017497|NCT01891643|Elotuzumab|elotuzumab|mesh-list
15017498|NCT01891643|BB 1101|bb 1101|mesh-list
15017499|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15017500|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
15017501|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
15017502|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017503|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017504|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15017505|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
15017506|NCT01891643|Hormones|hormones|mesh-ancestor
15017507|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15017508|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15017509|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017510|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
15017511|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017512|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017513|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
15017514|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15017515|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15017516|NCT01891643|Growth Substances|growth substances|mesh-ancestor
15017517|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
15017518|NCT01891708|Bevacizumab|bevacizumab|mesh-list
15017519|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15017520|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017521|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15017522|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15017523|NCT01891708|Growth Substances|growth substances|mesh-ancestor
15017524|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017525|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
15017526|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
15017527|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15017528|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
15017529|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
15017530|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017531|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017532|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15017533|NCT01891812|Analgesics|analgesics|mesh-ancestor
15017534|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
15017535|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017536|NCT01891851|Ritonavir|ritonavir|mesh-list
15017537|NCT01891851|Simeprevir|simeprevir|mesh-list
15017538|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15017539|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15017540|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
15017541|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017542|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017543|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15017544|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15017545|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
15017546|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017547|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15017548|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15017549|NCT01891916|Caseins|caseins|mesh-list
15017550|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
15017551|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
15017552|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017553|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
15017554|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017555|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
15017556|NCT01892098|Astringents|astringents|mesh-ancestor
15017557|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017558|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
15034187|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
15034188|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15034189|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
15034190|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15034191|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034192|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
15034193|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
15034194|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
15034195|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034196|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15034197|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15034198|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034199|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15034200|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15034201|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15034202|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
15034203|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034204|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
15034205|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
15034206|NCT01993979|Gemcitabine|gemcitabine|mesh-list
15034207|NCT01993979|Cisplatin|cisplatin|mesh-list
15034208|NCT01993979|Carboplatin|carboplatin|mesh-list
15034209|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034210|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15034211|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
15034212|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034213|NCT01993979|Antiviral Agents|antiviral agents|mesh-ancestor
15034214|NCT01993979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034215|NCT01993979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034216|NCT01993979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15034217|NCT01993979|Immunologic Factors|immunologic factors|mesh-ancestor
15034218|NCT01993979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034219|NCT01994031|Paclitaxel|paclitaxel|mesh-list
15034220|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15034221|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15034222|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034223|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
15034224|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
15034225|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
15034226|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034227|NCT01994070|Procainamide|procainamide|mesh-list
15034228|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15034229|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15034230|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15034231|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15034232|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034233|NCT01994096|Caspofungin|caspofungin|mesh-list
15034234|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
15034235|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034236|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034237|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034238|NCT01994265|Warfarin|warfarin|mesh-list
15034239|NCT01994265|Dabigatran|dabigatran|mesh-list
15034240|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
15034241|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
15034242|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15034243|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
15034244|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034245|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034246|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
15034247|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
15034248|NCT01994330|Coagulants|coagulants|mesh-ancestor
15034249|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15034250|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
15034251|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034252|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
15034253|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15017559|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
15017560|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15017561|NCT01892150|Protective Agents|protective agents|mesh-ancestor
15017562|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017563|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
15017564|NCT01892176|Ubiquinone|ubiquinone|mesh-list
15017565|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
15017566|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
15017567|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017568|NCT01892176|Vitamins|vitamins|mesh-ancestor
15017569|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15017570|NCT01892241|Entecavir|entecavir|mesh-list
15017571|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
15017572|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017573|NCT01892254|Metformin|metformin|mesh-list
15017574|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15017575|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017576|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
15017577|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15017578|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017579|NCT01892332|Lidocaine|lidocaine|mesh-list
15017580|NCT01892332|Fentanyl|fentanyl|mesh-list
15017581|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
15017582|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
15017583|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017584|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017585|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
15017586|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017587|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15017588|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15017589|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15017590|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15017591|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017592|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15017593|NCT01892332|Narcotics|narcotics|mesh-ancestor
15017594|NCT01892332|Analgesics|analgesics|mesh-ancestor
15017595|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15017596|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15017597|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
15017598|NCT01892384|BI 409306|bi 409306|mesh-list
15017599|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15017600|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017601|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017602|NCT01892488|Sultamicillin|sultamicillin|mesh-list
15017603|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
15017604|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15017605|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017606|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017607|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017608|NCT01892527|Cetuximab|cetuximab|mesh-list
15017609|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15017610|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017611|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15017612|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
15017613|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017614|NCT01892631|Vaccines|vaccines|mesh-list
15017615|NCT01892631|Immunologic Factors|immunologic factors|mesh-ancestor
15017616|NCT01892631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017617|NCT01892644|Deferasirox|deferasirox|mesh-list
15017618|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15017619|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
15017620|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
15017621|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017622|NCT01892683|Propofol|propofol|mesh-list
15017623|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
15017624|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017625|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017626|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15017627|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15017628|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
15017629|NCT01892748|Vitamin D|vitamin d|mesh-list
15017630|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
15017631|NCT01892748|Vitamins|vitamins|mesh-ancestor
15017632|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
15017633|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017634|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15017635|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15017636|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
15017637|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15017638|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15017639|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
15017640|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017641|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017642|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15017643|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
15017644|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15017645|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15017646|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15017647|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
15017648|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017649|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017650|NCT01892813|Bupropion|bupropion|mesh-list
15017651|NCT01892813|Nicotine|nicotine|mesh-list
15017652|NCT01892813|Varenicline|varenicline|mesh-list
15017653|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15017654|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
15017655|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017656|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017657|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15017658|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15017659|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
15017660|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017661|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017662|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15017663|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
15017664|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15017665|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15017666|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15017667|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15017668|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
15017669|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15017670|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15017671|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017672|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
15017673|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15017674|NCT01892995|Ketamine|ketamine|mesh-list
15017675|NCT01892995|Analgesics|analgesics|mesh-ancestor
15017676|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
15017677|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017678|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017679|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15017680|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15017681|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
15017682|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
15017683|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017684|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15017685|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15017686|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017687|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017688|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
15017689|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15017690|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
15017691|NCT01893060|Povidone|povidone|mesh-list
15017692|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15017693|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017694|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
15017695|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
15017696|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
15017697|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
15017698|NCT01893099|Sorafenib|sorafenib|mesh-list
15017699|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017700|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15017701|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017702|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017703|NCT01893177|Vaccines|vaccines|mesh-list
15017704|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
15017705|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017706|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
15017707|NCT01893229|Valproic Acid|valproic acid|mesh-list
15017708|NCT01893229|Olanzapine|olanzapine|mesh-list
15017709|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15017710|NCT01893229|Ziprasidone|ziprasidone|mesh-list
15017711|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
15017712|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
15017713|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
15017714|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017715|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017716|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15017717|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15017718|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15017719|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017720|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15017721|NCT01893229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15017722|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15017723|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15017724|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017725|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017726|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
15017727|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
15017728|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017729|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
15017730|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15017731|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15017732|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
15017733|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
15017734|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
15017735|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15017736|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15017737|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15017738|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15017739|NCT01893294|Gemcitabine|gemcitabine|mesh-list
15017740|NCT01893294|Fluorouracil|fluorouracil|mesh-list
15017741|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15017742|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
15017743|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017744|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017745|NCT01893294|Antiviral Agents|antiviral agents|mesh-ancestor
15017746|NCT01893294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017747|NCT01893294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017748|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15017749|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
15017750|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017751|NCT01893385|Vitamin D|vitamin d|mesh-list
15017752|NCT01893385|Vitamins|vitamins|mesh-ancestor
15017753|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
15017754|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017755|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15017756|NCT01893424|Dronabinol|dronabinol|mesh-list
15017757|NCT01893424|Nabiximols|nabiximols|mesh-list
15017758|NCT01893424|Cannabidiol|cannabidiol|mesh-list
15017759|NCT01893424|Piperine|piperine|mesh-list
15017760|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
15017761|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
15017762|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017763|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15017764|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15017765|NCT01893424|Analgesics|analgesics|mesh-ancestor
15017766|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
15017767|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017768|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15017769|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15017770|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017771|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017772|NCT01893424|Hormones|hormones|mesh-ancestor
15017773|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15017774|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15017775|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017776|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
15017777|NCT01893450|Bromocriptine|bromocriptine|mesh-list
15017778|NCT01893450|Methimazole|methimazole|mesh-list
15017779|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15017780|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017781|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017782|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15017783|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15017784|NCT01893450|Protective Agents|protective agents|mesh-ancestor
15017785|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017786|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
15017787|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15017788|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
15017789|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14524721|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
14524722|NCT03695094|Levetiracetam|levetiracetam|mesh-list
14524723|NCT03695094|Brivaracetam|brivaracetam|mesh-list
14524724|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
14524725|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
14524726|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14524727|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524728|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524729|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14524730|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524731|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14524732|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14524733|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524734|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14524735|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14524736|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14524737|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14524738|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14524739|NCT03695367|Acetaminophen|acetaminophen|mesh-list
14524740|NCT03695367|Ibuprofen|ibuprofen|mesh-list
14524741|NCT03695367|Ketorolac|ketorolac|mesh-list
14524742|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14524743|NCT03695367|Analgesics|analgesics|mesh-ancestor
14524744|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
14524745|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524746|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524747|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
14524748|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14524749|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14524750|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14524751|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14524752|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524753|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524754|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
14524755|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
14524756|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14524757|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524758|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14524759|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14524760|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14524761|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14524762|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017790|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15017791|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
15017792|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15017793|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
15017794|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
15017795|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017796|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
15017797|NCT01893541|Propranolol|propranolol|mesh-list
15017798|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15017799|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15017800|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
15017801|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017802|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017803|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017804|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15017805|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15017806|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
15017807|NCT01893658|Omalizumab|omalizumab|mesh-list
15017808|NCT01893658|Prednisone|prednisone|mesh-list
15017809|NCT01893658|Prednisolone|prednisolone|mesh-list
15017810|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15017811|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
15017812|NCT01893658|Hormones|hormones|mesh-ancestor
15017813|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15017814|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017815|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15017816|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017817|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15017818|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15017819|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
15017820|NCT01893723|Remifentanil|remifentanil|mesh-list
15017821|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15017822|NCT01893723|Narcotics|narcotics|mesh-ancestor
15017823|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017824|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017825|NCT01893723|Analgesics|analgesics|mesh-ancestor
15017826|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
15017827|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017828|NCT01893788|Eplerenone|eplerenone|mesh-list
15017829|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15017830|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
15017831|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15017832|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017833|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15017834|NCT01893788|Diuretics|diuretics|mesh-ancestor
15017835|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
15017836|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15034254|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034255|NCT01994460|Linezolid|linezolid|mesh-list
15034256|NCT01994460|Ethambutol|ethambutol|mesh-list
15034257|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15034258|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034259|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15034260|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034261|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034262|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
15034263|NCT01994525|Vaccines|vaccines|mesh-list
15034264|NCT01994525|Immunologic Factors|immunologic factors|mesh-ancestor
14524763|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524764|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524765|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
14524766|NCT03696758|Metoprolol|metoprolol|mesh-list
14524767|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
14524768|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
14524769|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14524770|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14524771|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524772|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524773|NCT03696758|Urological Agents|urological agents|mesh-ancestor
14524774|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14524775|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14524776|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
14524777|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
14524778|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524779|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524780|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15034265|NCT01994525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034266|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
15034267|NCT01994642|Dexamethasone|dexamethasone|mesh-list
15034268|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
15034269|NCT01994642|BB 1101|bb 1101|mesh-list
15034270|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15034271|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
15034272|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
15034273|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034274|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034275|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15034276|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
15034277|NCT01994642|Hormones|hormones|mesh-ancestor
15034278|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15034279|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15034280|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034281|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
15034282|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034283|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034284|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15034285|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034286|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15034287|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15034288|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15034289|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15017837|NCT01893996|Adalimumab|adalimumab|mesh-list
15017838|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15017839|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15017840|NCT01894035|Iloprost|iloprost|mesh-list
15017841|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15017842|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
15017843|NCT01894048|Beclomethasone|beclomethasone|mesh-list
15017844|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15017845|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
15017846|NCT01894048|Hormones|hormones|mesh-ancestor
15017847|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15017848|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017849|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15017850|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
15017851|NCT01894061|Bevacizumab|bevacizumab|mesh-list
15017852|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15017853|NCT01894061|Antibodies|antibodies|mesh-list
15017854|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
15017855|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15017856|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017857|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15017858|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15017859|NCT01894061|Growth Substances|growth substances|mesh-ancestor
15017860|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017861|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
15017862|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
15017863|NCT01894269|Lamivudine|lamivudine|mesh-list
15017864|NCT01894269|Entecavir|entecavir|mesh-list
15017865|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15017866|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15017867|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017868|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017869|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
15017870|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017871|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15017872|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15017873|NCT01894295|Vitamin D|vitamin d|mesh-list
15017874|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
15017875|NCT01894295|Vitamins|vitamins|mesh-ancestor
15017876|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
15017877|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017878|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15017879|NCT01894308|Testosterone|testosterone|mesh-list
15017880|NCT01894308|Androgens|androgens|mesh-ancestor
15017881|NCT01894308|Hormones|hormones|mesh-ancestor
15017882|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15017883|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017884|NCT01894334|Edaravone|edaravone|mesh-list
15017885|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
15017886|NCT01894334|Urinastatin|urinastatin|mesh-list
15017887|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15017888|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15017889|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017890|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
15017891|NCT01894334|Coagulants|coagulants|mesh-ancestor
15017892|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15017893|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
15017894|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15017895|NCT01894334|Protective Agents|protective agents|mesh-ancestor
15017896|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017897|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15017898|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15017899|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
15017900|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15017901|NCT01894360|Belimumab|belimumab|mesh-list
15017902|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15017903|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
15017904|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017905|NCT01894412|Etanercept|etanercept|mesh-list
15017906|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15017907|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15017908|NCT01894412|Analgesics|analgesics|mesh-ancestor
15017909|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
15017910|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017911|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017912|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15017913|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15017914|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15017915|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15017916|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
15017917|NCT01894451|Bevacizumab|bevacizumab|mesh-list
15017918|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
15017919|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15017920|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017921|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15017922|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15017923|NCT01894451|Growth Substances|growth substances|mesh-ancestor
15017924|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017925|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
15017926|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15017927|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017928|NCT01894633|Chloroquine|chloroquine|mesh-list
15017929|NCT01894633|Amebicides|amebicides|mesh-ancestor
15017930|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15017931|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15017932|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15017933|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
15017934|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15017935|NCT01894685|Mesalamine|mesalamine|mesh-list
15017936|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15017937|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15017938|NCT01894685|Analgesics|analgesics|mesh-ancestor
15017939|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
15017940|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017941|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017942|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15017943|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15017944|NCT01894711|Trastuzumab|trastuzumab|mesh-list
15017945|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15017946|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15017947|NCT01894789|Clopidogrel|clopidogrel|mesh-list
15017948|NCT01894789|Ticagrelor|ticagrelor|mesh-list
15017949|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15017950|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15017951|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15017952|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15017953|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
15017954|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017955|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017956|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017957|NCT01894815|Dexetimide|dexetimide|mesh-list
15017958|NCT01894815|Citalopram|citalopram|mesh-list
15017959|NCT01894815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15017960|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15017961|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15017962|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017963|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017964|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
15017965|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017966|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15017967|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
15017968|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15017969|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15017970|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15017971|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
15017972|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
15017973|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017974|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15017975|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15017976|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
15017977|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
15017978|NCT01894867|Antacids|antacids|mesh-ancestor
15017979|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017980|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15017981|NCT01895010|Tropisetron|tropisetron|mesh-list
15017982|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
15017983|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
15017984|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15017985|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017986|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15017987|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15017988|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15017989|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
15017990|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15017991|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15017992|NCT01895023|Midazolam|midazolam|mesh-list
15017993|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
15017994|NCT01895023|GABA Modulators|gaba modulators|mesh-list
15017995|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15017996|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15017997|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15017998|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15017999|NCT01895023|Analgesics|analgesics|mesh-ancestor
15018000|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
15018001|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018002|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15018003|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15018004|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15018005|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
15018006|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018007|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018008|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15018009|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15018010|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15018011|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15018012|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15018013|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
15018014|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
15018015|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
15018016|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
15018017|NCT01895049|Prednisone|prednisone|mesh-list
15018018|NCT01895049|Everolimus|everolimus|mesh-list
15018019|NCT01895049|Tacrolimus|tacrolimus|mesh-list
15018020|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
15018021|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15018022|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15018023|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
15018024|NCT01895049|Hormones|hormones|mesh-ancestor
15018025|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018026|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018027|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15018028|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018029|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15018030|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
15018031|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15018032|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018033|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018034|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15018035|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15018036|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
15018037|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15018038|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018039|NCT01895075|Budesonide|budesonide|mesh-list
15018040|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15018041|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15018042|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
15018043|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018044|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018045|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15018046|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
15018047|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
15018048|NCT01895075|Hormones|hormones|mesh-ancestor
15018049|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018050|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
15018051|NCT01895205|Hematinics|hematinics|mesh-ancestor
15018052|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
15018053|NCT01895218|Hematinics|hematinics|mesh-ancestor
15018054|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
15018055|NCT01895231|Hematinics|hematinics|mesh-ancestor
15018056|NCT01895257|Leucovorin|leucovorin|mesh-list
15018057|NCT01895257|Fluorouracil|fluorouracil|mesh-list
15018058|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
15018059|NCT01895257|Antidotes|antidotes|mesh-ancestor
15018060|NCT01895257|Protective Agents|protective agents|mesh-ancestor
15018061|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018062|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
15018063|NCT01895257|Vitamins|vitamins|mesh-ancestor
15018064|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
15018065|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
15018066|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018067|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14802602|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14802603|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14802604|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802605|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14802606|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
14802607|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802608|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14802609|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14802610|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15018068|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018069|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15018070|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
15018071|NCT01895296|Pasireotide|pasireotide|mesh-list
15018072|NCT01895296|Hormones|hormones|mesh-ancestor
15018073|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018074|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802611|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
14802612|NCT00798083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14802613|NCT00798083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14802614|NCT00798148|Carboplatin|carboplatin|mesh-list
15018075|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
15018076|NCT01895348|Remifentanil|remifentanil|mesh-list
15018077|NCT01895348|Propofol|propofol|mesh-list
15018078|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15018079|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018080|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018081|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15018082|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
15018083|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
15018084|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15018085|NCT01895348|Analgesics|analgesics|mesh-ancestor
15018086|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
15018087|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018088|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15018089|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15018090|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15018091|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
15018092|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018093|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018094|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15018095|NCT01895348|Narcotics|narcotics|mesh-ancestor
15018096|NCT01895400|Cilostazol|cilostazol|mesh-list
15018097|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15018098|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
15018099|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018100|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018101|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15018102|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
15018103|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15018104|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15018105|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018106|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15018107|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
15018108|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15018109|NCT01895400|Protective Agents|protective agents|mesh-ancestor
15018110|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15018111|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15018112|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018113|NCT01895569|Metformin|metformin|mesh-list
15018114|NCT01895569|Pioglitazone|pioglitazone|mesh-list
15018115|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15018116|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15018117|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018118|NCT01895569|Incretins|incretins|mesh-ancestor
15018119|NCT01895569|Hormones|hormones|mesh-ancestor
15018120|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018121|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15018122|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
15018123|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018124|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018125|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
15018126|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
15018127|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018128|NCT01895621|Protective Agents|protective agents|mesh-ancestor
15018129|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018130|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
15018131|NCT01895621|Vitamins|vitamins|mesh-ancestor
15018132|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
15034290|NCT01994668|Lorazepam|lorazepam|mesh-list
15034291|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
15018133|NCT01895764|Adalimumab|adalimumab|mesh-list
15018134|NCT01895764|Methotrexate|methotrexate|mesh-list
15018135|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15018136|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
15018137|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15018138|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018139|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15018140|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
15018141|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018142|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018143|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
15018144|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018145|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15018146|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15018147|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
15018148|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15018149|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15018150|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15018151|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15018152|NCT01895829|Hematinics|hematinics|mesh-ancestor
15018153|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15018154|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15018155|NCT01895881|Estradiol|estradiol|mesh-list
15018156|NCT01895881|Estrogens|estrogens|mesh-ancestor
15018157|NCT01895881|Hormones|hormones|mesh-ancestor
15018158|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018159|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018160|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
15018161|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15018162|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018163|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15018164|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
15018165|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15018166|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018167|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018168|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018169|NCT01895998|Albuterol|albuterol|mesh-list
15018170|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15018171|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
15018172|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018173|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018174|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15018175|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
15018176|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
15018177|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15018178|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15018179|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15018180|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15018181|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
15018182|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018183|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018184|NCT01896011|Teriparatide|teriparatide|mesh-list
15018185|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15018186|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018187|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15018188|NCT01896180|Latanoprost|latanoprost|mesh-list
15018189|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15018190|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15018191|NCT01896245|Sevoflurane|sevoflurane|mesh-list
15018192|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15018193|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15018194|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
15018195|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
15018196|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018197|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018198|NCT01896284|Aflibercept|aflibercept|mesh-list
15018199|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15018200|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15018201|NCT01896284|Growth Substances|growth substances|mesh-ancestor
15018202|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018203|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
15018204|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018205|NCT01896323|Ketoconazole|ketoconazole|mesh-list
15018206|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
15018207|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018208|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15018209|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15018210|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018211|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018212|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15018213|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
15018214|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018215|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018216|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15018217|NCT01896336|Zolpidem|zolpidem|mesh-list
15018218|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15018219|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15018220|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018221|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018222|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15018223|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
15018224|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
15018225|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018226|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018227|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15018228|NCT01896349|Amitriptyline|amitriptyline|mesh-list
15018229|NCT01896349|Risperidone|risperidone|mesh-list
15018230|NCT01896349|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15018231|NCT01896349|Sulpiride|sulpiride|mesh-list
15018232|NCT01896349|Mirtazapine|mirtazapine|mesh-list
15018233|NCT01896349|Trazodone|trazodone|mesh-list
15018234|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
15018235|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
15018236|NCT01896349|Citalopram|citalopram|mesh-list
15018237|NCT01896349|Bupropion|bupropion|mesh-list
15018238|NCT01896349|Sertraline|sertraline|mesh-list
15018239|NCT01896349|Fluoxetine|fluoxetine|mesh-list
15018240|NCT01896349|Paroxetine|paroxetine|mesh-list
15018241|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15018242|NCT01896349|Nortriptyline|nortriptyline|mesh-list
15018243|NCT01896349|Imipramine|imipramine|mesh-list
15018244|NCT01896349|Clomipramine|clomipramine|mesh-list
15018245|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
15018246|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15018247|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
15018248|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018249|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018250|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018251|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15018252|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15018253|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018254|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15018255|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15018256|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
15018257|NCT01896349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15018258|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15018259|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15018260|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15018261|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524781|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14524782|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14524783|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
14524784|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524785|NCT03697252|Xanomeline|xanomeline|mesh-list
14524786|NCT03697252|Trospium chloride|trospium chloride|mesh-list
14524787|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
14524788|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
14524789|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524790|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524791|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14524792|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14524793|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
14524794|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524795|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018262|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15018263|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15018264|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15018265|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018266|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15018267|NCT01896349|Analgesics|analgesics|mesh-ancestor
15018268|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
15018269|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15018270|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
15018271|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
15018272|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15018273|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15018274|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15018275|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15018276|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
15018277|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15018278|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15018279|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15018280|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15018281|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15018282|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15018283|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15018284|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15018285|NCT01896388|Ifenprodil|ifenprodil|mesh-list
15018286|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15018287|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15018288|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
15018289|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018290|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018291|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018292|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
15018293|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15018294|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15018295|NCT01896440|Ondansetron|ondansetron|mesh-list
15018296|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
15018297|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
15018298|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018299|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018300|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15018301|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
15018302|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
15018303|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15018304|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
15018305|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018306|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018307|NCT01896440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15018308|NCT01896440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15018309|NCT01896440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018310|NCT01896440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15018311|NCT01896440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15018312|NCT01896518|Nicotine|nicotine|mesh-list
15018313|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15018314|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
15018315|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018316|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018317|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15018318|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15018319|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
15018320|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018321|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018322|NCT01896609|Interferons|interferons|mesh-list
15018323|NCT01896609|Ribavirin|ribavirin|mesh-list
15018324|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
15018325|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
15018326|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15018327|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
15018328|NCT01896609|Complement Factor H|complement factor h|mesh-list
15018329|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018330|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
15018331|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018332|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
15018333|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018334|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
15018335|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018336|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15018337|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15018338|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15018339|NCT01896622|Ritonavir|ritonavir|mesh-list
15018340|NCT01896622|Cobicistat|cobicistat|mesh-list
15018341|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15018342|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15018343|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
15018344|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018345|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018346|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15018347|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15018348|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
15018349|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018350|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15018351|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15018352|NCT01896661|Amlodipine|amlodipine|mesh-list
15018353|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
15018354|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
15018355|NCT01896661|Amiloride|amiloride|mesh-list
15018356|NCT01896661|Calcium|calcium|mesh-list
15018357|NCT01896661|Diuretics|diuretics|mesh-list
15018358|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15018359|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018360|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15018361|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15018362|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018363|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
15018364|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
15018365|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15018366|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
15018367|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15018368|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15018369|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15018370|NCT01896739|Vaccines|vaccines|mesh-list
15018371|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
15018372|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018373|NCT01896960|Fentanyl|fentanyl|mesh-list
15018374|NCT01896960|Bupivacaine|bupivacaine|mesh-list
15018375|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
15018376|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
15018377|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018378|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018379|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
14802615|NCT00798148|Etoposide|etoposide|mesh-list
14802616|NCT00798148|Melphalan|melphalan|mesh-list
14802617|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802618|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14802619|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14802620|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14802621|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802622|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802623|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15018380|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018381|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15018382|NCT01896960|Narcotics|narcotics|mesh-ancestor
15018383|NCT01896960|Analgesics|analgesics|mesh-ancestor
15018384|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15018385|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15018386|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
15018387|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15018388|NCT01897012|Romidepsin|romidepsin|mesh-list
15018389|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018390|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15018391|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018392|NCT01897038|Sorafenib|sorafenib|mesh-list
15018393|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018394|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15018395|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018396|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018397|NCT01897051|Rifaximin|rifaximin|mesh-list
15018398|NCT01897051|Propranolol|propranolol|mesh-list
15018399|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15018400|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15018401|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
15018402|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018403|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018404|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018405|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15018406|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15018407|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
15018408|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15018409|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018410|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15018411|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
15018412|NCT01897116|Vemurafenib|vemurafenib|mesh-list
15018413|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
15018414|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15018415|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15018416|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018417|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018418|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018419|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15018420|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018421|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15018422|NCT01897324|Hormones|hormones|mesh-list
15018423|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018424|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018425|NCT01897337|Aprepitant|aprepitant|mesh-list
15018426|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
15018427|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
15018428|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018429|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018430|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15018431|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15018432|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018433|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018434|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
15018435|NCT01897428|Salicylates|salicylates|mesh-list
15018436|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15018437|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15018438|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15018439|NCT01897428|Analgesics|analgesics|mesh-ancestor
15018440|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
15018441|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018442|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018443|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15018444|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15018445|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15018446|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018447|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018448|NCT01897441|Paclitaxel|paclitaxel|mesh-list
15018449|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
15018450|NCT01897441|Doxorubicin|doxorubicin|mesh-list
15018451|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15018452|NCT01897441|Trastuzumab|trastuzumab|mesh-list
15018453|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15034292|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
15018454|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15018455|NCT01897441|Antibodies|antibodies|mesh-list
15018456|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
15018457|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15018458|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15018459|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018460|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
15018461|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
15018462|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
15018463|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018464|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15018465|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
15018466|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018467|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15018468|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15018469|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
15018470|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15018471|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15018472|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15018473|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15018474|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018475|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
15018476|NCT01897454|Leucovorin|leucovorin|mesh-list
15018477|NCT01897454|Folic Acid|folic acid|mesh-list
15018478|NCT01897454|Gemcitabine|gemcitabine|mesh-list
15018479|NCT01897454|Fluorouracil|fluorouracil|mesh-list
15018480|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
15018481|NCT01897454|Irinotecan|irinotecan|mesh-list
15018482|NCT01897454|Camptothecin|camptothecin|mesh-list
15018483|NCT01897454|Calcium|calcium|mesh-list
15018484|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
15018485|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15018486|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
15018487|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018488|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018489|NCT01897454|Antiviral Agents|antiviral agents|mesh-ancestor
15018490|NCT01897454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018491|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018492|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15018493|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
15018494|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018495|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15018496|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15018497|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15018498|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15018499|NCT01897454|Antidotes|antidotes|mesh-ancestor
15018500|NCT01897454|Protective Agents|protective agents|mesh-ancestor
15018501|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
15018502|NCT01897454|Vitamins|vitamins|mesh-ancestor
15018503|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
15018504|NCT01897454|Hematinics|hematinics|mesh-ancestor
15018505|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15034293|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
15034294|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034295|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034296|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15034297|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15034298|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034299|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15034300|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15034301|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15034302|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
15034303|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
15034304|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034305|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034306|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
15034307|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
15034308|NCT01994733|Calcium|calcium|mesh-list
15034309|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15034310|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034311|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15034312|NCT01994733|Antacids|antacids|mesh-ancestor
15034313|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034314|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15034315|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
15034316|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15034317|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15034318|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
15034319|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
15034320|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034321|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034322|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15034323|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
15034324|NCT01994759|Hormones|hormones|mesh-ancestor
15034325|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14802624|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
14802625|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14802626|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802627|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
14802628|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802629|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
14802630|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14802631|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802632|NCT00798252|Paclitaxel|paclitaxel|mesh-list
14802633|NCT00798252|Docetaxel|docetaxel|mesh-list
14802634|NCT00798252|Doxorubicin|doxorubicin|mesh-list
14802635|NCT00798252|Capecitabine|capecitabine|mesh-list
14802636|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14802637|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802638|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
14802639|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
15034326|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15034327|NCT01994759|Protective Agents|protective agents|mesh-ancestor
15034328|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
15034329|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15034330|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
15034331|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034332|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15034333|NCT01994941|Clopidogrel|clopidogrel|mesh-list
15034334|NCT01994941|Ticagrelor|ticagrelor|mesh-list
15034335|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15034336|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15034337|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15034338|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15034339|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
14802640|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
14802641|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802642|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14802643|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14802644|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14802645|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802646|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15034340|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802647|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
15034341|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018506|NCT01897636|Vaccines|vaccines|mesh-list
15018507|NCT01897636|Immunologic Factors|immunologic factors|mesh-ancestor
15018508|NCT01897636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018509|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
15018510|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
15018511|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15018512|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15018513|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018514|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018515|NCT01897740|Urological Agents|urological agents|mesh-ancestor
15018516|NCT01897753|Hormones|hormones|mesh-list
15018517|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018518|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018519|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
15018520|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018521|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018522|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15018523|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018524|NCT01897844|Somatostatin|somatostatin|mesh-list
15018525|NCT01897844|Hormones|hormones|mesh-ancestor
15018526|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018527|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018528|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
15018529|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15018530|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018531|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
15018532|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
15018533|NCT01898039|Vaccines|vaccines|mesh-list
15018534|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
15018535|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018536|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15018537|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15018538|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15018539|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
15018540|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018541|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018542|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15018543|NCT01898052|Anesthetics|anesthetics|mesh-list
15018544|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
15018545|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018546|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018547|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
15018548|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
15018549|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018550|NCT01898065|Misonidazole|misonidazole|mesh-list
15018551|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018552|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15018553|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15018554|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018555|NCT01898104|Capecitabine|capecitabine|mesh-list
15018556|NCT01898104|Valproic Acid|valproic acid|mesh-list
15018557|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15018558|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
15018559|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018560|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018561|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
15018562|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018563|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
15018564|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802648|NCT00798343|Vaccines|vaccines|mesh-list
14802649|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
14802650|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802651|NCT00798395|Zopiclone|zopiclone|mesh-list
14802652|NCT00798395|Mirtazapine|mirtazapine|mesh-list
14802653|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14802654|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802655|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802656|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
14802657|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802658|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14802659|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
14802660|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
14802661|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802662|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802663|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15018565|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018566|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
15018567|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15018568|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018569|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15018570|NCT01898169|Nicotine|nicotine|mesh-list
15018571|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15018572|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
14802664|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14802665|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14802666|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14802667|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14802668|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
14802669|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14802670|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14802671|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
15018573|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018574|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018575|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15018576|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15018577|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
15018578|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018579|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018580|NCT01898182|Kinetin|kinetin|mesh-list
15018581|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
15018582|NCT01898182|Growth Substances|growth substances|mesh-ancestor
15018583|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018584|NCT01898221|Ethanol|ethanol|mesh-list
14524796|NCT03697252|Urological Agents|urological agents|mesh-ancestor
14524797|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14524798|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14524799|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14524800|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14524801|NCT03697993|Levofloxacin|levofloxacin|mesh-list
14524802|NCT03697993|Ofloxacin|ofloxacin|mesh-list
14524803|NCT03697993|Fosfomycin|fosfomycin|mesh-list
14524804|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14524805|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524806|NCT03697993|Renal Agents|renal agents|mesh-ancestor
14524807|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14524808|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14524809|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14524810|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524811|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524812|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018585|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15018586|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018587|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018588|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018589|NCT01898338|Daptomycin|daptomycin|mesh-list
15018590|NCT01898338|Fosfomycin|fosfomycin|mesh-list
15018591|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15018592|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018593|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
15018594|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
15018595|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15018596|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018597|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15018598|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
15018599|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15018600|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018601|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018602|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018603|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15018604|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15018605|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15018606|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
15018607|NCT01898494|Carboplatin|carboplatin|mesh-list
15018608|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018609|NCT01898507|Nicotine|nicotine|mesh-list
15018610|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15018611|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
15018612|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018613|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018614|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15018615|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15018616|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
15018617|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018618|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018619|NCT01898520|Nabiximols|nabiximols|mesh-list
15018620|NCT01898520|Analgesics|analgesics|mesh-ancestor
15018621|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
15018622|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018623|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018624|NCT01898585|Vemurafenib|vemurafenib|mesh-list
15018625|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018626|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15018627|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018628|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018629|NCT01898624|Mirabegron|mirabegron|mesh-list
15018630|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15018631|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15018632|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15018633|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
15018634|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018635|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018636|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018637|NCT01898624|Urological Agents|urological agents|mesh-ancestor
15018638|NCT01898676|Valproic Acid|valproic acid|mesh-list
15018639|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
15018640|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018641|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018642|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
15018643|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018644|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018645|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
15018646|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15018647|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018648|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15018649|NCT01898728|Iodine|iodine|mesh-list
15018650|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
15018651|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
15018652|NCT01898728|Povidone|povidone|mesh-list
15018653|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15018654|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15018655|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15018656|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018657|NCT01898728|Trace Elements|trace elements|mesh-ancestor
15018658|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
15018659|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018660|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
15018661|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
15018662|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
15018663|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15018664|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018665|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018666|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15018667|NCT01898819|Analgesics|analgesics|mesh-ancestor
15018668|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
15018669|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018670|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15018671|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15018672|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15018673|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
15018674|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018675|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018676|NCT01898897|Anesthetics|anesthetics|mesh-list
15018677|NCT01898897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018678|NCT01898897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018679|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15018680|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15018681|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15018682|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
15018683|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018684|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15018685|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15018686|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524813|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14524814|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14524815|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
14524816|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14524817|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524818|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14524819|NCT03700892|Protective Agents|protective agents|mesh-ancestor
14524820|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524821|NCT03701061|Vaccines|vaccines|mesh-list
14524822|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
14524823|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018687|NCT01899066|Carboplatin|carboplatin|mesh-list
15018688|NCT01899066|Etoposide|etoposide|mesh-list
15018689|NCT01899066|Vincristine|vincristine|mesh-list
15018690|NCT01899066|Ranibizumab|ranibizumab|mesh-list
15018691|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018692|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15018693|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15018694|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15018695|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018696|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018697|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
15018698|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
15018699|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
15018700|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15018701|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15018702|NCT01899066|Growth Substances|growth substances|mesh-ancestor
15018703|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018704|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
15018705|NCT01899105|Ivacaftor|ivacaftor|mesh-list
15018706|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15018707|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15018708|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018709|NCT01899118|Capecitabine|capecitabine|mesh-list
15018710|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
15018711|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
15018712|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15018713|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
15018714|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018715|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018716|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15018717|NCT01899170|Carfentanil|carfentanil|mesh-list
15018718|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15018719|NCT01899170|Narcotics|narcotics|mesh-ancestor
15018720|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018721|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018722|NCT01899170|Analgesics|analgesics|mesh-ancestor
15018723|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
15018724|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018725|NCT01899248|Sevoflurane|sevoflurane|mesh-list
15018726|NCT01899248|Desflurane|desflurane|mesh-list
14524824|NCT03701074|Acetaminophen|acetaminophen|mesh-list
14524825|NCT03701074|Ibuprofen|ibuprofen|mesh-list
14524826|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14524827|NCT03701074|Analgesics|analgesics|mesh-ancestor
14524828|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
14524829|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524830|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524831|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
14524832|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14524833|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14524834|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14524835|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15018727|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15018728|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15018729|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
15018730|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
15018731|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018732|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034342|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034343|NCT01994967|Bupivacaine|bupivacaine|mesh-list
15034344|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
15034345|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
15034346|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
15034347|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034348|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034349|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
15018733|NCT01899326|Desipramine|desipramine|mesh-list
15018734|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018735|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15018736|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
15018737|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15018738|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018739|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018740|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15018741|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15018742|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15018743|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
15018744|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018745|NCT01899430|Metformin|metformin|mesh-list
15018746|NCT01899430|Liraglutide|liraglutide|mesh-list
15018747|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15018748|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018749|NCT01899430|Incretins|incretins|mesh-ancestor
15018750|NCT01899430|Hormones|hormones|mesh-ancestor
15018751|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018752|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
15018753|NCT01899521|Astringents|astringents|mesh-ancestor
15018754|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018755|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
15018756|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15018757|NCT01899690|Clindamycin|clindamycin|mesh-list
15018758|NCT01899690|Cephalexin|cephalexin|mesh-list
15018759|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018760|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15018761|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018762|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018763|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
15018764|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15018765|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15018766|NCT01899755|Adalimumab|adalimumab|mesh-list
15018767|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15018768|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15018769|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15018770|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15018771|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018772|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
15018773|NCT01899794|Oxybutynin|oxybutynin|mesh-list
15018774|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
15018775|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
15018776|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018777|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018778|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15018779|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15018780|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
15018781|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018782|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018783|NCT01899794|Urological Agents|urological agents|mesh-ancestor
15018784|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15018785|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018786|NCT01899794|Renal Agents|renal agents|mesh-ancestor
15018787|NCT01899820|Lumefantrine|lumefantrine|mesh-list
15018788|NCT01899820|Artemether|artemether|mesh-list
15018789|NCT01899820|Piperaquine|piperaquine|mesh-list
15018790|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15018791|NCT01899820|Artenimol|artenimol|mesh-list
15018792|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
15018793|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15018794|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15018795|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018796|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
15018797|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15018798|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018799|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
15018800|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
15018801|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15018802|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
15018803|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018804|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018805|NCT01899846|Progestins|progestins|mesh-ancestor
15018806|NCT01899846|Hormones|hormones|mesh-ancestor
15018807|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
15018808|NCT01900015|Efavirenz|efavirenz|mesh-list
15018809|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
15018810|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15018811|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15018812|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018813|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018814|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
15018815|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018816|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15018817|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15018818|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15018819|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15018820|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15018821|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15018822|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15018823|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15018824|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15018825|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15018826|NCT01900028|Itraconazole|itraconazole|mesh-list
15018827|NCT01900028|Olaparib|olaparib|mesh-list
15018828|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15018829|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018830|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018831|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018832|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
15018833|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018834|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15018835|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15018836|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15018837|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
15018838|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018839|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018840|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15018841|NCT01900041|Minoxidil|minoxidil|mesh-list
15018842|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15018843|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
15018844|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15018845|NCT01900093|Hormones|hormones|mesh-ancestor
15018846|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018847|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018848|NCT01900106|Ritonavir|ritonavir|mesh-list
15018849|NCT01900106|Darunavir|darunavir|mesh-list
15018850|NCT01900106|Lamivudine|lamivudine|mesh-list
15018851|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
14524836|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524837|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524838|NCT03704376|Clonidine|clonidine|mesh-list
14524839|NCT03704376|Ropivacaine|ropivacaine|mesh-list
14524840|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
14524841|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
14524842|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524843|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524844|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
14524845|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018852|NCT01900106|Abacavir|abacavir|mesh-list
15018853|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
15018854|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15018855|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15018856|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
15018857|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018858|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018859|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15018860|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15018861|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
15018862|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018863|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15018864|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15018865|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15018866|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15018867|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15018868|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15018869|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
15018870|NCT01900158|Gemcitabine|gemcitabine|mesh-list
15018871|NCT01900158|Cisplatin|cisplatin|mesh-list
15018872|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018873|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15018874|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
15018875|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018876|NCT01900158|Antiviral Agents|antiviral agents|mesh-ancestor
15018877|NCT01900158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018878|NCT01900158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018879|NCT01900158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15018880|NCT01900158|Immunologic Factors|immunologic factors|mesh-ancestor
15018881|NCT01900158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018882|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
15018883|NCT01900197|Hematinics|hematinics|mesh-ancestor
15018884|NCT01900301|Scopolamine|scopolamine|mesh-list
15018885|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15018886|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15018887|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
15018888|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
15018889|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018890|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018891|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15018892|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
15018893|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15018894|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
15018895|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018896|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018897|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15018898|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
15018899|NCT01900327|Gemcitabine|gemcitabine|mesh-list
15018900|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15018901|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
15018902|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018903|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018904|NCT01900327|Antiviral Agents|antiviral agents|mesh-ancestor
15018905|NCT01900327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15018906|NCT01900327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018907|NCT01900327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15018908|NCT01900327|Immunologic Factors|immunologic factors|mesh-ancestor
15018909|NCT01900327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018910|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
15018911|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15018912|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018913|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018914|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15018915|NCT01900405|Analgesics|analgesics|mesh-ancestor
15018916|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
14524846|NCT03704376|Analgesics|analgesics|mesh-ancestor
15018917|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018918|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15018919|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15018920|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15018921|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
15018922|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018923|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018924|NCT01900496|Rituximab|rituximab|mesh-list
15018925|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15018926|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15018927|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018928|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
15018929|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018930|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15018931|NCT01900509|Dexamethasone|dexamethasone|mesh-list
15018932|NCT01900509|Etoposide|etoposide|mesh-list
15018933|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
15018934|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15018935|NCT01900509|Clofarabine|clofarabine|mesh-list
15018936|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15018937|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
15018938|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
15018939|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018940|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018941|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15018942|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
15018943|NCT01900509|Hormones|hormones|mesh-ancestor
15018944|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15018945|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15018946|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018947|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15018948|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15018949|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15018950|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018951|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018952|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15018953|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
15018954|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15018955|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
15018956|NCT01900587|Tapentadol|tapentadol|mesh-list
15018957|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15018958|NCT01900587|Narcotics|narcotics|mesh-ancestor
15018959|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15018960|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018961|NCT01900587|Analgesics|analgesics|mesh-ancestor
15018962|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
15018963|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018964|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15018965|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15018966|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15018967|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018968|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
15018969|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15018970|NCT01900639|Aspirin|aspirin|mesh-list
15018971|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15018972|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15018973|NCT01900639|Analgesics|analgesics|mesh-ancestor
15018974|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
15018975|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018976|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018977|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15018978|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15018979|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15018980|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15034350|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15018981|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018982|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15018983|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15018984|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15018985|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
15018986|NCT01900717|Leucovorin|leucovorin|mesh-list
15018987|NCT01900717|Bevacizumab|bevacizumab|mesh-list
15018988|NCT01900717|Fluorouracil|fluorouracil|mesh-list
15018989|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
15018990|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15018991|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15018992|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15018993|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15018994|NCT01900717|Growth Substances|growth substances|mesh-ancestor
15018995|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15018996|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
15018997|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
15018998|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15018999|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15019000|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15019001|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
15019002|NCT01900717|Antidotes|antidotes|mesh-ancestor
15019003|NCT01900717|Protective Agents|protective agents|mesh-ancestor
15019004|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
15019005|NCT01900717|Vitamins|vitamins|mesh-ancestor
15019006|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
15019007|NCT01900795|Ibuprofen|ibuprofen|mesh-list
15019008|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15019009|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15019010|NCT01900795|Analgesics|analgesics|mesh-ancestor
15019011|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
15019012|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019013|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019014|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15019015|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15019016|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15019017|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019018|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019019|NCT01900847|Ketamine|ketamine|mesh-list
15019020|NCT01900847|Morphine|morphine|mesh-list
15019021|NCT01900847|Analgesics|analgesics|mesh-ancestor
15019022|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
15019023|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019024|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019025|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15019026|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15019027|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
15019028|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
15019029|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019030|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15019031|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15019032|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019033|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019034|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15019035|NCT01900847|Narcotics|narcotics|mesh-ancestor
15019036|NCT01900860|Vitamin D|vitamin d|mesh-list
15019037|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
15019038|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
15019039|NCT01900860|Vitamins|vitamins|mesh-list
15019040|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
15019041|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019042|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15019043|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15019044|NCT01900886|Ribavirin|ribavirin|mesh-list
15019045|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15019046|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
15019047|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019048|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
15019049|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034351|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15034352|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15034353|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034354|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
15034355|NCT01995006|Dipyrone|dipyrone|mesh-list
15034356|NCT01995006|Naproxen|naproxen|mesh-list
15034357|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15034358|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15034359|NCT01995006|Analgesics|analgesics|mesh-ancestor
15034360|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
15034361|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034362|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034363|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15034364|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15034365|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
15034366|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15034367|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019050|NCT01900938|Midazolam|midazolam|mesh-list
15019051|NCT01900938|Propofol|propofol|mesh-list
15019052|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15019053|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019054|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019055|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14802672|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14802673|NCT00798460|Lamivudine|lamivudine|mesh-list
14802674|NCT00798460|Adefovir|adefovir|mesh-list
14802675|NCT00798460|Clevudine|clevudine|mesh-list
14802676|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14802677|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14802678|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802679|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019056|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
15019057|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
15019058|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15019059|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15019060|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15019061|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15019062|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
15019063|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
15019064|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019065|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019066|NCT01900951|Temozolomide|temozolomide|mesh-list
15019067|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15019068|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
15019069|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019070|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019071|NCT01901003|Lorazepam|lorazepam|mesh-list
15019072|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
15019073|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
15019074|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
15019075|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524847|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14524848|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
14524849|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
14524850|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15019076|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019077|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15019078|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15019079|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019080|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15019081|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15019082|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15019083|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
15019084|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
15019085|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019086|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019087|NCT01901120|Mirabegron|mirabegron|mesh-list
15019088|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15019089|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15019090|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15019091|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
15019092|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019093|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019094|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019095|NCT01901120|Urological Agents|urological agents|mesh-ancestor
15019096|NCT01901172|Posaconazole|posaconazole|mesh-list
15019097|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
15019098|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019099|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15019100|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15019101|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15019102|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15019103|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15019104|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019105|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019106|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15019107|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
15019108|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15019109|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019110|NCT01901198|Interferons|interferons|mesh-list
15019111|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
15019112|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
15019113|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019114|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
15019115|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019116|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
15019117|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019118|NCT01901276|Omeprazole|omeprazole|mesh-list
15019119|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15019120|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15019121|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15019122|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019123|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019124|NCT01901380|Caseins|caseins|mesh-list
15019125|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
15019126|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
15019127|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019128|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
15019129|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15019130|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019131|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019132|NCT01901471|Cyclosporine|cyclosporine|mesh-list
15019133|NCT01901471|Cyclosporins|cyclosporins|mesh-list
15019134|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019135|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019136|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15019137|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
15019138|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019139|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
15019140|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019141|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
15019142|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15019143|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15019144|NCT01901484|Praziquantel|praziquantel|mesh-list
15019145|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
15019146|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15019147|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019148|NCT01901549|Metoprolol|metoprolol|mesh-list
15019149|NCT01901549|Lisinopril|lisinopril|mesh-list
15019150|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15019151|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15019152|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
15019153|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
15019154|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019155|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019156|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15019157|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15019158|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15019159|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
15019160|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019161|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019162|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14802680|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
14802681|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802682|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14802683|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14802684|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
15019163|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
15019164|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019165|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15019166|NCT01901549|Protective Agents|protective agents|mesh-ancestor
15019167|NCT01901601|Anesthetics|anesthetics|mesh-list
14802685|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14802686|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802687|NCT00798525|Lepirudin|lepirudin|mesh-list
14802688|NCT00798525|Argatroban|argatroban|mesh-list
14802689|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
14802690|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15019168|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019169|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019170|NCT01901640|Udenafil|udenafil|mesh-list
15019171|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15019172|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15019173|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019174|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019175|NCT01901666|Hormones|hormones|mesh-list
15019176|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15019177|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019178|NCT01901692|Sorafenib|sorafenib|mesh-list
15019179|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019180|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15019181|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019182|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019183|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15019184|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15019185|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019186|NCT01901861|Incretins|incretins|mesh-ancestor
15019187|NCT01901861|Hormones|hormones|mesh-ancestor
15019188|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15019189|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15019190|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
15019191|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019192|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019193|NCT01902017|Ketotifen|ketotifen|mesh-list
15019194|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
15019195|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
15019196|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15019197|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
15019198|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
15019199|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019200|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019201|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019202|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15019203|NCT01902108|Clonidine|clonidine|mesh-list
15019204|NCT01902108|Bupivacaine|bupivacaine|mesh-list
15019205|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
15019206|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
15019207|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019208|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019209|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
15019210|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019211|NCT01902108|Analgesics|analgesics|mesh-ancestor
15019212|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15019213|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
15019214|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
15019215|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15019216|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15019217|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15019218|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
15019219|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019220|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019221|NCT01902121|Insulin|insulin|mesh-list
15019222|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15019223|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15019224|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019225|NCT01902160|Sirolimus|sirolimus|mesh-list
15019226|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15019227|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15019228|NCT01902160|Antibodies|antibodies|mesh-list
15019229|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
15019230|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15019231|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
15019232|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
15019233|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019234|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019235|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15019236|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019237|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15019238|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
15019239|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15019240|NCT01902186|Ritonavir|ritonavir|mesh-list
15019241|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15019242|NCT01902186|Tenofovir|tenofovir|mesh-list
15019243|NCT01902186|Emtricitabine|emtricitabine|mesh-list
14524851|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15019244|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
15019245|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15019246|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15019247|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
15019248|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019249|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019250|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15019251|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15019252|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
15019253|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019254|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15019255|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15019256|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15019257|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15019258|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15019259|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15019260|NCT01902225|Doxorubicin|doxorubicin|mesh-list
15019261|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15019262|NCT01902225|Romidepsin|romidepsin|mesh-list
15019263|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15019264|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019265|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15019266|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15019267|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019268|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019269|NCT01902238|Ethanol|ethanol|mesh-list
15019270|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
15019271|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15019272|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019273|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019274|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019275|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019276|NCT01902342|Oseltamivir|oseltamivir|mesh-list
15019277|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
15019278|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019279|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019280|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019281|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
15019282|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15019283|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15019284|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019285|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
15019286|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
15019287|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
15019288|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15019289|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019290|NCT01902498|Aspirin|aspirin|mesh-list
15019291|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15019292|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15019293|NCT01902498|Analgesics|analgesics|mesh-ancestor
15019294|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
15019295|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019296|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019297|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15019298|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15019299|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15019300|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15019301|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019302|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15019303|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15019304|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019305|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
15019306|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
15019307|NCT01902511|Lenograstim|lenograstim|mesh-list
15019308|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15019309|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
15019310|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019311|NCT01902511|Hematinics|hematinics|mesh-ancestor
15019312|NCT01902524|Fentanyl|fentanyl|mesh-list
15019313|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15019314|NCT01902524|Narcotics|narcotics|mesh-ancestor
15019315|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019316|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019317|NCT01902524|Analgesics|analgesics|mesh-ancestor
15019318|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
15019319|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019320|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15019321|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15019322|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
15019323|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
15019324|NCT01902537|Prucalopride|prucalopride|mesh-list
15019325|NCT01902537|Laxatives|laxatives|mesh-ancestor
15019326|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15019327|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
15019328|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15019329|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
15019330|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019331|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019332|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019333|NCT01902550|Metoprolol|metoprolol|mesh-list
15019334|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15019335|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15019336|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
15019337|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
15019338|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019339|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019340|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15019341|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15019342|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15019343|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
15019344|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019345|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019346|NCT01902641|Rocuronium|rocuronium|mesh-list
15019347|NCT01902641|Succinylcholine|succinylcholine|mesh-list
15019348|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15019349|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15019350|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15019351|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019352|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019353|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
15034368|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034369|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
15034370|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
15034371|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15034372|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15034373|NCT01995019|Prednisolone|prednisolone|mesh-list
15034374|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
15034375|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15034376|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
15034377|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15034378|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
15034379|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
15034380|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034381|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034382|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15034383|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
15034384|NCT01995019|Hormones|hormones|mesh-ancestor
15034385|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15034386|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15034387|NCT01995019|Protective Agents|protective agents|mesh-ancestor
15034388|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15034389|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034390|NCT01995032|Metformin|metformin|mesh-list
15034391|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15034392|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034393|NCT01995058|Prednisone|prednisone|mesh-list
15034394|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
15034395|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15034396|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
15019354|NCT01902771|Imiquimod|imiquimod|mesh-list
15019355|NCT01902771|Vaccines|vaccines|mesh-list
15019356|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
15019357|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019358|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15019359|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019360|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
15019361|NCT01902810|Propranolol|propranolol|mesh-list
15019362|NCT01902810|Metoprolol|metoprolol|mesh-list
15019363|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15019364|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15019365|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
15019366|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019367|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019368|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019369|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13967954|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13967955|NCT03113448|Capsaicin|capsaicin|mesh-list
13967956|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
13967957|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
13967958|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
13967959|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802691|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
15019370|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15019371|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
15019372|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
15019373|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
15019374|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524852|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14524853|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
14524854|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524855|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802692|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802693|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802694|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
14802695|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14802696|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14802697|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14802698|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
15019375|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13967960|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524856|NCT03704467|Carboplatin|carboplatin|mesh-list
14524857|NCT03704467|Avelumab|avelumab|mesh-list
14524858|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524859|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14524860|NCT03705273|Dexamethasone|dexamethasone|mesh-list
14524861|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
14524862|NCT03705273|BB 1101|bb 1101|mesh-list
14524863|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14524864|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
14802699|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14802700|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14524865|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
14524866|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524867|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524868|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14524869|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
14524870|NCT03705273|Hormones|hormones|mesh-ancestor
14524871|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14524872|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14524873|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524874|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
14802701|NCT00798616|Prednisolone|prednisolone|mesh-list
14802702|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
14802703|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14802704|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
14802705|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14802706|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
14802707|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
14802708|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019376|NCT01902862|Rituximab|rituximab|mesh-list
15019377|NCT01902862|Bortezomib|bortezomib|mesh-list
15019378|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15019379|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019380|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
15019381|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019382|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15019383|NCT01902875|Paclitaxel|paclitaxel|mesh-list
15019384|NCT01902875|Cisplatin|cisplatin|mesh-list
15019385|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15019386|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019387|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
15019388|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
15019389|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
15019390|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019391|NCT01903018|Cisplatin|cisplatin|mesh-list
15019392|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019393|NCT01903057|Azithromycin|azithromycin|mesh-list
15019394|NCT01903057|Ivermectin|ivermectin|mesh-list
15019395|NCT01903057|Albendazole|albendazole|mesh-list
15019396|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15019397|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019398|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15019399|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
15019400|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
15019401|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15019402|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15019403|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
15019404|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
15019405|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
15019406|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019407|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019408|NCT01903070|Linagliptin|linagliptin|mesh-list
15019409|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15019410|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524875|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524876|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524877|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
14524878|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14524879|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
14524880|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14524881|NCT03706313|Bupivacaine|bupivacaine|mesh-list
14524882|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
14524883|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
14524884|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524885|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019411|NCT01903070|Incretins|incretins|mesh-ancestor
15019412|NCT01903070|Hormones|hormones|mesh-ancestor
15019413|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15019414|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15019415|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
15019416|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019417|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019418|NCT01903083|Gemcitabine|gemcitabine|mesh-list
15019419|NCT01903083|Tadalafil|tadalafil|mesh-list
15019420|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15019421|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
15019422|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019423|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019424|NCT01903083|Antiviral Agents|antiviral agents|mesh-ancestor
15019425|NCT01903083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019426|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019427|NCT01903083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15019428|NCT01903083|Immunologic Factors|immunologic factors|mesh-ancestor
15019429|NCT01903083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019430|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
15019431|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15019432|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15019433|NCT01903083|Urological Agents|urological agents|mesh-ancestor
15019434|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
15019435|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15019436|NCT01903109|Cevimeline|cevimeline|mesh-list
15019437|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15019438|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
15019439|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019440|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019441|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15019442|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15019443|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
15019444|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019445|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019446|NCT01903122|Cevimeline|cevimeline|mesh-list
15019447|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15019448|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
14524886|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
15019449|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019450|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019451|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15019452|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15019453|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
15019454|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019455|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019456|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15019457|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
15019458|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15019459|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15019460|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15019461|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019462|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019463|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15019464|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
15019465|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019466|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15019467|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
15019468|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15019469|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
15019470|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019471|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
15019472|NCT01903330|Bevacizumab|bevacizumab|mesh-list
15019473|NCT01903330|Sargramostim|sargramostim|mesh-list
15019474|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15019475|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
15019476|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019477|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15019478|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15019479|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
15019480|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019481|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019482|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15019483|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15019484|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15019485|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15019486|NCT01903330|Growth Substances|growth substances|mesh-ancestor
15019487|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
15019488|NCT01903421|Fentanyl|fentanyl|mesh-list
15019489|NCT01903421|Bupivacaine|bupivacaine|mesh-list
15019490|NCT01903421|Anesthetics|anesthetics|mesh-list
15019491|NCT01903421|Propofol|propofol|mesh-list
15019492|NCT01903421|Sevoflurane|sevoflurane|mesh-list
15019493|NCT01903421|Isoflurane|isoflurane|mesh-list
15019494|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
15019495|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019496|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019497|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
15019498|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019499|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15019500|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15019501|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
15019502|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15019503|NCT01903421|Narcotics|narcotics|mesh-ancestor
15019504|NCT01903421|Analgesics|analgesics|mesh-ancestor
15019505|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15019506|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15019507|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15019508|NCT01903473|Sirolimus|sirolimus|mesh-list
15019509|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15019510|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019511|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15019512|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019513|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
15019514|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15019515|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
15019516|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019517|NCT01903681|Melatonin|melatonin|mesh-list
15019518|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
15019519|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019520|NCT01903681|Protective Agents|protective agents|mesh-ancestor
15019521|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019522|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019523|NCT01903694|Sorafenib|sorafenib|mesh-list
15019524|NCT01903694|Pravastatin|pravastatin|mesh-list
15019525|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019526|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15019527|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019528|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019529|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15019530|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15019531|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
15019532|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15019533|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15019534|NCT01903785|Albuterol|albuterol|mesh-list
15019535|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15019536|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
15019537|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019538|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019539|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15019540|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
15019541|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
15019542|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15019543|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15019544|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15019545|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15019546|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
15019547|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019548|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019549|NCT01903824|Modafinil|modafinil|mesh-list
15019550|NCT01903824|Donepezil|donepezil|mesh-list
15019551|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15019552|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019553|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019554|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
15019555|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019556|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019557|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
15019558|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15019559|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15019560|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15019561|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15019562|NCT01904045|Tacrolimus|tacrolimus|mesh-list
15019563|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802709|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802710|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14802711|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
14802712|NCT00798616|Hormones|hormones|mesh-ancestor
14802713|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14802714|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14802715|NCT00798616|Protective Agents|protective agents|mesh-ancestor
14802716|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14802717|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802718|NCT00798772|Micronutrients|micronutrients|mesh-list
14802719|NCT00798772|Trace Elements|trace elements|mesh-list
14802720|NCT00798772|Antioxidants|antioxidants|mesh-list
14802721|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802722|NCT00798772|Protective Agents|protective agents|mesh-ancestor
14802723|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802724|NCT00798785|Rituximab|rituximab|mesh-list
14802725|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14802726|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802727|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
14802728|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802729|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15019564|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
15019565|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019566|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15019567|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019568|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019569|NCT01904097|Pregabalin|pregabalin|mesh-list
15019570|NCT01904097|Analgesics|analgesics|mesh-ancestor
15019571|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
15019572|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019573|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019574|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
15019575|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15019576|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15019577|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019578|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15019579|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15019580|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15019581|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019582|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15019583|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
15019584|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
15019585|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
15019586|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15019587|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019588|NCT01904110|Vitamins|vitamins|mesh-ancestor
15019589|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
15019590|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15019591|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15019592|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15019593|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019594|NCT01904162|Finafloxacin|finafloxacin|mesh-list
15019595|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15019596|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019597|NCT01904162|Renal Agents|renal agents|mesh-ancestor
15019598|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15019599|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15019600|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15019601|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524887|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529856|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
14529857|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529858|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529859|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14529860|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14529861|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14529862|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529863|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
14529864|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529865|NCT03591458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14802730|NCT00798876|Vitamin E|vitamin e|mesh-list
14802731|NCT00798876|Vitamins|vitamins|mesh-ancestor
14802732|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
14802733|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802734|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
14802735|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802736|NCT00798876|Protective Agents|protective agents|mesh-ancestor
14802737|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
14802738|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14802739|NCT00798915|Incretins|incretins|mesh-ancestor
14802740|NCT00798915|Hormones|hormones|mesh-ancestor
14802741|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14802742|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802743|NCT00798954|Sirolimus|sirolimus|mesh-list
14802744|NCT00798954|Paclitaxel|paclitaxel|mesh-list
14802745|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14802746|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802747|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
15019602|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019603|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019604|NCT01904214|Siponimod|siponimod|mesh-list
15019605|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15019606|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019607|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15019608|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
15019609|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019610|NCT01904253|Topotecan|topotecan|mesh-list
15019611|NCT01904253|Amrubicin|amrubicin|mesh-list
15019612|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15019613|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15019614|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019615|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019616|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019617|NCT01904357|Cefazolin|cefazolin|mesh-list
15019618|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15019619|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034397|NCT01995058|Hormones|hormones|mesh-ancestor
15034398|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15034399|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034400|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15034401|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034402|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15034403|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034404|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034405|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
15034406|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15034407|NCT01995084|Imidazole|imidazole|mesh-list
15034408|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034409|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035540|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15035541|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15035542|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
15035543|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035544|NCT02001948|Morphine|morphine|mesh-list
15035545|NCT02001948|Bupivacaine|bupivacaine|mesh-list
15035546|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
15035547|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
15035548|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802748|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
14802749|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
14802750|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802751|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15035549|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802752|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802753|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14802754|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
14802755|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15019620|NCT01904487|Tiagabine|tiagabine|mesh-list
15019621|NCT01904487|Flumazenil|flumazenil|mesh-list
15019622|NCT01904487|Antidotes|antidotes|mesh-ancestor
15019623|NCT01904487|Protective Agents|protective agents|mesh-ancestor
15019624|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019625|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
15019626|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
15019627|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019628|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019629|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
15019630|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
15019631|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15019632|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15019633|NCT01904500|Cefazolin|cefazolin|mesh-list
15019634|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15019635|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019636|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
15019637|NCT01904539|Cathartics|cathartics|mesh-ancestor
15019638|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15019639|NCT01904591|Vitamin E|vitamin e|mesh-list
15019640|NCT01904591|Selenium|selenium|mesh-list
15019641|NCT01904591|Vitamins|vitamins|mesh-ancestor
15019642|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
15019643|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019644|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
15019645|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019646|NCT01904591|Protective Agents|protective agents|mesh-ancestor
15019647|NCT01904591|Trace Elements|trace elements|mesh-ancestor
15019648|NCT01904643|Cytarabine|cytarabine|mesh-list
15019649|NCT01904643|Etoposide|etoposide|mesh-list
15019650|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
15019651|NCT01904643|Lenalidomide|lenalidomide|mesh-list
15019652|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
15019653|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15019654|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019655|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15019656|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15019657|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019658|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019659|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15019660|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
15019661|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
15019662|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019663|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15019664|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
15019665|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019666|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15019667|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14524888|NCT03708211|Esomeprazole|esomeprazole|mesh-list
14524889|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14524890|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14524891|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14524892|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524893|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524894|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
14524895|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
14524896|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14524897|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14524898|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
14524899|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524900|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524901|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019668|NCT01904643|Growth Substances|growth substances|mesh-ancestor
15019669|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
15019670|NCT01904643|Analgesics|analgesics|mesh-ancestor
15019671|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
15019672|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019673|NCT01904682|ON 01910|on 01910|mesh-list
15019674|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019675|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15019676|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019677|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019678|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
15019679|NCT01904695|Diuretics|diuretics|mesh-list
15019680|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15019681|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
15019682|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
15019683|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019684|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
15019685|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019686|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019687|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15019688|NCT01904734|Clomiphene|clomiphene|mesh-list
15019689|NCT01904734|Enclomiphene|enclomiphene|mesh-list
15019690|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
15019691|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15019692|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
15019693|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15019694|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019695|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15019696|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
15019697|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15019698|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15019699|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15019700|NCT01904747|Palbociclib|palbociclib|mesh-list
15019701|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019702|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15019703|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019704|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019705|NCT01904786|Melatonin|melatonin|mesh-list
15019706|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
15019707|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019708|NCT01904786|Protective Agents|protective agents|mesh-ancestor
15019709|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019710|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019711|NCT01904981|Atenolol|atenolol|mesh-list
15019712|NCT01904981|Valsartan|valsartan|mesh-list
15019713|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
15019714|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15019715|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15019716|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15019717|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019718|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15019719|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
15019720|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019721|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019722|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15019723|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
15019724|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
15019725|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019726|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13967961|NCT03113500|Prednisone|prednisone|mesh-list
13967962|NCT03113500|Cortisone|cortisone|mesh-list
13967963|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
13967964|NCT03113500|Doxorubicin|doxorubicin|mesh-list
13967965|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13967966|NCT03113500|Etoposide|etoposide|mesh-list
13967967|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
13967968|NCT03113500|Daunorubicin|daunorubicin|mesh-list
13967969|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
13967970|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
13967971|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13967972|NCT03113500|Antibodies|antibodies|mesh-list
13967973|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
13967974|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13967975|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
13967976|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13967977|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
13967978|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019727|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15019728|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
15019729|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019730|NCT01905059|Lamivudine|lamivudine|mesh-list
15019731|NCT01905059|Lopinavir|lopinavir|mesh-list
15019732|NCT01905059|Darunavir|darunavir|mesh-list
15019733|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
15019734|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
15019735|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15019736|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15019737|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019738|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019739|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
15019740|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019741|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13967979|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13967980|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13967981|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
15019742|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15019743|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15019744|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15019745|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15019746|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
15019747|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15019748|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15019749|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15019750|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15019751|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019752|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
15019753|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019754|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019755|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15019756|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019757|NCT01905150|Leucovorin|leucovorin|mesh-list
14524902|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524903|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14524904|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524905|NCT03710161|Vitamin D|vitamin d|mesh-list
14524906|NCT03710161|Vitamins|vitamins|mesh-ancestor
14524907|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
14524908|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019758|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
13967982|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13967983|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13967984|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13967985|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13967986|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13967987|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13967988|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967989|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13967990|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
13967991|NCT03113500|Hormones|hormones|mesh-ancestor
13967992|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13967993|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13967994|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15019759|NCT01905150|Gemcitabine|gemcitabine|mesh-list
15019760|NCT01905150|Fluorouracil|fluorouracil|mesh-list
15019761|NCT01905150|Docetaxel|docetaxel|mesh-list
15019762|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
15019763|NCT01905150|Irinotecan|irinotecan|mesh-list
15019764|NCT01905150|Mitomycins|mitomycins|mesh-list
15019765|NCT01905150|Mitomycin|mitomycin|mesh-list
15019766|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
15019767|NCT01905150|Vitamins|vitamins|mesh-ancestor
15019768|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
15019769|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019770|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15019771|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
15019772|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019773|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019774|NCT01905150|Antiviral Agents|antiviral agents|mesh-ancestor
15019775|NCT01905150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019776|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019777|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15019778|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
15019779|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
15019780|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
15019781|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
15019782|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15019783|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15019784|NCT01905150|Antidotes|antidotes|mesh-ancestor
15019785|NCT01905150|Protective Agents|protective agents|mesh-ancestor
15019786|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
15019787|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
15019788|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15019789|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
15019790|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15019791|NCT01905215|Vaccines|vaccines|mesh-list
15019792|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
15019793|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019794|NCT01905371|Amphetamine|amphetamine|mesh-list
15019795|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
15019796|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15019797|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019798|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
15019799|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
15019800|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019801|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
15019802|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019803|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019804|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
15019805|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15019806|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15019807|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15019808|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15019809|NCT01905501|Anesthetics|anesthetics|mesh-list
15019810|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019811|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019812|NCT01905566|Clopidogrel|clopidogrel|mesh-list
15019813|NCT01905566|Ticagrelor|ticagrelor|mesh-list
15019814|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15019815|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15019816|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15019817|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15019818|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
15019819|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019820|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019821|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019822|NCT01905618|Nicotine|nicotine|mesh-list
15019823|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15019824|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
15019825|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034410|NCT01995188|Bevacizumab|bevacizumab|mesh-list
15019826|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019827|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15019828|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15019829|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
15019830|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019831|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019832|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
15019833|NCT01905631|Promethazine|promethazine|mesh-list
15019834|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15019835|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15019836|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019837|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019838|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
15019839|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
15019840|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
15019841|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019842|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
15019843|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
15019844|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15019845|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15019846|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
15019847|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
15019848|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019849|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019850|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15019851|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
15019852|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
15019853|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
15019854|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15019855|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
15019856|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019857|NCT01905696|Expectorants|expectorants|mesh-ancestor
15019858|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
15019859|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15019860|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
15019861|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019862|NCT01905696|Protective Agents|protective agents|mesh-ancestor
15019863|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019864|NCT01905696|Antidotes|antidotes|mesh-ancestor
15019865|NCT01905774|Deferasirox|deferasirox|mesh-list
15019866|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15019867|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
15019868|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
15019869|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019870|NCT01905904|Sevoflurane|sevoflurane|mesh-list
15019871|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15019872|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15019873|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
15019874|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
15019875|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019876|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019877|NCT01906073|Fentanyl|fentanyl|mesh-list
15019878|NCT01906073|Morphine|morphine|mesh-list
15019879|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15019880|NCT01906073|Narcotics|narcotics|mesh-ancestor
15019881|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019882|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524909|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14524910|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
14524911|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14524912|NCT03710590|Nicotine|nicotine|mesh-list
14524913|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14524914|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
14524915|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524916|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524917|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15019883|NCT01906073|Analgesics|analgesics|mesh-ancestor
15019884|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
15019885|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019886|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15019887|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15019888|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
15019889|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
15019890|NCT01906125|Palbociclib|palbociclib|mesh-list
15019891|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019892|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15019893|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019894|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034411|NCT01995188|Carboplatin|carboplatin|mesh-list
15034412|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15034413|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034414|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15034415|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15034416|NCT01995188|Growth Substances|growth substances|mesh-ancestor
15034417|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034418|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
15034419|NCT01995214|Propofol|propofol|mesh-list
15034420|NCT01995214|Sevoflurane|sevoflurane|mesh-list
15034421|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15034422|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034423|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524918|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14524919|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
14524920|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524921|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524922|NCT03710889|Abaloparatide|abaloparatide|mesh-list
14524923|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14524924|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034424|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15034425|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
15034426|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
15034427|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15034428|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15034429|NCT01995292|Anesthetics|anesthetics|mesh-list
15034430|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
15034431|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034432|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034433|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
15034434|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034435|NCT01995331|Cyclosporine|cyclosporine|mesh-list
15034436|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
15034437|NCT01995331|Cyclosporins|cyclosporins|mesh-list
15034438|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15034439|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
15034440|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034441|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15034442|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15034443|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
15034444|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034445|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019895|NCT01906216|Sorafenib|sorafenib|mesh-list
15019896|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019897|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15019898|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019899|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019900|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
14802756|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
14802757|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802758|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
14802759|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14802760|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
14802761|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14802762|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019901|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15019902|NCT01906242|Eusol|eusol|mesh-list
15019903|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15019904|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019905|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
15019906|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15019907|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019908|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
14524925|NCT03711578|Tenalisib|tenalisib|mesh-list
14524926|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
14524927|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524928|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524929|NCT03712280|Rifaximin|rifaximin|mesh-list
14524930|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
14524931|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14524932|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14524933|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14524934|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14524935|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
14524936|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524937|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524938|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14524939|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14524940|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14524941|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524942|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524943|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14524944|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524945|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802763|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14802764|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14802765|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15019909|NCT01906307|Giapreza|giapreza|mesh-list
15019910|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15019911|NCT01906411|Dopamine|dopamine|mesh-list
15019912|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15019913|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
15019914|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
15019915|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019916|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019917|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
15019918|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019919|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802766|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
14802767|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
14802768|NCT00798993|Calcifediol|calcifediol|mesh-list
15019920|NCT01906411|Protective Agents|protective agents|mesh-ancestor
15019921|NCT01906450|Azithromycin|azithromycin|mesh-list
15019922|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15019923|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019924|NCT01906528|Mivacurium|mivacurium|mesh-list
15019925|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15019926|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15019927|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15019928|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524946|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
14524947|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15019929|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019930|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15019931|NCT01906580|Entecavir|entecavir|mesh-list
15019932|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
15019933|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019934|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
15019935|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
15019936|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019937|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15019938|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019939|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15019940|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
15019941|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019942|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14524948|NCT03712917|Topiramate|topiramate|mesh-list
14524949|NCT03712917|Flunarizine|flunarizine|mesh-list
14524950|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
14524951|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14524952|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524953|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14524954|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14524955|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524956|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14524957|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14524958|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
14524959|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
14524960|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14524961|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
14524962|NCT03714022|Abatacept|abatacept|mesh-list
14524963|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14524964|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524965|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14524966|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14524967|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
14524968|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524969|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14524970|NCT03714672|Diclofenac|diclofenac|mesh-list
14524971|NCT03714672|Tramadol|tramadol|mesh-list
14524972|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14524973|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14524974|NCT03714672|Analgesics|analgesics|mesh-ancestor
14524975|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
14524976|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524977|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524978|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14524979|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14524980|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14524981|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14524982|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14524983|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15019943|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019944|NCT01906749|Colchicine|colchicine|mesh-list
15019945|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
15019946|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15019947|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
15019948|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
15019949|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
15019950|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019951|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019952|NCT01906762|Acetaminophen|acetaminophen|mesh-list
15019953|NCT01906762|Morphine|morphine|mesh-list
15019954|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15019955|NCT01906762|Narcotics|narcotics|mesh-ancestor
15019956|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15019957|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019958|NCT01906762|Analgesics|analgesics|mesh-ancestor
15019959|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
15019960|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15019961|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15019962|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
15019963|NCT01906788|Lumefantrine|lumefantrine|mesh-list
14802769|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14802770|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802771|NCT00798993|Vitamins|vitamins|mesh-ancestor
14802772|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
14802773|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14802774|NCT00799045|Clopidogrel|clopidogrel|mesh-list
14802775|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14802776|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14802777|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14802778|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15019964|NCT01906788|Artemether|artemether|mesh-list
15019965|NCT01906788|Primaquine|primaquine|mesh-list
15019966|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15019967|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
15019968|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15019969|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15019970|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15019971|NCT01906801|Diacetylrhein|diacetylrhein|mesh-list
15019972|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15019973|NCT01906814|Carboplatin|carboplatin|mesh-list
15019974|NCT01906814|Etoposide|etoposide|mesh-list
15019975|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
15019976|NCT01906814|Vincristine|vincristine|mesh-list
15019977|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15019978|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15019979|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15019980|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15019981|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15019982|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019983|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
15019984|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
15019985|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
15019986|NCT01906853|Vaccines|vaccines|mesh-list
15019987|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
15019988|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
15019989|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15019990|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15019991|NCT01906879|Bismuth|bismuth|mesh-list
15019992|NCT01906879|Antacids|antacids|mesh-ancestor
14802779|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
15019993|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15019994|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15019995|NCT01906944|Triamcinolone|triamcinolone|mesh-list
15019996|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15019997|NCT01906944|Bupivacaine|bupivacaine|mesh-list
15019998|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
15019999|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
15020000|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15020001|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020002|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
15020003|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020004|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15020005|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
15020006|NCT01906944|Hormones|hormones|mesh-ancestor
15020007|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15020008|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020009|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
15020010|NCT01907009|Melphalan|melphalan|mesh-list
15020011|NCT01907009|Lenograstim|lenograstim|mesh-list
15020012|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15020013|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
15020014|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020015|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020016|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15020017|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020018|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
15020019|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020020|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15020021|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
15020022|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15020023|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
15020024|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15020025|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
15020026|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020027|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020028|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
15020029|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
15020030|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15020031|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
15020032|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020033|NCT01907061|Expectorants|expectorants|mesh-ancestor
15020034|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
15020035|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15020036|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
15020037|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020038|NCT01907061|Protective Agents|protective agents|mesh-ancestor
15020039|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020040|NCT01907061|Antidotes|antidotes|mesh-ancestor
15020041|NCT01907165|Copper|copper|mesh-list
15020042|NCT01907165|Temozolomide|temozolomide|mesh-list
15020043|NCT01907165|Disulfiram|disulfiram|mesh-list
15020044|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15020045|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
15020046|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020047|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020048|NCT01907165|Trace Elements|trace elements|mesh-ancestor
15020049|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
15020050|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020051|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15020052|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
15020053|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020054|NCT01907191|Bupivacaine|bupivacaine|mesh-list
15020055|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
15020056|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
15020057|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15020058|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020059|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
15020060|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020061|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
15020062|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15020063|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15020064|NCT01907204|Prednisolone|prednisolone|mesh-list
15020065|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
15020066|NCT01907204|Budesonide|budesonide|mesh-list
15020067|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15020068|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
15020069|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15020070|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
15020071|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
15020072|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020073|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020074|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15020075|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
15020076|NCT01907204|Hormones|hormones|mesh-ancestor
15020077|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15020078|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15020079|NCT01907204|Protective Agents|protective agents|mesh-ancestor
15020080|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15020081|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020082|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15020083|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15020084|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
15020085|NCT01907230|Entecavir|entecavir|mesh-list
15020086|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
15020087|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020088|NCT01907308|Docetaxel|docetaxel|mesh-list
15020089|NCT01907308|Trebananib|trebananib|mesh-list
15020090|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020091|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
15020092|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
15020093|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
15020094|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020095|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15020096|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15020097|NCT01907308|Growth Substances|growth substances|mesh-ancestor
15020098|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020099|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
15020100|NCT01907373|Probenecid|probenecid|mesh-list
15020101|NCT01907373|Olmesartan|olmesartan|mesh-list
15020102|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
15020103|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15020104|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15020105|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15020106|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020107|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
15020108|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
15020109|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15020110|NCT01907373|Renal Agents|renal agents|mesh-ancestor
15020111|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
15020112|NCT01907529|Docetaxel|docetaxel|mesh-list
15020113|NCT01907529|Epirubicin|epirubicin|mesh-list
15020114|NCT01907529|Endostar protein|endostar protein|mesh-list
15020115|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020116|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
15020117|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020118|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15020119|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15020120|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
15020121|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020122|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020123|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15020124|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
15020125|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
15020126|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
15020127|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15020128|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15020129|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15020130|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020131|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15020132|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15020133|NCT01907529|Growth Substances|growth substances|mesh-ancestor
15020134|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
15020135|NCT01907594|Cycloserine|cycloserine|mesh-list
15020136|NCT01907594|Nicotine|nicotine|mesh-list
15020137|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15020138|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
15020139|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020140|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020141|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15020142|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15020143|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
15020144|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020145|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020146|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15020147|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020148|NCT01907594|Renal Agents|renal agents|mesh-ancestor
15020149|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15020150|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
15020151|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15020152|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
15020153|NCT01907633|Domperidone|domperidone|mesh-list
15020154|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
15020155|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
15020156|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020157|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020158|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15020159|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15020160|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
15020161|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020162|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020163|NCT01907685|Docetaxel|docetaxel|mesh-list
15020164|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020165|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
15020166|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
15020167|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
15034446|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15020168|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034447|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034448|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
15034449|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034450|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
15034451|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15034452|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
15034453|NCT01995344|Fludarabine|fludarabine|mesh-list
15034454|NCT01995344|Interleukin-2|interleukin-2|mesh-list
15034455|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15034456|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
15034457|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034458|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15034459|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15034460|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
15034461|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034462|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034463|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15034464|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15034465|NCT01995344|Analgesics|analgesics|mesh-ancestor
15034466|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
15034467|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034468|NCT01995370|Aspirin|aspirin|mesh-list
15034469|NCT01995370|Cilostazol|cilostazol|mesh-list
15034470|NCT01995370|Clopidogrel|clopidogrel|mesh-list
15020169|NCT01907724|Simeprevir|simeprevir|mesh-list
15020170|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
15020171|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020172|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
15020173|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020174|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020175|NCT01907776|Arbekacin|arbekacin|mesh-list
15020176|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15020177|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020178|NCT01907802|Dabrafenib|dabrafenib|mesh-list
15020179|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020180|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15020181|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020182|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020183|NCT01907867|Finafloxacin|finafloxacin|mesh-list
15020184|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15020185|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020186|NCT01907867|Renal Agents|renal agents|mesh-ancestor
15020187|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15020188|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15020189|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15020190|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020191|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020192|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020193|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
15020194|NCT01907880|Pamidronate|pamidronate|mesh-list
15020195|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15020196|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020197|NCT01907984|Diclofenac|diclofenac|mesh-list
15020198|NCT01907984|Midazolam|midazolam|mesh-list
15020199|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15020200|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15020201|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15020202|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020203|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15020204|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15020205|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15020206|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15020207|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
15020208|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
15020209|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
15020210|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
15020211|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020212|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020213|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15020214|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15020215|NCT01907984|Analgesics|analgesics|mesh-ancestor
15020216|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
15020217|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020218|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15020219|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15020220|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15020221|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020222|NCT01907997|Lidocaine|lidocaine|mesh-list
15020223|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
15020224|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
15020225|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15020226|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020227|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
15020228|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020229|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15020230|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15020231|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15020232|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15020233|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020234|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15020235|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15020236|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
15020237|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020238|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020239|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15020240|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
15020241|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
15020242|NCT01908075|Hormones|hormones|mesh-ancestor
15020243|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15020244|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
15020245|NCT01908114|Vaccines|vaccines|mesh-list
15020246|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
15020247|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020248|NCT01908257|Lesinurad|lesinurad|mesh-list
15020249|NCT01908257|Ranitidine|ranitidine|mesh-list
15020250|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
15020251|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15020252|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15020253|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15020254|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
15020255|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
15020256|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020257|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020258|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020259|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
15020260|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15020261|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
15020262|NCT01908257|Renal Agents|renal agents|mesh-ancestor
15020263|NCT01908283|Vaccines|vaccines|mesh-list
15020264|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
15020265|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020266|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15020267|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
15020268|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
15020269|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15020270|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15020271|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15020272|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15020273|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020274|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15020275|NCT01908296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15020276|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15020277|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15020278|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020279|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020280|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
15020281|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15020282|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15020283|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15020284|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020285|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15020286|NCT01908322|Sorafenib|sorafenib|mesh-list
15020287|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020288|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15020289|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020290|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020291|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15020292|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
15020293|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
15020294|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020295|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
15020296|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020297|NCT01908348|Erythritol|erythritol|mesh-list
15020298|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
15020299|NCT01908387|Azacitidine|azacitidine|mesh-list
15020300|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15020301|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
15020302|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020303|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020304|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020305|NCT01908452|Pyridoxine|pyridoxine|mesh-list
15020306|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
15020307|NCT01908452|Vitamins|vitamins|mesh-ancestor
15020308|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
15020309|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020310|NCT01908465|Ebastine|ebastine|mesh-list
15020311|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15020312|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
15020313|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
15020314|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020315|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020316|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020317|NCT01908478|Gemcitabine|gemcitabine|mesh-list
15020318|NCT01908478|Veliparib|veliparib|mesh-list
15020319|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15020320|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
15020321|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020322|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020323|NCT01908478|Antiviral Agents|antiviral agents|mesh-ancestor
15020324|NCT01908478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020325|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020326|NCT01908478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020327|NCT01908478|Immunologic Factors|immunologic factors|mesh-ancestor
15020328|NCT01908478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020329|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15020330|NCT01908556|Letrozole|letrozole|mesh-list
15020331|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020332|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15020333|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15020334|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020335|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020336|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15020337|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
15020338|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15020339|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020340|NCT01908621|Cytarabine|cytarabine|mesh-list
15020341|NCT01908621|Lenograstim|lenograstim|mesh-list
15020342|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15020343|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
15020344|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967995|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
15020345|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15020346|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
15020347|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020348|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020349|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
15020350|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020351|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020352|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15020353|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
15020354|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020355|NCT01908777|Cytarabine|cytarabine|mesh-list
15020356|NCT01908777|Etoposide|etoposide|mesh-list
15020357|NCT01908777|Melphalan|melphalan|mesh-list
15020358|NCT01908777|Carmustine|carmustine|mesh-list
15020359|NCT01908777|Romidepsin|romidepsin|mesh-list
15020360|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15020361|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020362|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15020363|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15020364|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020365|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020366|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15020367|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
15020368|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
15020369|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020370|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020371|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
15020372|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020373|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15020374|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
15020375|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15020376|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15020377|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
15020378|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15020379|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020380|NCT01909037|Curcumin|curcumin|mesh-list
15020381|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15020382|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15020383|NCT01909037|Analgesics|analgesics|mesh-ancestor
15020384|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
15020385|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020386|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020387|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15020388|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15020389|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020390|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020391|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020392|NCT01909063|Vitamin D|vitamin d|mesh-list
15020393|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
15020394|NCT01909063|Vitamins|vitamins|mesh-list
15020395|NCT01909063|Vitamin E|vitamin e|mesh-list
15020396|NCT01909063|Vitamin A|vitamin a|mesh-list
15020397|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
15020398|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020399|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15020400|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15020401|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
15020402|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020403|NCT01909063|Protective Agents|protective agents|mesh-ancestor
15020404|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
15020405|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
15020406|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
15020407|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15020408|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020409|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
15020410|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020411|NCT01909115|Vitamin D|vitamin d|mesh-list
15020412|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
15020413|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
15020414|NCT01909115|Vitamins|vitamins|mesh-list
15020415|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
15020416|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020417|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15020418|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15020419|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
15020420|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
15020421|NCT01909219|Cathartics|cathartics|mesh-ancestor
15020422|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15034471|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15034472|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15034473|NCT01995370|Analgesics|analgesics|mesh-ancestor
15034474|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
15034475|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034476|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034477|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15034478|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15034479|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15034480|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15034481|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034482|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15034483|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15034484|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034485|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
15034486|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15034487|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15034488|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15034489|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
15034490|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034491|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15034492|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
15034493|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15034494|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
15034495|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
15034496|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15034497|NCT01995370|Protective Agents|protective agents|mesh-ancestor
15034498|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15034499|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15034500|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15034501|NCT01995695|Vaccines|vaccines|mesh-list
15034502|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
15034503|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034504|NCT01995734|Pasireotide|pasireotide|mesh-list
15034505|NCT01995734|Hormones|hormones|mesh-ancestor
15034506|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15034507|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020423|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
15020424|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
15020425|NCT01909557|Vitamins|vitamins|mesh-ancestor
15020426|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
15020427|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020428|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
15020429|NCT01909622|Vitamin D|vitamin d|mesh-list
15020430|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
15020431|NCT01909622|Vitamins|vitamins|mesh-list
15020432|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
15020433|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020434|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15020435|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15020436|NCT01909661|Caseins|caseins|mesh-list
15020437|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
15020438|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
15020439|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020440|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
15020441|NCT01909752|Imiquimod|imiquimod|mesh-list
15020442|NCT01909752|Vaccines|vaccines|mesh-list
15020443|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
15020444|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020445|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020446|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15020447|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15020448|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
15020449|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020450|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020451|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15020452|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15020453|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
15020454|NCT01909830|Gemcitabine|gemcitabine|mesh-list
15020455|NCT01909830|Pemetrexed|pemetrexed|mesh-list
15020456|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15020457|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
15020458|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020459|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020460|NCT01909830|Antiviral Agents|antiviral agents|mesh-ancestor
15020461|NCT01909830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020462|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020463|NCT01909830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020464|NCT01909830|Immunologic Factors|immunologic factors|mesh-ancestor
15020465|NCT01909830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020466|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15020467|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15020468|NCT01909843|Gontivimab|gontivimab|mesh-list
15020469|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
15020470|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020471|NCT01909856|Dexamethasone|dexamethasone|mesh-list
15020472|NCT01909856|Palonosetron|palonosetron|mesh-list
15020473|NCT01909856|Granisetron|granisetron|mesh-list
15020474|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020475|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15020476|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
15020477|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
15020478|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020479|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020480|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15020481|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
15020482|NCT01909856|Hormones|hormones|mesh-ancestor
15020483|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15020484|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15020485|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15020486|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15020487|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
15020488|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020489|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020490|NCT01910077|Tacrolimus|tacrolimus|mesh-list
15020491|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020492|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
15020493|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020494|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15020495|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020496|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020497|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
15020498|NCT01910090|Famotidine|famotidine|mesh-list
15020499|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15020500|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15020501|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15020502|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
15020503|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
15020504|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020505|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020506|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13967996|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
14802780|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802781|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802782|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802783|NCT00799071|Posaconazole|posaconazole|mesh-list
14802784|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
14802785|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802786|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14802787|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14802788|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14802789|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14802790|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14802791|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802792|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802793|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14802794|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
14802795|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14802796|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802797|NCT00799136|Prednisone|prednisone|mesh-list
14802798|NCT00799136|Vincristine|vincristine|mesh-list
14802799|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14802800|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
14802801|NCT00799136|Hormones|hormones|mesh-ancestor
14802802|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14802803|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802804|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14802805|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802806|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14802807|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
15020507|NCT01910090|Analgesics|analgesics|mesh-ancestor
15020508|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
15020509|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020510|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15020511|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15020512|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15020513|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15020514|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15020515|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020516|NCT01910142|Vitamin K|vitamin k|mesh-list
15020517|NCT01910142|Calcium|calcium|mesh-list
15020518|NCT01910142|Vitamins|vitamins|mesh-ancestor
15020519|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
15020520|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020521|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15020522|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15020523|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15020524|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020525|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
15020526|NCT01910142|Coagulants|coagulants|mesh-ancestor
15020527|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
15020528|NCT01910155|Dexamethasone|dexamethasone|mesh-list
15020529|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15020530|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
15020531|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
15020532|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020533|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020534|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15020535|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
15020536|NCT01910155|Hormones|hormones|mesh-ancestor
15020537|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15020538|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15034508|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15020539|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020540|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15020541|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020542|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15020543|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15020544|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020545|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020546|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15020547|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15020548|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
15020549|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15020550|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020551|NCT01910246|Metformin|metformin|mesh-list
15020552|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15020553|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020554|NCT01910259|Amiloride|amiloride|mesh-list
15020555|NCT01910259|Riluzole|riluzole|mesh-list
15020556|NCT01910259|Fluoxetine|fluoxetine|mesh-list
15020557|NCT01910259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15020558|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15020559|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15020560|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020561|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020562|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
15020563|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020564|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15020565|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
15020566|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15020567|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15020568|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15020569|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020570|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
15020571|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15020572|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15020573|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15020574|NCT01910259|Protective Agents|protective agents|mesh-ancestor
15020575|NCT01910259|Diuretics|diuretics|mesh-ancestor
15020576|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
13967997|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
15020577|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
15020578|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15020579|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15020580|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15020581|NCT01910285|Sufentanil|sufentanil|mesh-list
15020582|NCT01910285|Dsuvia|dsuvia|mesh-list
15020583|NCT01910285|Remifentanil|remifentanil|mesh-list
15020584|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15020585|NCT01910285|Narcotics|narcotics|mesh-ancestor
15020586|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15020587|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020588|NCT01910285|Analgesics|analgesics|mesh-ancestor
15020589|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
15020590|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020591|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15020592|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15020593|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
15020594|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
15020595|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
15020596|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15020597|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15020598|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15020599|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15020600|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020601|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
15020602|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020603|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020604|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15020605|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020606|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
15020607|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15020608|NCT01910415|Ivacaftor|ivacaftor|mesh-list
15020609|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15020610|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020611|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15020612|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15020613|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020614|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020615|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020616|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15020617|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
15020618|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15020619|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020620|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15020621|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15020622|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15020623|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15020624|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15020625|NCT01910428|Asparaginase|asparaginase|mesh-list
15020626|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020627|NCT01910480|Ketoconazole|ketoconazole|mesh-list
15020628|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
15020629|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020630|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15020631|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15020632|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020633|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020634|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15020635|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
15020636|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15020637|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020638|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15020639|NCT01910506|Verinurad|verinurad|mesh-list
15020640|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
15020641|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15020642|NCT01910532|Clevidipine|clevidipine|mesh-list
15020643|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15020644|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15020645|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020646|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15020647|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020648|NCT01910545|OTS167|ots167|mesh-list
15020649|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13967998|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
15020650|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020651|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020652|NCT01910610|Bevacizumab|bevacizumab|mesh-list
15020653|NCT01910610|Cetuximab|cetuximab|mesh-list
15020654|NCT01910610|Panitumumab|panitumumab|mesh-list
15020655|NCT01910610|Irinotecan|irinotecan|mesh-list
15020656|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15020657|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020658|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15020659|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15020660|NCT01910610|Growth Substances|growth substances|mesh-ancestor
15020661|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020662|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
15020663|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15020664|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15020665|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13967999|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
15034509|NCT01995799|Hematinics|hematinics|mesh-ancestor
15020666|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020667|NCT01910766|Ubiquinone|ubiquinone|mesh-list
15020668|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
15020669|NCT01910766|Clomiphene|clomiphene|mesh-list
15020670|NCT01910766|Enclomiphene|enclomiphene|mesh-list
15020671|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
15020672|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15020673|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
15020674|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15020675|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020676|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15020677|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
15020678|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15020679|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15020680|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15020681|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
15020682|NCT01910766|Vitamins|vitamins|mesh-ancestor
15020683|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
15020684|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020685|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
15020686|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020687|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15020688|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15020689|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
14802808|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
14802809|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
14802810|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802811|NCT00799149|Etoricoxib|etoricoxib|mesh-list
14802812|NCT00799149|Gabapentin|gabapentin|mesh-list
14802813|NCT00799149|Analgesics|analgesics|mesh-ancestor
14802814|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
14802815|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802816|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802817|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
15020690|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020691|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020692|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15020693|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
15020694|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020695|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
15020696|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020697|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15020698|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15020699|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
15020700|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020701|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802818|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15020702|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15020703|NCT01910883|Finafloxacin|finafloxacin|mesh-list
15020704|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
15020705|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15020706|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15020707|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020708|NCT01910883|Renal Agents|renal agents|mesh-ancestor
15020709|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15020710|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15020711|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15020712|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020713|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020714|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020715|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15020716|NCT01910987|Dexamethasone|dexamethasone|mesh-list
15020717|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
15020718|NCT01910987|Bortezomib|bortezomib|mesh-list
15020719|NCT01910987|BB 1101|bb 1101|mesh-list
15020720|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15020721|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
15020722|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
15020723|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020724|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020725|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15020726|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
15020727|NCT01910987|Hormones|hormones|mesh-ancestor
15020728|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15020729|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15020730|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020731|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
15020732|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020733|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020734|NCT01911195|Isoflurane|isoflurane|mesh-list
15020735|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15020736|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
15020737|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
15020738|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15020739|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034510|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15034511|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15034512|NCT01995890|Nepafenac|nepafenac|mesh-list
15034513|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15034514|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15020740|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
15020741|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15020742|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
15020743|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020744|NCT01911247|Metformin|metformin|mesh-list
15020745|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15020746|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020747|NCT01911299|Choline|choline|mesh-list
15020748|NCT01911299|Glycerol|glycerol|mesh-list
15020749|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
15020750|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15020751|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
15020752|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020753|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15020754|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15020755|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
15020756|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15020757|NCT01911299|Protective Agents|protective agents|mesh-ancestor
15020758|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020759|NCT01911325|Docetaxel|docetaxel|mesh-list
15020760|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020761|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
15020762|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
15020763|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
15020764|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020765|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
15020766|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15020767|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
15020768|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020769|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020770|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15020771|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
15020772|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
15020773|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15020774|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
15020775|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020776|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020777|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
15020778|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15020779|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15020780|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15020781|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15020782|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020783|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
15020784|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020785|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020786|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15020787|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020788|NCT01911455|Acamprosate|acamprosate|mesh-list
15020789|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15020790|NCT01911468|Metformin|metformin|mesh-list
15020791|NCT01911468|Liraglutide|liraglutide|mesh-list
15020792|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14802819|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14802820|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802821|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14802822|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14802823|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14802824|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802825|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802826|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
14802827|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14802828|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14802829|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14802830|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14802831|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14802832|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14802833|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802834|NCT00799175|Ketorolac|ketorolac|mesh-list
14802835|NCT00799175|Epinephrine|epinephrine|mesh-list
14802836|NCT00799175|Ropivacaine|ropivacaine|mesh-list
14802837|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
14802838|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
14802839|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802840|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802841|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
14802842|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802843|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14802844|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14802845|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
14802846|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802847|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802848|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14802849|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14802850|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
14802851|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14802852|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
14802853|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
14802854|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
14802855|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14802856|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14802857|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14802858|NCT00799175|Analgesics|analgesics|mesh-ancestor
14802859|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14802860|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14802861|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14802862|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802863|NCT00799188|Everolimus|everolimus|mesh-list
14802864|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802865|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802866|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
14802867|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802868|NCT00799201|Naloxone|naloxone|mesh-list
14802869|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14802870|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802871|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
14802872|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802873|NCT00799214|Metronidazole|metronidazole|mesh-list
14802874|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802875|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14802876|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14802877|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14802878|NCT00799240|Cisplatin|cisplatin|mesh-list
14802879|NCT00799240|Pemetrexed|pemetrexed|mesh-list
14802880|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14802881|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802882|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802883|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802884|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14802885|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15020793|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15020794|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020795|NCT01911468|Incretins|incretins|mesh-ancestor
15020796|NCT01911468|Hormones|hormones|mesh-ancestor
15020797|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15020798|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
15020799|NCT01911494|Methyldopa|methyldopa|mesh-list
15020800|NCT01911494|Analgesics|analgesics|mesh-ancestor
15020801|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
15020802|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802886|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
14802887|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802888|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
14802889|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14802890|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802891|NCT00799448|Insulin|insulin|mesh-list
14802892|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14802893|NCT00799448|Repaglinide|repaglinide|mesh-list
14802894|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
14802895|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
14802896|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
14802897|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14802898|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020803|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020804|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
15020805|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15020806|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15020807|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
15020808|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15020809|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15020810|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020811|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15020812|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
15020813|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14524984|NCT03714672|Narcotics|narcotics|mesh-ancestor
14524985|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524986|NCT03714919|Acetaminophen|acetaminophen|mesh-list
14524987|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
14524988|NCT03714919|Ketamine|ketamine|mesh-list
14524989|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
14524990|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14524991|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14524992|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14524993|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14524994|NCT03714919|Analgesics|analgesics|mesh-ancestor
14524995|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
14524996|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14524997|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14524998|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14524999|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14525000|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
14525001|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525002|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525003|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14525004|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14525005|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
14525006|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
14525007|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14525008|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14525009|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
14525010|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
14525011|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
14525012|NCT03716024|Linezolid|linezolid|mesh-list
14525013|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15020814|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15020815|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
15020816|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
15020817|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15020818|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15020819|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15020820|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
15020821|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020822|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15020823|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020824|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15020825|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020826|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020827|NCT01911598|Paclitaxel|paclitaxel|mesh-list
15020828|NCT01911598|Carboplatin|carboplatin|mesh-list
15020829|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15020830|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020831|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
15020832|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
15020833|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
15020834|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020835|NCT01911624|Enoxaparin|enoxaparin|mesh-list
15020836|NCT01911624|Dabigatran|dabigatran|mesh-list
15020837|NCT01911624|Argatroban|argatroban|mesh-list
15020838|NCT01911624|Thrombin|thrombin|mesh-list
15020839|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
15020840|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15020841|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15020842|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020843|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
15020844|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15020845|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
15020846|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020847|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
15020848|NCT01911624|Coagulants|coagulants|mesh-ancestor
15020849|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15020850|NCT01911728|Pioglitazone|pioglitazone|mesh-list
14802899|NCT00799513|Lenalidomide|lenalidomide|mesh-list
14802900|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
14802901|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802902|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14802903|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14802904|NCT00799513|Growth Substances|growth substances|mesh-ancestor
14802905|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
14802906|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802907|NCT00799539|Prednisone|prednisone|mesh-list
14802908|NCT00799539|Bortezomib|bortezomib|mesh-list
14802909|NCT00799539|Melphalan|melphalan|mesh-list
14802910|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14802911|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
14802912|NCT00799539|Hormones|hormones|mesh-ancestor
14802913|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14802914|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802915|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14802916|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802917|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14802918|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
14802919|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802920|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14802921|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020851|NCT01911728|Midazolam|midazolam|mesh-list
15020852|NCT01911728|Omeprazole|omeprazole|mesh-list
15020853|NCT01911728|Warfarin|warfarin|mesh-list
15020854|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15020855|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15020856|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14802922|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
14802923|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
14802924|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
14802925|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020857|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020858|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15020859|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15020860|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15020861|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15020862|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
15020863|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
15020864|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
15020865|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
15020866|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020867|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020868|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15020869|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
15020870|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15020871|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15020872|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15020873|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020874|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15020875|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
15020876|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020877|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
15020878|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020879|NCT01911949|Epinephrine|epinephrine|mesh-list
15020880|NCT01911949|Bupivacaine|bupivacaine|mesh-list
15020881|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
15020882|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
15020883|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15020884|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020885|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
15020886|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020887|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15020888|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15020889|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
15020890|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15020891|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020892|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15020893|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15020894|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
15020895|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15020896|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
15020897|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
15020898|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
15020899|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15020900|NCT01911975|Lacosamide|lacosamide|mesh-list
15020901|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
15020902|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15020903|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15020904|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15020905|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020906|NCT01912053|Gemcitabine|gemcitabine|mesh-list
15020907|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020908|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15020909|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
15020910|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020911|NCT01912053|Antiviral Agents|antiviral agents|mesh-ancestor
15020912|NCT01912053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020913|NCT01912053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020914|NCT01912053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15020915|NCT01912053|Immunologic Factors|immunologic factors|mesh-ancestor
15034515|NCT01995890|Analgesics|analgesics|mesh-ancestor
14525014|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525015|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14525016|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525017|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525018|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
14525019|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
14525020|NCT03716076|Carbetocin|carbetocin|mesh-list
14525021|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
14525022|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14525023|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525024|NCT03717012|Nintedanib|nintedanib|mesh-list
14525025|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14525026|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14802926|NCT00799682|Travoprost|travoprost|mesh-list
14802927|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14802928|NCT00799682|Latanoprost|latanoprost|mesh-list
14802929|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14802930|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14802931|NCT00799760|Oseltamivir|oseltamivir|mesh-list
14802932|NCT00799760|Zanamivir|zanamivir|mesh-list
14802933|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
14802934|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802935|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14802936|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802937|NCT00799838|Amoxicillin|amoxicillin|mesh-list
14802938|NCT00799838|Ketoprofen|ketoprofen|mesh-list
14802939|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14802940|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14802941|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14802942|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14802943|NCT00799838|Analgesics|analgesics|mesh-ancestor
15020916|NCT01912053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020917|NCT01912066|Aceclofenac|aceclofenac|mesh-list
15020918|NCT01912066|Misoprostol|misoprostol|mesh-list
15020919|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15020920|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
15020921|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15020922|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020923|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15020924|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15020925|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
15020926|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15020927|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15020928|NCT01912066|Analgesics|analgesics|mesh-ancestor
15020929|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
15020930|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020931|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15020932|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15020933|NCT01912118|Remifentanil|remifentanil|mesh-list
15020934|NCT01912118|Propofol|propofol|mesh-list
15020935|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15020936|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15020937|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020938|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15020939|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
15020940|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
15020941|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15020942|NCT01912118|Narcotics|narcotics|mesh-ancestor
15020943|NCT01912118|Analgesics|analgesics|mesh-ancestor
15020944|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
15020945|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020946|NCT01912378|Oxytocin|oxytocin|mesh-list
15020947|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
15020948|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15020949|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020950|NCT01912391|Selegiline|selegiline|mesh-list
15020951|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
15020952|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15020953|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15020954|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15020955|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15020956|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020957|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020958|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15020959|NCT01912391|Protective Agents|protective agents|mesh-ancestor
15020960|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020961|NCT01912443|Bevacizumab|bevacizumab|mesh-list
15020962|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15020963|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15020964|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15020965|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15020966|NCT01912443|Growth Substances|growth substances|mesh-ancestor
15020967|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020968|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
15020969|NCT01912534|Valsartan|valsartan|mesh-list
15020970|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15020971|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15020972|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15020973|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020974|NCT01912573|Naloxone|naloxone|mesh-list
15020975|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15020976|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020977|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
15020978|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15020979|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
15020980|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
15020981|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15020982|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15020983|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15020984|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15020985|NCT01912586|Urological Agents|urological agents|mesh-ancestor
15020986|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
15020987|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15020988|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
15020989|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15020990|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
15020991|NCT01912638|Protective Agents|protective agents|mesh-ancestor
15020992|NCT01912651|Cephalexin|cephalexin|mesh-list
15020993|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15020994|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15020995|NCT01912677|Labetalol|labetalol|mesh-list
15020996|NCT01912677|Methyldopa|methyldopa|mesh-list
15020997|NCT01912677|Nifedipine|nifedipine|mesh-list
15020998|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15020999|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15021000|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021001|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15021002|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021003|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
15021004|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
15021005|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15021006|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15021007|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15021008|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
15021009|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021010|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15021011|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
14525027|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525028|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021012|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
15021013|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021014|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15021015|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15021016|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
15021017|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15021018|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15021019|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15021020|NCT01912755|Lidocaine|lidocaine|mesh-list
15021021|NCT01912755|Epinephrine|epinephrine|mesh-list
15021022|NCT01912755|Racepinephrine|racepinephrine|mesh-list
15021023|NCT01912755|Carticaine|carticaine|mesh-list
15021024|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
15021025|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
15021026|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
15021027|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021028|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021029|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
15021030|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021031|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15021032|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15021033|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14802944|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
14802945|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802946|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802947|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14802948|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14802949|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14802950|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021034|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15021035|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021036|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15021037|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15021038|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
15021039|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021040|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15021041|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15021042|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
15021043|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15021044|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
15021045|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
15021046|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
15021047|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15021048|NCT01912820|Quercetin|quercetin|mesh-list
15021049|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
15021050|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021051|NCT01912820|Protective Agents|protective agents|mesh-ancestor
15021052|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021053|NCT01912898|Vitamin D|vitamin d|mesh-list
15021054|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
15021055|NCT01912898|Vitamins|vitamins|mesh-list
15021056|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
15021057|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021058|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15021059|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15021060|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
15021061|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15021062|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
15034516|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
15034517|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034518|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034519|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15034520|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15034521|NCT01996085|Amlodipine|amlodipine|mesh-list
15034522|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15034523|NCT01996085|Telmisartan|telmisartan|mesh-list
15034524|NCT01996085|Lisinopril|lisinopril|mesh-list
15034525|NCT01996085|Nebivolol|nebivolol|mesh-list
15034526|NCT01996085|Indapamide|indapamide|mesh-list
15034527|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15034528|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15034529|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15034530|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034531|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15034532|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034533|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
15034534|NCT01996085|Diuretics|diuretics|mesh-ancestor
15034535|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
15021063|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
15021064|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
15021065|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15021066|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15021067|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15021068|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15021069|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021070|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021071|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021072|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021073|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15021074|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15021075|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
15021076|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021077|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15021078|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021079|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021080|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
15021081|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15021082|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021083|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15021084|NCT01913054|Fentanyl|fentanyl|mesh-list
15021085|NCT01913054|Propofol|propofol|mesh-list
15021086|NCT01913054|Etomidate|etomidate|mesh-list
15021087|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15021088|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021089|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021090|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15021091|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
15021092|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
15021093|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15021094|NCT01913054|Narcotics|narcotics|mesh-ancestor
15021095|NCT01913054|Analgesics|analgesics|mesh-ancestor
14525029|NCT03717051|Nicotine|nicotine|mesh-list
14525030|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14525031|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
14525032|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021096|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
15021097|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021098|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15021099|NCT01913106|Valacyclovir|valacyclovir|mesh-list
15021100|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
15021101|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15021102|NCT01913119|Romidepsin|romidepsin|mesh-list
15021103|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15021104|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021105|NCT01913379|Itraconazole|itraconazole|mesh-list
15021106|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
15021107|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
15021108|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15021109|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15021110|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15021111|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021112|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021113|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15021114|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
15021115|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15021116|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021117|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15021118|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15021119|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
15021120|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15021121|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15021122|NCT01913431|Entecavir|entecavir|mesh-list
15021123|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
15021124|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15021125|NCT01913444|Antithrombins|antithrombins|mesh-list
15021126|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
15021127|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15021128|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
15021129|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021130|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021131|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
15021132|NCT01913691|Ipilimumab|ipilimumab|mesh-list
15021133|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15021134|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021135|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15021136|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021137|NCT01913808|Iron|iron|mesh-list
15021138|NCT01913808|Glycine|glycine|mesh-list
15021139|NCT01913808|Trace Elements|trace elements|mesh-ancestor
15021140|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
15021141|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021142|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
15021143|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021144|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021145|NCT01913834|Teriparatide|teriparatide|mesh-list
15021146|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15021147|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021148|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15021149|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
15021150|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
15021151|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15021152|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15021153|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021154|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021155|NCT01913847|Urological Agents|urological agents|mesh-ancestor
15021156|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15021157|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15021158|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
15021159|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
15021160|NCT01913964|Vitamins|vitamins|mesh-ancestor
15021161|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
15021162|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021163|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
15021164|NCT01913990|Dexamethasone|dexamethasone|mesh-list
15021165|NCT01913990|Ondansetron|ondansetron|mesh-list
15021166|NCT01913990|Aprepitant|aprepitant|mesh-list
15021167|NCT01913990|Antiemetics|antiemetics|mesh-list
15021168|NCT01913990|Emetics|emetics|mesh-list
15021169|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15021170|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
15021171|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021172|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021173|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15021174|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
15021175|NCT01913990|Hormones|hormones|mesh-ancestor
15021176|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15021177|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15021178|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021179|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
15021180|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
15021181|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15021182|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
15021183|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021184|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021185|NCT01913990|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15021186|NCT01913990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15021187|NCT01913990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021188|NCT01913990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15021189|NCT01913990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15021190|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15021191|NCT01914042|Morphine|morphine|mesh-list
15021192|NCT01914042|Milnacipran|milnacipran|mesh-list
14802951|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802952|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14802953|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
14802954|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802955|NCT00799890|Protective Agents|protective agents|mesh-ancestor
14802956|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525033|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525034|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14525035|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14525036|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
14525037|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525038|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525039|NCT03717064|Pitavastatin|pitavastatin|mesh-list
14525040|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14525041|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14525042|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14525043|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
14525044|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525045|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525046|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14525047|NCT03717155|Gemcitabine|gemcitabine|mesh-list
14525048|NCT03717155|Carboplatin|carboplatin|mesh-list
14525049|NCT03717155|Cetuximab|cetuximab|mesh-list
14525050|NCT03717155|Avelumab|avelumab|mesh-list
14525051|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14525052|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14525053|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
14525054|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525055|NCT03717155|Antiviral Agents|antiviral agents|mesh-ancestor
14525056|NCT03717155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525057|NCT03717155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525058|NCT03717155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14525059|NCT03717155|Immunologic Factors|immunologic factors|mesh-ancestor
14802957|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15021193|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
15021194|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15021195|NCT01914042|Narcotics|narcotics|mesh-ancestor
15021196|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021197|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021198|NCT01914042|Analgesics|analgesics|mesh-ancestor
15021199|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
15021200|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14802958|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14802959|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802960|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14802961|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
14802962|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14802963|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802964|NCT00800137|Heparin|heparin|mesh-list
14802965|NCT00800137|Calcium heparin|calcium heparin|mesh-list
14802966|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14802967|NCT00800137|Tinzaparin|tinzaparin|mesh-list
14802968|NCT00800137|Dalteparin|dalteparin|mesh-list
14802969|NCT00800137|Warfarin|warfarin|mesh-list
15021201|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15021202|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15021203|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15021204|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021205|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021206|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15021207|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
15021208|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15021209|NCT01914081|Resveratrol|resveratrol|mesh-list
15021210|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
15021211|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021212|NCT01914081|Protective Agents|protective agents|mesh-ancestor
15021213|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021214|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021215|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15021216|NCT01914133|Acarbose|acarbose|mesh-list
15021217|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
15021218|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021219|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021220|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15021221|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021222|NCT01914146|Insulin|insulin|mesh-list
15021223|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15021224|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15021225|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021226|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
15021227|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15021228|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15021229|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021230|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
15021231|NCT01914211|Coagulants|coagulants|mesh-ancestor
15021232|NCT01914237|Castor Oil|castor oil|mesh-list
15021233|NCT01914237|Cathartics|cathartics|mesh-ancestor
15021234|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15021235|NCT01914250|Analgesics|analgesics|mesh-list
15021236|NCT01914250|Tetracaine|tetracaine|mesh-list
15021237|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
15021238|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021239|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021240|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
15021241|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
14525060|NCT03717155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525061|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14525062|NCT03717506|Clindamycin|clindamycin|mesh-list
14525063|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
14525064|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
14525065|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14525066|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525067|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14525068|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021242|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021243|NCT01914367|Vaccines|vaccines|mesh-list
15021244|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
15021245|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021246|NCT01914380|Aflibercept|aflibercept|mesh-list
15021247|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15021248|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15021249|NCT01914380|Growth Substances|growth substances|mesh-ancestor
15021250|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021251|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
15021252|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021253|NCT01914419|Oxytocin|oxytocin|mesh-list
15021254|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
15021255|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15021256|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021257|NCT01914432|Telmisartan|telmisartan|mesh-list
15021258|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15021259|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15021260|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15021261|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
15021262|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021263|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15034536|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15021264|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15021265|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021266|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15021267|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15021268|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15021269|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
15021270|NCT01914562|Cathartics|cathartics|mesh-ancestor
15021271|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15021272|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
15021273|NCT01914627|Salicylates|salicylates|mesh-list
15021274|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15021275|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
15021276|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
15021277|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
15021278|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15021279|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15021280|NCT01914627|Analgesics|analgesics|mesh-ancestor
15021281|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
15021282|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021283|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021284|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15021285|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15021286|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15021287|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021288|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034537|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15034538|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15034539|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15034540|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
15034541|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034542|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15034543|NCT01996085|Protective Agents|protective agents|mesh-ancestor
15034544|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15034545|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15034546|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15034547|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
15034548|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034549|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15034550|NCT01996150|Eusol|eusol|mesh-list
15034551|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
15034552|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034553|NCT01996189|Insulin|insulin|mesh-list
15034554|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15034555|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034556|NCT01996293|Lamotrigine|lamotrigine|mesh-list
15034557|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
15034558|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15034559|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15021289|NCT01914692|Somatostatin|somatostatin|mesh-list
15021290|NCT01914692|Hormones|hormones|mesh-ancestor
15021291|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15021292|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021293|NCT01914718|Rituximab|rituximab|mesh-list
15021294|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15021295|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021296|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
15021297|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021298|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15021299|NCT01914744|Lamivudine|lamivudine|mesh-list
15021300|NCT01914744|Entecavir|entecavir|mesh-list
15021301|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15021302|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15021303|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021304|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021305|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
15021306|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15021307|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15021308|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15021309|NCT01914770|Belimumab|belimumab|mesh-list
15021310|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15021311|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
15021312|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021313|NCT01914822|Methylphenidate|methylphenidate|mesh-list
15021314|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15021315|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021316|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15021317|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15021318|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15021319|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021320|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
15021321|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021322|NCT01914900|Docetaxel|docetaxel|mesh-list
15021323|NCT01914900|Fluorouracil|fluorouracil|mesh-list
15021324|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021325|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
15021326|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
15021327|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
15021328|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021329|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
15021330|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15021331|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15021332|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
15021333|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021334|NCT01914939|Oxytocin|oxytocin|mesh-list
15021335|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
15021336|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15021337|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021338|NCT01914965|Bupropion|bupropion|mesh-list
15021339|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15021340|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
15021341|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15021342|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15021343|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15021344|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15021345|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021346|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
15021347|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021348|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021349|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15021350|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15021351|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021352|NCT01915069|Cilostazol|cilostazol|mesh-list
15021353|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15021354|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
15021355|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021356|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021357|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15021358|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
15021359|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15021360|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15021361|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021362|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15021363|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
15021364|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15021365|NCT01915069|Protective Agents|protective agents|mesh-ancestor
15021366|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15021367|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15021368|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021369|NCT01915082|Azithromycin|azithromycin|mesh-list
15021370|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15021371|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525069|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525070|NCT03719586|Remdesivir|remdesivir|mesh-list
14525071|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
14525072|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525073|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
14525074|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525075|NCT03720119|Lidocaine|lidocaine|mesh-list
14525076|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
14525077|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
14525078|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525079|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525080|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
15021372|NCT01915134|Gemcitabine|gemcitabine|mesh-list
15021373|NCT01915134|Cisplatin|cisplatin|mesh-list
15021374|NCT01915134|Endostatins|endostatins|mesh-list
15021375|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021376|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15021377|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
15021378|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021379|NCT01915134|Antiviral Agents|antiviral agents|mesh-ancestor
15021380|NCT01915134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15021381|NCT01915134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021382|NCT01915134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15021383|NCT01915134|Immunologic Factors|immunologic factors|mesh-ancestor
15021384|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021385|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15021386|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15021387|NCT01915134|Growth Substances|growth substances|mesh-ancestor
15021388|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
15021389|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
15021390|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15021391|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
15021392|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021393|NCT01915264|Metformin|metformin|mesh-list
15021394|NCT01915264|Acarbose|acarbose|mesh-list
15021395|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15021396|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021397|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15021398|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021399|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021400|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
15021401|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15021402|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021403|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021404|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15021405|NCT01915277|Analgesics|analgesics|mesh-ancestor
15021406|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
15021407|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021408|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15021409|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15021410|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15021411|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
15021412|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021413|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021414|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
15021415|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15021416|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15021417|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15021418|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15021419|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021420|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
15021421|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021422|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021423|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15021424|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021425|NCT01915472|Irinotecan|irinotecan|mesh-list
15021426|NCT01915472|Labetuzumab|labetuzumab|mesh-list
15021427|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
15021428|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
15021429|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021430|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14802970|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
14802971|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14802972|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14802973|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802974|NCT00800150|Fludarabine|fludarabine|mesh-list
14802975|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
14802976|NCT00800150|Melphalan|melphalan|mesh-list
14802977|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14802978|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14802979|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
14802980|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802981|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14802982|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
14802983|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14802984|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14802985|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
14802986|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14525081|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525082|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14525083|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14525084|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14525085|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14525086|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525087|NCT03720470|Abrocitinib|abrocitinib|mesh-list
14525088|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14525089|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525090|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525091|NCT03720847|Estradiol|estradiol|mesh-list
14525092|NCT03720847|Progesterone|progesterone|mesh-list
14525093|NCT03720847|Estrogens|estrogens|mesh-ancestor
14525094|NCT03720847|Hormones|hormones|mesh-ancestor
14525095|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14525096|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525097|NCT03720847|Progestins|progestins|mesh-ancestor
14525098|NCT03721172|Apremilast|apremilast|mesh-list
14525099|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14525100|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14525101|NCT03721172|Analgesics|analgesics|mesh-ancestor
15021431|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15021432|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021433|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021434|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021435|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15021436|NCT01915537|Infliximab|infliximab|mesh-list
15021437|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
15021438|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15021439|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15021440|NCT01915550|Insulin|insulin|mesh-list
15021441|NCT01915550|Metformin|metformin|mesh-list
15021442|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15021443|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
15021444|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15021445|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021446|NCT01915602|Sorafenib|sorafenib|mesh-list
14525102|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
14525103|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529866|NCT03591458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15021447|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021448|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15021449|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021450|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021451|NCT01915758|Clindamycin|clindamycin|mesh-list
15021452|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
15021453|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
15021454|NCT01915758|Tretinoin|tretinoin|mesh-list
15021455|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15021456|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15021457|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15021458|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021459|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021460|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021461|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
15021462|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
15021463|NCT01915810|Nicotine|nicotine|mesh-list
15021464|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15021465|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
15021466|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021467|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021468|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15021469|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15021470|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
15021471|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021472|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021473|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15021474|NCT01915901|Bismuth|bismuth|mesh-list
15021475|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
15021476|NCT01915901|Antacids|antacids|mesh-ancestor
15021477|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021478|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15021479|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
15021480|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15021481|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
15021482|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021483|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
15021484|NCT01915979|Betamethasone|betamethasone|mesh-list
15021485|NCT01915979|Mitogens|mitogens|mesh-list
15021486|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
15021487|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021488|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15021489|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
15021490|NCT01915979|Hormones|hormones|mesh-ancestor
15021491|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15021492|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021493|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15021494|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
15021495|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15021496|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15021497|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021498|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15021499|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15021500|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021501|NCT01916174|Insulin|insulin|mesh-list
15021502|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15021503|NCT01916174|Liraglutide|liraglutide|mesh-list
15021504|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
15021505|NCT01916174|Xultophy|xultophy|mesh-list
15021506|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15021507|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021508|NCT01916174|Incretins|incretins|mesh-ancestor
15021509|NCT01916174|Hormones|hormones|mesh-ancestor
15021510|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15021511|NCT01916187|Imetelstat|imetelstat|mesh-list
15021512|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
15021513|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021514|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021515|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15021516|NCT01916200|Paroxetine|paroxetine|mesh-list
15021517|NCT01916200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15021518|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15021519|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15021520|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021521|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021522|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
15021523|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021524|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15021525|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
15021526|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15021527|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15021528|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15021529|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034560|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034561|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15034562|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034563|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15034564|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15034565|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034566|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15034567|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15034568|NCT01996306|Leucovorin|leucovorin|mesh-list
15034569|NCT01996306|Bevacizumab|bevacizumab|mesh-list
15034570|NCT01996306|Fluorouracil|fluorouracil|mesh-list
15034571|NCT01996306|Capecitabine|capecitabine|mesh-list
15034572|NCT01996306|Irinotecan|irinotecan|mesh-list
15034573|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15034574|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034575|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15021530|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
15021531|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15021532|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
15021533|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021534|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
15021535|NCT01916213|Protective Agents|protective agents|mesh-ancestor
15021536|NCT01916252|Dexamethasone|dexamethasone|mesh-list
15021537|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
15021538|NCT01916252|Lenalidomide|lenalidomide|mesh-list
15021539|NCT01916252|Bortezomib|bortezomib|mesh-list
15021540|NCT01916252|Melphalan|melphalan|mesh-list
15021541|NCT01916252|Busulfan|busulfan|mesh-list
15021542|NCT01916252|BB 1101|bb 1101|mesh-list
15021543|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15021544|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
15021545|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
15021546|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021547|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021548|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15021549|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
15021550|NCT01916252|Hormones|hormones|mesh-ancestor
15021551|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15021552|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15021553|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021554|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
15021555|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15021556|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15021557|NCT01916252|Growth Substances|growth substances|mesh-ancestor
15021558|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
15021559|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15021560|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
15021561|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021562|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15021563|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15021564|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
15021565|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021566|NCT01916265|Glucagon|glucagon|mesh-list
15021567|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15021568|NCT01916265|Hormones|hormones|mesh-ancestor
15021569|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15021570|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021571|NCT01916278|Lidocaine|lidocaine|mesh-list
15021572|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
14802987|NCT00800215|Lacosamide|lacosamide|mesh-list
14802988|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
14802989|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14802990|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14802991|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14802992|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14802993|NCT00800267|Timolol|timolol|mesh-list
14802994|NCT00800267|Latanoprost|latanoprost|mesh-list
14802995|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15021573|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
15021574|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021575|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021576|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
15021577|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021578|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15021579|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15021580|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15021581|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15021582|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021583|NCT01916382|Nitisinone|nitisinone|mesh-list
15021584|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021585|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021586|NCT01916395|Sumatriptan|sumatriptan|mesh-list
15021587|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15021588|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15021589|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15021590|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
15021591|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021592|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021593|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021594|NCT01916408|Wobenzym|wobenzym|mesh-list
15021595|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15021596|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
15021597|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021598|NCT01916447|Bevacizumab|bevacizumab|mesh-list
15021599|NCT01916447|Irinotecan|irinotecan|mesh-list
15021600|NCT01916447|Camptothecin|camptothecin|mesh-list
15021601|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15021602|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021603|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15021604|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15021605|NCT01916447|Growth Substances|growth substances|mesh-ancestor
15021606|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021607|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
15021608|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15021609|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15021610|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021611|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021612|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15021613|NCT01916577|Plerixafor|plerixafor|mesh-list
15021614|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15021615|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15021616|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
15021617|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15021618|NCT01916642|Lidocaine|lidocaine|mesh-list
15021619|NCT01916642|Etomidate|etomidate|mesh-list
15021620|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
15021621|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
15021622|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021623|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021624|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
15021625|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021626|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15021627|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15021628|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15021629|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15021630|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021631|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15021632|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15021633|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
14525104|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525105|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525106|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525107|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
14525108|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14525109|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529867|NCT03591458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021634|NCT01916707|Enoxaparin|enoxaparin|mesh-list
15021635|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
15021636|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15021637|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15021638|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021639|NCT01916733|Insulin|insulin|mesh-list
15021640|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15021641|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021642|NCT01916785|Dasatinib|dasatinib|mesh-list
15021643|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021644|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15021645|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021646|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021647|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
15021648|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15021649|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15021650|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15021651|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
15021652|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15021653|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021654|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15021655|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021656|NCT01916863|Canagliflozin|canagliflozin|mesh-list
15021657|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
15021658|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15021659|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021660|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15021661|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021662|NCT01916902|Ticagrelor|ticagrelor|mesh-list
15021663|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14802996|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14802997|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
14802998|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14802999|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803000|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803001|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14803002|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14803003|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14803004|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14803005|NCT00800280|Cimetidine|cimetidine|mesh-list
14803006|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14803007|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14803008|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15021664|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15021665|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15021666|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15021667|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
15021668|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021669|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021670|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021671|NCT01916915|Tramadol|tramadol|mesh-list
15021672|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
15021673|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15021674|NCT01916915|Narcotics|narcotics|mesh-ancestor
15021675|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021676|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021677|NCT01916915|Analgesics|analgesics|mesh-ancestor
15021678|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
15021679|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021680|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
15021681|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
15021682|NCT01916954|Lumefantrine|lumefantrine|mesh-list
15021683|NCT01916954|Artemether|artemether|mesh-list
15021684|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15021685|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
15021686|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15021687|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15021688|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15021689|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
15021690|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15021691|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15021692|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021693|NCT01917032|Folic Acid|folic acid|mesh-list
15021694|NCT01917032|Vitamin A|vitamin a|mesh-list
15021695|NCT01917032|Micronutrients|micronutrients|mesh-list
15021696|NCT01917032|Trace Elements|trace elements|mesh-list
15021697|NCT01917032|Tretinoin|tretinoin|mesh-list
15021698|NCT01917032|Vitamins|vitamins|mesh-ancestor
15021699|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021700|NCT01917032|Hematinics|hematinics|mesh-ancestor
15021701|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
15021702|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021703|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
15021704|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
15021705|NCT01917045|Sufentanil|sufentanil|mesh-list
15021706|NCT01917045|Morphine|morphine|mesh-list
15021707|NCT01917045|Dsuvia|dsuvia|mesh-list
15021708|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15021709|NCT01917045|Narcotics|narcotics|mesh-ancestor
15021710|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021711|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021712|NCT01917045|Analgesics|analgesics|mesh-ancestor
15021713|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
15021714|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021715|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15021716|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15021717|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
15021718|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
15021719|NCT01917058|Abatacept|abatacept|mesh-list
15021720|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15021721|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021722|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021723|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15021724|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
15021725|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021726|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15021727|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
15021728|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15021729|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021730|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021731|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15021732|NCT01917097|Analgesics|analgesics|mesh-ancestor
15021733|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
15021734|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021735|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15021736|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15021737|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15021738|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
15021739|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021740|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021741|NCT01917149|Metoprolol|metoprolol|mesh-list
15021742|NCT01917149|Valsartan|valsartan|mesh-list
15021743|NCT01917149|Benazepril|benazepril|mesh-list
15021744|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15021745|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15021746|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15021747|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021748|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15021749|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
15021750|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
15021751|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021752|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021753|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15021754|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15021755|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15021756|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
15021757|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021758|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15021759|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
15021760|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021761|NCT01917279|Docetaxel|docetaxel|mesh-list
15021762|NCT01917279|Capecitabine|capecitabine|mesh-list
15021763|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021764|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
15021765|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
15021766|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
15021767|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021768|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15021769|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
15021770|NCT01917318|Iloperidone|iloperidone|mesh-list
15021771|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15021772|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15021773|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021774|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021775|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15021776|NCT01917331|Beclomethasone|beclomethasone|mesh-list
15021777|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
15021778|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
15021779|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15021780|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
15021781|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021782|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021783|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15021784|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
15021785|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15021786|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15021787|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15021788|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
15021789|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021790|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021791|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15021792|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15021793|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15021794|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
15021795|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15021796|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
15021797|NCT01917331|Hormones|hormones|mesh-ancestor
15021798|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15021799|NCT01917448|Morphine|morphine|mesh-list
15021800|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15021801|NCT01917448|Narcotics|narcotics|mesh-ancestor
15021802|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021803|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021804|NCT01917448|Analgesics|analgesics|mesh-ancestor
15021805|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
15021806|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021807|NCT01917552|Capecitabine|capecitabine|mesh-list
15021808|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15021809|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
15021810|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021811|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803009|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
14803010|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
14803011|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525110|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525111|NCT03722238|Ibuprofen|ibuprofen|mesh-list
14525112|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14525113|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14525114|NCT03722238|Analgesics|analgesics|mesh-ancestor
14525115|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
14525116|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525117|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525118|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525119|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525120|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14525121|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525122|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525123|NCT03722524|Amlodipine|amlodipine|mesh-list
14525124|NCT03722524|Perindopril|perindopril|mesh-list
14525125|NCT03722524|Indapamide|indapamide|mesh-list
14525126|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
14525127|NCT03722524|Diuretics|diuretics|mesh-list
14525128|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14525129|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14525130|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14525131|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14525132|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525133|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14525134|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021812|NCT01917578|Paclitaxel|paclitaxel|mesh-list
15021813|NCT01917578|Docetaxel|docetaxel|mesh-list
15021814|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15021815|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
15021816|NCT01917578|Carboplatin|carboplatin|mesh-list
15021817|NCT01917578|Doxorubicin|doxorubicin|mesh-list
15021818|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15021819|NCT01917578|Fluorouracil|fluorouracil|mesh-list
15021820|NCT01917578|Trastuzumab|trastuzumab|mesh-list
15021821|NCT01917578|Epirubicin|epirubicin|mesh-list
15021822|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15021823|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021824|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
15021825|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
15021826|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
15021827|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021828|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15021829|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
15021830|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021831|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15021832|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15021833|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
15021834|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15021835|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15021836|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15021837|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15021838|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021839|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
15021840|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15021841|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15021842|NCT01917617|Gemcitabine|gemcitabine|mesh-list
15021843|NCT01917617|Cisplatin|cisplatin|mesh-list
15021844|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15021845|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021846|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15021847|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
15021848|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021849|NCT01917617|Antiviral Agents|antiviral agents|mesh-ancestor
15021850|NCT01917617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15021851|NCT01917617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021852|NCT01917617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15021853|NCT01917617|Immunologic Factors|immunologic factors|mesh-ancestor
15021854|NCT01917617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021855|NCT01917708|Abatacept|abatacept|mesh-list
15021856|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15021857|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021858|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021859|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15021860|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
15021861|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021862|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15021863|NCT01917721|Doxycycline|doxycycline|mesh-list
15021864|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15021865|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15021866|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
15021867|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15021868|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15021869|NCT01917799|Aspirin|aspirin|mesh-list
15021870|NCT01917799|Heparin|heparin|mesh-list
15021871|NCT01917799|Enoxaparin|enoxaparin|mesh-list
15021872|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15021873|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15021874|NCT01917799|Analgesics|analgesics|mesh-ancestor
15021875|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
15021876|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021877|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021878|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15021879|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15021880|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15021881|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15021882|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021883|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15021884|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15021885|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021886|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
15021887|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
15034576|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15034577|NCT01996306|Growth Substances|growth substances|mesh-ancestor
15034578|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034579|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
15034580|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
15034581|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034582|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15034583|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15034584|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
15034585|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15034586|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15034587|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034588|NCT01996306|Antidotes|antidotes|mesh-ancestor
15034589|NCT01996306|Protective Agents|protective agents|mesh-ancestor
15034590|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
15034591|NCT01996306|Vitamins|vitamins|mesh-ancestor
15034592|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
15034593|NCT01996358|Rocuronium|rocuronium|mesh-list
15034594|NCT01996358|Succinylcholine|succinylcholine|mesh-list
15034595|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15034596|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15034597|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15034598|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034599|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034600|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
15034601|NCT01996384|Lidocaine|lidocaine|mesh-list
15021888|NCT01917877|Dexamethasone|dexamethasone|mesh-list
15021889|NCT01917877|Bevacizumab|bevacizumab|mesh-list
15021890|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15021891|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021892|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15021893|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15021894|NCT01917877|Growth Substances|growth substances|mesh-ancestor
15021895|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021896|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
15021897|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15021898|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
15021899|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
15021900|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021901|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15021902|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
15021903|NCT01917877|Hormones|hormones|mesh-ancestor
15021904|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15021905|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15021906|NCT01917890|Curcumin|curcumin|mesh-list
15021907|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15021908|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15021909|NCT01917890|Analgesics|analgesics|mesh-ancestor
14803012|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803013|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803014|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15021910|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
15021911|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021912|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803015|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14803016|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803017|NCT00800293|Betamethasone|betamethasone|mesh-list
14803018|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
14803019|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15021913|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15021914|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15021915|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021916|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021917|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021918|NCT01918098|Oxycodone|oxycodone|mesh-list
15021919|NCT01918098|Naloxone|naloxone|mesh-list
15021920|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15021921|NCT01918098|Narcotics|narcotics|mesh-ancestor
15021922|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15021923|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021924|NCT01918098|Analgesics|analgesics|mesh-ancestor
15021925|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
15021926|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021927|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15021928|NCT01918111|Adenosine|adenosine|mesh-list
15021929|NCT01918111|Analgesics|analgesics|mesh-ancestor
15021930|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
15021931|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15021932|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021933|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15021934|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
15021935|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15021936|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
15021937|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
15021938|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15021939|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021940|NCT01918124|Paclitaxel|paclitaxel|mesh-list
15021941|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
15021942|NCT01918124|Cisplatin|cisplatin|mesh-list
15021943|NCT01918124|Carboplatin|carboplatin|mesh-list
15021944|NCT01918124|Doxorubicin|doxorubicin|mesh-list
15021945|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15021946|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021947|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
15021948|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
15021949|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
15021950|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021951|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15021952|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
15021953|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021954|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15021955|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15021956|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
15021957|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15021958|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15021959|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15021960|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15021961|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021962|NCT01918150|Cobalt|cobalt|mesh-list
15021963|NCT01918150|Chromium|chromium|mesh-list
14525135|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
14525136|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
14525137|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
14525138|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525139|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14525140|NCT03722576|Calcium|calcium|mesh-list
14529868|NCT03590743|Apixaban|apixaban|mesh-list
15021964|NCT01918150|Trace Elements|trace elements|mesh-ancestor
15021965|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
15021966|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021967|NCT01918176|Palbociclib|palbociclib|mesh-list
15021968|NCT01918176|Rabeprazole|rabeprazole|mesh-list
15021969|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021970|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15021971|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021972|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021973|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15021974|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15021975|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15021976|NCT01918241|Lenograstim|lenograstim|mesh-list
15021977|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15021978|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
15021979|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15021980|NCT01918254|Paclitaxel|paclitaxel|mesh-list
15021981|NCT01918254|Pertuzumab|pertuzumab|mesh-list
15021982|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15021983|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15021984|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
15021985|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
15021986|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
15021987|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021988|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15021989|NCT01918358|Valsartan|valsartan|mesh-list
15021990|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15021991|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15021992|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15021993|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
15021994|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15021995|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14803020|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
14803021|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14803022|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803023|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
14803024|NCT00800293|Hormones|hormones|mesh-ancestor
14803025|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14803026|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803027|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14803028|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
14803029|NCT00800306|Simendan|simendan|mesh-list
15021996|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15021997|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15021998|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15021999|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15022000|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15022001|NCT01918384|Arbekacin|arbekacin|mesh-list
15022002|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15022003|NCT01918475|Carbetocin|carbetocin|mesh-list
15022004|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
15022005|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15022006|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022007|NCT01918488|Amiloride|amiloride|mesh-list
15022008|NCT01918488|Triamterene|triamterene|mesh-list
15022009|NCT01918488|Diuretics|diuretics|mesh-ancestor
15022010|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
15022011|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022012|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
15022013|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15022014|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15022015|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022016|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15022017|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15022018|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
15022019|NCT01918514|Analgesics|analgesics|mesh-ancestor
15022020|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
15022021|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022022|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022023|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
15022024|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022025|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15022026|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
15022027|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15022028|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15022029|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022030|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15022031|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
15022032|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15022033|NCT01918527|Capecitabine|capecitabine|mesh-list
15022034|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
15022035|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15022036|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
15022037|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022038|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022039|NCT01918631|Tenofovir|tenofovir|mesh-list
15022040|NCT01918631|Entecavir|entecavir|mesh-list
14803030|NCT00800306|Dobutamine|dobutamine|mesh-list
14803031|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14803032|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
14803033|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14803034|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14803035|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803036|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803037|NCT00800306|Protective Agents|protective agents|mesh-ancestor
14803038|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803039|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
14803040|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
14803041|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022041|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
15022042|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15022043|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15022044|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15022045|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022046|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022047|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15022048|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15022049|NCT01918644|Capecitabine|capecitabine|mesh-list
15022050|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15022051|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
15022052|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022053|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022054|NCT01918709|Valsartan|valsartan|mesh-list
15022055|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15022056|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15022057|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15022058|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
15022059|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022060|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15022061|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15022062|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022063|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15022064|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15022065|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13968000|NCT03113695|Lenalidomide|lenalidomide|mesh-list
15022066|NCT01918813|Vancomycin|vancomycin|mesh-list
15022067|NCT01918813|Mupirocin|mupirocin|mesh-list
15022068|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15022069|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15022070|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15022071|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022072|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022073|NCT01918852|Bevacizumab|bevacizumab|mesh-list
15022074|NCT01918852|Capecitabine|capecitabine|mesh-list
15022075|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15022076|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022077|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15022078|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15022079|NCT01918852|Growth Substances|growth substances|mesh-ancestor
15022080|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022081|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
15022082|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15022083|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
15022084|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022085|NCT01918865|Metformin|metformin|mesh-list
15022086|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15022087|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022088|NCT01918878|Aflibercept|aflibercept|mesh-list
15022089|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15022090|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15022091|NCT01918878|Growth Substances|growth substances|mesh-ancestor
15022092|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022093|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
15022094|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022095|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
15022096|NCT01918904|Antidotes|antidotes|mesh-ancestor
15022097|NCT01918904|Protective Agents|protective agents|mesh-ancestor
15022098|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022099|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
15022100|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022101|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
15022102|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15022103|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15022104|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
15022105|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
15022106|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
15022107|NCT01918917|Morphine|morphine|mesh-list
15022108|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
15022109|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15022110|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022111|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803042|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14803043|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14803044|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14803045|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
14803046|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803047|NCT00800319|ALKS-33|alks-33|mesh-list
14803048|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14803049|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803050|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
14803051|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803052|NCT00800358|Calcitriol|calcitriol|mesh-list
14803053|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14803054|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803055|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14803056|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14803057|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803058|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14803059|NCT00800358|Vitamins|vitamins|mesh-ancestor
14803060|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
14803061|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14803062|NCT00800423|Timolol|timolol|mesh-list
15022112|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15022113|NCT01918917|Analgesics|analgesics|mesh-ancestor
15022114|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
15022115|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022116|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15022117|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15022118|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15022119|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
15022120|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022121|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022122|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15022123|NCT01918917|Narcotics|narcotics|mesh-ancestor
13968001|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
14803063|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14803064|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14803065|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14803066|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
14803067|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803068|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803069|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803070|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14803071|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14803072|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14803073|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15022124|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
15022125|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
15022126|NCT01918995|Regadenoson|regadenoson|mesh-list
15022127|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
15022128|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15022129|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
15022130|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
15022131|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022132|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022133|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022134|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15022135|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
15022136|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15022137|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15022138|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15022139|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022140|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022141|NCT01919047|Mirabegron|mirabegron|mesh-list
15022142|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15022143|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15022144|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15022145|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
15022146|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022147|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022148|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022149|NCT01919047|Urological Agents|urological agents|mesh-ancestor
15022150|NCT01919203|Remifentanil|remifentanil|mesh-list
15022151|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15022152|NCT01919203|Narcotics|narcotics|mesh-ancestor
15022153|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022154|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022155|NCT01919203|Analgesics|analgesics|mesh-ancestor
15022156|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
15022157|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022158|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
15022159|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
15022160|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
15022161|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
15022162|NCT01919255|Citric Acid|citric acid|mesh-list
15022163|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
15022164|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15022165|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
15022166|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
15022167|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022168|NCT01919255|Cathartics|cathartics|mesh-ancestor
15022169|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15022170|NCT01919255|Antacids|antacids|mesh-ancestor
15022171|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
13968002|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
15022172|NCT01919294|Testosterone|testosterone|mesh-list
15022173|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
15022174|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
15022175|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15022176|NCT01919294|Androgens|androgens|mesh-ancestor
15022177|NCT01919294|Hormones|hormones|mesh-ancestor
15022178|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022179|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022180|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15022181|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022182|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
15022183|NCT01919346|Eculizumab|eculizumab|mesh-list
15022184|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15022185|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15022186|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
15022187|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022188|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
15022189|NCT01919424|Miotics|miotics|mesh-ancestor
15022190|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
15034602|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
15022191|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022192|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022193|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15022194|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
15022195|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
15022196|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15022197|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15022198|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
15022199|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022200|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034603|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
15034604|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034605|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034606|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
15034607|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034608|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15034609|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15034610|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15034611|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15034612|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034613|NCT01996423|Vitamin D|vitamin d|mesh-list
15034614|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
15034615|NCT01996423|Vitamins|vitamins|mesh-ancestor
15034616|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
15034617|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034618|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15034619|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15034620|NCT01996462|Dexetimide|dexetimide|mesh-list
15034621|NCT01996462|Citalopram|citalopram|mesh-list
15034622|NCT01996462|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15034623|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15034624|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15034625|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034626|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022201|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
15022202|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15022203|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
15022204|NCT01919593|Povidone|povidone|mesh-list
15022205|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15022206|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15022207|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
15022208|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
15022209|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
15022210|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
15022211|NCT01919619|Lenalidomide|lenalidomide|mesh-list
15022212|NCT01919619|Ipilimumab|ipilimumab|mesh-list
15022213|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
15022214|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022215|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15022216|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15022217|NCT01919619|Growth Substances|growth substances|mesh-ancestor
15022218|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
15022219|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022220|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15022221|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15022222|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022223|NCT01919788|Insulin|insulin|mesh-list
15022224|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15022225|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022226|NCT01919879|Cetuximab|cetuximab|mesh-list
15022227|NCT01919879|Afatinib|afatinib|mesh-list
15022228|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15022229|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022230|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15022231|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022232|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022233|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
15022234|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
15022235|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15022236|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022237|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022238|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
15022239|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15022240|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022241|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022242|NCT01919905|Vitamin D|vitamin d|mesh-list
15022243|NCT01919905|Vitamins|vitamins|mesh-ancestor
15022244|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
15022245|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022246|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15022247|NCT01919918|Adenosine|adenosine|mesh-list
14525141|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14525142|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525143|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
14525144|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14525145|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14525146|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14525147|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
14525148|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525149|NCT03746002|Metolazone|metolazone|mesh-list
14525150|NCT03746002|Furosemide|furosemide|mesh-list
14803074|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14803075|NCT00800462|Bromides|bromides|mesh-list
14803076|NCT00800462|Oxybutynin|oxybutynin|mesh-list
14803077|NCT00800462|Darifenacin|darifenacin|mesh-list
14803078|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
14803079|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
14803080|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
14803081|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803082|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022248|NCT01919918|Analgesics|analgesics|mesh-ancestor
15022249|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
15022250|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022251|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022252|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15022253|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
15022254|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15022255|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
15022256|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
15022257|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022258|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022259|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
15022260|NCT01920022|Mifepristone|mifepristone|mesh-list
15022261|NCT01920022|Etonogestrel|etonogestrel|mesh-list
15022262|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15022263|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022264|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15022265|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
15022266|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15022267|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15034627|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
14803083|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14803084|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14525151|NCT03746002|Diuretics|diuretics|mesh-ancestor
14525152|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
14525153|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525154|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14525155|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14525156|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525157|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14525158|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14525159|NCT03789292|Adalimumab|adalimumab|mesh-list
14525160|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803085|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
14803086|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803087|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803088|NCT00800462|Urological Agents|urological agents|mesh-ancestor
14803089|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
14803090|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14803091|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
14525161|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15022268|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15022269|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15022270|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15022271|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
15022272|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022273|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
15022274|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15022275|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15022276|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
15022277|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
15022278|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
15022279|NCT01920113|Remifentanil|remifentanil|mesh-list
15022280|NCT01920113|Propofol|propofol|mesh-list
15022281|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15022282|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022283|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022284|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15022285|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
15022286|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
15022287|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15022288|NCT01920113|Analgesics|analgesics|mesh-ancestor
15022289|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
15022290|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022291|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15022292|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15022293|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15022294|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
15022295|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022296|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022297|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15022298|NCT01920113|Narcotics|narcotics|mesh-ancestor
15022299|NCT01920191|Poly ICLC|poly iclc|mesh-list
15022300|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
15022301|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
15022302|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022303|NCT01920204|Midostaurin|midostaurin|mesh-list
15022304|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14525162|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
14525163|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
14525164|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
15022305|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15022306|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022307|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022308|NCT01920269|Mitomycins|mitomycins|mesh-list
15022309|NCT01920269|Mitomycin|mitomycin|mesh-list
15022310|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15022311|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022312|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
15022313|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022314|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15022315|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022316|NCT01920334|Zolpidem|zolpidem|mesh-list
15022317|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15022318|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15022319|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803092|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803093|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14803094|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
14803095|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14803096|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803097|NCT00800527|Diclofenac|diclofenac|mesh-list
14803098|NCT00800527|Gabapentin|gabapentin|mesh-list
14803099|NCT00800527|Analgesics|analgesics|mesh-ancestor
15022320|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022321|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15022322|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
15022323|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
15022324|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022325|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022326|NCT01920386|Acetaminophen|acetaminophen|mesh-list
15022327|NCT01920386|Tramadol|tramadol|mesh-list
15022328|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15022329|NCT01920386|Analgesics|analgesics|mesh-ancestor
15022330|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
15022331|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022332|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022333|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
15022334|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15022335|NCT01920386|Narcotics|narcotics|mesh-ancestor
15022336|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022337|NCT01920503|Doxorubicin|doxorubicin|mesh-list
15022338|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15022339|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022340|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15022341|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15022342|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022343|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022344|NCT01920516|Melphalan|melphalan|mesh-list
15022345|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15022346|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
15022347|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022348|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022349|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15022350|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15022351|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
15022352|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022353|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
15022354|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15022355|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022356|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022357|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15022358|NCT01920542|Analgesics|analgesics|mesh-ancestor
15022359|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
15022360|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022361|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15022362|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15022363|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15022364|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
15022365|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022366|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022367|NCT01920737|Leucovorin|leucovorin|mesh-list
15022368|NCT01920737|Cytarabine|cytarabine|mesh-list
15022369|NCT01920737|Dexamethasone|dexamethasone|mesh-list
15022370|NCT01920737|Prednisone|prednisone|mesh-list
15022371|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
15022372|NCT01920737|Methotrexate|methotrexate|mesh-list
15022373|NCT01920737|Vincristine|vincristine|mesh-list
15022374|NCT01920737|Daunorubicin|daunorubicin|mesh-list
15022375|NCT01920737|Asparaginase|asparaginase|mesh-list
15022376|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
14525165|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022377|NCT01920737|Pegaspargase|pegaspargase|mesh-list
15022378|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15022379|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
15022380|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022381|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15022382|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15022383|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
15022384|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022385|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022386|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15022387|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15022388|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
15022389|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
15022390|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022391|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15022392|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
15022393|NCT01920737|Hormones|hormones|mesh-ancestor
15022394|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022395|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15022396|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15022397|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
15022398|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14803100|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
14803101|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803102|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022399|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15022400|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
15022401|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
15022402|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022403|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15022404|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15022405|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
15022406|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15022407|NCT01920737|Antidotes|antidotes|mesh-ancestor
15022408|NCT01920737|Protective Agents|protective agents|mesh-ancestor
15022409|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
15022410|NCT01920737|Vitamins|vitamins|mesh-ancestor
15022411|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
15022412|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15022413|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
15022414|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
15022415|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
15022416|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15022417|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15022418|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15022419|NCT01920919|Dexamethasone|dexamethasone|mesh-list
15022420|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15022421|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
15022422|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
15022423|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022424|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022425|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15022426|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
15022427|NCT01920919|Hormones|hormones|mesh-ancestor
15022428|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022429|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15022430|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022431|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15022432|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15022433|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15022434|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022435|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022436|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15022437|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15022438|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022439|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
15022440|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022441|NCT01920984|Bevacizumab|bevacizumab|mesh-list
15022442|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15022443|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022444|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15022445|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15022446|NCT01920984|Growth Substances|growth substances|mesh-ancestor
15022447|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022448|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
15022449|NCT01921010|Niacin|niacin|mesh-list
15022450|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
15022451|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15022452|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
15022453|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022454|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15022455|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
15022456|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
15022457|NCT01921010|Vitamins|vitamins|mesh-ancestor
15022458|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
15022459|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022460|NCT01921192|Folic Acid|folic acid|mesh-list
15022461|NCT01921192|Hematinics|hematinics|mesh-ancestor
15022462|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
15022463|NCT01921192|Vitamins|vitamins|mesh-ancestor
15022464|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
15022465|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034628|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034629|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15034630|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
15034631|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15034632|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15034633|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15034634|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
15034635|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
15034636|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034637|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15034638|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15034639|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
15034640|NCT01996475|Dexetimide|dexetimide|mesh-list
15034641|NCT01996475|Citalopram|citalopram|mesh-list
15034642|NCT01996475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15022466|NCT01921218|Cyclosporine|cyclosporine|mesh-list
15022467|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
15022468|NCT01921218|Prednisone|prednisone|mesh-list
15022469|NCT01921218|Abatacept|abatacept|mesh-list
15022470|NCT01921218|Tacrolimus|tacrolimus|mesh-list
15022471|NCT01921218|Cyclosporins|cyclosporins|mesh-list
15022472|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
15022473|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15022474|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
15022475|NCT01921218|Hormones|hormones|mesh-ancestor
15022476|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022477|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022478|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15022479|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022480|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15022481|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
15022482|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022483|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022484|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
15022485|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15022486|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
15022487|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15022488|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15022489|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15022490|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
15022491|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15022492|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15022493|NCT01921231|Bupivacaine|bupivacaine|mesh-list
15022494|NCT01921231|Prilocaine|prilocaine|mesh-list
15022495|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
15022496|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
15022497|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022498|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022499|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
15022500|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022501|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
15022502|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
15022503|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15022504|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803103|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
14803104|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14803105|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15022505|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022506|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15022507|NCT01921361|Analgesics|analgesics|mesh-ancestor
15022508|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
15022509|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022510|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15022511|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15022512|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15022513|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
15022514|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022515|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022516|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
15022517|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
15022518|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
15022519|NCT01921374|Interferons|interferons|mesh-list
15022520|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
15022521|NCT01921374|Interleukin-2|interleukin-2|mesh-list
15022522|NCT01921374|Interleukin-4|interleukin-4|mesh-list
15022523|NCT01921374|Dinoprostone|dinoprostone|mesh-list
15022524|NCT01921374|Hormones|hormones|mesh-list
15022525|NCT01921374|Estradiol|estradiol|mesh-list
15022526|NCT01921374|Testosterone|testosterone|mesh-list
15022527|NCT01921374|Progesterone|progesterone|mesh-list
15022528|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15022529|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15022530|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
15022531|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
15022532|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15022533|NCT01921374|Antibodies|antibodies|mesh-list
15022534|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
14803106|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803107|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14803108|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14803109|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14803110|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803111|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022535|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
15022536|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
15022537|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
15022538|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
15022539|NCT01921374|Uric Acid|uric acid|mesh-list
15022540|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022541|NCT01921374|Vitamins|vitamins|mesh-ancestor
15022542|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
15022543|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022544|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
15022545|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15022546|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022547|NCT01921374|Estrogens|estrogens|mesh-ancestor
15022548|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15022549|NCT01921374|Androgens|androgens|mesh-ancestor
15022550|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
15022551|NCT01921374|Progestins|progestins|mesh-ancestor
15022552|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15022553|NCT01921374|Analgesics|analgesics|mesh-ancestor
15022554|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
15022555|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022556|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
15022557|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022558|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022559|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
15022560|NCT01921374|Protective Agents|protective agents|mesh-ancestor
15022561|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
15022562|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15022563|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15022564|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
15022565|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
15022566|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022567|NCT01921426|Protective Agents|protective agents|mesh-ancestor
15022568|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022569|NCT01921582|Methylphenidate|methylphenidate|mesh-list
15022570|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15022571|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022572|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15022573|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15022574|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15022575|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022576|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
15022577|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022578|NCT01921647|Amoxicillin|amoxicillin|mesh-list
15022579|NCT01921647|Clarithromycin|clarithromycin|mesh-list
15022580|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15022581|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15022582|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15022583|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022584|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022585|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15022586|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15022587|NCT01921673|Docetaxel|docetaxel|mesh-list
15022588|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022589|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
15022590|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
15022591|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
15022592|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022593|NCT01921738|Azithromycin|azithromycin|mesh-list
15022594|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15022595|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15022596|NCT01921790|Gemcitabine|gemcitabine|mesh-list
15022597|NCT01921790|Dexamethasone|dexamethasone|mesh-list
15022598|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
15022599|NCT01921790|Bevacizumab|bevacizumab|mesh-list
15022600|NCT01921790|Pegaspargase|pegaspargase|mesh-list
15022601|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15022602|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
15022603|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
15022604|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022605|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022606|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15022607|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
15022608|NCT01921790|Hormones|hormones|mesh-ancestor
15022609|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022610|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15022611|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022612|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15022613|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
15022614|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022615|NCT01921790|Antiviral Agents|antiviral agents|mesh-ancestor
15022616|NCT01921790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15022617|NCT01921790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022618|NCT01921790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15022619|NCT01921790|Immunologic Factors|immunologic factors|mesh-ancestor
15022620|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15022621|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15022622|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15022623|NCT01921790|Growth Substances|growth substances|mesh-ancestor
15022624|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
15022625|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
15022626|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15022627|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
15022628|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
14803112|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
14803113|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14803114|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14803115|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803116|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14803117|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14803118|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022629|NCT01921868|Vitamins|vitamins|mesh-ancestor
15022630|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
15022631|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803119|NCT00800553|Donepezil|donepezil|mesh-list
15022632|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
15022633|NCT01921920|Omeprazole|omeprazole|mesh-list
15022634|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15022635|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15022636|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15022637|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022638|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022639|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15022640|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15022641|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15022642|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
15022643|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022644|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15022645|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15022646|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022647|NCT01921972|Memantine|memantine|mesh-list
15022648|NCT01921972|Galantamine|galantamine|mesh-list
15022649|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15022650|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15022651|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
15022652|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022653|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022654|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022655|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15022656|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15022657|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15022658|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022659|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
15022660|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15022661|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
15022662|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022663|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
15022664|NCT01921985|Terlipressin|terlipressin|mesh-list
15022665|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15022666|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15022667|NCT01922141|Amlodipine|amlodipine|mesh-list
15022668|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15022669|NCT01922141|Ramipril|ramipril|mesh-list
15022670|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15022671|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15022672|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15022673|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022674|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15022675|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022676|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
15022677|NCT01922141|Diuretics|diuretics|mesh-ancestor
15022678|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
15022679|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15022680|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15022681|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
15022682|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022683|NCT01922154|Ranibizumab|ranibizumab|mesh-list
15022684|NCT01922154|Mitomycin|mitomycin|mesh-list
15022685|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15022686|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15022687|NCT01922154|Growth Substances|growth substances|mesh-ancestor
15022688|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022689|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
15022690|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022691|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
15022692|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022693|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15022694|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15022695|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022696|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15022697|NCT01922193|Hormones|hormones|mesh-ancestor
15022698|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022699|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022700|NCT01922375|Naftopidil|naftopidil|mesh-list
14525166|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525167|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
14525168|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525169|NCT03812224|Erenumab|erenumab|mesh-list
14803120|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15022701|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15022702|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15022703|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
15022704|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022705|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022706|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022707|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15022708|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14803121|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803122|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803123|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
14803124|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803125|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803126|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
14803127|NCT00800566|Clofarabine|clofarabine|mesh-list
14803128|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14803129|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
15022709|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15022710|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15022711|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15022712|NCT01922427|RNS60|rns60|mesh-list
15022713|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15022714|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15022715|NCT01922427|Analgesics|analgesics|mesh-ancestor
15022716|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
15022717|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022718|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022719|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15022720|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15022721|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15022722|NCT01922466|Loxoprofen|loxoprofen|mesh-list
15022723|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15022724|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15022725|NCT01922466|Analgesics|analgesics|mesh-ancestor
15022726|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
15022727|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022728|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022729|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15022730|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15022731|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15022732|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022733|NCT01922596|Ropivacaine|ropivacaine|mesh-list
15022734|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
15022735|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
14525170|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14525171|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525172|NCT03812224|Analgesics|analgesics|mesh-ancestor
14525173|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
14525174|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525175|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022736|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022737|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022738|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
15022739|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022740|NCT01922687|Amlodipine|amlodipine|mesh-list
15022741|NCT01922687|Atorvastatin|atorvastatin|mesh-list
15022742|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15022743|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15022744|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
15022745|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022746|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15022747|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15022748|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022749|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15022750|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15022751|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15022752|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15022753|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022754|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
15022755|NCT01922713|Vitamin A|vitamin a|mesh-list
15022756|NCT01922713|Beta Carotene|beta carotene|mesh-list
15022757|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
15022758|NCT01922713|Vitamins|vitamins|mesh-ancestor
15022759|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
15022760|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022761|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
15022762|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022763|NCT01922713|Protective Agents|protective agents|mesh-ancestor
15022764|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15022765|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022766|NCT01922713|Provitamins|provitamins|mesh-ancestor
15022767|NCT01922765|Amoxicillin|amoxicillin|mesh-list
15022768|NCT01922765|Metronidazole|metronidazole|mesh-list
15022769|NCT01922765|Clarithromycin|clarithromycin|mesh-list
15022770|NCT01922765|Rabeprazole|rabeprazole|mesh-list
15022771|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14525176|NCT03828422|Calcium|calcium|mesh-list
14525177|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15022772|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15022773|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15022774|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15022775|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15022776|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022777|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022778|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15022779|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15022780|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15022781|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15022782|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15022783|NCT01922804|Vitamins|vitamins|mesh-list
15022784|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
15022785|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022786|NCT01922817|Saxagliptin|saxagliptin|mesh-list
15022787|NCT01922817|Incretins|incretins|mesh-ancestor
15022788|NCT01922817|Hormones|hormones|mesh-ancestor
15022789|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022790|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022791|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15022792|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
15022793|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022794|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022795|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15022796|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
15022797|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15022798|NCT01922921|Trastuzumab|trastuzumab|mesh-list
15022799|NCT01922921|Pertuzumab|pertuzumab|mesh-list
15022800|NCT01922921|Antibodies|antibodies|mesh-list
15022801|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
15022802|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15022803|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
15022804|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022805|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022806|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15022807|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15022808|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
15022809|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15022810|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
15022811|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15022812|NCT01922921|Protective Agents|protective agents|mesh-ancestor
15034643|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15034644|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15034645|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034646|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034647|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
15034648|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034649|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15034650|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
15034651|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15034652|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15034653|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15034654|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
14525178|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525179|NCT03829618|Lidocaine|lidocaine|mesh-list
14525180|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
14525181|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
14525182|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525183|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525184|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
14525185|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525186|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14525187|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14525188|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14525189|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14525190|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525191|NCT03830333|Metronidazole|metronidazole|mesh-list
15034655|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
15034656|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034657|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15034658|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15034659|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
15034660|NCT01996488|Olanzapine|olanzapine|mesh-list
15034661|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
15034662|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
15034663|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034664|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034665|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15022813|NCT01922999|Melatonin|melatonin|mesh-list
14803130|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803131|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803132|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
14803133|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
14803134|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14803135|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14803136|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803137|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803138|NCT00800592|Urological Agents|urological agents|mesh-ancestor
14803139|NCT00800709|Memantine|memantine|mesh-list
14803140|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14803141|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14803142|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
14803143|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803144|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803145|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803146|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15022814|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
15022815|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022816|NCT01922999|Protective Agents|protective agents|mesh-ancestor
15022817|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022818|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022819|NCT01923012|Vitamin K|vitamin k|mesh-list
15022820|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
15022821|NCT01923012|Vitamins|vitamins|mesh-ancestor
15022822|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
15022823|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022824|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15022825|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15022826|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022827|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
15022828|NCT01923012|Coagulants|coagulants|mesh-ancestor
15022829|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
15022830|NCT01923064|Polidocanol|polidocanol|mesh-list
15022831|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022832|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15022833|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15022834|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15022835|NCT01923077|Simvastatin|simvastatin|mesh-list
15022836|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15022837|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15022838|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
15022839|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022840|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15022841|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15022842|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022843|NCT01923090|Finasteride|finasteride|mesh-list
15022844|NCT01923090|Dutasteride|dutasteride|mesh-list
15022845|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15022846|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15022847|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022848|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022849|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
15022850|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022851|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022852|NCT01923090|Urological Agents|urological agents|mesh-ancestor
15022853|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15022854|NCT01923194|Hormones|hormones|mesh-ancestor
15022855|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022856|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525192|NCT03830333|Meropenem|meropenem|mesh-list
14525193|NCT03830333|Tazobactam|tazobactam|mesh-list
14525194|NCT03830333|Ceftolozane|ceftolozane|mesh-list
14525195|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14525196|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525197|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14525198|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14525199|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14525200|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15022857|NCT01923259|Donepezil|donepezil|mesh-list
15022858|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15022859|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022860|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022861|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
15022862|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022863|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022864|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
15022865|NCT01923337|Irinotecan|irinotecan|mesh-list
15022866|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15022867|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15022868|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022869|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022870|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022871|NCT01923376|Lactulose|lactulose|mesh-list
15022872|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15022873|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15022874|NCT01923376|Laxatives|laxatives|mesh-ancestor
15022875|NCT01923454|Acetazolamide|acetazolamide|mesh-list
15022876|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
15022877|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15022878|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022879|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022880|NCT01923454|Diuretics|diuretics|mesh-ancestor
15022881|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
15022882|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022883|NCT01923545|Lenograstim|lenograstim|mesh-list
15022884|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15022885|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
15022886|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022887|NCT01923558|Donepezil|donepezil|mesh-list
15022888|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15022889|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022890|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022891|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
15022892|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15022893|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022894|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
15022895|NCT01923584|Ubiquinone|ubiquinone|mesh-list
15022896|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
15022897|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525201|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525202|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525203|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14525204|NCT03830333|Renal Agents|renal agents|mesh-ancestor
15022898|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
15022899|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
15022900|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022901|NCT01923597|Protective Agents|protective agents|mesh-ancestor
15022902|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022903|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15022904|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15022905|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022906|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15022907|NCT01923623|Ropivacaine|ropivacaine|mesh-list
15022908|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
15022909|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
15022910|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022911|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022912|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
15022913|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022914|NCT01923649|Lanreotide|lanreotide|mesh-list
15022915|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022916|NCT01923818|Aspirin|aspirin|mesh-list
15022917|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
15022918|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15022919|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15022920|NCT01923818|Analgesics|analgesics|mesh-ancestor
15022921|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
15022922|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022923|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022924|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15022925|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15022926|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15022927|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15022928|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022929|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15022930|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15022931|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15022932|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
15022933|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15022934|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
15022935|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15022936|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
15022937|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
15022938|NCT01923831|Dexamethasone|dexamethasone|mesh-list
15022939|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
15022940|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15022941|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
15022942|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
15022943|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15022944|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022945|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15022946|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
15022947|NCT01923831|Hormones|hormones|mesh-ancestor
15022948|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022949|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15022950|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022951|NCT01923831|Analgesics|analgesics|mesh-ancestor
15022952|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
15022953|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
15022954|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15022955|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15022956|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
15022957|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15022958|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15022959|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022960|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15022961|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
15022962|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15022963|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
15022964|NCT01923844|Beractant|beractant|mesh-list
15022965|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
15022966|NCT01923857|Enclomiphene|enclomiphene|mesh-list
15022967|NCT01923857|Clomiphene|clomiphene|mesh-list
15022968|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
15022969|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15022970|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
15022971|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022972|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022973|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15022974|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
15022975|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15022976|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15022977|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15022978|NCT01923870|Enclomiphene|enclomiphene|mesh-list
15022979|NCT01923870|Clomiphene|clomiphene|mesh-list
15022980|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
15022981|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15022982|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
15022983|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15022984|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15022985|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15022986|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
15022987|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15022988|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15022989|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15022990|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15022991|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15022992|NCT01923935|Melphalan|melphalan|mesh-list
15022993|NCT01923935|Busulfan|busulfan|mesh-list
15022994|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15022995|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
15022996|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15022997|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15022998|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15022999|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15023000|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
15023001|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023002|NCT01923948|Pregabalin|pregabalin|mesh-list
15023003|NCT01923948|Analgesics|analgesics|mesh-ancestor
15023004|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
15023005|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023006|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023007|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
15023008|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15023009|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15023010|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023011|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15023012|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15023013|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15023014|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15023015|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15023016|NCT01923974|Melatonin|melatonin|mesh-list
15023017|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
15023018|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023019|NCT01923974|Protective Agents|protective agents|mesh-ancestor
15023020|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023021|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15023022|NCT01923987|Cetuximab|cetuximab|mesh-list
15023023|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15023024|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023025|NCT01924000|Minoxidil|minoxidil|mesh-list
15023026|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15023027|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
15023028|NCT01924013|Vitamin D|vitamin d|mesh-list
15023029|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
15023030|NCT01924013|Vitamins|vitamins|mesh-ancestor
15023031|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
15023032|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023033|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15023034|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15023035|NCT01924052|Calcitonin|calcitonin|mesh-list
15023036|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
15023037|NCT01924052|Katacalcin|katacalcin|mesh-list
15023038|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15023039|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023040|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15023041|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
15023042|NCT01924065|Anticoagulants|anticoagulants|mesh-list
15023043|NCT01924078|Capecitabine|capecitabine|mesh-list
15023044|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15023045|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15023046|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
15023047|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023048|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023049|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15023050|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023051|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15023052|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
15023053|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15023054|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023055|NCT01924091|Dapivirine|dapivirine|mesh-list
15023056|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15023057|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15023058|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
15023059|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023060|NCT01924104|Aspirin|aspirin|mesh-list
15023061|NCT01924104|Heparin|heparin|mesh-list
15023062|NCT01924104|Calcium heparin|calcium heparin|mesh-list
15023063|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15023064|NCT01924104|Tinzaparin|tinzaparin|mesh-list
15023065|NCT01924104|Dalteparin|dalteparin|mesh-list
15023066|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15023067|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15023068|NCT01924104|Analgesics|analgesics|mesh-ancestor
15023069|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
14803147|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14803148|NCT00800722|Sirolimus|sirolimus|mesh-list
14803149|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14803150|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803151|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14803152|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803153|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
14803154|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14803155|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
14803156|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803157|NCT00800748|Ribavirin|ribavirin|mesh-list
14803158|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14803159|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
14803160|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023070|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023071|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023072|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15023073|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15023074|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15023075|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15023076|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023077|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15023078|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15023079|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023080|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
15023081|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
14525205|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
14525206|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
14525207|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525208|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
14525209|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14525210|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525211|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
14525212|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529869|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15023082|NCT01924234|Morphine|morphine|mesh-list
15023083|NCT01924234|Remifentanil|remifentanil|mesh-list
15023084|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15023085|NCT01924234|Narcotics|narcotics|mesh-ancestor
15023086|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15023087|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023088|NCT01924234|Analgesics|analgesics|mesh-ancestor
15023089|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
15023090|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023091|NCT01924260|Gemcitabine|gemcitabine|mesh-list
15023092|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15023093|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
15023094|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023095|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023096|NCT01924260|Antiviral Agents|antiviral agents|mesh-ancestor
15023097|NCT01924260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023098|NCT01924260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023099|NCT01924260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15023100|NCT01924260|Immunologic Factors|immunologic factors|mesh-ancestor
15023101|NCT01924260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023102|NCT01924273|Talaporfin|talaporfin|mesh-list
15023103|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023104|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15023105|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
15023106|NCT01924286|Prednisone|prednisone|mesh-list
15023107|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15023108|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
15023109|NCT01924286|Hormones|hormones|mesh-ancestor
15023110|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15023111|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023112|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15023113|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023114|NCT01924325|Aspirin|aspirin|mesh-list
15023115|NCT01924325|Apixaban|apixaban|mesh-list
15023116|NCT01924325|Clopidogrel|clopidogrel|mesh-list
14803161|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
14803162|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803163|NCT00800761|Deferiprone|deferiprone|mesh-list
14803164|NCT00800761|Deferoxamine|deferoxamine|mesh-list
14803165|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14803166|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
14803167|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
14803168|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803169|NCT00800761|Siderophores|siderophores|mesh-ancestor
14803170|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
14803171|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
14803172|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803173|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14803174|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14803175|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14803176|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
14803177|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803178|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14803179|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14803180|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803181|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
15023117|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15023118|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15023119|NCT01924325|Analgesics|analgesics|mesh-ancestor
15023120|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
15023121|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023122|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023123|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15023124|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15023125|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15023126|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15023127|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023128|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15023129|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15023130|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023131|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
15023132|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15023133|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15023134|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15023135|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
15023136|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15023137|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15023138|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
15023139|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15023140|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
15023141|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
15023142|NCT01924468|Haloperidol|haloperidol|mesh-list
15023143|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
15023144|NCT01924468|Methylphenidate|methylphenidate|mesh-list
15023145|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15023146|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023147|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15023148|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15023149|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15023150|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023151|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
15023152|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15023153|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
15023154|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
15023155|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023156|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15023157|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15023158|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15023159|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15023160|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15023161|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15023162|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15023163|NCT01924481|Theobromine|theobromine|mesh-list
15023164|NCT01924481|Caffeine|caffeine|mesh-list
15023165|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15023166|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023167|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15023168|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023169|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023170|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15023171|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15023172|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
15023173|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15023174|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15023175|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
15023176|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023177|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15023178|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
15023179|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
15023180|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15023181|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
15023182|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15023183|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15023184|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15023185|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15023186|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034666|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15034667|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15034668|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034669|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15023187|NCT01924624|Thalidomide|thalidomide|mesh-list
15023188|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15023189|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
15023190|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023191|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
15023192|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15023193|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803182|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14803183|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803184|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803185|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14803186|NCT00800826|Analgesics|analgesics|mesh-ancestor
14803187|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
14803188|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803189|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14803190|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14803191|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14803192|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
14803193|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803194|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803195|NCT00800917|Sirolimus|sirolimus|mesh-list
14803196|NCT00800917|Bevacizumab|bevacizumab|mesh-list
14803197|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14803198|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803199|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14803200|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14803201|NCT00800917|Growth Substances|growth substances|mesh-ancestor
14803202|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803203|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
14803204|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14803205|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803206|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14803207|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
14803208|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14803209|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
14803210|NCT00800930|Butyric Acid|butyric acid|mesh-list
14803211|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
14803212|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
14803213|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803214|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023194|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15023195|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15023196|NCT01924624|Growth Substances|growth substances|mesh-ancestor
15023197|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
15023198|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023199|NCT01924637|Insulin|insulin|mesh-list
15023200|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15023201|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
15023202|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
15023203|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15023204|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15023205|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023206|NCT01924676|Oxycodone|oxycodone|mesh-list
15023207|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15023208|NCT01924676|Narcotics|narcotics|mesh-ancestor
15023209|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15023210|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023211|NCT01924676|Analgesics|analgesics|mesh-ancestor
15023212|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
15023213|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023214|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15023215|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
15023216|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15023217|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
15023218|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023219|NCT01924910|Vitamin D|vitamin d|mesh-list
15023220|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
15023221|NCT01924910|Vitamins|vitamins|mesh-ancestor
15023222|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
15023223|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023224|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15023225|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15023226|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15023227|NCT01925027|Sirolimus|sirolimus|mesh-list
15023228|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15023229|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023230|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15023231|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023232|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
15023233|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15023234|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
15023235|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023236|NCT01925066|Vancomycin|vancomycin|mesh-list
15023237|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15023238|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023239|NCT01925092|Mifepristone|mifepristone|mesh-list
15023240|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15023241|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
15023242|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15023243|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023244|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15023245|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15023246|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15023247|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
15023248|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15023249|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15023250|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
15023251|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15023252|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
15023253|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15023254|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15023255|NCT01925287|Curcumin|curcumin|mesh-list
15023256|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15023257|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15023258|NCT01925287|Analgesics|analgesics|mesh-ancestor
15023259|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
15023260|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023261|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023262|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15023263|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15023264|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023265|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034670|NCT01996488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15023266|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023267|NCT01925300|Bisoprolol|bisoprolol|mesh-list
15023268|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15023269|NCT01925300|Calcium|calcium|mesh-list
15023270|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15023271|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023272|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15023273|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15023274|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
15023275|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023276|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15023277|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15023278|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023279|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15023280|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
15023281|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
15023282|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023283|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15023284|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15023285|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15023286|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
15023287|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15023288|NCT01925352|Mitogens|mitogens|mesh-list
15023289|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
15023290|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023291|NCT01925378|Nelfinavir|nelfinavir|mesh-list
15023292|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15023293|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15023294|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
15023295|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023296|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023297|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15023298|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15023299|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
15023300|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023301|NCT01925456|Fesoterodine|fesoterodine|mesh-list
15023302|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15023303|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15023304|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
15023305|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15023306|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023307|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023308|NCT01925456|Urological Agents|urological agents|mesh-ancestor
15023309|NCT01925547|Curcumin|curcumin|mesh-list
15023310|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15023311|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15023312|NCT01925547|Analgesics|analgesics|mesh-ancestor
15023313|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
15023314|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023315|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023316|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15023317|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15023318|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023319|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023320|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023321|NCT01925638|Ketoconazole|ketoconazole|mesh-list
15023322|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
15023323|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023324|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15023325|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15023326|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023327|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023328|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15023329|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
15023330|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15023331|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023332|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15023333|NCT01925729|Phenylephrine|phenylephrine|mesh-list
15023334|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
15023335|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
15023336|NCT01925729|Ephedrine|ephedrine|mesh-list
15023337|NCT01925729|Histamine|histamine|mesh-list
15023338|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15023339|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
15023340|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023341|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023342|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15023343|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
15023344|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
15023345|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15023346|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15023347|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
15023348|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
15023349|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15023350|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023351|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15023352|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15023353|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15023354|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
15023355|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15023356|NCT01925729|Protective Agents|protective agents|mesh-ancestor
15023357|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
15023358|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
15023359|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
15023360|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15023361|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
15023362|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15023363|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
15023364|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023365|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023366|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
15023367|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15023368|NCT01925820|Entecavir|entecavir|mesh-list
15023369|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
15023370|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023371|NCT01925859|Dexamethasone|dexamethasone|mesh-list
15023372|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
15023373|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15023374|NCT01925859|BB 1101|bb 1101|mesh-list
15023375|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15023376|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
15023377|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
15023378|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023379|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023380|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15023381|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
15023382|NCT01925859|Hormones|hormones|mesh-ancestor
15023383|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15023384|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15023385|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023386|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
15023387|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023388|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023389|NCT01925898|Midazolam|midazolam|mesh-list
15023390|NCT01925898|Ketamine|ketamine|mesh-list
15023391|NCT01925898|Analgesics|analgesics|mesh-ancestor
15023392|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
15023393|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023394|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023395|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15023396|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15023397|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
15023398|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
15023399|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15023400|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15023401|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15023402|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15023403|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023404|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15023405|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15023406|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15023407|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15023408|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15023409|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
15023410|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
15023411|NCT01925911|Midazolam|midazolam|mesh-list
15023412|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15023413|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15023414|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15023415|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023416|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15023417|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15023418|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15023419|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15023420|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
15023421|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
15023422|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
15023423|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
15023424|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15023425|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023426|NCT01925937|Ubiquinone|ubiquinone|mesh-list
15023427|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
15023428|NCT01925937|Atorvastatin|atorvastatin|mesh-list
15023429|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15023430|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15023431|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
15023432|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023433|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15023434|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15023435|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023436|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
15023437|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023438|NCT01925937|Vitamins|vitamins|mesh-ancestor
15023439|NCT01926041|Varenicline|varenicline|mesh-list
15023440|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15023441|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15023442|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
15023443|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15023444|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023445|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023446|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
15023447|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
15023448|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023449|NCT01926132|Protective Agents|protective agents|mesh-ancestor
15023450|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023451|NCT01926132|Vitamins|vitamins|mesh-ancestor
15023452|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
15023453|NCT01926158|Denosumab|denosumab|mesh-list
15023454|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15023455|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023456|NCT01926197|Leucovorin|leucovorin|mesh-list
15023457|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
15023458|NCT01926197|Irinotecan|irinotecan|mesh-list
15023459|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023460|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15023461|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15023462|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023463|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023464|NCT01926197|Antidotes|antidotes|mesh-ancestor
15023465|NCT01926197|Protective Agents|protective agents|mesh-ancestor
15023466|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023467|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
15023468|NCT01926197|Vitamins|vitamins|mesh-ancestor
15023469|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
15023470|NCT01926210|Letrozole|letrozole|mesh-list
15023471|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023472|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15023473|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15023474|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023475|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023476|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15023477|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
15023478|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15023479|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023480|NCT01926236|Leucovorin|leucovorin|mesh-list
15023481|NCT01926236|Folic Acid|folic acid|mesh-list
15023482|NCT01926236|Fluorouracil|fluorouracil|mesh-list
15023483|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
15023484|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
15023485|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
15023486|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023487|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15023488|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023489|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15023490|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
15023491|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023492|NCT01926236|Antidotes|antidotes|mesh-ancestor
15023493|NCT01926236|Protective Agents|protective agents|mesh-ancestor
15023494|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
15023495|NCT01926236|Vitamins|vitamins|mesh-ancestor
15023496|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
15023497|NCT01926236|Hematinics|hematinics|mesh-ancestor
15023498|NCT01926288|Entecavir|entecavir|mesh-list
15023499|NCT01926288|Maleic acid|maleic acid|mesh-list
15023500|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023501|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023502|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
15023503|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034671|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15034672|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14525213|NCT03862755|Heparin|heparin|mesh-list
15034673|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034674|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034675|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
15034676|NCT01996501|Olanzapine|olanzapine|mesh-list
15023504|NCT01926379|Isoniazid|isoniazid|mesh-list
15023505|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
15023506|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15023507|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023508|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15023509|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15023510|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
15023511|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023512|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15023513|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
15023514|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
15023515|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15023516|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023517|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15023518|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15023519|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
15023520|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15023521|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
15023522|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023523|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15023524|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023525|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023526|NCT01926587|Azacitidine|azacitidine|mesh-list
15023527|NCT01926587|ON 01910|on 01910|mesh-list
15023528|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15023529|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
15023530|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023531|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023532|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023533|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15023534|NCT01926639|Rituximab|rituximab|mesh-list
15023535|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15023536|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023537|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
15023538|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023539|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15023540|NCT01926652|Amlodipine|amlodipine|mesh-list
15023541|NCT01926652|Candesartan|candesartan|mesh-list
15023542|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
15023543|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15023544|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15023545|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15023546|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023547|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15023548|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023549|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
15023550|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15023551|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15023552|NCT01926665|Dexamethasone|dexamethasone|mesh-list
15023553|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15023554|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
15023555|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
15023556|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023557|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023558|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15023559|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
15023560|NCT01926665|Hormones|hormones|mesh-ancestor
15023561|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15023562|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15023563|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023564|NCT01926769|Metformin|metformin|mesh-list
15023565|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15023566|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023567|NCT01926821|Sizofiran|sizofiran|mesh-list
15023568|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15023569|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
15023570|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023571|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15023572|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023573|NCT01926847|Riociguat|riociguat|mesh-list
15023574|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
15023575|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023576|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15023577|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
15023578|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023579|NCT01926899|Bortezomib|bortezomib|mesh-list
15023580|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023581|NCT01927029|Progesterone|progesterone|mesh-list
15023582|NCT01927029|Progestins|progestins|mesh-ancestor
15023583|NCT01927029|Hormones|hormones|mesh-ancestor
15023584|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15023585|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023586|NCT01927224|Nifurtimox|nifurtimox|mesh-list
15023587|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15023588|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15023589|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15023590|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023591|NCT01927263|Infliximab|infliximab|mesh-list
15023592|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
15023593|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15023594|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15023595|NCT01927315|Fenofibrate|fenofibrate|mesh-list
15023596|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15023597|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
15023598|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023599|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15023600|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
15023601|NCT01927328|Hematinics|hematinics|mesh-ancestor
15023602|NCT01927406|Timolol|timolol|mesh-list
15023603|NCT01927406|Bimatoprost|bimatoprost|mesh-list
15023604|NCT01927406|Travoprost|travoprost|mesh-list
15023605|NCT01927406|Latanoprost|latanoprost|mesh-list
15023606|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15023607|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15023608|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
15023609|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15023610|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023611|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023612|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15023613|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15023614|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15023615|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15023616|NCT01927484|Methotrexate|methotrexate|mesh-list
15023617|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15023618|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
15023619|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15023620|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023621|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15023622|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
15023623|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023624|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023625|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
15023626|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023627|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15023628|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15023629|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
15023630|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15023631|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15023632|NCT01927588|Prednisone|prednisone|mesh-list
15023633|NCT01927588|Everolimus|everolimus|mesh-list
15023634|NCT01927588|Tacrolimus|tacrolimus|mesh-list
15023635|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15023636|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
15023637|NCT01927588|Hormones|hormones|mesh-ancestor
15023638|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15023639|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023640|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15023641|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023642|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15023643|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
15023644|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15023645|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023646|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023647|NCT01927640|Cocaine|cocaine|mesh-list
15023648|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
15023649|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15023650|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15023651|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023652|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15023653|NCT01927640|Analgesics|analgesics|mesh-ancestor
15023654|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
15023655|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023656|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15023657|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15023658|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15023659|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
15023660|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15023661|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023662|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
15023663|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
15023664|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15023665|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15023666|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15023667|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15023668|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
15023669|NCT01927679|Vitamin E|vitamin e|mesh-list
15023670|NCT01927679|Antioxidants|antioxidants|mesh-list
15023671|NCT01927679|Vitamins|vitamins|mesh-ancestor
15023672|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
15023673|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023674|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023675|NCT01927679|Protective Agents|protective agents|mesh-ancestor
15023676|NCT01927835|Vaccines|vaccines|mesh-list
15023677|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
15023678|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023679|NCT01927874|Bupivacaine|bupivacaine|mesh-list
15023680|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
15023681|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
15023682|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15023683|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023684|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
15023685|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023686|NCT01927913|Deferasirox|deferasirox|mesh-list
15023687|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15023688|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
15023689|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
15023690|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023691|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
15023692|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15023693|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
15023694|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023695|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023696|NCT01928043|Curcumin|curcumin|mesh-list
15023697|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15023698|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15023699|NCT01928043|Analgesics|analgesics|mesh-ancestor
15023700|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
15023701|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023702|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023703|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15023704|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15023705|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023706|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023707|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023708|NCT01928056|Montelukast|montelukast|mesh-list
15023709|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15023710|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
15023711|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15023712|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
15023713|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15023714|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023715|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15023716|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15023717|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034677|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
15034678|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
15034679|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034680|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034681|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15034682|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15034683|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15034684|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034685|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15034686|NCT01996501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15034687|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15034688|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15034689|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034690|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034691|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
15034692|NCT01996579|Lactoferrin|lactoferrin|mesh-list
15034693|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034694|NCT01996618|Ranolazine|ranolazine|mesh-list
15034695|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15034696|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15034697|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034698|NCT01996683|Deferiprone|deferiprone|mesh-list
15034699|NCT01996683|Deferoxamine|deferoxamine|mesh-list
15034700|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15034701|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
15034702|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
15034703|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034704|NCT01996683|Siderophores|siderophores|mesh-ancestor
15034705|NCT01996696|Metformin|metformin|mesh-list
15034706|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15034707|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034708|NCT01996735|Ticagrelor|ticagrelor|mesh-list
15034709|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15034710|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15034711|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15034712|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15034713|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
15034714|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034715|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034716|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034717|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
15034718|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15034719|NCT01996761|Protective Agents|protective agents|mesh-ancestor
15034720|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034721|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
15023718|NCT01928069|Montelukast|montelukast|mesh-list
15023719|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15023720|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
15023721|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15023722|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
14525214|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14525215|NCT03862755|Tinzaparin|tinzaparin|mesh-list
14525216|NCT03862755|Dalteparin|dalteparin|mesh-list
14525217|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
14525218|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14525219|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14525220|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525221|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
14525222|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14525223|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525224|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14525225|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023723|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15023724|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023725|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15023726|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15023727|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023728|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
15023729|NCT01928134|Calcium|calcium|mesh-list
15023730|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15023731|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023732|NCT01928134|Antacids|antacids|mesh-ancestor
15023733|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023734|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15023735|NCT01928160|Carboplatin|carboplatin|mesh-list
15023736|NCT01928160|Pemetrexed|pemetrexed|mesh-list
15023737|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15023738|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023739|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023740|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023741|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15023742|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15023743|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15023744|NCT01928316|Mizolastine|mizolastine|mesh-list
15023745|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15023746|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15023747|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
15023748|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
15023749|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15023750|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023751|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023752|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15023753|NCT01928407|Darunavir|darunavir|mesh-list
15023754|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15023755|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15023756|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
15023757|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023758|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023759|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15023760|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15023761|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
15023762|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023763|NCT01928459|Infigratinib|infigratinib|mesh-list
15023764|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023765|NCT01928498|Paclitaxel|paclitaxel|mesh-list
15023766|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15023767|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023768|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
15023769|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
15023770|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
15034722|NCT01996865|Rituximab|rituximab|mesh-list
15023771|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023772|NCT01928511|Interferons|interferons|mesh-list
15023773|NCT01928511|Tenofovir|tenofovir|mesh-list
15023774|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
15023775|NCT01928511|Lamivudine|lamivudine|mesh-list
15023776|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
15023777|NCT01928511|Entecavir|entecavir|mesh-list
15023778|NCT01928511|Adefovir|adefovir|mesh-list
15023779|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15023780|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023781|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
15023782|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023783|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15023784|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15023785|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023786|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023787|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15023788|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15023789|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
15023790|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023791|NCT01928537|ON 01910|on 01910|mesh-list
15023792|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023793|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15023794|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023795|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023796|NCT01928563|Udenafil|udenafil|mesh-list
15023797|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15023798|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15023799|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023800|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023801|NCT01928576|Nivolumab|nivolumab|mesh-list
15023802|NCT01928576|Azacitidine|azacitidine|mesh-list
15023803|NCT01928576|Entinostat|entinostat|mesh-list
15023804|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15023805|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023806|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15023807|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023808|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15023809|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
15023810|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023811|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15023812|NCT01928628|Valsartan|valsartan|mesh-list
15023813|NCT01928628|Lercanidipine|lercanidipine|mesh-list
15023814|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15023815|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15023816|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15023817|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023818|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15023819|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15023820|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15023821|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525226|NCT03885596|Acetaminophen|acetaminophen|mesh-list
14525227|NCT03885596|Celecoxib|celecoxib|mesh-list
14525228|NCT03885596|Ketorolac|ketorolac|mesh-list
14525229|NCT03885596|Lidocaine|lidocaine|mesh-list
14525230|NCT03885596|Fentanyl|fentanyl|mesh-list
14525231|NCT03885596|Bupivacaine|bupivacaine|mesh-list
14525232|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
15023822|NCT01928823|Cycloserine|cycloserine|mesh-list
15023823|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15023824|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023825|NCT01928823|Renal Agents|renal agents|mesh-ancestor
15023826|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15023827|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
15023828|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15023829|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
15023830|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023831|NCT01928875|Anesthetics|anesthetics|mesh-list
15023832|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15023833|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023834|NCT01928888|Famotidine|famotidine|mesh-list
15023835|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
15023836|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15023837|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15023838|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15023839|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
15023840|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
15023841|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525233|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
14525234|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034723|NCT01996865|Lenalidomide|lenalidomide|mesh-list
15023842|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023843|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023844|NCT01928888|Antacids|antacids|mesh-ancestor
15023845|NCT01928901|Thymol|thymol|mesh-list
15023846|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023847|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15023848|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
15023849|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
15023850|NCT01928914|Tafenoquine|tafenoquine|mesh-list
15023851|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15023852|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023853|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15023854|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15023855|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023856|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023857|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023858|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
15023859|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15023860|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15023861|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15023862|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15023863|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15023864|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
15023865|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023866|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15023867|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15023868|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023869|NCT01929096|Edaravone|edaravone|mesh-list
15023870|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15023871|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
15023872|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023873|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14525235|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525236|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
14525237|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525238|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14525239|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14525240|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14525241|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14525242|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525243|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14525244|NCT03885596|Narcotics|narcotics|mesh-ancestor
14525245|NCT03885596|Analgesics|analgesics|mesh-ancestor
14525246|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14525247|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14525248|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
14525249|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14525250|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
14525251|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14525252|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15023874|NCT01929096|Protective Agents|protective agents|mesh-ancestor
15023875|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023876|NCT01929161|Oxytocin|oxytocin|mesh-list
15023877|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
15023878|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15023879|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023880|NCT01929187|Amorolfine|amorolfine|mesh-list
15023881|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
15023882|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023883|NCT01929213|Bosentan|bosentan|mesh-list
15023884|NCT01929213|Udenafil|udenafil|mesh-list
15023885|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15023886|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15023887|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023888|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15023889|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15023890|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023891|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
15023892|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
15023893|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15023894|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15023895|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023896|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15023897|NCT01929252|Analgesics|analgesics|mesh-ancestor
15023898|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
15023899|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15023900|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15023901|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15023902|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15023903|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
15023904|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15023905|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023906|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
15023907|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
15023908|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15023909|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15023910|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
15023911|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023912|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023913|NCT01929278|Clindamycin|clindamycin|mesh-list
15023914|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
15023915|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
15023916|NCT01929278|Tretinoin|tretinoin|mesh-list
15023917|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15023918|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023919|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15023920|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023921|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023922|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023923|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
15023924|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
15023925|NCT01929330|Dutasteride|dutasteride|mesh-list
15023926|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15023927|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15023928|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023929|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023930|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
15023931|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15023932|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023933|NCT01929382|Interferons|interferons|mesh-list
15023934|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
15023935|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023936|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
15023937|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023938|NCT01929421|Gemcitabine|gemcitabine|mesh-list
15023939|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15023940|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
15023941|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023942|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023943|NCT01929421|Antiviral Agents|antiviral agents|mesh-ancestor
15023944|NCT01929421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023945|NCT01929421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023946|NCT01929421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15023947|NCT01929421|Immunologic Factors|immunologic factors|mesh-ancestor
15023948|NCT01929421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023949|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
15023950|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023951|NCT01929512|Metformin|metformin|mesh-list
15023952|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15023953|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15023954|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023955|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15023956|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15023957|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
15023958|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023959|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15023960|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15023961|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023962|NCT01929577|Peficitinib|peficitinib|mesh-list
15023963|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803215|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803216|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
14803217|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14803218|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803219|NCT00801034|Calcium|calcium|mesh-list
14803220|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15023964|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023965|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15023966|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
15023967|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023968|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15023969|NCT01929590|Laxatives|laxatives|mesh-ancestor
15023970|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15023971|NCT01929603|Rifampin|rifampin|mesh-list
15023972|NCT01929603|Olaparib|olaparib|mesh-list
15023973|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15023974|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15023975|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023976|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023977|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15023978|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
15023979|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14803221|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803222|NCT00801047|Remifentanil|remifentanil|mesh-list
14803223|NCT00801047|Bupivacaine|bupivacaine|mesh-list
14803224|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
14803225|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
15023980|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15023981|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
15023982|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15023983|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15023984|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15023985|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15023986|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15023987|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15023988|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15023989|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
15023990|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15023991|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
15023992|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
15023993|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15023994|NCT01929668|Protective Agents|protective agents|mesh-ancestor
15023995|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15023996|NCT01929668|Vitamins|vitamins|mesh-ancestor
15023997|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
15023998|NCT01929746|Daclizumab|daclizumab|mesh-list
15023999|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15024000|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
15024001|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024002|NCT01929798|Pancrelipase|pancrelipase|mesh-list
15024003|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15024004|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
15024005|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15024006|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
15024007|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024008|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024009|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15024010|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
15024011|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15024012|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
15024013|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024014|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024015|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15024016|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
15024017|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
15024018|NCT01929824|Protective Agents|protective agents|mesh-ancestor
15024019|NCT01929915|Fentanyl|fentanyl|mesh-list
15024020|NCT01929915|Morphine|morphine|mesh-list
15024021|NCT01929915|Bupivacaine|bupivacaine|mesh-list
15024022|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
15024023|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
15024024|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024025|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024026|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
15024027|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024028|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15024029|NCT01929915|Narcotics|narcotics|mesh-ancestor
15024030|NCT01929915|Analgesics|analgesics|mesh-ancestor
15024031|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15024032|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15024033|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
15024034|NCT01929941|Gemcitabine|gemcitabine|mesh-list
15024035|NCT01929941|Paclitaxel|paclitaxel|mesh-list
15024036|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15024037|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024038|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
15024039|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
15024040|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
15024041|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024042|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15024043|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
15024044|NCT01929941|Antiviral Agents|antiviral agents|mesh-ancestor
15024045|NCT01929941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15024046|NCT01929941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024047|NCT01929941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15024048|NCT01929941|Immunologic Factors|immunologic factors|mesh-ancestor
15024049|NCT01929941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024050|NCT01930019|Thiopental|thiopental|mesh-list
15024051|NCT01930019|Etomidate|etomidate|mesh-list
15024052|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
15024053|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024054|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024055|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15024056|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15024057|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
15024058|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
15024059|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
15024060|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
15024061|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024062|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034724|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15034725|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034726|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
15034727|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034728|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15034729|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15034730|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15034731|NCT01996865|Growth Substances|growth substances|mesh-ancestor
15034732|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
15034733|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15034734|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
15034735|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15034736|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15035550|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
15035551|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035552|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15035553|NCT02001948|Narcotics|narcotics|mesh-ancestor
15035554|NCT02001948|Analgesics|analgesics|mesh-ancestor
15035555|NCT02001974|Paclitaxel|paclitaxel|mesh-list
15035556|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15035557|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035558|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
15035559|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
15035560|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
15035561|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035562|NCT02002000|Vitamin D|vitamin d|mesh-list
15035563|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
15035564|NCT02002000|Vitamins|vitamins|mesh-ancestor
15035565|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
15035566|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035567|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15035568|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15035569|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
15035570|NCT02002039|Hematinics|hematinics|mesh-ancestor
15035571|NCT02002065|Vaccines|vaccines|mesh-list
15035572|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
15035573|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035574|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15035575|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
15035576|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15035577|NCT02002078|Prednisolone|prednisolone|mesh-list
15035578|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
15035579|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15035580|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
15035581|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15035582|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
15035583|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
15035584|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035585|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035586|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15035587|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
15035588|NCT02002078|Hormones|hormones|mesh-ancestor
15035589|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035590|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15035591|NCT02002078|Protective Agents|protective agents|mesh-ancestor
15035592|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15035593|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035594|NCT02002156|Vaccines|vaccines|mesh-list
15024063|NCT01930201|Anesthetics|anesthetics|mesh-list
15024064|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024065|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024066|NCT01930292|Paclitaxel|paclitaxel|mesh-list
15024067|NCT01930292|Carboplatin|carboplatin|mesh-list
15024068|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15024069|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024070|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
15024071|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
15024072|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
15024073|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024074|NCT01930318|Parecoxib|parecoxib|mesh-list
15024075|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15024076|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15024077|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024078|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024079|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15024080|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15024081|NCT01930318|Analgesics|analgesics|mesh-ancestor
15024082|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
15024083|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024084|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024085|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15024086|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15024087|NCT01930331|Piperaquine|piperaquine|mesh-list
15024088|NCT01930331|Artenimol|artenimol|mesh-list
15024089|NCT01930331|Artemisinins|artemisinins|mesh-list
15024090|NCT01930331|Artemisinin|artemisinin|mesh-list
15024091|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
15024092|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15024093|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15024094|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15024095|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15024096|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
15024097|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
15024098|NCT01930396|Heparin|heparin|mesh-list
15024099|NCT01930396|Calcium heparin|calcium heparin|mesh-list
15024100|NCT01930396|Tinzaparin|tinzaparin|mesh-list
15024101|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15024102|NCT01930396|Dalteparin|dalteparin|mesh-list
15024103|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
15024104|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15024105|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15024106|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024107|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
15024108|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024109|NCT01930552|Leucovorin|leucovorin|mesh-list
15024110|NCT01930552|Fluorouracil|fluorouracil|mesh-list
15024111|NCT01930552|Irinotecan|irinotecan|mesh-list
15024112|NCT01930552|Aflibercept|aflibercept|mesh-list
15024113|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
15024114|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024115|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15024116|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024117|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15024118|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
15024119|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024120|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15024121|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15024122|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024123|NCT01930552|Antidotes|antidotes|mesh-ancestor
15024124|NCT01930552|Protective Agents|protective agents|mesh-ancestor
15024125|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
15024126|NCT01930552|Vitamins|vitamins|mesh-ancestor
15024127|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
15024128|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15024129|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15024130|NCT01930552|Growth Substances|growth substances|mesh-ancestor
15024131|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
15024132|NCT01930591|Clopidogrel|clopidogrel|mesh-list
15024133|NCT01930591|Ticagrelor|ticagrelor|mesh-list
15024134|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15024135|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15024136|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15024137|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15024138|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
15024139|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024140|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024141|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024142|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
15024143|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15024144|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15024145|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15024146|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024147|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024148|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15024149|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15024150|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024151|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
15024152|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024153|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15024154|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15024155|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15024156|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15024157|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024158|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15024159|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
15024160|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15024161|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
15024162|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024163|NCT01930734|Dobutamine|dobutamine|mesh-list
15024164|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15024165|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
15024166|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
15024167|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024168|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024169|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15024170|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15024171|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15024172|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
15024173|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024174|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803226|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803227|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803228|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
14803229|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803230|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14803231|NCT00801047|Narcotics|narcotics|mesh-ancestor
14525253|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525254|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14525255|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14525256|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525257|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14525258|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14525259|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14525260|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
14525261|NCT03889158|Vaccines|vaccines|mesh-list
15024175|NCT01930734|Protective Agents|protective agents|mesh-ancestor
15024176|NCT01930773|Clopidogrel|clopidogrel|mesh-list
15024177|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15024178|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15024179|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15024180|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15024181|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
15024182|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024183|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024184|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024185|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
15024186|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15024187|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15024188|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15024189|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15024190|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024191|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
15024192|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024193|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024194|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15024195|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024196|NCT01930812|Listerine|listerine|mesh-list
15024197|NCT01930812|Fluorides|fluorides|mesh-list
15024198|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
15024199|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
15024200|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
15024201|NCT01930812|Protective Agents|protective agents|mesh-ancestor
15024202|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024203|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15024204|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15024205|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15024206|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024207|NCT01930864|Metformin|metformin|mesh-list
15024208|NCT01930864|Irinotecan|irinotecan|mesh-list
15024209|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15024210|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024211|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15024212|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15024213|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024214|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024215|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024216|NCT01930877|Lidocaine|lidocaine|mesh-list
15024217|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
15024218|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
15024219|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024220|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024221|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
15024222|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024223|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15024224|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15024225|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15024226|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15024227|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024228|NCT01930916|Anticoagulants|anticoagulants|mesh-list
15024229|NCT01930916|Antibodies|antibodies|mesh-list
15024230|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
15024231|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
15024232|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
15024233|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024234|NCT01930955|Amoxicillin|amoxicillin|mesh-list
15024235|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15024236|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15024237|NCT01931033|Oxytocin|oxytocin|mesh-list
15024238|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
15024239|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15024240|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024241|NCT01931085|Triclabendazole|triclabendazole|mesh-list
15024242|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15024243|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
15024244|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15024245|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15024246|NCT01931098|Topotecan|topotecan|mesh-list
15024247|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15024248|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15024249|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024250|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024251|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024252|NCT01931137|Insulin|insulin|mesh-list
15024253|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15024254|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024255|NCT01931189|Infliximab|infliximab|mesh-list
15024256|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
15024257|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15024258|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15024259|NCT01931215|Clonidine|clonidine|mesh-list
15024260|NCT01931215|Morphine|morphine|mesh-list
15024261|NCT01931215|Ropivacaine|ropivacaine|mesh-list
15024262|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
15024263|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024264|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024265|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15024266|NCT01931215|Narcotics|narcotics|mesh-ancestor
15024267|NCT01931215|Analgesics|analgesics|mesh-ancestor
15024268|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
15024269|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024270|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
15024271|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15024272|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
15024273|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
15024274|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15024275|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15024276|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15024277|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
15024278|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024279|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024280|NCT01931293|Folic Acid|folic acid|mesh-list
15024281|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
15024282|NCT01931293|Vitamins|vitamins|mesh-ancestor
15024283|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
15024284|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024285|NCT01931293|Hematinics|hematinics|mesh-ancestor
15024286|NCT01931306|Afatinib|afatinib|mesh-list
15024287|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024288|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15024289|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024290|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024291|NCT01931319|Baclofen|baclofen|mesh-list
15024292|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15024293|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024294|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15024295|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024296|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
15024297|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
15024298|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
15024299|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024300|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024301|NCT01931332|Heroin|heroin|mesh-list
15024302|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15024303|NCT01931332|Narcotics|narcotics|mesh-ancestor
15024304|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024305|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024306|NCT01931332|Analgesics|analgesics|mesh-ancestor
15024307|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
15024308|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024309|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15024310|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15024311|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024312|NCT01931410|Misoprostol|misoprostol|mesh-list
15024313|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15024314|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
15024315|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15024316|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024317|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15024318|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15024319|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
15024320|NCT01931501|Montelukast|montelukast|mesh-list
15024321|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15024322|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
15024323|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15024324|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
15024325|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15024326|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024327|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15024328|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15024329|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024330|NCT01931514|Montelukast|montelukast|mesh-list
15024331|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15024332|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
15024333|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15024334|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
15034737|NCT01997099|Diazepam|diazepam|mesh-list
15024335|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15024336|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024337|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15024338|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15024339|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024340|NCT01931592|Gentamicins|gentamicins|mesh-list
15024341|NCT01931592|Colistin|colistin|mesh-list
15024342|NCT01931592|Fosfomycin|fosfomycin|mesh-list
15024343|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15024344|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15024345|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15024346|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024347|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024348|NCT01931657|Mifepristone|mifepristone|mesh-list
15024349|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
15024350|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15024351|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
15024352|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15024353|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024354|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15024355|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15024356|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15024357|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
15024358|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15024359|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15024360|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
15024361|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15024362|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
15024363|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15024364|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15024365|NCT01931683|Remifentanil|remifentanil|mesh-list
15024366|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15024367|NCT01931683|Narcotics|narcotics|mesh-ancestor
15024368|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024369|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024370|NCT01931683|Analgesics|analgesics|mesh-ancestor
15024371|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
15024372|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034738|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15034739|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
15034740|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
15034741|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
15034742|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525262|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
15024373|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
15024374|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
15024375|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024376|NCT01931787|Protective Agents|protective agents|mesh-ancestor
15024377|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024378|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
15024379|NCT01931787|Vitamins|vitamins|mesh-ancestor
15024380|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
15024381|NCT01931982|Liraglutide|liraglutide|mesh-list
15024382|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15024383|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024384|NCT01931982|Incretins|incretins|mesh-ancestor
15024385|NCT01931982|Hormones|hormones|mesh-ancestor
15024386|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15024387|NCT01932151|Terlipressin|terlipressin|mesh-list
15024388|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15024389|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15024390|NCT01932177|Everolimus|everolimus|mesh-list
15024391|NCT01932177|Sorafenib|sorafenib|mesh-list
15024392|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024393|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15024394|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
15024395|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024396|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15024397|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024398|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024399|NCT01932203|Aspirin|aspirin|mesh-list
15024400|NCT01932203|Cilostazol|cilostazol|mesh-list
15024401|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15024402|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15024403|NCT01932203|Analgesics|analgesics|mesh-ancestor
15024404|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
15024405|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024406|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024407|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15024408|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15024409|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15024410|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15024411|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024412|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15024413|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15024414|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024415|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
15024416|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15024417|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
15024418|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15024419|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
15024420|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
15024421|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15024422|NCT01932203|Protective Agents|protective agents|mesh-ancestor
15024423|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15024424|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15024425|NCT01932229|Afatinib|afatinib|mesh-list
15024426|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024427|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15024428|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024429|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024430|NCT01932268|Rifampin|rifampin|mesh-list
15024431|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15024432|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
15024433|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15024434|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15024435|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
15024436|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15024437|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024438|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024439|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15024440|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15024441|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15024442|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15024443|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15024444|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15024445|NCT01932320|Ketoconazole|ketoconazole|mesh-list
15024446|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
15024447|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15024448|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15024449|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15024450|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024451|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024452|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15024453|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
15024454|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15024455|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024456|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15024457|NCT01932372|Etanercept|etanercept|mesh-list
15024458|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
15024459|NCT01932372|Tofacitinib|tofacitinib|mesh-list
15024460|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15024461|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15024462|NCT01932372|Analgesics|analgesics|mesh-ancestor
15024463|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
15024464|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024465|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024466|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15024467|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15024468|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15024469|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
15024470|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15024471|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024472|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024473|NCT01932385|Sorafenib|sorafenib|mesh-list
15024474|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024475|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15024476|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024477|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024478|NCT01932424|Propofol|propofol|mesh-list
15024479|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15024480|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024481|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024482|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15024483|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
15024484|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
15024485|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
15024486|NCT01932502|Clobazam|clobazam|mesh-list
15024487|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
15024488|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15024489|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15024490|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024491|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024492|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15024493|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15024494|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
15024495|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
15024496|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024497|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024498|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
15024499|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15024500|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15024501|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024502|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024503|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15024504|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15024505|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15024506|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15024507|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
15024508|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024509|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024510|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15024511|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15024512|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
15024513|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15024514|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15024515|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
15024516|NCT01932554|Ibuprofen|ibuprofen|mesh-list
15024517|NCT01932554|Fentanyl|fentanyl|mesh-list
15024518|NCT01932554|Morphine|morphine|mesh-list
15024519|NCT01932554|Hydromorphone|hydromorphone|mesh-list
15024520|NCT01932554|Narcotics|narcotics|mesh-list
15024521|NCT01932554|Abciximab|abciximab|mesh-list
15024522|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15024523|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024524|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024525|NCT01932554|Analgesics|analgesics|mesh-ancestor
15024526|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
15024527|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024528|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15024529|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15024530|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
15024531|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
15024532|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15024533|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15024534|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15024535|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15024536|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15024537|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024538|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024539|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
15024540|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15024541|NCT01932580|Docetaxel|docetaxel|mesh-list
15024542|NCT01932580|Fluorouracil|fluorouracil|mesh-list
15024543|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
15024544|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024545|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
15024546|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
15024547|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
15024548|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024549|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
15024550|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15024551|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15024552|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
15024553|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024554|NCT01932918|Ketorolac|ketorolac|mesh-list
15024555|NCT01932918|Morphine|morphine|mesh-list
15024556|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15024557|NCT01932918|Narcotics|narcotics|mesh-ancestor
15024558|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024559|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024560|NCT01932918|Analgesics|analgesics|mesh-ancestor
15024561|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
15024562|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024563|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15024564|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15024565|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15024566|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15024567|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15024568|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024569|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024570|NCT01932931|Vitamin D|vitamin d|mesh-list
15024571|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
15024572|NCT01932931|Vitamins|vitamins|mesh-ancestor
15024573|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
15024574|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024575|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15024576|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15024577|NCT01933022|Leuprolide|leuprolide|mesh-list
15024578|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15024579|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
15024580|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15024581|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024582|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15024583|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024584|NCT01933061|Paclitaxel|paclitaxel|mesh-list
15024585|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15024586|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15024587|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024588|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
15024589|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
15024590|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
15024591|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024592|NCT01933152|Ranibizumab|ranibizumab|mesh-list
15024593|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15024594|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15024595|NCT01933152|Growth Substances|growth substances|mesh-ancestor
15024596|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024597|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
15024598|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024599|NCT01933347|Gefitinib|gefitinib|mesh-list
15024600|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024601|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15024602|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024603|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024604|NCT01933360|Misoprostol|misoprostol|mesh-list
15024605|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15024606|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
15024607|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15024608|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024609|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15024610|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15024611|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
15034743|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034744|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15034745|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15034746|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15034747|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15034748|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15034749|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15034750|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15034751|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15034752|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15034753|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
15034754|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
15034755|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
15034756|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
15034757|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034758|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525263|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525264|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
14525265|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525266|NCT03889158|Protective Agents|protective agents|mesh-ancestor
14525267|NCT03889158|Vitamins|vitamins|mesh-ancestor
15034759|NCT01997112|Acetaminophen|acetaminophen|mesh-list
15034760|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15034761|NCT01997112|Analgesics|analgesics|mesh-ancestor
15034762|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
15034763|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024612|NCT01933412|Vaccines|vaccines|mesh-list
15024613|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
15024614|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024615|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
15024616|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15024617|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024618|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
15024619|NCT01933503|Cathartics|cathartics|mesh-ancestor
15024620|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15024621|NCT01933516|Rituximab|rituximab|mesh-list
15024622|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15024623|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024624|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
15024625|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024626|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15024627|NCT01933542|Morphine|morphine|mesh-list
15024628|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
15024629|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15024630|NCT01933542|Narcotics|narcotics|mesh-ancestor
15024631|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024632|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024633|NCT01933542|Analgesics|analgesics|mesh-ancestor
15024634|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
15024635|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024636|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15024637|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15024638|NCT01933568|Cisplatin|cisplatin|mesh-list
15024639|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803232|NCT00801047|Analgesics|analgesics|mesh-ancestor
14803233|NCT00801086|Ethanol|ethanol|mesh-list
14803234|NCT00801086|Tempol|tempol|mesh-list
14803235|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14803236|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803237|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803238|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803239|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
14803240|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803241|NCT00801086|Protective Agents|protective agents|mesh-ancestor
14803242|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14803243|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803244|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14803245|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14803246|NCT00801125|Natalizumab|natalizumab|mesh-list
14803247|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
14803248|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803249|NCT00801151|Vinorelbine|vinorelbine|mesh-list
14803250|NCT00801151|Vorinostat|vorinostat|mesh-list
14803251|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15024640|NCT01933698|Amoxicillin|amoxicillin|mesh-list
15024641|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15024642|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15024643|NCT01933711|Rituximab|rituximab|mesh-list
15024644|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15024645|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024646|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
15024647|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024648|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15024649|NCT01933724|Prednisone|prednisone|mesh-list
15024650|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
15024651|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803252|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024652|NCT01933724|Hormones|hormones|mesh-ancestor
15024653|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15024654|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024655|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15024656|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024657|NCT01933815|Bevacizumab|bevacizumab|mesh-list
15024658|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15024659|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024660|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15024661|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15024662|NCT01933815|Growth Substances|growth substances|mesh-ancestor
15024663|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024664|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
15024665|NCT01933906|Interferons|interferons|mesh-list
15024666|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
15024667|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
15024668|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15024669|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024670|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
15024671|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15024672|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
15024673|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024674|NCT01933945|Sorafenib|sorafenib|mesh-list
15024675|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024676|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15024677|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024678|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024679|NCT01933971|Lenograstim|lenograstim|mesh-list
15024680|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15024681|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
15024682|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024683|NCT01933997|Pyridoxine|pyridoxine|mesh-list
15024684|NCT01933997|Metadoxine|metadoxine|mesh-list
15024685|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15024686|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
15024687|NCT01933997|Vitamins|vitamins|mesh-ancestor
15024688|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
15024689|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024690|NCT01934023|Varenicline|varenicline|mesh-list
15024691|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15024692|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15024693|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
14525268|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
14525269|NCT03897348|Lacosamide|lacosamide|mesh-list
15024694|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024695|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024696|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024697|NCT01934049|Anesthetics|anesthetics|mesh-list
15024698|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024699|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024700|NCT01934088|Fentanyl|fentanyl|mesh-list
15024701|NCT01934088|Midazolam|midazolam|mesh-list
15024702|NCT01934088|Propofol|propofol|mesh-list
15024703|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15024704|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024705|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024706|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15024707|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
15024708|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
15024709|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15024710|NCT01934088|Narcotics|narcotics|mesh-ancestor
15024711|NCT01934088|Analgesics|analgesics|mesh-ancestor
15024712|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
15024713|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024714|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15024715|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15024716|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15024717|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15024718|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
15024719|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
15024720|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024721|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024722|NCT01934127|Vaccines|vaccines|mesh-list
15024723|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
15024724|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024725|NCT01934166|Nalmefene|nalmefene|mesh-list
15024726|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15024727|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024728|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
15024729|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024730|NCT01934361|Carboplatin|carboplatin|mesh-list
15024731|NCT01934361|Lomustine|lomustine|mesh-list
15024732|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024733|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15024734|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
15024735|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024736|NCT01934569|Losartan|losartan|mesh-list
15024737|NCT01934569|Midazolam|midazolam|mesh-list
15024738|NCT01934569|Caffeine|caffeine|mesh-list
15024739|NCT01934569|Omeprazole|omeprazole|mesh-list
15024740|NCT01934569|Pravastatin|pravastatin|mesh-list
15024741|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15024742|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15024743|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024744|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024745|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15024746|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15024747|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15024748|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15024749|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
15024750|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
15024751|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
15024752|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
15024753|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024754|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024755|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15024756|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15024757|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15024758|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15024759|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15024760|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15024761|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15024762|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024763|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15024764|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15024765|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15024766|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15024767|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
15024768|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14525270|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
14529870|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
15024769|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15024770|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
15024771|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15024772|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15024773|NCT01934634|Gemcitabine|gemcitabine|mesh-list
15024774|NCT01934634|Paclitaxel|paclitaxel|mesh-list
14525271|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14525272|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14525273|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14525274|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525275|NCT03907033|Bupivacaine|bupivacaine|mesh-list
14525276|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
14525277|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
14525278|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525279|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525280|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
14525281|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525282|NCT03920215|Varenicline|varenicline|mesh-list
14525283|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15024775|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15024776|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024777|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
15024778|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
15024779|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
15024780|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024781|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15024782|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
15024783|NCT01934634|Antiviral Agents|antiviral agents|mesh-ancestor
15024784|NCT01934634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15024785|NCT01934634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024786|NCT01934634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15024787|NCT01934634|Immunologic Factors|immunologic factors|mesh-ancestor
15024788|NCT01934634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024789|NCT01934712|Insulin|insulin|mesh-list
15024790|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15024791|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
14803253|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
14803254|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
14803255|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
14803256|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803257|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14803258|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803259|NCT00801177|Necitumumab|necitumumab|mesh-list
15024792|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
15024793|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15024794|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15024795|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024796|NCT01934777|Vitamin E|vitamin e|mesh-list
15024797|NCT01934777|Choline|choline|mesh-list
15024798|NCT01934777|Vitamins|vitamins|mesh-ancestor
15024799|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
15024800|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024801|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
15024802|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024803|NCT01934777|Protective Agents|protective agents|mesh-ancestor
15024804|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
15024805|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15024806|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
15024807|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15024808|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15024809|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
15024810|NCT01934816|Liraglutide|liraglutide|mesh-list
15024811|NCT01934816|Exenatide|exenatide|mesh-list
15024812|NCT01934816|Glucagon|glucagon|mesh-list
15024813|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15024814|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15024815|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024816|NCT01934816|Incretins|incretins|mesh-ancestor
15024817|NCT01934816|Hormones|hormones|mesh-ancestor
15024818|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15024819|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15024820|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15024821|NCT01934829|Sorafenib|sorafenib|mesh-list
15024822|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024823|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15024824|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024825|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024826|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15024827|NCT01934933|Celecoxib|celecoxib|mesh-list
15024828|NCT01934933|Etanercept|etanercept|mesh-list
15024829|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15024830|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15024831|NCT01934933|Analgesics|analgesics|mesh-ancestor
15024832|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
15024833|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024834|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024835|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15024836|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15024837|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15024838|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15024839|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024840|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024841|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14803260|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15024842|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15024843|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
15024844|NCT01935063|Lidocaine|lidocaine|mesh-list
15024845|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
15024846|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
15024847|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024848|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024849|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
15024850|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024851|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15024852|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15024853|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15024854|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15024855|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034764|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034765|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
15034766|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15034767|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15034768|NCT01997164|Aflibercept|aflibercept|mesh-list
15034769|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15034770|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15034771|NCT01997164|Growth Substances|growth substances|mesh-ancestor
15034772|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034773|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
15034774|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034775|NCT01997190|Valacyclovir|valacyclovir|mesh-list
15034776|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
15034777|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034778|NCT01997203|Vitamin D|vitamin d|mesh-list
15034779|NCT01997203|Interferons|interferons|mesh-list
15034780|NCT01997203|Ribavirin|ribavirin|mesh-list
15034781|NCT01997203|Vitamins|vitamins|mesh-ancestor
15034782|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
15034783|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034784|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15034785|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034786|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
15034787|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034788|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
15024856|NCT01935089|Interferons|interferons|mesh-list
15024857|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
15024858|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
15024859|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15024860|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024861|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
15024862|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15024863|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
15024864|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024865|NCT01935115|Ketamine|ketamine|mesh-list
15024866|NCT01935115|Propofol|propofol|mesh-list
15024867|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15024868|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15024869|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024870|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15024871|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
15024872|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
15024873|NCT01935115|Analgesics|analgesics|mesh-ancestor
15024874|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
15024875|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024876|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15024877|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15024878|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14803261|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14803262|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024879|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024880|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803263|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
14803264|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803265|NCT00801255|Lactams|lactams|mesh-list
14803266|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14803267|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803268|NCT00801268|Emodin|emodin|mesh-list
14803269|NCT00801268|Cathartics|cathartics|mesh-ancestor
14803270|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14803271|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14803272|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803273|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803274|NCT00801281|Prednisone|prednisone|mesh-list
14803275|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
14803276|NCT00801281|Rituximab|rituximab|mesh-list
14803277|NCT00801281|Doxorubicin|doxorubicin|mesh-list
14803278|NCT00801281|Vincristine|vincristine|mesh-list
15024881|NCT01935128|Everolimus|everolimus|mesh-list
15024882|NCT01935128|Tacrolimus|tacrolimus|mesh-list
15024883|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15024884|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
15024885|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024886|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15024887|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024888|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024889|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024890|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
15024891|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
15024892|NCT01935141|Growth Substances|growth substances|mesh-ancestor
15024893|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024894|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
15024895|NCT01935193|Analgesics|analgesics|mesh-ancestor
15024896|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
15024897|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024898|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024899|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15024900|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15024901|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525284|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14525285|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
14525286|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525287|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525288|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525289|NCT03921151|Mirtazapine|mirtazapine|mesh-list
14525290|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
14525291|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14525292|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14525293|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
14525294|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
14525295|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525296|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525297|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525298|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14525299|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14525300|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525301|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14525302|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14525303|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14525304|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
14525305|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14525306|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14525307|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
14525308|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14525309|NCT03927911|Bupivacaine|bupivacaine|mesh-list
14525310|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
14525311|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
14525312|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525313|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525314|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
14525315|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525316|NCT03938857|Fentanyl|fentanyl|mesh-list
14803279|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14803280|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
14803281|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803282|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14803283|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14803284|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
14803285|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803286|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803287|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14803288|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14803289|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14803290|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14803291|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14803292|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803293|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525317|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
14525318|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14525319|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525320|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525321|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14525322|NCT03938857|Analgesics|analgesics|mesh-ancestor
14803294|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
14803295|NCT00801281|Hormones|hormones|mesh-ancestor
14525323|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
14525324|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525325|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14525326|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14525327|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14525328|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
14525329|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525330|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525331|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14525332|NCT03938857|Narcotics|narcotics|mesh-ancestor
14525333|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14525334|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14525335|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
14525336|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
14525337|NCT03945981|Lamivudine|lamivudine|mesh-list
15024902|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15024903|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15024904|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15024905|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024906|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024907|NCT01935206|Naloxone|naloxone|mesh-list
15024908|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15024909|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024910|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
15024911|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024912|NCT01935310|Imiquimod|imiquimod|mesh-list
15024913|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15024914|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
15024915|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024916|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024917|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
15024918|NCT01935492|Paclitaxel|paclitaxel|mesh-list
15024919|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15024920|NCT01935492|Bevacizumab|bevacizumab|mesh-list
15024921|NCT01935492|Doxorubicin|doxorubicin|mesh-list
15024922|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15024923|NCT01935492|Capecitabine|capecitabine|mesh-list
15024924|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15024925|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15024926|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
15024927|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
15024928|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
15024929|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024930|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15024931|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15024932|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15024933|NCT01935492|Growth Substances|growth substances|mesh-ancestor
15024934|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024935|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
15024936|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15024937|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15024938|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15024939|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024940|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15024941|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
15024942|NCT01935505|Bupropion|bupropion|mesh-list
15024943|NCT01935505|Nicotine|nicotine|mesh-list
15024944|NCT01935505|Varenicline|varenicline|mesh-list
15024945|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15024946|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
15024947|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024948|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024949|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15024950|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14803296|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14803297|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14803298|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14803299|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
14803300|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
15024951|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
15024952|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024953|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024954|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15024955|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
15024956|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15024957|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14525338|NCT03945981|Dolutegravir|dolutegravir|mesh-list
14803301|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
14803302|NCT00801294|Nintedanib|nintedanib|mesh-list
14803303|NCT00801294|Afatinib|afatinib|mesh-list
14803304|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803305|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14803306|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803307|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024958|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15024959|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15024960|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
15024961|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15024962|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15024963|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024964|NCT01935518|Fasudil|fasudil|mesh-list
15024965|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15024966|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15024967|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024968|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15024969|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024970|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
14803308|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14803309|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14803310|NCT00801385|Sorafenib|sorafenib|mesh-list
15024971|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15024972|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024973|NCT01935531|Diclofenac|diclofenac|mesh-list
14803311|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803312|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14803313|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803314|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803315|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
14803316|NCT00801411|Docetaxel|docetaxel|mesh-list
15024974|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
15024975|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15024976|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15024977|NCT01935531|Analgesics|analgesics|mesh-ancestor
15024978|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
15024979|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15024980|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024981|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15024982|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15024983|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15024984|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15024985|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024986|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15024987|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
15024988|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
15024989|NCT01935531|Protective Agents|protective agents|mesh-ancestor
15024990|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
15024991|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15024992|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15024993|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15024994|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
15024995|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15024996|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15024997|NCT01935557|Heparin|heparin|mesh-list
15024998|NCT01935557|Calcium heparin|calcium heparin|mesh-list
15024999|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
15025000|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15025001|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15025002|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025003|NCT01935596|Ropivacaine|ropivacaine|mesh-list
15025004|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
15025005|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
15025006|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
15025007|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025008|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025009|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
15025010|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025011|NCT01935648|Ropivacaine|ropivacaine|mesh-list
15025012|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
15025013|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
15025014|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525339|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14525340|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15025015|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025016|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
15025017|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025018|NCT01935674|Ritonavir|ritonavir|mesh-list
15025019|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15025020|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15025021|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15025022|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
15025023|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525341|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525342|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525343|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
14525344|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525345|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14525346|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14525347|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14525348|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14525349|NCT03954834|Tirzepatide|tirzepatide|mesh-list
14525350|NCT03954834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14525351|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525352|NCT03954834|Incretins|incretins|mesh-ancestor
14525353|NCT03954834|Hormones|hormones|mesh-ancestor
14803317|NCT00801411|Doxorubicin|doxorubicin|mesh-list
14803318|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15025024|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803319|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14803320|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
14803321|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803322|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14803323|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15025025|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15025026|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15025027|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
15025028|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803324|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
14803325|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803326|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803327|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14803328|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
14803329|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
14803330|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
14803331|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15025029|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15025030|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15025031|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15025032|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15025033|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
15025034|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15025035|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15025036|NCT01935713|Nicotine|nicotine|mesh-list
15025037|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15025038|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
14803332|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14803333|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14803334|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803335|NCT00801450|Triamcinolone|triamcinolone|mesh-list
14803336|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14803337|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14803338|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14803339|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803340|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
14803341|NCT00801450|Hormones|hormones|mesh-ancestor
14803342|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14803343|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803344|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14803345|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
14803346|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803347|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803348|NCT00801489|Cytarabine|cytarabine|mesh-list
14803349|NCT00801489|Fludarabine|fludarabine|mesh-list
14803350|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
14803351|NCT00801489|Decitabine|decitabine|mesh-list
14803352|NCT00801489|Idarubicin|idarubicin|mesh-list
14803353|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
14803354|NCT00801489|Calicheamicins|calicheamicins|mesh-list
14803355|NCT00801489|Lenograstim|lenograstim|mesh-list
14803356|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803357|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15025039|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025040|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025041|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15025042|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15025043|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
15025044|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025045|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025046|NCT01935778|Docetaxel|docetaxel|mesh-list
15025047|NCT01935778|Capecitabine|capecitabine|mesh-list
15025048|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
15025049|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025050|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
15025051|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
15025052|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
14803358|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
14803359|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803360|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14803361|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
14803362|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803363|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
14803364|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803365|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14803366|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803367|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14525354|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14525355|NCT03958071|Pirfenidone|pirfenidone|mesh-list
14525356|NCT03958071|Nintedanib|nintedanib|mesh-list
14803368|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14803369|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14525357|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14525358|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14525359|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525360|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525361|NCT03958071|Analgesics|analgesics|mesh-ancestor
14525362|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
14525363|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803370|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14803371|NCT00801515|Maraviroc|maraviroc|mesh-list
14803372|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14803373|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14803374|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803375|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14803376|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14803377|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
14803378|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803379|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14803380|NCT00801528|Diclofenac|diclofenac|mesh-list
14803381|NCT00801528|Ropivacaine|ropivacaine|mesh-list
14803382|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
14803383|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
14803384|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803385|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803386|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
15025053|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025054|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15025055|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
15025056|NCT01935804|Metformin|metformin|mesh-list
15025057|NCT01935804|Pioglitazone|pioglitazone|mesh-list
14803387|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803388|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14803389|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15025058|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15025059|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025060|NCT01935817|Vitamin E|vitamin e|mesh-list
15025061|NCT01935817|Silybin|silybin|mesh-list
15025062|NCT01935817|Vitamins|vitamins|mesh-ancestor
15025063|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
15025064|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025065|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
15025066|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803390|NCT00801528|Analgesics|analgesics|mesh-ancestor
14803391|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803392|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14803393|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14803394|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803395|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803396|NCT00801580|Doxorubicin|doxorubicin|mesh-list
14803397|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14803398|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14803399|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803400|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15025067|NCT01935817|Protective Agents|protective agents|mesh-ancestor
14803401|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14803402|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803403|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803404|NCT00801606|Zinc|zinc|mesh-list
14803405|NCT00801606|Trace Elements|trace elements|mesh-list
14803406|NCT00801606|Micronutrients|micronutrients|mesh-list
14803407|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803408|NCT00801697|Vaccines|vaccines|mesh-list
14803409|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
14803410|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803411|NCT00801736|Paclitaxel|paclitaxel|mesh-list
14803412|NCT00801736|Cisplatin|cisplatin|mesh-list
14803413|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14803414|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803415|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
14803416|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
14803417|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
14803418|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803419|NCT00801788|Oxycodone|oxycodone|mesh-list
14803420|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14803421|NCT00801788|Narcotics|narcotics|mesh-ancestor
14803422|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803423|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803424|NCT00801788|Analgesics|analgesics|mesh-ancestor
14803425|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
14803426|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025068|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15025069|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025070|NCT01935830|Ritonavir|ritonavir|mesh-list
15025071|NCT01935830|Efavirenz|efavirenz|mesh-list
15025072|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15025073|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15025074|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
15025075|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035642|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803427|NCT00801853|Interleukin-4|interleukin-4|mesh-list
14803428|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14803429|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
14803430|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803431|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803432|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14803433|NCT00801866|Bevacizumab|bevacizumab|mesh-list
14803434|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14803435|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803436|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15025076|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025077|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15025078|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15025079|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
15025080|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025081|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15025082|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15025083|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15025084|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14803437|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14803438|NCT00801866|Growth Substances|growth substances|mesh-ancestor
14803439|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803440|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
14803441|NCT00801879|Mupirocin|mupirocin|mesh-list
14803442|NCT00801879|Calcium|calcium|mesh-list
14803443|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14803444|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803445|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14803446|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803447|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14803448|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025085|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14803449|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803450|NCT00801905|Nepafenac|nepafenac|mesh-list
14803451|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14803452|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15025086|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15025087|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14803453|NCT00801905|Analgesics|analgesics|mesh-ancestor
14803454|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
14803455|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803456|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803457|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803458|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14803459|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
15025088|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15025089|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15025090|NCT01935869|Petrolatum|petrolatum|mesh-list
15025091|NCT01935869|Emollients|emollients|mesh-ancestor
14803460|NCT00801918|Ifosfamide|ifosfamide|mesh-list
14803461|NCT00801918|Etoposide|etoposide|mesh-list
14803462|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
14803463|NCT00801918|Interleukin-2|interleukin-2|mesh-list
14803464|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14803465|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
14803466|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025092|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
15025093|NCT01935882|Lumefantrine|lumefantrine|mesh-list
15025094|NCT01935882|Artemether|artemether|mesh-list
15025095|NCT01935882|Primaquine|primaquine|mesh-list
15025096|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15025097|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
15025098|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15025099|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15025100|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025101|NCT01935908|Levetiracetam|levetiracetam|mesh-list
15025102|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
15025103|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
15025104|NCT01935973|Trametinib|trametinib|mesh-list
15025105|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025106|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15025107|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025108|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025109|NCT01936012|Lisinopril|lisinopril|mesh-list
15025110|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15025111|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
15025112|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025113|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025114|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15025115|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15025116|NCT01936012|Protective Agents|protective agents|mesh-ancestor
15025117|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025118|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15025119|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
14803467|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14803468|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14803469|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
14803470|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803471|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803472|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14803473|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14803474|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14803475|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14803476|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803477|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14803478|NCT00801918|Analgesics|analgesics|mesh-ancestor
14803479|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
14803480|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803481|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
14803482|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14803483|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14803484|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
14803485|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803486|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803487|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803488|NCT00801944|Urological Agents|urological agents|mesh-ancestor
14803489|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
14803490|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14803491|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14803492|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14803493|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
14803494|NCT00801957|Tacrolimus|tacrolimus|mesh-list
15025120|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15025121|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025122|NCT01936025|Incretins|incretins|mesh-ancestor
15025123|NCT01936025|Hormones|hormones|mesh-ancestor
15025124|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15025125|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15025126|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
15025127|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025128|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025129|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
15025130|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
15025131|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15025132|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15025133|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025134|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
15025135|NCT01936064|Epirubicin|epirubicin|mesh-list
15025136|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15025137|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
15025138|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025139|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15025140|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15025141|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
15025142|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025143|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025144|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15025145|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15025146|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15025147|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15025148|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025149|NCT01936090|Bortezomib|bortezomib|mesh-list
14803495|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14803496|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
14803497|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803498|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14803499|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803500|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803501|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803502|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
14803503|NCT00802009|Dexamethasone|dexamethasone|mesh-list
14803504|NCT00802009|Mepivacaine|mepivacaine|mesh-list
14803505|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803506|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
14803507|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
14803508|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803509|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025150|NCT01936090|Melphalan|melphalan|mesh-list
14803510|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14803511|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
14803512|NCT00802009|Hormones|hormones|mesh-ancestor
14803513|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14803514|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14803515|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803516|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
14803517|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
14803518|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803519|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
14803520|NCT00802035|Baclofen|baclofen|mesh-list
14803521|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14803522|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025151|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025152|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14803523|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14803524|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803525|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14803526|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
14803527|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
14803528|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803529|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803530|NCT00802048|Ropivacaine|ropivacaine|mesh-list
14803531|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
14803532|NCT00802048|Anesthetics|anesthetics|mesh-list
14803533|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803534|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803535|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
14803536|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803537|NCT00802087|Acetaminophen|acetaminophen|mesh-list
14803538|NCT00802087|Hydrocodone|hydrocodone|mesh-list
14803539|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14803540|NCT00802087|Analgesics|analgesics|mesh-ancestor
14803541|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
14803542|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025153|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
15025154|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025155|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15025156|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15025157|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
15025158|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025159|NCT01936103|Atorvastatin|atorvastatin|mesh-list
15025160|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15025161|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15025162|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
15025163|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025164|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15025165|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14803543|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803544|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
14803545|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14803546|NCT00802087|Narcotics|narcotics|mesh-ancestor
14803547|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803548|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
15025166|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025167|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
15025168|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
14803549|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
14803550|NCT00802139|Iron|iron|mesh-list
14803551|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14803552|NCT00802139|Trace Elements|trace elements|mesh-ancestor
15025169|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15025170|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
15025171|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025172|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15025173|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15025174|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
15025175|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14803553|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
14803554|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803555|NCT00802139|Hematinics|hematinics|mesh-ancestor
15025176|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803556|NCT00802217|Capsaicin|capsaicin|mesh-list
14803557|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
15025177|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025178|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15025179|NCT01936233|Aspirin|aspirin|mesh-list
15025180|NCT01936233|Lamivudine|lamivudine|mesh-list
15035643|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15025181|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15025182|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15025183|NCT01936233|Analgesics|analgesics|mesh-ancestor
15025184|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
15025185|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025186|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025187|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15025188|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15025189|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15025190|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15025191|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025192|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15025193|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15025194|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025195|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
15025196|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15025197|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15025198|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
15025199|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025200|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15025201|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15025202|NCT01936285|Colchicine|colchicine|mesh-list
15025203|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
15025204|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14803558|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
14803559|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
14803560|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803561|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803562|NCT00802230|Terbutaline|terbutaline|mesh-list
14803563|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14803564|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
14803565|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803566|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803567|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14803568|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
14803569|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
14803570|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
14803571|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14803572|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14803573|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15025205|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
15025206|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
15025207|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
15025208|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025209|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025210|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
15025211|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
15025212|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15025213|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15025214|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025215|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025216|NCT01936350|Urological Agents|urological agents|mesh-ancestor
15025217|NCT01936532|Dexamethasone|dexamethasone|mesh-list
14803574|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14803575|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
14803576|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025218|NCT01936532|Lenalidomide|lenalidomide|mesh-list
15025219|NCT01936532|Ixazomib|ixazomib|mesh-list
15025220|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15025221|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
15025222|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
15025223|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025224|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025225|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15025226|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
15025227|NCT01936532|Hormones|hormones|mesh-ancestor
15025228|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15025229|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15025230|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025231|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
15025232|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14803577|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803578|NCT00802243|Leflunomide|leflunomide|mesh-list
14803579|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803580|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803581|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14803582|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
14803583|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803584|NCT00802282|Psilocybin|psilocybin|mesh-list
14803585|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
14803586|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803587|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14803588|NCT00802308|Morphine|morphine|mesh-list
14803589|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14803590|NCT00802308|Narcotics|narcotics|mesh-ancestor
14803591|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803592|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803593|NCT00802308|Analgesics|analgesics|mesh-ancestor
14803594|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
14803595|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803596|NCT00802321|Dutasteride|dutasteride|mesh-list
14803597|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14803598|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14803599|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803600|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803601|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
14803602|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14803603|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803604|NCT00802334|Ritonavir|ritonavir|mesh-list
14803605|NCT00802334|Lopinavir|lopinavir|mesh-list
14803606|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14803607|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14803608|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
14803609|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803610|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803611|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14803612|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14803613|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
14803614|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803615|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14803616|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14803617|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
14803618|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
14803619|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14803620|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14803621|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
15025233|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15025234|NCT01936532|Growth Substances|growth substances|mesh-ancestor
15025235|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
14803622|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803623|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803624|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803625|NCT00802373|Urological Agents|urological agents|mesh-ancestor
14803626|NCT00802451|Mesalamine|mesalamine|mesh-list
14803627|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14803628|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14803629|NCT00802451|Analgesics|analgesics|mesh-ancestor
14803630|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
15025236|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
15025237|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025238|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025239|NCT01936545|Propofol|propofol|mesh-list
15025240|NCT01936545|Desflurane|desflurane|mesh-list
15025241|NCT01936545|Liver Extracts|liver extracts|mesh-list
15025242|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15025243|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025244|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025245|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14803631|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803632|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803633|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15025246|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
15025247|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
15025248|NCT01936545|Hematinics|hematinics|mesh-ancestor
15025249|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15034789|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034790|NCT01997255|Everolimus|everolimus|mesh-list
15034791|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15034792|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15034793|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
15034794|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034795|NCT01997294|Atorvastatin|atorvastatin|mesh-list
15034796|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15034797|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15034798|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
15034799|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034800|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15035644|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
14803634|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14803635|NCT00802568|Fludarabine|fludarabine|mesh-list
14803636|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
14803637|NCT00802568|Busulfan|busulfan|mesh-list
14803638|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14803639|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803640|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14803641|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
14803642|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803643|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14803644|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
14803645|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803646|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
14803647|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14803648|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14803649|NCT00802581|Anesthetics|anesthetics|mesh-list
14803650|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
14803651|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803652|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803653|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
14803654|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025250|NCT01936636|Fentanyl|fentanyl|mesh-list
15025251|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15025252|NCT01936636|Narcotics|narcotics|mesh-ancestor
15025253|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025254|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025255|NCT01936636|Analgesics|analgesics|mesh-ancestor
15025256|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
15025257|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025258|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15025259|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14525364|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803655|NCT00802594|Pafuramidine|pafuramidine|mesh-list
14803656|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14803657|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14803658|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14803659|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803660|NCT00802646|Epinephrine|epinephrine|mesh-list
14803661|NCT00802646|Fentanyl|fentanyl|mesh-list
14803662|NCT00802646|Bupivacaine|bupivacaine|mesh-list
14803663|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
14803664|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
14803665|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525365|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14525366|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14525367|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525368|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525369|NCT03968159|Pimavanserin|pimavanserin|mesh-list
14525370|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14525371|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14525372|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14525373|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14525374|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525375|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525376|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14525377|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14525378|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14525379|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
14525380|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525381|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525382|NCT03970824|Adalimumab|adalimumab|mesh-list
14525383|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525384|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525385|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
14525386|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14525387|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14525388|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
14525389|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525390|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025260|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
15025261|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
15025262|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15025263|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15025264|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15025265|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
15025266|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025267|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15025268|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15025269|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025270|NCT01936961|Antibodies|antibodies|mesh-list
15025271|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
15025272|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025273|NCT01937013|Oxytocin|oxytocin|mesh-list
15025274|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
15025275|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15025276|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025277|NCT01937078|Famotidine|famotidine|mesh-list
15025278|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15025279|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15025280|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15025281|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
15025282|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
15025283|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025284|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025285|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025286|NCT01937104|Remifentanil|remifentanil|mesh-list
15025287|NCT01937104|Desflurane|desflurane|mesh-list
15025288|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15025289|NCT01937104|Narcotics|narcotics|mesh-ancestor
15025290|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025291|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025292|NCT01937104|Analgesics|analgesics|mesh-ancestor
15025293|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
15025294|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025295|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15025296|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
15025297|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
15025298|NCT01937156|Granisetron|granisetron|mesh-list
15025299|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
15025300|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
15025301|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025302|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025303|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15025304|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15025305|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
15025306|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035645|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14525391|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525392|NCT03979807|Bromides|bromides|mesh-list
14803666|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803667|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
14803668|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803669|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14803670|NCT00802646|Narcotics|narcotics|mesh-ancestor
14803671|NCT00802646|Analgesics|analgesics|mesh-ancestor
14803672|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14803673|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14803674|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
15025307|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025308|NCT01937169|Levodopa|levodopa|mesh-list
15025309|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15025310|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15025311|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
15025312|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025313|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025314|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025315|NCT01937182|Citalopram|citalopram|mesh-list
15025316|NCT01937182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
14525393|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
14525394|NCT03979807|Olodaterol|olodaterol|mesh-list
14525395|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14525396|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
14525397|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525398|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525399|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14525400|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
14525401|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
14525402|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14803675|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15025317|NCT01937182|Serotonin|serotonin|mesh-list
15025318|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15025319|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15025320|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025321|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025322|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
15025323|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025324|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15025325|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
15025326|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15025327|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15025328|NCT01937234|Metoclopramide|metoclopramide|mesh-list
14803676|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15025329|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
15025330|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
15025331|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025332|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025333|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15025334|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15025335|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15025336|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
15025337|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025338|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025339|NCT01937325|Ivacaftor|ivacaftor|mesh-list
15025340|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15025341|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15025342|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025343|NCT01937338|AZD7624|azd7624|mesh-list
15025344|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15025345|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025346|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025347|NCT01937442|Thalidomide|thalidomide|mesh-list
15025348|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15025349|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
15025350|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803677|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
14803678|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803679|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803680|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14803681|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14803682|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
14803683|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14803684|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
14803685|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
15025351|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
15025352|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15025353|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025354|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15025355|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14803686|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
14803687|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14803688|NCT00802802|Efavirenz|efavirenz|mesh-list
14803689|NCT00802802|Rifampin|rifampin|mesh-list
14803690|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14803691|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14803692|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025356|NCT01937442|Growth Substances|growth substances|mesh-ancestor
15025357|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
15025358|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025359|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
15025360|NCT01937494|Histamine|histamine|mesh-list
15025361|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
15025362|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
15025363|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025364|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525403|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
14525404|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525405|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525406|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
14525407|NCT03982069|Vaccines|vaccines|mesh-list
14803693|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025365|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803694|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
14803695|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803696|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14803697|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14803698|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14803699|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14803700|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14803701|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14803702|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14803703|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
14803704|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14803705|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
14803706|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14803707|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14803708|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14803709|NCT00802815|Etanercept|etanercept|mesh-list
14803710|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14803711|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14803712|NCT00802815|Analgesics|analgesics|mesh-ancestor
14803713|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
14803714|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803715|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803716|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803717|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14803718|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14803719|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14803720|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
14803721|NCT00802828|Famotidine|famotidine|mesh-list
14803722|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14803723|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14803724|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14803725|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
14803726|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
14803727|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803728|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803729|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803730|NCT00802906|Bevacizumab|bevacizumab|mesh-list
14803731|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14803732|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803733|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14803734|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14803735|NCT00802906|Growth Substances|growth substances|mesh-ancestor
15025366|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
15025367|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
14803736|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803737|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
14803738|NCT00802958|Clobetasol|clobetasol|mesh-list
14803739|NCT00802958|Halobetasol|halobetasol|mesh-list
14803740|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14803741|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803742|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
14803743|NCT00802958|Hormones|hormones|mesh-ancestor
14803744|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14803745|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803746|NCT00803166|Clobetasol|clobetasol|mesh-list
14803747|NCT00803166|Halobetasol|halobetasol|mesh-list
14803748|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14803749|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803750|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
14803751|NCT00803166|Hormones|hormones|mesh-ancestor
14803752|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14803753|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803754|NCT00803192|Famotidine|famotidine|mesh-list
14803755|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14803756|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14803757|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14803758|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
14803759|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
14803760|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803761|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803762|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803763|NCT00803218|Fluticasone|fluticasone|mesh-list
14803764|NCT00803218|Xhance|xhance|mesh-list
14803765|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803766|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14803767|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
14803768|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803769|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803770|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14803771|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
14803772|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
14803773|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15025368|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025369|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
15025370|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025371|NCT01937611|Midazolam|midazolam|mesh-list
15025372|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
15025373|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15025374|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025375|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025376|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15025377|NCT01937611|Analgesics|analgesics|mesh-ancestor
15025378|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
15025379|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025380|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15025381|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15025382|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15025383|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
15025384|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025385|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025386|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15025387|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15025388|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15025389|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15025390|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15025391|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
15025392|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
15025393|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
15025394|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
15025395|NCT01937650|Metronidazole|metronidazole|mesh-list
15025396|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025397|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15025398|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15025399|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15025400|NCT01937728|Interferons|interferons|mesh-list
15025401|NCT01937728|Ribavirin|ribavirin|mesh-list
15025402|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
15025403|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
15025404|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15025405|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025406|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
14803774|NCT00803309|Interferons|interferons|mesh-list
14803775|NCT00803309|Ribavirin|ribavirin|mesh-list
14803776|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
14803777|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
14803778|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14803779|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803780|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
14803781|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803782|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
14803783|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803784|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
14803785|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803786|NCT00803335|Estrogens|estrogens|mesh-list
14803787|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14803788|NCT00803335|Hormones|hormones|mesh-ancestor
14803789|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14803790|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803791|NCT00803374|Ipilimumab|ipilimumab|mesh-list
14803792|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14803793|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14803794|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803795|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14803796|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803797|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
14803798|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803799|NCT00803387|Travoprost|travoprost|mesh-list
14803800|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14803801|NCT00803439|Clobetasol|clobetasol|mesh-list
14803802|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803803|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
14803804|NCT00803439|Hormones|hormones|mesh-ancestor
14803805|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14803806|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803807|NCT00803465|Fluticasone|fluticasone|mesh-list
14803808|NCT00803465|Xhance|xhance|mesh-list
14803809|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803810|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14803811|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
14803812|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803813|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803814|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14803815|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
14803816|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
14803817|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14803818|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
14803819|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
14803820|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803821|NCT00803530|Protective Agents|protective agents|mesh-ancestor
14803822|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803823|NCT00803530|Vitamins|vitamins|mesh-ancestor
14803824|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
14803825|NCT00803556|Paclitaxel|paclitaxel|mesh-list
14803826|NCT00803556|Trastuzumab|trastuzumab|mesh-list
14803827|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14803828|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803829|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14803830|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14803831|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14803832|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803833|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14803834|NCT00803699|Selenium|selenium|mesh-list
14803835|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
14803836|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803837|NCT00803699|Protective Agents|protective agents|mesh-ancestor
14803838|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803839|NCT00803699|Trace Elements|trace elements|mesh-ancestor
14803840|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
14803841|NCT00803725|Fentanyl|fentanyl|mesh-list
14803842|NCT00803725|Mepivacaine|mepivacaine|mesh-list
14803843|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14803844|NCT00803725|Narcotics|narcotics|mesh-ancestor
14803845|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14803846|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803847|NCT00803725|Analgesics|analgesics|mesh-ancestor
14803848|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
14803849|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803850|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14803851|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14803852|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
14803853|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
14803854|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
14803855|NCT00803764|Naproxen|naproxen|mesh-list
14803856|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14803857|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15025407|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025408|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
15025409|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803858|NCT00803764|Analgesics|analgesics|mesh-ancestor
14803859|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
14803860|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803861|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803862|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803863|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14803864|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
14803865|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14803866|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803867|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803868|NCT00803803|Pilocarpine|pilocarpine|mesh-list
14803869|NCT00803803|Miotics|miotics|mesh-ancestor
14803870|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
14803871|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803872|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803873|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14803874|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14803875|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
14803876|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025410|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
15025411|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025412|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
15025413|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15025414|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
15025415|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803877|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803878|NCT00803816|Everolimus|everolimus|mesh-list
14803879|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803880|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14803881|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
14803882|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803883|NCT00803829|Sulfalene|sulfalene|mesh-list
14803884|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803885|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14803886|NCT00803829|Renal Agents|renal agents|mesh-ancestor
15025416|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025417|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15025418|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
15025419|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15025420|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
15025421|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025422|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025423|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15025424|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
15025425|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
15025426|NCT01937754|Protective Agents|protective agents|mesh-ancestor
15025427|NCT01937767|Fentanyl|fentanyl|mesh-list
15025428|NCT01937767|Remifentanil|remifentanil|mesh-list
15025429|NCT01937767|Propofol|propofol|mesh-list
15025430|NCT01937767|Sevoflurane|sevoflurane|mesh-list
15025431|NCT01937767|Rocuronium|rocuronium|mesh-list
15025432|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15025433|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025434|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025435|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15025436|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
15025437|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
15025438|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15025439|NCT01937767|Narcotics|narcotics|mesh-ancestor
15025440|NCT01937767|Analgesics|analgesics|mesh-ancestor
15025441|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
15025442|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025443|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15025444|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15025445|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15025446|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15025447|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15025448|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15025449|NCT01937806|Tenofovir|tenofovir|mesh-list
15025450|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
15025451|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025452|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15025453|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15025454|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803887|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
14803888|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14803889|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14803890|NCT00803842|Doxycycline|doxycycline|mesh-list
14803891|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14803892|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803893|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
14803894|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14803895|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14803896|NCT00803868|Varenicline|varenicline|mesh-list
14803897|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14803898|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14803899|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
14803900|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803901|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803902|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803903|NCT00803907|Imiquimod|imiquimod|mesh-list
14803904|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
14803905|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14803906|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803907|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803908|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
14803909|NCT00803933|Pentamidine|pentamidine|mesh-list
14803910|NCT00803933|Pafuramidine|pafuramidine|mesh-list
14803911|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
14803912|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14803913|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14803914|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14803915|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14803916|NCT00803946|Ibuprofen|ibuprofen|mesh-list
14803917|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14803918|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14803919|NCT00803946|Analgesics|analgesics|mesh-ancestor
14803920|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
14803921|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803922|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803923|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14803924|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14803925|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14803926|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803927|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803928|NCT00803972|Insulin|insulin|mesh-list
14803929|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14803930|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
14803931|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14803932|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803933|NCT00804050|Vitamins|vitamins|mesh-list
14803934|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
14803935|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803936|NCT00804115|Timolol|timolol|mesh-list
14803937|NCT00804115|Latanoprost|latanoprost|mesh-list
14803938|NCT00804115|Pilocarpine|pilocarpine|mesh-list
14803939|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14803940|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14803941|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
14803942|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803943|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803944|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803945|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14803946|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14803947|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15025455|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025456|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14803948|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14803949|NCT00804115|Miotics|miotics|mesh-ancestor
14803950|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
14803951|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14803952|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14803953|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14803954|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
14803955|NCT00804206|Bevacizumab|bevacizumab|mesh-list
14803956|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14803957|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803958|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14803959|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14803960|NCT00804206|Growth Substances|growth substances|mesh-ancestor
14803961|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803962|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
14803963|NCT00804219|Vaccines|vaccines|mesh-list
14803964|NCT00804219|Immunologic Factors|immunologic factors|mesh-ancestor
14803965|NCT00804219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803966|NCT00804245|Choline|choline|mesh-list
14803967|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
14803968|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14803969|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
14803970|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803971|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14803972|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14803973|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
14803974|NCT00804271|Memantine|memantine|mesh-list
14803975|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14803976|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14803977|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
14803978|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14803979|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803980|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025457|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15025458|NCT01937832|Ertapenem|ertapenem|mesh-list
15025459|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15025460|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025461|NCT01938092|Diazepam|diazepam|mesh-list
14525408|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
14525409|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525410|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
14525411|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
14525412|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525413|NCT04011592|Ketamine|ketamine|mesh-list
14525414|NCT04011592|Analgesics|analgesics|mesh-ancestor
14525415|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
14525416|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525417|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525418|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14525419|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14525420|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
14525421|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
14803981|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14803982|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14803983|NCT00804297|Octreotide|octreotide|mesh-list
14803984|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14803985|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14803986|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803987|NCT00804310|Lapatinib|lapatinib|mesh-list
14803988|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803989|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14803990|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14803991|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14803992|NCT00804336|Everolimus|everolimus|mesh-list
14803993|NCT00804336|Pasireotide|pasireotide|mesh-list
14803994|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14803995|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14803996|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
14803997|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14803998|NCT00804336|Hormones|hormones|mesh-ancestor
14803999|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804000|NCT00804388|Vitamin E|vitamin e|mesh-list
14804001|NCT00804388|Vitamins|vitamins|mesh-ancestor
14804002|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
14804003|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804004|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
14804005|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804006|NCT00804388|Protective Agents|protective agents|mesh-ancestor
14804007|NCT00804401|Naproxen|naproxen|mesh-list
14804008|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14804009|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14804010|NCT00804401|Analgesics|analgesics|mesh-ancestor
14804011|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
15025462|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15025463|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
15025464|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
15025465|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
15025466|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025467|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025468|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15025469|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14804012|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025470|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025471|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14804013|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804014|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804015|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14804016|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
14804017|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14804018|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804019|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804020|NCT00804440|Ibuprofen|ibuprofen|mesh-list
14804021|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14804022|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14804023|NCT00804440|Analgesics|analgesics|mesh-ancestor
14804024|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
14804025|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804026|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804027|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804028|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14804029|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14804030|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804031|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804032|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14804033|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
14804034|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14804035|NCT00804531|Prednisolone|prednisolone|mesh-list
14804036|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
14804037|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14804038|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
14804039|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804040|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
14804041|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
14804042|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804043|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804044|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14804045|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
14804046|NCT00804531|Hormones|hormones|mesh-ancestor
14804047|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804048|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14804049|NCT00804531|Protective Agents|protective agents|mesh-ancestor
14804050|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14804051|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804052|NCT00804622|Tenofovir|tenofovir|mesh-list
14804053|NCT00804622|Telbivudine|telbivudine|mesh-list
14804054|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
14804055|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804056|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15025472|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15025473|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15025474|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15025475|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15025476|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15025477|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
15025478|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
15025479|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
15025480|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
15025481|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025482|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025483|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
14804057|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14804058|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804059|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804060|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14804061|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14804062|NCT00804674|Bupivacaine|bupivacaine|mesh-list
14804063|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
14804064|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
14804065|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14804066|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804067|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
14804068|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804069|NCT00804752|Vitamin D|vitamin d|mesh-list
14804070|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
14804071|NCT00804752|Vitamins|vitamins|mesh-list
15025484|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15025485|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025486|NCT01938144|Acetaminophen|acetaminophen|mesh-list
15025487|NCT01938144|Ibuprofen|ibuprofen|mesh-list
15025488|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15025489|NCT01938144|Analgesics|analgesics|mesh-ancestor
15025490|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
15025491|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025492|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025493|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
15025494|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15025495|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15025496|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14804072|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
14804073|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804074|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14804075|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14804076|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14804077|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
14804078|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14804079|NCT00804830|Bevacizumab|bevacizumab|mesh-list
14804080|NCT00804830|Doxorubicin|doxorubicin|mesh-list
14804081|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14804082|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804083|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14804084|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14804085|NCT00804830|Growth Substances|growth substances|mesh-ancestor
14804086|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804087|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
14804088|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14804089|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14804090|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14804091|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804092|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804093|NCT00804856|Cytarabine|cytarabine|mesh-list
14804094|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15025497|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14804095|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
14804096|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025498|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025499|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025500|NCT01938183|Metronidazole|metronidazole|mesh-list
15025501|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025502|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15025503|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15025504|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15025505|NCT01938235|Exenatide|exenatide|mesh-list
15025506|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15025507|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025508|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15025509|NCT01938235|Incretins|incretins|mesh-ancestor
15025510|NCT01938235|Hormones|hormones|mesh-ancestor
15025511|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15025512|NCT01938248|Aspirin|aspirin|mesh-list
15025513|NCT01938248|Apixaban|apixaban|mesh-list
15025514|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15025515|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15025516|NCT01938248|Analgesics|analgesics|mesh-ancestor
15025517|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
15025518|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025519|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025520|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15025521|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15025522|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15025523|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15025524|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025525|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15025526|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15025527|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025528|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
14804097|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804098|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
14804099|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804100|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14804101|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
14804102|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804103|NCT00804895|Cortivazol|cortivazol|mesh-list
14804104|NCT00804895|Verapamil|verapamil|mesh-list
14804105|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14804106|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14804107|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14804108|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804109|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14804110|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804111|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
14804112|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804113|NCT00804921|Bevacizumab|bevacizumab|mesh-list
14804114|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14804115|NCT00804921|Acetazolamide|acetazolamide|mesh-list
14804116|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14804117|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804118|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14804119|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14804120|NCT00804921|Growth Substances|growth substances|mesh-ancestor
14804121|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804122|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
14804123|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14804124|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14804125|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14804126|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14804127|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
14804128|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14804129|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804130|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
14804131|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14804132|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804133|NCT00804921|Diuretics|diuretics|mesh-ancestor
14804134|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
14804135|NCT00804934|Ranibizumab|ranibizumab|mesh-list
14804136|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14804137|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14804138|NCT00804934|Growth Substances|growth substances|mesh-ancestor
14804139|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804140|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
14804141|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804142|NCT00804947|Melphalan|melphalan|mesh-list
14804143|NCT00804947|Busulfan|busulfan|mesh-list
14804144|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14804145|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
14804146|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804147|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804148|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14804149|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14804150|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
14804151|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804152|NCT00804960|Letrozole|letrozole|mesh-list
14804153|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804154|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14804155|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14804156|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804157|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804158|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14804159|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
14804160|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804161|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804162|NCT00805012|Docetaxel|docetaxel|mesh-list
14804163|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804164|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
14804165|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
14804166|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
14804167|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025529|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15025530|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
15025531|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15025532|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
15025533|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
15025534|NCT01938261|Acetaminophen|acetaminophen|mesh-list
15025535|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15025536|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15025537|NCT01938261|Analgesics|analgesics|mesh-ancestor
15025538|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
15025539|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025540|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025541|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
15025542|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
15025543|NCT01938300|Analgesics|analgesics|mesh-ancestor
15025544|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
15025545|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025546|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025547|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
15025548|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025549|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15025550|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
15025551|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15025552|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15025553|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025554|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15025555|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
15025556|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15025557|NCT01938417|Tobramycin|tobramycin|mesh-list
15025558|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15025559|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025560|NCT01938443|Trametinib|trametinib|mesh-list
15025561|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025562|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15025563|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025564|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025565|NCT01938456|Docetaxel|docetaxel|mesh-list
15025566|NCT01938456|Trametinib|trametinib|mesh-list
15025567|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025568|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
15025569|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
15025570|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
15025571|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025572|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15025573|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804168|NCT00805064|Triamcinolone|triamcinolone|mesh-list
14804169|NCT00805064|Bevacizumab|bevacizumab|mesh-list
14804170|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14804171|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804172|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14804173|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15025574|NCT01938508|Minocycline|minocycline|mesh-list
15025575|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15025576|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025577|NCT01938547|Clevidipine|clevidipine|mesh-list
14804174|NCT00805064|Growth Substances|growth substances|mesh-ancestor
14804175|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804176|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
14804177|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804178|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
14804179|NCT00805064|Hormones|hormones|mesh-ancestor
14804180|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804181|NCT00805090|Itraconazole|itraconazole|mesh-list
14804182|NCT00805090|Diclofenac|diclofenac|mesh-list
14804183|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14804184|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14804185|NCT00805090|Analgesics|analgesics|mesh-ancestor
14804186|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
14804187|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804188|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804189|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804190|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14804191|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14804192|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804193|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804194|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
14804195|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804196|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14804197|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14804198|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14804199|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
14804200|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804201|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14804202|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
15025578|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15025579|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15025580|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025581|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15025582|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804203|NCT00805116|Vitamins|vitamins|mesh-ancestor
14804204|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
14804205|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804206|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
14804207|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804208|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
14804209|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15025583|NCT01938612|Durvalumab|durvalumab|mesh-list
15025584|NCT01938612|Tremelimumab|tremelimumab|mesh-list
15025585|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15025586|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025587|NCT01938729|Gemcitabine|gemcitabine|mesh-list
15025588|NCT01938729|Dexamethasone|dexamethasone|mesh-list
15025589|NCT01938729|Floxuridine|floxuridine|mesh-list
15025590|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804210|NCT00805233|Bromfenac|bromfenac|mesh-list
14804211|NCT00805233|Ranibizumab|ranibizumab|mesh-list
14804212|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14804213|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14804214|NCT00805233|Growth Substances|growth substances|mesh-ancestor
14804215|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804216|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
14804217|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804218|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14804219|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14804220|NCT00805233|Analgesics|analgesics|mesh-ancestor
14804221|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
15025591|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
15025592|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
14804222|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804223|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804224|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14804225|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
14804226|NCT00805298|Epinephrine|epinephrine|mesh-list
14804227|NCT00805298|Racepinephrine|racepinephrine|mesh-list
14804228|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
14804229|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804230|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
14804231|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
14804232|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804233|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804234|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14804235|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
14804236|NCT00805298|Hormones|hormones|mesh-ancestor
14804237|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804238|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14804239|NCT00805298|Protective Agents|protective agents|mesh-ancestor
14804240|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14804241|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14804242|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
14804243|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14804244|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804245|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14804246|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14804247|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14804248|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
14804249|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
14804250|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
14804251|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14804252|NCT00805311|Aspirin|aspirin|mesh-list
14804253|NCT00805311|Losartan|losartan|mesh-list
14804254|NCT00805311|Amlodipine|amlodipine|mesh-list
14804255|NCT00805311|Atorvastatin|atorvastatin|mesh-list
15025593|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025594|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025595|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15025596|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
15025597|NCT01938729|Hormones|hormones|mesh-ancestor
15025598|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804256|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14804257|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14804258|NCT00805311|Analgesics|analgesics|mesh-ancestor
14804259|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
14804260|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804261|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804262|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804263|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14804264|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14804265|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14804266|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804267|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14804268|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14804269|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804270|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
14804271|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14804272|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14804273|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
14804274|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14804275|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14804276|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14804277|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14804278|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14804279|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14804280|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
14804281|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14804282|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14804283|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14804284|NCT00805519|Chloroquine|chloroquine|mesh-list
14804285|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14804286|NCT00805519|Prednisolone|prednisolone|mesh-list
14804287|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14804288|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
14804289|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14804290|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
14804291|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14804292|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
14804293|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804294|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
14804295|NCT00805519|Hormones|hormones|mesh-ancestor
14804296|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804297|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804298|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14804299|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804300|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
14804301|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
14804302|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804303|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14804304|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14804305|NCT00805519|Protective Agents|protective agents|mesh-ancestor
14804306|NCT00805519|Amebicides|amebicides|mesh-ancestor
15025599|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15025600|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025601|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15025602|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
15025603|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025604|NCT01938729|Antiviral Agents|antiviral agents|mesh-ancestor
15025605|NCT01938729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025606|NCT01938729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025607|NCT01938729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15025608|NCT01938729|Immunologic Factors|immunologic factors|mesh-ancestor
15025609|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
15025610|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
15025611|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
15025612|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025613|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025614|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
15025615|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025616|NCT01938781|Entecavir|entecavir|mesh-list
15025617|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
15025618|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804307|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14804308|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14804309|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804310|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
14804311|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14804312|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14804313|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14804314|NCT00805519|Analgesics|analgesics|mesh-ancestor
14804315|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
14804316|NCT00805519|Filaricides|filaricides|mesh-ancestor
14804317|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
14804318|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
15025619|NCT01938820|Entecavir|entecavir|mesh-list
15025620|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
14525422|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525423|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14525424|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14525425|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14804319|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
14804320|NCT00805558|Metronidazole|metronidazole|mesh-list
14804321|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
15025621|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025622|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15025623|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
14804322|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14804323|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14804324|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804325|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14804326|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14804327|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804328|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804329|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804330|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14804331|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
14804332|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14804333|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804334|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14804335|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14804336|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14804337|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14804338|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14804339|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14804340|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14804341|NCT00805649|Dexamethasone|dexamethasone|mesh-list
14804342|NCT00805649|Bevacizumab|bevacizumab|mesh-list
14804343|NCT00805649|Temazepam|temazepam|mesh-list
14804344|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14804345|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804346|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14804347|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14804348|NCT00805649|Growth Substances|growth substances|mesh-ancestor
14804349|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804350|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
14804351|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804352|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
14804353|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
14804354|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804355|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14804356|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
14804357|NCT00805649|Hormones|hormones|mesh-ancestor
14804358|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804359|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14804360|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14804361|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14804362|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14804363|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14804364|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14804365|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
14804366|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
14804367|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14804368|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804369|NCT00805662|Oxytocin|oxytocin|mesh-list
14804370|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
14804371|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14804372|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804373|NCT00805701|Dutasteride|dutasteride|mesh-list
14804374|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14804375|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14804376|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804377|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804378|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
14804379|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804380|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804381|NCT00805857|Tipranavir|tipranavir|mesh-list
14804382|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14804383|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14804384|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
14804385|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804386|NCT00806169|Triamcinolone|triamcinolone|mesh-list
14804387|NCT00806169|Bevacizumab|bevacizumab|mesh-list
14804388|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14804389|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804390|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14804391|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14804392|NCT00806169|Growth Substances|growth substances|mesh-ancestor
14804393|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804394|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
14804395|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804396|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
14804397|NCT00806169|Hormones|hormones|mesh-ancestor
14804398|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804399|NCT00806247|Tapentadol|tapentadol|mesh-list
14804400|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14804401|NCT00806247|Narcotics|narcotics|mesh-ancestor
14804402|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14804403|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804404|NCT00806247|Analgesics|analgesics|mesh-ancestor
14804405|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
14804406|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804407|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14804408|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14804409|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14804410|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804411|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
14525426|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525427|NCT04032327|Bupivacaine|bupivacaine|mesh-list
14525428|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
14525429|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
14525430|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14804412|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14804413|NCT00806299|Loperamide|loperamide|mesh-list
14804414|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
14804415|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14804416|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14804417|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
14804418|NCT00806468|Coagulants|coagulants|mesh-ancestor
14804419|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14804420|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
14525431|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525432|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
14804421|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804422|NCT00806481|Sevelamer|sevelamer|mesh-list
14525433|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525434|NCT04036292|Varenicline|varenicline|mesh-list
14525435|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14525436|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14525437|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
14525438|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025624|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15025625|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15025626|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15025627|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025628|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025629|NCT01938872|Paclitaxel|paclitaxel|mesh-list
15025630|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15025631|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025632|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
14804423|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
14804424|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
14804425|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025633|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
15025634|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
15025635|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025636|NCT01938911|Oxytocin|oxytocin|mesh-list
15025637|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
15025638|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15025639|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025640|NCT01939054|Docetaxel|docetaxel|mesh-list
15025641|NCT01939054|Capecitabine|capecitabine|mesh-list
15025642|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
15025643|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025644|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
14804426|NCT00806611|Ethanol|ethanol|mesh-list
14804427|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14804428|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804429|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14804430|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804431|NCT00806663|Sunitinib|sunitinib|mesh-list
14804432|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804433|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14804434|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14804435|NCT00806663|Growth Substances|growth substances|mesh-ancestor
14804436|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804437|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
14804438|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14804439|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804440|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804441|NCT00806741|Phenylephrine|phenylephrine|mesh-list
14804442|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
15025645|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
14804443|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
14804444|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14804445|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
14804446|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
14804447|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804448|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804449|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
14804450|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14804451|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
14804452|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
14804453|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14804454|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14804455|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14804456|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
14804457|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14804458|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804459|NCT00806741|Protective Agents|protective agents|mesh-ancestor
14804460|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025646|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
15025647|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025648|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15025649|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
15025650|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15025651|NCT01939093|Thiamine|thiamine|mesh-list
15025652|NCT01939093|Cinnarizine|cinnarizine|mesh-list
15025653|NCT01939093|Diazepam|diazepam|mesh-list
15025654|NCT01939093|Vitamins|vitamins|mesh-ancestor
15025655|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
14804461|NCT00806754|Ciclesonide|ciclesonide|mesh-list
14804462|NCT00806754|Azelastine|azelastine|mesh-list
14804463|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
15025656|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025657|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
15025658|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14525439|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525440|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525441|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
15025659|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
15025660|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
15025661|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
15025662|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025663|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15025664|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15025665|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025666|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15025667|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15025668|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14804464|NCT00806754|Hormones|hormones|mesh-ancestor
14804465|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804466|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804467|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14804468|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14804469|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
14804470|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804471|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14804472|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
15025669|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15025670|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14525442|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14525443|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525444|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14525445|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14525446|NCT04052204|Avelumab|avelumab|mesh-list
14525447|NCT04052204|Talazoparib|talazoparib|mesh-list
14525448|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14525449|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14525450|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14525451|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525452|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525453|NCT04067011|Doxycycline|doxycycline|mesh-list
14525454|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
14525455|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14525456|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804473|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14804474|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804475|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804476|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14804477|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14804478|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
14804479|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
14804480|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14804481|NCT00806767|Fludarabine|fludarabine|mesh-list
14804482|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
14804483|NCT00806767|Busulfan|busulfan|mesh-list
14804484|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
14804485|NCT00806767|Antibodies|antibodies|mesh-list
14804486|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
14804487|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14804488|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14804489|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804490|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14804491|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
14804492|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804493|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14804494|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
14804495|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804496|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
14804497|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14804498|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14804499|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
14804500|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14804501|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14804502|NCT00806871|Prednisolone|prednisolone|mesh-list
14804503|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
14804504|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14804505|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
14804506|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804507|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
14804508|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
14804509|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804510|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804511|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14804512|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
14804513|NCT00806871|Hormones|hormones|mesh-ancestor
14804514|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804515|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14804516|NCT00806871|Protective Agents|protective agents|mesh-ancestor
14804517|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14804518|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804519|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
14804520|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14804521|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804522|NCT00806910|Conivaptan|conivaptan|mesh-list
14804523|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14804524|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804525|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
14804526|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804527|NCT00806923|Gemcitabine|gemcitabine|mesh-list
14804528|NCT00806923|Bevacizumab|bevacizumab|mesh-list
14804529|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15025671|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15025672|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
15025673|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
15025674|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
15025675|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
15025676|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025677|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025678|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15025679|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15025680|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15025681|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15025682|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
14804530|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804531|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14804532|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14804533|NCT00806923|Growth Substances|growth substances|mesh-ancestor
14804534|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804535|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
14804536|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14804537|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
14804538|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804539|NCT00806923|Antiviral Agents|antiviral agents|mesh-ancestor
14804540|NCT00806923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804541|NCT00806923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804542|NCT00806923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14804543|NCT00806923|Immunologic Factors|immunologic factors|mesh-ancestor
14804544|NCT00806936|Insulin|insulin|mesh-list
14804545|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14804546|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14804547|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804548|NCT00806962|Vaccines|vaccines|mesh-list
14804549|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
14804550|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804551|NCT00807053|Ciclesonide|ciclesonide|mesh-list
14804552|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
14804553|NCT00807053|Hormones|hormones|mesh-ancestor
14804554|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804555|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804556|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14804557|NCT00807066|Gefitinib|gefitinib|mesh-list
14804558|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804559|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14804560|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804561|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804562|NCT00807079|Carboplatin|carboplatin|mesh-list
14804563|NCT00807079|Topotecan|topotecan|mesh-list
15025683|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
15025684|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
15025685|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
15025686|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025687|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15025688|NCT01939327|Rituximab|rituximab|mesh-list
15025689|NCT01939327|Lenalidomide|lenalidomide|mesh-list
15025690|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15025691|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025692|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
15025693|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025694|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15025695|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15025696|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15025697|NCT01939327|Growth Substances|growth substances|mesh-ancestor
15025698|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
15025699|NCT01939379|Acetaminophen|acetaminophen|mesh-list
15025700|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15025701|NCT01939379|Morphine|morphine|mesh-list
15025702|NCT01939379|Oxycodone|oxycodone|mesh-list
15025703|NCT01939379|Analgesics|analgesics|mesh-list
15025704|NCT01939379|Ropivacaine|ropivacaine|mesh-list
15025705|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15025706|NCT01939379|Narcotics|narcotics|mesh-ancestor
15025707|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025708|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025709|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
15025710|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025711|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
15025712|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
15025713|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15025714|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15025715|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804564|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025716|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15025717|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
15025718|NCT01939418|Gemcitabine|gemcitabine|mesh-list
14804565|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14804566|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14804567|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804568|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804569|NCT00807118|Fesoterodine|fesoterodine|mesh-list
14804570|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14804571|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14804572|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
14804573|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14804574|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804575|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804576|NCT00807118|Urological Agents|urological agents|mesh-ancestor
15025719|NCT01939418|Everolimus|everolimus|mesh-list
15025720|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025721|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15025722|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
15025723|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025724|NCT01939418|Antiviral Agents|antiviral agents|mesh-ancestor
15025725|NCT01939418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025726|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025727|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15025728|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
15025729|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025730|NCT01939444|Naloxone|naloxone|mesh-list
15025731|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15025732|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025733|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
15025734|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025735|NCT01939457|Misoprostol|misoprostol|mesh-list
15025736|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15025737|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
15025738|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15025739|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025740|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15025741|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15025742|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
15025743|NCT01939483|Irinotecan|irinotecan|mesh-list
15025744|NCT01939483|Camptothecin|camptothecin|mesh-list
15025745|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15025746|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15025747|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025748|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025749|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025750|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15025751|NCT01939509|Atenolol|atenolol|mesh-list
15025752|NCT01939509|Bisoprolol|bisoprolol|mesh-list
15025753|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15025754|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15025755|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
15025756|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
15025757|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025758|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025759|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15025760|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15025761|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15025762|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
15025763|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025764|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025765|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15025766|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
15025767|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025768|NCT01939561|Lamotrigine|lamotrigine|mesh-list
15025769|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
15025770|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15025771|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15025772|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025773|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15025774|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804577|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
14804578|NCT00807196|Rituximab|rituximab|mesh-list
14804579|NCT00807196|Fludarabine|fludarabine|mesh-list
14804580|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14804581|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
14804582|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804583|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14804584|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14804585|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
14804586|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804587|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804588|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14804589|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14804590|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14804591|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14804592|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804593|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14804594|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14804595|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14804596|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804597|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
14804598|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14804599|NCT00807261|Gemcitabine|gemcitabine|mesh-list
14804600|NCT00807261|Docetaxel|docetaxel|mesh-list
14804601|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14804602|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
14804603|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804604|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804605|NCT00807261|Antiviral Agents|antiviral agents|mesh-ancestor
14804606|NCT00807261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804607|NCT00807261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804608|NCT00807261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14804609|NCT00807261|Immunologic Factors|immunologic factors|mesh-ancestor
14804610|NCT00807261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804611|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
14804612|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
14804613|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
14804614|NCT00807326|Simethicone|simethicone|mesh-list
14804615|NCT00807326|Loperamide|loperamide|mesh-list
14804616|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
14804617|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14804618|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
14804619|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804620|NCT00807326|Emollients|emollients|mesh-ancestor
14804621|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
14804622|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
14804623|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14804624|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14804625|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
14804626|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804627|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14804628|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14804629|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804630|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804631|NCT00807521|Dexamethasone|dexamethasone|mesh-list
14804632|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804633|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
14804634|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
14804635|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804636|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804637|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14804638|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
14804639|NCT00807521|Hormones|hormones|mesh-ancestor
14804640|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804641|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14804642|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804643|NCT00807534|Bromides|bromides|mesh-list
14804644|NCT00807534|Ipratropium|ipratropium|mesh-list
14804645|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
14804646|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14804647|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
14804648|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804649|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804650|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14804651|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
14804652|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14804653|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
14804654|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14804655|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804656|NCT00807547|Vaccines|vaccines|mesh-list
14804657|NCT00807547|Immunologic Factors|immunologic factors|mesh-ancestor
14804658|NCT00807547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804659|NCT00807625|Copper|copper|mesh-list
14804660|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14804661|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
14804662|NCT00807625|Trace Elements|trace elements|mesh-ancestor
14804663|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
14804664|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804665|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14804666|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
14804667|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14804668|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14804669|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14804670|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14804671|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804672|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14804673|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14804674|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14804675|NCT00807690|Tacrolimus|tacrolimus|mesh-list
15025775|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15025776|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15025777|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025778|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15025779|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15025780|NCT01939574|Bevacizumab|bevacizumab|mesh-list
15025781|NCT01939574|Temozolomide|temozolomide|mesh-list
15025782|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15025783|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025784|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15025785|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15025786|NCT01939574|Growth Substances|growth substances|mesh-ancestor
15025787|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025788|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
15025789|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15025790|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
15025791|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025792|NCT01939639|Oxytocin|oxytocin|mesh-list
15025793|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
14804676|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14804677|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
14804678|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804679|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14804680|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804681|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804682|NCT00807755|Carboplatin|carboplatin|mesh-list
14804683|NCT00807755|Etoposide|etoposide|mesh-list
14804684|NCT00807755|Everolimus|everolimus|mesh-list
14804685|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804686|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14804687|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14804688|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14804689|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804690|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804691|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14804692|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
14804693|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804694|NCT00807807|Folic Acid|folic acid|mesh-list
14804695|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
14804696|NCT00807807|Hematinics|hematinics|mesh-ancestor
14804697|NCT00807807|Vitamins|vitamins|mesh-ancestor
14804698|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
14804699|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804700|NCT00807859|Paclitaxel|paclitaxel|mesh-list
14804701|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14804702|NCT00807859|Capecitabine|capecitabine|mesh-list
14804703|NCT00807859|Trastuzumab|trastuzumab|mesh-list
14804704|NCT00807859|Lapatinib|lapatinib|mesh-list
14804705|NCT00807859|Trebananib|trebananib|mesh-list
14804706|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14804707|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804708|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
15025794|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15025795|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025796|NCT01939691|Prednisolone|prednisolone|mesh-list
15025797|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15025798|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
15025799|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15025800|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
15025801|NCT01939691|Nepafenac|nepafenac|mesh-list
15025802|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14804709|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
14804710|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
14804711|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804712|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14804713|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
14804714|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14804715|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14804716|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804717|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14804718|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14804719|NCT00807859|Growth Substances|growth substances|mesh-ancestor
14804720|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804721|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
15025803|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
15025804|NCT01939691|Difluprednate|difluprednate|mesh-list
15025805|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15025806|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
15025807|NCT01939691|Hormones|hormones|mesh-ancestor
15025808|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15025809|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025810|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15025811|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804722|NCT00807872|Antibodies|antibodies|mesh-list
14804723|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14804724|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
14804725|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804726|NCT00807950|Simvastatin|simvastatin|mesh-list
14804727|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14804728|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14804729|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
14804730|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804731|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14804732|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14804733|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025812|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
14804734|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
14804735|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14804736|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804737|NCT00808002|Tenofovir|tenofovir|mesh-list
14804738|NCT00808002|Emtricitabine|emtricitabine|mesh-list
14804739|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
14804740|NCT00808002|Maraviroc|maraviroc|mesh-list
14804741|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
14804742|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804743|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14804744|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14804745|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804746|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804747|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14804748|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14804749|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14804750|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14804751|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14804752|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14804753|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14804754|NCT00808054|Lidocaine|lidocaine|mesh-list
14804755|NCT00808054|Prilocaine|prilocaine|mesh-list
14804756|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
14804757|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
14804758|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14804759|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804760|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
14804761|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804762|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14804763|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14804764|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14804765|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14804766|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804767|NCT00808145|Gemcitabine|gemcitabine|mesh-list
14804768|NCT00808145|Cisplatin|cisplatin|mesh-list
14804769|NCT00808145|Sorafenib|sorafenib|mesh-list
14804770|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804771|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14804772|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
14804773|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804774|NCT00808145|Antiviral Agents|antiviral agents|mesh-ancestor
14804775|NCT00808145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025813|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
15025814|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804776|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804777|NCT00808145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14804778|NCT00808145|Immunologic Factors|immunologic factors|mesh-ancestor
14804779|NCT00808145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025815|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15025816|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15025817|NCT01939691|Protective Agents|protective agents|mesh-ancestor
15025818|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15025819|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15025820|NCT01939691|Analgesics|analgesics|mesh-ancestor
15025821|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
15025822|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15025823|NCT01939730|Rituximab|rituximab|mesh-list
15025824|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15025825|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025826|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
15025827|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025828|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15025829|NCT01939743|Diclofenac|diclofenac|mesh-list
15025830|NCT01939743|Lidocaine|lidocaine|mesh-list
15025831|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
15025832|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
15025833|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14804780|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14804781|NCT00808171|Lidocaine|lidocaine|mesh-list
14804782|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
14804783|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
15025834|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025835|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
15025836|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025837|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15025838|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15025839|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14804784|NCT00808171|Prilocaine|prilocaine|mesh-list
14804785|NCT00808171|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14804786|NCT00808171|Anesthetics|anesthetics|mesh-list
14804787|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14804788|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804789|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
14804790|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804791|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14804792|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14804793|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14804794|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14804795|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025840|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15025841|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804796|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14804797|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
14804798|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14804799|NCT00808171|Analgesics|analgesics|mesh-ancestor
14804800|NCT00808171|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14804801|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
14804802|NCT00808184|Midazolam|midazolam|mesh-list
14804803|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14804804|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14804805|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14804806|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804807|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14804808|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14804809|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14804810|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14804811|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
14804812|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
14804813|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
14804814|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
14804815|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14804816|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804817|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14804818|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14804819|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
14804820|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804821|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14804822|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14804823|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804824|NCT00808223|Alefacept|alefacept|mesh-list
14804825|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
14804826|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
14804827|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804828|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
14804829|NCT00808275|Calcium|calcium|mesh-list
14804830|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14804831|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804832|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14804833|NCT00808314|Dipyridamole|dipyridamole|mesh-list
14804834|NCT00808314|Regadenoson|regadenoson|mesh-list
14804835|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14804836|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804837|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804838|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14804839|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
14804840|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
14804841|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14804842|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
14804843|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
14804844|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14804845|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804846|NCT00808327|Fentanyl|fentanyl|mesh-list
14804847|NCT00808327|Bupivacaine|bupivacaine|mesh-list
14804848|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
14804849|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
14804850|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14804851|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804852|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
14804853|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804854|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14804855|NCT00808327|Narcotics|narcotics|mesh-ancestor
14804856|NCT00808327|Analgesics|analgesics|mesh-ancestor
14804857|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14804858|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14804859|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
14804860|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
14804861|NCT00808366|Clotrimazole|clotrimazole|mesh-list
14804862|NCT00808366|Miconazole|miconazole|mesh-list
14804863|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
14804864|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804865|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14804866|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14804867|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14804868|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804869|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804870|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14804871|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
14804872|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804873|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804874|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14804875|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14804876|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
15025842|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14804877|NCT00808392|Vaccines|vaccines|mesh-list
14804878|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
14804879|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804880|NCT00808418|Docetaxel|docetaxel|mesh-list
14804881|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025843|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15025844|NCT01939743|Analgesics|analgesics|mesh-ancestor
15025845|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15025846|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15025847|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15025848|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025849|NCT01939834|Insulin|insulin|mesh-list
15025850|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15025851|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804882|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
14804883|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
14804884|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
14804885|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804886|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14804887|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14804888|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14804889|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
14804890|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804891|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15025852|NCT01939886|Artesunate|artesunate|mesh-list
14804892|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14804893|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025853|NCT01939886|Lumefantrine|lumefantrine|mesh-list
15025854|NCT01939886|Artemether|artemether|mesh-list
15025855|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15025856|NCT01939886|Mefloquine|mefloquine|mesh-list
15025857|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
15025858|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15025859|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14804894|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
14804895|NCT00808704|Hematinics|hematinics|mesh-ancestor
14804896|NCT00808717|Atorvastatin|atorvastatin|mesh-list
14804897|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14804898|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14804899|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
14804900|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804901|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14804902|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15025860|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025861|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025862|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
15025863|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
15025864|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15025865|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
15025866|NCT01939912|Adenosine|adenosine|mesh-list
15025867|NCT01939912|Analgesics|analgesics|mesh-ancestor
15025868|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
15025869|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025870|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025871|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15025872|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
14804903|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804904|NCT00808743|Celecoxib|celecoxib|mesh-list
14804905|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14804906|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14804907|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14804908|NCT00808743|Analgesics|analgesics|mesh-ancestor
14804909|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
14804910|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804911|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804912|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15025873|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15025874|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
15025875|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
15025876|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025877|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025878|NCT01939990|Nebivolol|nebivolol|mesh-list
15025879|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15025880|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
14804913|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14804914|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14804915|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14804916|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804917|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804918|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14804919|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14804920|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
14804921|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14804922|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
14804923|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14804924|NCT00808795|Expectorants|expectorants|mesh-ancestor
14804925|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
14804926|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14804927|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
14804928|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804929|NCT00808795|Protective Agents|protective agents|mesh-ancestor
14804930|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804931|NCT00808795|Antidotes|antidotes|mesh-ancestor
14804932|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
14804933|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
14804934|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15025881|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15025882|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14804935|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14804936|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804937|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804938|NCT00808912|Urological Agents|urological agents|mesh-ancestor
14804939|NCT00808951|Artesunate|artesunate|mesh-list
14804940|NCT00808951|Lumefantrine|lumefantrine|mesh-list
14804941|NCT00808951|Artemether|artemether|mesh-list
14804942|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14804943|NCT00808951|Amodiaquine|amodiaquine|mesh-list
14804944|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
14804945|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15025883|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15025884|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
15025885|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025886|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025887|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025888|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
15025889|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025890|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804946|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14804947|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15025891|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025892|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14804948|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804949|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
14804950|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
14804951|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14804952|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
14804953|NCT00808977|Mesalamine|mesalamine|mesh-list
14804954|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14804955|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15025893|NCT01940172|Conatumumab|conatumumab|mesh-list
15025894|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15025895|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025896|NCT01940224|Pregabalin|pregabalin|mesh-list
15025897|NCT01940224|Morphine|morphine|mesh-list
15025898|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15025899|NCT01940224|Narcotics|narcotics|mesh-ancestor
15025900|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025901|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804956|NCT00808977|Analgesics|analgesics|mesh-ancestor
14804957|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
14804958|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14804959|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804960|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14804961|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15025902|NCT01940224|Analgesics|analgesics|mesh-ancestor
15025903|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
15025904|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025905|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
15025906|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15025907|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15025908|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804962|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14804963|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14804964|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804965|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
14804966|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14804967|NCT00809029|Incretins|incretins|mesh-ancestor
14804968|NCT00809029|Hormones|hormones|mesh-ancestor
14804969|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804970|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804971|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
14804972|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804973|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
14804974|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14804975|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804976|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14804977|NCT00809068|Tibolone|tibolone|mesh-list
14804978|NCT00809068|Fenofibrate|fenofibrate|mesh-list
14804979|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14804980|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
14804981|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14804982|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14804983|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
14804984|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
14804985|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14804986|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804987|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14804988|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14804989|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14804990|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14804991|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
14804992|NCT00809068|Hormones|hormones|mesh-ancestor
14804993|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14804994|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14804995|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14804996|NCT00809172|Cyclosporine|cyclosporine|mesh-list
14804997|NCT00809172|Methotrexate|methotrexate|mesh-list
14804998|NCT00809172|Cyclosporins|cyclosporins|mesh-list
14804999|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14805000|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
14805001|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14805002|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805003|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14805004|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
14805005|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805006|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805007|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
14805008|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805009|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14805010|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14805011|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
14805012|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14805013|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14805014|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
14805015|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805016|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14805017|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14805018|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
14805019|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14805020|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
14805021|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805022|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
14805023|NCT00809198|Protective Agents|protective agents|mesh-ancestor
14805024|NCT00809198|Laxatives|laxatives|mesh-ancestor
14805025|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14805026|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
14805027|NCT00809237|Gefitinib|gefitinib|mesh-list
14805028|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
14805029|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14805030|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14805031|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805032|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805033|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805034|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14805035|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805036|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14805037|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
14805038|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14805039|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805040|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14805041|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14805042|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805043|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805044|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805045|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
14805046|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14805047|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14805048|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805049|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
14805050|NCT00809393|Coagulants|coagulants|mesh-ancestor
14805051|NCT00809536|Metformin|metformin|mesh-list
14805052|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14805053|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805054|NCT00809549|Lenograstim|lenograstim|mesh-list
14805055|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14805056|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
15025909|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15025910|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15025911|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15025912|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15034801|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15034802|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034803|NCT01997580|Citalopram|citalopram|mesh-list
15034804|NCT01997580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15034805|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15034806|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15034807|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15034808|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15034809|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
15034810|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034811|NCT01997580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15034812|NCT01997580|Antidepressive Agents|antidepressive agents|mesh-ancestor
15034813|NCT01997580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15034814|NCT01997593|Ropivacaine|ropivacaine|mesh-list
15034815|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
15034816|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
15034817|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14805057|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805058|NCT00809627|Caffeine|caffeine|mesh-list
14805059|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14805060|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805061|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14805062|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805063|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805064|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15025913|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
15025914|NCT01940250|Analgesics|analgesics|mesh-ancestor
14805065|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14805066|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
14805067|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14805068|NCT00809692|Histamine|histamine|mesh-list
14805069|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
14805070|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
14805071|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
14805072|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14805073|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805074|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805075|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14805076|NCT00809705|Incretins|incretins|mesh-ancestor
14805077|NCT00809705|Hormones|hormones|mesh-ancestor
14805078|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805079|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805080|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
14805081|NCT00809718|Rifapentine|rifapentine|mesh-list
14805082|NCT00809718|Rifampin|rifampin|mesh-list
14805083|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15025915|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
15025916|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025917|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025918|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
15025919|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15025920|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15025921|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
15025922|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15025923|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15025924|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025925|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15025926|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
15025927|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15025928|NCT01940393|Cetirizine|cetirizine|mesh-list
15025929|NCT01940393|Fexofenadine|fexofenadine|mesh-list
15025930|NCT01940393|Desloratadine|desloratadine|mesh-list
14805084|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14805085|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
14805086|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805087|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14805088|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15025931|NCT01940393|Ebastine|ebastine|mesh-list
14805089|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805090|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805091|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14805092|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
14805093|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14805094|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
14805095|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14805096|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14805097|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14805098|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14805099|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14805100|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14805101|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14805102|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
14805103|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14805104|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805105|NCT00809744|Vitamins|vitamins|mesh-ancestor
14805106|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
14805107|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14805108|NCT00809796|Pentamidine|pentamidine|mesh-list
14805109|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
14805110|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805111|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14805112|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14805113|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14805114|NCT00809874|Caseins|caseins|mesh-list
14805115|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
14805116|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
14805117|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805118|NCT00809887|Micafungin|micafungin|mesh-list
14805119|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
14805120|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805121|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
14805122|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14805123|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805124|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14805125|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14805126|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805127|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805128|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805129|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14805130|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14805131|NCT00809939|Progesterone|progesterone|mesh-list
14805132|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
14805133|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
14805134|NCT00809939|Progestins|progestins|mesh-ancestor
14805135|NCT00809939|Hormones|hormones|mesh-ancestor
14805136|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805137|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805138|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14805139|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
14805140|NCT00810017|Trastuzumab|trastuzumab|mesh-list
14805141|NCT00810017|Etoposide|etoposide|mesh-list
14805142|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14805143|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805144|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15025932|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15025933|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15025934|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15025935|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
15025936|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
15025937|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15025938|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025939|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805145|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14805146|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14805147|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805148|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025940|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15025941|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
15025942|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
15025943|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15025944|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14805149|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14805150|NCT00810030|Hematinics|hematinics|mesh-ancestor
14805151|NCT00810121|Ketoprofen|ketoprofen|mesh-list
14805152|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14805153|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14805154|NCT00810121|Analgesics|analgesics|mesh-ancestor
14805155|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
14805156|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15025945|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025946|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
15025947|NCT01940419|Coagulants|coagulants|mesh-ancestor
15025948|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
14805157|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805158|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14805159|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14805160|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15025949|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15025950|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15025951|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025952|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
15025953|NCT01940536|Coagulants|coagulants|mesh-ancestor
15025954|NCT01940601|Lenograstim|lenograstim|mesh-list
15025955|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15025956|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
15025957|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025958|NCT01940627|Ubiquinone|ubiquinone|mesh-list
15025959|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
15025960|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
15025961|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025962|NCT01940627|Vitamins|vitamins|mesh-ancestor
15025963|NCT01940653|Estradiol|estradiol|mesh-list
15025964|NCT01940653|Progesterone|progesterone|mesh-list
15025965|NCT01940653|Estrogens|estrogens|mesh-ancestor
15025966|NCT01940653|Hormones|hormones|mesh-ancestor
14525457|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
14525458|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14525459|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14805161|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525460|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14525461|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14525462|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525463|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525464|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14525465|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14525466|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14525467|NCT04085341|Sunitinib|sunitinib|mesh-list
14805162|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805163|NCT00810316|Clonazepam|clonazepam|mesh-list
14805164|NCT00810316|Alprazolam|alprazolam|mesh-list
14805165|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14805166|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14805167|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805168|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14805169|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14805170|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14805171|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
14805172|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
14805173|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14805174|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805175|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
14805176|NCT00810381|Nitroprusside|nitroprusside|mesh-list
14805177|NCT00810381|Isosorbide|isosorbide|mesh-list
14805178|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14805179|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14805180|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
14805181|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
14805182|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14805183|NCT00810381|Diuretics|diuretics|mesh-ancestor
14805184|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
14805185|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805186|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14805187|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805188|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14805189|NCT00810446|Rifabutin|rifabutin|mesh-list
14805190|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14805191|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805192|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14805193|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
14805194|NCT00810524|Lamivudine|lamivudine|mesh-list
14805195|NCT00810524|Adefovir|adefovir|mesh-list
14805196|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14805197|NCT00810524|Telbivudine|telbivudine|mesh-list
14805198|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14805199|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14805200|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805201|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805202|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
14805203|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805204|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14805205|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14805206|NCT00810563|Bupivacaine|bupivacaine|mesh-list
14805207|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
14805208|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
14805209|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14805210|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805211|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
14805212|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14805213|NCT00810589|Insulin|insulin|mesh-list
14805214|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14805215|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
14805216|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
14805217|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14805218|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805219|NCT00810680|Valproic Acid|valproic acid|mesh-list
14805220|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
14805221|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805222|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805223|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
14805224|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14805225|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805226|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
14805227|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14805228|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14805229|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14805230|NCT00810706|Exemestane|exemestane|mesh-list
14805231|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805232|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14805233|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14805234|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034818|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025967|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15025968|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025969|NCT01940653|Progestins|progestins|mesh-ancestor
14805235|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805236|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14805237|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
14805238|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805239|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805240|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14805241|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
15025970|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
15025971|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15025972|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15025973|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025974|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
15025975|NCT01940692|Coagulants|coagulants|mesh-ancestor
15025976|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
15025977|NCT01940718|Testosterone|testosterone|mesh-list
15025978|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
15025979|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
15025980|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15025981|NCT01940718|Androgens|androgens|mesh-ancestor
15025982|NCT01940718|Hormones|hormones|mesh-ancestor
15025983|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15025984|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025985|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15025986|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025987|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
15025988|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15025989|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15025990|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15025991|NCT01940952|Donepezil|donepezil|mesh-list
14805242|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14805243|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
14805244|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805245|NCT00810849|Prednisolone|prednisolone|mesh-list
14805246|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14805247|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
14805248|NCT00810849|Hormones|hormones|mesh-ancestor
14805249|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805250|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805251|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14805252|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805253|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
14805254|NCT00810862|Lactitol|lactitol|mesh-list
14805255|NCT00810862|Cathartics|cathartics|mesh-ancestor
14805256|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15025992|NCT01940952|Udenafil|udenafil|mesh-list
15025993|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15025994|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15025995|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15025996|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
15025997|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14805257|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14805258|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14805259|NCT00810862|Analgesics|analgesics|mesh-ancestor
14805260|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
14805261|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14805262|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805263|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14805264|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14805265|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
14805266|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14805267|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
14805268|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14805269|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805270|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805271|NCT00810914|Bupivacaine|bupivacaine|mesh-list
14805272|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
14805273|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
14805274|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14805275|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805276|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
14805277|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14805278|NCT00810940|Mannitol|mannitol|mesh-list
14805279|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14805280|NCT00810940|Diuretics|diuretics|mesh-ancestor
15025998|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15025999|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
15026000|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15026001|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15026002|NCT01940965|Lixisenatide|lixisenatide|mesh-list
15026003|NCT01940965|Biguanides|biguanides|mesh-list
14805281|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
14805282|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805283|NCT00810953|Pentamidine|pentamidine|mesh-list
14805284|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
14805285|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805286|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14805287|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15026004|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15026005|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026006|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
15026007|NCT01940978|Methylphenidate|methylphenidate|mesh-list
15026008|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15026009|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026010|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15026011|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15026012|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15026013|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026014|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
15026015|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14805288|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14805289|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
15026016|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
14805290|NCT00811005|Methoxsalen|methoxsalen|mesh-list
14805291|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14805292|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
14805293|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14805294|NCT00811031|Prednisone|prednisone|mesh-list
14805295|NCT00811031|Docetaxel|docetaxel|mesh-list
14805296|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805297|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
14805298|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
14805299|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
14805300|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805301|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14805302|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
14805303|NCT00811031|Hormones|hormones|mesh-ancestor
14805304|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805305|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805306|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14805307|NCT00811083|Succimer|succimer|mesh-list
14805308|NCT00811083|Antidotes|antidotes|mesh-ancestor
14805309|NCT00811083|Protective Agents|protective agents|mesh-ancestor
14805310|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805311|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
14805312|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
14805313|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805314|NCT00811096|Chloroquine|chloroquine|mesh-list
14805315|NCT00811096|Tinidazole|tinidazole|mesh-list
14805316|NCT00811096|Amebicides|amebicides|mesh-ancestor
14805317|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14805318|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14805319|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805320|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
14805321|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14805322|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
14805323|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805324|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14805325|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14805326|NCT00811122|Corticosterone|corticosterone|mesh-list
14805327|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15026017|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
15026018|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15026019|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15026020|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
15026021|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
15026022|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15026023|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
15026024|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15026025|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15026026|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15026027|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026028|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15026029|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
15026030|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026031|NCT01941056|Vaccines|vaccines|mesh-list
15026032|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
14805328|NCT00811200|Triamcinolone|triamcinolone|mesh-list
14805329|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14805330|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14805331|NCT00811200|Ranibizumab|ranibizumab|mesh-list
14805332|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14805333|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14805334|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14805335|NCT00811200|Growth Substances|growth substances|mesh-ancestor
14805336|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805337|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
14805338|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805339|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14805340|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
14805341|NCT00811200|Hormones|hormones|mesh-ancestor
14805342|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805343|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14805344|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
14805345|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805346|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805347|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14805348|NCT00811226|Olmesartan|olmesartan|mesh-list
14805349|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14805350|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14805351|NCT00811226|Diuretics|diuretics|mesh-ancestor
14805352|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
14805353|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805354|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14805355|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14805356|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805357|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14805358|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14805359|NCT00811239|Antivenins|antivenins|mesh-list
14805360|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
14805361|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805362|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
14805363|NCT00811291|Folic Acid|folic acid|mesh-list
14805364|NCT00811291|Calcium|calcium|mesh-list
14805365|NCT00811291|Vitamins|vitamins|mesh-ancestor
14805366|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
14805367|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805368|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14805369|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14805370|NCT00811291|Hematinics|hematinics|mesh-ancestor
14805371|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
14805372|NCT00811330|Atorvastatin|atorvastatin|mesh-list
14805373|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14805374|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14805375|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
14805376|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805377|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14805378|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14805379|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805380|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
14805381|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14805382|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14805383|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14805384|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
14805385|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805386|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14805387|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14805388|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805389|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14805390|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805391|NCT00811369|Fulvestrant|fulvestrant|mesh-list
14805392|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14805393|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805394|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14805395|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14805396|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
14805397|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805398|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805399|NCT00811408|Cidofovir|cidofovir|mesh-list
14805400|NCT00811408|Carboplatin|carboplatin|mesh-list
14805401|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805402|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
14805403|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805404|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805405|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805406|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
14805407|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
14805408|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14805409|NCT00811421|Mefloquine|mefloquine|mesh-list
14805410|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
14805411|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14805412|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14805413|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805414|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14805415|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805416|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805417|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14805418|NCT00811421|Renal Agents|renal agents|mesh-ancestor
14805419|NCT00811447|Docetaxel|docetaxel|mesh-list
14805420|NCT00811447|Fluorouracil|fluorouracil|mesh-list
14805421|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805422|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
14805423|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
14805424|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
14805425|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805426|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
14805427|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14805428|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14805429|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
14805430|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805431|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
14805432|NCT00811460|Incretins|incretins|mesh-ancestor
14805433|NCT00811460|Hormones|hormones|mesh-ancestor
14805434|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805435|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805436|NCT00811486|Spironolactone|spironolactone|mesh-list
14805437|NCT00811486|Conivaptan|conivaptan|mesh-list
14805438|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14805439|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
14805440|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805441|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805442|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14805443|NCT00811486|Diuretics|diuretics|mesh-ancestor
14805444|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
14805445|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14805446|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805447|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14805448|NCT00811603|Cefazolin|cefazolin|mesh-list
14805449|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805450|NCT00811681|Pioglitazone|pioglitazone|mesh-list
14805451|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14805452|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805453|NCT00811746|Eszopiclone|eszopiclone|mesh-list
14805454|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14805455|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14805456|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805457|NCT00811759|Temozolomide|temozolomide|mesh-list
14805458|NCT00811759|Sorafenib|sorafenib|mesh-list
14805459|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14805460|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
14805461|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805462|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805463|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14805464|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805465|NCT00811785|Copper|copper|mesh-list
14805466|NCT00811785|Trace Elements|trace elements|mesh-ancestor
14805467|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
14805468|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805469|NCT00811837|Midazolam|midazolam|mesh-list
14805470|NCT00811837|Remifentanil|remifentanil|mesh-list
14805471|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14805472|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14805473|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14805474|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805475|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14805476|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14805477|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14805478|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14805479|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
14805480|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
14805481|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
14805482|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
14805483|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14805484|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805485|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14805486|NCT00811837|Narcotics|narcotics|mesh-ancestor
14805487|NCT00811837|Analgesics|analgesics|mesh-ancestor
14805488|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
14805489|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14805490|NCT00811876|Leuprolide|leuprolide|mesh-list
14805491|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14805492|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
14805493|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14805494|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805495|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14805496|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805497|NCT00811915|Sirolimus|sirolimus|mesh-list
14805498|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14805499|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805500|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14805501|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805502|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
14805503|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14805504|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
14805505|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805506|NCT00811967|Ribavirin|ribavirin|mesh-list
14805507|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14805508|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
14805509|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
14805510|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805511|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
14805512|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805513|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
14805514|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805515|NCT00811980|Vancomycin|vancomycin|mesh-list
14805516|NCT00811980|Linezolid|linezolid|mesh-list
14805517|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14805518|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805519|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14805520|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805521|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805522|NCT00811993|Gemcitabine|gemcitabine|mesh-list
14805523|NCT00811993|Etoposide|etoposide|mesh-list
14805524|NCT00811993|Docetaxel|docetaxel|mesh-list
14805525|NCT00811993|Bevacizumab|bevacizumab|mesh-list
14805526|NCT00811993|Carboplatin|carboplatin|mesh-list
14805527|NCT00811993|Capecitabine|capecitabine|mesh-list
14805528|NCT00811993|Trastuzumab|trastuzumab|mesh-list
14805529|NCT00811993|Irinotecan|irinotecan|mesh-list
14805530|NCT00811993|Cetuximab|cetuximab|mesh-list
14805531|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14805532|NCT00811993|Temozolomide|temozolomide|mesh-list
14805533|NCT00811993|Sorafenib|sorafenib|mesh-list
14805534|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14805535|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805536|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
14805537|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
14805538|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
14805539|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805540|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14805541|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14805542|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14805543|NCT00811993|Growth Substances|growth substances|mesh-ancestor
14805544|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805545|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
14805546|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14805547|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
14805548|NCT00811993|Antiviral Agents|antiviral agents|mesh-ancestor
14805549|NCT00811993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805550|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805551|NCT00811993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14805552|NCT00811993|Immunologic Factors|immunologic factors|mesh-ancestor
14805553|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14805554|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14805555|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14805556|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14805557|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14805558|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
14805559|NCT00812019|Vaccines|vaccines|mesh-list
14805560|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
14805561|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
14805562|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805563|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14805564|NCT00812032|Aspirin|aspirin|mesh-list
14805565|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14805566|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14805567|NCT00812032|Analgesics|analgesics|mesh-ancestor
14805568|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
14805569|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14805570|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805571|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14805572|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14805573|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15026033|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026034|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
15026035|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15026036|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
15026037|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
15026038|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
15026039|NCT01941134|Estradiol|estradiol|mesh-list
15026040|NCT01941134|Estrogens|estrogens|mesh-ancestor
15026041|NCT01941134|Hormones|hormones|mesh-ancestor
15026042|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026043|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026044|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15026045|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15026046|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15026047|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15026048|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15026049|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15026050|NCT01941173|Leucovorin|leucovorin|mesh-list
15026051|NCT01941173|Fluorouracil|fluorouracil|mesh-list
15026052|NCT01941173|Irinotecan|irinotecan|mesh-list
15026053|NCT01941173|Aflibercept|aflibercept|mesh-list
15026054|NCT01941173|Calcium|calcium|mesh-list
15026055|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
15026056|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
15026057|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14805574|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14805575|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805576|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14805577|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14805578|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805579|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
14805580|NCT00812123|Cyclosporine|cyclosporine|mesh-list
14805581|NCT00812123|Sirolimus|sirolimus|mesh-list
14805582|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
14805583|NCT00812123|Prednisone|prednisone|mesh-list
14805584|NCT00812123|Cyclosporins|cyclosporins|mesh-list
14805585|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14805586|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
14805587|NCT00812123|Hormones|hormones|mesh-ancestor
14805588|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805589|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805590|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14805591|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805592|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805593|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805594|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14805595|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
14805596|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
15026058|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026059|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
14805597|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15034819|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
14805598|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
14805599|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14805600|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14805601|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14805602|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14805603|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
14805604|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14805605|NCT00812175|Sorafenib|sorafenib|mesh-list
14805606|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805607|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14805608|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805609|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805610|NCT00812214|Eszopiclone|eszopiclone|mesh-list
14805611|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14805612|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026060|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026061|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15026062|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026063|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15026064|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
15026065|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15026066|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15026067|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026068|NCT01941173|Antidotes|antidotes|mesh-ancestor
15026069|NCT01941173|Protective Agents|protective agents|mesh-ancestor
15026070|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
14805613|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805614|NCT00812266|Carboplatin|carboplatin|mesh-list
14805615|NCT00812266|Etoposide|etoposide|mesh-list
14805616|NCT00812266|Topotecan|topotecan|mesh-list
14805617|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805618|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14805619|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14805620|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14805621|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805622|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805623|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14805624|NCT00812292|Rilpivirine|rilpivirine|mesh-list
14805625|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14805626|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14805627|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805628|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805629|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
14805630|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805631|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14805632|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14805633|NCT00812318|Cabotegravir|cabotegravir|mesh-list
14805634|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14805635|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14805636|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805637|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805638|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14805639|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14805640|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
14805641|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805642|NCT00812344|Ketoconazole|ketoconazole|mesh-list
14805643|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
14805644|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805645|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14805646|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14805647|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026071|NCT01941173|Vitamins|vitamins|mesh-ancestor
14805648|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805649|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14805650|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
14805651|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805652|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805653|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14805654|NCT00812370|Bivalirudin|bivalirudin|mesh-list
14805655|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
14805656|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14805657|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
14805658|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805659|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026072|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
15026073|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15026074|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15026075|NCT01941173|Growth Substances|growth substances|mesh-ancestor
15026076|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
15026077|NCT01941199|Metformin|metformin|mesh-list
15026078|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15026079|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026080|NCT01941225|Iloprost|iloprost|mesh-list
15026081|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15026082|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
15026083|NCT01941264|Lumefantrine|lumefantrine|mesh-list
15026084|NCT01941264|Artemether|artemether|mesh-list
14805660|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
14805661|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
14805662|NCT00812396|Testosterone|testosterone|mesh-list
14805663|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
14805664|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
14805665|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14805666|NCT00812396|Androgens|androgens|mesh-ancestor
14805667|NCT00812396|Hormones|hormones|mesh-ancestor
14805668|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805669|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805670|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14805671|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805672|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
14805673|NCT00812422|Ibuprofen|ibuprofen|mesh-list
14805674|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14805675|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14805676|NCT00812422|Analgesics|analgesics|mesh-ancestor
14805677|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
14805678|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14805679|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805680|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14805681|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14805682|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14805683|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805684|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805685|NCT00812435|Eptifibatide|eptifibatide|mesh-list
14805686|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14805687|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14805688|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
14805689|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805690|NCT00812448|Protective Agents|protective agents|mesh-ancestor
14805691|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805692|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14805693|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14805694|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805695|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14805696|NCT00812513|Becaplermin|becaplermin|mesh-list
14805697|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
14805698|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
14805699|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14805700|NCT00812513|Growth Substances|growth substances|mesh-ancestor
14805701|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805702|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
14805703|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14805704|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805705|NCT00812578|Vitamins|vitamins|mesh-ancestor
14805706|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
14805707|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14805708|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
15026085|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15026086|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
15026087|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15026088|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15026089|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026090|NCT01941316|Irinotecan|irinotecan|mesh-list
15026091|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15026092|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15026093|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026094|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026095|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026096|NCT01941329|Ranibizumab|ranibizumab|mesh-list
15026097|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15026098|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15026099|NCT01941329|Growth Substances|growth substances|mesh-ancestor
15026100|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026101|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
15026102|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026103|NCT01941407|Bevacizumab|bevacizumab|mesh-list
15026104|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15026105|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805709|NCT00812669|Rituximab|rituximab|mesh-list
15026106|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15026107|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15026108|NCT01941407|Growth Substances|growth substances|mesh-ancestor
15026109|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026110|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
15026111|NCT01941524|Poractant alfa|poractant alfa|mesh-list
15026112|NCT01941524|Beractant|beractant|mesh-list
15026113|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
15026114|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
15026115|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
15026116|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
15026117|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026118|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
15026119|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15026120|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15026121|NCT01941589|Prednisolone|prednisolone|mesh-list
15026122|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
15026123|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
15026124|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15026125|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14805710|NCT00812669|Fludarabine|fludarabine|mesh-list
14805711|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
14805712|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14805713|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
14805714|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805715|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14805716|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14805717|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
14805718|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805719|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805720|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14805721|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14805722|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14805723|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
14805724|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14805725|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14805726|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
14805727|NCT00812760|Levodopa|levodopa|mesh-list
14805728|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14805729|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14805730|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
14805731|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14805732|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805733|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805734|NCT00812786|Cyclosporine|cyclosporine|mesh-list
14805735|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
14805736|NCT00812786|Everolimus|everolimus|mesh-list
14805737|NCT00812786|Tacrolimus|tacrolimus|mesh-list
14805738|NCT00812786|Cyclosporins|cyclosporins|mesh-list
14805739|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14805740|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
14805741|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805742|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14805743|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805744|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805745|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
14805746|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805747|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
14805748|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14805749|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805750|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14805751|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14805752|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
14805753|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14805754|NCT00812825|Prednisolone|prednisolone|mesh-list
14805755|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14805756|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
14805757|NCT00812825|Hormones|hormones|mesh-ancestor
14805758|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805759|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805760|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14805761|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805762|NCT00812851|Dronabinol|dronabinol|mesh-list
14525468|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805763|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
14805764|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805765|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14805766|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14805767|NCT00812851|Analgesics|analgesics|mesh-ancestor
14805768|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
14805769|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14805770|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14805771|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14805772|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14805773|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805774|NCT00812851|Hormones|hormones|mesh-ancestor
14805775|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14525469|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14525470|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14525471|NCT04085341|Growth Substances|growth substances|mesh-ancestor
14525472|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525473|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
14525474|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14525475|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525476|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525477|NCT04094870|Sertraline|sertraline|mesh-list
14805776|NCT00812864|Capecitabine|capecitabine|mesh-list
15026126|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15026127|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15026128|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
14805777|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14805778|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
14805779|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805780|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805781|NCT00812994|Citalopram|citalopram|mesh-list
14805782|NCT00812994|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14805783|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14805784|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14805785|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805786|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026129|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15026130|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
15026131|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
15026132|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026133|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026134|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15026135|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
15026136|NCT01941589|Hormones|hormones|mesh-ancestor
14805787|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
14805788|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805789|NCT00812994|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14805790|NCT00812994|Antidepressive Agents|antidepressive agents|mesh-ancestor
14805791|NCT00812994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15026137|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026138|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15026139|NCT01941589|Protective Agents|protective agents|mesh-ancestor
15026140|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15026141|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026142|NCT01941602|Enoxaparin|enoxaparin|mesh-list
15026143|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
15026144|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15026145|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15026146|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026147|NCT01941641|Capecitabine|capecitabine|mesh-list
15026148|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15026149|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
15026150|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026151|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026152|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
15026153|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
15026154|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15026155|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15026156|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805792|NCT00813059|Bevacizumab|bevacizumab|mesh-list
14805793|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14805794|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805795|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14805796|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14805797|NCT00813059|Growth Substances|growth substances|mesh-ancestor
14805798|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805799|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
14805800|NCT00813072|Docetaxel|docetaxel|mesh-list
14805801|NCT00813072|Irinotecan|irinotecan|mesh-list
14805802|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805803|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
14805804|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
14805805|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
14805806|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805807|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14805808|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14805809|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805810|NCT00813137|Endostar protein|endostar protein|mesh-list
14805811|NCT00813137|Endostatins|endostatins|mesh-list
14805812|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14805813|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14805814|NCT00813137|Growth Substances|growth substances|mesh-ancestor
14805815|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805816|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
14805817|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805818|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14805819|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
14805820|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805821|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14805822|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14805823|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805824|NCT00813228|Incretins|incretins|mesh-ancestor
14805825|NCT00813228|Hormones|hormones|mesh-ancestor
14805826|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14805827|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14805828|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
14805829|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805830|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805831|NCT00813241|Celecoxib|celecoxib|mesh-list
14805832|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14805833|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14805834|NCT00813241|Analgesics|analgesics|mesh-ancestor
14805835|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
14805836|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14805837|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805838|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14805839|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14805840|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14805841|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14805842|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805843|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805844|NCT00813332|Docetaxel|docetaxel|mesh-list
14805845|NCT00813332|Endostar protein|endostar protein|mesh-list
14805846|NCT00813332|Endostatins|endostatins|mesh-list
14805847|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805848|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
14805849|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
14805850|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
14805851|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805852|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14805853|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14805854|NCT00813332|Growth Substances|growth substances|mesh-ancestor
14805855|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805856|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
14805857|NCT00813410|Insulin|insulin|mesh-list
14805858|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14805859|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805860|NCT00813436|Oxytocin|oxytocin|mesh-list
14805861|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
14805862|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14805863|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805864|NCT00813449|Dacarbazine|dacarbazine|mesh-list
14805865|NCT00813449|Endostar protein|endostar protein|mesh-list
14805866|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14805867|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
14805868|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805869|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805870|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14805871|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14805872|NCT00813449|Growth Substances|growth substances|mesh-ancestor
14805873|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805874|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
14805875|NCT00813475|Insulin|insulin|mesh-list
14805876|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14805877|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14805878|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805879|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
14805880|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
14805881|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805882|NCT00813527|Fenofibrate|fenofibrate|mesh-list
14805883|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14805884|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
14805885|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805886|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14805887|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
14805888|NCT00813631|Laxatives|laxatives|mesh-ancestor
14805889|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14805890|NCT00813696|Gemcitabine|gemcitabine|mesh-list
14805891|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805892|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14805893|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
14805894|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805895|NCT00813696|Antiviral Agents|antiviral agents|mesh-ancestor
14805896|NCT00813696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14805897|NCT00813696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805898|NCT00813696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14805899|NCT00813696|Immunologic Factors|immunologic factors|mesh-ancestor
14805900|NCT00813696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805901|NCT00813722|Losartan|losartan|mesh-list
14805902|NCT00813722|Atenolol|atenolol|mesh-list
14805903|NCT00813722|Amlodipine|amlodipine|mesh-list
14805904|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14805905|NCT00813722|Calcium|calcium|mesh-list
14805906|NCT00813722|Diuretics|diuretics|mesh-list
14805907|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14805908|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14805909|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805910|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14805911|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14805912|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14805913|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026157|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026158|NCT01941732|Urological Agents|urological agents|mesh-ancestor
15026159|NCT01941758|Vaccines|vaccines|mesh-list
15026160|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
15026161|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026162|NCT01941771|Capecitabine|capecitabine|mesh-list
14805914|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
14805915|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14805916|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14805917|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14805918|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
14805919|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14805920|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14805921|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
14805922|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14805923|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
14805924|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
14805925|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14805926|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14805927|NCT00813735|Dexetimide|dexetimide|mesh-list
14805928|NCT00813735|Eszopiclone|eszopiclone|mesh-list
14805929|NCT00813735|Citalopram|citalopram|mesh-list
14805930|NCT00813735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14805931|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14805932|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14805933|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805934|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14805935|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
14805936|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805937|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14805938|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
14805939|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14805940|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14805941|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14805942|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
14805943|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
14805944|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14805945|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14805946|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14805947|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
14805948|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14805949|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14805950|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
14805951|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14805952|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
14805953|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805954|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14805955|NCT00813891|Ranibizumab|ranibizumab|mesh-list
14805956|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14805957|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14805958|NCT00813891|Growth Substances|growth substances|mesh-ancestor
14805959|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805960|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
14805961|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805962|NCT00814008|Insulin|insulin|mesh-list
14805963|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14805964|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805965|NCT00814021|Sunitinib|sunitinib|mesh-list
14805966|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805967|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14805968|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14805969|NCT00814021|Growth Substances|growth substances|mesh-ancestor
14805970|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805971|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
14805972|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14805973|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14805974|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805975|NCT00814047|Yohimbine|yohimbine|mesh-list
14805976|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
14805977|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
14805978|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14805979|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14805980|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14805981|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14805982|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14805983|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
14805984|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14805985|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805986|NCT00814047|Urological Agents|urological agents|mesh-ancestor
14805987|NCT00814086|Paclitaxel|paclitaxel|mesh-list
14805988|NCT00814086|Cisplatin|cisplatin|mesh-list
14805989|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14805990|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14805991|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
14805992|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
14805993|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
14805994|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14805995|NCT00814125|Tamoxifen|tamoxifen|mesh-list
14805996|NCT00814125|Anastrozole|anastrozole|mesh-list
14805997|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14805998|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
14805999|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14806000|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806001|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14806002|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806003|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15026163|NCT01941771|Vinorelbine|vinorelbine|mesh-list
14806004|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14806005|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14806006|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14806007|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14806008|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806009|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806010|NCT00814216|Fluticasone|fluticasone|mesh-list
14806011|NCT00814216|Xhance|xhance|mesh-list
14806012|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14806013|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14806014|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
14806015|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806016|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806017|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14806018|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
14806019|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
14806020|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14806021|NCT00814229|Vaccines|vaccines|mesh-list
14806022|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
14806023|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
14806024|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806025|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14806026|NCT00814268|Aspirin|aspirin|mesh-list
14806027|NCT00814268|Clopidogrel|clopidogrel|mesh-list
14806028|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14806029|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14806030|NCT00814268|Analgesics|analgesics|mesh-ancestor
14806031|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
14806032|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806033|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806034|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14806035|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14806036|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14806037|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14806038|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806039|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14806040|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14806041|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806042|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
14806043|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14806044|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14806045|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14806046|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
14806047|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806048|NCT00814281|Montelukast|montelukast|mesh-list
14806049|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14806050|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
14806051|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14806052|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
14806053|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14806054|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806055|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14806056|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14806057|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806058|NCT00814359|Benzydamine|benzydamine|mesh-list
14806059|NCT00814359|Sucralfate|sucralfate|mesh-list
14806060|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14806061|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14806062|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14806063|NCT00814515|Cyclosporine|cyclosporine|mesh-list
14806064|NCT00814515|Cyclosporins|cyclosporins|mesh-list
14806065|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806066|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806067|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14806068|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
14806069|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806070|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
14806071|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806072|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
14806073|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14806074|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14806075|NCT00814528|Imiquimod|imiquimod|mesh-list
14806076|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14806077|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
14806078|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806079|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806080|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
14806081|NCT00814541|Dexamethasone|dexamethasone|mesh-list
14806082|NCT00814541|Doxorubicin|doxorubicin|mesh-list
14806083|NCT00814541|Bortezomib|bortezomib|mesh-list
14806084|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14806085|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
14806086|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
14806087|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806088|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806089|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14806090|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
14806091|NCT00814541|Hormones|hormones|mesh-ancestor
14806092|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14806093|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14806094|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806095|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14806096|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14806097|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14806098|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806099|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806100|NCT00814593|Carmustine|carmustine|mesh-list
14806101|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14806102|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
14806103|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806104|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806105|NCT00814606|Ribavirin|ribavirin|mesh-list
14806106|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14806107|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
14806108|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806109|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
14806110|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806111|NCT00814619|Capecitabine|capecitabine|mesh-list
14806112|NCT00814619|Panitumumab|panitumumab|mesh-list
14806113|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14806114|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
14806115|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806116|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806117|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14806118|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14806119|NCT00814723|Ezetimibe|ezetimibe|mesh-list
14806120|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14806121|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14806122|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
14806123|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806124|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14806125|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
14806126|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
14806127|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14806128|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14806129|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806130|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806131|NCT00814736|Urological Agents|urological agents|mesh-ancestor
14806132|NCT00814762|Vaccines|vaccines|mesh-list
14806133|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
14806134|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806135|NCT00814866|Adalimumab|adalimumab|mesh-list
14806136|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14806137|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14806138|NCT00814905|Clindamycin|clindamycin|mesh-list
14806139|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
14806140|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
14806141|NCT00814905|Gentamicins|gentamicins|mesh-list
14806142|NCT00814905|Ampicillin|ampicillin|mesh-list
14806143|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14806144|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806145|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14806146|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806147|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806148|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14806149|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14806150|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
14806151|NCT00814944|Sirolimus|sirolimus|mesh-list
14806152|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14806153|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806154|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14806155|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806156|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
14806157|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14806158|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
14806159|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806160|NCT00815022|Fentanyl|fentanyl|mesh-list
14806161|NCT00815022|Morphine|morphine|mesh-list
14806162|NCT00815022|Bupivacaine|bupivacaine|mesh-list
14806163|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
14806164|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
14806165|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14806166|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806167|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
14806168|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806169|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14806170|NCT00815022|Narcotics|narcotics|mesh-ancestor
14806171|NCT00815022|Analgesics|analgesics|mesh-ancestor
14806172|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14806173|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14806174|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
14806175|NCT00815048|Atropine|atropine|mesh-list
14806176|NCT00815048|Fentanyl|fentanyl|mesh-list
14806177|NCT00815048|Remifentanil|remifentanil|mesh-list
14806178|NCT00815048|Succinylcholine|succinylcholine|mesh-list
14806179|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14806180|NCT00815048|Narcotics|narcotics|mesh-ancestor
14806181|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14806182|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806183|NCT00815048|Analgesics|analgesics|mesh-ancestor
14806184|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
14806185|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806186|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14806187|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14806188|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
14806189|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
14806190|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14806191|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14806192|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
14806193|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14806194|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
14806195|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
14806196|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
14806197|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14806198|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14806199|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
14806200|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806201|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806202|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
15026164|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15026165|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
15026166|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026167|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026168|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15026169|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
15026170|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
14806203|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14806204|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15026171|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
15026172|NCT01941810|Lactoferrin|lactoferrin|mesh-list
15026173|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026174|NCT01941875|Progesterone|progesterone|mesh-list
15026175|NCT01941875|Progestins|progestins|mesh-ancestor
15026176|NCT01941875|Hormones|hormones|mesh-ancestor
15026177|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026178|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026179|NCT01941888|Midazolam|midazolam|mesh-list
15026180|NCT01941888|Propofol|propofol|mesh-list
15026181|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15026182|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026183|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026184|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15026185|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
15026186|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
15026187|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15026188|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15026189|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15026190|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15026191|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
15026192|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
15026193|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026194|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026195|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
15026196|NCT01941901|Bleomycin|bleomycin|mesh-list
15026197|NCT01941901|Calcium|calcium|mesh-list
14806205|NCT00815204|Dexamethasone|dexamethasone|mesh-list
14806206|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14806207|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
14806208|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
14806209|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806210|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806211|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14806212|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
14806213|NCT00815204|Hormones|hormones|mesh-ancestor
14806214|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14806215|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14806216|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806217|NCT00815256|Riboflavin|riboflavin|mesh-list
14806218|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
14806219|NCT00815256|Vitamins|vitamins|mesh-ancestor
14806220|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
14806221|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806222|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14806223|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
14806224|NCT00815269|Sevoflurane|sevoflurane|mesh-list
14806225|NCT00815269|Desflurane|desflurane|mesh-list
14806226|NCT00815269|Isoflurane|isoflurane|mesh-list
14806227|NCT00815269|Halothane|halothane|mesh-list
14806228|NCT00815269|Enflurane|enflurane|mesh-list
14806229|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14806230|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14806231|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
14806232|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
14806233|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14806234|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806235|NCT00815282|Vaccines|vaccines|mesh-list
14806236|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
14806237|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806238|NCT00815373|Timolol|timolol|mesh-list
14806239|NCT00815373|Dorzolamide|dorzolamide|mesh-list
14806240|NCT00815373|Latanoprost|latanoprost|mesh-list
14806241|NCT00815373|Maleic acid|maleic acid|mesh-list
14806242|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14806243|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14806244|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
14806245|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806246|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806247|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806248|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14806249|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14806250|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806251|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14806252|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14806253|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14806254|NCT00815399|Metformin|metformin|mesh-list
14806255|NCT00815399|Pioglitazone|pioglitazone|mesh-list
14806256|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14806257|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806258|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
14806259|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026198|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15026199|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026200|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15026201|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15026202|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026203|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
15026204|NCT01941914|Calcium|calcium|mesh-list
14806260|NCT00815503|Ropivacaine|ropivacaine|mesh-list
14806261|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
14806262|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
14806263|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14806264|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806265|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
14806266|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806267|NCT00815542|Dinoprostone|dinoprostone|mesh-list
14806268|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
14806269|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14806270|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806271|NCT00815568|Vidarabine|vidarabine|mesh-list
14806272|NCT00815568|Fludarabine|fludarabine|mesh-list
14806273|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
14806274|NCT00815568|Busulfan|busulfan|mesh-list
15026205|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15026206|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026207|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14806275|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806276|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14806277|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
14806278|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026208|NCT01941953|Metformin|metformin|mesh-list
15026209|NCT01941953|Fluorouracil|fluorouracil|mesh-list
15026210|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15026211|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026212|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
15026213|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026214|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15026215|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026216|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15026217|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
15026218|NCT01941966|Capecitabine|capecitabine|mesh-list
15026219|NCT01941966|Mitomycins|mitomycins|mesh-list
15026220|NCT01941966|Mitomycin|mitomycin|mesh-list
14806279|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14806280|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
14806281|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806282|NCT00815568|Antiviral Agents|antiviral agents|mesh-ancestor
14806283|NCT00815568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806284|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
14806285|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14806286|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14806287|NCT00815594|Bevacizumab|bevacizumab|mesh-list
14806288|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14806289|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806290|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14806291|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14806292|NCT00815594|Growth Substances|growth substances|mesh-ancestor
14806293|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806294|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
14806295|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
14806296|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
14806297|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14806298|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14806299|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806300|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806301|NCT00815646|Urological Agents|urological agents|mesh-ancestor
14806302|NCT00815841|Methylphenidate|methylphenidate|mesh-list
14806303|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14806304|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806305|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14806306|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14806307|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14806308|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806309|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
14806310|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806311|NCT00815854|Folic Acid|folic acid|mesh-list
14806312|NCT00815854|Hematinics|hematinics|mesh-ancestor
15026221|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15026222|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
15026223|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026224|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026225|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15026226|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
15026227|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15026228|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026229|NCT01941979|Leucovorin|leucovorin|mesh-list
14806313|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
14806314|NCT00815854|Vitamins|vitamins|mesh-ancestor
14806315|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
14806316|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806317|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
14806318|NCT00815867|Hematinics|hematinics|mesh-ancestor
14806319|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
14806320|NCT00815893|Propofol|propofol|mesh-list
14806321|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14806322|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14806323|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806324|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14806325|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
14806326|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
14806327|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14806328|NCT00815893|Analgesics|analgesics|mesh-ancestor
14806329|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
14806330|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806331|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14806332|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14806333|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14806334|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
14806335|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806336|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806337|NCT00815945|Carboplatin|carboplatin|mesh-list
14806338|NCT00815945|Doxorubicin|doxorubicin|mesh-list
14806339|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806340|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14806341|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14806342|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14806343|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026230|NCT01941979|Capecitabine|capecitabine|mesh-list
15026231|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
15026232|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15026233|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
15026234|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026235|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026236|NCT01941979|Antidotes|antidotes|mesh-ancestor
15026237|NCT01941979|Protective Agents|protective agents|mesh-ancestor
15026238|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026239|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
14806344|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806345|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
14806346|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
14806347|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806348|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14806349|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806350|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14806351|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
14806352|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806353|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14806354|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806355|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
14806356|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
14806357|NCT00816127|Coagulants|coagulants|mesh-ancestor
14806358|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14806359|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
14806360|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806361|NCT00816140|Clarithromycin|clarithromycin|mesh-list
14806362|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14806363|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026240|NCT01941979|Vitamins|vitamins|mesh-ancestor
15026241|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
15034820|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034821|NCT01997632|Vaccines|vaccines|mesh-list
15034822|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
15034823|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034824|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
15034825|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15034826|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15034827|NCT01997658|Prednisolone|prednisolone|mesh-list
14806364|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15034828|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
14806365|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806366|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806367|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14806368|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14806369|NCT00816205|Nifedipine|nifedipine|mesh-list
14806370|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14806371|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14806372|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806373|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14806374|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806375|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
14806376|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
14806377|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14806378|NCT00816218|Pioglitazone|pioglitazone|mesh-list
14806379|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14806380|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806381|NCT00816244|Atorvastatin|atorvastatin|mesh-list
14806382|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14806383|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14806384|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
14806385|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806386|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14806387|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14806388|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806389|NCT00816283|Dasatinib|dasatinib|mesh-list
14806390|NCT00816283|Vorinostat|vorinostat|mesh-list
14806391|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806392|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14806393|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806394|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806395|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14806396|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14806397|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14806398|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806399|NCT00816413|Cyclosporine|cyclosporine|mesh-list
14806400|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
14806401|NCT00816413|Pentostatin|pentostatin|mesh-list
14806402|NCT00816413|Cyclosporins|cyclosporins|mesh-list
14806403|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806404|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806405|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14806406|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
15026242|NCT01942070|Everolimus|everolimus|mesh-list
15026243|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026244|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14806407|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806408|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
15026245|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
14806409|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806410|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
14806411|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14806412|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14806413|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14806414|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806415|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14806416|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
14806417|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14806418|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14806419|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
14806420|NCT00816426|Rifampin|rifampin|mesh-list
14806421|NCT00816426|Isoniazid|isoniazid|mesh-list
14806422|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
14806423|NCT00816426|Kanamycin|kanamycin|mesh-list
14806424|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14806425|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806426|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14806427|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14806428|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806429|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806430|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806431|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14806432|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
14806433|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
14806434|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14806435|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14806436|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14806437|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14806438|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14806439|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14806440|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14806441|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
14806442|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14806443|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
14806444|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14806445|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14806446|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
14806447|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14806448|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14806449|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14806450|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14806451|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806452|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
14806453|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806454|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806455|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14806456|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806457|NCT00816543|Docetaxel|docetaxel|mesh-list
14806458|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
14806459|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806460|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
14806461|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
14806462|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
14806463|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806464|NCT00816634|Paclitaxel|paclitaxel|mesh-list
14806465|NCT00816634|Capecitabine|capecitabine|mesh-list
14806466|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14806467|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806468|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
14806469|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
14806470|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
14806471|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806472|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14806473|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
15026246|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026247|NCT01942109|Torsemide|torsemide|mesh-list
15026248|NCT01942109|Furosemide|furosemide|mesh-list
15026249|NCT01942109|Diuretics|diuretics|mesh-ancestor
15026250|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
15026251|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806474|NCT00816660|Factor VIII|factor viii|mesh-list
14806475|NCT00816660|Coagulants|coagulants|mesh-ancestor
14806476|NCT00816673|Melatonin|melatonin|mesh-list
14806477|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
14806478|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806479|NCT00816673|Protective Agents|protective agents|mesh-ancestor
14806480|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806481|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14806482|NCT00816699|Anesthetics|anesthetics|mesh-list
14806483|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14806484|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806485|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
14806486|NCT00816712|Testosterone|testosterone|mesh-list
14806487|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
14806488|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
14806489|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14806490|NCT00816712|Androgens|androgens|mesh-ancestor
14806491|NCT00816712|Hormones|hormones|mesh-ancestor
14806492|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14806493|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806494|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14806495|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806496|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
15026252|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15026253|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15026254|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026255|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15026256|NCT01942174|Methotrexate|methotrexate|mesh-list
15026257|NCT01942174|Vaccines|vaccines|mesh-list
15026258|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14806497|NCT00816790|Tazobactam|tazobactam|mesh-list
14806498|NCT00816790|Piperacillin|piperacillin|mesh-list
14806499|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14806500|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14806501|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806502|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14806503|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806504|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806505|NCT00816816|Docetaxel|docetaxel|mesh-list
14806506|NCT00816816|Fluorouracil|fluorouracil|mesh-list
14806507|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806508|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
14806509|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
14806510|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
14806511|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806512|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
14806513|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14806514|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14806515|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
14806516|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806517|NCT00816855|Docetaxel|docetaxel|mesh-list
14806518|NCT00816855|Fluorouracil|fluorouracil|mesh-list
14806519|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806520|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
14806521|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
14806522|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
14806523|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806524|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
14806525|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14806526|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14806527|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
15026259|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15026260|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
15026261|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15026262|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026263|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15026264|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
15026265|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026266|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026267|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
14806528|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806529|NCT00816868|Capecitabine|capecitabine|mesh-list
14806530|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14806531|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14806532|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
14806533|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806534|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806535|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14806536|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806537|NCT00816894|Olanzapine|olanzapine|mesh-list
14806538|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
14806539|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
14806540|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806541|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806542|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14806543|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14806544|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14806545|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14806546|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14806547|NCT00816894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14806548|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14806549|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14806550|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806551|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806552|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
14806553|NCT00816959|Bleomycin|bleomycin|mesh-list
14806554|NCT00816959|Dacarbazine|dacarbazine|mesh-list
14806555|NCT00816959|Vinblastine|vinblastine|mesh-list
14806556|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15026268|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026269|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15026270|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15026271|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
15026272|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14806557|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806558|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806559|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14806560|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
14806561|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14806562|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
14806563|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
14806564|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
14806565|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14806566|NCT00817011|Mirtazapine|mirtazapine|mesh-list
14806567|NCT00817011|Trazodone|trazodone|mesh-list
14806568|NCT00817011|Bupropion|bupropion|mesh-list
14806569|NCT00817011|Fluoxetine|fluoxetine|mesh-list
14806570|NCT00817011|Paroxetine|paroxetine|mesh-list
14806571|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15026273|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15026274|NCT01942187|Aripiprazole|aripiprazole|mesh-list
15026275|NCT01942187|Bupropion|bupropion|mesh-list
15026276|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15026277|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
15026278|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15026279|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15026280|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15026281|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15026282|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026283|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
15026284|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026285|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026286|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15026287|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15026288|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026289|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15026290|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15026291|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026292|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
15026293|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14806572|NCT00817011|Citalopram|citalopram|mesh-list
14806573|NCT00817011|Sertraline|sertraline|mesh-list
14806574|NCT00817011|Nortriptyline|nortriptyline|mesh-list
14806575|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14806576|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
14806577|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14806578|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14806579|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14806580|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14806581|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806582|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
14806583|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806584|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806585|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14806586|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14806587|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806588|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14806589|NCT00817011|Analgesics|analgesics|mesh-ancestor
14806590|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
15026294|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14806591|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806592|NCT00817011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14806593|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
14806594|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14806595|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
14806596|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
15026295|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
14806597|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14806598|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14806599|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14806600|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14806601|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14806602|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15026296|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15026297|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15026298|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15026299|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15026300|NCT01942291|Niacin|niacin|mesh-list
15026301|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
14806603|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
14806604|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14806605|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15026302|NCT01942291|Vitamins|vitamins|mesh-ancestor
14806606|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14806607|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14806608|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14806609|NCT00817037|Nifedipine|nifedipine|mesh-list
14806610|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
14806611|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14806612|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14806613|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806614|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14806615|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806616|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
14806617|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
14806618|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14806619|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14806620|NCT00817245|Amoxicillin|amoxicillin|mesh-list
14806621|NCT00817245|Metronidazole|metronidazole|mesh-list
14806622|NCT00817245|Omeprazole|omeprazole|mesh-list
14806623|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14806624|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806625|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14806626|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14806627|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14806628|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14806629|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14806630|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806631|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806632|NCT00817258|Cisplatin|cisplatin|mesh-list
14806633|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806634|NCT00817271|Glucagon|glucagon|mesh-list
14806635|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14806636|NCT00817271|Hormones|hormones|mesh-ancestor
14806637|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026303|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
14806638|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806639|NCT00817284|Bevacizumab|bevacizumab|mesh-list
14806640|NCT00817284|Irinotecan|irinotecan|mesh-list
14806641|NCT00817284|Temozolomide|temozolomide|mesh-list
14806642|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15026304|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806643|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806644|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14806645|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14806646|NCT00817284|Growth Substances|growth substances|mesh-ancestor
14806647|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806648|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
14806649|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14806650|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14806651|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806652|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806653|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14806654|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
14806655|NCT00817375|Milnacipran|milnacipran|mesh-list
14806656|NCT00817375|Mirtazapine|mirtazapine|mesh-list
14806657|NCT00817375|Sertraline|sertraline|mesh-list
15026305|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
15026306|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15026307|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
15026308|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026309|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15026310|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
15026311|NCT01942304|Calcium|calcium|mesh-list
15026312|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15026313|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026314|NCT01942343|Droperidol|droperidol|mesh-list
15026315|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15026316|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
15026317|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
15026318|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026319|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026320|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15026321|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15026322|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15026323|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026324|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15026325|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15026326|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14806658|NCT00817375|Fluoxetine|fluoxetine|mesh-list
15026327|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
15026328|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026329|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026330|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15026331|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
15026332|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15026333|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
15026334|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14806659|NCT00817375|Paroxetine|paroxetine|mesh-list
14806660|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14806661|NCT00817375|Nortriptyline|nortriptyline|mesh-list
14806662|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
14806663|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14806664|NCT00817375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14806665|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14806666|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14806667|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806668|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806669|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
14806670|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806671|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14806672|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14806673|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14806674|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806675|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14806676|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14806677|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
14806678|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
14806679|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14806680|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14806681|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14806682|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14806683|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14806684|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14806685|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
14806686|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14806687|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14806688|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14806689|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14806690|NCT00817375|Analgesics|analgesics|mesh-ancestor
14806691|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
14806692|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806693|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14806694|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14806695|NCT00817466|Epinephrine|epinephrine|mesh-list
14806696|NCT00817466|Racepinephrine|racepinephrine|mesh-list
14806697|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
14806698|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14806699|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14806700|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
14806701|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806702|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806703|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806704|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14806705|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14806706|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
14806707|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806708|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14806709|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
14806710|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
14806711|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
14806712|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14806713|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
14806714|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14806715|NCT00817583|Docetaxel|docetaxel|mesh-list
14806716|NCT00817583|Fluorouracil|fluorouracil|mesh-list
14806717|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806718|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
15026335|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026336|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15026337|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15026338|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026339|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14806719|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
14806720|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
14806721|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806722|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
14806723|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14806724|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14806725|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
14806726|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806727|NCT00817622|Vitamin E|vitamin e|mesh-list
14806728|NCT00817622|Vitamins|vitamins|mesh-ancestor
14806729|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
14806730|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806731|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
14806732|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806733|NCT00817622|Protective Agents|protective agents|mesh-ancestor
14806734|NCT00817648|Risperidone|risperidone|mesh-list
14806735|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14806736|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14806737|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
14806738|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806739|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525478|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
14525479|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14525480|NCT04094870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14525481|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14525482|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14525483|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525484|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525485|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
14525486|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525487|NCT04103515|Cimetidine|cimetidine|mesh-list
14525488|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14525489|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14806740|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806741|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14806742|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14806743|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14806744|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15026340|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15026341|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15026342|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026343|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026344|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15026345|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15026346|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15026347|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
15026348|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026349|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026350|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15026351|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15026352|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
15026353|NCT01942447|Vancomycin|vancomycin|mesh-list
15026354|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15026355|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026356|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
14806745|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14806746|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
14806747|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
14806748|NCT00817661|Vitamin A|vitamin a|mesh-list
14806749|NCT00817661|Vitamins|vitamins|mesh-ancestor
14806750|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
14806751|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806752|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
14806753|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14806754|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806755|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14806756|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
14806757|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14806758|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806759|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806760|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806761|NCT00817713|Ivermectin|ivermectin|mesh-list
14806762|NCT00817713|Albendazole|albendazole|mesh-list
14806763|NCT00817713|Praziquantel|praziquantel|mesh-list
14806764|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14806765|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806766|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
14806767|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
14806768|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14806769|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14806770|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
14806771|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
14806772|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
14806773|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806774|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806775|NCT00817739|Leuprolide|leuprolide|mesh-list
14806776|NCT00817739|Flutamide|flutamide|mesh-list
14806777|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14806778|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
14806779|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14806780|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806781|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14806782|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806783|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
14806784|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
14806785|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14806786|NCT00817765|Ritonavir|ritonavir|mesh-list
14806787|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
14806788|NCT00817765|Posaconazole|posaconazole|mesh-list
14806789|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14806790|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15026357|NCT01942460|Hematinics|hematinics|mesh-ancestor
15026358|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15026359|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15026360|NCT01942551|Tadalafil|tadalafil|mesh-list
15026361|NCT01942551|Dutasteride|dutasteride|mesh-list
15026362|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
15026363|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15026364|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15026365|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026366|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806791|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
14806792|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806793|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806794|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15026367|NCT01942551|Urological Agents|urological agents|mesh-ancestor
15026368|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15026369|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15026370|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
15026371|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026372|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026373|NCT01942577|Protective Agents|protective agents|mesh-list
15026374|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026375|NCT01942681|Propiverine|propiverine|mesh-list
15026376|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
15026377|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
15026378|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026379|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026380|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15026381|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15026382|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
15026383|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026384|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026385|NCT01942681|Urological Agents|urological agents|mesh-ancestor
15026386|NCT01942889|Antioxidants|antioxidants|mesh-list
15026387|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026388|NCT01942889|Protective Agents|protective agents|mesh-ancestor
15026389|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026390|NCT01943019|Linagliptin|linagliptin|mesh-list
15026391|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15026392|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026393|NCT01943019|Incretins|incretins|mesh-ancestor
15026394|NCT01943019|Hormones|hormones|mesh-ancestor
15026395|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026396|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14525490|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14525491|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
14525492|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
14525493|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525494|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525495|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525496|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14525497|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14806795|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14525498|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525499|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
14525500|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15026397|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
15026398|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026399|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525501|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
14525502|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525503|NCT04123405|Expectorants|expectorants|mesh-ancestor
14525504|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
14525505|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14525506|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
14806796|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
14806797|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806798|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14806799|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14806800|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
14806801|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
14806802|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14525507|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525508|NCT04123405|Protective Agents|protective agents|mesh-ancestor
14806803|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14806804|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14806805|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14806806|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
14806807|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14806808|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026400|NCT01943058|Megestrol|megestrol|mesh-list
15026401|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
15026402|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
15026403|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15026404|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
15026405|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15026406|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026407|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15026408|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15026409|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15026410|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15026411|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14806809|NCT00817895|Cisplatin|cisplatin|mesh-list
14806810|NCT00817895|Fluorouracil|fluorouracil|mesh-list
14806811|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806812|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
14806813|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806814|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14806815|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14806816|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
14806817|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806818|NCT00817934|Bisacodyl|bisacodyl|mesh-list
14806819|NCT00817934|Cathartics|cathartics|mesh-ancestor
14806820|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14806821|NCT00817934|Laxatives|laxatives|mesh-ancestor
14806822|NCT00817960|Methylphenidate|methylphenidate|mesh-list
14806823|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14806824|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806825|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14806826|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14806827|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14806828|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806829|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
14806830|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806831|NCT00817973|Caseins|caseins|mesh-list
15026412|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026413|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
15026414|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15026415|NCT01943136|Mupirocin|mupirocin|mesh-list
15026416|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15026417|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026418|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15026419|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15034829|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14806832|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
14806833|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
14806834|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806835|NCT00818038|Natalizumab|natalizumab|mesh-list
14806836|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
14806837|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806838|NCT00818090|Paclitaxel|paclitaxel|mesh-list
14806839|NCT00818090|Cisplatin|cisplatin|mesh-list
14806840|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14806841|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806842|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
14806843|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
14806844|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
14806845|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806846|NCT00818103|Interferons|interferons|mesh-list
14806847|NCT00818103|Atorvastatin|atorvastatin|mesh-list
14806848|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806849|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
14806850|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806851|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14806852|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14806853|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
14806854|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806855|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14806856|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14806857|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026420|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026421|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
15026422|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15026423|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
15026424|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026425|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15026426|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15026427|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
15026428|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026429|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026430|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15026431|NCT01943240|Ropivacaine|ropivacaine|mesh-list
15026432|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
15026433|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
14806858|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14806859|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14806860|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14806861|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14806862|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806863|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525509|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525510|NCT04123405|Antidotes|antidotes|mesh-ancestor
14525511|NCT04138758|Bromides|bromides|mesh-list
14525512|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
14525513|NCT04138758|Olodaterol|olodaterol|mesh-list
14525514|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14525515|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
14525516|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525517|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525518|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14525519|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
14525520|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
14525521|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14525522|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
14525523|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525524|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525525|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
14525526|NCT04147715|Dolutegravir|dolutegravir|mesh-list
14525527|NCT04147715|Midazolam|midazolam|mesh-list
14525528|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14525529|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14525530|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525531|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525532|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14525533|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14525534|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14525535|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14525536|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
14525537|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
14525538|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
14525539|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
14525540|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525541|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525542|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14525543|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14525544|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806864|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806865|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
14806866|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14806867|NCT00818194|Cyclosporine|cyclosporine|mesh-list
14806868|NCT00818194|Tacrolimus|tacrolimus|mesh-list
14806869|NCT00818194|Cyclosporins|cyclosporins|mesh-list
14806870|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14806871|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
14806872|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806873|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14806874|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525545|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14525546|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14525547|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
14525548|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525549|NCT04160091|FX006|fx006|mesh-list
14525550|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525551|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
14525552|NCT04160091|Hormones|hormones|mesh-ancestor
14525553|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14525554|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525555|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14525556|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
14525557|NCT04164758|Pimavanserin|pimavanserin|mesh-list
14525558|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14525559|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
14525560|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14525561|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14525562|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14525563|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525564|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525565|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14525566|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14525567|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14525568|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14525569|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
14525570|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806875|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806876|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
14806877|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806878|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
14806879|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14806880|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
14806881|NCT00818298|Ziprasidone|ziprasidone|mesh-list
14806882|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14806883|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
14806884|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806885|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806886|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806887|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14806888|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14806889|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14806890|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14525571|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525572|NCT04165031|Docetaxel|docetaxel|mesh-list
14525573|NCT04165031|Cetuximab|cetuximab|mesh-list
14525574|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14525575|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14525576|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
14525577|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
14525578|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
14525579|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525580|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14525581|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14525582|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525583|NCT04171414|Adalimumab|adalimumab|mesh-list
14525584|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525585|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525586|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
14525587|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14525588|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026434|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026435|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525589|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14525590|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14525591|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525592|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525593|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14525594|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
14525595|NCT04184297|Olodaterol|olodaterol|mesh-list
14525596|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14525597|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
14525598|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026436|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
15026437|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026438|NCT01943305|Vaccines|vaccines|mesh-list
14525599|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525600|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14525601|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
14525602|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
14525603|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14525604|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
14525605|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525606|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525607|NCT04189848|Dulaglutide|dulaglutide|mesh-list
14525608|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14525609|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525610|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
14525611|NCT04211909|Velpatasvir|velpatasvir|mesh-list
14525612|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
14525613|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525614|NCT04218110|Ethanol|ethanol|mesh-list
14525615|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
14525616|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14525617|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
14525618|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026439|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
14525619|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026440|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026441|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
15026442|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
15026443|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15026444|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15026445|NCT01943422|Interferons|interferons|mesh-list
14525620|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525621|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
14525622|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
14525623|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14525624|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14525625|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
14525626|NCT04223843|Olodaterol|olodaterol|mesh-list
14525627|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14525628|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
14525629|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525630|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525631|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14525632|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
14525633|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
14525634|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14525635|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
14525636|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525637|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525638|NCT04229303|Voriconazole|voriconazole|mesh-list
14525639|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
14525640|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525641|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14525642|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14525643|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525644|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525645|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14525646|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
14525647|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14525648|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525649|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15026446|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
15026447|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
15026448|NCT01943422|Vemurafenib|vemurafenib|mesh-list
15026449|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026450|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
15026451|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026452|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
15026453|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026454|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15026455|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026456|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026457|NCT01943487|Verapamil|verapamil|mesh-list
15026458|NCT01943487|Tamsulosin|tamsulosin|mesh-list
15026459|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
15026460|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15026461|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15026462|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15026463|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
15026464|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026465|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026466|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026467|NCT01943487|Urological Agents|urological agents|mesh-ancestor
15026468|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15026469|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15026470|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
14525650|NCT04256603|Gabapentin|gabapentin|mesh-list
14525651|NCT04256603|Analgesics|analgesics|mesh-ancestor
14525652|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
14525653|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525654|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525655|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
14525656|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14525657|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14525658|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525659|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14525660|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15026471|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15026472|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15026473|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15026474|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15026475|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
15026476|NCT01943526|Natalizumab|natalizumab|mesh-list
15026477|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
15026478|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034830|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
15034831|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15034832|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
15034833|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
15034834|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15034835|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15034836|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15034837|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
15034838|NCT01997658|Hormones|hormones|mesh-ancestor
15034839|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14525661|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14525662|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525663|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525664|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
14525665|NCT04290494|Plasminogen|plasminogen|mesh-list
14525666|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14525667|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14525668|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529871|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14529872|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
14529873|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529874|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529875|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
14529876|NCT03580382|Trametinib|trametinib|mesh-list
14529877|NCT03580382|Antibodies|antibodies|mesh-list
14529878|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
14529879|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529880|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529881|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14806891|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14806892|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
14806893|NCT00818350|Sunitinib|sunitinib|mesh-list
14806894|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026479|NCT01943617|Entecavir|entecavir|mesh-list
15026480|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
15026481|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525669|NCT04303156|Islatravir|islatravir|mesh-list
14525670|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
14525671|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525672|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525673|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525674|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14525675|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14525676|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14525677|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14525678|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14525679|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
14525680|NCT04323852|Vitamin D|vitamin d|mesh-list
14525681|NCT04323852|Vitamins|vitamins|mesh-ancestor
14525682|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
14525683|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525684|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14525685|NCT04327843|Haloperidol|haloperidol|mesh-list
14525686|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
14525687|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
14525688|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
14525689|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525690|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525691|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14525692|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14525693|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14525694|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525695|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14525696|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14525697|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
14525698|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525699|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525700|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14525701|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
14525702|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
14525703|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14525704|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14525705|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525706|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525707|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525708|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525709|NCT04347954|Iodine|iodine|mesh-list
14525710|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
14525711|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
14525712|NCT04347954|Povidone|povidone|mesh-list
14525713|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14525714|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525715|NCT04347954|Trace Elements|trace elements|mesh-ancestor
14525716|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
14525717|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525718|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
14525719|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
14525720|NCT04358068|Azithromycin|azithromycin|mesh-list
14525721|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
14525722|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14525723|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525724|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
14525725|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14525726|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14525727|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525728|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525729|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525730|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
14525731|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14525732|NCT04373421|Benzydamine|benzydamine|mesh-list
14525733|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14525734|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525735|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
14525736|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
14525737|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525738|NCT04398732|Etanercept|etanercept|mesh-list
14525739|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14525740|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14525741|NCT04398732|Analgesics|analgesics|mesh-ancestor
14525742|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
14525743|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525744|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525745|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525746|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525747|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14525748|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14525749|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
14525750|NCT04401293|Heparin|heparin|mesh-list
14525751|NCT04401293|Enoxaparin|enoxaparin|mesh-list
14525752|NCT04401293|Calcium heparin|calcium heparin|mesh-list
14525753|NCT04401293|Dalteparin|dalteparin|mesh-list
14525754|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
14525755|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
14525756|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14525757|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14525758|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525759|NCT04420572|Betamethasone|betamethasone|mesh-list
14525760|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525761|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
14525762|NCT04420572|Hormones|hormones|mesh-ancestor
14525763|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14525764|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525765|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14525766|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
14525767|NCT04428411|Etanercept|etanercept|mesh-list
14525768|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14525769|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14525770|NCT04428411|Analgesics|analgesics|mesh-ancestor
14525771|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
14525772|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525773|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525774|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14806895|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14806896|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14806897|NCT00818350|Growth Substances|growth substances|mesh-ancestor
14806898|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806899|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
14806900|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14806901|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806902|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806903|NCT00818415|Naproxen|naproxen|mesh-list
14806904|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14806905|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14806906|NCT00818415|Analgesics|analgesics|mesh-ancestor
14806907|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
14806908|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806909|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806910|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525775|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525776|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14525777|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14525778|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
14525779|NCT04495283|Acetaminophen|acetaminophen|mesh-list
14525780|NCT04495283|Pregabalin|pregabalin|mesh-list
14525781|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14525782|NCT04495283|Analgesics|analgesics|mesh-ancestor
14525783|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
14525784|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525785|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525786|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
14525787|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
14525788|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14806911|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14806912|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
14806913|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14806914|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806915|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026482|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
15026483|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15026484|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
15026485|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026486|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026487|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15026488|NCT01943630|Protective Agents|protective agents|mesh-ancestor
15026489|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15026490|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14525789|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14525790|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525791|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14525792|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14525793|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14525794|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525795|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14525796|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
14525797|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14525798|NCT04501640|Mirabegron|mirabegron|mesh-list
14525799|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
14525800|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14525801|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14525802|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
14525803|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525804|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525805|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525806|NCT04501640|Urological Agents|urological agents|mesh-ancestor
14525807|NCT04501952|Remdesivir|remdesivir|mesh-list
14525808|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
14525809|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525810|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
14525811|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525812|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
14525813|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14525814|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
14525815|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14525816|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
14525817|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525818|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525819|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
14525820|NCT04507763|Etanercept|etanercept|mesh-list
14525821|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14525822|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14525823|NCT04507763|Analgesics|analgesics|mesh-ancestor
14525824|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
14525825|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525826|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525827|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14806916|NCT00818584|Micafungin|micafungin|mesh-list
14806917|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
14806918|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806919|NCT00818610|Amoxicillin|amoxicillin|mesh-list
14806920|NCT00818610|Clarithromycin|clarithromycin|mesh-list
14806921|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
14806922|NCT00818610|Cefuroxime|cefuroxime|mesh-list
14806923|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
14806924|NCT00818610|Lactams|lactams|mesh-list
14806925|NCT00818610|beta-Lactams|beta-lactams|mesh-list
14806926|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14806927|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806928|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14806929|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806930|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806931|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14806932|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14806933|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14806934|NCT00818675|Sirolimus|sirolimus|mesh-list
14806935|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14806936|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806937|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14806938|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806939|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
14806940|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14806941|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
14806942|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806943|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14806944|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
14806945|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
14806946|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14806947|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14806948|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806949|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806950|NCT00818701|Urological Agents|urological agents|mesh-ancestor
14806951|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
14806952|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806953|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
14806954|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14806955|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14806956|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806957|NCT00818870|Omeprazole|omeprazole|mesh-list
14806958|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14806959|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14525828|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525829|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14525830|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14525831|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
14525832|NCT04854707|Menotropins|menotropins|mesh-list
14525833|NCT04854707|Hormones|hormones|mesh-list
14525834|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14525835|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14525836|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525837|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14525838|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
14525839|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14525840|NCT04926233|Bromides|bromides|mesh-list
14525841|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
14525842|NCT04926233|Olodaterol|olodaterol|mesh-list
14525843|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14525844|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
14525845|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525846|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525847|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14525848|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
14525849|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
14525850|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14525851|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
14525852|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525853|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525854|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
14525855|NCT04943159|Afamelanotide|afamelanotide|mesh-list
14525856|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
14525857|NCT04525157|Afamelanotide|afamelanotide|mesh-list
14525858|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
14525859|NCT04523831|Doxycycline|doxycycline|mesh-list
14525860|NCT04523831|Ivermectin|ivermectin|mesh-list
14525861|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14525862|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525863|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
14525864|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14525865|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14525866|NCT04511520|Trimetazidine|trimetazidine|mesh-list
14525867|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
14525868|NCT04507776|Etanercept|etanercept|mesh-list
14525869|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14525870|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14525871|NCT04507776|Analgesics|analgesics|mesh-ancestor
14525872|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
14525873|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525874|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525875|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525876|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525877|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14806960|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14806961|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14806962|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525878|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14806963|NCT00819000|Interferon-beta|interferon-beta|mesh-list
14806964|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
14806965|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
14806966|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
14806967|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14806968|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
14806969|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806970|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14525879|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
14525880|NCT04495374|Pregabalin|pregabalin|mesh-list
14525881|NCT04495374|Analgesics|analgesics|mesh-ancestor
14525882|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
14525883|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525884|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525885|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
14525886|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14525887|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14525888|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525889|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14525890|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14525891|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14525892|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525893|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14525894|NCT04495712|Spironolactone|spironolactone|mesh-list
14525895|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14525896|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
14525897|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14525898|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525899|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14525900|NCT04495712|Diuretics|diuretics|mesh-ancestor
14525901|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
14525902|NCT04490499|Vaccines|vaccines|mesh-list
14525903|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
14525904|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525905|NCT04490239|Heparin|heparin|mesh-list
14525906|NCT04490239|Calcium heparin|calcium heparin|mesh-list
14525907|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
14525908|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14525909|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14525910|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525911|NCT04467424|Lidocaine|lidocaine|mesh-list
14525912|NCT04467424|Ketamine|ketamine|mesh-list
14525913|NCT04467424|Propofol|propofol|mesh-list
14525914|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
14525915|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
14525916|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525917|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525918|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
14525919|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525920|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14525921|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14525922|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14525923|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14525924|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525925|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14806971|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525926|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14525927|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
14525928|NCT04467424|Analgesics|analgesics|mesh-ancestor
14525929|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14525930|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14525931|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14525932|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14525933|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
14525934|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14529882|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026491|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525935|NCT04448561|Morphine|morphine|mesh-list
14525936|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14525937|NCT04448561|Narcotics|narcotics|mesh-ancestor
14525938|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14525939|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525940|NCT04448561|Analgesics|analgesics|mesh-ancestor
14525941|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
14525942|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525943|NCT04459585|Dabigatran|dabigatran|mesh-list
14525944|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
14525945|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14525946|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
14525947|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14525948|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525949|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
14525950|NCT04456634|Lumefantrine|lumefantrine|mesh-list
14525951|NCT04456634|Artemether|artemether|mesh-list
14525952|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14525953|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
14525954|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14525955|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14525956|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525957|NCT04439214|Nivolumab|nivolumab|mesh-list
14525958|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14525959|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14525960|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14525961|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14525962|NCT04428502|Etanercept|etanercept|mesh-list
14525963|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14525964|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14525965|NCT04428502|Analgesics|analgesics|mesh-ancestor
14525966|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
14525967|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525968|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525969|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14806972|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14806973|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
14806974|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806975|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
14806976|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14806977|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14806978|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14806979|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14525970|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525971|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14525972|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14525973|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
14525974|NCT04428424|Etanercept|etanercept|mesh-list
14525975|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14525976|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14525977|NCT04428424|Analgesics|analgesics|mesh-ancestor
14525978|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
14525979|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14525980|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525981|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14525982|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14525983|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14525984|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14525985|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
14525986|NCT04428359|Vitamin D|vitamin d|mesh-list
14525987|NCT04428359|Vitamins|vitamins|mesh-ancestor
14525988|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
14525989|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14525990|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14525991|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
14525992|NCT04410159|Listerine|listerine|mesh-list
14525993|NCT04410159|Povidone|povidone|mesh-list
14525994|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
14525995|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
14525996|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14525997|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14525998|NCT04425850|Ivermectin|ivermectin|mesh-list
14525999|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526000|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526001|NCT04425863|Aspirin|aspirin|mesh-list
14526002|NCT04425863|Ivermectin|ivermectin|mesh-list
14526003|NCT04425863|Dexamethasone|dexamethasone|mesh-list
14526004|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
14526005|NCT04425863|Enoxaparin|enoxaparin|mesh-list
14526006|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14526007|NCT04425863|BB 1101|bb 1101|mesh-list
14526008|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14526009|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
14526010|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
14526011|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526012|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526013|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14526014|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
14526015|NCT04425863|Hormones|hormones|mesh-ancestor
14526016|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14526017|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14526018|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526019|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
14526020|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526021|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526022|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14526023|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14526024|NCT04425863|Analgesics|analgesics|mesh-ancestor
14526025|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
14526026|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526027|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14526028|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14526029|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14526030|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14526031|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
14526032|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
14526033|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526034|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526035|NCT04425746|Afamelanotide|afamelanotide|mesh-list
14526036|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
14526037|NCT04422561|Ivermectin|ivermectin|mesh-list
14526038|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526039|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526040|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
14526041|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14526042|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14526043|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
14526044|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526045|NCT04407507|Ivermectin|ivermectin|mesh-list
14526046|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526047|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526048|NCT04406194|Favipiravir|favipiravir|mesh-list
14526049|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
15026492|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026493|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
15026494|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026495|NCT01943760|Tramadol|tramadol|mesh-list
15026496|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15026497|NCT01943760|Narcotics|narcotics|mesh-ancestor
15026498|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15026499|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026500|NCT01943760|Analgesics|analgesics|mesh-ancestor
15026501|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
15026502|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026503|NCT01943786|Cetuximab|cetuximab|mesh-list
15026504|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15026505|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026506|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14526050|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526051|NCT04403399|Varenicline|varenicline|mesh-list
14526052|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14526053|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14526054|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
14806980|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806981|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
14806982|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14806983|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806984|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14526055|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526056|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526057|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526058|NCT04400682|Favipiravir|favipiravir|mesh-list
14526059|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
14526060|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526061|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
14526062|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14526063|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526064|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
14526065|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
14526066|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14806985|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14806986|NCT00819078|Bupropion|bupropion|mesh-list
14806987|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14806988|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
14806989|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14806990|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14806991|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14806992|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14806993|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14806994|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
14806995|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526067|NCT04399122|Acetaminophen|acetaminophen|mesh-list
14530133|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14526068|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14526069|NCT04399122|Oxycodone|oxycodone|mesh-list
14526070|NCT04399122|Codeine|codeine|mesh-list
14526071|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14526072|NCT04399122|Analgesics|analgesics|mesh-ancestor
14526073|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
14526074|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526075|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526076|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
14526077|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14526078|NCT04399122|Narcotics|narcotics|mesh-ancestor
14526079|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14526080|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
14526081|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
14526082|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14526083|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14526084|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526085|NCT04397445|Ranitidine|ranitidine|mesh-list
14526086|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
14526087|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14526088|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14526089|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14526090|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
14526091|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
14526092|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526093|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526094|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526095|NCT04396639|Factor VIII|factor viii|mesh-list
14526096|NCT04396639|Coagulants|coagulants|mesh-ancestor
14526097|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
14526098|NCT04393493|Furosemide|furosemide|mesh-list
14526099|NCT04393493|Spironolactone|spironolactone|mesh-list
14526100|NCT04393493|Diuretics|diuretics|mesh-ancestor
14526101|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
14526102|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526103|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
14526104|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14526105|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526106|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14526107|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
14526108|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14526109|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14526110|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14526111|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14526112|NCT04392362|Adenosine|adenosine|mesh-list
14526113|NCT04392362|Analgesics|analgesics|mesh-ancestor
14526114|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
14526115|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526116|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526117|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14526118|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
14526119|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14526120|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
14526121|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
14526122|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526123|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526124|NCT04392141|Colchicine|colchicine|mesh-list
14526125|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
14526126|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526127|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
14526128|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
14526129|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
14526130|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526131|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526132|NCT04391842|Diclofenac|diclofenac|mesh-list
14526133|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14526134|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14526135|NCT04391842|Analgesics|analgesics|mesh-ancestor
14526136|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
14526137|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526138|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526139|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14526140|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526141|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14526142|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526143|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526144|NCT04390022|Ivermectin|ivermectin|mesh-list
14526145|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526146|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526147|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
14526148|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526149|NCT04374500|Verapamil|verapamil|mesh-list
14526150|NCT04374500|Nitroprusside|nitroprusside|mesh-list
14526151|NCT04374500|Acetylcholine|acetylcholine|mesh-list
14526152|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
14526153|NCT04374500|Bradykinin|bradykinin|mesh-list
14526154|NCT04374500|Substance P|substance p|mesh-list
14526155|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14526156|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14526157|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14526158|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526159|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14526160|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526161|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14526162|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14526163|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14526164|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
14526165|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526166|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
14526167|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
14526168|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
14526169|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526170|NCT04370548|Clindamycin|clindamycin|mesh-list
14526171|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
14526172|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
14526173|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14526174|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14806996|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14806997|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14526175|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14526176|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526177|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526178|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14526179|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
14526180|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526181|NCT04358991|Ceftazidime|ceftazidime|mesh-list
14526182|NCT04358991|Avibactam|avibactam|mesh-list
14526183|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
14526184|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14526185|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526186|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14526187|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526188|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526189|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
14526190|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
14526191|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14526192|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526193|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526194|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526195|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526196|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526197|NCT04352660|Mitomycins|mitomycins|mesh-list
14526198|NCT04352660|Mitomycin|mitomycin|mesh-list
14526199|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14526200|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526201|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
14526202|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526203|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14526204|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526205|NCT04349917|Methylphenidate|methylphenidate|mesh-list
14526206|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14526207|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526208|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14526209|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14526210|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14526211|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526212|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
14526213|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526214|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
14526215|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526216|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
14526217|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
14526218|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14526219|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526220|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526221|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526222|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526223|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526224|NCT04343222|Bromfenac|bromfenac|mesh-list
14526225|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
14526226|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14526227|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14526228|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14526229|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14526230|NCT04343222|Analgesics|analgesics|mesh-ancestor
14526231|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
14526232|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526233|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526234|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14526235|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526236|NCT04343092|Ivermectin|ivermectin|mesh-list
14526237|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526238|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526239|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
14526240|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14526241|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14526242|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14526243|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526244|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14526245|NCT04342663|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14526246|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14526247|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14526248|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526249|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526250|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
14526251|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14526252|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
14526253|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14526254|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14526255|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526256|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14526257|NCT04342130|Morphine|morphine|mesh-list
14526258|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14526259|NCT04342130|Narcotics|narcotics|mesh-ancestor
14526260|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14526261|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526262|NCT04342130|Analgesics|analgesics|mesh-ancestor
14526263|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
14526264|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526265|NCT04340557|Losartan|losartan|mesh-list
14526266|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14526267|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14526268|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14526269|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14526270|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526271|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14526272|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
14526273|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526274|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529883|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529884|NCT03565328|Niacinamide|niacinamide|mesh-list
14529885|NCT03565328|Niacin|niacin|mesh-list
14529886|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
14529887|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
14529888|NCT03565328|Vitamins|vitamins|mesh-ancestor
14529889|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
14529890|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529891|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14529892|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
14529893|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529894|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14529895|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
14529896|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
14529897|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
14529898|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529899|NCT03538015|Carvedilol|carvedilol|mesh-list
14529900|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14529901|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14529902|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
14529903|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529904|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529905|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529906|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14529907|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
14529908|NCT03538015|Protective Agents|protective agents|mesh-ancestor
14529909|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14529910|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14529911|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14529912|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
14529913|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14526275|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
14526276|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14526277|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14526278|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526279|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
14526280|NCT04338074|Coagulants|coagulants|mesh-ancestor
14526281|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
14526282|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14526283|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026507|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15026508|NCT01943812|Estradiol|estradiol|mesh-list
15026509|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15026510|NCT01943812|Progesterone|progesterone|mesh-list
14526284|NCT04335552|Azithromycin|azithromycin|mesh-list
14526285|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
14526286|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14526287|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526288|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
14526289|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14526290|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526291|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526292|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526293|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526294|NCT04334876|Antibodies|antibodies|mesh-list
14526295|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
14526296|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
14526297|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526298|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
14526299|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
14526300|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14526301|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526302|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526303|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526304|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526305|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526306|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
14526307|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
14526308|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14526309|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526310|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526311|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526312|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526313|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526314|NCT04322968|Ketorolac|ketorolac|mesh-list
14526315|NCT04322968|Ketamine|ketamine|mesh-list
14526316|NCT04322968|Analgesics|analgesics|mesh-ancestor
14526317|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
14526318|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526319|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526320|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14526321|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14526322|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
14526323|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
14526324|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14526325|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14526326|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14526327|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526328|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526329|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14526330|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14526331|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14526332|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526333|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14526334|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526335|NCT04332107|Azithromycin|azithromycin|mesh-list
14526336|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15026511|NCT01943812|Estrogens|estrogens|mesh-ancestor
15026512|NCT01943812|Hormones|hormones|mesh-ancestor
15026513|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14526337|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526338|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
14526339|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14526340|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14526341|NCT04323592|Prednisolone|prednisolone|mesh-list
14526342|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
14526343|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14526344|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
14526345|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14526346|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
14526347|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
14526348|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526349|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526350|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14806998|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14806999|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807000|NCT00819104|Metoprolol|metoprolol|mesh-list
14807001|NCT00819104|Amlodipine|amlodipine|mesh-list
14526351|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
14526352|NCT04323592|Hormones|hormones|mesh-ancestor
14526353|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14526354|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14526355|NCT04323592|Protective Agents|protective agents|mesh-ancestor
14526356|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14526357|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526358|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
14526359|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
14526360|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14526361|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526362|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526363|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807002|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14807003|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14526364|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526365|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526366|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
14807004|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14807005|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807006|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14807007|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807008|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
14807009|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14807010|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
14807011|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
14807012|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807013|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14807014|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14807015|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14807016|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
14807017|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807018|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
14807019|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
14807020|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14807021|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
14807022|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807023|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14807024|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14807025|NCT00819325|Pioglitazone|pioglitazone|mesh-list
14807026|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14807027|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807028|NCT00819351|Asparaginase|asparaginase|mesh-list
14807029|NCT00819351|Pegaspargase|pegaspargase|mesh-list
14807030|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807031|NCT00819377|Milrinone|milrinone|mesh-list
14807032|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14807033|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14807034|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
14807035|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14807036|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14807037|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807038|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807039|NCT00819377|Protective Agents|protective agents|mesh-ancestor
14807040|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807041|NCT00819468|Teduglutide|teduglutide|mesh-list
14807042|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14807043|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14807044|NCT00819468|Protective Agents|protective agents|mesh-ancestor
14807045|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807046|NCT00819520|Ivermectin|ivermectin|mesh-list
14526367|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
14526368|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14526369|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526370|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526371|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526372|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526373|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526374|NCT04322526|Naltrexone|naltrexone|mesh-list
14526375|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14526376|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14526377|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526378|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
14526379|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526380|NCT04322682|Colchicine|colchicine|mesh-list
14526381|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
14526382|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526383|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
14526384|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
14526385|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
14526386|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526387|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15026514|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026515|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14526388|NCT04322396|Azithromycin|azithromycin|mesh-list
14526389|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
14526390|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14526391|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526392|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
14526393|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14526394|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526395|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526396|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526397|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526398|NCT04318535|Griseofulvin|griseofulvin|mesh-list
14526399|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
14526400|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526401|NCT04314037|Praziquantel|praziquantel|mesh-list
14526402|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
14526403|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14807047|NCT00819520|Malathion|malathion|mesh-list
14807048|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14807049|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807050|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14807051|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807052|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807053|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
14807054|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807055|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807056|NCT00819572|Antibodies|antibodies|mesh-list
14526404|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526405|NCT04310085|Lumefantrine|lumefantrine|mesh-list
14526406|NCT04310085|Artemether|artemether|mesh-list
14526407|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14526408|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
14526409|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14526410|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526411|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14807057|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
14526412|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
14807058|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
14526413|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
14526414|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14526415|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14526416|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526417|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526418|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526419|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526420|NCT04307940|Acetaminophen|acetaminophen|mesh-list
14526421|NCT04307940|Naproxen|naproxen|mesh-list
14526422|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14526423|NCT04307940|Hydrocodone|hydrocodone|mesh-list
14526424|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14526425|NCT04307940|Analgesics|analgesics|mesh-ancestor
14526426|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
14526427|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526428|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026516|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
15026517|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15026518|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14526429|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
14526430|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14526431|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14526432|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526433|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
14526434|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14526435|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526436|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526437|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14526438|NCT04307940|Narcotics|narcotics|mesh-ancestor
14526439|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14526440|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
14526441|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
14526442|NCT04297631|Tobramycin|tobramycin|mesh-list
14526443|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14526444|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526445|NCT04297241|Isosorbide|isosorbide|mesh-list
14526446|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
14526447|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
14526448|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14526449|NCT04297241|Diuretics|diuretics|mesh-ancestor
14526450|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
14526451|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526452|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
14526453|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
14526454|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026519|NCT01943812|Progestins|progestins|mesh-ancestor
15026520|NCT01943877|Propolis|propolis|mesh-list
15026521|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026522|NCT01943942|Montelukast|montelukast|mesh-list
15026523|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15026524|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
15026525|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15026526|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
14526455|NCT04292535|Insulin|insulin|mesh-list
14526456|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14526457|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
14526458|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
14526459|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
14526460|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14526461|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526462|NCT04292171|Gabapentin|gabapentin|mesh-list
14526463|NCT04292171|Analgesics|analgesics|mesh-ancestor
14526464|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
14526465|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526466|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526467|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
14526468|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14526469|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14526470|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14526471|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14526472|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14526473|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14526474|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526475|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526476|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
14526477|NCT04292899|Remdesivir|remdesivir|mesh-list
14526478|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
14526479|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526480|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
14526481|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526482|NCT04292730|Remdesivir|remdesivir|mesh-list
14526483|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
14526484|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526485|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
14526486|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026527|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026528|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026529|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15026530|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15026531|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026532|NCT01943994|Psilocybin|psilocybin|mesh-list
15026533|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
15026534|NCT01943994|Nicotine|nicotine|mesh-list
15026535|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15026536|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
15026537|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026538|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026539|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15026540|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15026541|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
15026542|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026543|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026544|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
15026545|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15026546|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15026547|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
15026548|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15026549|NCT01944033|Terbutaline|terbutaline|mesh-list
15026550|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14807059|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807060|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
14807061|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14807062|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
14807063|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807064|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807065|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14807066|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
15026551|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
15026552|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026553|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026554|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15026555|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
14526487|NCT04290676|Dexamethasone|dexamethasone|mesh-list
14526488|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
14526489|NCT04290676|BB 1101|bb 1101|mesh-list
14526490|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14526491|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
14526492|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
14526493|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526494|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526495|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14526496|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
14526497|NCT04290676|Hormones|hormones|mesh-ancestor
14807067|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14807068|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
14807069|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807070|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807071|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14807072|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
14807073|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
14807074|NCT00819676|Protective Agents|protective agents|mesh-ancestor
14807075|NCT00819728|Docetaxel|docetaxel|mesh-list
14807076|NCT00819728|Irinotecan|irinotecan|mesh-list
14526498|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14526499|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14526500|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526501|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
14526502|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026556|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
14526503|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526504|NCT04290039|Atropine|atropine|mesh-list
14526505|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14526506|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14526507|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14526508|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14526509|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14526510|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
14526511|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526512|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526513|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14526514|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
14526515|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
14526516|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
14807077|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807078|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
14807079|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
14807080|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
15026557|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
14526517|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14807081|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026558|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15026559|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15026560|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15026561|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15026562|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
15026563|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026564|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026565|NCT01944085|Acetaminophen|acetaminophen|mesh-list
15026566|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
15026567|NCT01944085|Ibuprofen|ibuprofen|mesh-list
15026568|NCT01944085|Vitamins|vitamins|mesh-ancestor
15026569|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
15026570|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526518|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14526519|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
14526520|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526521|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526522|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
14526523|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14526524|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526525|NCT04284930|Bupivacaine|bupivacaine|mesh-list
14807082|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14807083|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14526526|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
14526527|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
14526528|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14526529|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526530|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
14526531|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526532|NCT04283773|Antibodies|antibodies|mesh-list
14526533|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
14526534|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14526535|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
14526536|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526537|NCT04277936|Levetiracetam|levetiracetam|mesh-list
14526538|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
14526539|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
14526540|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
14526541|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
14526542|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
14526543|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14526544|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526545|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
14526546|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526547|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
14526548|NCT04272775|Dexamethasone|dexamethasone|mesh-list
14526549|NCT04272775|Lenalidomide|lenalidomide|mesh-list
14526550|NCT04272775|Ixazomib|ixazomib|mesh-list
14526551|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14807084|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526552|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
14526553|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
14526554|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526555|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526556|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14526557|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
15026571|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15026572|NCT01944085|Analgesics|analgesics|mesh-ancestor
15026573|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
15026574|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15026575|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
15026576|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15026577|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14526558|NCT04272775|Hormones|hormones|mesh-ancestor
14526559|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14526560|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14526561|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526562|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
14526563|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14526564|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14526565|NCT04272775|Growth Substances|growth substances|mesh-ancestor
14526566|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
14526567|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
14526568|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526569|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526570|NCT04267770|Insulin|insulin|mesh-list
14526571|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14526572|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14526573|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526574|NCT04249336|Listerine|listerine|mesh-list
14526575|NCT04249336|Calcium|calcium|mesh-list
14526576|NCT04249336|Fluorides|fluorides|mesh-list
14526577|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
14526578|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14526579|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526580|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
14526581|NCT04249336|Protective Agents|protective agents|mesh-ancestor
14526582|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14526583|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526584|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
14526585|NCT04249310|Olodaterol|olodaterol|mesh-list
14526586|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14526587|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
14526588|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526589|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526590|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14526591|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
14526592|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
14526593|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14526594|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
14526595|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526596|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526597|NCT04238650|Bevacizumab|bevacizumab|mesh-list
14526598|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14526599|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526600|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14526601|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14526602|NCT04238650|Growth Substances|growth substances|mesh-ancestor
14526603|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026578|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526604|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
14526605|NCT04238663|Bevacizumab|bevacizumab|mesh-list
14526606|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14526607|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526608|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14526609|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14526610|NCT04238663|Growth Substances|growth substances|mesh-ancestor
14526611|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526612|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
14526613|NCT04203225|Lidocaine|lidocaine|mesh-list
14526614|NCT04203225|Epinephrine|epinephrine|mesh-list
14526615|NCT04203225|Tetracaine|tetracaine|mesh-list
14526616|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
14526617|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
14526618|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530134|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
14807085|NCT00819754|Bevacizumab|bevacizumab|mesh-list
14807086|NCT00819754|Capecitabine|capecitabine|mesh-list
14807087|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
14807088|NCT00819754|Irinotecan|irinotecan|mesh-list
14807089|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14807090|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807091|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14807092|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14807093|NCT00819754|Growth Substances|growth substances|mesh-ancestor
14807094|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807095|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
14807096|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14807097|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
14807098|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807099|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14807100|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14807101|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807102|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
14807103|NCT00819806|Vaccines|vaccines|mesh-list
14807104|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
14807105|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807106|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14807107|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14807108|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14807109|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
14807110|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807111|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14807112|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14807113|NCT00819845|Carvedilol|carvedilol|mesh-list
14807114|NCT00819845|Ramipril|ramipril|mesh-list
15026579|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15026580|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026581|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026582|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
15026583|NCT01944085|Protective Agents|protective agents|mesh-ancestor
15026584|NCT01944176|Simvastatin|simvastatin|mesh-list
15026585|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15026586|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15026587|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
15026588|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526619|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526620|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
15026589|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15026590|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15026591|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526621|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526622|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14526623|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14526624|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14526625|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14526626|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526627|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14526628|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14526629|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
14526630|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526631|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14526632|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14526633|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
14526634|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14526635|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
14526636|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
14526637|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
14526638|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14526639|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
14526640|NCT04222699|Mupirocin|mupirocin|mesh-list
14526641|NCT04222699|Calcium|calcium|mesh-list
14526642|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14526643|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526644|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14526645|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526646|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
14526647|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14526648|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14526649|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526650|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529914|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14529915|NCT03509207|Vorinostat|vorinostat|mesh-list
14529916|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529917|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14529918|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529919|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529920|NCT03490916|Acetazolamide|acetazolamide|mesh-list
14529921|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
14529922|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14529923|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529924|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529925|NCT03490916|Diuretics|diuretics|mesh-ancestor
14529926|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
14529927|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530135|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
14530136|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530137|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15026592|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15026593|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
15026594|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15026595|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15026596|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15026597|NCT01944215|Caffeine|caffeine|mesh-list
14526651|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
14526652|NCT04218799|Mupirocin|mupirocin|mesh-list
14526653|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14526654|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526655|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
14526656|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14526657|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14526658|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526659|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526660|NCT04204057|Tenalisib|tenalisib|mesh-list
14526661|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
14526662|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526663|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526664|NCT04207840|Epinephrine|epinephrine|mesh-list
14526665|NCT04207840|Racepinephrine|racepinephrine|mesh-list
14526666|NCT04207840|Albuterol|albuterol|mesh-list
14526667|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
14526668|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14526669|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14526670|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
14526671|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526672|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526673|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526674|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14526675|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14526676|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
14526677|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526678|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14526679|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
14526680|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
14526681|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
14526682|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14526683|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
14526684|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14526685|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14526686|NCT04198948|Gliclazide|gliclazide|mesh-list
14526687|NCT04198948|Omeprazole|omeprazole|mesh-list
14526688|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14526689|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14526690|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14526691|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526692|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526693|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14526694|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526695|NCT04204200|Vitamins|vitamins|mesh-list
14526696|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
14526697|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
14526698|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526699|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
14526700|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526701|NCT04204200|Protective Agents|protective agents|mesh-ancestor
14526702|NCT04194151|Propofol|propofol|mesh-list
15026598|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15026599|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026600|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15026601|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15026602|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15026603|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15026604|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15026605|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
15026606|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15026607|NCT01944384|Spironolactone|spironolactone|mesh-list
15026608|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15026609|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
15026610|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15026611|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15026612|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14526703|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14526704|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14526705|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526706|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14526707|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
14526708|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
14526709|NCT04186806|Muramidase|muramidase|mesh-list
14526710|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526711|NCT04184999|Dexamethasone|dexamethasone|mesh-list
14526712|NCT04184999|Prednisolone|prednisolone|mesh-list
14526713|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14526714|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
14526715|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14526716|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
14526717|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14526718|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
14526719|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14526720|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
14526721|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
14526722|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526723|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526724|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14526725|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
14526726|NCT04184999|Hormones|hormones|mesh-ancestor
14526727|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14526728|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14526729|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526730|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14526731|NCT04184999|Protective Agents|protective agents|mesh-ancestor
14526732|NCT04184271|Fluorides|fluorides|mesh-list
14526733|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
14526734|NCT04184271|Protective Agents|protective agents|mesh-ancestor
14526735|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526736|NCT04179461|Vitamin D|vitamin d|mesh-list
14526737|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
14526738|NCT04179461|Fluticasone|fluticasone|mesh-list
14526739|NCT04179461|Xhance|xhance|mesh-list
14526740|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
14526741|NCT04179461|Cetirizine|cetirizine|mesh-list
14526742|NCT04179461|Loratadine|loratadine|mesh-list
15026613|NCT01944384|Diuretics|diuretics|mesh-ancestor
14526743|NCT04179461|Azithromycin|azithromycin|mesh-list
14526744|NCT04179461|Budesonide|budesonide|mesh-list
14526745|NCT04179461|Beclomethasone|beclomethasone|mesh-list
14526746|NCT04179461|Emollients|emollients|mesh-list
14526747|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
14526748|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
14526749|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14526750|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14526751|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
14526752|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
14526753|NCT04179461|Vitamins|vitamins|mesh-ancestor
14526754|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
14526755|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526756|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14526757|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14526758|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14526759|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
14526760|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526761|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14526762|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
14526763|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
14526764|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14526765|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14526766|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
14526767|NCT04179461|Hormones|hormones|mesh-ancestor
14526768|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14526769|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14526770|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526771|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14526772|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14526773|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14526774|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
14526775|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526776|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526777|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
14526778|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14526779|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
14526780|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14526781|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
14526782|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
14526783|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
14526784|NCT04179474|Erenumab|erenumab|mesh-list
14526785|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
14526786|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526787|NCT04179474|Analgesics|analgesics|mesh-ancestor
14526788|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
14526789|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526790|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526791|NCT04177862|Fentanyl|fentanyl|mesh-list
14526792|NCT04177862|Sufentanil|sufentanil|mesh-list
14526793|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14526794|NCT04177862|Narcotics|narcotics|mesh-ancestor
14526795|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14526796|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526797|NCT04177862|Analgesics|analgesics|mesh-ancestor
14526798|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
14526799|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526800|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14526801|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14526802|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
14526803|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
14526804|NCT04175262|Sunitinib|sunitinib|mesh-list
14526805|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526806|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14526807|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14526808|NCT04175262|Growth Substances|growth substances|mesh-ancestor
14529928|NCT03477903|Metoclopramide|metoclopramide|mesh-list
14526809|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526810|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
14526811|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14526812|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526813|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526814|NCT04173429|Nadroparin|nadroparin|mesh-list
14526815|NCT04173429|Warfarin|warfarin|mesh-list
14526816|NCT04173429|Calcium|calcium|mesh-list
14526817|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14526818|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526819|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
14526820|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14526821|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14526822|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526823|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14526824|NCT04169061|Hormones|hormones|mesh-ancestor
14526825|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14526826|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526827|NCT04157738|Insulin|insulin|mesh-list
14526828|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14526829|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
14526830|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
14526831|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14526832|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526833|NCT04156646|Esomeprazole|esomeprazole|mesh-list
14526834|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14526835|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14526836|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14526837|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526838|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526839|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
14526840|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14526841|NCT04169113|Narcotics|narcotics|mesh-ancestor
14526842|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14526843|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526844|NCT04169113|Analgesics|analgesics|mesh-ancestor
14526845|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
14526846|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526847|NCT04160975|Vaccines|vaccines|mesh-list
14526848|NCT04160975|Immunologic Factors|immunologic factors|mesh-ancestor
14526849|NCT04160975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526850|NCT04167189|Lidocaine|lidocaine|mesh-list
14526851|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
14526852|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
14526853|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14526854|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526855|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
14526856|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526857|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14526858|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14526859|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14526860|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14526861|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526862|NCT04162795|Loratadine|loratadine|mesh-list
14526863|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
14526864|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
14526865|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14526866|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14526867|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14526868|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
14526869|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
14526870|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526871|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526872|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526873|NCT04161144|Sirolimus|sirolimus|mesh-list
14526874|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14526875|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526876|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14526877|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526878|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
14526879|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14526880|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
14526881|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526882|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14526883|NCT04150861|Hormones|hormones|mesh-ancestor
14526884|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14526885|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526886|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14526887|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526888|NCT04150224|Macozinone|macozinone|mesh-list
14526889|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
14526890|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14526891|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526892|NCT04149405|Diphosphonates|diphosphonates|mesh-list
14526893|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14526894|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526895|NCT04141930|Baloxavir|baloxavir|mesh-list
14526896|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
14526897|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526898|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526899|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526900|NCT04142242|Vaccines|vaccines|mesh-list
14526901|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
14526902|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526903|NCT04139018|Timolol|timolol|mesh-list
14526904|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14526905|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14526906|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
14526907|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526908|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526909|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526910|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14526911|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14526912|NCT04131556|Maribavir|maribavir|mesh-list
14526913|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
14526914|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526915|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
14526916|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14526917|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526918|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14526919|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14526920|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14526921|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526922|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
14526923|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526924|NCT04137627|Melatonin|melatonin|mesh-list
14526925|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
14526926|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526927|NCT04137627|Protective Agents|protective agents|mesh-ancestor
14526928|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526929|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14526930|NCT04136145|Belimumab|belimumab|mesh-list
14526931|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14526932|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
14526933|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526934|NCT04132336|Naproxen|naproxen|mesh-list
14526935|NCT04132336|Caffeine|caffeine|mesh-list
14526936|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14526937|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526938|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14526939|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526940|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526941|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14526942|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14526943|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
14526944|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14526945|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14526946|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14526947|NCT04132336|Analgesics|analgesics|mesh-ancestor
14526948|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
14526949|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14526950|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14526951|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14526952|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
14526953|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14526954|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14526955|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14526956|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14526957|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
14526958|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14526959|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526960|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14526961|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14526962|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14526963|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14526964|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14807115|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14807116|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14807117|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14807118|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
14807119|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14807120|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807121|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807122|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14807123|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
14807124|NCT00819845|Protective Agents|protective agents|mesh-ancestor
14807125|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14807126|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14807127|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14807128|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
14807129|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14807130|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14807131|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
14807132|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14807133|NCT00819962|Bupivacaine|bupivacaine|mesh-list
14807134|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
14807135|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
14807136|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14807137|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14807138|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
14807139|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807140|NCT00819975|Caseins|caseins|mesh-list
14807141|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
14807142|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
15026614|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
14526965|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14526966|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14526967|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14529929|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
14529930|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
14529931|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14529932|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14529933|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14529934|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14529935|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14529936|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
14529937|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14529938|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14529939|NCT03469258|Pancrelipase|pancrelipase|mesh-list
14529940|NCT03469258|Pancreatin|pancreatin|mesh-list
14529941|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14529942|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
14529943|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14529944|NCT03465891|Atezolizumab|atezolizumab|mesh-list
14529945|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14529946|NCT03465735|Heparin|heparin|mesh-list
14529947|NCT03465735|Enoxaparin|enoxaparin|mesh-list
14529948|NCT03465735|Dalteparin|dalteparin|mesh-list
14529949|NCT03465735|Warfarin|warfarin|mesh-list
14529950|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
14529951|NCT03465735|Dabigatran|dabigatran|mesh-list
14526968|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
14526969|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14526970|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526971|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14526972|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14526973|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526974|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14526975|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14526976|NCT04123665|Fluorides|fluorides|mesh-list
14526977|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
14526978|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
14526979|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
14526980|NCT04123665|Protective Agents|protective agents|mesh-ancestor
14526981|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14526982|NCT04121078|Rifampin|rifampin|mesh-list
14526983|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14526984|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
14526985|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14526986|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14526987|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
14526988|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14526989|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14526990|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807143|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14807144|NCT00819988|Pregabalin|pregabalin|mesh-list
14807145|NCT00819988|Analgesics|analgesics|mesh-ancestor
14807146|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
15026615|NCT01944410|Mitogens|mitogens|mesh-list
14526991|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14526992|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14526993|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14526994|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14526995|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14526996|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14526997|NCT04117607|Rezafungin|rezafungin|mesh-list
14526998|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
14526999|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527000|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
14527001|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14527002|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
14527003|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527004|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
14527005|NCT04115358|Protective Agents|protective agents|mesh-ancestor
14527006|NCT04114058|Bupivacaine|bupivacaine|mesh-list
14527007|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
14527008|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
14527009|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527010|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527011|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
14527012|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527013|NCT04112160|Ketorolac|ketorolac|mesh-list
14527014|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14527015|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14527016|NCT04112160|Analgesics|analgesics|mesh-ancestor
14527017|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
14527018|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807147|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14807148|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527019|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527020|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14527021|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14527022|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14527023|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14529952|NCT03465735|Apixaban|apixaban|mesh-list
14527024|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527025|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
14527026|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
14527027|NCT04112069|Pancrelipase|pancrelipase|mesh-list
14527028|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14527029|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527030|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14527031|NCT04105972|Ivacaftor|ivacaftor|mesh-list
14527032|NCT04105972|Elexacaftor|elexacaftor|mesh-list
14527033|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14527034|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14527035|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527036|NCT04102956|Kallikreins|kallikreins|mesh-list
14527037|NCT04102956|Coagulants|coagulants|mesh-ancestor
14527038|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
14527039|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
14527040|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14527041|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527042|NCT04102345|Zolpidem|zolpidem|mesh-list
14527043|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14527044|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14527045|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14527046|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527047|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
14527048|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
14527049|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
14527050|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527051|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527052|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14527053|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14527054|NCT04089982|Varenicline|varenicline|mesh-list
14527055|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14527056|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14527057|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
14527058|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527059|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527060|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527061|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
14527062|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14527063|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527064|NCT04098575|Empagliflozin|empagliflozin|mesh-list
14527065|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14527066|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527067|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14527068|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527069|NCT04094883|Vaccines|vaccines|mesh-list
14527070|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
14527071|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527072|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14527073|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14527074|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14527075|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14527076|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527077|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
14527078|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527079|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527080|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14527081|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14527082|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
14527083|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14527084|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
14527085|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527086|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
14527087|NCT04081610|Protective Agents|protective agents|mesh-ancestor
14527088|NCT04081324|Lasmiditan|lasmiditan|mesh-list
14527089|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14527090|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
14527091|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14527092|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527093|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527094|NCT04076787|Sunitinib|sunitinib|mesh-list
14527095|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14527096|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14527097|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14527098|NCT04076787|Growth Substances|growth substances|mesh-ancestor
14527099|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527100|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
14527101|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14527102|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527103|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527104|NCT04042324|Heparin|heparin|mesh-list
14527105|NCT04042324|Calcium heparin|calcium heparin|mesh-list
14527106|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
14527107|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527108|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14527109|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14527110|NCT04070287|Antibodies|antibodies|mesh-list
14527111|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
14527112|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
14527113|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527114|NCT04050722|Listerine|listerine|mesh-list
14527115|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
14527116|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
14527117|NCT04050722|Protective Agents|protective agents|mesh-ancestor
14527118|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14527119|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14527120|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527121|NCT04069221|Cobicistat|cobicistat|mesh-list
14527122|NCT04069221|Artefenomel|artefenomel|mesh-list
14527123|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14527124|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14527125|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
14527126|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14527127|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14527128|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14527129|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14527130|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14527131|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
14527132|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14527133|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14527134|NCT04066647|Dexamethasone|dexamethasone|mesh-list
14527135|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14527136|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
14527137|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
14530167|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530168|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530169|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530170|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14530171|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14530172|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
14530173|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
14530174|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
14530175|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530176|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14530177|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14530178|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14530179|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530180|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15035648|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15035649|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
15035650|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968303|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13968304|NCT03111810|Prednisolone|prednisolone|mesh-list
13968305|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13968306|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
13968307|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13968308|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
13968309|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13968310|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
13968311|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14530181|NCT03219372|Pravastatin|pravastatin|mesh-list
13968312|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
13968313|NCT03111810|Hormones|hormones|mesh-ancestor
15035651|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035652|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
15035653|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
15035654|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
15035655|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035656|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15035657|NCT02002325|Plasminogen|plasminogen|mesh-list
15035658|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15035659|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15035660|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035661|NCT02002377|Aflibercept|aflibercept|mesh-list
15035662|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15035663|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15035664|NCT02002377|Growth Substances|growth substances|mesh-ancestor
15035665|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035666|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
15035667|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035668|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15035669|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15035670|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035671|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15035672|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
15035673|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035674|NCT02002403|Danazol|danazol|mesh-list
15035675|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15035676|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
15035677|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035678|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530182|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14530183|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14530184|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
14530185|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530186|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14530187|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14530188|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530189|NCT03217175|Glucagon|glucagon|mesh-list
14530190|NCT03217175|Pancrelipase|pancrelipase|mesh-list
15035679|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
15035680|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
15035681|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15035682|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15035683|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
15035684|NCT02002598|Dexamethasone|dexamethasone|mesh-list
15035685|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
15035686|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14530191|NCT03217175|Pancreatin|pancreatin|mesh-list
14243450|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14243451|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243452|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14243453|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243454|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
14243455|NCT00195039|Antibodies|antibodies|mesh-list
14243456|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14243457|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
14243458|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243459|NCT00195273|Cyclosporine|cyclosporine|mesh-list
14243460|NCT00195273|Sirolimus|sirolimus|mesh-list
14243461|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
14243462|NCT00195273|Cyclosporins|cyclosporins|mesh-list
14243463|NCT00195273|Daclizumab|daclizumab|mesh-list
14243464|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243465|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243466|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243467|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
14243468|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243469|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
14243470|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243471|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
14243472|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243473|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14243474|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14243475|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243476|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14243477|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
14243478|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14243479|NCT00195338|Etanercept|etanercept|mesh-list
14243480|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14243481|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14243482|NCT00195338|Analgesics|analgesics|mesh-ancestor
14243483|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
14243484|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243485|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243486|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243487|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243488|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14243489|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243490|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
14243491|NCT00195351|Metronidazole|metronidazole|mesh-list
14243492|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
14243493|NCT00195351|Tigecycline|tigecycline|mesh-list
14243494|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243495|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14243496|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14243497|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14243498|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14243499|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243500|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243501|NCT00195403|Etanercept|etanercept|mesh-list
14243502|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14243503|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14243504|NCT00195403|Analgesics|analgesics|mesh-ancestor
14243505|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
14243506|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035687|NCT02002598|BB 1101|bb 1101|mesh-list
15035688|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15035689|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
15035690|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
15035691|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035692|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035693|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15035694|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
15035695|NCT02002598|Hormones|hormones|mesh-ancestor
15035696|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14243507|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035697|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15035698|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035699|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
15035700|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035701|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035702|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15035703|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
15035704|NCT02002611|Warfarin|warfarin|mesh-list
15035705|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
13968314|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13968315|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968316|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13968317|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968318|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
13968319|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
13968320|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968321|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13968322|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13968323|NCT03111810|Protective Agents|protective agents|mesh-ancestor
13968324|NCT03111537|Nicotine|nicotine|mesh-list
13968325|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13968326|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
13968327|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968328|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968329|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13968330|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13968331|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
13968332|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968333|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968334|NCT03111511|Drospirenone|drospirenone|mesh-list
13968335|NCT03111511|Midazolam|midazolam|mesh-list
13968336|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13968337|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
13968338|NCT03111511|Betadex|betadex|mesh-list
13968339|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13968340|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13968341|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968342|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968343|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13968344|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13968345|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13968346|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13968347|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
13968348|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
13968349|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
13968350|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
13968351|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968352|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968353|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13968354|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13968355|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13968356|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
13968357|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13968358|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13968359|NCT03111511|Estrogens|estrogens|mesh-ancestor
13968360|NCT03111511|Hormones|hormones|mesh-ancestor
13968361|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13968362|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13968363|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
13968364|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13968365|NCT03111511|Diuretics|diuretics|mesh-ancestor
13968366|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
13968367|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
13968368|NCT03111485|Levodopa|levodopa|mesh-list
13968369|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13968370|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13968371|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13968372|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
13968373|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968374|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968375|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968376|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13968377|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
13968378|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
13968379|NCT03111342|Lidocaine|lidocaine|mesh-list
15035706|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
15035707|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14530192|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530193|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14530194|NCT03217175|Hormones|hormones|mesh-ancestor
14530195|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530196|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14530197|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14530198|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968380|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
13968381|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
14243508|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243509|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243510|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14243511|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243512|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
14243513|NCT00195429|Sirolimus|sirolimus|mesh-list
14243514|NCT00195429|Prednisone|prednisone|mesh-list
14243515|NCT00195429|Tacrolimus|tacrolimus|mesh-list
14243516|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243517|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
14243518|NCT00195429|Hormones|hormones|mesh-ancestor
14530199|NCT03232892|Trametinib|trametinib|mesh-list
14530200|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530201|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14530202|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530203|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530204|NCT03169530|Ethanol|ethanol|mesh-list
14530205|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14530206|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530207|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530208|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530209|NCT03189433|Dantrolene|dantrolene|mesh-list
14530210|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14530211|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530212|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14530213|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530214|NCT03172026|Maraviroc|maraviroc|mesh-list
14530215|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14530216|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
13968382|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968383|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968384|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
13968385|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968386|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13968387|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13968388|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14530217|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530218|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14530219|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14530220|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
14530221|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530222|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
14530223|NCT03161964|Propranolol|propranolol|mesh-list
14530224|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15035708|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15035709|NCT02002663|Prednisolone|prednisolone|mesh-list
15035710|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
15035711|NCT02002663|Morphine|morphine|mesh-list
15035712|NCT02002663|Ropivacaine|ropivacaine|mesh-list
15035713|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15035714|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
15035715|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15035716|NCT02002663|Narcotics|narcotics|mesh-ancestor
15035717|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15035718|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035719|NCT02002663|Analgesics|analgesics|mesh-ancestor
15035720|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
15035721|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035722|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
15035723|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
15035724|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15035725|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
15035726|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
14530225|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14530226|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
14530227|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530228|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530229|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530230|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14530231|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14530232|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
14530233|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
14530234|NCT03150160|Travoprost|travoprost|mesh-list
14530235|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15035727|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14530236|NCT03150160|Brinzolamide|brinzolamide|mesh-list
14530237|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14530238|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14530239|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14530240|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14530241|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14530242|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
15035728|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
15035729|NCT02002663|Hormones|hormones|mesh-ancestor
15035730|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035731|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15035732|NCT02002663|Protective Agents|protective agents|mesh-ancestor
15035733|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15035734|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035735|NCT02002715|Budesonide|budesonide|mesh-list
14530243|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530244|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530245|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530246|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14530247|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530248|NCT03109418|Ketamine|ketamine|mesh-list
14530249|NCT03109418|Analgesics|analgesics|mesh-ancestor
14530250|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
14530251|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530252|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530253|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14530254|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14530255|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
14530256|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
14530257|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530258|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14530259|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14530260|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530261|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530262|NCT03120676|Atezolizumab|atezolizumab|mesh-list
14530263|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035736|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15035737|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14530264|NCT03109873|Metformin|metformin|mesh-list
13968389|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13968390|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968391|NCT03111420|Clopidogrel|clopidogrel|mesh-list
13968392|NCT03111420|Ticagrelor|ticagrelor|mesh-list
13968393|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13968394|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13968395|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13968396|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13968397|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13968398|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
13968399|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968400|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968401|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968402|NCT03111433|Ubiquinone|ubiquinone|mesh-list
13968403|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
13968404|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968405|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
13968406|NCT03111433|Vitamins|vitamins|mesh-ancestor
13968407|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
13968408|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13968409|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968410|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968411|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13968412|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
13968413|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13968414|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968415|NCT03111446|Anesthetics|anesthetics|mesh-list
13968416|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968417|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968418|NCT03111186|Acetaminophen|acetaminophen|mesh-list
13968419|NCT03111186|Ibuprofen|ibuprofen|mesh-list
15035738|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
15035739|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035740|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035741|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15035742|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
15035743|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
15035744|NCT02002715|Hormones|hormones|mesh-ancestor
15035745|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035746|NCT02002741|Acetaminophen|acetaminophen|mesh-list
15035747|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15035748|NCT02002741|Analgesics|analgesics|mesh-ancestor
15035749|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
15035750|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035751|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035752|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
15035753|NCT02002754|Bambuterol|bambuterol|mesh-list
15035754|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15035755|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
15035756|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035757|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035758|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15035759|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
15035760|NCT02002806|Ethanol|ethanol|mesh-list
15035761|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15035762|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15035763|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530265|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14530266|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530267|NCT03113071|Decitabine|decitabine|mesh-list
14530268|NCT03113071|Digoxin|digoxin|mesh-list
14530269|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14530270|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
14530271|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530272|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530273|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530274|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14530275|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14530276|NCT03113071|Protective Agents|protective agents|mesh-ancestor
14530277|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530278|NCT03110900|Lorazepam|lorazepam|mesh-list
14530279|NCT03110900|Haloperidol|haloperidol|mesh-list
14530280|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
14530281|NCT03110900|Loxapine|loxapine|mesh-list
14530282|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
15035764|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035765|NCT02002819|Levetiracetam|levetiracetam|mesh-list
15035766|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
15035767|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
15035768|NCT02002858|Nicotine|nicotine|mesh-list
15035769|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15035770|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
15035771|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035772|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035773|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15035774|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15035775|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
15035776|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035777|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530283|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
14243519|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14243520|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243521|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14243522|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243523|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243524|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
14243525|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14243526|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243527|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243528|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14243529|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243530|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14243531|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
14243532|NCT00195442|Factor VIII|factor viii|mesh-list
14243533|NCT00195442|Coagulants|coagulants|mesh-ancestor
14243534|NCT00195494|Etanercept|etanercept|mesh-list
14243535|NCT00195494|Methotrexate|methotrexate|mesh-list
14243536|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14243537|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
14243538|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14243539|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243540|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243541|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
14243542|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530284|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530285|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530286|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14530287|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14530288|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14530289|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530290|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14530291|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14530292|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
14530293|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530294|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530295|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14530296|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
14530297|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14530298|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15035778|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
15035779|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15035780|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15035781|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035782|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
15035783|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035784|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035785|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
15035786|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15035787|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15035788|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15035789|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15035790|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035791|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
15035792|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035793|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035794|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15035795|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035796|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
15035797|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15035798|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15035799|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035800|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
15035801|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035802|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035803|NCT02003209|Carboplatin|carboplatin|mesh-list
15035804|NCT02003209|Docetaxel|docetaxel|mesh-list
15035805|NCT02003209|Trastuzumab|trastuzumab|mesh-list
15035806|NCT02003209|Pertuzumab|pertuzumab|mesh-list
15035807|NCT02003209|Goserelin|goserelin|mesh-list
15035808|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
15035809|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15035810|NCT02003209|Antibodies|antibodies|mesh-list
15035811|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
15035812|NCT02003209|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15035813|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15035814|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
15035815|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035816|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035817|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
15035818|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
15035819|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
15035820|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035821|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15035822|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15035823|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035824|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15035825|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
15035826|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035827|NCT02003313|Vaccines|vaccines|mesh-list
15035828|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
15035829|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035830|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15035831|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15035832|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035833|NCT02003495|Vaccines|vaccines|mesh-list
15035834|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
15035835|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035836|NCT02003664|Baclofen|baclofen|mesh-list
15035837|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15035838|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035839|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15035840|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035841|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
15035842|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
15035843|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
15035844|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035845|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530299|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
14530300|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
14530301|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
14530302|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14530303|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14530304|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14530305|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15035846|NCT02003677|Insulin|insulin|mesh-list
15035847|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15035848|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
15035849|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
15035850|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15035851|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15035852|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035853|NCT02003742|Tamsulosin|tamsulosin|mesh-list
15035854|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15035855|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15035856|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15035857|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
14243543|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530306|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530307|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
14530308|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530309|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035858|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035859|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035860|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035861|NCT02003742|Urological Agents|urological agents|mesh-ancestor
15035862|NCT02003768|Propofol|propofol|mesh-list
15035863|NCT02003768|Desflurane|desflurane|mesh-list
15035864|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15035865|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15035866|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035867|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15035868|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
15035869|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
15035870|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14530310|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14530311|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530312|NCT03065933|Clonidine|clonidine|mesh-list
14530313|NCT03065933|Analgesics|analgesics|mesh-ancestor
14530314|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
14530315|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530316|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243544|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
14243545|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243546|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14243547|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243548|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
14243549|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243550|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13968420|NCT03111186|Oxycodone|oxycodone|mesh-list
13968421|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13968422|NCT03111186|Analgesics|analgesics|mesh-ancestor
13968423|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
13968424|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968425|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968426|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
13968427|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13968428|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13968429|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13968430|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13968431|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968432|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968433|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13968434|NCT03111186|Narcotics|narcotics|mesh-ancestor
13968435|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968436|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
13968437|NCT03111121|Neostigmine|neostigmine|mesh-list
13968438|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13968439|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968440|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968441|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
13968442|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968443|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968444|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13968445|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
13968446|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035871|NCT02003885|Desflurane|desflurane|mesh-list
15035872|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15035873|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
15035874|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
15035875|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15035876|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035877|NCT02004067|Cyclosporine|cyclosporine|mesh-list
15035878|NCT02004067|Castor Oil|castor oil|mesh-list
15035879|NCT02004067|Cyclosporins|cyclosporins|mesh-list
15035880|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035881|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035882|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15035883|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
15035884|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035885|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
15035886|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15035887|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
15035888|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15035889|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15035890|NCT02004067|Cathartics|cathartics|mesh-ancestor
15035891|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15035892|NCT02004171|Nicotine|nicotine|mesh-list
15035893|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15035894|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
15035895|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035896|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035897|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15035898|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15035899|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
15035900|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035901|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035902|NCT02004184|Pemetrexed|pemetrexed|mesh-list
15035903|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035904|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035905|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035906|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15035907|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15035908|NCT02004197|Amoxicillin|amoxicillin|mesh-list
15035909|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
15035910|NCT02004197|Bismuth|bismuth|mesh-list
15035911|NCT02004197|Ranitidine|ranitidine|mesh-list
15035912|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
15035913|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035914|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15035915|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15035916|NCT02004197|Antacids|antacids|mesh-ancestor
15035917|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15035918|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15035919|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15035920|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
15035921|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
15035922|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035923|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035924|NCT02004301|Diclofenac|diclofenac|mesh-list
15035925|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15035926|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15035927|NCT02004301|Analgesics|analgesics|mesh-ancestor
15035928|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
15035929|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15035930|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035931|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15035932|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15035933|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15035934|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035935|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035936|NCT02004314|Chloroquine|chloroquine|mesh-list
15035937|NCT02004314|Amebicides|amebicides|mesh-ancestor
15035938|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15035939|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15035940|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15035941|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
15035942|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15035943|NCT02004418|Choline|choline|mesh-list
15035944|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
15035945|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15035946|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
15035947|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035948|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15035949|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15035950|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
15035951|NCT02004509|Anticoagulants|anticoagulants|mesh-list
15035952|NCT02004574|Betamethasone|betamethasone|mesh-list
15035953|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
15035954|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15035955|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
15035956|NCT02004574|Calcipotriene|calcipotriene|mesh-list
15035957|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15035958|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15035959|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
15035960|NCT02004574|Hormones|hormones|mesh-ancestor
15035961|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035962|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035963|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15035964|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
15035965|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
15035966|NCT02004652|Prucalopride|prucalopride|mesh-list
15035967|NCT02004652|Laxatives|laxatives|mesh-ancestor
15035968|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15035969|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
15035970|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14243551|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14243552|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14243553|NCT00195494|Analgesics|analgesics|mesh-ancestor
14243554|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
14243555|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243556|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243557|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14243558|NCT00195507|Etanercept|etanercept|mesh-list
14243559|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14243560|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14243561|NCT00195507|Analgesics|analgesics|mesh-ancestor
14243562|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
14243563|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243564|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243565|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243566|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243567|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14243568|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243569|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
14243570|NCT00195624|Cyclosporine|cyclosporine|mesh-list
14243571|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
14243572|NCT00195624|Cyclosporins|cyclosporins|mesh-list
14243573|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15035971|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
15035972|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15035973|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035974|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035975|NCT02004769|Docetaxel|docetaxel|mesh-list
14530317|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14530318|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
14530319|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
14530320|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14530321|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14530322|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14530323|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
14530324|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530325|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035976|NCT02004769|Capecitabine|capecitabine|mesh-list
15035977|NCT02004769|Trastuzumab|trastuzumab|mesh-list
15035978|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035979|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
15035980|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
15035981|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
15035982|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15035983|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14530326|NCT03070002|Denosumab|denosumab|mesh-list
14530327|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14530328|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530329|NCT03050398|Letrozole|letrozole|mesh-list
14530330|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530331|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14530332|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14530333|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530334|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530335|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14530336|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
15035984|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
15035985|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15035986|NCT02004782|Prednisolone|prednisolone|mesh-list
15035987|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15035988|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
15035989|NCT02004782|Hormones|hormones|mesh-ancestor
15035990|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15035991|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035992|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15035993|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15035994|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
15035995|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
15035996|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
15035997|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15035998|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15035999|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
15036000|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036001|NCT02004860|Ciclopirox|ciclopirox|mesh-list
15036002|NCT02004860|Tacrolimus|tacrolimus|mesh-list
15036003|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15036004|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
15036005|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036006|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15036007|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036008|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036009|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
15036010|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036011|NCT02004899|Fentanyl|fentanyl|mesh-list
15036012|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15036013|NCT02004899|Narcotics|narcotics|mesh-ancestor
15036014|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036015|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036016|NCT02004899|Analgesics|analgesics|mesh-ancestor
15036017|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
15036018|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036019|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15036020|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14530337|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530338|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530339|NCT03042780|Folfirinox|folfirinox|mesh-list
14530340|NCT03042780|Sargramostim|sargramostim|mesh-list
14530341|NCT03042780|Lenograstim|lenograstim|mesh-list
14530342|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
14530343|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530344|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14530345|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530346|NCT03029832|Atezolizumab|atezolizumab|mesh-list
13968447|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13968448|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13968449|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13968450|NCT03110952|Vaccines|vaccines|mesh-list
13968451|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
13968452|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968453|NCT03111069|Doxorubicin|doxorubicin|mesh-list
13968454|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13968455|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13968456|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968457|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13968458|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13968459|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968460|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968461|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
13968462|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13968463|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
13968464|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968465|NCT03110757|Antacids|antacids|mesh-ancestor
13968466|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968467|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13968468|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
13968469|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13968470|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13968471|NCT03110848|Prednisolone|prednisolone|mesh-list
13968472|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
13968473|NCT03110848|Atorvastatin|atorvastatin|mesh-list
13968474|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13968475|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
13968476|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
13968477|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13968478|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13968479|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
13968480|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968481|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13968482|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13968483|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968484|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13968485|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
13968486|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
13968487|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968488|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968489|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13968490|NCT03110848|Hormones|hormones|mesh-ancestor
13968491|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13968492|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13968493|NCT03110848|Protective Agents|protective agents|mesh-ancestor
13968494|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13968495|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243574|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243575|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243576|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
14243577|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243578|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
14243579|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243580|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
14243581|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243582|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14243583|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14243584|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243585|NCT00195650|Adalimumab|adalimumab|mesh-list
14243586|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243587|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243588|NCT00195663|Adalimumab|adalimumab|mesh-list
14243589|NCT00195663|Methotrexate|methotrexate|mesh-list
14243590|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14243591|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
14243592|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14243593|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036021|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
15036022|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
15036023|NCT02005068|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
15036024|NCT02005068|Cephalosporins|cephalosporins|mesh-list
15036025|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15036026|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530347|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530348|NCT03031340|Pregabalin|pregabalin|mesh-list
14530349|NCT03031340|Analgesics|analgesics|mesh-ancestor
14530350|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
14530351|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530352|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530353|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
14530354|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15036027|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15036028|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15036029|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15036030|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15036031|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036032|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036033|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036034|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15036035|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
15036036|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15036037|NCT02005120|Bevacizumab|bevacizumab|mesh-list
15036038|NCT02005120|Endostatins|endostatins|mesh-list
15036039|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15036040|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036041|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15036042|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15036043|NCT02005120|Growth Substances|growth substances|mesh-ancestor
15036044|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530355|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14530356|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530357|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14530358|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14530359|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15036045|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
15036046|NCT02005289|Lenalidomide|lenalidomide|mesh-list
15036047|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
15036048|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036049|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15036050|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15036051|NCT02005289|Growth Substances|growth substances|mesh-ancestor
15036052|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
15036053|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036054|NCT02005302|Vitamin D|vitamin d|mesh-list
15036055|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
15036056|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
15036057|NCT02005302|Vitamins|vitamins|mesh-list
14530360|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530361|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14530362|NCT03007719|Fluorides|fluorides|mesh-list
14530363|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
14530364|NCT03007719|Protective Agents|protective agents|mesh-ancestor
14530365|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530366|NCT03010423|Nicorandil|nicorandil|mesh-list
14530367|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14530368|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14530369|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
14530370|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
14530371|NCT03010423|Vitamins|vitamins|mesh-ancestor
14530372|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
14530373|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530374|NCT02985801|Pancrelipase|pancrelipase|mesh-list
14530375|NCT02985801|Pancreatin|pancreatin|mesh-list
14530376|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15036058|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
15036059|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036060|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15036061|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15036062|NCT02005315|Gemcitabine|gemcitabine|mesh-list
15036063|NCT02005315|Paclitaxel|paclitaxel|mesh-list
15036064|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15036065|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036066|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
15036067|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
15036068|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
14530377|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
15036069|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036070|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15036071|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
15036072|NCT02005315|Antiviral Agents|antiviral agents|mesh-ancestor
13968496|NCT03110653|Remifentanil|remifentanil|mesh-list
15036073|NCT02005315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036074|NCT02005315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036075|NCT02005315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15036076|NCT02005315|Immunologic Factors|immunologic factors|mesh-ancestor
15036077|NCT02005315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036078|NCT02005419|Metformin|metformin|mesh-list
15036079|NCT02005419|Gemcitabine|gemcitabine|mesh-list
15036080|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15036081|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
15036082|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036083|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036084|NCT02005419|Antiviral Agents|antiviral agents|mesh-ancestor
15036085|NCT02005419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036086|NCT02005419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036087|NCT02005419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15036088|NCT02005419|Immunologic Factors|immunologic factors|mesh-ancestor
15036089|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036090|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15036091|NCT02005523|RNS60|rns60|mesh-list
15036092|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15036093|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15036094|NCT02005523|Analgesics|analgesics|mesh-ancestor
15036095|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
15036096|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036097|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036098|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15036099|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15036100|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15036101|NCT02005575|Dexamethasone|dexamethasone|mesh-list
15036102|NCT02005575|Bupivacaine|bupivacaine|mesh-list
15036103|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15036104|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
15036105|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
15036106|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036107|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036108|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15036109|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
15036110|NCT02005575|Hormones|hormones|mesh-ancestor
15036111|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15036112|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15036113|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036114|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
15036115|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
15036116|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036117|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
15036118|NCT02005588|Iron|iron|mesh-list
15036119|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
15036120|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
15036121|NCT02005588|Trace Elements|trace elements|mesh-ancestor
15036122|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
15036123|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036124|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
15036125|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
15036126|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036127|NCT02005653|Doxycycline|doxycycline|mesh-list
15036128|NCT02005653|Albendazole|albendazole|mesh-list
15036129|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
15036130|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15036131|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036132|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
15036133|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15036134|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15036135|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
15036136|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
15036137|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15036138|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
15036139|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
15036140|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
15036141|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968497|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13968498|NCT03110653|Narcotics|narcotics|mesh-ancestor
13968499|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968500|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530378|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14530379|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15036142|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036143|NCT02005653|Filaricides|filaricides|mesh-ancestor
15036144|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
15036145|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
15036146|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968501|NCT03110653|Analgesics|analgesics|mesh-ancestor
13968502|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
13968503|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968504|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
13968505|NCT03110640|Fludarabine|fludarabine|mesh-list
14530380|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14530381|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14530382|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530383|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
14530384|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036147|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
15036148|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15036149|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036150|NCT02005718|Vitamins|vitamins|mesh-ancestor
15036151|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
15036152|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15036153|NCT02005757|Mizoribine|mizoribine|mesh-list
15036154|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15036155|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15036156|NCT02005757|Analgesics|analgesics|mesh-ancestor
15036157|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
15036158|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036159|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036160|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15036161|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15036162|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15036163|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036164|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15036165|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036166|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
15036167|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15036168|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15036169|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036170|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036171|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15036172|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
15036173|NCT02005770|Propofol|propofol|mesh-list
15036174|NCT02005770|Sevoflurane|sevoflurane|mesh-list
15036175|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15036176|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036177|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036178|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15036179|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
15036180|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
14530385|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530386|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14530387|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530388|NCT02994251|Gemcitabine|gemcitabine|mesh-list
14530389|NCT02994251|Doxorubicin|doxorubicin|mesh-list
14530390|NCT02994251|Mitomycins|mitomycins|mesh-list
14530391|NCT02994251|Mitomycin|mitomycin|mesh-list
14530392|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530393|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14530394|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
14530395|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530396|NCT02994251|Antiviral Agents|antiviral agents|mesh-ancestor
14530397|NCT02994251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530398|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530399|NCT02994251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14530400|NCT02994251|Immunologic Factors|immunologic factors|mesh-ancestor
14530401|NCT02994251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243594|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15036181|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14530402|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14530403|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14530404|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14530405|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
14530406|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14530407|NCT02971839|Ivacaftor|ivacaftor|mesh-list
14530408|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
14530409|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14530410|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530411|NCT02985840|Dexamethasone|dexamethasone|mesh-list
14530412|NCT02985840|Ondansetron|ondansetron|mesh-list
14530413|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14530414|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
14530415|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
14530416|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530417|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530418|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14530419|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
14530420|NCT02985840|Hormones|hormones|mesh-ancestor
15036182|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15036183|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
15036184|NCT02005783|Docetaxel|docetaxel|mesh-list
15036185|NCT02005783|Epirubicin|epirubicin|mesh-list
15036186|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15036187|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
15036188|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036189|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15036190|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15036191|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
15036192|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036193|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036194|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15036195|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
15036196|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
15036197|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
14243595|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
14243596|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243597|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243598|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
14243599|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243600|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14243601|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243602|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
14243603|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243604|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15036198|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15036199|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15036200|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15036201|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036202|NCT02005822|Valganciclovir|valganciclovir|mesh-list
15036203|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
15036204|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036205|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14530421|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530422|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14530423|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530424|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
14530425|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
14530426|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14530427|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
14530428|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530429|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530430|NCT02985840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14530431|NCT02985840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14530432|NCT02985840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530433|NCT02985840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14530434|NCT02985840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14530435|NCT02974803|Trametinib|trametinib|mesh-list
15036206|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
15036207|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
15036208|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15036209|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15036210|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036211|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036212|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15036213|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036214|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15036215|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036216|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036217|NCT02006173|Lidocaine|lidocaine|mesh-list
15036218|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
15036219|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
15036220|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036221|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036222|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
15036223|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036224|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15036225|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15036226|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15036227|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15036228|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036229|NCT02006225|Plerixafor|plerixafor|mesh-list
15036230|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15036231|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15036232|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
15036233|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036234|NCT02006277|Crizotinib|crizotinib|mesh-list
15036235|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15036236|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036237|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15036238|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036239|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036240|NCT02006355|Ropivacaine|ropivacaine|mesh-list
15036241|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
15036242|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
15036243|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036244|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036245|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
15036246|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036247|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15036248|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15036249|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15036250|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
14530436|NCT02974803|Dabrafenib|dabrafenib|mesh-list
15036251|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036252|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036253|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
15036254|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036255|NCT02006498|Silymarin|silymarin|mesh-list
15036256|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
15036257|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036258|NCT02006498|Protective Agents|protective agents|mesh-ancestor
15036259|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036260|NCT02006589|Candesartan|candesartan|mesh-list
15036261|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
15036262|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15036263|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15036264|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15036265|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036266|NCT02006602|Candesartan|candesartan|mesh-list
15036267|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
15036268|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15036269|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15036270|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15036271|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036272|NCT02006745|Ribavirin|ribavirin|mesh-list
15036273|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
15036274|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036275|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
15036276|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036277|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15036278|NCT02006849|Hormones|hormones|mesh-ancestor
15036279|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15036280|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036281|NCT02006914|Chromium|chromium|mesh-list
15036282|NCT02006914|Picolinic acid|picolinic acid|mesh-list
15036283|NCT02006914|Trace Elements|trace elements|mesh-ancestor
15036284|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
15036285|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036286|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15036287|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
15036288|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
15036289|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036290|NCT02006966|Lidocaine|lidocaine|mesh-list
15036291|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
15036292|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
15036293|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036294|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036295|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
15036296|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036297|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15036298|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15036299|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15036300|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15036301|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036302|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
15036303|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036304|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15036305|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15036306|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
15036307|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036308|NCT02007148|Docetaxel|docetaxel|mesh-list
15036309|NCT02007148|Capecitabine|capecitabine|mesh-list
15036310|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036311|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
15036312|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
15036313|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
15036314|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036315|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15036316|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
15036317|NCT02007161|Diclofenac|diclofenac|mesh-list
15036318|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15036319|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15036320|NCT02007161|Analgesics|analgesics|mesh-ancestor
15036321|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
13968506|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13968507|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
13968508|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968509|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13968510|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13968511|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
13968512|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968513|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968514|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13968515|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
15036322|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036323|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036324|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15036325|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15036326|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15036327|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036328|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530437|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968516|NCT03110341|Hematinics|hematinics|mesh-ancestor
13968517|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
13968518|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13968519|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
13968520|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968521|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
13968522|NCT03110679|Protective Agents|protective agents|mesh-ancestor
13968523|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
13968524|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13968525|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968526|NCT03110510|Leucovorin|leucovorin|mesh-list
13968527|NCT03110510|Fluorouracil|fluorouracil|mesh-list
13968528|NCT03110510|Irinotecan|irinotecan|mesh-list
13968529|NCT03110510|Calcium|calcium|mesh-list
13968530|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
13968531|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13968532|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968533|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
13968534|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968535|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13968536|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530438|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14530439|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530440|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530441|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
14530442|NCT02974686|Everolimus|everolimus|mesh-list
14530443|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530444|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14530445|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
14530446|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530447|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14530448|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14530449|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
14530450|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14530451|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530452|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530453|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530454|NCT02956005|Tacrolimus|tacrolimus|mesh-list
14530455|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14530456|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
14530457|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530458|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14530459|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036329|NCT02007174|Bevacizumab|bevacizumab|mesh-list
15036330|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15036331|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036332|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15036333|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15036334|NCT02007174|Growth Substances|growth substances|mesh-ancestor
15036335|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036336|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
15036337|NCT02007330|Lidocaine|lidocaine|mesh-list
15036338|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
15036339|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
15036340|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530460|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530461|NCT02966184|Albuterol|albuterol|mesh-list
14530462|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14530463|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
14530464|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530465|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530466|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14530467|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
14530468|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
14530469|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14530470|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14530471|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14530472|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14530473|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
14530474|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530475|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530476|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14530477|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14530478|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14530479|NCT02954159|Vedolizumab|vedolizumab|mesh-list
14530480|NCT02954159|Tacrolimus|tacrolimus|mesh-list
14530481|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14530482|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
15036341|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530483|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530484|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14530485|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530486|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530487|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14530488|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
14530489|NCT02947022|Zinc|zinc|mesh-list
14530490|NCT02947022|Edetic Acid|edetic acid|mesh-list
14530491|NCT02947022|Calcium|calcium|mesh-list
14530492|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
14530493|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14530494|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530495|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14530496|NCT02947022|Trace Elements|trace elements|mesh-ancestor
14530497|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
14530498|NCT02947022|Antidotes|antidotes|mesh-ancestor
14530499|NCT02947022|Protective Agents|protective agents|mesh-ancestor
14530500|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
14530501|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
14530502|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530503|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14530504|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
14530505|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14530506|NCT02936999|Vitamin D|vitamin d|mesh-list
14530507|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
14530508|NCT02936999|Vitamins|vitamins|mesh-ancestor
14530509|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
14530510|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530511|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14530512|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14530513|NCT02950480|Zafirlukast|zafirlukast|mesh-list
14530514|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15036342|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
15036343|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036344|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15036345|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15036346|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15036347|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15036348|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036349|NCT02007408|Lidocaine|lidocaine|mesh-list
15036350|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
15036351|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
15036352|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036353|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530515|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
14530516|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14530517|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
14530518|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530519|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530520|NCT02936206|Tamoxifen|tamoxifen|mesh-list
14530521|NCT02936206|Fulvestrant|fulvestrant|mesh-list
14530522|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14530523|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
14530524|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530525|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530526|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14530527|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530528|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15036354|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
14530529|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14530530|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14530531|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14530532|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
14530533|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
14530534|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530535|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530536|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530537|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
14530538|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
15036355|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036356|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15036357|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15036358|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15036359|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15036360|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036361|NCT02007447|Oxytocin|oxytocin|mesh-list
15036362|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
15036363|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15036364|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036365|NCT02007603|Amoxicillin|amoxicillin|mesh-list
15036366|NCT02007603|Ampicillin|ampicillin|mesh-list
15036367|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
15036368|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
15036369|NCT02007603|Sulbactam|sulbactam|mesh-list
15036370|NCT02007603|Sultamicillin|sultamicillin|mesh-list
15036371|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15036372|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036373|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036374|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036375|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15036376|NCT02007629|Riociguat|riociguat|mesh-list
15036377|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
15036378|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036379|NCT02007655|Apixaban|apixaban|mesh-list
15036380|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15036381|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
15036382|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15036383|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
15036384|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036385|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036386|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
15036387|NCT02007746|Liver Extracts|liver extracts|mesh-list
13968537|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13968538|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
13968539|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13968540|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13968541|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968542|NCT03110510|Antidotes|antidotes|mesh-ancestor
13968543|NCT03110510|Protective Agents|protective agents|mesh-ancestor
14243605|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243606|NCT00195676|Adalimumab|adalimumab|mesh-list
14243607|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243608|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243609|NCT00195702|Adalimumab|adalimumab|mesh-list
14243610|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243611|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243612|NCT00195715|Adalimumab|adalimumab|mesh-list
14243613|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243614|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243615|NCT00195819|Adalimumab|adalimumab|mesh-list
14243616|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243617|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243618|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
14243619|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14243620|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
14243621|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15036388|NCT02007746|Hematinics|hematinics|mesh-ancestor
15036389|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
15036390|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15036391|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036392|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036393|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15036394|NCT02007798|Analgesics|analgesics|mesh-ancestor
15036395|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
15036396|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036397|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15036398|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15036399|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15036400|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
15036401|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036402|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036403|NCT02007837|Aspirin|aspirin|mesh-list
15036404|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15036405|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15036406|NCT02007837|Analgesics|analgesics|mesh-ancestor
15036407|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
15036408|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036409|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036410|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243622|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243623|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13968544|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
15036411|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15036412|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15036413|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15036414|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036415|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15036416|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14530539|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
14530540|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14530541|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14530542|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530543|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
14530544|NCT02908516|Coagulants|coagulants|mesh-ancestor
14530545|NCT02920450|Paclitaxel|paclitaxel|mesh-list
14530546|NCT02920450|Carboplatin|carboplatin|mesh-list
14530547|NCT02920450|Gedatolisib|gedatolisib|mesh-list
15036417|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036418|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
15036419|NCT02007850|Ropivacaine|ropivacaine|mesh-list
15036420|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
15036421|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
15036422|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036423|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036424|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
15036425|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036426|NCT02007915|Pamidronate|pamidronate|mesh-list
15036427|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15036428|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968545|NCT03110510|Vitamins|vitamins|mesh-ancestor
15036429|NCT02007928|Olanzapine|olanzapine|mesh-list
15036430|NCT02007928|Risperidone|risperidone|mesh-list
14243624|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14243625|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14243626|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
14243627|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15036431|NCT02007928|Aripiprazole|aripiprazole|mesh-list
15036432|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15036433|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
14530548|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14530549|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530550|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
14530551|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
14530552|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
14530553|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530554|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15036434|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036435|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036436|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036437|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15036438|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15036439|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036440|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15036441|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14530555|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530556|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14530557|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14530558|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
14530559|NCT02920177|Hormones|hormones|mesh-ancestor
15036442|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
15036443|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
15036444|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
15036445|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036446|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15036447|NCT02007928|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15036448|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15036449|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15036450|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
15036451|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
15036452|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15036453|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15036454|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15036455|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15036456|NCT02008006|Cytarabine|cytarabine|mesh-list
15036457|NCT02008006|Etoposide|etoposide|mesh-list
14530560|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530561|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530562|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14530563|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
14530564|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14530565|NCT02926638|Rilotumumab|rilotumumab|mesh-list
14530566|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14530567|NCT02926638|Antibodies|antibodies|mesh-list
14530568|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
14530569|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14530570|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
14530571|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530572|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530573|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14243628|NCT00196326|Estradiol|estradiol|mesh-list
14243629|NCT00196326|Estrogens|estrogens|mesh-ancestor
14243630|NCT00196326|Hormones|hormones|mesh-ancestor
14243631|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14243632|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243633|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14243634|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
14530574|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530575|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530576|NCT02920242|Rifaximin|rifaximin|mesh-list
14530577|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14530578|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530579|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14530580|NCT02892500|Betamethasone|betamethasone|mesh-list
14530581|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
14530582|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
14530583|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
14530584|NCT02892500|Bupivacaine|bupivacaine|mesh-list
14530585|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
14530586|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
14530587|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
14530588|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530589|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530590|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
14530591|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530592|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14530593|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
14530594|NCT02892500|Hormones|hormones|mesh-ancestor
14530595|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530596|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14530597|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
14530598|NCT02899728|Cisplatin|cisplatin|mesh-list
14530599|NCT02899728|Carboplatin|carboplatin|mesh-list
14530600|NCT02899728|Etoposide|etoposide|mesh-list
14530601|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
14530602|NCT02899728|Olaparib|olaparib|mesh-list
14530603|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
14530604|NCT02899728|Cediranib|cediranib|mesh-list
14530605|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
14530606|NCT02899728|Maleic acid|maleic acid|mesh-list
14530607|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036458|NCT02008006|Melphalan|melphalan|mesh-list
15036459|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15036460|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15036461|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036462|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15036463|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15036464|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530608|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15036465|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036466|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15036467|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
15036468|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
15036469|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036470|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15036471|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
15036472|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036473|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15036474|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
15036475|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15036476|NCT02008019|Everolimus|everolimus|mesh-list
15036477|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036478|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15036479|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
15036480|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036481|NCT02008123|Primidone|primidone|mesh-list
15036482|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
15036483|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
15036484|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
15036485|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036486|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036487|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036488|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
15036489|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14530609|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14530610|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14530611|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530612|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530613|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
14530614|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
14530615|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
15036490|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14530616|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
14530617|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
14530618|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14530619|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
14530620|NCT02875067|Lenalidomide|lenalidomide|mesh-list
14530621|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14530622|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530623|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
15036491|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036492|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
15036493|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968546|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
13968547|NCT03110484|Pemetrexed|pemetrexed|mesh-list
13968548|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13968549|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968550|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968551|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968552|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13968553|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13968554|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13968555|NCT03110094|Adalimumab|adalimumab|mesh-list
13968556|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13968557|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13968558|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
13968559|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13968560|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
13968561|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968562|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968563|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
13968564|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
13968565|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968566|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13968567|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13968568|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13968569|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13968570|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968571|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968572|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968573|NCT03110172|Analgesics|analgesics|mesh-ancestor
13968574|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
13968575|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968576|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
14530624|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036494|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036495|NCT02008162|Bromides|bromides|mesh-list
15036496|NCT02008162|Albuterol|albuterol|mesh-list
15036497|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
15036498|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
15036499|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
15036500|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036501|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036502|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15036503|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
15036504|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
15036505|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15036506|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
15036507|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036508|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036509|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
15036510|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
15036511|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15036512|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15036513|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15036514|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15036515|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
15036516|NCT02008201|Vitamin D|vitamin d|mesh-list
15036517|NCT02008201|Vitamins|vitamins|mesh-ancestor
15036518|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
14530625|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14530626|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14530627|NCT02875067|Growth Substances|growth substances|mesh-ancestor
14530628|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
14530629|NCT02868892|Pemetrexed|pemetrexed|mesh-list
15036519|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036520|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15036521|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
15036522|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15036523|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036524|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036525|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15036526|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15036527|NCT02008214|Protective Agents|protective agents|mesh-ancestor
15036528|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036529|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
15036530|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15036531|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
15036532|NCT02008383|Panitumumab|panitumumab|mesh-list
15036533|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15036534|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036535|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
15036536|NCT02008422|Tegafur|tegafur|mesh-list
15036537|NCT02008422|Endostar protein|endostar protein|mesh-list
15036538|NCT02008422|Endostatins|endostatins|mesh-list
15036539|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036540|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15036541|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
15036542|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036543|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15036544|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15036545|NCT02008422|Growth Substances|growth substances|mesh-ancestor
15036546|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036547|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
15036548|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
15036549|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15036550|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15036551|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036552|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
15036553|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036554|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036555|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
15036556|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15036557|NCT02008578|Antibodies|antibodies|mesh-list
15036558|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
15036559|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036560|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
15036561|NCT02008721|Protective Agents|protective agents|mesh-ancestor
15036562|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036563|NCT02008734|Palbociclib|palbociclib|mesh-list
15036564|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036565|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15036566|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036567|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036568|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
15036569|NCT02008747|Analgesics|analgesics|mesh-ancestor
15036570|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
14530630|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530631|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530632|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530633|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14530634|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14530635|NCT02828124|Nivolumab|nivolumab|mesh-list
14530636|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14530637|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530638|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14530639|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530640|NCT02826551|Bupivacaine|bupivacaine|mesh-list
14530641|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
14530642|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
14530643|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530644|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530645|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
14530646|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530647|NCT02819804|Nivolumab|nivolumab|mesh-list
14530648|NCT02819804|Dasatinib|dasatinib|mesh-list
14530649|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14530650|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530651|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14530652|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530653|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15036571|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036572|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036573|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
15036574|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036575|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15036576|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
15036577|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15036578|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15036579|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036580|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15036581|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
15036582|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15036583|NCT02008786|Ramipril|ramipril|mesh-list
15036584|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15036585|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15036586|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15036587|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
15036588|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036589|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15036590|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15036591|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036592|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15036593|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
15036594|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15036595|NCT02008968|Allopurinol|allopurinol|mesh-list
15036596|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
15036597|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036598|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036599|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
15036600|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15036601|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15036602|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
15036603|NCT02008968|Protective Agents|protective agents|mesh-ancestor
15036604|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036605|NCT02008981|Aspirin|aspirin|mesh-list
15036606|NCT02008981|Turmeric extract|turmeric extract|mesh-list
15036607|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15036608|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15036609|NCT02008981|Analgesics|analgesics|mesh-ancestor
15036610|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
15036611|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036612|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036613|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15036614|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15036615|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15036616|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15036617|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530654|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530655|NCT02806960|Glucagon|glucagon|mesh-list
14530656|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14530657|NCT02806960|Hormones|hormones|mesh-ancestor
14530658|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530659|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530660|NCT02815397|Metformin|metformin|mesh-list
14530661|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14530662|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530663|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
14530664|NCT02802592|Hematinics|hematinics|mesh-ancestor
14530665|NCT02774148|Acetaminophen|acetaminophen|mesh-list
14530666|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14530667|NCT02774148|Analgesics|analgesics|mesh-ancestor
14530668|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
14530669|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036618|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15036619|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15036620|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036621|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
15036622|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
15036623|NCT02008981|Protective Agents|protective agents|mesh-ancestor
15036624|NCT02009007|Phenylephrine|phenylephrine|mesh-list
15036625|NCT02009007|Dopamine|dopamine|mesh-list
15036626|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
15036627|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15036628|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
15036629|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
15036630|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036631|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036632|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
15036633|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15036634|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
15036635|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
15036636|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15036637|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15036638|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15036639|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
15036640|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036641|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036642|NCT02009007|Protective Agents|protective agents|mesh-ancestor
15036643|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
15036644|NCT02009098|Cefuroxime|cefuroxime|mesh-list
15036645|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
15036646|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15036647|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036648|NCT02009189|Taurolidine|taurolidine|mesh-list
15036649|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530670|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530671|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
14530672|NCT02773576|Risperidone|risperidone|mesh-list
14530673|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14530674|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
14530675|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530676|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530677|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530678|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14530679|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14530680|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530681|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14530682|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14530683|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
14530684|NCT02730793|Aztreonam|aztreonam|mesh-list
14530685|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14530686|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530687|NCT02744352|Ropivacaine|ropivacaine|mesh-list
14530688|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
14530689|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
14530690|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036650|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15036651|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530691|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530692|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
14530693|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530694|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
14530695|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14530696|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
14530697|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
14530698|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530699|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530700|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14530701|NCT02757521|Analgesics|analgesics|mesh-ancestor
14530702|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
14530703|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530704|NCT02758132|Denosumab|denosumab|mesh-list
14530705|NCT02758132|Prednisone|prednisone|mesh-list
14530706|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14530707|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
14530708|NCT02758132|Hormones|hormones|mesh-ancestor
14530709|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530710|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530711|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15036652|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
15036653|NCT02009202|Cathartics|cathartics|mesh-ancestor
15036654|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15036655|NCT02009215|Piperaquine|piperaquine|mesh-list
14530712|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530713|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14530714|NCT02734940|Lidocaine|lidocaine|mesh-list
14530715|NCT02734940|Fentanyl|fentanyl|mesh-list
14530716|NCT02734940|Ketamine|ketamine|mesh-list
14530717|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
14530718|NCT02734940|Morphine|morphine|mesh-list
14530719|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
14530720|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
14530721|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036656|NCT02009215|Artenimol|artenimol|mesh-list
15036657|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
14243635|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14243636|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14243637|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14243638|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14243639|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14243640|NCT00196976|Edetic Acid|edetic acid|mesh-list
14243641|NCT00196976|Vaccines|vaccines|mesh-list
14243642|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
14243643|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
14243644|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243645|NCT00196976|Antidotes|antidotes|mesh-ancestor
14243646|NCT00196976|Protective Agents|protective agents|mesh-ancestor
14243647|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
14243648|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
14243649|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243650|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14243651|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
14243652|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14243653|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14243654|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
14243655|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243656|NCT00197106|Fluticasone|fluticasone|mesh-list
14243657|NCT00197106|Xhance|xhance|mesh-list
14530722|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036658|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15036659|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15036660|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036661|NCT02009280|Anesthetics|anesthetics|mesh-list
15036662|NCT02009280|Propofol|propofol|mesh-list
15036663|NCT02009280|Sevoflurane|sevoflurane|mesh-list
15036664|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036665|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036666|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15036667|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15036668|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
15036669|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15036670|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15036671|NCT02009306|Fentanyl|fentanyl|mesh-list
15036672|NCT02009306|Midazolam|midazolam|mesh-list
15036673|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15036674|NCT02009306|Narcotics|narcotics|mesh-ancestor
15036675|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036676|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036677|NCT02009306|Analgesics|analgesics|mesh-ancestor
15036678|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
15036679|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036680|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15036681|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15036682|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
15036683|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
15036684|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15036685|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15036686|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15036687|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15036688|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
15036689|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
15036690|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036691|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036692|NCT02009410|Pancrelipase|pancrelipase|mesh-list
15036693|NCT02009410|Pancreatin|pancreatin|mesh-list
15036694|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15036695|NCT02009436|Azacitidine|azacitidine|mesh-list
14243658|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15036696|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15036697|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
13968577|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13968578|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
13968579|NCT03109886|Maleic acid|maleic acid|mesh-list
13968580|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968581|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968582|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
13968583|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
13968584|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
13968585|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
13968586|NCT03110198|Mesalamine|mesalamine|mesh-list
13968587|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13968588|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13968589|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13968590|NCT03110198|Analgesics|analgesics|mesh-ancestor
13968591|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
13968592|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968593|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968594|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13968595|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
13968596|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13968597|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
13968598|NCT03109977|Pertuzumab|pertuzumab|mesh-list
13968599|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13968600|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968601|NCT03110055|Grazoprevir|grazoprevir|mesh-list
13968602|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
13968603|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13968604|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
13968605|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13968606|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968607|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968608|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13968609|NCT03109990|Analgesics|analgesics|mesh-ancestor
13968610|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
13968611|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968612|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13968613|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13968614|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15036698|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036699|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530723|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
14530724|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530725|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15036700|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036701|NCT02009449|Leucovorin|leucovorin|mesh-list
15036702|NCT02009449|Gemcitabine|gemcitabine|mesh-list
15036703|NCT02009449|Paclitaxel|paclitaxel|mesh-list
15036704|NCT02009449|Docetaxel|docetaxel|mesh-list
15036705|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15036706|NCT02009449|Carboplatin|carboplatin|mesh-list
15036707|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
15036708|NCT02009449|Fluorouracil|fluorouracil|mesh-list
15036709|NCT02009449|Capecitabine|capecitabine|mesh-list
15036710|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
15036711|NCT02009449|Nivolumab|nivolumab|mesh-list
15036712|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
15036713|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15036714|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036715|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
15036716|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
15036717|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
15036718|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036719|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15036720|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
13968615|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
13968616|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036721|NCT02009449|Antiviral Agents|antiviral agents|mesh-ancestor
15036722|NCT02009449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530726|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14530727|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14530728|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14530729|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530730|NCT02734940|Analgesics|analgesics|mesh-ancestor
14530731|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14530732|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14530733|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
14530734|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14530735|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14530736|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530737|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14530738|NCT02734940|Narcotics|narcotics|mesh-ancestor
14530739|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14530740|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14530741|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14530742|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14530743|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14530744|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14530745|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
15036723|NCT02009449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036724|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15036725|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
15036726|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036727|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15036728|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15036729|NCT02009449|Antidotes|antidotes|mesh-ancestor
15036730|NCT02009449|Protective Agents|protective agents|mesh-ancestor
15036731|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
15036732|NCT02009449|Vitamins|vitamins|mesh-ancestor
15036733|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
15036734|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
15036735|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
15036736|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15036737|NCT02009462|Protective Agents|protective agents|mesh-ancestor
15036738|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036739|NCT02009488|Canagliflozin|canagliflozin|mesh-list
15036740|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15036741|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036742|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15036743|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036744|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
15036745|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
15036746|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15036747|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
15036748|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15036749|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15036750|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15036751|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15036752|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036753|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
15036754|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036755|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036756|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15036757|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036758|NCT02009592|Rifaximin|rifaximin|mesh-list
15036759|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15036760|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036761|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15036762|NCT02009618|Rifaximin|rifaximin|mesh-list
15036763|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15036764|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036765|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15036766|NCT02009631|Veliparib|veliparib|mesh-list
15036767|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15036768|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036769|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036770|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036771|NCT02009709|Riboflavin|riboflavin|mesh-list
15036772|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15036773|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15036774|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
15036775|NCT02009709|Vitamins|vitamins|mesh-ancestor
15036776|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
14530746|NCT02749617|Apixaban|apixaban|mesh-list
14530747|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14530748|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
14530749|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14530750|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
14530751|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530752|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530753|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
14530754|NCT02749227|Pasireotide|pasireotide|mesh-list
14530755|NCT02749227|Hormones|hormones|mesh-ancestor
14530756|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530757|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036777|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530758|NCT02746263|Acetaminophen|acetaminophen|mesh-list
14530759|NCT02746263|Morphine|morphine|mesh-list
14530760|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15036778|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15036779|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
15036780|NCT02009748|Vitamin D|vitamin d|mesh-list
15036781|NCT02009748|Vitamins|vitamins|mesh-ancestor
15036782|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
15036783|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036784|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15036785|NCT02009787|Vitamin D|vitamin d|mesh-list
15036786|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
15036787|NCT02009787|Vitamins|vitamins|mesh-ancestor
15036788|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
15036789|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036790|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15036791|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15036792|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
15036793|NCT02009943|Hematinics|hematinics|mesh-ancestor
15036794|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
15036795|NCT02010164|Ubiquinone|ubiquinone|mesh-list
15036796|NCT02010164|Vitamins|vitamins|mesh-ancestor
15036797|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
15036798|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036799|NCT02010372|Vaccines|vaccines|mesh-list
15036800|NCT02010372|Immunologic Factors|immunologic factors|mesh-ancestor
15036801|NCT02010372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036802|NCT02010385|Octreotide|octreotide|mesh-list
15036803|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15036804|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15036805|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036806|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
15036807|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15036808|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15036809|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
15036810|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036811|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036812|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
15036813|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15036814|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15036815|NCT02010723|Polidocanol|polidocanol|mesh-list
15036816|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15036817|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15036818|NCT02010762|Vitamin D|vitamin d|mesh-list
15036819|NCT02010762|Vitamins|vitamins|mesh-ancestor
15036820|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
15036821|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036822|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15036823|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
15036824|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15036825|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15036826|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15036827|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15036828|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036829|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
15036830|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036831|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036832|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15036833|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036834|NCT02010827|Glucagon|glucagon|mesh-list
15036835|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15036836|NCT02010827|Hormones|hormones|mesh-ancestor
15036837|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530761|NCT02746263|Narcotics|narcotics|mesh-ancestor
14530762|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530763|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036838|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036839|NCT02010905|Losartan|losartan|mesh-list
15036840|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15036841|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15036842|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15036843|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15036844|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036845|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
15036846|NCT02010944|Mirabegron|mirabegron|mesh-list
15036847|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15036848|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15036849|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
15036850|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530764|NCT02746263|Analgesics|analgesics|mesh-ancestor
14530765|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
14530766|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036851|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036852|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036853|NCT02010944|Urological Agents|urological agents|mesh-ancestor
15036854|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15036855|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15036856|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15036857|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
15036858|NCT02010957|Etomidate|etomidate|mesh-list
15036859|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15036860|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036861|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036862|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14530767|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14530768|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
14530769|NCT02721277|SMOFlipid|smoflipid|mesh-list
14530770|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14530771|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14530772|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14530773|NCT02732327|Vancomycin|vancomycin|mesh-list
14530774|NCT02732327|Meropenem|meropenem|mesh-list
14530775|NCT02732327|Tazobactam|tazobactam|mesh-list
14530776|NCT02732327|Linezolid|linezolid|mesh-list
14530777|NCT02732327|Piperacillin|piperacillin|mesh-list
14530778|NCT02732327|Cefepime|cefepime|mesh-list
14530779|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14530780|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15036863|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
15036864|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
15036865|NCT02010970|Itraconazole|itraconazole|mesh-list
15036866|NCT02010970|Diltiazem|diltiazem|mesh-list
15036867|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
15036868|NCT02010970|Midazolam|midazolam|mesh-list
14530781|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530782|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15036869|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15036870|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036871|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15036872|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15036873|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036874|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15036875|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15036876|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15036877|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15036878|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
15036879|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
15036880|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
15036881|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
15036882|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036883|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036884|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
15036885|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036886|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15036887|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15036888|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036889|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15036890|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
15036891|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15036892|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15036893|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15036894|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15036895|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
14530783|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530784|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530785|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14530786|NCT02726399|Capecitabine|capecitabine|mesh-list
15036896|NCT02011126|Imetelstat|imetelstat|mesh-list
15036897|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
15036898|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036899|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036900|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15036901|NCT02011191|Biotin|biotin|mesh-list
15036902|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
15036903|NCT02011191|Vitamins|vitamins|mesh-ancestor
15036904|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
14530787|NCT02726399|Trastuzumab|trastuzumab|mesh-list
15036905|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036906|NCT02011321|Clevidipine|clevidipine|mesh-list
15036907|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15036908|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15036909|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036910|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15036911|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036912|NCT02011347|Ketamine|ketamine|mesh-list
15036913|NCT02011347|Analgesics|analgesics|mesh-ancestor
15036914|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
15036915|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036916|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036917|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15036918|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14530788|NCT02726399|Ramucirumab|ramucirumab|mesh-list
14530789|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530790|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14530791|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
14530792|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530793|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14530794|NCT02720510|Dexamethasone|dexamethasone|mesh-list
14530795|NCT02720510|Lenalidomide|lenalidomide|mesh-list
14530796|NCT02720510|Bortezomib|bortezomib|mesh-list
14530797|NCT02720510|Panobinostat|panobinostat|mesh-list
14530798|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14530799|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
14530800|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
14530801|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530802|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530803|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14530804|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
14530805|NCT02720510|Hormones|hormones|mesh-ancestor
14530806|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530807|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14530808|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530809|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
14530810|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14530811|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14530812|NCT02720510|Growth Substances|growth substances|mesh-ancestor
14530813|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
14530814|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14530815|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530816|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530817|NCT02717949|Ribavirin|ribavirin|mesh-list
14530818|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
14530819|NCT02717949|Ledipasvir|ledipasvir|mesh-list
14530820|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
14530821|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530822|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
14530823|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530824|NCT02717130|Aripiprazole|aripiprazole|mesh-list
14530825|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
14530826|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14530827|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15036919|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
15036920|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
15036921|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036922|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15036923|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15036924|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036925|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036926|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
15036927|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15036928|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036929|NCT02011620|Isosorbide|isosorbide|mesh-list
15036930|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15036931|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15036932|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15036933|NCT02011620|Diuretics|diuretics|mesh-ancestor
15036934|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
15036935|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036936|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
15036937|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15036938|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036939|NCT02011633|Metformin|metformin|mesh-list
15036940|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15036941|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15036942|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036943|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15036944|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15036945|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
15036946|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036947|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15036948|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15036949|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036950|NCT02011659|Ramosetron|ramosetron|mesh-list
15036951|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
15036952|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
15036953|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15036954|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036955|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15036956|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15036957|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
15036958|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036959|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036960|NCT02011737|Naftopidil|naftopidil|mesh-list
15036961|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15036962|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15036963|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
15036964|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036965|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036966|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036967|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15036968|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15036969|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15036970|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15036971|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15036972|NCT02011750|Valproic Acid|valproic acid|mesh-list
15036973|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
14530828|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14530829|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530830|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530831|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
15036974|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036975|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036976|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
15036977|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15036978|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036979|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
15036980|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15036981|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15036982|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15036983|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
14530832|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
14530833|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530834|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530835|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14530836|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14530837|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
14530838|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14530839|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14530840|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14530841|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14530842|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
14530843|NCT02709083|Dasatinib|dasatinib|mesh-list
14530844|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530845|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14530846|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530847|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530848|NCT02693171|Dinutuximab|dinutuximab|mesh-list
14530849|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530850|NCT02696226|Aspirin|aspirin|mesh-list
15036984|NCT02011828|Vitamin D|vitamin d|mesh-list
15036985|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15036986|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15036987|NCT02011828|Vitamins|vitamins|mesh-ancestor
15036988|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
15036989|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15036990|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
15036991|NCT02011841|Rifaximin|rifaximin|mesh-list
15036992|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15036993|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15036994|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15036995|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14530851|NCT02696226|Warfarin|warfarin|mesh-list
14530852|NCT02696226|Clopidogrel|clopidogrel|mesh-list
14530853|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14530854|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14530855|NCT02696226|Analgesics|analgesics|mesh-ancestor
15036996|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15036997|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15036998|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15036999|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15037000|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15037001|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15037002|NCT02011880|Corylifolin|corylifolin|mesh-list
15037003|NCT02011880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15037004|NCT02011880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530856|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
15037005|NCT02011880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530857|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530858|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530859|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14530860|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14530861|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14530862|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14530863|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530864|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14530865|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14530866|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530867|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
14530868|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14530869|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14530870|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14530871|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
14530872|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037006|NCT02011880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15037007|NCT02011880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15037008|NCT02011880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037009|NCT02011906|Vitamins|vitamins|mesh-list
15037010|NCT02011906|Vitamin E|vitamin e|mesh-list
15037011|NCT02011906|Tocopherols|tocopherols|mesh-list
14530873|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
14530874|NCT02706691|Infigratinib|infigratinib|mesh-list
15037012|NCT02011906|Tocotrienols|tocotrienols|mesh-list
15037013|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
15037014|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
15037015|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037016|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
15037017|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037018|NCT02011906|Protective Agents|protective agents|mesh-ancestor
15037019|NCT02011958|Amphotericin B|amphotericin b|mesh-list
15037020|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15037021|NCT02011958|Miltefosine|miltefosine|mesh-list
15037022|NCT02011958|Amebicides|amebicides|mesh-ancestor
15037023|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15037024|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15037025|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15037026|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15037027|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
15037028|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037029|NCT02011971|Vinpocetine|vinpocetine|mesh-list
15037030|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15037031|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037032|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037033|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
15037034|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15037035|NCT02011971|Protective Agents|protective agents|mesh-ancestor
15037036|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037037|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
15037038|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15037039|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15037040|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
15037041|NCT02012049|Risperidone|risperidone|mesh-list
15037042|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15037043|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
15037044|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037045|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037046|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037047|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15037048|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15037049|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037050|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15037051|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15037052|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
15037053|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
15037054|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037055|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15037056|NCT02012075|Metoprolol|metoprolol|mesh-list
15037057|NCT02012075|Carvedilol|carvedilol|mesh-list
15037058|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15037059|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15037060|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
15037061|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
15037062|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037063|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037064|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15037065|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15037066|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15037067|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
15037068|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037069|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037070|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
15037071|NCT02012075|Protective Agents|protective agents|mesh-ancestor
15037072|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15037073|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15037074|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15037075|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
15037076|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15037077|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15037078|NCT02012088|Prednisone|prednisone|mesh-list
15037079|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
14243659|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243660|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14243661|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
14243662|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243663|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037080|NCT02012088|Rituximab|rituximab|mesh-list
15037081|NCT02012088|Doxorubicin|doxorubicin|mesh-list
15037082|NCT02012088|Vincristine|vincristine|mesh-list
15037083|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15037084|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
15037085|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037086|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15037087|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15037088|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
15037089|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037090|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037091|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15037092|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15037093|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15037094|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15037095|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15037096|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037097|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15037098|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
15037099|NCT02012088|Hormones|hormones|mesh-ancestor
15037100|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15037101|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15037102|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15037103|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
15037104|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
15037105|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
15037106|NCT02012114|Cysteamine|cysteamine|mesh-list
15037107|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
15037108|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037109|NCT02012140|Ticagrelor|ticagrelor|mesh-list
15037110|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15037111|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15037112|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15037113|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15037114|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
15037115|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037116|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037117|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037118|NCT02012166|Insulin|insulin|mesh-list
15037119|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15037120|NCT02012166|Octreotide|octreotide|mesh-list
15037121|NCT02012166|Glucagon|glucagon|mesh-list
15037122|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15037123|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037124|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15037125|NCT02012166|Hormones|hormones|mesh-ancestor
15037126|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15037127|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15037128|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037129|NCT02012244|Fentanyl|fentanyl|mesh-list
15037130|NCT02012244|Anesthetics|anesthetics|mesh-list
15037131|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
15037132|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15037133|NCT02012244|Narcotics|narcotics|mesh-ancestor
15037134|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037135|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037136|NCT02012244|Analgesics|analgesics|mesh-ancestor
15037137|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
15037138|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037139|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15037140|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15037141|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
14530875|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530876|NCT02708849|Lamotrigine|lamotrigine|mesh-list
14530877|NCT02708849|Ketamine|ketamine|mesh-list
14530878|NCT02708849|Analgesics|analgesics|mesh-ancestor
14530879|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
14530880|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530881|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530882|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14530883|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14530884|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
14530885|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
14530886|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530887|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14530888|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14530889|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530890|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530891|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
14530892|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14530893|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14530894|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14530895|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14530896|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14530897|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15037142|NCT02012296|Mifepristone|mifepristone|mesh-list
14530898|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14530899|NCT02693717|Pemetrexed|pemetrexed|mesh-list
14530900|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530901|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530902|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530903|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14530904|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14530905|NCT02693002|Norethindrone|norethindrone|mesh-list
14530906|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
14530907|NCT02693002|Estradiol|estradiol|mesh-list
14530908|NCT02693002|Estrogens|estrogens|mesh-ancestor
14530909|NCT02693002|Hormones|hormones|mesh-ancestor
14530910|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14530911|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530912|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15037143|NCT02012296|Androgens|androgens|mesh-list
15037144|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15037145|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
15037146|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15037147|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037148|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15037149|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15037150|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15037151|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
15037152|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15037153|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15037154|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
15037155|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15037156|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
15037157|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15037158|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15037159|NCT02012296|Hormones|hormones|mesh-ancestor
15037160|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15037161|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
15037162|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037163|NCT02012322|Ubiquinone|ubiquinone|mesh-list
15037164|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
15037165|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
14530913|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
14530914|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14530915|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14530916|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14530917|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14530918|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14530919|NCT02689518|Aflibercept|aflibercept|mesh-list
14530920|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14530921|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14530922|NCT02689518|Growth Substances|growth substances|mesh-ancestor
14530923|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530924|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
14530925|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14530926|NCT02687165|Cycloserine|cycloserine|mesh-list
14530927|NCT02687165|Milnacipran|milnacipran|mesh-list
14530928|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
14530929|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14530930|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14530931|NCT02687165|Renal Agents|renal agents|mesh-ancestor
14530932|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14530933|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
14530934|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14530935|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
14530936|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530937|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14530938|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14530939|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14530940|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530941|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530942|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15037166|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037167|NCT02012322|Vitamins|vitamins|mesh-ancestor
15037168|NCT02012335|Ketamine|ketamine|mesh-list
15037169|NCT02012335|Analgesics|analgesics|mesh-ancestor
15037170|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
15037171|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968617|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968618|NCT03109847|Metformin|metformin|mesh-list
13968619|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13968620|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968621|NCT03109691|Dexamethasone|dexamethasone|mesh-list
13968622|NCT03109691|Bupivacaine|bupivacaine|mesh-list
13968623|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13968624|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
13968625|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
13968626|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968627|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968628|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13968629|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
13968630|NCT03109691|Hormones|hormones|mesh-ancestor
13968631|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13968632|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13968633|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968634|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
13968635|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
13968636|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968637|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
13968638|NCT03109730|Tenofovir|tenofovir|mesh-list
13968639|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13968640|NCT03109730|Entecavir|entecavir|mesh-list
14530943|NCT02687165|Analgesics|analgesics|mesh-ancestor
14530944|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
15037172|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037173|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15037174|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15037175|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
14530945|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530946|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
14530947|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14530948|NCT02679560|Bupivacaine|bupivacaine|mesh-list
14530949|NCT02679560|Ropivacaine|ropivacaine|mesh-list
14530950|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
14530951|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
14530952|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530953|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037176|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
14243664|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14243665|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
14243666|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
14243667|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14243668|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14243669|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14243670|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14243671|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
14243672|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243673|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243674|NCT00197145|Aplaviroc|aplaviroc|mesh-list
14243675|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14243676|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14243677|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243678|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14243679|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14243680|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
14243681|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243682|NCT00197184|Vaccines|vaccines|mesh-list
14243683|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
14243684|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243685|NCT00198029|Hylan|hylan|mesh-list
14243686|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
14243687|NCT00198029|Protective Agents|protective agents|mesh-ancestor
14243688|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243689|NCT00198081|Celecoxib|celecoxib|mesh-list
14243690|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
14243691|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14243692|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14243693|NCT00198081|Analgesics|analgesics|mesh-ancestor
14243694|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
14243695|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243696|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243697|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243698|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15037177|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037178|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15037179|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15037180|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037181|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037182|NCT02012387|Omalizumab|omalizumab|mesh-list
15037183|NCT02012387|Vaccines|vaccines|mesh-list
15037184|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15037185|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
15037186|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037187|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15037188|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15037189|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
13968641|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
13968642|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13968643|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13968644|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13968645|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968646|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968647|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13968648|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13968649|NCT03109756|Gaboxadol|gaboxadol|mesh-list
13968650|NCT03109756|Analgesics|analgesics|mesh-ancestor
13968651|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
13968652|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968653|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968654|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
13968655|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
13968656|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
13968657|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037190|NCT02012465|Insulin|insulin|mesh-list
15037191|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
15037192|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15037193|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037194|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15037195|NCT02012517|Cefazolin|cefazolin|mesh-list
15037196|NCT02012517|Cephalexin|cephalexin|mesh-list
15037197|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15037198|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15037199|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
15037200|NCT02012556|Tesamorelin|tesamorelin|mesh-list
15037201|NCT02012556|Growth Substances|growth substances|mesh-ancestor
15037202|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037203|NCT02012569|Hemostatics|hemostatics|mesh-list
15037204|NCT02012569|Coagulants|coagulants|mesh-ancestor
15037205|NCT02012595|Donepezil|donepezil|mesh-list
15037206|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14530954|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
14530955|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14530956|NCT02674204|Atorvastatin|atorvastatin|mesh-list
14530957|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14530958|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14530959|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
14530960|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530961|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14530962|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14530963|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530964|NCT02671461|Aspirin|aspirin|mesh-list
14530965|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14530966|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14530967|NCT02671461|Analgesics|analgesics|mesh-ancestor
14530968|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
14530969|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037207|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037208|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037209|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
15037210|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037211|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037212|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
15037213|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
15037214|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037215|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
15037216|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037217|NCT02012777|Propranolol|propranolol|mesh-list
15037218|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15037219|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15037220|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
15037221|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530970|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037222|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037223|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037224|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15037225|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15037226|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
15037227|NCT02012920|Seviteronel|seviteronel|mesh-list
15037228|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037229|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15037230|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037231|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037232|NCT02012933|Amifampridine|amifampridine|mesh-list
15037233|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15037234|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037235|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037236|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15037237|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15037238|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037239|NCT02012946|Simendan|simendan|mesh-list
15037240|NCT02012946|Dobutamine|dobutamine|mesh-list
15037241|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15037242|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
15037243|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15037244|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14530971|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14530972|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14530973|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14530974|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14530975|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530976|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14530977|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14530978|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14530979|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
14530980|NCT02663752|Deferasirox|deferasirox|mesh-list
14530981|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14530982|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
14530983|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
14530984|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530985|NCT02658357|Risperidone|risperidone|mesh-list
14530986|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14530987|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
14530988|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14530989|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14530990|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14530991|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14530992|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14530993|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14530994|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14530995|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14530996|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
15037245|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037246|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037247|NCT02012946|Protective Agents|protective agents|mesh-ancestor
15037248|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037249|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
15037250|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
15037251|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037252|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15037253|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15037254|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15037255|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
14530997|NCT02658877|Omalizumab|omalizumab|mesh-list
14530998|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14530999|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14531000|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
14531001|NCT02654639|Bevacizumab|bevacizumab|mesh-list
14531002|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14531003|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531004|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14531005|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14531006|NCT02654639|Growth Substances|growth substances|mesh-ancestor
14531007|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531008|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
14531009|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
14531010|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531011|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
14531012|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531013|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531014|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14531015|NCT02634606|Tocotrienols|tocotrienols|mesh-list
14531016|NCT02634606|Vitamin E|vitamin e|mesh-list
14531017|NCT02634606|Tocopherols|tocopherols|mesh-list
14531018|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
14531019|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531020|NCT02634606|Protective Agents|protective agents|mesh-ancestor
14531021|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531022|NCT02634606|Vitamins|vitamins|mesh-ancestor
14531023|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
14531024|NCT02634827|Decitabine|decitabine|mesh-list
14531025|NCT02634827|Midostaurin|midostaurin|mesh-list
14531026|NCT02634827|Staurosporine|staurosporine|mesh-list
14531027|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14531028|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
14531029|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531030|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531031|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531032|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14531033|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
14531034|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14531035|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531036|NCT02638129|Naltrexone|naltrexone|mesh-list
14531037|NCT02638129|Bupropion|bupropion|mesh-list
14531038|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14531039|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14531040|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531041|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
14531042|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531043|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14531044|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
14531045|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14531046|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14531047|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14531048|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14531049|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531050|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
14531051|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531052|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14531053|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14531054|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531055|NCT02623959|Doxycycline|doxycycline|mesh-list
14531056|NCT02623959|Fentanyl|fentanyl|mesh-list
14531057|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15037256|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037257|NCT02012998|Vaccines|vaccines|mesh-list
15037258|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
15037259|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037260|NCT02013089|Everolimus|everolimus|mesh-list
15037261|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15037262|NCT02013089|Sorafenib|sorafenib|mesh-list
15037263|NCT02013089|Sunitinib|sunitinib|mesh-list
15037264|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
15037265|NCT02013089|Gefitinib|gefitinib|mesh-list
15037266|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037267|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15037268|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
15037269|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037270|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15037271|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037272|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037273|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15037274|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15037275|NCT02013089|Growth Substances|growth substances|mesh-ancestor
15037276|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
15037277|NCT02013102|Decitabine|decitabine|mesh-list
15037278|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15037279|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
15037280|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037281|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037282|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037283|NCT02013115|Budesonide|budesonide|mesh-list
15037284|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15037285|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15037286|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
15037287|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037288|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037289|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15037290|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
15037291|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
15037292|NCT02013115|Hormones|hormones|mesh-ancestor
15037293|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15037294|NCT02013154|Paclitaxel|paclitaxel|mesh-list
15037295|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
15037296|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15037297|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037298|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
15037299|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
15037300|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
15037301|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037302|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15037303|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15037304|NCT02013219|Atezolizumab|atezolizumab|mesh-list
15037305|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037306|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15037307|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037308|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037309|NCT02013232|Aripiprazole|aripiprazole|mesh-list
15037310|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
15037311|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15037312|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15037313|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15037314|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037315|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037316|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
15037317|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
15037318|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037319|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037320|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15037321|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15037322|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
15037323|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15037324|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15037325|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15037326|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15037327|NCT02013258|Oxytocin|oxytocin|mesh-list
15037328|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
15037329|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15037330|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037331|NCT02013271|Paclitaxel|paclitaxel|mesh-list
15037332|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15037333|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037334|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
15037335|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
15037336|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
15037337|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037338|NCT02013362|Folic Acid|folic acid|mesh-list
15037339|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
15037340|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
15037341|NCT02013362|Vitamins|vitamins|mesh-ancestor
15037342|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
15037343|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037344|NCT02013362|Hematinics|hematinics|mesh-ancestor
15037345|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
15037346|NCT02013427|Naproxen|naproxen|mesh-list
15037347|NCT02013427|Omeprazole|omeprazole|mesh-list
15037348|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15037349|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15037350|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15037351|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037352|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037353|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15037354|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15037355|NCT02013427|Analgesics|analgesics|mesh-ancestor
15037356|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
15037357|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037358|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037359|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15037360|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15037361|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
15037362|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15037363|NCT02013453|Paclitaxel|paclitaxel|mesh-list
15037364|NCT02013453|Carboplatin|carboplatin|mesh-list
15037365|NCT02013453|Fluorouracil|fluorouracil|mesh-list
15037366|NCT02013453|Pemetrexed|pemetrexed|mesh-list
15037367|NCT02013453|Omeprazole|omeprazole|mesh-list
15037368|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15037369|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037370|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
15037371|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
15037372|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
15037373|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037374|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
15037375|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15037376|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15037377|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
15037378|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037379|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037380|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15037381|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15037382|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15037383|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15037384|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15037385|NCT02013492|Propranolol|propranolol|mesh-list
15037386|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15037387|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15037388|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
15037389|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037390|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037391|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037392|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15037393|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15037394|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
15037395|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
15037396|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14531058|NCT02623959|Narcotics|narcotics|mesh-ancestor
14531059|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14531060|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531061|NCT02623959|Analgesics|analgesics|mesh-ancestor
14531062|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
14531063|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531064|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14531065|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14531066|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
14531067|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
15037397|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037398|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037399|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15037400|NCT02013570|Analgesics|analgesics|mesh-ancestor
15037401|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
15037402|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037403|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15037404|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15037405|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15037406|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
15037407|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037408|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037409|NCT02013648|Cytarabine|cytarabine|mesh-list
15037410|NCT02013648|Daunorubicin|daunorubicin|mesh-list
15037411|NCT02013648|Dasatinib|dasatinib|mesh-list
15037412|NCT02013648|Idarubicin|idarubicin|mesh-list
14531068|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15037413|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15037414|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
15037415|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037416|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037417|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
15037418|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15037419|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15037420|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
15037421|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037422|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15037423|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15037424|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15037425|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037426|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15037427|NCT02013700|Remestemcel-l|remestemcel-l|mesh-list
15037428|NCT02013700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15037429|NCT02013700|Antiviral Agents|antiviral agents|mesh-ancestor
15037430|NCT02013700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15037431|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
15037432|NCT02013856|Procyanidin|procyanidin|mesh-list
15037433|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
15037434|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037435|NCT02013856|Protective Agents|protective agents|mesh-ancestor
15037436|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037437|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15037438|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15037439|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15037440|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
15037441|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15037442|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037443|NCT02013960|Misoprostol|misoprostol|mesh-list
15037444|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15037445|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
15037446|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15037447|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037448|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15037449|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15037450|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
15037451|NCT02013986|Midazolam|midazolam|mesh-list
15037452|NCT02013986|Propofol|propofol|mesh-list
15037453|NCT02013986|Etomidate|etomidate|mesh-list
15037454|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15037455|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037456|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037457|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15037458|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
15037459|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
15037460|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15037461|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15037462|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15037463|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14531069|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531070|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
14531071|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14531072|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14531073|NCT02631148|Melatonin|melatonin|mesh-list
14531074|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
14531075|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531076|NCT02631148|Protective Agents|protective agents|mesh-ancestor
14531077|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531078|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14531079|NCT02630472|Quinine|quinine|mesh-list
14531080|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
14531081|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14531082|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14531083|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531084|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15037464|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
15037465|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
15037466|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037467|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037468|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15037469|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15037470|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15037471|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15037472|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037473|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
15037474|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037475|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037476|NCT02014103|Tacrolimus|tacrolimus|mesh-list
15037477|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15037478|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
15037479|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037480|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15037481|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037482|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531085|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531086|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14531087|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531088|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14531089|NCT02630472|Analgesics|analgesics|mesh-ancestor
14531090|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
14531091|NCT02626520|Gemcitabine|gemcitabine|mesh-list
14531092|NCT02626520|Paclitaxel|paclitaxel|mesh-list
14531093|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14531094|NCT02626520|Fluorouracil|fluorouracil|mesh-list
14531095|NCT02626520|Irinotecan|irinotecan|mesh-list
14531096|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14531097|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531098|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
14531099|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
14531100|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
14531101|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531102|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14531103|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
14531104|NCT02626520|Antiviral Agents|antiviral agents|mesh-ancestor
14531105|NCT02626520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531106|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531107|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531108|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
14531109|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531110|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14531111|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14531112|NCT02614898|Eculizumab|eculizumab|mesh-list
14531113|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14531114|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531115|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
14531116|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531117|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
14531118|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14531119|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531120|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14531121|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531122|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
14531123|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
14531124|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14531125|NCT02619812|Antibodies|antibodies|mesh-list
14531126|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
14531127|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531128|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14531129|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14531130|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
14531131|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531132|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14531133|NCT02614586|Ondansetron|ondansetron|mesh-list
14531134|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
15037483|NCT02014337|Mifepristone|mifepristone|mesh-list
15037484|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15037485|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
15037486|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15037487|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037488|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15037489|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15037490|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15037491|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
15037492|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15037493|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15037494|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
15037495|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15037496|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
15037497|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15037498|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15037499|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
15037500|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15037501|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
15037502|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037503|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
15037504|NCT02014428|Protective Agents|protective agents|mesh-ancestor
15037505|NCT02014454|Propranolol|propranolol|mesh-list
15037506|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15037507|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15037508|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13968658|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968659|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13968660|NCT03109795|Clonidine|clonidine|mesh-list
13968661|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13968662|NCT03109795|Diuretics|diuretics|mesh-ancestor
13968663|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
13968664|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968665|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13968666|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13968667|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968668|NCT03109795|Analgesics|analgesics|mesh-ancestor
13968669|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
13968670|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968671|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
13968672|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
13968673|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13968674|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13968675|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13968676|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
13968677|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968678|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
13968679|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968680|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968681|NCT03109600|Vaccines|vaccines|mesh-list
13968682|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13968683|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
13968684|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968685|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
13968686|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13968687|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13968688|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968689|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
13968690|NCT03109652|Coagulants|coagulants|mesh-ancestor
13968691|NCT03109392|Lidocaine|lidocaine|mesh-list
13968692|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
13968693|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
13968694|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968695|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968696|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
13968697|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968698|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14531135|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
15037509|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15037510|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
15037511|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037512|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037513|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037514|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15037515|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15037516|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
15037517|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
14531136|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531137|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531138|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14531139|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
14531140|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
14531141|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14531142|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
14531143|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531144|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531145|NCT02614586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14531146|NCT02614586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14531147|NCT02614586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14531148|NCT02614586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14531149|NCT02614586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14531150|NCT02606279|Valsartan|valsartan|mesh-list
14531151|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14531152|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14531153|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14531154|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531155|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
14531156|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14531157|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
14531158|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531159|NCT02605824|Expectorants|expectorants|mesh-ancestor
15037518|NCT02014506|Fludarabine|fludarabine|mesh-list
15037519|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15037520|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15037521|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
15037522|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037523|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15037524|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15037525|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
15037526|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037527|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037528|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14243699|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14243700|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243701|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243702|NCT00198107|Cycloserine|cycloserine|mesh-list
14243703|NCT00198107|Aripiprazole|aripiprazole|mesh-list
14243704|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
14243705|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14243706|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14243707|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14243708|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14243709|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243710|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
14243711|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
15037529|NCT02014532|Montelukast|montelukast|mesh-list
15037530|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
15037531|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15037532|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
15037533|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
15037534|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15037535|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037536|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15037537|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15037538|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037539|NCT02014545|Lucanthone|lucanthone|mesh-list
15037540|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
15037541|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15037542|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
15037543|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15037544|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531160|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
14531161|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14531162|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
14531163|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531164|NCT02605824|Protective Agents|protective agents|mesh-ancestor
14531165|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531166|NCT02605824|Antidotes|antidotes|mesh-ancestor
14531167|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
14531168|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
14531169|NCT02598622|Vitamins|vitamins|mesh-ancestor
14531170|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
14531171|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531172|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
15037545|NCT02014558|Voriconazole|voriconazole|mesh-list
15037546|NCT02014558|Cephalexin|cephalexin|mesh-list
15037547|NCT02014558|Midazolam|midazolam|mesh-list
15037548|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15037549|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15037550|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14531173|NCT02589145|Pyridoxine|pyridoxine|mesh-list
14531174|NCT02589145|Gemcitabine|gemcitabine|mesh-list
14531175|NCT02589145|Dexamethasone|dexamethasone|mesh-list
14531176|NCT02589145|Rituximab|rituximab|mesh-list
14531177|NCT02589145|Lenalidomide|lenalidomide|mesh-list
14531178|NCT02589145|Melphalan|melphalan|mesh-list
14531179|NCT02589145|Busulfan|busulfan|mesh-list
14531180|NCT02589145|Vorinostat|vorinostat|mesh-list
14531181|NCT02589145|Enoxaparin|enoxaparin|mesh-list
14531182|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14531183|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
14531184|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
14531185|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531186|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531187|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14531188|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
14531189|NCT02589145|Hormones|hormones|mesh-ancestor
14531190|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14531191|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14531192|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531193|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14531194|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
14531195|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14531196|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14531197|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
14531198|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531199|NCT02589145|Antiviral Agents|antiviral agents|mesh-ancestor
14243712|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243713|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243714|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14243715|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14243716|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
14531200|NCT02589145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531201|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531202|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531203|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15037551|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037552|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15037553|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15037554|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15037555|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15037556|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
15037557|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
15037558|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
15037559|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
15037560|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037561|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037562|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
15037563|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15037564|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15037565|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15037566|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037567|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15037568|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
15037569|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15037570|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15037571|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15037572|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
15037573|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
15037574|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531204|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14531205|NCT02589145|Growth Substances|growth substances|mesh-ancestor
14531206|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
14531207|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14243717|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14243718|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14243719|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14531208|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
14531209|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14531210|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
14531211|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14531212|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14531213|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14531214|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
14531215|NCT02589145|Vitamins|vitamins|mesh-ancestor
14531216|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
15037575|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037576|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037577|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
15037578|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14531217|NCT02582749|Bicalutamide|bicalutamide|mesh-list
14531218|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
14531219|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
14531220|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
14531221|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14531222|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531223|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531224|NCT02593682|Suvorexant|suvorexant|mesh-list
14531225|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14531226|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14531227|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14531228|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531229|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
14531230|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531231|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531232|NCT02587650|Ceritinib|ceritinib|mesh-list
14531233|NCT02587650|Entrectinib|entrectinib|mesh-list
14531234|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531235|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14531236|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037579|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037580|NCT02014714|Fentanyl|fentanyl|mesh-list
15037581|NCT02014714|Morphine|morphine|mesh-list
15037582|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15037583|NCT02014714|Narcotics|narcotics|mesh-ancestor
15037584|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037585|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037586|NCT02014714|Analgesics|analgesics|mesh-ancestor
15037587|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
15037588|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037589|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15037590|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15037591|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
15037592|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
15037593|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15037594|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15037595|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
15037596|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037597|NCT02014727|Antacids|antacids|mesh-ancestor
15037598|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531237|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531238|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
14531239|NCT02569957|Topotecan|topotecan|mesh-list
14531240|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14531241|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14531242|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14531243|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531244|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531245|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531246|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
14531247|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531248|NCT02569957|Expectorants|expectorants|mesh-ancestor
14531249|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
14531250|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14531251|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
14531252|NCT02569957|Protective Agents|protective agents|mesh-ancestor
14531253|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531254|NCT02569957|Antidotes|antidotes|mesh-ancestor
14531255|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
14531256|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
14531257|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
14531258|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14531259|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14531260|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
14531261|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
14531262|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531263|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531264|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531265|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14531266|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
14531267|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14531268|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14531269|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14531270|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531271|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531272|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
13968699|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13968700|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13968701|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13968702|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968703|NCT03109379|Trospium chloride|trospium chloride|mesh-list
13968704|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
13968705|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
13968706|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968707|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968708|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13968709|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13968710|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
13968711|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968712|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968713|NCT03109379|Urological Agents|urological agents|mesh-ancestor
13968714|NCT03109080|Olaparib|olaparib|mesh-list
13968715|NCT03109080|Adenosine|adenosine|mesh-list
13968716|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13968717|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968718|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968719|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968720|NCT03109080|Analgesics|analgesics|mesh-ancestor
13968721|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
13968722|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968723|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968724|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13968725|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
13968726|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13968727|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
13968728|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
13968729|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968730|NCT03109158|Cetuximab|cetuximab|mesh-list
13968731|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13968732|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968733|NCT03109119|Propofol|propofol|mesh-list
13968734|NCT03109119|Sevoflurane|sevoflurane|mesh-list
13968735|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13968736|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968737|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037599|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15037600|NCT02014753|Cobalt|cobalt|mesh-list
15037601|NCT02014753|Chromium|chromium|mesh-list
15037602|NCT02014753|Everolimus|everolimus|mesh-list
15037603|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037604|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15037605|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
15037606|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037607|NCT02014753|Trace Elements|trace elements|mesh-ancestor
14531273|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037608|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
15037609|NCT02014831|Cetuximab|cetuximab|mesh-list
13968738|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13968739|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
13968740|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
13968741|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13968742|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13968743|NCT03109314|Donepezil|donepezil|mesh-list
14243720|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14243721|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14243722|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243723|NCT00198107|Renal Agents|renal agents|mesh-ancestor
14243724|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14243725|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
14243726|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14243727|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
14243728|NCT00198133|Pemetrexed|pemetrexed|mesh-list
14243729|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968744|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13968745|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968746|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968747|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
13968748|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968749|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968750|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
14243730|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243731|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243732|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14243733|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14243734|NCT00198822|Vitamin A|vitamin a|mesh-list
14243735|NCT00198822|Beta Carotene|beta carotene|mesh-list
14243736|NCT00198822|Carotenoids|carotenoids|mesh-list
14243737|NCT00198822|Vitamins|vitamins|mesh-ancestor
14243738|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
14243739|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243740|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
14243741|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243742|NCT00198822|Protective Agents|protective agents|mesh-ancestor
14243743|NCT00198822|Provitamins|provitamins|mesh-ancestor
14243744|NCT00199381|Istradefylline|istradefylline|mesh-list
14243745|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14243746|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14243747|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14243748|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
14243749|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243750|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243751|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243752|NCT00199797|Leucovorin|leucovorin|mesh-list
14243753|NCT00199797|Fluorouracil|fluorouracil|mesh-list
14243754|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
14243755|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
14243756|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243757|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243758|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243759|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243760|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
14243761|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243762|NCT00199797|Antidotes|antidotes|mesh-ancestor
14243763|NCT00199797|Protective Agents|protective agents|mesh-ancestor
14243764|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
14243765|NCT00199797|Vitamins|vitamins|mesh-ancestor
14243766|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
14243767|NCT00200161|Temozolomide|temozolomide|mesh-list
14531274|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14531275|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14531276|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531277|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
14531278|NCT02549716|Acetaminophen|acetaminophen|mesh-list
14531279|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14531280|NCT02549716|Analgesics|analgesics|mesh-ancestor
14531281|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
14531282|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531283|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531284|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
14531285|NCT02531308|Metformin|metformin|mesh-list
14531286|NCT02531308|Prednisone|prednisone|mesh-list
14531287|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
14531288|NCT02531308|Rituximab|rituximab|mesh-list
14531289|NCT02531308|Doxorubicin|doxorubicin|mesh-list
14531290|NCT02531308|Vincristine|vincristine|mesh-list
14531291|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531292|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
14531293|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531294|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14531295|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14531296|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
14531297|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531298|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531299|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14531300|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14531301|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14531302|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14531303|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14531304|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14531305|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531306|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14531307|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
14531308|NCT02531308|Hormones|hormones|mesh-ancestor
14531309|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14531310|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14531311|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14531312|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
14531313|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
14531314|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
14531315|NCT02534038|Quinidine|quinidine|mesh-list
14531316|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
14531317|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
14531318|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
14531319|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14531320|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14531321|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531322|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531323|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531324|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14531325|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14531326|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
14531327|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14531328|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
14531329|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14531330|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14531331|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531332|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531333|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14531334|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15037610|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15037611|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037612|NCT02014922|Vitamin E|vitamin e|mesh-list
15037613|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
15037614|NCT02014922|Tocopherols|tocopherols|mesh-list
15037615|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15037616|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15037617|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
15037618|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15037619|NCT02014922|Laxatives|laxatives|mesh-ancestor
15037620|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15037621|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
15037622|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037623|NCT02014922|Protective Agents|protective agents|mesh-ancestor
15037624|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243768|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14243769|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
14243770|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243771|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243772|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
14243773|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
14243774|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14243775|NCT00200356|Ozagrel|ozagrel|mesh-list
14243776|NCT00200356|Edaravone|edaravone|mesh-list
14243777|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14243778|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
14243779|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243780|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14243781|NCT00200356|Protective Agents|protective agents|mesh-ancestor
14243782|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531335|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
14531336|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14531337|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14531338|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14531339|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14531340|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14531341|NCT02520726|Sertraline|sertraline|mesh-list
14531342|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
14531343|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14531344|NCT02520726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14531345|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14531346|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14531347|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531348|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531349|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
14531350|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531351|NCT02518750|Cytarabine|cytarabine|mesh-list
14531352|NCT02518750|Dexamethasone|dexamethasone|mesh-list
14531353|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
14531354|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
14531355|NCT02518750|Methotrexate|methotrexate|mesh-list
15037625|NCT02014922|Vitamins|vitamins|mesh-ancestor
15037626|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
15037627|NCT02015156|Trastuzumab|trastuzumab|mesh-list
15037628|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15037629|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037630|NCT02015169|Lapatinib|lapatinib|mesh-list
15037631|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037632|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15037633|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037634|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037635|NCT02015182|Bupivacaine|bupivacaine|mesh-list
15037636|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
15037637|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
15037638|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037639|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037640|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
15037641|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037642|NCT02015260|Citric Acid|citric acid|mesh-list
15037643|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
15037644|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15037645|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
14531356|NCT02518750|Etoposide|etoposide|mesh-list
14531357|NCT02518750|Vincristine|vincristine|mesh-list
14531358|NCT02518750|Bortezomib|bortezomib|mesh-list
14531359|NCT02518750|Asparaginase|asparaginase|mesh-list
14531360|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
14531361|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
14531362|NCT02518750|Clofarabine|clofarabine|mesh-list
14531363|NCT02518750|Panobinostat|panobinostat|mesh-list
14531364|NCT02518750|Pegaspargase|pegaspargase|mesh-list
14531365|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531366|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
14531367|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531368|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14531369|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14531370|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
14531371|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531372|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531373|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14531374|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14531375|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
14531376|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
14531377|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531378|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14531379|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
14531380|NCT02518750|Hormones|hormones|mesh-ancestor
14531381|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14531382|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14531383|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14531384|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
14531385|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14531386|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14531387|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
14531388|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
14531389|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037646|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
15037647|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037648|NCT02015299|Linagliptin|linagliptin|mesh-list
15037649|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15037650|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15037651|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037652|NCT02015299|Incretins|incretins|mesh-ancestor
15037653|NCT02015299|Hormones|hormones|mesh-ancestor
15037654|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15037655|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
15037656|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531390|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14531391|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14531392|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14531393|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14531394|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14531395|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
14531396|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531397|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
14531398|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
14531399|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
14531400|NCT02518750|Analgesics|analgesics|mesh-ancestor
14531401|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
15037657|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037658|NCT02015312|Silicon|silicon|mesh-list
15037659|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
15037660|NCT02015312|Mannitol|mannitol|mesh-list
15037661|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15037662|NCT02015312|Diuretics|diuretics|mesh-ancestor
15037663|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
15037664|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037665|NCT02015312|Trace Elements|trace elements|mesh-ancestor
15037666|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
14531402|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13968751|NCT03108846|Citalopram|citalopram|mesh-list
13968752|NCT03108846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13968753|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13968754|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13968755|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968756|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968757|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
14243783|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243784|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14243785|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14243786|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
14243787|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
14243788|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243789|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14243790|NCT00200902|Citalopram|citalopram|mesh-list
14243791|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14243792|NCT00200902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14243793|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14243794|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15037667|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
15037668|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968758|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968759|NCT03108846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13968760|NCT03108846|Antidepressive Agents|antidepressive agents|mesh-ancestor
13968761|NCT03108846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13968762|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
13968763|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13968764|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968765|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968766|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13968767|NCT03108937|Analgesics|analgesics|mesh-ancestor
13968768|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
13968769|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968770|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13968771|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13968772|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13968773|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
13968774|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968775|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531403|NCT02515851|Bupivacaine|bupivacaine|mesh-list
14531404|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
14531405|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
14531406|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14531407|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037669|NCT02015312|Protective Agents|protective agents|mesh-ancestor
15037670|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15037671|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15037672|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037673|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15037674|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
15037675|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15037676|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
15037677|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15037678|NCT02015403|Expectorants|expectorants|mesh-ancestor
15037679|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
15037680|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15037681|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
15037682|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531408|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
14531409|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531410|NCT02506985|Warfarin|warfarin|mesh-list
14531411|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
14531412|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
14531413|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14531414|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
14531415|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14531416|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
14531417|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531418|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531419|NCT02514252|Fentanyl|fentanyl|mesh-list
14531420|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14531421|NCT02514252|Narcotics|narcotics|mesh-ancestor
14531422|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14531423|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531424|NCT02514252|Analgesics|analgesics|mesh-ancestor
14531425|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
14531426|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531427|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15037683|NCT02015403|Protective Agents|protective agents|mesh-ancestor
15037684|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037685|NCT02015403|Antidotes|antidotes|mesh-ancestor
15037686|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
15037687|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
15037688|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531428|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14531429|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
14531430|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
14531431|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
14531432|NCT02501759|Antidotes|antidotes|mesh-ancestor
14531433|NCT02501759|Protective Agents|protective agents|mesh-ancestor
14531434|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531435|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
14531436|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
14531437|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531438|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13968776|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14243795|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531439|NCT02487277|Gemcitabine|gemcitabine|mesh-list
14531440|NCT02487277|Paclitaxel|paclitaxel|mesh-list
14531441|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14531442|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531443|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
15037689|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
15037690|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
15037691|NCT02015507|Ivacaftor|ivacaftor|mesh-list
15037692|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15037693|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15037694|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15037695|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15037696|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037697|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037698|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037699|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15037700|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15037701|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15037702|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15037703|NCT02015559|Protective Agents|protective agents|mesh-list
15037704|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037705|NCT02015598|Carbocysteine|carbocysteine|mesh-list
15037706|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15037707|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15037708|NCT02015598|Expectorants|expectorants|mesh-ancestor
15037709|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
15037710|NCT02015611|Vitamin D|vitamin d|mesh-list
15037711|NCT02015611|Vitamins|vitamins|mesh-ancestor
15037712|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
15037713|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037714|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15037715|NCT02015650|Fluorouracil|fluorouracil|mesh-list
15037716|NCT02015650|Cetuximab|cetuximab|mesh-list
15037717|NCT02015650|Mitomycins|mitomycins|mesh-list
15037718|NCT02015650|Mitomycin|mitomycin|mesh-list
15037719|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
15037720|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037721|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15037722|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037723|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15037724|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
15037725|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037726|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15037727|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15037728|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
15037729|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15037730|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037731|NCT02015728|Etoposide|etoposide|mesh-list
15037732|NCT02015728|Everolimus|everolimus|mesh-list
15037733|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15037734|NCT02015728|Temozolomide|temozolomide|mesh-list
15037735|NCT02015728|Sorafenib|sorafenib|mesh-list
15037736|NCT02015728|Dasatinib|dasatinib|mesh-list
15037737|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15037738|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037739|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15037740|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15037741|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037742|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037743|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15037744|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
15037745|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037746|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15037747|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15037748|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
15037749|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15037750|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037751|NCT02015923|Panitumumab|panitumumab|mesh-list
15037752|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15037753|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037754|NCT02015949|Methylphenidate|methylphenidate|mesh-list
15037755|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15037756|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037757|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15037758|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15037759|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15037760|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037761|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
15037762|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037763|NCT02015988|Simvastatin|simvastatin|mesh-list
15037764|NCT02015988|Fenofibrate|fenofibrate|mesh-list
15037765|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15037766|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15037767|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
15037768|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037769|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15037770|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15037771|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037772|NCT02016001|Fluorides|fluorides|mesh-list
15037773|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
15037774|NCT02016001|Protective Agents|protective agents|mesh-ancestor
15037775|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531444|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
14531445|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
15037776|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
15037777|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15037778|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15037779|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15037780|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15037781|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037782|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037783|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037784|NCT02016196|Rifaximin|rifaximin|mesh-list
15037785|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15037786|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15037787|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15037788|NCT02016209|Paclitaxel|paclitaxel|mesh-list
15037789|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14531446|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531447|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14531448|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
14531449|NCT02487277|Antiviral Agents|antiviral agents|mesh-ancestor
14531450|NCT02487277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531451|NCT02487277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531452|NCT02487277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531453|NCT02487277|Immunologic Factors|immunologic factors|mesh-ancestor
14531454|NCT02487277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531455|NCT02499887|Prednisone|prednisone|mesh-list
14531456|NCT02499887|Albuterol|albuterol|mesh-list
14531457|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14531458|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
14531459|NCT02499887|Hormones|hormones|mesh-ancestor
14531460|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14531461|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531462|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15037790|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15037791|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037792|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
15037793|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
15037794|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
15037795|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037796|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
15037797|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15037798|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15037799|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037800|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037801|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15037802|NCT02016261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15037803|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15037804|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15037805|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037806|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037807|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
15037808|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15037809|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
15037810|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15037811|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15037812|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968777|NCT03108833|Saruplase|saruplase|mesh-list
13968778|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13968779|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13968780|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968781|NCT03108963|Metformin|metformin|mesh-list
13968782|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13968783|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968784|NCT03108989|Neostigmine|neostigmine|mesh-list
13968785|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13968786|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968787|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968788|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
13968789|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968790|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968791|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13968792|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
13968793|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968794|NCT03108872|Anticoagulants|anticoagulants|mesh-list
13968795|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13968796|NCT03108690|Meropenem|meropenem|mesh-list
13968797|NCT03108690|Tazobactam|tazobactam|mesh-list
13968798|NCT03108690|Piperacillin|piperacillin|mesh-list
13968799|NCT03108690|Ampicillin|ampicillin|mesh-list
13968800|NCT03108690|Cefuroxime|cefuroxime|mesh-list
15037813|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15037814|NCT02016274|Paclitaxel|paclitaxel|mesh-list
15037815|NCT02016274|Cisplatin|cisplatin|mesh-list
15037816|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15037817|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037818|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
15037819|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
15037820|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
15037821|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037822|NCT02016287|Paclitaxel|paclitaxel|mesh-list
15037823|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13968801|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
13968802|NCT03108690|Lactams|lactams|mesh-list
13968803|NCT03108690|beta-Lactams|beta-lactams|mesh-list
13968804|NCT03108690|Penicillin G|penicillin g|mesh-list
13968805|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
13968806|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13968807|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13968808|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
13968809|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13968810|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968811|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968812|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
13968813|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13968814|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15037824|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037825|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
15037826|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
15037827|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
15037828|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037829|NCT02016365|Doxycycline|doxycycline|mesh-list
15037830|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
15037831|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15037832|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15037833|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
15037834|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15037835|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15037836|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15037837|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15037838|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
15037839|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15037840|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037841|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037842|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15037843|NCT02016391|Analgesics|analgesics|mesh-ancestor
15037844|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
15037845|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037846|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15037847|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15037848|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15037849|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
15037850|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037851|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037852|NCT02016417|Gemcitabine|gemcitabine|mesh-list
15037853|NCT02016417|Cisplatin|cisplatin|mesh-list
15037854|NCT02016417|Docetaxel|docetaxel|mesh-list
15037855|NCT02016417|Fluorouracil|fluorouracil|mesh-list
15037856|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037857|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15037858|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
15037859|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037860|NCT02016417|Antiviral Agents|antiviral agents|mesh-ancestor
14531463|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531464|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14531465|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
14531466|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531467|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14243796|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243797|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
14243798|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243799|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14243800|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
14243801|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14243802|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243803|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14243804|NCT00200902|Analgesics|analgesics|mesh-ancestor
14243805|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
14243806|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
14243807|NCT00200967|Beclomethasone|beclomethasone|mesh-list
14243808|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14243809|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14243810|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
14243811|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243812|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243813|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14243814|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
14531468|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
14531469|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
14531470|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14531471|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14531472|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14531473|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14531474|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
14531475|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531476|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531477|NCT02504099|Ritonavir|ritonavir|mesh-list
14531478|NCT02504099|Ribavirin|ribavirin|mesh-list
14531479|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14531480|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14531481|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
14531482|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531483|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531484|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14531485|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14531486|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
14531487|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531488|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14531489|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14531490|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
14531491|NCT02500901|Niraparib|niraparib|mesh-list
14531492|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14531493|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531494|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531495|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531496|NCT02496039|Quinidine|quinidine|mesh-list
14531497|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
14531498|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
14531499|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
14531500|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14531501|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14531502|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531503|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531504|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531505|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14531506|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14531507|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
14531508|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14531509|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
14531510|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14531511|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14531512|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531513|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531514|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14531515|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14531516|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
14531517|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14531518|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14531519|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14531520|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14531521|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14531522|NCT02492295|Propofol|propofol|mesh-list
14531523|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14531524|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14531525|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531526|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14531527|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
14531528|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
14531529|NCT02473445|Cysteamine|cysteamine|mesh-list
14531530|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
14531531|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531532|NCT02491411|Dexamethasone|dexamethasone|mesh-list
14531533|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
14531534|NCT02491411|Ichthammol|ichthammol|mesh-list
14531535|NCT02491411|BB 1101|bb 1101|mesh-list
14531536|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14531537|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
14531538|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
14531539|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531540|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531541|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14531542|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
14531543|NCT02491411|Hormones|hormones|mesh-ancestor
14531544|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14531545|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13968815|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968816|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
13968817|NCT03108807|Coagulants|coagulants|mesh-ancestor
13968818|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
13968819|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
13968820|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13968821|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13968822|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13968823|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968824|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13968825|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13968826|NCT03108313|Fluorides|fluorides|mesh-list
13968827|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
13968828|NCT03108313|Protective Agents|protective agents|mesh-ancestor
13968829|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968830|NCT03108625|Vortioxetine|vortioxetine|mesh-list
14531546|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531547|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
14531548|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037861|NCT02016417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15037862|NCT02016417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037863|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531549|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531550|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
14531551|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14531552|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14531553|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14531554|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14531555|NCT02468583|Triamcinolone|triamcinolone|mesh-list
14531556|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14531557|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14531558|NCT02468583|FX006|fx006|mesh-list
14531559|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14531560|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14531561|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
14531562|NCT02468583|Hormones|hormones|mesh-ancestor
14531563|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14531564|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531565|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531566|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
14531567|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531568|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531569|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14531570|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531571|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14531572|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037864|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
13968831|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
13968832|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13968833|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13968834|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13968835|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14531573|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531574|NCT02469415|Azacitidine|azacitidine|mesh-list
14531575|NCT02469415|Decitabine|decitabine|mesh-list
14531576|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14531577|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
14531578|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531579|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531580|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531581|NCT02434146|Phenylephrine|phenylephrine|mesh-list
14531582|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
14531583|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14531584|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
14531585|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
14531586|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531587|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531588|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
14531589|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14531590|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
14531591|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
15037865|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037866|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
15037867|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
15037868|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
15037869|NCT02016443|Tizanidine|tizanidine|mesh-list
15037870|NCT02016443|Analgesics|analgesics|mesh-ancestor
15037871|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
15037872|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037873|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037874|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
15037875|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15037876|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15037877|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
15037878|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
15037879|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15037880|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15037881|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15037882|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
15037883|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037884|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037885|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
15037886|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
15037887|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037888|NCT02016495|Protective Agents|protective agents|mesh-ancestor
15037889|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037890|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
15037891|NCT02016495|Vitamins|vitamins|mesh-ancestor
15037892|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
15037893|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15037894|NCT02016547|Abciximab|abciximab|mesh-list
15037895|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15037896|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15037897|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037898|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
15037899|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15037900|NCT02016664|Ketamine|ketamine|mesh-list
15037901|NCT02016664|Analgesics|analgesics|mesh-ancestor
15037902|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
15037903|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037904|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037905|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15037906|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15037907|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
15037908|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
15037909|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037910|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15037911|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15037912|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037913|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037914|NCT02016703|Erythritol|erythritol|mesh-list
15037915|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
15037916|NCT02016729|Trametinib|trametinib|mesh-list
15037917|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037918|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15037919|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037920|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037921|NCT02016807|Sucralfate|sucralfate|mesh-list
15037922|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15037923|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15037924|NCT02016820|Omeprazole|omeprazole|mesh-list
15037925|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15037926|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15037927|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15037928|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037929|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037930|NCT02016846|Liraglutide|liraglutide|mesh-list
15037931|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15037932|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037933|NCT02016846|Incretins|incretins|mesh-ancestor
15037934|NCT02016846|Hormones|hormones|mesh-ancestor
15037935|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15037936|NCT02016976|Midazolam|midazolam|mesh-list
15037937|NCT02016976|Meperidine|meperidine|mesh-list
15037938|NCT02016976|Analgesics|analgesics|mesh-list
15037939|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
15037940|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037941|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037942|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15037943|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15037944|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037945|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15037946|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15037947|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15037948|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15037949|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
15037950|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
15037951|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
15037952|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
15037953|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15037954|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037955|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15037956|NCT02016976|Narcotics|narcotics|mesh-ancestor
15037957|NCT02017119|Lactulose|lactulose|mesh-list
15037958|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15037959|NCT02017197|Warfarin|warfarin|mesh-list
15037960|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
15037961|NCT02017314|Morphine|morphine|mesh-list
15037962|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15037963|NCT02017314|Narcotics|narcotics|mesh-ancestor
15037964|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037965|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037966|NCT02017314|Analgesics|analgesics|mesh-ancestor
15037967|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
15037968|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037969|NCT02017340|Nilvadipine|nilvadipine|mesh-list
15037970|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15037971|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15037972|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15037973|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037974|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15037975|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037976|NCT02017392|Lidocaine|lidocaine|mesh-list
15037977|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
15037978|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
15037979|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15037980|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037981|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
15037982|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15037983|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15037984|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15037985|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15037986|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15037987|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037988|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
15037989|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15037990|NCT02017405|Antibodies|antibodies|mesh-list
15037991|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
15037992|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15037993|NCT02017457|Azacitidine|azacitidine|mesh-list
15037994|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15037995|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
15037996|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15037997|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15037998|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15037999|NCT02017561|Metformin|metformin|mesh-list
15038000|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15038001|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038002|NCT02017600|Fluorouracil|fluorouracil|mesh-list
15038003|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038004|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
15038005|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038006|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15038007|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15038008|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
15038009|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038010|NCT02017613|Tenalisib|tenalisib|mesh-list
15038011|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
15038012|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038013|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038014|NCT02017639|Simvastatin|simvastatin|mesh-list
15038015|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15038016|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15038017|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
15038018|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038019|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15038020|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15038021|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038022|NCT02017704|Leucovorin|leucovorin|mesh-list
15038023|NCT02017704|Capecitabine|capecitabine|mesh-list
15038024|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
15038025|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15038026|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
15038027|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038028|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038029|NCT02017704|Antidotes|antidotes|mesh-ancestor
15038030|NCT02017704|Protective Agents|protective agents|mesh-ancestor
15038031|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038032|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
15038033|NCT02017704|Vitamins|vitamins|mesh-ancestor
15038034|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
14243815|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15038035|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
15038036|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15038037|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038038|NCT02018055|Aspirin|aspirin|mesh-list
15038039|NCT02018055|Clopidogrel|clopidogrel|mesh-list
15038040|NCT02018055|Ticagrelor|ticagrelor|mesh-list
15038041|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15038042|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15038043|NCT02018055|Analgesics|analgesics|mesh-ancestor
15038044|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
15038045|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038046|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038047|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15038048|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15038049|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15038050|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15038051|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038052|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15038053|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15038054|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038055|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
15038056|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15038057|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15038058|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15038059|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
15038060|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038061|NCT02018081|Levofloxacin|levofloxacin|mesh-list
15038062|NCT02018081|Ofloxacin|ofloxacin|mesh-list
15038063|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15038064|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038065|NCT02018081|Renal Agents|renal agents|mesh-ancestor
15038066|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15038067|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15038068|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15038069|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038070|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038071|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038072|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15038073|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15038074|NCT02018094|Iodine|iodine|mesh-list
15038075|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
15038076|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
15038077|NCT02018094|Metronidazole|metronidazole|mesh-list
15038078|NCT02018094|Clindamycin|clindamycin|mesh-list
15038079|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15038080|NCT02018094|Teicoplanin|teicoplanin|mesh-list
15038081|NCT02018094|Povidone|povidone|mesh-list
15038082|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15038083|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038084|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
15038085|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15038086|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15038087|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15038088|NCT02018094|Trace Elements|trace elements|mesh-ancestor
15038089|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
15038090|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038091|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15038092|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038093|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038094|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
15038095|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
15038096|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15038097|NCT02018133|Vitamin D|vitamin d|mesh-list
15038098|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
15038099|NCT02018133|Vitamins|vitamins|mesh-ancestor
15038100|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
15038101|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038102|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15038103|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15038104|NCT02018159|Menotropins|menotropins|mesh-list
15038105|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15038106|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
15038107|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15038108|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038109|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
15038110|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
15038111|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
15038112|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038113|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038114|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
15038115|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038116|NCT02018263|Cocaine|cocaine|mesh-list
15038117|NCT02018263|Nicotine|nicotine|mesh-list
15038118|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15038119|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
15038120|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038121|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038122|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15038123|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15038124|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
15038125|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038126|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038127|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
15038128|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
15038129|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038130|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
15038131|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15038132|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15038133|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15038134|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15038135|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
15038136|NCT02018276|Lidocaine|lidocaine|mesh-list
15038137|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
15038138|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
15038139|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038140|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038141|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
15038142|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038143|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15038144|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15038145|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15038146|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15038147|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038148|NCT02018289|Triclosan|triclosan|mesh-list
15038149|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15038150|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038151|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15038152|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15038153|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
15038154|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038155|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15038156|NCT02018328|Curcumin|curcumin|mesh-list
15038157|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15038158|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15038159|NCT02018328|Analgesics|analgesics|mesh-ancestor
15038160|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
15038161|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038162|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968836|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038163|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15038164|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15038165|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038166|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038167|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038168|NCT02018367|Proflavine|proflavine|mesh-list
15038169|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15038170|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038171|NCT02018419|Vaccines|vaccines|mesh-list
15038172|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
15038173|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038174|NCT02018523|Lenalidomide|lenalidomide|mesh-list
15038175|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
15038176|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038177|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15038178|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15038179|NCT02018523|Growth Substances|growth substances|mesh-ancestor
15038180|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
15038181|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038182|NCT02018536|Simeprevir|simeprevir|mesh-list
15038183|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
15038184|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038185|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
15038186|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038187|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038188|NCT02018588|Tryptophan|tryptophan|mesh-list
15038189|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15038190|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
15038191|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15038192|NCT02018601|Acetaminophen|acetaminophen|mesh-list
13968837|NCT03108625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13968838|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13968839|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15038193|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15038194|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15038195|NCT02018601|Analgesics|analgesics|mesh-ancestor
15038196|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
15038197|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038198|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038199|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
13968840|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968841|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968842|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
13968843|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13968844|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13968845|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13968846|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13968847|NCT03108300|Doxorubicin|doxorubicin|mesh-list
13968848|NCT03108300|Propranolol|propranolol|mesh-list
13968849|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13968850|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968851|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13968852|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13968853|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968854|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968855|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13968856|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13968857|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
13968858|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968859|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968860|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13968861|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13968862|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
13968863|NCT03108326|Infliximab|infliximab|mesh-list
13968864|NCT03108326|Ustekinumab|ustekinumab|mesh-list
13968865|NCT03108326|Vedolizumab|vedolizumab|mesh-list
13968866|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13968867|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
13968868|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13968869|NCT03108365|Hemostatics|hemostatics|mesh-list
13968870|NCT03108365|Chitosan|chitosan|mesh-list
13968871|NCT03108365|Coagulants|coagulants|mesh-ancestor
13968872|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13968873|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13968874|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
13968875|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968876|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13968877|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
13968878|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
13968879|NCT03108248|Doxorubicin|doxorubicin|mesh-list
13968880|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
13968881|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
13968882|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13968883|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968884|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13968885|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13968886|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968887|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968888|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
13968889|NCT03108248|Coagulants|coagulants|mesh-ancestor
13968890|NCT03108287|Amoxicillin|amoxicillin|mesh-list
15038200|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15038201|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15038202|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15038203|NCT02018731|Metformin|metformin|mesh-list
15038204|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15038205|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038206|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
15038207|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
15038208|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
13968891|NCT03108287|Clarithromycin|clarithromycin|mesh-list
13968892|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
13968893|NCT03108287|Rabeprazole|rabeprazole|mesh-list
13968894|NCT03108287|Bismuth|bismuth|mesh-list
13968895|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15038209|NCT02018757|Estrogens|estrogens|mesh-ancestor
15038210|NCT02018757|Hormones|hormones|mesh-ancestor
15038211|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15038212|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038213|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15038214|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038215|NCT02018783|Listerine|listerine|mesh-list
15038216|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
15038217|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
15038218|NCT02018783|Protective Agents|protective agents|mesh-ancestor
15038219|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038220|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15038221|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038222|NCT02018796|Misoprostol|misoprostol|mesh-list
15038223|NCT02018796|Mifepristone|mifepristone|mesh-list
15038224|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15038225|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
15038226|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15038227|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038228|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15038229|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15038230|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
15038231|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15038232|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15038233|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15038234|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15038235|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
15038236|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15038237|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15038238|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
15038239|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15038240|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
15038241|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15038242|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15038243|NCT02018861|Rituximab|rituximab|mesh-list
15038244|NCT02018861|Carboplatin|carboplatin|mesh-list
15038245|NCT02018861|Etoposide|etoposide|mesh-list
15038246|NCT02018861|Ifosfamide|ifosfamide|mesh-list
15038247|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15038248|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038249|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
15038250|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038251|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15038252|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15038253|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15038254|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15038255|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038256|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038257|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15038258|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
15038259|NCT02018874|Gemcitabine|gemcitabine|mesh-list
15038260|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15038261|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
15038262|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038263|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038264|NCT02018874|Antiviral Agents|antiviral agents|mesh-ancestor
15038265|NCT02018874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038266|NCT02018874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038267|NCT02018874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15038268|NCT02018874|Immunologic Factors|immunologic factors|mesh-ancestor
15038269|NCT02018874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038270|NCT02018965|Vitamins|vitamins|mesh-list
15038271|NCT02018965|Niacin|niacin|mesh-list
15038272|NCT02018965|Niacinamide|niacinamide|mesh-list
15038273|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
15038274|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
15038275|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
15038276|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038277|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15038278|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
15038279|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038280|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15038281|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
15038282|NCT02018991|Everolimus|everolimus|mesh-list
15038283|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038284|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15038285|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
15038286|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038287|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
15038288|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15038289|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15038290|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15038291|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15038292|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038293|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
15038294|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038295|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038296|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15038297|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038298|NCT02019056|Pyridoxine|pyridoxine|mesh-list
15038299|NCT02019056|Metadoxine|metadoxine|mesh-list
15038300|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15038301|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
15038302|NCT02019056|Vitamins|vitamins|mesh-ancestor
15038303|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
15038304|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038305|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
15038306|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15038307|NCT02019160|Fluorides|fluorides|mesh-list
15038308|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
15038309|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
15038310|NCT02019160|Protective Agents|protective agents|mesh-ancestor
15038311|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038312|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15038313|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038314|NCT02019186|Vitamins|vitamins|mesh-list
15038315|NCT02019186|Ascorbic Acid|ascorbic acid|mesh-list
15038316|NCT02019186|Vitamin E|vitamin e|mesh-list
15038317|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
15038318|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038319|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
15038320|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038321|NCT02019186|Protective Agents|protective agents|mesh-ancestor
15038322|NCT02019290|Midazolam|midazolam|mesh-list
15038323|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15038324|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15038325|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038326|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243816|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14243817|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14243818|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
14243819|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243820|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243821|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243822|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
14243823|NCT00200967|Hormones|hormones|mesh-ancestor
14243824|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14243825|NCT00201123|Interferons|interferons|mesh-list
14243826|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
14531592|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14531593|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14531594|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14531595|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
14531596|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531597|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531598|NCT02434146|Protective Agents|protective agents|mesh-ancestor
14531599|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
14531600|NCT02447887|Ixazomib|ixazomib|mesh-list
14531601|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531602|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
14531603|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531604|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531605|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
14531606|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531607|NCT02439970|Valganciclovir|valganciclovir|mesh-list
14531608|NCT02439970|Brincidofovir|brincidofovir|mesh-list
14531609|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
14531610|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531611|NCT02439957|Valganciclovir|valganciclovir|mesh-list
14531612|NCT02439957|Brincidofovir|brincidofovir|mesh-list
14531613|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
14531614|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531615|NCT02436265|Dexamethasone|dexamethasone|mesh-list
14531616|NCT02436265|Ropivacaine|ropivacaine|mesh-list
14531617|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14531618|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
14531619|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
14531620|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531621|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038327|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15038328|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15038329|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15038330|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15038331|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
15038332|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
15038333|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
15038334|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
15038335|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038336|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038337|NCT02019329|Risperidone|risperidone|mesh-list
15038338|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15038339|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
15038340|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038341|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038342|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038343|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15038344|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15038345|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038346|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15038347|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15038348|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
15038349|NCT02019355|Fluorouracil|fluorouracil|mesh-list
15038350|NCT02019355|Calcipotriene|calcipotriene|mesh-list
15038351|NCT02019355|Petrolatum|petrolatum|mesh-list
15038352|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
15038353|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038354|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15038355|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038356|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15038357|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
15038358|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038359|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
15038360|NCT02019355|Emollients|emollients|mesh-ancestor
15038361|NCT02019381|Vitamin D|vitamin d|mesh-list
15038362|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
15038363|NCT02019381|Vitamins|vitamins|mesh-list
15038364|NCT02019381|Calcium|calcium|mesh-list
15038365|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
15038366|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038367|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15038368|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15038369|NCT02019446|Terbinafine|terbinafine|mesh-list
15038370|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
15038371|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038372|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038373|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038374|NCT02019459|Nicotine|nicotine|mesh-list
15038375|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15038376|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
15038377|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038378|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038379|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15038380|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15038381|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
15038382|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038383|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038384|NCT02019485|Tapentadol|tapentadol|mesh-list
15038385|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15038386|NCT02019485|Narcotics|narcotics|mesh-ancestor
15038387|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038388|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038389|NCT02019485|Analgesics|analgesics|mesh-ancestor
15038390|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
15038391|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038392|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15038393|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15038394|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15038395|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968896|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038396|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
13968897|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13968898|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968899|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968900|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13968901|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13968902|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13968903|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13968904|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13968905|NCT03108287|Antacids|antacids|mesh-ancestor
13968906|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
13968907|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13968908|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968909|NCT03108274|Fexofenadine|fexofenadine|mesh-list
13968910|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
13968911|NCT03108274|Midazolam|midazolam|mesh-list
13968912|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13968913|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13968914|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968915|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968916|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13968917|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13968918|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13968919|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13968920|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
13968921|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
13968922|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
13968923|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
13968924|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968925|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968926|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13968927|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968928|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13968929|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
13968930|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13968931|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13968932|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13968933|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13968934|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13968935|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13968936|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
13968937|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
13968938|NCT03107858|Dopamine|dopamine|mesh-list
13968939|NCT03107858|Norepinephrine|norepinephrine|mesh-list
13968940|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13968941|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15038397|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038398|NCT02019524|Folic Acid|folic acid|mesh-list
15038399|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
15038400|NCT02019524|Molgramostim|molgramostim|mesh-list
15038401|NCT02019524|Vaccines|vaccines|mesh-list
15038402|NCT02019524|Sargramostim|sargramostim|mesh-list
15038403|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
15038404|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038405|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968942|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
13968943|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968944|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968945|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968946|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
13968947|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
13968948|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968949|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15038406|NCT02019524|Hematinics|hematinics|mesh-ancestor
15038407|NCT02019524|Vitamins|vitamins|mesh-ancestor
15038408|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
15038409|NCT02019784|Rifaximin|rifaximin|mesh-list
15038410|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15038411|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038412|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15038413|NCT02019797|Desflurane|desflurane|mesh-list
15038414|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15038415|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
13968950|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13968951|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
15038416|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
15038417|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038418|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038419|NCT02019810|Dobutamine|dobutamine|mesh-list
15038420|NCT02019810|Norepinephrine|norepinephrine|mesh-list
15038421|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15038422|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15038423|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
15038424|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038425|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038426|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038427|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
15038428|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
15038429|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038430|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15038431|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15038432|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15038433|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15038434|NCT02019810|Protective Agents|protective agents|mesh-ancestor
15038435|NCT02019836|Vitamin D|vitamin d|mesh-list
15038436|NCT02019836|Vitamins|vitamins|mesh-ancestor
15038437|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
15038438|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038439|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15038440|NCT02019875|Clarithromycin|clarithromycin|mesh-list
15038441|NCT02019875|Rifampin|rifampin|mesh-list
15038442|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15038443|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038444|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15038445|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038446|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038447|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15038448|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15038449|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15038450|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
15038451|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
15038452|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15038453|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15038454|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15038455|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15038456|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15038457|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15038458|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15038459|NCT02020005|Nicotine|nicotine|mesh-list
15038460|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15038461|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
15038462|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038463|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038464|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15038465|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15038466|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
15038467|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038468|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038469|NCT02020070|Ipilimumab|ipilimumab|mesh-list
15038470|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15038471|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038472|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15038473|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038474|NCT02020122|Pregabalin|pregabalin|mesh-list
15038475|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15038476|NCT02020122|Analgesics|analgesics|mesh-ancestor
15038477|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
15038478|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038479|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038480|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
15038481|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15038482|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15038483|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038484|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15038485|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15038486|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15038487|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038488|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15038489|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15038490|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15038491|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038492|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
15038493|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
15038494|NCT02020161|Methotrexate|methotrexate|mesh-list
15038495|NCT02020161|Idarubicin|idarubicin|mesh-list
15038496|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15038497|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
15038498|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15038499|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038500|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15038501|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
15038502|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038503|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038504|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
15038505|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038506|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15038507|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15038508|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
15038509|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15038510|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15038511|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15038512|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15038513|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15038514|NCT02020200|Methylphenidate|methylphenidate|mesh-list
15038515|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15038516|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038517|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15038518|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15038519|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15038520|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038521|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
15038522|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038523|NCT02020213|Posaconazole|posaconazole|mesh-list
15038524|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
15038525|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038526|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15038527|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15038528|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15038529|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15038530|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15038531|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038532|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038533|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15038534|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
15038535|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15038536|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038537|NCT02020330|Lumefantrine|lumefantrine|mesh-list
15038538|NCT02020330|Artemether|artemether|mesh-list
15038539|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15038540|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
15038541|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15038542|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15038543|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038544|NCT02020499|Lanreotide|lanreotide|mesh-list
15038545|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038546|NCT02020551|Lidocaine|lidocaine|mesh-list
15038547|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
15038548|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
15038549|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038550|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038551|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
15038552|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038553|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15038554|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15038555|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15038556|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15038557|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038558|NCT02020603|Epinephrine|epinephrine|mesh-list
15038559|NCT02020603|Racepinephrine|racepinephrine|mesh-list
15038560|NCT02020603|Hemostatics|hemostatics|mesh-list
15038561|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
15038562|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15038563|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15038564|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
15038565|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038566|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038567|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038568|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15038569|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15038570|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
15038571|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038572|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15038573|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
15038574|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
15038575|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
15038576|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15038577|NCT02020603|Coagulants|coagulants|mesh-ancestor
15038578|NCT02020629|Lixisenatide|lixisenatide|mesh-list
15038579|NCT02020629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15038580|NCT02020629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038581|NCT02020681|Fluorides|fluorides|mesh-list
15038582|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
15038583|NCT02020681|Protective Agents|protective agents|mesh-ancestor
15038584|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038585|NCT02020694|Vitamin D|vitamin d|mesh-list
15038586|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
15038587|NCT02020694|Vitamins|vitamins|mesh-list
15038588|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
15038589|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038590|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15038591|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15038592|NCT02020720|Fluorides|fluorides|mesh-list
15038593|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
15038594|NCT02020720|Protective Agents|protective agents|mesh-ancestor
15038595|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038596|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
15038597|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15038598|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15038599|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15038600|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15038601|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038602|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
15038603|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038604|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038605|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15038606|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038607|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15038608|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15038609|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
15038610|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15038611|NCT02021097|Estradiol|estradiol|mesh-list
15038612|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15038613|NCT02021097|Estrogens|estrogens|mesh-ancestor
15038614|NCT02021097|Hormones|hormones|mesh-ancestor
15038615|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15038616|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038617|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15038618|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
15038619|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15038620|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15038621|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15038622|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15038623|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15038624|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
15038625|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15038626|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15038627|NCT02021123|Anidulafungin|anidulafungin|mesh-list
15038628|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
15038629|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038630|NCT02021201|Risperidone|risperidone|mesh-list
15038631|NCT02021201|Sertindole|sertindole|mesh-list
15038632|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15038633|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
15038634|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038635|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038636|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038637|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15038638|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15038639|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038640|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15038641|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15038642|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
15038643|NCT02021214|Methylphenidate|methylphenidate|mesh-list
15038644|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15038645|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038646|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15038647|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15038648|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15038649|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038650|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
15038651|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038652|NCT02021240|Dexamethasone|dexamethasone|mesh-list
15038653|NCT02021240|Ketamine|ketamine|mesh-list
15038654|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15038655|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
15038656|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
15038657|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038658|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038659|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15038660|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
15038661|NCT02021240|Hormones|hormones|mesh-ancestor
15038662|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15038663|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15038664|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038665|NCT02021240|Analgesics|analgesics|mesh-ancestor
15038666|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
15038667|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15038668|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15038669|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
15038670|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
15038671|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038672|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15038673|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15038674|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038675|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038676|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
13968952|NCT03107858|Protective Agents|protective agents|mesh-ancestor
15038677|NCT02021409|Hematinics|hematinics|mesh-ancestor
15038678|NCT02021422|Fluorouracil|fluorouracil|mesh-list
15038679|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
15038680|NCT02021422|Irinotecan|irinotecan|mesh-list
15038681|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15038682|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
15038683|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038684|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15038685|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038686|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15038687|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
15038688|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038689|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15038690|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15038691|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038692|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15038693|NCT02021474|Phenol|phenol|mesh-list
15038694|NCT02021474|Histamine|histamine|mesh-list
15038695|NCT02021474|Histamine phosphate|histamine phosphate|mesh-list
15038696|NCT02021474|Histamine Agonists|histamine agonists|mesh-ancestor
15038697|NCT02021474|Histamine Agents|histamine agents|mesh-ancestor
15038698|NCT02021474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038699|NCT02021474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038700|NCT02021474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038701|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15038702|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038703|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
15038704|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15038705|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15038706|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15038707|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038708|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
13968953|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
13968954|NCT03107962|Antibodies|antibodies|mesh-list
13968955|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
13968956|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
13968957|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968958|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13968959|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13968960|NCT03107884|Metformin|metformin|mesh-list
13968961|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13968962|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968963|NCT03107923|Dobutamine|dobutamine|mesh-list
13968964|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13968965|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
13968966|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
13968967|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968968|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968969|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13968970|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15038709|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13968971|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13968972|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
13968973|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13968974|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968975|NCT03107923|Protective Agents|protective agents|mesh-ancestor
13968976|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
13968977|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13968978|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13968979|NCT03107702|Melatonin|melatonin|mesh-list
15038710|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038711|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
15038712|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
15038713|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038714|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038715|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038716|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
15038717|NCT02021825|Analgesics|analgesics|mesh-ancestor
15038718|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
15038719|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038720|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038721|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038722|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15038723|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15038724|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038725|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038726|NCT02021851|Dexamethasone|dexamethasone|mesh-list
13968980|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
13968981|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968982|NCT03107702|Protective Agents|protective agents|mesh-ancestor
13968983|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968984|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968985|NCT03107481|Acetaminophen|acetaminophen|mesh-list
13968986|NCT03107481|Hydromorphone|hydromorphone|mesh-list
13968987|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13968988|NCT03107481|Analgesics|analgesics|mesh-ancestor
13968989|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
13968990|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13968991|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13968992|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
13968993|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13968994|NCT03107481|Narcotics|narcotics|mesh-ancestor
13968995|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13968996|NCT03107429|Acetazolamide|acetazolamide|mesh-list
15038727|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
15038728|NCT02021851|Ondansetron|ondansetron|mesh-list
15038729|NCT02021851|Aprepitant|aprepitant|mesh-list
15038730|NCT02021851|BB 1101|bb 1101|mesh-list
15038731|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15038732|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
15038733|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
15038734|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038735|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038736|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15038737|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
15038738|NCT02021851|Hormones|hormones|mesh-ancestor
15038739|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15038740|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15038741|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038742|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
15038743|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038744|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038745|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
15038746|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
15038747|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15038748|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
15038749|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038750|NCT02021851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15038751|NCT02021851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15038752|NCT02021851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038753|NCT02021851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15038754|NCT02021851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15038755|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15038756|NCT02021864|Vitamin D|vitamin d|mesh-list
15038757|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
15038758|NCT02021864|Vitamins|vitamins|mesh-ancestor
15038759|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
15038760|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038761|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15038762|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15038763|NCT02022059|Lidocaine|lidocaine|mesh-list
15038764|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
15038765|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
15038766|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038767|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038768|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
15038769|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038770|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15038771|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15038772|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15038773|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15038774|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038775|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15038776|NCT02022163|Vaccines|vaccines|mesh-list
15038777|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
15038778|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038779|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15038780|NCT02022163|Antacids|antacids|mesh-ancestor
15038781|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038782|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15038783|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15038784|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15038785|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
15038786|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15038787|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
15038788|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15038789|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038790|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15038791|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15038792|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038793|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15038794|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
15038795|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15038796|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
15038797|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15038798|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038799|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15038800|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15038801|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038802|NCT02022254|Metformin|metformin|mesh-list
15038803|NCT02022254|Warfarin|warfarin|mesh-list
15038804|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15038805|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038806|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
15038807|NCT02022280|Lansoprazole|lansoprazole|mesh-list
15038808|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
15038809|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15038810|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15038811|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15038812|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038813|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038814|NCT02022293|Atorvastatin|atorvastatin|mesh-list
15038815|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15038816|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15038817|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
15038818|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038819|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15038820|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15038821|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038822|NCT02022358|Leucovorin|leucovorin|mesh-list
15038823|NCT02022358|Folic Acid|folic acid|mesh-list
15038824|NCT02022358|Methotrexate|methotrexate|mesh-list
15038825|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
15038826|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15038827|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
15038828|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15038829|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038830|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15038831|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
15038832|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038833|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038834|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
15038835|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038836|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15038837|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15038838|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
14243827|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243828|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
14243829|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243830|NCT00201448|Vaccines|vaccines|mesh-list
14243831|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
14243832|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531622|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14531623|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
14531624|NCT02436265|Hormones|hormones|mesh-ancestor
14531625|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14531626|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14531627|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038839|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15038840|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15038841|NCT02022358|Antidotes|antidotes|mesh-ancestor
15038842|NCT02022358|Protective Agents|protective agents|mesh-ancestor
15038843|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
15038844|NCT02022358|Vitamins|vitamins|mesh-ancestor
15038845|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
15038846|NCT02022358|Hematinics|hematinics|mesh-ancestor
15038847|NCT02022475|Vitamin D|vitamin d|mesh-list
15038848|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
15038849|NCT02022475|Vitamins|vitamins|mesh-ancestor
15038850|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
15038851|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038852|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15038853|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15038854|NCT02022488|Midazolam|midazolam|mesh-list
15038855|NCT02022488|Ketamine|ketamine|mesh-list
15038856|NCT02022488|Alfentanil|alfentanil|mesh-list
15038857|NCT02022488|Analgesics|analgesics|mesh-ancestor
15038858|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
15038859|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038860|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038861|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15038862|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15038863|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
15038864|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
15038865|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038866|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15038867|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15038868|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038869|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038870|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15038871|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15038872|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15038873|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15038874|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15038875|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
15038876|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
15038877|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15038878|NCT02022488|Narcotics|narcotics|mesh-ancestor
15038879|NCT02022527|Aspirin|aspirin|mesh-list
15038880|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
15038881|NCT02022527|Salicylates|salicylates|mesh-list
15038882|NCT02022527|Warfarin|warfarin|mesh-list
15038883|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15038884|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15038885|NCT02022527|Analgesics|analgesics|mesh-ancestor
15038886|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
15038887|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038888|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038889|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15038890|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15038891|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15038892|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15038893|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13968997|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
13968998|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13968999|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969000|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969001|NCT03107429|Diuretics|diuretics|mesh-ancestor
13969002|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
15038894|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15038895|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15038896|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038897|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
15038898|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
15038899|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243833|NCT00201643|Dexamethasone|dexamethasone|mesh-list
15038900|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
15038901|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
15038902|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
15038903|NCT02022540|Ranibizumab|ranibizumab|mesh-list
15038904|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15038905|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15038906|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15038907|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15038908|NCT02022540|Growth Substances|growth substances|mesh-ancestor
15038909|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038910|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
15038911|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038912|NCT02022644|Irinotecan|irinotecan|mesh-list
15038913|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15038914|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15038915|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038916|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038917|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038918|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
15038919|NCT02022709|Sertraline|sertraline|mesh-list
15038920|NCT02022709|Fluoxetine|fluoxetine|mesh-list
15038921|NCT02022709|Paroxetine|paroxetine|mesh-list
15038922|NCT02022709|Citalopram|citalopram|mesh-list
15038923|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
15038924|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15038925|NCT02022709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15038926|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15038927|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15038928|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038929|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15038930|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
15038931|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038932|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15038933|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15038934|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15038935|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038936|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15038937|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15038938|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038939|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15038940|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15038941|NCT02022722|Triamcinolone|triamcinolone|mesh-list
15038942|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15038943|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15038944|NCT02022722|Bupivacaine|bupivacaine|mesh-list
15038945|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15038946|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
15038947|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
15038948|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15038949|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038950|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
15038951|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15038952|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15038953|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
15038954|NCT02022722|Hormones|hormones|mesh-ancestor
15038955|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15038956|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15038957|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
15038958|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038959|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038960|NCT02022761|Laninamivir|laninamivir|mesh-list
15038961|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
15038962|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15038963|NCT02022852|Capecitabine|capecitabine|mesh-list
15038964|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15038965|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
15038966|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038967|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038968|NCT02022917|Bevacizumab|bevacizumab|mesh-list
15038969|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15038970|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038971|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15038972|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15038973|NCT02022917|Growth Substances|growth substances|mesh-ancestor
15038974|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038975|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
15038976|NCT02022930|Triamcinolone|triamcinolone|mesh-list
15038977|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15038978|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15038979|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15038980|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15038981|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
15038982|NCT02022930|Hormones|hormones|mesh-ancestor
15038983|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15038984|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15038985|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15038986|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
15038987|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15038988|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038989|NCT02023021|Gemcitabine|gemcitabine|mesh-list
15038990|NCT02023021|Paclitaxel|paclitaxel|mesh-list
15038991|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15038992|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15038993|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
15038994|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
15038995|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
15038996|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15038997|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15038998|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
15038999|NCT02023021|Antiviral Agents|antiviral agents|mesh-ancestor
15039000|NCT02023021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039001|NCT02023021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039002|NCT02023021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039003|NCT02023021|Immunologic Factors|immunologic factors|mesh-ancestor
15039004|NCT02023021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039005|NCT02023047|Nifedipine|nifedipine|mesh-list
15039006|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15039007|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15039008|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039009|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15039010|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039011|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
15039012|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
15039013|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15039014|NCT02023086|Tropicamide|tropicamide|mesh-list
15039015|NCT02023086|Mydriatics|mydriatics|mesh-list
15039016|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
15039017|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039018|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039019|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15039020|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15039021|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
15039022|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039023|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039024|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
15039025|NCT02023164|Promethazine|promethazine|mesh-list
15039026|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15039027|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15039028|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15039029|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039030|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
15039031|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
15039032|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
15039033|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039034|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
15039035|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
15039036|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15039037|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15039038|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
15039039|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
15039040|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039041|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039042|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15039043|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
15039044|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
15039045|NCT02023359|Everolimus|everolimus|mesh-list
15039046|NCT02023359|Exemestane|exemestane|mesh-list
15039047|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039048|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039049|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
15039050|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039051|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15039052|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15039053|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039054|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039055|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15039056|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
15039057|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15039058|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
15039059|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
15039060|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15039061|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
15039062|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039063|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039064|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15039065|NCT02023450|Ritonavir|ritonavir|mesh-list
15039066|NCT02023450|Saquinavir|saquinavir|mesh-list
15039067|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15039068|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15039069|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
15039070|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039071|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039072|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15039073|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15039074|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
15039075|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039076|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15039077|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15039078|NCT02023463|Leuprolide|leuprolide|mesh-list
15039079|NCT02023463|Goserelin|goserelin|mesh-list
15039080|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15039081|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
15039082|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15039083|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039084|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15039085|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039086|NCT02023554|Azithromycin|azithromycin|mesh-list
15039087|NCT02023554|Theophylline|theophylline|mesh-list
15039088|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15039089|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039090|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15039091|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
15039092|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039093|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039094|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15039095|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
15039096|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15039097|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039098|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039099|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
15039100|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15039101|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15039102|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
15039103|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039104|NCT02023567|Serotonin|serotonin|mesh-list
15039105|NCT02023567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
15039106|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15039107|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
15039108|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039109|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039110|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039111|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15039112|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15039113|NCT02023593|Leucovorin|leucovorin|mesh-list
15039114|NCT02023593|Fluorouracil|fluorouracil|mesh-list
15039115|NCT02023593|Irinotecan|irinotecan|mesh-list
15039116|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
15039117|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039118|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15039119|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039120|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039121|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
15039122|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969003|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969004|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13969005|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13969006|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243834|NCT00201643|Betamethasone|betamethasone|mesh-list
14243835|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243836|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
15039123|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15039124|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15039125|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039126|NCT02023593|Antidotes|antidotes|mesh-ancestor
15039127|NCT02023593|Protective Agents|protective agents|mesh-ancestor
15039128|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
15039129|NCT02023593|Vitamins|vitamins|mesh-ancestor
15039130|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
15039131|NCT02023684|Lidocaine|lidocaine|mesh-list
15039132|NCT02023684|Ropivacaine|ropivacaine|mesh-list
15039133|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
15039134|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
15039135|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15039136|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039137|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
15039138|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039139|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15039140|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15039141|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15039142|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15039143|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039144|NCT02023710|Paclitaxel|paclitaxel|mesh-list
15039145|NCT02023710|Bevacizumab|bevacizumab|mesh-list
15039146|NCT02023710|Carboplatin|carboplatin|mesh-list
15039147|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15039148|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039149|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
15039150|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
15039151|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
15039152|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039153|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15039154|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15039155|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15039156|NCT02023710|Growth Substances|growth substances|mesh-ancestor
15039157|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039158|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
15039159|NCT02023840|Metronidazole|metronidazole|mesh-list
15039160|NCT02023840|Erythritol|erythritol|mesh-list
15039161|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039162|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15039163|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15039164|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15039165|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
15039166|NCT02023853|Metronidazole|metronidazole|mesh-list
15039167|NCT02023853|Erythritol|erythritol|mesh-list
15039168|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039169|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15039170|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15039171|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15039172|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
15039173|NCT02023892|Atorvastatin|atorvastatin|mesh-list
14243837|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
14243838|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243839|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969007|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
13969008|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13969009|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969010|NCT03107247|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
13969011|NCT03107247|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13969012|NCT03107247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969013|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
14243840|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14243841|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
14243842|NCT00201643|Hormones|hormones|mesh-ancestor
14243843|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14243844|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14243845|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243846|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14243847|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
14243848|NCT00201734|Paclitaxel|paclitaxel|mesh-list
14243849|NCT00201734|Carboplatin|carboplatin|mesh-list
14243850|NCT00201734|Capecitabine|capecitabine|mesh-list
14243851|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14243852|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243853|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
14243854|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
14243855|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
14243856|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243857|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243858|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
14243859|NCT00201760|Gemcitabine|gemcitabine|mesh-list
14243860|NCT00201760|Trastuzumab|trastuzumab|mesh-list
14243861|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243862|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243863|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
14243864|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243865|NCT00201760|Antiviral Agents|antiviral agents|mesh-ancestor
14243866|NCT00201760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243867|NCT00201760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243868|NCT00201760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243869|NCT00201760|Immunologic Factors|immunologic factors|mesh-ancestor
14243870|NCT00201760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039174|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15039175|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15039176|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
15039177|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039178|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14243871|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14243872|NCT00201773|Celecoxib|celecoxib|mesh-list
14243873|NCT00201773|Exemestane|exemestane|mesh-list
14243874|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14243875|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14243876|NCT00201773|Analgesics|analgesics|mesh-ancestor
14243877|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
14531628|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
15039179|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15039180|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039181|NCT02023931|Sulforaphane|sulforaphane|mesh-list
15039182|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13969014|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13969015|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13969016|NCT03107338|Analgesics|analgesics|mesh-ancestor
13969017|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
13969018|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039183|NCT02023931|Protective Agents|protective agents|mesh-ancestor
15039184|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039185|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039186|NCT02024009|Gemcitabine|gemcitabine|mesh-list
15039187|NCT02024009|Nelfinavir|nelfinavir|mesh-list
15039188|NCT02024009|Paclitaxel|paclitaxel|mesh-list
15039189|NCT02024009|Capecitabine|capecitabine|mesh-list
15039190|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15039191|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039192|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
15039193|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
15039194|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
15039195|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039196|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15039197|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
15039198|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
15039199|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039200|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039201|NCT02024009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039202|NCT02024009|Immunologic Factors|immunologic factors|mesh-ancestor
15039203|NCT02024009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039204|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15039205|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15039206|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
15039207|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15039208|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15039209|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
15039210|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
15039211|NCT02024022|Cathartics|cathartics|mesh-ancestor
15039212|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15039213|NCT02024152|Cetirizine|cetirizine|mesh-list
15039214|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15039215|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15039216|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15039217|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
15039218|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
15039219|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039220|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039221|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039222|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
15039223|NCT02024217|Tegafur|tegafur|mesh-list
15039224|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039225|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15039226|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
15039227|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039228|NCT02024230|Warfarin|warfarin|mesh-list
15039229|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
15039230|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
15039231|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15039232|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
15039233|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15039234|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
15039235|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039236|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039237|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
15039238|NCT02024256|Analgesics|analgesics|mesh-ancestor
15039239|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
15039240|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039241|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039242|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
15039243|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15039244|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15039245|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
15039246|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15039247|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15039248|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039249|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15039250|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
15039251|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15039252|NCT02024295|Choline|choline|mesh-list
15039253|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
15039254|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
15039255|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15039256|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
15039257|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039258|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15039259|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15039260|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
15039261|NCT02024308|Cytarabine|cytarabine|mesh-list
15039262|NCT02024308|Fludarabine|fludarabine|mesh-list
15039263|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039264|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15039265|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
15039266|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039267|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039268|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
15039269|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039270|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
15039271|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039272|NCT02024334|Leflunomide|leflunomide|mesh-list
15039273|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039274|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039275|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039276|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
15039277|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039278|NCT02024373|Atorvastatin|atorvastatin|mesh-list
15039279|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15039280|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15039281|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
15039282|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039283|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15039284|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15039285|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039286|NCT02024425|Antioxidants|antioxidants|mesh-list
15039287|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039288|NCT02024425|Protective Agents|protective agents|mesh-ancestor
15039289|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039290|NCT02024555|Azithromycin|azithromycin|mesh-list
15039291|NCT02024555|Levofloxacin|levofloxacin|mesh-list
15039292|NCT02024555|Ofloxacin|ofloxacin|mesh-list
15039293|NCT02024555|Rifampin|rifampin|mesh-list
15039294|NCT02024555|Ethambutol|ethambutol|mesh-list
15039295|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15039296|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039297|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15039298|NCT02024555|Renal Agents|renal agents|mesh-ancestor
15039299|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15039300|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15039301|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039302|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039303|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039304|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15039305|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15039306|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15039307|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
15039308|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
15039309|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15039310|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15039311|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15039312|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15039313|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15039314|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15039315|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15039316|NCT02024568|Pregabalin|pregabalin|mesh-list
15039317|NCT02024568|Analgesics|analgesics|mesh-ancestor
15039318|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
15039319|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039320|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039321|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
15039322|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15039323|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15039324|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039325|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15039326|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15039327|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15039328|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15039329|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15039330|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
15039331|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15039332|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
15039333|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
15039334|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15039335|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039336|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15039337|NCT02024594|Analgesics|analgesics|mesh-ancestor
15039338|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
15039339|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243878|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243879|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243880|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243881|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243882|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14243883|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14243884|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243885|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243886|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039340|NCT02024633|Gemcitabine|gemcitabine|mesh-list
15039341|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15039342|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
15039343|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039344|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039345|NCT02024633|Antiviral Agents|antiviral agents|mesh-ancestor
15039346|NCT02024633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039347|NCT02024633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039348|NCT02024633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039349|NCT02024633|Immunologic Factors|immunologic factors|mesh-ancestor
13969019|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969020|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13969021|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969022|NCT03107507|Levetiracetam|levetiracetam|mesh-list
13969023|NCT03107507|Phenobarbital|phenobarbital|mesh-list
13969024|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
13969025|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
13969026|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13969027|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969028|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969029|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13969030|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13969031|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969032|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969033|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
13969034|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
13969035|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13969036|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13969037|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13969038|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
13969039|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
13969040|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13969041|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
13969042|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
13969043|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969044|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969045|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13969046|NCT03107078|Hormones|hormones|mesh-ancestor
13969047|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13969048|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13969049|NCT03107078|Protective Agents|protective agents|mesh-ancestor
13969050|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
13969051|NCT03106948|Penicillamine|penicillamine|mesh-list
13969052|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
13969053|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969054|NCT03106948|Protective Agents|protective agents|mesh-ancestor
13969055|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969056|NCT03106948|Vitamins|vitamins|mesh-ancestor
13969057|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
13969058|NCT03106948|Antidotes|antidotes|mesh-ancestor
13969059|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
13969060|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
15039350|NCT02024633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039351|NCT02024659|Budesonide|budesonide|mesh-list
15039352|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15039353|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15039354|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
15039355|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039356|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039357|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15039358|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
15039359|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
15039360|NCT02024659|Hormones|hormones|mesh-ancestor
15039361|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15039362|NCT02024841|Docetaxel|docetaxel|mesh-list
15039363|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039364|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
15039365|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
15039366|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
15039367|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039368|NCT02024906|Caseins|caseins|mesh-list
15039369|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
15039370|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
15039371|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039372|NCT02024919|Diltiazem|diltiazem|mesh-list
15039373|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15039374|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15039375|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15039376|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039377|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15039378|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039379|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
15039380|NCT02024945|Propiverine|propiverine|mesh-list
15039381|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
15039382|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
15039383|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039384|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039385|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15039386|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15039387|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
15039388|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039389|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039390|NCT02024945|Urological Agents|urological agents|mesh-ancestor
15039391|NCT02024984|Clomiphene|clomiphene|mesh-list
15039392|NCT02024984|Enclomiphene|enclomiphene|mesh-list
15039393|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
15039394|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15039395|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
15039396|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15039397|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039398|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15039399|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
15039400|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15039401|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15039402|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15039403|NCT02025010|Prednisone|prednisone|mesh-list
15039404|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
15039405|NCT02025010|Glucocorticoids|glucocorticoids|mesh-list
15039406|NCT02025010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15039407|NCT02025010|Hormones|hormones|mesh-ancestor
15039408|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15039409|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039410|NCT02025010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15039411|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039412|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15039413|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039414|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039415|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
13969061|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969062|NCT03107169|Vancomycin|vancomycin|mesh-list
13969063|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13969064|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969065|NCT03106831|Norepinephrine|norepinephrine|mesh-list
13969066|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13969067|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13969068|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
13969069|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969070|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969071|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969072|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
13969073|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
13969074|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969075|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13969076|NCT03106740|Minocycline|minocycline|mesh-list
13969077|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13969078|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969079|NCT03106597|Amlodipine|amlodipine|mesh-list
13969080|NCT03106597|Manidipine|manidipine|mesh-list
13969081|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13969082|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13969083|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13969084|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969085|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13969086|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969087|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
13969088|NCT03106818|Ketorolac|ketorolac|mesh-list
13969089|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
15039416|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15039417|NCT02025023|Triamcinolone|triamcinolone|mesh-list
15039418|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15039419|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15039420|NCT02025023|Fluorouracil|fluorouracil|mesh-list
15039421|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15039422|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
15039423|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039424|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15039425|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039426|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039427|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
15039428|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039429|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15039430|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
15039431|NCT02025023|Hormones|hormones|mesh-ancestor
15039432|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15039433|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039434|NCT02025036|Capecitabine|capecitabine|mesh-list
15039435|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
15039436|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15039437|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
15039438|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039439|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039440|NCT02025140|Anesthetics|anesthetics|mesh-list
15039441|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15039442|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039443|NCT02025166|Acetaminophen|acetaminophen|mesh-list
15039444|NCT02025166|Lornoxicam|lornoxicam|mesh-list
15039445|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15039446|NCT02025166|Analgesics|analgesics|mesh-ancestor
15039447|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
15039448|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039449|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039450|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
15039451|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15039452|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15039453|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15039454|NCT02025192|Capecitabine|capecitabine|mesh-list
15039455|NCT02025192|Trastuzumab|trastuzumab|mesh-list
15039456|NCT02025192|Tucatinib|tucatinib|mesh-list
15039457|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15039458|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
15039459|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039460|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039461|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15039462|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15039463|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039464|NCT02025218|Gefitinib|gefitinib|mesh-list
15039465|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039466|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15039467|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039468|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039469|NCT02025348|Metoprolol|metoprolol|mesh-list
15039470|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15039471|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15039472|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
15039473|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
15039474|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039475|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039476|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15039477|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15039478|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15039479|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
15039480|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039481|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039482|NCT02025361|Lidocaine|lidocaine|mesh-list
15039483|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
15039484|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
15039485|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15039486|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039487|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
15039488|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039489|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15039490|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15039491|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15039492|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15039493|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039494|NCT02025374|Bupivacaine|bupivacaine|mesh-list
15039495|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
15039496|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
15039497|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
15039498|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15039499|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039500|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
15039501|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039502|NCT02025465|Metoprolol|metoprolol|mesh-list
15039503|NCT02025465|Diltiazem|diltiazem|mesh-list
15039504|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15039505|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15039506|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
15039507|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
15039508|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039509|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039510|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15039511|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15039512|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15039513|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
13969090|NCT03106818|Bupivacaine|bupivacaine|mesh-list
13969091|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
13969092|NCT03106818|Anesthetics|anesthetics|mesh-list
13969093|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969094|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969095|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
13969096|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969097|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13969098|NCT03106818|Analgesics|analgesics|mesh-ancestor
13969099|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15039514|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039515|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039516|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15039517|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15039518|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15039519|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
15039520|NCT02025491|Amphotericin B|amphotericin b|mesh-list
15039521|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15039522|NCT02025491|Amebicides|amebicides|mesh-ancestor
15039523|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15039524|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15039525|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039526|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15039527|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
15039528|NCT02025608|Pramipexole|pramipexole|mesh-list
15039529|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
15039530|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039531|NCT02025608|Protective Agents|protective agents|mesh-ancestor
15039532|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039533|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15039534|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15039535|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
15039536|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
15039537|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039538|NCT02025712|Everolimus|everolimus|mesh-list
15039539|NCT02025712|Exemestane|exemestane|mesh-list
15039540|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039541|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039542|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
15039543|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039544|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15039545|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15039546|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039547|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039548|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15039549|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
15039550|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15039551|NCT02025803|Capecitabine|capecitabine|mesh-list
15039552|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15039553|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
15039554|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039555|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039556|NCT02025855|Methadone|methadone|mesh-list
15039557|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15039558|NCT02025855|Narcotics|narcotics|mesh-ancestor
15039559|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15039560|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039561|NCT02025855|Analgesics|analgesics|mesh-ancestor
15039562|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
15039563|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039564|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
15039565|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
15039566|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
15039567|NCT02025868|Darunavir|darunavir|mesh-list
15039568|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15039569|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15039570|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
15039571|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969100|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15039572|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15039573|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15039574|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039575|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039576|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15039577|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15039578|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
15039579|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
15039580|NCT02025881|Thiotepa|thiotepa|mesh-list
15039581|NCT02025881|Carboplatin|carboplatin|mesh-list
15039582|NCT02025881|Etoposide|etoposide|mesh-list
15039583|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039584|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
15039585|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039586|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15039587|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15039588|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
15039589|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039590|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039591|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15039592|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15039593|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15039594|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15039595|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039596|NCT02025998|Ibudilast|ibudilast|mesh-list
15039597|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15039598|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
15039599|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039600|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039601|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15039602|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
15039603|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15039604|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039605|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039606|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15039607|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
15039608|NCT02026050|Dexamethasone|dexamethasone|mesh-list
15039609|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
15039610|NCT02026050|BB 1101|bb 1101|mesh-list
15039611|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15039612|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
15039613|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
15039614|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039615|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039616|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15039617|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
15039618|NCT02026050|Hormones|hormones|mesh-ancestor
15039619|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15039620|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15039621|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039622|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
15039623|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039624|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039625|NCT02026219|Clopidogrel|clopidogrel|mesh-list
15039626|NCT02026219|Ticagrelor|ticagrelor|mesh-list
15039627|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15039628|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15039629|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15039630|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15039631|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
15039632|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039633|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039634|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039635|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
15039636|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
15039637|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15039638|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15039639|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039640|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039641|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039642|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15039643|NCT02026310|Metformin|metformin|mesh-list
15039644|NCT02026310|Glimepiride|glimepiride|mesh-list
15039645|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15039646|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039647|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15039648|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039649|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
14243887|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14243888|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14243889|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14243890|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
14243891|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14243892|NCT00201825|Docetaxel|docetaxel|mesh-list
14243893|NCT00201825|Capecitabine|capecitabine|mesh-list
14243894|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243895|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
14243896|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
14243897|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
14243898|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243899|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14243900|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
14243901|NCT00201838|Gemcitabine|gemcitabine|mesh-list
14243902|NCT00201838|Etanercept|etanercept|mesh-list
14243903|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15039650|NCT02026479|Dexamethasone|dexamethasone|mesh-list
15039651|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
15039652|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15039653|NCT02026479|BB 1101|bb 1101|mesh-list
15039654|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15039655|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
15039656|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
15039657|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039658|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039659|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15039660|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
15039661|NCT02026479|Hormones|hormones|mesh-ancestor
15039662|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15039663|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15039664|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039665|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
15039666|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039667|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039668|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
15039669|NCT02026492|Miotics|miotics|mesh-ancestor
15039670|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
15039671|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039672|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039673|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15039674|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
15039675|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
15039676|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15039677|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15039678|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
15039679|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039680|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039681|NCT02026505|Bortezomib|bortezomib|mesh-list
15039682|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243904|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
15039683|NCT02026518|Vitamin D|vitamin d|mesh-list
15039684|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
15039685|NCT02026518|Vitamins|vitamins|mesh-ancestor
15039686|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
15039687|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039688|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15039689|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15039690|NCT02026583|Simvastatin|simvastatin|mesh-list
15039691|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15039692|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15039693|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
15039694|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039695|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15039696|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15039697|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039698|NCT02026765|Heparin|heparin|mesh-list
15039699|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
15039700|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15039701|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15039702|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039703|NCT02026778|Betahistine|betahistine|mesh-list
15039704|NCT02026778|Ondansetron|ondansetron|mesh-list
15039705|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
15039706|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
15039707|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039708|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039709|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15039710|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
15039711|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
15039712|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15039713|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
15039714|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039715|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039716|NCT02026778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15039717|NCT02026778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15039718|NCT02026778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15039719|NCT02026778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15039720|NCT02026778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13969101|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969102|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13969103|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969104|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969105|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13969106|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
13969107|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13969108|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14243905|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243906|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243907|NCT00201838|Antiviral Agents|antiviral agents|mesh-ancestor
14243908|NCT00201838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243909|NCT00201838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243910|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14243911|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
14243912|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243913|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14243914|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15039721|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
15039722|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
15039723|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
15039724|NCT02026817|Metformin|metformin|mesh-list
15039725|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15039726|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15039727|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039728|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15039729|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15039730|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
15039731|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039732|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15039733|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15039734|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039735|NCT02026856|Selenious Acid|selenious acid|mesh-list
15039736|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
15039737|NCT02026856|Trace Elements|trace elements|mesh-ancestor
15039738|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
15039739|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039740|NCT02026869|Metformin|metformin|mesh-list
15039741|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15039742|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039743|NCT02026921|Carboplatin|carboplatin|mesh-list
15039744|NCT02026921|Docetaxel|docetaxel|mesh-list
15039745|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039746|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
15039747|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
15039748|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
15039749|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039750|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
15039751|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
15039752|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039753|NCT02026973|Fulvestrant|fulvestrant|mesh-list
15039754|NCT02026973|Anastrozole|anastrozole|mesh-list
15039755|NCT02026973|Somatostatin|somatostatin|mesh-list
15039756|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15039757|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039758|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15039759|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14243915|NCT00201838|Analgesics|analgesics|mesh-ancestor
14243916|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
14243917|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243918|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14243919|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15039760|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
15039761|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15039762|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969109|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13969110|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
13969111|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13969112|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
13969113|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13969114|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
13969115|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969116|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969117|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13969118|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
13969119|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969120|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969121|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13969122|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
13969123|NCT03106623|Mirabegron|mirabegron|mesh-list
13969124|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13969125|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13969126|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
13969127|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969128|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969129|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969130|NCT03106623|Urological Agents|urological agents|mesh-ancestor
13969131|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13969132|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13969133|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13969134|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
13969135|NCT03106610|Nivolumab|nivolumab|mesh-list
13969136|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13969137|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969138|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13969139|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969140|NCT03106571|Methamphetamine|methamphetamine|mesh-list
13969141|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13969142|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969143|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
13969144|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
14531629|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
15039763|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15039764|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15039765|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039766|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039767|NCT02026973|Hormones|hormones|mesh-ancestor
15039768|NCT02027064|Interferons|interferons|mesh-list
15039769|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
15039770|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039771|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
15039772|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039773|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
15039774|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039775|NCT02027103|Metformin|metformin|mesh-list
15039776|NCT02027103|Pioglitazone|pioglitazone|mesh-list
15039777|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15039778|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039779|NCT02027220|Dexamethasone|dexamethasone|mesh-list
15039780|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
15039781|NCT02027220|Bortezomib|bortezomib|mesh-list
15039782|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039783|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
15039784|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039785|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15039786|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15039787|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
15039788|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039789|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039790|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15039791|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15039792|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
15039793|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
15039794|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039795|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15039796|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
15039797|NCT02027220|Hormones|hormones|mesh-ancestor
15039798|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15039799|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15039800|NCT02027298|Abatacept|abatacept|mesh-list
15039801|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15039802|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039803|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039804|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039805|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
15039806|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039807|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15039808|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
15039809|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
15039810|NCT02027324|Povidone|povidone|mesh-list
15039811|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15039812|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039813|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
15039814|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
15039815|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
15039816|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
15039817|NCT02027337|Drospirenone|drospirenone|mesh-list
15039818|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15039819|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
15039820|NCT02027337|Cyproterone|cyproterone|mesh-list
15039821|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
15039822|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15039823|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15039824|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15039825|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
15039826|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15039827|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039828|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15039829|NCT02027337|Estrogens|estrogens|mesh-ancestor
15039830|NCT02027337|Hormones|hormones|mesh-ancestor
15039831|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15039832|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15039833|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
15039834|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15039835|NCT02027337|Diuretics|diuretics|mesh-ancestor
15039836|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
15039837|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
15039838|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039839|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15039840|NCT02027363|Capecitabine|capecitabine|mesh-list
15039841|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15039842|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
15039843|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039844|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039845|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
15039846|NCT02027454|Cabotegravir|cabotegravir|mesh-list
15039847|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15039848|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039849|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15039850|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15039851|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039852|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039853|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039854|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15039855|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15039856|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15039857|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15039858|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
15039859|NCT02027493|Interferons|interferons|mesh-list
15039860|NCT02027493|Ribavirin|ribavirin|mesh-list
15039861|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
15039862|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
15039863|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15039864|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039865|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
15039866|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039867|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
15039868|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039869|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
15039870|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039871|NCT02027532|Vancomycin|vancomycin|mesh-list
15039872|NCT02027532|Cefazolin|cefazolin|mesh-list
15039873|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15039874|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039875|NCT02027675|Micronutrients|micronutrients|mesh-list
15039876|NCT02027675|Trace Elements|trace elements|mesh-list
15039877|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039878|NCT02027753|Metformin|metformin|mesh-list
15039879|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
15039880|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15039881|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14243920|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14243921|NCT00201851|Tamoxifen|tamoxifen|mesh-list
15039882|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039883|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
15039884|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039885|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039886|NCT02027792|Diclofenac|diclofenac|mesh-list
15039887|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15039888|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15039889|NCT02027792|Analgesics|analgesics|mesh-ancestor
15039890|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
15039891|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15039892|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039893|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15039894|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15039895|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15039896|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039897|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039898|NCT02027870|Sirolimus|sirolimus|mesh-list
15039899|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15039900|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15039901|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15039902|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039903|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
15039904|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039905|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
15039906|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243922|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14243923|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
14243924|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15039907|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
15039908|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
15039909|NCT02027922|Protective Agents|protective agents|mesh-ancestor
15039910|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039911|NCT02027961|Durvalumab|durvalumab|mesh-list
15039912|NCT02027961|Trametinib|trametinib|mesh-list
15039913|NCT02027961|Dabrafenib|dabrafenib|mesh-list
15039914|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15039915|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039916|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15039917|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039918|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039919|NCT02027987|Valproic Acid|valproic acid|mesh-list
15039920|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
15039921|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039922|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039923|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
15039924|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039925|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039926|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
15039927|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15039928|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15039929|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15039930|NCT02028026|Citalopram|citalopram|mesh-list
15039931|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
15039932|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13969145|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969146|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
13969147|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969148|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969149|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
13969150|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13969151|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13969152|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13969153|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13969154|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13969155|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13969156|NCT03106545|Bupivacaine|bupivacaine|mesh-list
15039933|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15039934|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15039935|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039936|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15039937|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
15039938|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039939|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15039940|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
15039941|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15039942|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15039943|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15039944|NCT02028078|Insulin|insulin|mesh-list
15039945|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15039946|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15039947|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039948|NCT02028234|Omeprazole|omeprazole|mesh-list
15039949|NCT02028234|Pantoprazole|pantoprazole|mesh-list
15039950|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15039951|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15039952|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15039953|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039954|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039955|NCT02028260|Modafinil|modafinil|mesh-list
15039956|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15039957|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039958|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15039959|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15039960|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15039961|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039962|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15039963|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
15039964|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
15039965|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15039966|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15039967|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15039968|NCT02028364|Everolimus|everolimus|mesh-list
15039969|NCT02028364|Exemestane|exemestane|mesh-list
15039970|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039971|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039972|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
15039973|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039974|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15039975|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15039976|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039977|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039978|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15039979|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
15039980|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15039981|NCT02028403|BMS-936559|bms-936559|mesh-list
15039982|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15039983|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15039984|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15039985|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
15039986|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039987|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
15039988|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
15039989|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15039990|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15039991|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
15039992|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
15039993|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15039994|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15039995|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15039996|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15039997|NCT02028429|Urological Agents|urological agents|mesh-ancestor
15039998|NCT02028494|Capecitabine|capecitabine|mesh-list
15039999|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15040000|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
15040001|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040002|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040003|NCT02028507|Capecitabine|capecitabine|mesh-list
15040004|NCT02028507|Fulvestrant|fulvestrant|mesh-list
15040005|NCT02028507|Palbociclib|palbociclib|mesh-list
15040006|NCT02028507|Exemestane|exemestane|mesh-list
15040007|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15040008|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
15040009|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040010|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040011|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15040012|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15040013|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15040014|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
15040015|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15040016|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040017|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15040018|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040019|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15040020|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15040021|NCT02028533|Oxytocin|oxytocin|mesh-list
15040022|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
15040023|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15040024|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040025|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
15040026|NCT02028598|Clomipramine|clomipramine|mesh-list
15040027|NCT02028598|Citric Acid|citric acid|mesh-list
15040028|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
15040029|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
15040030|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15040031|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
15040032|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
15040033|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040034|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
15040035|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15040036|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15040037|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040038|NCT02028598|Urological Agents|urological agents|mesh-ancestor
15040039|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15040040|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
15040041|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15040042|NCT02028598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15040043|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15040044|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15040045|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040046|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
15040047|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040048|NCT02028663|Esomeprazole|esomeprazole|mesh-list
15040049|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15040050|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15040051|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15040052|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040053|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040054|NCT02028689|Metformin|metformin|mesh-list
15040055|NCT02028689|Lesinurad|lesinurad|mesh-list
15040056|NCT02028689|Furosemide|furosemide|mesh-list
15040057|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15040058|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040059|NCT02028689|Diuretics|diuretics|mesh-ancestor
15040060|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
15040061|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15040062|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15040063|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040064|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
15040065|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15040066|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
15040067|NCT02028689|Renal Agents|renal agents|mesh-ancestor
15040068|NCT02028806|Leucovorin|leucovorin|mesh-list
15040069|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
15040070|NCT02028806|Irinotecan|irinotecan|mesh-list
15040071|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040072|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15040073|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15040074|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040075|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040076|NCT02028806|Antidotes|antidotes|mesh-ancestor
15040077|NCT02028806|Protective Agents|protective agents|mesh-ancestor
15040078|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040079|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
15040080|NCT02028806|Vitamins|vitamins|mesh-ancestor
15040081|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
15040082|NCT02028819|Dolutegravir|dolutegravir|mesh-list
13969157|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
13969158|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
13969159|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969160|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969161|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
13969162|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969163|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
13969164|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13969165|NCT03106454|Norethindrone|norethindrone|mesh-list
13969166|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
13969167|NCT03106454|Estradiol|estradiol|mesh-list
13969168|NCT03106454|Estrogens|estrogens|mesh-ancestor
13969169|NCT03106454|Hormones|hormones|mesh-ancestor
14243925|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040083|NCT02028819|Ibalizumab|ibalizumab|mesh-list
15040084|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15040085|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15040086|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040087|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040088|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15040089|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15040090|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
15040091|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040092|NCT02028910|Ondansetron|ondansetron|mesh-list
15040093|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
15040094|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
15040095|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040096|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040097|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15040098|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
15040099|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
15040100|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15040101|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
15040102|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040103|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040104|NCT02028910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15040105|NCT02028910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15040106|NCT02028910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15040107|NCT02028910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15040108|NCT02028910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15040109|NCT02028923|Morphine|morphine|mesh-list
15040110|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15040111|NCT02028923|Narcotics|narcotics|mesh-ancestor
15040112|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15040113|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040114|NCT02028923|Analgesics|analgesics|mesh-ancestor
15040115|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
15040116|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040117|NCT02028949|Idarubicin|idarubicin|mesh-list
15040118|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15040119|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040120|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15040121|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15040122|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040123|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040124|NCT02029001|Everolimus|everolimus|mesh-list
15040125|NCT02029001|Sorafenib|sorafenib|mesh-list
15040126|NCT02029001|Durvalumab|durvalumab|mesh-list
15040127|NCT02029001|Olaparib|olaparib|mesh-list
15040128|NCT02029001|Lapatinib|lapatinib|mesh-list
15040129|NCT02029001|Tremelimumab|tremelimumab|mesh-list
15040130|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040131|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15040132|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
15040133|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040134|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15040135|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040136|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040137|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15040138|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15040139|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
15040140|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15040141|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
15040142|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040143|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
15040144|NCT02029105|Protective Agents|protective agents|mesh-ancestor
15040145|NCT02029118|Aspirin|aspirin|mesh-list
15040146|NCT02029118|Metoprolol|metoprolol|mesh-list
15040147|NCT02029118|Ramipril|ramipril|mesh-list
15040148|NCT02029118|Atorvastatin|atorvastatin|mesh-list
15040149|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15040150|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15040151|NCT02029118|Analgesics|analgesics|mesh-ancestor
15040152|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
15040153|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040154|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040155|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15040156|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15040157|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15040158|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15040159|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040160|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15040161|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15040162|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040163|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
15040164|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15040165|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15040166|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
15040167|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15040168|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15040169|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15040170|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15040171|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
15040172|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
15040173|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15040174|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15040175|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15040176|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
15040177|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040178|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15040179|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
15040180|NCT02029313|Montelukast|montelukast|mesh-list
15040181|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15040182|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
15040183|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15040184|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
15040185|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15040186|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040187|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15040188|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15040189|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040190|NCT02029378|Eculizumab|eculizumab|mesh-list
15040191|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15040192|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15040193|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
15040194|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040195|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15040196|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15040197|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15040198|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040199|NCT02029482|Ponesimod|ponesimod|mesh-list
15040200|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15040201|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040202|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15040203|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
15040204|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040205|NCT02029534|Atorvastatin|atorvastatin|mesh-list
15040206|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15040207|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15040208|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
15040209|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040210|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15040211|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15040212|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969170|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13969171|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969172|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13969173|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
13969174|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13969175|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13969176|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13969177|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13969178|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13969179|NCT03106454|Trace Elements|trace elements|mesh-ancestor
13969180|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
13969181|NCT03106363|Ethanol|ethanol|mesh-list
13969182|NCT03106363|Dronabinol|dronabinol|mesh-list
13969183|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13969184|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969185|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969186|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040213|NCT02029573|Temozolomide|temozolomide|mesh-list
15040214|NCT02029573|Atorvastatin|atorvastatin|mesh-list
15040215|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15040216|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15040217|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
15040218|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040219|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15040220|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15040221|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040222|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15040223|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
15040224|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040225|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
15040226|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040227|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15040228|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15040229|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040230|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040231|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
15040232|NCT02029599|Acetaminophen|acetaminophen|mesh-list
15040233|NCT02029599|Methotrexate|methotrexate|mesh-list
15040234|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15040235|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
15040236|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15040237|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040238|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15040239|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
15040240|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040241|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040242|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
15040243|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040244|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15040245|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15040246|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
13969187|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
15040247|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15040248|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15040249|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15040250|NCT02029599|Analgesics|analgesics|mesh-ancestor
15040251|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
15040252|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040253|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
15040254|NCT02029612|Nicotine|nicotine|mesh-list
15040255|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15040256|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
15040257|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040258|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040259|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15040260|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15040261|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
15040262|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040263|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040264|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15040265|NCT02029625|Ezetimibe|ezetimibe|mesh-list
15040266|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15040267|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15040268|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
15040269|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040270|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15040271|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15040272|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040273|NCT02029794|Acetic Acid|acetic acid|mesh-list
15040274|NCT02029794|Retinol acetate|retinol acetate|mesh-list
15040275|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15040276|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040277|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15040278|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
15040279|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040280|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15040281|NCT02029794|Protective Agents|protective agents|mesh-ancestor
15040282|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040283|NCT02029898|Remifentanil|remifentanil|mesh-list
15040284|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15040285|NCT02029898|Narcotics|narcotics|mesh-ancestor
15040286|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15040287|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040288|NCT02029898|Analgesics|analgesics|mesh-ancestor
15040289|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
15040290|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040291|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
15040292|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15040293|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040294|NCT02029937|Proflavine|proflavine|mesh-list
15040295|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15040296|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040297|NCT02029950|Cytarabine|cytarabine|mesh-list
15040298|NCT02029950|Etoposide|etoposide|mesh-list
15040299|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
15040300|NCT02029950|Daunorubicin|daunorubicin|mesh-list
15040301|NCT02029950|Idarubicin|idarubicin|mesh-list
15040302|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
15040303|NCT02029950|Pomalidomide|pomalidomide|mesh-list
15040304|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15040305|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040306|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15040307|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15040308|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040309|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040310|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15040311|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
15040312|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
15040313|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040314|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15040315|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
15040316|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040317|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15040318|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15040319|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15040320|NCT02029950|Growth Substances|growth substances|mesh-ancestor
15040321|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
15040322|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
15040323|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
15040324|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
15040325|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
15040326|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
15040327|NCT02030054|Atorvastatin|atorvastatin|mesh-list
15040328|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15040329|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15040330|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15040331|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
15040332|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040333|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15040334|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15040335|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040336|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
15040337|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15040338|NCT02030314|Diuretics|diuretics|mesh-ancestor
15040339|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
15040340|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040341|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15040342|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15040343|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040344|NCT02030483|Dexamethasone|dexamethasone|mesh-list
15040345|NCT02030483|Lenalidomide|lenalidomide|mesh-list
15040346|NCT02030483|Palbociclib|palbociclib|mesh-list
15040347|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15040348|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
15040349|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
15040350|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040351|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040352|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15040353|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
15040354|NCT02030483|Hormones|hormones|mesh-ancestor
15040355|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15040356|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15040357|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040358|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
15040359|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15040360|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15040361|NCT02030483|Growth Substances|growth substances|mesh-ancestor
15040362|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
15040363|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15040364|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040365|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040366|NCT02030561|Trastuzumab|trastuzumab|mesh-list
15040367|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15040368|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040369|NCT02030639|ON 01910|on 01910|mesh-list
15040370|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040371|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15040372|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040373|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040374|NCT02030678|Irinotecan|irinotecan|mesh-list
15040375|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13969188|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15040376|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15040377|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040378|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040379|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040380|NCT02030717|Clonidine|clonidine|mesh-list
15040381|NCT02030717|Anesthetics|anesthetics|mesh-list
15040382|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15040383|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040384|NCT02030717|Analgesics|analgesics|mesh-ancestor
15040385|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
15040386|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040387|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15040388|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
15040389|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
15040390|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15040391|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15040392|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15040393|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
15040394|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040395|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040396|NCT02030912|Amoxicillin|amoxicillin|mesh-list
15040397|NCT02030912|Minocycline|minocycline|mesh-list
15040398|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15040399|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040400|NCT02030964|Eflornithine|eflornithine|mesh-list
15040401|NCT02030964|Celecoxib|celecoxib|mesh-list
15040402|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
15040403|NCT02030964|Topotecan|topotecan|mesh-list
15040404|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15040405|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
15040406|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040407|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15040408|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15040409|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
15040410|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040411|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040412|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15040413|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15040414|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15040415|NCT02030964|Analgesics|analgesics|mesh-ancestor
15040416|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
15040417|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040418|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15040419|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15040420|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15040421|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040422|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15040423|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15040424|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15040425|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15040426|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15040427|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040428|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
15040429|NCT02030977|Resveratrol|resveratrol|mesh-list
15040430|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
15040431|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040432|NCT02030977|Protective Agents|protective agents|mesh-ancestor
15040433|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040434|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040435|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15040436|NCT02031016|Fentanyl|fentanyl|mesh-list
15040437|NCT02031016|Remifentanil|remifentanil|mesh-list
15040438|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15040439|NCT02031016|Narcotics|narcotics|mesh-ancestor
15040440|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15040441|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040442|NCT02031016|Analgesics|analgesics|mesh-ancestor
15040443|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
15040444|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040445|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15040446|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15040447|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
15040448|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
15040449|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15040450|NCT02031081|Prucalopride|prucalopride|mesh-list
15040451|NCT02031081|Laxatives|laxatives|mesh-ancestor
15040452|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15040453|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
15040454|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15040455|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
15040456|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040457|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040458|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040459|NCT02031211|Etanercept|etanercept|mesh-list
15040460|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15040461|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15040462|NCT02031211|Analgesics|analgesics|mesh-ancestor
15040463|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
15040464|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040465|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040466|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15040467|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15040468|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15040469|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15040470|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
15040471|NCT02031289|Folic Acid|folic acid|mesh-list
15040472|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
15040473|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
15040474|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
15040475|NCT02031289|Vitamins|vitamins|mesh-ancestor
15040476|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
15040477|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040478|NCT02031289|Hematinics|hematinics|mesh-ancestor
15040479|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
13969189|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15040480|NCT02031367|Triamcinolone|triamcinolone|mesh-list
15040481|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15040482|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15040483|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15040484|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15040485|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
15040486|NCT02031367|Hormones|hormones|mesh-ancestor
15040487|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15040488|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040489|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15040490|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
15040491|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040492|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040493|NCT02031419|Rituximab|rituximab|mesh-list
15040494|NCT02031419|Spebrutinib|spebrutinib|mesh-list
15040495|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15040496|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040497|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
15040498|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040499|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15040500|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15040501|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040502|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040503|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
15040504|NCT02031510|Bupivacaine|bupivacaine|mesh-list
15040505|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
15040506|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
15040507|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15040508|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040509|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
15040510|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040511|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15040512|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15040513|NCT02031510|Analgesics|analgesics|mesh-ancestor
15040514|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15040515|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15040516|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15040517|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
15040518|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040519|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040520|NCT02031523|Analgesics|analgesics|mesh-list
15040521|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
15040522|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040523|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040524|NCT02031601|Carboplatin|carboplatin|mesh-list
15040525|NCT02031601|Docetaxel|docetaxel|mesh-list
15040526|NCT02031601|Pemetrexed|pemetrexed|mesh-list
15040527|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15040528|NCT02031601|Gefitinib|gefitinib|mesh-list
15040529|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040530|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
15040531|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
15040532|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
15040533|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040534|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040535|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15040536|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15040537|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14243926|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15040538|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
15040539|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
15040540|NCT02031692|Calcium|calcium|mesh-list
15040541|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15040542|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040543|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15040544|NCT02031692|Vitamins|vitamins|mesh-ancestor
15040545|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
15040546|NCT02031692|Antacids|antacids|mesh-ancestor
15040547|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040548|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15040549|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15040550|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
15040551|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040552|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15040553|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040554|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15040555|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040556|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040557|NCT02031861|Nifedipine|nifedipine|mesh-list
15040558|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15040559|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15040560|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040561|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15040562|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040563|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
15040564|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
15040565|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15040566|NCT02031939|Capecitabine|capecitabine|mesh-list
15040567|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
15040568|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15040569|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
15040570|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040571|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040572|NCT02031965|Dexamethasone|dexamethasone|mesh-list
15040573|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15040574|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
15040575|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
15040576|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040577|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040578|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15040579|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
15040580|NCT02031965|Hormones|hormones|mesh-ancestor
15040581|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15040582|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15040583|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040584|NCT02031991|Bevacizumab|bevacizumab|mesh-list
15040585|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15040586|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040587|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15040588|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15040589|NCT02031991|Growth Substances|growth substances|mesh-ancestor
15040590|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040591|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
15040592|NCT02032043|Ivermectin|ivermectin|mesh-list
15040593|NCT02032043|Albendazole|albendazole|mesh-list
15040594|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15040595|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040596|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
15040597|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
15040598|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15040599|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15040600|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
15040601|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
15040602|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
13969190|NCT03106363|Analgesics|analgesics|mesh-ancestor
13969191|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
13969192|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969193|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13969194|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13969195|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969196|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969197|NCT03106363|Hormones|hormones|mesh-ancestor
13969198|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13969199|NCT03106519|Bupivacaine|bupivacaine|mesh-list
13969200|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
13969201|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
13969202|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969203|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969204|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
13969205|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040603|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040604|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040605|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
15040606|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15040607|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
15040608|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15040609|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
15040610|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040611|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
15040612|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15040613|NCT02032134|Protective Agents|protective agents|mesh-ancestor
15040614|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040615|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15040616|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
15040617|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040618|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
15040619|NCT02032186|Cathartics|cathartics|mesh-ancestor
15040620|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13969206|NCT03106389|Misoprostol|misoprostol|mesh-list
14243927|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243928|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14243929|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13969207|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15040621|NCT02032290|Clopidogrel|clopidogrel|mesh-list
15040622|NCT02032290|Ticagrelor|ticagrelor|mesh-list
14243930|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14243931|NCT00201864|Fulvestrant|fulvestrant|mesh-list
14243932|NCT00201864|Exemestane|exemestane|mesh-list
14243933|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14243934|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243935|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14243936|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14243937|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
14243938|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14243939|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243940|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14243941|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14243942|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243943|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243944|NCT00201877|Rituximab|rituximab|mesh-list
14243945|NCT00201877|Bortezomib|bortezomib|mesh-list
14243946|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14243947|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243948|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
14243949|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243950|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14243951|NCT00202449|Prazosin|prazosin|mesh-list
14243952|NCT00202449|Paroxetine|paroxetine|mesh-list
14243953|NCT00202449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14243954|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14243955|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14243956|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243957|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14243958|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
14243959|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243960|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14243961|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
14243962|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14243963|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15040623|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15040624|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15040625|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15040626|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15040627|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
15040628|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040629|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040630|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040631|NCT02032303|Ticagrelor|ticagrelor|mesh-list
15040632|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15040633|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15040634|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15040635|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15040636|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15040637|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
15040638|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040639|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040640|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040641|NCT02032355|Anesthetics|anesthetics|mesh-list
15040642|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15040643|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040644|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
15040645|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15040646|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
15040647|NCT02032394|Povidone|povidone|mesh-list
15040648|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15040649|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040650|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
15040651|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
15040652|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
15040653|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
15040654|NCT02032654|Floxacillin|floxacillin|mesh-list
15040655|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15040656|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040657|NCT02032784|Octreotide|octreotide|mesh-list
15040658|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15040659|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15040660|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040661|NCT02032797|Progesterone|progesterone|mesh-list
15040662|NCT02032797|Progestins|progestins|mesh-ancestor
15040663|NCT02032797|Hormones|hormones|mesh-ancestor
15040664|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15040665|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040666|NCT02032836|Iloprost|iloprost|mesh-list
15040667|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15040668|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
15040669|NCT02032927|Acetaminophen|acetaminophen|mesh-list
15040670|NCT02032927|Oxycodone|oxycodone|mesh-list
15040671|NCT02032927|Codeine|codeine|mesh-list
15040672|NCT02032927|Naloxone|naloxone|mesh-list
15040673|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15040674|NCT02032927|Analgesics|analgesics|mesh-ancestor
15040675|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
15040676|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040677|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040678|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
15040679|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15040680|NCT02032927|Narcotics|narcotics|mesh-ancestor
15040681|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15040682|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15040683|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
15040684|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
15040685|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
15040686|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15040687|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15040688|NCT02033018|Aflibercept|aflibercept|mesh-list
15040689|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15040690|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15040691|NCT02033018|Growth Substances|growth substances|mesh-ancestor
15040692|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040693|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
15040694|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040695|NCT02033031|Bevacizumab|bevacizumab|mesh-list
15040696|NCT02033031|Ranibizumab|ranibizumab|mesh-list
15040697|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15040698|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040699|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15040700|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15040701|NCT02033031|Growth Substances|growth substances|mesh-ancestor
15040702|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040703|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
15040704|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
15040705|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040706|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040707|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
15040708|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15040709|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040710|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
15040711|NCT02033239|Insulin|insulin|mesh-list
15040712|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15040713|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
15040714|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
15040715|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15040716|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15040717|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040718|NCT02033356|Lidocaine|lidocaine|mesh-list
15040719|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
15040720|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
15040721|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15040722|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040723|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
15040724|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040725|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15040726|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15040727|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15040728|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15040729|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040730|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15040731|NCT02033408|Amoxicillin|amoxicillin|mesh-list
15040732|NCT02033408|Metronidazole|metronidazole|mesh-list
15040733|NCT02033408|Vancomycin|vancomycin|mesh-list
15040734|NCT02033408|Doxycycline|doxycycline|mesh-list
15040735|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
15040736|NCT02033408|Gentamicins|gentamicins|mesh-list
15040737|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040738|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15040739|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15040740|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
15040741|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13969208|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
13969209|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13969210|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969211|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13969212|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13969213|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
13969214|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13969215|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13969216|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040742|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15040743|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040744|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040745|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040746|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15040747|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15040748|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15040749|NCT02033434|Ketamine|ketamine|mesh-list
15040750|NCT02033434|Analgesics|analgesics|mesh-ancestor
15040751|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
15040752|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040753|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040754|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15040755|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15040756|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
15040757|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
15040758|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15040759|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13969217|NCT03106402|Bromfenac|bromfenac|mesh-list
14243964|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15040760|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15040761|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040762|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040763|NCT02033512|Hormones|hormones|mesh-list
15040764|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15040765|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040766|NCT02033538|Paclitaxel|paclitaxel|mesh-list
15040767|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15040768|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15040769|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040770|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
15040771|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
15040772|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
15040773|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040774|NCT02033551|Paclitaxel|paclitaxel|mesh-list
15040775|NCT02033551|Carboplatin|carboplatin|mesh-list
15040776|NCT02033551|Veliparib|veliparib|mesh-list
15040777|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15040778|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040779|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
15040780|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
15040781|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
15040782|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040783|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15040784|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040785|NCT02033603|Ropivacaine|ropivacaine|mesh-list
15040786|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
15040787|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
15040788|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15040789|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040790|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
15040791|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040792|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15040793|NCT02033707|Scopolamine|scopolamine|mesh-list
15040794|NCT02033707|Hallucinogens|hallucinogens|mesh-list
15040795|NCT02033707|Nicotine|nicotine|mesh-list
15040796|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15040797|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
15040798|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040799|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040800|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15040801|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15040802|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
15040803|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040804|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040805|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15040806|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
15040807|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15040808|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
15040809|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15040810|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15040811|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15040812|NCT02033733|Cisatracurium|cisatracurium|mesh-list
15040813|NCT02033733|Atracurium|atracurium|mesh-list
15040814|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
15040815|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15040816|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040817|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969218|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13969219|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13969220|NCT03106402|Analgesics|analgesics|mesh-ancestor
13969221|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
13969222|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969223|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969224|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13969225|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969226|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
13969227|NCT03106298|Hematinics|hematinics|mesh-ancestor
13969228|NCT03106324|Lenalidomide|lenalidomide|mesh-list
13969229|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
13969230|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969231|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13969232|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13969233|NCT03106324|Growth Substances|growth substances|mesh-ancestor
13969234|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
13969235|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969236|NCT03105830|Acetaminophen|acetaminophen|mesh-list
13969237|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13969238|NCT03105830|Analgesics|analgesics|mesh-ancestor
13969239|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
13969240|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969241|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969242|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
13969243|NCT03105986|Probenecid|probenecid|mesh-list
13969244|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
13969245|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
13969246|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969247|NCT03105986|Renal Agents|renal agents|mesh-ancestor
13969248|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
13969249|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13969250|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969251|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
13969252|NCT03105661|Atenolol|atenolol|mesh-list
13969253|NCT03105661|Labetalol|labetalol|mesh-list
13969254|NCT03105661|Nifedipine|nifedipine|mesh-list
13969255|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13969256|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13969257|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969258|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13969259|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969260|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
13969261|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
13969262|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13969263|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13969264|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13969265|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
13969266|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
13969267|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969268|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13969269|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15040818|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15040819|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15040820|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15040821|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
15040822|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040823|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040824|NCT02033798|Tamsulosin|tamsulosin|mesh-list
15040825|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15040826|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15040827|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15040828|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
15040829|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040830|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969270|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13969271|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
13969272|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040831|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040832|NCT02033798|Urological Agents|urological agents|mesh-ancestor
15040833|NCT02033941|Phenol|phenol|mesh-list
15040834|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15040835|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040836|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
15040837|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15040838|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15040839|NCT02033967|Milrinone|milrinone|mesh-list
15040840|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
15040841|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15040842|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15040843|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15040844|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15040845|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040846|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040847|NCT02033967|Protective Agents|protective agents|mesh-ancestor
15040848|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040849|NCT02034071|Diazoxide|diazoxide|mesh-list
15040850|NCT02034071|Choline|choline|mesh-list
15040851|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
15040852|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15040853|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
15040854|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040855|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15040856|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15040857|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
15040858|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15040859|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
15040860|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15040861|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040862|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15040863|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040864|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040865|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15040866|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15040867|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040868|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15040869|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15040870|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15040871|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040872|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
15040873|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040874|NCT02034253|Risperidone|risperidone|mesh-list
15040875|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15040876|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
15040877|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040878|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040879|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040880|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15040881|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15040882|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15040883|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15040884|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15040885|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
15040886|NCT02034292|Aspirin|aspirin|mesh-list
15040887|NCT02034292|Clopidogrel|clopidogrel|mesh-list
15040888|NCT02034292|APD791|apd791|mesh-list
15040889|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15040890|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15040891|NCT02034292|Analgesics|analgesics|mesh-ancestor
15040892|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
15040893|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15040894|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040895|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15040896|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15040897|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15040898|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15040899|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040900|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15040901|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15040902|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040903|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
15040904|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15040905|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15040906|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14243965|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531630|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14531631|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
14531632|NCT02429583|Vaccines|vaccines|mesh-list
14531633|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
14531634|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531635|NCT02417870|Aldesleukin|aldesleukin|mesh-list
14531636|NCT02417870|Interleukin-2|interleukin-2|mesh-list
14531637|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531638|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14531639|NCT02417870|Analgesics|analgesics|mesh-ancestor
14531640|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
14531641|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531642|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531643|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14531644|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14531645|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
14531646|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531647|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14531648|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
14531649|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531650|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
14531651|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531652|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14531653|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
14531654|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531655|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
14531656|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531657|NCT02413047|Methotrexate|methotrexate|mesh-list
14531658|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
14243966|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14243967|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14243968|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14243969|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14243970|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
14243971|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
14243972|NCT00202644|Anagrelide|anagrelide|mesh-list
14243973|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14243974|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
14243975|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14243976|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243977|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13969273|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
13969274|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13969275|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14243978|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14243979|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14243980|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14243981|NCT00202722|Remifentanil|remifentanil|mesh-list
14243982|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14243983|NCT00202722|Narcotics|narcotics|mesh-ancestor
14243984|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14243985|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243986|NCT00202722|Analgesics|analgesics|mesh-ancestor
14243987|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
14243988|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14243989|NCT00202839|Ribavirin|ribavirin|mesh-list
14243990|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14243991|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
14243992|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
14243993|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14243994|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
14243995|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14243996|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
14243997|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14243998|NCT00202930|Rituximab|rituximab|mesh-list
14243999|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14244000|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244001|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
14244002|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244003|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14244004|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
14244005|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
14244006|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14244007|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
14244008|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244009|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244010|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14244011|NCT00203047|Prednisone|prednisone|mesh-list
14244012|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
14244013|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
14244014|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14244015|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
14244016|NCT00203047|Hormones|hormones|mesh-ancestor
14244017|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244018|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244019|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14244020|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244021|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14244022|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
14244023|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244024|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14244025|NCT00203216|Levetiracetam|levetiracetam|mesh-list
14244026|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
14244027|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
14244028|NCT00203229|Lamotrigine|lamotrigine|mesh-list
14244029|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
14244030|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14244031|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15040907|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
15040908|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040909|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15040910|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15040911|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
15040912|NCT02034331|Acetylcholine|acetylcholine|mesh-list
15040913|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040914|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
15040915|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15040916|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
15040917|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969276|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
13969277|NCT03105791|Narcotics|narcotics|mesh-ancestor
13969278|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969279|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969280|NCT03105791|Analgesics|analgesics|mesh-ancestor
13969281|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
15040918|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040919|NCT02034500|Vaccines|vaccines|mesh-list
15040920|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
15040921|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040922|NCT02034604|Tamsulosin|tamsulosin|mesh-list
15040923|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15040924|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15040925|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15040926|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
15040927|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15040928|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040929|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040930|NCT02034604|Urological Agents|urological agents|mesh-ancestor
15040931|NCT02034630|Busulfan|busulfan|mesh-list
15040932|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
15040933|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040934|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15040935|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
15040936|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040937|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15040938|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040939|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13969282|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969283|NCT03105674|Anesthetics|anesthetics|mesh-list
13969284|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
13969285|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969286|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969287|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
13969288|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969289|NCT03105765|Ketamine|ketamine|mesh-list
13969290|NCT03105765|Analgesics|analgesics|mesh-ancestor
13969291|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
13969292|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969293|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969294|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13969295|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13969296|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
13969297|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
13969298|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969299|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13969300|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13969301|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969302|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969303|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
13969304|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13969305|NCT03105505|Permethrin|permethrin|mesh-list
13969306|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13969307|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969308|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969309|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13969310|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969311|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13969312|NCT03105193|Lidocaine|lidocaine|mesh-list
13969313|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
13969314|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
13969315|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969316|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969317|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
13969318|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969319|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13969320|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13969321|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13969322|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13969323|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969324|NCT03105310|Interferons|interferons|mesh-list
13969325|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
13969326|NCT03105310|Ezetimibe|ezetimibe|mesh-list
13969327|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969328|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
13969329|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969330|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
13969331|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969332|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13969333|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13969334|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
14244032|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969335|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969336|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13969337|NCT03105583|Vitamins|vitamins|mesh-list
13969338|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
13969339|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969340|NCT03105180|Mannitol|mannitol|mesh-list
13969341|NCT03105180|Sorbitol|sorbitol|mesh-list
13969342|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13969343|NCT03105180|Diuretics|diuretics|mesh-ancestor
13969344|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
13969345|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969346|NCT03105180|Cathartics|cathartics|mesh-ancestor
15040940|NCT02034838|Ritonavir|ritonavir|mesh-list
15040941|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15040942|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15040943|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15040944|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
15040945|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040946|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040947|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15040948|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15040949|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
15040950|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040951|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15040952|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15040953|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
15040954|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13969347|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15040955|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
14244033|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14244034|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244035|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14244036|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14244037|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244038|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14244039|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14244040|NCT00203242|Valproic Acid|valproic acid|mesh-list
14244041|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
14244042|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244043|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244044|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
14244045|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244046|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244047|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
14244048|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14244049|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244050|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14244051|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
14244052|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14244053|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
14244054|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
14244055|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244056|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244057|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244058|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14244059|NCT00203268|Analgesics|analgesics|mesh-ancestor
14244060|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
14244061|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14244062|NCT00203294|Triamcinolone|triamcinolone|mesh-list
14244063|NCT00203294|Lidocaine|lidocaine|mesh-list
14244064|NCT00203294|Bupivacaine|bupivacaine|mesh-list
14244065|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
14244066|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
14244067|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244068|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244069|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
14244070|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14244071|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14244072|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14244073|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14244074|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14244075|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244076|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14244077|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
14244078|NCT00203294|Hormones|hormones|mesh-ancestor
14244079|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244080|NCT00203307|Olanzapine|olanzapine|mesh-list
14244081|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
14244082|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
14244083|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14244084|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244085|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14244086|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14244087|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14244088|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244089|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14244090|NCT00203307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14244091|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14244092|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14244093|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244094|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244095|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
14244096|NCT00203411|Bevacizumab|bevacizumab|mesh-list
14244097|NCT00203411|Capecitabine|capecitabine|mesh-list
14244098|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14244099|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244100|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14244101|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14244102|NCT00203411|Growth Substances|growth substances|mesh-ancestor
14244103|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244104|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
14531659|NCT02413047|Azathioprine|azathioprine|mesh-list
15040956|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040957|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
15040958|NCT02034890|Protective Agents|protective agents|mesh-ancestor
15040959|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
15040960|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15040961|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040962|NCT02034981|Crizotinib|crizotinib|mesh-list
15040963|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040964|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15040965|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040966|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040967|NCT02035020|Interferons|interferons|mesh-list
15040968|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
15040969|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040970|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
15040971|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040972|NCT02035072|Gemcitabine|gemcitabine|mesh-list
15040973|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
15040974|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15040975|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
15040976|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040977|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15040978|NCT02035072|Antiviral Agents|antiviral agents|mesh-ancestor
15040979|NCT02035072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15040980|NCT02035072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040981|NCT02035072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15040982|NCT02035072|Immunologic Factors|immunologic factors|mesh-ancestor
15040983|NCT02035072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040984|NCT02035215|Atorvastatin|atorvastatin|mesh-list
13969348|NCT03105115|Fentanyl|fentanyl|mesh-list
13969349|NCT03105115|Bupivacaine|bupivacaine|mesh-list
13969350|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
13969351|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
13969352|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969353|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969354|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
13969355|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969356|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13969357|NCT03105115|Narcotics|narcotics|mesh-ancestor
13969358|NCT03105115|Analgesics|analgesics|mesh-ancestor
13969359|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13969360|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13969361|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
13969362|NCT03105349|Ribavirin|ribavirin|mesh-list
13969363|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
13969364|NCT03105349|Grazoprevir|grazoprevir|mesh-list
13969365|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
13969366|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969367|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
13969368|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969369|NCT03105245|Thiopental|thiopental|mesh-list
13969370|NCT03105245|Anesthetics|anesthetics|mesh-list
13969371|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969372|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969373|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
13969374|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13969375|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13969376|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
13969377|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
13969378|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
13969379|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969380|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969381|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
13969382|NCT03105336|Fludarabine|fludarabine|mesh-list
13969383|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13969384|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
13969385|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969386|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969387|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13969388|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
13969389|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969390|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969391|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13969392|NCT03105375|Omeprazole|omeprazole|mesh-list
13969393|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13969394|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13969395|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13969396|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969397|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969398|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
13969399|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13969400|NCT03105466|Tacrolimus|tacrolimus|mesh-list
13969401|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13969402|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
13969403|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969404|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13969405|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969406|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969407|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13969408|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13969409|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13969410|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969411|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
13969412|NCT03105466|Hormones|hormones|mesh-ancestor
13969413|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13969414|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13969415|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
13969416|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969417|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
13969418|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13969419|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
13969420|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969421|NCT03104959|Expectorants|expectorants|mesh-ancestor
13969422|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
13969423|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13969424|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
13969425|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969426|NCT03104959|Protective Agents|protective agents|mesh-ancestor
13969427|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969428|NCT03104959|Antidotes|antidotes|mesh-ancestor
13969429|NCT03104998|Ubiquinone|ubiquinone|mesh-list
15040985|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15040986|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15040987|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
15040988|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15040989|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14244105|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14244106|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
14244107|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244108|NCT00203424|Bevacizumab|bevacizumab|mesh-list
14244109|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14531660|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14531661|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
14531662|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14531663|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531664|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14531665|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
14531666|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531667|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531668|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
14531669|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531670|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14531671|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244110|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14244111|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244112|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14244113|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14531672|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
13969430|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
13969431|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
13969432|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969433|NCT03104998|Vitamins|vitamins|mesh-ancestor
13969434|NCT03104790|Vaccines|vaccines|mesh-list
13969435|NCT03104790|Immunologic Factors|immunologic factors|mesh-ancestor
13969436|NCT03104790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969437|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
13969438|NCT03104855|Calcifediol|calcifediol|mesh-list
13969439|NCT03104855|Vitamins|vitamins|mesh-ancestor
13969440|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
13969441|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969442|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13969443|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
13969444|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13969445|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969446|NCT03104634|Bromides|bromides|mesh-list
13969447|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
13969448|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13969449|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
13969450|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969451|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969452|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13969453|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
13969454|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13969455|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13969456|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13969457|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
13969458|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969459|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969460|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
13969461|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
13969462|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13969463|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969464|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13969465|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
13969466|NCT03104426|Hematinics|hematinics|mesh-ancestor
13969467|NCT03104439|Nivolumab|nivolumab|mesh-list
13969468|NCT03104439|Ipilimumab|ipilimumab|mesh-list
15040990|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15040991|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15040992|NCT02035371|Insulin|insulin|mesh-list
15040993|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15040994|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
15040995|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
15040996|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15040997|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15040998|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15040999|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
15041000|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15041001|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15041002|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15041003|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15041004|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041005|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
15041006|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041007|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041008|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15041009|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041010|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15041011|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15041012|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15041013|NCT02035488|Tobramycin|tobramycin|mesh-list
15041014|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15041015|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969469|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15041016|NCT02035527|Docetaxel|docetaxel|mesh-list
13969470|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969471|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13969472|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969473|NCT03104335|Apatinib|apatinib|mesh-list
13969474|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969475|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13969476|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969477|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969478|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
13969479|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13969480|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
13969481|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13969482|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969483|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13969484|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13969485|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13969486|NCT03104140|Ketamine|ketamine|mesh-list
13969487|NCT03104140|Thiopental|thiopental|mesh-list
13969488|NCT03104140|Analgesics|analgesics|mesh-ancestor
13969489|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
13969490|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969491|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969492|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13969493|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13969494|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
13969495|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
13969496|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969497|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13969498|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13969499|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969500|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969501|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
13969502|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13969503|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
13969504|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
14244114|NCT00203424|Growth Substances|growth substances|mesh-ancestor
14244115|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244116|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
14244117|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14244118|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244119|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244120|NCT00203476|Niacin|niacin|mesh-list
14244121|NCT00203476|Ezetimibe|ezetimibe|mesh-list
14244122|NCT00203476|Colestipol|colestipol|mesh-list
14244123|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14244124|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14244125|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
14244126|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244127|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14244128|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
14244129|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
14244130|NCT00203476|Vitamins|vitamins|mesh-ancestor
14244131|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
14531673|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969505|NCT03104010|Hormones|hormones|mesh-list
14244132|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969506|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041017|NCT02035527|Sorafenib|sorafenib|mesh-list
15041018|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041019|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
15041020|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
15041021|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
15041022|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041023|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15041024|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041025|NCT02035709|Hydromorphone|hydromorphone|mesh-list
15041026|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15041027|NCT02035709|Narcotics|narcotics|mesh-ancestor
15041028|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041029|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041030|NCT02035709|Analgesics|analgesics|mesh-ancestor
15041031|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
15041032|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969507|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969508|NCT03103893|Sirolimus|sirolimus|mesh-list
13969509|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13969510|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969511|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13969512|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969513|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
13969514|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13969515|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
13969516|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969517|NCT03104036|Mesalamine|mesalamine|mesh-list
13969518|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13969519|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13969520|NCT03104036|Analgesics|analgesics|mesh-ancestor
13969521|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
13969522|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969523|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969524|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13969525|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969526|NCT03103867|Insulin|insulin|mesh-list
13969527|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13969528|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969529|NCT03103685|Clopidogrel|clopidogrel|mesh-list
13969530|NCT03103685|Ticagrelor|ticagrelor|mesh-list
13969531|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13969532|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13969533|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13969534|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13969535|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13969536|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
13969537|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969538|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969539|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969540|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
13969541|NCT03103555|Bortezomib|bortezomib|mesh-list
13969542|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244133|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
14244134|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
14244135|NCT00203502|Bevacizumab|bevacizumab|mesh-list
14244136|NCT00203502|Docetaxel|docetaxel|mesh-list
14244137|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244138|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
14244139|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244140|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14244141|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14244142|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
14244143|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244144|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244145|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14244146|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14244147|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14244148|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14244149|NCT00203502|Growth Substances|growth substances|mesh-ancestor
14244150|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
15041033|NCT02035787|Metformin|metformin|mesh-list
15041034|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15041035|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041036|NCT02035800|Adalimumab|adalimumab|mesh-list
15041037|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15041038|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15041039|NCT02035891|Colchicine|colchicine|mesh-list
15041040|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
15041041|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15041042|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
15041043|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
15041044|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
15041045|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041046|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041047|NCT02035904|Morphine|morphine|mesh-list
15041048|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
15041049|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15041050|NCT02035904|Narcotics|narcotics|mesh-ancestor
15041051|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041052|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041053|NCT02035904|Analgesics|analgesics|mesh-ancestor
15041054|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
15041055|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041056|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
15041057|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
15041058|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
15041059|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15041060|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041061|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041062|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15041063|NCT02035930|Analgesics|analgesics|mesh-ancestor
15041064|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
15041065|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041066|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15041067|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15041068|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15041069|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
15041070|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041071|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041072|NCT02035943|Insulin|insulin|mesh-list
15041073|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15041074|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15041075|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041076|NCT02035956|Vaccines|vaccines|mesh-list
15041077|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
15041078|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041079|NCT02035982|Rivastigmine|rivastigmine|mesh-list
15041080|NCT02035982|Donepezil|donepezil|mesh-list
15041081|NCT02035982|Galantamine|galantamine|mesh-list
15041082|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
15041083|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041084|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041085|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
15041086|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041087|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041088|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
15041089|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15041090|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
15041091|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041092|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14244151|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
14244152|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
14244153|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
14244154|NCT00203931|Pemetrexed|pemetrexed|mesh-list
14244155|NCT00203931|Cetuximab|cetuximab|mesh-list
14244156|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244157|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244158|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244159|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14244160|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14244161|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14244162|NCT00203996|Pioglitazone|pioglitazone|mesh-list
14244163|NCT00203996|Leuprolide|leuprolide|mesh-list
14244164|NCT00203996|Estrogens|estrogens|mesh-list
14244165|NCT00203996|Progestins|progestins|mesh-list
14244166|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14244167|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244168|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14244169|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
14244170|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14244171|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14244172|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244173|NCT00203996|Hormones|hormones|mesh-ancestor
14531674|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15041093|NCT02035982|Protective Agents|protective agents|mesh-ancestor
15041094|NCT02036008|Liver Extracts|liver extracts|mesh-list
15041095|NCT02036008|Hematinics|hematinics|mesh-ancestor
15041096|NCT02036060|Prednisone|prednisone|mesh-list
15041097|NCT02036060|Docetaxel|docetaxel|mesh-list
15041098|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041099|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
15041100|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
15041101|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
15041102|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041103|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15041104|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
15041105|NCT02036060|Hormones|hormones|mesh-ancestor
15041106|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041107|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041108|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15041109|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
15041110|NCT02036073|Hematinics|hematinics|mesh-ancestor
13969543|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
13969544|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969545|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969546|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13969547|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
13969548|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969549|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969550|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13969551|NCT03103412|Tofacitinib|tofacitinib|mesh-list
13969552|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13969553|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969554|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969555|NCT03103568|Tolbutamide|tolbutamide|mesh-list
13969556|NCT03103568|Metoprolol|metoprolol|mesh-list
13969557|NCT03103568|Furosemide|furosemide|mesh-list
13969558|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
13969559|NCT03103568|Nitisinone|nitisinone|mesh-list
13969560|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13969561|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13969562|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
13969563|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
13969564|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969565|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969566|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13969567|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13969568|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13969569|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
13969570|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969571|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969572|NCT03103568|Diuretics|diuretics|mesh-ancestor
13969573|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
13969574|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13969575|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13969576|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13969577|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969578|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13969579|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13969580|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13969581|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
13969582|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969583|NCT03103646|Itraconazole|itraconazole|mesh-list
13969584|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
13969585|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
13969586|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969587|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13969588|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13969589|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969590|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041111|NCT02036086|Vemurafenib|vemurafenib|mesh-list
15041112|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041113|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15041114|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041115|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041116|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
15041117|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15041118|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15041119|NCT02036125|Prednisolone|prednisolone|mesh-list
15041120|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
15041121|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15041122|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
15041123|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15041124|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
15041125|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
15041126|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041127|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041128|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15041129|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
15041130|NCT02036125|Hormones|hormones|mesh-ancestor
15041131|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041132|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15041133|NCT02036125|Protective Agents|protective agents|mesh-ancestor
15041134|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15041135|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041136|NCT02036151|Fluorides|fluorides|mesh-list
15041137|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
15041138|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
15041139|NCT02036151|Protective Agents|protective agents|mesh-ancestor
15041140|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041141|NCT02036164|Paclitaxel|paclitaxel|mesh-list
15041142|NCT02036164|Cisplatin|cisplatin|mesh-list
15041143|NCT02036164|Carboplatin|carboplatin|mesh-list
15041144|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15041145|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041146|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
15041147|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
15041148|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
15041149|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041150|NCT02036229|Ivermectin|ivermectin|mesh-list
15041151|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15041152|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15041153|NCT02036242|Sufentanil|sufentanil|mesh-list
15041154|NCT02036242|Ropivacaine|ropivacaine|mesh-list
14244174|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244175|NCT00204373|Lansoprazole|lansoprazole|mesh-list
15041155|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
15041156|NCT02036242|Anesthetics|anesthetics|mesh-list
13969591|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13969592|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
13969593|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13969594|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969595|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13969596|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
13969597|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13969598|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969599|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
13969600|NCT03103399|Levodopa|levodopa|mesh-list
13969601|NCT03103399|Carbidopa|carbidopa|mesh-list
13969602|NCT03103399|Entacapone|entacapone|mesh-list
13969603|NCT03103399|Benserazide|benserazide|mesh-list
13969604|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
13969605|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
13969606|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13969607|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13969608|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
13969609|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969610|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969611|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969612|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969613|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
13969614|NCT03103334|Methotrexate|methotrexate|mesh-list
13969615|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13969616|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
13969617|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13969618|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969619|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13969620|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
13969621|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969622|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969623|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
13969624|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969625|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13969626|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13969627|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
13969628|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969629|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13969630|NCT03103152|Aspirin|aspirin|mesh-list
13969631|NCT03103152|Vitamin D|vitamin d|mesh-list
13969632|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
13969633|NCT03103152|Vitamins|vitamins|mesh-list
13969634|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
13969635|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969636|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13969637|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13969638|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13969639|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13969640|NCT03103152|Analgesics|analgesics|mesh-ancestor
13969641|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
13969642|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969643|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13969644|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969645|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13969646|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13969647|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969648|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13969649|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13969650|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969651|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
13969652|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
13969653|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14244176|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
15041157|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041158|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041159|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
15041160|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041161|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15041162|NCT02036242|Narcotics|narcotics|mesh-ancestor
15041163|NCT02036242|Analgesics|analgesics|mesh-ancestor
15041164|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15041165|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15041166|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
15041167|NCT02036255|Taurolidine|taurolidine|mesh-list
15041168|NCT02036255|Heparin|heparin|mesh-list
15041169|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
15041170|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15041171|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15041172|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041173|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15041174|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14244177|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14244178|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14244179|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14244180|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244181|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244182|NCT00205374|Cidofovir|cidofovir|mesh-list
14244183|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
14244184|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14244185|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244186|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244187|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
14244188|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14244189|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14244190|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
14244191|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14244192|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244193|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14244194|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14244195|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14244196|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14244197|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14244198|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14244199|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14244200|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244201|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244202|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244203|NCT00205699|Olanzapine|olanzapine|mesh-list
14244204|NCT00205699|Risperidone|risperidone|mesh-list
14244205|NCT00205699|Aripiprazole|aripiprazole|mesh-list
14244206|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14244207|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
14244208|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244209|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244210|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244211|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14244212|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14244213|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244214|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14244215|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14244216|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
14244217|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
14244218|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
14244219|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14244220|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14244221|NCT00205699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14244222|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14244223|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14244224|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
14244225|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
14244226|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14244227|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14244228|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14244229|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14244230|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
14244231|NCT00205712|Ketamine|ketamine|mesh-list
14244232|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14244233|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244234|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244235|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14244236|NCT00205712|Analgesics|analgesics|mesh-ancestor
14244237|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
14244238|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14244239|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14244240|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14244241|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14244242|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
14244243|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244244|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041175|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969654|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13969655|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13969656|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969657|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
13969658|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969659|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969660|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
13969661|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13969662|NCT03103009|Pasireotide|pasireotide|mesh-list
13969663|NCT03103009|Hormones|hormones|mesh-ancestor
13969664|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13969665|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969666|NCT03103022|Acetaminophen|acetaminophen|mesh-list
13969667|NCT03103022|Ibuprofen|ibuprofen|mesh-list
13969668|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13969669|NCT03103022|Analgesics|analgesics|mesh-ancestor
13969670|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
13969671|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969672|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969673|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
13969674|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13969675|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13969676|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969677|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13969678|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969679|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969680|NCT03102658|Micafungin|micafungin|mesh-list
13969681|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
13969682|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531675|NCT02422303|Ketamine|ketamine|mesh-list
14531676|NCT02422303|Analgesics|analgesics|mesh-ancestor
14531677|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
14531678|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531679|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531680|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14531681|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14531682|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
14531683|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
13969692|NCT03102801|Insulin|insulin|mesh-list
13969693|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13969694|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13969695|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969696|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
13969697|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13969698|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244245|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14244246|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14244247|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
14244248|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
14244249|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14244250|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14244251|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
14244252|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14244253|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14244254|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
14244255|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244256|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244257|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14244258|NCT00205803|Vaccines|vaccines|mesh-list
14244259|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14244260|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
14244261|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244262|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
14531684|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041176|NCT02036281|Substance P|substance p|mesh-list
15041177|NCT02036281|Neurokinin A|neurokinin a|mesh-list
15041178|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041179|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969699|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
13969700|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13969701|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969702|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969703|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13969704|NCT03102359|Analgesics|analgesics|mesh-ancestor
13969705|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
13969706|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969707|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13969708|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13969709|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13969710|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
13969711|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969712|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244263|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14244264|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244265|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14244266|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
14244267|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14244268|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14244269|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244270|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244271|NCT00206102|Risperidone|risperidone|mesh-list
14244272|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14244273|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14244274|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
14244275|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244276|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244277|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244278|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14244279|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14244280|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244281|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14244282|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14244283|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
14244284|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
14244285|NCT00206323|Topiramate|topiramate|mesh-list
14244286|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
14244287|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14244288|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244289|NCT00206336|Topiramate|topiramate|mesh-list
14244290|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
14244291|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14244292|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244293|NCT00206427|Lapatinib|lapatinib|mesh-list
14244294|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244295|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14244296|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244297|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244298|NCT00206440|Esomeprazole|esomeprazole|mesh-list
14244299|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14244300|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14244301|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14244302|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244303|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244304|NCT00206518|Docetaxel|docetaxel|mesh-list
14244305|NCT00206518|Doxorubicin|doxorubicin|mesh-list
14244306|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14244307|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
14244308|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244309|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
14244310|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
14244311|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
14244312|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244313|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14244314|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14244315|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14244316|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244317|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244318|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
14244319|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244320|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14244321|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14244322|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
14244323|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14244324|NCT00206726|Fludarabine|fludarabine|mesh-list
13969713|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
13969714|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
13969715|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13969716|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13969717|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969718|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969719|NCT03102398|Urological Agents|urological agents|mesh-ancestor
13969720|NCT03101995|Gemcitabine|gemcitabine|mesh-list
13969721|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13969722|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
13969723|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041180|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041181|NCT02036359|Docetaxel|docetaxel|mesh-list
15041182|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15041183|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041184|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
15041185|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
15041186|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
15041187|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041188|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15041189|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041190|NCT02036372|Insulin|insulin|mesh-list
15041191|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15041192|NCT02036372|Liraglutide|liraglutide|mesh-list
15041193|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15041194|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041195|NCT02036372|Incretins|incretins|mesh-ancestor
15041196|NCT02036372|Hormones|hormones|mesh-ancestor
15041197|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041198|NCT02036437|Misoprostol|misoprostol|mesh-list
15041199|NCT02036437|Dinoprostone|dinoprostone|mesh-list
15041200|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15041201|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
15041202|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15041203|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041204|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15041205|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15041206|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
15041207|NCT02036463|Prednisone|prednisone|mesh-list
15041208|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15041209|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
15041210|NCT02036463|Hormones|hormones|mesh-ancestor
15041211|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041212|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041213|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15041214|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041215|NCT02036489|Prednisone|prednisone|mesh-list
15041216|NCT02036489|Vincristine|vincristine|mesh-list
15041217|NCT02036489|Daunorubicin|daunorubicin|mesh-list
15041218|NCT02036489|Asparaginase|asparaginase|mesh-list
15041219|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
15041220|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15041221|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
15041222|NCT02036489|Hormones|hormones|mesh-ancestor
15041223|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041224|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041225|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15041226|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041227|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15041228|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
15041229|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
15041230|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
15041231|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041232|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15041233|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15041234|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15041235|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041236|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
15041237|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15041238|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15041239|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
15041240|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15041241|NCT02036528|Doxycycline|doxycycline|mesh-list
15041242|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
15041243|NCT02036528|Gentamicins|gentamicins|mesh-list
15041244|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15041245|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15041246|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
15041247|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13969724|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969725|NCT03101995|Antiviral Agents|antiviral agents|mesh-ancestor
13969726|NCT03101995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969727|NCT03101995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969728|NCT03101995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13969729|NCT03101995|Immunologic Factors|immunologic factors|mesh-ancestor
13969730|NCT03101995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969731|NCT03102242|Atezolizumab|atezolizumab|mesh-list
13969732|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969733|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
13969734|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13969735|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969736|NCT03102320|Gemcitabine|gemcitabine|mesh-list
13969737|NCT03102320|Maytansine|maytansine|mesh-list
13969738|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969739|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13969740|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
13969741|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969742|NCT03102320|Antiviral Agents|antiviral agents|mesh-ancestor
13969743|NCT03102320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969744|NCT03102320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969745|NCT03102320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13969746|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
14244325|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
15041248|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15041249|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15041250|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15041251|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041252|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041253|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041254|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15041255|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15041256|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14531685|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14531686|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14531687|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531688|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531689|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14531690|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14531691|NCT02410551|Vidarabine|vidarabine|mesh-list
14531692|NCT02410551|Fludarabine|fludarabine|mesh-list
14531693|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
14531694|NCT02410551|Busulfan|busulfan|mesh-list
14531695|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531696|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14531697|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
15041257|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
15041258|NCT02036554|Everolimus|everolimus|mesh-list
15041259|NCT02036554|Tacrolimus|tacrolimus|mesh-list
13969747|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969748|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13969749|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
13969750|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
13969751|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
13969752|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
13969753|NCT03102021|Hematinics|hematinics|mesh-ancestor
13969754|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13969755|NCT03101930|Liraglutide|liraglutide|mesh-list
13969756|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13969757|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969758|NCT03101930|Incretins|incretins|mesh-ancestor
13969759|NCT03101930|Hormones|hormones|mesh-ancestor
13969760|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13969761|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13969762|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
13969763|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969764|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969765|NCT03101800|Azathioprine|azathioprine|mesh-list
13969766|NCT03101800|Allopurinol|allopurinol|mesh-list
14244326|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244327|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14244328|NCT00207090|Rifampin|rifampin|mesh-list
14244329|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14244330|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
14244331|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14244332|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14244333|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
14244334|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14244335|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244336|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244337|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14244338|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14531698|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531699|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531700|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
14531701|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531702|NCT02410551|Antiviral Agents|antiviral agents|mesh-ancestor
14531703|NCT02410551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531704|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
14531705|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14531706|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14531707|NCT02411643|Calcipotriene|calcipotriene|mesh-list
14531708|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
14531709|NCT02409355|Gemcitabine|gemcitabine|mesh-list
14531710|NCT02409355|Carboplatin|carboplatin|mesh-list
14531711|NCT02409355|Atezolizumab|atezolizumab|mesh-list
14531712|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531713|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14531714|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
15041260|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15041261|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
15041262|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041263|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15041264|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041265|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041266|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041267|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15041268|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15041269|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
15041270|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15041271|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15041272|NCT02036697|Fentanyl|fentanyl|mesh-list
15041273|NCT02036697|Morphine|morphine|mesh-list
15041274|NCT02036697|Bupivacaine|bupivacaine|mesh-list
15041275|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
15041276|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
15041277|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041278|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041279|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
15041280|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041281|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15041282|NCT02036697|Narcotics|narcotics|mesh-ancestor
15041283|NCT02036697|Analgesics|analgesics|mesh-ancestor
15041284|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13969767|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
13969768|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969769|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969770|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
13969771|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969772|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13969773|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
13969774|NCT03101800|Protective Agents|protective agents|mesh-ancestor
13969775|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969776|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13969777|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969778|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13969779|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
13969780|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
13969781|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
13969782|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13969783|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
13969784|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969785|NCT03101423|Interleukin-2|interleukin-2|mesh-list
13969786|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969787|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13969788|NCT03101423|Analgesics|analgesics|mesh-ancestor
13969789|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
13969790|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969791|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969792|NCT03101579|Folic Acid|folic acid|mesh-list
13969793|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
13969794|NCT03101579|Hydroxocobalamin|hydroxocobalamin|mesh-list
13969795|NCT03101579|Dexamethasone|dexamethasone|mesh-list
13969796|NCT03101579|Pemetrexed|pemetrexed|mesh-list
13969797|NCT03101579|Vitamins|vitamins|mesh-ancestor
13969798|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
13969799|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969800|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13969801|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
13969802|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
13969803|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969804|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13969805|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
15041285|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15041286|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
15041287|NCT02036723|Bevacizumab|bevacizumab|mesh-list
15041288|NCT02036723|Ranibizumab|ranibizumab|mesh-list
15041289|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15041290|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041291|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15041292|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15041293|NCT02036723|Growth Substances|growth substances|mesh-ancestor
15041294|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041295|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
15041296|NCT02036736|Propofol|propofol|mesh-list
15041297|NCT02036736|Anesthetics|anesthetics|mesh-list
15041298|NCT02036736|Desflurane|desflurane|mesh-list
15041299|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14244339|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13969806|NCT03101579|Hormones|hormones|mesh-ancestor
13969807|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041300|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041301|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041302|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15041303|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
15041304|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15041305|NCT02036827|Bromides|bromides|mesh-list
15041306|NCT02036827|Rocuronium|rocuronium|mesh-list
13969808|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13969809|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969810|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969811|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969812|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13969813|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13969814|NCT03101579|Hematinics|hematinics|mesh-ancestor
13969815|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
13969816|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
13969817|NCT03101709|Fludarabine|fludarabine|mesh-list
13969818|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13969819|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
13969820|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969821|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969822|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13969823|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
13969824|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969825|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969826|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13969827|NCT03101475|Durvalumab|durvalumab|mesh-list
13969828|NCT03101475|Tremelimumab|tremelimumab|mesh-list
13969829|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13969830|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969831|NCT03101501|Mitomycins|mitomycins|mesh-list
15041307|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
15041308|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15041309|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15041310|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15041311|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041312|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041313|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15041314|NCT02036879|Norethindrone|norethindrone|mesh-list
15041315|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
15041316|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
15041317|NCT02036879|Estradiol|estradiol|mesh-list
15041318|NCT02036879|Estrogens|estrogens|mesh-ancestor
15041319|NCT02036879|Hormones|hormones|mesh-ancestor
15041320|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041321|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041322|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15041323|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
15041324|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14244340|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14244341|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14244342|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14244343|NCT00207142|Ritonavir|ritonavir|mesh-list
14244344|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14244345|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14244346|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15041325|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15041326|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15041327|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15041328|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15041329|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15041330|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
15041331|NCT02036983|Anesthetics|anesthetics|mesh-list
15041332|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
15041333|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041334|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041335|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
15041336|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041337|NCT02037009|Anesthetics|anesthetics|mesh-list
15041338|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041339|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041340|NCT02037035|Ketamine|ketamine|mesh-list
15041341|NCT02037035|Analgesics|analgesics|mesh-ancestor
15041342|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
15041343|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041344|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041345|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13969832|NCT03101501|Mitomycin|mitomycin|mesh-list
13969833|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13969834|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969835|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
13969836|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969837|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13969838|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969839|NCT03101319|Vitamin D|vitamin d|mesh-list
13969840|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
13969841|NCT03101319|Vitamins|vitamins|mesh-ancestor
13969842|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
13969843|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969844|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13969845|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13969846|NCT03101280|Atezolizumab|atezolizumab|mesh-list
13969847|NCT03101280|Rucaparib|rucaparib|mesh-list
13969848|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969849|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13969850|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969851|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969852|NCT03101644|Darunavir|darunavir|mesh-list
13969853|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13969854|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13969855|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
13969856|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969857|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969858|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13969859|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13969860|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
13969861|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969862|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13969863|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13969864|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969865|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
13969866|NCT03100955|Cisplatin|cisplatin|mesh-list
13969867|NCT03100955|Etoposide|etoposide|mesh-list
13969868|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
13969869|NCT03100955|Apatinib|apatinib|mesh-list
13969870|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969871|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13969872|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13969873|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13969874|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13969875|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969876|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13969877|NCT03101137|Dexamethasone|dexamethasone|mesh-list
13969878|NCT03101137|Bupivacaine|bupivacaine|mesh-list
13969879|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13969880|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
13969881|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
13969882|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969883|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969884|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13969885|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
13969886|NCT03101137|Hormones|hormones|mesh-ancestor
13969887|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13969888|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13969889|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969890|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
13969891|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
13969892|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969893|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
13969894|NCT03101085|Equol|equol|mesh-list
13969895|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
13969896|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
13969897|NCT03101085|Estrogens|estrogens|mesh-ancestor
13969898|NCT03101085|Hormones|hormones|mesh-ancestor
13969899|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13969900|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969901|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
13969902|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13969903|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13969904|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969905|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
13969906|NCT03101124|Coagulants|coagulants|mesh-ancestor
13969907|NCT03101254|Vemurafenib|vemurafenib|mesh-list
13969908|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969909|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13969910|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244347|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
13969911|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969912|NCT03100994|Bupivacaine|bupivacaine|mesh-list
13969913|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
13969914|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
13969915|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969916|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969917|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
13969918|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969919|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
13969920|NCT03100877|Melphalan|melphalan|mesh-list
13969921|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
13969922|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
13969923|NCT03100877|Lenalidomide|lenalidomide|mesh-list
13969924|NCT03100877|Lenograstim|lenograstim|mesh-list
13969925|NCT03100877|Mitogens|mitogens|mesh-list
13969926|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13969927|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
13969928|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969929|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969930|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13969931|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
13969932|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969933|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13969934|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13969935|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13969936|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14244348|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244349|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244350|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14244351|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14244352|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
14244353|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14244354|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14244355|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14244356|NCT00207714|Golimumab|golimumab|mesh-list
14244357|NCT00207714|Infliximab|infliximab|mesh-list
14244358|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
14244359|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14244360|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14244361|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14244362|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14244363|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244364|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
14244365|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244366|NCT00207727|Ustekinumab|ustekinumab|mesh-list
14244367|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
14244368|NCT00207740|Golimumab|golimumab|mesh-list
14244369|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14244370|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14244371|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244372|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
14244373|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244374|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
14244375|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14244376|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14244377|NCT00208026|Analgesics|analgesics|mesh-ancestor
14244378|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
14244379|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14244380|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244381|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14244382|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14244383|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
14244384|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244385|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
14244386|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14244387|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244388|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244389|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
14244390|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14244391|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14244392|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244393|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
14244394|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244395|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244396|NCT00208767|Valsartan|valsartan|mesh-list
14244397|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14244398|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14244399|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14244400|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244401|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
14244402|NCT00208975|Rituximab|rituximab|mesh-list
14244403|NCT00208975|Fludarabine|fludarabine|mesh-list
14244404|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
14244405|NCT00208975|Sargramostim|sargramostim|mesh-list
14244406|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244407|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
14244408|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244409|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14244410|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14244411|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
14244412|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244413|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244414|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14244415|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14244416|NCT00208975|Analgesics|analgesics|mesh-ancestor
14244417|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
14244418|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14244419|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15041346|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15041347|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
15041348|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
15041349|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041350|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15041351|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15041352|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041353|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041354|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
15041355|NCT02037126|Promethazine|promethazine|mesh-list
15041356|NCT02037126|Psilocybin|psilocybin|mesh-list
15041357|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15041358|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15041359|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041360|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041361|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
15041362|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
15041363|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
15041364|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041365|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
15041366|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
15041367|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15041368|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15041369|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
15041370|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
15041371|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041372|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041373|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15041374|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
15041375|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
15041376|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
15041377|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13969937|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13969938|NCT03100877|Growth Substances|growth substances|mesh-ancestor
13969939|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
13969940|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
14244420|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14244421|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244422|NCT00209092|Docetaxel|docetaxel|mesh-list
14244423|NCT00209092|Capecitabine|capecitabine|mesh-list
14244424|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244425|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
14244426|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
14244427|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
14244428|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244429|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14244430|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
14244431|NCT00209170|Citalopram|citalopram|mesh-list
13969941|NCT03100604|Sevoflurane|sevoflurane|mesh-list
14244432|NCT00209170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14244433|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14244434|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14244435|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244436|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13969942|NCT03100604|Desflurane|desflurane|mesh-list
14244437|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
14244438|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244439|NCT00209170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14244440|NCT00209170|Antidepressive Agents|antidepressive agents|mesh-ancestor
14244441|NCT00209170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14244442|NCT00209560|Fospropofol|fospropofol|mesh-list
14244443|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14244444|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244445|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244446|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
14244447|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244448|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14244449|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244450|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244451|NCT00210184|Leucovorin|leucovorin|mesh-list
14244452|NCT00210184|Fluorouracil|fluorouracil|mesh-list
14244453|NCT00210184|Irinotecan|irinotecan|mesh-list
13969943|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13969944|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13969945|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
13969946|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
13969947|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969948|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969949|NCT03100513|Lactulose|lactulose|mesh-list
13969950|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13969951|NCT03100734|Etanercept|etanercept|mesh-list
14244454|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
14244455|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244456|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14244457|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244458|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244459|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
14244460|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244461|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14244462|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14244463|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244464|NCT00210184|Antidotes|antidotes|mesh-ancestor
14244465|NCT00210184|Protective Agents|protective agents|mesh-ancestor
14244466|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
14244467|NCT00210184|Vitamins|vitamins|mesh-ancestor
14244468|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
14244469|NCT00210353|Rituximab|rituximab|mesh-list
14244470|NCT00210353|Chlorambucil|chlorambucil|mesh-list
14244471|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14244472|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244473|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
14244474|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244475|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14244476|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14244477|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
14244478|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244479|NCT00210470|Zinc|zinc|mesh-list
14531715|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531716|NCT02409355|Antiviral Agents|antiviral agents|mesh-ancestor
14531717|NCT02409355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531718|NCT02409355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531719|NCT02409355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531720|NCT02409355|Immunologic Factors|immunologic factors|mesh-ancestor
14531721|NCT02409355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531722|NCT02392377|Leucovorin|leucovorin|mesh-list
14531723|NCT02392377|Paclitaxel|paclitaxel|mesh-list
14531724|NCT02392377|Carboplatin|carboplatin|mesh-list
14531725|NCT02392377|Fluorouracil|fluorouracil|mesh-list
14531726|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
14531727|NCT02392377|Calcium|calcium|mesh-list
14531728|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
14531729|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14531730|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531731|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
14531732|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
14531733|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
14531734|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531735|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14531736|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041378|NCT02037191|Methotrexate|methotrexate|mesh-list
15041379|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15041380|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
15041381|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15041382|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041383|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15041384|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
15041385|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041386|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041387|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
15041388|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041389|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15041390|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15041391|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
15041392|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15041393|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15041394|NCT02037399|Dexamethasone|dexamethasone|mesh-list
15041395|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15041396|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
15041397|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
14531737|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
14531738|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14531739|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531740|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
14531741|NCT02392377|Antidotes|antidotes|mesh-ancestor
14531742|NCT02392377|Protective Agents|protective agents|mesh-ancestor
14531743|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
14531744|NCT02392377|Vitamins|vitamins|mesh-ancestor
14531745|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
15041398|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041399|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041400|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15041401|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
13969952|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13969953|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13969954|NCT03100734|Analgesics|analgesics|mesh-ancestor
13969955|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
13969956|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969957|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969958|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13969959|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969960|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13969961|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13969962|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
13969963|NCT03100565|Lidocaine|lidocaine|mesh-list
13969964|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
13969965|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
13969966|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13969967|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969968|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
15041402|NCT02037399|Hormones|hormones|mesh-ancestor
13969969|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969970|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13969971|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13969972|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13969973|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13969974|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13969975|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
13969976|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13969977|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13969978|NCT03100253|Adalimumab|adalimumab|mesh-list
13969979|NCT03100253|Etanercept|etanercept|mesh-list
13969980|NCT03100253|Golimumab|golimumab|mesh-list
13969981|NCT03100253|Infliximab|infliximab|mesh-list
13969982|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
13969983|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13969984|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13969985|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
13969986|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13969987|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13969988|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13969989|NCT03100253|Analgesics|analgesics|mesh-ancestor
13969990|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
13969991|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13969992|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13969993|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13969994|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
13969995|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
13969996|NCT03100318|Dotinurad|dotinurad|mesh-list
13969997|NCT03100318|Benzbromarone|benzbromarone|mesh-list
13969998|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
13969999|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
13970000|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13970001|NCT03100318|Renal Agents|renal agents|mesh-ancestor
13970002|NCT03100422|Armin|armin|mesh-list
13970003|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13970004|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970005|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970006|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
13970007|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041403|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041404|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15041405|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041406|NCT02037412|Clopidogrel|clopidogrel|mesh-list
15041407|NCT02037412|Ticagrelor|ticagrelor|mesh-list
15041408|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15041409|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15041410|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15041411|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15041412|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
15041413|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041414|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041415|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041416|NCT02037464|Capsaicin|capsaicin|mesh-list
15041417|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
15041418|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
15041419|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
15041420|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041421|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041422|NCT02037503|Ketamine|ketamine|mesh-list
15041423|NCT02037503|Analgesics|analgesics|mesh-ancestor
15041424|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
15041425|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041426|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041427|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15041428|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14244480|NCT00210470|Indomethacin|indomethacin|mesh-list
15041429|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
15041430|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
15041431|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041432|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15041433|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15041434|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041435|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041436|NCT02037516|Neostigmine|neostigmine|mesh-list
15041437|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15041438|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041439|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041440|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
15041441|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041442|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041443|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15041444|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
15041445|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041446|NCT02037633|Fentanyl|fentanyl|mesh-list
15041447|NCT02037633|Ropivacaine|ropivacaine|mesh-list
15041448|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
15041449|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
13970008|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970009|NCT03100019|Resveratrol|resveratrol|mesh-list
13970010|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
13970011|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970012|NCT03100019|Protective Agents|protective agents|mesh-ancestor
13970013|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970014|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970015|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13970016|NCT03100071|Apixaban|apixaban|mesh-list
13970017|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13970018|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
13970019|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13970020|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
13970021|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970022|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970023|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
13970024|NCT03100006|Nivolumab|nivolumab|mesh-list
13970025|NCT03100006|Oregovomab|oregovomab|mesh-list
13970026|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13970027|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244481|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
14244482|NCT00210470|Omeprazole|omeprazole|mesh-list
14244483|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244484|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
14244485|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244486|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14244487|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14244488|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
14244489|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244490|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244491|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14244492|NCT00210470|Trace Elements|trace elements|mesh-ancestor
14244493|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
14244494|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14244495|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14244496|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14244497|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244498|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14244499|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14244500|NCT00210470|Analgesics|analgesics|mesh-ancestor
14244501|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
14244502|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14244503|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14244504|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
14244505|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
14244506|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14244507|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14244508|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
14244509|NCT00210626|Hematinics|hematinics|mesh-ancestor
14244510|NCT00211081|Spironolactone|spironolactone|mesh-list
14244511|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14244512|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
14244513|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244514|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244515|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14244516|NCT00211081|Diuretics|diuretics|mesh-ancestor
14244517|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
14531746|NCT02394665|Temozolomide|temozolomide|mesh-list
14531747|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14531748|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
14531749|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531750|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531751|NCT02389712|Lamotrigine|lamotrigine|mesh-list
14531752|NCT02389712|Fluoxetine|fluoxetine|mesh-list
14531753|NCT02389712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14531754|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14531755|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14531756|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531757|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531758|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
14531759|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531760|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14531761|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
14531762|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14531763|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14531764|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14531765|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531766|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
14531767|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14531768|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14531769|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14531770|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14531771|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14531772|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14531773|NCT02390362|Rituximab|rituximab|mesh-list
14531774|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14531775|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531776|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
14531777|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531778|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14531779|NCT02383433|Gemcitabine|gemcitabine|mesh-list
14531780|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14531781|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
15041450|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244518|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15041451|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041452|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
15041453|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041454|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15041455|NCT02037633|Narcotics|narcotics|mesh-ancestor
15041456|NCT02037633|Analgesics|analgesics|mesh-ancestor
15041457|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15041458|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15041459|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
15041460|NCT02037672|Metformin|metformin|mesh-list
15041461|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15041462|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041463|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
15041464|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
15041465|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
15041466|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041467|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041468|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
15041469|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041470|NCT02037724|Iron|iron|mesh-list
15041471|NCT02037724|Trace Elements|trace elements|mesh-ancestor
15041472|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
15041473|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041474|NCT02037737|Abatacept|abatacept|mesh-list
15041475|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15041476|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041477|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041478|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15041479|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
15041480|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041481|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15041482|NCT02037802|Fentanyl|fentanyl|mesh-list
15041483|NCT02037802|Meperidine|meperidine|mesh-list
15041484|NCT02037802|Bupivacaine|bupivacaine|mesh-list
15041485|NCT02037802|Propofol|propofol|mesh-list
15041486|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
15041487|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
15041488|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041489|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041490|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
15041491|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041492|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15041493|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15041494|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
15041495|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15041496|NCT02037802|Narcotics|narcotics|mesh-ancestor
15041497|NCT02037802|Analgesics|analgesics|mesh-ancestor
15041498|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15041499|NCT02037815|Mannitol|mannitol|mesh-list
15041500|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15041501|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13970028|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13970029|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970030|NCT03099720|Ropivacaine|ropivacaine|mesh-list
13970031|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
13970032|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
13970033|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13970034|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970035|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
13970036|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970037|NCT03099759|Vitamin D|vitamin d|mesh-list
13970038|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
13970039|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
13970040|NCT03099759|Vitamins|vitamins|mesh-ancestor
13970041|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
13970042|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970043|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13970044|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13970045|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
13970046|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
13970047|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970048|NCT03099824|Protective Agents|protective agents|mesh-ancestor
13970049|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970050|NCT03099785|Rifamycins|rifamycins|mesh-list
13970051|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
13970052|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13970053|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970054|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13970055|NCT03099590|Puerarin|puerarin|mesh-list
13970056|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
13970057|NCT03099499|TIC10 compound|tic10 compound|mesh-list
13970058|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970059|NCT03099616|Propofol|propofol|mesh-list
13970060|NCT03099616|Desflurane|desflurane|mesh-list
13970061|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13970062|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13970063|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970064|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13970065|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
13970066|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
13970067|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13970068|NCT03099382|Docetaxel|docetaxel|mesh-list
13970069|NCT03099382|Irinotecan|irinotecan|mesh-list
13970070|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970071|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
13970072|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
13970073|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
13970074|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970075|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13970076|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13970077|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970078|NCT03099278|Ezetimibe|ezetimibe|mesh-list
13970079|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13970080|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13970081|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
13970082|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970083|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13970084|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
13970085|NCT03099122|Prednisone|prednisone|mesh-list
13970086|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
13970087|NCT03099122|Tacrolimus|tacrolimus|mesh-list
13970088|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
13970089|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13970090|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
13970091|NCT03099122|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13970092|NCT03099122|Antibodies|antibodies|mesh-list
13970093|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13970094|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
13970095|NCT03099122|Hormones|hormones|mesh-ancestor
13970096|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13970097|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970098|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13970099|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970100|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13970101|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
13970102|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13970103|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970104|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970105|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13970106|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13970107|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
13970108|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13970109|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970110|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
13970111|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
13970112|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970113|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13970114|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13970115|NCT03099122|Protective Agents|protective agents|mesh-ancestor
13970116|NCT03099408|Metronidazole|metronidazole|mesh-list
13970117|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970118|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13970119|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13970120|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15041502|NCT02037815|Diuretics|diuretics|mesh-ancestor
13970121|NCT03099265|Leucovorin|leucovorin|mesh-list
15041503|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
15041504|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041505|NCT02037919|Etonogestrel|etonogestrel|mesh-list
13970122|NCT03099265|Fluorouracil|fluorouracil|mesh-list
15041506|NCT02037919|Desogestrel|desogestrel|mesh-list
15041507|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15041508|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
15041509|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15041510|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041511|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15041512|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15041513|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15041514|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15041515|NCT02037919|Progestins|progestins|mesh-ancestor
15041516|NCT02037919|Hormones|hormones|mesh-ancestor
15041517|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041518|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
15041519|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15041520|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15041521|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
13970123|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
13970124|NCT03099265|Irinotecan|irinotecan|mesh-list
13970125|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
13970126|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970127|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13970128|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970129|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13970130|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
13970131|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970132|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13970133|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13970134|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970135|NCT03099265|Antidotes|antidotes|mesh-ancestor
13970136|NCT03099265|Protective Agents|protective agents|mesh-ancestor
13970137|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
13970138|NCT03099265|Vitamins|vitamins|mesh-ancestor
13970139|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
13970140|NCT03099213|Ramipril|ramipril|mesh-list
13970141|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13970142|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
13970143|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970144|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970145|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14244519|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14244520|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
14244521|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041522|NCT02037997|Docetaxel|docetaxel|mesh-list
13970146|NCT03098875|Remifentanil|remifentanil|mesh-list
13970147|NCT03098875|Propofol|propofol|mesh-list
13970148|NCT03098875|Sevoflurane|sevoflurane|mesh-list
13970149|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13970150|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13970151|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970152|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13970153|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
13970154|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
13970155|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13970156|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13970157|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13970158|NCT03098875|Narcotics|narcotics|mesh-ancestor
13970159|NCT03098875|Analgesics|analgesics|mesh-ancestor
13970160|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
13970161|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970162|NCT03099031|Tinzaparin|tinzaparin|mesh-list
13970163|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13970164|NCT03099031|Dalteparin|dalteparin|mesh-list
13970165|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
13970166|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13970167|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13970168|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970169|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
13970170|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13970171|NCT03098823|Prednisone|prednisone|mesh-list
13970172|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13970173|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
13970174|NCT03098823|Hormones|hormones|mesh-ancestor
13970175|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13970176|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970177|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13970178|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970179|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
13970180|NCT03098810|Astringents|astringents|mesh-ancestor
13970181|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970182|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
13970183|NCT03098680|Verapamil|verapamil|mesh-list
13970184|NCT03098680|Nicardipine|nicardipine|mesh-list
13970185|NCT03098680|Phentolamine|phentolamine|mesh-list
13970186|NCT03098680|Phenylephrine|phenylephrine|mesh-list
13970187|NCT03098680|Dobutamine|dobutamine|mesh-list
13970188|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
13970189|NCT03098680|Albuterol|albuterol|mesh-list
13970190|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13970191|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
13970192|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970193|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970194|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13970195|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
14244522|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244523|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244524|NCT00211185|Prednisone|prednisone|mesh-list
14244525|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
14244526|NCT00211185|Doxorubicin|doxorubicin|mesh-list
14244527|NCT00211185|Vincristine|vincristine|mesh-list
14244528|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
14244529|NCT00211185|Sargramostim|sargramostim|mesh-list
14244530|NCT00211185|Lenograstim|lenograstim|mesh-list
14244531|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244532|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
14244533|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244534|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14244535|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14244536|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
14244537|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244538|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244539|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14244540|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14244541|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14244542|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14244543|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244544|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14244545|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
14244546|NCT00211185|Hormones|hormones|mesh-ancestor
14244547|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244548|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14244549|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14244550|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
14244551|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
14244552|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
14244553|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14244554|NCT00211510|Insulin|insulin|mesh-list
14244555|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14244556|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244557|NCT00211536|Insulin|insulin|mesh-list
14244558|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14244559|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14244560|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244561|NCT00211692|Interferons|interferons|mesh-list
14244562|NCT00211692|Ribavirin|ribavirin|mesh-list
14244563|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
14244564|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
14244565|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041523|NCT02037997|Pemetrexed|pemetrexed|mesh-list
15041524|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15041525|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041526|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
15041527|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
15041528|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
15041529|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041530|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041531|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15041532|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15041533|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15041534|NCT02038062|Sevoflurane|sevoflurane|mesh-list
15041535|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15041536|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15041537|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
15041538|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
15041539|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041540|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970196|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
13970197|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13970198|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13970199|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13970200|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13970201|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
13970202|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970203|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970204|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13970205|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
13970206|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
13970207|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13970208|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
13970209|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13970210|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13970211|NCT03098680|Protective Agents|protective agents|mesh-ancestor
13970212|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13970213|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13970214|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13970215|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13970216|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
13970217|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
13970218|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13970219|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13970220|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13970221|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
13970222|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970223|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970224|NCT03098407|Buprenorphine|buprenorphine|mesh-list
13970225|NCT03098407|Methadone|methadone|mesh-list
13970226|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13970227|NCT03098407|Narcotics|narcotics|mesh-ancestor
13970228|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13970229|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970230|NCT03098407|Analgesics|analgesics|mesh-ancestor
13970231|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
13970232|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970233|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13970234|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
13970235|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
13970236|NCT03098589|Lenalidomide|lenalidomide|mesh-list
13970237|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
13970238|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970239|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13970240|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13970241|NCT03098589|Growth Substances|growth substances|mesh-ancestor
13970242|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
13970243|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970244|NCT03098368|Rotigotine|rotigotine|mesh-list
13970245|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
13970246|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
13970247|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970248|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970249|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970250|NCT03098355|Interleukin-2|interleukin-2|mesh-list
13970251|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970252|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13970253|NCT03098355|Analgesics|analgesics|mesh-ancestor
13970254|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
13970255|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970256|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970257|NCT03098342|Amorolfine|amorolfine|mesh-list
13970258|NCT03098342|Methylene Blue|methylene blue|mesh-list
13970259|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970260|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970261|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
13970262|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970263|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
13970264|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13970265|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13970266|NCT03098225|Prednisolone|prednisolone|mesh-list
15041541|NCT02038257|Petrolatum|petrolatum|mesh-list
15041542|NCT02038257|Emollients|emollients|mesh-ancestor
15041543|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
15041544|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
15041545|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15041546|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
15041547|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
15041548|NCT02038335|Etonogestrel|etonogestrel|mesh-list
15041549|NCT02038335|Norethindrone|norethindrone|mesh-list
15041550|NCT02038335|Estradiol|estradiol|mesh-list
15041551|NCT02038335|Estrogens|estrogens|mesh-ancestor
15041552|NCT02038335|Hormones|hormones|mesh-ancestor
15041553|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041554|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041555|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15041556|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
15041557|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15041558|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15041559|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15041560|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15041561|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15041562|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15041563|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15041564|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041565|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15041566|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
15041567|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15041568|NCT02038452|Prednisolone|prednisolone|mesh-list
13970267|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
13970268|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13970269|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
13970270|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13970271|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
13970272|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
13970273|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970274|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970275|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13970276|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
13970277|NCT03098225|Hormones|hormones|mesh-ancestor
13970278|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13970279|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13970280|NCT03098225|Protective Agents|protective agents|mesh-ancestor
13970281|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13970282|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970283|NCT03098160|Ipilimumab|ipilimumab|mesh-list
13970284|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13970285|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970286|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13970287|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970288|NCT03098199|Menotropins|menotropins|mesh-list
13970289|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970290|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13970291|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
13970292|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13970293|NCT03098121|Grazoprevir|grazoprevir|mesh-list
13970294|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
13970295|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970296|NCT03097939|Nivolumab|nivolumab|mesh-list
13970297|NCT03097939|Ipilimumab|ipilimumab|mesh-list
13970298|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13970299|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970300|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13970301|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970302|NCT03097848|Sorafenib|sorafenib|mesh-list
13970303|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970304|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13970305|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970306|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970307|NCT03097900|Caffeine|caffeine|mesh-list
13970308|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
13970309|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970310|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13970311|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970312|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13970313|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970314|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13970315|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13970316|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
13970317|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970318|NCT03097835|Anesthetics|anesthetics|mesh-list
13970319|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244566|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
14244567|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14244568|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
14244569|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244570|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
14244571|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244572|NCT00211757|Valproic Acid|valproic acid|mesh-list
14244573|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
14244574|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244575|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244576|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
14244577|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244578|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244579|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
14244580|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14244581|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244582|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14244583|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14244584|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14244585|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14244586|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14244587|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244588|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244589|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244590|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14244591|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
14244592|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13970320|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970321|NCT03097601|Sunitinib|sunitinib|mesh-list
13970322|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970323|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13970324|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13970325|NCT03097601|Growth Substances|growth substances|mesh-ancestor
13970326|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970327|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
15041569|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
15041570|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15041571|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
15041572|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15041573|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
15041574|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
15041575|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041576|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041577|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15041578|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
15041579|NCT02038452|Hormones|hormones|mesh-ancestor
15041580|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041581|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15041582|NCT02038452|Protective Agents|protective agents|mesh-ancestor
15041583|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15041584|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041585|NCT02038491|Anesthetics|anesthetics|mesh-list
15041586|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041587|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041588|NCT02038621|Paclitaxel|paclitaxel|mesh-list
15041589|NCT02038621|Capecitabine|capecitabine|mesh-list
15041590|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
15041591|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15041592|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041593|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
15041594|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
15041595|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
15041596|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041597|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13970328|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13970329|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970330|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970331|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
13970332|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13970333|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
13970334|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970335|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970336|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13970337|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
13970338|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
13970339|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13970340|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
13970341|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970342|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970343|NCT03097445|Nicotine|nicotine|mesh-list
13970344|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13970345|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
13970346|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970347|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970348|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13970349|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13970350|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
13970351|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970352|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970353|NCT03097406|Imidacloprid|imidacloprid|mesh-list
13970354|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
13970355|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970356|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970357|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970358|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
13970359|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
13970360|NCT03097120|Estrogens|estrogens|mesh-list
13970361|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15041598|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
15041599|NCT02038634|Betamethasone|betamethasone|mesh-list
15041600|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15041601|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
15041602|NCT02038634|Hormones|hormones|mesh-ancestor
15041603|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041604|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970362|NCT03097120|Hormones|hormones|mesh-ancestor
15041605|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14244593|NCT00211887|Interferons|interferons|mesh-list
14244594|NCT00211887|Interferon-beta|interferon-beta|mesh-list
14244595|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
14244596|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
14244597|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
14244598|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244599|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
14244600|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14244601|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
14244602|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244603|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14244604|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244605|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14244606|NCT00212134|Dipivefrin|dipivefrin|mesh-list
14244607|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14244608|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
14244609|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244610|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244611|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041606|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
15041607|NCT02038699|TIC10 compound|tic10 compound|mesh-list
15041608|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041609|NCT02038816|Azacitidine|azacitidine|mesh-list
15041610|NCT02038816|Deferasirox|deferasirox|mesh-list
15041611|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15041612|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
15041613|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041614|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041615|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041616|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15041617|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
15041618|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
15041619|NCT02038842|Vaccines|vaccines|mesh-list
15041620|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
15041621|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041622|NCT02038868|Tamsulosin|tamsulosin|mesh-list
15041623|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15041624|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15041625|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15041626|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
15041627|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041628|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041629|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041630|NCT02038868|Urological Agents|urological agents|mesh-ancestor
15041631|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
15041632|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15041633|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
15041634|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970363|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13970364|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970365|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13970366|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13970367|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13970368|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
13970369|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13970370|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13970371|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13970372|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
13970373|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13970374|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970375|NCT03097068|Ranibizumab|ranibizumab|mesh-list
13970376|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13970377|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13970378|NCT03097068|Growth Substances|growth substances|mesh-ancestor
13970379|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970380|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
13970381|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970382|NCT03097211|Levodopa|levodopa|mesh-list
13970383|NCT03097211|Benserazide|benserazide|mesh-list
13970384|NCT03097211|Resveratrol|resveratrol|mesh-list
13970385|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
13970386|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13970387|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13970388|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
13970389|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970390|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970391|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970392|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
13970393|NCT03097211|Protective Agents|protective agents|mesh-ancestor
13970394|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970395|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14244612|NCT00212758|Hormones|hormones|mesh-list
14244613|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244614|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244615|NCT00213135|Cladribine|cladribine|mesh-list
14244616|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244617|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244618|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
14244619|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244620|NCT00213148|Anastrozole|anastrozole|mesh-list
14244621|NCT00213148|Citric Acid|citric acid|mesh-list
14244622|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
14244623|NCT00213148|Clomiphene|clomiphene|mesh-list
14244624|NCT00213148|Enclomiphene|enclomiphene|mesh-list
14244625|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
14244626|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
14244627|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14244628|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
14244629|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
14244630|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244631|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14244632|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244633|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14244634|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14244635|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244636|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14244637|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
14244638|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244639|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244640|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14244641|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
14244642|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14244643|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14244644|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14244645|NCT00213239|Remifentanil|remifentanil|mesh-list
14244646|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14244647|NCT00213239|Narcotics|narcotics|mesh-ancestor
13970396|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13970397|NCT03097198|Tropicamide|tropicamide|mesh-list
13970398|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13970399|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
13970400|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
13970401|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970402|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970403|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13970404|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13970405|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
13970406|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970407|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970408|NCT03097003|Apremilast|apremilast|mesh-list
13970409|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13970410|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13970411|NCT03097003|Analgesics|analgesics|mesh-ancestor
13970412|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
13970413|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970414|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970415|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13970416|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13970417|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13970418|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13970419|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970420|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970421|NCT03096990|Apremilast|apremilast|mesh-list
13970422|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13970423|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13970424|NCT03096990|Analgesics|analgesics|mesh-ancestor
13970425|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
13970426|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041635|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041636|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15041637|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
15041638|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
15041639|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15041640|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
15041641|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041642|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041643|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
15041644|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15041645|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
15041646|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041647|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041648|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15041649|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
15041650|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
15041651|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15041652|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
15041653|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041654|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041655|NCT02039063|Quetmolimab|quetmolimab|mesh-list
15041656|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15041657|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15041658|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
15041659|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041660|NCT02039323|Tenofovir|tenofovir|mesh-list
15041661|NCT02039323|Maraviroc|maraviroc|mesh-list
15041662|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
15041663|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15041664|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15041665|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15041666|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041667|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041668|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15041669|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15041670|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15041671|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15041672|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15041673|NCT02039336|Docetaxel|docetaxel|mesh-list
15041674|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041675|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
15041676|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
13970427|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970428|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13970429|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13970430|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13970431|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13970432|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970433|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970434|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
13970435|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
13970436|NCT03096782|Melphalan|melphalan|mesh-list
13970437|NCT03096782|Busulfan|busulfan|mesh-list
13970438|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
13970439|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
13970440|NCT03096782|Rituximab|rituximab|mesh-list
13970441|NCT03096782|Fludarabine|fludarabine|mesh-list
13970442|NCT03096782|Clofarabine|clofarabine|mesh-list
13970443|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13970444|NCT03096782|Tacrolimus|tacrolimus|mesh-list
13970445|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
13970446|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
13970447|NCT03096782|Antibodies|antibodies|mesh-list
13970448|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
13970449|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13970450|NCT03096782|Lenograstim|lenograstim|mesh-list
13970451|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13970452|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
13970453|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970454|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13970455|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13970456|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
13970457|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970458|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970459|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13970460|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13970461|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
13970462|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13970463|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13970464|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970465|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13970466|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13970467|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
13970468|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13970469|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970470|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
13970471|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
13970472|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970473|NCT03096756|Protective Agents|protective agents|mesh-ancestor
13970474|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970475|NCT03096704|Vitamin D|vitamin d|mesh-list
13970476|NCT03096704|Vitamins|vitamins|mesh-ancestor
13970477|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
13970478|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970479|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13970480|NCT03096470|Anesthetics|anesthetics|mesh-list
13970481|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13970482|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970483|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
13970484|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970485|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
13970486|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
13970487|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
13970488|NCT03096327|Montelukast|montelukast|mesh-list
13970489|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13970490|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
13970491|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13970492|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
13970493|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13970494|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970495|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13970496|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13970497|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970498|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
13970499|NCT03096340|Irinotecan|irinotecan|mesh-list
13970500|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13970501|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970502|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13970503|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13970504|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970505|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970506|NCT03096392|Insulin|insulin|mesh-list
13970507|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13970508|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
13970509|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13970510|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970511|NCT03096522|Phenytoin|phenytoin|mesh-list
13970512|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
13970513|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13970514|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13970515|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13970516|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970517|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13970518|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13970519|NCT03096457|Paromomycin|paromomycin|mesh-list
13970520|NCT03096457|Pentamidine|pentamidine|mesh-list
13970521|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13970522|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970523|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13970524|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13970525|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
13970526|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13970527|NCT03096405|Methicillin|methicillin|mesh-list
13970528|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13970529|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970530|NCT03096249|Oxytocin|oxytocin|mesh-list
13970531|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
13970532|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13970533|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970534|NCT03096223|KHK4083|khk4083|mesh-list
13970535|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
13970536|NCT03095872|Petrolatum|petrolatum|mesh-list
13970537|NCT03095872|Emollients|emollients|mesh-ancestor
13970538|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
13970539|NCT03096080|XL647|xl647|mesh-list
13970540|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970541|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13970542|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970543|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970544|NCT03096184|Apatinib|apatinib|mesh-list
13970545|NCT03096184|Tegafur|tegafur|mesh-list
13970546|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970547|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13970548|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970549|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970550|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13970551|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
13970552|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
13970553|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
13970554|NCT03096028|Vitamins|vitamins|mesh-ancestor
13970555|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
13970556|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970557|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
13970558|NCT03096028|Hematinics|hematinics|mesh-ancestor
13970559|NCT03095547|Cyclosporine|cyclosporine|mesh-list
13970560|NCT03095547|Posaconazole|posaconazole|mesh-list
13970561|NCT03095547|Olorofim|olorofim|mesh-list
13970562|NCT03095547|Pantoprazole|pantoprazole|mesh-list
13970563|NCT03095547|Tacrolimus|tacrolimus|mesh-list
13970564|NCT03095547|Cyclosporins|cyclosporins|mesh-list
13970565|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13970566|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
13970567|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970568|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13970569|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970570|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970571|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
13970572|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970573|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
13970574|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13970575|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13970576|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13970577|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13970578|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13970579|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13970580|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13970581|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13970582|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13970583|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13970584|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
13970585|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13970586|NCT03095703|Sirolimus|sirolimus|mesh-list
13970587|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13970588|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970589|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13970590|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970591|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
13970592|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13970593|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
13970594|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244648|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244649|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244650|NCT00213239|Analgesics|analgesics|mesh-ancestor
14244651|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
14244652|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14244653|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
14244654|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14244655|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244656|NCT00214019|Fluticasone|fluticasone|mesh-list
14244657|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14244658|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14244659|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14244660|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14244661|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
14244662|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14244663|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244664|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14244665|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
14244666|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
14244667|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14244668|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14244669|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14244670|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14244671|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
14244672|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244673|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244674|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
14244675|NCT00214019|Hormones|hormones|mesh-ancestor
14244676|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244677|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
14531782|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531783|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531784|NCT02383433|Antiviral Agents|antiviral agents|mesh-ancestor
14531785|NCT02383433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531786|NCT02383433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531787|NCT02383433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531788|NCT02383433|Immunologic Factors|immunologic factors|mesh-ancestor
14531789|NCT02383433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531790|NCT02382588|Ganciclovir|ganciclovir|mesh-list
14531791|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
14531792|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14531793|NCT02379390|Prednisone|prednisone|mesh-list
14531794|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
14531795|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14531796|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
14531797|NCT02379390|Hormones|hormones|mesh-ancestor
14531798|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14531799|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531800|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14531801|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531802|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14531803|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531804|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531805|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
14531806|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14531807|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14531808|NCT02373865|Glimepiride|glimepiride|mesh-list
14531809|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14531810|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531811|NCT02373865|Incretins|incretins|mesh-ancestor
14531812|NCT02373865|Hormones|hormones|mesh-ancestor
15041677|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
13970595|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
13970596|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13970597|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13970598|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970599|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13970600|NCT03095469|Analgesics|analgesics|mesh-ancestor
13970601|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
13970602|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970603|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13970604|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13970605|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13970606|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
13970607|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970608|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970609|NCT03095404|Lidocaine|lidocaine|mesh-list
13970610|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13970611|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
13970612|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
13970613|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13970614|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970615|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
13970616|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970617|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13970618|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13970619|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13970620|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13970621|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970622|NCT03095274|Durvalumab|durvalumab|mesh-list
13970623|NCT03095274|Tremelimumab|tremelimumab|mesh-list
13970624|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13970625|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970626|NCT03095144|Anesthetics|anesthetics|mesh-list
13970627|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13970628|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970629|NCT03095352|Carboplatin|carboplatin|mesh-list
13970630|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
13970631|NCT03095352|Trastuzumab|trastuzumab|mesh-list
13970632|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970633|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13970634|NCT03095209|Paclitaxel|paclitaxel|mesh-list
13970635|NCT03095209|Carboplatin|carboplatin|mesh-list
13970636|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13970637|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970638|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
13970639|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
13970640|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
13970641|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970642|NCT03095222|Ketamine|ketamine|mesh-list
13970643|NCT03095222|Analgesics|analgesics|mesh-ancestor
13970644|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
13970645|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970646|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970647|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13970648|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13970649|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
13970650|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
13970651|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13970652|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13970653|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13970654|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970655|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970656|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
13970657|NCT03095378|Tetracycline|tetracycline|mesh-list
13970658|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13970659|NCT03095378|Citric Acid|citric acid|mesh-list
13970660|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
13970661|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13970662|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970663|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970664|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
13970665|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13970666|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
13970667|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
13970668|NCT03095326|Zinc|zinc|mesh-list
13970669|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
13970670|NCT03095326|Vaccines|vaccines|mesh-list
13970671|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
13970672|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970673|NCT03095326|Trace Elements|trace elements|mesh-ancestor
13970674|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
13970675|NCT03095326|Astringents|astringents|mesh-ancestor
13970676|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
13970677|NCT03095235|Riboflavin|riboflavin|mesh-list
13970678|NCT03095235|Vitamins|vitamins|mesh-ancestor
13970679|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
13970680|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970681|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
13970682|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13970683|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
13970684|NCT03095105|Resveratrol|resveratrol|mesh-list
13970685|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
13970686|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970687|NCT03095105|Protective Agents|protective agents|mesh-ancestor
13970688|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970689|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970690|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13970691|NCT03095079|Endostatins|endostatins|mesh-list
13970692|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13970693|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13970694|NCT03095079|Growth Substances|growth substances|mesh-ancestor
13970695|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970696|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
13970697|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970698|NCT03095040|Everolimus|everolimus|mesh-list
13970699|NCT03095040|Vorolanib|vorolanib|mesh-list
13970700|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970701|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13970702|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
13970703|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970704|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13970705|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970706|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970707|NCT03095001|Paclitaxel|paclitaxel|mesh-list
13970708|NCT03095001|Bevacizumab|bevacizumab|mesh-list
13970709|NCT03095001|Carboplatin|carboplatin|mesh-list
13970710|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13970711|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970712|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
13970713|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
13970714|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
13970715|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970716|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13970717|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13970718|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13970719|NCT03095001|Growth Substances|growth substances|mesh-ancestor
13970720|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970721|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
13970722|NCT03094663|Cefazolin|cefazolin|mesh-list
13970723|NCT03094663|Dexamethasone|dexamethasone|mesh-list
13970724|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
13970725|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
13970726|NCT03094663|Epinephrine|epinephrine|mesh-list
13970727|NCT03094663|Bupivacaine|bupivacaine|mesh-list
13970728|NCT03094663|BB 1101|bb 1101|mesh-list
13970729|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13970730|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
13970731|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
13970732|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970733|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970734|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13970735|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
13970736|NCT03094663|Hormones|hormones|mesh-ancestor
13970737|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13970738|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13970739|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970740|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
13970741|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970742|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970743|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
13970744|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
13970745|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13970746|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
13970747|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13970748|NCT03094663|Protective Agents|protective agents|mesh-ancestor
13970749|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13970750|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13970751|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
13970752|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970753|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13970754|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13970755|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13970756|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
13970757|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
13970758|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
13970759|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13970760|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13970761|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970762|NCT03094286|Durvalumab|durvalumab|mesh-list
13970763|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13970764|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970765|NCT03094481|Epinephrine|epinephrine|mesh-list
13970766|NCT03094481|Bupivacaine|bupivacaine|mesh-list
13970767|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
13970768|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
13970769|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13970770|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970771|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
13970772|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970773|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13970774|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13970775|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
13970776|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970777|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970778|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13970779|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13970780|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
13970781|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13970782|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
13970783|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
13970784|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
13970785|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13970786|NCT03094533|Propofol|propofol|mesh-list
13970787|NCT03094533|Sevoflurane|sevoflurane|mesh-list
13970788|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13970789|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13970790|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970791|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13970792|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
13970793|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
13970794|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13970795|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13970796|NCT03094403|Azelaic acid|azelaic acid|mesh-list
13970797|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970798|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
13970799|NCT03094468|Terbinafine|terbinafine|mesh-list
13970800|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
13970801|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970802|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970803|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970804|NCT03094507|Darunavir|darunavir|mesh-list
13970805|NCT03094507|Dolutegravir|dolutegravir|mesh-list
13970806|NCT03094507|Cobicistat|cobicistat|mesh-list
13970807|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13970808|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13970809|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
13970810|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970811|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970812|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13970813|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13970814|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
13970815|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970816|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13970817|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13970818|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13970819|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13970820|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
13970821|NCT03094182|Hematinics|hematinics|mesh-ancestor
13970822|NCT03094442|Dexamethasone|dexamethasone|mesh-list
13970823|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13970824|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
13970825|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
13970826|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970827|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970828|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13970829|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
13970830|NCT03094442|Hormones|hormones|mesh-ancestor
13970831|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13970832|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13970833|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970834|NCT03094247|Amoxicillin|amoxicillin|mesh-list
13970835|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13970836|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970837|NCT03094156|Resveratrol|resveratrol|mesh-list
13970838|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
13970839|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
13970840|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970841|NCT03094156|Protective Agents|protective agents|mesh-ancestor
13970842|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970843|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970844|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13970845|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
13970846|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970847|NCT03093805|Calcipotriene|calcipotriene|mesh-list
13970848|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
13970849|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
13970850|NCT03093883|Hematinics|hematinics|mesh-ancestor
13970851|NCT03093909|Gemcitabine|gemcitabine|mesh-list
13970852|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13970853|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
13970854|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970855|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970856|NCT03093909|Antiviral Agents|antiviral agents|mesh-ancestor
13970857|NCT03093909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970858|NCT03093909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970859|NCT03093909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13970860|NCT03093909|Immunologic Factors|immunologic factors|mesh-ancestor
13970861|NCT03093909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244678|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14244679|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244680|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244681|NCT00214461|Vaccines|vaccines|mesh-list
14244682|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
14244683|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244684|NCT00214890|Tenofovir|tenofovir|mesh-list
14244685|NCT00214890|Abacavir|abacavir|mesh-list
14244686|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
14244687|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14244688|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14244689|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14244690|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244691|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244692|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14244693|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14244694|NCT00215137|Citalopram|citalopram|mesh-list
14244695|NCT00215137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14244696|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14244697|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14244698|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244699|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244700|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
14244701|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244702|NCT00215137|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14244703|NCT00215137|Antidepressive Agents|antidepressive agents|mesh-ancestor
14244704|NCT00215137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14244705|NCT00215150|Ziprasidone|ziprasidone|mesh-list
14244706|NCT00215150|Sertraline|sertraline|mesh-list
14244707|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
14244708|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14244709|NCT00215150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14244710|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14244711|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14244712|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244713|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244714|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
14244715|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970862|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
13970863|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
13970864|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
13970865|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13970866|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13970867|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13970868|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970869|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
13970870|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
13970871|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
13970872|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970873|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
13970874|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13970875|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970876|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
13970877|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13970878|NCT03093545|Antibodies|antibodies|mesh-list
13970879|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
13970880|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970881|NCT03093597|Petrolatum|petrolatum|mesh-list
13970882|NCT03093597|Emollients|emollients|mesh-ancestor
13970883|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
13970884|NCT03093402|Lenabasum|lenabasum|mesh-list
13970885|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13970886|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13970887|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13970888|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970889|NCT03093402|Hormones|hormones|mesh-ancestor
13970890|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13970891|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970892|NCT03093129|Artesunate|artesunate|mesh-list
13970893|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
13970894|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13970895|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13970896|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13970897|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970898|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
13970899|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
13970900|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13970901|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
13970902|NCT03093389|Resveratrol|resveratrol|mesh-list
13970903|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
13970904|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970905|NCT03093389|Protective Agents|protective agents|mesh-ancestor
13970906|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970907|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970908|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13970909|NCT03093090|Furosemide|furosemide|mesh-list
13970910|NCT03093090|Diuretics|diuretics|mesh-ancestor
13970911|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
13970912|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970913|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13970914|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13970915|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970916|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
13970917|NCT03093168|Fludarabine|fludarabine|mesh-list
13970918|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13970919|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
13970920|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970921|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13970922|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13970923|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
13970924|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970925|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970926|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13970927|NCT03093103|Empagliflozin|empagliflozin|mesh-list
13970928|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13970929|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970930|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13970931|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970932|NCT03092986|Paclitaxel|paclitaxel|mesh-list
13970933|NCT03092986|Vinblastine|vinblastine|mesh-list
13970934|NCT03092986|Carboplatin|carboplatin|mesh-list
13970935|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13970936|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970937|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
13970938|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
13970939|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
13970940|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970941|NCT03092908|Acetic Acid|acetic acid|mesh-list
13970942|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13970943|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15041678|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041679|NCT02039362|Tenofovir|tenofovir|mesh-list
15041680|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
15041681|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15041682|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13970949|NCT03092817|Dexamethasone|dexamethasone|mesh-list
13970950|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13970951|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
13970952|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
13970953|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970954|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970955|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13970956|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
13970957|NCT03092817|Hormones|hormones|mesh-ancestor
13970958|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13970959|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13970960|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970961|NCT03092856|Axitinib|axitinib|mesh-list
13970962|NCT03092856|Antibodies|antibodies|mesh-list
13970963|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
13970964|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970965|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13970966|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13970967|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970968|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970969|NCT03092765|Quetmolimab|quetmolimab|mesh-list
13970970|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13970971|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
13970972|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
13970973|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13970974|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
13970975|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970976|NCT03092310|Pancrelipase|pancrelipase|mesh-list
13970977|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13970978|NCT03092193|Naproxen|naproxen|mesh-list
13970979|NCT03092193|Esomeprazole|esomeprazole|mesh-list
13970980|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13970981|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13970982|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13970983|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13970984|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13970985|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13970986|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13970987|NCT03092193|Analgesics|analgesics|mesh-ancestor
13970988|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
13970989|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13970990|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13970991|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13970992|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13970993|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
13970994|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13970995|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15041683|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15041684|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041685|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041686|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15041687|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15041688|NCT02039453|Fentanyl|fentanyl|mesh-list
15041689|NCT02039453|Meperidine|meperidine|mesh-list
15041690|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15041691|NCT02039453|Narcotics|narcotics|mesh-ancestor
15041692|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041693|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041694|NCT02039453|Analgesics|analgesics|mesh-ancestor
15041695|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
15041696|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041697|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13970996|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
13970997|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13970998|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13970999|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
13971000|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971001|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13971002|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13971003|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971004|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971005|NCT03092466|Ropivacaine|ropivacaine|mesh-list
13971006|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
13971007|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
13971008|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971009|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971010|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
13971011|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971012|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
13971013|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
13971014|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971015|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14244716|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14244717|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14244718|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14244719|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244720|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14244721|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
14244722|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14244723|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
14244724|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14244725|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
14244726|NCT00215644|Capecitabine|capecitabine|mesh-list
14244727|NCT00215644|Epirubicin|epirubicin|mesh-list
14244728|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244729|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14244730|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
14244731|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244732|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14244733|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14244734|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14244735|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244736|NCT00215787|Lansoprazole|lansoprazole|mesh-list
14244737|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
14244738|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14244739|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14244740|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14244741|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244742|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244743|NCT00215930|Gemcitabine|gemcitabine|mesh-list
14244744|NCT00215930|Carboplatin|carboplatin|mesh-list
14244745|NCT00215930|Docetaxel|docetaxel|mesh-list
14244746|NCT00215930|Vinorelbine|vinorelbine|mesh-list
14244747|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244748|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14244749|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
14244750|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244751|NCT00215930|Antiviral Agents|antiviral agents|mesh-ancestor
14244752|NCT00215930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14244753|NCT00215930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244754|NCT00215930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244755|NCT00215930|Immunologic Factors|immunologic factors|mesh-ancestor
14244756|NCT00215930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244757|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
14244758|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
14244759|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
14244760|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14244761|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
14244762|NCT00215943|Thalidomide|thalidomide|mesh-list
14244763|NCT00215943|Dexamethasone|dexamethasone|mesh-list
14244764|NCT00215943|Doxorubicin|doxorubicin|mesh-list
14244765|NCT00215943|Vincristine|vincristine|mesh-list
14244766|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14244767|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14244768|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
14531813|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244769|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
14244770|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971016|NCT03092076|Ticagrelor|ticagrelor|mesh-list
13971017|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13971018|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13971019|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13971020|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13971021|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
13971022|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971023|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971024|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971025|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
13971026|NCT03091894|Propofol|propofol|mesh-list
13971027|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13971028|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971029|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971030|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13971031|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
13971032|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
13971033|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13971034|NCT03091894|Analgesics|analgesics|mesh-ancestor
13971035|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
13971036|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971037|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13971038|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13971039|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13971040|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
13971041|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971042|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971043|NCT03091881|Granisetron|granisetron|mesh-list
13971044|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
13971045|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
13971046|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971047|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041698|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15041699|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
15041700|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
15041701|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
15041702|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
15041703|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15041704|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041705|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041706|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
15041707|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15041708|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041709|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041710|NCT02039492|Spironolactone|spironolactone|mesh-list
15041711|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15041712|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
13971048|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13971049|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13971050|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
13971051|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971052|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971053|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13971054|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13971055|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
13971056|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971057|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13971058|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13971059|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
13971060|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
13971061|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971062|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971063|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
13971064|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
13971065|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
13971066|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971067|NCT03091712|Insulin|insulin|mesh-list
13971068|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13971069|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971070|NCT03091699|Nicotine|nicotine|mesh-list
13971071|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13971072|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
13971073|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971074|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971075|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13971076|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13971077|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
13971078|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971079|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971080|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
13971081|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971082|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971083|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
13971084|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971085|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971086|NCT03091491|Nivolumab|nivolumab|mesh-list
13971087|NCT03091491|Ipilimumab|ipilimumab|mesh-list
13971088|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13971089|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971090|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13971091|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971092|NCT03091569|Vitamin K|vitamin k|mesh-list
13971093|NCT03091569|Vitamins|vitamins|mesh-ancestor
13971094|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
13971095|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971096|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13971097|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13971098|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971099|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
13971100|NCT03091569|Coagulants|coagulants|mesh-ancestor
13971101|NCT03091595|Drospirenone|drospirenone|mesh-list
13971102|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13971103|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13971104|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13971105|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13971106|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
13971107|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13971108|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971109|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13971110|NCT03091595|Estrogens|estrogens|mesh-ancestor
13971111|NCT03091595|Hormones|hormones|mesh-ancestor
13971112|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13971113|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13971114|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
13971115|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13971116|NCT03091595|Diuretics|diuretics|mesh-ancestor
13971117|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
13971118|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
13971119|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971120|NCT03091504|Albuterol|albuterol|mesh-list
13971121|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13971122|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
13971123|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971124|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971125|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13971126|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
13971127|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
13971128|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13971129|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13971130|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13971131|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13971132|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
13971133|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971134|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971135|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
13971136|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13971137|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971138|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971139|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13971140|NCT03091166|Analgesics|analgesics|mesh-ancestor
13971141|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
13971142|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971143|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13971144|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13971145|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13971146|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
13971147|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971148|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971149|NCT03091075|Oxandrolone|oxandrolone|mesh-list
13971150|NCT03091075|Androgens|androgens|mesh-ancestor
13971151|NCT03091075|Hormones|hormones|mesh-ancestor
13971152|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13971153|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971154|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
13971155|NCT03091257|Trametinib|trametinib|mesh-list
13971156|NCT03091257|Dabrafenib|dabrafenib|mesh-list
13971157|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971158|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13971159|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971160|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971161|NCT03090971|Diclofenac|diclofenac|mesh-list
13971162|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13971163|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13971164|NCT03090971|Analgesics|analgesics|mesh-ancestor
13971165|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
13971166|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971167|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971168|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13971169|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13971170|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13971171|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971172|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971173|NCT03090698|Triamcinolone|triamcinolone|mesh-list
13971174|NCT03090698|Hylan|hylan|mesh-list
13971175|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13971176|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
13971177|NCT03090698|Hormones|hormones|mesh-ancestor
13971178|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13971179|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971180|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
13971181|NCT03090698|Protective Agents|protective agents|mesh-ancestor
13971182|NCT03090776|Ketamine|ketamine|mesh-list
13971183|NCT03090776|Analgesics|analgesics|mesh-ancestor
13971184|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
13971185|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971186|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971187|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13971188|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13971189|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
13971190|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
13971191|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971192|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13971193|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13971194|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971195|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971196|NCT03090880|Tinzaparin|tinzaparin|mesh-list
13971197|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13971198|NCT03090880|Dalteparin|dalteparin|mesh-list
13971199|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
13971200|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13971201|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13971202|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971203|NCT03090503|Risperidone|risperidone|mesh-list
13971204|NCT03090503|Aripiprazole|aripiprazole|mesh-list
13971205|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13971206|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
13971207|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971208|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971209|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971210|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13971211|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13971212|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971213|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13971214|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13971215|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
13971216|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
13971217|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
13971218|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13971219|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13971220|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13971221|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13971222|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
13971223|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13971224|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971225|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971226|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13971227|NCT03090516|Donepezil|donepezil|mesh-list
13971228|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13971229|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971230|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971231|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
13971232|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971233|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971234|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
14244771|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244772|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14244773|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
14244774|NCT00215943|Hormones|hormones|mesh-ancestor
14244775|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244776|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14244777|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244778|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14244779|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14244780|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14244781|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244782|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244783|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14244784|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
14244785|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
14244786|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
14244787|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244788|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
14244789|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
14244790|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14244791|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14244792|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14244793|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14244794|NCT00215943|Growth Substances|growth substances|mesh-ancestor
14244795|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
14244796|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14244797|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
14244798|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14244799|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14244800|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244801|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14244802|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244803|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14244804|NCT00216086|Capecitabine|capecitabine|mesh-list
14244805|NCT00216086|Irinotecan|irinotecan|mesh-list
14244806|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14244807|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
14244808|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244809|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244810|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14244811|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14244812|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244813|NCT00216099|Folic Acid|folic acid|mesh-list
14244814|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
14244815|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
14244816|NCT00216099|Pemetrexed|pemetrexed|mesh-list
14244817|NCT00216099|Vitamins|vitamins|mesh-ancestor
14244818|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
14244819|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244820|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244821|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244822|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244823|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14244824|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14244825|NCT00216099|Hematinics|hematinics|mesh-ancestor
14244826|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
14244827|NCT00216125|Docetaxel|docetaxel|mesh-list
14244828|NCT00216125|Etoposide|etoposide|mesh-list
14244829|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244830|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
13971235|NCT03090269|Methylphenidate|methylphenidate|mesh-list
13971236|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13971237|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971238|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13971239|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13971240|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13971241|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971242|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
13971243|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971244|NCT03090087|Regadenoson|regadenoson|mesh-list
13971245|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
13971246|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13971247|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
13971248|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
13971249|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971250|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971251|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971252|NCT03090152|Bupivacaine|bupivacaine|mesh-list
13971253|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
13971254|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
13971255|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971256|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971257|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
13971258|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971259|NCT03089957|Urinastatin|urinastatin|mesh-list
13971260|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
13971261|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13971262|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
13971263|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971264|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971265|NCT03090048|Vitamin A|vitamin a|mesh-list
13971266|NCT03090048|Azithromycin|azithromycin|mesh-list
13971267|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
13971268|NCT03090048|Vitamins|vitamins|mesh-ancestor
13971269|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
13971270|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971271|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13971272|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971273|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
13971274|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971275|NCT03090048|Protective Agents|protective agents|mesh-ancestor
13971276|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13971277|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971278|NCT03090035|Interferons|interferons|mesh-list
13971279|NCT03090035|Ribavirin|ribavirin|mesh-list
13971280|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971281|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
13971282|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971283|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
13971284|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971285|NCT03089983|Isoniazid|isoniazid|mesh-list
13971286|NCT03089983|Rifapentine|rifapentine|mesh-list
13971287|NCT03089983|Buprenorphine|buprenorphine|mesh-list
13971288|NCT03089983|Methadone|methadone|mesh-list
13971289|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13971290|NCT03089983|Naloxone|naloxone|mesh-list
13971291|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13971292|NCT03089983|Narcotics|narcotics|mesh-ancestor
13971293|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971294|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971295|NCT03089983|Analgesics|analgesics|mesh-ancestor
13971296|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
13971297|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971298|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13971299|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
13971300|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
13971301|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
13971302|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13971303|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971304|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
13971305|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13971306|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
13971307|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971308|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13971309|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13971310|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
13971311|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
13971312|NCT03090009|Analgesics|analgesics|mesh-ancestor
15041713|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041714|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041715|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15041716|NCT02039492|Diuretics|diuretics|mesh-ancestor
15041717|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
15041718|NCT02039518|Gemcitabine|gemcitabine|mesh-list
15041719|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15041720|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
15041721|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041722|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041723|NCT02039518|Antiviral Agents|antiviral agents|mesh-ancestor
15041724|NCT02039518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15041725|NCT02039518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041726|NCT02039518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15041727|NCT02039518|Immunologic Factors|immunologic factors|mesh-ancestor
15041728|NCT02039518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041729|NCT02039531|Mitogens|mitogens|mesh-list
15041730|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
15041731|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
15041732|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041733|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15041734|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
15041735|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041736|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
15041737|NCT02039531|Protective Agents|protective agents|mesh-ancestor
15041738|NCT02039661|Lidocaine|lidocaine|mesh-list
15041739|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
15041740|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
15041741|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041742|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041743|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
15041744|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041745|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15041746|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15041747|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15041748|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15041749|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041750|NCT02039700|Lesinurad|lesinurad|mesh-list
15041751|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
15041752|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15041753|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
15041754|NCT02039700|Renal Agents|renal agents|mesh-ancestor
15041755|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15041756|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15041757|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15041758|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15041759|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15041760|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
15041761|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041762|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041763|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971313|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
13971314|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971315|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971316|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13971317|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13971318|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13971319|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13971320|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13971321|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971322|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971323|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13971324|NCT03089671|Vitamins|vitamins|mesh-list
13971325|NCT03089671|Riboflavin|riboflavin|mesh-list
13971326|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
13971327|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
13971328|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971329|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13971330|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
13971331|NCT03089645|Docetaxel|docetaxel|mesh-list
13971332|NCT03089645|Durvalumab|durvalumab|mesh-list
13971333|NCT03089645|Tremelimumab|tremelimumab|mesh-list
13971334|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13971335|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971336|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
13971337|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
13971338|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
15041764|NCT02039791|Paclitaxel|paclitaxel|mesh-list
15041765|NCT02039791|Carboplatin|carboplatin|mesh-list
15041766|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
15041767|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15041768|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971339|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971340|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13971341|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
13971342|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971343|NCT03089567|Listerine|listerine|mesh-list
13971344|NCT03089567|Fluorides|fluorides|mesh-list
13971345|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
13971346|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
13971347|NCT03089567|Protective Agents|protective agents|mesh-ancestor
13971348|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971349|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13971350|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971351|NCT03089658|Avelumab|avelumab|mesh-list
13971352|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13971353|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971354|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
13971355|NCT03089333|Glyburide|glyburide|mesh-list
13971356|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13971357|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971358|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13971359|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971360|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
13971361|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
13971362|NCT03089073|Coagulants|coagulants|mesh-ancestor
13971363|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13971364|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
13971365|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971366|NCT03088891|Antioxidants|antioxidants|mesh-list
13971367|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971368|NCT03088891|Protective Agents|protective agents|mesh-ancestor
13971369|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244831|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
14244832|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
14244833|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244834|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14244835|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14244836|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14244837|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244838|NCT00216203|Pemetrexed|pemetrexed|mesh-list
14244839|NCT00216203|Cetuximab|cetuximab|mesh-list
14244840|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244841|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041769|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
15041770|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
15041771|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
15041772|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041773|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15041774|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15041775|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
15041776|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15041777|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
15041778|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971370|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
13971371|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13971372|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971373|NCT03088631|Metformin|metformin|mesh-list
13971374|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13971375|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971376|NCT03088670|Metformin|metformin|mesh-list
13971377|NCT03088670|Vildagliptin|vildagliptin|mesh-list
13971378|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13971379|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971380|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13971381|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
13971382|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971383|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971384|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
13971385|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
13971386|NCT03088709|Tacrolimus|tacrolimus|mesh-list
13971387|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13971388|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
13971389|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971390|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13971391|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13971392|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
13971393|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971394|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971395|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13971396|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13971397|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971398|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13971399|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13971400|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
13971401|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13971402|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971403|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
13971404|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13971405|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971406|NCT03088358|Enoxaparin|enoxaparin|mesh-list
13971407|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
13971408|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13971409|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13971410|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971411|NCT03088254|Amlodipine|amlodipine|mesh-list
13971412|NCT03088254|Telmisartan|telmisartan|mesh-list
13971413|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13971414|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13971415|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13971416|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13971417|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971418|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13971419|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971420|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
13971421|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13971422|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13971423|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
13971424|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13971425|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13971426|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971427|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13971428|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14244842|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244843|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14244844|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14244845|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14244846|NCT00216476|Risperidone|risperidone|mesh-list
14244847|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14244848|NCT00216476|Aripiprazole|aripiprazole|mesh-list
14244849|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14244850|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
14244851|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244852|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244853|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244854|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13971429|NCT03088371|Lidocaine|lidocaine|mesh-list
13971430|NCT03088371|Bupivacaine|bupivacaine|mesh-list
13971431|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
13971432|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
13971433|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971434|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971435|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
13971436|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971437|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13971438|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13971439|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13971440|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13971441|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971442|NCT03088410|Zidovudine|zidovudine|mesh-list
13971443|NCT03088410|Nevirapine|nevirapine|mesh-list
13971444|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
13971445|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971446|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13971447|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13971448|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971449|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
13971450|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971451|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13971452|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13971453|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13971454|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13971455|NCT03088540|Gemcitabine|gemcitabine|mesh-list
13971456|NCT03088540|Paclitaxel|paclitaxel|mesh-list
13971457|NCT03088540|Carboplatin|carboplatin|mesh-list
13971458|NCT03088540|Pemetrexed|pemetrexed|mesh-list
13971459|NCT03088540|Cemiplimab|cemiplimab|mesh-list
13971460|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13971461|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971462|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
13971463|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
13971464|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
13971465|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971466|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13971467|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
13971468|NCT03088540|Antiviral Agents|antiviral agents|mesh-ancestor
13971469|NCT03088540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971470|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971471|NCT03088540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13971472|NCT03088540|Immunologic Factors|immunologic factors|mesh-ancestor
13971473|NCT03088540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971474|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13971475|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13971476|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13971477|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
13971478|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
13971479|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971480|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13971481|NCT03088306|Acetaminophen|acetaminophen|mesh-list
13971482|NCT03088306|Fentanyl|fentanyl|mesh-list
13971483|NCT03088306|Ketamine|ketamine|mesh-list
13971484|NCT03088306|Gabapentin|gabapentin|mesh-list
13971485|NCT03088306|Hydromorphone|hydromorphone|mesh-list
13971486|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
13971487|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971488|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971489|NCT03088306|Analgesics|analgesics|mesh-ancestor
13971490|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
13971491|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971492|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13971493|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13971494|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
13971495|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13971496|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13971497|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971498|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971499|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13971500|NCT03088306|Narcotics|narcotics|mesh-ancestor
13971501|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13971502|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13971503|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
13971504|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
13971505|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13971506|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13971507|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13971508|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
13971509|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
13971510|NCT03088293|Infliximab|infliximab|mesh-list
13971511|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13971512|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
13971513|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971514|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13971515|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13971516|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
13971517|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971518|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971519|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13971520|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
13971521|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13971522|NCT03087968|Prednisolone|prednisolone|mesh-list
13971523|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13971524|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
13971525|NCT03087968|Hormones|hormones|mesh-ancestor
13971526|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13971527|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971528|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13971529|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971530|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
13971531|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
13971532|NCT03087942|Growth Substances|growth substances|mesh-ancestor
13971533|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971534|NCT03088046|Progesterone|progesterone|mesh-list
13971535|NCT03088046|Progestins|progestins|mesh-ancestor
13971536|NCT03088046|Hormones|hormones|mesh-ancestor
13971537|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13971538|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971539|NCT03088384|Ketamine|ketamine|mesh-list
13971540|NCT03088384|Analgesics|analgesics|mesh-ancestor
13971541|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
13971542|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971543|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971544|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13971545|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13971546|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
13971547|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
13971548|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971549|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13971550|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13971551|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971552|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971553|NCT03088176|Trametinib|trametinib|mesh-list
13971554|NCT03088176|Dabrafenib|dabrafenib|mesh-list
13971555|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
13971556|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971557|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13971558|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971559|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971560|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13971561|NCT03088072|Aspirin|aspirin|mesh-list
13971562|NCT03088072|Warfarin|warfarin|mesh-list
13971563|NCT03088072|Edoxaban|edoxaban|mesh-list
13971564|NCT03088072|Clopidogrel|clopidogrel|mesh-list
13971565|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13971566|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13971567|NCT03088072|Analgesics|analgesics|mesh-ancestor
13971568|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
13971569|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971570|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971571|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13971572|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13971573|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13971574|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13971575|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971576|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13971577|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13971578|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971579|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
13971580|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14244855|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13971581|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13971582|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13971583|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
13971584|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971585|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
13971586|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13971587|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
13971588|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13971589|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
13971590|NCT03087890|Trimethoprim|trimethoprim|mesh-list
13971591|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
13971592|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
13971593|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13971594|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971595|NCT03087890|Renal Agents|renal agents|mesh-ancestor
13971596|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
13971597|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13971598|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13971599|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13971600|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971601|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971602|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13971603|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13971604|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13971605|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13971606|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
13971607|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13971608|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971609|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
13971610|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971611|NCT03087903|Protective Agents|protective agents|mesh-ancestor
13971612|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971613|NCT03087877|Acetaminophen|acetaminophen|mesh-list
13971614|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13971615|NCT03087877|Analgesics|analgesics|mesh-ancestor
13971616|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
13971617|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971618|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971619|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
13971620|NCT03087864|Paclitaxel|paclitaxel|mesh-list
13971621|NCT03087864|Carboplatin|carboplatin|mesh-list
13971622|NCT03087864|Atezolizumab|atezolizumab|mesh-list
13971623|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13971624|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971625|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
13971626|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
13971627|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
13971628|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971629|NCT03087669|Norepinephrine|norepinephrine|mesh-list
13971630|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13971631|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13971632|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
13971633|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971634|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971635|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971636|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
13971637|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
13971638|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971639|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13971640|NCT03087578|Mirabegron|mirabegron|mesh-list
13971641|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13971642|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15041779|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
15041780|NCT02039804|Protective Agents|protective agents|mesh-ancestor
15041781|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15041782|NCT02039869|Omeprazole|omeprazole|mesh-list
15041783|NCT02039869|Sucralfate|sucralfate|mesh-list
15041784|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15041785|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15041786|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15041787|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041788|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041789|NCT02039960|Bupropion|bupropion|mesh-list
15041790|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15041791|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
15041792|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13971643|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13971644|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
13971645|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971646|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971647|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971648|NCT03087578|Urological Agents|urological agents|mesh-ancestor
13971649|NCT03087539|Abciximab|abciximab|mesh-list
13971650|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
13971651|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13971652|NCT03087708|Naloxegol|naloxegol|mesh-list
13971653|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13971654|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971655|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
13971656|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971657|NCT03087201|Nabiximols|nabiximols|mesh-list
13971658|NCT03087201|Analgesics|analgesics|mesh-ancestor
13971659|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
13971660|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971661|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971662|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
13971663|NCT03087032|Liraglutide|liraglutide|mesh-list
13971664|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13971665|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971666|NCT03087032|Incretins|incretins|mesh-ancestor
13971667|NCT03087032|Hormones|hormones|mesh-ancestor
13971668|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244856|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244857|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14244858|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14244859|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
14244860|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
14244861|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
14244862|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14244863|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14244864|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14244865|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14244866|NCT00216671|Risperidone|risperidone|mesh-list
14244867|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14244868|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
14244869|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14244870|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244871|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244872|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14244873|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14244874|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14244875|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14244876|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14244877|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
14244878|NCT00216736|Dexamethasone|dexamethasone|mesh-list
14244879|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14244880|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
14244881|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
14244882|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14244883|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244884|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14244885|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
14244886|NCT00216736|Hormones|hormones|mesh-ancestor
14244887|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244888|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14244889|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244890|NCT00217022|Budesonide|budesonide|mesh-list
14244891|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14244892|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14244893|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
14244894|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14244895|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244896|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14244897|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
14244898|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
14244899|NCT00217022|Hormones|hormones|mesh-ancestor
14244900|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244901|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
14244902|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244903|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
14244904|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13971669|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
13971670|NCT03087162|Lansoprazole|lansoprazole|mesh-list
13971671|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13971672|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13971673|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13971674|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971675|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971676|NCT03087149|Vitamin D|vitamin d|mesh-list
13971677|NCT03087149|Vitamins|vitamins|mesh-ancestor
13971678|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
13971679|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971680|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13971681|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
13971682|NCT03087136|Antibodies|antibodies|mesh-list
13971683|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
13971684|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971685|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13971686|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13971687|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971688|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
13971689|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971690|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
13971691|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13971692|NCT03087136|Protective Agents|protective agents|mesh-ancestor
13971693|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13971694|NCT03087071|Panitumumab|panitumumab|mesh-list
13971695|NCT03087071|Trametinib|trametinib|mesh-list
13971696|NCT03087071|Antibodies|antibodies|mesh-list
13971697|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
13971698|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13971699|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
13971700|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971701|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971702|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13971703|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971704|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971705|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
13971706|NCT03086720|Eusol|eusol|mesh-list
13971707|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
13971708|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971709|NCT03086681|Cisplatin|cisplatin|mesh-list
13971710|NCT03086681|Endostar protein|endostar protein|mesh-list
13971711|NCT03086681|Endostatins|endostatins|mesh-list
13971712|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971713|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13971714|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13971715|NCT03086681|Growth Substances|growth substances|mesh-ancestor
13971716|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971717|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
13971718|NCT03086759|Triamcinolone|triamcinolone|mesh-list
13971719|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13971720|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13971721|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13971722|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13971723|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
13971724|NCT03086759|Hormones|hormones|mesh-ancestor
13971725|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13971726|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971727|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13971728|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
13971729|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971730|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971731|NCT03086733|Metformin|metformin|mesh-list
13971732|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13971733|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971734|NCT03086785|Apatinib|apatinib|mesh-list
13971735|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971736|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13971737|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971738|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971739|NCT03086382|Lacosamide|lacosamide|mesh-list
13971740|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
13971741|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13971742|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13971743|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13971744|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971745|NCT03086538|Pemetrexed|pemetrexed|mesh-list
13971746|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13971747|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971748|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971749|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971750|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13971751|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13971752|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13971753|NCT03086226|Itraconazole|itraconazole|mesh-list
13971754|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
13971755|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971756|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13971757|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13971758|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971759|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971760|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13971761|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
13971762|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13971763|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971764|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13971765|NCT03086291|Simvastatin|simvastatin|mesh-list
13971766|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13971767|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13971768|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
13971769|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971770|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13971771|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13971772|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971773|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
13971774|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
13971775|NCT03086564|Estrogens|estrogens|mesh-ancestor
13971776|NCT03086564|Hormones|hormones|mesh-ancestor
13971777|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13971778|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971779|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13971780|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971781|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
13971782|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13971783|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971784|NCT03086473|Caffeine|caffeine|mesh-list
13971785|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
13971786|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971787|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13971788|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971789|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13971790|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971791|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13971792|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13971793|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
13971794|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971795|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
13971796|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13971797|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971798|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971799|NCT03086174|Antibodies|antibodies|mesh-list
13971800|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13971801|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
13971802|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971803|NCT03085992|Bevacizumab|bevacizumab|mesh-list
13971804|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13971805|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971806|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13971807|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13971808|NCT03085992|Growth Substances|growth substances|mesh-ancestor
13971809|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971810|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
13971811|NCT03086005|Metformin|metformin|mesh-list
13971812|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13971813|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971814|NCT03086070|Omeprazole|omeprazole|mesh-list
13971815|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13971816|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13971817|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13971818|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971819|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971820|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
13971821|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
13971822|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13971823|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13971824|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971825|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971826|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971827|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13971828|NCT03086148|Ketamine|ketamine|mesh-list
13971829|NCT03086148|Analgesics|analgesics|mesh-ancestor
13971830|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
13971831|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971832|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971833|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13971834|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13971835|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
13971836|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
13971837|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971838|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13971839|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13971840|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971841|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971842|NCT03085654|Oxytocin|oxytocin|mesh-list
13971843|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
13971844|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13971845|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971846|NCT03085628|Oxytocin|oxytocin|mesh-list
13971847|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
13971848|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13971849|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971850|NCT03085771|Deferoxamine|deferoxamine|mesh-list
13971851|NCT03085771|Siderophores|siderophores|mesh-ancestor
13971852|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13971853|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
13971854|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
13971855|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971856|NCT03085784|Aflibercept|aflibercept|mesh-list
13971857|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13971858|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13971859|NCT03085784|Growth Substances|growth substances|mesh-ancestor
13971860|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971861|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
13971862|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971863|NCT03085849|Durvalumab|durvalumab|mesh-list
13971864|NCT03085849|Tremelimumab|tremelimumab|mesh-list
13971865|NCT03085849|Guadecitabine|guadecitabine|mesh-list
13971866|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13971867|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971868|NCT03085823|Sirolimus|sirolimus|mesh-list
13971869|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13971870|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971871|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13971872|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971873|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
13971874|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13971875|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
13971876|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971877|NCT03085563|Midazolam|midazolam|mesh-list
13971878|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
13971879|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13971880|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14244905|NCT00217399|Sorafenib|sorafenib|mesh-list
14244906|NCT00217399|Anastrozole|anastrozole|mesh-list
14244907|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244908|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14244909|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041793|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15041794|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15041795|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15041796|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041797|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
15041798|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041799|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041800|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13971881|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971882|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971883|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13971884|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13971885|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13971886|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13971887|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
13971888|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
13971889|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
13971890|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
13971891|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13971892|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971893|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13971894|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13971895|NCT03085563|Analgesics|analgesics|mesh-ancestor
13971896|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
13971897|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971898|NCT03085225|Durvalumab|durvalumab|mesh-list
13971899|NCT03085225|Trabectedin|trabectedin|mesh-list
13971900|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13971901|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971902|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13971903|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
13971904|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244910|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244911|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14244912|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14244913|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14244914|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14244915|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
14244916|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244917|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244918|NCT00217425|Prednisone|prednisone|mesh-list
14244919|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
14244920|NCT00217425|Bevacizumab|bevacizumab|mesh-list
14244921|NCT00217425|Doxorubicin|doxorubicin|mesh-list
14244922|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14244923|NCT00217425|Vincristine|vincristine|mesh-list
14244924|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244925|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
14244926|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244927|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14244928|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14244929|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
14244930|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244931|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244932|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14244933|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14244934|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14244935|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14244936|NCT00217425|Growth Substances|growth substances|mesh-ancestor
14244937|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
14244938|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14244939|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14244940|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14244941|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244942|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14244943|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
14244944|NCT00217425|Hormones|hormones|mesh-ancestor
14244945|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244946|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14244947|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14244948|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
14244949|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
14244950|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
14244951|NCT00217438|Melphalan|melphalan|mesh-list
14244952|NCT00217438|Amifostine|amifostine|mesh-list
14244953|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14244954|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
14244955|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244956|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244957|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14244958|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14244959|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
13971905|NCT03085368|Trastuzumab|trastuzumab|mesh-list
13971906|NCT03085368|Lapatinib|lapatinib|mesh-list
13971907|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13971908|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971909|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13971910|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971911|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971912|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13971913|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13971914|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
13971915|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13971916|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13971917|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971918|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
13971919|NCT03085394|Coagulants|coagulants|mesh-ancestor
13971920|NCT03085186|Crizotinib|crizotinib|mesh-list
13971921|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971922|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13971923|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971924|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971925|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
13971926|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13971927|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13971928|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971929|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13971930|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13971931|NCT03084978|Anesthetics|anesthetics|mesh-list
13971932|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971933|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971934|NCT03085030|Antioxidants|antioxidants|mesh-list
13971935|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971936|NCT03085030|Protective Agents|protective agents|mesh-ancestor
13971937|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971938|NCT03084809|Leucovorin|leucovorin|mesh-list
13971939|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
13971940|NCT03084809|Fluorouracil|fluorouracil|mesh-list
13971941|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
13971942|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971943|NCT03084809|Antidotes|antidotes|mesh-ancestor
13971944|NCT03084809|Protective Agents|protective agents|mesh-ancestor
13971945|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971946|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
13971947|NCT03084809|Vitamins|vitamins|mesh-ancestor
13971948|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
13971949|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
13971950|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971951|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13971952|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13971953|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
13971954|NCT03084588|Methadone|methadone|mesh-list
13971955|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13971956|NCT03084588|Narcotics|narcotics|mesh-ancestor
13971957|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13971958|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971959|NCT03084588|Analgesics|analgesics|mesh-ancestor
13971960|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
13971961|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971962|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
13971963|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
13971964|NCT03084575|Glycerol|glycerol|mesh-list
13971965|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
13971966|NCT03084575|Protective Agents|protective agents|mesh-ancestor
13971967|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971968|NCT03084783|Dexamethasone|dexamethasone|mesh-list
13971969|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13971970|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
13971971|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
13971972|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13971973|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971974|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13971975|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
13971976|NCT03084783|Hormones|hormones|mesh-ancestor
13971977|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13971978|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13971979|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971980|NCT03084250|Tenofovir|tenofovir|mesh-list
13971981|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13971982|NCT03084250|Entecavir|entecavir|mesh-list
13971983|NCT03084250|Adefovir|adefovir|mesh-list
13971984|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
13971985|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13971986|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13971987|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13971988|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13971989|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971990|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13971991|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13971992|NCT03084419|Abatacept|abatacept|mesh-list
13971993|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13971994|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13971995|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13971996|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13971997|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
13971998|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13971999|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13972000|NCT03084328|Vitamin D|vitamin d|mesh-list
13972001|NCT03084328|Vitamins|vitamins|mesh-ancestor
13972002|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
13972003|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972004|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13972005|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
13972006|NCT03084380|Fludarabine|fludarabine|mesh-list
13972007|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13972008|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
13972009|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972010|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13972011|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13972012|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
15041801|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15041802|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041803|NCT02039999|Citric Acid|citric acid|mesh-list
15041804|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
15041805|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15041806|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
15041807|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15041808|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
15041809|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
15041810|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041811|NCT02040064|Gefitinib|gefitinib|mesh-list
15041812|NCT02040064|Tremelimumab|tremelimumab|mesh-list
15041813|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041814|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15041815|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041816|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041817|NCT02040142|Mitomycins|mitomycins|mesh-list
15041818|NCT02040142|Mitomycin|mitomycin|mesh-list
15041819|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15041820|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041821|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
15041822|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041823|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15041824|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041825|NCT02040220|Aflibercept|aflibercept|mesh-list
15041826|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15041827|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15041828|NCT02040220|Growth Substances|growth substances|mesh-ancestor
15041829|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041830|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
15041831|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041832|NCT02040246|Metformin|metformin|mesh-list
15041833|NCT02040246|Repaglinide|repaglinide|mesh-list
15041834|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15041835|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041836|NCT02040285|Metoclopramide|metoclopramide|mesh-list
15041837|NCT02040285|Bisacodyl|bisacodyl|mesh-list
15041838|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
15041839|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
15041840|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041841|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041842|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15041843|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15041844|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15041845|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
15041846|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972013|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972014|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972015|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13972016|NCT03084237|Docetaxel|docetaxel|mesh-list
13972017|NCT03084237|Trastuzumab|trastuzumab|mesh-list
13972018|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972019|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
13972020|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
13972021|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
13972022|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972023|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13972024|NCT03084601|Calcium|calcium|mesh-list
13972025|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13972026|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972027|NCT03084029|Oxytocin|oxytocin|mesh-list
13972028|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
13972029|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13972030|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972031|NCT03083821|Entecavir|entecavir|mesh-list
13972032|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
13972033|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972034|NCT03083782|Cyclosporine|cyclosporine|mesh-list
13972035|NCT03083782|Apixaban|apixaban|mesh-list
13972036|NCT03083782|Tacrolimus|tacrolimus|mesh-list
13972037|NCT03083782|Cyclosporins|cyclosporins|mesh-list
13972038|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13972039|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
13972040|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972041|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13972042|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972043|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972044|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
13972045|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972046|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
13972047|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13972048|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13972049|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
13972050|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13972051|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
13972052|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
13972053|NCT03083834|Cosyntropin|cosyntropin|mesh-list
13972054|NCT03083834|Hormones|hormones|mesh-ancestor
13972055|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972056|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972057|NCT03083613|Paclitaxel|paclitaxel|mesh-list
13972058|NCT03083613|Raltitrexed|raltitrexed|mesh-list
13972059|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13972060|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972061|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
13972062|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
13972063|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
13972064|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972065|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13972066|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
13972067|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13972068|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972069|NCT03083691|Nivolumab|nivolumab|mesh-list
13972070|NCT03083691|Ipilimumab|ipilimumab|mesh-list
13972071|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13972072|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972073|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13972074|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972075|NCT03083704|Enoxaparin|enoxaparin|mesh-list
13972076|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
13972077|NCT03083704|Apixaban|apixaban|mesh-list
13972078|NCT03083704|Edoxaban|edoxaban|mesh-list
13972079|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
13972080|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13972081|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
13972082|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13972083|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
13972084|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972085|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972086|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
13972087|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13972088|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14244960|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972089|NCT03083457|Anesthetics|anesthetics|mesh-list
13972090|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
13972091|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972092|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972093|NCT03083405|Opipramol|opipramol|mesh-list
13972094|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13972095|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
13972096|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13972097|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13972098|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13972099|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13972100|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972101|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
13972102|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972103|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972104|NCT03083431|Propranolol|propranolol|mesh-list
13972105|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13972106|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13972107|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
13972108|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972109|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972110|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972111|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13972112|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13972113|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
13972114|NCT03083353|Isradipine|isradipine|mesh-list
13972115|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13972116|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13972117|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13972118|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972119|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13972120|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972121|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
13972122|NCT03083210|Lanreotide|lanreotide|mesh-list
13972123|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972124|NCT03083184|Ethanol|ethanol|mesh-list
13972125|NCT03083184|Enoxaparin|enoxaparin|mesh-list
13972126|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
13972127|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13972128|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13972129|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972130|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13972131|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972132|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972133|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972134|NCT03083041|Apatinib|apatinib|mesh-list
13972135|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972136|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13972137|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972138|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972139|NCT03083080|Epinephrine|epinephrine|mesh-list
13972140|NCT03083080|Ropivacaine|ropivacaine|mesh-list
13972141|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
13972142|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
13972143|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972144|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972145|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
13972146|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972147|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13972148|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13972149|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
13972150|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972151|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972152|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13972153|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13972154|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
13972155|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13972156|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
13972157|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
13972158|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
13972159|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13972160|NCT03082846|Temozolomide|temozolomide|mesh-list
13972161|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13972162|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
13972163|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972164|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972165|NCT03082885|Thymalfasin|thymalfasin|mesh-list
13972166|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13972167|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
13972168|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972169|NCT03082677|Ixazomib|ixazomib|mesh-list
13972170|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972171|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
13972172|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972173|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972174|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13972175|NCT03082742|Furosemide|furosemide|mesh-list
13972176|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13972177|NCT03082742|Diuretics|diuretics|mesh-ancestor
13972178|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
13972179|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972180|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13972181|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13972182|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972183|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13972184|NCT03082755|Gabapentin|gabapentin|mesh-list
13972185|NCT03082755|Analgesics|analgesics|mesh-ancestor
13972186|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
13972187|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972188|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972189|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
13972190|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13972191|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13972192|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972193|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13972194|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13972195|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13972196|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972197|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972198|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
13972199|NCT03082339|Cortisone|cortisone|mesh-list
13972200|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13972201|NCT03082300|Naquotinib|naquotinib|mesh-list
13972202|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972203|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13972204|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972205|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972206|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13972207|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972208|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
13972209|NCT03082534|Cetuximab|cetuximab|mesh-list
13972210|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13972211|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972212|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
13972213|NCT03082573|Hormones|hormones|mesh-ancestor
13972214|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972215|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972216|NCT03082352|Metoprolol|metoprolol|mesh-list
13972217|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13972218|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13972219|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
13972220|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
13972221|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972222|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972223|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13972224|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13972225|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13972226|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
13972227|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972228|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972229|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
13972230|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13972231|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13972232|NCT03082092|Prednisolone|prednisolone|mesh-list
13972233|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
13972234|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13972235|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
13972236|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13972237|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
13972238|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
13972239|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972240|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972241|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13972242|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
13972243|NCT03082092|Hormones|hormones|mesh-ancestor
13972244|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972245|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13972246|NCT03082092|Protective Agents|protective agents|mesh-ancestor
13972247|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13972248|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972249|NCT03082183|Rifampin|rifampin|mesh-list
13972250|NCT03082183|BI 425809|bi 425809|mesh-list
13972251|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13972252|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
13972253|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13972254|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972255|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
13972256|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13972257|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972258|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972259|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13972260|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13972261|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13972262|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13972263|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13972264|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13972265|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
13972266|NCT03082053|Capecitabine|capecitabine|mesh-list
13972267|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13972268|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
13972269|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972270|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972271|NCT03081923|Durvalumab|durvalumab|mesh-list
13972272|NCT03081923|Tremelimumab|tremelimumab|mesh-list
13972273|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13972274|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244961|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14244962|NCT00217438|Protective Agents|protective agents|mesh-ancestor
14244963|NCT00217464|Fulvestrant|fulvestrant|mesh-list
14244964|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14244965|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244966|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14244967|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14244968|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
14244969|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14244970|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244971|NCT00217581|Bevacizumab|bevacizumab|mesh-list
14244972|NCT00217581|Docetaxel|docetaxel|mesh-list
14244973|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
14244974|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14244975|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244976|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14244977|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14244978|NCT00217581|Growth Substances|growth substances|mesh-ancestor
14244979|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244980|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
15041847|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041848|NCT02040285|Cathartics|cathartics|mesh-ancestor
15041849|NCT02040285|Laxatives|laxatives|mesh-ancestor
15041850|NCT02040311|Topiramate|topiramate|mesh-list
15041851|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
15041852|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15041853|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041854|NCT02040350|Pralidoxime|pralidoxime|mesh-list
15041855|NCT02040350|Antidotes|antidotes|mesh-ancestor
15041856|NCT02040350|Protective Agents|protective agents|mesh-ancestor
15041857|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041858|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
15041859|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
15041860|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041861|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
15041862|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972275|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13972276|NCT03081949|Selenium|selenium|mesh-list
13972277|NCT03081949|Selenious Acid|selenious acid|mesh-list
13972278|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
13972279|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
13972280|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972281|NCT03081949|Protective Agents|protective agents|mesh-ancestor
13972282|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972283|NCT03081949|Trace Elements|trace elements|mesh-ancestor
13972284|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
13972285|NCT03081832|Oxytocin|oxytocin|mesh-list
13972286|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
13972287|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13972288|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972289|NCT03082482|Nicotine|nicotine|mesh-list
13972290|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13972291|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
13972292|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972293|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972294|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13972295|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13972296|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
13972297|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972298|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972299|NCT03081494|Spartalizumab|spartalizumab|mesh-list
13972300|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13972301|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972302|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972303|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
13972304|NCT03081702|Itraconazole|itraconazole|mesh-list
13972305|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
13972306|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13972307|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13972308|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972309|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972310|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972311|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13972312|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
13972313|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13972314|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13972315|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13972316|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
13972317|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972318|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972319|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13972320|NCT03081728|Acetaminophen|acetaminophen|mesh-list
13972321|NCT03081728|Diclofenac|diclofenac|mesh-list
13972322|NCT03081728|Ropivacaine|ropivacaine|mesh-list
13972323|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
13972324|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
13972325|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972326|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972327|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
13972328|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972329|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13972330|NCT03081728|Analgesics|analgesics|mesh-ancestor
13972331|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
13972332|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13972333|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13972334|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13972335|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13972336|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972337|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972338|NCT03081689|Paclitaxel|paclitaxel|mesh-list
13972339|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13972340|NCT03081689|Carboplatin|carboplatin|mesh-list
13972341|NCT03081689|Nivolumab|nivolumab|mesh-list
13972342|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13972343|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972344|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
13972345|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
13972346|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
13972347|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972348|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13972349|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13972350|NCT03081676|Glimepiride|glimepiride|mesh-list
13972351|NCT03081676|Glucagon|glucagon|mesh-list
13972352|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
13972353|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13972354|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13972355|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13972356|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972357|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13972358|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
13972359|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13972360|NCT03081676|Hormones|hormones|mesh-ancestor
13972361|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972362|NCT03081676|Incretins|incretins|mesh-ancestor
13972363|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
13972364|NCT03081416|Dexamethasone|dexamethasone|mesh-list
13972365|NCT03081416|Ketorolac|ketorolac|mesh-list
13972366|NCT03081416|Ketamine|ketamine|mesh-list
13972367|NCT03081416|Metoclopramide|metoclopramide|mesh-list
13972368|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13972369|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
13972370|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
13972371|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972372|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972373|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13972374|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
13972375|NCT03081416|Hormones|hormones|mesh-ancestor
13972376|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972377|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13972378|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972379|NCT03081416|Analgesics|analgesics|mesh-ancestor
13972380|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
13972381|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13972382|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13972383|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
13972384|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
13972385|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972386|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13972387|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13972388|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972389|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972390|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13972391|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13972392|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13972393|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13972394|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972395|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13972396|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13972397|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
13972398|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13972399|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13972400|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
13972401|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13972402|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
13972403|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
13972404|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13972405|NCT03081039|Gemcitabine|gemcitabine|mesh-list
13972406|NCT03081039|Carboplatin|carboplatin|mesh-list
13972407|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972408|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13972409|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
13972410|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972411|NCT03081039|Antiviral Agents|antiviral agents|mesh-ancestor
13972412|NCT03081039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972413|NCT03081039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972414|NCT03081039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13972415|NCT03081039|Immunologic Factors|immunologic factors|mesh-ancestor
13972416|NCT03081039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972417|NCT03081169|Heparin|heparin|mesh-list
13972418|NCT03081169|Enoxaparin|enoxaparin|mesh-list
13972419|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
13972420|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
13972421|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13972422|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13972423|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972424|NCT03081442|Misoprostol|misoprostol|mesh-list
13972425|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
13972426|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13972427|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
13972428|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13972429|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14244981|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
14244982|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
14244983|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
14244984|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244985|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
14244986|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14244987|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244988|NCT00217620|Sorafenib|sorafenib|mesh-list
14244989|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244990|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14244991|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14244992|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14244993|NCT00217672|Bevacizumab|bevacizumab|mesh-list
14244994|NCT00217672|Docetaxel|docetaxel|mesh-list
14244995|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14244996|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14244997|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13972430|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13972431|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13972432|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
13972433|NCT03080974|Nivolumab|nivolumab|mesh-list
13972434|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13972435|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972436|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13972437|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972438|NCT03080675|Vitamins|vitamins|mesh-list
13972439|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
14244998|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14244999|NCT00217672|Growth Substances|growth substances|mesh-ancestor
14245000|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245001|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
14245002|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
14245003|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
14245004|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
14245005|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245006|NCT00217971|Dronabinol|dronabinol|mesh-list
14245007|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
14245008|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245009|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245010|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14245011|NCT00217971|Analgesics|analgesics|mesh-ancestor
14245012|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
14245013|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245014|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14245015|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14245016|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245017|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245018|NCT00217971|Hormones|hormones|mesh-ancestor
14245019|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14245020|NCT00218023|Naltrexone|naltrexone|mesh-list
14245021|NCT00218023|Levodopa|levodopa|mesh-list
14245022|NCT00218023|Carbidopa|carbidopa|mesh-list
14245023|NCT00218023|Modafinil|modafinil|mesh-list
14245024|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14245025|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14245026|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245027|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
14245028|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245029|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14245030|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14245031|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
14245032|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245033|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245034|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14245035|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245036|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14245037|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14245038|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14245039|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14245040|NCT00218062|Modafinil|modafinil|mesh-list
13972440|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041863|NCT02040376|Metformin|metformin|mesh-list
15041864|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15041865|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041866|NCT02040402|Vaccines|vaccines|mesh-list
15041867|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
13972441|NCT03080740|Metronidazole|metronidazole|mesh-list
13972442|NCT03080740|Clindamycin|clindamycin|mesh-list
13972443|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
13972444|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
13972445|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972446|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13972447|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13972448|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13972449|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13972450|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972451|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972452|NCT03080766|Decitabine|decitabine|mesh-list
15041868|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041869|NCT02040415|Eperisone|eperisone|mesh-list
15041870|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
15041871|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15041872|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15041873|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041874|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15041875|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041876|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15041877|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15041878|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041879|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
15041880|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
15041881|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
15041882|NCT02040441|Spironolactone|spironolactone|mesh-list
15041883|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15041884|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
15041885|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041886|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041887|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15041888|NCT02040441|Diuretics|diuretics|mesh-ancestor
15041889|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
15041890|NCT02040454|Paclitaxel|paclitaxel|mesh-list
15041891|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15041892|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15041893|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
15041894|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
15041895|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
15041896|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041897|NCT02040571|Insulin|insulin|mesh-list
15041898|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15041899|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041900|NCT02040597|Beclomethasone|beclomethasone|mesh-list
15041901|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
15041902|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
15041903|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15041904|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
15041905|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972453|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13972454|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
13972455|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972456|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972457|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972458|NCT03080441|Midodrine|midodrine|mesh-list
13972459|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
13972460|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
13972461|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972462|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972463|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13972464|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13972465|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13972466|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13972467|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
13972468|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972469|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972470|NCT03080805|Capecitabine|capecitabine|mesh-list
13972471|NCT03080805|Lapatinib|lapatinib|mesh-list
15041906|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972472|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13972473|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
13972474|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972475|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972476|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13972477|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972478|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
13972479|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
13972480|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972481|NCT03080363|Lidocaine|lidocaine|mesh-list
13972482|NCT03080363|Bupivacaine|bupivacaine|mesh-list
13972483|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
13972484|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
13972485|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972486|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972487|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
13972488|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972489|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13972490|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13972491|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13972492|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13972493|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245041|NCT00218062|Amphetamine|amphetamine|mesh-list
14245042|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
14245043|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14245044|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245045|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14245046|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14245047|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14245048|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245049|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
14245050|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
14245051|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245052|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
14245053|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245054|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
14245055|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14245056|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14245057|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14245058|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14245059|NCT00218257|Progesterone|progesterone|mesh-list
14245060|NCT00218257|Progestins|progestins|mesh-ancestor
14245061|NCT00218257|Hormones|hormones|mesh-ancestor
14245062|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14245063|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245064|NCT00218296|Lobeline|lobeline|mesh-list
14245065|NCT00218296|Nicotine|nicotine|mesh-list
14245066|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14245067|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
14245068|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245069|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245070|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14245071|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14245072|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
14245073|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245074|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245075|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
14245076|NCT00218387|Modafinil|modafinil|mesh-list
14245077|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14245078|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245079|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14245080|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14245081|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14245082|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245083|NCT00218426|Naltrexone|naltrexone|mesh-list
14245084|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14245085|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14245086|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245087|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
14245088|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245089|NCT00218439|Paroxetine|paroxetine|mesh-list
14245090|NCT00218439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14245091|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13972494|NCT03080324|Fentanyl|fentanyl|mesh-list
13972495|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13972496|NCT03080324|Narcotics|narcotics|mesh-ancestor
13972497|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972498|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972499|NCT03080324|Analgesics|analgesics|mesh-ancestor
13972500|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
13972501|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972502|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13972503|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13972504|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
13972505|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
13972506|NCT03080545|Calcitriol|calcitriol|mesh-list
13972507|NCT03080545|Betamethasone|betamethasone|mesh-list
13972508|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13972509|NCT03080545|Calcipotriene|calcipotriene|mesh-list
13972510|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13972511|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
13972512|NCT03080545|Hormones|hormones|mesh-ancestor
13972513|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972514|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972515|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13972516|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
13972517|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13972518|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13972519|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13972520|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972521|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13972522|NCT03080545|Vitamins|vitamins|mesh-ancestor
13972523|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
13972524|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13972525|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
13972526|NCT03080480|Pioglitazone|pioglitazone|mesh-list
13972527|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13972528|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972529|NCT03080350|Fentanyl|fentanyl|mesh-list
13972530|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13972531|NCT03080350|Narcotics|narcotics|mesh-ancestor
13972532|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972533|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972534|NCT03080350|Analgesics|analgesics|mesh-ancestor
13972535|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
13972536|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972537|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13972538|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13972539|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
13972540|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
13972541|NCT03080181|Pasireotide|pasireotide|mesh-list
13972542|NCT03080181|Hormones|hormones|mesh-ancestor
13972543|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972544|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972545|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
13972546|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13972547|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13972548|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972549|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972550|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13972551|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13972552|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13972553|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
13972554|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972555|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972556|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13972557|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13972558|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
13972559|NCT03079973|Calcipotriene|calcipotriene|mesh-list
13972560|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
13972561|NCT03079830|Pirinitramide|pirinitramide|mesh-list
13972562|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13972563|NCT03079830|Narcotics|narcotics|mesh-ancestor
13972564|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972565|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972566|NCT03079830|Analgesics|analgesics|mesh-ancestor
13972567|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
13972568|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972569|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13972570|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972571|NCT03079895|Nicotine|nicotine|mesh-list
13972572|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13972573|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
13972574|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972575|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972576|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13972577|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13972578|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
13972579|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972580|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972581|NCT03079687|Olaparib|olaparib|mesh-list
13972582|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13972583|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972584|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972585|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972586|NCT03079440|Capecitabine|capecitabine|mesh-list
13972587|NCT03079440|Temozolomide|temozolomide|mesh-list
13972588|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13972589|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
13972590|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972591|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972592|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13972593|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
13972594|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
13972595|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13972596|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13972597|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13972598|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13972599|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972600|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
13972601|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972602|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972603|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13972604|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972605|NCT03079453|Dexamethasone|dexamethasone|mesh-list
13972606|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13972607|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
13972608|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
13972609|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972610|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972611|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13972612|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
13972613|NCT03079453|Hormones|hormones|mesh-ancestor
13972614|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972615|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13972616|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972617|NCT03079388|Azithromycin|azithromycin|mesh-list
13972618|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
13972619|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
13972620|NCT03079388|Albendazole|albendazole|mesh-list
13972621|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
13972622|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13972623|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972624|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
13972625|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13972626|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13972627|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13972628|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972629|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972630|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13972631|NCT03079388|Renal Agents|renal agents|mesh-ancestor
13972632|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
13972633|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
13972634|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13972635|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
13972636|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
13972637|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
13972638|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972639|NCT03079544|Asparaginase|asparaginase|mesh-list
13972640|NCT03079544|Pegaspargase|pegaspargase|mesh-list
13972641|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972642|NCT03079505|Dasatinib|dasatinib|mesh-list
13972643|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972644|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13972645|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972646|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972647|NCT03079427|Gemcitabine|gemcitabine|mesh-list
13972648|NCT03079427|Cisplatin|cisplatin|mesh-list
13972649|NCT03079427|Capecitabine|capecitabine|mesh-list
13972650|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972651|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13972652|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
13972653|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972654|NCT03079427|Antiviral Agents|antiviral agents|mesh-ancestor
13972655|NCT03079427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972656|NCT03079427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972657|NCT03079427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13972658|NCT03079427|Immunologic Factors|immunologic factors|mesh-ancestor
13972659|NCT03079427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972660|NCT03079219|Dexamethasone|dexamethasone|mesh-list
13972661|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
13972662|NCT03079219|Ondansetron|ondansetron|mesh-list
13972663|NCT03079219|Olanzapine|olanzapine|mesh-list
13972664|NCT03079219|Aprepitant|aprepitant|mesh-list
13972665|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
13972666|NCT03079219|BB 1101|bb 1101|mesh-list
13972667|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13972668|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
13972669|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
13972670|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972671|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972672|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13972673|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
13972674|NCT03079219|Hormones|hormones|mesh-ancestor
13972675|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972676|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13972677|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972678|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
13972679|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972680|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972681|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
13972682|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
13972683|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13972684|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
13972685|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972686|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13972687|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13972688|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972689|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13972690|NCT03079219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13972691|NCT03079219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13972692|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13972693|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13972694|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13972695|NCT03079271|Benzocaine|benzocaine|mesh-list
13972696|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
13972697|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
13972698|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972699|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972700|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
13972701|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972702|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
13972703|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13972704|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
13972705|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972706|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972707|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13972708|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
13972709|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13972710|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
13972711|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972712|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972713|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13972714|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
13972715|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
13972716|NCT03078933|Protective Agents|protective agents|mesh-ancestor
13972717|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
13972718|NCT03079167|Hematinics|hematinics|mesh-ancestor
13972719|NCT03078829|Leuprolide|leuprolide|mesh-list
13972720|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13972721|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
13972722|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13972723|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972724|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13972725|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972726|NCT03079011|Letrozole|letrozole|mesh-list
13972727|NCT03079011|Fulvestrant|fulvestrant|mesh-list
13972728|NCT03079011|Palbociclib|palbociclib|mesh-list
13972729|NCT03079011|Anastrozole|anastrozole|mesh-list
13972730|NCT03079011|Exemestane|exemestane|mesh-list
13972731|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
13972732|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972733|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13972734|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972735|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972736|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13972737|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
13972738|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972739|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972740|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13972741|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13972742|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13972743|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
13972744|NCT03079050|Lansoprazole|lansoprazole|mesh-list
13972745|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13972746|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13972747|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13972748|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972749|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972750|NCT03079076|Bupivacaine|bupivacaine|mesh-list
13972751|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
13972752|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
13972753|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972754|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972755|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
13972756|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972757|NCT03079141|Eplerenone|eplerenone|mesh-list
13972758|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13972759|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
13972760|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041907|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15041908|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
15041909|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15041910|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15041911|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15041912|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
15041913|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041914|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041915|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15041916|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15041917|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15041918|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
15041919|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15041920|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
15041921|NCT02040597|Hormones|hormones|mesh-ancestor
15041922|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15041923|NCT02040636|Vaccines|vaccines|mesh-list
15041924|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
15041925|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041926|NCT02040649|Midazolam|midazolam|mesh-list
15041927|NCT02040649|Propofol|propofol|mesh-list
15041928|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15041929|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041930|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041931|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15041932|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
15041933|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
15041934|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15041935|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15041936|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15041937|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15041938|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
15041939|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
15041940|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041941|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041942|NCT02040662|Morphine|morphine|mesh-list
13972761|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972762|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13972763|NCT03079141|Diuretics|diuretics|mesh-ancestor
13972764|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
13972765|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14245092|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14245093|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245094|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245095|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
14245096|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245097|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14245098|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
14245099|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245100|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14245101|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14245102|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245103|NCT00218465|Glycine|glycine|mesh-list
14245104|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
14245105|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245106|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245107|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245108|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
14245109|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14245110|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
14245111|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245112|NCT00218491|Expectorants|expectorants|mesh-ancestor
14245113|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
14245114|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14245115|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
14245116|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245117|NCT00218491|Protective Agents|protective agents|mesh-ancestor
14245118|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245119|NCT00218491|Antidotes|antidotes|mesh-ancestor
14245120|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14245121|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14245122|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14245123|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14245124|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245125|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
14245126|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245127|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245128|NCT00219141|Losartan|losartan|mesh-list
14245129|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14245130|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14245131|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14245132|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14245133|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245134|NCT00219284|Levodopa|levodopa|mesh-list
14245135|NCT00219284|Carbidopa|carbidopa|mesh-list
14245136|NCT00219284|Entacapone|entacapone|mesh-list
14245137|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14245138|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14245139|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14245140|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
14245141|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245142|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245143|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245144|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14245145|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245146|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
14245147|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14245148|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
14245149|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
14245150|NCT00219349|Citalopram|citalopram|mesh-list
14245151|NCT00219349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14245152|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14245153|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14245154|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245155|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245156|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
14245157|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245158|NCT00219349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13972766|NCT03079115|Atorvastatin|atorvastatin|mesh-list
13972767|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13972768|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13972769|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
13972770|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041943|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15041944|NCT02040662|Narcotics|narcotics|mesh-ancestor
15041945|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041946|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041947|NCT02040662|Analgesics|analgesics|mesh-ancestor
15041948|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
15041949|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041950|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
15041951|NCT02040818|Tigecycline|tigecycline|mesh-list
15041952|NCT02040818|Heparin|heparin|mesh-list
13972771|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13972772|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13972773|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972774|NCT03078842|Zinc|zinc|mesh-list
13972775|NCT03078842|Trace Elements|trace elements|mesh-ancestor
13972776|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
13972777|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972778|NCT03078725|Metformin|metformin|mesh-list
13972779|NCT03078725|Glyburide|glyburide|mesh-list
13972780|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13972781|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972782|NCT03078465|Clopidogrel|clopidogrel|mesh-list
13972783|NCT03078465|Ticagrelor|ticagrelor|mesh-list
13972784|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13972785|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13972786|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13972787|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13972788|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
13972789|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972790|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972791|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972792|NCT03078777|Fexofenadine|fexofenadine|mesh-list
13972793|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13972794|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13972795|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13972796|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
13972797|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
13972798|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972799|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972800|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972801|NCT03078374|Warfarin|warfarin|mesh-list
13972802|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
13972803|NCT03078309|Cannabidiol|cannabidiol|mesh-list
13972804|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
13972805|NCT03078569|Testosterone|testosterone|mesh-list
13972806|NCT03078569|Androgens|androgens|mesh-ancestor
13972807|NCT03078569|Hormones|hormones|mesh-ancestor
13972808|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972809|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972810|NCT03078257|Aspirin|aspirin|mesh-list
13972811|NCT03078257|Tirofiban|tirofiban|mesh-list
13972812|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
13972813|NCT03078257|Clopidogrel|clopidogrel|mesh-list
13972814|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13972815|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13972816|NCT03078257|Analgesics|analgesics|mesh-ancestor
13972817|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
13972818|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972819|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972820|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13972821|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13972822|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13972823|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15041953|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13972824|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972825|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13972826|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13972827|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972828|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
13972829|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15041954|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
14245159|NCT00219349|Antidepressive Agents|antidepressive agents|mesh-ancestor
14245160|NCT00219349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245161|NCT00219544|Pregabalin|pregabalin|mesh-list
14245162|NCT00219544|Analgesics|analgesics|mesh-ancestor
14245163|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
14245164|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245165|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245166|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
14245167|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14245168|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14245169|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245170|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14245171|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14245172|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14245173|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14245174|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245175|NCT00219557|Gemcitabine|gemcitabine|mesh-list
14245176|NCT00219557|Axitinib|axitinib|mesh-list
14245177|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14245178|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
14245179|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245180|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245181|NCT00219557|Antiviral Agents|antiviral agents|mesh-ancestor
14245182|NCT00219557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245183|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245184|NCT00219557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14245185|NCT00219557|Immunologic Factors|immunologic factors|mesh-ancestor
14245186|NCT00219557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245187|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14245188|NCT00220636|Aripiprazole|aripiprazole|mesh-list
14245189|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
14245190|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245191|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14245192|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14245193|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14245194|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245195|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
14245196|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
14245197|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245198|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245199|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14245200|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14245201|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
14245202|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14245203|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14245204|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14245205|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14245206|NCT00220701|Dexetimide|dexetimide|mesh-list
14245207|NCT00220701|Citalopram|citalopram|mesh-list
14245208|NCT00220701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14245209|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14245210|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14245211|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245212|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245213|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
15041955|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15041956|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15041957|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041958|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
15041959|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15041960|NCT02040818|Expectorants|expectorants|mesh-ancestor
15041961|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
15041962|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15041963|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
15041964|NCT02040818|Protective Agents|protective agents|mesh-ancestor
15041965|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041966|NCT02040818|Antidotes|antidotes|mesh-ancestor
15041967|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15041968|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15041969|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15041970|NCT02040831|Vaccines|vaccines|mesh-list
15041971|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
15041972|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041973|NCT02040883|Olanzapine|olanzapine|mesh-list
15041974|NCT02040883|Risperidone|risperidone|mesh-list
13972830|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13972831|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13972832|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
13972833|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972834|NCT03078231|Mydriatics|mydriatics|mesh-list
13972835|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
13972836|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972837|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972838|NCT03078062|Dexamethasone|dexamethasone|mesh-list
13972839|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13972840|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
13972841|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
13972842|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972843|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972844|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13972845|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
13972846|NCT03078062|Hormones|hormones|mesh-ancestor
13972847|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972848|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13972849|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972850|NCT03078101|Empagliflozin|empagliflozin|mesh-list
13972851|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13972852|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972853|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13972854|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972855|NCT03077633|Progesterone|progesterone|mesh-list
13972856|NCT03077633|Progestins|progestins|mesh-ancestor
13972857|NCT03077633|Hormones|hormones|mesh-ancestor
13972858|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972859|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972860|NCT03077698|Megestrol|megestrol|mesh-list
13972861|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
13972862|NCT03077698|Progestins|progestins|mesh-list
13972863|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
13972864|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13972865|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13972866|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13972867|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
13972868|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13972869|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972870|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13972871|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13972872|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13972873|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972874|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
13972875|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13972876|NCT03077698|Hormones|hormones|mesh-ancestor
13972877|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972878|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
13972879|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
13972880|NCT03077581|Anesthetics|anesthetics|mesh-list
13972881|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972882|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972883|NCT03077828|Carboplatin|carboplatin|mesh-list
13972884|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
13972885|NCT03077828|Etoposide|etoposide|mesh-list
13972886|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
13972887|NCT03077828|Ifosfamide|ifosfamide|mesh-list
13972888|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
13972889|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
13972890|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13972891|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13972892|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13972893|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13972894|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13972895|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972896|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972897|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13972898|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
13972899|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
13972900|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
13972901|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
13972902|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
13972903|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
13972904|NCT03077503|Fentanyl|fentanyl|mesh-list
13972905|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
13972906|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13972907|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972908|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972909|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13972910|NCT03077503|Analgesics|analgesics|mesh-ancestor
13972911|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
13972912|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972913|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13972914|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13972915|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13972916|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
13972917|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972918|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972919|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13972920|NCT03077503|Narcotics|narcotics|mesh-ancestor
13972921|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13972922|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13972923|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
13972924|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
13972925|NCT03077516|Meloxicam|meloxicam|mesh-list
13972926|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13972927|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13972928|NCT03077516|Analgesics|analgesics|mesh-ancestor
13972929|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
13972930|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972931|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972932|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13972933|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13972934|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13972935|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13972936|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972937|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972938|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13972939|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13972940|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13972941|NCT03077555|Estradiol|estradiol|mesh-list
13972942|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13972943|NCT03077555|Estrogens|estrogens|mesh-ancestor
13972944|NCT03077555|Hormones|hormones|mesh-ancestor
13972945|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13972946|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972947|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13972948|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
13972949|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13972950|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13972951|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13972952|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13972953|NCT03077451|Nelfinavir|nelfinavir|mesh-list
13972954|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13972955|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13972956|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
13972957|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972958|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972959|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13972960|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13972961|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
13972962|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972963|NCT03077217|Rifaximin|rifaximin|mesh-list
13972964|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13972965|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972966|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14245214|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245215|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14245216|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
14245217|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245218|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14245219|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14245220|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
14245221|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
14245222|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245223|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14245224|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14245225|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
13972967|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
13972968|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13972969|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
13972970|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972971|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
13972972|NCT03077009|Protective Agents|protective agents|mesh-ancestor
13972973|NCT03076905|Olorofim|olorofim|mesh-list
13972974|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
13972975|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13972976|NCT03076710|Bupivacaine|bupivacaine|mesh-list
13972977|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
13972978|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
13972979|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13972980|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972981|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
13972982|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972983|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13972984|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13972985|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13972986|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13972987|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13972988|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13972989|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13972990|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972991|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
13972992|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13972993|NCT03076684|Allopurinol|allopurinol|mesh-list
13972994|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
13972995|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13972996|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13972997|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
13972998|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13972999|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13973000|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
13973001|NCT03076684|Protective Agents|protective agents|mesh-ancestor
13973002|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973003|NCT03076151|Tacrolimus|tacrolimus|mesh-list
13973004|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13973005|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
13973006|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973007|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13973008|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973009|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973010|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
13973011|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
13973012|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13973013|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973014|NCT03076112|Incretins|incretins|mesh-ancestor
13973015|NCT03076112|Hormones|hormones|mesh-ancestor
13973016|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973017|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13973018|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
13973019|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973020|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973021|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13973022|NCT03076203|Niraparib|niraparib|mesh-list
13973023|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
13973024|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13973025|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973026|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973027|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973028|NCT03076320|Adapalene|adapalene|mesh-list
13973029|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
13973030|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
13973031|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13973032|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13973033|NCT03076320|Analgesics|analgesics|mesh-ancestor
13973034|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
13973035|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973036|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973037|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973038|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13973039|NCT03076281|Metformin|metformin|mesh-list
13973040|NCT03076281|Doxycycline|doxycycline|mesh-list
13973041|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13973042|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973043|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13973044|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973045|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
13973046|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13973047|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13973048|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
13973049|NCT03076021|Isotretinoin|isotretinoin|mesh-list
13973050|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
13973051|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
13973052|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13973053|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13973054|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973055|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973056|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973057|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
13973058|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
13973059|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13973060|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973061|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973062|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13973063|NCT03076099|Analgesics|analgesics|mesh-ancestor
13973064|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
13973065|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973066|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13973067|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15041975|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15041976|NCT02040883|Aripiprazole|aripiprazole|mesh-list
15041977|NCT02040883|Ziprasidone|ziprasidone|mesh-list
15041978|NCT02040883|Tandospirone|tandospirone|mesh-list
15041979|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15041980|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
15041981|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15041982|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15041983|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15041984|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15041985|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15041986|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15041987|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15041988|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15041989|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
15041990|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
15041991|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
15041992|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15041993|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15041994|NCT02040883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13973068|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13973069|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
13973070|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973071|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973072|NCT03075657|Haloperidol|haloperidol|mesh-list
13973073|NCT03075657|Risperidone|risperidone|mesh-list
13973074|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
13973075|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15041995|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15041996|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15041997|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
15041998|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
15041999|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15042000|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15042001|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15042002|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15042003|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15042004|NCT02040909|Propofol|propofol|mesh-list
15042005|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15042006|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15042007|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042008|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15042009|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
15042010|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
15042011|NCT02040935|Trastuzumab|trastuzumab|mesh-list
15042012|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15042013|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042014|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
15042015|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13973076|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
13973077|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973078|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973079|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973080|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13973081|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13973082|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973083|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13973084|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13973085|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
13973086|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
13973087|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
13973088|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973089|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13973090|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13973091|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
13973092|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13973093|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13973094|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13973095|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973096|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
13973097|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973098|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973099|NCT03075358|Lidocaine|lidocaine|mesh-list
13973100|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
13973101|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
13973102|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973103|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973104|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
13973105|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973106|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13973107|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13973108|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13973109|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13973110|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245226|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
14245227|NCT00220727|Antibodies|antibodies|mesh-list
14245228|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
14245229|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14245230|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14245231|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
14245232|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
14245233|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245234|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
14245235|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14245236|NCT00220740|Antibodies|antibodies|mesh-list
14245237|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
14245238|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14245239|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
14245240|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
14245241|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245242|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
14245243|NCT00220779|Antibodies|antibodies|mesh-list
14245244|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
14245245|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14245246|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14245247|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
14245248|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
14245249|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245250|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
14245251|NCT00220805|Antibodies|antibodies|mesh-list
14245252|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
14245253|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14245254|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14245255|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
14245256|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
14245257|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245258|NCT00220961|Pioglitazone|pioglitazone|mesh-list
14245259|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14245260|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245261|NCT00221104|Pravastatin|pravastatin|mesh-list
14245262|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14245263|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14245264|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
14245265|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245266|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13973111|NCT03074942|Reslizumab|reslizumab|mesh-list
13973112|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13973113|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
13973114|NCT03074968|Benzydamine|benzydamine|mesh-list
13973115|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973116|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
13973117|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
13973118|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973119|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
13973120|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973121|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973122|NCT03074994|Anesthetics|anesthetics|mesh-list
13973123|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
13973124|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973125|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973126|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
13973127|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973128|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13973129|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973130|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13973131|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973132|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973133|NCT03075241|Zolpidem|zolpidem|mesh-list
13973134|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13973135|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13973136|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973137|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973138|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
13973139|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
13973140|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
13973141|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973142|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973143|NCT03074825|Chiauranib|chiauranib|mesh-list
13973144|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973145|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13973146|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973147|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973148|NCT03074773|Dexamethasone|dexamethasone|mesh-list
13973149|NCT03074773|Bupivacaine|bupivacaine|mesh-list
13973150|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973151|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
13973152|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
13973153|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973154|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973155|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13973156|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
13973157|NCT03074773|Hormones|hormones|mesh-ancestor
13973158|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973159|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13973160|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973161|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
13973162|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
13973163|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973164|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
13973165|NCT03074786|Tenofovir|tenofovir|mesh-list
13973166|NCT03074786|Emtricitabine|emtricitabine|mesh-list
13973167|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13973168|NCT03074786|Dapivirine|dapivirine|mesh-list
13973169|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
13973170|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973171|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13973172|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13973173|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973174|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973175|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13973176|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13973177|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
13973178|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13973179|NCT03074591|Hematinics|hematinics|mesh-ancestor
13973180|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
13973181|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
13973182|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
13973183|NCT03074578|Hormones|hormones|mesh-ancestor
13973184|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973185|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973186|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973187|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973198|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
13973199|NCT03074448|Cathartics|cathartics|mesh-ancestor
13973200|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13973201|NCT03074435|Ivermectin|ivermectin|mesh-list
13973202|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13973203|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973204|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
13973205|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13973206|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
13973207|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973208|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
13973209|NCT03074344|Protective Agents|protective agents|mesh-ancestor
13973210|NCT03074097|Bupivacaine|bupivacaine|mesh-list
13973211|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
13973212|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
13973213|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973214|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973215|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
13973216|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973217|NCT03074123|Cosyntropin|cosyntropin|mesh-list
13973218|NCT03074123|Hormones|hormones|mesh-ancestor
13973219|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973220|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973221|NCT03073928|Ropivacaine|ropivacaine|mesh-list
13973222|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
13973223|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
13973224|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973225|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973226|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
13973227|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973228|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
13973229|NCT03074136|Eusol|eusol|mesh-list
13973230|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
13973231|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973232|NCT03073850|Aspirin|aspirin|mesh-list
13973233|NCT03073850|Edoxaban|edoxaban|mesh-list
13973234|NCT03073850|Anticoagulants|anticoagulants|mesh-list
13973235|NCT03073850|Clopidogrel|clopidogrel|mesh-list
13973236|NCT03073850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13973237|NCT03073850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13973238|NCT03073850|Analgesics|analgesics|mesh-ancestor
13973239|NCT03073850|Sensory System Agents|sensory system agents|mesh-ancestor
13973240|NCT03073850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973241|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973242|NCT03073850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973243|NCT03073850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13973244|NCT03073850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13973245|NCT03073850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13973246|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973247|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13973248|NCT03073850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13973249|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973250|NCT03073850|Antipyretics|antipyretics|mesh-ancestor
13973251|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13973252|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13973253|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13973254|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
13973255|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973256|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13973257|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
13973258|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13973259|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
13973260|NCT03073863|Atorvastatin|atorvastatin|mesh-list
13973261|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13973262|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13973263|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
13973264|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973265|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13973266|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13973267|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973268|NCT03073889|Ropivacaine|ropivacaine|mesh-list
13973269|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
13973270|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
13973271|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973272|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973273|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
15042016|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042017|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15042018|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15042019|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042020|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042021|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042022|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15042023|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15042024|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15042025|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
15042026|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042027|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15042028|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15042029|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042030|NCT02041143|Caseins|caseins|mesh-list
15042031|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
15042032|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
15042033|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042034|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15042035|NCT02041234|Liraglutide|liraglutide|mesh-list
15042036|NCT02041234|Empagliflozin|empagliflozin|mesh-list
15042037|NCT02041234|Linagliptin|linagliptin|mesh-list
15042038|NCT02041234|Canagliflozin|canagliflozin|mesh-list
15042039|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15042040|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15042041|NCT02041234|Orlistat|orlistat|mesh-list
15042042|NCT02041234|Incretins|incretins|mesh-list
15042043|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15042044|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042045|NCT02041234|Hormones|hormones|mesh-ancestor
15042046|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042047|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
15042048|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042049|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042050|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15042051|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15042052|NCT02041273|Palbociclib|palbociclib|mesh-list
15042053|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042054|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15042055|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042056|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042057|NCT02041338|Paclitaxel|paclitaxel|mesh-list
15042058|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15042059|NCT02041338|Carboplatin|carboplatin|mesh-list
15042060|NCT02041338|Epirubicin|epirubicin|mesh-list
15042061|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15042062|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042063|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
15042064|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
15042065|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
15042066|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973274|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245267|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14245268|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245269|NCT00221195|Thrombin|thrombin|mesh-list
14245270|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
14245271|NCT00221195|Coagulants|coagulants|mesh-ancestor
14245272|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
14245273|NCT00221299|Hormones|hormones|mesh-list
14245274|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
14245275|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973275|NCT03073694|Melphalan|melphalan|mesh-list
13973276|NCT03073694|Mitomycins|mitomycins|mesh-list
13973277|NCT03073694|Mitomycin|mitomycin|mesh-list
13973278|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13973279|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
13973280|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973281|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973282|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14245276|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245277|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14245278|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14245279|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245280|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14245281|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14245282|NCT00221338|Gabapentin|gabapentin|mesh-list
14245283|NCT00221338|Analgesics|analgesics|mesh-ancestor
14245284|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
14245285|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245286|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245287|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
14245288|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14245289|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14245290|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14245291|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245292|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14245293|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14245294|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245295|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245296|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
14245297|NCT00221403|Valproic Acid|valproic acid|mesh-list
14245298|NCT00221403|Risperidone|risperidone|mesh-list
14245299|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14245300|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14245301|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
14245302|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245303|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531814|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14531815|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
14531816|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531817|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531818|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14531819|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531820|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
14531821|NCT02369744|Tamsulosin|tamsulosin|mesh-list
14531822|NCT02369744|Silodosin|silodosin|mesh-list
14531823|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14531824|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14531825|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14531826|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
14531827|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531828|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531829|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531830|NCT02369744|Urological Agents|urological agents|mesh-ancestor
14531831|NCT02379585|Paclitaxel|paclitaxel|mesh-list
14531832|NCT02379585|Docetaxel|docetaxel|mesh-list
14531833|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
14531834|NCT02379585|Doxorubicin|doxorubicin|mesh-list
14531835|NCT02379585|Trastuzumab|trastuzumab|mesh-list
14531836|NCT02379585|Pertuzumab|pertuzumab|mesh-list
13973283|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13973284|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
13973285|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973286|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13973287|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13973288|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973289|NCT03073408|Propofol|propofol|mesh-list
13973290|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13973291|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973292|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973293|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13973294|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
13973295|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
13973296|NCT03073317|Mitogens|mitogens|mesh-list
13973297|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
13973298|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973299|NCT03073343|Betaine|betaine|mesh-list
13973300|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13973301|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
13973302|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13973303|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
13973304|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973305|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13973306|NCT03072992|Curcumin|curcumin|mesh-list
13973307|NCT03072992|Paclitaxel|paclitaxel|mesh-list
13973308|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13973309|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973310|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
13973311|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
13973312|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
13973313|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973314|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13973315|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13973316|NCT03072992|Analgesics|analgesics|mesh-ancestor
13973317|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
13973318|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973319|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973320|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973321|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13973322|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973323|NCT03073265|Apixaban|apixaban|mesh-list
13973324|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13973325|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
13973326|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13973327|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
13973328|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973329|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973330|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
13973331|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13973332|NCT03073057|Budesonide|budesonide|mesh-list
13973333|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
13973334|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
13973335|NCT03073057|Charcoal|charcoal|mesh-list
13973336|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973337|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13973338|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
13973339|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973340|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973341|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13973342|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
13973343|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
13973344|NCT03073057|Hormones|hormones|mesh-ancestor
13973345|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973346|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13973347|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13973348|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13973349|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
13973350|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973351|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973352|NCT03073057|Antidotes|antidotes|mesh-ancestor
13973353|NCT03073057|Protective Agents|protective agents|mesh-ancestor
13973354|NCT03073018|Fosinopril|fosinopril|mesh-list
13973355|NCT03073018|Pravastatin|pravastatin|mesh-list
13973356|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13973357|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13973358|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
13973359|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973360|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13973361|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13973362|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973363|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13973364|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
13973365|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13973366|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
13973367|NCT03073369|Vitamin D|vitamin d|mesh-list
13973368|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13973369|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973370|NCT03073369|Vitamins|vitamins|mesh-ancestor
13973371|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
13973372|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13973373|NCT03072849|Fluticasone|fluticasone|mesh-list
13973374|NCT03072849|Azithromycin|azithromycin|mesh-list
13973375|NCT03072849|Montelukast|montelukast|mesh-list
13973376|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973377|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13973378|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
13973379|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973380|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973381|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13973382|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
13973383|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
13973384|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13973385|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13973386|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973387|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13973388|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
13973389|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973390|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13973391|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13973392|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973393|NCT03072771|Cytarabine|cytarabine|mesh-list
13973394|NCT03072771|Etoposide|etoposide|mesh-list
13973395|NCT03072771|Melphalan|melphalan|mesh-list
13973396|NCT03072771|Carmustine|carmustine|mesh-list
13973397|NCT03072771|Blinatumomab|blinatumomab|mesh-list
13973398|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13973399|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973400|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13973401|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13973402|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973403|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973404|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13973405|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
13973406|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
13973407|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973408|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13973409|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
13973410|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973411|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13973412|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
13973413|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13973414|NCT03072485|Metformin|metformin|mesh-list
13973415|NCT03072485|Sirolimus|sirolimus|mesh-list
13973416|NCT03072485|Diclofenac|diclofenac|mesh-list
13973417|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13973418|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973419|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13973420|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973421|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13973422|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973423|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
13973424|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13973425|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
13973426|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13973427|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13973428|NCT03072485|Analgesics|analgesics|mesh-ancestor
13973429|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
13973430|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973431|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973432|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13973433|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13973434|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973435|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973436|NCT03072589|Regadenoson|regadenoson|mesh-list
13973437|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
13973438|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13973439|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
13973440|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
13973441|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973442|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973443|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973444|NCT03072511|Nicotine|nicotine|mesh-list
13973445|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13973446|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
13973447|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973448|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973449|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13973450|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13973451|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
13973452|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973453|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973454|NCT03072264|Fluoxetine|fluoxetine|mesh-list
13973455|NCT03072264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13973456|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13973457|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13973458|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973459|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973460|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
13973461|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973462|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13973463|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
13973464|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13973465|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13973466|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13973467|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973468|NCT03072394|Lidocaine|lidocaine|mesh-list
13973469|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
13973470|NCT03072394|Anesthetics|anesthetics|mesh-list
13973471|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973472|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973473|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
13973474|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973475|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13973476|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13973477|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13973478|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13973479|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973480|NCT03072329|Bupivacaine|bupivacaine|mesh-list
13973481|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
13973482|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
13973483|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973484|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973485|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
13973486|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973487|NCT03072082|Aspirin|aspirin|mesh-list
13973488|NCT03072082|Metoprolol|metoprolol|mesh-list
13973489|NCT03072082|Isosorbide|isosorbide|mesh-list
13973490|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
13973491|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
13973492|NCT03072082|Trimetazidine|trimetazidine|mesh-list
13973493|NCT03072082|Clopidogrel|clopidogrel|mesh-list
13973494|NCT03072082|Atorvastatin|atorvastatin|mesh-list
13973495|NCT03072082|Calcium|calcium|mesh-list
13973496|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13973497|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973498|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13973499|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13973500|NCT03072082|Analgesics|analgesics|mesh-ancestor
13973501|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
13973502|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973503|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973504|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13973505|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13973506|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13973507|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973508|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13973509|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13973510|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973511|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
13973512|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13973513|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13973514|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
13973515|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13973516|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13973517|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13973518|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13973519|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13973520|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
13973521|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973522|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13973523|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13973524|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
13973525|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
13973526|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13973527|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13973528|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13973529|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
13973530|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13973531|NCT03072082|Diuretics|diuretics|mesh-ancestor
13973532|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
15042067|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15042068|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15042069|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15042070|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042071|NCT02041351|Docetaxel|docetaxel|mesh-list
15042072|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042073|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
14245304|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245305|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15042074|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
15042075|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
15042076|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042077|NCT02041455|Amitriptyline|amitriptyline|mesh-list
15042078|NCT02041455|Melatonin|melatonin|mesh-list
15042079|NCT02041455|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15042080|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
15042081|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042082|NCT02041455|Protective Agents|protective agents|mesh-ancestor
15042083|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042084|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15042085|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15042086|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
15042087|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15042088|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15042089|NCT02041455|Analgesics|analgesics|mesh-ancestor
15042090|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
15042091|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042092|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15042093|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15042094|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15042095|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
15042096|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042097|NCT02041455|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15042098|NCT02041455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13973533|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
13973534|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13973535|NCT03072290|Triamcinolone|triamcinolone|mesh-list
13973536|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13973537|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13973538|NCT03072290|Lidocaine|lidocaine|mesh-list
13973539|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13973540|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
13973541|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
13973542|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973543|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973544|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
13973545|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973546|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14245306|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13973547|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13973548|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13973549|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13973550|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973551|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973552|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
13973553|NCT03072290|Hormones|hormones|mesh-ancestor
13973554|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973555|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13973556|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
13973557|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973558|NCT03072121|Aspirin|aspirin|mesh-list
13973559|NCT03072121|Metoprolol|metoprolol|mesh-list
13973560|NCT03072121|Isosorbide|isosorbide|mesh-list
13973561|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
13973562|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
13973563|NCT03072121|Trimetazidine|trimetazidine|mesh-list
13973564|NCT03072121|Clopidogrel|clopidogrel|mesh-list
13973565|NCT03072121|Atorvastatin|atorvastatin|mesh-list
13973566|NCT03072121|Calcium|calcium|mesh-list
13973567|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13973568|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973569|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13973570|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13973571|NCT03072121|Analgesics|analgesics|mesh-ancestor
13973572|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
13973573|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973574|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973575|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14245307|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14245308|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245309|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14245310|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
14245311|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
14245312|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245313|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
14245314|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
14245315|NCT00222105|Thalidomide|thalidomide|mesh-list
14245316|NCT00222105|Dexamethasone|dexamethasone|mesh-list
14245317|NCT00222105|Doxorubicin|doxorubicin|mesh-list
14245318|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14245319|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14245320|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
14245321|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
14245322|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245323|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245324|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14245325|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
14245326|NCT00222105|Hormones|hormones|mesh-ancestor
14245327|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14245328|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14245329|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245330|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14245331|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14245332|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14245333|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245334|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245335|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14245336|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
14245337|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
14245338|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14245339|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245340|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14245341|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14245342|NCT00222105|Growth Substances|growth substances|mesh-ancestor
14245343|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
13973576|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13973577|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13973578|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973579|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13973580|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13973581|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973582|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
13973583|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13973584|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14245344|NCT00222131|Esomeprazole|esomeprazole|mesh-list
14245345|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14245346|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13973585|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
13973586|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13973587|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13973588|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13973589|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13973590|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13973591|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
13973592|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973593|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13973594|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13973595|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
13973596|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
13973597|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13973598|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13973599|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13973600|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
13973601|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13973602|NCT03072121|Diuretics|diuretics|mesh-ancestor
13973603|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
13973604|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
13973605|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
13973606|NCT03072173|Xylometazoline|xylometazoline|mesh-list
13973607|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
13973608|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13973609|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
13973610|NCT03072199|Rituximab|rituximab|mesh-list
13973611|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13973612|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973613|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
13973614|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973615|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14245347|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14245348|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245349|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245350|NCT00222729|Bevacizumab|bevacizumab|mesh-list
14245351|NCT00222729|Pemetrexed|pemetrexed|mesh-list
14245352|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14245353|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245354|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14245355|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14245356|NCT00222729|Growth Substances|growth substances|mesh-ancestor
14245357|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245358|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
14245359|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245360|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245361|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14245362|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14245363|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
14245364|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
14245365|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245366|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14245367|NCT00223080|Antacids|antacids|mesh-ancestor
14245368|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245369|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14245370|NCT00223236|Choline|choline|mesh-list
14245371|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
14245372|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
14245373|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14245374|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
14245375|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245376|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14245377|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14245378|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
14245379|NCT00223262|Lamotrigine|lamotrigine|mesh-list
14245380|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
14245381|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14245382|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14245383|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245384|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14245385|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245386|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14245387|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14245388|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14245389|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13973616|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
13973617|NCT03071861|Hematinics|hematinics|mesh-ancestor
13973618|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
13973619|NCT03071679|Imiquimod|imiquimod|mesh-list
13973620|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13973621|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
13973622|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973623|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973624|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
13973625|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973626|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
13973627|NCT03071666|Vitamins|vitamins|mesh-ancestor
13973628|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
13973629|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973630|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
13973631|NCT03071822|Gemcitabine|gemcitabine|mesh-list
13973632|NCT03071822|Dexamethasone|dexamethasone|mesh-list
13973633|NCT03071822|Etoposide|etoposide|mesh-list
13973634|NCT03071822|Asparaginase|asparaginase|mesh-list
13973635|NCT03071822|Ifosfamide|ifosfamide|mesh-list
13973636|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973637|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973638|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
13973639|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
13973640|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973641|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973642|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13973643|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
13973644|NCT03071822|Hormones|hormones|mesh-ancestor
13973645|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973646|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13973647|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13973648|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
13973649|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973650|NCT03071822|Antiviral Agents|antiviral agents|mesh-ancestor
13973651|NCT03071822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973652|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973653|NCT03071822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13973654|NCT03071822|Immunologic Factors|immunologic factors|mesh-ancestor
13973655|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13973656|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13973657|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13973658|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13973659|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
13973660|NCT03071731|Bromides|bromides|mesh-list
13973661|NCT03071731|Ipratropium|ipratropium|mesh-list
13973662|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
13973663|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
13973664|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
13973665|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973666|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973667|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13973668|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
13973669|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973670|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973671|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13973672|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
13973673|NCT03071536|Furosemide|furosemide|mesh-list
13973674|NCT03071536|Diuretics|diuretics|mesh-ancestor
13973675|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
13973676|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973677|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13973678|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13973679|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973680|NCT03071575|Vaccines|vaccines|mesh-list
13973681|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
13973682|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973683|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
13973684|NCT03071549|Salicylates|salicylates|mesh-list
13973685|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973686|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
13973687|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
13973688|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
13973689|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13973690|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13973691|NCT03071549|Analgesics|analgesics|mesh-ancestor
13973692|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
13973693|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973694|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973695|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973696|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13973697|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13973698|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973699|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973700|NCT03071770|Ivosidenib|ivosidenib|mesh-list
13973701|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973702|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973703|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973704|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
13973705|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
13973706|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13973707|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
13973708|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973709|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973710|NCT03071705|Metformin|metformin|mesh-list
13973711|NCT03071705|Gefitinib|gefitinib|mesh-list
13973712|NCT03071705|Afatinib|afatinib|mesh-list
13973713|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13973714|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973715|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973716|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13973717|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973718|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973719|NCT03071289|Cisplatin|cisplatin|mesh-list
13973720|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973721|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
13973722|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
13973723|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
13973724|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973725|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973726|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
13973727|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13973728|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
13973729|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13973730|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
13973731|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973732|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973733|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
13973734|NCT03071055|Ranibizumab|ranibizumab|mesh-list
13973735|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13973736|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13973737|NCT03071055|Growth Substances|growth substances|mesh-ancestor
13973738|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973739|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
13973740|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973741|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13973742|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
13973743|NCT03071172|Progesterone|progesterone|mesh-list
13973744|NCT03071172|Hormones|hormones|mesh-ancestor
13973745|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973746|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973747|NCT03071172|Progestins|progestins|mesh-ancestor
13973748|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
13973749|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13973750|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
13973751|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13973752|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13973753|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13973754|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245390|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14245391|NCT00223496|Aripiprazole|aripiprazole|mesh-list
14245392|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
14245393|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245394|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14245395|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14245396|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14245397|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245398|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
14245399|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
14245400|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245401|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973755|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
13973756|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13973757|NCT03071042|Docetaxel|docetaxel|mesh-list
13973758|NCT03071042|Apatinib|apatinib|mesh-list
13973759|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973760|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
13973761|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
13973762|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
13973763|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973764|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13973765|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973766|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13973767|NCT03071068|Antibodies|antibodies|mesh-list
13973768|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
13973769|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13973770|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
13973771|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973772|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973773|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
13973774|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13973775|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13973776|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13973777|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973778|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
13973779|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13973780|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13973781|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973782|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
13973783|NCT03070847|Coagulants|coagulants|mesh-ancestor
13973784|NCT03070665|Norepinephrine|norepinephrine|mesh-list
13973785|NCT03070665|Ephedrine|ephedrine|mesh-list
13973786|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13973787|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13973788|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
13973789|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973790|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973791|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973792|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
13973793|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
13973794|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973795|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13973796|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13973797|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
13973798|NCT03070574|Mesalamine|mesalamine|mesh-list
13973799|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13973800|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13973801|NCT03070574|Analgesics|analgesics|mesh-ancestor
13973802|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
15042099|NCT02041481|Leucovorin|leucovorin|mesh-list
15042100|NCT02041481|Fluorouracil|fluorouracil|mesh-list
15042101|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
15042102|NCT02041481|Calcium|calcium|mesh-list
15042103|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
15042104|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15042105|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042106|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
15042107|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042108|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15042109|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042110|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042111|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
15042112|NCT02041481|Antidotes|antidotes|mesh-ancestor
15042113|NCT02041481|Protective Agents|protective agents|mesh-ancestor
15042114|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
15042115|NCT02041481|Vitamins|vitamins|mesh-ancestor
15042116|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
15042117|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
15042118|NCT02041546|Poractant alfa|poractant alfa|mesh-list
15042119|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
15042120|NCT02041650|Ticagrelor|ticagrelor|mesh-list
15042121|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15042122|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15042123|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13973803|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042124|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15042125|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
13973804|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973805|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973806|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13973807|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
13973808|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13973809|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973810|NCT03070704|Liraglutide|liraglutide|mesh-list
13973811|NCT03070704|Xultophy|xultophy|mesh-list
13973812|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13973813|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973814|NCT03070704|Incretins|incretins|mesh-ancestor
13973815|NCT03070704|Hormones|hormones|mesh-ancestor
13973816|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973817|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
13973818|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
13973819|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13973820|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973821|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13973822|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973823|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13973824|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13973825|NCT03070678|Analgesics|analgesics|mesh-ancestor
13973826|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
13973827|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973828|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973829|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13973830|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13973831|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973832|NCT03070522|Prednisone|prednisone|mesh-list
13973833|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973834|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
13973835|NCT03070522|Hormones|hormones|mesh-ancestor
13973836|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973837|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973838|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13973839|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973840|NCT03070613|Lectins|lectins|mesh-list
13973841|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
13973842|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
13973843|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973844|NCT03070613|Coagulants|coagulants|mesh-ancestor
13973845|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
13973846|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13973847|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042126|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042127|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042128|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042129|NCT02041767|Ertapenem|ertapenem|mesh-list
15042130|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15042131|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973848|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13973849|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13973850|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13973851|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973852|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
13973853|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973854|NCT03070379|Lidocaine|lidocaine|mesh-list
13973855|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
13973856|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
13973857|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973858|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973859|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
13973860|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973861|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13973862|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13973863|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13973864|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13973865|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973866|NCT03070405|Tenofovir|tenofovir|mesh-list
13973867|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
13973868|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
15042132|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
13973869|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973870|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13973871|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13973872|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973873|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973874|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13973875|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13973876|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
13973877|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14245402|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14245403|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14245404|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
14245405|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14245406|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14245407|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14245408|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14245409|NCT00223665|Leuprolide|leuprolide|mesh-list
14245410|NCT00223665|Flutamide|flutamide|mesh-list
14245411|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14245412|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
14245413|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14245414|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245415|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14245416|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245417|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
14245418|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
14245419|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14245420|NCT00223678|Sirolimus|sirolimus|mesh-list
14245421|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14245422|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245423|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14245424|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245425|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
14245426|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14245427|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
14245428|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245429|NCT00223704|Icatibant|icatibant|mesh-list
14245430|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
14245431|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14245432|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14245433|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245434|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
14245435|NCT00223704|Coagulants|coagulants|mesh-ancestor
14245436|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14245437|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14245438|NCT00223704|Analgesics|analgesics|mesh-ancestor
14245439|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
14245440|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245441|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245442|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14245443|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14245444|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
14245445|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
14245446|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14245447|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14245448|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
14245449|NCT00223821|Oxybutynin|oxybutynin|mesh-list
14245450|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
14245451|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
14245452|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245453|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245454|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14245455|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14245456|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
14245457|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245458|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245459|NCT00223821|Urological Agents|urological agents|mesh-ancestor
14245460|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
14245461|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
14245462|NCT00223977|Hematinics|hematinics|mesh-ancestor
14245463|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
14245464|NCT00224016|Oxybutynin|oxybutynin|mesh-list
14245465|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
14245466|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
14245467|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973878|NCT03070353|Dextrans|dextrans|mesh-list
13973879|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
13973880|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
13973881|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
13973882|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
13973883|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
13973884|NCT03070275|Coagulants|coagulants|mesh-ancestor
13973885|NCT03070223|Pitavastatin|pitavastatin|mesh-list
13973886|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13973887|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13973888|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13973889|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
13973890|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973891|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973892|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13973893|NCT03070028|Phenol|phenol|mesh-list
13973894|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13973895|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973896|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
13973897|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
13973898|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13973899|NCT03070054|Epinephrine|epinephrine|mesh-list
13973900|NCT03070054|Bupivacaine|bupivacaine|mesh-list
13973901|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
13973902|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
13973903|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13973904|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973905|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
13973906|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973907|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13973908|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13973909|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
13973910|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973911|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973912|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13973913|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13973914|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
13973915|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13973916|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
13973917|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
13973918|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
13973919|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13973920|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
13973921|NCT03069963|Antacids|antacids|mesh-ancestor
13973922|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973923|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13973924|NCT03069976|Metronidazole|metronidazole|mesh-list
13973925|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973926|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13973927|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13973928|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13973929|NCT03069950|Leucovorin|leucovorin|mesh-list
13973930|NCT03069950|Dexamethasone|dexamethasone|mesh-list
13973931|NCT03069950|Fluorouracil|fluorouracil|mesh-list
13973932|NCT03069950|Irinotecan|irinotecan|mesh-list
13973933|NCT03069950|Panitumumab|panitumumab|mesh-list
13973934|NCT03069950|Floxuridine|floxuridine|mesh-list
13973935|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13973936|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
13973937|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
13973938|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13973939|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973940|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13973941|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
13973942|NCT03069950|Hormones|hormones|mesh-ancestor
13973943|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973944|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13973945|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973946|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
13973947|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973948|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13973949|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042133|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15042134|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042135|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15042136|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
15042137|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042138|NCT02042170|Hormones|hormones|mesh-list
15042139|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042140|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042141|NCT02042196|Cetrorelix|cetrorelix|mesh-list
15042142|NCT02042196|Estradiol|estradiol|mesh-list
15042143|NCT02042196|Estrogens|estrogens|mesh-ancestor
15042144|NCT02042196|Hormones|hormones|mesh-ancestor
15042145|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042146|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042147|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15042148|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15042149|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
15042150|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
15042151|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
15042152|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042153|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
15042154|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042155|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042156|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15042157|NCT02042326|Sirolimus|sirolimus|mesh-list
15042158|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15042159|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042160|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15042161|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245468|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245469|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14245470|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15042162|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
15042163|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042164|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
15042165|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042166|NCT02042391|Cytarabine|cytarabine|mesh-list
15042167|NCT02042391|Prednisone|prednisone|mesh-list
13973950|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
13973951|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13973952|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13973953|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13973954|NCT03069950|Antidotes|antidotes|mesh-ancestor
13973955|NCT03069950|Protective Agents|protective agents|mesh-ancestor
15042168|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
15042169|NCT02042391|Rituximab|rituximab|mesh-list
15042170|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
15042171|NCT02042391|Doxorubicin|doxorubicin|mesh-list
15042172|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15042173|NCT02042391|Vincristine|vincristine|mesh-list
15042174|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042175|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
15042176|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042177|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15042178|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15042179|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
15042180|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042181|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042182|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15042183|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15042184|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15042185|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
15042186|NCT02042391|Hormones|hormones|mesh-ancestor
15042187|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042188|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15042189|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15042190|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
13973956|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
13973957|NCT03069950|Vitamins|vitamins|mesh-ancestor
15042191|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
15042192|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13973958|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
13973959|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13973960|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13973961|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13973962|NCT03069781|Estradiol|estradiol|mesh-list
13973963|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13973964|NCT03069781|Estrogens|estrogens|mesh-ancestor
13973965|NCT03069781|Hormones|hormones|mesh-ancestor
13973966|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13973967|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973968|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13973969|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
13973970|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13973971|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13973972|NCT03069820|Docetaxel|docetaxel|mesh-list
13973973|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973974|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
13973975|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
13973976|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
13973977|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973978|NCT03069768|Varenicline|varenicline|mesh-list
15042193|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15042194|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15042195|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13973979|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13973980|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13973981|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
13973982|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973983|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973984|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973985|NCT03069924|Nicotine|nicotine|mesh-list
13973986|NCT03069924|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13973987|NCT03069924|Autonomic Agents|autonomic agents|mesh-ancestor
13973988|NCT03069924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042196|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042197|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15042198|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
15042199|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
15042200|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
15042201|NCT02042482|Ubiquinone|ubiquinone|mesh-list
15042202|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
15042203|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
15042204|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042205|NCT02042482|Vitamins|vitamins|mesh-ancestor
15042206|NCT02042495|Metformin|metformin|mesh-list
15042207|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15042208|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042209|NCT02042573|Sertraline|sertraline|mesh-list
15042210|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
15042211|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15042212|NCT02042573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15042213|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15042214|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15042215|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042216|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042217|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
15042218|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042219|NCT02042599|Sevoflurane|sevoflurane|mesh-list
15042220|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15042221|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15042222|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
15042223|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
13973989|NCT03069924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13973990|NCT03069924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13973991|NCT03069924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13973992|NCT03069924|Cholinergic Agents|cholinergic agents|mesh-ancestor
13973993|NCT03069924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13973994|NCT03069924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13973995|NCT03069703|Rituximab|rituximab|mesh-list
13973996|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13973997|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13973998|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
13973999|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974000|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13974001|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
13974002|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13974003|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13974004|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13974005|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13974006|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974007|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
13974008|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974009|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974010|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13974011|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974012|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
13974013|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
13974014|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974015|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974016|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974017|NCT03069638|Analgesics|analgesics|mesh-ancestor
13974018|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
13974019|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974020|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13974021|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13974022|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13974023|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
13974024|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974025|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974026|NCT03069339|Carvedilol|carvedilol|mesh-list
13974027|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13974028|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13974029|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
13974030|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974031|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974032|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974033|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13974034|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
13974035|NCT03069339|Protective Agents|protective agents|mesh-ancestor
13974036|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13974037|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13974038|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13974039|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
13974040|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13974041|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13974042|NCT03069001|Ribavirin|ribavirin|mesh-list
13974043|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
13974044|NCT03069001|Simeprevir|simeprevir|mesh-list
13974045|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
13974046|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974047|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
13974048|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974049|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
13974050|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974051|NCT03069131|Rifaximin|rifaximin|mesh-list
13974052|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13974053|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974054|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13974055|NCT03069027|Lidocaine|lidocaine|mesh-list
13974056|NCT03069027|Epinephrine|epinephrine|mesh-list
13974057|NCT03069027|Racepinephrine|racepinephrine|mesh-list
13974058|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
13974059|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
13974060|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
13974061|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974062|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974063|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
13974064|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974065|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13974066|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13974067|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13974068|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13974069|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974070|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13974071|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13974072|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
13974073|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974074|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13974075|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13974076|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
13974077|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13974078|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
13974079|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
13974080|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
13974081|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13974082|NCT03069183|Ropivacaine|ropivacaine|mesh-list
13974083|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
13974084|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
13974085|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974086|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974087|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
13974088|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974089|NCT03069248|Interferons|interferons|mesh-list
13974090|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
13974091|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
13974092|NCT03069248|Rituximab|rituximab|mesh-list
13974093|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13974094|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974095|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
13974096|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974097|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13974098|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
13974099|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974100|NCT03068975|Alvimopan|alvimopan|mesh-list
13974101|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13974102|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
13974103|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974104|NCT03068936|Cisplatin|cisplatin|mesh-list
13974105|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974106|NCT03068832|Poly I-C|poly i-c|mesh-list
13974107|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
13974108|NCT03068832|Poly ICLC|poly iclc|mesh-list
13974109|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
13974110|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
13974111|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974112|NCT03068832|Laxatives|laxatives|mesh-ancestor
13974113|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13974114|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
13974115|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974116|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
13974117|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13974118|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974119|NCT03068910|Spironolactone|spironolactone|mesh-list
13974120|NCT03068910|Progesterone|progesterone|mesh-list
13974121|NCT03068910|Progestins|progestins|mesh-ancestor
13974122|NCT03068910|Hormones|hormones|mesh-ancestor
13974123|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13974124|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974125|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13974126|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
13974127|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13974128|NCT03068910|Diuretics|diuretics|mesh-ancestor
13974129|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
13974130|NCT03069144|Calcitriol|calcitriol|mesh-list
13974131|NCT03069144|Calcipotriene|calcipotriene|mesh-list
13974132|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
13974133|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13974134|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974135|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13974136|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13974137|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974138|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13974139|NCT03069144|Vitamins|vitamins|mesh-ancestor
13974140|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
13974141|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13974142|NCT03068650|Rindopepimut|rindopepimut|mesh-list
13974143|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13974144|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974145|NCT03068624|Aldesleukin|aldesleukin|mesh-list
13974146|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
13974147|NCT03068624|Ipilimumab|ipilimumab|mesh-list
13974148|NCT03068624|Interleukin-2|interleukin-2|mesh-list
13974149|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13974150|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
13974151|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974152|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13974153|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13974154|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
13974155|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974156|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974157|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13974158|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13974159|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13974160|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974161|NCT03068624|Analgesics|analgesics|mesh-ancestor
13974162|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
13974163|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974164|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13974165|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13974166|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
13974167|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245471|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
14245472|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245473|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245474|NCT00224016|Urological Agents|urological agents|mesh-ancestor
14245475|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14245476|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245477|NCT00224016|Renal Agents|renal agents|mesh-ancestor
14245478|NCT00224029|Oxybutynin|oxybutynin|mesh-list
14245479|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
14245480|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
14245481|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245482|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245483|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14245484|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14245485|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
14245486|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245487|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245488|NCT00224029|Urological Agents|urological agents|mesh-ancestor
14245489|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
14245490|NCT00224042|Hematinics|hematinics|mesh-ancestor
14245491|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
14245492|NCT00224055|Hematinics|hematinics|mesh-ancestor
14245493|NCT00224107|Silodosin|silodosin|mesh-list
14245494|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14245495|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14245496|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14245497|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
14245498|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245499|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245500|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245501|NCT00224107|Urological Agents|urological agents|mesh-ancestor
14245502|NCT00224120|Silodosin|silodosin|mesh-list
14245503|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14245504|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14245505|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14245506|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
14245507|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245508|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245509|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245510|NCT00224120|Urological Agents|urological agents|mesh-ancestor
14245511|NCT00224133|Silodosin|silodosin|mesh-list
14245512|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14245513|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14245514|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14245515|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
14245516|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245517|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974168|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
13974169|NCT03068533|Calcium|calcium|mesh-list
13974170|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13974171|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974172|NCT03068533|Antacids|antacids|mesh-ancestor
13974173|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974174|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13974175|NCT03068442|Flutemetamol|flutemetamol|mesh-list
13974176|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13974177|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974178|NCT03068429|Sertraline|sertraline|mesh-list
13974179|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
13974180|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13974181|NCT03068429|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13974182|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13974183|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13974184|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974185|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974186|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
13974187|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974188|NCT03068351|Daratumumab|daratumumab|mesh-list
13974189|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974190|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13974191|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13974192|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13974193|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13974194|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974195|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974196|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974197|NCT03068247|Analgesics|analgesics|mesh-ancestor
13974198|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
13974199|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974200|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
13974201|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13974202|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
13974203|NCT03068065|Metformin|metformin|mesh-list
13974204|NCT03068065|Liraglutide|liraglutide|mesh-list
13974205|NCT03068065|Gliclazide|gliclazide|mesh-list
13974206|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13974207|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974208|NCT03068065|Incretins|incretins|mesh-ancestor
13974209|NCT03068065|Hormones|hormones|mesh-ancestor
13974210|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13974211|NCT03068234|Pirfenidone|pirfenidone|mesh-list
13974212|NCT03068234|Analgesics|analgesics|mesh-ancestor
13974213|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
13974214|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974215|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974216|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13974217|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974218|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13974219|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13974220|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974221|NCT03068260|Acetaminophen|acetaminophen|mesh-list
13974222|NCT03068260|Ibuprofen|ibuprofen|mesh-list
13974223|NCT03068260|Morphine|morphine|mesh-list
13974224|NCT03068260|Ropivacaine|ropivacaine|mesh-list
13974225|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13974226|NCT03068260|Narcotics|narcotics|mesh-ancestor
13974227|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974228|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974229|NCT03068260|Analgesics|analgesics|mesh-ancestor
13974230|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
13974231|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974232|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
13974233|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
13974234|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974235|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
13974236|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13974237|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13974238|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13974239|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13974240|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974241|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974242|NCT03068208|Methylene Blue|methylene blue|mesh-list
13974243|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974244|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974245|NCT03067974|Ketamine|ketamine|mesh-list
13974246|NCT03067974|Analgesics|analgesics|mesh-ancestor
13974247|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
13974248|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974249|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974250|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13974251|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13974252|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
13974253|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
13974254|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974255|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13974256|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13974257|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974258|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974259|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
13974260|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13974261|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974262|NCT03067883|Ritonavir|ritonavir|mesh-list
13974263|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13974264|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13974265|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
13974266|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974267|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974268|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13974269|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13974270|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
13974271|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974272|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13974273|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13974274|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
13974275|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
13974276|NCT03067896|Bupivacaine|bupivacaine|mesh-list
13974277|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
13974278|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
13974279|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974280|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974281|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
13974282|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974283|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13974284|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974285|NCT03067896|Analgesics|analgesics|mesh-ancestor
13974286|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13974287|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13974288|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13974289|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
13974290|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974291|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974292|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13974293|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
13974294|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13974295|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13974296|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13974297|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
13974298|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13974299|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
13974300|NCT03067740|Bupivacaine|bupivacaine|mesh-list
13974301|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
13974302|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
13974303|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974304|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974305|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
13974306|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974307|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13974308|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974309|NCT03067740|Analgesics|analgesics|mesh-ancestor
13974310|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13974311|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13974312|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13974313|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
13974314|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974315|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974316|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
13974317|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
13974318|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974319|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
13974320|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974321|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974322|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
13974323|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13974324|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13974325|NCT03067753|Prednisolone|prednisolone|mesh-list
13974326|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
13974327|NCT03067753|Hormones|hormones|mesh-list
13974328|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13974329|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
13974330|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13974331|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974332|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13974333|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
13974334|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
13974335|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974336|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13974337|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
13974338|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13974339|NCT03067753|Protective Agents|protective agents|mesh-ancestor
13974340|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15042224|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15042225|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042226|NCT02042612|Sevoflurane|sevoflurane|mesh-list
15042227|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15042228|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15042229|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
15042230|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
15042231|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15042232|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042233|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15042234|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15042235|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042236|NCT02042664|Metformin|metformin|mesh-list
15042237|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15042238|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042239|NCT02042690|Dexamethasone|dexamethasone|mesh-list
15042240|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
15042241|NCT02042690|Methotrexate|methotrexate|mesh-list
15042242|NCT02042690|Epirubicin|epirubicin|mesh-list
15042243|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
15042244|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042245|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
13974341|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974342|NCT03067792|Leucovorin|leucovorin|mesh-list
13974343|NCT03067792|Docetaxel|docetaxel|mesh-list
13974344|NCT03067792|Fluorouracil|fluorouracil|mesh-list
13974345|NCT03067792|Irinotecan|irinotecan|mesh-list
13974346|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042246|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974347|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
13974348|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
13974349|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
13974350|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974351|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
13974352|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13974353|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13974354|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
13974355|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974356|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13974357|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13974358|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974359|NCT03067792|Antidotes|antidotes|mesh-ancestor
13974360|NCT03067792|Protective Agents|protective agents|mesh-ancestor
13974361|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
13974362|NCT03067792|Vitamins|vitamins|mesh-ancestor
13974363|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
13974364|NCT03067597|Dinoprostone|dinoprostone|mesh-list
13974365|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
13974366|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13974367|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974368|NCT03067688|Amlodipine|amlodipine|mesh-list
13974369|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
13974370|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13974371|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13974372|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13974373|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13974374|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974375|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13974376|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974377|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
13974378|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13974379|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13974380|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
13974381|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13974382|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13974383|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974384|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13974385|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13974386|NCT03067727|Dinoprostone|dinoprostone|mesh-list
13974387|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
13974388|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13974389|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974390|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
13974391|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974392|NCT03067103|Ketamine|ketamine|mesh-list
13974393|NCT03067103|Tramadol|tramadol|mesh-list
13974394|NCT03067103|Analgesics|analgesics|mesh-ancestor
13974395|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
13974396|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974397|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974398|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13974399|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13974400|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
13974401|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
13974402|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974403|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13974404|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13974405|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974406|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974407|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13974408|NCT03067103|Narcotics|narcotics|mesh-ancestor
13974409|NCT03067168|Bupivacaine|bupivacaine|mesh-list
13974410|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
13974411|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
13974412|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974413|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974414|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
13974415|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974416|NCT03067194|Celecoxib|celecoxib|mesh-list
13974417|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13974418|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974419|NCT03067194|Analgesics|analgesics|mesh-ancestor
13974420|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
13974421|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974422|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974423|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13974424|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13974425|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13974426|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13974427|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974428|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974429|NCT03067051|Verteporfin|verteporfin|mesh-list
13974430|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13974431|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
13974432|NCT03067415|Latanoprost|latanoprost|mesh-list
13974433|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13974434|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14245518|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245519|NCT00224133|Urological Agents|urological agents|mesh-ancestor
14245520|NCT00224289|Latanoprost|latanoprost|mesh-list
14245521|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14245522|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14245523|NCT00224484|Vaccines|vaccines|mesh-list
14245524|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
14245525|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245526|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14245527|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14245528|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14245529|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531837|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14531838|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531839|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
14531840|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
14531841|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
14531842|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531843|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531844|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
14531845|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531846|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14531847|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14531848|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
14531849|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14531850|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14531851|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14531852|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14531853|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531854|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14531855|NCT02370888|Lenalidomide|lenalidomide|mesh-list
14531856|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
14531857|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531858|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14531859|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14531860|NCT02370888|Growth Substances|growth substances|mesh-ancestor
14531861|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
14531862|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531863|NCT02367170|Midazolam|midazolam|mesh-list
14531864|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14531865|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14531866|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14531867|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531868|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14531869|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14531870|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14531871|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14531872|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
14531873|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
14531874|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
14531875|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
14531876|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531877|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531878|NCT02365233|Insulin|insulin|mesh-list
14531879|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14531880|NCT02365233|Pioglitazone|pioglitazone|mesh-list
14531881|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14531882|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
14531883|NCT02365233|Saxagliptin|saxagliptin|mesh-list
14531884|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14531885|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14531886|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531887|NCT02365233|Incretins|incretins|mesh-ancestor
13974435|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
13974436|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13974437|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13974438|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13974439|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13974440|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974441|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
13974442|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974443|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974444|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13974445|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974446|NCT03066791|Curcumin|curcumin|mesh-list
13974447|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13974448|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974449|NCT03066791|Analgesics|analgesics|mesh-ancestor
13974450|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
13974451|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974452|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974453|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13974454|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13974455|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974456|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974457|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974458|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
13974459|NCT03066817|Vitamin D|vitamin d|mesh-list
13974460|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13974461|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974462|NCT03066817|Vitamins|vitamins|mesh-ancestor
13974463|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
13974464|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13974465|NCT03066661|Entrectinib|entrectinib|mesh-list
13974466|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13974467|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974468|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974469|NCT03066700|Hemostatics|hemostatics|mesh-list
13974470|NCT03066700|Coagulants|coagulants|mesh-ancestor
13974471|NCT03066557|Apatinib|apatinib|mesh-list
13974472|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
13974473|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974474|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13974475|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974476|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974477|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
13974478|NCT03066557|Estrogens|estrogens|mesh-ancestor
13974479|NCT03066557|Hormones|hormones|mesh-ancestor
13974480|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13974481|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974482|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13974483|NCT03066544|Dexamethasone|dexamethasone|mesh-list
13974484|NCT03066544|Ketorolac|ketorolac|mesh-list
13974485|NCT03066544|Naratriptan|naratriptan|mesh-list
13974486|NCT03066544|Bupivacaine|bupivacaine|mesh-list
13974487|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13974488|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
13974489|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
13974490|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974491|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974492|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13974493|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
13974494|NCT03066544|Hormones|hormones|mesh-ancestor
13974495|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13974496|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13974497|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974498|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
13974499|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
13974500|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15042247|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15042248|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15042249|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
15042250|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042251|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042252|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15042253|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15042254|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
15042255|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
13974501|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
13974502|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13974503|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974504|NCT03066544|Analgesics|analgesics|mesh-ancestor
13974505|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13974506|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13974507|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245530|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
14245531|NCT00224874|Etanercept|etanercept|mesh-list
14245532|NCT00224874|Pentostatin|pentostatin|mesh-list
14245533|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
14245534|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14245535|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245536|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14245537|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
14245538|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15042256|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042257|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15042258|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
15042259|NCT02042690|Hormones|hormones|mesh-ancestor
15042260|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042261|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15042262|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042263|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15042264|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
15042265|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15042266|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15042267|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
15042268|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
15042269|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15042270|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15042271|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15042272|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15042273|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15042274|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
15042275|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
15042276|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042277|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
15042278|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042279|NCT02042742|Protective Agents|protective agents|mesh-ancestor
15042280|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042281|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15042282|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15042283|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
15042284|NCT02042989|Vorinostat|vorinostat|mesh-list
15042285|NCT02042989|Ixazomib|ixazomib|mesh-list
15042286|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042287|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15042288|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042289|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042290|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
15042291|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15042292|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15042293|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042294|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15042295|NCT02043054|Liraglutide|liraglutide|mesh-list
15042296|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15042297|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042298|NCT02043054|Incretins|incretins|mesh-ancestor
15042299|NCT02043054|Hormones|hormones|mesh-ancestor
13974508|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974509|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13974510|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
13974511|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13974512|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
13974513|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974514|NCT03066466|Methotrexate|methotrexate|mesh-list
13974515|NCT03066466|Atorvastatin|atorvastatin|mesh-list
13974516|NCT03066466|Tacrolimus|tacrolimus|mesh-list
13974517|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13974518|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
13974519|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13974520|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974521|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13974522|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
13974523|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974524|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974525|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
13974526|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974527|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13974528|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13974529|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
13974530|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13974531|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13974532|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13974533|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13974534|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13974535|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13974536|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13974537|NCT03066518|Melatonin|melatonin|mesh-list
13974538|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
13974539|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974540|NCT03066518|Protective Agents|protective agents|mesh-ancestor
13974541|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974542|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974543|NCT03066427|Sunitinib|sunitinib|mesh-list
13974544|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974545|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13974546|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13974547|NCT03066427|Growth Substances|growth substances|mesh-ancestor
13974548|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974549|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
13974550|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13974551|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974552|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974553|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
13974554|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
13974555|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
13974556|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974557|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
13974558|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13974559|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974560|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
13974561|NCT03066115|Ketorolac|ketorolac|mesh-list
13974562|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13974563|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974564|NCT03066115|Analgesics|analgesics|mesh-ancestor
13974565|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
13974566|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974567|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974568|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13974569|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13974570|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13974571|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974572|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974573|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
13974574|NCT03066115|Protective Agents|protective agents|mesh-ancestor
13974575|NCT03066115|Vitamins|vitamins|mesh-ancestor
13974576|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
13974577|NCT03066154|Ritonavir|ritonavir|mesh-list
13974578|NCT03066154|Docetaxel|docetaxel|mesh-list
13974579|NCT03066154|Androgens|androgens|mesh-list
13974580|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974581|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
13974582|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
13974583|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
13974584|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974585|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13974586|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13974587|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
13974588|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974589|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13974590|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13974591|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
13974592|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974593|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13974594|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13974595|NCT03066154|Hormones|hormones|mesh-ancestor
13974596|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13974597|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974598|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
13974599|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13974600|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974601|NCT03065868|Clarithromycin|clarithromycin|mesh-list
13974602|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13974603|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974604|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13974605|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974606|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974607|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13974608|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13974609|NCT03066011|Voriconazole|voriconazole|mesh-list
13974610|NCT03066011|Posaconazole|posaconazole|mesh-list
13974611|NCT03066011|Isavuconazole|isavuconazole|mesh-list
13974612|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
13974613|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974614|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13974615|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13974616|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974617|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974618|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13974619|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
13974620|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13974621|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974622|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13974623|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13974624|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13974625|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13974626|NCT03065998|Baclofen|baclofen|mesh-list
13974627|NCT03065998|Opipramol|opipramol|mesh-list
13974628|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13974629|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974630|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13974631|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974632|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13974633|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
13974634|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
13974635|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974636|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974637|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13974638|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
13974639|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13974640|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13974641|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13974642|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13974643|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
13974644|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
13974645|NCT03065816|Antacids|antacids|mesh-ancestor
13974646|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974647|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13974648|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
13974649|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13974650|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974651|NCT03065504|Turmeric extract|turmeric extract|mesh-list
13974652|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
13974653|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974654|NCT03065504|Protective Agents|protective agents|mesh-ancestor
13974655|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974656|NCT03065387|Everolimus|everolimus|mesh-list
13974657|NCT03065387|Palbociclib|palbociclib|mesh-list
13974658|NCT03065387|Trametinib|trametinib|mesh-list
13974659|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974660|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13974661|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
13974662|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974663|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13974664|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974665|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974666|NCT03065569|Bupivacaine|bupivacaine|mesh-list
13974667|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
13974668|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
13974669|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974670|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974671|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
13974672|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974673|NCT03065660|Mifepristone|mifepristone|mesh-list
13974674|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13974675|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
13974676|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13974677|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974678|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13974679|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13974680|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13974681|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
13974682|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13974683|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13974684|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
13974685|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13974686|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
13974687|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13974688|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13974689|NCT03065621|Palbociclib|palbociclib|mesh-list
13974690|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974691|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13974692|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974693|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245539|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245540|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245541|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245542|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14245543|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14245544|NCT00224874|Analgesics|analgesics|mesh-ancestor
14245545|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
14245546|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245547|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245548|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14245549|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14245550|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14245551|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14245552|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
14245553|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14245554|NCT00224952|Carbamazepine|carbamazepine|mesh-list
14245555|NCT00224952|Valproic Acid|valproic acid|mesh-list
15042300|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042301|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15042302|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
15042303|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042304|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974694|NCT03065309|Remifentanil|remifentanil|mesh-list
13974695|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13974696|NCT03065309|Narcotics|narcotics|mesh-ancestor
13974697|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974698|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974699|NCT03065309|Analgesics|analgesics|mesh-ancestor
13974700|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
13974701|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974702|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13974703|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13974704|NCT03064906|Pancrelipase|pancrelipase|mesh-list
13974705|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13974706|NCT03064633|Dexamethasone|dexamethasone|mesh-list
13974707|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
13974708|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
13974709|NCT03064633|Bupivacaine|bupivacaine|mesh-list
13974710|NCT03064633|BB 1101|bb 1101|mesh-list
13974711|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13974712|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
13974713|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
13974714|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974715|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974716|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13974717|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
13974718|NCT03064633|Hormones|hormones|mesh-ancestor
13974719|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13974720|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13974721|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974722|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
13974723|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974724|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974725|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
13974726|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
13974727|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974728|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
13974729|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13974730|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974731|NCT03064633|Analgesics|analgesics|mesh-ancestor
13974732|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13974733|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13974734|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13974735|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
13974736|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974737|NCT03064542|Carbimazole|carbimazole|mesh-list
13974738|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
13974739|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
13974740|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13974741|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974742|NCT03064568|Misoprostol|misoprostol|mesh-list
13974743|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13974744|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
13974745|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13974746|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974747|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13974748|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13974749|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
13974750|NCT03064282|Papaverine|papaverine|mesh-list
13974751|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13974752|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974753|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974754|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
13974755|NCT03064282|Urological Agents|urological agents|mesh-ancestor
13974756|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
13974757|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
13974758|NCT03064191|Calcium|calcium|mesh-list
13974759|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13974760|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974761|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13974762|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13974763|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974764|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
13974765|NCT03064165|Epinephrine|epinephrine|mesh-list
13974766|NCT03064165|Bupivacaine|bupivacaine|mesh-list
13974767|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
14245556|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
13974768|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
13974769|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974770|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974771|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
13974772|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974773|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13974774|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13974775|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
13974776|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974777|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974778|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13974779|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13974780|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
13974781|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13974782|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
13974783|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
13974784|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
13974785|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13974786|NCT03064295|Adenosine|adenosine|mesh-list
13974787|NCT03064295|Regadenoson|regadenoson|mesh-list
13974788|NCT03064295|Analgesics|analgesics|mesh-ancestor
13974789|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
13974790|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974791|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974792|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13974793|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
13974794|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
13974795|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
13974796|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
13974797|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974798|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974799|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
13974800|NCT03064243|Apatinib|apatinib|mesh-list
13974801|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974802|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13974803|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974804|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974805|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
13974806|NCT03063983|Methotrexate|methotrexate|mesh-list
13974807|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13974808|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
13974809|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974810|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13974811|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13974812|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
13974813|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974814|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974815|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13974816|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13974817|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
13974818|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15042305|NCT02043171|Vitamin D|vitamin d|mesh-list
15042306|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
15042307|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
15042308|NCT02043171|Vitamins|vitamins|mesh-list
15042309|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
15042310|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042311|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15042312|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15042313|NCT02043223|Vitamins|vitamins|mesh-list
15042314|NCT02043223|Vitamin A|vitamin a|mesh-list
15042315|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
15042316|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
13974819|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13974820|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
13974821|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
13974822|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974823|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13974824|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15042317|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042318|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
15042319|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042320|NCT02043223|Protective Agents|protective agents|mesh-ancestor
13974825|NCT03064035|Thrombin|thrombin|mesh-list
13974826|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
13974827|NCT03064035|Coagulants|coagulants|mesh-ancestor
15042321|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15042322|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974828|NCT03063762|Bevacizumab|bevacizumab|mesh-list
13974829|NCT03063762|Atezolizumab|atezolizumab|mesh-list
13974830|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13974831|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974832|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14245557|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245558|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245559|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
14245560|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245561|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245562|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
14245563|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14245564|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14245565|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245566|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14245567|NCT00224952|Analgesics|analgesics|mesh-ancestor
14245568|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
14245569|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245570|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14245571|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14245572|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14245573|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14245574|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14245575|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
14245576|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14245577|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14245578|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
14245579|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245580|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245581|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14245582|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
14245583|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245584|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14245585|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14245586|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14245587|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
14245588|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245589|NCT00225212|Rituximab|rituximab|mesh-list
14245590|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14245591|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245592|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
14245593|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245594|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14245595|NCT00225251|Bupropion|bupropion|mesh-list
14245596|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14245597|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
14245598|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245599|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14245600|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14245601|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14245602|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245603|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
14245604|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245605|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245606|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14245607|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14245608|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245609|NCT00225277|Pioglitazone|pioglitazone|mesh-list
14245610|NCT00225277|Glimepiride|glimepiride|mesh-list
14245611|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14245612|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245613|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14245614|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14245615|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
14245616|NCT00225420|Docetaxel|docetaxel|mesh-list
13974833|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13974834|NCT03063762|Growth Substances|growth substances|mesh-ancestor
13974835|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974836|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
13974837|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
13974838|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13974839|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13974840|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974841|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
13974842|NCT03063892|Coagulants|coagulants|mesh-ancestor
13974843|NCT03063905|Buprenorphine|buprenorphine|mesh-list
13974844|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13974845|NCT03063905|Narcotics|narcotics|mesh-ancestor
13974846|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974847|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974848|NCT03063905|Analgesics|analgesics|mesh-ancestor
13974849|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
13974850|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974851|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13974852|NCT03063710|Olaparib|olaparib|mesh-list
13974853|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13974854|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974855|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974856|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974857|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
13974858|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
13974859|NCT03063775|Coagulants|coagulants|mesh-ancestor
13974860|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
13974861|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
13974862|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974863|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
13974864|NCT03063580|Rifampin|rifampin|mesh-list
13974865|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13974866|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
13974867|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15042323|NCT02043288|Gemcitabine|gemcitabine|mesh-list
15042324|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15042325|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
15042326|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042327|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042328|NCT02043288|Antiviral Agents|antiviral agents|mesh-ancestor
15042329|NCT02043288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042330|NCT02043288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042331|NCT02043288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042332|NCT02043288|Immunologic Factors|immunologic factors|mesh-ancestor
15042333|NCT02043288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042334|NCT02043314|Isoniazid|isoniazid|mesh-list
15042335|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
15042336|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15042337|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042338|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15042339|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15042340|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
15042341|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042342|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15042343|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
15042344|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
15042345|NCT02043457|Hormones|hormones|mesh-list
15042346|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042347|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042348|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
15042349|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15042350|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042351|NCT02043717|Vitamin D|vitamin d|mesh-list
15042352|NCT02043717|Vitamins|vitamins|mesh-ancestor
15042353|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
15042354|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042355|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15042356|NCT02043730|Gemcitabine|gemcitabine|mesh-list
15042357|NCT02043730|Paclitaxel|paclitaxel|mesh-list
15042358|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15042359|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042360|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
15042361|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
15042362|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
15042363|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042364|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15042365|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
15042366|NCT02043730|Antiviral Agents|antiviral agents|mesh-ancestor
15042367|NCT02043730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042368|NCT02043730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042369|NCT02043730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042370|NCT02043730|Immunologic Factors|immunologic factors|mesh-ancestor
13974868|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974869|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
13974870|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13974871|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974872|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974873|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13974874|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13974875|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13974876|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13974877|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13974878|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13974879|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13974880|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13974881|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974882|NCT03063541|Aspirin|aspirin|mesh-list
13974883|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13974884|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974885|NCT03063541|Analgesics|analgesics|mesh-ancestor
13974886|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
13974887|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974888|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974889|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13974890|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13974891|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13974892|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13974893|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974894|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13974895|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13974896|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974897|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
13974898|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
13974899|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
13974900|NCT03063723|Ledipasvir|ledipasvir|mesh-list
13974901|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
13974902|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974903|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
13974904|NCT03063671|Ketamine|ketamine|mesh-list
13974905|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13974906|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974907|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974908|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974909|NCT03063671|Analgesics|analgesics|mesh-ancestor
13974910|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
13974911|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974912|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13974913|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13974914|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13974915|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
13974916|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974917|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974918|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13974919|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13974920|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
15042371|NCT02043730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042372|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
15042373|NCT02043756|Analgesics|analgesics|mesh-ancestor
15042374|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
15042375|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042376|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042377|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042378|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15042379|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15042380|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042381|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042382|NCT02043821|Capecitabine|capecitabine|mesh-list
15042383|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13974921|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
13974922|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13974923|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13974924|NCT03063632|Interferons|interferons|mesh-list
13974925|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
13974926|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
13974927|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13974928|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974929|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
13974930|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13974931|NCT03063788|Copper|copper|mesh-list
13974932|NCT03063788|Trace Elements|trace elements|mesh-ancestor
13974933|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
13974934|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245617|NCT00225420|Leuprolide|leuprolide|mesh-list
14245618|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245619|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
14245620|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
14245621|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
14245622|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245623|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14245624|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
14245625|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14245626|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245627|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14245628|NCT00225498|Olanzapine|olanzapine|mesh-list
14245629|NCT00225498|Risperidone|risperidone|mesh-list
14245630|NCT00225498|Ziprasidone|ziprasidone|mesh-list
14245631|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14245632|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
14245633|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245634|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245635|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245636|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14245637|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14245638|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14245639|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245640|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14245641|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
14245642|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
14245643|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
14245644|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245645|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14245646|NCT00225498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14245647|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14245648|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14245649|NCT00225732|Ibuprofen|ibuprofen|mesh-list
14245650|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14245651|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14245652|NCT00225732|Analgesics|analgesics|mesh-ancestor
14245653|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
14245654|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245655|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245656|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15042384|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
15042385|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042386|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042387|NCT02043886|Acarbose|acarbose|mesh-list
15042388|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15042389|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974935|NCT03063658|Acetaminophen|acetaminophen|mesh-list
13974936|NCT03063658|Ibuprofen|ibuprofen|mesh-list
13974937|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13974938|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13974939|NCT03063658|Analgesics|analgesics|mesh-ancestor
13974940|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
13974941|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974942|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974943|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13974944|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13974945|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13974946|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974947|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974948|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
13974949|NCT03063619|Tamoxifen|tamoxifen|mesh-list
13974950|NCT03063619|Afimoxifene|afimoxifene|mesh-list
13974951|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13974952|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
13974953|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13974954|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974955|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13974956|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13974957|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13974958|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13974959|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13974960|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13974961|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13974962|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13974963|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974964|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974965|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13974966|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13974967|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974968|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
13974969|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974970|NCT03063866|Fentanyl|fentanyl|mesh-list
13974971|NCT03063866|Midazolam|midazolam|mesh-list
13974972|NCT03063866|Propofol|propofol|mesh-list
13974973|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13974974|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13974975|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974976|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13974977|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
13974978|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
13974979|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13974980|NCT03063866|Narcotics|narcotics|mesh-ancestor
13974981|NCT03063866|Analgesics|analgesics|mesh-ancestor
13974982|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
13974983|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13974984|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13974985|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13974986|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13974987|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13974988|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
13974989|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
15042390|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042391|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15042392|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042393|NCT02043912|Haloperidol|haloperidol|mesh-list
15042394|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
15042395|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
15042396|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
15042397|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042398|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042399|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15042400|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15042401|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15042402|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15042403|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15042404|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15042405|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
15042406|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042407|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042408|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13974990|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974991|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974992|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
13974993|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13974994|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13974995|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13974996|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
13974997|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13974998|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13974999|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
13975000|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13975001|NCT03063307|Fluorides|fluorides|mesh-list
13975002|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
13975003|NCT03063307|Protective Agents|protective agents|mesh-ancestor
13975004|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975005|NCT03063359|Fentanyl|fentanyl|mesh-list
13975006|NCT03063359|Morphine|morphine|mesh-list
13975007|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13975008|NCT03063359|Narcotics|narcotics|mesh-ancestor
13975009|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975010|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975011|NCT03063359|Analgesics|analgesics|mesh-ancestor
13975012|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
13975013|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975014|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13975015|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13975016|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
13975017|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
15042409|NCT02043977|Propofol|propofol|mesh-list
15042410|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15042411|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15042412|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042413|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15042414|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
15042415|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
15042416|NCT02044120|Irinotecan|irinotecan|mesh-list
15042417|NCT02044120|Temozolomide|temozolomide|mesh-list
15042418|NCT02044120|Niraparib|niraparib|mesh-list
15042419|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15042420|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13975018|NCT03063190|Vitamin D|vitamin d|mesh-list
13975019|NCT03063190|Vitamins|vitamins|mesh-ancestor
13975020|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
13975021|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975022|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13975023|NCT03063242|Sargramostim|sargramostim|mesh-list
13975024|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
13975025|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975026|NCT03062943|Nintedanib|nintedanib|mesh-list
13975027|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042421|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042422|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042423|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042424|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15042425|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
13975028|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13975029|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975030|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975031|NCT03062839|Melatonin|melatonin|mesh-list
13975032|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
13975033|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975034|NCT03062839|Protective Agents|protective agents|mesh-ancestor
13975035|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975036|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975037|NCT03062800|Thalidomide|thalidomide|mesh-list
13975038|NCT03062800|Carboplatin|carboplatin|mesh-list
13975039|NCT03062800|Pemetrexed|pemetrexed|mesh-list
13975040|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975041|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975042|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975043|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13975044|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13975045|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13975046|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
15042426|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13975047|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042427|NCT02044133|Vitamin D|vitamin d|mesh-list
15042428|NCT02044133|Vitamins|vitamins|mesh-ancestor
13975048|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
13975049|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13975050|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975051|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13975052|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13975053|NCT03062800|Growth Substances|growth substances|mesh-ancestor
13975054|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
13975055|NCT03062813|Entecavir|entecavir|mesh-list
13975056|NCT03062813|Tacrolimus|tacrolimus|mesh-list
13975057|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13975058|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
13975059|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975060|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13975061|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975062|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975063|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
13975064|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975065|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
13975066|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
13975067|NCT03062904|Miotics|miotics|mesh-ancestor
13975068|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
13975069|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975070|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975071|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13975072|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
13975073|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
13975074|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
13975075|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13975076|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
13975077|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975078|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975079|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13975080|NCT03062787|Triamcinolone|triamcinolone|mesh-list
13975081|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13975082|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13975083|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
13975084|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13975085|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13975086|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
13975087|NCT03062787|Hormones|hormones|mesh-ancestor
13975088|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13975089|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975090|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13975091|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
13975092|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975093|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975094|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13975095|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
13975096|NCT03062787|Protective Agents|protective agents|mesh-ancestor
13975097|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
13975098|NCT03063073|Bupivacaine|bupivacaine|mesh-list
13975099|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
13975100|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
13975101|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975102|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975103|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
13975104|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975105|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13975106|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13975107|NCT03063073|Analgesics|analgesics|mesh-ancestor
13975108|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13975109|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13975110|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13975111|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
13975112|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975113|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975114|NCT03063112|Ethanol|ethanol|mesh-list
13975115|NCT03063112|Lidocaine|lidocaine|mesh-list
13975116|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
13975117|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
13975118|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975119|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975120|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
13975121|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975122|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13975123|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13975124|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13975125|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13975126|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975127|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13975128|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975129|NCT03063060|Vitamin D|vitamin d|mesh-list
13975130|NCT03063060|Calcium|calcium|mesh-list
13975131|NCT03063060|Vitamins|vitamins|mesh-ancestor
13975132|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
13975133|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975134|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13975135|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13975136|NCT03062644|Celecoxib|celecoxib|mesh-list
13975137|NCT03062644|Tramadol|tramadol|mesh-list
13975138|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13975139|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13975140|NCT03062644|Analgesics|analgesics|mesh-ancestor
13975141|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
13975142|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975143|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975144|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13975145|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13975146|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13975147|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13975148|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975149|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975150|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13975151|NCT03062644|Narcotics|narcotics|mesh-ancestor
13975152|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975153|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
13975154|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
13975155|NCT03062436|Protective Agents|protective agents|mesh-ancestor
13975156|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975157|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
13975158|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
13975159|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975160|NCT03062631|Amifampridine|amifampridine|mesh-list
13975161|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13975162|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975163|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975164|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13975165|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13975166|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975167|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
13975168|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975169|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
13975170|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975171|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975172|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13975173|NCT03062462|Clopidogrel|clopidogrel|mesh-list
13975174|NCT03062462|Ticagrelor|ticagrelor|mesh-list
13975175|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13975176|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13975177|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13975178|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13975179|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
13975180|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975181|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975182|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975183|NCT03062319|Anticoagulants|anticoagulants|mesh-list
13975184|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
13975185|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13975186|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13975187|NCT03061955|Vaccines|vaccines|mesh-list
13975188|NCT03061955|Immunologic Factors|immunologic factors|mesh-ancestor
13975189|NCT03061955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245657|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14245658|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14245659|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245660|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245661|NCT00225758|Lapatinib|lapatinib|mesh-list
14245662|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975190|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
13975191|NCT03061838|Rituximab|rituximab|mesh-list
13975192|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13975193|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975194|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
13975195|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975196|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13975197|NCT03061981|Metformin|metformin|mesh-list
13975198|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13975199|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975200|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
13975201|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975202|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
13975203|NCT03062163|Resveratrol|resveratrol|mesh-list
13975204|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
13975205|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975206|NCT03062163|Protective Agents|protective agents|mesh-ancestor
13975207|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975208|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975209|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13975210|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
13975211|NCT03062163|Vitamins|vitamins|mesh-ancestor
13975212|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
13975213|NCT03061734|Acetaminophen|acetaminophen|mesh-list
13975214|NCT03061734|Naltrexone|naltrexone|mesh-list
13975215|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13975216|NCT03061734|Analgesics|analgesics|mesh-ancestor
13975217|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
13975218|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975219|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975220|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
13975221|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13975222|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13975223|NCT03062150|Cycloserine|cycloserine|mesh-list
13975224|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
13975225|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13975226|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975227|NCT03062150|Renal Agents|renal agents|mesh-ancestor
13975228|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13975229|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
13975230|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13975231|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
13975232|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975233|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13975234|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
13975235|NCT03061656|Melphalan|melphalan|mesh-list
13975236|NCT03061656|Thiotepa|thiotepa|mesh-list
13975237|NCT03061656|Carboplatin|carboplatin|mesh-list
13975238|NCT03061656|Etoposide|etoposide|mesh-list
13975239|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13975240|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
13975241|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975242|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13975243|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13975244|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
13975245|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975246|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975247|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13975248|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13975249|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13975250|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13975251|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975252|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
13975253|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13975254|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13975255|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975256|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
13975257|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
13975258|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13975259|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
13975260|NCT03061604|Octreotide|octreotide|mesh-list
13975261|NCT03061604|Hemostatics|hemostatics|mesh-list
13975262|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975263|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15042429|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
13975264|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13975265|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975266|NCT03061604|Coagulants|coagulants|mesh-ancestor
13975267|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
13975268|NCT03061565|Hematinics|hematinics|mesh-ancestor
13975269|NCT03061253|Nicotine|nicotine|mesh-list
13975270|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13975271|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
13975272|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975273|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975274|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13975275|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13975276|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
13975277|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975278|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975279|NCT03061058|Docetaxel|docetaxel|mesh-list
13975280|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
13975281|NCT03061058|Irinotecan|irinotecan|mesh-list
13975282|NCT03061058|Pemetrexed|pemetrexed|mesh-list
13975283|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975284|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
13975285|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
13975286|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
13975287|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975288|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13975289|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13975290|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975291|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13975292|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13975293|NCT03061006|Warfarin|warfarin|mesh-list
13975294|NCT03061006|Dabigatran|dabigatran|mesh-list
13975295|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
13975296|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
13975297|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13975298|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
13975299|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975300|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975301|NCT03061227|Glucagon|glucagon|mesh-list
13975302|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13975303|NCT03061227|Hormones|hormones|mesh-ancestor
13975304|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13975305|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975306|NCT03061136|Clonazepam|clonazepam|mesh-list
13975307|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
13975308|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
13975309|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
13975310|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975311|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975312|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975313|NCT03061032|Ribavirin|ribavirin|mesh-list
13975314|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
13975315|NCT03061032|Ledipasvir|ledipasvir|mesh-list
13975316|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
13975317|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975318|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
13975319|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975320|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
13975321|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13975322|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13975323|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975324|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
13975325|NCT03060889|Coagulants|coagulants|mesh-ancestor
13975326|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
13975327|NCT03060603|Hematinics|hematinics|mesh-ancestor
13975328|NCT03060707|Bromides|bromides|mesh-list
13975329|NCT03060707|Rocuronium|rocuronium|mesh-list
13975330|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
13975331|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13975332|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13975333|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13975334|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975335|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975336|NCT03060681|Bupivacaine|bupivacaine|mesh-list
13975337|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
13975338|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
13975339|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975340|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975341|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
13975342|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975343|NCT03060850|Abivertinib|abivertinib|mesh-list
13975344|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13975345|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042430|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042431|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15042432|NCT02044146|Clopidogrel|clopidogrel|mesh-list
15042433|NCT02044146|Ticagrelor|ticagrelor|mesh-list
15042434|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15042435|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15042436|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15042437|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15042438|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14245663|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14245664|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245665|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245666|NCT00225784|Gemcitabine|gemcitabine|mesh-list
14245667|NCT00225784|Cetuximab|cetuximab|mesh-list
14245668|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14245669|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
14245670|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245671|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245672|NCT00225784|Antiviral Agents|antiviral agents|mesh-ancestor
14245673|NCT00225784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245674|NCT00225784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245675|NCT00225784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14245676|NCT00225784|Immunologic Factors|immunologic factors|mesh-ancestor
14245677|NCT00225784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245678|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14245679|NCT00226239|Docetaxel|docetaxel|mesh-list
14245680|NCT00226239|Cetuximab|cetuximab|mesh-list
14245681|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245682|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
14245683|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
14245684|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
14245685|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245686|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14245687|NCT00226577|Gemcitabine|gemcitabine|mesh-list
14245688|NCT00226577|Pemetrexed|pemetrexed|mesh-list
14245689|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14245690|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
14245691|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245692|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245693|NCT00226577|Antiviral Agents|antiviral agents|mesh-ancestor
14245694|NCT00226577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042439|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
15042440|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042441|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042442|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042443|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
15042444|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15042445|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15042446|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042447|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15042448|NCT02044224|Analgesics|analgesics|mesh-ancestor
15042449|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
15042450|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042451|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15042452|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15042453|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15042454|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
15042455|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042456|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042457|NCT02044250|Aspirin|aspirin|mesh-list
13975346|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975347|NCT03060798|Desflurane|desflurane|mesh-list
13975348|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13975349|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
13975350|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
13975351|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975352|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975353|NCT03060785|Tenofovir|tenofovir|mesh-list
13975354|NCT03060785|Emtricitabine|emtricitabine|mesh-list
13975355|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
13975356|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975357|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13975358|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13975359|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975360|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975361|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13975362|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13975363|NCT03060278|Nicotine|nicotine|mesh-list
13975364|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13975365|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
13975366|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975367|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975368|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13975369|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13975370|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
13975371|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975372|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975373|NCT03060434|Acetaminophen|acetaminophen|mesh-list
13975374|NCT03060434|Ibuprofen|ibuprofen|mesh-list
13975375|NCT03060434|Pregabalin|pregabalin|mesh-list
13975376|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
13975377|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13975378|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13975379|NCT03060434|Analgesics|analgesics|mesh-ancestor
13975380|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
13975381|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975382|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975383|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13975384|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13975385|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13975386|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975387|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975388|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
13975389|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13975390|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13975391|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13975392|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13975393|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13975394|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975395|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13975396|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
13975397|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13975398|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13975399|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13975400|NCT03060434|Protective Agents|protective agents|mesh-ancestor
13975401|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
13975402|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13975403|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
14245695|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245696|NCT00226577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14245697|NCT00226577|Immunologic Factors|immunologic factors|mesh-ancestor
14245698|NCT00226577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245699|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14245700|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14245701|NCT00226590|Gemcitabine|gemcitabine|mesh-list
14245702|NCT00226590|Paclitaxel|paclitaxel|mesh-list
14245703|NCT00226590|Carboplatin|carboplatin|mesh-list
14245704|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14245705|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245706|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
14245707|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
14245708|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
14245709|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245710|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14245711|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
14245712|NCT00226590|Antiviral Agents|antiviral agents|mesh-ancestor
14245713|NCT00226590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245714|NCT00226590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245715|NCT00226590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14245716|NCT00226590|Immunologic Factors|immunologic factors|mesh-ancestor
14245717|NCT00226590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975404|NCT03060304|Tamoxifen|tamoxifen|mesh-list
13975405|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13975406|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14245718|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
14245719|NCT00226655|Hormones|hormones|mesh-ancestor
14245720|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14245721|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245722|NCT00226811|Sunitinib|sunitinib|mesh-list
14245723|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245724|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14245725|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14245726|NCT00226811|Growth Substances|growth substances|mesh-ancestor
14245727|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245728|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
14245729|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14245730|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245731|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245732|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
14245733|NCT00226941|Promethazine|promethazine|mesh-list
14245734|NCT00226941|Capecitabine|capecitabine|mesh-list
14245735|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
14245736|NCT00226941|Cetuximab|cetuximab|mesh-list
14245737|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14245738|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
14245739|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245740|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245741|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14245742|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14245743|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14531888|NCT02365233|Hormones|hormones|mesh-ancestor
14531889|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042458|NCT02044250|Clopidogrel|clopidogrel|mesh-list
15042459|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15042460|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15042461|NCT02044250|Analgesics|analgesics|mesh-ancestor
15042462|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
15042463|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042464|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042465|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15042466|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15042467|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15042468|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15042469|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042470|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15042471|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15042472|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042473|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
15042474|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15042475|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15042476|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15042477|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
15042478|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042479|NCT02044354|Docetaxel|docetaxel|mesh-list
15042480|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042481|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
15042482|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
15042483|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
15042484|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042485|NCT02044497|Oxycodone|oxycodone|mesh-list
15042486|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15042487|NCT02044497|Narcotics|narcotics|mesh-ancestor
15042488|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15042489|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042490|NCT02044497|Analgesics|analgesics|mesh-ancestor
15042491|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
15042492|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042493|NCT02044549|Oxytocin|oxytocin|mesh-list
15042494|NCT02044549|Carbetocin|carbetocin|mesh-list
15042495|NCT02044549|Methylergonovine|methylergonovine|mesh-list
15042496|NCT02044549|Syntometrine|syntometrine|mesh-list
15042497|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
13975407|NCT03060304|Estradiol|estradiol|mesh-list
13975408|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13975409|NCT03060304|Estrogens|estrogens|mesh-ancestor
13975410|NCT03060304|Hormones|hormones|mesh-ancestor
13975411|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13975412|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975413|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13975414|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
13975415|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13975416|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13975417|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13975418|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
13975419|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13975420|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975421|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13975422|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13975423|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13975424|NCT03060265|Acetaminophen|acetaminophen|mesh-list
13975425|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13975426|NCT03060265|Analgesics|analgesics|mesh-ancestor
13975427|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
13975428|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975429|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975430|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
13975431|NCT03060083|Nicotine|nicotine|mesh-list
13975432|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13975433|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
13975434|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975435|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975436|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13975437|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13975438|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
13975439|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975440|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975441|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
13975442|NCT03060070|Ketamine|ketamine|mesh-list
13975443|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13975444|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975445|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975446|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13975447|NCT03060070|Analgesics|analgesics|mesh-ancestor
13975448|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
13975449|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975450|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13975451|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13975452|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13975453|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
13975454|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975455|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975456|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13975457|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13975458|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
13975459|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
13975460|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13975461|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13975462|NCT03059888|Abatacept|abatacept|mesh-list
13975463|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13975464|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975465|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975466|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13975467|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
13975468|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975469|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13975470|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
13975471|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
13975472|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975473|NCT03059849|Adalimumab|adalimumab|mesh-list
13975474|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13975475|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13975476|NCT03060018|Oxitropium|oxitropium|mesh-list
13975477|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
13975478|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
13975479|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975480|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975481|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
13975482|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13975483|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13975484|NCT03059979|Prednisolone|prednisolone|mesh-list
13975485|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
13975486|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13975487|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
13975488|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13975489|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
13975490|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
13975491|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975492|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975493|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13975494|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
13975495|NCT03059979|Hormones|hormones|mesh-ancestor
13975496|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13975497|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13975498|NCT03059979|Protective Agents|protective agents|mesh-ancestor
13975499|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13975500|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975501|NCT03060044|Fluticasone|fluticasone|mesh-list
13975502|NCT03060044|Xhance|xhance|mesh-list
13975503|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14245744|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14245745|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245746|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
14245747|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
14245748|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
14245749|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245750|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
14245751|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
14245752|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14245753|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14245754|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
14245755|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
14245756|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245757|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14245758|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
14245759|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
14245760|NCT00227019|Vitamins|vitamins|mesh-list
14245761|NCT00227019|Folic Acid|folic acid|mesh-list
14245762|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
14245763|NCT00227019|Hydroxocobalamin|hydroxocobalamin|mesh-list
14245764|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
14245765|NCT00227019|Dexamethasone|dexamethasone|mesh-list
14245766|NCT00227019|Bevacizumab|bevacizumab|mesh-list
14245767|NCT00227019|Pemetrexed|pemetrexed|mesh-list
14245768|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14245769|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245770|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14245771|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14245772|NCT00227019|Growth Substances|growth substances|mesh-ancestor
14245773|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245774|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
14245775|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
14245776|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14245777|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
14245778|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
14245779|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245780|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14245781|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
14245782|NCT00227019|Hormones|hormones|mesh-ancestor
14245783|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14245784|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14245785|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245786|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245787|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14245788|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14245789|NCT00227019|Hematinics|hematinics|mesh-ancestor
14245790|NCT00227266|Valproic Acid|valproic acid|mesh-list
14245791|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
14245792|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245793|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245794|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
14245795|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245796|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245797|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
14245798|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14245799|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14245800|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245801|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14245802|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
13975504|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
13975505|NCT03060044|Charcoal|charcoal|mesh-list
13975506|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13975507|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13975508|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
13975509|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975510|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975511|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13975512|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
13975513|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
13975514|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13975515|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13975516|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13975517|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13975518|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
13975519|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975520|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975521|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
13975522|NCT03060044|Hormones|hormones|mesh-ancestor
13975523|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042498|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15042499|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042500|NCT02044601|Paclitaxel|paclitaxel|mesh-list
15042501|NCT02044601|Carboplatin|carboplatin|mesh-list
13975524|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
13975525|NCT03060044|Antidotes|antidotes|mesh-ancestor
13975526|NCT03060044|Protective Agents|protective agents|mesh-ancestor
13975527|NCT03059719|Exenatide|exenatide|mesh-list
13975528|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13975529|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975530|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13975531|NCT03059719|Incretins|incretins|mesh-ancestor
13975532|NCT03059719|Hormones|hormones|mesh-ancestor
13975533|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13975534|NCT03059862|Tryptophan|tryptophan|mesh-list
13975535|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13975536|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
13975537|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13975538|NCT03060031|Oxytocin|oxytocin|mesh-list
13975539|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
13975540|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13975541|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975542|NCT03060005|Dextrans|dextrans|mesh-list
13975543|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
13975544|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
13975545|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
13975546|NCT03059940|Nicotine|nicotine|mesh-list
13975547|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
13975548|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13975549|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
13975550|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975551|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975552|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13975553|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13975554|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
13975555|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975556|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975557|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
13975558|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
13975559|NCT03059667|Carboplatin|carboplatin|mesh-list
13975560|NCT03059667|Etoposide|etoposide|mesh-list
13975561|NCT03059667|Atezolizumab|atezolizumab|mesh-list
13975562|NCT03059667|Topotecan|topotecan|mesh-list
13975563|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975564|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13975565|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13975566|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13975567|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975568|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975569|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15042502|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15042503|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15042504|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042505|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
15042506|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
15042507|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
15042508|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042509|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13975570|NCT03059563|Varenicline|varenicline|mesh-list
13975571|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13975572|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13975573|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
13975574|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975575|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975576|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975577|NCT03059615|Doxorubicin|doxorubicin|mesh-list
13975578|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13975579|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975580|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13975581|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13975582|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975583|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975584|NCT03059277|Aflibercept|aflibercept|mesh-list
13975585|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13975586|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13975587|NCT03059277|Growth Substances|growth substances|mesh-ancestor
13975588|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975589|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
13975590|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975591|NCT03059316|Labetalol|labetalol|mesh-list
13975592|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
13975593|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
13975594|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13975595|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13975596|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
13975597|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975598|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975599|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975600|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13975601|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
13975602|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
13975603|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975604|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13975605|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13975606|NCT03059303|Simeprevir|simeprevir|mesh-list
13975607|NCT03059303|Odalasvir|odalasvir|mesh-list
13975608|NCT03059303|Omeprazole|omeprazole|mesh-list
13975609|NCT03059303|Lansoprazole|lansoprazole|mesh-list
13975610|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
13975611|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13975612|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13975613|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13975614|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975615|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975616|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
13975617|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975618|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
13975619|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
13975620|NCT03059537|Cathartics|cathartics|mesh-ancestor
13975621|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13975622|NCT03059238|Celecoxib|celecoxib|mesh-list
13975623|NCT03059238|Parecoxib|parecoxib|mesh-list
13975624|NCT03059238|Oxycodone|oxycodone|mesh-list
13975625|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13975626|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13975627|NCT03059238|Analgesics|analgesics|mesh-ancestor
13975628|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
13975629|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975630|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975631|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13975632|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13975633|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13975634|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13975635|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975636|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975637|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13975638|NCT03059238|Narcotics|narcotics|mesh-ancestor
13975639|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975640|NCT03059134|Mirabegron|mirabegron|mesh-list
13975641|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13975642|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13975643|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13975644|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
13975645|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975646|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975647|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975648|NCT03059134|Urological Agents|urological agents|mesh-ancestor
13975649|NCT03059147|Nivolumab|nivolumab|mesh-list
13975650|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13975651|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975652|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13975653|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975654|NCT03058939|Tamoxifen|tamoxifen|mesh-list
13975655|NCT03058939|Paclitaxel|paclitaxel|mesh-list
13975656|NCT03058939|Carboplatin|carboplatin|mesh-list
13975657|NCT03058939|Trastuzumab|trastuzumab|mesh-list
13975658|NCT03058939|Letrozole|letrozole|mesh-list
13975659|NCT03058939|Pertuzumab|pertuzumab|mesh-list
13975660|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13975661|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975662|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
13975663|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
13975664|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
13975665|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975666|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13975667|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13975668|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13975669|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975670|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13975671|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
13975672|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13975673|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975674|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13975675|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13975676|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13975677|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13975678|NCT03058978|Etonogestrel|etonogestrel|mesh-list
13975679|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13975680|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
13975681|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13975682|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975683|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13975684|NCT03059004|TEMPO|tempo|mesh-list
13975685|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
13975686|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975687|NCT03059004|Protective Agents|protective agents|mesh-ancestor
13975688|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975689|NCT03058900|Methotrexate|methotrexate|mesh-list
13975690|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13975691|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
13975692|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13975693|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975694|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13975695|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
13975696|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975697|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975698|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
13975699|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975700|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13975701|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13975702|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
13975703|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13975704|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13975705|NCT03058835|Tenofovir|tenofovir|mesh-list
13975706|NCT03058835|Emtricitabine|emtricitabine|mesh-list
13975707|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
13975708|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975709|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13975710|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13975711|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975712|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975713|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13975714|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13975715|NCT03059017|Albuterol|albuterol|mesh-list
13975716|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13975717|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
13975718|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245803|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13975719|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975720|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13975721|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
13975722|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
13975723|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13975724|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13975725|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13975726|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13975727|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
13975728|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975729|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975730|NCT03058744|Clobetasol|clobetasol|mesh-list
13975731|NCT03058744|Halobetasol|halobetasol|mesh-list
13975732|NCT03058744|Tazarotene|tazarotene|mesh-list
13975733|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
13975734|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
13975735|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13975736|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13975737|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
13975738|NCT03058744|Hormones|hormones|mesh-ancestor
13975739|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13975740|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975741|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
13975742|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13975743|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975744|NCT03059056|Empagliflozin|empagliflozin|mesh-list
13975745|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13975746|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975747|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13975748|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975749|NCT03058666|Calfactant|calfactant|mesh-list
13975750|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
13975751|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
14245804|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14245805|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14245806|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14245807|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245808|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
14245809|NCT00227370|Valganciclovir|valganciclovir|mesh-list
14245810|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
14245811|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245812|NCT00227539|Pemetrexed|pemetrexed|mesh-list
14245813|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14245814|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245815|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245816|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245817|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14245818|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14245819|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14245820|NCT00227591|Prednisone|prednisone|mesh-list
14245821|NCT00227591|Lenalidomide|lenalidomide|mesh-list
14245822|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14245823|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
14245824|NCT00227591|Hormones|hormones|mesh-ancestor
14245825|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14245826|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245827|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14245828|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245829|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
14245830|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14245831|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14245832|NCT00227591|Growth Substances|growth substances|mesh-ancestor
14245833|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
14245834|NCT00227617|Leucovorin|leucovorin|mesh-list
14245835|NCT00227617|Bevacizumab|bevacizumab|mesh-list
14245836|NCT00227617|Fluorouracil|fluorouracil|mesh-list
14245837|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
14245838|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14245839|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245840|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14245841|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14245842|NCT00227617|Growth Substances|growth substances|mesh-ancestor
14245843|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245844|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
14245845|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
14531890|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
13975752|NCT03058354|Propofol|propofol|mesh-list
13975753|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
13975754|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975755|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975756|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13975757|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13975758|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
13975759|NCT03058419|Midazolam|midazolam|mesh-list
13975760|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
13975761|NCT03058419|Caffeine|caffeine|mesh-list
13975762|NCT03058419|Bupropion|bupropion|mesh-list
13975763|NCT03058419|Omeprazole|omeprazole|mesh-list
13975764|NCT03058419|Warfarin|warfarin|mesh-list
13975765|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13975766|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13975767|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975768|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975769|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13975770|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13975771|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13975772|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13975773|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
13975774|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
13975775|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
13975776|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
13975777|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975778|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975779|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
13975780|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13975781|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13975782|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13975783|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975784|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13975785|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13975786|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13975787|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13975788|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
13975789|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13975790|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
13975791|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13975792|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13975793|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13975794|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
13975795|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13975796|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13975797|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
13975798|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
13975799|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13975800|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13975801|NCT03058536|Progesterone|progesterone|mesh-list
13975802|NCT03058536|Progestins|progestins|mesh-ancestor
13975803|NCT03058536|Hormones|hormones|mesh-ancestor
13975804|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13975805|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975806|NCT03058341|Propofol|propofol|mesh-list
13975807|NCT03058341|Sevoflurane|sevoflurane|mesh-list
13975808|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13975809|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975810|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975811|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13975812|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
13975813|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
13975814|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13975815|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13975816|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
13975817|NCT03058289|Ipilimumab|ipilimumab|mesh-list
13975818|NCT03058289|Antibodies|antibodies|mesh-list
13975819|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
13975820|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
13975821|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975822|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13975823|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975824|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13975825|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975826|NCT03058471|Methotrexate|methotrexate|mesh-list
13975827|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13975828|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
13975829|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13975830|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975831|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13975832|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
13975833|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975834|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975835|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
13975836|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975837|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13975838|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13975839|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
13975840|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13975841|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13975842|NCT03058263|Neostigmine|neostigmine|mesh-list
13975843|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13975844|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975845|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975846|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
13975847|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975848|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975849|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13975850|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
13975851|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975852|NCT03058224|Acetaminophen|acetaminophen|mesh-list
13975853|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13975854|NCT03058224|Analgesics|analgesics|mesh-ancestor
13975855|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
13975856|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975857|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975858|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
13975859|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
13975860|NCT03058237|Baclofen|baclofen|mesh-list
13975861|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13975862|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975863|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13975864|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975865|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13975866|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
13975867|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
13975868|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975869|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975870|NCT03058094|Pemetrexed|pemetrexed|mesh-list
13975871|NCT03058094|Abivertinib|abivertinib|mesh-list
13975872|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975873|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975874|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975875|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13975876|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13975877|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13975878|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
13975879|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
13975880|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13975881|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13975882|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975883|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13975884|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975885|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975886|NCT03057951|Empagliflozin|empagliflozin|mesh-list
13975887|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13975888|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975889|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13975890|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975891|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
13975892|NCT03057847|Velpatasvir|velpatasvir|mesh-list
13975893|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
13975894|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975895|NCT03057769|Indomethacin|indomethacin|mesh-list
13975896|NCT03057769|Epinephrine|epinephrine|mesh-list
13975897|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13975898|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13975899|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
13975900|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13975901|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975902|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975903|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13975904|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13975905|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
13975906|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975907|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13975908|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
13975909|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
13975910|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
13975911|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13975912|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13975913|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13975914|NCT03057769|Analgesics|analgesics|mesh-ancestor
13975915|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
13975916|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13975917|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13975918|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
13975919|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
13975920|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13975921|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13975922|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975923|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
13975924|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13975925|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975926|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
13975927|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13975928|NCT03057509|Octreotide|octreotide|mesh-list
13975929|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13975930|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13975931|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975932|NCT03057483|Vaccines|vaccines|mesh-list
13975933|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
13975934|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975935|NCT03057470|Insulin|insulin|mesh-list
13975936|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13975937|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13975938|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975939|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
13975940|NCT03057314|Calcium|calcium|mesh-list
13975941|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13975942|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975943|NCT03057314|Antacids|antacids|mesh-ancestor
13975944|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975945|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13975946|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
13975947|NCT03057574|Hormones|hormones|mesh-ancestor
13975948|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13975949|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975950|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
13975951|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
13975952|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
13975953|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975954|NCT03057145|Olaparib|olaparib|mesh-list
13975955|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13975956|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13975957|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13975958|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245846|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245847|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14245848|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14245849|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
14245850|NCT00227617|Antidotes|antidotes|mesh-ancestor
14245851|NCT00227617|Protective Agents|protective agents|mesh-ancestor
14245852|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
14245853|NCT00227617|Vitamins|vitamins|mesh-ancestor
14245854|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
14245855|NCT00227721|Gemcitabine|gemcitabine|mesh-list
14245856|NCT00227721|Docetaxel|docetaxel|mesh-list
14245857|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14245858|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
14245859|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245860|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245861|NCT00227721|Antiviral Agents|antiviral agents|mesh-ancestor
14245862|NCT00227721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245863|NCT00227721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245864|NCT00227721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13975959|NCT03057041|Fentanyl|fentanyl|mesh-list
13975960|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13975961|NCT03057041|Narcotics|narcotics|mesh-ancestor
13975962|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975963|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975964|NCT03057041|Analgesics|analgesics|mesh-ancestor
13975965|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
13975966|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975967|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13975968|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13975969|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
13975970|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
13975971|NCT03056846|Sulfalene|sulfalene|mesh-list
13975972|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13975973|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13975974|NCT03056846|Renal Agents|renal agents|mesh-ancestor
13975975|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
13975976|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13975977|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13975978|NCT03057015|Dexamethasone|dexamethasone|mesh-list
13975979|NCT03057015|Clonidine|clonidine|mesh-list
13975980|NCT03057015|Epinephrine|epinephrine|mesh-list
13975981|NCT03057015|Ropivacaine|ropivacaine|mesh-list
13975982|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13975983|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
13975984|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
13975985|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13975986|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13975987|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13975988|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
13975989|NCT03057015|Hormones|hormones|mesh-ancestor
13975990|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13975991|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13975992|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13975993|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
13975994|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
13975995|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13975996|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
13975997|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13975998|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13975999|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
13976000|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976001|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976002|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13976003|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13976004|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13976005|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
13976006|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
13976007|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
13976008|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13976009|NCT03057015|Analgesics|analgesics|mesh-ancestor
13976010|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13976011|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
13976012|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13976013|NCT03056924|Vaccines|vaccines|mesh-list
13976014|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
13976015|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976016|NCT03056833|Paclitaxel|paclitaxel|mesh-list
13976017|NCT03056833|Carboplatin|carboplatin|mesh-list
13976018|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13976019|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976020|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
13976021|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
13976022|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
13976023|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976024|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13976025|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13976026|NCT03056495|Vorinostat|vorinostat|mesh-list
13976027|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976028|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13976029|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976030|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976031|NCT03056625|Vitamin A|vitamin a|mesh-list
13976032|NCT03056625|Vitamins|vitamins|mesh-ancestor
13976033|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
13976034|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976035|NCT03056703|Aspirin|aspirin|mesh-list
13976036|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13976037|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13976038|NCT03056703|Analgesics|analgesics|mesh-ancestor
13976039|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
13976040|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976041|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976042|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13976043|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13976044|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13976045|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13976046|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976047|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13976048|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13976049|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976050|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
13976051|NCT03056482|Haloperidol|haloperidol|mesh-list
13976052|NCT03056482|Ondansetron|ondansetron|mesh-list
13976053|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
13976054|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
13976055|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
13976056|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976057|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976058|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13976059|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
13976060|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
13976061|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13976062|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
13976063|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976064|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976065|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13976066|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13976067|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976068|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13976069|NCT03056482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13976070|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13976071|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
13976072|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13976073|NCT03056599|Gemcitabine|gemcitabine|mesh-list
13976074|NCT03056599|Interferons|interferons|mesh-list
13976075|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
13976076|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
13976077|NCT03056599|Aldesleukin|aldesleukin|mesh-list
13976078|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
13976079|NCT03056599|Docetaxel|docetaxel|mesh-list
13976080|NCT03056599|Doxorubicin|doxorubicin|mesh-list
13976081|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
13976082|NCT03056599|Nivolumab|nivolumab|mesh-list
13976083|NCT03056599|Bortezomib|bortezomib|mesh-list
13976084|NCT03056599|Ipilimumab|ipilimumab|mesh-list
13976085|NCT03056599|Atezolizumab|atezolizumab|mesh-list
13976086|NCT03056599|Durvalumab|durvalumab|mesh-list
13976087|NCT03056599|Avelumab|avelumab|mesh-list
13976088|NCT03056599|Trabectedin|trabectedin|mesh-list
13976089|NCT03056599|Olaratumab|olaratumab|mesh-list
13976090|NCT03056599|Entrectinib|entrectinib|mesh-list
13976091|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13976092|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
13976093|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976094|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976095|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
13976096|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13976097|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976098|NCT03056599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13976099|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
13976100|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976101|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
13976102|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
13976103|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
13976104|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13976105|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13976106|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13976107|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13976108|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13976109|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13976110|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13976111|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13976112|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
13976113|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13976114|NCT03056391|Acetaminophen|acetaminophen|mesh-list
13976115|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13976116|NCT03056391|Analgesics|analgesics|mesh-ancestor
13976117|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
13976118|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976119|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976120|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
13976121|NCT03056274|Metformin|metformin|mesh-list
13976122|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13976123|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13976124|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976125|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13976126|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13976127|NCT03056118|Aspirin|aspirin|mesh-list
13976128|NCT03056118|Clopidogrel|clopidogrel|mesh-list
13976129|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13976130|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13976131|NCT03056118|Analgesics|analgesics|mesh-ancestor
13976132|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
13976133|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976134|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976135|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13976136|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13976137|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13976138|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13976139|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976140|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13976141|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13976142|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976143|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
13976144|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13976145|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13976146|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13976147|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
13976148|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976149|NCT03056079|Aflibercept|aflibercept|mesh-list
13976150|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13976151|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13976152|NCT03056079|Growth Substances|growth substances|mesh-ancestor
13976153|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976154|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
13976155|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976156|NCT03056053|Zolpidem|zolpidem|mesh-list
13976157|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
13976158|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13976159|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976160|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976161|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
13976162|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
13976163|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
13976164|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976165|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976166|NCT03056261|Anesthetics|anesthetics|mesh-list
13976167|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976168|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976169|NCT03056092|Ranibizumab|ranibizumab|mesh-list
13976170|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13976171|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13976172|NCT03056092|Growth Substances|growth substances|mesh-ancestor
13976173|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976174|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
13976175|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976176|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
13976177|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
13976178|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13976179|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976180|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976181|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
13976182|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13976183|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976184|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976185|NCT03055663|Midazolam|midazolam|mesh-list
13976186|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
13976187|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13976188|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976189|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976190|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13976191|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13976192|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13976193|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13976194|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
13976195|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
13976196|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
13976197|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
13976198|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976199|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976200|NCT03055741|Donepezil|donepezil|mesh-list
13976201|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13976202|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976203|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976204|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
13976205|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976206|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976207|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
13976208|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13976209|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13976210|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13976211|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976212|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976213|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13976214|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13976215|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976216|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
13976217|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976218|NCT03055793|Budesonide|budesonide|mesh-list
13976219|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
13976220|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13976221|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13976222|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
13976223|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976224|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976225|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13976226|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
13976227|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
13976228|NCT03055793|Hormones|hormones|mesh-ancestor
13976229|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13976230|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13976231|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13976232|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13976233|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
13976234|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976235|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976236|NCT03055546|Oxytocin|oxytocin|mesh-list
13976237|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
13976238|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13976239|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976240|NCT03055507|Acetaminophen|acetaminophen|mesh-list
13976241|NCT03055507|Ibuprofen|ibuprofen|mesh-list
13976242|NCT03055507|Oxycodone|oxycodone|mesh-list
13976243|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13976244|NCT03055507|Analgesics|analgesics|mesh-ancestor
13976245|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
13976246|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976247|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976248|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
13976249|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13976250|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13976251|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13976252|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13976253|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976254|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976255|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13976256|NCT03055507|Narcotics|narcotics|mesh-ancestor
13976257|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976258|NCT03055234|Treprostinil|treprostinil|mesh-list
13976259|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13976260|NCT03055312|Bicalutamide|bicalutamide|mesh-list
13976261|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
13976262|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
13976263|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13976264|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976265|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976266|NCT03055247|Ibuprofen|ibuprofen|mesh-list
13976267|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13976268|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13976269|NCT03055247|Analgesics|analgesics|mesh-ancestor
13976270|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
13976271|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976272|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976273|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13976274|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13976275|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13976276|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976277|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976278|NCT03055442|Inositol|inositol|mesh-list
13976279|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
13976280|NCT03055442|Vitamins|vitamins|mesh-ancestor
13976281|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
13976282|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976283|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
13976284|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13976285|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
13976286|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13976287|NCT03055377|Expectorants|expectorants|mesh-ancestor
13976288|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
13976289|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13976290|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
13976291|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976292|NCT03055377|Protective Agents|protective agents|mesh-ancestor
13976293|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976294|NCT03055377|Antidotes|antidotes|mesh-ancestor
13976295|NCT03055091|Sorbitol|sorbitol|mesh-list
13976296|NCT03055091|Cathartics|cathartics|mesh-ancestor
13976297|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13976298|NCT03054896|Venetoclax|venetoclax|mesh-list
13976299|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976300|NCT03054948|SMOFlipid|smoflipid|mesh-list
13976301|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
13976302|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13976303|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13976304|NCT03054831|Oxycodone|oxycodone|mesh-list
13976305|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13976306|NCT03054831|Narcotics|narcotics|mesh-ancestor
13976307|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976308|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976309|NCT03054831|Analgesics|analgesics|mesh-ancestor
13976310|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
13976311|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976312|NCT03054766|Ranibizumab|ranibizumab|mesh-list
13976313|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13976314|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13976315|NCT03054766|Growth Substances|growth substances|mesh-ancestor
13976316|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976317|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
13976318|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976319|NCT03054662|Hemostatics|hemostatics|mesh-list
13976320|NCT03054662|Coagulants|coagulants|mesh-ancestor
13976321|NCT03054610|Betamethasone|betamethasone|mesh-list
13976322|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
13976323|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13976324|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
13976325|NCT03054610|Ropivacaine|ropivacaine|mesh-list
13976326|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
13976327|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13976328|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
13976329|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13976330|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13976331|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
13976332|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
13976333|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976334|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976335|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
13976336|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976337|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13976338|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13976339|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976340|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
14245865|NCT00227721|Immunologic Factors|immunologic factors|mesh-ancestor
13976341|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976342|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13976343|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
13976344|NCT03054610|Hormones|hormones|mesh-ancestor
13976345|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13976346|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13976347|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
13976348|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13976349|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13976350|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
13976351|NCT03054532|Durvalumab|durvalumab|mesh-list
13976352|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13976353|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976354|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
13976355|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13976356|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13976357|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13976358|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13976359|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976360|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
13976361|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976362|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976363|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13976364|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976365|NCT03054207|Clopidogrel|clopidogrel|mesh-list
13976366|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13976367|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13976368|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13976369|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13976370|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13976371|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
13976372|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976373|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976374|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976375|NCT03054285|Levetiracetam|levetiracetam|mesh-list
13976376|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
13976377|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
13976378|NCT03054467|Amlodipine|amlodipine|mesh-list
13976379|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13976380|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13976381|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13976382|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976383|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13976384|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976385|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
13976386|NCT03054168|Goserelin|goserelin|mesh-list
13976387|NCT03054168|Testosterone|testosterone|mesh-list
13976388|NCT03054168|Hormones|hormones|mesh-ancestor
13976389|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13976390|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976391|NCT03054168|Androgens|androgens|mesh-ancestor
13976392|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13976393|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976394|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13976395|NCT03054220|Tramadol|tramadol|mesh-list
13976396|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
13976397|NCT03054220|Paroxetine|paroxetine|mesh-list
13976398|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13976399|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13976400|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13976401|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976402|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976403|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976404|NCT03054220|Analgesics|analgesics|mesh-ancestor
13976405|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
13976406|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976407|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
13976408|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13976409|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
13976410|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13976411|NCT03054220|Narcotics|narcotics|mesh-ancestor
13976412|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976413|NCT03054220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13976414|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
13976415|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13976416|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13976417|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13976418|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976419|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
13976420|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
13976421|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13976422|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13976423|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
13976424|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13976425|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13976426|NCT03054259|Prednisolone|prednisolone|mesh-list
13976427|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
13976428|NCT03054259|Rituximab|rituximab|mesh-list
13976429|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13976430|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
13976431|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13976432|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976433|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
13976434|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976435|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13976436|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13976437|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
13976438|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
13976439|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976440|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13976441|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
13976442|NCT03054259|Hormones|hormones|mesh-ancestor
13976443|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13976444|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13976445|NCT03054259|Protective Agents|protective agents|mesh-ancestor
13976446|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13976447|NCT03053739|Bosentan|bosentan|mesh-list
13976448|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
13976449|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
13976450|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13976451|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13976452|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976453|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976454|NCT03053739|Urological Agents|urological agents|mesh-ancestor
13976455|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13976456|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
13976457|NCT03053856|Paclitaxel|paclitaxel|mesh-list
13976458|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
13976459|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13976460|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976461|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
13976462|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
13976463|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
13976464|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976465|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13976466|NCT03053869|Diazepam|diazepam|mesh-list
13976467|NCT03053869|Lorazepam|lorazepam|mesh-list
13976468|NCT03053869|Alprazolam|alprazolam|mesh-list
13976469|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
13976470|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
13976471|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
13976472|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976473|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976474|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13976475|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13976476|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976477|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13976478|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13976479|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13976480|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
13976481|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
13976482|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976483|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976484|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13976485|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13976486|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13976487|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13976488|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
13976489|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
13976490|NCT03053947|Ketamine|ketamine|mesh-list
13976491|NCT03053947|Analgesics|analgesics|mesh-ancestor
13976492|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
13976493|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976494|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976495|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13976496|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13976497|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
13976498|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
13976499|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976500|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13976501|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13976502|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976503|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976504|NCT03053830|Ketamine|ketamine|mesh-list
13976505|NCT03053830|Analgesics|analgesics|mesh-ancestor
13976506|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
13976507|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976508|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976509|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13976510|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13976511|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
13976512|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
13976513|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976514|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13976515|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13976516|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976517|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976518|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
13976519|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13976520|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
13976521|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976522|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976523|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13976524|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
13976525|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13976526|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
13976527|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976528|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976529|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13976530|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
13976531|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
13976532|NCT03053388|Protective Agents|protective agents|mesh-ancestor
13976533|NCT03053544|Metformin|metformin|mesh-list
13976534|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13976535|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245866|NCT00227721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245867|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
14245868|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
14245869|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
14245870|NCT00227760|Cediranib|cediranib|mesh-list
14245871|NCT00227760|Maleic acid|maleic acid|mesh-list
14245872|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245873|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245874|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245875|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14245876|NCT00227994|Donepezil|donepezil|mesh-list
14245877|NCT00227994|Galantamine|galantamine|mesh-list
14245878|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14245879|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245880|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245881|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
14245882|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14245883|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245884|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
14245885|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14245886|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
14245887|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245888|NCT00228423|Clopidogrel|clopidogrel|mesh-list
14245889|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14245890|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14245891|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14245892|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14245893|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
14245894|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976536|NCT03053622|Mirikizumab|mirikizumab|mesh-list
13976537|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13976538|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13976539|NCT03053622|Analgesics|analgesics|mesh-ancestor
13976540|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
13976541|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976542|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976543|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13976544|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13976545|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13976546|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13976547|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
13976548|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
13976549|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
13976550|NCT03053414|Vitamin D|vitamin d|mesh-list
13976551|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
13976552|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
13976553|NCT03053414|Vitamins|vitamins|mesh-ancestor
13976554|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
13976555|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976556|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13976557|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13976558|NCT03053505|Vancomycin|vancomycin|mesh-list
13976559|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
13976560|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13976561|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245895|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245896|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245897|NCT00228553|Modafinil|modafinil|mesh-list
14245898|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14245899|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976562|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13976563|NCT03053284|Pasireotide|pasireotide|mesh-list
13976564|NCT03053284|Hormones|hormones|mesh-ancestor
13976565|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13976566|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976567|NCT03053219|Abivertinib|abivertinib|mesh-list
13976568|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13976569|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976570|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976571|NCT03052998|Ivermectin|ivermectin|mesh-list
13976572|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
13976573|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13976574|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13976575|NCT03053167|Irinotecan|irinotecan|mesh-list
13976576|NCT03053167|Raltitrexed|raltitrexed|mesh-list
13976577|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13976578|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13976579|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976580|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976581|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976582|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13976583|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
13976584|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13976585|NCT03052933|Gemcitabine|gemcitabine|mesh-list
13976586|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13976587|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
13976588|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976589|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976590|NCT03052933|Antiviral Agents|antiviral agents|mesh-ancestor
13976591|NCT03052933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13976592|NCT03052933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976593|NCT03052933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13976594|NCT03052933|Immunologic Factors|immunologic factors|mesh-ancestor
13976595|NCT03052933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976596|NCT03052673|Fentanyl|fentanyl|mesh-list
13976597|NCT03052673|Ketamine|ketamine|mesh-list
13976598|NCT03052673|Analgesics|analgesics|mesh-ancestor
13976599|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
13976600|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976601|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976602|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13976603|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13976604|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
13976605|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
13976606|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976607|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13976608|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13976609|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976610|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976611|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13976612|NCT03052673|Narcotics|narcotics|mesh-ancestor
13976613|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13976614|NCT03052569|Agerafenib|agerafenib|mesh-list
13976615|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13976616|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976617|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976618|NCT03052660|Midazolam|midazolam|mesh-list
13976619|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13976620|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13976621|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976622|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976623|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13976624|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13976625|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13976626|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13976627|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
13976628|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
13976629|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
13976630|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
13976631|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976632|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976633|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
13976634|NCT03052348|Betamethasone|betamethasone|mesh-list
13976635|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
13976636|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13976637|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
13976638|NCT03052348|Ether|ether|mesh-list
13976639|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13976640|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13976641|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
13976642|NCT03052348|Hormones|hormones|mesh-ancestor
13976643|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13976644|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976645|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13976646|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
13976647|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13976648|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
13976649|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
13976650|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976651|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13976652|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13976653|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13976654|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976655|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976656|NCT03052400|Mifepristone|mifepristone|mesh-list
13976657|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13976658|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
13976659|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13976660|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976661|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13976662|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13976663|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13976664|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
13976665|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13976666|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13976667|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
13976668|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13976669|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
13976670|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13976671|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13976672|NCT03052361|Ondansetron|ondansetron|mesh-list
13976673|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
13976674|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
13976675|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976676|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976677|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13976678|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
13976679|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
13976680|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13976681|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
13976682|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976683|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976684|NCT03052361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13976685|NCT03052361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13976686|NCT03052361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976687|NCT03052361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13976688|NCT03052361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13976689|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13976690|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13976691|NCT03051932|Acetaminophen|acetaminophen|mesh-list
13976692|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13976693|NCT03051932|Analgesics|analgesics|mesh-ancestor
13976694|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
13976695|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976696|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976697|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
13976698|NCT03051945|Ketamine|ketamine|mesh-list
13976699|NCT03051945|Analgesics|analgesics|mesh-ancestor
13976700|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
13976701|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976702|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976703|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13976704|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13976705|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
13976706|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
13976707|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976708|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13976709|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13976710|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976711|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976712|NCT03051906|Cetuximab|cetuximab|mesh-list
13976713|NCT03051906|Durvalumab|durvalumab|mesh-list
13976714|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13976715|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976716|NCT03051841|Dexamethasone|dexamethasone|mesh-list
13976717|NCT03051841|Bortezomib|bortezomib|mesh-list
13976718|NCT03051841|CKD-581|ckd-581|mesh-list
13976719|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13976720|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
13976721|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
13976722|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976723|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976724|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13976725|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
13976726|NCT03051841|Hormones|hormones|mesh-ancestor
13976727|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13976728|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13976729|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976730|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976731|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976732|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13976733|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13976734|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13976735|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245900|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14245901|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14245902|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14245903|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245904|NCT00228566|Modafinil|modafinil|mesh-list
14245905|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14245906|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245907|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14245908|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14245909|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14245910|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245911|NCT00228813|Sargramostim|sargramostim|mesh-list
14245912|NCT00228813|Lenograstim|lenograstim|mesh-list
14245913|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
14245914|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245915|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14245916|NCT00228943|Tryptophan|tryptophan|mesh-list
14245917|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14531891|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976736|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13976737|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13976738|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976739|NCT03051711|Pyrazole|pyrazole|mesh-list
13976740|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976741|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976742|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13976743|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13976744|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976745|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13976746|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13976747|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976748|NCT03051529|Anesthetics|anesthetics|mesh-list
13976749|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976750|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976751|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13976752|NCT03051698|Metronidazole|metronidazole|mesh-list
13976753|NCT03051698|Vancomycin|vancomycin|mesh-list
13976754|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
13976755|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13976756|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13976757|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13976758|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13976759|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13976760|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976761|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976762|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976763|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13976764|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13976765|NCT03051503|Fentanyl|fentanyl|mesh-list
13976766|NCT03051503|Morphine|morphine|mesh-list
13976767|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13976768|NCT03051503|Narcotics|narcotics|mesh-ancestor
13976769|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976770|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976771|NCT03051503|Analgesics|analgesics|mesh-ancestor
13976772|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
13976773|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976774|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13976775|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13976776|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
13976777|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
13976778|NCT03051451|Metformin|metformin|mesh-list
13976779|NCT03051451|Fluoxetine|fluoxetine|mesh-list
13976780|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13976781|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976782|NCT03051451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13976783|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13976784|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13976785|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976786|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976787|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
13976788|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13976789|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
13976790|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13976791|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13976792|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13976793|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976794|NCT03051373|Gemcitabine|gemcitabine|mesh-list
13976795|NCT03051373|Paclitaxel|paclitaxel|mesh-list
13976796|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13976797|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13976798|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245918|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
13976799|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
13976800|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
13976801|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
13976802|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976803|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13976804|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
13976805|NCT03051373|Antiviral Agents|antiviral agents|mesh-ancestor
13976806|NCT03051373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13976807|NCT03051373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976808|NCT03051373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13976809|NCT03051373|Immunologic Factors|immunologic factors|mesh-ancestor
13976810|NCT03051373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976811|NCT03051087|Ganirelix|ganirelix|mesh-list
13976812|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
13976813|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13976814|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976815|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
13976816|NCT03051269|Calcium|calcium|mesh-list
13976817|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13976818|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976819|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13976820|NCT03051243|Insulin|insulin|mesh-list
13976821|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13976822|NCT03051243|Linagliptin|linagliptin|mesh-list
13976823|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13976824|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976825|NCT03051243|Incretins|incretins|mesh-ancestor
13976826|NCT03051243|Hormones|hormones|mesh-ancestor
13976827|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13976828|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13976829|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
13976830|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976831|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976832|NCT03050866|Antiemetics|antiemetics|mesh-list
13976833|NCT03050866|Histamine|histamine|mesh-list
13976834|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
13976835|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
13976836|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
13976837|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
13976838|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976839|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976840|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976841|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
13976842|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976843|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13976844|NCT03050905|Ritonavir|ritonavir|mesh-list
13976845|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13976846|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13976847|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
13976848|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976849|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976850|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13976851|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13976852|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
13976853|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13976854|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13976855|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13976856|NCT03050827|Oxybutynin|oxybutynin|mesh-list
13976857|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
13976858|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
13976859|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976860|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976861|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13976862|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13976863|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
13976864|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976865|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976866|NCT03050827|Urological Agents|urological agents|mesh-ancestor
13976867|NCT03050957|Menthol|menthol|mesh-list
13976868|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
13976869|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
13976870|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
13976871|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
13976872|NCT03051009|Coagulants|coagulants|mesh-ancestor
13976873|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13976874|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
13976875|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976876|NCT03051022|Dexamethasone|dexamethasone|mesh-list
13976877|NCT03051022|Morphine|morphine|mesh-list
13976878|NCT03051022|Bupivacaine|bupivacaine|mesh-list
13976879|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13976880|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
13976881|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
13976882|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976883|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976884|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13976885|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
13976886|NCT03051022|Hormones|hormones|mesh-ancestor
13976887|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13976888|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13976889|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976890|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
13976891|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
13976892|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976893|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
13976894|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13976895|NCT03051022|Narcotics|narcotics|mesh-ancestor
13976896|NCT03051022|Analgesics|analgesics|mesh-ancestor
13976897|NCT03050710|Lidocaine|lidocaine|mesh-list
13976898|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
13976899|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
13976900|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976901|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976902|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
13976903|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976904|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13976905|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13976906|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13976907|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13976908|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976909|NCT03050437|Pemetrexed|pemetrexed|mesh-list
13976910|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976911|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976912|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976913|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13976914|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13976915|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
13976916|NCT03050411|Apatinib|apatinib|mesh-list
13976917|NCT03050411|Gefitinib|gefitinib|mesh-list
13976918|NCT03050411|Osimertinib|osimertinib|mesh-list
13976919|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976920|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13976921|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976922|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976923|NCT03050554|Avelumab|avelumab|mesh-list
13976924|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13976925|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976926|NCT03050086|Minocycline|minocycline|mesh-list
13976927|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13976928|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13976929|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
13976930|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13976931|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13976932|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13976933|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
13976934|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976935|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976936|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976937|NCT03050177|Gefitinib|gefitinib|mesh-list
13976938|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976939|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13976940|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976941|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976942|NCT03050229|Empagliflozin|empagliflozin|mesh-list
13976943|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13976944|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976945|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13976946|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245919|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14245920|NCT00229619|Rituximab|rituximab|mesh-list
14245921|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14245922|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245923|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
14245924|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245925|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14245926|NCT00229658|Pramlintide|pramlintide|mesh-list
14245927|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14245928|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245929|NCT00229723|Gefitinib|gefitinib|mesh-list
14245930|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042510|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976947|NCT03050164|Gefitinib|gefitinib|mesh-list
13976948|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13976949|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13976950|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976951|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245931|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14245932|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245933|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245934|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14245935|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245936|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14245937|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245938|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245939|NCT00230178|Allopurinol|allopurinol|mesh-list
14245940|NCT00230178|Rasburicase|rasburicase|mesh-list
14245941|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
14245942|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245943|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245944|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
14245945|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14245946|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14245947|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
14245948|NCT00230178|Protective Agents|protective agents|mesh-ancestor
14245949|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245950|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
14245951|NCT00230282|Fludarabine|fludarabine|mesh-list
14245952|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
14245953|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14245954|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
14245955|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245956|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14245957|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14245958|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
14245959|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245960|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245961|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14245962|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14245963|NCT00230737|Melatonin|melatonin|mesh-list
14245964|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
14245965|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245966|NCT00230737|Protective Agents|protective agents|mesh-ancestor
14245967|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245968|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14245969|NCT00230971|Metronidazole|metronidazole|mesh-list
14245970|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
14245971|NCT00230971|Tigecycline|tigecycline|mesh-list
14245972|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14245973|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14245974|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14245975|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14245976|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14245977|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245978|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245979|NCT00231309|Sargramostim|sargramostim|mesh-list
14245980|NCT00231309|Lenograstim|lenograstim|mesh-list
14245981|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
14245982|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245983|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14245984|NCT00231465|Docetaxel|docetaxel|mesh-list
14245985|NCT00231465|Gefitinib|gefitinib|mesh-list
14245986|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14245987|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
14245988|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
14245989|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
14245990|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14245991|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14245992|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14245993|NCT00231478|Granisetron|granisetron|mesh-list
14245994|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
14245995|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
14245996|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14245997|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14245998|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14245999|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14246000|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
13976952|NCT03049930|Ketamine|ketamine|mesh-list
13976953|NCT03049930|Analgesics|analgesics|mesh-ancestor
13976954|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
13976955|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976956|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976957|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13976958|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13976959|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
13976960|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
13976961|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976962|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13976963|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13976964|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13976965|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976966|NCT03049878|Acetaminophen|acetaminophen|mesh-list
13976967|NCT03049878|Codeine|codeine|mesh-list
13976968|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13976969|NCT03049878|Analgesics|analgesics|mesh-ancestor
13976970|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
13976971|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976972|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976973|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
13976974|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13976975|NCT03049878|Narcotics|narcotics|mesh-ancestor
13976976|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976977|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
13976978|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
13976979|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
13976980|NCT03049163|Propoxycaine|propoxycaine|mesh-list
13976981|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
13976982|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13976983|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13976984|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
13976985|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
13976986|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13976987|NCT03049176|Tenofovir|tenofovir|mesh-list
13976988|NCT03049176|Emtricitabine|emtricitabine|mesh-list
13976989|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13976990|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
13976991|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
13976992|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13976993|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13976994|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13976995|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13976996|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13976997|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13976998|NCT03049059|Hydroquinone|hydroquinone|mesh-list
13976999|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
13977000|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977001|NCT03049059|Protective Agents|protective agents|mesh-ancestor
13977002|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977003|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13977004|NCT03049293|Midazolam|midazolam|mesh-list
13977005|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13977006|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13977007|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977008|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977009|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13977010|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13977011|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13977012|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13977013|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
13977014|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
13977015|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
13977016|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
13977017|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977018|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977019|NCT03049267|Apremilast|apremilast|mesh-list
13977020|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13977021|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13977022|NCT03049267|Analgesics|analgesics|mesh-ancestor
13977023|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
13977024|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977025|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977026|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13977027|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13977028|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13977029|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13977030|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977031|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977032|NCT03049046|Caffeic acid|caffeic acid|mesh-list
13977033|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
13977034|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977035|NCT03049046|Protective Agents|protective agents|mesh-ancestor
13977036|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977037|NCT03049085|Aspirin|aspirin|mesh-list
13977038|NCT03049085|Ascorbic Acid|ascorbic acid|mesh-list
13977039|NCT03049085|Vitamins|vitamins|mesh-ancestor
13977040|NCT03049085|Micronutrients|micronutrients|mesh-ancestor
13977041|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977042|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13977043|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13977044|NCT03049085|Analgesics|analgesics|mesh-ancestor
13977045|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
13977046|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977047|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13977048|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13977049|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13977050|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13977051|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977052|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13977053|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13977054|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977055|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
13977056|NCT03049085|Antioxidants|antioxidants|mesh-ancestor
13977057|NCT03049085|Protective Agents|protective agents|mesh-ancestor
13977058|NCT03049345|Methylene Blue|methylene blue|mesh-list
13977059|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977060|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977061|NCT03048877|Apatinib|apatinib|mesh-list
13977062|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977063|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13977064|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977065|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977066|NCT03048825|Colchicine|colchicine|mesh-list
13977067|NCT03048825|Spironolactone|spironolactone|mesh-list
13977068|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13977069|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
13977070|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13977071|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977072|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13977073|NCT03048825|Diuretics|diuretics|mesh-ancestor
13977074|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
13977075|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
13977076|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13977077|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
13977078|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
13977079|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
13977080|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977081|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977082|NCT03048942|Paclitaxel|paclitaxel|mesh-list
13977083|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13977084|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977085|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
13977086|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
13977087|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
13977088|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977089|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13977090|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977091|NCT03048474|Nivolumab|nivolumab|mesh-list
13977092|NCT03048474|Ipilimumab|ipilimumab|mesh-list
13977093|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13977094|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977095|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13977096|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246001|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246002|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246003|NCT00231777|Ondansetron|ondansetron|mesh-list
14246004|NCT00231777|Aprepitant|aprepitant|mesh-list
14246005|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
13977097|NCT03048214|Anesthetics|anesthetics|mesh-list
13977098|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977099|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977100|NCT03048110|Itraconazole|itraconazole|mesh-list
13977101|NCT03048110|Rifampin|rifampin|mesh-list
13977102|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
13977103|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977104|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13977105|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13977106|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977107|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977108|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13977109|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
13977110|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13977111|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977112|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13977113|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13977114|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
13977115|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13977116|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
13977117|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13977118|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13977119|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13977120|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13977121|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13977122|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13977123|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13977124|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13977125|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13977126|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977127|NCT03047837|Aspirin|aspirin|mesh-list
13977128|NCT03047837|Metformin|metformin|mesh-list
13977129|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13977130|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977131|NCT03047837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13977132|NCT03047837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13977133|NCT03047837|Analgesics|analgesics|mesh-ancestor
13977134|NCT03047837|Sensory System Agents|sensory system agents|mesh-ancestor
13977135|NCT03047837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977136|NCT03047837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13977137|NCT03047837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13977138|NCT03047837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13977139|NCT03047837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13977140|NCT03047837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977141|NCT03047837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13977142|NCT03047837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13977143|NCT03047837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977144|NCT03047837|Antipyretics|antipyretics|mesh-ancestor
13977145|NCT03048084|Levetiracetam|levetiracetam|mesh-list
13977146|NCT03048084|Valproic Acid|valproic acid|mesh-list
13977147|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
13977148|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
13977149|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977150|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977151|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
13977152|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977153|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977154|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
13977155|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13977156|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977157|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13977158|NCT03048136|Nivolumab|nivolumab|mesh-list
13977159|NCT03048136|Ipilimumab|ipilimumab|mesh-list
13977160|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13977161|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977162|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13977163|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977164|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
13977165|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13977166|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
13977167|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977168|NCT03048019|Tirofiban|tirofiban|mesh-list
13977169|NCT03048019|Cangrelor|cangrelor|mesh-list
13977170|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13977171|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13977172|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977173|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13977174|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13977175|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13977176|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13977177|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
13977178|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977179|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977180|NCT03047772|Atorvastatin|atorvastatin|mesh-list
13977181|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13977182|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13977183|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
13977184|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977185|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13977186|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13977187|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977188|NCT03047538|Amlodipine|amlodipine|mesh-list
13977189|NCT03047538|Perindopril|perindopril|mesh-list
13977190|NCT03047538|Atorvastatin|atorvastatin|mesh-list
13977191|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13977192|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13977193|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
13977194|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977195|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13977196|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13977197|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977198|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13977199|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13977200|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13977201|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13977202|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977203|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
13977204|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13977205|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
13977206|NCT03047473|Avelumab|avelumab|mesh-list
13977207|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13977208|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977209|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
13977210|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13977211|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13977212|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13977213|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13977214|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977215|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
13977216|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977217|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977218|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13977219|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977220|NCT03047733|Tacrolimus|tacrolimus|mesh-list
13977221|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13977222|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
13977223|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977224|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13977225|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977226|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977227|NCT03047278|Cetirizine|cetirizine|mesh-list
13977228|NCT03047278|Gabapentin|gabapentin|mesh-list
13977229|NCT03047278|Analgesics|analgesics|mesh-ancestor
13977230|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
13977231|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977232|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977233|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
13977234|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13977235|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13977236|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977237|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13977238|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13977239|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13977240|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977241|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977242|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
13977243|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13977244|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13977245|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13977246|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
13977247|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
13977248|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
13977249|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13977250|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
13977251|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977252|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
13977253|NCT03047096|Protective Agents|protective agents|mesh-ancestor
13977254|NCT03046953|Avelumab|avelumab|mesh-list
13977255|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13977256|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977257|NCT03046979|Apatinib|apatinib|mesh-list
13977258|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977259|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13977260|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977261|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977262|NCT03047057|Lidocaine|lidocaine|mesh-list
13977263|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
13977264|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
13977265|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977266|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977267|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
13977268|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977269|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13977270|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13977271|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13977272|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13977273|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977274|NCT03047109|Phenylephrine|phenylephrine|mesh-list
13977275|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
13977276|NCT03047109|Ephedrine|ephedrine|mesh-list
13977277|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13977278|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
13977279|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
13977280|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977281|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977282|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
13977283|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13977284|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
13977285|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
13977286|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13977287|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13977288|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13977289|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
13977290|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977291|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977292|NCT03047109|Protective Agents|protective agents|mesh-ancestor
13977293|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13977294|NCT03047265|Paclitaxel|paclitaxel|mesh-list
13977295|NCT03047265|Cisplatin|cisplatin|mesh-list
13977296|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13977297|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977298|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
13977299|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
13977300|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
13977301|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977302|NCT03046901|Vancomycin|vancomycin|mesh-list
13977303|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13977304|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977305|NCT03046836|Oxytocin|oxytocin|mesh-list
13977306|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
13977307|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13977308|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977309|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
13977310|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
13977311|NCT03046758|Metronidazole|metronidazole|mesh-list
13977312|NCT03046758|Fosfomycin|fosfomycin|mesh-list
13977313|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977314|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13977315|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13977316|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14246006|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
14246007|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977317|NCT03046511|Cefazolin|cefazolin|mesh-list
13977318|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13977319|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977320|NCT03046719|Bupivacaine|bupivacaine|mesh-list
13977321|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
13977322|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
13977323|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977324|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977325|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
13977326|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977327|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13977328|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977329|NCT03046173|Mitogens|mitogens|mesh-list
13977330|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
13977331|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977332|NCT03046017|Lidocaine|lidocaine|mesh-list
13977333|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
13977334|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
13977335|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977336|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977337|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
13977338|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977339|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13977340|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13977341|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13977342|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13977343|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977344|NCT03046251|Natalizumab|natalizumab|mesh-list
13977345|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
13977346|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977347|NCT03046108|Triamcinolone|triamcinolone|mesh-list
13977348|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13977349|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13977350|NCT03046108|Mepivacaine|mepivacaine|mesh-list
13977351|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13977352|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13977353|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
13977354|NCT03046108|Hormones|hormones|mesh-ancestor
13977355|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13977356|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977357|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13977358|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
13977359|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977360|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977361|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
13977362|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
13977363|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977364|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
13977365|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977366|NCT03046290|Lidocaine|lidocaine|mesh-list
13977367|NCT03046290|Ropivacaine|ropivacaine|mesh-list
13977368|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
13977369|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
13977370|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977371|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977372|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
13977373|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977374|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13977375|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13977376|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13977377|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13977378|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977379|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
13977380|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13977381|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977382|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977383|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13977384|NCT03046238|Analgesics|analgesics|mesh-ancestor
13977385|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
13977386|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977387|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13977388|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13977389|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13977390|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
13977391|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977392|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977393|NCT03045783|Cefotiam|cefotiam|mesh-list
13977394|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13977395|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977396|NCT03045770|Leucovorin|leucovorin|mesh-list
13977397|NCT03045770|Paclitaxel|paclitaxel|mesh-list
13977398|NCT03045770|Fluorouracil|fluorouracil|mesh-list
13977399|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
13977400|NCT03045770|Irinotecan|irinotecan|mesh-list
13977401|NCT03045770|Calcium|calcium|mesh-list
13977402|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
13977403|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13977404|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977405|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
13977406|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
13977407|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
13977408|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977409|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13977410|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977411|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
13977412|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13977413|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13977414|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
13977415|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13977416|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13977417|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977418|NCT03045770|Antidotes|antidotes|mesh-ancestor
13977419|NCT03045770|Protective Agents|protective agents|mesh-ancestor
13977420|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
13977421|NCT03045770|Vitamins|vitamins|mesh-ancestor
13977422|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
13977423|NCT03045627|Cytarabine|cytarabine|mesh-list
13977424|NCT03045627|Aclarubicin|aclarubicin|mesh-list
13977425|NCT03045627|Lenograstim|lenograstim|mesh-list
13977426|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13977427|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
13977428|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977429|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977430|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
13977431|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977432|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13977433|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
13977434|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977435|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13977436|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13977437|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13977438|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13977439|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977440|NCT03045484|Oxycodone|oxycodone|mesh-list
13977441|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13977442|NCT03045484|Narcotics|narcotics|mesh-ancestor
13977443|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977444|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977445|NCT03045484|Analgesics|analgesics|mesh-ancestor
13977446|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
13977447|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977448|NCT03045471|Prednisolone|prednisolone|mesh-list
13977449|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13977450|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
13977451|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13977452|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
13977453|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
13977454|NCT03045471|Rituximab|rituximab|mesh-list
13977455|NCT03045471|Etoposide|etoposide|mesh-list
13977456|NCT03045471|Vincristine|vincristine|mesh-list
13977457|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13977458|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
13977459|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13977460|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
13977461|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977462|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13977463|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13977464|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
13977465|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977466|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977467|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13977468|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13977469|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13977470|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13977471|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13977472|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977473|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13977474|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
13977475|NCT03045471|Hormones|hormones|mesh-ancestor
13977476|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13977477|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13977478|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
13977479|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
13977480|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977481|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13977482|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13977483|NCT03045471|Protective Agents|protective agents|mesh-ancestor
13977484|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
13977485|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
13977486|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
13977487|NCT03045510|Decitabine|decitabine|mesh-list
13977488|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13977489|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
13977490|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977491|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977492|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977493|NCT03045406|Dalteparin|dalteparin|mesh-list
13977494|NCT03045406|Tinzaparin|tinzaparin|mesh-list
13977495|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
13977496|NCT03045406|Apixaban|apixaban|mesh-list
13977497|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13977498|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
13977499|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13977500|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
13977501|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977502|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977503|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
13977504|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13977505|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13977506|NCT03045185|Metronidazole|metronidazole|mesh-list
13977507|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
13977508|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977509|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13977510|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13977511|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13977512|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13977513|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13977514|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977515|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977516|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977517|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13977518|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13977519|NCT03045198|Azithromycin|azithromycin|mesh-list
13977520|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13977521|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977522|NCT03045341|Naltrexone|naltrexone|mesh-list
13977523|NCT03045341|Bupropion|bupropion|mesh-list
13977524|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
13977525|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13977526|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977527|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
13977528|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977529|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13977530|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
13977531|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13977532|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13977533|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13977534|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13977535|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977536|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
13977537|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977538|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13977539|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13977540|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246008|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246009|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13977541|NCT03045393|Maytansine|maytansine|mesh-list
13977542|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13977543|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977544|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
13977545|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
13977546|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
13977547|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977548|NCT03045133|Morphine|morphine|mesh-list
13977549|NCT03045133|Methadone|methadone|mesh-list
13977550|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13977551|NCT03045133|Narcotics|narcotics|mesh-ancestor
13977552|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977553|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977554|NCT03045133|Analgesics|analgesics|mesh-ancestor
13977555|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
13977556|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977557|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
13977558|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
13977559|NCT03045016|Prazosin|prazosin|mesh-list
13977560|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13977561|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13977562|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13977563|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13977564|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
13977565|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977566|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246010|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
13977567|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977568|NCT03045029|Treprostinil|treprostinil|mesh-list
13977569|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13977570|NCT03044912|Mirabegron|mirabegron|mesh-list
13977571|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13977572|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13977573|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13977574|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
13977575|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977576|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977577|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977578|NCT03044912|Urological Agents|urological agents|mesh-ancestor
13977579|NCT03044964|Ranolazine|ranolazine|mesh-list
13977580|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13977581|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13977582|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977583|NCT03044873|BMS-986165|bms-986165|mesh-list
13977584|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13977585|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13977586|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13977587|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
13977588|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977589|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13977590|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13977591|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977592|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
13977593|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13977594|NCT03044626|Nivolumab|nivolumab|mesh-list
13977595|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13977596|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977597|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13977598|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977599|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
13977600|NCT03044743|Fludarabine|fludarabine|mesh-list
14246011|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
14246012|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14246013|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
14246014|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246015|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246016|NCT00231777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14246017|NCT00231777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14246018|NCT00231777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14246019|NCT00231777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14246020|NCT00231777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14531892|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531893|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
14531894|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13977601|NCT03044743|Interleukin-2|interleukin-2|mesh-list
13977602|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13977603|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
13977604|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977605|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13977606|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13977607|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
13977608|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977609|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977610|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13977611|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13977612|NCT03044743|Analgesics|analgesics|mesh-ancestor
13977613|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
13977614|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977615|NCT03044795|Veliparib|veliparib|mesh-list
13977616|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13977617|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977618|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977619|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977620|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13977621|NCT03044665|Ezetimibe|ezetimibe|mesh-list
13977622|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13977623|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13977624|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
13977625|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977626|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13977627|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13977628|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977629|NCT03044587|Leucovorin|leucovorin|mesh-list
13977630|NCT03044587|Gemcitabine|gemcitabine|mesh-list
13977631|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977632|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13977633|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
13977634|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977635|NCT03044587|Antiviral Agents|antiviral agents|mesh-ancestor
13977636|NCT03044587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977637|NCT03044587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977638|NCT03044587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13977639|NCT03044587|Immunologic Factors|immunologic factors|mesh-ancestor
13977640|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977641|NCT03044587|Antidotes|antidotes|mesh-ancestor
13977642|NCT03044587|Protective Agents|protective agents|mesh-ancestor
13977643|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
13977644|NCT03044587|Vitamins|vitamins|mesh-ancestor
13977645|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
13977646|NCT03044808|Lidocaine|lidocaine|mesh-list
13977647|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
13977648|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
13977649|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977650|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977651|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
13977652|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977653|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13977654|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13977655|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13977656|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13977657|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977658|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
13977659|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977660|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
13977661|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13977662|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13977663|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977664|NCT03044561|Urological Agents|urological agents|mesh-ancestor
13977665|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
13977666|NCT03044522|Narcotics|narcotics|mesh-ancestor
13977667|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977668|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977669|NCT03044522|Analgesics|analgesics|mesh-ancestor
13977670|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
13977671|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977672|NCT03044938|Albuterol|albuterol|mesh-list
13977673|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13977674|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
13977675|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977676|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977677|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13977678|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
13977679|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
13977680|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13977681|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13977682|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13977683|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13977684|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
13977685|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977686|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977687|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
13977688|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
13977689|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13977690|NCT03044366|Anesthetics|anesthetics|mesh-list
13977691|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977692|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977693|NCT03044379|Dapivirine|dapivirine|mesh-list
13977694|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13977695|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13977696|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
13977697|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977698|NCT03044171|Listerine|listerine|mesh-list
13977699|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
13977700|NCT03044171|Fluorides|fluorides|mesh-list
13977701|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
13977702|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
13977703|NCT03044171|Protective Agents|protective agents|mesh-ancestor
13977704|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977705|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13977706|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977707|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
13977708|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
13977709|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13977710|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13977711|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977712|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
13977713|NCT03044184|Coagulants|coagulants|mesh-ancestor
13977714|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
13977715|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13977716|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13977717|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977718|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13977719|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13977720|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977721|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977722|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
13977723|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13977724|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13977725|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977726|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
13977727|NCT03044041|Coagulants|coagulants|mesh-ancestor
13977728|NCT03044093|Misoprostol|misoprostol|mesh-list
13977729|NCT03044093|Mifepristone|mifepristone|mesh-list
13977730|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13977731|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
13977732|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13977733|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977734|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13977735|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13977736|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
13977737|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13977738|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13977739|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13977740|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13977741|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
13977742|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13977743|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13977744|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
13977745|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13977746|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
13977747|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13977748|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13977749|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13977750|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
13977751|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13977752|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13977753|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977754|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977755|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13977756|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13977757|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977758|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
13977759|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977760|NCT03043677|Adalimumab|adalimumab|mesh-list
13977761|NCT03043677|Golimumab|golimumab|mesh-list
13977762|NCT03043677|Infliximab|infliximab|mesh-list
13977763|NCT03043677|Ustekinumab|ustekinumab|mesh-list
13977764|NCT03043677|Vedolizumab|vedolizumab|mesh-list
13977765|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13977766|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13977767|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
13977768|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13977769|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
13977770|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13977771|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
13977772|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977773|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
13977774|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13977775|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
13977776|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13977777|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977778|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13977779|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13977780|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13977781|NCT03043989|Clarithromycin|clarithromycin|mesh-list
13977782|NCT03043989|Docetaxel|docetaxel|mesh-list
13977783|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977784|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
13977785|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
13977786|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
13977787|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977788|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13977789|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977790|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13977791|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977792|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13977793|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13977794|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
13977795|NCT03043664|Lanreotide|lanreotide|mesh-list
13977796|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13977797|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977821|NCT03043950|Panitumumab|panitumumab|mesh-list
13977822|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13977823|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977824|NCT03043612|Doxazosin|doxazosin|mesh-list
13977825|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13977826|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13977827|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13977828|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13977829|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
13977830|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977831|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977832|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977833|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
13977834|NCT03043521|Lansoprazole|lansoprazole|mesh-list
13977835|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13977836|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13977837|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13977838|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977839|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246021|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14246022|NCT00231842|Ifosfamide|ifosfamide|mesh-list
14246023|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246024|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14246025|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
14246026|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246027|NCT00231868|Paclitaxel|paclitaxel|mesh-list
14246028|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14246029|NCT00231868|Carboplatin|carboplatin|mesh-list
14246030|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14246031|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246032|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
14246033|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
14246034|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
14246035|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246036|NCT00231894|Pioglitazone|pioglitazone|mesh-list
14246037|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14246038|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246039|NCT00232180|Eplerenone|eplerenone|mesh-list
14246040|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14246041|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
14246042|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14246043|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246044|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14246045|NCT00232180|Diuretics|diuretics|mesh-ancestor
14246046|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
14246047|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14246048|NCT00232479|Carboplatin|carboplatin|mesh-list
14246049|NCT00232479|Docetaxel|docetaxel|mesh-list
14246050|NCT00232479|Trastuzumab|trastuzumab|mesh-list
14246051|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246052|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
14246053|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
14246054|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
14246055|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246056|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14246057|NCT00232505|Carboplatin|carboplatin|mesh-list
14246058|NCT00232505|Cetuximab|cetuximab|mesh-list
14246059|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246060|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14246061|NCT00232583|Metformin|metformin|mesh-list
14246062|NCT00232583|Pioglitazone|pioglitazone|mesh-list
14246063|NCT00232583|Glyburide|glyburide|mesh-list
14246064|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14246065|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246066|NCT00232596|Ezogabine|ezogabine|mesh-list
14246067|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
14246068|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14246069|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246070|NCT00232739|Sirolimus|sirolimus|mesh-list
14246071|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14246072|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14246073|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14246074|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246075|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
14246076|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14246077|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
14246078|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246079|NCT00233064|Palivizumab|palivizumab|mesh-list
14246080|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
13977840|NCT03043547|Leucovorin|leucovorin|mesh-list
13977841|NCT03043547|Antidotes|antidotes|mesh-ancestor
13977842|NCT03043547|Protective Agents|protective agents|mesh-ancestor
13977843|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977844|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
13977845|NCT03043547|Vitamins|vitamins|mesh-ancestor
13977846|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
13977847|NCT03043430|Midazolam|midazolam|mesh-list
13977848|NCT03043430|Ketamine|ketamine|mesh-list
13977849|NCT03043430|Analgesics|analgesics|mesh-ancestor
13977850|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
13977851|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977852|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977853|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13977854|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13977855|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
13977856|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
13977857|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977858|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13977859|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13977860|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977861|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977862|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13977863|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13977864|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13977865|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13977866|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13977867|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
13977868|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
13977869|NCT03043248|Digoxin|digoxin|mesh-list
13977870|NCT03043248|Midazolam|midazolam|mesh-list
13977871|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13977872|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13977873|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977874|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977875|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13977876|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13977877|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13977878|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13977879|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
13977880|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
13977881|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
13977882|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
13977883|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977884|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977885|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13977886|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13977887|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977888|NCT03043248|Protective Agents|protective agents|mesh-ancestor
13977889|NCT03043326|Tenofovir|tenofovir|mesh-list
13977890|NCT03043326|Emtricitabine|emtricitabine|mesh-list
13977891|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
13977892|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977893|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13977894|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13977895|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977896|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977897|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13977898|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13977899|NCT03043482|Calcitriol|calcitriol|mesh-list
13977900|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13977901|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977902|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
13977903|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13977904|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977905|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13977906|NCT03043482|Vitamins|vitamins|mesh-ancestor
13977907|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
13977908|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13977909|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
13977910|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13977911|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13977912|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13977913|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14531895|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
13977914|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977915|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
13977916|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977917|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977918|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13977919|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977920|NCT03043443|Melatonin|melatonin|mesh-list
13977921|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
13977922|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977923|NCT03043443|Protective Agents|protective agents|mesh-ancestor
13977924|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977925|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977926|NCT03043495|Dexamethasone|dexamethasone|mesh-list
13977927|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13977928|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
13977929|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
13977930|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977931|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977932|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13977933|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
13977934|NCT03043495|Hormones|hormones|mesh-ancestor
13977935|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13977936|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13977937|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13977938|NCT03043157|Rocuronium|rocuronium|mesh-list
13977939|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13977940|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13977941|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13977942|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977943|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977944|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13977945|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13977946|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13977947|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
13977948|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977949|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13977950|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13977951|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13977952|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
13977953|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13977954|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13977955|NCT03042936|Insulin|insulin|mesh-list
13977956|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13977957|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977958|NCT03042923|Mannitol|mannitol|mesh-list
13977959|NCT03042923|Lactulose|lactulose|mesh-list
13977960|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13977961|NCT03042923|Diuretics|diuretics|mesh-ancestor
13977962|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
13977963|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977964|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13977965|NCT03043053|Oxytocin|oxytocin|mesh-list
13977966|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
13977967|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13977968|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977969|NCT03043001|Memantine|memantine|mesh-list
13977970|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13977971|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13977972|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
13977973|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13977974|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13977975|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977976|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13977977|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13977978|NCT03043027|Bupivacaine|bupivacaine|mesh-list
13977979|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
13977980|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
13977981|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13977982|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977983|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
13977984|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13977985|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13977986|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13977987|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13977988|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
13977989|NCT03043014|Misoprostol|misoprostol|mesh-list
13977990|NCT03043014|Mifepristone|mifepristone|mesh-list
13977991|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13977992|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
13977993|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13977994|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13977995|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13977996|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13977997|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
13977998|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13977999|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13978000|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13978001|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13978002|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
13978003|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13978004|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13978005|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
13978006|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13978007|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
13978008|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13978009|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13978010|NCT03042871|Ranibizumab|ranibizumab|mesh-list
13978011|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13978012|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13978013|NCT03042871|Growth Substances|growth substances|mesh-ancestor
13978014|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978015|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
13978016|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978017|NCT03042546|Calcium|calcium|mesh-list
13978018|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13978019|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978020|NCT03042637|Tacrolimus|tacrolimus|mesh-list
13978021|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13978022|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
13978023|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978024|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13978025|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978026|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978027|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
13978028|NCT03042429|Ifosfamide|ifosfamide|mesh-list
13978029|NCT03042429|Cisplatin|cisplatin|mesh-list
13978030|NCT03042429|Doxorubicin|doxorubicin|mesh-list
13978031|NCT03042429|Etoposide|etoposide|mesh-list
13978032|NCT03042429|Topotecan|topotecan|mesh-list
13978033|NCT03042429|Vindesine|vindesine|mesh-list
13978034|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13978035|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
13978036|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978037|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13978038|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13978039|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
13978040|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978041|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978042|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13978043|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13978044|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13978045|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13978046|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978047|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13978048|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13978049|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
13978050|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
13978051|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
13978052|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
13978053|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13978054|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13978055|NCT03042377|Calcium|calcium|mesh-list
13978056|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13978057|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978058|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13978059|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13978060|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
13978061|NCT03042611|Apatinib|apatinib|mesh-list
13978062|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978063|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13978064|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978065|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978066|NCT03042325|Alogliptin|alogliptin|mesh-list
13978067|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13978068|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978069|NCT03042325|Incretins|incretins|mesh-ancestor
13978070|NCT03042325|Hormones|hormones|mesh-ancestor
13978071|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13978072|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13978073|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
13978074|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978075|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978076|NCT03042260|Trimethoprim|trimethoprim|mesh-list
13978077|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
13978078|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
13978079|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13978080|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13978081|NCT03042260|Renal Agents|renal agents|mesh-ancestor
13978082|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
13978083|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13978084|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13978085|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13978086|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978087|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978088|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13978089|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13978090|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13978091|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13978092|NCT03042234|Insulin|insulin|mesh-list
13978093|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13978094|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13978095|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978096|NCT03041883|Riboflavin|riboflavin|mesh-list
13978097|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
13978098|NCT03041883|Vitamins|vitamins|mesh-ancestor
13978099|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
13978100|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978101|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13978102|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
13978103|NCT03041935|Acetaminophen|acetaminophen|mesh-list
13978104|NCT03041935|Dexamethasone|dexamethasone|mesh-list
13978105|NCT03041935|Ketorolac|ketorolac|mesh-list
13978106|NCT03041935|Morphine|morphine|mesh-list
13978107|NCT03041935|Remifentanil|remifentanil|mesh-list
13978108|NCT03041935|Ondansetron|ondansetron|mesh-list
13978109|NCT03041935|Propofol|propofol|mesh-list
13978110|NCT03041935|Ropivacaine|ropivacaine|mesh-list
13978111|NCT03041935|Sevoflurane|sevoflurane|mesh-list
13978112|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13978113|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
13978114|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
13978115|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978116|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978117|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13978118|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
13978119|NCT03041935|Hormones|hormones|mesh-ancestor
13978120|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13978121|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13978122|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978123|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13978124|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978125|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13978126|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
13978127|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
13978128|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13978129|NCT03041935|Narcotics|narcotics|mesh-ancestor
13978130|NCT03041935|Analgesics|analgesics|mesh-ancestor
13978131|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
13978132|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
13978133|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13978134|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
13978135|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13978136|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13978137|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
13978138|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
13978139|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13978140|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
13978141|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246081|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13978142|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978143|NCT03041935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13978144|NCT03041935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13978145|NCT03041935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13978146|NCT03041935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13978147|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13978148|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13978149|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13978150|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978151|NCT03042013|Naquotinib|naquotinib|mesh-list
13978152|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978153|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13978154|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978155|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978156|NCT03042000|Capecitabine|capecitabine|mesh-list
13978157|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
13978158|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13978159|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
13978160|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978161|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978162|NCT03041948|Acetaminophen|acetaminophen|mesh-list
13978163|NCT03041948|Dexamethasone|dexamethasone|mesh-list
13978164|NCT03041948|Ketorolac|ketorolac|mesh-list
13978165|NCT03041948|Morphine|morphine|mesh-list
13978166|NCT03041948|Remifentanil|remifentanil|mesh-list
13978167|NCT03041948|Ondansetron|ondansetron|mesh-list
13978168|NCT03041948|Propofol|propofol|mesh-list
13978169|NCT03041948|Sevoflurane|sevoflurane|mesh-list
13978170|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13978171|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
13978172|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
13978173|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978174|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978175|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13978176|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
13978177|NCT03041948|Hormones|hormones|mesh-ancestor
13978178|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13978179|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13978180|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978181|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13978182|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978183|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13978184|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
13978185|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
13978186|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13978187|NCT03041948|Narcotics|narcotics|mesh-ancestor
13978188|NCT03041948|Analgesics|analgesics|mesh-ancestor
13978189|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
13978190|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13978191|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
13978192|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13978193|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13978194|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
13978195|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
13978196|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13978197|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
13978198|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13978199|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978200|NCT03041948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13978201|NCT03041948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13978202|NCT03041948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13978203|NCT03041948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13978204|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13978205|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13978206|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13978207|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978208|NCT03042182|Vaccines|vaccines|mesh-list
13978209|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
13978210|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978211|NCT03042091|Metronidazole|metronidazole|mesh-list
13978212|NCT03042091|Ethanol|ethanol|mesh-list
14246082|NCT00233103|Sertraline|sertraline|mesh-list
13978213|NCT03042091|Neomycin|neomycin|mesh-list
13978214|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13978215|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13978216|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13978217|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13978218|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13978219|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978220|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978221|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13978222|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978223|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978224|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
13978225|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13978226|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13978227|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978228|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
13978229|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13978230|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978231|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
13978232|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
13978233|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13978234|NCT03041779|Acetaminophen|acetaminophen|mesh-list
13978235|NCT03041779|Diclofenac|diclofenac|mesh-list
13978236|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13978237|NCT03041779|Analgesics|analgesics|mesh-ancestor
13978238|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
13978239|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978240|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978241|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
13978242|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13978243|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13978244|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13978245|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13978246|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978247|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246083|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
14246084|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14246085|NCT00233103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14246086|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14246087|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14246088|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246089|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246090|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
14246091|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246092|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14246093|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
14246094|NCT00233363|Rebamipide|rebamipide|mesh-list
14246095|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14246096|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14246097|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
14246098|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246099|NCT00233363|Protective Agents|protective agents|mesh-ancestor
14246100|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246101|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246102|NCT00233389|Rebamipide|rebamipide|mesh-list
14246103|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14246104|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14246105|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
14246106|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246107|NCT00233389|Protective Agents|protective agents|mesh-ancestor
14246108|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246109|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246110|NCT00233454|Midostaurin|midostaurin|mesh-list
14246111|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246112|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14246113|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246114|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246115|NCT00233480|Atorvastatin|atorvastatin|mesh-list
14246116|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14246117|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14246118|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
14246119|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246120|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14246121|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14246122|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246123|NCT00233948|Nelfinavir|nelfinavir|mesh-list
14246124|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14246125|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14246126|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
13978252|NCT03041506|Lidocaine|lidocaine|mesh-list
13978253|NCT03041506|Midazolam|midazolam|mesh-list
13978254|NCT03041506|Ketamine|ketamine|mesh-list
13978255|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
13978256|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
14246127|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246128|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246129|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14246130|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13978257|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978258|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978259|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
14246131|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
14246132|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14246133|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
14246134|NCT00233987|Melphalan|melphalan|mesh-list
14246135|NCT00233987|Carmustine|carmustine|mesh-list
14246136|NCT00233987|Etoposide|etoposide|mesh-list
14246137|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14246138|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
14246139|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246140|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14246141|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14246142|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
14246143|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246144|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246145|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14246146|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14246147|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14246148|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14246149|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246150|NCT00234039|Gemcitabine|gemcitabine|mesh-list
14246151|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14246152|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
14246153|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246154|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246155|NCT00234039|Antiviral Agents|antiviral agents|mesh-ancestor
14246156|NCT00234039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14246157|NCT00234039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246158|NCT00234039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14246159|NCT00234039|Immunologic Factors|immunologic factors|mesh-ancestor
14246160|NCT00234039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246161|NCT00234052|Bevacizumab|bevacizumab|mesh-list
14246162|NCT00234052|Carboplatin|carboplatin|mesh-list
14246163|NCT00234052|Pemetrexed|pemetrexed|mesh-list
14246164|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14246165|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246166|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14246167|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14246168|NCT00234052|Growth Substances|growth substances|mesh-ancestor
14246169|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246170|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
14246171|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246172|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246173|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14246174|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14246175|NCT00234065|Aspirin|aspirin|mesh-list
13978260|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978261|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13978262|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13978263|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13978264|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13978265|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978266|NCT03041506|Analgesics|analgesics|mesh-ancestor
13978267|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13978268|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13978269|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
13978270|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14246176|NCT00234065|Cilostazol|cilostazol|mesh-list
14246177|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14246178|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13978271|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13978272|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13978273|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13978274|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13978275|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13978276|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13978277|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13978278|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
13978279|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
13978280|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13978281|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13978282|NCT03040999|Cisplatin|cisplatin|mesh-list
13978283|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
13978284|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978285|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13978286|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
13978287|NCT03041012|Romidepsin|romidepsin|mesh-list
13978288|NCT03041012|Antibodies, Blocking|antibodies, blocking|mesh-list
13978289|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
13978290|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13978291|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13978292|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978293|NCT03041012|Immunologic Factors|immunologic factors|mesh-ancestor
13978294|NCT03041012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978312|NCT03040934|Sirolimus|sirolimus|mesh-list
13978313|NCT03040934|Everolimus|everolimus|mesh-list
13978314|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978315|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13978316|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
13978317|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978318|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13978319|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13978320|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13978321|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
13978322|NCT03040791|Nivolumab|nivolumab|mesh-list
13978323|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13978324|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978325|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13978326|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978327|NCT03040830|Progesterone|progesterone|mesh-list
13978328|NCT03040830|Progestins|progestins|mesh-ancestor
13978329|NCT03040830|Hormones|hormones|mesh-ancestor
13978330|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13978331|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978332|NCT03040752|Nifedipine|nifedipine|mesh-list
13978333|NCT03040752|Ritodrine|ritodrine|mesh-list
13978334|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13978335|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13978336|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978337|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13978338|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978339|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
13978340|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
13978341|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13978342|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
13978343|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
13978344|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978345|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13978346|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13978347|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13978348|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
14246179|NCT00234065|Analgesics|analgesics|mesh-ancestor
13978349|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13978350|NCT03040817|Esomeprazole|esomeprazole|mesh-list
13978351|NCT03040817|Mosapride|mosapride|mesh-list
13978352|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978353|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13978354|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13978355|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13978356|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978357|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13978358|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
13978359|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13978360|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978361|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
13978362|NCT03040765|Denosumab|denosumab|mesh-list
13978363|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13978364|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978365|NCT03040635|Risdiplam|risdiplam|mesh-list
13978366|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13978367|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978368|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978369|NCT03040596|Fluticasone|fluticasone|mesh-list
13978370|NCT03040596|Xhance|xhance|mesh-list
13978371|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13978372|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13978373|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
13978374|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978375|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978376|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13978377|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
13978378|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
13978379|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13978380|NCT03040531|Vitamin D|vitamin d|mesh-list
13978381|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
13978382|NCT03040531|Alendronate|alendronate|mesh-list
13978383|NCT03040531|Genistein|genistein|mesh-list
13978384|NCT03040531|Calcium|calcium|mesh-list
13978385|NCT03040531|Vitamins|vitamins|mesh-ancestor
13978386|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
13978387|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978388|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13978389|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13978390|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
13978391|NCT03040531|Protective Agents|protective agents|mesh-ancestor
13978392|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978393|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13978394|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978395|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978396|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
13978397|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
13978398|NCT03040531|Estrogens|estrogens|mesh-ancestor
13978399|NCT03040531|Hormones|hormones|mesh-ancestor
13978400|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13978401|NCT03040219|Folic Acid|folic acid|mesh-list
13978402|NCT03040219|Hematinics|hematinics|mesh-ancestor
13978403|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
13978404|NCT03040219|Vitamins|vitamins|mesh-ancestor
13978405|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
13978406|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978407|NCT03040141|Oseltamivir|oseltamivir|mesh-list
13978408|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
13978409|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13978410|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978411|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978412|NCT03040401|Aldesleukin|aldesleukin|mesh-list
13978413|NCT03040401|Interleukin-2|interleukin-2|mesh-list
13978414|NCT03040401|Histamine|histamine|mesh-list
13978415|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
13978416|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978417|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13978418|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13978419|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
13978420|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13978421|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13978422|NCT03040401|Analgesics|analgesics|mesh-ancestor
13978423|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
13978424|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978425|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978426|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
13978427|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
13978428|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13978429|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978430|NCT03040180|Bleomycin|bleomycin|mesh-list
13978431|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13978432|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978433|NCT03040167|Epinephrine|epinephrine|mesh-list
13978434|NCT03040167|Bupivacaine|bupivacaine|mesh-list
13978435|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
13978436|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
13978437|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978438|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978439|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
13978440|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978441|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13978442|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13978443|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
13978444|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13978445|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978446|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13978447|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13978448|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
13978449|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13978450|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
13978451|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
13978452|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
13978453|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13978454|NCT03040193|Lidocaine|lidocaine|mesh-list
13978455|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
13978456|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
13978457|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978458|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978459|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
13978460|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978461|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13978462|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13978463|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13978464|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13978465|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246180|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
14246181|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14246182|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246183|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14246184|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14246185|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14246186|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14246187|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246188|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14246189|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14246190|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246191|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
14246192|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14246193|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
14246194|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14246195|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
14246196|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
14246197|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14246198|NCT00234065|Protective Agents|protective agents|mesh-ancestor
14246199|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14246200|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14246201|NCT00234078|Rebamipide|rebamipide|mesh-list
14246202|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14246203|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14246204|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
14246205|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246206|NCT00234078|Protective Agents|protective agents|mesh-ancestor
14246207|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246208|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246209|NCT00234104|Tolvaptan|tolvaptan|mesh-list
14246210|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14246211|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246212|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
14246213|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246214|NCT00234494|Gemcitabine|gemcitabine|mesh-list
14246215|NCT00234494|Bevacizumab|bevacizumab|mesh-list
13978466|NCT03040128|Minocycline|minocycline|mesh-list
13978467|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13978468|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13978469|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
13978470|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
13978471|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13978472|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978473|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978474|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
13978475|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13978476|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978477|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978478|NCT03039842|Valproic Acid|valproic acid|mesh-list
13978479|NCT03039842|Memantine|memantine|mesh-list
13978480|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
13978481|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13978482|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13978483|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
13978484|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13978485|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978486|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978487|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13978488|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13978489|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
13978490|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
13978491|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
13978492|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978493|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
13978494|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
13978495|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13978496|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978497|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13978498|NCT03039608|Prednisone|prednisone|mesh-list
13978499|NCT03039608|Triamcinolone|triamcinolone|mesh-list
13978500|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13978501|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
13978502|NCT03039608|Hormones|hormones|mesh-ancestor
13978503|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13978504|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978505|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13978506|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978507|NCT03039413|Copper|copper|mesh-list
13978508|NCT03039413|Trace Elements|trace elements|mesh-ancestor
13978509|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
13978510|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978511|NCT03039491|Vaccines|vaccines|mesh-list
13978512|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
13978513|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
13978514|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978515|NCT03039426|Diclofenac|diclofenac|mesh-list
13978516|NCT03039426|Bupivacaine|bupivacaine|mesh-list
13978517|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
13978518|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
13978519|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978520|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978521|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
13978522|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978523|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13978524|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13978525|NCT03039426|Analgesics|analgesics|mesh-ancestor
13978526|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13978527|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13978528|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13978529|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978530|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978531|NCT03039478|Erythritol|erythritol|mesh-list
13978532|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
13978533|NCT03039205|Clopidogrel|clopidogrel|mesh-list
13978534|NCT03039205|Ticagrelor|ticagrelor|mesh-list
14246216|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13978535|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13978536|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13978537|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13978538|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13978539|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
13978540|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13978541|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978542|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978543|NCT03039257|Vitamin A|vitamin a|mesh-list
13978544|NCT03039257|Vitamins|vitamins|mesh-ancestor
13978545|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
13978546|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978547|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
13978548|NCT03038919|Testosterone|testosterone|mesh-list
13978549|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
13978550|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
13978551|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13978552|NCT03038919|Androgens|androgens|mesh-ancestor
13978553|NCT03038919|Hormones|hormones|mesh-ancestor
13978554|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13978555|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978556|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13978557|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978558|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
13978559|NCT03039101|Montelukast|montelukast|mesh-list
13978560|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13978561|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
13978562|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
13978563|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
13978564|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13978565|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978566|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
13978567|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13978568|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978569|NCT03038958|Prilocaine|prilocaine|mesh-list
13978570|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
13978571|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
13978572|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
13978573|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978574|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978575|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
13978576|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978577|NCT03039075|Metformin|metformin|mesh-list
13978578|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13978579|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978580|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
13978581|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
13978582|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13978583|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
13978584|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13978585|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978586|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13978587|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13978588|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978589|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
13978590|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
13978591|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
13978592|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978593|NCT03038607|Aspirin|aspirin|mesh-list
13978594|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13978595|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13978596|NCT03038607|Analgesics|analgesics|mesh-ancestor
13978597|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
13978598|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978599|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978600|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13978601|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13978602|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13978603|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13978604|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978605|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13978606|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13978607|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978608|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
13978609|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
13978610|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13978611|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978612|NCT03038516|Vitamins|vitamins|mesh-ancestor
13978613|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
13978614|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13978615|NCT03038477|Durvalumab|durvalumab|mesh-list
13978616|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13978617|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978618|NCT03038503|Terlipressin|terlipressin|mesh-list
13978619|NCT03038503|Methylene Blue|methylene blue|mesh-list
13978620|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978621|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978622|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13978623|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13978624|NCT03038451|Amlodipine|amlodipine|mesh-list
13978625|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13978626|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13978627|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13978628|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978629|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13978630|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978631|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
13978632|NCT03038243|Vaccines|vaccines|mesh-list
13978633|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
13978634|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978635|NCT03038295|Propranolol|propranolol|mesh-list
13978636|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13978637|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13978638|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
13978639|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042511|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
13978640|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978641|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978642|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13978643|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13978644|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
13978645|NCT03038321|Levofloxacin|levofloxacin|mesh-list
13978646|NCT03038321|Lornoxicam|lornoxicam|mesh-list
13978647|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13978648|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13978649|NCT03038321|Renal Agents|renal agents|mesh-ancestor
13978650|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13978651|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13978652|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13978653|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978654|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978655|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978656|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13978657|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13978658|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13978659|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13978660|NCT03038321|Analgesics|analgesics|mesh-ancestor
13978661|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
13978662|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978663|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978664|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13978665|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13978666|NCT03038282|Chromium|chromium|mesh-list
13978667|NCT03038282|Chromous chloride|chromous chloride|mesh-list
13978668|NCT03038282|Trace Elements|trace elements|mesh-ancestor
13978669|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
13978670|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978671|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
13978672|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978673|NCT03038282|Protective Agents|protective agents|mesh-ancestor
14246217|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042512|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15042513|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
15042514|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042515|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15042516|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042517|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15042518|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042519|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
15042520|NCT02044653|Hematinics|hematinics|mesh-ancestor
15042521|NCT02044809|Cannabidiol|cannabidiol|mesh-list
15042522|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
13978674|NCT03038217|Capecitabine|capecitabine|mesh-list
13978675|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
13978676|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13978677|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
13978678|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978679|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978680|NCT03038425|Ropivacaine|ropivacaine|mesh-list
13978681|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
13978682|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
13978683|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978684|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978685|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
13978686|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978687|NCT03038256|Capecitabine|capecitabine|mesh-list
13978688|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13978689|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
13978690|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978691|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978692|NCT03038230|Antibodies|antibodies|mesh-list
13978693|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13978694|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
13978695|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978696|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
13978697|NCT03038334|Analgesics|analgesics|mesh-ancestor
13978698|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
13978699|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978700|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978701|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
13978702|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978703|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13978704|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
13978705|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13978706|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13978707|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978708|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13978709|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
13978710|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13978711|NCT03037970|Becaplermin|becaplermin|mesh-list
13978712|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
13978713|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
13978714|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14246218|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14246219|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14246220|NCT00234494|Growth Substances|growth substances|mesh-ancestor
14246221|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246222|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
14246223|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14246224|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
14246225|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246226|NCT00234494|Antiviral Agents|antiviral agents|mesh-ancestor
14246227|NCT00234494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14246228|NCT00234494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246229|NCT00234494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14246230|NCT00234494|Immunologic Factors|immunologic factors|mesh-ancestor
14246231|NCT00234832|Sibutramine|sibutramine|mesh-list
13978715|NCT03037970|Growth Substances|growth substances|mesh-ancestor
13978716|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978717|NCT03037944|Drospirenone|drospirenone|mesh-list
13978718|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
13978719|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
13978720|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
13978721|NCT03037944|Estradiol|estradiol|mesh-list
13978722|NCT03037944|Estrogens|estrogens|mesh-ancestor
13978723|NCT03037944|Hormones|hormones|mesh-ancestor
13978724|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13978725|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978726|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13978727|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
13978728|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13978729|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13978730|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13978731|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13978732|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14246232|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
13978733|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13978734|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
13978735|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13978736|NCT03037944|Diuretics|diuretics|mesh-ancestor
13978737|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
13978738|NCT03038048|Ranibizumab|ranibizumab|mesh-list
13978739|NCT03038048|Aflibercept|aflibercept|mesh-list
13978740|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13978741|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13978742|NCT03038048|Growth Substances|growth substances|mesh-ancestor
13978743|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978744|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
13978745|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978746|NCT03037775|Nicotine|nicotine|mesh-list
13978747|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13978748|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
13978749|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978750|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978751|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13978752|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13978753|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
13978754|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13978755|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978756|NCT03037736|Bevacizumab|bevacizumab|mesh-list
13978757|NCT03037736|Fluorouracil|fluorouracil|mesh-list
13978758|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13978759|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978760|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13978761|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13978762|NCT03037736|Growth Substances|growth substances|mesh-ancestor
13978763|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978764|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
13978765|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
13978766|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978767|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13978768|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13978769|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
13978770|NCT03037892|Fentanyl|fentanyl|mesh-list
13978771|NCT03037892|Midazolam|midazolam|mesh-list
13978772|NCT03037892|Remifentanil|remifentanil|mesh-list
13978773|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13978774|NCT03037892|Narcotics|narcotics|mesh-ancestor
13978775|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978776|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978777|NCT03037892|Analgesics|analgesics|mesh-ancestor
13978778|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
13978779|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978780|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13978781|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13978782|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
13978783|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
13978784|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13978785|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13978786|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13978787|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13978788|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
13978789|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
13978790|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13978791|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978792|NCT03038009|Pantoprazole|pantoprazole|mesh-list
13978793|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13978794|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13978795|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13978796|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978797|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978798|NCT03037606|Rabeprazole|rabeprazole|mesh-list
13978799|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13978800|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13978801|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13978802|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978803|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978804|NCT03037593|Vitamin D|vitamin d|mesh-list
13978805|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
13978806|NCT03037593|Vitamins|vitamins|mesh-ancestor
13978807|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
13978808|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978809|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13978810|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13978811|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
13978812|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13978813|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13978814|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978815|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
13978816|NCT03037515|Coagulants|coagulants|mesh-ancestor
13978817|NCT03037372|Atorvastatin|atorvastatin|mesh-list
13978818|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13978819|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
13978820|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13978821|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13978822|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
13978823|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978824|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13978825|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978826|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
13978827|NCT03037437|Sorafenib|sorafenib|mesh-list
13978828|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978829|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13978830|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978831|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978832|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
13978833|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13978834|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13978835|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13978836|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13978837|NCT03036995|Apremilast|apremilast|mesh-list
13978838|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13978839|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13978840|NCT03036995|Analgesics|analgesics|mesh-ancestor
13978841|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
13978842|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978843|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978844|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13978845|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13978846|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13978847|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13978848|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978849|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978850|NCT03036826|Meropenem|meropenem|mesh-list
13978851|NCT03036826|Tazobactam|tazobactam|mesh-list
13978852|NCT03036826|Piperacillin|piperacillin|mesh-list
13978853|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
13978854|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13978855|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13978856|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13978857|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978858|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978859|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
13978860|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13978861|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13978862|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13978863|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978864|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13978865|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978866|NCT03037073|Analgesics|analgesics|mesh-ancestor
13978867|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
13978868|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978869|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
13978870|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13978871|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
13978872|NCT03036891|Naloxegol|naloxegol|mesh-list
13978873|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13978874|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978875|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
13978876|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978877|NCT03036800|Liraglutide|liraglutide|mesh-list
13978878|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13978879|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978880|NCT03036800|Incretins|incretins|mesh-ancestor
13978881|NCT03036800|Hormones|hormones|mesh-ancestor
13978882|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13978883|NCT03036904|Prednisone|prednisone|mesh-list
13978884|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
13978885|NCT03036904|Rituximab|rituximab|mesh-list
13978886|NCT03036904|Doxorubicin|doxorubicin|mesh-list
13978887|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13978888|NCT03036904|Etoposide|etoposide|mesh-list
13978889|NCT03036904|Vincristine|vincristine|mesh-list
13978890|NCT03036904|Venetoclax|venetoclax|mesh-list
13978891|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13978892|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
13978893|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978894|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13978895|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13978896|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
13978897|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978898|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978899|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13978900|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13978901|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13978902|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13978903|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13978904|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978905|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13978906|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
13978907|NCT03036904|Hormones|hormones|mesh-ancestor
13978908|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13978909|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13978910|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13978911|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
13978912|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
13978913|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
13978914|NCT03036748|Amiloride|amiloride|mesh-list
13978915|NCT03036748|Diuretics|diuretics|mesh-ancestor
13978916|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
13978917|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978918|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
13978919|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13978920|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13978921|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978922|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
13978923|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14246233|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14246234|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
14246235|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14246236|NCT00234884|Adalimumab|adalimumab|mesh-list
14246237|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14246238|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14246239|NCT00235391|Deferasirox|deferasirox|mesh-list
14246240|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14246241|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
14246242|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
14246243|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246244|NCT00235443|Lacosamide|lacosamide|mesh-list
14246245|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
14246246|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14246247|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14246248|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14246249|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531896|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531897|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14531898|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14531899|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
14531900|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531901|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531902|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14531903|NCT02353468|Dexamethasone|dexamethasone|mesh-list
14531904|NCT02353468|Lenalidomide|lenalidomide|mesh-list
14531905|NCT02353468|Bortezomib|bortezomib|mesh-list
14531906|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14531907|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
14531908|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
14531909|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531910|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531911|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14531912|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
14531913|NCT02353468|Hormones|hormones|mesh-ancestor
15042523|NCT02044952|Mesalamine|mesalamine|mesh-list
13978924|NCT03036488|Paclitaxel|paclitaxel|mesh-list
13978925|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
13978926|NCT03036488|Carboplatin|carboplatin|mesh-list
13978927|NCT03036488|Doxorubicin|doxorubicin|mesh-list
13978928|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
13978929|NCT03036488|Epirubicin|epirubicin|mesh-list
13978930|NCT03036488|Lenograstim|lenograstim|mesh-list
13978931|NCT03036488|Sargramostim|sargramostim|mesh-list
13978932|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13978933|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978934|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
13978935|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
13978936|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
13978937|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978938|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13978939|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
13978940|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978941|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13978942|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13978943|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
13978944|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13978945|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13978946|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13978947|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13978948|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978949|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13978950|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13978951|NCT03036605|Dexamethasone|dexamethasone|mesh-list
13978952|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
13978953|NCT03036605|Bupivacaine|bupivacaine|mesh-list
13978954|NCT03036605|BB 1101|bb 1101|mesh-list
13978955|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13978956|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
13978957|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
13978958|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978959|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978960|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13978961|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
13978962|NCT03036605|Hormones|hormones|mesh-ancestor
13978963|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13978964|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13978965|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13978966|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
13978967|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978968|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978969|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
13978970|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
13978971|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978972|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
13978973|NCT03036501|Risdiplam|risdiplam|mesh-list
13978974|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13978975|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978976|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978977|NCT03036514|Sufentanil|sufentanil|mesh-list
13978978|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13978979|NCT03036514|Narcotics|narcotics|mesh-ancestor
13978980|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978981|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978982|NCT03036514|Analgesics|analgesics|mesh-ancestor
13978983|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
13978984|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13978985|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13978986|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13978987|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
13978988|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
13978989|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
13978990|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
13978991|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13978992|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13978993|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13978994|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
13978995|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13978996|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13978997|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13978998|NCT03036644|Nicotine|nicotine|mesh-list
13978999|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13979000|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
13979001|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979002|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979003|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13979004|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13979005|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
13979006|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979007|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979008|NCT03036046|Fluconazole|fluconazole|mesh-list
13979009|NCT03036046|Posaconazole|posaconazole|mesh-list
13979010|NCT03036046|Olorofim|olorofim|mesh-list
13979011|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
13979012|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979013|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13979014|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13979015|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979016|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979017|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13979018|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
13979019|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13979020|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979021|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13979022|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13979023|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
13979024|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13979025|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13979026|NCT03036202|Epinephrine|epinephrine|mesh-list
13979027|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13979028|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13979029|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
13979030|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979031|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979032|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979033|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13979034|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13979035|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
13979036|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979037|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13979038|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
13979039|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
13979040|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
13979041|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13979042|NCT03036059|Ivermectin|ivermectin|mesh-list
13979043|NCT03036059|Albendazole|albendazole|mesh-list
13979044|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13979045|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979046|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
13979047|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
13979048|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13979049|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13979050|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
13979051|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
13979052|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
13979053|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979054|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979055|NCT03036111|Trimebutine|trimebutine|mesh-list
13979056|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13979057|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
13979058|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
13979059|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979060|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979061|NCT03036085|Epinephrine|epinephrine|mesh-list
13979062|NCT03036085|Bupivacaine|bupivacaine|mesh-list
13979063|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
13979064|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
13979065|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979066|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979067|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
13979068|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979069|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13979070|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13979071|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
13979072|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979073|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979074|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13979075|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13979076|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
13979077|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13979078|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
13979079|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
13979080|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
13979081|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13979082|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
13979083|NCT03035838|Aprepitant|aprepitant|mesh-list
13979084|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
13979085|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
13979086|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979087|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979088|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13979089|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13979090|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979091|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979092|NCT03035656|Ropivacaine|ropivacaine|mesh-list
13979093|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
13979094|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
13979095|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979096|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979097|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
13979098|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979099|NCT03035695|Hemostatics|hemostatics|mesh-list
13979100|NCT03035695|Coagulants|coagulants|mesh-ancestor
13979101|NCT03035578|Morphine|morphine|mesh-list
13979102|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13979103|NCT03035578|Narcotics|narcotics|mesh-ancestor
13979104|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979105|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979106|NCT03035578|Analgesics|analgesics|mesh-ancestor
13979107|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
13979108|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979109|NCT03035617|Bupivacaine|bupivacaine|mesh-list
13979110|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
13979111|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
13979112|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14246250|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
14246251|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
14246252|NCT00235573|Vitamins|vitamins|mesh-ancestor
14246253|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
14246254|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246255|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
14246256|NCT00235573|Hematinics|hematinics|mesh-ancestor
14246257|NCT00235716|Vitamins|vitamins|mesh-list
14246258|NCT00235716|Vitamin E|vitamin e|mesh-list
14246259|NCT00235716|Tocopherols|tocopherols|mesh-list
14246260|NCT00235716|Tocotrienols|tocotrienols|mesh-list
14246261|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
14246262|NCT00235716|Memantine|memantine|mesh-list
14246263|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
14246264|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246265|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
14246266|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246267|NCT00235716|Protective Agents|protective agents|mesh-ancestor
14246268|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14246269|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13979113|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979114|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
13979115|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979116|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
13979117|NCT03035357|Daratumumab|daratumumab|mesh-list
13979118|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979119|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
13979120|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
13979121|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
13979122|NCT03035305|Amodiaquine|amodiaquine|mesh-list
13979123|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
13979124|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13979125|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13979126|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979127|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13979128|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979129|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979130|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13979131|NCT03035305|Renal Agents|renal agents|mesh-ancestor
13979132|NCT03035214|Dexamethasone|dexamethasone|mesh-list
13979133|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
13979134|NCT03035214|BB 1101|bb 1101|mesh-list
13979135|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13979136|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
13979137|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
13979138|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979139|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979140|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13979141|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
13979142|NCT03035214|Hormones|hormones|mesh-ancestor
13979143|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13979144|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13979145|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979146|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
13979147|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979148|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979149|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
13979150|NCT03035331|Vaccines|vaccines|mesh-list
13979151|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
13979152|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979153|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13979154|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979155|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13979156|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
13979157|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979158|NCT03035084|Vitamin D|vitamin d|mesh-list
13979159|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
13979160|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
13979161|NCT03035084|Vitamins|vitamins|mesh-list
13979162|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
13979163|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979164|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13979165|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13979166|NCT03034941|Metformin|metformin|mesh-list
13979167|NCT03034941|Liraglutide|liraglutide|mesh-list
13979168|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13979169|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979170|NCT03034941|Incretins|incretins|mesh-ancestor
13979171|NCT03034941|Hormones|hormones|mesh-ancestor
13979172|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13979173|NCT03034850|Doxorubicin|doxorubicin|mesh-list
13979174|NCT03034850|Fluorouracil|fluorouracil|mesh-list
13979175|NCT03034850|Ifosfamide|ifosfamide|mesh-list
13979176|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13979177|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979178|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13979179|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13979180|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979181|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979182|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
13979183|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13979184|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13979185|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
13979186|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979187|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13979188|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
13979189|NCT03034759|Insulin|insulin|mesh-list
13979190|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13979191|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979192|NCT03035058|Vedolizumab|vedolizumab|mesh-list
13979193|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13979194|NCT03035045|Acetaminophen|acetaminophen|mesh-list
13979195|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13979196|NCT03035045|Analgesics|analgesics|mesh-ancestor
13979197|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
13979198|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979199|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979200|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
14246270|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
14246271|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246272|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14246273|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14246274|NCT00235755|Ezogabine|ezogabine|mesh-list
14246275|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
14246276|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14246277|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246278|NCT00235833|Adalimumab|adalimumab|mesh-list
14246279|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14246280|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14246281|NCT00235872|Adalimumab|adalimumab|mesh-list
14246282|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14246283|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14246284|NCT00235989|Interferons|interferons|mesh-list
14246285|NCT00235989|Interferon-beta|interferon-beta|mesh-list
14246286|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
14246287|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246288|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
14246289|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14246290|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
14246291|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246292|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14246293|NCT00236080|Modafinil|modafinil|mesh-list
14246294|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14246295|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246296|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14246297|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14246298|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14246299|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246300|NCT00236184|Rabeprazole|rabeprazole|mesh-list
14246301|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14246302|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14246303|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14246304|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246305|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246306|NCT00236197|Rabeprazole|rabeprazole|mesh-list
14246307|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14246308|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14246309|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14246310|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246311|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246312|NCT00236899|Gemcitabine|gemcitabine|mesh-list
14246313|NCT00236899|Paclitaxel|paclitaxel|mesh-list
14246314|NCT00236899|Docetaxel|docetaxel|mesh-list
14246315|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14246316|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246317|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
14246318|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
14246319|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
14246320|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246321|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14246322|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
14246323|NCT00236899|Antiviral Agents|antiviral agents|mesh-ancestor
14246324|NCT00236899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14246325|NCT00236899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246326|NCT00236899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14246327|NCT00236899|Immunologic Factors|immunologic factors|mesh-ancestor
14246328|NCT00236899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246329|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
14246330|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14246331|NCT00236938|Hematinics|hematinics|mesh-ancestor
14246332|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
14246333|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14246334|NCT00236951|Hematinics|hematinics|mesh-ancestor
14246335|NCT00236977|Iron|iron|mesh-list
13979201|NCT03034733|Dexamethasone|dexamethasone|mesh-list
13979202|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13979203|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
13979204|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
13979205|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979206|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979207|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13979208|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
13979209|NCT03034733|Hormones|hormones|mesh-ancestor
13979210|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13979211|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13979212|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979213|NCT03034707|Biotin|biotin|mesh-list
13979214|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
13979215|NCT03034707|Vitamins|vitamins|mesh-ancestor
13979216|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
13979217|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979218|NCT03034408|Mannitol|mannitol|mesh-list
13979219|NCT03034408|Baclofen|baclofen|mesh-list
13979220|NCT03034408|Nalmefene|nalmefene|mesh-list
13979221|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
13979222|NCT03034408|Diuretics|diuretics|mesh-ancestor
13979223|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
13979224|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979225|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13979226|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13979227|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979228|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
13979229|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
13979230|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
13979231|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979232|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979233|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13979234|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
13979235|NCT03034382|Lidocaine|lidocaine|mesh-list
13979236|NCT03034382|Epinephrine|epinephrine|mesh-list
13979237|NCT03034382|Morphine|morphine|mesh-list
13979238|NCT03034382|Nalbuphine|nalbuphine|mesh-list
13979239|NCT03034382|Bupivacaine|bupivacaine|mesh-list
13979240|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
13979241|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
13979242|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979243|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979244|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
13979245|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979246|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13979247|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13979248|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13979249|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13979250|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979251|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13979252|NCT03034382|Narcotics|narcotics|mesh-ancestor
13979253|NCT03034382|Analgesics|analgesics|mesh-ancestor
13979254|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13979255|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13979256|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
13979257|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979258|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13979259|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13979260|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
13979261|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13979262|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
13979263|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
13979264|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
13979265|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13979266|NCT03034304|Ifosfamide|ifosfamide|mesh-list
13979267|NCT03034304|Antibodies|antibodies|mesh-list
13979268|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
13979269|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979270|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13979271|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
13979272|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979273|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979274|NCT03034005|Budesonide|budesonide|mesh-list
13979275|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13979276|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13979277|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
13979278|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979279|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979280|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13979281|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
13979282|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
13979283|NCT03034005|Hormones|hormones|mesh-ancestor
13979284|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13979285|NCT03033589|Bupivacaine|bupivacaine|mesh-list
13979286|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13979287|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
13979288|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
13979289|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979290|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979291|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
13979292|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979293|NCT03033537|Verapamil|verapamil|mesh-list
13979294|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
13979295|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13979296|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979297|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13979298|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13979299|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979300|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
13979301|NCT03033758|Budesonide|budesonide|mesh-list
13979302|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
13979303|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13979304|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13979305|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
13979306|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979307|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979308|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13979309|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
13979310|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
13979311|NCT03033758|Hormones|hormones|mesh-ancestor
13979312|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13979313|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13979314|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13979315|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13979316|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
13979317|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979318|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979319|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
13979320|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13979321|NCT03033654|Protective Agents|protective agents|mesh-ancestor
13979322|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979323|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
13979324|NCT03033732|Buprenorphine|buprenorphine|mesh-list
13979325|NCT03033732|Methadone|methadone|mesh-list
13979326|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13979327|NCT03033732|Naloxone|naloxone|mesh-list
13979328|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13979329|NCT03033732|Narcotics|narcotics|mesh-ancestor
13979330|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979331|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979332|NCT03033732|Analgesics|analgesics|mesh-ancestor
13979333|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
13979334|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979335|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13979336|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
13979337|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
13979338|NCT03033472|Clindamycin|clindamycin|mesh-list
13979339|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
13979340|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
13979341|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13979342|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979343|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13979344|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979345|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979346|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13979347|NCT03033836|Dolutegravir|dolutegravir|mesh-list
13979348|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13979349|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13979350|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979351|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979352|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
13979353|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979354|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13979355|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13979356|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13979357|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13979358|NCT03033446|Nivolumab|nivolumab|mesh-list
13979359|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13979360|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979361|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13979362|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979363|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
13979364|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13979365|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13979366|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13979367|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13979368|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979369|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
13979370|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979371|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979372|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13979373|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979374|NCT03033121|Hormones|hormones|mesh-list
13979375|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13979376|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979377|NCT03033264|Dinoprostone|dinoprostone|mesh-list
13979378|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
13979379|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13979380|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979381|NCT03033199|Dexamethasone|dexamethasone|mesh-list
13979382|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13979383|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
13979384|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
13979385|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979386|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979387|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13979388|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
13979389|NCT03033199|Hormones|hormones|mesh-ancestor
13979390|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13979391|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13979392|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979393|NCT03033368|Rilpivirine|rilpivirine|mesh-list
13979394|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13979395|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13979396|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979397|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979398|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
13979399|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979400|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13979401|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13979402|NCT03033147|Amoxicillin|amoxicillin|mesh-list
13979403|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
13979404|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
13979405|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13979406|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13979407|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979408|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13979409|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979410|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979411|NCT03033342|Omeprazole|omeprazole|mesh-list
13979412|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13979413|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13979414|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13979415|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979416|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979417|NCT03033095|Etanercept|etanercept|mesh-list
13979418|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13979419|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13979420|NCT03033095|Analgesics|analgesics|mesh-ancestor
13979421|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
13979422|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979423|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979424|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13979425|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13979426|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13979427|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13979428|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
14246336|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14246337|NCT00236977|Trace Elements|trace elements|mesh-ancestor
14246338|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
14246339|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246340|NCT00236977|Hematinics|hematinics|mesh-ancestor
14246341|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
14246342|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14246343|NCT00237042|Estradiol|estradiol|mesh-list
14246344|NCT00237042|Estrogens|estrogens|mesh-ancestor
14246345|NCT00237042|Hormones|hormones|mesh-ancestor
14246346|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14246347|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246348|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14246349|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
14246350|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14246351|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14246352|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14246353|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14246354|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14246355|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
14246356|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246357|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14246358|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246359|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246360|NCT00237458|Lacosamide|lacosamide|mesh-list
14246361|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
14246362|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14246363|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14246364|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14246365|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246366|NCT00237666|Ziprasidone|ziprasidone|mesh-list
14246367|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14246368|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
14246369|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246370|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246371|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246372|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14246373|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14246374|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14246375|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14246376|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14246377|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
14246378|NCT00237718|Vitamin E|vitamin e|mesh-list
14246379|NCT00237718|Tocopherols|tocopherols|mesh-list
14246380|NCT00237718|Tocotrienols|tocotrienols|mesh-list
14246381|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
14246382|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
14246383|NCT00237718|Vitamins|vitamins|mesh-ancestor
14246384|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
14246385|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246386|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
14246387|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246388|NCT00237718|Protective Agents|protective agents|mesh-ancestor
14246389|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
14246390|NCT00238108|Melatonin|melatonin|mesh-list
14246391|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
14246392|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246393|NCT00238108|Protective Agents|protective agents|mesh-ancestor
14246394|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246395|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14246396|NCT00238121|Sorafenib|sorafenib|mesh-list
14246397|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246398|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14246399|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246400|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246401|NCT00238238|Rituximab|rituximab|mesh-list
14246402|NCT00238238|Lenalidomide|lenalidomide|mesh-list
14246403|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14246404|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246405|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
14246406|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246407|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14246408|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13979429|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
13979430|NCT03032978|Calcium|calcium|mesh-list
13979431|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13979432|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979433|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13979434|NCT03033160|Estradiol|estradiol|mesh-list
13979435|NCT03033160|Estrogens|estrogens|mesh-ancestor
13979436|NCT03033160|Hormones|hormones|mesh-ancestor
13979437|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13979438|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979439|NCT03033316|Dexamethasone|dexamethasone|mesh-list
13979440|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13979441|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
13979442|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
13979443|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979444|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979445|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13979446|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
13979447|NCT03033316|Hormones|hormones|mesh-ancestor
13979448|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13979449|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13979450|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979451|NCT03032848|Estrogens|estrogens|mesh-list
13979452|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
13979453|NCT03032848|Hormones|hormones|mesh-ancestor
13979454|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13979455|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979456|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
13979457|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
13979458|NCT03032783|Tacrolimus|tacrolimus|mesh-list
13979459|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13979460|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
13979461|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979462|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13979463|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13979464|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
13979465|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979466|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979467|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13979468|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13979469|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979470|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13979471|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13979472|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
13979473|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13979474|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979475|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
13979476|NCT03032666|Velpatasvir|velpatasvir|mesh-list
13979477|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
13979478|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979479|NCT03032536|Tenofovir|tenofovir|mesh-list
13979480|NCT03032536|Entecavir|entecavir|mesh-list
13979481|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
13979482|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979483|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13979484|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13979485|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979486|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979487|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13979488|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13979489|NCT03032484|Bevacizumab|bevacizumab|mesh-list
13979490|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13979491|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979492|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13979493|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13979494|NCT03032484|Growth Substances|growth substances|mesh-ancestor
13979495|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979496|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
13979497|NCT03032614|Carboplatin|carboplatin|mesh-list
13979498|NCT03032614|Veliparib|veliparib|mesh-list
13979499|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979500|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13979501|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979502|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979503|NCT03032458|Ketorolac|ketorolac|mesh-list
13979504|NCT03032458|Lidocaine|lidocaine|mesh-list
13979505|NCT03032458|Meperidine|meperidine|mesh-list
13979506|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
13979507|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
13979508|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979509|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979510|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
13979511|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979512|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13979513|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13979514|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13979515|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13979516|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979517|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13979518|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13979519|NCT03032458|Analgesics|analgesics|mesh-ancestor
13979520|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13979521|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13979522|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13979523|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979524|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13979525|NCT03032458|Narcotics|narcotics|mesh-ancestor
13979526|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13979527|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
13979528|NCT03032406|Everolimus|everolimus|mesh-list
13979529|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979530|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13979531|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
13979532|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979533|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
13979534|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13979535|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13979536|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979537|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979538|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979539|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13979540|NCT03032367|Bedaquiline|bedaquiline|mesh-list
13979541|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
13979542|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13979543|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979544|NCT03032419|Vaccines|vaccines|mesh-list
13979545|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
13979546|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979547|NCT03032042|Azithromycin|azithromycin|mesh-list
13979548|NCT03032042|Albendazole|albendazole|mesh-list
13979549|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13979550|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979551|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
13979552|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13979553|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
13979554|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13979555|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13979556|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
13979557|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
13979558|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
13979559|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979560|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979561|NCT03032315|Amlodipine|amlodipine|mesh-list
13979562|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
13979563|NCT03032315|Telmisartan|telmisartan|mesh-list
13979564|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
13979565|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13979566|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13979567|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13979568|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979569|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13979570|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979571|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
13979572|NCT03032315|Diuretics|diuretics|mesh-ancestor
13979573|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
13979574|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
13979575|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13979576|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13979577|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
13979578|NCT03032107|Trastuzumab|trastuzumab|mesh-list
13979579|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15042524|NCT02044952|Triptolide|triptolide|mesh-list
13979580|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13979581|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979582|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
13979583|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
13979584|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
13979585|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979586|NCT03031834|Quinapril|quinapril|mesh-list
13979587|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13979588|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
13979589|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979590|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979591|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13979592|NCT03031691|Trifluridine|trifluridine|mesh-list
13979593|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
13979594|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979595|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
13979596|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979597|NCT03031808|Lidocaine|lidocaine|mesh-list
13979598|NCT03031808|Rocuronium|rocuronium|mesh-list
13979599|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
13979600|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
13979601|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979602|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979603|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
13979604|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979605|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13979606|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13979607|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13979608|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13979609|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979610|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13979611|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13979612|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13979613|NCT03031756|Glycine|glycine|mesh-list
13979614|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
13979615|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979616|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979617|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979618|NCT03031535|Octreotide|octreotide|mesh-list
13979619|NCT03031535|Hormones|hormones|mesh-list
13979620|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
13979621|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13979622|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979623|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13979624|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13979625|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246409|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14246410|NCT00238238|Growth Substances|growth substances|mesh-ancestor
14246411|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
14246412|NCT00238303|Vorinostat|vorinostat|mesh-list
14246413|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246414|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14246415|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246416|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246417|NCT00238355|Voriconazole|voriconazole|mesh-list
14246418|NCT00238355|Caspofungin|caspofungin|mesh-list
14246419|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
14246420|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14246421|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14246422|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14246423|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246424|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246425|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14246426|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
14246427|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14246428|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246429|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14246430|NCT00238433|Melphalan|melphalan|mesh-list
14246431|NCT00238433|Busulfan|busulfan|mesh-list
14246432|NCT00238433|Thiotepa|thiotepa|mesh-list
14246433|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
14246434|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979626|NCT03031210|Amoxicillin|amoxicillin|mesh-list
13979627|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13979628|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979629|NCT03031405|Oxytocin|oxytocin|mesh-list
13979630|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
13979631|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13979632|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979633|NCT03031444|Leucovorin|leucovorin|mesh-list
13979634|NCT03031444|Cetuximab|cetuximab|mesh-list
13979635|NCT03031444|Fluorouracil|fluorouracil|mesh-list
13979636|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
13979637|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13979638|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979639|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
13979640|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979641|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13979642|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13979643|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
13979644|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979645|NCT03031444|Antidotes|antidotes|mesh-ancestor
13979646|NCT03031444|Protective Agents|protective agents|mesh-ancestor
13979647|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
13979648|NCT03031444|Vitamins|vitamins|mesh-ancestor
13979649|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
13979650|NCT03031249|Cytarabine|cytarabine|mesh-list
13979651|NCT03031249|Tretinoin|tretinoin|mesh-list
13979652|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
13979653|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13979654|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
13979655|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979656|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979657|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
13979658|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979659|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13979660|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
13979661|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979662|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
13979663|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
13979664|NCT03031184|Mirtazapine|mirtazapine|mesh-list
13979665|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
13979666|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13979667|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13979668|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
13979669|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
13979670|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979671|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979672|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979673|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13979674|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13979675|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979676|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
13979677|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13979678|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13979679|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
13979680|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
13979681|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13979682|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
13979683|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
13979684|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13979685|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
13979686|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13979687|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13979688|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
13979689|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979690|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
13979691|NCT03031327|Protective Agents|protective agents|mesh-ancestor
13979692|NCT03031353|Misoprostol|misoprostol|mesh-list
13979693|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13979694|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
13979695|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13979696|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979697|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13979698|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13979699|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
13979700|NCT03031483|Clarithromycin|clarithromycin|mesh-list
13979701|NCT03031483|Lenalidomide|lenalidomide|mesh-list
13979702|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
13979703|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979704|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13979705|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13979706|NCT03031483|Growth Substances|growth substances|mesh-ancestor
13979707|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
13979708|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979709|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13979710|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979711|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13979712|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979713|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979714|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13979715|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13979716|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
13979717|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13979718|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
13979719|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979720|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
13979721|NCT03031054|Protective Agents|protective agents|mesh-ancestor
13979722|NCT03030911|Fentanyl|fentanyl|mesh-list
13979723|NCT03030911|Midazolam|midazolam|mesh-list
13979724|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
13979725|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13979726|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979727|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979728|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13979729|NCT03030911|Analgesics|analgesics|mesh-ancestor
13979730|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
13979731|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979732|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13979733|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13979734|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13979735|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
13979736|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979737|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979738|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13979739|NCT03030911|Narcotics|narcotics|mesh-ancestor
13979740|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13979741|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13979742|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
13979743|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
13979744|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13979745|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13979746|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13979747|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
13979748|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
13979749|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
13979750|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13979751|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979752|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979753|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13979754|NCT03030950|Analgesics|analgesics|mesh-ancestor
13979755|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
13979756|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979757|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13979758|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13979759|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13979760|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
13979761|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979762|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979763|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13979764|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13979765|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13979766|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979767|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979768|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
13979769|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979770|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13979771|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13979772|NCT03030937|Irinotecan|irinotecan|mesh-list
13979773|NCT03030937|Apatinib|apatinib|mesh-list
13979774|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13979775|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13979776|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979777|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979778|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979779|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13979780|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
13979781|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13979782|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
13979783|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979784|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13979785|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13979786|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
13979787|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979788|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979789|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13979790|NCT03030690|Methamphetamine|methamphetamine|mesh-list
13979791|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13979792|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979793|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
13979794|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
13979795|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979796|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
13979797|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979798|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979799|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
13979800|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13979801|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13979802|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13979803|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13979804|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
13979805|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
13979806|NCT03030716|Procyanidin|procyanidin|mesh-list
13979807|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13979808|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979809|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
13979810|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979811|NCT03030716|Protective Agents|protective agents|mesh-ancestor
13979812|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979813|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13979814|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13979815|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979816|NCT03031119|Atorvastatin|atorvastatin|mesh-list
13979817|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13979818|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13979819|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
13979820|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979821|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13979822|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13979823|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979824|NCT03030430|Bevacizumab|bevacizumab|mesh-list
13979825|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13979826|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979827|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13979828|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13979829|NCT03030430|Growth Substances|growth substances|mesh-ancestor
13979830|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979831|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
13979832|NCT03030703|Inositol|inositol|mesh-list
13979833|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
13979834|NCT03030703|Vitamins|vitamins|mesh-ancestor
13979835|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
13979836|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979837|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
13979838|NCT03030469|Analgesics|analgesics|mesh-list
13979839|NCT03030469|Narcotics|narcotics|mesh-ancestor
13979840|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979841|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979842|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
13979843|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979844|NCT03030560|Lidocaine|lidocaine|mesh-list
13979845|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
13979846|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
13979847|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979848|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979849|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
13979850|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979851|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13979852|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13979853|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13979854|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13979855|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979856|NCT03030677|Lidocaine|lidocaine|mesh-list
13979857|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
13979858|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
13979859|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979860|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979861|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
13979862|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979863|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13979864|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13979865|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13979866|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13979867|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979868|NCT03031262|Cytarabine|cytarabine|mesh-list
13979869|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13979870|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
13979871|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979872|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979873|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
13979874|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979875|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13979876|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
13979877|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979878|NCT03030131|Durvalumab|durvalumab|mesh-list
13979879|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13979880|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979881|NCT03030287|Paclitaxel|paclitaxel|mesh-list
13979882|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
13979883|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13979884|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979885|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
13979886|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
13979887|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
13979888|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979889|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
13979890|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979891|NCT03030300|Metformin|metformin|mesh-list
13979892|NCT03030300|Pioglitazone|pioglitazone|mesh-list
13979893|NCT03030300|Insulin|insulin|mesh-list
13979894|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13979895|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979896|NCT03030001|Antibodies|antibodies|mesh-list
13979897|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
13979898|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979899|NCT03030196|Denosumab|denosumab|mesh-list
13979900|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13979901|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979902|NCT03030105|Scopolamine|scopolamine|mesh-list
13979903|NCT03030105|Donepezil|donepezil|mesh-list
13979904|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
13979905|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13979906|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979907|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979908|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
13979909|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979910|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979911|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
13979912|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13979913|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
13979914|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
13979915|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979916|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13979917|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
13979918|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13979919|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13979920|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
14246435|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14246436|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
14246437|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246438|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979921|NCT03030248|Vancomycin|vancomycin|mesh-list
13979922|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13979923|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979924|NCT03030157|Pirarubicin|pirarubicin|mesh-list
13979925|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979926|NCT03029533|Leuprolide|leuprolide|mesh-list
13979927|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13979928|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
13979929|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13979930|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979931|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13979932|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13979933|NCT03029676|Fentanyl|fentanyl|mesh-list
13979934|NCT03029676|Midazolam|midazolam|mesh-list
13979935|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
13979936|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13979937|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979938|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13979939|NCT03029676|Narcotics|narcotics|mesh-ancestor
13979940|NCT03029676|Analgesics|analgesics|mesh-ancestor
13979941|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
13979942|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979943|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13979944|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13979945|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
13979946|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13979947|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13979948|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13979949|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13979950|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
13979951|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
13979952|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979953|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979954|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
13979955|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13979956|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13979957|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
13979958|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13979959|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13979960|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13979961|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13979962|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979963|NCT03029455|Ivacaftor|ivacaftor|mesh-list
13979964|NCT03029455|VX-659|vx-659|mesh-list
13979965|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
13979966|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13979967|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979968|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
13979969|NCT03029494|Vitamins|vitamins|mesh-ancestor
13979970|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
13979971|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979972|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
13979973|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979974|NCT03029494|Protective Agents|protective agents|mesh-ancestor
13979975|NCT03029845|Propranolol|propranolol|mesh-list
13979976|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13979977|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13979978|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
13979979|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13979980|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13979981|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979982|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13979983|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13979984|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
13979985|NCT03029442|Denosumab|denosumab|mesh-list
13979986|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13979987|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979988|NCT03029390|Metformin|metformin|mesh-list
13979989|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13979990|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979991|NCT03029429|Theophylline|theophylline|mesh-list
13979992|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13979993|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
13979994|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13979995|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13979996|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13979997|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
13979998|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13979999|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980000|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980001|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
13980002|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13980003|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13980004|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
13980005|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980006|NCT03029351|Exenatide|exenatide|mesh-list
13980007|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13980008|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980009|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13980010|NCT03029351|Incretins|incretins|mesh-ancestor
13980011|NCT03029351|Hormones|hormones|mesh-ancestor
13980012|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13980013|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
13980014|NCT03029273|Fludarabine|fludarabine|mesh-list
13980015|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13980016|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
13980017|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980018|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13980019|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13980020|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
13980021|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980022|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980023|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13980024|NCT03029013|Apatinib|apatinib|mesh-list
13980025|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980026|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13980027|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980028|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980029|NCT03028883|Buprenorphine|buprenorphine|mesh-list
13980030|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13980031|NCT03028883|Narcotics|narcotics|mesh-ancestor
13980032|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980033|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980034|NCT03028883|Analgesics|analgesics|mesh-ancestor
13980035|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
13980036|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980037|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13980038|NCT03029169|Amiodarone|amiodarone|mesh-list
13980039|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
13980040|NCT03029169|Propafenone|propafenone|mesh-list
13980041|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
13980042|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
13980043|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13980044|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980045|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13980046|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13980047|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13980048|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980049|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13980050|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13980051|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13980052|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13980053|NCT03028701|Budesonide|budesonide|mesh-list
13980054|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
13980055|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13980056|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13980057|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
13980058|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980059|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980060|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13980061|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
13980062|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
13980063|NCT03028701|Hormones|hormones|mesh-ancestor
13980064|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13980065|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13980066|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13980067|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13980068|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
13980069|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980070|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980071|NCT03028766|Adavosertib|adavosertib|mesh-list
13980072|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980073|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980074|NCT03028909|Oseltamivir|oseltamivir|mesh-list
13980075|NCT03028909|MEDI8852|medi8852|mesh-list
13980076|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
13980077|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980078|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980079|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980080|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
13980081|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13980082|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980083|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
13980084|NCT03028298|Citric Acid|citric acid|mesh-list
13980085|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
13980086|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
13980087|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
13980088|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
13980089|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
13980090|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980091|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
13980092|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13980093|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13980094|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980095|NCT03028298|Urological Agents|urological agents|mesh-ancestor
13980096|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
13980097|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13980098|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
13980099|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980100|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
13980101|NCT03028428|Protective Agents|protective agents|mesh-ancestor
13980102|NCT03028571|Trimethaphan|trimethaphan|mesh-list
13980103|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
13980104|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13980105|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13980106|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
13980107|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
13980108|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980109|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980110|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
13980111|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13980112|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
13980113|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980114|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980115|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
13980116|NCT03028532|Clomiphene|clomiphene|mesh-list
13980117|NCT03028532|Enclomiphene|enclomiphene|mesh-list
13980118|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
13980119|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13980120|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
13980121|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13980122|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980123|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13980124|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
13980125|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13980126|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13980127|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13980128|NCT03028350|Ifetroban|ifetroban|mesh-list
13980129|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13980130|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
13980131|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980132|NCT03027960|Empagliflozin|empagliflozin|mesh-list
13980133|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13980134|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980135|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13980136|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246439|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14246440|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14246441|NCT00238615|Carboplatin|carboplatin|mesh-list
14246442|NCT00238615|Docetaxel|docetaxel|mesh-list
14246443|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246444|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
14246445|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
14246446|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
14246447|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980137|NCT03027934|Ticagrelor|ticagrelor|mesh-list
13980138|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13980139|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13980140|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13980141|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13980142|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13980143|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
13980144|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980145|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980146|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980147|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
13980148|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
13980149|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13980150|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13980151|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980152|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
13980153|NCT03027973|Coagulants|coagulants|mesh-ancestor
13980154|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13980155|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
13980156|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13980157|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980158|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13980159|NCT03027908|Fluorides|fluorides|mesh-list
13980160|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
13980161|NCT03027908|Protective Agents|protective agents|mesh-ancestor
13980162|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980163|NCT03027843|Hormones|hormones|mesh-list
13980164|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13980165|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980166|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
13980167|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13980168|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980169|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13980170|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13980171|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980172|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980173|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980174|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13980175|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13980176|NCT03027674|Nifedipine|nifedipine|mesh-list
13980177|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
13980178|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
13980179|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13980180|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13980181|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980182|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980183|NCT03027674|Urological Agents|urological agents|mesh-ancestor
13980184|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13980185|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13980186|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13980187|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980188|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
13980189|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13980190|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
13980191|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13980192|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
13980193|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13980194|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980195|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13980196|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13980197|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13980198|NCT03027284|Gemcitabine|gemcitabine|mesh-list
13980199|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980200|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13980201|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
13980202|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980203|NCT03027284|Antiviral Agents|antiviral agents|mesh-ancestor
13980204|NCT03027284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980205|NCT03027284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980206|NCT03027284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13980207|NCT03027284|Immunologic Factors|immunologic factors|mesh-ancestor
13980208|NCT03027284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980209|NCT03027167|Aspirin|aspirin|mesh-list
13980210|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13980211|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13980212|NCT03027167|Analgesics|analgesics|mesh-ancestor
13980213|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
13980214|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980215|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980216|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13980217|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13980218|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13980219|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13980220|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980221|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13980222|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13980223|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980224|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
13980225|NCT03027219|Alprostadil|alprostadil|mesh-list
13980226|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13980227|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
13980228|NCT03027219|Urological Agents|urological agents|mesh-ancestor
13980229|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13980230|NCT03026933|Calcium|calcium|mesh-list
13980231|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13980232|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980233|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13980234|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13980235|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
13980236|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980237|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13980238|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13980239|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980240|NCT03026842|Cytarabine|cytarabine|mesh-list
13980241|NCT03026842|Decitabine|decitabine|mesh-list
13980242|NCT03026842|Daunorubicin|daunorubicin|mesh-list
13980243|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
13980244|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
13980245|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13980246|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
13980247|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980248|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980249|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
13980250|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980251|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13980252|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
13980253|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980254|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13980255|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13980256|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13980257|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980258|NCT03026842|Analgesics|analgesics|mesh-ancestor
13980259|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
13980260|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980261|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13980262|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
13980263|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980264|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
13980265|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
13980266|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
13980267|NCT03027115|Tamsulosin|tamsulosin|mesh-list
13980268|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13980269|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13980270|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13980271|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
13980272|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980273|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980274|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980275|NCT03027115|Urological Agents|urological agents|mesh-ancestor
13980276|NCT03026881|Paclitaxel|paclitaxel|mesh-list
13980277|NCT03026881|Apatinib|apatinib|mesh-list
13980278|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13980279|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980280|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
13980281|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
13980282|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
13980283|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980284|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13980285|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980286|NCT03026946|Cyclosporine|cyclosporine|mesh-list
13980287|NCT03026946|Alitretinoin|alitretinoin|mesh-list
13980288|NCT03026946|Cyclosporins|cyclosporins|mesh-list
13980289|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980290|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980291|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13980292|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
13980293|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980294|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
13980295|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980296|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
13980297|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13980298|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13980299|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980300|NCT03026907|Azathioprine|azathioprine|mesh-list
13980301|NCT03026907|Alitretinoin|alitretinoin|mesh-list
13980302|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980303|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
13980304|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
13980305|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980306|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13980307|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13980308|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
13980309|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980310|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13980311|NCT03026790|Buprenorphine|buprenorphine|mesh-list
13980312|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13980313|NCT03026790|Naloxone|naloxone|mesh-list
13980314|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13980315|NCT03026790|Narcotics|narcotics|mesh-ancestor
13980316|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980317|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980318|NCT03026790|Analgesics|analgesics|mesh-ancestor
13980319|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
13980320|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980321|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13980322|NCT03026725|Calcium|calcium|mesh-list
13980323|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13980324|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980325|NCT03026478|Betamethasone|betamethasone|mesh-list
13980326|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
13980327|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13980328|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
13980329|NCT03026478|Clobetasol|clobetasol|mesh-list
13980330|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13980331|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13980332|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
13980333|NCT03026478|Hormones|hormones|mesh-ancestor
13980334|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13980335|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980336|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13980337|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
14246448|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
14246449|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14246450|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246451|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14246452|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
14246453|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14246454|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14246455|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246456|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246457|NCT00239356|Aripiprazole|aripiprazole|mesh-list
14246458|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
14246459|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14246460|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14246461|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14246462|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14246463|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246464|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
14246465|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
14246466|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246467|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246468|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14246469|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13980338|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
13980339|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13980340|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980341|NCT03026244|Vitamin D|vitamin d|mesh-list
13980342|NCT03026244|Caseins|caseins|mesh-list
13980343|NCT03026244|Vitamins|vitamins|mesh-ancestor
13980344|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
13980345|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980346|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13980347|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
13980348|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
13980349|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980350|NCT03026140|Celecoxib|celecoxib|mesh-list
13980351|NCT03026140|Nivolumab|nivolumab|mesh-list
13980352|NCT03026140|Ipilimumab|ipilimumab|mesh-list
13980353|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13980354|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980355|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13980356|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980357|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13980358|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13980359|NCT03026140|Analgesics|analgesics|mesh-ancestor
13980360|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
13980361|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980362|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980363|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13980364|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13980365|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13980366|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13980367|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980368|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
13980369|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
13980370|NCT03026036|Raclopride|raclopride|mesh-list
13980371|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13980372|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13980373|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980374|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980375|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13980376|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13980377|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
13980378|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980379|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980380|NCT03026023|Ribavirin|ribavirin|mesh-list
13980381|NCT03026023|Grazoprevir|grazoprevir|mesh-list
13980382|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
13980383|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980384|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
13980385|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980386|NCT03025841|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
13980387|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13980388|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980389|NCT03025750|Vaccines|vaccines|mesh-list
13980390|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
13980391|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980392|NCT03025867|Niraparib|niraparib|mesh-list
13980393|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13980394|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980395|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980396|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980397|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
13980398|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13980399|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
13980400|NCT03025880|Gemcitabine|gemcitabine|mesh-list
13980401|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
13980402|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13980403|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
13980404|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980405|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980406|NCT03025880|Antiviral Agents|antiviral agents|mesh-ancestor
13980407|NCT03025880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980408|NCT03025880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980409|NCT03025880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13980410|NCT03025880|Immunologic Factors|immunologic factors|mesh-ancestor
13980411|NCT03025880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980412|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13980413|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
13980414|NCT03025828|Hormones|hormones|mesh-ancestor
13980415|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13980416|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980417|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
13980418|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13980419|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980420|NCT03025893|Sunitinib|sunitinib|mesh-list
13980421|NCT03025893|Lomustine|lomustine|mesh-list
13980422|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980423|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13980424|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13980425|NCT03025893|Growth Substances|growth substances|mesh-ancestor
13980426|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980427|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
13980428|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13980429|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980430|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980431|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13980432|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
13980433|NCT03025906|Valproic Acid|valproic acid|mesh-list
13980434|NCT03025906|Phenobarbital|phenobarbital|mesh-list
13980435|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
13980436|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980437|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980438|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
13980439|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980440|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980441|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
13980442|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13980443|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980444|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13980445|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13980446|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13980447|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13980448|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
13980449|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13980450|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13980451|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13980452|NCT03025477|Paclitaxel|paclitaxel|mesh-list
13980453|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13980454|NCT03025477|Cisplatin|cisplatin|mesh-list
13980455|NCT03025477|Carboplatin|carboplatin|mesh-list
13980456|NCT03025477|Epirubicin|epirubicin|mesh-list
13980457|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13980458|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980459|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
13980460|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
13980461|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
13980462|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980463|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13980464|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13980465|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13980466|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980467|NCT03025594|Ketorolac|ketorolac|mesh-list
13980468|NCT03025594|Epinephrine|epinephrine|mesh-list
13980469|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
13980470|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13980471|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13980472|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
13980473|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980474|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980475|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980476|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13980477|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13980478|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
13980479|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980480|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13980481|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
13980482|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
13980483|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
13980484|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13980485|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13980486|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13980487|NCT03025594|Analgesics|analgesics|mesh-ancestor
13980488|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
13980489|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13980490|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13980491|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13980492|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980493|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
13980494|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
13980495|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980496|NCT03025282|Betamethasone|betamethasone|mesh-list
13980497|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
13980498|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13980499|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13980500|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
13980501|NCT03025282|Hormones|hormones|mesh-ancestor
13980502|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13980503|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980504|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13980505|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
13980506|NCT03025256|Nivolumab|nivolumab|mesh-list
13980507|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13980508|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980509|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13980510|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980511|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
13980512|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13980513|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980514|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980515|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13980516|NCT03025295|Analgesics|analgesics|mesh-ancestor
13980517|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
13980518|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980519|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13980520|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13980521|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13980522|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
13980523|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980524|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980525|NCT03025009|Insulin|insulin|mesh-list
13980526|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13980527|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
13980528|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13980529|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980530|NCT03024879|Erythromycin|erythromycin|mesh-list
13980531|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
13980532|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
13980533|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
13980534|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13980535|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980536|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13980537|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13980538|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980539|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980540|NCT03024905|Misoprostol|misoprostol|mesh-list
13980541|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13980542|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
13980543|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13980544|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980545|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13980546|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13980547|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
13980548|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
13980549|NCT03024957|Morphine|morphine|mesh-list
13980550|NCT03024957|Bupivacaine|bupivacaine|mesh-list
13980551|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
13980552|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
13980553|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980554|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980555|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
13980556|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980557|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13980558|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13980559|NCT03024957|Analgesics|analgesics|mesh-ancestor
13980560|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13980561|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13980562|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13980563|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
13980564|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980565|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980566|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13980567|NCT03024957|Narcotics|narcotics|mesh-ancestor
13980568|NCT03025113|Ketoprofen|ketoprofen|mesh-list
13980569|NCT03025113|Amitriptyline|amitriptyline|mesh-list
13980570|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
13980571|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13980572|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13980573|NCT03025113|Analgesics|analgesics|mesh-ancestor
13980574|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
13980575|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980576|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980577|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13980578|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13980579|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13980580|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980581|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980582|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
13980583|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
13980584|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13980585|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13980586|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13980587|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13980588|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980589|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13980590|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13980591|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13980592|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
13980593|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246470|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
14246471|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14246472|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14246473|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14246474|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14246475|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
14246476|NCT00239590|Testosterone|testosterone|mesh-list
14246477|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
14246478|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
14246479|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14246480|NCT00239590|Androgens|androgens|mesh-ancestor
14246481|NCT00239590|Hormones|hormones|mesh-ancestor
14246482|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14246483|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246484|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14246485|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246486|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
14246487|NCT00239642|Iron|iron|mesh-list
14246488|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14246489|NCT00239642|Trace Elements|trace elements|mesh-ancestor
14246490|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
14246491|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246492|NCT00239642|Hematinics|hematinics|mesh-ancestor
14246493|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14246494|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14246495|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14246496|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
14246497|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246498|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14246499|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14246500|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246501|NCT00240071|Tamoxifen|tamoxifen|mesh-list
14246502|NCT00240071|Bevacizumab|bevacizumab|mesh-list
14246503|NCT00240071|Letrozole|letrozole|mesh-list
14246504|NCT00240071|Exemestane|exemestane|mesh-list
14246505|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14246506|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246507|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14246508|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14246509|NCT00240071|Growth Substances|growth substances|mesh-ancestor
14246510|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246511|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
14246512|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14246513|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14246514|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980594|NCT03024840|Propofol|propofol|mesh-list
13980595|NCT03024840|Sevoflurane|sevoflurane|mesh-list
13980596|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13980597|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980598|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980599|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13980600|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
13980601|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
13980602|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13980603|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13980604|NCT03024814|Acetaminophen|acetaminophen|mesh-list
13980605|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13980606|NCT03024814|Analgesics|analgesics|mesh-ancestor
13980607|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
13980608|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980609|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980610|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
13980611|NCT03024502|Clotrimazole|clotrimazole|mesh-list
13980612|NCT03024502|Miconazole|miconazole|mesh-list
13980613|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13980614|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980615|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
13980616|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13980617|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13980618|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980619|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980620|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13980621|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
13980622|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13980623|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980624|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13980625|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13980626|NCT03024580|Tamoxifen|tamoxifen|mesh-list
13980627|NCT03024580|Letrozole|letrozole|mesh-list
13980628|NCT03024580|Fulvestrant|fulvestrant|mesh-list
13980629|NCT03024580|Anastrozole|anastrozole|mesh-list
13980630|NCT03024580|Exemestane|exemestane|mesh-list
13980631|NCT03024580|Megestrol|megestrol|mesh-list
13980632|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
13980633|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980634|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13980635|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13980636|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980637|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980638|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13980639|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
13980640|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13980641|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980642|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13980643|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13980644|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13980645|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13980646|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
13980647|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
13980648|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13980649|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13980650|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
13980651|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13980652|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13980653|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13980654|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
13980655|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13980656|NCT03024489|Cetuximab|cetuximab|mesh-list
13980657|NCT03024489|Palbociclib|palbociclib|mesh-list
13980658|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13980659|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980660|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13980661|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980662|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980663|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
13980664|NCT03024515|Narcotics|narcotics|mesh-ancestor
13980665|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980666|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980667|NCT03024515|Analgesics|analgesics|mesh-ancestor
13980668|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
13980669|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980670|NCT03024450|Trastuzumab|trastuzumab|mesh-list
13980671|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13980672|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980673|NCT03024697|Anesthetics|anesthetics|mesh-list
13980674|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
13980675|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980676|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980677|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
13980678|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980687|NCT03024476|Olmesartan|olmesartan|mesh-list
13980688|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13980689|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13980690|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13980691|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980692|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
13980693|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13980694|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
13980695|NCT03024216|Atezolizumab|atezolizumab|mesh-list
13980696|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980697|NCT03023982|Morphine|morphine|mesh-list
13980698|NCT03023982|Bupivacaine|bupivacaine|mesh-list
13980699|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
13980700|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
13980701|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980702|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980703|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
13980704|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980705|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13980706|NCT03023982|Narcotics|narcotics|mesh-ancestor
13980707|NCT03023982|Analgesics|analgesics|mesh-ancestor
13980708|NCT03023852|Oseltamivir|oseltamivir|mesh-list
13980709|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
13980710|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980711|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980712|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980713|NCT03023774|Sargramostim|sargramostim|mesh-list
13980714|NCT03023774|Lenograstim|lenograstim|mesh-list
13980715|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
13980716|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980717|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13980718|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
13980719|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
13980720|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
13980721|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980722|NCT03023904|Nivolumab|nivolumab|mesh-list
13980723|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13980724|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980725|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13980726|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980727|NCT03023527|Dexamethasone|dexamethasone|mesh-list
13980728|NCT03023527|Nivolumab|nivolumab|mesh-list
13980729|NCT03023527|Pomalidomide|pomalidomide|mesh-list
13980730|NCT03023527|Elotuzumab|elotuzumab|mesh-list
13980731|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13980732|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
13980733|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
13980734|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980735|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980736|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13980737|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
13980738|NCT03023527|Hormones|hormones|mesh-ancestor
13980739|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13980740|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13980741|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980742|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13980743|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13980744|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980745|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
13980746|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13980747|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13980748|NCT03023527|Growth Substances|growth substances|mesh-ancestor
13980749|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
13980750|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
13980751|NCT03023514|Progesterone|progesterone|mesh-list
13980752|NCT03023514|Progestins|progestins|mesh-ancestor
13980753|NCT03023514|Hormones|hormones|mesh-ancestor
13980754|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13980755|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980756|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
13980757|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980758|NCT03023514|Protective Agents|protective agents|mesh-ancestor
13980759|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
13980760|NCT03023514|Vitamins|vitamins|mesh-ancestor
13980761|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
13980762|NCT03023501|Gabapentin|gabapentin|mesh-list
13980763|NCT03023501|Analgesics|analgesics|mesh-ancestor
13980764|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
13980765|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980766|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980767|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
13980768|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13980769|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13980770|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980771|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13980772|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13980773|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13980774|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980775|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980776|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
13980777|NCT03023436|Fluorouracil|fluorouracil|mesh-list
13980778|NCT03023436|Capecitabine|capecitabine|mesh-list
13980779|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980780|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
13980781|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980782|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13980783|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13980784|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
13980785|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980786|NCT03023046|Prednisone|prednisone|mesh-list
13980787|NCT03023046|Cortisone|cortisone|mesh-list
13980788|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
13980789|NCT03023046|Rituximab|rituximab|mesh-list
13980790|NCT03023046|Doxorubicin|doxorubicin|mesh-list
13980791|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13980792|NCT03023046|Etoposide|etoposide|mesh-list
13980793|NCT03023046|Vincristine|vincristine|mesh-list
13980794|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
13980795|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
13980796|NCT03023046|Daunorubicin|daunorubicin|mesh-list
13980797|NCT03023046|Dasatinib|dasatinib|mesh-list
13980798|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
13980799|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
13980800|NCT03023046|Antibodies|antibodies|mesh-list
13980801|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
13980802|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13980803|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13980804|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
13980805|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980806|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13980807|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13980808|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
13980809|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980810|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980811|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13980812|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13980813|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13980814|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13980815|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980816|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13980817|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
13980818|NCT03023046|Hormones|hormones|mesh-ancestor
13980819|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13980820|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13980821|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13980822|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
13980823|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
13980824|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
13980825|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13980826|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
13980827|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
13980828|NCT03023306|Antiemetics|antiemetics|mesh-list
13980829|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
13980830|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980831|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980832|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13980833|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
13980834|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13980835|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13980836|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980837|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
13980838|NCT03023189|Coagulants|coagulants|mesh-ancestor
14246515|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246516|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14246517|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
14246518|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14246519|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14246520|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14246521|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14246522|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14246523|NCT00240097|Carboplatin|carboplatin|mesh-list
14246524|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
14246525|NCT00240097|Irinotecan|irinotecan|mesh-list
14246526|NCT00240097|Etoposide|etoposide|mesh-list
14246527|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246528|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14246529|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14246530|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246531|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246532|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14246533|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14246534|NCT00240110|Valproic Acid|valproic acid|mesh-list
14246535|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
14246536|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
14246537|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14246538|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246539|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246540|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
14246541|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14246542|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14246543|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246544|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
14246545|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
14246546|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246547|NCT00240162|Vatalanib|vatalanib|mesh-list
14246548|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14246549|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246550|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246551|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14246552|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14246553|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14246554|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
14246555|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246556|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14246557|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14246558|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980839|NCT03023111|Miltefosine|miltefosine|mesh-list
13980840|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
13980841|NCT03023111|Molgramostim|molgramostim|mesh-list
13980842|NCT03023111|Sargramostim|sargramostim|mesh-list
13980843|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
13980844|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980845|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980846|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
13980847|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13980848|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13980849|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13980850|NCT03023358|Prednisone|prednisone|mesh-list
13980851|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
13980852|NCT03023358|Doxorubicin|doxorubicin|mesh-list
13980853|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13980854|NCT03023358|Vincristine|vincristine|mesh-list
13980855|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13980856|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
13980857|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980858|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13980859|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13980860|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
13980861|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980862|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980863|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13980864|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13980865|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13980866|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13980867|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980868|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13980869|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
13980870|NCT03023358|Hormones|hormones|mesh-ancestor
13980871|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13980872|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13980873|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13980874|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
13980875|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
13980876|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
13980877|NCT03023059|Levodopa|levodopa|mesh-list
13980878|NCT03023059|Carbidopa|carbidopa|mesh-list
13980879|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13980880|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13980881|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13980882|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
13980883|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980884|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980885|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980886|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13980887|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980888|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13980889|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
13980890|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
13980891|NCT03023319|Pemetrexed|pemetrexed|mesh-list
13980892|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980893|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980894|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980895|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13980896|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13980897|NCT03023020|Aspirin|aspirin|mesh-list
13980898|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
13980899|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13980900|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13980901|NCT03023020|Analgesics|analgesics|mesh-ancestor
13980902|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
13980903|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980904|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980905|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13980906|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13980907|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13980908|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13980909|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980910|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13980911|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980912|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
13980913|NCT03023007|Anesthetics|anesthetics|mesh-list
13980914|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980915|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980916|NCT03022838|Caffeine|caffeine|mesh-list
13980917|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13980918|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980919|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13980920|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980921|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980922|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13980923|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13980924|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
13980925|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980926|NCT03022877|Simendan|simendan|mesh-list
13980927|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13980928|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
13980929|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
13980930|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13980931|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980932|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980933|NCT03022877|Protective Agents|protective agents|mesh-ancestor
13980934|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980935|NCT03022773|Carotenoids|carotenoids|mesh-list
13980936|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
13980937|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980938|NCT03022773|Protective Agents|protective agents|mesh-ancestor
13980939|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980940|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
13980941|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13980942|NCT03022747|Allopurinol|allopurinol|mesh-list
13980943|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
13980944|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980945|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980946|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
13980947|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13980948|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13980949|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
13980950|NCT03022747|Protective Agents|protective agents|mesh-ancestor
13980951|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980952|NCT03022565|Vorinostat|vorinostat|mesh-list
13980953|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980954|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13980955|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980956|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980957|NCT03022318|Levodopa|levodopa|mesh-list
13980958|NCT03022318|Carbidopa|carbidopa|mesh-list
13980959|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13980960|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13980961|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13980962|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
13980963|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980964|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980965|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980966|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13980967|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980968|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13980969|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
13980970|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
13980971|NCT03022409|Olaparib|olaparib|mesh-list
13980972|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13980973|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13980974|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980975|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13980976|NCT03022240|Ondansetron|ondansetron|mesh-list
13980977|NCT03022240|Propofol|propofol|mesh-list
13980978|NCT03022240|Sevoflurane|sevoflurane|mesh-list
13980979|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13980980|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13980981|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13980982|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13980983|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
13980984|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
13980985|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13980986|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13980987|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
13980988|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
13980989|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13980990|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13980991|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
13980992|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
13980993|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13980994|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
13980995|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13980996|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13980997|NCT03022240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13980998|NCT03022240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13980999|NCT03022240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13981000|NCT03022240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13981001|NCT03022201|Domperidone|domperidone|mesh-list
13981002|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
13981003|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
13981004|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981005|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981006|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13981007|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13981008|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
13981009|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981010|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981011|NCT03022253|Acetaminophen|acetaminophen|mesh-list
13981012|NCT03022253|Ibuprofen|ibuprofen|mesh-list
13981013|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13981014|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13981015|NCT03022253|Analgesics|analgesics|mesh-ancestor
13981016|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
13981017|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981018|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981019|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13981020|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13981021|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13981022|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981023|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981024|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
13981025|NCT03022500|Durvalumab|durvalumab|mesh-list
13981026|NCT03022500|Tremelimumab|tremelimumab|mesh-list
13981027|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13981028|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981029|NCT03021772|Dexamethasone|dexamethasone|mesh-list
13981030|NCT03021772|Neostigmine|neostigmine|mesh-list
13981031|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13981032|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
13981033|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
13981034|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981035|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981036|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13981037|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
13981038|NCT03021772|Hormones|hormones|mesh-ancestor
13981039|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13981040|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13981041|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981042|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13981043|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981044|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981045|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
13981046|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981047|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13981048|NCT03022123|Prednisone|prednisone|mesh-list
13981049|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
13981050|NCT03022123|Doxorubicin|doxorubicin|mesh-list
13981051|NCT03022123|Vincristine|vincristine|mesh-list
13981052|NCT03022123|Epirubicin|epirubicin|mesh-list
13981053|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13981054|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
13981055|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981056|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13981057|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13981058|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
13981059|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981060|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981061|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13981062|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13981063|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13981064|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13981065|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981066|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13981067|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
13981068|NCT03022123|Hormones|hormones|mesh-ancestor
13981069|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13981070|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13981071|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13981072|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
13981073|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
13981074|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor
13981075|NCT03021785|Bevacizumab|bevacizumab|mesh-list
13981076|NCT03021785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13981077|NCT03021785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981078|NCT03021785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13981079|NCT03021785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13981080|NCT03021785|Growth Substances|growth substances|mesh-ancestor
13981081|NCT03021785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981082|NCT03021785|Growth Inhibitors|growth inhibitors|mesh-ancestor
13981083|NCT03022006|Grazoprevir|grazoprevir|mesh-list
13981084|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
13981085|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981086|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
13981087|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13981088|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981089|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13981090|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13981091|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981092|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981093|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981094|NCT03021486|Haloperidol|haloperidol|mesh-list
13981095|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
13981096|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
13981097|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
13981098|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
13981099|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981100|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981101|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13981102|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13981103|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13981104|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981105|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13981106|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13981107|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
13981108|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981109|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981110|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13981111|NCT03021629|Vitamin D|vitamin d|mesh-list
13981112|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
13981113|NCT03021629|Vitamins|vitamins|mesh-ancestor
13981114|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
13981115|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981116|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13981117|NCT03021590|Amoxicillin|amoxicillin|mesh-list
13981118|NCT03021590|Clarithromycin|clarithromycin|mesh-list
13981119|NCT03021590|Levofloxacin|levofloxacin|mesh-list
13981120|NCT03021590|Ofloxacin|ofloxacin|mesh-list
13981121|NCT03021590|Tinidazole|tinidazole|mesh-list
13981122|NCT03021590|Esomeprazole|esomeprazole|mesh-list
13981123|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13981124|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981125|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13981126|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13981127|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13981128|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981129|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981130|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13981131|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13981132|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13981133|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13981134|NCT03021590|Renal Agents|renal agents|mesh-ancestor
13981135|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13981136|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13981137|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981138|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13981139|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
13981140|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
13981141|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13981142|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13981143|NCT03021694|Caseins|caseins|mesh-list
13981144|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
13981145|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
13981146|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246559|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
14246560|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14246561|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
14246562|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14246563|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246564|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14246565|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
14246566|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14246567|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
14246568|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246569|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246570|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
14246571|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
14246572|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
14246573|NCT00240487|Protective Agents|protective agents|mesh-ancestor
14246574|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
14246575|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14246576|NCT00240526|Antibodies|antibodies|mesh-list
14246577|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
14246578|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246579|NCT00240981|Testosterone|testosterone|mesh-list
14246580|NCT00240981|Androgens|androgens|mesh-ancestor
14246581|NCT00240981|Hormones|hormones|mesh-ancestor
14246582|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14246583|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246584|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
14246585|NCT00240994|Sirolimus|sirolimus|mesh-list
14246586|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
14246587|NCT00240994|Tacrolimus|tacrolimus|mesh-list
14246588|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14246589|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
14246590|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246591|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14246592|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246593|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246594|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14246595|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246596|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14246597|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
14246598|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14246599|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14246600|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
14246601|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14246602|NCT00241176|Aripiprazole|aripiprazole|mesh-list
14246603|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
14246604|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14246605|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14246606|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14246607|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14246608|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246609|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
14246610|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
14246611|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246612|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246613|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14246614|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14246615|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
14246616|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14246617|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14246618|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14246619|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14246620|NCT00241358|Plerixafor|plerixafor|mesh-list
14246621|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14246622|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14246623|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
14246624|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14246625|NCT00241631|Fluticasone|fluticasone|mesh-list
14246626|NCT00241631|Xhance|xhance|mesh-list
14246627|NCT00241631|Theophylline|theophylline|mesh-list
13981147|NCT03021395|Decitabine|decitabine|mesh-list
13981148|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13981149|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
13981150|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981151|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981152|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981153|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
13981154|NCT03021317|Hormones|hormones|mesh-ancestor
13981155|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13981156|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981157|NCT03021330|Cytarabine|cytarabine|mesh-list
13981158|NCT03021330|Daunorubicin|daunorubicin|mesh-list
13981159|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13981160|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
13981161|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981162|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981163|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
13981164|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981165|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13981166|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
13981167|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981168|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13981169|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13981170|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13981171|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981172|NCT03021421|Bupivacaine|bupivacaine|mesh-list
13981173|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
13981174|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
13981175|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981176|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981177|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
13981178|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981179|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
13981180|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13981181|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981182|NCT03020979|Apatinib|apatinib|mesh-list
13981183|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981184|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13981185|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981186|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981187|NCT03020953|Estrogens|estrogens|mesh-list
13981188|NCT03020953|Hormones|hormones|mesh-ancestor
13981189|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13981190|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981191|NCT03020914|Methamphetamine|methamphetamine|mesh-list
13981192|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13981193|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981194|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
13981195|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
13981196|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981197|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
13981198|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981199|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981200|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
13981201|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13981202|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13981203|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13981204|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13981205|NCT03020940|Cefuroxime|cefuroxime|mesh-list
13981206|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
13981207|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13981208|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981209|NCT03020901|Teicoplanin|teicoplanin|mesh-list
13981210|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13981211|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981212|NCT03020680|Ubiquinone|ubiquinone|mesh-list
13981213|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
13981214|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
13981215|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981216|NCT03020680|Vitamins|vitamins|mesh-ancestor
13981217|NCT03020563|Bupivacaine|bupivacaine|mesh-list
13981218|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
13981219|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
13981220|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981221|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981222|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
13981223|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981224|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
13981225|NCT03020706|Analgesics|analgesics|mesh-ancestor
13981226|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
13981227|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981228|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981229|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
13981230|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981231|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13981232|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
13981233|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13981234|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13981235|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981236|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13981237|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
13981238|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13981239|NCT03020602|Ubiquinone|ubiquinone|mesh-list
13981240|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
13981241|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
13981242|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981243|NCT03020602|Vitamins|vitamins|mesh-ancestor
13981244|NCT03020589|Tacrolimus|tacrolimus|mesh-list
13981245|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13981246|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
13981247|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981248|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13981249|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981250|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981251|NCT03020368|Diclofenac|diclofenac|mesh-list
13981252|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13981253|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13981254|NCT03020368|Analgesics|analgesics|mesh-ancestor
13981255|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
13981256|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981257|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981258|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13981259|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13981260|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13981261|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981262|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981263|NCT03020329|Paclitaxel|paclitaxel|mesh-list
13981264|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13981265|NCT03020329|Cisplatin|cisplatin|mesh-list
13981266|NCT03020329|Fluorouracil|fluorouracil|mesh-list
13981267|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13981268|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981269|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
13981270|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
13981271|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
13981272|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981273|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
13981274|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13981275|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13981276|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
13981277|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981278|NCT03020303|Spironolactone|spironolactone|mesh-list
13981279|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13981280|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
13981281|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13981282|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981283|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13981284|NCT03020303|Diuretics|diuretics|mesh-ancestor
13981285|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
13981286|NCT03020134|Ritonavir|ritonavir|mesh-list
13981287|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13981288|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13981289|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
13981290|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981291|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981292|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13981293|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13981294|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
13981295|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981296|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13981297|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13981298|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13981299|NCT03020056|Antioxidants|antioxidants|mesh-list
13981300|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13981301|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981302|NCT03020056|Protective Agents|protective agents|mesh-ancestor
13981303|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981304|NCT03019822|Amphetamine|amphetamine|mesh-list
13981305|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
13981306|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
13981307|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
13981308|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13981309|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981310|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
13981311|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
13981312|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981313|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
13981314|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981315|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981316|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
13981317|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13981318|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13981319|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13981320|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13981321|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
13981322|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13981323|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
13981324|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13981325|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13981326|NCT03019991|Ritonavir|ritonavir|mesh-list
13981327|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13981328|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13981329|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
13981330|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981331|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981332|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13981333|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13981334|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
13981335|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981336|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13981337|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13981338|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
13981339|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
13981340|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13981341|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13981342|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981343|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981344|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981345|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13981346|NCT03019835|Neostigmine|neostigmine|mesh-list
13981347|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13981348|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981349|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981350|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
13981351|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981352|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981353|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13981354|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
13981355|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981356|NCT03019848|Curcumin|curcumin|mesh-list
13981357|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13981358|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13981359|NCT03019848|Analgesics|analgesics|mesh-ancestor
13981360|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
13981361|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981362|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981363|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13981364|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13981365|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981366|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981367|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981368|NCT03019809|Plerixafor|plerixafor|mesh-list
13981369|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13981370|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13981371|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
13981372|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981373|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
13981374|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14246628|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14246629|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14246630|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
14246631|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14246632|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246633|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14246634|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
14246635|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
14246636|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14246637|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14246638|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246639|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246640|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
14246641|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14246642|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14246643|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
14246644|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246645|NCT00241644|Vaccines|vaccines|mesh-list
14246646|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
14246647|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246648|NCT00241839|Allopurinol|allopurinol|mesh-list
14246649|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
14246650|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
14246651|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246652|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246653|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
14246654|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14246655|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14246656|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
14246657|NCT00241839|Protective Agents|protective agents|mesh-ancestor
14246658|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246659|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14246660|NCT00241839|Diuretics|diuretics|mesh-ancestor
14246661|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
14246662|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14246663|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14246664|NCT00241904|Propranolol|propranolol|mesh-list
14246665|NCT00241904|Metoprolol|metoprolol|mesh-list
14246666|NCT00241904|Atenolol|atenolol|mesh-list
14246667|NCT00241904|Lisinopril|lisinopril|mesh-list
14246668|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
14246669|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14246670|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14246671|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14246672|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
14246673|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246674|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246675|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246676|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14246677|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14246678|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
14246679|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
14246680|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
13981375|NCT03019666|Niacinamide|niacinamide|mesh-list
13981376|NCT03019666|Niacin|niacin|mesh-list
13981377|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
13981378|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
13981379|NCT03019666|Vitamins|vitamins|mesh-ancestor
13981380|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
13981381|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981382|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13981383|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
13981384|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981385|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13981386|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
13981387|NCT03019536|Flutemetamol|flutemetamol|mesh-list
13981388|NCT03019536|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13981389|NCT03019536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981390|NCT03019523|Caffeine|caffeine|mesh-list
13981391|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13981392|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981393|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13981394|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981395|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981396|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13981397|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13981398|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
13981399|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981400|NCT03019562|Fentanyl|fentanyl|mesh-list
13981401|NCT03019562|Oxycodone|oxycodone|mesh-list
13981402|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13981403|NCT03019562|Narcotics|narcotics|mesh-ancestor
13981404|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981405|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981406|NCT03019562|Analgesics|analgesics|mesh-ancestor
13981407|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
13981408|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981409|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13981410|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13981411|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
13981412|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
13981413|NCT03019237|Omalizumab|omalizumab|mesh-list
13981414|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13981415|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13981416|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
13981417|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
13981418|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13981419|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981420|NCT03019081|Isoproterenol|isoproterenol|mesh-list
13981421|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13981422|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13981423|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
13981424|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981425|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981426|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981427|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13981428|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
13981429|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981430|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13981431|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
13981432|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13981433|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
13981434|NCT03019081|Protective Agents|protective agents|mesh-ancestor
13981435|NCT03019120|Vitamin D|vitamin d|mesh-list
13981436|NCT03019120|Vitamins|vitamins|mesh-ancestor
13981437|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
13981438|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981439|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13981440|NCT03018899|Anesthetics|anesthetics|mesh-list
13981441|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981442|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981443|NCT03018990|Ethanol|ethanol|mesh-list
13981444|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13981445|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981446|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981447|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981448|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
13981449|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981450|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981451|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
13981452|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13981453|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13981454|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981455|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
13981456|NCT03019198|Coagulants|coagulants|mesh-ancestor
13981457|NCT03018821|Tenofovir|tenofovir|mesh-list
13981458|NCT03018821|Entecavir|entecavir|mesh-list
13981459|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
13981460|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981461|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13981462|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13981463|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981464|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981465|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13981466|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13981467|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13981468|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13981469|NCT03018665|Metformin|metformin|mesh-list
13981470|NCT03018665|Exenatide|exenatide|mesh-list
13981471|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13981472|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981473|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13981474|NCT03018665|Incretins|incretins|mesh-ancestor
13981475|NCT03018665|Hormones|hormones|mesh-ancestor
13981476|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13981477|NCT03018626|Prednisone|prednisone|mesh-list
13981478|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
13981479|NCT03018626|Rituximab|rituximab|mesh-list
13981480|NCT03018626|Doxorubicin|doxorubicin|mesh-list
13981481|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13981482|NCT03018626|Etoposide|etoposide|mesh-list
13981483|NCT03018626|Vincristine|vincristine|mesh-list
13981484|NCT03018626|Bleomycin|bleomycin|mesh-list
13981485|NCT03018626|Vindesine|vindesine|mesh-list
13981486|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13981487|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
13981488|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981489|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13981490|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13981491|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
13981492|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981493|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981494|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13981495|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13981496|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13981497|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15042525|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15042526|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15042527|NCT02044952|Analgesics|analgesics|mesh-ancestor
15042528|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
15042529|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042530|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981498|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13981499|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981500|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13981501|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
13981502|NCT03018626|Hormones|hormones|mesh-ancestor
13981503|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13981504|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13981505|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13981506|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
13981507|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
13981508|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
13981509|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
13981510|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13981511|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13981512|NCT03018535|Prednisolone|prednisolone|mesh-list
13981513|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
13981514|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
13981515|NCT03018535|Rituximab|rituximab|mesh-list
13981516|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13981517|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
13981518|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13981519|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
13981520|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981521|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13981522|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13981523|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
13981524|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981525|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981526|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13981527|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13981528|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13981529|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
13981530|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
13981531|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981532|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13981533|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
13981534|NCT03018535|Hormones|hormones|mesh-ancestor
13981535|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13981536|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13981537|NCT03018535|Protective Agents|protective agents|mesh-ancestor
13981538|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13981539|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
13981540|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13981541|NCT03018652|Antibodies|antibodies|mesh-list
13981542|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
13981543|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
13981544|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
13981545|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981546|NCT03018704|Topiramate|topiramate|mesh-list
13981547|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
13981548|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13981549|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981550|NCT03018756|Fentanyl|fentanyl|mesh-list
13981551|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13981552|NCT03018756|Narcotics|narcotics|mesh-ancestor
13981553|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981554|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981555|NCT03018756|Analgesics|analgesics|mesh-ancestor
13981556|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
13981557|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981558|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13981559|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13981560|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
13981561|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
13981562|NCT03018444|Atorvastatin|atorvastatin|mesh-list
13981563|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13981564|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13981565|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
13981566|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981567|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13981568|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13981569|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981570|NCT03018418|Mitomycins|mitomycins|mesh-list
13981571|NCT03018418|Mitomycin|mitomycin|mesh-list
13981572|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13981573|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981574|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
13981575|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981576|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13981577|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981578|NCT03018171|Clonidine|clonidine|mesh-list
13981579|NCT03018171|Sufentanil|sufentanil|mesh-list
13981580|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13981581|NCT03018171|Narcotics|narcotics|mesh-ancestor
13981582|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981583|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981584|NCT03018171|Analgesics|analgesics|mesh-ancestor
13981585|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
13981586|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981587|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13981588|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13981589|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
13981590|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
13981591|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13981592|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
13981593|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
13981594|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13981595|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13981596|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13981597|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
13981598|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981599|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981600|NCT03018301|Ketamine|ketamine|mesh-list
13981601|NCT03018301|Analgesics|analgesics|mesh-ancestor
13981602|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
13981603|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981604|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981605|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13981606|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13981607|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
13981608|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
13981609|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981610|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13981611|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13981612|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981613|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981614|NCT03018236|Ethanol|ethanol|mesh-list
13981615|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
13981616|NCT03018236|Cocaine|cocaine|mesh-list
13981617|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13981618|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13981619|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981620|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981621|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981622|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
13981623|NCT03018236|Expectorants|expectorants|mesh-ancestor
13981624|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
13981625|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13981626|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
13981627|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981628|NCT03018236|Protective Agents|protective agents|mesh-ancestor
13981629|NCT03018236|Antidotes|antidotes|mesh-ancestor
13981630|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
13981631|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
13981632|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
13981633|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981634|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13981635|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13981636|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13981637|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13981638|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
13981639|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981640|NCT03018015|Ibuprofen|ibuprofen|mesh-list
13981641|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13981642|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13981643|NCT03018015|Analgesics|analgesics|mesh-ancestor
13981644|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
13981645|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981646|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981647|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13981648|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13981649|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13981650|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981651|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981652|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
13981653|NCT03017963|Antidotes|antidotes|mesh-ancestor
13981654|NCT03017963|Protective Agents|protective agents|mesh-ancestor
13981655|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981656|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
13981657|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981658|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
13981659|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13981660|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981661|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
13981662|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
13981663|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
13981664|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
13981665|NCT03018366|Estradiol|estradiol|mesh-list
13981666|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
13981667|NCT03018366|Progesterone|progesterone|mesh-list
13981668|NCT03018366|Estrogens|estrogens|mesh-ancestor
13981669|NCT03018366|Hormones|hormones|mesh-ancestor
13981670|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13981671|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981672|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13981673|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
13981674|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13981675|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13981676|NCT03018366|Progestins|progestins|mesh-ancestor
13981677|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
13981678|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
13981679|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981680|NCT03017872|Ritonavir|ritonavir|mesh-list
13981681|NCT03017872|Darunavir|darunavir|mesh-list
13981682|NCT03017872|Dolutegravir|dolutegravir|mesh-list
13981683|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13981684|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13981685|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
13981686|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981687|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981688|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13981689|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13981690|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
13981691|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981692|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13981693|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13981694|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13981695|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14246681|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14246682|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14246683|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
14246684|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246685|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14246686|NCT00241904|Protective Agents|protective agents|mesh-ancestor
14246687|NCT00242216|Ritonavir|ritonavir|mesh-list
14246688|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14246689|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
14246690|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14246691|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14246692|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
14246693|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246694|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246695|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14246696|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14246697|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
14246698|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14246699|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14246700|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14246701|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
14246702|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14246703|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246704|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246705|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14246706|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14246707|NCT00242502|Bevacizumab|bevacizumab|mesh-list
14246708|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14246709|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14246710|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246711|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14246712|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14246713|NCT00242502|Growth Substances|growth substances|mesh-ancestor
14246714|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246715|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
14246716|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14246717|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246718|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246719|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
14246720|NCT00242567|Androgens|androgens|mesh-list
14246721|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14246722|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246723|NCT00242567|Hormones|hormones|mesh-ancestor
14246724|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14246725|NCT00242580|Triamcinolone|triamcinolone|mesh-list
14246726|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14246727|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14246728|NCT00242580|Verteporfin|verteporfin|mesh-list
14246729|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14246730|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14246731|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
13981696|NCT03017703|Eplerenone|eplerenone|mesh-list
13981697|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
13981698|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
13981699|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13981700|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981701|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
13981702|NCT03017703|Diuretics|diuretics|mesh-ancestor
13981703|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
13981704|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13981705|NCT03017768|Tryptophan|tryptophan|mesh-list
13981706|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13981707|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
13981708|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13981709|NCT03017807|Antibodies|antibodies|mesh-list
13981710|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
13981711|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981712|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
13981713|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13981714|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13981715|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13981716|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13981717|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981718|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
13981719|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981720|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981721|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13981722|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981723|NCT03017495|Midazolam|midazolam|mesh-list
13981724|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13981725|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13981726|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981727|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981728|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13981729|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13981730|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13981731|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13981732|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
13981733|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
13981734|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
13981735|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
13981736|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981737|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981738|NCT03017222|Ondansetron|ondansetron|mesh-list
13981739|NCT03017222|Ramosetron|ramosetron|mesh-list
13981740|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
13981741|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
13981742|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981743|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981744|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13981745|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
13981746|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
13981747|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13981748|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
13981749|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981750|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981751|NCT03017222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13981752|NCT03017222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13981753|NCT03017222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981754|NCT03017222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13981755|NCT03017222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13981756|NCT03017248|Ketamine|ketamine|mesh-list
13981757|NCT03017248|Morphine|morphine|mesh-list
13981758|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13981759|NCT03017248|Analgesics|analgesics|mesh-ancestor
13981760|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
13981761|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981762|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981763|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13981764|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13981765|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
13981766|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
13981767|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981768|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13981769|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13981770|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246732|NCT00242580|Hormones|hormones|mesh-ancestor
13981771|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981772|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13981773|NCT03017248|Narcotics|narcotics|mesh-ancestor
13981774|NCT03017391|Dexamethasone|dexamethasone|mesh-list
13981775|NCT03017391|Metoclopramide|metoclopramide|mesh-list
13981776|NCT03017391|Granisetron|granisetron|mesh-list
13981777|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13981778|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
13981779|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
13981780|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981781|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981782|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13981783|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
13981784|NCT03017391|Hormones|hormones|mesh-ancestor
13981785|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13981786|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13981787|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981788|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13981789|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13981790|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
13981791|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981792|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981793|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13981794|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
13981795|NCT03017326|Gemcitabine|gemcitabine|mesh-list
13981796|NCT03017326|Carboplatin|carboplatin|mesh-list
13981797|NCT03017326|Doxorubicin|doxorubicin|mesh-list
13981798|NCT03017326|Fluorouracil|fluorouracil|mesh-list
13981799|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
13981800|NCT03017326|Irinotecan|irinotecan|mesh-list
13981801|NCT03017326|Etoposide|etoposide|mesh-list
13981802|NCT03017326|Vincristine|vincristine|mesh-list
13981803|NCT03017326|Sorafenib|sorafenib|mesh-list
13981804|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981805|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13981806|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
13981807|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981808|NCT03017326|Antiviral Agents|antiviral agents|mesh-ancestor
13981809|NCT03017326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981810|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981811|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13981812|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
13981813|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981814|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13981815|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13981816|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13981817|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13981818|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13981819|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
13981820|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
13981821|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
13981822|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13981823|NCT03017430|Ketorolac|ketorolac|mesh-list
13981824|NCT03017430|Phenazepam|phenazepam|mesh-list
13981825|NCT03017430|Clonidine|clonidine|mesh-list
13981826|NCT03017430|Pregabalin|pregabalin|mesh-list
13981827|NCT03017430|Metoclopramide|metoclopramide|mesh-list
13981828|NCT03017430|Loperamide|loperamide|mesh-list
13981829|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
13981830|NCT03017430|Analgesics|analgesics|mesh-ancestor
13981831|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
13981832|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981833|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981834|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
13981835|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13981836|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13981837|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981838|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13981839|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13981840|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13981841|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981842|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13981843|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13981844|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13981845|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13981846|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13981847|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13981848|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981849|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13981850|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
13981851|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
13981852|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13981853|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13981854|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13981855|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
13981856|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13981857|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
13981858|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13981859|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
13981860|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13981861|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
13981862|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13981863|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
13981864|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13981865|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
13981866|NCT03017352|Exenatide|exenatide|mesh-list
13981867|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13981868|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981869|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13981870|NCT03017352|Incretins|incretins|mesh-ancestor
13981871|NCT03017352|Hormones|hormones|mesh-ancestor
13981872|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13981873|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
13981874|NCT03017404|Docetaxel|docetaxel|mesh-list
13981875|NCT03017404|Doxorubicin|doxorubicin|mesh-list
13981876|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13981877|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13981878|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
13981879|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981880|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13981881|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13981882|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
13981883|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981884|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981885|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13981886|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
13981887|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
13981888|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
13981889|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13981890|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13981891|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13981892|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981893|NCT03016884|Vaccines|vaccines|mesh-list
13981894|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
13981895|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981896|NCT03016988|Cytarabine|cytarabine|mesh-list
13981897|NCT03016988|Fludarabine|fludarabine|mesh-list
13981898|NCT03016988|Bortezomib|bortezomib|mesh-list
13981899|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981900|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13981901|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
13981902|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981903|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13981904|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
13981905|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981906|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
13981907|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981908|NCT03017066|Anesthetics|anesthetics|mesh-list
13981909|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13981910|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981911|NCT03016832|Irbesartan|irbesartan|mesh-list
13981912|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13981913|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13981914|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13981915|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981916|NCT03016871|Carboplatin|carboplatin|mesh-list
13981917|NCT03016871|Nivolumab|nivolumab|mesh-list
13981918|NCT03016871|Etoposide|etoposide|mesh-list
13981919|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
13981920|NCT03016871|Ifosfamide|ifosfamide|mesh-list
13981921|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
13981922|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
13981923|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981924|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13981925|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13981926|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981927|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13981928|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13981929|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13981930|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981931|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13981932|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
13981933|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
13981934|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
13981935|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
13981936|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
13981937|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
13981938|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
13981939|NCT03016806|Melphalan|melphalan|mesh-list
13981940|NCT03016806|Busulfan|busulfan|mesh-list
13981941|NCT03016806|Fludarabine|fludarabine|mesh-list
13981942|NCT03016806|Mesna|mesna|mesh-list
13981943|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13981944|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
13981945|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981946|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13981947|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13981948|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
13981949|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981950|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981951|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13981952|NCT03016806|Protective Agents|protective agents|mesh-ancestor
13981953|NCT03016715|Sirolimus|sirolimus|mesh-list
13981954|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13981955|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13981956|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13981957|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981958|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
13981959|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13981960|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
13981961|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981962|NCT03016793|Puerarin|puerarin|mesh-list
13981963|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
13981964|NCT03016741|Prednisone|prednisone|mesh-list
13981965|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
13981966|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13981967|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
13981968|NCT03016741|Hormones|hormones|mesh-ancestor
13981969|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13981970|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981971|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13981972|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13981973|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13981974|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981975|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981976|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
13981977|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13981978|NCT03016650|Acetaminophen|acetaminophen|mesh-list
13981979|NCT03016650|Ibuprofen|ibuprofen|mesh-list
13981980|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13981981|NCT03016650|Analgesics|analgesics|mesh-ancestor
13981982|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
13981983|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13981984|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13981985|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
13981986|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13981987|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13981988|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13981989|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13981990|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13981991|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13981992|NCT03016611|Ticagrelor|ticagrelor|mesh-list
13981993|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
13981994|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13981995|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13981996|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13981997|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13981998|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
13981999|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982000|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982001|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982002|NCT03016442|Dinoprostone|dinoprostone|mesh-list
13982003|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
13982004|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13982005|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982006|NCT03016260|Adalimumab|adalimumab|mesh-list
13982007|NCT03016260|Etanercept|etanercept|mesh-list
13982008|NCT03016260|Golimumab|golimumab|mesh-list
13982009|NCT03016260|Infliximab|infliximab|mesh-list
13982010|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
13982011|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982012|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13982013|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
13982014|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13982015|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13982016|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13982017|NCT03016260|Analgesics|analgesics|mesh-ancestor
13982018|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
13982019|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982020|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982021|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13982022|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
13982023|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
13982024|NCT03016234|Propofol|propofol|mesh-list
13982025|NCT03016234|Desflurane|desflurane|mesh-list
13982026|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13982027|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982028|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982029|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13982030|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
13982031|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
13982032|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13982033|NCT03016468|Treprostinil|treprostinil|mesh-list
13982034|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14246733|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14246734|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246735|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14246736|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
14246737|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246738|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246739|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14246740|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
14246741|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
14246742|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14246743|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246744|NCT00242632|Memantine|memantine|mesh-list
14246745|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14246746|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14246747|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
14246748|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14246749|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246750|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246751|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14246752|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14246753|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
14246754|NCT00242710|Estrogens|estrogens|mesh-list
14246755|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14246756|NCT00242710|Hormones|hormones|mesh-ancestor
14246757|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14246758|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246759|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14246760|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14246761|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
14246762|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14246763|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
14246764|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
14246765|NCT00243022|Vitamins|vitamins|mesh-ancestor
14246766|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
14246767|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246768|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
14246769|NCT00243022|Hematinics|hematinics|mesh-ancestor
14246770|NCT00243061|Cediranib|cediranib|mesh-list
14246771|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246772|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246773|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246774|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13982035|NCT03016208|Misoprostol|misoprostol|mesh-list
13982036|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13982037|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
13982038|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13982039|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982040|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13982041|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13982042|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
13982043|NCT03016000|Thalidomide|thalidomide|mesh-list
13982044|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13982045|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
13982046|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982047|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
13982048|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13982049|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13982050|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13982051|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13982052|NCT03016000|Growth Substances|growth substances|mesh-ancestor
13982053|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
13982054|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982055|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
13982056|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982057|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982058|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982059|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13982060|NCT03016039|Curcumin|curcumin|mesh-list
13982061|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13982062|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13982063|NCT03016039|Analgesics|analgesics|mesh-ancestor
13982064|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
13982065|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982066|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982067|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982068|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13982069|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982070|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982071|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982072|NCT03015818|Calcium|calcium|mesh-list
13982073|NCT03015818|Fluorides|fluorides|mesh-list
13982074|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13982075|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982076|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
13982077|NCT03015818|Protective Agents|protective agents|mesh-ancestor
13982078|NCT03015857|Phenylephrine|phenylephrine|mesh-list
13982079|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
13982080|NCT03015857|Norepinephrine|norepinephrine|mesh-list
13982081|NCT03015857|Fentanyl|fentanyl|mesh-list
13982082|NCT03015857|Bupivacaine|bupivacaine|mesh-list
13982083|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
13982084|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
13982085|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982086|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982087|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
13982088|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982089|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13982090|NCT03015857|Narcotics|narcotics|mesh-ancestor
13982091|NCT03015857|Analgesics|analgesics|mesh-ancestor
13982092|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13982093|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13982094|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
13982095|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
13982096|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
13982097|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
13982098|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
13982099|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13982100|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
13982101|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
13982102|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13982103|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13982104|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13982105|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
13982106|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982107|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982108|NCT03015857|Protective Agents|protective agents|mesh-ancestor
13982109|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
13982110|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13982111|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982112|NCT03015922|Lenalidomide|lenalidomide|mesh-list
13982113|NCT03015922|Pomalidomide|pomalidomide|mesh-list
13982114|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
13982115|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982116|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13982117|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13982118|NCT03015922|Growth Substances|growth substances|mesh-ancestor
13982119|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
13982120|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982121|NCT03015727|Docetaxel|docetaxel|mesh-list
13982122|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982123|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
13982124|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
13982125|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
13982126|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982127|NCT03015896|Nivolumab|nivolumab|mesh-list
13982128|NCT03015896|Lenalidomide|lenalidomide|mesh-list
13982129|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13982130|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982131|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13982132|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982133|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
13982134|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982135|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13982136|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13982137|NCT03015896|Growth Substances|growth substances|mesh-ancestor
13982138|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
13982139|NCT03015831|Colchicine|colchicine|mesh-list
13982140|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
13982141|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13982142|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
13982143|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
13982144|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
13982145|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982146|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982147|NCT03015701|Mifepristone|mifepristone|mesh-list
13982148|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13982149|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
13982150|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13982151|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982152|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13982153|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14246775|NCT00243074|Cediranib|cediranib|mesh-list
13982154|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13982155|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
13982156|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13982157|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13982158|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
13982159|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13982160|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
13982161|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13982162|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13982163|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
13982164|NCT03015675|Vitamins|vitamins|mesh-ancestor
13982165|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
13982166|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982167|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
13982168|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982169|NCT03015675|Protective Agents|protective agents|mesh-ancestor
13982170|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
13982171|NCT03015519|Incretins|incretins|mesh-ancestor
13982172|NCT03015519|Hormones|hormones|mesh-ancestor
13982173|NCT03015519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13982174|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982175|NCT03015610|Lansoprazole|lansoprazole|mesh-list
13982176|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
13982177|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13982178|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13982179|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13982180|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982181|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982182|NCT03015350|Sevoflurane|sevoflurane|mesh-list
13982183|NCT03015350|Desflurane|desflurane|mesh-list
13982184|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13982185|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13982186|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
13982187|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
13982188|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982189|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982190|NCT03015246|Morphine|morphine|mesh-list
13982191|NCT03015246|Buprenorphine|buprenorphine|mesh-list
13982192|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13982193|NCT03015246|Naloxone|naloxone|mesh-list
13982194|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13982195|NCT03015246|Narcotics|narcotics|mesh-ancestor
13982196|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982197|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982198|NCT03015246|Analgesics|analgesics|mesh-ancestor
13982199|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
13982200|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982201|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13982202|NCT03014947|Adalimumab|adalimumab|mesh-list
13982203|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982204|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13982205|NCT03015168|Capecitabine|capecitabine|mesh-list
13982206|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13982207|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
13982208|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982209|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982210|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
13982211|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
13982212|NCT03014843|Bromides|bromides|mesh-list
13982213|NCT03014843|Naloxone|naloxone|mesh-list
13982214|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
13982215|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
13982216|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13982217|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982218|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
13982219|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982220|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
13982221|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13982222|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
13982223|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13982224|NCT03014882|Expectorants|expectorants|mesh-ancestor
13982225|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
13982226|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13982227|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
13982228|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982229|NCT03014882|Protective Agents|protective agents|mesh-ancestor
13982230|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982231|NCT03014882|Antidotes|antidotes|mesh-ancestor
13982232|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
13982233|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
13982234|NCT03014713|Dezocine|dezocine|mesh-list
13982235|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13982236|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982237|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982238|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13982239|NCT03014713|Analgesics|analgesics|mesh-ancestor
13982240|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
13982241|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982242|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13982243|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13982244|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13982245|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
13982246|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982247|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982248|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13982249|NCT03014713|Narcotics|narcotics|mesh-ancestor
13982250|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13982251|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982252|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13982253|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13982254|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982255|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13982256|NCT03014687|Cefdinir|cefdinir|mesh-list
13982257|NCT03014687|Cephalosporins|cephalosporins|mesh-list
13982258|NCT03014687|Trimethoprim|trimethoprim|mesh-list
13982259|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
13982260|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13982261|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13982262|NCT03014687|Renal Agents|renal agents|mesh-ancestor
13982263|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
13982264|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13982265|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13982266|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13982267|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982268|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982269|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13982270|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
13982271|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13982272|NCT03014804|Nivolumab|nivolumab|mesh-list
13982273|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13982274|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982275|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13982276|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982277|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
13982278|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13982279|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
13982280|NCT03014778|Povidone|povidone|mesh-list
13982281|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13982282|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13982283|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
13982284|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
13982285|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
13982286|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
14246776|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246777|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246778|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246779|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14246780|NCT00243152|Lamotrigine|lamotrigine|mesh-list
14246781|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
14246782|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14246783|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14246784|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246785|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14246786|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246787|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14246788|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14246789|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14246790|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14246791|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14246792|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
14246793|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246794|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13982287|NCT03014440|Cannabidiol|cannabidiol|mesh-list
13982288|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
13982289|NCT03014323|Galantamine|galantamine|mesh-list
13982290|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13982291|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982292|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982293|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
13982294|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982295|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982296|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
13982297|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
13982298|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982299|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
13982300|NCT03014297|Everolimus|everolimus|mesh-list
13982301|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
13982302|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982303|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13982304|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
13982305|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982306|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13982307|NCT03014167|Albendazole|albendazole|mesh-list
13982308|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
13982309|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13982310|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13982311|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
13982312|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13982313|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13982314|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
13982315|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
13982316|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
13982317|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982318|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982319|NCT03014076|Trastuzumab|trastuzumab|mesh-list
13982320|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13982321|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982322|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
13982323|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13982324|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13982325|NCT03013959|Analgesics|analgesics|mesh-ancestor
13982326|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
13982327|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982328|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982329|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982330|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13982331|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
13982332|NCT03013881|Trastuzumab|trastuzumab|mesh-list
13982333|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13982334|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982335|NCT03013751|Udenafil|udenafil|mesh-list
13982336|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13982337|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13982338|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982339|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982340|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
13982341|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
13982342|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13982343|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
13982344|NCT03013790|Melatonin|melatonin|mesh-list
13982345|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
13982346|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982347|NCT03013790|Protective Agents|protective agents|mesh-ancestor
13982348|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982349|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982350|NCT03013335|Nivolumab|nivolumab|mesh-list
13982351|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13982352|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982353|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13982354|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982355|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
13982356|NCT03013439|Hematinics|hematinics|mesh-ancestor
13982357|NCT03013218|Paclitaxel|paclitaxel|mesh-list
13982358|NCT03013218|Rituximab|rituximab|mesh-list
13982359|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
13982360|NCT03013218|Trastuzumab|trastuzumab|mesh-list
13982361|NCT03013218|Ramucirumab|ramucirumab|mesh-list
13982362|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13982363|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982364|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
13982365|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
13982366|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
13982367|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982368|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13982369|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
13982370|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982371|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13982372|NCT03013387|Octreotide|octreotide|mesh-list
13982373|NCT03013387|Edotreotide|edotreotide|mesh-list
13982374|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13982375|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13982376|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982377|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13982378|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982379|NCT03013556|Tenofovir|tenofovir|mesh-list
13982380|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13982381|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
13982382|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
13982383|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13982384|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13982385|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13982386|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982387|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982388|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13982389|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13982390|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
13982391|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982392|NCT03013205|Triamcinolone|triamcinolone|mesh-list
13982393|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
13982394|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
13982395|NCT03013205|Lidocaine|lidocaine|mesh-list
13982396|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
13982397|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982398|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
13982399|NCT03013205|Hormones|hormones|mesh-ancestor
13982400|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13982401|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982402|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13982403|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
13982404|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982405|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982406|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
13982407|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
13982408|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982409|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
13982410|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982411|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13982412|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13982413|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13982414|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13982415|NCT03013400|Ebselen|ebselen|mesh-list
13982416|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13982417|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13982418|NCT03013400|Analgesics|analgesics|mesh-ancestor
13982419|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
13982420|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982421|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982422|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982423|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13982424|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13982425|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13982426|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
13982427|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982428|NCT03013400|Protective Agents|protective agents|mesh-ancestor
13982429|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13982430|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982431|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13982432|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
13982433|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13982434|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982435|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982436|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13982437|NCT03013634|Analgesics|analgesics|mesh-ancestor
13982438|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
13982439|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982440|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13982441|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13982442|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13982443|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
13982444|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982445|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982446|NCT03013322|Physostigmine|physostigmine|mesh-list
13982447|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13982448|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982449|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982450|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
13982451|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982452|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982453|NCT03013322|Miotics|miotics|mesh-ancestor
13982454|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
13982455|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982456|NCT03013361|Bupivacaine|bupivacaine|mesh-list
13982457|NCT03013361|Ropivacaine|ropivacaine|mesh-list
13982458|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
13982459|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
13982460|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982461|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982462|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
13982463|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982464|NCT03013036|Fentanyl|fentanyl|mesh-list
13982465|NCT03013036|Midazolam|midazolam|mesh-list
13982466|NCT03013036|Propofol|propofol|mesh-list
13982467|NCT03013036|Sevoflurane|sevoflurane|mesh-list
13982468|NCT03013036|Rocuronium|rocuronium|mesh-list
13982469|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13982470|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982471|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982472|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13982473|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
13982474|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
13982475|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13982476|NCT03013036|Narcotics|narcotics|mesh-ancestor
13982477|NCT03013036|Analgesics|analgesics|mesh-ancestor
13982478|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
13982479|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982480|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13982481|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13982482|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13982483|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13982484|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
13982485|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
13982486|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982487|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982488|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13982489|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13982490|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13982491|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13982492|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13982493|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
13982494|NCT03013010|Tegafur|tegafur|mesh-list
13982495|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982496|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13982497|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
13982498|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982499|NCT03012945|Anesthetics|anesthetics|mesh-list
13982500|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982501|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982502|NCT03013140|Anesthetics|anesthetics|mesh-list
13982503|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982504|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982505|NCT03013075|Morphine|morphine|mesh-list
13982506|NCT03013075|Bupivacaine|bupivacaine|mesh-list
13982507|NCT03013075|Anesthetics|anesthetics|mesh-list
13982508|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
13982509|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
13982510|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982511|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982512|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
14246795|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982513|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982514|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13982515|NCT03013075|Narcotics|narcotics|mesh-ancestor
13982516|NCT03013075|Analgesics|analgesics|mesh-ancestor
14246796|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246797|NCT00243347|Cediranib|cediranib|mesh-list
14246798|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246799|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14246800|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246801|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246802|NCT00243386|Factor VIII|factor viii|mesh-list
14246803|NCT00243386|Coagulants|coagulants|mesh-ancestor
14246804|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
14246805|NCT00243412|Rituximab|rituximab|mesh-list
14246806|NCT00243412|Methotrexate|methotrexate|mesh-list
14246807|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14246808|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246809|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
14246810|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246811|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14246812|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14246813|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
14246814|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14246815|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14246816|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
14246817|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246818|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
14246819|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246820|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14246821|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14246822|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14246823|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14246824|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
14246825|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
14246826|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14246827|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14246828|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
14246829|NCT00243412|Hormones|hormones|mesh-ancestor
14246830|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14246831|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14246832|NCT00243412|Protective Agents|protective agents|mesh-ancestor
14246833|NCT00243503|Trastuzumab|trastuzumab|mesh-list
14246834|NCT00243503|Sunitinib|sunitinib|mesh-list
14246835|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14246836|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246837|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14246838|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14246839|NCT00243503|Growth Substances|growth substances|mesh-ancestor
14246840|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246841|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
14246842|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14246843|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246844|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246845|NCT00243659|Factor VIII|factor viii|mesh-list
14246846|NCT00243659|Coagulants|coagulants|mesh-ancestor
14246847|NCT00243932|Ubiquinone|ubiquinone|mesh-list
14246848|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
14246849|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
14246850|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246851|NCT00243932|Vitamins|vitamins|mesh-ancestor
14246852|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
14246853|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
14246854|NCT00244374|Vaccines|vaccines|mesh-list
14246855|NCT00244374|Immunologic Factors|immunologic factors|mesh-ancestor
14246856|NCT00244374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246857|NCT00244621|Candesartan|candesartan|mesh-list
14246858|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
14246859|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14246860|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14246861|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14246862|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246863|NCT00244712|Tenofovir|tenofovir|mesh-list
14246864|NCT00244712|Lamivudine|lamivudine|mesh-list
14246865|NCT00244712|Emtricitabine|emtricitabine|mesh-list
14246866|NCT00244712|Abacavir|abacavir|mesh-list
14246867|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
14246868|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13982517|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
13982518|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13982519|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982520|NCT03013101|Antibodies|antibodies|mesh-list
13982521|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13982522|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
13982523|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982524|NCT03013114|Bortezomib|bortezomib|mesh-list
13982525|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531914|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14531915|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14531916|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531917|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
14531918|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14531919|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14531920|NCT02353468|Growth Substances|growth substances|mesh-ancestor
14531921|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
14531922|NCT02360059|Metformin|metformin|mesh-list
14531923|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14531924|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531925|NCT02345460|Leucovorin|leucovorin|mesh-list
14531926|NCT02345460|Fluorouracil|fluorouracil|mesh-list
14531927|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
14531928|NCT02345460|Irinotecan|irinotecan|mesh-list
14531929|NCT02345460|Calcium|calcium|mesh-list
14531930|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
13982543|NCT03012880|Dexamethasone|dexamethasone|mesh-list
13982544|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
13982545|NCT03012880|Lenalidomide|lenalidomide|mesh-list
13982546|NCT03012880|Daratumumab|daratumumab|mesh-list
13982547|NCT03012880|Ixazomib|ixazomib|mesh-list
13982548|NCT03012880|Ichthammol|ichthammol|mesh-list
13982549|NCT03012880|BB 1101|bb 1101|mesh-list
13982550|NCT03012880|Glycine|glycine|mesh-list
13982551|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982552|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
13982553|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
13982554|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982555|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982556|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13982557|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
13982558|NCT03012880|Hormones|hormones|mesh-ancestor
13982559|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13982560|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13982561|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982562|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
13982563|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13982564|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13982565|NCT03012880|Growth Substances|growth substances|mesh-ancestor
13982566|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
13982567|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982568|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
13982569|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982570|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
13982571|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
13982572|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982573|NCT03012646|Treprostinil|treprostinil|mesh-list
13982574|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13982575|NCT03012763|Acetaminophen|acetaminophen|mesh-list
13982576|NCT03012763|Fexofenadine|fexofenadine|mesh-list
13982577|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
13982578|NCT03012763|Valsartan|valsartan|mesh-list
13982579|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13982580|NCT03012763|Analgesics|analgesics|mesh-ancestor
13982581|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
13982582|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982583|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982584|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
13982585|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13982586|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13982587|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13982588|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982589|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13982590|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
13982591|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
13982592|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
13982593|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
13982594|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14531931|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13982595|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13982596|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13982597|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982598|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13982599|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13982600|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13982601|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13982602|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13982603|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982604|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982605|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
13982606|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13982607|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13982608|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13982609|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
13982610|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13982611|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982612|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
13982613|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13982614|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982615|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
13982616|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982617|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
13982618|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13982619|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13982620|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982621|NCT03012386|Urological Agents|urological agents|mesh-ancestor
13982622|NCT03012321|Prednisone|prednisone|mesh-list
13982623|NCT03012321|Olaparib|olaparib|mesh-list
13982624|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
13982625|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982626|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
13982627|NCT03012321|Hormones|hormones|mesh-ancestor
13982628|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13982629|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982630|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13982631|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982632|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13982633|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982634|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982635|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13982636|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
13982637|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13982638|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
13982639|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13982640|NCT03012347|Protective Agents|protective agents|mesh-ancestor
13982641|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982642|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
13982643|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
13982644|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
13982645|NCT03012360|Linezolid|linezolid|mesh-list
13982646|NCT03012360|Imipenem|imipenem|mesh-list
13982647|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13982648|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13982649|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13982650|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13982651|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982652|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982653|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982654|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13982655|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13982656|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13982657|NCT03011970|Oxytocin|oxytocin|mesh-list
13982658|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
13982659|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13982660|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982661|NCT03011905|Acetaminophen|acetaminophen|mesh-list
13982662|NCT03011905|Dexamethasone|dexamethasone|mesh-list
13982663|NCT03011905|Etoricoxib|etoricoxib|mesh-list
13982664|NCT03011905|Oxycodone|oxycodone|mesh-list
13982665|NCT03011905|Ropivacaine|ropivacaine|mesh-list
13982666|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982667|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
13982668|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
13982669|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982670|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982671|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13982672|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
13982673|NCT03011905|Hormones|hormones|mesh-ancestor
13982674|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13982675|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13982676|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982677|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
13982678|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
13982679|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982680|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
13982681|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13982682|NCT03011905|Analgesics|analgesics|mesh-ancestor
13982683|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
13982684|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13982685|NCT03011905|Narcotics|narcotics|mesh-ancestor
13982686|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13982687|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13982688|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13982689|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13982690|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982691|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982692|NCT03011918|Vitamin D|vitamin d|mesh-list
13982693|NCT03011918|Vitamins|vitamins|mesh-ancestor
13982694|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
13982695|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982696|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13982697|NCT03012009|Lidocaine|lidocaine|mesh-list
13982698|NCT03012009|Epinephrine|epinephrine|mesh-list
13982699|NCT03012009|Racepinephrine|racepinephrine|mesh-list
13982700|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
13982701|NCT03012009|Anesthetics|anesthetics|mesh-list
13982702|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
13982703|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
13982704|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982705|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982706|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
13982707|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982708|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13982709|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13982710|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13982711|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13982712|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982713|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13982714|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13982715|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
13982716|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982717|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13982718|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13982719|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
13982720|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13982721|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
13982722|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
13982723|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
13982724|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13982725|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13982726|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
13982727|NCT03012113|Mirabegron|mirabegron|mesh-list
13982728|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
13982729|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13982730|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13982731|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
13982732|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982733|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982734|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982735|NCT03012113|Urological Agents|urological agents|mesh-ancestor
13982736|NCT03011931|Simvastatin|simvastatin|mesh-list
13982737|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13982738|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13982739|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
13982740|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982741|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13982742|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13982743|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982744|NCT03011996|Amoxicillin|amoxicillin|mesh-list
13982745|NCT03011996|Clarithromycin|clarithromycin|mesh-list
13982746|NCT03011996|Pantoprazole|pantoprazole|mesh-list
13982747|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13982748|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13982749|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13982750|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982751|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982752|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13982753|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13982754|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13982755|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13982756|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13982757|NCT03011684|Tamoxifen|tamoxifen|mesh-list
13982758|NCT03011684|Letrozole|letrozole|mesh-list
13982759|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982760|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13982761|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13982762|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982763|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982764|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13982765|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
13982766|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13982767|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982768|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13982769|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13982770|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13982771|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13982772|NCT03011476|Donepezil|donepezil|mesh-list
13982773|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13982774|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982775|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982776|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
13982777|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982778|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982779|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
13982780|NCT03011463|Clarithromycin|clarithromycin|mesh-list
13982781|NCT03011463|Ranitidine|ranitidine|mesh-list
13982782|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
13982783|NCT03011463|Trospium chloride|trospium chloride|mesh-list
13982784|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13982785|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13982786|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13982787|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982788|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982789|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13982790|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13982791|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13982792|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13982793|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
13982794|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
13982795|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
13982796|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982797|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982798|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
13982799|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
13982800|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982801|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13982802|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13982803|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
13982804|NCT03011463|Urological Agents|urological agents|mesh-ancestor
13982805|NCT03011645|Ziprasidone|ziprasidone|mesh-list
13982806|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13982807|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
13982808|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982809|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982810|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982811|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13982812|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13982813|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982814|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13982815|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13982816|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
13982817|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
13982818|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982819|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
13982820|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13982821|NCT03011567|Acetaminophen|acetaminophen|mesh-list
13982822|NCT03011567|Ibuprofen|ibuprofen|mesh-list
13982823|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13982824|NCT03011567|Analgesics|analgesics|mesh-ancestor
13982825|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
13982826|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982827|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982828|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
13982829|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13982830|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982831|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13982832|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13982833|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982834|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246869|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14246870|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14246871|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246872|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246873|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14246874|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14246875|NCT00244725|Warfarin|warfarin|mesh-list
14246876|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
14246877|NCT00244855|Dexamethasone|dexamethasone|mesh-list
14246878|NCT00244855|Rituximab|rituximab|mesh-list
14246879|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14246880|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
14246881|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
14246882|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14246883|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246884|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14246885|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
14246886|NCT00244855|Hormones|hormones|mesh-ancestor
14246887|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14246888|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14246889|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246890|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14246891|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
14246892|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14246893|NCT00244881|Cediranib|cediranib|mesh-list
14246894|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246895|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246896|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246897|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14246898|NCT00244933|Gemcitabine|gemcitabine|mesh-list
14246899|NCT00244933|Genistein|genistein|mesh-list
14246900|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14246901|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
14246902|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246903|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246904|NCT00244933|Antiviral Agents|antiviral agents|mesh-ancestor
14246905|NCT00244933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14246906|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246907|NCT00244933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14246908|NCT00244933|Immunologic Factors|immunologic factors|mesh-ancestor
14246909|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246910|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14246911|NCT00244933|Protective Agents|protective agents|mesh-ancestor
14246912|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14246913|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
14246914|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14246915|NCT00244933|Estrogens|estrogens|mesh-ancestor
14246916|NCT00244933|Hormones|hormones|mesh-ancestor
14246917|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14246918|NCT00244985|Rituximab|rituximab|mesh-list
14246919|NCT00244985|Doxorubicin|doxorubicin|mesh-list
14246920|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14246921|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14246922|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246923|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
14246924|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246925|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14246926|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13982835|NCT03011281|Tofacitinib|tofacitinib|mesh-list
13982836|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13982837|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982838|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982839|NCT03011177|Linagliptin|linagliptin|mesh-list
13982840|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13982841|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982842|NCT03011177|Incretins|incretins|mesh-ancestor
13982843|NCT03011177|Hormones|hormones|mesh-ancestor
13982844|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13982845|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13982846|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
13982847|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982848|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982849|NCT03011268|Adalimumab|adalimumab|mesh-list
13982850|NCT03011268|Golimumab|golimumab|mesh-list
13982851|NCT03011268|Infliximab|infliximab|mesh-list
13982852|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13982853|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982854|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13982855|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
13982856|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13982857|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
13982858|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13982859|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
13982860|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982861|NCT03010917|Ethanol|ethanol|mesh-list
13982862|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13982863|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13982864|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982865|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982866|NCT03010865|Butyric Acid|butyric acid|mesh-list
13982867|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
13982868|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
13982869|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982870|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982871|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982872|NCT03011008|Liraglutide|liraglutide|mesh-list
13982873|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13982874|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982875|NCT03011008|Incretins|incretins|mesh-ancestor
13982876|NCT03011008|Hormones|hormones|mesh-ancestor
13982877|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13982878|NCT03010995|Prazosin|prazosin|mesh-list
13982879|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13982880|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13982881|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13982882|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13982883|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
13982884|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982885|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982886|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982887|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
13982888|NCT03011125|Lansoprazole|lansoprazole|mesh-list
13982889|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13982890|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13982891|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13982892|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982893|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982894|NCT03011060|Capecitabine|capecitabine|mesh-list
13982895|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13982896|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
13982897|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982898|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982899|NCT03010670|Oxytocin|oxytocin|mesh-list
13982900|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
13982901|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13982902|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982903|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
13982904|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
13982905|NCT03010579|Hematinics|hematinics|mesh-list
13982906|NCT03010761|Citalopram|citalopram|mesh-list
13982907|NCT03010761|Moclobemide|moclobemide|mesh-list
13982908|NCT03010761|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13982909|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13982910|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13982911|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982912|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13982913|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
13982914|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982915|NCT03010761|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13982916|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
13982917|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13982918|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13982919|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982920|NCT03011021|Liraglutide|liraglutide|mesh-list
13982921|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13982922|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982923|NCT03011021|Incretins|incretins|mesh-ancestor
13982924|NCT03011021|Hormones|hormones|mesh-ancestor
13982925|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13982926|NCT03010540|Fentanyl|fentanyl|mesh-list
13982927|NCT03010540|Morphine|morphine|mesh-list
13982928|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13982929|NCT03010540|Narcotics|narcotics|mesh-ancestor
13982930|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982931|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982932|NCT03010540|Analgesics|analgesics|mesh-ancestor
13982933|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
13982934|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982935|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13982936|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13982937|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
13982938|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
13982939|NCT03010475|Furosemide|furosemide|mesh-list
13982940|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13982941|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13982942|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13982943|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
13982944|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13982945|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13982946|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13982947|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13982948|NCT03010475|Diuretics|diuretics|mesh-ancestor
13982949|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
13982950|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982951|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
13982952|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13982953|NCT03010436|Benralizumab|benralizumab|mesh-list
13982954|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13982955|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
13982956|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
13982957|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13982958|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982959|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
13982960|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13982961|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
13982962|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982963|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
13982964|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13982965|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
13982966|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13982967|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982968|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13982969|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13982970|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13982971|NCT03010202|Dexamethasone|dexamethasone|mesh-list
13982972|NCT03010202|Rituximab|rituximab|mesh-list
13982973|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13982974|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
13982975|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
13982976|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13982977|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982978|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13982979|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
13982980|NCT03010202|Hormones|hormones|mesh-ancestor
13982981|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13982982|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13982983|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13982984|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13982985|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
13982986|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13982987|NCT03010098|Remifentanil|remifentanil|mesh-list
13982988|NCT03010098|Propofol|propofol|mesh-list
13982989|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13982990|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13982991|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13982992|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13982993|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
13982994|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
13982995|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13982996|NCT03010098|Narcotics|narcotics|mesh-ancestor
13982997|NCT03010098|Analgesics|analgesics|mesh-ancestor
13982998|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
13982999|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983000|NCT03009981|Prednisone|prednisone|mesh-list
13983001|NCT03009981|Leuprolide|leuprolide|mesh-list
13983002|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
13983003|NCT03009981|Bicalutamide|bicalutamide|mesh-list
13983004|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13983005|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
13983006|NCT03009981|Hormones|hormones|mesh-ancestor
13983007|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13983008|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983009|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13983010|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983011|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13983012|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
13983013|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13983014|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13983015|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983016|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983017|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
13983018|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13983019|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
13983020|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
13983021|NCT03010072|Hematinics|hematinics|mesh-ancestor
13983022|NCT03009877|Fentanyl|fentanyl|mesh-list
13983023|NCT03009877|Midazolam|midazolam|mesh-list
13983024|NCT03009877|Propofol|propofol|mesh-list
13983025|NCT03009877|Rocuronium|rocuronium|mesh-list
13983026|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13983027|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983028|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983029|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13983030|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
13983031|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
13983032|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13983033|NCT03009877|Narcotics|narcotics|mesh-ancestor
13983034|NCT03009877|Analgesics|analgesics|mesh-ancestor
13983035|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
13983036|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983037|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13983038|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13983039|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13983040|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13983041|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
13983042|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
13983043|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983044|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983045|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13983046|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13983047|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13983048|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
13983049|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13983050|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13983051|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
13983052|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983053|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13983054|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
13983055|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13983056|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
13983057|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983058|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983059|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13983060|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
13983061|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13983062|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
13983063|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983064|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983065|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13983066|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
13983067|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
13983068|NCT03009643|Protective Agents|protective agents|mesh-ancestor
14246927|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14246928|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14246929|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246930|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246931|NCT00245011|Ifosfamide|ifosfamide|mesh-list
14246932|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
14246933|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246934|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14246935|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
14246936|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246937|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246938|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14246939|NCT00245011|Analgesics|analgesics|mesh-ancestor
14246940|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
14246941|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531932|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531933|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
14531934|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531935|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14531936|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531937|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531938|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
14531939|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14531940|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14531941|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531942|NCT02345460|Antidotes|antidotes|mesh-ancestor
14531943|NCT02345460|Protective Agents|protective agents|mesh-ancestor
14531944|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
14531945|NCT02345460|Vitamins|vitamins|mesh-ancestor
14531946|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
14531947|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
14531948|NCT02351063|Diuretics|diuretics|mesh-list
14531949|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14531950|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14531951|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
14531952|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
14531953|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531954|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531955|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
14531956|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14531957|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14531958|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
14531959|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14531960|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14531961|NCT02345772|Docetaxel|docetaxel|mesh-list
14531962|NCT02345772|Trastuzumab|trastuzumab|mesh-list
14531963|NCT02345772|Fulvestrant|fulvestrant|mesh-list
14531964|NCT02345772|Pertuzumab|pertuzumab|mesh-list
14531965|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531966|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
14531967|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
14531968|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
14531969|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531970|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14531971|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14531972|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14531973|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14531974|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
14531975|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14531976|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531977|NCT02353572|Dexamethasone|dexamethasone|mesh-list
14531978|NCT02353572|Bortezomib|bortezomib|mesh-list
14531979|NCT02353572|Melphalan|melphalan|mesh-list
14531980|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14531981|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
14531982|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
13983069|NCT03009604|Simethicone|simethicone|mesh-list
13983070|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
13983071|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983072|NCT03009604|Emollients|emollients|mesh-ancestor
13983073|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
13983074|NCT03009682|Olaparib|olaparib|mesh-list
13983075|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13983076|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983077|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983078|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983079|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
13983080|NCT03009799|Laxatives|laxatives|mesh-ancestor
13983081|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13983082|NCT03009461|Sorafenib|sorafenib|mesh-list
13983083|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983084|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13983085|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983086|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983087|NCT03009838|Letrozole|letrozole|mesh-list
13983088|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983089|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13983090|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13983091|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983092|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983093|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13983094|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
13983095|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13983096|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983097|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
13983098|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13983099|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13983100|NCT03009500|Prednisolone|prednisolone|mesh-list
13983101|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
13983102|NCT03009500|Lidocaine|lidocaine|mesh-list
13983103|NCT03009500|Bupivacaine|bupivacaine|mesh-list
13983104|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13983105|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
13983106|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
13983107|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
13983108|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983109|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983110|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
13983111|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983112|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13983113|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13983114|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13983115|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13983116|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983117|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13983118|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
13983119|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
13983120|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13983121|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
13983122|NCT03009500|Hormones|hormones|mesh-ancestor
13983123|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13983124|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13983125|NCT03009500|Protective Agents|protective agents|mesh-ancestor
13983126|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13983127|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983128|NCT03009513|Glimepiride|glimepiride|mesh-list
13983129|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13983130|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13983131|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983132|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13983133|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
13983134|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
13983135|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13983136|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13983137|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13983138|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
13983139|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983140|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13983141|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13983142|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983143|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13983144|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
13983145|NCT03009526|Piperaquine|piperaquine|mesh-list
13983146|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
13983147|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
13983148|NCT03009526|Artenimol|artenimol|mesh-list
13983149|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
13983150|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13983151|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13983152|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13983153|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13983154|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983155|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983156|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13983157|NCT03009526|Renal Agents|renal agents|mesh-ancestor
13983158|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
13983159|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13983160|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13983161|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13983162|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
13983163|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13983164|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
13983165|NCT03009292|Lenvatinib|lenvatinib|mesh-list
13983166|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983167|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13983168|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983169|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983170|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
13983171|NCT03009578|Hematinics|hematinics|mesh-ancestor
13983172|NCT03009097|Atorvastatin|atorvastatin|mesh-list
13983173|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13983174|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13983175|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
13983176|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983177|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13983178|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13983179|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983180|NCT03009045|Tedizolid|tedizolid|mesh-list
13983181|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
13983182|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
13983183|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13983184|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13983185|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13983186|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983187|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983188|NCT03009058|Leucovorin|leucovorin|mesh-list
13983189|NCT03009058|Folic Acid|folic acid|mesh-list
13983190|NCT03009058|Gemcitabine|gemcitabine|mesh-list
13983191|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
13983192|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
13983193|NCT03009058|Fluorouracil|fluorouracil|mesh-list
13983194|NCT03009058|Capecitabine|capecitabine|mesh-list
13983195|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
13983196|NCT03009058|Nivolumab|nivolumab|mesh-list
13983197|NCT03009058|Irinotecan|irinotecan|mesh-list
13983198|NCT03009058|Cetuximab|cetuximab|mesh-list
13983199|NCT03009058|Ipilimumab|ipilimumab|mesh-list
13983200|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
13983201|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
13983202|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13983203|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
13983204|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983205|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13983206|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13983207|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
13983208|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983209|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983210|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13983211|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13983212|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
13983213|NCT03009058|Antiviral Agents|antiviral agents|mesh-ancestor
13983214|NCT03009058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13983215|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983216|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13983217|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13983218|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
13983219|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13983220|NCT03009058|Antidotes|antidotes|mesh-ancestor
13983221|NCT03009058|Protective Agents|protective agents|mesh-ancestor
13983222|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
13983223|NCT03009058|Vitamins|vitamins|mesh-ancestor
13983224|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
13983225|NCT03009058|Hematinics|hematinics|mesh-ancestor
13983226|NCT03009409|Ketamine|ketamine|mesh-list
13983227|NCT03009409|Analgesics|analgesics|mesh-ancestor
13983228|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
13983229|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983230|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983231|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13983232|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13983233|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
13983234|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
13983235|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983236|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13983237|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13983238|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983239|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983240|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
13983241|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
13983242|NCT03009006|Calcium|calcium|mesh-list
13983243|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13983244|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983245|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13983246|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13983247|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13983248|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
13983249|NCT03008876|Acetaminophen|acetaminophen|mesh-list
13983250|NCT03008876|Ibuprofen|ibuprofen|mesh-list
13983251|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13983252|NCT03008876|Analgesics|analgesics|mesh-ancestor
13983253|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
13983254|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983255|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983256|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
13983257|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13983258|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13983259|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13983260|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13983261|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983262|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983263|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
13983264|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13983265|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13983266|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983267|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
13983268|NCT03008655|Coagulants|coagulants|mesh-ancestor
13983269|NCT03008512|Paclitaxel|paclitaxel|mesh-list
13983270|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13983271|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983272|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
13983273|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
13983274|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
13983275|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983276|NCT03008551|Metformin|metformin|mesh-list
13983277|NCT03008551|Empagliflozin|empagliflozin|mesh-list
13983278|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13983279|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983280|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13983281|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983282|NCT03008408|Everolimus|everolimus|mesh-list
13983283|NCT03008408|Letrozole|letrozole|mesh-list
13983284|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983285|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13983286|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
13983287|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983288|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13983289|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13983290|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983291|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983292|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13983293|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
13983294|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13983295|NCT03008317|Chromium|chromium|mesh-list
13983296|NCT03008317|Trace Elements|trace elements|mesh-ancestor
13983297|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
13983298|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983299|NCT03008252|Caseins|caseins|mesh-list
13983300|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
13983301|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
13983302|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246942|NCT00245037|Cyclosporine|cyclosporine|mesh-list
14246943|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
14246944|NCT00245037|Methotrexate|methotrexate|mesh-list
14246945|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
14246946|NCT00245037|Fludarabine|fludarabine|mesh-list
14246947|NCT00245037|Busulfan|busulfan|mesh-list
14246948|NCT00245037|Phenytoin|phenytoin|mesh-list
14246949|NCT00245037|Cyclosporins|cyclosporins|mesh-list
14246950|NCT00245037|Sargramostim|sargramostim|mesh-list
14246951|NCT00245037|Lenograstim|lenograstim|mesh-list
14246952|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14246953|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
14246954|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14246955|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246956|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14246957|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
14246958|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246959|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246960|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
14246961|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246962|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14246963|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14246964|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
14246965|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14246966|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14246967|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
14246968|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14246969|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14246970|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14246971|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14246972|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
14246973|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14246974|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
14246975|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14246976|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14246977|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14246978|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
14246979|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14246980|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14246981|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14246982|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14246983|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14246984|NCT00245050|Pyridoxine|pyridoxine|mesh-list
14246985|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
14246986|NCT00245050|Doxorubicin|doxorubicin|mesh-list
14246987|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14246988|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14246989|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14246990|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14246991|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14246992|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14246993|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14246994|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
14246995|NCT00245050|Vitamins|vitamins|mesh-ancestor
14246996|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
14246997|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14246998|NCT00245063|Cediranib|cediranib|mesh-list
14246999|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247000|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247001|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247002|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14247003|NCT00245102|Sorafenib|sorafenib|mesh-list
14247004|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247005|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14247006|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247007|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247008|NCT00245557|Sertraline|sertraline|mesh-list
14247009|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
14247010|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14247011|NCT00245557|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13983303|NCT03008148|Temozolomide|temozolomide|mesh-list
13983304|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13983305|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
13983306|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983307|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983308|NCT03007927|Dexamethasone|dexamethasone|mesh-list
13983309|NCT03007927|Bupivacaine|bupivacaine|mesh-list
13983310|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13983311|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
13983312|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
13983313|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983314|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983315|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13983316|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
13983317|NCT03007927|Hormones|hormones|mesh-ancestor
13983318|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13983319|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13983320|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983321|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
13983322|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
13983323|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983324|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
13983325|NCT03008005|Dronabinol|dronabinol|mesh-list
13983326|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
13983327|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983328|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13983329|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13983330|NCT03008005|Analgesics|analgesics|mesh-ancestor
13983331|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
13983332|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983333|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
13983334|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
13983335|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983336|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983337|NCT03008005|Hormones|hormones|mesh-ancestor
13983338|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13983339|NCT03008109|Endostatins|endostatins|mesh-list
13983340|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983341|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13983342|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13983343|NCT03008109|Growth Substances|growth substances|mesh-ancestor
13983344|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983345|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
13983346|NCT03007992|Vinorelbine|vinorelbine|mesh-list
13983347|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13983348|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983349|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
13983350|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
13983351|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
13983352|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983353|NCT03008057|Vitamin D|vitamin d|mesh-list
13983354|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
13983355|NCT03008057|Vitamins|vitamins|mesh-list
13983356|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
13983357|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983358|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13983359|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13983360|NCT03008083|Clopidogrel|clopidogrel|mesh-list
13983361|NCT03008083|Ticagrelor|ticagrelor|mesh-list
13983362|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13983363|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13983364|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13983365|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13983366|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
13983367|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983368|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983369|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983370|NCT03007810|Hemay005|hemay005|mesh-list
13983371|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
13983372|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
13983373|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13983374|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983375|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983376|NCT03007797|Vaccines|vaccines|mesh-list
13983377|NCT03007797|Immunologic Factors|immunologic factors|mesh-ancestor
13983378|NCT03007797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983379|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
13983380|NCT03007446|Apatinib|apatinib|mesh-list
13983381|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983382|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13983383|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983384|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983385|NCT03007420|Lidocaine|lidocaine|mesh-list
13983386|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
13983387|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
13983388|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983389|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983390|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
13983391|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983392|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13983393|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13983394|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13983395|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13983396|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983397|NCT03007381|Ketorolac|ketorolac|mesh-list
13983398|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
13983399|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13983400|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13983401|NCT03007381|Analgesics|analgesics|mesh-ancestor
13983402|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
13983403|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983404|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983405|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13983406|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13983407|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13983408|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983409|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983410|NCT03007303|Olanzapine|olanzapine|mesh-list
13983411|NCT03007303|Risperidone|risperidone|mesh-list
13983412|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
13983413|NCT03007303|Ziprasidone|ziprasidone|mesh-list
13983414|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
13983415|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13983416|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
13983417|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983418|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983419|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983420|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13983421|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983422|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13983423|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13983424|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
13983425|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
13983426|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
13983427|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983428|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13983429|NCT03007303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
13983430|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13983431|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13983432|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
13983433|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
13983434|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13983435|NCT03007589|Protective Agents|protective agents|mesh-ancestor
13983436|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983437|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
13983438|NCT03007342|Amoxicillin|amoxicillin|mesh-list
13983439|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
13983440|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
13983441|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
13983442|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13983443|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13983444|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13983445|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983446|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983447|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
13983448|NCT03007537|Hematinics|hematinics|mesh-ancestor
13983449|NCT03007563|Bilirubin|bilirubin|mesh-list
13983450|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
14247012|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13983451|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983452|NCT03007563|Protective Agents|protective agents|mesh-ancestor
13983453|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983454|NCT03007407|Durvalumab|durvalumab|mesh-list
13983455|NCT03007407|Tremelimumab|tremelimumab|mesh-list
13983456|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13983457|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983458|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
13983459|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13983460|NCT03007524|Calcium|calcium|mesh-list
13983461|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13983462|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983463|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13983464|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13983465|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13983466|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
13983467|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983468|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13983469|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13983470|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983471|NCT03007654|Chitosan|chitosan|mesh-list
13983472|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13983473|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13983474|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
13983475|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983476|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13983477|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
13983478|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
13983479|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
13983480|NCT03007654|Coagulants|coagulants|mesh-ancestor
13983481|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
13983482|NCT03007160|Diuretics|diuretics|mesh-ancestor
13983483|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
13983484|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983485|NCT03007160|Expectorants|expectorants|mesh-ancestor
13983486|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
13983487|NCT03006874|Esomeprazole|esomeprazole|mesh-list
13983488|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13983489|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13983490|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13983491|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983492|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983493|NCT03006965|Factor VIII|factor viii|mesh-list
13983494|NCT03006965|BAX 855|bax 855|mesh-list
13983495|NCT03006965|Coagulants|coagulants|mesh-ancestor
13983496|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
13983497|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
13983498|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13983499|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13983500|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13983501|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13983502|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983503|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
13983504|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983505|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983506|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13983507|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983508|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13983509|NCT03007121|Sufentanil|sufentanil|mesh-list
13983510|NCT03007121|Morphine|morphine|mesh-list
13983511|NCT03007121|Dsuvia|dsuvia|mesh-list
13983512|NCT03007121|Bupivacaine|bupivacaine|mesh-list
13983513|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
13983514|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
13983515|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983516|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983517|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
13983518|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983519|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13983520|NCT03007121|Narcotics|narcotics|mesh-ancestor
13983521|NCT03007121|Analgesics|analgesics|mesh-ancestor
13983522|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13983523|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13983524|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
13983525|NCT03006835|Clopidogrel|clopidogrel|mesh-list
13983526|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13983527|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13983528|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13983529|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13983530|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
13983531|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983532|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983533|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983534|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13983535|NCT03006809|Metronidazole|metronidazole|mesh-list
13983536|NCT03006809|Vancomycin|vancomycin|mesh-list
13983537|NCT03006809|Neomycin|neomycin|mesh-list
13983538|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13983539|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13983540|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13983541|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13983542|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983543|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983544|NCT03006952|Losartan|losartan|mesh-list
13983545|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
13983546|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13983547|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13983548|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13983549|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13983550|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983551|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13983552|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983553|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13983554|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13983555|NCT03006952|Protective Agents|protective agents|mesh-ancestor
13983556|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983557|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
13983558|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13983559|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
13983560|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
13983561|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
13983562|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13983563|NCT03006757|Protective Agents|protective agents|mesh-ancestor
13983564|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983565|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
13983566|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
13983567|NCT03006679|Meropenem|meropenem|mesh-list
13983568|NCT03006679|Tazobactam|tazobactam|mesh-list
13983569|NCT03006679|Piperacillin|piperacillin|mesh-list
13983570|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
13983571|NCT03006679|Vaborbactam|vaborbactam|mesh-list
13983572|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13983573|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13983574|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13983575|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983576|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983577|NCT03006614|Gemcitabine|gemcitabine|mesh-list
13983578|NCT03006614|Cisplatin|cisplatin|mesh-list
13983579|NCT03006614|Docetaxel|docetaxel|mesh-list
13983580|NCT03006614|Capecitabine|capecitabine|mesh-list
13983581|NCT03006614|Trastuzumab|trastuzumab|mesh-list
13983582|NCT03006614|Vinorelbine|vinorelbine|mesh-list
13983583|NCT03006614|Epirubicin|epirubicin|mesh-list
13983584|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983585|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13983586|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
13983587|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983588|NCT03006614|Antiviral Agents|antiviral agents|mesh-ancestor
13983589|NCT03006614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13983590|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983591|NCT03006614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13983592|NCT03006614|Immunologic Factors|immunologic factors|mesh-ancestor
13983593|NCT03006614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983594|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
13983595|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
13983596|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
13983597|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13983598|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13983599|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13983600|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13983601|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14247013|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14247014|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247015|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247016|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
14247017|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247018|NCT00245583|Topiramate|topiramate|mesh-list
14247019|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
14247020|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14247021|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247022|NCT00245635|Fluoxetine|fluoxetine|mesh-list
14247023|NCT00245635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14247024|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14247025|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14247026|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247027|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247028|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
14247029|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247030|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14247031|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
14247032|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14247033|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14247034|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14247035|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247036|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
14247037|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247038|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
14247039|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247040|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14247041|NCT00245856|Dalteparin|dalteparin|mesh-list
14247042|NCT00245856|Tinzaparin|tinzaparin|mesh-list
14247043|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14247044|NCT00245856|Warfarin|warfarin|mesh-list
14247045|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
14247046|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14247047|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14247048|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247049|NCT00246012|Dacarbazine|dacarbazine|mesh-list
14247050|NCT00246012|Intetumumab|intetumumab|mesh-list
14247051|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14247052|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
14247053|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247054|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247055|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14247056|NCT00246025|Dabigatran|dabigatran|mesh-list
14247057|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
14247058|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14247059|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
14247060|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247061|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247062|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
14247063|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
14247064|NCT00246129|Daclizumab|daclizumab|mesh-list
13983602|NCT03006380|Oxytocin|oxytocin|mesh-list
13983603|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
13983604|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13983605|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983606|NCT03006445|Dotinurad|dotinurad|mesh-list
13983607|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
13983608|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
13983609|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13983610|NCT03006445|Renal Agents|renal agents|mesh-ancestor
13983611|NCT03006627|Morphine|morphine|mesh-list
13983612|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13983613|NCT03006627|Narcotics|narcotics|mesh-ancestor
13983614|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983615|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983616|NCT03006627|Analgesics|analgesics|mesh-ancestor
13983617|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
13983618|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983619|NCT03006250|Sevoflurane|sevoflurane|mesh-list
13983620|NCT03006250|Desflurane|desflurane|mesh-list
13983621|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13983622|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13983623|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
13983624|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
13983625|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983626|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983627|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
13983628|NCT03006419|Basiliximab|basiliximab|mesh-list
13983629|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
13983630|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983631|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13983632|NCT03006705|Capecitabine|capecitabine|mesh-list
13983633|NCT03006705|Tegafur|tegafur|mesh-list
13983634|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
13983635|NCT03006705|Nivolumab|nivolumab|mesh-list
13983636|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13983637|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
13983638|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983639|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983640|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13983641|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13983642|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
13983643|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
14247065|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14247066|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247067|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247068|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
14247069|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247070|NCT00246259|Risperidone|risperidone|mesh-list
14247071|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
14247072|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14247073|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
14247074|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247075|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247076|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247077|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14247078|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14247079|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14247080|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
13983644|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13983645|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
13983646|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
13983647|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983648|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983649|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13983650|NCT03006211|Analgesics|analgesics|mesh-ancestor
13983651|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
13983652|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983653|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14247081|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
13983654|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
13983655|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13983656|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
13983657|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13983658|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
13983659|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983660|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983661|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
13983662|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
13983663|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
13983664|NCT03006211|Protective Agents|protective agents|mesh-ancestor
13983665|NCT03006146|Molgramostim|molgramostim|mesh-list
13983666|NCT03006146|Sargramostim|sargramostim|mesh-list
13983667|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
13983668|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983669|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983670|NCT03006003|Alendronate|alendronate|mesh-list
13983671|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
13983672|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13983673|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983674|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13983675|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
13983676|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13983677|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13983678|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13983679|NCT03006107|Piroxicam|piroxicam|mesh-list
13983680|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13983681|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13983682|NCT03006107|Analgesics|analgesics|mesh-ancestor
13983683|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
13983684|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983685|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983686|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13983687|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13983688|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13983689|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983690|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983691|NCT03006081|Aflibercept|aflibercept|mesh-list
13983692|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13983693|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13983694|NCT03006081|Growth Substances|growth substances|mesh-ancestor
13983695|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983696|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
13983697|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983698|NCT03005860|Fentanyl|fentanyl|mesh-list
13983699|NCT03005860|Propofol|propofol|mesh-list
13983700|NCT03005860|Sevoflurane|sevoflurane|mesh-list
13983701|NCT03005860|Atracurium|atracurium|mesh-list
13983702|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13983703|NCT03005860|Narcotics|narcotics|mesh-ancestor
13983704|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983705|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983706|NCT03005860|Analgesics|analgesics|mesh-ancestor
13983707|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
13983708|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983709|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13983710|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13983711|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
13983712|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
13983713|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983714|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13983715|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13983716|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
13983717|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
13983718|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13983719|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
13983720|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13983721|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
13983722|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983723|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13983724|NCT03006042|Bupivacaine|bupivacaine|mesh-list
13983725|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
13983726|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
13983727|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983728|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983729|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
13983730|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983731|NCT03005639|Vemurafenib|vemurafenib|mesh-list
13983732|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983733|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13983734|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983735|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983736|NCT03005496|Vitamin D|vitamin d|mesh-list
13983737|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
13983738|NCT03005496|Beta Carotene|beta carotene|mesh-list
13983739|NCT03005496|Zinc|zinc|mesh-list
13983740|NCT03005496|Dexamethasone|dexamethasone|mesh-list
13983741|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
13983742|NCT03005496|Nifedipine|nifedipine|mesh-list
13983743|NCT03005496|BB 1101|bb 1101|mesh-list
13983744|NCT03005496|Carotenoids|carotenoids|mesh-list
13983745|NCT03005496|Picolinic acid|picolinic acid|mesh-list
13983746|NCT03005496|Vitamins|vitamins|mesh-ancestor
13983747|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
13983748|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983749|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13983750|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
13983751|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
13983752|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983753|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13983754|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
13983755|NCT03005496|Hormones|hormones|mesh-ancestor
13983756|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13983757|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13983758|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983759|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
13983760|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983761|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983762|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13983763|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13983764|NCT03005496|Trace Elements|trace elements|mesh-ancestor
13983765|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13983766|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13983767|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
13983768|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
13983769|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13983770|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
13983771|NCT03005496|Protective Agents|protective agents|mesh-ancestor
13983772|NCT03005496|Provitamins|provitamins|mesh-ancestor
13983773|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
13983774|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
13983775|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
13983776|NCT03005808|Ropivacaine|ropivacaine|mesh-list
13983777|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
13983778|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
13983779|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983780|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983781|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
13983782|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983783|NCT03005665|Acetazolamide|acetazolamide|mesh-list
13983784|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
13983785|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13983786|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983787|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983788|NCT03005665|Diuretics|diuretics|mesh-ancestor
13983789|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
13983790|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983791|NCT03005405|Methamphetamine|methamphetamine|mesh-list
13983792|NCT03005405|Fluorides|fluorides|mesh-list
13983793|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
13983794|NCT03005405|Protective Agents|protective agents|mesh-ancestor
13983795|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983796|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13983797|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
13983798|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
13983799|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983800|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
13983801|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983802|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983803|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
13983804|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
13983805|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13983806|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13983807|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13983808|NCT03005444|Enoxaparin|enoxaparin|mesh-list
13983809|NCT03005444|Nadroparin|nadroparin|mesh-list
13983810|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
13983811|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
13983812|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
13983813|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
13983814|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
13983815|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983816|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983817|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
13983818|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13983819|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13983820|NCT03005704|Aspirin|aspirin|mesh-list
13983821|NCT03005704|Ticagrelor|ticagrelor|mesh-list
13983822|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13983823|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13983824|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13983825|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13983826|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
13983827|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983828|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983829|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983830|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13983831|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13983832|NCT03005704|Analgesics|analgesics|mesh-ancestor
13983833|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
13983834|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983835|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13983836|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13983837|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13983838|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13983839|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13983840|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983841|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
13983842|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
13983843|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13983844|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
13983845|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983846|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983847|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13983848|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
13983849|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13983850|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13983851|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13983852|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
13983853|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983854|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983855|NCT03005678|Denosumab|denosumab|mesh-list
13983856|NCT03005678|Alendronate|alendronate|mesh-list
13983857|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13983858|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983859|NCT03005548|Morphine|morphine|mesh-list
13983860|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13983861|NCT03005548|Narcotics|narcotics|mesh-ancestor
13983862|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983863|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983864|NCT03005548|Analgesics|analgesics|mesh-ancestor
13983865|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
13983866|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983867|NCT03005483|Gabapentin|gabapentin|mesh-list
13983868|NCT03005483|Analgesics|analgesics|mesh-ancestor
13983869|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
13983870|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983871|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983872|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
13983873|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13983874|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13983875|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983876|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13983877|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13983878|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13983879|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13983880|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983881|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
13983882|NCT03005522|Dexamethasone|dexamethasone|mesh-list
13983883|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13983884|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
13983885|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
13983886|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983887|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983888|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13983889|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
13983890|NCT03005522|Hormones|hormones|mesh-ancestor
13983891|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13983892|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13983893|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983894|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
13983895|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
13983896|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13983897|NCT03005353|Clotrimazole|clotrimazole|mesh-list
13983898|NCT03005353|Miconazole|miconazole|mesh-list
13983899|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13983900|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13983901|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
13983902|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13983903|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13983904|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983905|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983906|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13983907|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
13983908|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13983909|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983910|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13983911|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13983912|NCT03005015|Doxorubicin|doxorubicin|mesh-list
13983913|NCT03005015|Lenvatinib|lenvatinib|mesh-list
13983914|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13983915|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983916|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13983917|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13983918|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983919|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983920|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13983921|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
13983922|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
13983923|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13983924|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983925|NCT03005340|Vitamins|vitamins|mesh-ancestor
13983926|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
13983927|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13983928|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13983929|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13983930|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
13983931|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13983932|NCT03005171|Lidocaine|lidocaine|mesh-list
13983933|NCT03005171|Bupivacaine|bupivacaine|mesh-list
13983934|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
13983935|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
13983936|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13983937|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983938|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
13983939|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983940|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13983941|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13983942|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13983943|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13983944|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983945|NCT03005366|Flecainide|flecainide|mesh-list
13983946|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13983947|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13983948|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13983949|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13983950|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983951|NCT03005184|Icatibant|icatibant|mesh-list
13983952|NCT03005184|Valsartan|valsartan|mesh-list
13983953|NCT03005184|Enalapril|enalapril|mesh-list
13983954|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
13983955|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13983956|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13983957|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13983958|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983959|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13983960|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
13983961|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13983962|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13983963|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13983964|NCT03005184|Analgesics|analgesics|mesh-ancestor
13983965|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
13983966|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13983967|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983968|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13983969|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13983970|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
13983971|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
13983972|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
13983973|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13983974|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
13983975|NCT03005002|Durvalumab|durvalumab|mesh-list
13983976|NCT03005002|Ipilimumab|ipilimumab|mesh-list
13983977|NCT03005002|Tremelimumab|tremelimumab|mesh-list
13983978|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
13983979|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13983980|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
13983981|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13983982|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983983|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
13983984|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13983985|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13983986|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983987|NCT03004833|Nivolumab|nivolumab|mesh-list
13983988|NCT03004833|Doxorubicin|doxorubicin|mesh-list
13983989|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13983990|NCT03004833|Dacarbazine|dacarbazine|mesh-list
13983991|NCT03004833|Vinblastine|vinblastine|mesh-list
13983992|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13983993|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13983994|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13983995|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13983996|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13983997|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13983998|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13983999|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984000|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13984001|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
13984002|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13984003|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
13984004|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
13984005|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
14247082|NCT00246324|Interferons|interferons|mesh-list
14247083|NCT00246324|Interferon-beta|interferon-beta|mesh-list
14247084|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
14247085|NCT00246324|Doxycycline|doxycycline|mesh-list
14247086|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247087|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
14247088|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14247089|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14247090|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
14247091|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14247092|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14247093|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
14247094|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247095|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14247096|NCT00246337|Rizatriptan|rizatriptan|mesh-list
14247097|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14247098|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
14247099|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247100|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247101|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247102|NCT00246376|Niacin|niacin|mesh-list
14247103|NCT00246376|Fenofibrate|fenofibrate|mesh-list
13984006|NCT03004768|BMS-986165|bms-986165|mesh-list
13984007|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
13984008|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13984009|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984010|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984011|NCT03005236|Tacrolimus|tacrolimus|mesh-list
13984012|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13984013|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
13984014|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984015|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
13984016|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984017|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984018|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13984019|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
13984020|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984021|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
13984022|NCT03004625|Ribavirin|ribavirin|mesh-list
13984023|NCT03004625|Asunaprevir|asunaprevir|mesh-list
13984024|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
13984025|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984026|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
13984027|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984028|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
13984029|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984030|NCT03004612|Metformin|metformin|mesh-list
13984031|NCT03004612|Linagliptin|linagliptin|mesh-list
13984032|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13984033|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984034|NCT03004612|Incretins|incretins|mesh-ancestor
13984035|NCT03004612|Hormones|hormones|mesh-ancestor
13984036|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13984037|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13984038|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
13984039|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984040|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984041|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
13984042|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
13984043|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13984044|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
13984045|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13984046|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984047|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984048|NCT03004183|Valacyclovir|valacyclovir|mesh-list
13984049|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
13984050|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13984051|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984052|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
13984053|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984054|NCT03004287|Thalidomide|thalidomide|mesh-list
13984055|NCT03004287|Dexamethasone|dexamethasone|mesh-list
13984056|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
13984057|NCT03004287|Melphalan|melphalan|mesh-list
13984058|NCT03004287|Doxorubicin|doxorubicin|mesh-list
13984059|NCT03004287|Etoposide|etoposide|mesh-list
13984060|NCT03004287|Lenalidomide|lenalidomide|mesh-list
13984061|NCT03004287|Bortezomib|bortezomib|mesh-list
13984062|NCT03004287|Daratumumab|daratumumab|mesh-list
13984063|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13984064|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
13984065|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984066|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13984067|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13984068|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
13984069|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984070|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984071|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13984072|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13984073|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
13984074|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
13984075|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984076|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13984077|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
13984078|NCT03004287|Hormones|hormones|mesh-ancestor
13984079|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13984080|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13984081|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13984082|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13984083|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13984084|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984085|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13984086|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13984087|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13984088|NCT03004287|Growth Substances|growth substances|mesh-ancestor
13984089|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
13984090|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
13984091|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13984092|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984093|NCT03004105|Durvalumab|durvalumab|mesh-list
13984094|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13984095|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984096|NCT03004339|Betamethasone|betamethasone|mesh-list
13984097|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
13984098|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
13984099|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
13984100|NCT03004339|Calcipotriene|calcipotriene|mesh-list
13984101|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
13984102|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13984103|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
13984104|NCT03004339|Hormones|hormones|mesh-ancestor
13984105|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13984106|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984107|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13984108|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
13984109|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
13984110|NCT03004066|Daptomycin|daptomycin|mesh-list
13984111|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13984112|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984113|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13984114|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13984115|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13984116|NCT03004222|Bupivacaine|bupivacaine|mesh-list
13984117|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
13984118|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
13984119|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984120|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984121|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
13984122|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984123|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
13984124|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13984125|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984126|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
13984127|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
13984128|NCT03004209|Hematinics|hematinics|mesh-ancestor
13984129|NCT03004261|Ganciclovir|ganciclovir|mesh-list
13984130|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
13984131|NCT03004261|Foscarnet|foscarnet|mesh-list
13984132|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
13984133|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984134|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13984135|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984136|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984137|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13984138|NCT03004014|Propofol|propofol|mesh-list
13984139|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13984140|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984141|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984142|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13984143|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
13984144|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
13984145|NCT03004001|Atorvastatin|atorvastatin|mesh-list
13984146|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13984147|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13984148|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13984149|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
13984150|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984151|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13984152|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13984153|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984154|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
13984155|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984156|NCT03003884|Propofol|propofol|mesh-list
13984157|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13984158|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984159|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984160|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13984161|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
13984162|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
13984163|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
13984164|NCT03003832|Analgesics|analgesics|mesh-list
13984165|NCT03003832|Narcotics|narcotics|mesh-ancestor
13984166|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984167|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984168|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
13984169|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984170|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
13984171|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13984172|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13984173|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984174|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
13984175|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
13984176|NCT03003728|Melphalan|melphalan|mesh-list
13984177|NCT03003728|Elotuzumab|elotuzumab|mesh-list
13984178|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13984179|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
13984180|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984181|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984182|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13984183|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13984184|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
13984185|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984186|NCT03003637|Nivolumab|nivolumab|mesh-list
13984187|NCT03003637|Ipilimumab|ipilimumab|mesh-list
13984188|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13984189|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984190|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13984191|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984192|NCT03003611|Anesthetics|anesthetics|mesh-list
13984193|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984194|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984195|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13984196|NCT03003273|Amoxicillin|amoxicillin|mesh-list
13984197|NCT03003273|Levofloxacin|levofloxacin|mesh-list
13984198|NCT03003273|Ofloxacin|ofloxacin|mesh-list
13984199|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
13984200|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
13984201|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984202|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13984203|NCT03003273|Renal Agents|renal agents|mesh-ancestor
13984204|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13984205|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13984206|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984207|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984208|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984209|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13984210|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13984211|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
13984212|NCT03003416|Dexamethasone|dexamethasone|mesh-list
13984213|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13984214|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
13984215|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
13984216|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984217|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984218|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13984219|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
13984220|NCT03003416|Hormones|hormones|mesh-ancestor
13984221|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13984222|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13984223|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984224|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
13984225|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13984226|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247104|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14247105|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
14247106|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247107|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14247108|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
14247109|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
14247110|NCT00246376|Vitamins|vitamins|mesh-ancestor
14247111|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
13984227|NCT03003143|Vigabatrin|vigabatrin|mesh-list
13984228|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
13984229|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984230|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984231|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
13984232|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13984233|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984234|NCT03003039|Rituximab|rituximab|mesh-list
13984235|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13984236|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984237|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
13984238|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984239|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13984240|NCT03002844|Gemcitabine|gemcitabine|mesh-list
13984241|NCT03002844|Carboplatin|carboplatin|mesh-list
13984242|NCT03002844|Pemetrexed|pemetrexed|mesh-list
13984243|NCT03002844|Gefitinib|gefitinib|mesh-list
13984244|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984245|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13984246|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
13984247|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984248|NCT03002844|Antiviral Agents|antiviral agents|mesh-ancestor
13984249|NCT03002844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984250|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984251|NCT03002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13984252|NCT03002844|Immunologic Factors|immunologic factors|mesh-ancestor
13984253|NCT03002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984254|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13984255|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13984256|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13984257|NCT03002831|Tegafur|tegafur|mesh-list
13984258|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13984259|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
13984260|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984261|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984262|NCT03002961|Buprenorphine|buprenorphine|mesh-list
13984263|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
13984264|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13984265|NCT03002961|Narcotics|narcotics|mesh-ancestor
13984266|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984267|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984268|NCT03002961|Analgesics|analgesics|mesh-ancestor
13984269|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
13984270|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984271|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13984272|NCT03002805|Doxorubicin|doxorubicin|mesh-list
13984273|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13984274|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984275|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13984276|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13984277|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984278|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984279|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
13984280|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
13984281|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984282|NCT03002935|Vitamins|vitamins|mesh-ancestor
13984283|NCT03002792|Anesthetics|anesthetics|mesh-list
13984284|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984285|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984286|NCT03002675|Exenatide|exenatide|mesh-list
13984287|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13984288|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984289|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13984290|NCT03002675|Incretins|incretins|mesh-ancestor
13984291|NCT03002675|Hormones|hormones|mesh-ancestor
13984292|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13984293|NCT03002493|Rifampin|rifampin|mesh-list
13984294|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13984295|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
13984296|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13984297|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984298|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
13984299|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13984300|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984301|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984302|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
13984303|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
13984304|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
13984305|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
13984306|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
13984307|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
13984308|NCT03002428|Teriparatide|teriparatide|mesh-list
13984309|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13984310|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984311|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13984312|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
13984313|NCT03002545|Cathartics|cathartics|mesh-ancestor
13984314|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13984315|NCT03002649|Tofacitinib|tofacitinib|mesh-list
13984316|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984317|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13984318|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984319|NCT03002636|Anesthetics|anesthetics|mesh-list
13984320|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984321|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984322|NCT03002389|Fluticasone|fluticasone|mesh-list
13984323|NCT03002389|Xhance|xhance|mesh-list
13984324|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13984325|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13984326|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
13984327|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984328|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984329|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13984330|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
13984331|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
13984332|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
13984333|NCT03002259|Dexamethasone|dexamethasone|mesh-list
13984334|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13984335|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
13984336|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
13984337|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984338|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984339|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13984340|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
13984341|NCT03002259|Hormones|hormones|mesh-ancestor
13984342|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13984343|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13984344|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984345|NCT03002376|Cemiplimab|cemiplimab|mesh-list
13984346|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13984347|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984348|NCT03002064|Docetaxel|docetaxel|mesh-list
13984349|NCT03002064|Fluorouracil|fluorouracil|mesh-list
13984350|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984351|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
13984352|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
13984353|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
13984354|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984355|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
13984356|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13984357|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13984358|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
13984359|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984360|NCT03002090|Iron|iron|mesh-list
13984361|NCT03002090|Trace Elements|trace elements|mesh-ancestor
13984362|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
13984363|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984364|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
13984365|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13984366|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984367|NCT03001882|Nivolumab|nivolumab|mesh-list
13984368|NCT03001882|Ipilimumab|ipilimumab|mesh-list
13984369|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13984370|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984371|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13984372|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984373|NCT03001960|Clopidogrel|clopidogrel|mesh-list
13984374|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13984375|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13984376|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13984377|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13984378|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
13984379|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13984380|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984381|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984382|NCT03001687|Vitamin D|vitamin d|mesh-list
13984383|NCT03001687|Vitamins|vitamins|mesh-ancestor
13984384|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
13984385|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984386|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13984387|NCT03001739|Urapidil|urapidil|mesh-list
13984388|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13984389|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
13984390|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13984391|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
13984392|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13984393|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984394|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984395|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13984396|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13984397|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13984398|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
13984399|NCT03001609|Abivertinib|abivertinib|mesh-list
13984400|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13984401|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984402|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247112|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247113|NCT00246441|Paroxetine|paroxetine|mesh-list
14247114|NCT00246441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14247115|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14247116|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14247117|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247118|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247119|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
14247120|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247121|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14247122|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
14247123|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14247124|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14247125|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14247126|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247127|NCT00246519|Atenolol|atenolol|mesh-list
14247128|NCT00246519|Metoprolol|metoprolol|mesh-list
14247129|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14247130|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
14247131|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14247132|NCT00246519|Diuretics|diuretics|mesh-ancestor
14247133|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
14247134|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247135|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14247136|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14247137|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531983|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531984|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14531985|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14531986|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
14531987|NCT02353572|Hormones|hormones|mesh-ancestor
14531988|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14531989|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14531990|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14531991|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15042531|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15042532|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15042533|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042534|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
15042535|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15042536|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
15042537|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15042538|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042539|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
13984403|NCT03001726|Docetaxel|docetaxel|mesh-list
13984404|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
13984405|NCT03001726|Tegafur|tegafur|mesh-list
13984406|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984407|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
13984408|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
13984409|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
13984410|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984411|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13984412|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
13984413|NCT03001661|Dinoprostone|dinoprostone|mesh-list
13984414|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
13984415|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13984416|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984417|NCT03001635|Oxytocin|oxytocin|mesh-list
13984418|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
13984419|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13984420|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984421|NCT03001570|Cetuximab|cetuximab|mesh-list
13984422|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13984423|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984424|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13984425|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13984426|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
13984427|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13984428|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
13984429|NCT03001349|Octreotide|octreotide|mesh-list
13984430|NCT03001349|Edotreotide|edotreotide|mesh-list
13984431|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13984432|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13984433|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984434|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984435|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13984436|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
13984437|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13984438|NCT03001193|Oxytocin|oxytocin|mesh-list
13984439|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
13984440|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13984441|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984442|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
13984443|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
13984444|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
13984445|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
13984446|NCT03001102|Povidone|povidone|mesh-list
13984447|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984448|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
13984449|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
13984450|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
13984451|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
13984452|NCT03000946|Octreotide|octreotide|mesh-list
13984453|NCT03000946|Somatostatin|somatostatin|mesh-list
13984454|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13984455|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13984456|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984457|NCT03000946|Hormones|hormones|mesh-ancestor
13984458|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13984459|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984460|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
13984461|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
13984462|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984463|NCT03000660|Dexamethasone|dexamethasone|mesh-list
13984464|NCT03000660|Venetoclax|venetoclax|mesh-list
13984465|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13984466|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
13984467|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
13984468|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984469|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984470|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13984471|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
13984472|NCT03000660|Hormones|hormones|mesh-ancestor
13984473|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13984474|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13984475|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984476|NCT03000413|Fentanyl|fentanyl|mesh-list
13984477|NCT03000413|Ketamine|ketamine|mesh-list
13984478|NCT03000413|Analgesics|analgesics|mesh-ancestor
13984479|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
13984480|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984481|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984482|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13984483|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13984484|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
13984485|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
13984486|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984487|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13984488|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13984489|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13984490|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984491|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13984492|NCT03000413|Narcotics|narcotics|mesh-ancestor
13984493|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13984494|NCT03000777|Melatonin|melatonin|mesh-list
13984495|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
13984496|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984497|NCT03000777|Protective Agents|protective agents|mesh-ancestor
13984498|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984499|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984500|NCT03000634|Dexamethasone|dexamethasone|mesh-list
13984501|NCT03000634|Lenalidomide|lenalidomide|mesh-list
13984502|NCT03000634|Bortezomib|bortezomib|mesh-list
13984503|NCT03000634|Elotuzumab|elotuzumab|mesh-list
13984504|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13984505|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
13984506|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
13984507|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984508|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984509|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13984510|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
13984511|NCT03000634|Hormones|hormones|mesh-ancestor
13984512|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13984513|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13984514|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984515|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
13984516|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13984517|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13984518|NCT03000634|Growth Substances|growth substances|mesh-ancestor
13984519|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
13984520|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13984521|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
13984522|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13984523|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13984524|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
13984525|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984526|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
13984527|NCT03000556|Protective Agents|protective agents|mesh-ancestor
13984528|NCT03000387|Nicotine|nicotine|mesh-list
13984529|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13984530|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
13984531|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984532|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984533|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13984534|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13984535|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
13984536|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13984537|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984538|NCT03000127|Testosterone|testosterone|mesh-list
13984539|NCT03000127|Androgens|androgens|mesh-ancestor
13984540|NCT03000127|Hormones|hormones|mesh-ancestor
13984541|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13984542|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984543|NCT03000218|Metformin|metformin|mesh-list
13984544|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
13984545|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13984546|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984547|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
13984548|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13984549|NCT03000205|Lidocaine|lidocaine|mesh-list
13984550|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
13984551|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
13984552|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984553|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984554|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
13984555|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042540|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13984556|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13984557|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13984558|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13984559|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13984560|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984561|NCT03000036|Doxorubicin|doxorubicin|mesh-list
13984562|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
13984563|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13984564|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984565|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13984566|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13984567|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984568|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984569|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
13984570|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
13984571|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
13984572|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
13984573|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
13984574|NCT02999958|Antioxidants|antioxidants|mesh-list
13984575|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13984576|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984577|NCT02999958|Protective Agents|protective agents|mesh-ancestor
13984578|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984579|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
13984580|NCT02999958|Vitamins|vitamins|mesh-ancestor
13984581|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
13984582|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
13984583|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
13984584|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984585|NCT02999958|Expectorants|expectorants|mesh-ancestor
13984586|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
13984587|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13984588|NCT02999958|Antidotes|antidotes|mesh-ancestor
13984589|NCT02999776|Etanercept|etanercept|mesh-list
13984590|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13984591|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13984592|NCT02999776|Analgesics|analgesics|mesh-ancestor
13984593|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
13984594|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984595|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984596|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13984597|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13984598|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13984599|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13984600|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
13984601|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
13984602|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13984603|NCT02999815|Antibodies|antibodies|mesh-list
13984604|NCT02999815|Antitoxins|antitoxins|mesh-list
13984605|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
13984606|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247138|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14247139|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
14247140|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
14247141|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14247142|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14247143|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14247144|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14247145|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
14247146|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247147|NCT00246571|Sunitinib|sunitinib|mesh-list
14247148|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247149|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14247150|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14247151|NCT00246571|Growth Substances|growth substances|mesh-ancestor
14247152|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247153|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
14247154|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14247155|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247156|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247157|NCT00246740|Doxycycline|doxycycline|mesh-list
14247158|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14247159|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14247160|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
14247161|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14247162|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14247163|NCT00246753|Lapatinib|lapatinib|mesh-list
13984607|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
13984608|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13984609|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
13984610|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984611|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13984612|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13984613|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
13984614|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984615|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984616|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13984617|NCT02999841|Vildagliptin|vildagliptin|mesh-list
13984618|NCT02999841|Acarbose|acarbose|mesh-list
13984619|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13984620|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984621|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
13984622|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
13984623|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984624|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984625|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
13984626|NCT02999906|Treprostinil|treprostinil|mesh-list
13984627|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13984628|NCT02999724|Gabapentin|gabapentin|mesh-list
13984629|NCT02999724|Analgesics|analgesics|mesh-ancestor
13984630|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
13984631|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984632|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984633|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
13984634|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13984635|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13984636|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984637|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13984638|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13984639|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13984640|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13984641|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984642|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
13984643|NCT02999919|Bupivacaine|bupivacaine|mesh-list
13984644|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
13984645|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
13984646|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984647|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984648|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
13984649|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984650|NCT02999594|Tramadol|tramadol|mesh-list
13984651|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13984652|NCT02999594|Narcotics|narcotics|mesh-ancestor
13984653|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984654|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984655|NCT02999594|Analgesics|analgesics|mesh-ancestor
13984656|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
13984657|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984658|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13984659|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13984660|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984661|NCT02999295|Nivolumab|nivolumab|mesh-list
13984662|NCT02999295|Ramucirumab|ramucirumab|mesh-list
13984663|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13984664|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984665|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13984666|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984667|NCT02999230|Listerine|listerine|mesh-list
13984668|NCT02999230|Fluorides|fluorides|mesh-list
13984669|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
13984670|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
13984671|NCT02999230|Protective Agents|protective agents|mesh-ancestor
13984672|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984673|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13984674|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984675|NCT02999204|Vitamin D|vitamin d|mesh-list
13984676|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
13984677|NCT02999204|Vitamins|vitamins|mesh-ancestor
13984678|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
13984679|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984680|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13984681|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13984682|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
13984683|NCT02999217|Hematinics|hematinics|mesh-ancestor
13984684|NCT02999126|Remifentanil|remifentanil|mesh-list
13984685|NCT02999126|Propofol|propofol|mesh-list
13984686|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13984687|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984688|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984689|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13984690|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
13984691|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
13984692|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13984693|NCT02999126|Narcotics|narcotics|mesh-ancestor
13984694|NCT02999126|Analgesics|analgesics|mesh-ancestor
13984695|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
13984696|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984697|NCT02998970|Empagliflozin|empagliflozin|mesh-list
13984698|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13984699|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984700|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13984701|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984702|NCT02998918|Curcumin|curcumin|mesh-list
13984703|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13984704|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13984705|NCT02998918|Analgesics|analgesics|mesh-ancestor
13984706|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
13984707|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984708|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984709|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13984710|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13984711|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984712|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984713|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984714|NCT02998827|Thalidomide|thalidomide|mesh-list
13984715|NCT02998827|Azathioprine|azathioprine|mesh-list
13984716|NCT02998827|Infliximab|infliximab|mesh-list
13984717|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
13984718|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13984719|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13984720|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13984721|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
13984722|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984723|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
13984724|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13984725|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984726|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13984727|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13984728|NCT02998827|Growth Substances|growth substances|mesh-ancestor
13984729|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
13984730|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984731|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
13984732|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984733|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13984734|NCT02998905|Aspirin|aspirin|mesh-list
13984735|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13984736|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13984737|NCT02998905|Analgesics|analgesics|mesh-ancestor
13984738|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
13984739|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984740|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984741|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13984742|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13984743|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13984744|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13984745|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984746|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13984747|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13984748|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984749|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
13984750|NCT02998736|Tadalafil|tadalafil|mesh-list
13984751|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
13984752|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13984753|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13984754|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984755|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984756|NCT02998736|Urological Agents|urological agents|mesh-ancestor
13984757|NCT02998606|Naloxegol|naloxegol|mesh-list
13984758|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
13984759|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984760|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
13984761|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984762|NCT02998437|Amoxicillin|amoxicillin|mesh-list
13984763|NCT02998437|Clarithromycin|clarithromycin|mesh-list
13984764|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13984765|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984766|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13984767|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984768|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984769|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13984770|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13984771|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
13984772|NCT02998567|Guadecitabine|guadecitabine|mesh-list
13984773|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13984774|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984775|NCT02998424|Propofol|propofol|mesh-list
13984776|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13984777|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984778|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984779|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13984780|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
13984781|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
13984782|NCT02998242|Apatinib|apatinib|mesh-list
13984783|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984784|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13984785|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984786|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984787|NCT02998398|Infliximab|infliximab|mesh-list
13984788|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
13984789|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13984790|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13984791|NCT02998268|Paclitaxel|paclitaxel|mesh-list
13984792|NCT02998268|Carboplatin|carboplatin|mesh-list
13984793|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
13984794|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13984795|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984796|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
13984797|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
13984798|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
13984799|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984800|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14247164|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247165|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14247166|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247167|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247168|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
14247169|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
14247170|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14247171|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14247172|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247173|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14247174|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247175|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14247176|NCT00247416|Gemcitabine|gemcitabine|mesh-list
14247177|NCT00247416|Dexamethasone|dexamethasone|mesh-list
14247178|NCT00247416|Carboplatin|carboplatin|mesh-list
14247179|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14247180|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
14247181|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
14247182|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14247183|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247184|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247185|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
14247186|NCT00247416|Hormones|hormones|mesh-ancestor
14247187|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14247188|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14247189|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247190|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14247191|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
14247192|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247193|NCT00247416|Antiviral Agents|antiviral agents|mesh-ancestor
14247194|NCT00247416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984801|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
13984802|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13984803|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13984804|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
13984805|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984806|NCT02997969|Vaccines|vaccines|mesh-list
13984807|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
13984808|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
13984809|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984810|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13984811|NCT02997995|Durvalumab|durvalumab|mesh-list
13984812|NCT02997995|Tremelimumab|tremelimumab|mesh-list
13984813|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13984814|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984815|NCT02997800|Labetalol|labetalol|mesh-list
13984816|NCT02997800|Fentanyl|fentanyl|mesh-list
13984817|NCT02997800|Esmolol|esmolol|mesh-list
13984818|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13984819|NCT02997800|Narcotics|narcotics|mesh-ancestor
13984820|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984821|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984822|NCT02997800|Analgesics|analgesics|mesh-ancestor
13984823|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
13984824|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984825|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13984826|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13984827|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
13984828|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
13984829|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
13984830|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
13984831|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13984832|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
13984833|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13984834|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984835|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13984836|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
13984837|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
13984838|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
13984839|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13984840|NCT02997982|Valacyclovir|valacyclovir|mesh-list
13984841|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
13984842|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984843|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
13984844|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
13984845|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13984846|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
13984847|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984848|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
13984849|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
13984850|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
13984851|NCT02997332|Docetaxel|docetaxel|mesh-list
13984852|NCT02997332|Fluorouracil|fluorouracil|mesh-list
13984853|NCT02997332|Durvalumab|durvalumab|mesh-list
13984854|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984855|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
13984856|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
14247195|NCT00247416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247196|NCT00247416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247197|NCT00247416|Immunologic Factors|immunologic factors|mesh-ancestor
14247198|NCT00247624|Eszopiclone|eszopiclone|mesh-list
14247199|NCT00247624|Fluoxetine|fluoxetine|mesh-list
14247200|NCT00247624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14247201|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14247202|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14247203|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247204|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247205|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
14247206|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247207|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14247208|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
14247209|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14247210|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14247211|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14247212|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247213|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14247214|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14247215|NCT00247676|Sunitinib|sunitinib|mesh-list
14247216|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247217|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14247218|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14247219|NCT00247676|Growth Substances|growth substances|mesh-ancestor
14247220|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247221|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
14247222|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14247223|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247224|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247225|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
14247226|NCT00247962|Etanercept|etanercept|mesh-list
14247227|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14247228|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14247229|NCT00247962|Analgesics|analgesics|mesh-ancestor
14247230|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
14247231|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14247232|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247233|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14247234|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14247235|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247236|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247237|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
14247238|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14247239|NCT00248170|Letrozole|letrozole|mesh-list
14247240|NCT00248170|Anastrozole|anastrozole|mesh-list
14247241|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247242|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14247243|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14247244|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247245|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247246|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14247247|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
14247248|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14247249|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247250|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14247251|NCT00248495|Pemetrexed|pemetrexed|mesh-list
14247252|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247253|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984857|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
13984858|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984859|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
13984860|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13984861|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13984862|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
13984863|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984864|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13984865|NCT02997215|Lidocaine|lidocaine|mesh-list
13984866|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
13984867|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
13984868|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984869|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984870|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
13984871|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984872|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13984873|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13984874|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13984875|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13984876|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984877|NCT02996916|Amlodipine|amlodipine|mesh-list
13984878|NCT02996916|Olmesartan|olmesartan|mesh-list
13984879|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13984880|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13984881|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13984882|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984883|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13984884|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984885|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
13984886|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13984887|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13984888|NCT02996942|Factor VIII|factor viii|mesh-list
13984889|NCT02996942|Coagulants|coagulants|mesh-ancestor
13984890|NCT02997059|Fluconazole|fluconazole|mesh-list
13984891|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
13984892|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984893|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
13984894|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13984895|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984896|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984897|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13984898|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
13984899|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13984900|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984901|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
13984902|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
13984903|NCT02996734|Denosumab|denosumab|mesh-list
13984904|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13984905|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984906|NCT02996656|Cefazolin|cefazolin|mesh-list
13984907|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
13984908|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13984909|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984910|NCT02996721|Vitamin D|vitamin d|mesh-list
13984911|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
13984912|NCT02996721|Vitamins|vitamins|mesh-ancestor
13984913|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
13984914|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984915|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13984916|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13984917|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
13984918|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
13984919|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13984920|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
13984921|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984922|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13984923|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13984924|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
13984925|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984926|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984927|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13984928|NCT02996695|Artesunate|artesunate|mesh-list
13984929|NCT02996695|Chloroquine|chloroquine|mesh-list
13984930|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
13984931|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13984932|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13984933|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984934|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984935|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
13984936|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
13984937|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
13984938|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
13984939|NCT02996695|Amebicides|amebicides|mesh-ancestor
13984940|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13984941|NCT02996513|Vitamin A|vitamin a|mesh-list
13984942|NCT02996513|Vitamins|vitamins|mesh-ancestor
13984943|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
13984944|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247254|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247255|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14247256|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14247257|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
14247258|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14247259|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14247260|NCT00248534|Prednisolone|prednisolone|mesh-list
14247261|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
14247262|NCT00248534|Rituximab|rituximab|mesh-list
14247263|NCT00248534|Temozolomide|temozolomide|mesh-list
14247264|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14247265|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
14247266|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14247267|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247268|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
14247269|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247270|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14247271|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14247272|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
14247273|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247274|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14247275|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
14247276|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
14247277|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14247278|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247279|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
14247280|NCT00248534|Hormones|hormones|mesh-ancestor
14247281|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14247282|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14247283|NCT00248534|Protective Agents|protective agents|mesh-ancestor
14247284|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14247285|NCT00248547|Dexamethasone|dexamethasone|mesh-list
14247286|NCT00248547|Ondansetron|ondansetron|mesh-list
14247287|NCT00248547|Aprepitant|aprepitant|mesh-list
14247288|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14247289|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
14247290|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
14247291|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14247292|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247293|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247294|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
14247295|NCT00248547|Hormones|hormones|mesh-ancestor
14247296|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14247297|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14247298|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247299|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
14247300|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
14247301|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14247302|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
14247303|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247304|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247305|NCT00248547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14247306|NCT00248547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14247307|NCT00248547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14247308|NCT00248547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14247309|NCT00248547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14247310|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14247311|NCT00248560|Gemcitabine|gemcitabine|mesh-list
14247312|NCT00248560|Docetaxel|docetaxel|mesh-list
14247313|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14247314|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
14247315|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247316|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247317|NCT00248560|Antiviral Agents|antiviral agents|mesh-ancestor
14247318|NCT00248560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14247319|NCT00248560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247320|NCT00248560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247321|NCT00248560|Immunologic Factors|immunologic factors|mesh-ancestor
14247322|NCT00248560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247323|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
14247324|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
14247325|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
14247326|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
13984945|NCT02996487|Vancomycin|vancomycin|mesh-list
13984946|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13984947|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984948|NCT02996409|Lidocaine|lidocaine|mesh-list
13984949|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
13984950|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
13984951|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984952|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984953|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
13984954|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984955|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13984956|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13984957|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13984958|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13984959|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984960|NCT02996318|Sirolimus|sirolimus|mesh-list
13984961|NCT02996318|Paclitaxel|paclitaxel|mesh-list
13984962|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13984963|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984964|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
13984965|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
13984966|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
13984967|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984968|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13984969|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984970|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13984971|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
13984972|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13984973|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
13984974|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984975|NCT02996227|Bupivacaine|bupivacaine|mesh-list
13984976|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
13984977|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
13984978|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13984979|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984980|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
13984981|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13984982|NCT02996214|Gemcitabine|gemcitabine|mesh-list
13984983|NCT02996214|Paclitaxel|paclitaxel|mesh-list
13984984|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13984985|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13984986|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
13984987|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
13984988|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
13984989|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13984990|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13984991|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
13984992|NCT02996214|Antiviral Agents|antiviral agents|mesh-ancestor
13984993|NCT02996214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13984994|NCT02996214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13984995|NCT02996214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13984996|NCT02996214|Immunologic Factors|immunologic factors|mesh-ancestor
13984997|NCT02996214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13984998|NCT02995954|Amlodipine|amlodipine|mesh-list
13984999|NCT02995954|Perindopril|perindopril|mesh-list
13985000|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13985001|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13985002|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13985003|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985004|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13985005|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985006|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
13985007|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
13985008|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
13985009|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985010|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
13985011|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13985012|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985013|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985014|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13985015|NCT02996058|Analgesics|analgesics|mesh-ancestor
13985016|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
13985017|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14531992|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
13985018|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13985019|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13985020|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13985021|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
13985022|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985023|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985024|NCT02996019|Etrolizumab|etrolizumab|mesh-list
13985025|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13985026|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
13985027|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985028|NCT02995772|Tamoxifen|tamoxifen|mesh-list
13985029|NCT02995772|Fluorouracil|fluorouracil|mesh-list
13985030|NCT02995772|Letrozole|letrozole|mesh-list
13985031|NCT02995772|Anastrozole|anastrozole|mesh-list
13985032|NCT02995772|Exemestane|exemestane|mesh-list
13985033|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
13985034|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
13985035|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985036|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13985037|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985038|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13985039|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
13985040|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985041|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985042|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13985043|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13985044|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
13985045|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985046|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13985047|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13985048|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13985049|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13985050|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
13985051|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
13985052|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13985053|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
13985054|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985055|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
13985056|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
13985057|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985058|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985059|NCT02995720|Amlodipine|amlodipine|mesh-list
13985060|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13985061|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13985062|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13985063|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13985064|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985065|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13985066|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985067|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
13985068|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13985069|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13985070|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
13985071|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13985072|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13985073|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985074|NCT02995707|Thalidomide|thalidomide|mesh-list
13985075|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13985076|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
13985077|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985078|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
13985079|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13985080|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985081|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13985082|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13985083|NCT02995707|Growth Substances|growth substances|mesh-ancestor
13985084|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
13985085|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985086|NCT02995746|Dexamethasone|dexamethasone|mesh-list
13985087|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13985088|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
13985089|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
13985090|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985091|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985092|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13985093|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
13985094|NCT02995746|Hormones|hormones|mesh-ancestor
13985095|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985096|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13985097|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985098|NCT02995512|Colchicine|colchicine|mesh-list
13985099|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
13985100|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13985101|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
13985102|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
13985103|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
13985104|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985105|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985106|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
13985107|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985108|NCT02995655|Azacitidine|azacitidine|mesh-list
13985109|NCT02995655|Heparin|heparin|mesh-list
13985110|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13985111|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
13985112|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985113|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985114|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985115|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
13985116|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13985117|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13985118|NCT02995291|Phentolamine|phentolamine|mesh-list
13985119|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13985120|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
13985121|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
13985122|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985123|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985124|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985125|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13985126|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
13985127|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
13985128|NCT02995330|Testosterone|testosterone|mesh-list
13985129|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
13985130|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
13985131|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13985132|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13985133|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
13985134|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985135|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13985136|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13985137|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
13985138|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985139|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985140|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13985141|NCT02995330|Androgens|androgens|mesh-ancestor
13985142|NCT02995330|Hormones|hormones|mesh-ancestor
13985143|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985144|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13985145|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
13985146|NCT02995187|Apatinib|apatinib|mesh-list
13985147|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985148|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13985149|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985150|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985151|NCT02995057|Nickel|nickel|mesh-list
13985152|NCT02995057|Trace Elements|trace elements|mesh-ancestor
13985153|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
13985154|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985155|NCT02995304|Midazolam|midazolam|mesh-list
13985156|NCT02995304|Morphine|morphine|mesh-list
13985157|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13985158|NCT02995304|Narcotics|narcotics|mesh-ancestor
13985159|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985160|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985161|NCT02995304|Analgesics|analgesics|mesh-ancestor
13985162|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
13985163|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985164|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13985165|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13985166|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13985167|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13985168|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13985169|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13985170|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
13985171|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
13985172|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
13985173|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
13985174|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985175|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985176|NCT02994927|Prednisone|prednisone|mesh-list
13985177|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
13985178|NCT02994927|Rituximab|rituximab|mesh-list
13985179|NCT02994927|Azathioprine|azathioprine|mesh-list
13985180|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13985181|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
13985182|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985183|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13985184|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13985185|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
13985186|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985187|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985188|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13985189|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13985190|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13985191|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
13985192|NCT02994927|Hormones|hormones|mesh-ancestor
13985193|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985194|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13985195|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
13985196|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13985197|NCT02994953|Avelumab|avelumab|mesh-list
13985198|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
13985199|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13985200|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985201|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
13985202|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985203|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
13985204|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
13985205|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
13985206|NCT02995083|Prednisolone|prednisolone|mesh-list
13985207|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
13985208|NCT02995083|Lidocaine|lidocaine|mesh-list
13985209|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
13985210|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
13985211|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
13985212|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
13985213|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985214|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985215|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
13985216|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985217|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13985218|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13985219|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13985220|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13985221|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985222|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13985223|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
13985224|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
13985225|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13985226|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
13985227|NCT02995083|Hormones|hormones|mesh-ancestor
13985228|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985229|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13985230|NCT02995083|Protective Agents|protective agents|mesh-ancestor
13985231|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13985232|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985233|NCT02994745|Atorvastatin|atorvastatin|mesh-list
13985234|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13985235|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13985236|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
13985237|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985238|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13985239|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13985240|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247327|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13985241|NCT02994888|Cetuximab|cetuximab|mesh-list
13985242|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13985243|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985244|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
13985245|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
13985246|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
13985247|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985248|NCT02994875|Expectorants|expectorants|mesh-ancestor
13985249|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
13985250|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13985251|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
13985252|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985253|NCT02994875|Protective Agents|protective agents|mesh-ancestor
13985254|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985255|NCT02994875|Antidotes|antidotes|mesh-ancestor
13985256|NCT02994719|Amantadine|amantadine|mesh-list
13985257|NCT02994719|Levodopa|levodopa|mesh-list
13985258|NCT02994719|Carbidopa|carbidopa|mesh-list
13985259|NCT02994719|Pramipexole|pramipexole|mesh-list
13985260|NCT02994719|Ropinirole|ropinirole|mesh-list
13985261|NCT02994719|Entacapone|entacapone|mesh-list
13985262|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
13985263|NCT02994719|Tolcapone|tolcapone|mesh-list
13985264|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13985265|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13985266|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
13985267|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985268|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985269|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985270|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
13985271|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985272|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
13985273|NCT02994719|Protective Agents|protective agents|mesh-ancestor
13985274|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
13985275|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
13985276|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985277|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13985278|NCT02994719|Analgesics|analgesics|mesh-ancestor
13985279|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
13985280|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985281|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
13985282|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
13985283|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
13985284|NCT02995005|Tenofovir|tenofovir|mesh-list
13985285|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
13985286|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985287|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13985288|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13985289|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985290|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985291|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13985292|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13985293|NCT02994576|Atezolizumab|atezolizumab|mesh-list
13985294|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985295|NCT02994381|Ozanimod|ozanimod|mesh-list
13985296|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
13985297|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985298|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13985299|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
13985300|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985301|NCT02994602|ST 1435|st 1435|mesh-list
13985302|NCT02994602|Testosterone|testosterone|mesh-list
13985303|NCT02994602|Androgens|androgens|mesh-ancestor
13985304|NCT02994602|Hormones|hormones|mesh-ancestor
13985305|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985306|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985307|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13985308|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
13985309|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13985310|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13985311|NCT02994290|Vaccines|vaccines|mesh-list
13985312|NCT02994290|Immunologic Factors|immunologic factors|mesh-ancestor
13985313|NCT02994290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985314|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
13985315|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13985316|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
13985317|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
15042541|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
13985318|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985319|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985320|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13985321|NCT02994433|Analgesics|analgesics|mesh-ancestor
13985322|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
13985323|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985324|NCT02994485|Simvastatin|simvastatin|mesh-list
13985325|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13985326|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13985327|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
13985328|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985329|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13985330|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13985331|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985332|NCT02994173|Ketamine|ketamine|mesh-list
13985333|NCT02994173|Oxycodone|oxycodone|mesh-list
13985334|NCT02994173|Esketamine|esketamine|mesh-list
13985335|NCT02994173|Analgesics|analgesics|mesh-ancestor
13985336|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
13985337|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985338|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985339|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13985340|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13985341|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
13985342|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
13985343|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985344|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13985345|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13985346|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985347|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985348|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13985349|NCT02994173|Narcotics|narcotics|mesh-ancestor
13985350|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
13985351|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13985352|NCT02994082|Bupropion|bupropion|mesh-list
13985353|NCT02994082|Nicotine|nicotine|mesh-list
13985354|NCT02994082|Varenicline|varenicline|mesh-list
13985355|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13985356|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
13985357|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985358|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985359|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13985360|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13985361|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
13985362|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985363|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985364|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
13985365|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
13985366|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13985367|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
13985368|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13985369|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13985370|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
13985371|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
13985372|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13985373|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985374|NCT02995096|Sirolimus|sirolimus|mesh-list
13985375|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13985376|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985377|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13985378|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985379|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
13985380|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13985381|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
14247328|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14247329|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14247330|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247331|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247332|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247333|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14247334|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
14247335|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13985382|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985383|NCT02993991|Durvalumab|durvalumab|mesh-list
13985384|NCT02993991|Mocetinostat|mocetinostat|mesh-list
13985385|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13985386|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985387|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
13985388|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985389|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985390|NCT02993835|Iron|iron|mesh-list
13985391|NCT02993835|Trace Elements|trace elements|mesh-ancestor
13985392|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
13985393|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985394|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
13985395|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
13985396|NCT02993718|Propofol|propofol|mesh-list
13985397|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13985398|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985399|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985400|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13985401|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
13985402|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
13985403|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13985404|NCT02993718|Analgesics|analgesics|mesh-ancestor
13985405|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
13985406|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985407|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13985408|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13985409|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13985410|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
13985411|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985412|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985413|NCT02993575|Floxacillin|floxacillin|mesh-list
13985414|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13985415|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985416|NCT02993640|Vasopressins|vasopressins|mesh-list
13985417|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
13985418|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
13985419|NCT02993640|Coagulants|coagulants|mesh-ancestor
13985420|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13985421|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
13985422|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
13985423|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985424|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
13985425|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13985426|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
13985427|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985428|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13985429|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985430|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13985431|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985432|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
13985433|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13985434|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
13985435|NCT02993367|Protective Agents|protective agents|mesh-ancestor
13985436|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985437|NCT02993523|Azacitidine|azacitidine|mesh-list
13985438|NCT02993523|Venetoclax|venetoclax|mesh-list
13985439|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13985440|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
13985441|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985442|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985443|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985444|NCT02993588|Melatonin|melatonin|mesh-list
13985445|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
13985446|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985447|NCT02993588|Protective Agents|protective agents|mesh-ancestor
13985448|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985449|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985450|NCT02993705|Trabectedin|trabectedin|mesh-list
13985451|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13985452|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
13985453|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985454|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985455|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
13985456|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
13985457|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14247336|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
13985458|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985459|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
13985460|NCT02993341|Coagulants|coagulants|mesh-ancestor
13985461|NCT02993315|Vaccines|vaccines|mesh-list
13985462|NCT02993315|Immunologic Factors|immunologic factors|mesh-ancestor
13985463|NCT02993315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985464|NCT02993094|Carboplatin|carboplatin|mesh-list
13985465|NCT02993094|Ixazomib|ixazomib|mesh-list
13985466|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985467|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
13985468|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985469|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247337|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14247338|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
14247339|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14247340|NCT00248625|Expectorants|expectorants|mesh-ancestor
14247341|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
14247342|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14247343|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
14247344|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247345|NCT00248625|Protective Agents|protective agents|mesh-ancestor
14247346|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247347|NCT00248625|Antidotes|antidotes|mesh-ancestor
14247348|NCT00248651|Amitriptyline|amitriptyline|mesh-list
14247349|NCT00248651|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
14247350|NCT00248651|Citalopram|citalopram|mesh-list
14247351|NCT00248651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14247352|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14247353|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14247354|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247355|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247356|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
14247357|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247358|NCT00248651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14247359|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
14247360|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14247361|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14247362|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14247363|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14247364|NCT00248651|Analgesics|analgesics|mesh-ancestor
14247365|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
14247366|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14247367|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
14247368|NCT00248651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14247369|NCT00248651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14247370|NCT00248651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14247371|NCT00248807|Enalaprilat|enalaprilat|mesh-list
14247372|NCT00248807|Enalapril|enalapril|mesh-list
14247373|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14247374|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
14247375|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247376|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247377|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14247378|NCT00248833|Vaccines|vaccines|mesh-list
14247379|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
14247380|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247381|NCT00249002|Paclitaxel|paclitaxel|mesh-list
14247382|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14247383|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14247384|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247385|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
14247386|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
14247387|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
14247388|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247389|NCT00249249|Atorvastatin|atorvastatin|mesh-list
14247390|NCT00249249|Pitavastatin|pitavastatin|mesh-list
14247391|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14247392|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14247393|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
14247394|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247395|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14247396|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14247397|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247398|NCT00249288|Folic Acid|folic acid|mesh-list
14247399|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
13985470|NCT02993159|Tamoxifen|tamoxifen|mesh-list
13985471|NCT02993159|Afimoxifene|afimoxifene|mesh-list
13985472|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13985473|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
13985474|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985475|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985476|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13985477|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985478|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
13985479|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
13985480|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
13985481|NCT02993029|Celecoxib|celecoxib|mesh-list
13985482|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13985483|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13985484|NCT02993029|Analgesics|analgesics|mesh-ancestor
13985485|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
13985486|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985487|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985488|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13985489|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13985490|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13985491|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13985492|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985493|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985494|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
13985495|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13985496|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985497|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13985498|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
13985499|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13985500|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985501|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985502|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985503|NCT02992964|Nivolumab|nivolumab|mesh-list
13985504|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13985505|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985506|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13985507|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985508|NCT02992808|Menotropins|menotropins|mesh-list
13985509|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13985510|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
13985511|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13985512|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985513|NCT02992756|Mitogens|mitogens|mesh-list
13985514|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
13985515|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985516|NCT02992938|Acetazolamide|acetazolamide|mesh-list
13985517|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
13985518|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
13985519|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985520|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985521|NCT02992938|Diuretics|diuretics|mesh-ancestor
13985522|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
13985523|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985524|NCT02992886|Raltitrexed|raltitrexed|mesh-list
13985525|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13985526|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
13985527|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985528|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985529|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13985530|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985531|NCT02992925|Vaccines|vaccines|mesh-list
13985532|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
13985533|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985534|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
13985535|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13985536|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985537|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985538|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13985539|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
13985540|NCT02992678|Protective Agents|protective agents|mesh-ancestor
13985541|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985542|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
13985543|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13985544|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
13985545|NCT02992912|Atezolizumab|atezolizumab|mesh-list
13985546|NCT02992912|Antibodies|antibodies|mesh-list
13985547|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
13985548|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985549|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985550|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13985551|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
13985552|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985553|NCT02992496|Midazolam|midazolam|mesh-list
13985554|NCT02992496|Ketamine|ketamine|mesh-list
13985555|NCT02992496|Analgesics|analgesics|mesh-ancestor
13985556|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
13985557|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985558|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985559|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13985560|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13985561|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
13985562|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
13985563|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985564|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13985565|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13985566|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985567|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985568|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13985569|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13985570|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13985571|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13985572|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13985573|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
13985574|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
13985575|NCT02992665|Ionophores|ionophores|mesh-list
13985576|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13985577|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985578|NCT02992548|Pravastatin|pravastatin|mesh-list
13985579|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13985580|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13985581|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
13985582|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985583|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13985584|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13985585|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985586|NCT02992652|Allopurinol|allopurinol|mesh-list
13985587|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
13985588|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985589|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985590|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
13985591|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13985592|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
13985593|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
13985594|NCT02992652|Protective Agents|protective agents|mesh-ancestor
13985595|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985596|NCT02992457|Interferons|interferons|mesh-list
13985597|NCT02992457|Ribavirin|ribavirin|mesh-list
13985598|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
13985599|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
13985600|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
13985601|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
13985602|NCT02992457|Ledipasvir|ledipasvir|mesh-list
13985603|NCT02992457|Simeprevir|simeprevir|mesh-list
13985604|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
13985605|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985606|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
13985607|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985608|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
13985609|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985610|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
13985611|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985612|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
13985613|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985614|NCT02992392|Dextrans|dextrans|mesh-list
13985615|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
13985616|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
13985617|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
13985618|NCT02992340|Gemcitabine|gemcitabine|mesh-list
13985619|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985620|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13985621|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
13985622|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985623|NCT02992340|Antiviral Agents|antiviral agents|mesh-ancestor
13985624|NCT02992340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985625|NCT02992340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985626|NCT02992340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13985627|NCT02992340|Immunologic Factors|immunologic factors|mesh-ancestor
13985628|NCT02992340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985629|NCT02992028|Vitamins|vitamins|mesh-list
13985630|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
13985631|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985632|NCT02991950|Parnaparin|parnaparin|mesh-list
13985633|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
13985634|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13985635|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13985636|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985637|NCT02991781|Varenicline|varenicline|mesh-list
13985638|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13985639|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13985640|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
13985641|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985642|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985643|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985644|NCT02991768|Budesonide|budesonide|mesh-list
13985645|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13985646|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13985647|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
13985648|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985649|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985650|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13985651|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
13985652|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
13985653|NCT02991768|Hormones|hormones|mesh-ancestor
13985654|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985655|NCT02991612|Rifaximin|rifaximin|mesh-list
13985656|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13985657|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985658|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13985659|NCT02991339|Dexamethasone|dexamethasone|mesh-list
13985660|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
13985661|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
13985662|NCT02991339|BB 1101|bb 1101|mesh-list
13985663|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13985664|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
13985665|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
13985666|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985667|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985668|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13985669|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
13985670|NCT02991339|Hormones|hormones|mesh-ancestor
13985671|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985672|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13985673|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985674|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
13985675|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985676|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247400|NCT00249288|Hematinics|hematinics|mesh-ancestor
14247401|NCT00249288|Vitamins|vitamins|mesh-ancestor
14247402|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
14247403|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247404|NCT00249379|Acamprosate|acamprosate|mesh-list
14247405|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14247406|NCT00249444|Mirtazapine|mirtazapine|mesh-list
14247407|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
14247408|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14247409|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14247410|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
14247411|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
14247412|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247413|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247414|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247415|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14247416|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14247417|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14247418|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14247419|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
13985696|NCT02991209|Testosterone|testosterone|mesh-list
13985697|NCT02991209|Androgens|androgens|mesh-ancestor
13985698|NCT02991209|Hormones|hormones|mesh-ancestor
13985699|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985700|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985701|NCT02991196|Nivolumab|nivolumab|mesh-list
13985702|NCT02991196|DS-8273a|ds-8273a|mesh-list
13985703|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13985704|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985705|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13985706|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985707|NCT02991131|Linezolid|linezolid|mesh-list
13985708|NCT02991131|Tedizolid|tedizolid|mesh-list
13985709|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
13985710|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13985711|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985712|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13985713|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985714|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985715|NCT02991157|Nimodipine|nimodipine|mesh-list
13985716|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13985717|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13985718|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13985719|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985720|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13985721|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985722|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
13985723|NCT02990975|Ketamine|ketamine|mesh-list
13985724|NCT02990975|Analgesics|analgesics|mesh-ancestor
13985725|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
13985726|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985727|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985728|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13985729|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13985730|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
13985731|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
13985732|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985733|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13985734|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13985735|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985736|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985737|NCT02991053|Ketamine|ketamine|mesh-list
13985738|NCT02991053|Analgesics|analgesics|mesh-ancestor
13985739|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
13985740|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985741|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985742|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13985743|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13985744|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
13985745|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
13985746|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985747|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13985748|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13985749|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985750|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985751|NCT02990728|Metformin|metformin|mesh-list
13985752|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13985753|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985754|NCT02990962|Triamcinolone|triamcinolone|mesh-list
13985755|NCT02990962|Lidocaine|lidocaine|mesh-list
13985756|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13985757|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
13985758|NCT02990962|Hormones|hormones|mesh-ancestor
13985759|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985760|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985761|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985762|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
13985763|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
13985764|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985765|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
13985766|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985767|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13985768|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13985769|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13985770|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13985771|NCT02990702|Bupivacaine|bupivacaine|mesh-list
13985772|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
13985773|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
13985774|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985775|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985776|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
13985777|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985778|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
13985779|NCT02990845|Leuprolide|leuprolide|mesh-list
13985780|NCT02990845|Exemestane|exemestane|mesh-list
13985781|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13985782|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985783|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
13985784|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
13985785|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13985786|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985787|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13985788|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
13985789|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
13985790|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985791|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985792|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
13985793|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
13985794|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985795|NCT02990884|Ketamine|ketamine|mesh-list
13985796|NCT02990884|Analgesics|analgesics|mesh-ancestor
13985797|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
13985798|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985799|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985800|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13985801|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13985802|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
13985803|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
13985804|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985805|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13985806|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13985807|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985808|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985809|NCT02990858|Leronlimab|leronlimab|mesh-list
13985810|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
13985811|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
13985812|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985813|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13985814|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13985815|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
13985816|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985817|NCT02990403|Aspirin|aspirin|mesh-list
13985818|NCT02990403|Prednisone|prednisone|mesh-list
13985819|NCT02990403|Heparin|heparin|mesh-list
13985820|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
13985821|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
13985822|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
13985823|NCT02990403|Antibodies|antibodies|mesh-list
13985824|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13985825|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
13985826|NCT02990403|Hormones|hormones|mesh-ancestor
13985827|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985828|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985829|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13985830|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985831|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14247420|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14247421|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
14247422|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14247423|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14247424|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
14247425|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14247426|NCT00249769|Vaccines|vaccines|mesh-list
14247427|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
14247428|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247429|NCT00249795|Irbesartan|irbesartan|mesh-list
14247430|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14247431|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14247432|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14247433|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247434|NCT00249808|Antibodies|antibodies|mesh-list
14247435|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14247436|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
14247437|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247438|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14247439|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14247440|NCT00249834|Hormones|hormones|mesh-ancestor
14247441|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14247442|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247443|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14247444|NCT00249873|Clopidogrel|clopidogrel|mesh-list
14247445|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14247446|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14247447|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14247448|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14247449|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
14247450|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247451|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247452|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247453|NCT00250432|Caspofungin|caspofungin|mesh-list
14247454|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
14247455|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14247456|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247457|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247458|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
14247459|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14247460|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
14247461|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14247462|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247463|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14247464|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
14247465|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14247466|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14247467|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14247468|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
14247469|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247470|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247471|NCT00250705|Aripiprazole|aripiprazole|mesh-list
14247472|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
14247473|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14247474|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14247475|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14247476|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14247477|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247478|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
14247479|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
14247480|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985832|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13985833|NCT02990403|Analgesics|analgesics|mesh-ancestor
13985834|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
13985835|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985836|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13985837|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13985838|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13985839|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985840|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13985841|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13985842|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985843|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
13985844|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
13985845|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
13985846|NCT02990403|Progestins|progestins|mesh-ancestor
13985847|NCT02990455|Nicotine|nicotine|mesh-list
13985848|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13985849|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
13985850|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985851|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985852|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13985853|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13985854|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
13985855|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985856|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985857|NCT02990364|Lidocaine|lidocaine|mesh-list
13985858|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
13985859|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
13985860|NCT02990364|Anesthetics|anesthetics|mesh-list
13985861|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13985862|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985863|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
13985864|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985865|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13985866|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13985867|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13985868|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13985869|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985870|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
13985871|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
13985872|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13985873|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985874|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
13985875|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
13985876|NCT02990507|Testosterone|testosterone|mesh-list
13985877|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
13985878|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
13985879|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13985880|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985881|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
13985882|NCT02990507|Hormones|hormones|mesh-ancestor
13985883|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985884|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985885|NCT02990507|Androgens|androgens|mesh-ancestor
13985886|NCT02990468|Cisplatin|cisplatin|mesh-list
13985887|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985888|NCT02990546|Midodrine|midodrine|mesh-list
13985889|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
13985890|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
13985891|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13985892|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985893|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13985894|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
13985895|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13985896|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13985897|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
13985898|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13985899|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985900|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
13985901|NCT02990286|Rituximab|rituximab|mesh-list
13985902|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13985903|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985904|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
13985905|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985906|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13985907|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13985908|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
13985909|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
13985910|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13985911|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985912|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985913|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985914|NCT02990312|Sirolimus|sirolimus|mesh-list
13985915|NCT02990312|Maraviroc|maraviroc|mesh-list
13985916|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13985917|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985918|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13985919|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985920|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
13985921|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13985922|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
13985923|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985924|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
13985925|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
13985926|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985927|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13985928|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13985929|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
13985930|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
13985931|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
13985932|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985933|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
13985934|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
13985935|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13985936|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985937|NCT02990078|Urological Agents|urological agents|mesh-ancestor
13985938|NCT02989870|Sorafenib|sorafenib|mesh-list
13985939|NCT02989870|Bavituximab|bavituximab|mesh-list
13985940|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985941|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13985942|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985943|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985944|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13985945|NCT02989662|Mifepristone|mifepristone|mesh-list
13985946|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13985947|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
13985948|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13985949|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985950|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13985951|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13985952|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13985953|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
13985954|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13985955|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13985956|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
13985957|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985958|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
13985959|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13985960|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13985961|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
13985962|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
13985963|NCT02990013|Povidone|povidone|mesh-list
13985964|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13985965|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985966|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
13985967|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
13985968|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
13985969|NCT02989701|Plerixafor|plerixafor|mesh-list
13985970|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13985971|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13985972|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
13985973|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14247481|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247482|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14247483|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14247484|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
14247485|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14247486|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14247487|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14247488|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14247489|NCT00250835|Celecoxib|celecoxib|mesh-list
14247490|NCT00250835|Capecitabine|capecitabine|mesh-list
14247491|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
13985974|NCT02989584|Gemcitabine|gemcitabine|mesh-list
13985975|NCT02989584|Atezolizumab|atezolizumab|mesh-list
13985976|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13985977|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13985978|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
13985979|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13985980|NCT02989584|Antiviral Agents|antiviral agents|mesh-ancestor
13985981|NCT02989584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13985982|NCT02989584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13985983|NCT02989584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13985984|NCT02989584|Immunologic Factors|immunologic factors|mesh-ancestor
13985985|NCT02989584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985986|NCT02989519|Progesterone|progesterone|mesh-list
13985987|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
13985988|NCT02989519|Progestins|progestins|mesh-ancestor
13985989|NCT02989519|Hormones|hormones|mesh-ancestor
13985990|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13985991|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985992|NCT02989623|Copper|copper|mesh-list
13985993|NCT02989623|Trace Elements|trace elements|mesh-ancestor
13985994|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
13985995|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13985996|NCT02989558|Aspirin|aspirin|mesh-list
13985997|NCT02989558|Clopidogrel|clopidogrel|mesh-list
13985998|NCT02989558|Ticagrelor|ticagrelor|mesh-list
13985999|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13986000|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13986001|NCT02989558|Analgesics|analgesics|mesh-ancestor
13986002|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
13986003|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986004|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986005|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986006|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13986007|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13986008|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13986009|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986010|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13986011|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13986012|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986013|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
13986014|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
13986015|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
13986016|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13986017|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
13986018|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986019|NCT02989467|Aprepitant|aprepitant|mesh-list
13986020|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
13986021|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
13986022|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986023|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986024|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986025|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
13986026|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986027|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986028|NCT02989324|Misoprostol|misoprostol|mesh-list
13986029|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13986030|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
13986031|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13986032|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986033|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13986034|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986035|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
13986036|NCT02989259|Apatinib|apatinib|mesh-list
13986037|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986038|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13986039|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986040|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986041|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
13986042|NCT02989272|Analgesics|analgesics|mesh-ancestor
13986043|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
13986044|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986045|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986046|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
13986047|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13986048|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13986049|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
13986050|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13986051|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13986052|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986053|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13986054|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
13986055|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13986056|NCT02989038|Nicotine|nicotine|mesh-list
13986057|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
13986058|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
13986059|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986060|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986061|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
13986062|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13986063|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
13986064|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986065|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986066|NCT02989207|Mitomycins|mitomycins|mesh-list
13986067|NCT02989207|Mitomycin|mitomycin|mesh-list
13986068|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13986069|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986070|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
13986071|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986072|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13986073|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986074|NCT02989311|Iron|iron|mesh-list
13986075|NCT02989311|Trace Elements|trace elements|mesh-ancestor
13986076|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
13986077|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986078|NCT02989129|Quercetin|quercetin|mesh-list
13986079|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
13986080|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986081|NCT02989129|Protective Agents|protective agents|mesh-ancestor
13986082|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986083|NCT02988999|Erythritol|erythritol|mesh-list
13986084|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
13986085|NCT02989012|Oseltamivir|oseltamivir|mesh-list
13986086|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
13986087|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13986088|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986089|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986090|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
13986091|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
13986092|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13986093|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
13986094|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986095|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986096|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13986097|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
13986098|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
13986099|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13986100|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13986101|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
13986102|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986103|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986104|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
13986105|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13986106|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
13986107|NCT02988921|Paclitaxel|paclitaxel|mesh-list
13986108|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13986109|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986110|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
13986111|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
13986112|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
13986113|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986114|NCT02988908|Donepezil|donepezil|mesh-list
13986115|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
13986116|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986117|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986118|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
13986119|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986120|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986121|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
13986122|NCT02988700|Bupivacaine|bupivacaine|mesh-list
13986123|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
13986124|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
13986125|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13986126|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986127|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
13986128|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986129|NCT02988362|Amlodipine|amlodipine|mesh-list
13986130|NCT02988362|Candesartan|candesartan|mesh-list
13986131|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
13986132|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13986133|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13986134|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986135|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13986136|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986137|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
13986138|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
13986139|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
13986140|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
13986141|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
13986142|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
13986143|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13986144|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986145|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986146|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986147|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
13986148|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13986149|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
13986150|NCT02987998|Etoposide|etoposide|mesh-list
13986151|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986152|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13986153|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13986154|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13986155|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13986156|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986157|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986158|NCT02988440|Sorafenib|sorafenib|mesh-list
13986159|NCT02988440|Spartalizumab|spartalizumab|mesh-list
13986160|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986161|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
13986162|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986163|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986164|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13986165|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
13986166|NCT02988089|Amoxicillin|amoxicillin|mesh-list
13986167|NCT02988089|Metronidazole|metronidazole|mesh-list
13986168|NCT02988089|Clarithromycin|clarithromycin|mesh-list
13986169|NCT02988089|Levofloxacin|levofloxacin|mesh-list
13986170|NCT02988089|Ofloxacin|ofloxacin|mesh-list
13986171|NCT02988089|Tetracycline|tetracycline|mesh-list
13986172|NCT02988089|Tinidazole|tinidazole|mesh-list
13986173|NCT02988089|Furazolidone|furazolidone|mesh-list
13986174|NCT02988089|Bismuth|bismuth|mesh-list
13986175|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
13986176|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13986177|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13986178|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13986179|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13986180|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986181|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986182|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13986183|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13986184|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
13986185|NCT02988089|Renal Agents|renal agents|mesh-ancestor
13986186|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13986187|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13986188|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986189|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
13986190|NCT02988089|Antacids|antacids|mesh-ancestor
13986191|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986192|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
13986193|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
13986194|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
13986195|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
13986196|NCT02988063|Polidocanol|polidocanol|mesh-list
13986197|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
13986198|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13986199|NCT02987985|Acetaminophen|acetaminophen|mesh-list
13986200|NCT02987985|Dexamethasone|dexamethasone|mesh-list
13986201|NCT02987985|Lidocaine|lidocaine|mesh-list
13986202|NCT02987985|Fentanyl|fentanyl|mesh-list
13986203|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
13986204|NCT02987985|Ketamine|ketamine|mesh-list
13986205|NCT02987985|Gabapentin|gabapentin|mesh-list
13986206|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
13986207|NCT02987985|Ondansetron|ondansetron|mesh-list
13986208|NCT02987985|Sevoflurane|sevoflurane|mesh-list
13986209|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986210|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
13986211|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
13986212|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986213|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986214|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986215|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
13986216|NCT02987985|Hormones|hormones|mesh-ancestor
13986217|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13986218|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13986219|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986220|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
13986221|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
13986222|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13986223|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
13986224|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13986225|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
13986226|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
13986227|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13986228|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986229|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13986230|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13986231|NCT02987985|Analgesics|analgesics|mesh-ancestor
13986232|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13986233|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13986234|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13986235|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
13986236|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986237|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
13986238|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13986239|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
13986240|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13986241|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13986242|NCT02987985|Narcotics|narcotics|mesh-ancestor
13986243|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13986244|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
13986245|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13986246|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13986247|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
13986248|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13986249|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13986250|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13986251|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
13986252|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
13986253|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
13986254|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
13986255|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
13986256|NCT02987985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14247492|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14247493|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
14247494|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247495|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247496|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14247497|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14247498|NCT00250835|Analgesics|analgesics|mesh-ancestor
14247499|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
13986257|NCT02987920|Acetaminophen|acetaminophen|mesh-list
13986258|NCT02987920|Celecoxib|celecoxib|mesh-list
13986259|NCT02987920|Ketorolac|ketorolac|mesh-list
13986260|NCT02987920|Oxycodone|oxycodone|mesh-list
13986261|NCT02987920|Gabapentin|gabapentin|mesh-list
13986262|NCT02987920|Hydromorphone|hydromorphone|mesh-list
13986263|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
13986264|NCT02987920|Pantoprazole|pantoprazole|mesh-list
13986265|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14247500|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14247501|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247502|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14247503|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14247504|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14247505|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14247506|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247507|NCT00250926|Dexamethasone|dexamethasone|mesh-list
14247508|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
14531993|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14531994|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14531995|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14531996|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
14531997|NCT02343263|Bupivacaine|bupivacaine|mesh-list
14531998|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14531999|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
14532000|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
14532001|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532002|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532003|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
14532004|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532005|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
14532006|NCT02343263|Coagulants|coagulants|mesh-ancestor
14532007|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
14532008|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
14532009|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532010|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
14532011|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532012|NCT02341495|Vitamin D|vitamin d|mesh-list
14532013|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
14532014|NCT02341495|Azacitidine|azacitidine|mesh-list
14532015|NCT02341495|Deferasirox|deferasirox|mesh-list
14532016|NCT02341495|Vitamins|vitamins|mesh-ancestor
14532017|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
14532018|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532019|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14532020|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14532021|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
14532022|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532023|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532024|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532025|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14532026|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14532027|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
14532028|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
14532029|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
14532030|NCT02318901|Trastuzumab|trastuzumab|mesh-list
14532031|NCT02318901|Cetuximab|cetuximab|mesh-list
14532032|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
14532033|NCT02318901|Maytansine|maytansine|mesh-list
14532034|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14532035|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532036|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14532037|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
14532038|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
14532039|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
14532040|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532041|NCT02317276|Triamcinolone|triamcinolone|mesh-list
14532042|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14532043|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14532044|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14532045|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14532046|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
14532047|NCT02317276|Hormones|hormones|mesh-ancestor
14532048|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14532049|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532050|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13986266|NCT02987920|Analgesics|analgesics|mesh-ancestor
14247509|NCT00250926|Rituximab|rituximab|mesh-list
14532051|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
13986267|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
13986268|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986269|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986270|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
13986271|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13986272|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986273|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13986274|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
13986275|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13986276|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986277|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986278|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13986279|NCT02987920|Narcotics|narcotics|mesh-ancestor
13986280|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13986281|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
13986282|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13986283|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13986284|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13986285|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
13986286|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
13986287|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986288|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
13986289|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13986290|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986291|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13986292|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
13986293|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
13986294|NCT02987907|Dexamethasone|dexamethasone|mesh-list
13986295|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986296|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
13986297|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
13986298|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986299|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986300|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986301|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
13986302|NCT02987907|Hormones|hormones|mesh-ancestor
13986303|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13986304|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13986305|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986306|NCT02987751|Insulin|insulin|mesh-list
13986307|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
13986308|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13986309|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986310|NCT02987699|Leucovorin|leucovorin|mesh-list
13986311|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
13986312|NCT02987699|Fluorouracil|fluorouracil|mesh-list
13986313|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
13986314|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986315|NCT02987699|Antidotes|antidotes|mesh-ancestor
13986316|NCT02987699|Protective Agents|protective agents|mesh-ancestor
13986317|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986318|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
13986319|NCT02987699|Vitamins|vitamins|mesh-ancestor
13986320|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
13986321|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
13986322|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986323|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13986324|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13986325|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
13986326|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
13986327|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13986328|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986329|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13986330|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986331|NCT02987556|Insulin|insulin|mesh-list
13986332|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13986333|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986334|NCT02987465|Norepinephrine|norepinephrine|mesh-list
13986335|NCT02987465|Acetylcholine|acetylcholine|mesh-list
13986336|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
13986337|NCT02987465|Hematinics|hematinics|mesh-ancestor
13986338|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
13986339|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
13986340|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
13986341|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986342|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247510|NCT00250926|Bortezomib|bortezomib|mesh-list
13986343|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986344|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13986345|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13986346|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
13986347|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
13986348|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
13986349|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986350|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13986351|NCT02987400|Venetoclax|venetoclax|mesh-list
13986352|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
13986353|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986354|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13986355|NCT02987218|Propofol|propofol|mesh-list
13986356|NCT02987218|Desflurane|desflurane|mesh-list
13986357|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13986358|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13986359|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986360|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13986361|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
13986362|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
13986363|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13986364|NCT02987270|Piperaquine|piperaquine|mesh-list
13986365|NCT02987270|Artenimol|artenimol|mesh-list
13986366|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
13986367|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
13986368|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
13986369|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13986370|NCT02987244|Prednisone|prednisone|mesh-list
13986371|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
13986372|NCT02987244|Etoposide|etoposide|mesh-list
13986373|NCT02987244|Epirubicin|epirubicin|mesh-list
13986374|NCT02987244|Vindesine|vindesine|mesh-list
13986375|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13986376|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
13986377|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986378|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13986379|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13986380|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
13986381|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986382|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986383|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13986384|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986385|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
13986386|NCT02987244|Hormones|hormones|mesh-ancestor
13986387|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13986388|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13986389|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13986390|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13986391|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13986392|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986393|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13986394|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
13986395|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
13986396|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
13986397|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
13986398|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13986399|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986400|NCT02987348|Insulin|insulin|mesh-list
13986401|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
13986402|NCT02987348|Exenatide|exenatide|mesh-list
13986403|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
13986404|NCT02987348|Glucagon|glucagon|mesh-list
13986405|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
13986406|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13986407|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986408|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
13986409|NCT02987348|Incretins|incretins|mesh-ancestor
13986410|NCT02987348|Hormones|hormones|mesh-ancestor
13986411|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13986412|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986413|NCT02986685|Rabeprazole|rabeprazole|mesh-list
13986414|NCT02986685|Trimebutine|trimebutine|mesh-list
13986415|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986416|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986417|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13986418|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986419|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13986420|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
13986421|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
13986422|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986423|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986424|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
13986425|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
13986426|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
13986427|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
13986428|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
13986429|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
13986430|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13986431|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986432|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
13986433|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986434|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986435|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13986436|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986437|NCT02986906|Triamcinolone|triamcinolone|mesh-list
13986438|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986439|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
13986440|NCT02986906|Hormones|hormones|mesh-ancestor
13986441|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13986442|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986443|NCT02986347|Epinephrine|epinephrine|mesh-list
13986444|NCT02986347|Racepinephrine|racepinephrine|mesh-list
13986445|NCT02986347|Anesthetics|anesthetics|mesh-list
13986446|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
13986447|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13986448|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986449|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13986450|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13986451|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
13986452|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986453|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986454|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
13986455|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13986456|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
13986457|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986458|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13986459|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
13986460|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
13986461|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
13986462|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
13986463|NCT02986503|Cisplatin|cisplatin|mesh-list
13986464|NCT02986503|Doxorubicin|doxorubicin|mesh-list
13986465|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
13986466|NCT02986503|Methotrexate|methotrexate|mesh-list
13986467|NCT02986503|Ifosfamide|ifosfamide|mesh-list
13986468|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
13986469|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986470|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
13986471|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
13986472|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
13986473|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986474|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986475|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13986476|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
13986477|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13986478|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986479|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13986480|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
13986481|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
13986482|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
13986483|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13986484|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
13986485|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13986486|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13986487|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13986488|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
13986489|NCT02986451|Clarithromycin|clarithromycin|mesh-list
13986490|NCT02986451|Dexamethasone|dexamethasone|mesh-list
13986491|NCT02986451|Lenalidomide|lenalidomide|mesh-list
13986492|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986493|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
13986494|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
13986495|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986496|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247511|NCT00250926|BB 1101|bb 1101|mesh-list
13986497|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986498|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
13986499|NCT02986451|Hormones|hormones|mesh-ancestor
13986500|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13986501|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13986502|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986503|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
13986504|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
13986505|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
13986506|NCT02986451|Growth Substances|growth substances|mesh-ancestor
13986507|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
13986508|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13986509|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13986510|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
13986511|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986512|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986513|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13986514|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13986515|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
13986516|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13986517|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247512|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14247513|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
14247514|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
14247515|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14247516|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247517|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247518|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
14247519|NCT00250926|Hormones|hormones|mesh-ancestor
14247520|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14247521|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14247522|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247523|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
14247524|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247525|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247526|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14247527|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
14247528|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14247529|NCT00251004|Cyclosporine|cyclosporine|mesh-list
14247530|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
14247531|NCT00251004|Everolimus|everolimus|mesh-list
14247532|NCT00251004|Cyclosporins|cyclosporins|mesh-list
14247533|NCT00251004|Basiliximab|basiliximab|mesh-list
14247534|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247535|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247536|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247537|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
14247538|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247539|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
14247540|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14247541|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
14247542|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14247543|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14247544|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247545|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14247546|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14247547|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
14247548|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14247549|NCT00251225|Docetaxel|docetaxel|mesh-list
14247550|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
14247551|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247552|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
14247553|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
14247554|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
14247555|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247556|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14247557|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247558|NCT00251303|Riluzole|riluzole|mesh-list
14247559|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
14247560|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14247561|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14247562|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247563|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532052|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986518|NCT02986334|Naproxen|naproxen|mesh-list
13986519|NCT02986334|Omeprazole|omeprazole|mesh-list
13986520|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13986521|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986522|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13986523|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986524|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986525|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13986526|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13986527|NCT02986334|Analgesics|analgesics|mesh-ancestor
13986528|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
13986529|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986530|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986531|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986532|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13986533|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
13986534|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13986535|NCT02986321|Budesonide|budesonide|mesh-list
13986536|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986537|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
13986538|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
13986539|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986540|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986541|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
13986542|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
13986543|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
13986544|NCT02986321|Hormones|hormones|mesh-ancestor
13986545|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13986546|NCT02986594|Aspirin|aspirin|mesh-list
13986547|NCT02986594|Heparin|heparin|mesh-list
13986548|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13986549|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13986550|NCT02986594|Analgesics|analgesics|mesh-ancestor
13986551|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
13986552|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986553|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986554|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986555|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13986556|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
13986557|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
13986558|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986559|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
13986560|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13986561|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986562|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
13986563|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
13986564|NCT02986100|Rucaparib|rucaparib|mesh-list
13986565|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13986566|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986567|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986568|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986569|NCT02985736|Desoximetasone|desoximetasone|mesh-list
13986570|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986571|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
13986572|NCT02985736|Hormones|hormones|mesh-ancestor
13986573|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13986574|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986575|NCT02985697|Midazolam|midazolam|mesh-list
13986576|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
13986577|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
13986578|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
13986579|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13986580|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986581|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13986582|NCT02985697|Analgesics|analgesics|mesh-ancestor
13986583|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
13986584|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986585|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
13986586|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
13986587|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
13986588|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
13986589|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986590|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986591|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13986592|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13986593|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13986594|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13986595|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13986596|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
13986597|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
13986598|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
13986599|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
13986600|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
13986601|NCT02985866|Pancrelipase|pancrelipase|mesh-list
13986602|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986603|NCT02985983|Brodalumab|brodalumab|mesh-list
13986604|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
13986605|NCT02985749|Oxytocin|oxytocin|mesh-list
13986606|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
13986607|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13986608|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986609|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
13986610|NCT02985905|Astringents|astringents|mesh-ancestor
13986611|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986612|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
13986613|NCT02985658|Cisplatin|cisplatin|mesh-list
13986614|NCT02985658|Vinorelbine|vinorelbine|mesh-list
13986615|NCT02985658|Veliparib|veliparib|mesh-list
13986616|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986617|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13986618|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
13986619|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
13986620|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
13986621|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986622|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
13986623|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986624|NCT02985671|Acetaminophen|acetaminophen|mesh-list
13986625|NCT02985671|Diclofenac|diclofenac|mesh-list
13986626|NCT02985671|Orphenadrine|orphenadrine|mesh-list
13986627|NCT02985671|Caffeine|caffeine|mesh-list
13986628|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13986629|NCT02985671|Analgesics|analgesics|mesh-ancestor
13986630|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
13986631|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986632|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986633|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
13986634|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13986635|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986636|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13986637|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13986638|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986639|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986640|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13986641|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13986642|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13986643|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13986644|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
13986645|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986646|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
13986647|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
13986648|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
13986649|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
13986650|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
13986651|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
13986652|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
13986653|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
13986654|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
13986655|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
13986656|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13986665|NCT02985593|KHK4083|khk4083|mesh-list
13986666|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
13986667|NCT02985606|Caffeine|caffeine|mesh-list
13986668|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
13986669|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986670|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
13986671|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986672|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986673|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
13986674|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
13986675|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
13986676|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986677|NCT02985229|Misoprostol|misoprostol|mesh-list
13986678|NCT02985229|Mifepristone|mifepristone|mesh-list
13986679|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13986680|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
13986681|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13986682|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986683|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13986684|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986685|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
13986686|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
13986687|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
13986688|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
13986689|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
13986690|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
13986691|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
13986692|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
13986693|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
13986694|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13986695|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
13986696|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
13986697|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
13986698|NCT02985372|Cytarabine|cytarabine|mesh-list
13986699|NCT02985372|Decitabine|decitabine|mesh-list
13986700|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13986701|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
13986702|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986703|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986704|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
13986705|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13986706|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13986707|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
13986708|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986709|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986710|NCT02985216|Pregabalin|pregabalin|mesh-list
13986711|NCT02985216|Analgesics|analgesics|mesh-ancestor
13986712|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
13986713|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986714|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986715|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
13986716|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
13986717|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
13986718|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986719|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
13986720|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
13986721|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
13986722|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13986723|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
13986724|NCT02985333|Dexamethasone|dexamethasone|mesh-list
13986725|NCT02985333|Paclitaxel|paclitaxel|mesh-list
13986726|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
13986727|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13986728|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986729|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
13986730|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
13986731|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
13986732|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986733|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13986734|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
13986735|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986736|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13986737|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
13986738|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
13986739|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
13986740|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986741|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
13986742|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
13986743|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986744|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986745|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
13986746|NCT02985333|Hormones|hormones|mesh-ancestor
13986747|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13986748|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
13986749|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
13986750|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
13986751|NCT02985190|Azacitidine|azacitidine|mesh-list
13986752|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
13986753|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
13986754|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986755|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986756|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986757|NCT02985177|Ibuprofen|ibuprofen|mesh-list
13986758|NCT02985177|Fentanyl|fentanyl|mesh-list
13986759|NCT02985177|Hydromorphone|hydromorphone|mesh-list
13986760|NCT02985177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13986761|NCT02985177|Narcotics|narcotics|mesh-ancestor
13986762|NCT02985177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13986763|NCT02985177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986764|NCT02985177|Analgesics|analgesics|mesh-ancestor
13986765|NCT02985177|Sensory System Agents|sensory system agents|mesh-ancestor
13986766|NCT02985177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986767|NCT02985177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13986768|NCT02985177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13986769|NCT02985177|Anesthetics, General|anesthetics, general|mesh-ancestor
13986770|NCT02985177|Anesthetics|anesthetics|mesh-ancestor
13986771|NCT02985177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13986772|NCT02985177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13986773|NCT02985177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986774|NCT02985177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13986775|NCT02985177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13986776|NCT02985177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986777|NCT02985177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986778|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
13986779|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
13986780|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986781|NCT02985255|Docetaxel|docetaxel|mesh-list
13986782|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986783|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
13986784|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
13986785|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
13986786|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986787|NCT02985203|Vinorelbine|vinorelbine|mesh-list
13986788|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
13986789|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986790|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
13986791|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
13986792|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
13986793|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986794|NCT02985554|Nivolumab|nivolumab|mesh-list
13986795|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
13986796|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986797|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
13986798|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986799|NCT02985242|Empagliflozin|empagliflozin|mesh-list
13986800|NCT02985242|Glimepiride|glimepiride|mesh-list
13986801|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
13986802|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986803|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13986804|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986805|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
13986806|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13986807|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
13986808|NCT02985281|Ribavirin|ribavirin|mesh-list
13986809|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
13986810|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
13986811|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986812|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
13986813|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13986814|NCT02985125|Everolimus|everolimus|mesh-list
13986815|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
13986816|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
13986817|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
13986818|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986819|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
13986820|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
13986821|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
13986822|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
13986823|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986824|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
13986825|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
13986826|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986827|NCT02984930|Esomeprazole|esomeprazole|mesh-list
13986828|NCT02984930|Mosapride|mosapride|mesh-list
13986829|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13986830|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986831|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
13986832|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986833|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986834|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
13986835|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
13986836|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
13986837|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986838|NCT02985086|Cefoxitin|cefoxitin|mesh-list
13986839|NCT02985086|Misoprostol|misoprostol|mesh-list
13986840|NCT02985086|Oxytocin|oxytocin|mesh-list
13986841|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
13986842|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
13986843|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986844|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
13986845|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
13986846|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
13986847|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
13986848|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
13986849|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13986850|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
13986851|NCT02984865|Sufentanil|sufentanil|mesh-list
13986852|NCT02984865|Nalbuphine|nalbuphine|mesh-list
13986853|NCT02984865|Dsuvia|dsuvia|mesh-list
13986854|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
13986855|NCT02984865|Narcotics|narcotics|mesh-ancestor
13986856|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
13986857|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986858|NCT02984865|Analgesics|analgesics|mesh-ancestor
13986859|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
13986860|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
13986861|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
13986862|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
13986863|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
13986864|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
13986865|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
13986866|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
13986867|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
13986868|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
13986869|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
13986870|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986871|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986872|NCT02984852|Tenofovir|tenofovir|mesh-list
13986873|NCT02984852|Emtricitabine|emtricitabine|mesh-list
13986874|NCT02984852|Darunavir|darunavir|mesh-list
13986875|NCT02984852|Cobicistat|cobicistat|mesh-list
13986876|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
13986877|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
13986878|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
13986879|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
13986880|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
13986881|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
13986882|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
13986883|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
13986884|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
13986885|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
13986886|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
13986887|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
13986888|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
13986889|NCT02984722|Metformin|metformin|mesh-list
13986890|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
13986891|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
13986892|NCT02984696|Estradiol|estradiol|mesh-list
13986893|NCT02984696|Estrogens|estrogens|mesh-ancestor
13986894|NCT02984696|Hormones|hormones|mesh-ancestor
13986895|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
13986896|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247564|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247565|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14247566|NCT00251303|Protective Agents|protective agents|mesh-ancestor
14247567|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
14247568|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
14247569|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14247570|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247571|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247572|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
14247573|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14247574|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14247575|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247576|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14247577|NCT00251589|Vorinostat|vorinostat|mesh-list
14247578|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247579|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14247580|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247581|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247582|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14247583|NCT00251641|Methotrexate|methotrexate|mesh-list
14247584|NCT00251641|Infliximab|infliximab|mesh-list
14247585|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14247586|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
14247587|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14247588|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247589|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14247590|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
14247591|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247592|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247593|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
14247594|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247595|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14247596|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247597|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
14247598|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14247599|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14247600|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247601|NCT00251693|Lansoprazole|lansoprazole|mesh-list
14247602|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
14247603|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14247604|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247605|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14247606|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247607|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247608|NCT00251719|Lansoprazole|lansoprazole|mesh-list
14247609|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
14247610|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14247611|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247612|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14247613|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247614|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247615|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
14247616|NCT00251745|Lansoprazole|lansoprazole|mesh-list
14247617|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14247618|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247619|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14247620|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247621|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247622|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
14247623|NCT00251758|Lansoprazole|lansoprazole|mesh-list
14247624|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14247625|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247626|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14247627|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247628|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247629|NCT00251927|Esomeprazole|esomeprazole|mesh-list
14247630|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14247631|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247632|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14247633|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247634|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247635|NCT00251979|Esomeprazole|esomeprazole|mesh-list
14247636|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14247637|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247638|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14247639|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247640|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247641|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14247642|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
14247643|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247644|NCT00252239|Plasminogen|plasminogen|mesh-list
14247645|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14247646|NCT00252239|Tenecteplase|tenecteplase|mesh-list
14247647|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14247648|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14247649|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247650|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
14247651|NCT00252499|Fenofibrate|fenofibrate|mesh-list
14247652|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14247653|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247654|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14247655|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
14247656|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247657|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14247658|NCT00252564|Leucovorin|leucovorin|mesh-list
14247659|NCT00252564|Bevacizumab|bevacizumab|mesh-list
14247660|NCT00252564|Cetuximab|cetuximab|mesh-list
14247661|NCT00252564|Fluorouracil|fluorouracil|mesh-list
14247662|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
14247663|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14247664|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247665|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14247666|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14247667|NCT00252564|Growth Substances|growth substances|mesh-ancestor
14247668|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247669|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
14247670|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
14247671|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247672|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14247673|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247674|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
14247675|NCT00252564|Antidotes|antidotes|mesh-ancestor
14247676|NCT00252564|Protective Agents|protective agents|mesh-ancestor
14247677|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
14247678|NCT00252564|Vitamins|vitamins|mesh-ancestor
14247679|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
14247680|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
14247681|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
14247682|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14247683|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247684|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247685|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
14247686|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14247687|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14247688|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247689|NCT00252694|Candesartan|candesartan|mesh-list
14247690|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14247691|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14247692|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14247693|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247694|NCT00252720|Candesartan|candesartan|mesh-list
14247695|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14247696|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14247697|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14247698|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247699|NCT00252733|Candesartan|candesartan|mesh-list
14247700|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
14247701|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14247702|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14247703|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14247704|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247705|NCT00252967|Atorvastatin|atorvastatin|mesh-list
14247706|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14247707|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14247708|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
14247709|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247710|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14247711|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14247712|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532053|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532054|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
14532055|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
14532056|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
14532057|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14532058|NCT02299206|Protective Agents|protective agents|mesh-ancestor
14532059|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532060|NCT02302859|Nicotine|nicotine|mesh-list
14532061|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14532062|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
14532063|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532064|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532065|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14532066|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14532067|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
14532068|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532069|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532070|NCT02297230|Paclitaxel|paclitaxel|mesh-list
14532071|NCT02297230|Capecitabine|capecitabine|mesh-list
14532072|NCT02297230|Trastuzumab|trastuzumab|mesh-list
14532073|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14532074|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532075|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
14532076|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
14532077|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
14532078|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532079|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14532080|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
14532081|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14532082|NCT02284906|Pioglitazone|pioglitazone|mesh-list
14532083|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14532084|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532085|NCT02282332|Ticagrelor|ticagrelor|mesh-list
14532086|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14532087|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14532088|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14532089|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14532090|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
14532091|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532092|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532093|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532094|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14532095|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14532096|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532097|NCT02276560|Gemcitabine|gemcitabine|mesh-list
14532098|NCT02276560|Paclitaxel|paclitaxel|mesh-list
14532099|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14532100|NCT02276560|Cisplatin|cisplatin|mesh-list
14532101|NCT02276560|Pemetrexed|pemetrexed|mesh-list
14532102|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14532103|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532104|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
14532105|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
14532106|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
14532107|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532108|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14532109|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
14532110|NCT02276560|Antiviral Agents|antiviral agents|mesh-ancestor
14532111|NCT02276560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532112|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532113|NCT02276560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532114|NCT02276560|Immunologic Factors|immunologic factors|mesh-ancestor
14532115|NCT02276560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532116|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14532117|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14532118|NCT02280252|Paclitaxel|paclitaxel|mesh-list
14532119|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14532120|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532121|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
14532122|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
14532123|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
14247713|NCT00253370|Cisplatin|cisplatin|mesh-list
14247714|NCT00253370|Docetaxel|docetaxel|mesh-list
14247715|NCT00253370|Sorafenib|sorafenib|mesh-list
14247716|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247717|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
14247718|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
14247719|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
14247720|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247721|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14247722|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247723|NCT00253435|Carboplatin|carboplatin|mesh-list
14247724|NCT00253435|Etoposide|etoposide|mesh-list
14247725|NCT00253435|Melphalan|melphalan|mesh-list
14247726|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247727|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14247728|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14247729|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14247730|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247731|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247732|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
14247733|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247734|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14247735|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
14247736|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14247737|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247738|NCT00253513|Fludarabine|fludarabine|mesh-list
14247739|NCT00253513|Treosulfan|treosulfan|mesh-list
14247740|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247741|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247742|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14247743|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
14247744|NCT00253630|Vorinostat|vorinostat|mesh-list
14247745|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247746|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14247747|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247748|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247749|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14247750|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
14247751|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247752|NCT00253643|Protective Agents|protective agents|mesh-ancestor
14247753|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247754|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14247755|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14247756|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247757|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14247758|NCT00253747|Methylphenidate|methylphenidate|mesh-list
14247759|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14247760|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247761|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14247762|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14247763|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14247764|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247765|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
14247766|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247767|NCT00253890|Trazodone|trazodone|mesh-list
14247768|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14247769|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14247770|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14247771|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247772|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14247773|NCT00253890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14247774|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14247775|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14247776|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247777|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247778|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
14247779|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14247780|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
14247781|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
14247782|NCT00254163|Rituximab|rituximab|mesh-list
14247783|NCT00254163|Fludarabine|fludarabine|mesh-list
14247784|NCT00254163|Pentostatin|pentostatin|mesh-list
14247785|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247786|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
14247787|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247788|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14247789|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14247790|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
14247791|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247792|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247793|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14247794|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14247795|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
14247796|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247797|NCT00254293|Abatacept|abatacept|mesh-list
14247798|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14247799|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14247800|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247801|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247802|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247803|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
14247804|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247805|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14247806|NCT00254397|Leuprolide|leuprolide|mesh-list
14247807|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14247808|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
14247809|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14247810|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247811|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14247812|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247813|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
14247814|NCT00254410|Rituximab|rituximab|mesh-list
14247815|NCT00254410|Fludarabine|fludarabine|mesh-list
14247816|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
14247817|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247818|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
14247819|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247820|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14247821|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14247822|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
14247823|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247824|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247825|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14247826|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14247827|NCT00254410|Analgesics|analgesics|mesh-ancestor
14247828|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
14247829|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14247830|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14247831|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14247832|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247833|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14247834|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14247835|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14247836|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14247837|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247838|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
14247839|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247840|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247841|NCT00254488|Valproic Acid|valproic acid|mesh-list
14247842|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14247843|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247844|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247845|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
14247846|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14247847|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14247848|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247849|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
14247850|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
14247851|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247852|NCT00254540|Sunitinib|sunitinib|mesh-list
14247853|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247854|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14247855|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14247856|NCT00254540|Growth Substances|growth substances|mesh-ancestor
14247857|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247858|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
14247859|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14247860|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247861|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247862|NCT00254566|Azithromycin|azithromycin|mesh-list
14247863|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
14247864|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14247865|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14247866|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14247867|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14247868|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14247869|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247870|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247871|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247872|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14247873|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
14247874|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14247875|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247876|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14247877|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14247878|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14247879|NCT00254592|Paclitaxel|paclitaxel|mesh-list
14247880|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14247881|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
14247882|NCT00254592|Bevacizumab|bevacizumab|mesh-list
14247883|NCT00254592|Carboplatin|carboplatin|mesh-list
14247884|NCT00254592|Doxorubicin|doxorubicin|mesh-list
14247885|NCT00254592|Trastuzumab|trastuzumab|mesh-list
14247886|NCT00254592|Sargramostim|sargramostim|mesh-list
14247887|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14247888|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247889|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
14247890|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
14247891|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
14247892|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247893|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247894|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
14247895|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247896|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14247897|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14247898|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
14247899|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14247900|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14247901|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14247902|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14247903|NCT00254592|Growth Substances|growth substances|mesh-ancestor
14247904|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
14247905|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14247906|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14247907|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14247908|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247909|NCT00254982|Infliximab|infliximab|mesh-list
14247910|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
14247911|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247912|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14247913|NCT00255008|Ribavirin|ribavirin|mesh-list
14247914|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14247915|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
14247916|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
14247917|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247918|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
14247919|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14247920|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
14247921|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247922|NCT00255034|Ribavirin|ribavirin|mesh-list
14247923|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14247924|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
14247925|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
14247926|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247927|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
14247928|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14247929|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
14247930|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247931|NCT00255086|Memantine|memantine|mesh-list
14247932|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14247933|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14247934|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
14247935|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14247936|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247937|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247938|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14247939|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14247940|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
14247941|NCT00255151|Lansoprazole|lansoprazole|mesh-list
14247942|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14247943|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247944|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14247945|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247946|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247947|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
14247948|NCT00255164|Lansoprazole|lansoprazole|mesh-list
14247949|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14247950|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247951|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14247952|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247953|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247954|NCT00255177|Mifepristone|mifepristone|mesh-list
14247955|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14247956|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
14247957|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14247958|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247959|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14247960|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14247961|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14247962|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
14247963|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14247964|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14247965|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
14247966|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14247967|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
14247968|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14247969|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14247970|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
14247971|NCT00255190|Lansoprazole|lansoprazole|mesh-list
14247972|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14247973|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14247974|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14247975|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247976|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247977|NCT00255346|Dasatinib|dasatinib|mesh-list
14247978|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247979|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14247980|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14247981|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247982|NCT00255684|Cyclosporine|cyclosporine|mesh-list
14247983|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
14247984|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
14247985|NCT00255684|Fludarabine|fludarabine|mesh-list
14247986|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
14247987|NCT00255684|Cyclosporins|cyclosporins|mesh-list
14247988|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14247989|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
14247990|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14247991|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14247992|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14247993|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
14247994|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14247995|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14247996|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14247997|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14247998|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
14247999|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248000|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
14248001|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248002|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
14248003|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14248004|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14248005|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14248006|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
14248007|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14248008|NCT00255723|Carboplatin|carboplatin|mesh-list
14248009|NCT00255723|Etoposide|etoposide|mesh-list
14248010|NCT00255723|Ifosfamide|ifosfamide|mesh-list
14248011|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248012|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14248013|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14248014|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14248015|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248016|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248017|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14248018|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
14248019|NCT00255801|Doxorubicin|doxorubicin|mesh-list
14248020|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14248021|NCT00255801|Bexarotene|bexarotene|mesh-list
14248022|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14248023|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248024|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14248025|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14248026|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248027|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248028|NCT00255840|Ritonavir|ritonavir|mesh-list
14248029|NCT00255840|Lopinavir|lopinavir|mesh-list
14248030|NCT00255840|Lamivudine|lamivudine|mesh-list
14248031|NCT00255840|Nevirapine|nevirapine|mesh-list
14248032|NCT00255840|Stavudine|stavudine|mesh-list
14248033|NCT00255840|Efavirenz|efavirenz|mesh-list
14248034|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14248035|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14248036|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
14248037|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248038|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248039|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14248040|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14248041|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
14248042|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248043|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14248044|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14248045|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14248046|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14248047|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14248048|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14248049|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14248050|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14248051|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14248052|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
14248053|NCT00256204|Rasagiline|rasagiline|mesh-list
14248054|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
14248055|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248056|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248057|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14248058|NCT00256204|Protective Agents|protective agents|mesh-ancestor
14248059|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248060|NCT00256217|Anastrozole|anastrozole|mesh-list
14248061|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14248062|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248063|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14248064|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14248065|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248066|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248067|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14248068|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
14248069|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14248070|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248071|NCT00256243|Paclitaxel|paclitaxel|mesh-list
14248072|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
14248073|NCT00256243|Carboplatin|carboplatin|mesh-list
14248074|NCT00256243|Doxorubicin|doxorubicin|mesh-list
14248075|NCT00256243|Trastuzumab|trastuzumab|mesh-list
14248076|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14248077|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248078|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
14248079|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
14248080|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
14248081|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248082|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248083|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
14248084|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248085|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248086|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14248087|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
14248088|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14248089|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14248090|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14248091|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14248092|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248093|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14248094|NCT00256282|Docetaxel|docetaxel|mesh-list
14248095|NCT00256282|Vinorelbine|vinorelbine|mesh-list
14248096|NCT00256282|Sargramostim|sargramostim|mesh-list
14248097|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248098|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
14248099|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
14248100|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
14248101|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248102|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14248103|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
14248104|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248105|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
14248106|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248107|NCT00256451|Ethanol|ethanol|mesh-list
14248108|NCT00256451|Naltrexone|naltrexone|mesh-list
14248109|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14248110|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248111|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14248112|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248113|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14248114|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14248115|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
14248116|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248117|NCT00256698|Fulvestrant|fulvestrant|mesh-list
14248118|NCT00256698|Anastrozole|anastrozole|mesh-list
14248119|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14248120|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248121|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14248122|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14248123|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
14248124|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14248125|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248126|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14248127|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14248128|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248129|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248130|NCT00256750|Cyclosporine|cyclosporine|mesh-list
14248131|NCT00256750|Abatacept|abatacept|mesh-list
14248132|NCT00256750|Cyclosporins|cyclosporins|mesh-list
14248133|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248134|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248135|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248136|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
14248137|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248138|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
14248139|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248140|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
14248141|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248142|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14248143|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14248144|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248145|NCT00256776|Thalidomide|thalidomide|mesh-list
14248146|NCT00256776|Dexamethasone|dexamethasone|mesh-list
14248147|NCT00256776|Bortezomib|bortezomib|mesh-list
14248148|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14248149|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
14248150|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
14248151|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248152|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248153|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14248154|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
14248155|NCT00256776|Hormones|hormones|mesh-ancestor
14248156|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14248157|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14248158|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248159|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248160|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
14248161|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
14248162|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14248163|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248164|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14248165|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14248166|NCT00256776|Growth Substances|growth substances|mesh-ancestor
14248167|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
14248168|NCT00256854|Ropinirole|ropinirole|mesh-list
14248169|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14248170|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14248171|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
14248172|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
14248173|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248174|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248175|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248176|NCT00256997|Risperidone|risperidone|mesh-list
14248177|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
14248178|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14248179|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
14248180|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248181|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248182|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248183|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14248184|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14248185|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14248186|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14248187|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
14248188|NCT00257010|Almotriptan|almotriptan|mesh-list
14248189|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14248190|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
14248191|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248192|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248193|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248194|NCT00257166|Ziprasidone|ziprasidone|mesh-list
14248195|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14248196|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
14248197|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248198|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248199|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248200|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14248201|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14248202|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14248203|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14248204|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14248205|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
14248206|NCT00257192|Ziprasidone|ziprasidone|mesh-list
14248207|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14248208|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
14248209|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248210|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248211|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248212|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14248213|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14248214|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14248215|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14248216|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14248217|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
14248218|NCT00257309|Tenecteplase|tenecteplase|mesh-list
14248219|NCT00257309|Clopidogrel|clopidogrel|mesh-list
14248220|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14248221|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14248222|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14248223|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14248224|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
14248225|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248226|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248227|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248228|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14248229|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14248230|NCT00257556|Menotropins|menotropins|mesh-list
14248231|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14248232|NCT00257556|Hormones|hormones|mesh-ancestor
14248233|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14248234|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248235|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14248236|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
14248237|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14248238|NCT00257608|Bevacizumab|bevacizumab|mesh-list
14248239|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14248240|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14248241|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248242|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14248243|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14248244|NCT00257608|Growth Substances|growth substances|mesh-ancestor
14248245|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248246|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
14248247|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14248248|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248249|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248250|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
14248251|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14248252|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14248253|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14248254|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14248255|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248256|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
14248257|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248258|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248259|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14248260|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248261|NCT00257686|Pravastatin|pravastatin|mesh-list
14248262|NCT00257686|Pitavastatin|pitavastatin|mesh-list
14248263|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14248264|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14248265|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
14248266|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248267|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14248268|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14248269|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248270|NCT00257725|Methylphenidate|methylphenidate|mesh-list
14248271|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14248272|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248273|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14248274|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14248275|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14248276|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248277|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
14248278|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248279|NCT00257894|Baclofen|baclofen|mesh-list
14248280|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248281|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14248282|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14248283|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248284|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
14248285|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
14248286|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
14248287|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248288|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248289|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14248290|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248291|NCT00257920|Vitamins|vitamins|mesh-ancestor
14248292|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
14248293|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14248294|NCT00257933|Prednisolone|prednisolone|mesh-list
14248295|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14248296|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
14248297|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14248298|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
14248299|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14248300|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
14248301|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14248302|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
14248303|NCT00257933|Hormones|hormones|mesh-ancestor
14248304|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14248305|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248306|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14248307|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248308|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
14248309|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
14248310|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248311|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14248312|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14248313|NCT00257933|Protective Agents|protective agents|mesh-ancestor
14248314|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14248315|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14248316|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14248317|NCT00258128|Analgesics|analgesics|mesh-ancestor
14248318|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
14248319|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248320|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248321|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14248322|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248323|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
14248324|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248325|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
14248326|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248327|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248328|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14248329|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
14248330|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248331|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248332|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14248333|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
14248334|NCT00258206|Rituximab|rituximab|mesh-list
14248335|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248336|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
14248337|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248338|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248339|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14248340|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
14248341|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248342|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248343|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14248344|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14248345|NCT00258310|Capecitabine|capecitabine|mesh-list
14248346|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14248347|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
14248348|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248349|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248350|NCT00258349|Trastuzumab|trastuzumab|mesh-list
14248351|NCT00258349|Vorinostat|vorinostat|mesh-list
14248352|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14248353|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248354|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14248355|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248356|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248357|NCT00258362|Carboplatin|carboplatin|mesh-list
14248358|NCT00258362|Docetaxel|docetaxel|mesh-list
14248359|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248360|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
14248361|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
14248362|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
14532124|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532125|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
15042542|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042543|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15042544|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15042545|NCT02044965|Trimethoprim|trimethoprim|mesh-list
15042546|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
15042547|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042548|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15042549|NCT02044965|Renal Agents|renal agents|mesh-ancestor
15042550|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
15042551|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15042552|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15042553|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15042554|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042555|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248363|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248364|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
14248365|NCT00258440|Hematinics|hematinics|mesh-ancestor
14248366|NCT00258817|Vaccines|vaccines|mesh-list
14248367|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
14248368|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248369|NCT00258830|Vaccines|vaccines|mesh-list
14248370|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
14248371|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248372|NCT00258856|Vaccines|vaccines|mesh-list
14248373|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
14248374|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248375|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
14248376|NCT00258960|Doxorubicin|doxorubicin|mesh-list
14248377|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14248378|NCT00258960|Trastuzumab|trastuzumab|mesh-list
14248379|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248380|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
14248381|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248382|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248383|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14248384|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
14248385|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248386|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248387|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14248388|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14248389|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14248390|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14248391|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248392|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14248393|NCT00259012|Pantoprazole|pantoprazole|mesh-list
14248394|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14248395|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14248396|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14248397|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248398|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248399|NCT00259090|Fulvestrant|fulvestrant|mesh-list
14248400|NCT00259090|Anastrozole|anastrozole|mesh-list
14248401|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14248402|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248403|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14248404|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14248405|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
14248406|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14248407|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248408|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14248409|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14248410|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248411|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248412|NCT00259272|Olanzapine|olanzapine|mesh-list
14248413|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
14248414|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
14248415|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248416|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248417|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14248418|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14248419|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14248420|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14248421|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14248422|NCT00259272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14248423|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14248424|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14248425|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248426|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248427|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
14248428|NCT00259285|Pemetrexed|pemetrexed|mesh-list
14248429|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248430|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248431|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248432|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14248433|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14248434|NCT00259298|Teriparatide|teriparatide|mesh-list
14248435|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14248436|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248437|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14248438|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
14248439|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
14248440|NCT00259610|Etanercept|etanercept|mesh-list
14248441|NCT00259610|Methotrexate|methotrexate|mesh-list
14248442|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14248443|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
14248444|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14248445|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248446|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14248447|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
14248448|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248449|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248450|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
14248451|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248452|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14248453|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248454|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
14248455|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248456|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14248457|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
14248458|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14248459|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14248460|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248461|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14248462|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14248463|NCT00259610|Analgesics|analgesics|mesh-ancestor
14248464|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
14248465|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248466|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14248467|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14248468|NCT00259649|Eletriptan|eletriptan|mesh-list
14248469|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14248470|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
14248471|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248472|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248473|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248474|NCT00259740|Denosumab|denosumab|mesh-list
14248475|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14248476|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248477|NCT00259857|Alendronate|alendronate|mesh-list
14248478|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14248479|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248480|NCT00260065|Decitabine|decitabine|mesh-list
14248481|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14248482|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
14248483|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248484|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248485|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248486|NCT00260208|Cyclosporine|cyclosporine|mesh-list
14248487|NCT00260208|Tacrolimus|tacrolimus|mesh-list
14248488|NCT00260208|Cyclosporins|cyclosporins|mesh-list
14248489|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248490|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
14248491|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248492|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14248493|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248494|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248495|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
14248496|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248497|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
14248498|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248499|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14248500|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14248501|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14248502|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14248503|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248504|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
14248505|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248506|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248507|NCT00260689|Cyclosporine|cyclosporine|mesh-list
14248508|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
14248509|NCT00260689|Cyclosporins|cyclosporins|mesh-list
14248510|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14248511|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
14248512|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248513|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248514|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248515|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
14248516|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248517|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
14248518|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248519|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
14248520|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248521|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14248522|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14248523|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248524|NCT00260832|Cytarabine|cytarabine|mesh-list
14248525|NCT00260832|Decitabine|decitabine|mesh-list
14248526|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14248527|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
14248528|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248529|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248530|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
14248531|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248532|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248533|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
14248534|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248535|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532126|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
14532127|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14532128|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
14532129|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532130|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532131|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14532132|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
14532133|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
14532134|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14532135|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
14532136|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532137|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532138|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14532139|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14532140|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14532141|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
14532142|NCT02273752|Everolimus|everolimus|mesh-list
14532143|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532144|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532145|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
14532146|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532147|NCT02271594|Insulin|insulin|mesh-list
14532148|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14532149|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532150|NCT02263365|Loperamide|loperamide|mesh-list
14532151|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
14532152|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14532153|NCT02266797|Dexamethasone|dexamethasone|mesh-list
14532154|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14532155|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
14532156|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
14532157|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532158|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532159|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14532160|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
14532161|NCT02266797|Hormones|hormones|mesh-ancestor
14532162|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14532163|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14532164|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532165|NCT02253394|Ambrisentan|ambrisentan|mesh-list
14532166|NCT02253394|Spironolactone|spironolactone|mesh-list
14532167|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14532168|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
14532169|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14532170|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532171|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14532172|NCT02253394|Diuretics|diuretics|mesh-ancestor
14532173|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
14532174|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14532175|NCT02241551|Gemcitabine|gemcitabine|mesh-list
14532176|NCT02241551|Paclitaxel|paclitaxel|mesh-list
14532177|NCT02241551|Fluorouracil|fluorouracil|mesh-list
14248536|NCT00260962|Olanzapine|olanzapine|mesh-list
14248537|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
14248538|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
14248539|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248540|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248541|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14248542|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14248543|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14248544|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14248545|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14248546|NCT00260962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14248547|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14248548|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14248549|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248550|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248551|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
14248552|NCT00261443|Valproic Acid|valproic acid|mesh-list
14248553|NCT00261443|Aripiprazole|aripiprazole|mesh-list
14248554|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
14248555|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
14248556|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14248557|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14248558|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14248559|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14248560|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248561|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
14248562|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
14248563|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248564|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248565|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14248566|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14248567|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
14248568|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14248569|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14248570|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14248571|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14248572|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248573|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
14248574|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
14248575|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
14248576|NCT00261495|Oxycodone|oxycodone|mesh-list
14248577|NCT00261495|Hydromorphone|hydromorphone|mesh-list
14248578|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14248579|NCT00261495|Narcotics|narcotics|mesh-ancestor
14248580|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14248581|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248582|NCT00261495|Analgesics|analgesics|mesh-ancestor
14248583|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
14248584|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248585|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
14248586|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14248587|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248588|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248589|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14248590|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14248591|NCT00261950|Cinacalcet|cinacalcet|mesh-list
14248592|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14248593|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248594|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14248595|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
14248596|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14248597|NCT00262002|Vaccines|vaccines|mesh-list
14248598|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
14248599|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248600|NCT00262028|Vaccines|vaccines|mesh-list
14248601|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
14248602|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248603|NCT00262041|Vaccines|vaccines|mesh-list
14248604|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
14248605|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248606|NCT00262067|Bevacizumab|bevacizumab|mesh-list
14248607|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14248608|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248609|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14248610|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14248611|NCT00262067|Growth Substances|growth substances|mesh-ancestor
14248612|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248613|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
14248614|NCT00262080|Ecallantide|ecallantide|mesh-list
14248615|NCT00262080|Analgesics|analgesics|mesh-ancestor
14248616|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
14248617|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248618|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248619|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14248620|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14248621|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14248622|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248623|NCT00262223|Sertraline|sertraline|mesh-list
14248624|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
14248625|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14248626|NCT00262223|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14248627|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14248628|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14248629|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248630|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248631|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
14248632|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248633|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14248634|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14248635|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248636|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
14248637|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248638|NCT00262522|Ritonavir|ritonavir|mesh-list
14248639|NCT00262522|Lopinavir|lopinavir|mesh-list
14248640|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14248641|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14248642|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14248643|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
14248644|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248645|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248646|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14248647|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14248648|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
14248649|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248650|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14248651|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14248652|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14248653|NCT00262600|Warfarin|warfarin|mesh-list
14248654|NCT00262600|Dabigatran|dabigatran|mesh-list
14248655|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
14248656|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
14248657|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14248658|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
14248659|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248660|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248661|NCT00262639|Gabapentin|gabapentin|mesh-list
14248662|NCT00262639|Flumazenil|flumazenil|mesh-list
14248663|NCT00262639|Analgesics|analgesics|mesh-ancestor
14248664|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
14248665|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248666|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248667|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
14248668|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14248669|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14248670|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14248671|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14248672|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14248673|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14248674|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248675|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248676|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
14248677|NCT00262639|Antidotes|antidotes|mesh-ancestor
14248678|NCT00262639|Protective Agents|protective agents|mesh-ancestor
14248679|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
14248680|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
14248681|NCT00262730|Temozolomide|temozolomide|mesh-list
14248682|NCT00262730|Poly ICLC|poly iclc|mesh-list
14248683|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14248684|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
14248685|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248686|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248687|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
14248688|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
14248689|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248690|NCT00262821|Tirapazamine|tirapazamine|mesh-list
14248691|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248692|NCT00262834|Vorinostat|vorinostat|mesh-list
14248693|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248694|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14248695|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248696|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248697|NCT00262847|Paclitaxel|paclitaxel|mesh-list
14248698|NCT00262847|Bevacizumab|bevacizumab|mesh-list
14248699|NCT00262847|Carboplatin|carboplatin|mesh-list
14248700|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14248701|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14248702|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
14248703|NCT00262847|Antibodies|antibodies|mesh-list
14248704|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
14248705|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14248706|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
14248707|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14248708|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248709|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
14248710|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
14248711|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
14248712|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248713|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14248714|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14248715|NCT00262847|Growth Substances|growth substances|mesh-ancestor
14248716|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248717|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
14248718|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
14248719|NCT00262860|Gemcitabine|gemcitabine|mesh-list
14248720|NCT00262860|Bortezomib|bortezomib|mesh-list
14248721|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14248722|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
14248723|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248724|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248725|NCT00262860|Antiviral Agents|antiviral agents|mesh-ancestor
14248726|NCT00262860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248727|NCT00262860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248728|NCT00262860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248729|NCT00262860|Immunologic Factors|immunologic factors|mesh-ancestor
14248730|NCT00262860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248731|NCT00262873|Bortezomib|bortezomib|mesh-list
14248732|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248733|NCT00262925|Leucovorin|leucovorin|mesh-list
14248734|NCT00262925|Dexamethasone|dexamethasone|mesh-list
14248735|NCT00262925|Methotrexate|methotrexate|mesh-list
14248736|NCT00262925|Vincristine|vincristine|mesh-list
14248737|NCT00262925|Asparaginase|asparaginase|mesh-list
14248738|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
14248739|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
14248740|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14248741|NCT00262925|Antibodies|antibodies|mesh-list
14248742|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
14248743|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14248744|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
14248745|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
14248746|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248747|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14248748|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
14248749|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
14248750|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248751|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14248752|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
14248753|NCT00262925|Hormones|hormones|mesh-ancestor
14248754|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14248755|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14248756|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248757|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14248758|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
14248759|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14248760|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14248761|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
14248762|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248763|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
14248764|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248765|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14248766|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248767|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248768|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14248769|NCT00262925|Antidotes|antidotes|mesh-ancestor
14248770|NCT00262925|Protective Agents|protective agents|mesh-ancestor
14248771|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
14248772|NCT00262925|Vitamins|vitamins|mesh-ancestor
14248773|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
14248774|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14248775|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
14248776|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
14248777|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
14248778|NCT00262951|Interferons|interferons|mesh-list
14248779|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
14248780|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
14248781|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
14248782|NCT00262951|Cisplatin|cisplatin|mesh-list
14248783|NCT00262951|Fluorouracil|fluorouracil|mesh-list
14248784|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248785|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
14248786|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248787|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14248788|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248789|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
14248790|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248791|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
14248792|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248793|NCT00262964|Niacin|niacin|mesh-list
14248794|NCT00262964|Fenofibrate|fenofibrate|mesh-list
14248795|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14248796|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
14248797|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248798|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14248799|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
14248800|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
14248801|NCT00262964|Vitamins|vitamins|mesh-ancestor
14248802|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
14248803|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248804|NCT00263211|Aspirin|aspirin|mesh-list
14248805|NCT00263211|Clopidogrel|clopidogrel|mesh-list
14248806|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14248807|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14248808|NCT00263211|Analgesics|analgesics|mesh-ancestor
14248809|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
14248810|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248811|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248812|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14248813|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248814|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14248815|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14248816|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248817|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14248818|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14248819|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248820|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
14248821|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14248822|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14248823|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14248824|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
14248825|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248826|NCT00263328|Tacrolimus|tacrolimus|mesh-list
14248827|NCT00263328|Tofacitinib|tofacitinib|mesh-list
14248828|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248829|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
14248830|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248831|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14248832|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248833|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248834|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14248835|NCT00263575|Fentanyl|fentanyl|mesh-list
14248836|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14248837|NCT00263575|Narcotics|narcotics|mesh-ancestor
15042556|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14248838|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14248839|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248840|NCT00263575|Analgesics|analgesics|mesh-ancestor
14248841|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
14248842|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248843|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14248844|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14248845|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
14248846|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
14248847|NCT00263588|Lapatinib|lapatinib|mesh-list
14248848|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248849|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14248850|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248851|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248852|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
14248853|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14248854|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248855|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248856|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14248857|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14248858|NCT00264004|Cediranib|cediranib|mesh-list
14248859|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248860|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14248861|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248862|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248863|NCT00264238|Memantine|memantine|mesh-list
14248864|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14248865|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14248866|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
14248867|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248868|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248869|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248870|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14248871|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14248872|NCT00264290|Valganciclovir|valganciclovir|mesh-list
14248873|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
14248874|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248875|NCT00264303|Levocetirizine|levocetirizine|mesh-list
14248876|NCT00264303|Desloratadine|desloratadine|mesh-list
14248877|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14248878|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14248879|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
14248880|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
14248881|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248882|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248883|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248884|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14248885|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
14248886|NCT00264381|Dalteparin|dalteparin|mesh-list
14248887|NCT00264381|Tinzaparin|tinzaparin|mesh-list
14248888|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
14248889|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
14248890|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14248891|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14248892|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248893|NCT00264498|Gemcitabine|gemcitabine|mesh-list
14248894|NCT00264498|Carboplatin|carboplatin|mesh-list
14248895|NCT00264498|Gefitinib|gefitinib|mesh-list
14248896|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248897|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14248898|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
14248899|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248900|NCT00264498|Antiviral Agents|antiviral agents|mesh-ancestor
14248901|NCT00264498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14248902|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248903|NCT00264498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248904|NCT00264498|Immunologic Factors|immunologic factors|mesh-ancestor
14248905|NCT00264498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248906|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14248907|NCT00264537|Golimumab|golimumab|mesh-list
14248908|NCT00264537|Methotrexate|methotrexate|mesh-list
14248909|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14248910|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14248911|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
14248912|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14248913|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248914|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14248915|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
14248916|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248917|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248918|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
14248919|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248920|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14248921|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248922|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
14248923|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248924|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14248925|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14248926|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14248927|NCT00264550|Golimumab|golimumab|mesh-list
14248928|NCT00264550|Methotrexate|methotrexate|mesh-list
14248929|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14248930|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14248931|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
14248932|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14248933|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248934|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14248935|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
14248936|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248937|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14248938|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
14248939|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14248940|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14248941|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248942|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
14248943|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14248944|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14248945|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14248946|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14248947|NCT00264641|Insulin|insulin|mesh-list
14248948|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14248949|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14248950|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248951|NCT00264797|Methylphenidate|methylphenidate|mesh-list
14248952|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14248953|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248954|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14248955|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14248956|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14248957|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248958|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
14248959|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14248960|NCT00264849|Omalizumab|omalizumab|mesh-list
14248961|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14248962|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14248963|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
14248964|NCT00264875|Pregabalin|pregabalin|mesh-list
14248965|NCT00264875|Analgesics|analgesics|mesh-ancestor
14248966|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
14248967|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14248968|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248969|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
14248970|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14248971|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14248972|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14248973|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14248974|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14248975|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14248976|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14248977|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14248978|NCT00265083|Golimumab|golimumab|mesh-list
14248979|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14248980|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14248981|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14248982|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248983|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
14248984|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248985|NCT00265096|Golimumab|golimumab|mesh-list
14248986|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14248987|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14248988|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14248989|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14248990|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
14248991|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14248992|NCT00265109|Levetiracetam|levetiracetam|mesh-list
14248993|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
14248994|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
14248995|NCT00265122|Ustekinumab|ustekinumab|mesh-list
14248996|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
14248997|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
14248998|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14248999|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249000|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
14249001|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14249002|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249003|NCT00265239|Edaravone|edaravone|mesh-list
14249004|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14249005|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
14249006|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249007|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14249008|NCT00265239|Protective Agents|protective agents|mesh-ancestor
14249009|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249010|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14249011|NCT00265317|Sunitinib|sunitinib|mesh-list
14249012|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249013|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14249014|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249015|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249016|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14249017|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14249018|NCT00265317|Growth Substances|growth substances|mesh-ancestor
14249019|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249020|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
14249021|NCT00265330|Ziprasidone|ziprasidone|mesh-list
14249022|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14249023|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
14249024|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14249025|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249026|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249027|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14249028|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14249029|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14249030|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14249031|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14249032|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
14249033|NCT00265382|Ziprasidone|ziprasidone|mesh-list
14249034|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14249035|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
14249036|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14249037|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249038|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249039|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14249040|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14249041|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14249042|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14249043|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14249044|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
14249045|NCT00265395|Interferons|interferons|mesh-list
14249046|NCT00265395|Ribavirin|ribavirin|mesh-list
14249047|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
14249048|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
14249049|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14249050|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249051|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
14249052|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14249053|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
14249054|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249055|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
14249056|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249057|NCT00265616|Pentobarbital|pentobarbital|mesh-list
14249058|NCT00265616|Thiopental|thiopental|mesh-list
14249059|NCT00265616|Propofol|propofol|mesh-list
14249060|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14249061|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14249062|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249063|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14249064|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
14249065|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
14249066|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
14249067|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
14249068|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
14249069|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14249070|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249071|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14249072|NCT00265759|Letrozole|letrozole|mesh-list
14249073|NCT00265759|Anastrozole|anastrozole|mesh-list
14249074|NCT00265759|Exemestane|exemestane|mesh-list
14249075|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249076|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14249077|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14249078|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249079|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249080|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14249081|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
14249082|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14249083|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249084|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14249085|NCT00265785|Pemetrexed|pemetrexed|mesh-list
14249086|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249087|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249088|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249089|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14249090|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14249091|NCT00265850|Leucovorin|leucovorin|mesh-list
14249092|NCT00265850|Folic Acid|folic acid|mesh-list
14249093|NCT00265850|Bevacizumab|bevacizumab|mesh-list
14249094|NCT00265850|Cetuximab|cetuximab|mesh-list
14249095|NCT00265850|Fluorouracil|fluorouracil|mesh-list
14249096|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
14249097|NCT00265850|Irinotecan|irinotecan|mesh-list
14249098|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
14249099|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249100|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249101|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14249102|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14249103|NCT00265850|Growth Substances|growth substances|mesh-ancestor
14249104|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249105|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
14249106|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
14249107|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249108|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14249109|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249110|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
14249111|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14249112|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14249113|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249114|NCT00265850|Antidotes|antidotes|mesh-ancestor
14249115|NCT00265850|Protective Agents|protective agents|mesh-ancestor
14249116|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
14249117|NCT00265850|Vitamins|vitamins|mesh-ancestor
14249118|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
14249119|NCT00265850|Hematinics|hematinics|mesh-ancestor
14249120|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
14249121|NCT00265889|Melphalan|melphalan|mesh-list
14249122|NCT00265889|Busulfan|busulfan|mesh-list
14249123|NCT00265889|Etoposide|etoposide|mesh-list
14249124|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249125|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
14249126|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249127|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14249128|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14249129|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
14249130|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249131|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249132|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14249133|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14249134|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14249135|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14249136|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249137|NCT00265941|Cetuximab|cetuximab|mesh-list
14249138|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249139|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249140|NCT00266032|Drospirenone|drospirenone|mesh-list
14249141|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14249142|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
14249143|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14249144|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249145|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14249146|NCT00266032|Diuretics|diuretics|mesh-ancestor
14249147|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
14249148|NCT00266110|Trastuzumab|trastuzumab|mesh-list
14249149|NCT00266110|Vinorelbine|vinorelbine|mesh-list
14249150|NCT00266110|Sargramostim|sargramostim|mesh-list
14249151|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249152|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249153|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14249154|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
14249155|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
14249156|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
14249157|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249158|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
14249159|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249160|NCT00266227|Rituximab|rituximab|mesh-list
14249161|NCT00266227|Methotrexate|methotrexate|mesh-list
14249162|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249163|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249164|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
14249165|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249166|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14249167|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14249168|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
14249169|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14249170|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14249171|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
14249172|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249173|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
14249174|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249175|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14249176|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249177|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14249178|NCT00266279|Capecitabine|capecitabine|mesh-list
14249179|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
14249180|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14249181|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
14249182|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249183|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249184|NCT00266409|Alprazolam|alprazolam|mesh-list
14249185|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14249186|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14249187|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249188|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14249189|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14249190|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14249191|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
14249192|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
14249193|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14249194|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249195|NCT00266630|Carbamazepine|carbamazepine|mesh-list
14249196|NCT00266630|Valproic Acid|valproic acid|mesh-list
14249197|NCT00266630|Olanzapine|olanzapine|mesh-list
14249198|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
14249199|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
14249200|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249201|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249202|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14249203|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14249204|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14249205|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14249206|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14249207|NCT00266630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14249208|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14249209|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14249210|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249211|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14249212|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
14249213|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249214|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
14249215|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
14249216|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
14249217|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14249218|NCT00266630|Analgesics|analgesics|mesh-ancestor
14249219|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
14249220|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14249221|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14249222|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14249223|NCT00266656|Hormones|hormones|mesh-list
14249224|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14249225|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249226|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
14249227|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249228|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249229|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
14249230|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
14249231|NCT00266708|Diphosphonates|diphosphonates|mesh-list
14249232|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14249233|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14249234|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249235|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14249236|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249237|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14249238|NCT00266799|Doxorubicin|doxorubicin|mesh-list
14249239|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14249240|NCT00266799|Capecitabine|capecitabine|mesh-list
14249241|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14249242|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249243|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14249244|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14249245|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249246|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249247|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14249248|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
14249249|NCT00266812|Temozolomide|temozolomide|mesh-list
14249250|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14249251|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
14249252|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249253|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249254|NCT00266851|Azithromycin|azithromycin|mesh-list
14249255|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14249256|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14249257|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
14249258|NCT00266864|Testosterone|testosterone|mesh-list
14249259|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
14249260|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
14249261|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
14249262|NCT00266864|Androgens|androgens|mesh-ancestor
14249263|NCT00266864|Hormones|hormones|mesh-ancestor
14249264|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14249265|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249266|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14249267|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249268|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
14249269|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
14249270|NCT00267007|Hematinics|hematinics|mesh-ancestor
14249271|NCT00267020|Gemcitabine|gemcitabine|mesh-list
14249272|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14249273|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
14249274|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249275|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249276|NCT00267020|Antiviral Agents|antiviral agents|mesh-ancestor
14249277|NCT00267020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14249278|NCT00267020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249279|NCT00267020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249280|NCT00267020|Immunologic Factors|immunologic factors|mesh-ancestor
14249281|NCT00267020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249282|NCT00267046|Doxorubicin|doxorubicin|mesh-list
14249283|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14249284|NCT00267046|Vincristine|vincristine|mesh-list
14249285|NCT00267046|Ifosfamide|ifosfamide|mesh-list
14249286|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249287|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14249288|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14249289|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14249290|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249291|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249292|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14249293|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
14249294|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
14249295|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
14249296|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14249297|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
14249298|NCT00267059|Lenalidomide|lenalidomide|mesh-list
14249299|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
14249300|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249301|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14249302|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14249303|NCT00267059|Growth Substances|growth substances|mesh-ancestor
14249304|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
14249305|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249306|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
14249307|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249308|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14249309|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249310|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249311|NCT00267111|Tetracaine|tetracaine|mesh-list
14249312|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
14249313|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
14249314|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14249315|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249316|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
14249317|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249318|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
14249319|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14249320|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249321|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14249322|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
14249323|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14249324|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14249325|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249326|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249327|NCT00267189|Cyclosporine|cyclosporine|mesh-list
14249328|NCT00267189|Everolimus|everolimus|mesh-list
14249329|NCT00267189|Azathioprine|azathioprine|mesh-list
14249330|NCT00267189|Tacrolimus|tacrolimus|mesh-list
14249331|NCT00267189|Cyclosporins|cyclosporins|mesh-list
14249332|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
14249333|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249334|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249335|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
14249336|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249337|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14249338|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249339|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249340|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
14249341|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14249342|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14249343|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
14249344|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
14249345|NCT00267202|Omalizumab|omalizumab|mesh-list
14249346|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
14249347|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249348|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14249349|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14249350|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
14532178|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
14532179|NCT02241551|Irinotecan|irinotecan|mesh-list
14532180|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14532181|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532182|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
14532183|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
14532184|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
14532185|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042557|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15042558|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15042559|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
15042560|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15042561|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042562|NCT02045017|Dexamethasone|dexamethasone|mesh-list
15042563|NCT02045017|Pomalidomide|pomalidomide|mesh-list
15042564|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15042565|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
15042566|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
15042567|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249351|NCT00267293|Acetaminophen|acetaminophen|mesh-list
14249352|NCT00267293|Ibuprofen|ibuprofen|mesh-list
14249353|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14249354|NCT00267293|Analgesics|analgesics|mesh-ancestor
14249355|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
14249356|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249357|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249358|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
14249359|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14249360|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14249361|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14249362|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14249363|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249364|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249365|NCT00267488|Topotecan|topotecan|mesh-list
14249366|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14249367|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14249368|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249369|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249370|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249371|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
14249372|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14249373|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249374|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249375|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14249376|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14249377|NCT00267670|Protective Agents|protective agents|mesh-ancestor
14249378|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249379|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
14249380|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14249381|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
14249382|NCT00267696|Gemcitabine|gemcitabine|mesh-list
14249383|NCT00267696|Bevacizumab|bevacizumab|mesh-list
14249384|NCT00267696|Carboplatin|carboplatin|mesh-list
14249385|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249386|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249387|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14249388|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14249389|NCT00267696|Growth Substances|growth substances|mesh-ancestor
14249390|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249391|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
14249392|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14249393|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
14249394|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249395|NCT00267696|Antiviral Agents|antiviral agents|mesh-ancestor
14249396|NCT00267696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14249397|NCT00267696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249398|NCT00267696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249399|NCT00267696|Immunologic Factors|immunologic factors|mesh-ancestor
14249400|NCT00267748|Sunitinib|sunitinib|mesh-list
14249401|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249402|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14249403|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14249404|NCT00267748|Growth Substances|growth substances|mesh-ancestor
14249405|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249406|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
14249407|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14249408|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249409|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249410|NCT00267865|Leucovorin|leucovorin|mesh-list
14249411|NCT00267865|Rituximab|rituximab|mesh-list
14249412|NCT00267865|Methotrexate|methotrexate|mesh-list
14249413|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249414|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249415|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
14249416|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249417|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14249418|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14249419|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
14249420|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14249421|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14249422|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
14249423|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249424|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
14249425|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249426|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14249427|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249428|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14249429|NCT00267865|Antidotes|antidotes|mesh-ancestor
14249430|NCT00267865|Protective Agents|protective agents|mesh-ancestor
14249431|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
14249432|NCT00267865|Vitamins|vitamins|mesh-ancestor
14249433|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
14249434|NCT00267956|Ustekinumab|ustekinumab|mesh-list
14249435|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
14249436|NCT00267969|Ustekinumab|ustekinumab|mesh-list
14249437|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
14249438|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
14249439|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249440|NCT00268242|Gemcitabine|gemcitabine|mesh-list
14249441|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
14249442|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14249443|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
14249444|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249445|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249446|NCT00268242|Antiviral Agents|antiviral agents|mesh-ancestor
14249447|NCT00268242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14249448|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249449|NCT00268242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249450|NCT00268242|Immunologic Factors|immunologic factors|mesh-ancestor
14249451|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249452|NCT00268242|Analgesics|analgesics|mesh-ancestor
14249453|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
14249454|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249455|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14249456|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14249457|NCT00268346|Gefitinib|gefitinib|mesh-list
14249458|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249459|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14249460|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249461|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249462|NCT00268437|Carboplatin|carboplatin|mesh-list
14249463|NCT00268437|Pemetrexed|pemetrexed|mesh-list
14249464|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249465|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249466|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249467|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14249468|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14249469|NCT00268762|Argatroban|argatroban|mesh-list
14249470|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
14249471|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14249472|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
14249473|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249474|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249475|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
14249476|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14249477|NCT00268905|Carboplatin|carboplatin|mesh-list
14249478|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249479|NCT00268983|Iodine|iodine|mesh-list
14249480|NCT00268983|Rituximab|rituximab|mesh-list
14249481|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
14249482|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14249483|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249484|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249485|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
14249486|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249487|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14249488|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14249489|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14249490|NCT00268983|Trace Elements|trace elements|mesh-ancestor
14249491|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
14249492|NCT00269087|Fluticasone|fluticasone|mesh-list
14249493|NCT00269087|Xhance|xhance|mesh-list
14249494|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14249495|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14249496|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14249497|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
14249498|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249499|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249500|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14249501|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
14249502|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
14249503|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14249504|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14249505|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14249506|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14249507|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
14249508|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14249509|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249510|NCT00269113|Rituximab|rituximab|mesh-list
14249511|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249512|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249513|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
14249514|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249515|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14249516|NCT00269152|Carboplatin|carboplatin|mesh-list
14249517|NCT00269152|Pemetrexed|pemetrexed|mesh-list
14249518|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249519|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249520|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249521|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14249522|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14249523|NCT00269399|Vancomycin|vancomycin|mesh-list
14249524|NCT00269399|Rifaximin|rifaximin|mesh-list
14249525|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14249526|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14249527|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14249528|NCT00269919|Risperidone|risperidone|mesh-list
14249529|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14249530|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
14249531|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14249532|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249533|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249534|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14249535|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14249536|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14249537|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14249538|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14249539|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
14249540|NCT00270205|Vaccines|vaccines|mesh-list
14249541|NCT00270205|Immunologic Factors|immunologic factors|mesh-ancestor
14249542|NCT00270205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249543|NCT00270231|Naltrexone|naltrexone|mesh-list
14249544|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14249545|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14249546|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249547|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
14249548|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249549|NCT00270257|Buprenorphine|buprenorphine|mesh-list
14249550|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14249551|NCT00270257|Naloxone|naloxone|mesh-list
14249552|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14249553|NCT00270257|Narcotics|narcotics|mesh-ancestor
14249554|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14249555|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249556|NCT00270257|Analgesics|analgesics|mesh-ancestor
14249557|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
14249558|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249559|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14249560|NCT00270296|Ritonavir|ritonavir|mesh-list
14249561|NCT00270296|Lopinavir|lopinavir|mesh-list
14249562|NCT00270296|Lamivudine|lamivudine|mesh-list
14249563|NCT00270296|Zidovudine|zidovudine|mesh-list
14249564|NCT00270296|Nevirapine|nevirapine|mesh-list
14249565|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14249566|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14249567|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14249568|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
14249569|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249570|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249571|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14249572|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14249573|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
14249574|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14249575|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14249576|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14249577|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14249578|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14249579|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
14249580|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14249581|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14249582|NCT00270634|Tacrolimus|tacrolimus|mesh-list
14249583|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249584|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
14249585|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249586|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14249587|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249588|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249589|NCT00270790|Carboplatin|carboplatin|mesh-list
14249590|NCT00270790|Amifostine|amifostine|mesh-list
14249591|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249592|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14249593|NCT00270790|Protective Agents|protective agents|mesh-ancestor
14249594|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249595|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
14249596|NCT00270894|Docetaxel|docetaxel|mesh-list
14249597|NCT00270894|Trastuzumab|trastuzumab|mesh-list
14249598|NCT00270894|Epirubicin|epirubicin|mesh-list
14249599|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249600|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
14249601|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249602|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14249603|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14249604|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
14249605|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249606|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249607|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14249608|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
14249609|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
14249610|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
14249611|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249612|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14249613|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14249614|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14249615|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249616|NCT00271024|Naltrexone|naltrexone|mesh-list
14249617|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14249618|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14249619|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249620|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
14249621|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249622|NCT00271219|Buprenorphine|buprenorphine|mesh-list
14249623|NCT00271219|Methadone|methadone|mesh-list
14249624|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14249625|NCT00271219|Narcotics|narcotics|mesh-ancestor
14249626|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14249627|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249628|NCT00271219|Analgesics|analgesics|mesh-ancestor
14249629|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
14249630|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249631|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14249632|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
14249633|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
14249634|NCT00271505|Bevacizumab|bevacizumab|mesh-list
14249635|NCT00271505|Carboplatin|carboplatin|mesh-list
14249636|NCT00271505|Docetaxel|docetaxel|mesh-list
14249637|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249638|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249639|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14249640|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14249641|NCT00271505|Growth Substances|growth substances|mesh-ancestor
14249642|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249643|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
14249644|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
14249645|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
14249646|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
14249647|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249648|NCT00271570|Infliximab|infliximab|mesh-list
14249649|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
14249650|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14249651|NCT00271570|Antibodies|antibodies|mesh-list
14249652|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
14249653|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14249654|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
14249655|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249656|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
14249657|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14249658|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14249659|NCT00271596|Citalopram|citalopram|mesh-list
14249660|NCT00271596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14249661|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14249662|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14249663|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249664|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14249665|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
14249666|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249667|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14249668|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
14249669|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14249670|NCT00271609|Bevacizumab|bevacizumab|mesh-list
14249671|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249672|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249673|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14249674|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14249675|NCT00271609|Growth Substances|growth substances|mesh-ancestor
14249676|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249677|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
14249678|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14249679|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249680|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14249681|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249682|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249683|NCT00272311|Aspirin|aspirin|mesh-list
14249684|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14249685|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14249686|NCT00272311|Analgesics|analgesics|mesh-ancestor
14249687|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
14249688|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249689|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249690|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14249691|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14249692|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14249693|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14249694|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249695|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14249696|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14249697|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249698|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
14249699|NCT00272337|Aspirin|aspirin|mesh-list
14249700|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14249701|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14249702|NCT00272337|Analgesics|analgesics|mesh-ancestor
14249703|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
14249704|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249705|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249706|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14249707|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14249708|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14249709|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14249710|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249711|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14249712|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14249713|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249714|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
14249715|NCT00272779|Emtricitabine|emtricitabine|mesh-list
14249716|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14249717|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
14249718|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14249719|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14249720|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14249721|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249722|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249723|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14249724|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14249725|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14249726|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14249727|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
14249728|NCT00272792|Verapamil|verapamil|mesh-list
14249729|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14249730|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14249731|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14249732|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249733|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14249734|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249735|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
14249736|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
14249737|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
14249738|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14249739|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249740|NCT00272987|Paclitaxel|paclitaxel|mesh-list
14249741|NCT00272987|Trastuzumab|trastuzumab|mesh-list
14249742|NCT00272987|Lapatinib|lapatinib|mesh-list
14249743|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14249744|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249745|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
14249746|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
14249747|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
14249748|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249749|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249750|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14249751|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249752|NCT00273052|Metoprolol|metoprolol|mesh-list
14249753|NCT00273052|Carvedilol|carvedilol|mesh-list
14249754|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14249755|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14249756|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
14249757|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
14249758|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249759|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249760|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14249761|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14249762|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14249763|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
14249764|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14249765|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249766|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
14249767|NCT00273052|Protective Agents|protective agents|mesh-ancestor
14249768|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14249769|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14249770|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14249771|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
14249772|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14249773|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14249774|NCT00273754|Caffeine|caffeine|mesh-list
14249775|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14249776|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249777|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14249778|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249779|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249780|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14249781|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14249782|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
14249783|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14249784|NCT00273910|Imiquimod|imiquimod|mesh-list
14249785|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14249786|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
14249787|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249788|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249789|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
14249790|NCT00274261|Nonoxynol|nonoxynol|mesh-list
14249791|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
14249792|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
14249793|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249794|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14249795|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
14249796|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14249797|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14249798|NCT00274287|Sargramostim|sargramostim|mesh-list
14249799|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
14249800|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249801|NCT00274456|Paclitaxel|paclitaxel|mesh-list
14249802|NCT00274456|Docetaxel|docetaxel|mesh-list
14249803|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14249804|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14249805|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249806|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
14249807|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
14249808|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
14249809|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249810|NCT00274469|Fulvestrant|fulvestrant|mesh-list
14249811|NCT00274469|Anastrozole|anastrozole|mesh-list
14249812|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14249813|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249814|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14249815|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14249816|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
14249817|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14249818|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249819|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14249820|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14249821|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249822|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249823|NCT00274651|Belinostat|belinostat|mesh-list
14249824|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249825|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14249826|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249827|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249828|NCT00274742|Blinatumomab|blinatumomab|mesh-list
14249829|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
14249830|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249831|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
14249832|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249833|NCT00274768|Capecitabine|capecitabine|mesh-list
14249834|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14249835|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
14249836|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249837|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249838|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
14249839|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
14249840|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249841|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249842|NCT00274846|Aldesleukin|aldesleukin|mesh-list
14249843|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
14249844|NCT00274846|Fludarabine|fludarabine|mesh-list
14249845|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
14249846|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249847|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
14249848|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249849|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14249850|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14249851|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
14249852|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249853|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249854|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14249855|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14249856|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
14249857|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14249858|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14249859|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
14249860|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14249861|NCT00274924|Prednisone|prednisone|mesh-list
14249862|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
14249863|NCT00274924|Ifosfamide|ifosfamide|mesh-list
14249864|NCT00274924|Rituximab|rituximab|mesh-list
14249865|NCT00274924|Carboplatin|carboplatin|mesh-list
14249866|NCT00274924|Doxorubicin|doxorubicin|mesh-list
14249867|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14249868|NCT00274924|Etoposide|etoposide|mesh-list
14249869|NCT00274924|Vincristine|vincristine|mesh-list
14249870|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
14249871|NCT00274924|Lenograstim|lenograstim|mesh-list
14249872|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249873|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
14249874|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249875|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14249876|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14249877|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
14532186|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14249878|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249879|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249880|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14249881|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14249882|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14249883|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14249884|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14249885|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249886|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14249887|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
14249888|NCT00274924|Hormones|hormones|mesh-ancestor
14249889|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14249890|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14249891|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14249892|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14249893|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
14249894|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
14249895|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
14249896|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
14249897|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
14249898|NCT00274937|Fluorouracil|fluorouracil|mesh-list
14249899|NCT00274937|Amifostine|amifostine|mesh-list
14249900|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249901|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
14249902|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249903|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14249904|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249905|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
14249906|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249907|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14249908|NCT00274937|Protective Agents|protective agents|mesh-ancestor
14249909|NCT00275002|Temozolomide|temozolomide|mesh-list
14249910|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
14249911|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14249912|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
14249913|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249914|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249915|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249916|NCT00275028|Cediranib|cediranib|mesh-list
14249917|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249918|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249919|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249920|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14249921|NCT00275262|Leuprolide|leuprolide|mesh-list
14249922|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14249923|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
14249924|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14249925|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249926|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14249927|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249928|NCT00275275|Pramipexole|pramipexole|mesh-list
14249929|NCT00275275|Ropinirole|ropinirole|mesh-list
14249930|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
14249931|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249932|NCT00275275|Protective Agents|protective agents|mesh-ancestor
14249933|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249934|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14249935|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14249936|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
14249937|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
14249938|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14249939|NCT00275301|Olanzapine|olanzapine|mesh-list
14249940|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
14249941|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
14249942|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249943|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249944|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14249945|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14249946|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14249947|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14249948|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14249949|NCT00275301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14249950|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14249951|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14249952|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249953|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14249954|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
14249955|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
14249956|NCT00275509|Dexamethasone|dexamethasone|mesh-list
14249957|NCT00275509|Prednisone|prednisone|mesh-list
14249958|NCT00275509|Tacrolimus|tacrolimus|mesh-list
14249959|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
14249960|NCT00275509|Daclizumab|daclizumab|mesh-list
14249961|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14249962|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
14249963|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
14249964|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249965|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249966|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14249967|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
14249968|NCT00275509|Hormones|hormones|mesh-ancestor
14249969|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14249970|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14249971|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249972|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14249973|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
14249974|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14249975|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14249976|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14249977|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14249978|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14249979|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
14249980|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14249981|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14249982|NCT00275561|Fluticasone|fluticasone|mesh-list
14249983|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14249984|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14249985|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
14249986|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14249987|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249988|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14249989|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
14249990|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
14249991|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14249992|NCT00275821|Ranibizumab|ranibizumab|mesh-list
14249993|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14249994|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14249995|NCT00275821|Growth Substances|growth substances|mesh-ancestor
14249996|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14249997|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
14249998|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14249999|NCT00275834|Zonisamide|zonisamide|mesh-list
14250000|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
14250001|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14250002|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14250003|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250004|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14250005|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250006|NCT00276094|Tamoxifen|tamoxifen|mesh-list
14250007|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14250008|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
14250009|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14250010|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250011|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14250012|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250013|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14250014|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14250015|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14250016|NCT00276250|Abatacept|abatacept|mesh-list
14250017|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14250018|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250019|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250020|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250021|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
14250022|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250023|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250024|NCT00276380|Aspirin|aspirin|mesh-list
14250025|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14250026|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14250027|NCT00276380|Analgesics|analgesics|mesh-ancestor
14250028|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
14250029|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14250030|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250031|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14250032|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250033|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14250034|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14250035|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250036|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14250037|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14250038|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250039|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
14250040|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
14250041|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14250042|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250043|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250044|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
14250045|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14250046|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250047|NCT00276549|Gemcitabine|gemcitabine|mesh-list
14250048|NCT00276549|Docetaxel|docetaxel|mesh-list
14250049|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14250050|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
14250051|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250052|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250053|NCT00276549|Antiviral Agents|antiviral agents|mesh-ancestor
14250054|NCT00276549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250055|NCT00276549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250056|NCT00276549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250057|NCT00276549|Immunologic Factors|immunologic factors|mesh-ancestor
14250058|NCT00276549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250059|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
14250060|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
14250061|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
14250062|NCT00276614|Bortezomib|bortezomib|mesh-list
14250063|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250064|NCT00276744|Gemcitabine|gemcitabine|mesh-list
14250065|NCT00276744|Sirolimus|sirolimus|mesh-list
14250066|NCT00276744|Capecitabine|capecitabine|mesh-list
14250067|NCT00276744|Docetaxel|docetaxel|mesh-list
14250068|NCT00276744|Irinotecan|irinotecan|mesh-list
14250069|NCT00276744|Cetuximab|cetuximab|mesh-list
14250070|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14250071|NCT00276744|Mitomycins|mitomycins|mesh-list
14250072|NCT00276744|Mitomycin|mitomycin|mesh-list
14250073|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14250074|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
14250075|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250076|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250077|NCT00276744|Antiviral Agents|antiviral agents|mesh-ancestor
14250078|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250079|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250080|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250081|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
14250082|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250083|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
14250084|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
14250085|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
14250086|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14250087|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14250088|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250089|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14250090|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14250091|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14250092|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
14250093|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
14250094|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14250095|NCT00276861|Gemcitabine|gemcitabine|mesh-list
14250096|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
14250097|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14250098|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
14250099|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250100|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250101|NCT00276861|Antiviral Agents|antiviral agents|mesh-ancestor
14250102|NCT00276861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250103|NCT00276861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250104|NCT00276861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250105|NCT00276861|Immunologic Factors|immunologic factors|mesh-ancestor
14250106|NCT00276861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250107|NCT00277212|Lamotrigine|lamotrigine|mesh-list
14250108|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
14250109|NCT00277212|Aripiprazole|aripiprazole|mesh-list
14250110|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
14250111|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14250112|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14250113|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14250114|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14250115|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250116|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
14250117|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
14250118|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14250119|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250120|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14250121|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14250122|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
14250123|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14250124|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14250125|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14250126|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14250127|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14250128|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14250129|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14250130|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14250131|NCT00277355|Minocycline|minocycline|mesh-list
14250132|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14250133|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250134|NCT00277394|Heparin|heparin|mesh-list
14250135|NCT00277394|Tinzaparin|tinzaparin|mesh-list
14250136|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
14250137|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14250138|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14250139|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532187|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
14532188|NCT02241551|Antiviral Agents|antiviral agents|mesh-ancestor
14532189|NCT02241551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532190|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532191|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532192|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
14532193|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532194|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14532195|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14532196|NCT02232880|Abatacept|abatacept|mesh-list
14532197|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14532198|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532199|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532200|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532201|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
14532202|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532203|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14532204|NCT02239627|Clonidine|clonidine|mesh-list
14532205|NCT02239627|Analgesics|analgesics|mesh-ancestor
14532206|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
14532207|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532208|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532209|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14532210|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
14532211|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
14532212|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14532213|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14532214|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14532215|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
14532216|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532217|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532218|NCT02244944|Ezetimibe|ezetimibe|mesh-list
14532219|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14532220|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14532221|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
14532222|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532223|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14532224|NCT02241187|Cetuximab|cetuximab|mesh-list
14250140|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
14250141|NCT00278109|Doxorubicin|doxorubicin|mesh-list
14250142|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250143|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
14250144|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250145|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250146|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14250147|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
14250148|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250149|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250150|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14250151|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14250152|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14250153|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14250154|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250155|NCT00278148|Paclitaxel|paclitaxel|mesh-list
14250156|NCT00278148|Carboplatin|carboplatin|mesh-list
14250157|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14250158|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14250159|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250160|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
14250161|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
14250162|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
14250163|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250164|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14250165|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250166|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
14250167|NCT00278161|Rituximab|rituximab|mesh-list
14250168|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250169|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
14250170|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250171|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250172|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14250173|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
14250174|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250175|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250176|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14250177|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250178|NCT00278395|Vorinostat|vorinostat|mesh-list
14250179|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250180|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14250181|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250182|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250183|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
14250184|NCT00278512|Fludarabine|fludarabine|mesh-list
14250185|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
14250186|NCT00278512|Tacrolimus|tacrolimus|mesh-list
14250187|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
14250188|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250189|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
14250190|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250191|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250192|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14250193|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
14250194|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250195|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250196|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14250197|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14250198|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250199|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250200|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
14250201|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14250202|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14250203|NCT00278564|Prednisolone|prednisolone|mesh-list
14250204|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
14250205|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
14250206|NCT00278564|Rituximab|rituximab|mesh-list
14250207|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14250208|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
14250209|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250210|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
14250211|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250212|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250213|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15042568|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250214|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
14250215|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250216|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250217|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14250218|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250219|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14250220|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
14250221|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
14250222|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14250223|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14250224|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
14250225|NCT00278564|Hormones|hormones|mesh-ancestor
14250226|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14250227|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14250228|NCT00278564|Protective Agents|protective agents|mesh-ancestor
14250229|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14250230|NCT00278863|Capecitabine|capecitabine|mesh-list
14250231|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14250232|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
14250233|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250234|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250235|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
14250236|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250237|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14250238|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250239|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250240|NCT00278889|Leucovorin|leucovorin|mesh-list
14250241|NCT00278889|Bevacizumab|bevacizumab|mesh-list
14250242|NCT00278889|Fluorouracil|fluorouracil|mesh-list
14250243|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
14250244|NCT00278889|Cediranib|cediranib|mesh-list
14250245|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250246|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250247|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14250248|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14250249|NCT00278889|Growth Substances|growth substances|mesh-ancestor
14250250|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250251|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
14250252|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
14250253|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250254|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14250255|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250256|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
14250257|NCT00278889|Antidotes|antidotes|mesh-ancestor
14250258|NCT00278889|Protective Agents|protective agents|mesh-ancestor
14250259|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
14250260|NCT00278889|Vitamins|vitamins|mesh-ancestor
14250261|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
14250262|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14250263|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250264|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
14250265|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14250266|NCT00278954|Antibodies|antibodies|mesh-list
14250267|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
14250268|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14250269|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
14250270|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250271|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
14250272|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
14250273|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
14250274|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
14250275|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
14250276|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14250277|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250278|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
14250279|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250280|NCT00279305|Rituximab|rituximab|mesh-list
14250281|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250282|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250283|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
14250284|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250285|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250286|NCT00279708|Atorvastatin|atorvastatin|mesh-list
14250287|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14250288|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14250289|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
14250290|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250291|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14250292|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14250293|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250294|NCT00279812|Selenium|selenium|mesh-list
14250295|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
14250296|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250297|NCT00279812|Protective Agents|protective agents|mesh-ancestor
14250298|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250299|NCT00279812|Trace Elements|trace elements|mesh-ancestor
14250300|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
14250301|NCT00279916|Triamcinolone|triamcinolone|mesh-list
14250302|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
14250303|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
14250304|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
14250305|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14250306|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
14250307|NCT00279916|Hormones|hormones|mesh-ancestor
14250308|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14250309|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250310|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250311|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
14250312|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250313|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250314|NCT00280059|Pregabalin|pregabalin|mesh-list
14250315|NCT00280059|Lamotrigine|lamotrigine|mesh-list
14250316|NCT00280059|Analgesics|analgesics|mesh-ancestor
14250317|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
14250318|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14250319|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250320|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
14250321|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14250322|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14250323|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250324|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14250325|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14250326|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14250327|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14250328|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14250329|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14250330|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14250331|NCT00280150|Paclitaxel|paclitaxel|mesh-list
14250332|NCT00280150|Bevacizumab|bevacizumab|mesh-list
14250333|NCT00280150|Carboplatin|carboplatin|mesh-list
14250334|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14250335|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14250336|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250337|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
14250338|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
14250339|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
14250340|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250341|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250342|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14250343|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14250344|NCT00280150|Growth Substances|growth substances|mesh-ancestor
14250345|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250346|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
14250347|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14250348|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250349|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
14250350|NCT00280241|Rituximab|rituximab|mesh-list
14250351|NCT00280241|Fludarabine|fludarabine|mesh-list
14250352|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250353|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
14250354|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250355|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250356|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14250357|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
14250358|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250359|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250360|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14250361|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250362|NCT00280293|Lamotrigine|lamotrigine|mesh-list
14250363|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
14250364|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14250365|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14250366|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250367|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14250368|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250369|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14250370|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14250371|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14250372|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14250373|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14250374|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
14250375|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
14250376|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14250377|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14250378|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14250379|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14250380|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250381|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
14250382|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14250383|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250384|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14250385|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14250386|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14250387|NCT00280397|Lenvatinib|lenvatinib|mesh-list
14250388|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250389|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14250390|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250391|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250392|NCT00280566|Ziprasidone|ziprasidone|mesh-list
14250393|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14250394|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
14250395|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14250396|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250397|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250398|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14250399|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14250400|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14250401|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14250402|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14250403|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
14250404|NCT00280735|Carboplatin|carboplatin|mesh-list
14250405|NCT00280735|Docetaxel|docetaxel|mesh-list
14250406|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250407|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
14250408|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
14250409|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
14250410|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250411|NCT00280748|Pemetrexed|pemetrexed|mesh-list
14250412|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250413|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250414|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250415|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14250416|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14250417|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14250418|NCT00281021|Digoxin|digoxin|mesh-list
14250419|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250420|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14250421|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250422|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250423|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14250424|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14250425|NCT00281021|Protective Agents|protective agents|mesh-ancestor
14250426|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250427|NCT00281528|Paclitaxel|paclitaxel|mesh-list
14250428|NCT00281528|Bevacizumab|bevacizumab|mesh-list
14250429|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14250430|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14250431|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250432|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
14250433|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
14250434|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
14250435|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250436|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250437|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14250438|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14250439|NCT00281528|Growth Substances|growth substances|mesh-ancestor
14250440|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250441|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
14250442|NCT00281580|Amlodipine|amlodipine|mesh-list
14250443|NCT00281580|Telmisartan|telmisartan|mesh-list
14250444|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14250445|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14250446|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14250447|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250448|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14250449|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250450|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
14250451|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14250452|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14250453|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14250454|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
14250455|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250456|NCT00281697|Bevacizumab|bevacizumab|mesh-list
14250457|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250458|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250459|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14250460|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14250461|NCT00281697|Growth Substances|growth substances|mesh-ancestor
14250462|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250463|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
14250464|NCT00281827|Gemcitabine|gemcitabine|mesh-list
14250465|NCT00281827|Thalidomide|thalidomide|mesh-list
14250466|NCT00281827|Carboplatin|carboplatin|mesh-list
14250467|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250468|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14250469|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
14250470|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250471|NCT00281827|Antiviral Agents|antiviral agents|mesh-ancestor
14250472|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250473|NCT00281827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250474|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250475|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
14250476|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250477|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
14250478|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14250479|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14250480|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14250481|NCT00281827|Growth Substances|growth substances|mesh-ancestor
14250482|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
14250483|NCT00281840|Bevacizumab|bevacizumab|mesh-list
14250484|NCT00281840|Docetaxel|docetaxel|mesh-list
14250485|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250486|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250487|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14250488|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14250489|NCT00281840|Growth Substances|growth substances|mesh-ancestor
14250490|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250491|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
14250492|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
14250493|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
14250494|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
14250495|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250496|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
14250497|NCT00281918|Rituximab|rituximab|mesh-list
14250498|NCT00281918|Fludarabine|fludarabine|mesh-list
14250499|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
14250500|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250501|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
14250502|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250503|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250504|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14250505|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
14250506|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250507|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250508|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14250509|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250510|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14250511|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
14250512|NCT00281957|Sirolimus|sirolimus|mesh-list
14250513|NCT00281957|Sorafenib|sorafenib|mesh-list
14250514|NCT00281957|Tipifarnib|tipifarnib|mesh-list
14250515|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250516|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14250517|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250518|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250519|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14250520|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250521|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14250522|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
14250523|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250524|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
14250525|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250526|NCT00282048|Axitinib|axitinib|mesh-list
14250527|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250528|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14250529|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250530|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250531|NCT00282087|Gemcitabine|gemcitabine|mesh-list
14250532|NCT00282087|Docetaxel|docetaxel|mesh-list
14250533|NCT00282087|Doxorubicin|doxorubicin|mesh-list
14250534|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14250535|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
14250536|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250537|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250538|NCT00282087|Antiviral Agents|antiviral agents|mesh-ancestor
14250539|NCT00282087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250540|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250541|NCT00282087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250542|NCT00282087|Immunologic Factors|immunologic factors|mesh-ancestor
14250543|NCT00282087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250544|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
14250545|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
14250546|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
14250547|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14250548|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14250549|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14250550|NCT00282243|Tacrolimus|tacrolimus|mesh-list
14250551|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250552|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
14250553|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250554|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14250555|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250556|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250557|NCT00282256|Tacrolimus|tacrolimus|mesh-list
14250558|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250559|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
14250560|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250561|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14250562|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250563|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250564|NCT00282282|Sirolimus|sirolimus|mesh-list
14250565|NCT00282282|Fludarabine|fludarabine|mesh-list
14250566|NCT00282282|Busulfan|busulfan|mesh-list
14250567|NCT00282282|Tacrolimus|tacrolimus|mesh-list
14250568|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250569|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250570|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250571|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
14250572|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250573|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14250574|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250575|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14250576|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250577|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14250578|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
14250579|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
14250580|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14250581|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14250582|NCT00282308|Rituximab|rituximab|mesh-list
14250583|NCT00282308|Methotrexate|methotrexate|mesh-list
14250584|NCT00282308|Vaccines|vaccines|mesh-list
14250585|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14250586|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
14250587|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
14250588|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250589|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250590|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250591|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250592|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14250593|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
14250594|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14250595|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14250596|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
14250597|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250598|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
14250599|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250600|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14250601|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250602|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14250603|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14250604|NCT00282347|Acetaminophen|acetaminophen|mesh-list
14250605|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
14250606|NCT00282347|Promethazine|promethazine|mesh-list
14250607|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
14250608|NCT00282347|Prednisone|prednisone|mesh-list
14250609|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
14250610|NCT00282347|Rituximab|rituximab|mesh-list
14250611|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250612|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250613|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
14250614|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250615|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250616|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14250617|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
14250618|NCT00282347|Hormones|hormones|mesh-ancestor
14250619|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14250620|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14250621|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14250622|NCT00282347|Analgesics|analgesics|mesh-ancestor
14250623|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
14250624|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14250625|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
14250626|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14250627|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14250628|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
14250629|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14250630|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250631|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250632|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250633|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
14250634|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
14250635|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14250636|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14250637|NCT00282347|Protective Agents|protective agents|mesh-ancestor
14250638|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14250639|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14250640|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14250641|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
14250642|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
14250643|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14250644|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
14250645|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
14250646|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14250647|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14250648|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
14250649|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
14250650|NCT00282412|Cyclosporine|cyclosporine|mesh-list
14250651|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
14250652|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
14250653|NCT00282412|Fludarabine|fludarabine|mesh-list
14250654|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
14250655|NCT00282412|Cyclosporins|cyclosporins|mesh-list
14250656|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250657|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
14250658|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250659|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250660|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14250661|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
14250662|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250663|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250664|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14250665|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250666|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
14250667|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250668|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
14250669|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14250670|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14250671|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14250672|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
14250673|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14250674|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250675|NCT00282464|Ziprasidone|ziprasidone|mesh-list
14250676|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14250677|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
14250678|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14250679|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250680|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250681|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14250682|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14250683|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14250684|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14250685|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14250686|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
14250687|NCT00282568|Tacrolimus|tacrolimus|mesh-list
14250688|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250689|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
14250690|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250691|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14250692|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250693|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250694|NCT00282828|Clonazepam|clonazepam|mesh-list
14250695|NCT00282828|Sertraline|sertraline|mesh-list
14250696|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14250697|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
14250698|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14250699|NCT00282828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14250700|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14250701|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14250702|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250703|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14250704|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
14250705|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250706|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14250707|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14250708|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
14250709|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
14250710|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
14250711|NCT00282919|Azithromycin|azithromycin|mesh-list
14250712|NCT00282919|Chloroquine|chloroquine|mesh-list
14250713|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14250714|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250715|NCT00282919|Amebicides|amebicides|mesh-ancestor
14250716|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14250717|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14250718|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
14250719|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250720|NCT00282971|Insulin|insulin|mesh-list
14250721|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14250722|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250723|NCT00282984|Varenicline|varenicline|mesh-list
14250724|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14250725|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14250726|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
14250727|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14250728|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250729|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250730|NCT00283049|Insulin|insulin|mesh-list
14250731|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14250732|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
14250733|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
14250734|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14250735|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250736|NCT00283062|Docetaxel|docetaxel|mesh-list
14250737|NCT00283062|Leuprolide|leuprolide|mesh-list
14250738|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250739|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
14250740|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
14250741|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
14250742|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250743|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14250744|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
14250745|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14250746|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250747|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14250748|NCT00283244|Gemcitabine|gemcitabine|mesh-list
14250749|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14250750|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14250751|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
14250752|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250753|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250754|NCT00283244|Antiviral Agents|antiviral agents|mesh-ancestor
14250755|NCT00283244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250756|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250757|NCT00283244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250758|NCT00283244|Immunologic Factors|immunologic factors|mesh-ancestor
14250759|NCT00283244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250760|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14250761|NCT00283387|Betaine|betaine|mesh-list
14250762|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14250763|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
14250764|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14250765|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
14250766|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250767|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14250768|NCT00283504|Omalizumab|omalizumab|mesh-list
14250769|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14250770|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14250771|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
14250772|NCT00283595|Hormones|hormones|mesh-list
14250773|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14250774|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250775|NCT00283686|Telmisartan|telmisartan|mesh-list
14250776|NCT00283686|Lisinopril|lisinopril|mesh-list
14250777|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14250778|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14250779|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14250780|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14250781|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250782|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
14250783|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250784|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14250785|NCT00283686|Protective Agents|protective agents|mesh-ancestor
14250786|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250787|NCT00283712|Infliximab|infliximab|mesh-list
14250788|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
14250789|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14250790|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250791|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
14250792|NCT00283803|Hormones|hormones|mesh-list
14250793|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14250794|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
14250795|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14250796|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250797|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250798|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
14250799|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14250800|NCT00283803|Protective Agents|protective agents|mesh-ancestor
14250801|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14250802|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250803|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250804|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14250805|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14250806|NCT00283803|Analgesics|analgesics|mesh-ancestor
14250807|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
14250808|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14250809|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14250810|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250811|NCT00283816|Metformin|metformin|mesh-list
14250812|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
14250813|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
14250814|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
14250815|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14250816|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250817|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14250818|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14250819|NCT00284050|Ranibizumab|ranibizumab|mesh-list
14250820|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14250821|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14250822|NCT00284050|Growth Substances|growth substances|mesh-ancestor
14250823|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250824|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
14250825|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250826|NCT00284089|Ranibizumab|ranibizumab|mesh-list
14250827|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14250828|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14250829|NCT00284089|Growth Substances|growth substances|mesh-ancestor
14250830|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250831|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
14250832|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250833|NCT00284141|Aflibercept|aflibercept|mesh-list
14250834|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14250835|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14250836|NCT00284141|Growth Substances|growth substances|mesh-ancestor
14250837|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250838|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
14250839|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250840|NCT00284180|Trastuzumab|trastuzumab|mesh-list
14250841|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250842|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250843|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
14250844|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14250845|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14250846|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14250847|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14250848|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250849|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
14250850|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14250851|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250852|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14250853|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14250854|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14250855|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14250856|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14250857|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532225|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14532226|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532227|NCT02239926|Ranolazine|ranolazine|mesh-list
14532228|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14532229|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14532230|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532231|NCT02234011|Ketamine|ketamine|mesh-list
14532232|NCT02234011|Analgesics|analgesics|mesh-ancestor
14532233|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
14532234|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532235|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532236|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14532237|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14532238|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
14532239|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
14532240|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532241|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14532242|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14532243|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532244|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532245|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
14532246|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14532247|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14532248|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532249|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
14532250|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
14532251|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532252|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
14532253|NCT02224599|Imiquimod|imiquimod|mesh-list
14532254|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532255|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
14250858|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
14250859|NCT00284934|Prednisone|prednisone|mesh-list
14250860|NCT00284934|Tacrolimus|tacrolimus|mesh-list
14250861|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14250862|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
14250863|NCT00284934|Hormones|hormones|mesh-ancestor
14250864|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14250865|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250866|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14250867|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250868|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250869|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
14250870|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14250871|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250872|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250873|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14250874|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14250875|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
14250876|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14250877|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250878|NCT00285012|Varenicline|varenicline|mesh-list
14250879|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14250880|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14250881|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
14250882|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14250883|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250884|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250885|NCT00285467|Vitamin D|vitamin d|mesh-list
14250886|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
14250887|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
14250888|NCT00285467|Vitamins|vitamins|mesh-ancestor
14250889|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
14250890|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250891|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14250892|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14250893|NCT00285584|Bupropion|bupropion|mesh-list
14250894|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14250895|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
14250896|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14250897|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14250898|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14250899|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14250900|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250901|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
14250902|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14250903|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250904|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14250905|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14250906|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250907|NCT00285779|Etanercept|etanercept|mesh-list
14250908|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14250909|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14250910|NCT00285779|Analgesics|analgesics|mesh-ancestor
14250911|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
14250912|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14250913|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250914|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14250915|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250916|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14250917|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250918|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
14250919|NCT00285818|Mifepristone|mifepristone|mesh-list
14250920|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14250921|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
14250922|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14250923|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250924|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14250925|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14250926|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14250927|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
14250928|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14250929|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14250930|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
14250931|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14250932|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
14250933|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14250934|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14250935|NCT00285857|Lovastatin|lovastatin|mesh-list
14250936|NCT00285857|L 647318|l 647318|mesh-list
14250937|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
14250938|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14250939|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
14250940|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250941|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14250942|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14250943|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14250944|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250945|NCT00286091|Denosumab|denosumab|mesh-list
14250946|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14250947|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250948|NCT00286156|Sirolimus|sirolimus|mesh-list
14250949|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14250950|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14250951|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14250952|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250953|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
14250954|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14250955|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
14250956|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250957|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
14250958|NCT00286182|Hematinics|hematinics|mesh-ancestor
14250959|NCT00286221|Fentanyl|fentanyl|mesh-list
14250960|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14250961|NCT00286221|Narcotics|narcotics|mesh-ancestor
14250962|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14250963|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250964|NCT00286221|Analgesics|analgesics|mesh-ancestor
14250965|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
14250966|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14250967|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14250968|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14250969|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
14250970|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
14250971|NCT00286234|Niacin|niacin|mesh-list
14250972|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
14250973|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14250974|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
14250975|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14250976|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14250977|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
14250978|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
14250979|NCT00286234|Vitamins|vitamins|mesh-ancestor
14250980|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
14250981|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250982|NCT00286325|Rituximab|rituximab|mesh-list
14250983|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14250984|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14250985|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
14250986|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250987|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14250988|NCT00286429|Insulin|insulin|mesh-list
14250989|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14250990|NCT00286429|Alogliptin|alogliptin|mesh-list
14250991|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14250992|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14250993|NCT00286429|Incretins|incretins|mesh-ancestor
14250994|NCT00286429|Hormones|hormones|mesh-ancestor
14250995|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14250996|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14250997|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
14250998|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14250999|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251000|NCT00286442|Metformin|metformin|mesh-list
14251001|NCT00286442|Alogliptin|alogliptin|mesh-list
14251002|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14251003|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251004|NCT00286442|Incretins|incretins|mesh-ancestor
14251005|NCT00286442|Hormones|hormones|mesh-ancestor
14251006|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251007|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14251008|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
14251009|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251010|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251011|NCT00286455|Alogliptin|alogliptin|mesh-list
14251012|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14251013|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251014|NCT00286455|Incretins|incretins|mesh-ancestor
14251015|NCT00286455|Hormones|hormones|mesh-ancestor
14251016|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251017|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14251018|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
14251019|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251020|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251021|NCT00286468|Alogliptin|alogliptin|mesh-list
14251022|NCT00286468|Glyburide|glyburide|mesh-list
14251023|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14251024|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251025|NCT00286468|Incretins|incretins|mesh-ancestor
14251026|NCT00286468|Hormones|hormones|mesh-ancestor
14251027|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251028|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14251029|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
14251030|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251031|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251032|NCT00286494|Pioglitazone|pioglitazone|mesh-list
14251033|NCT00286494|Alogliptin|alogliptin|mesh-list
14251034|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14251035|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251036|NCT00286494|Incretins|incretins|mesh-ancestor
14251037|NCT00286494|Hormones|hormones|mesh-ancestor
14251038|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251039|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14251040|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
14251041|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251042|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251043|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14251044|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14251045|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14251046|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14251047|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251048|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
14251049|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14251050|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251051|NCT00287053|Valproic Acid|valproic acid|mesh-list
14251052|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
14251053|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251054|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251055|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
14251056|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14251057|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251058|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
14251059|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14251060|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14251061|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14251062|NCT00287222|Bevacizumab|bevacizumab|mesh-list
14251063|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14251064|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14251065|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251066|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14251067|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14251068|NCT00287222|Growth Substances|growth substances|mesh-ancestor
14251069|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251070|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
14251071|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14251072|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251073|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251074|NCT00287287|Lenalidomide|lenalidomide|mesh-list
14251075|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
14251076|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251077|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14251078|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14251079|NCT00287287|Growth Substances|growth substances|mesh-ancestor
14251080|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
14251081|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251082|NCT00287339|Esomeprazole|esomeprazole|mesh-list
14251083|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14251084|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14251085|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14251086|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251087|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251088|NCT00287586|Testosterone|testosterone|mesh-list
14251089|NCT00287586|Androgens|androgens|mesh-ancestor
14251090|NCT00287586|Hormones|hormones|mesh-ancestor
14251091|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251092|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251093|NCT00287690|Genistein|genistein|mesh-list
14251094|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14251095|NCT00287690|Protective Agents|protective agents|mesh-ancestor
14251096|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251097|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251098|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14251099|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251100|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251101|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
14251102|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14251103|NCT00287690|Estrogens|estrogens|mesh-ancestor
14251104|NCT00287690|Hormones|hormones|mesh-ancestor
14251105|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251106|NCT00287716|Pirfenidone|pirfenidone|mesh-list
14251107|NCT00287716|Analgesics|analgesics|mesh-ancestor
14251108|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
14251109|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251110|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251111|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14251112|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14251113|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251114|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14251115|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251116|NCT00287729|Pirfenidone|pirfenidone|mesh-list
14251117|NCT00287729|Analgesics|analgesics|mesh-ancestor
14251118|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
14251119|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251120|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251121|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14251122|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14251123|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251124|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14251125|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251126|NCT00287872|Thalidomide|thalidomide|mesh-list
14251127|NCT00287872|Bortezomib|bortezomib|mesh-list
14251128|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251129|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251130|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
14251131|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251132|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
14251133|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14251134|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251135|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14251136|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14251137|NCT00287872|Growth Substances|growth substances|mesh-ancestor
14251138|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
14251139|NCT00287989|Paclitaxel|paclitaxel|mesh-list
14251140|NCT00287989|Carboplatin|carboplatin|mesh-list
14251141|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14251142|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14251143|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251144|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
14251145|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
14251146|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
14251147|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251148|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14251149|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251150|NCT00288015|Bevacizumab|bevacizumab|mesh-list
14251151|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14251152|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251153|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14251154|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14251155|NCT00288015|Growth Substances|growth substances|mesh-ancestor
14251156|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251157|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
14251158|NCT00288054|Docetaxel|docetaxel|mesh-list
14251159|NCT00288054|Cetuximab|cetuximab|mesh-list
14251160|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251161|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
14251162|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
14251163|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
14251164|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251165|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14251166|NCT00288067|Rituximab|rituximab|mesh-list
14251167|NCT00288067|Fenretinide|fenretinide|mesh-list
14251168|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14251169|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251170|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
14251171|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251172|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14251173|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14251174|NCT00288067|Protective Agents|protective agents|mesh-ancestor
14251175|NCT00288366|Aripiprazole|aripiprazole|mesh-list
14251176|NCT00288366|Ziprasidone|ziprasidone|mesh-list
14251177|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
14251178|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14251179|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14251180|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14251181|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14251182|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251183|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
14251184|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
14251185|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14251186|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251187|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14251188|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14251189|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
14251190|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14251191|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14251192|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14251193|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14251194|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
14251195|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14251196|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14251197|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14251198|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14251199|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251200|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
14251201|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14251202|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251203|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14251204|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251205|NCT00288574|Fluoxetine|fluoxetine|mesh-list
14251206|NCT00288574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14251207|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14251208|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14251209|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251210|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14251211|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
14251212|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251213|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14251214|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
14251215|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14251216|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14251217|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14251218|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251219|NCT00288587|Diuretics|diuretics|mesh-list
14251220|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14251221|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
14251222|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251223|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14251224|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251225|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14251226|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
14251227|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14251228|NCT00288600|Antibodies|antibodies|mesh-list
14251229|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
14251230|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14251231|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
14251232|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251233|NCT00288626|Cytarabine|cytarabine|mesh-list
14251234|NCT00288626|Prednisone|prednisone|mesh-list
14251235|NCT00288626|Etoposide|etoposide|mesh-list
14251236|NCT00288626|Melphalan|melphalan|mesh-list
14251237|NCT00288626|Carmustine|carmustine|mesh-list
14251238|NCT00288626|Sargramostim|sargramostim|mesh-list
14251239|NCT00288626|Lenograstim|lenograstim|mesh-list
14251240|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251241|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
14251242|NCT00288626|Hormones|hormones|mesh-ancestor
14251243|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251244|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251245|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14251246|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251247|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14251248|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14251249|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14251250|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251251|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251252|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14251253|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
14251254|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
14251255|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251256|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251257|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
14251258|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14251259|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
14251260|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14251261|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14251262|NCT00288639|Pregabalin|pregabalin|mesh-list
14251263|NCT00288639|Analgesics|analgesics|mesh-ancestor
14251264|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
14251265|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251266|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251267|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
14251268|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14251269|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14251270|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251271|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14251272|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14251273|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14251274|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14251275|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14251276|NCT00288704|Rilonacept|rilonacept|mesh-list
14251277|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251278|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
14251279|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14251280|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251281|NCT00289211|Complement C1s|complement c1s|mesh-list
14251282|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14251283|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14251284|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
14251285|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251286|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14251287|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251288|NCT00289536|Factor VIII|factor viii|mesh-list
14251289|NCT00289536|Coagulants|coagulants|mesh-ancestor
14251290|NCT00289653|Nicotine|nicotine|mesh-list
14251291|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14251292|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
14251293|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251294|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251295|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14251296|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14251297|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
14251298|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14251299|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251300|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14251301|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
14251302|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251303|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14251304|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14251305|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251306|NCT00289848|Incretins|incretins|mesh-ancestor
14251307|NCT00289848|Hormones|hormones|mesh-ancestor
14251308|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251309|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14251310|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
14251311|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251312|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251313|NCT00289900|Atorvastatin|atorvastatin|mesh-list
14251314|NCT00289900|Simvastatin|simvastatin|mesh-list
14251315|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14251316|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14251317|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
14251318|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251319|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14251320|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14251321|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251322|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14251323|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14251324|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251325|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251326|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
14251327|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251328|NCT00289991|Itraconazole|itraconazole|mesh-list
14251329|NCT00289991|Voriconazole|voriconazole|mesh-list
14251330|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
14251331|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251332|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14251333|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14251334|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251335|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251336|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14251337|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
14251338|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251339|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251340|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14251341|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
14251342|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
14251343|NCT00290290|Povidone|povidone|mesh-list
14251344|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14251345|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251346|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
14251347|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
14251348|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
14251349|NCT00290329|Vaccines|vaccines|mesh-list
14251350|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
14251351|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251352|NCT00290342|Edetic Acid|edetic acid|mesh-list
14251353|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
14251354|NCT00290342|Antidotes|antidotes|mesh-ancestor
14251355|NCT00290342|Protective Agents|protective agents|mesh-ancestor
14251356|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251357|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
14251358|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
14251359|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251360|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14251361|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
14251362|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14251363|NCT00290433|Cytarabine|cytarabine|mesh-list
14251364|NCT00290433|Dexamethasone|dexamethasone|mesh-list
14251365|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
14251366|NCT00290433|Doxorubicin|doxorubicin|mesh-list
14251367|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14251368|NCT00290433|Methotrexate|methotrexate|mesh-list
14251369|NCT00290433|Vincristine|vincristine|mesh-list
14251370|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251371|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
14251372|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251373|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14251374|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14251375|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
14251376|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251377|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251378|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14251379|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251380|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
14251381|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
14251382|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251383|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14251384|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
14251385|NCT00290433|Hormones|hormones|mesh-ancestor
14251386|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251387|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14251388|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14251389|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14251390|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14251391|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251392|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14251393|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
14251394|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14251395|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14251396|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
14251397|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
14251398|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14251399|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14251400|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
14251401|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251402|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14251403|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
14251404|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
14251405|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
14251406|NCT00290472|Sirolimus|sirolimus|mesh-list
14251407|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14251408|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251409|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14251410|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251411|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
14251412|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251413|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
14251414|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251415|NCT00290498|Cytarabine|cytarabine|mesh-list
14251416|NCT00290498|Dexamethasone|dexamethasone|mesh-list
14251417|NCT00290498|Prednisone|prednisone|mesh-list
14251418|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
14251419|NCT00290498|Rituximab|rituximab|mesh-list
14251420|NCT00290498|Doxorubicin|doxorubicin|mesh-list
14251421|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14251422|NCT00290498|Methotrexate|methotrexate|mesh-list
14251423|NCT00290498|Vincristine|vincristine|mesh-list
14251424|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251425|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
14251426|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251427|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14251428|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14251429|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
14251430|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251431|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251432|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14251433|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251434|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
14251435|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
14251436|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251437|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14251438|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
14251439|NCT00290498|Hormones|hormones|mesh-ancestor
14251440|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251441|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14251442|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14251443|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14251444|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14251445|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14251446|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251447|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14251448|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
14251449|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14251450|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14251451|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
14251452|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
14251453|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14251454|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14251455|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
14251456|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251457|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14251458|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
14251459|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
14251460|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
14251461|NCT00290537|Paclitaxel|paclitaxel|mesh-list
14251462|NCT00290537|Carboplatin|carboplatin|mesh-list
14251463|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14251464|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251465|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
14251466|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
14251467|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
14251468|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251469|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
14251470|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14251471|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14251472|NCT00290589|Prednisolone|prednisolone|mesh-list
14251473|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
14251474|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14251475|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
14251476|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251477|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
14251478|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
14251479|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251480|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251481|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14251482|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
14251483|NCT00290589|Hormones|hormones|mesh-ancestor
14251484|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251485|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14251486|NCT00290589|Protective Agents|protective agents|mesh-ancestor
14251487|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14251488|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251489|NCT00290615|Bevacizumab|bevacizumab|mesh-list
14251490|NCT00290615|Cetuximab|cetuximab|mesh-list
14251491|NCT00290615|Capecitabine|capecitabine|mesh-list
14251492|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
14251493|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14251494|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251495|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14251496|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14251497|NCT00290615|Growth Substances|growth substances|mesh-ancestor
14251498|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251499|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
14251500|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14251501|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
14251502|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251503|NCT00290654|Tamoxifen|tamoxifen|mesh-list
14251504|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14251505|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
14251506|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251507|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251508|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14251509|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251510|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14251511|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14251512|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14251513|NCT00290693|Docetaxel|docetaxel|mesh-list
14251514|NCT00290693|Capecitabine|capecitabine|mesh-list
14251515|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251516|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
14251517|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
14251518|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
14251519|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251520|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14251521|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
14251522|NCT00290706|Gemcitabine|gemcitabine|mesh-list
14251523|NCT00290706|Bortezomib|bortezomib|mesh-list
14251524|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14251525|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
14251526|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251527|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251528|NCT00290706|Antiviral Agents|antiviral agents|mesh-ancestor
14251529|NCT00290706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251530|NCT00290706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251531|NCT00290706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251532|NCT00290706|Immunologic Factors|immunologic factors|mesh-ancestor
14251533|NCT00290706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251534|NCT00290732|Doxorubicin|doxorubicin|mesh-list
14251535|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14251536|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14251537|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251538|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14251539|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14251540|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251541|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251542|NCT00290745|Tamoxifen|tamoxifen|mesh-list
14251543|NCT00290745|Letrozole|letrozole|mesh-list
14251544|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251545|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251546|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14251547|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14251548|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251549|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14251550|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
14251551|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251552|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251553|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14251554|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14251555|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14251556|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14532256|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532257|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14532258|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14532259|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
14532260|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532261|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532262|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14532263|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14532264|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
14532265|NCT02200328|Metronidazole|metronidazole|mesh-list
14532266|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532267|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14532268|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14532269|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14532270|NCT02181790|Acitretin|acitretin|mesh-list
14532271|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
14532272|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
14532273|NCT02177266|Colchicine|colchicine|mesh-list
14532274|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
14532275|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14532276|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
14532277|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
14532278|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
14532279|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532280|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532281|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14532282|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14532283|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532284|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14532285|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14532286|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14532287|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532288|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
14532289|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532290|NCT02177773|Octreotide|octreotide|mesh-list
14532291|NCT02177773|Edotreotide|edotreotide|mesh-list
14532292|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14532293|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14532294|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532295|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14532296|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532297|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
14532298|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
14532299|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14532300|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14532301|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042569|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14251557|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
14251558|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
14251559|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251560|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14251561|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251562|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251563|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
14251564|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14251565|NCT00290810|Bevacizumab|bevacizumab|mesh-list
14251566|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14251567|NCT00290810|Antibodies|antibodies|mesh-list
14251568|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
14251569|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14251570|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251571|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14251572|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14251573|NCT00290810|Growth Substances|growth substances|mesh-ancestor
14251574|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251575|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
14251576|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
14251577|NCT00291135|Letrozole|letrozole|mesh-list
14251578|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251579|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14251580|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14251581|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251582|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251583|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14251584|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
14251585|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251586|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251587|NCT00291226|Glycine|glycine|mesh-list
14251588|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
14251589|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14251590|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251591|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251592|NCT00291330|Warfarin|warfarin|mesh-list
14251593|NCT00291330|Dabigatran|dabigatran|mesh-list
14251594|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
14251595|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
14251596|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14251597|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
14251598|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251599|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251600|NCT00291577|Docetaxel|docetaxel|mesh-list
14251601|NCT00291577|Sunitinib|sunitinib|mesh-list
14251602|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251603|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
14251604|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
14251605|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
14251606|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251607|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14251608|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14251609|NCT00291577|Growth Substances|growth substances|mesh-ancestor
14251610|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251611|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
14251612|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14251613|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251614|NCT00291642|Cetirizine|cetirizine|mesh-list
14251615|NCT00291642|Levocetirizine|levocetirizine|mesh-list
14251616|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14251617|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14251618|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14251619|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
14251620|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
14251621|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14251622|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251623|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251624|NCT00291655|Levetiracetam|levetiracetam|mesh-list
14251625|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
14251626|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
14251627|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
14251628|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251629|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
14251630|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251631|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14251632|NCT00291694|Celecoxib|celecoxib|mesh-list
14251633|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14251634|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14251635|NCT00291694|Analgesics|analgesics|mesh-ancestor
14251636|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
14251637|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251638|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251639|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251640|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14251641|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14251642|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14251643|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251644|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251645|NCT00292162|Metoprolol|metoprolol|mesh-list
14251646|NCT00292162|Carvedilol|carvedilol|mesh-list
14251647|NCT00292162|Ramipril|ramipril|mesh-list
14251648|NCT00292162|Enalapril|enalapril|mesh-list
14251649|NCT00292162|Lisinopril|lisinopril|mesh-list
14251650|NCT00292162|Bisoprolol|bisoprolol|mesh-list
14251651|NCT00292162|Perindopril|perindopril|mesh-list
14251652|NCT00292162|Captopril|captopril|mesh-list
14251653|NCT00292162|Spironolactone|spironolactone|mesh-list
14251654|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
14251655|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
14251656|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14251657|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14251658|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14251659|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
14251660|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
14251661|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251662|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251663|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14251664|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14251665|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
14251666|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14251667|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251668|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
14251669|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251670|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14251671|NCT00292162|Diuretics|diuretics|mesh-ancestor
14251672|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
14251673|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
14251674|NCT00292162|Protective Agents|protective agents|mesh-ancestor
14251675|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14251676|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14251677|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14251678|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
14251679|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14251680|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14251681|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
14251682|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251683|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14251684|NCT00292188|Pregabalin|pregabalin|mesh-list
14251685|NCT00292188|Analgesics|analgesics|mesh-ancestor
14251686|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
14251687|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251688|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251689|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
14251690|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14251691|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14251692|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251693|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14251694|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14251695|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14251696|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14251697|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14251698|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
14251699|NCT00292227|Rotigotine|rotigotine|mesh-list
14251700|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14251701|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251702|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14251703|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14251704|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251705|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251706|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042570|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
14251707|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251708|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
14251709|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
14251710|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14251711|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14251712|NCT00292370|Paroxetine|paroxetine|mesh-list
14251713|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
14251714|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14251715|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14251716|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14251717|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14251718|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251719|NCT00292370|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14251720|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14251721|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14251722|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251723|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14251724|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
14251725|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14251726|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14251727|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14251728|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251729|NCT00292461|Lamotrigine|lamotrigine|mesh-list
14251730|NCT00292461|Zonisamide|zonisamide|mesh-list
14251731|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
14251732|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14251733|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14251734|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251735|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14251736|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251737|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14251738|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14251739|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14251740|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14251741|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14251742|NCT00292591|Vitamin D|vitamin d|mesh-list
14251743|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
14251744|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
14251745|NCT00292591|Vitamins|vitamins|mesh-list
14251746|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
14251747|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251748|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14251749|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14251750|NCT00292942|Artesunate|artesunate|mesh-list
14251751|NCT00292942|Mannitol|mannitol|mesh-list
14251752|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
14251753|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14251754|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14251755|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251756|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251757|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
14251758|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
14251759|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14251760|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
14251761|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
14251762|NCT00292942|Diuretics|diuretics|mesh-ancestor
14251763|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
14251764|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251765|NCT00292981|Complement C1s|complement c1s|mesh-list
14251766|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
14251767|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
14251768|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
14251769|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251770|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
14251771|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251772|NCT00293020|Fentanyl|fentanyl|mesh-list
14251773|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14251774|NCT00293020|Narcotics|narcotics|mesh-ancestor
14251775|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14251776|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251777|NCT00293020|Analgesics|analgesics|mesh-ancestor
14251778|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
14251779|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251780|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14251781|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14251782|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
14251783|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
14251784|NCT00293033|Fentanyl|fentanyl|mesh-list
14251785|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14251786|NCT00293033|Narcotics|narcotics|mesh-ancestor
14251787|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14251788|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251789|NCT00293033|Analgesics|analgesics|mesh-ancestor
14251790|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
14251791|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251792|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14251793|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14251794|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
14251795|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
14251796|NCT00293059|Dienogest|dienogest|mesh-list
14251797|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14251798|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14251799|NCT00293059|Estradiol|estradiol|mesh-list
14251800|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14251801|NCT00293059|Estrogens|estrogens|mesh-ancestor
14251802|NCT00293059|Hormones|hormones|mesh-ancestor
14251803|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251804|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251805|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14251806|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
14251807|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14251808|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14251809|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14251810|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14251811|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14251812|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
14251813|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14251814|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251815|NCT00293202|Etanercept|etanercept|mesh-list
14251816|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14251817|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14251818|NCT00293202|Analgesics|analgesics|mesh-ancestor
14251819|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
14251820|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251821|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251822|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251823|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14251824|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14251825|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251826|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
14251827|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
14251828|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14251829|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14251830|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
14251831|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251832|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14251833|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14251834|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251835|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251836|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
14251837|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14251838|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14251839|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
14251840|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251841|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14251842|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14251843|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251844|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251845|NCT00293293|Taxane|taxane|mesh-list
14251846|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251847|NCT00293384|Dexamethasone|dexamethasone|mesh-list
14251848|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
14251849|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
14251850|NCT00293384|Aprepitant|aprepitant|mesh-list
14251851|NCT00293384|Granisetron|granisetron|mesh-list
14251852|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14251853|NCT00293384|BB 1101|bb 1101|mesh-list
14251854|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251855|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
14251856|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251857|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14251858|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14251859|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
15042571|NCT02045017|Hormones|hormones|mesh-ancestor
14251860|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251861|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251862|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14251863|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251864|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
14251865|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
14251866|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251867|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14251868|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
14251869|NCT00293384|Hormones|hormones|mesh-ancestor
14251870|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251871|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14251872|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
14251873|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251874|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14251875|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14251876|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14251877|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
14251878|NCT00293397|Doxorubicin|doxorubicin|mesh-list
14251879|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14251880|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14251881|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251882|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14251883|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14251884|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251885|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251886|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
14251887|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14251888|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
14251889|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251890|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14251891|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251892|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
14251893|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251894|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
14251895|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
14251896|NCT00293423|Protective Agents|protective agents|mesh-ancestor
14251897|NCT00293462|Sargramostim|sargramostim|mesh-list
14251898|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
14251899|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251900|NCT00293540|Tamoxifen|tamoxifen|mesh-list
14251901|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14251902|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
14251903|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251904|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251905|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14251906|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251907|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14251908|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14251909|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14251910|NCT00293579|Pemetrexed|pemetrexed|mesh-list
14251911|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251912|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14251913|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251914|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14251915|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14251916|NCT00293709|Etanercept|etanercept|mesh-list
14251917|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14251918|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14251919|NCT00293709|Analgesics|analgesics|mesh-ancestor
14251920|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
14251921|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251922|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251923|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251924|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14251925|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14251926|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251927|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
14251928|NCT00293722|Etanercept|etanercept|mesh-list
14251929|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14251930|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14251931|NCT00293722|Analgesics|analgesics|mesh-ancestor
14251932|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
14251933|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251934|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251935|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251936|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14251937|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14251938|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14251939|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
14251940|NCT00293813|Denosumab|denosumab|mesh-list
14251941|NCT00293813|Alendronate|alendronate|mesh-list
14251942|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14251943|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251944|NCT00294398|Fluticasone|fluticasone|mesh-list
14251945|NCT00294398|Xhance|xhance|mesh-list
14251946|NCT00294398|Budesonide|budesonide|mesh-list
14251947|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251948|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14251949|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
14251950|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251951|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251952|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14251953|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
14251954|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
14251955|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14251956|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
14251957|NCT00294398|Hormones|hormones|mesh-ancestor
14251958|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251959|NCT00294515|Valganciclovir|valganciclovir|mesh-list
14251960|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
14251961|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14251962|NCT00294554|Memantine|memantine|mesh-list
14251963|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14251964|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14251965|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
14251966|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14251967|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14251968|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251969|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14251970|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14251971|NCT00294632|Rituximab|rituximab|mesh-list
14251972|NCT00294632|Lenalidomide|lenalidomide|mesh-list
14251973|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14251974|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251975|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
14251976|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251977|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14251978|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14251979|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14251980|NCT00294632|Growth Substances|growth substances|mesh-ancestor
14251981|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
14251982|NCT00294658|Prednisone|prednisone|mesh-list
14251983|NCT00294658|Prednisolone|prednisolone|mesh-list
14251984|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251985|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
14251986|NCT00294658|Hormones|hormones|mesh-ancestor
14251987|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14251988|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251989|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14251990|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14251991|NCT00294671|Diflunisal|diflunisal|mesh-list
14251992|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14251993|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14251994|NCT00294671|Analgesics|analgesics|mesh-ancestor
14251995|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
14251996|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14251997|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14251998|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14251999|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252000|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14252001|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252002|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252003|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
14252004|NCT00294684|Prednisolone|prednisolone|mesh-list
14252005|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14252006|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
14252007|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
14252008|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252009|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252010|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14252011|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
14252012|NCT00294684|Hormones|hormones|mesh-ancestor
14252013|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252014|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14252015|NCT00294684|Protective Agents|protective agents|mesh-ancestor
14252016|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14252017|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252018|NCT00294723|Liraglutide|liraglutide|mesh-list
14252019|NCT00294723|Glimepiride|glimepiride|mesh-list
14252020|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14252021|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252022|NCT00294723|Incretins|incretins|mesh-ancestor
14252023|NCT00294723|Hormones|hormones|mesh-ancestor
14252024|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252025|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14252026|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252027|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
14252028|NCT00294762|Paclitaxel|paclitaxel|mesh-list
14252029|NCT00294762|Carboplatin|carboplatin|mesh-list
14252030|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14252031|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14252032|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252033|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
14252034|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
14252035|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
14252036|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252037|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14252038|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252039|NCT00295022|Montelukast|montelukast|mesh-list
14252040|NCT00295022|Levocetirizine|levocetirizine|mesh-list
14252041|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14252042|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
14252043|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14252044|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
14252045|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252046|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252047|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14252048|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14252049|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252050|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14252051|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14252052|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
14252053|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
14252054|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14252055|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
14252056|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14252057|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
14252058|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252059|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252060|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14252061|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14252062|NCT00295503|Bevacizumab|bevacizumab|mesh-list
14252063|NCT00295503|Pemetrexed|pemetrexed|mesh-list
14252064|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14252065|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252066|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14252067|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14252068|NCT00295503|Growth Substances|growth substances|mesh-ancestor
14252069|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252070|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
14252071|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252072|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252073|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14252074|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14252075|NCT00295620|Anastrozole|anastrozole|mesh-list
14252076|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14252077|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252078|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14252079|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14252080|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252081|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252082|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14252083|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
14252084|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252085|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252086|NCT00295633|Metformin|metformin|mesh-list
14252087|NCT00295633|Pioglitazone|pioglitazone|mesh-list
14252088|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
14252089|NCT00295633|Saxagliptin|saxagliptin|mesh-list
14252090|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14252091|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252092|NCT00295633|Incretins|incretins|mesh-ancestor
14252093|NCT00295633|Hormones|hormones|mesh-ancestor
14252094|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252095|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14252096|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
14252097|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252098|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252099|NCT00295750|Leuprolide|leuprolide|mesh-list
14252100|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14252101|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
14252102|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14252103|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252104|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14252105|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252106|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
14252107|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14252108|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252109|NCT00295932|Prednisone|prednisone|mesh-list
14252110|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
14252111|NCT00295932|Rituximab|rituximab|mesh-list
14252112|NCT00295932|Bortezomib|bortezomib|mesh-list
14252113|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252114|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
14252115|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252116|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252117|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14252118|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
14252119|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252120|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252121|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14252122|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14252123|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14252124|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
14252125|NCT00295932|Hormones|hormones|mesh-ancestor
14252126|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252127|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14252128|NCT00296036|Pyridoxine|pyridoxine|mesh-list
14252129|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
14252130|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
14252131|NCT00296036|Vitamins|vitamins|mesh-ancestor
14252132|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
14252133|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252134|NCT00296192|Rotigotine|rotigotine|mesh-list
14252135|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
14252136|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
14252137|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14252138|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252139|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252140|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
14252141|NCT00296244|Prednisone|prednisone|mesh-list
14252142|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
14252143|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14252144|NCT00296244|Tacrolimus|tacrolimus|mesh-list
14252145|NCT00296244|Basiliximab|basiliximab|mesh-list
14252146|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14252147|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
14252148|NCT00296244|Hormones|hormones|mesh-ancestor
14252149|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252150|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252151|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14252152|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252153|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252154|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
14252155|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14252156|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252157|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252158|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
14252159|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
14252160|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252161|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14252162|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14252163|NCT00296244|Protective Agents|protective agents|mesh-ancestor
14252164|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14252165|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14252166|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
14252167|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14252168|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252169|NCT00296296|Cyclosporine|cyclosporine|mesh-list
14252170|NCT00296296|Tacrolimus|tacrolimus|mesh-list
14252171|NCT00296296|Cyclosporins|cyclosporins|mesh-list
14252172|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252173|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
14252174|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252175|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14252176|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252177|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252178|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
14252179|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252180|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
14252181|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252182|NCT00296322|Mitomycins|mitomycins|mesh-list
14252183|NCT00296322|Mitomycin|mitomycin|mesh-list
14252184|NCT00296322|Doxifluridine|doxifluridine|mesh-list
14252185|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252186|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14252187|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
14252188|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252189|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14252190|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252191|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14252192|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
14252193|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252194|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
14252195|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252196|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
14252197|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14252198|NCT00296335|Mitomycins|mitomycins|mesh-list
14252199|NCT00296335|Mitomycin|mitomycin|mesh-list
14252200|NCT00296335|Doxifluridine|doxifluridine|mesh-list
14252201|NCT00296335|Floxuridine|floxuridine|mesh-list
14252202|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252203|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14252204|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
14252205|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252206|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14252207|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252208|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14252209|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
14252210|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252211|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
14252212|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252213|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
14252214|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14252215|NCT00296374|Atorvastatin|atorvastatin|mesh-list
14252216|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14252217|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14252218|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14252219|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
14252220|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252221|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14252222|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14252223|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252224|NCT00296400|Atorvastatin|atorvastatin|mesh-list
14252225|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14252226|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14252227|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14252228|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
14252229|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252230|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14252231|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14252232|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252233|NCT00296491|Fluticasone|fluticasone|mesh-list
14252234|NCT00296491|Xhance|xhance|mesh-list
14252235|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14252236|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
14252237|NCT00296491|Montelukast|montelukast|mesh-list
14252238|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14252239|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14252240|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
14252241|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252242|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252243|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14252244|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
14252245|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
14252246|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14252247|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14252248|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14252249|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14252250|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
14252251|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14252252|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252253|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14252254|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
14252255|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252256|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14252257|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14252258|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
14252259|NCT00296491|Hormones|hormones|mesh-ancestor
14252260|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
14252261|NCT00296504|Ritonavir|ritonavir|mesh-list
14252262|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
14252263|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14252264|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14252265|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
14252266|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252267|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252268|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14252269|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14252270|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
14252271|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252272|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14252273|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14252274|NCT00296517|Bupropion|bupropion|mesh-list
14252275|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14252276|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
14252277|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14252278|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14252279|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14252280|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14252281|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252282|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
14252283|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14252284|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252285|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14252286|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14252287|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252288|NCT00296647|Bupropion|bupropion|mesh-list
14252289|NCT00296647|Nicotine|nicotine|mesh-list
14252290|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14252291|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
14252292|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252293|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252294|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14252295|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14252296|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
14252297|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14252298|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252299|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14252300|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
14252301|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14252302|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14252303|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14252304|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14252305|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
14252306|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14252307|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14252308|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252309|NCT00296725|Fluoxetine|fluoxetine|mesh-list
14252310|NCT00296725|Imipramine|imipramine|mesh-list
14252311|NCT00296725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14252312|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14252313|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14252314|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252315|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14252316|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
14252317|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252318|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14252319|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
14252320|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14252321|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14252322|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14252323|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252324|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14252325|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14252326|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
14252327|NCT00296816|Bevacizumab|bevacizumab|mesh-list
14252328|NCT00296816|Docetaxel|docetaxel|mesh-list
14252329|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
14252330|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14252331|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252332|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14252333|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14252334|NCT00296816|Growth Substances|growth substances|mesh-ancestor
14252335|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252336|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
14252337|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
14252338|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
14252339|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
14252340|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252341|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
14252342|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14252343|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14252344|NCT00297037|Analgesics|analgesics|mesh-ancestor
14252345|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
14252346|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252347|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252348|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14252349|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252350|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
14252351|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252352|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
14252353|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14252354|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252355|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252356|NCT00297232|Natalizumab|natalizumab|mesh-list
14252357|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
14252358|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252359|NCT00297479|Nicotine|nicotine|mesh-list
14252360|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14252361|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
14252362|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252363|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252364|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14252365|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14252366|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
14252367|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14252368|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252369|NCT00297492|Nicotine|nicotine|mesh-list
14252370|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14252371|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
14252372|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252373|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252374|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14252375|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14252376|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
14252377|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14252378|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252379|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
14252380|NCT00297596|Trastuzumab|trastuzumab|mesh-list
14252381|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252382|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14252383|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
14252384|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252385|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
14252386|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252387|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252388|NCT00297778|Pramipexole|pramipexole|mesh-list
14252389|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
14252390|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252391|NCT00297778|Protective Agents|protective agents|mesh-ancestor
14252392|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252393|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14252394|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14252395|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
14252396|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
14252397|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14252398|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
14252399|NCT00297830|Alendronate|alendronate|mesh-list
14252400|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14252401|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532302|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532303|NCT02162979|Urological Agents|urological agents|mesh-ancestor
14532304|NCT02169830|Topiramate|topiramate|mesh-list
14532305|NCT02169830|Nortriptyline|nortriptyline|mesh-list
14532306|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
14532307|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14532308|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532309|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14532310|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
14532311|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14532312|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14532313|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14532314|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14532315|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532316|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
14532317|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532318|NCT02159040|Azacitidine|azacitidine|mesh-list
14532319|NCT02159040|Deferasirox|deferasirox|mesh-list
14532320|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14532321|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
14532322|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532323|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532324|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532325|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14532326|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
14532327|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
14532328|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
14532329|NCT02168270|Temozolomide|temozolomide|mesh-list
14532330|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14532331|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
14532332|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532333|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532334|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
14532335|NCT02168270|Protective Agents|protective agents|mesh-ancestor
14532336|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532337|NCT02168270|Vitamins|vitamins|mesh-ancestor
14532338|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
14532339|NCT02157116|Docetaxel|docetaxel|mesh-list
14532340|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532341|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
14532342|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
14532343|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
14532344|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042572|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042573|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15042574|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042575|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
15042576|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15042577|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15042578|NCT02045017|Growth Substances|growth substances|mesh-ancestor
15042579|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
15042580|NCT02045030|Aflibercept|aflibercept|mesh-list
15042581|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15042582|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14252402|NCT00297882|Artesunate|artesunate|mesh-list
14252403|NCT00297882|Lumefantrine|lumefantrine|mesh-list
14252404|NCT00297882|Artemether|artemether|mesh-list
14252405|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
14252406|NCT00297882|Amodiaquine|amodiaquine|mesh-list
14252407|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
14252408|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14252409|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14252410|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252411|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252412|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
14252413|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
14252414|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14252415|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
14252416|NCT00298038|Rifaximin|rifaximin|mesh-list
14252417|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14252418|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252419|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14252420|NCT00298155|Ketoconazole|ketoconazole|mesh-list
14252421|NCT00298155|Goserelin|goserelin|mesh-list
14252422|NCT00298155|Bicalutamide|bicalutamide|mesh-list
14252423|NCT00298155|Dutasteride|dutasteride|mesh-list
14252424|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14252425|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252426|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
14252427|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252428|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14252429|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14252430|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252431|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252432|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14252433|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
14252434|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252435|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252436|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14252437|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
14252438|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14252439|NCT00298233|Oseltamivir|oseltamivir|mesh-list
14252440|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
14252441|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252442|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252443|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252444|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
14252445|NCT00298272|Adalimumab|adalimumab|mesh-list
14252446|NCT00298272|Etanercept|etanercept|mesh-list
14252447|NCT00298272|Rituximab|rituximab|mesh-list
14252448|NCT00298272|Methotrexate|methotrexate|mesh-list
14252449|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14252450|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252451|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
14252452|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252453|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252454|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14252455|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
14252456|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14252457|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14252458|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
14252459|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252460|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
14252461|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252462|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14252463|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252464|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14252465|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14252466|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
14252467|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
14252468|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252469|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14252470|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
14252471|NCT00298272|Hormones|hormones|mesh-ancestor
14252472|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252473|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14252474|NCT00298272|Protective Agents|protective agents|mesh-ancestor
14252475|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14252476|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14252477|NCT00298272|Analgesics|analgesics|mesh-ancestor
14252478|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
14252479|NCT00298363|Tenofovir|tenofovir|mesh-list
14252480|NCT00298363|Emtricitabine|emtricitabine|mesh-list
14252481|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14252482|NCT00298363|Entecavir|entecavir|mesh-list
14252483|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
14252484|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252485|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14252486|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14252487|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252488|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252489|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14252490|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14252491|NCT00298610|Artesunate|artesunate|mesh-list
14252492|NCT00298610|Atovaquone|atovaquone|mesh-list
14252493|NCT00298610|Proguanil|proguanil|mesh-list
14252494|NCT00298610|Quinidine|quinidine|mesh-list
14252495|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
14252496|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
14252497|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14252498|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14252499|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252500|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252501|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
14252502|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
14252503|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14252504|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
14252505|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252506|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252507|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
14252508|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14252509|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14252510|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
14252511|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14252512|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252513|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14252514|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14252515|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14252516|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
14252517|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14252518|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14252519|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14252520|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14252521|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14252522|NCT00298766|Bortezomib|bortezomib|mesh-list
14252523|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252524|NCT00298831|Rocuronium|rocuronium|mesh-list
14252525|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14252526|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14252527|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14252528|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252529|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252530|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
14252531|NCT00299104|Rituximab|rituximab|mesh-list
14252532|NCT00299104|Methotrexate|methotrexate|mesh-list
14252533|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14252534|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252535|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
14252536|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252537|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252538|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14252539|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
14252540|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14252541|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14252542|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
14252543|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252544|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
14252545|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252546|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14252547|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252548|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14252549|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14252550|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
14252551|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
14252552|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252553|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14252554|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
14252555|NCT00299104|Hormones|hormones|mesh-ancestor
14252556|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252557|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14252558|NCT00299104|Protective Agents|protective agents|mesh-ancestor
14252559|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
14252560|NCT00299130|Rituximab|rituximab|mesh-list
14252561|NCT00299130|Methotrexate|methotrexate|mesh-list
14252562|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14252563|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252564|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
14252565|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252566|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252567|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14252568|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
14252569|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14252570|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14252571|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
14252572|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252573|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
14252574|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252575|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14252576|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252577|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14252578|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14252579|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
14252580|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
14252581|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252582|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14252583|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
14252584|NCT00299130|Hormones|hormones|mesh-ancestor
14252585|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252586|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14252587|NCT00299130|Protective Agents|protective agents|mesh-ancestor
14252588|NCT00299156|Clofarabine|clofarabine|mesh-list
14252589|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14252590|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
14252591|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252592|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252593|NCT00299182|Cytarabine|cytarabine|mesh-list
14252594|NCT00299182|Dexamethasone|dexamethasone|mesh-list
14252595|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
14252596|NCT00299182|Rituximab|rituximab|mesh-list
14252597|NCT00299182|Doxorubicin|doxorubicin|mesh-list
14252598|NCT00299182|Methotrexate|methotrexate|mesh-list
14252599|NCT00299182|Vincristine|vincristine|mesh-list
14252600|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252601|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
14252602|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252603|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252604|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14252605|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
14252606|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252607|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252608|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14252609|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14252610|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
14252611|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
14252612|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252613|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14252614|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
14252615|NCT00299182|Hormones|hormones|mesh-ancestor
14252616|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252617|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14252618|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14252619|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14252620|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14252621|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14252622|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252623|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14252624|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
14252625|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14252626|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14252627|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
14252628|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
14252629|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14252630|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14252631|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
14252632|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252633|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14252634|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
14252635|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
14252636|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
14252637|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
14252638|NCT00299221|Tacrolimus|tacrolimus|mesh-list
14252639|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252640|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
14252641|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252642|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14252643|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252644|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252645|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14252646|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252647|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14252648|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
14252649|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14252650|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252651|NCT00299494|Rituximab|rituximab|mesh-list
14252652|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
14252653|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14252654|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252655|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
14252656|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252657|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252658|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14252659|NCT00299546|Golimumab|golimumab|mesh-list
14252660|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14252661|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14252662|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14252663|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252664|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
14252665|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252666|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
14252667|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252668|NCT00299702|Aripiprazole|aripiprazole|mesh-list
14252669|NCT00299702|Risperidone|risperidone|mesh-list
14252670|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
14252671|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14252672|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14252673|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14252674|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14252675|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252676|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
14252677|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
14252678|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14252679|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252680|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14252681|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14252682|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
14252683|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14252684|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14252685|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14252686|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14252687|NCT00299741|Sunitinib|sunitinib|mesh-list
14252688|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252689|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14252690|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14252691|NCT00299741|Growth Substances|growth substances|mesh-ancestor
14252692|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252693|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
14252694|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14252695|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252696|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252697|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
14252698|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14252699|NCT00299988|Antibodies|antibodies|mesh-list
14252700|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
14252701|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
14252702|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
14252703|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252704|NCT00300053|Lenograstim|lenograstim|mesh-list
14252705|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14252706|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
14252707|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252708|NCT00300274|Cyclosporine|cyclosporine|mesh-list
14252709|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
14252710|NCT00300274|Everolimus|everolimus|mesh-list
14252711|NCT00300274|Cyclosporins|cyclosporins|mesh-list
14252712|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252713|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252714|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252715|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
14252716|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252717|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
14252718|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252719|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
14252720|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252721|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14252722|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252723|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14252724|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14252725|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
14252726|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14252727|NCT00300365|Aspirin|aspirin|mesh-list
14252728|NCT00300365|Niacin|niacin|mesh-list
14252729|NCT00300365|Pioglitazone|pioglitazone|mesh-list
14252730|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14252731|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14252732|NCT00300365|Analgesics|analgesics|mesh-ancestor
14252733|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
14252734|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252735|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252736|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14252737|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252738|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14252739|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14252740|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252741|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14252742|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14252743|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252744|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
14252745|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14252746|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14252747|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
14252748|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14252749|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
14252750|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
14252751|NCT00300365|Vitamins|vitamins|mesh-ancestor
14252752|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
14252753|NCT00300391|Haloperidol|haloperidol|mesh-list
14252754|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
14252755|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
14252756|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
14252757|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252758|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252759|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14252760|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14252761|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14252762|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14252763|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14252764|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14252765|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
14252766|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14252767|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252768|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14252769|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
14252770|NCT00300430|Atorvastatin|atorvastatin|mesh-list
14252771|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14252772|NCT00300430|Simvastatin|simvastatin|mesh-list
14252773|NCT00300430|Fenofibrate|fenofibrate|mesh-list
14252774|NCT00300430|Calcium|calcium|mesh-list
14252775|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14252776|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252777|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14252778|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14252779|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14252780|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
14252781|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252782|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14252783|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14252784|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252785|NCT00300456|Simvastatin|simvastatin|mesh-list
14252786|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14252787|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14252788|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
14252789|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252790|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14252791|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14252792|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252793|NCT00300469|Atorvastatin|atorvastatin|mesh-list
14252794|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14252795|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14252796|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
14252797|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252798|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14252799|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14252800|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252801|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14252802|NCT00300482|Calcium|calcium|mesh-list
14252803|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14252804|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252805|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14252806|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14252807|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
14252808|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252809|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14252810|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14252811|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252812|NCT00300495|Amiodarone|amiodarone|mesh-list
14252813|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14252814|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
14252815|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
14252816|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14252817|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252818|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14252819|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14252820|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14252821|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252822|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14252823|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14252824|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14252825|NCT00300677|Voriconazole|voriconazole|mesh-list
14252826|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
14252827|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252828|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14252829|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14252830|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252831|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252832|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14252833|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
14252834|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252835|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252836|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14252837|NCT00300742|Topiramate|topiramate|mesh-list
14252838|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
14252839|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14252840|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252841|NCT00300755|Pantoprazole|pantoprazole|mesh-list
14252842|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14252843|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14252844|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14252845|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252846|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252847|NCT00300885|Paclitaxel|paclitaxel|mesh-list
14252848|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14252849|NCT00300885|Carboplatin|carboplatin|mesh-list
14252850|NCT00300885|Sorafenib|sorafenib|mesh-list
14252851|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14252852|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252853|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
14252854|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
14252855|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
14252856|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252857|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14252858|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252859|NCT00301028|Paclitaxel|paclitaxel|mesh-list
14252860|NCT00301028|Carboplatin|carboplatin|mesh-list
14252861|NCT00301028|Cetuximab|cetuximab|mesh-list
14252862|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14252863|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252864|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
14252865|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
14252866|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
14252867|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252868|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14252869|NCT00301067|Calcitriol|calcitriol|mesh-list
14252870|NCT00301067|Temozolomide|temozolomide|mesh-list
14252871|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14252872|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
14252873|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252874|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252875|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14252876|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252877|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
14252878|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14252879|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14252880|NCT00301067|Vitamins|vitamins|mesh-ancestor
14252881|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
14252882|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14252883|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
14252884|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14252885|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252886|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252887|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14252888|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14252889|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14252890|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252891|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14252892|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252893|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252894|NCT00301756|Belinostat|belinostat|mesh-list
14252895|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252896|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14252897|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252898|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252899|NCT00301808|Docetaxel|docetaxel|mesh-list
14252900|NCT00301808|Pemetrexed|pemetrexed|mesh-list
14252901|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252902|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
14252903|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
14252904|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
14252905|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252906|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252907|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14252908|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14252909|NCT00301821|Prednisone|prednisone|mesh-list
14252910|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
14252911|NCT00301821|Rituximab|rituximab|mesh-list
14252912|NCT00301821|Doxorubicin|doxorubicin|mesh-list
14252913|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14252914|NCT00301821|Vincristine|vincristine|mesh-list
14252915|NCT00301821|Epratuzumab|epratuzumab|mesh-list
14252916|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252917|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
14252918|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252919|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252920|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14252921|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
14252922|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252923|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252924|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14252925|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14252926|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14252927|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14252928|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14252929|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252930|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14252931|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
14252932|NCT00301821|Hormones|hormones|mesh-ancestor
14252933|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252934|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14252935|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14252936|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
14252937|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
14252938|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
14252939|NCT00301834|Cyclosporine|cyclosporine|mesh-list
14252940|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
14252941|NCT00301834|Methotrexate|methotrexate|mesh-list
14252942|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
14252943|NCT00301834|Fludarabine|fludarabine|mesh-list
14252944|NCT00301834|Busulfan|busulfan|mesh-list
14252945|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
14252946|NCT00301834|Cyclosporins|cyclosporins|mesh-list
14252947|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14252948|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
14252949|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14252950|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252951|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14252952|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
14252953|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14252954|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252955|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
14252956|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14252957|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14252958|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14252959|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
14252960|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14252961|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14252962|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
14252963|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14252964|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14252965|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14252966|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
14252967|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
14252968|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14252969|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14252970|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
14252971|NCT00301834|Hormones|hormones|mesh-ancestor
14252972|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14252973|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14252974|NCT00301834|Protective Agents|protective agents|mesh-ancestor
14252975|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
14252976|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14252977|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14252978|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14252979|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
14252980|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14252981|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252982|NCT00301964|Bevacizumab|bevacizumab|mesh-list
14252983|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14252984|NCT00301964|Antibodies|antibodies|mesh-list
14252985|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
14252986|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14252987|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14252988|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14252989|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14252990|NCT00301964|Growth Substances|growth substances|mesh-ancestor
14252991|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14252992|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
14252993|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
14252994|NCT00302003|Cytarabine|cytarabine|mesh-list
14252995|NCT00302003|Dexamethasone|dexamethasone|mesh-list
14252996|NCT00302003|Prednisone|prednisone|mesh-list
14252997|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
14252998|NCT00302003|Ifosfamide|ifosfamide|mesh-list
14252999|NCT00302003|Doxorubicin|doxorubicin|mesh-list
14253000|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14253001|NCT00302003|Etoposide|etoposide|mesh-list
14253002|NCT00302003|Vincristine|vincristine|mesh-list
14253003|NCT00302003|Vinorelbine|vinorelbine|mesh-list
14253004|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
14253005|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14253006|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
14253007|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253008|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14253009|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14253010|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
14253011|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253012|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253013|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14253014|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14253015|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
14253016|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
14253017|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253018|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14253019|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
14253020|NCT00302003|Hormones|hormones|mesh-ancestor
14253021|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14253022|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14253023|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14253024|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14253025|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14253026|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253027|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14253028|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14253029|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
14253030|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
14253031|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253032|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
14253033|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
14253034|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
14253035|NCT00302068|Sertraline|sertraline|mesh-list
14253036|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
14253037|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14253038|NCT00302068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14253039|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14253040|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14253041|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253042|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253043|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
14253044|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253045|NCT00302081|Ribavirin|ribavirin|mesh-list
14253046|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14253047|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
14253048|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
14253049|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253050|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
14253051|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253052|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
14253053|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253054|NCT00302107|Mirtazapine|mirtazapine|mesh-list
14253055|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
14253056|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14253057|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14253058|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
14253059|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
14253060|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253061|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253062|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253063|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14253064|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14253065|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14253066|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14253067|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14253068|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14253069|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
14253070|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14253071|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14253072|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
14253073|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14253074|NCT00302133|Naltrexone|naltrexone|mesh-list
14253075|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14253076|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14253077|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253078|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
14253079|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253080|NCT00302159|Temozolomide|temozolomide|mesh-list
14253081|NCT00302159|Valproic Acid|valproic acid|mesh-list
14253082|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14253083|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
14253084|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253085|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253086|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
14253087|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253088|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
14253089|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253090|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253091|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
14253092|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14253093|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14253094|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14253095|NCT00302211|Bosentan|bosentan|mesh-list
14253096|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
14253097|NCT00302211|Iloprost|iloprost|mesh-list
14253098|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
14253099|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14253100|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14253101|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253102|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253103|NCT00302211|Urological Agents|urological agents|mesh-ancestor
14253104|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14253105|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14253106|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14253107|NCT00302458|Methylphenidate|methylphenidate|mesh-list
14253108|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14253109|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253110|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14253111|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14253112|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14253113|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253114|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
14253115|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253116|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14253117|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14253118|NCT00302731|Hormones|hormones|mesh-list
14253119|NCT00302731|Estradiol|estradiol|mesh-list
14253120|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14253121|NCT00302731|Progesterone|progesterone|mesh-list
14253122|NCT00302731|Estrogens|estrogens|mesh-list
14253123|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14253124|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253125|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14253126|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
14253127|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14253128|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14253129|NCT00302731|Progestins|progestins|mesh-ancestor
14253130|NCT00302848|Drospirenone|drospirenone|mesh-list
14253131|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
14253132|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
14253133|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
14253134|NCT00302848|Progestins|progestins|mesh-list
14253135|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14253136|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253137|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14253138|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14253139|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14253140|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14253141|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
14253142|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14253143|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14253144|NCT00302848|Diuretics|diuretics|mesh-ancestor
14253145|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
14253146|NCT00302848|Hormones|hormones|mesh-ancestor
14253147|NCT00302952|Lovastatin|lovastatin|mesh-list
14253148|NCT00302952|L 647318|l 647318|mesh-list
14253149|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
14253150|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14253151|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14253152|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
14253153|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253154|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14253155|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14253156|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253157|NCT00303108|Carboplatin|carboplatin|mesh-list
14253158|NCT00303108|Doxorubicin|doxorubicin|mesh-list
14253159|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14253160|NCT00303108|Trastuzumab|trastuzumab|mesh-list
14253161|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253162|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14253163|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14253164|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14253165|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253166|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253167|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14253168|NCT00303316|Vaccines|vaccines|mesh-list
14253169|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
14253170|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253171|NCT00303329|Deferasirox|deferasirox|mesh-list
14253172|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14253173|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
14253174|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
14253175|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253176|NCT00303446|Dutasteride|dutasteride|mesh-list
14253177|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
14253178|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14253179|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253180|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253181|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
14253182|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14253183|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253184|NCT00303459|Bosentan|bosentan|mesh-list
14253185|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14253186|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14253187|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253188|NCT00303485|Vitamin D|vitamin d|mesh-list
14253189|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
14253190|NCT00303485|Calcium|calcium|mesh-list
14253191|NCT00303485|Vitamins|vitamins|mesh-ancestor
14253192|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
14253193|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253194|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14253195|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14253196|NCT00303602|Olanzapine|olanzapine|mesh-list
14253197|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
14253198|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
14253199|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253200|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253201|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14253202|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14253203|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14253204|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14253205|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14253206|NCT00303602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14253207|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14253208|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14253209|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253210|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253211|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
14253212|NCT00303628|Leucovorin|leucovorin|mesh-list
14253213|NCT00303628|Bevacizumab|bevacizumab|mesh-list
14253214|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14253215|NCT00303628|Fluorouracil|fluorouracil|mesh-list
14253216|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
14253217|NCT00303628|Antibodies|antibodies|mesh-list
14253218|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
14253219|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14253220|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
14253221|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253222|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14253223|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14253224|NCT00303628|Growth Substances|growth substances|mesh-ancestor
14253225|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253226|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
14253227|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
14253228|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
14532345|NCT02152670|Raclopride|raclopride|mesh-list
14253229|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253230|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14253231|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14253232|NCT00303628|Antidotes|antidotes|mesh-ancestor
14253233|NCT00303628|Protective Agents|protective agents|mesh-ancestor
14253234|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
14253235|NCT00303628|Vitamins|vitamins|mesh-ancestor
14253236|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
14253237|NCT00303667|Vidarabine|vidarabine|mesh-list
14253238|NCT00303667|Aldesleukin|aldesleukin|mesh-list
14253239|NCT00303667|Cyclosporine|cyclosporine|mesh-list
14253240|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
14253241|NCT00303667|Fludarabine|fludarabine|mesh-list
14253242|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
14253243|NCT00303667|Interleukin-2|interleukin-2|mesh-list
14253244|NCT00303667|Cyclosporins|cyclosporins|mesh-list
14253245|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
14253246|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14253247|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
14253248|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253249|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14253250|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14253251|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
14253252|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253253|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253254|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14253255|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14253256|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
14253257|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
14253258|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253259|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253260|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
14253261|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
14253262|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14253263|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14253264|NCT00303667|Analgesics|analgesics|mesh-ancestor
14253265|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
14253266|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253267|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14253268|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14253269|NCT00303719|Cyclosporine|cyclosporine|mesh-list
14253270|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
14253271|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
14253272|NCT00303719|Fludarabine|fludarabine|mesh-list
14253273|NCT00303719|Cyclosporins|cyclosporins|mesh-list
14253274|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14253275|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14253276|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
14253277|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253278|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14253279|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14253280|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
14253281|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253282|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253283|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14253284|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253285|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
14253286|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253287|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
14253288|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14253289|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14253290|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14253291|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
14253292|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14253293|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14253294|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
14253295|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253296|NCT00303823|Protective Agents|protective agents|mesh-ancestor
14253297|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253298|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14253299|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14253300|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253301|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14253302|NCT00303862|Cediranib|cediranib|mesh-list
14253303|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253304|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253305|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253306|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14253307|NCT00303953|Belinostat|belinostat|mesh-list
14253308|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253309|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14253310|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253311|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253312|NCT00303966|Sorafenib|sorafenib|mesh-list
14253313|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253314|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14253315|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253316|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253317|NCT00304031|Temozolomide|temozolomide|mesh-list
14253318|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14253319|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
14253320|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253321|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253322|NCT00304083|Doxorubicin|doxorubicin|mesh-list
14253323|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14253324|NCT00304083|Etoposide|etoposide|mesh-list
14253325|NCT00304083|Ifosfamide|ifosfamide|mesh-list
14253326|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14253327|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253328|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14253329|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14253330|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253331|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253332|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14253333|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14253334|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
14253335|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14253336|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14253337|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14253338|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14253339|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253340|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
14253341|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253342|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253343|NCT00304187|Erythromycin|erythromycin|mesh-list
14253344|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
14253345|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14253346|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
14253347|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14253348|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253349|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14253350|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14253351|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253352|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253353|NCT00304278|Cisplatin|cisplatin|mesh-list
14253354|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14253355|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253356|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14253357|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253358|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253359|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
14253360|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14253361|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253362|NCT00304707|Bupropion|bupropion|mesh-list
14253363|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14253364|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
14253365|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14253366|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14253367|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14253368|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14253369|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253370|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
14253371|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253372|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253373|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14253374|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14253375|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253376|NCT00304746|Testosterone|testosterone|mesh-list
14253377|NCT00304746|Androgens|androgens|mesh-ancestor
14253378|NCT00304746|Hormones|hormones|mesh-ancestor
14253379|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14253380|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253381|NCT05267847|Anesthetics|anesthetics|mesh-list
14253382|NCT05267847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14253383|NCT05267847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532346|NCT02152670|Methylphenidate|methylphenidate|mesh-list
14532347|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
14532348|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14532349|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532350|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14532351|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14532352|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14532353|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532354|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
14532355|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532356|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14532357|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14532358|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532359|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14532360|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14532361|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532362|NCT02137096|Carboplatin|carboplatin|mesh-list
14532363|NCT02137096|Etoposide|etoposide|mesh-list
14532364|NCT02137096|Ifosfamide|ifosfamide|mesh-list
14532365|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
14532366|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532367|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14532368|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14532369|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14532370|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532371|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532372|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14532373|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
14532374|NCT02147834|Ranolazine|ranolazine|mesh-list
14532375|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14532376|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14532377|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532378|NCT02144155|Oxytocin|oxytocin|mesh-list
14532379|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
14532380|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14532381|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532382|NCT02140788|Metformin|metformin|mesh-list
14532383|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14532384|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532385|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
14532386|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14532387|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
14532388|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
14532389|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532390|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532391|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14532392|NCT02145169|Analgesics|analgesics|mesh-ancestor
14532393|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
14532394|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532395|NCT02130622|Promethazine|promethazine|mesh-list
14532396|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
14532397|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
14532398|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
14532399|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14532400|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
14532401|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
14532402|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532403|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532404|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532405|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14532406|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14532407|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14532408|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532409|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
14532410|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
14532411|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
14532412|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532413|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
14253384|NCT05267743|Lansoprazole|lansoprazole|mesh-list
14253385|NCT05267743|Dexlansoprazole|dexlansoprazole|mesh-list
14253386|NCT05267743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14253387|NCT05267743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14253388|NCT05267743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14253389|NCT05267743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253390|NCT05267743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042583|NCT02045030|Growth Substances|growth substances|mesh-ancestor
15042584|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042585|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
15042586|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042587|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
15042588|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14253397|NCT05267457|Vanadium|vanadium|mesh-list
14253398|NCT05267457|Trace Elements|trace elements|mesh-ancestor
14253399|NCT05267457|Micronutrients|micronutrients|mesh-ancestor
14253400|NCT05267457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253401|NCT05267392|Durvalumab|durvalumab|mesh-list
14253402|NCT05267392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14253403|NCT05267392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253404|NCT05267366|Bevacizumab|bevacizumab|mesh-list
14253405|NCT05267366|Carboplatin|carboplatin|mesh-list
14253406|NCT05267366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14253407|NCT05267366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14253408|NCT05267366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253409|NCT05267366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14253410|NCT05267366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14253411|NCT05267366|Growth Substances|growth substances|mesh-ancestor
14253412|NCT05267366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253413|NCT05267366|Growth Inhibitors|growth inhibitors|mesh-ancestor
14253414|NCT05267366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253415|NCT05267288|Afatinib|afatinib|mesh-list
14253416|NCT05267288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253417|NCT05267288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14253418|NCT05267288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253419|NCT05267288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253420|NCT05267054|Rituximab|rituximab|mesh-list
14253421|NCT05267054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14253422|NCT05267054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253423|NCT05267054|Immunologic Factors|immunologic factors|mesh-ancestor
14253424|NCT05267054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253425|NCT05267054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14253426|NCT05266937|Paclitaxel|paclitaxel|mesh-list
14253427|NCT05266937|Carboplatin|carboplatin|mesh-list
14253428|NCT05266937|Atezolizumab|atezolizumab|mesh-list
14253429|NCT05266937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14253430|NCT05266937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253431|NCT05266937|Tubulin Modulators|tubulin modulators|mesh-ancestor
14253432|NCT05266937|Antimitotic Agents|antimitotic agents|mesh-ancestor
14253433|NCT05266937|Mitosis Modulators|mitosis modulators|mesh-ancestor
14253434|NCT05266937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253435|NCT05266924|Hormones|hormones|mesh-list
14253436|NCT05266924|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14253437|NCT05266924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14253438|NCT05266924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253439|NCT05266859|Calcium|calcium|mesh-list
14253440|NCT05266859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14253441|NCT05266859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253442|NCT05266820|Thalidomide|thalidomide|mesh-list
14253443|NCT05266820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14253444|NCT05266820|Immunologic Factors|immunologic factors|mesh-ancestor
14253445|NCT05266820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253446|NCT05266820|Leprostatic Agents|leprostatic agents|mesh-ancestor
14253447|NCT05266820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14253448|NCT05266820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253449|NCT05266820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14253450|NCT05266820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14253451|NCT05266820|Growth Substances|growth substances|mesh-ancestor
14253452|NCT05266820|Growth Inhibitors|growth inhibitors|mesh-ancestor
14253453|NCT05266820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253454|NCT05266807|Vancomycin|vancomycin|mesh-list
14253455|NCT05266807|Fidaxomicin|fidaxomicin|mesh-list
14253456|NCT05266807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14253457|NCT05266807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253458|NCT05266794|Selenium|selenium|mesh-list
14253459|NCT05266794|Thioctic Acid|thioctic acid|mesh-list
15042589|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
14253460|NCT05266794|Antioxidants|antioxidants|mesh-ancestor
14253461|NCT05266794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253462|NCT05266794|Protective Agents|protective agents|mesh-ancestor
14253463|NCT05266794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253464|NCT05266794|Trace Elements|trace elements|mesh-ancestor
14253465|NCT05266794|Micronutrients|micronutrients|mesh-ancestor
14253466|NCT05266794|Vitamin B Complex|vitamin b complex|mesh-ancestor
14253467|NCT05266794|Vitamins|vitamins|mesh-ancestor
14253468|NCT05266716|Methamphetamine|methamphetamine|mesh-list
14253469|NCT05266716|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14253470|NCT05266716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253471|NCT05266716|Sympathomimetics|sympathomimetics|mesh-ancestor
14253472|NCT05266716|Autonomic Agents|autonomic agents|mesh-ancestor
14253473|NCT05266716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253474|NCT05266716|Dopamine Agents|dopamine agents|mesh-ancestor
14253475|NCT05266716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253476|NCT05266716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253477|NCT05266716|Adrenergic Agents|adrenergic agents|mesh-ancestor
14253478|NCT05266716|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14253479|NCT05266716|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14253480|NCT05266716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14253481|NCT05266716|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14253482|NCT05266690|Dextrans|dextrans|mesh-list
14253483|NCT05266690|Anticoagulants|anticoagulants|mesh-ancestor
14253484|NCT05266690|Plasma Substitutes|plasma substitutes|mesh-ancestor
14253485|NCT05266690|Blood Substitutes|blood substitutes|mesh-ancestor
14253486|NCT05266651|Tadalafil|tadalafil|mesh-list
14253487|NCT05266651|Vasodilator Agents|vasodilator agents|mesh-ancestor
14253488|NCT05266651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14253489|NCT05266651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14253490|NCT05266651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253491|NCT05266651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253492|NCT05266651|Urological Agents|urological agents|mesh-ancestor
14253493|NCT05266560|Propofol|propofol|mesh-list
14253494|NCT05266560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14253495|NCT05266560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14253496|NCT05266560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253497|NCT05266560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14253498|NCT05266560|Anesthetics, General|anesthetics, general|mesh-ancestor
14253499|NCT05266560|Anesthetics|anesthetics|mesh-ancestor
14253500|NCT05266534|Terlipressin|terlipressin|mesh-list
14253501|NCT05266534|Carbetocin|carbetocin|mesh-list
14253502|NCT05266534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14253503|NCT05266534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14253504|NCT05266534|Oxytocics|oxytocics|mesh-ancestor
14253505|NCT05266534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14253506|NCT05266534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253507|NCT05266274|Azacitidine|azacitidine|mesh-list
14253508|NCT05266274|Antibodies|antibodies|mesh-list
14253509|NCT05266274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14253510|NCT05266274|Immunologic Factors|immunologic factors|mesh-ancestor
14253511|NCT05266274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253512|NCT05266274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14253513|NCT05266274|Antimetabolites|antimetabolites|mesh-ancestor
14253514|NCT05266274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253515|NCT05266274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253516|NCT05266274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253517|NCT05266261|Cholecalciferol|cholecalciferol|mesh-list
14253518|NCT05266261|Ibandronic Acid|ibandronic acid|mesh-list
14253519|NCT05266261|Calcium Carbonate|calcium carbonate|mesh-list
14253520|NCT05266261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14253521|NCT05266261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253522|NCT05266261|Vitamins|vitamins|mesh-ancestor
14253523|NCT05266261|Micronutrients|micronutrients|mesh-ancestor
14253524|NCT05266261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14253525|NCT05266261|Antacids|antacids|mesh-ancestor
14253526|NCT05266261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253527|NCT05266261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14253528|NCT05266196|Cyclophosphamide|cyclophosphamide|mesh-list
14253529|NCT05266196|Topotecan|topotecan|mesh-list
14253530|NCT05266196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14253531|NCT05266196|Immunologic Factors|immunologic factors|mesh-ancestor
14253532|NCT05266196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253533|NCT05266196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14253534|NCT05266196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14253535|NCT05266196|Alkylating Agents|alkylating agents|mesh-ancestor
14253536|NCT05266196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253537|NCT05266196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253538|NCT05266196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14253539|NCT05266196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14253540|NCT05266196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14253541|NCT05266196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253542|NCT05266105|Palbociclib|palbociclib|mesh-list
14253543|NCT05266105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253544|NCT05266105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14253545|NCT05266105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253546|NCT05266105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253547|NCT05266066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14253548|NCT05266066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14253549|NCT05266066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253550|NCT05266066|Antitubercular Agents|antitubercular agents|mesh-ancestor
14253551|NCT05266040|Valacyclovir|valacyclovir|mesh-list
14253552|NCT05266040|Antiviral Agents|antiviral agents|mesh-ancestor
14253553|NCT05266040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253554|NCT05266027|Nalbuphine|nalbuphine|mesh-list
14253555|NCT05266027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14253556|NCT05266027|Narcotics|narcotics|mesh-ancestor
14253557|NCT05266027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14253558|NCT05266027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253559|NCT05266027|Analgesics|analgesics|mesh-ancestor
14253560|NCT05266027|Sensory System Agents|sensory system agents|mesh-ancestor
14253561|NCT05266027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253562|NCT05265975|Rituximab|rituximab|mesh-list
14253563|NCT05265975|Lenalidomide|lenalidomide|mesh-list
14253564|NCT05265975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14253565|NCT05265975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253566|NCT05265975|Immunologic Factors|immunologic factors|mesh-ancestor
14253567|NCT05265975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253568|NCT05265975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14253569|NCT05265975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14253570|NCT05265975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14253571|NCT05265975|Growth Substances|growth substances|mesh-ancestor
14253572|NCT05265975|Growth Inhibitors|growth inhibitors|mesh-ancestor
14532414|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
14532415|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14532416|NCT02133534|Atorvastatin|atorvastatin|mesh-list
14532417|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14532418|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14532419|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
14532420|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532421|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14532422|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14532423|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532424|NCT02134912|Pemetrexed|pemetrexed|mesh-list
14532425|NCT02134912|Crizotinib|crizotinib|mesh-list
14532426|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532427|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532428|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532429|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14532430|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14532431|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14532432|NCT02131155|Afatinib|afatinib|mesh-list
14532433|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532434|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14532435|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532436|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532437|NCT02117050|Interferons|interferons|mesh-list
14532438|NCT02117050|Interferon-beta|interferon-beta|mesh-list
14532439|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
14532440|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532441|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
14532442|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532443|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
14532444|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532445|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14532446|NCT02110069|Sirolimus|sirolimus|mesh-list
14532447|NCT02110069|Vincristine|vincristine|mesh-list
14532448|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14532449|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532450|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
14532451|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
14532452|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
14253573|NCT05265962|Decitabine|decitabine|mesh-list
14253574|NCT05265962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14253575|NCT05265962|Antimetabolites|antimetabolites|mesh-ancestor
14253576|NCT05265962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253577|NCT05265962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253578|NCT05265962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253579|NCT05265910|Loratadine|loratadine|mesh-list
14253580|NCT05265910|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
14253581|NCT05265910|Dextrans|dextrans|mesh-list
14253582|NCT05265910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14253583|NCT05265910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14253584|NCT05265910|Antipruritics|antipruritics|mesh-ancestor
14253585|NCT05265910|Dermatologic Agents|dermatologic agents|mesh-ancestor
14253586|NCT05265910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14253587|NCT05265910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
14253588|NCT05265910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14253589|NCT05265910|Histamine Antagonists|histamine antagonists|mesh-ancestor
14253590|NCT05265910|Histamine Agents|histamine agents|mesh-ancestor
14253591|NCT05265910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253592|NCT05265910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253593|NCT05265910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253594|NCT05265910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14253595|NCT05265910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14253596|NCT05265910|Analgesics|analgesics|mesh-ancestor
14253597|NCT05265910|Sensory System Agents|sensory system agents|mesh-ancestor
14253598|NCT05265910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253599|NCT05265910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14253600|NCT05265910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14253601|NCT05265910|Anticoagulants|anticoagulants|mesh-ancestor
14253602|NCT05265910|Plasma Substitutes|plasma substitutes|mesh-ancestor
14253603|NCT05265910|Blood Substitutes|blood substitutes|mesh-ancestor
14253604|NCT05265819|Hormones|hormones|mesh-list
14253605|NCT05265819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14253606|NCT05265819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253607|NCT05265806|Oxytocin|oxytocin|mesh-list
14253608|NCT05265806|Oxytocics|oxytocics|mesh-ancestor
14253609|NCT05265806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14253610|NCT05265806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253611|NCT05265793|Apatinib|apatinib|mesh-list
14253612|NCT05265793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253613|NCT05265793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14253614|NCT05265793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253615|NCT05265793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253616|NCT05240781|Sirolimus|sirolimus|mesh-list
14253617|NCT05240781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14253618|NCT05240781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253619|NCT05240781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14253620|NCT05240781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253621|NCT05240781|Antifungal Agents|antifungal agents|mesh-ancestor
14253622|NCT05240781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14253623|NCT05240781|Immunologic Factors|immunologic factors|mesh-ancestor
14253624|NCT05240781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253625|NCT05237596|Acetaminophen|acetaminophen|mesh-list
14253626|NCT05237596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14253627|NCT05237596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14253628|NCT05237596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14253629|NCT05237596|Analgesics|analgesics|mesh-ancestor
14253630|NCT05237596|Sensory System Agents|sensory system agents|mesh-ancestor
14253631|NCT05237596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253632|NCT05237596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253633|NCT05237596|Antipyretics|antipyretics|mesh-ancestor
14253634|NCT05237596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14253635|NCT05236036|Mycophenolic Acid|mycophenolic acid|mesh-list
14253636|NCT05236036|Temozolomide|temozolomide|mesh-list
14253637|NCT05236036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14253638|NCT05236036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253639|NCT05236036|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14253640|NCT05236036|Antitubercular Agents|antitubercular agents|mesh-ancestor
14253641|NCT05236036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14253642|NCT05236036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253643|NCT05236036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253644|NCT05236036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253645|NCT05236036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14253646|NCT05236036|Alkylating Agents|alkylating agents|mesh-ancestor
14253647|NCT05217498|Istradefylline|istradefylline|mesh-list
14253648|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
14253649|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14253650|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14253651|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
14253652|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253653|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253654|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253655|NCT05211804|Ranibizumab|ranibizumab|mesh-list
14253656|NCT05211804|Aflibercept|aflibercept|mesh-list
14253657|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253658|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14253659|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14253660|NCT05211804|Growth Substances|growth substances|mesh-ancestor
14253661|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253662|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
14253663|NCT05206435|Nicotine|nicotine|mesh-list
14253664|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14253665|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
14253666|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253667|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253668|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14253669|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14253670|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
14253671|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253672|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253673|NCT05201430|Capecitabine|capecitabine|mesh-list
14253674|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
14253675|NCT05201430|Irinotecan|irinotecan|mesh-list
14253676|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14253677|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
14253678|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253679|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253680|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14253681|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14253682|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253683|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
14253684|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14253685|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253686|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14253687|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14253688|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253689|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253690|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253691|NCT05185973|Micronutrients|micronutrients|mesh-list
14253692|NCT05185973|Trace Elements|trace elements|mesh-list
14253693|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253694|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
14253695|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14253696|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
14253697|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253698|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253699|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14253700|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
14253701|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
14253702|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14253703|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
14253704|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253705|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253706|NCT05156060|Ketamine|ketamine|mesh-list
14253707|NCT05156060|Gabapentin|gabapentin|mesh-list
14253708|NCT05156060|Analgesics|analgesics|mesh-ancestor
14253709|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
14253710|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253711|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253712|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14253713|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14253714|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
14253715|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
14253716|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14253717|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14253718|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14253719|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253720|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253721|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
14253722|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14253723|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14253724|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14253725|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
15042590|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042591|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15042592|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15042593|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15042594|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042595|NCT02045069|Ivermectin|ivermectin|mesh-list
15042596|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15042597|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042598|NCT02045290|Metformin|metformin|mesh-list
15042599|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15042600|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253745|NCT05117034|Morphine|morphine|mesh-list
14253746|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14253747|NCT05117034|Narcotics|narcotics|mesh-ancestor
14253748|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14253749|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253750|NCT05117034|Analgesics|analgesics|mesh-ancestor
14253751|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
14253752|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253753|NCT05092360|Gemcitabine|gemcitabine|mesh-list
14253754|NCT05092360|Paclitaxel|paclitaxel|mesh-list
14253755|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14253756|NCT05092360|Doxorubicin|doxorubicin|mesh-list
14253757|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14253758|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
14253759|NCT05092360|Topotecan|topotecan|mesh-list
14253760|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14253761|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253762|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
14253763|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
14253764|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
14253765|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253766|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14253767|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
14253768|NCT05092360|Antiviral Agents|antiviral agents|mesh-ancestor
14253769|NCT05092360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253770|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253771|NCT05092360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14253772|NCT05092360|Immunologic Factors|immunologic factors|mesh-ancestor
14253773|NCT05092360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253774|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14253775|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14253776|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14253777|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15042601|NCT02045368|Methotrexate|methotrexate|mesh-list
15042602|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15042603|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
15042604|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15042605|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042606|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15042607|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
15042608|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042609|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042610|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
15042611|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042612|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15042613|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042614|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
15042615|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15042616|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15042617|NCT02045589|Gemcitabine|gemcitabine|mesh-list
15042618|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14253778|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14253779|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14253780|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14253781|NCT05018091|Dexamethasone|dexamethasone|mesh-list
14253782|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
14253783|NCT05018091|BB 1101|bb 1101|mesh-list
14253784|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14253785|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
14253786|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
14253787|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253788|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253789|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14253790|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
14253791|NCT05018091|Hormones|hormones|mesh-ancestor
14253792|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14253793|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14253794|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253795|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
14253796|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253797|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253798|NCT04980482|Interferons|interferons|mesh-list
14253799|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
14253800|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
14253801|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14253802|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253803|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
14253804|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253805|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
14253806|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253807|NCT04974216|Rituximab|rituximab|mesh-list
14253808|NCT04974216|Lenalidomide|lenalidomide|mesh-list
14253809|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14253810|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253811|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
14253812|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253813|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14253814|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14253815|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14253816|NCT04974216|Growth Substances|growth substances|mesh-ancestor
14253817|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
14253818|NCT04923542|Hormones|hormones|mesh-list
14253819|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14253820|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253821|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
14253822|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14253823|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14253824|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14253825|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14253826|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253827|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
14253828|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253829|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253830|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14253831|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253832|NCT04786964|Folic Acid|folic acid|mesh-list
14253833|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
14253834|NCT04786964|Hydroxocobalamin|hydroxocobalamin|mesh-list
14253835|NCT04786964|Dexamethasone|dexamethasone|mesh-list
14253836|NCT04786964|Carboplatin|carboplatin|mesh-list
14253837|NCT04786964|Pemetrexed|pemetrexed|mesh-list
14253838|NCT04786964|Vitamins|vitamins|mesh-ancestor
14253839|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
14253840|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253841|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253842|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14253843|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
14253844|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
14253845|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253846|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14253847|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
14253848|NCT04786964|Hormones|hormones|mesh-ancestor
14253849|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14253850|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14253851|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253852|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253853|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14253854|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14253855|NCT04786964|Hematinics|hematinics|mesh-ancestor
14253856|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
14253857|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
14253858|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14253859|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253860|NCT04750226|Levodopa|levodopa|mesh-list
14253861|NCT04750226|Carbidopa|carbidopa|mesh-list
14253862|NCT04750226|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14253863|NCT04750226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14253864|NCT04750226|Dopamine Agents|dopamine agents|mesh-ancestor
14253865|NCT04750226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253866|NCT04750226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253867|NCT04750226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253868|NCT04750226|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14253869|NCT04750226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253870|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
14253871|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14253872|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
14253873|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253874|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14253875|NCT04641507|Tadalafil|tadalafil|mesh-list
14253876|NCT04641507|Tamsulosin|tamsulosin|mesh-list
14253877|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
14253878|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14253879|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14253880|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253881|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253882|NCT04641507|Urological Agents|urological agents|mesh-ancestor
14253883|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14253884|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14253885|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14253886|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
14253887|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253888|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253889|NCT04618744|Insulin|insulin|mesh-list
14253890|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14253891|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14253892|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253893|NCT04617457|Leucovorin|leucovorin|mesh-list
14253894|NCT04617457|Folic Acid|folic acid|mesh-list
14253895|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
14253896|NCT04617457|Irinotecan|irinotecan|mesh-list
14253897|NCT04617457|Fluorouracil|fluorouracil|mesh-list
14253898|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
14253899|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253900|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14253901|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14253902|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253903|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253904|NCT04617457|Antidotes|antidotes|mesh-ancestor
14253905|NCT04617457|Protective Agents|protective agents|mesh-ancestor
14253906|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253907|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
14253908|NCT04617457|Vitamins|vitamins|mesh-ancestor
14253909|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
14253910|NCT04617457|Hematinics|hematinics|mesh-ancestor
14253911|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
14253912|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14253913|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14253914|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
14532453|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532454|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14532455|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532456|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14532457|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
14532458|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532459|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
14532460|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532461|NCT02105116|Cytarabine|cytarabine|mesh-list
14532462|NCT02105116|Fludarabine|fludarabine|mesh-list
14532463|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
14532464|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532465|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14532466|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
14532467|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532468|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532469|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
14532470|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253915|NCT04586660|Denosumab|denosumab|mesh-list
14253916|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14253917|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253918|NCT04564846|Insulin|insulin|mesh-list
14253919|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14253920|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253921|NCT04528212|Glimepiride|glimepiride|mesh-list
14253922|NCT04528212|Curcumin|curcumin|mesh-list
14253923|NCT04528212|Fenofibrate|fenofibrate|mesh-list
14253924|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14253925|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14253926|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253927|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14253928|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
14253929|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14253930|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14253931|NCT04528212|Analgesics|analgesics|mesh-ancestor
14253932|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
14253933|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14253934|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14253935|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14253936|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14253937|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253938|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253939|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14253940|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
14253941|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14253942|NCT04493931|Rifampin|rifampin|mesh-list
14253943|NCT04493931|Digoxin|digoxin|mesh-list
14253944|NCT04493931|Midazolam|midazolam|mesh-list
14253945|NCT04493931|Cimetidine|cimetidine|mesh-list
14253946|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14253947|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14253948|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14253949|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253950|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14253951|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14253952|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14253953|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14253954|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
14253955|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
14253956|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
14253957|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
14253958|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253959|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253960|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14253961|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
14253962|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14253963|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253964|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
14253965|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14253966|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14253967|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14253968|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14253969|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14253970|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14253971|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14253972|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14253973|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14253974|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14253975|NCT04493931|Protective Agents|protective agents|mesh-ancestor
14253976|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14253977|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14253978|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
14253979|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
14253980|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
14253981|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
14253982|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14253983|NCT04489173|Trifluridine|trifluridine|mesh-list
14253984|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
14253985|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14253986|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
14253987|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14253988|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
14253989|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14253990|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14253991|NCT04476511|Vitamins|vitamins|mesh-ancestor
14253992|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
14253993|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14253994|NCT04445662|Varenicline|varenicline|mesh-list
14253995|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14253996|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14253997|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
14253998|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14253999|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254000|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254001|NCT04417621|Trametinib|trametinib|mesh-list
14254002|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254003|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14254004|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254005|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254006|NCT04413617|Tofacitinib|tofacitinib|mesh-list
14254007|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14254008|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254009|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254010|NCT04342572|Melphalan|melphalan|mesh-list
14254011|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14254012|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
14254013|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254014|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254015|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14254016|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254017|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
14254018|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254019|NCT04339426|Azithromycin|azithromycin|mesh-list
14254020|NCT04339426|Atovaquone|atovaquone|mesh-list
14254021|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14254022|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254023|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
14254024|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14254025|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14254026|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254027|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254028|NCT04338204|Tofacitinib|tofacitinib|mesh-list
14254029|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14254030|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254031|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254032|NCT04312503|Olanzapine|olanzapine|mesh-list
14254033|NCT04312503|Risperidone|risperidone|mesh-list
14254034|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14254035|NCT04312503|Aripiprazole|aripiprazole|mesh-list
14254036|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
14254037|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14254038|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
14254039|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14254040|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254041|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254042|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14254043|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14254044|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14254045|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14254046|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14254047|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
14254048|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
14254049|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
14254050|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254051|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14254052|NCT04312503|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14254053|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14254054|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14254055|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
14254056|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
14254057|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14254058|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14254059|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14254060|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14254061|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14254062|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14254063|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14254064|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
14254065|NCT04298463|Vancomycin|vancomycin|mesh-list
14254066|NCT04298463|Daptomycin|daptomycin|mesh-list
14254067|NCT04298463|Teicoplanin|teicoplanin|mesh-list
14254068|NCT04298463|Dalbavancin|dalbavancin|mesh-list
14254069|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14254070|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254071|NCT04260854|Bupivacaine|bupivacaine|mesh-list
14254072|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
14254073|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
14254074|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14254075|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254076|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
14254077|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254078|NCT04251351|Acetaminophen|acetaminophen|mesh-list
14254079|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14254080|NCT04251351|Analgesics|analgesics|mesh-ancestor
14254081|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
14254082|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254083|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254084|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
14254085|NCT04248569|Nivolumab|nivolumab|mesh-list
14254086|NCT04248569|Ipilimumab|ipilimumab|mesh-list
14254087|NCT04248569|Poly ICLC|poly iclc|mesh-list
14254088|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254089|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254090|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14254091|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254092|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
14254093|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
14254094|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254095|NCT04221750|Metformin|metformin|mesh-list
14254096|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14254097|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254098|NCT04220125|Midazolam|midazolam|mesh-list
14254099|NCT04220125|Ketamine|ketamine|mesh-list
14254100|NCT04220125|Analgesics|analgesics|mesh-ancestor
14254101|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
14254102|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254103|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254104|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14254105|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14254106|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
14254107|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
14254108|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14254109|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14254110|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14254111|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14254112|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254113|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14254114|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14254115|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14254116|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14254117|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14254118|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
14254119|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
14254120|NCT04209686|Paclitaxel|paclitaxel|mesh-list
14254121|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
14254122|NCT04209686|Olaparib|olaparib|mesh-list
14254123|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14254124|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254125|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
14254126|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
14254127|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
14254128|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254129|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254130|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14254131|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254132|NCT04207944|Sulindac|sulindac|mesh-list
14254133|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14254134|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14254135|NCT04207944|Analgesics|analgesics|mesh-ancestor
14254136|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
14254137|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254138|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254139|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14254140|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14254141|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254142|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14254143|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254144|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254145|NCT04177758|Vitamin D|vitamin d|mesh-list
14254146|NCT04177758|Vitamins|vitamins|mesh-ancestor
14254147|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
14254148|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254149|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14254150|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
14254151|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14254152|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14254153|NCT04157153|Sirolimus|sirolimus|mesh-list
14254154|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14254155|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254156|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14254157|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254158|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
14254159|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254160|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
14254161|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254162|NCT04145700|Gemcitabine|gemcitabine|mesh-list
14254163|NCT04145700|Docetaxel|docetaxel|mesh-list
14254164|NCT04145700|Ramucirumab|ramucirumab|mesh-list
14254165|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14254166|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
14254167|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254168|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254169|NCT04145700|Antiviral Agents|antiviral agents|mesh-ancestor
14254170|NCT04145700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254171|NCT04145700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254172|NCT04145700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254173|NCT04145700|Immunologic Factors|immunologic factors|mesh-ancestor
14254174|NCT04145700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254175|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
14254176|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
14254177|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
14254178|NCT04129619|Ether|ether|mesh-list
14254179|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14254180|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
14254181|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
14254182|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14254183|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254184|NCT04128722|Sirolimus|sirolimus|mesh-list
14254185|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14254186|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254187|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14254188|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254189|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
14254190|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254191|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
14254192|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254193|NCT04123873|Acetaminophen|acetaminophen|mesh-list
14254194|NCT04123873|Dexamethasone|dexamethasone|mesh-list
14254195|NCT04123873|Ibuprofen|ibuprofen|mesh-list
14254196|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14254197|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
14254198|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
14254199|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254200|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254201|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14254202|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
14254203|NCT04123873|Hormones|hormones|mesh-ancestor
14254204|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14254205|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14254206|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254207|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14254208|NCT04123873|Analgesics|analgesics|mesh-ancestor
14254209|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
14254210|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
14254211|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14254212|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14254213|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14254214|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254215|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254216|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
14254217|NCT04098068|Antibodies|antibodies|mesh-list
14254218|NCT04098068|Immunologic Factors|immunologic factors|mesh-ancestor
14254219|NCT04098068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254220|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254221|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254222|NCT04072445|Trifluridine|trifluridine|mesh-list
14254223|NCT04072445|Irinotecan|irinotecan|mesh-list
14254224|NCT04072445|Camptothecin|camptothecin|mesh-list
14254225|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14254226|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14254227|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254228|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254229|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254230|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14254231|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
14254232|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
14254233|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254234|NCT04061590|Cisplatin|cisplatin|mesh-list
14254235|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
14254236|NCT04061590|Pemetrexed|pemetrexed|mesh-list
14254237|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254238|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254239|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254240|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254241|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14254242|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14254243|NCT04042753|Nivolumab|nivolumab|mesh-list
14254244|NCT04042753|Ipilimumab|ipilimumab|mesh-list
14254245|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254246|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254247|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14254248|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254249|NCT04031833|Amphotericin B|amphotericin b|mesh-list
14254250|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
14254251|NCT04031833|Amebicides|amebicides|mesh-ancestor
14254252|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14254253|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14254254|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254255|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14254256|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
14254257|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
14254258|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
14254259|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254260|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14254261|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
14254262|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14254263|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254264|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14254265|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14254266|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14254267|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
14532471|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
14532472|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532473|NCT02094352|Ketamine|ketamine|mesh-list
14532474|NCT02094352|Analgesics|analgesics|mesh-ancestor
14532475|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
14532476|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532477|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532478|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14532479|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14532480|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
14532481|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
14532482|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532483|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14532484|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14532485|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532486|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532487|NCT02096042|Azacitidine|azacitidine|mesh-list
14532488|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14532489|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14532490|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
14532491|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532492|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532493|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532494|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14532495|NCT02088957|Phenytoin|phenytoin|mesh-list
14532496|NCT02088957|Brivaracetam|brivaracetam|mesh-list
14254268|NCT04016142|Paclitaxel|paclitaxel|mesh-list
14254269|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14254270|NCT04016142|Carboplatin|carboplatin|mesh-list
14254271|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14254272|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254273|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
14254274|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
14254275|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
14254276|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254277|NCT04005287|Pirenzepine|pirenzepine|mesh-list
14254278|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14254279|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14254280|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14254281|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14254282|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
14254283|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14254284|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254285|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254286|NCT03999554|Vaccines|vaccines|mesh-list
14254287|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
14254288|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254289|NCT03977467|Atezolizumab|atezolizumab|mesh-list
14254290|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254291|NCT03934567|Abexinostat|abexinostat|mesh-list
14254292|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14254293|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254294|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254295|NCT03917966|Docetaxel|docetaxel|mesh-list
14254296|NCT03917966|Apatinib|apatinib|mesh-list
14254297|NCT03917966|Nedaplatin|nedaplatin|mesh-list
14254298|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254299|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
14254300|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
14254301|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
14254302|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254303|NCT03917966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14254304|NCT03917966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254305|NCT03879798|Irinotecan|irinotecan|mesh-list
14254306|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14254307|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14254308|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254309|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254310|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254311|NCT03867487|Empagliflozin|empagliflozin|mesh-list
14254312|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14254313|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254314|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14254315|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254316|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14254317|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14254318|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14254319|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254320|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254321|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
14254322|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254323|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14254324|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14254325|NCT03801304|Atezolizumab|atezolizumab|mesh-list
14254326|NCT03801304|Vinorelbine|vinorelbine|mesh-list
14254327|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254328|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14254329|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
14254330|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
14254331|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
14254332|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254333|NCT03792841|Etanercept|etanercept|mesh-list
14254334|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
14254335|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
14254336|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254337|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254338|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14254339|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14254340|NCT03792841|Analgesics|analgesics|mesh-ancestor
14254341|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
14254342|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254343|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254344|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14254345|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14254346|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14254347|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254348|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
14254349|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254350|NCT03783416|Ixazomib|ixazomib|mesh-list
14254351|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254352|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
14254353|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254354|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254355|NCT03765983|Trastuzumab|trastuzumab|mesh-list
14254356|NCT03765983|GDC-0084|gdc-0084|mesh-list
14254357|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254358|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254359|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254360|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254361|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
14254362|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
14254363|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254364|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
14254365|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254366|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14254367|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14254368|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
14254369|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254370|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254371|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14254372|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254373|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
14254374|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
14254375|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254376|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254377|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
14254378|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254379|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
14254380|NCT03732352|Osimertinib|osimertinib|mesh-list
14254381|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14254382|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14254383|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254384|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254385|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14254386|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254387|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
14254388|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
14254389|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254390|NCT03709914|Fosfomycin|fosfomycin|mesh-list
14254391|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14254392|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254393|NCT03706053|Midodrine|midodrine|mesh-list
14254394|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
14254395|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
14254396|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254397|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254398|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14254399|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14254400|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14254401|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14254402|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
14254403|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14254404|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254405|NCT03684811|Gemcitabine|gemcitabine|mesh-list
14254406|NCT03684811|Nivolumab|nivolumab|mesh-list
14254407|NCT03684811|Azacitidine|azacitidine|mesh-list
14254408|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254409|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14254410|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
14254411|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254412|NCT03684811|Antiviral Agents|antiviral agents|mesh-ancestor
14254413|NCT03684811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254414|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254415|NCT03684811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254416|NCT03684811|Immunologic Factors|immunologic factors|mesh-ancestor
14254417|NCT03684811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254418|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254419|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14254420|NCT03638141|Durvalumab|durvalumab|mesh-list
14254421|NCT03638141|Ipilimumab|ipilimumab|mesh-list
14254422|NCT03638141|Tremelimumab|tremelimumab|mesh-list
14254423|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14254424|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254425|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254426|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
14254427|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254428|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14254429|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254430|NCT03617172|Misoprostol|misoprostol|mesh-list
14254431|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14254432|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
14254433|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14254434|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254435|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14254436|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14254437|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
14254438|NCT03587272|Sirolimus|sirolimus|mesh-list
14254439|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
14254440|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14254441|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254442|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14254443|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254444|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
14254445|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254446|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
14254447|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254448|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254449|NCT03563716|Atezolizumab|atezolizumab|mesh-list
14254450|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254451|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
14254452|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
14254453|NCT03518034|Testosterone|testosterone|mesh-list
14254454|NCT03518034|Androgens|androgens|mesh-ancestor
14254455|NCT03518034|Hormones|hormones|mesh-ancestor
14254456|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14254457|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254458|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
14254459|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
14254460|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14254461|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254462|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
14254463|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
14254464|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254465|NCT03366415|Gemcitabine|gemcitabine|mesh-list
14254466|NCT03366415|Cisplatin|cisplatin|mesh-list
14254467|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254468|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14254469|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
14254470|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254471|NCT03366415|Antiviral Agents|antiviral agents|mesh-ancestor
14254472|NCT03366415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254473|NCT03366415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254474|NCT03366415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254475|NCT03366415|Immunologic Factors|immunologic factors|mesh-ancestor
14254476|NCT03366415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254477|NCT03315910|Nicotine|nicotine|mesh-list
14254478|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14254479|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
14254480|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254481|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254482|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14254483|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14254484|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
14254485|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14254486|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254487|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
14254488|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254489|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254490|NCT03248167|Cannabidiol|cannabidiol|mesh-list
14254491|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
14254492|NCT03239015|Trastuzumab|trastuzumab|mesh-list
14254493|NCT03239015|Everolimus|everolimus|mesh-list
14254494|NCT03239015|Olaparib|olaparib|mesh-list
14254495|NCT03239015|Gefitinib|gefitinib|mesh-list
14254496|NCT03239015|Palbociclib|palbociclib|mesh-list
14254497|NCT03239015|Afatinib|afatinib|mesh-list
14254498|NCT03239015|Vemurafenib|vemurafenib|mesh-list
14254499|NCT03239015|Dabrafenib|dabrafenib|mesh-list
14254500|NCT03239015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
14254501|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254502|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254503|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254504|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
14254505|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254506|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14254507|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254508|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254509|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
14254510|NCT03239015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14254511|NCT03239015|Growth Substances|growth substances|mesh-ancestor
14254512|NCT03239015|Growth Inhibitors|growth inhibitors|mesh-ancestor
14254513|NCT03197935|Paclitaxel|paclitaxel|mesh-list
14254514|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
14254515|NCT03197935|Doxorubicin|doxorubicin|mesh-list
14254516|NCT03197935|Atezolizumab|atezolizumab|mesh-list
14254517|NCT03197935|Antibodies|antibodies|mesh-list
14254518|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14254519|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254520|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
14254521|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
14254522|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
14254523|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254524|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254525|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
14254526|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254527|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14254528|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14254529|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
14254530|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14254531|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14254532|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14254533|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14254534|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254535|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
14254536|NCT03161379|Nivolumab|nivolumab|mesh-list
14254537|NCT03161379|Pancrelipase|pancrelipase|mesh-list
14254538|NCT03161379|Vaccines|vaccines|mesh-list
14254539|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
14254540|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254541|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254542|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14254543|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14254544|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
14254545|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254546|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254547|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14254548|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254549|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14254550|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14254551|NCT03120780|Fentanyl|fentanyl|mesh-list
14254552|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14254553|NCT03120780|Narcotics|narcotics|mesh-ancestor
14254554|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14254555|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254556|NCT03120780|Analgesics|analgesics|mesh-ancestor
14254557|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
14254558|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254559|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14254560|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14254561|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
14254562|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
14254563|NCT03079921|Propranolol|propranolol|mesh-list
14254564|NCT03079921|Phentolamine|phentolamine|mesh-list
14254565|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14254566|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14254567|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
14254568|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14254569|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254570|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254571|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14254572|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14254573|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
14254574|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14254575|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
14254576|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254577|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254578|NCT03017131|Aldesleukin|aldesleukin|mesh-list
14254579|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
14254580|NCT03017131|Decitabine|decitabine|mesh-list
14254581|NCT03017131|Interleukin-2|interleukin-2|mesh-list
14254582|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254583|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
14254584|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254585|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14254586|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14254587|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
14254588|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254589|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254590|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14254591|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14254592|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
14254593|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254594|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14254595|NCT03017131|Analgesics|analgesics|mesh-ancestor
14254596|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
14254597|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254598|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14254599|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14254600|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
14254601|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254602|NCT03013933|Cyclosporine|cyclosporine|mesh-list
14254603|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14254604|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14254605|NCT03013933|Verapamil|verapamil|mesh-list
14254606|NCT03013933|Antibodies|antibodies|mesh-list
14254607|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
14254608|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14254609|NCT03013933|Cyclosporins|cyclosporins|mesh-list
14254610|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
14254611|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
14254612|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254613|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254614|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254615|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254616|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254617|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
14254618|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254619|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
14254620|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14254621|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14254622|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14254623|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14254624|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14254625|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14254626|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
14254627|NCT03007238|Aldesleukin|aldesleukin|mesh-list
14254628|NCT03007238|Interleukin-2|interleukin-2|mesh-list
14254629|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254630|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14254631|NCT03007238|Analgesics|analgesics|mesh-ancestor
14254632|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
14254633|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254634|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254635|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14254636|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14254637|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
14254638|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532497|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14532498|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
14532499|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14532500|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14532501|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14532502|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532503|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14532504|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14254639|NCT02823002|Lidocaine|lidocaine|mesh-list
14254640|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
14254641|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
14254642|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14254643|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254644|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
14254645|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254646|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14254647|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14254648|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14254649|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14254650|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254651|NCT02779257|Diazoxide|diazoxide|mesh-list
14254652|NCT02779257|Pasireotide|pasireotide|mesh-list
14254653|NCT02779257|Hormones|hormones|mesh-ancestor
14254654|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14254655|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254656|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14254657|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
14254658|NCT02678351|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
14254659|NCT02678351|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14254660|NCT02678351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254661|NCT02660411|Propofol|propofol|mesh-list
14254662|NCT02660411|Sevoflurane|sevoflurane|mesh-list
14254663|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14254664|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14254665|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254666|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14254667|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
14254668|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
14254669|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14254670|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14254671|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
14254672|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
14254673|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
14254674|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254675|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254676|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14254677|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14254678|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
14254679|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254680|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254681|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14254682|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254683|NCT02633137|Cytarabine|cytarabine|mesh-list
14254684|NCT02633137|Lenalidomide|lenalidomide|mesh-list
14254685|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14254686|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
14254687|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254688|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254689|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
14254690|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254691|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254692|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
14254693|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254694|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14254695|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14254696|NCT02633137|Growth Substances|growth substances|mesh-ancestor
14254697|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
14254698|NCT02624518|Bombesin|bombesin|mesh-list
14254699|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14254700|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254701|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254702|NCT02578732|Leucovorin|leucovorin|mesh-list
14254703|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
14254704|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254705|NCT02578732|Antidotes|antidotes|mesh-ancestor
14254706|NCT02578732|Protective Agents|protective agents|mesh-ancestor
14254707|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254708|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
14254709|NCT02578732|Vitamins|vitamins|mesh-ancestor
14254710|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
14254711|NCT02530437|Paclitaxel|paclitaxel|mesh-list
14254712|NCT02530437|Carboplatin|carboplatin|mesh-list
14254713|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14532505|NCT02075411|Bupivacaine|bupivacaine|mesh-list
14254714|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14254715|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254716|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
14254717|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
14254718|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
14254719|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254720|NCT02501434|Heparin|heparin|mesh-list
14254721|NCT02501434|Calcium heparin|calcium heparin|mesh-list
14254722|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
14254723|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14254724|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14254725|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254726|NCT02478255|Xenon|xenon|mesh-list
14254727|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
14254728|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
14254729|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
14254730|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14254731|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254732|NCT02462421|Canagliflozin|canagliflozin|mesh-list
14254733|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14254734|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254735|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14254736|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254737|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
14254738|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14254739|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254740|NCT02272790|Gemcitabine|gemcitabine|mesh-list
14254741|NCT02272790|Paclitaxel|paclitaxel|mesh-list
14254742|NCT02272790|Carboplatin|carboplatin|mesh-list
14254743|NCT02272790|Adavosertib|adavosertib|mesh-list
14254744|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14254745|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254746|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
14254747|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
14254748|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
14254749|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254750|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14254751|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
14254752|NCT02272790|Antiviral Agents|antiviral agents|mesh-ancestor
14254753|NCT02272790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254754|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254755|NCT02272790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254756|NCT02272790|Immunologic Factors|immunologic factors|mesh-ancestor
14254757|NCT02272790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254758|NCT02178410|Vitamin D|vitamin d|mesh-list
14254759|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
14254760|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
14254761|NCT02178410|Vitamins|vitamins|mesh-list
14254762|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
14254763|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254764|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14254765|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14254766|NCT01880541|Anesthetics|anesthetics|mesh-list
14254767|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14254768|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254769|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
14254770|NCT01852890|Gemcitabine|gemcitabine|mesh-list
14254771|NCT01852890|Vitamins|vitamins|mesh-ancestor
14254772|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
14254773|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254774|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14254775|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
14254776|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254777|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254778|NCT01852890|Antiviral Agents|antiviral agents|mesh-ancestor
14254779|NCT01852890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254780|NCT01852890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254781|NCT01852890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254782|NCT01852890|Immunologic Factors|immunologic factors|mesh-ancestor
14254783|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
14254784|NCT01852890|Protective Agents|protective agents|mesh-ancestor
14254785|NCT01684397|Bevacizumab|bevacizumab|mesh-list
14254786|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14254787|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
14254788|NCT01684397|Antibodies|antibodies|mesh-list
14254789|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
14254790|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14254791|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
14254792|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254793|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14254794|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14254795|NCT01684397|Growth Substances|growth substances|mesh-ancestor
14254796|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254797|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
14254798|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
14254799|NCT01650350|Naltrexone|naltrexone|mesh-list
14254800|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14254801|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14254802|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254803|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
14254804|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254805|NCT01595321|Leucovorin|leucovorin|mesh-list
14254806|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
14254807|NCT01595321|Fluorouracil|fluorouracil|mesh-list
14254808|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
14254809|NCT01595321|Irinotecan|irinotecan|mesh-list
14254810|NCT01595321|Folfirinox|folfirinox|mesh-list
14254811|NCT01595321|Vaccines|vaccines|mesh-list
14254812|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
14254813|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254814|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254815|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14254816|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14254817|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
14254818|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254819|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254820|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14254821|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
14254822|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14254823|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14254824|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14254825|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254826|NCT01595321|Antidotes|antidotes|mesh-ancestor
14254827|NCT01595321|Protective Agents|protective agents|mesh-ancestor
14254828|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
14254829|NCT01595321|Vitamins|vitamins|mesh-ancestor
14254830|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
14254831|NCT01552590|Tolvaptan|tolvaptan|mesh-list
14254832|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14254833|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254834|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
14254835|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254836|NCT01345136|Everolimus|everolimus|mesh-list
14254837|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254838|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254839|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
14254840|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254841|NCT01158417|Resveratrol|resveratrol|mesh-list
14254842|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
14254843|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254844|NCT01158417|Protective Agents|protective agents|mesh-ancestor
14254845|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254846|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254847|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14254848|NCT01000467|Probucol|probucol|mesh-list
14254849|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14254850|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14254851|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
14254852|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254853|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14254854|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
14254855|NCT01000467|Protective Agents|protective agents|mesh-ancestor
14254856|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254857|NCT00743197|Aspirin|aspirin|mesh-list
14254858|NCT00743197|Lisinopril|lisinopril|mesh-list
14254859|NCT00743197|Simvastatin|simvastatin|mesh-list
14254860|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14254861|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14254862|NCT00743197|Analgesics|analgesics|mesh-ancestor
14254863|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
14254864|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254865|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254866|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14254867|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14254868|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14254869|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14254870|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254871|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14254872|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14254873|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254874|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
14254875|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14254876|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14254877|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
14254878|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14254879|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14254880|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14254881|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
14254882|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14254883|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14254884|NCT00743197|Protective Agents|protective agents|mesh-ancestor
14254885|NCT00549978|Cilostazol|cilostazol|mesh-list
14254886|NCT00549978|Probucol|probucol|mesh-list
14254887|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14254888|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
14254889|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254890|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254891|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14254892|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
14254893|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14254894|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14254895|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254896|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14254897|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
14254898|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14254899|NCT00549978|Protective Agents|protective agents|mesh-ancestor
14254900|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
14254901|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14254902|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254903|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14254904|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14254905|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
14254906|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14254907|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
14254908|NCT00198328|Bleomycin|bleomycin|mesh-list
14254909|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14254910|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254911|NCT00198315|Bleomycin|bleomycin|mesh-list
14254912|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14254913|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254914|NCT00304954|Sirolimus|sirolimus|mesh-list
14254915|NCT00304954|Infliximab|infliximab|mesh-list
14254916|NCT00304954|Daclizumab|daclizumab|mesh-list
14254917|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14254918|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14254919|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14254920|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254921|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
14254922|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254923|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
14254924|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254925|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
14532506|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
14254926|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14254927|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14254928|NCT00305058|Morphine|morphine|mesh-list
14254929|NCT00305058|Hydromorphone|hydromorphone|mesh-list
14254930|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14254931|NCT00305058|Narcotics|narcotics|mesh-ancestor
14254932|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14254933|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254934|NCT00305058|Analgesics|analgesics|mesh-ancestor
14254935|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
14254936|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254937|NCT00305084|Doxorubicin|doxorubicin|mesh-list
14254938|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14254939|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254940|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14254941|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14254942|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254943|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254944|NCT00305110|Hydromorphone|hydromorphone|mesh-list
14254945|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14254946|NCT00305110|Narcotics|narcotics|mesh-ancestor
14254947|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14254948|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254949|NCT00305110|Analgesics|analgesics|mesh-ancestor
14254950|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
14254951|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14254952|NCT00305162|Clopidogrel|clopidogrel|mesh-list
14254953|NCT00305162|Cangrelor|cangrelor|mesh-list
14254954|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14254955|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14254956|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14254957|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14254958|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
14254959|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14254960|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254961|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254962|NCT00305448|Fulvestrant|fulvestrant|mesh-list
14254963|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14254964|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14254965|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14254966|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14254967|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
14254968|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14254969|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254970|NCT00305578|Memantine|memantine|mesh-list
14254971|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14254972|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14254973|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
14254974|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14254975|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254976|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254977|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14254978|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14254979|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14254980|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14254981|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254982|NCT00305604|Incretins|incretins|mesh-ancestor
14254983|NCT00305604|Hormones|hormones|mesh-ancestor
14254984|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14254985|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14254986|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
14254987|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14254988|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14254989|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
14254990|NCT00305682|Sirolimus|sirolimus|mesh-list
14254991|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
14254992|NCT00305682|Fludarabine|fludarabine|mesh-list
14254993|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14254994|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14254995|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
14254996|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14254997|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14254998|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14254999|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
14255000|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255001|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255002|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14255003|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14255004|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14255005|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
14255006|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14255007|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255008|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255009|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
14255010|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
14255011|NCT00305695|Imidazole|imidazole|mesh-list
14255012|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14255013|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255014|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255015|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255016|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
14255017|NCT00305760|Cetuximab|cetuximab|mesh-list
14255018|NCT00305760|Vaccines|vaccines|mesh-list
14255019|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
14255020|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255021|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255022|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255023|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14255024|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
14255025|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255026|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255027|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14255028|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14255029|NCT00305773|Vorinostat|vorinostat|mesh-list
14255030|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255031|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14255032|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255033|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255034|NCT00305864|Temozolomide|temozolomide|mesh-list
14255035|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
14255036|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14255037|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
14255038|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255039|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255040|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14255041|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
14255042|NCT00305877|Gemcitabine|gemcitabine|mesh-list
14255043|NCT00305877|Bevacizumab|bevacizumab|mesh-list
14255044|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14255045|NCT00305877|Cetuximab|cetuximab|mesh-list
14255046|NCT00305877|Capecitabine|capecitabine|mesh-list
14255047|NCT00305877|Antibodies|antibodies|mesh-list
14255048|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
14255049|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14255050|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255051|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14255052|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14255053|NCT00305877|Growth Substances|growth substances|mesh-ancestor
14255054|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255055|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
14255056|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
14255057|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14255058|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
14255059|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255060|NCT00305877|Antiviral Agents|antiviral agents|mesh-ancestor
14255061|NCT00305877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255062|NCT00305877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255063|NCT00305877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255064|NCT00305942|Carboplatin|carboplatin|mesh-list
14255065|NCT00305942|Topotecan|topotecan|mesh-list
14255066|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255067|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14255068|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14255069|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255070|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255071|NCT00306163|Fluticasone|fluticasone|mesh-list
14255072|NCT00306163|Ciclesonide|ciclesonide|mesh-list
14255073|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14255074|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14255075|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
14255076|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255077|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255078|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14255079|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
14255080|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
14255081|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14255082|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
14255083|NCT00306163|Hormones|hormones|mesh-ancestor
14255084|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14255085|NCT00306189|Denosumab|denosumab|mesh-list
14255086|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14255087|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255088|NCT00306202|Dasatinib|dasatinib|mesh-list
14255089|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255090|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14255091|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255092|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255093|NCT00306293|Valacyclovir|valacyclovir|mesh-list
14255094|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
14255095|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255096|NCT00306384|Alogliptin|alogliptin|mesh-list
14255097|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14255098|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255099|NCT00306384|Incretins|incretins|mesh-ancestor
14255100|NCT00306384|Hormones|hormones|mesh-ancestor
14255101|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14255102|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14255103|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
14255104|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255105|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255106|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14255107|NCT00306488|Antioxidants|antioxidants|mesh-list
14255108|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14255109|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255110|NCT00306488|Protective Agents|protective agents|mesh-ancestor
14255111|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255112|NCT00306527|Vaccines|vaccines|mesh-list
14255113|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
14255114|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255115|NCT00306592|Natalizumab|natalizumab|mesh-list
14255116|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
14255117|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532507|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
14532508|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532509|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532510|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
14532511|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532512|NCT02074904|Topiramate|topiramate|mesh-list
14532513|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
14532514|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14532515|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532516|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
14532517|NCT02081183|Prednisone|prednisone|mesh-list
14532518|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
14532519|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532520|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
14532521|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532522|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14532523|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14532524|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
14532525|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532526|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532527|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14532528|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14532529|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
14532530|NCT02081183|Hormones|hormones|mesh-ancestor
14532531|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14532532|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14532533|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14532534|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14532535|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
14532536|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14532537|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532538|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532539|NCT02075021|Paclitaxel|paclitaxel|mesh-list
14255118|NCT00306670|Prednisone|prednisone|mesh-list
14255119|NCT00306670|Rituximab|rituximab|mesh-list
14255120|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14255121|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255122|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
14255123|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255124|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255125|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14255126|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
14255127|NCT00306670|Hormones|hormones|mesh-ancestor
14255128|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14255129|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14255130|NCT00306787|Valacyclovir|valacyclovir|mesh-list
14255131|NCT00306787|Famciclovir|famciclovir|mesh-list
14255132|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
14255133|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255134|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14255135|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255136|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255137|NCT00306852|Mitomycins|mitomycins|mesh-list
14255138|NCT00306852|Mitomycin|mitomycin|mesh-list
14255139|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14255140|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255141|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
14255142|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255143|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14255144|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255145|NCT00306891|Cediranib|cediranib|mesh-list
14255146|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255147|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14255148|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255149|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255150|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14255151|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
14255152|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255153|NCT00307047|Paclitaxel|paclitaxel|mesh-list
14255154|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14255155|NCT00307047|Everolimus|everolimus|mesh-list
14255156|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14255157|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255158|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
14255159|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
14255160|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
14255161|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255162|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255163|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
14255164|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255165|NCT00307086|Bortezomib|bortezomib|mesh-list
14255166|NCT00307086|Melphalan|melphalan|mesh-list
14255167|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255168|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14255169|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
14255170|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255171|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14255172|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255173|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
14255174|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255175|NCT00307125|Rituximab|rituximab|mesh-list
14255176|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14255177|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255178|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
14255179|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255180|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255181|NCT00307151|Ritonavir|ritonavir|mesh-list
14255182|NCT00307151|Lopinavir|lopinavir|mesh-list
14255183|NCT00307151|Lamivudine|lamivudine|mesh-list
14255184|NCT00307151|Zidovudine|zidovudine|mesh-list
14255185|NCT00307151|Nevirapine|nevirapine|mesh-list
14255186|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14255187|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14255188|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
14255189|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255190|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255191|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14255192|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14255193|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
14255194|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255195|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14255196|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14255197|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14255198|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14255199|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
14255200|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14255201|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14255202|NCT00307294|Thalidomide|thalidomide|mesh-list
14255203|NCT00307294|Doxorubicin|doxorubicin|mesh-list
14255204|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14255205|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255206|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14255207|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14255208|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255209|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255210|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255211|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
14255212|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255213|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
14255214|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14255215|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255216|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14255217|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14255218|NCT00307294|Growth Substances|growth substances|mesh-ancestor
14255219|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
14255220|NCT00307437|Ustekinumab|ustekinumab|mesh-list
14255221|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
14255222|NCT00307489|Tenofovir|tenofovir|mesh-list
14255223|NCT00307489|Emtricitabine|emtricitabine|mesh-list
14255224|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
14255225|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255226|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14255227|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14255228|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255229|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255230|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14255231|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14255232|NCT00307684|Methylphenidate|methylphenidate|mesh-list
14255233|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14255234|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255235|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14255236|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14255237|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14255238|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255239|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
14255240|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14255241|NCT00307736|Bevacizumab|bevacizumab|mesh-list
14255242|NCT00307736|Fluorouracil|fluorouracil|mesh-list
14255243|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14255244|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14255245|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255246|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14255247|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14255248|NCT00307736|Growth Substances|growth substances|mesh-ancestor
14255249|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255250|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
14255251|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
14255252|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255253|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14255254|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255255|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
14255256|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14255257|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255258|NCT00307801|Dienogest|dienogest|mesh-list
14255259|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14255260|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14255261|NCT00307801|Estradiol|estradiol|mesh-list
14255262|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14255263|NCT00307801|Estrogens|estrogens|mesh-ancestor
14255264|NCT00307801|Hormones|hormones|mesh-ancestor
14255265|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14255266|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255267|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14255268|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
14255269|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14255270|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14255271|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14255272|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14255273|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14255274|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
14255275|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14255276|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255277|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
14255278|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255279|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
14255280|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255281|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255282|NCT00308074|Aripiprazole|aripiprazole|mesh-list
14255283|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
14255284|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14255285|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14255286|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14255287|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14255288|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255289|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
14255290|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
14255291|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14255292|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255293|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14255294|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14255295|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
14255296|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14255297|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14255298|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14255299|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14255300|NCT00308087|Rituximab|rituximab|mesh-list
14255301|NCT00308087|Molgramostim|molgramostim|mesh-list
14255302|NCT00308087|Sargramostim|sargramostim|mesh-list
14255303|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14255304|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255305|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
14255306|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255307|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255308|NCT00308139|Exenatide|exenatide|mesh-list
14255309|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14255310|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255311|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14255312|NCT00308139|Incretins|incretins|mesh-ancestor
14255313|NCT00308139|Hormones|hormones|mesh-ancestor
14255314|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14255315|NCT00308308|Insulin|insulin|mesh-list
14255316|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14255317|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255318|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
14255319|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255320|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
14255321|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255322|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255323|NCT00308620|Chloroquine|chloroquine|mesh-list
14255324|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
14255325|NCT00308620|Amebicides|amebicides|mesh-ancestor
14255326|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14255327|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14255328|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255329|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
14255330|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255331|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14255332|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14255333|NCT00308620|Analgesics|analgesics|mesh-ancestor
14255334|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
14255335|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255336|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255337|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14255338|NCT00308620|Filaricides|filaricides|mesh-ancestor
14255339|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
14255340|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
14255341|NCT00308711|Misoprostol|misoprostol|mesh-list
14255342|NCT00308711|Dinoprostone|dinoprostone|mesh-list
14255343|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14255344|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
14255345|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14255346|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255347|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14255348|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14255349|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
14255350|NCT00308737|Insulin|insulin|mesh-list
14255351|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14255352|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255353|NCT00308750|Carboplatin|carboplatin|mesh-list
14255354|NCT00308750|Docetaxel|docetaxel|mesh-list
14255355|NCT00308750|Pemetrexed|pemetrexed|mesh-list
14255356|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255357|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
14255358|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
14255359|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
14255360|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255361|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255362|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14255363|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14255364|NCT00309166|Vaccines|vaccines|mesh-list
14255365|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
14255366|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255367|NCT00309244|Insulin|insulin|mesh-list
14255368|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14255369|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
14255370|NCT00309244|Protamines|protamines|mesh-list
14255371|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14255372|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255373|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
14255374|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255375|NCT00309244|Coagulants|coagulants|mesh-ancestor
14255376|NCT00309465|Insulin|insulin|mesh-list
14255377|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14255378|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
14255379|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14255380|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255381|NCT00309608|Glimepiride|glimepiride|mesh-list
14255382|NCT00309608|Linagliptin|linagliptin|mesh-list
14255383|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14255384|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14255385|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255386|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255387|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
14255388|NCT00309608|Incretins|incretins|mesh-ancestor
14255389|NCT00309608|Hormones|hormones|mesh-ancestor
14255390|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14255391|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14255392|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
14255393|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255394|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255395|NCT00309738|Simvastatin|simvastatin|mesh-list
14255396|NCT00309738|Pitavastatin|pitavastatin|mesh-list
14255397|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14255398|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14255399|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
14255400|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255401|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14255402|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14255403|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255404|NCT00309751|Atorvastatin|atorvastatin|mesh-list
14255405|NCT00309751|Pitavastatin|pitavastatin|mesh-list
14255406|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14255407|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14255408|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
14255409|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255410|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14255411|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14255412|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255413|NCT00309777|Simvastatin|simvastatin|mesh-list
14255414|NCT00309777|Pitavastatin|pitavastatin|mesh-list
14255415|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14255416|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14255417|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
14255418|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255419|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14255420|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14255421|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255422|NCT00309842|Cyclosporine|cyclosporine|mesh-list
14255423|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
14255424|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
14255425|NCT00309842|Fludarabine|fludarabine|mesh-list
14255426|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
14255427|NCT00309842|Cyclosporins|cyclosporins|mesh-list
14255428|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255429|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
14255430|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255431|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255432|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14255433|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
14255434|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255435|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255436|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14255437|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14255438|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
14255439|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255440|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
14255441|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255442|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
14255443|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14255444|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14255445|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14255446|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
14255447|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14255448|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
14255449|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14255450|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14255451|NCT00309907|Prednisolone|prednisolone|mesh-list
14255452|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
14255453|NCT00309907|Etanercept|etanercept|mesh-list
14255454|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14255455|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
14255456|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14255457|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
14255458|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
14255459|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255460|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255461|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14255462|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
14255463|NCT00309907|Hormones|hormones|mesh-ancestor
14255464|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14255465|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14255466|NCT00309907|Protective Agents|protective agents|mesh-ancestor
14255467|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14255468|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255469|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14255470|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14255471|NCT00309907|Analgesics|analgesics|mesh-ancestor
14255472|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
14255473|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255474|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255475|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
14255476|NCT00309946|Cediranib|cediranib|mesh-list
14255477|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255478|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255479|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255480|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14255481|NCT00309959|Paclitaxel|paclitaxel|mesh-list
14255482|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14255483|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14255484|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255485|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
14255486|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
14255487|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
14255488|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255489|NCT00310037|Bortezomib|bortezomib|mesh-list
14255490|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255491|NCT00310050|Pemetrexed|pemetrexed|mesh-list
14255492|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255493|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255494|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255495|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14255496|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14255497|NCT00310076|Thalidomide|thalidomide|mesh-list
14255498|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255499|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
14255500|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255501|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
14255502|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14255503|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255504|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14255505|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14255506|NCT00310076|Growth Substances|growth substances|mesh-ancestor
14255507|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
14255508|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255509|NCT00310375|Ezogabine|ezogabine|mesh-list
14255510|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
14255511|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14255512|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255513|NCT00310401|Albuterol|albuterol|mesh-list
14255514|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14255515|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
14255516|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255517|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255518|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14255519|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
14255520|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
14255521|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14255522|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14255523|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14255524|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14255525|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
14255526|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14255527|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255528|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
14255529|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
14255530|NCT00310791|Hormones|hormones|mesh-list
14255531|NCT00310791|Estradiol|estradiol|mesh-list
14255532|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14255533|NCT00310791|Estrogens|estrogens|mesh-list
14255534|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
14255535|NCT00310791|Progestins|progestins|mesh-list
14255536|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14255537|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255538|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14255539|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
14255540|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14255541|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14255542|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14255543|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14255544|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14255545|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14255546|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
14255547|NCT00310804|Vaccines|vaccines|mesh-list
14255548|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
14255549|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255550|NCT00310817|Vaccines|vaccines|mesh-list
14255551|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
14255552|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255553|NCT00310856|Vaccines|vaccines|mesh-list
14255554|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
14255555|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255556|NCT00311155|Amlodipine|amlodipine|mesh-list
14255557|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
14255558|NCT00311155|Olmesartan|olmesartan|mesh-list
14255559|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
14255560|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14255561|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14255562|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14532540|NCT02075021|Lenalidomide|lenalidomide|mesh-list
14255563|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255564|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14255565|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255566|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
14255567|NCT00311155|Diuretics|diuretics|mesh-ancestor
14255568|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
14255569|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14255570|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14255571|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14255572|NCT00311246|Adalimumab|adalimumab|mesh-list
14255573|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14255574|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255575|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
14255576|NCT00311311|Sirolimus|sirolimus|mesh-list
14255577|NCT00311311|Prednisone|prednisone|mesh-list
14255578|NCT00311311|Tacrolimus|tacrolimus|mesh-list
14255579|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14255580|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
14255581|NCT00311311|Hormones|hormones|mesh-ancestor
14255582|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14255583|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255584|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14255585|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255586|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255587|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
14255588|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14255589|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255590|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255591|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14255592|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14255593|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
14255594|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14255595|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255596|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
14255597|NCT00311363|Gabapentin|gabapentin|mesh-list
14255598|NCT00311363|Analgesics|analgesics|mesh-ancestor
14255599|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
14255600|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255601|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255602|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
14255603|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14255604|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14255605|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14255606|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14255607|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14255608|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14255609|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14255610|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255611|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
14255612|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
14255613|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14255614|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14255615|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14255616|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14255617|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255618|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
14255619|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14255620|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255621|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14255622|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255623|NCT00311402|Aspirin|aspirin|mesh-list
14255624|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
14255625|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14255626|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14255627|NCT00311402|Analgesics|analgesics|mesh-ancestor
14255628|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
14255629|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255630|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255631|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14255632|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255633|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14255634|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14255635|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255636|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14255637|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14255638|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255639|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
14255640|NCT00311584|Irinotecan|irinotecan|mesh-list
14255641|NCT00311584|Temozolomide|temozolomide|mesh-list
14255642|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14255643|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14255644|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255645|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255646|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255647|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14255648|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
14255649|NCT00311623|Sirolimus|sirolimus|mesh-list
14255650|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14255651|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255652|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14255653|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255654|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
14255655|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255656|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
14255657|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255658|NCT00312195|Buprenorphine|buprenorphine|mesh-list
14255659|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14255660|NCT00312195|Narcotics|narcotics|mesh-ancestor
14255661|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14255662|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255663|NCT00312195|Analgesics|analgesics|mesh-ancestor
14255664|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
14255665|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255666|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14255667|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
14255668|NCT00312208|Docetaxel|docetaxel|mesh-list
14255669|NCT00312208|Doxorubicin|doxorubicin|mesh-list
14255670|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14255671|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255672|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
14255673|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255674|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255675|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14255676|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
14255677|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255678|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255679|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14255680|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
14255681|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
14255682|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
14255683|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14255684|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14255685|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14255686|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255687|NCT00312221|Oxycodone|oxycodone|mesh-list
14255688|NCT00312221|Buprenorphine|buprenorphine|mesh-list
14255689|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14255690|NCT00312221|Narcotics|narcotics|mesh-ancestor
14255691|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14255692|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255693|NCT00312221|Analgesics|analgesics|mesh-ancestor
14255694|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
14255695|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255696|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14255697|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
14255698|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
14255699|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14255700|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255701|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14255702|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14255703|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255704|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255705|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255706|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14255707|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
14255708|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14255709|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255710|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14255711|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14255712|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14255713|NCT00312377|Docetaxel|docetaxel|mesh-list
14255714|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255715|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
14255716|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
14255717|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
14255718|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255719|NCT00312494|Ziprasidone|ziprasidone|mesh-list
14255720|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14255721|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
14255722|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14255723|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255724|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255725|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14255726|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14255727|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14255728|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14255729|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14255730|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
14255731|NCT00312572|Buprenorphine|buprenorphine|mesh-list
14255732|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14255733|NCT00312572|Narcotics|narcotics|mesh-ancestor
14255734|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14255735|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255736|NCT00312572|Analgesics|analgesics|mesh-ancestor
14255737|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
14255738|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255739|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14255740|NCT00312728|Bevacizumab|bevacizumab|mesh-list
14255741|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14255742|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255743|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14255744|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14255745|NCT00312728|Growth Substances|growth substances|mesh-ancestor
14255746|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255747|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
14255748|NCT00312845|Rituximab|rituximab|mesh-list
14255749|NCT00312845|Bortezomib|bortezomib|mesh-list
14255750|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14255751|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255752|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
14255753|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255754|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255755|NCT00312858|Vaccines|vaccines|mesh-list
14255756|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14255757|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
14255758|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255759|NCT00312923|Policosanol|policosanol|mesh-list
14255760|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14255761|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14255762|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
14255763|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255764|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14255765|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14255766|NCT00313014|Oxycodone|oxycodone|mesh-list
14255767|NCT00313014|Buprenorphine|buprenorphine|mesh-list
14255768|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14255769|NCT00313014|Narcotics|narcotics|mesh-ancestor
14255770|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14255771|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255772|NCT00313014|Analgesics|analgesics|mesh-ancestor
14255773|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
14255774|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255775|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14255776|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
14255777|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
14255778|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255779|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255780|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
14255781|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14255782|NCT00313170|Fulvestrant|fulvestrant|mesh-list
14255783|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14255784|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255785|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14255786|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14255787|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
14255788|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14255789|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255790|NCT00313300|Apixaban|apixaban|mesh-list
14255791|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14255792|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
14255793|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14255794|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
14255795|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255796|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255797|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
14255798|NCT00313313|Metformin|metformin|mesh-list
14255799|NCT00313313|Saxagliptin|saxagliptin|mesh-list
14255800|NCT00313313|Glyburide|glyburide|mesh-list
14255801|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14255802|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255803|NCT00313313|Incretins|incretins|mesh-ancestor
14255804|NCT00313313|Hormones|hormones|mesh-ancestor
14255805|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14255806|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14255807|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
14255808|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255809|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255810|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14255811|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255812|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14255813|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255814|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255815|NCT00313586|Azacitidine|azacitidine|mesh-list
14255816|NCT00313586|Entinostat|entinostat|mesh-list
14255817|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14255818|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14255819|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
14255820|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255821|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255822|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255823|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
14255824|NCT00313612|Topotecan|topotecan|mesh-list
14255825|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255826|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14255827|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14255828|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255829|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255830|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
14255831|NCT00313716|Hematinics|hematinics|mesh-ancestor
14532541|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14532542|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532543|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
14532544|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
14532545|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
14532546|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532547|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
14532548|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532549|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14532550|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14532551|NCT02075021|Growth Substances|growth substances|mesh-ancestor
14532552|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
14532553|NCT02057237|Mitotane|mitotane|mesh-list
14532554|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14532555|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532556|NCT02058537|Bethanechol|bethanechol|mesh-list
14532557|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
14532558|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
14532559|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532560|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532561|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14532562|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14532563|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
14532564|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532565|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532566|NCT02038153|Lenalidomide|lenalidomide|mesh-list
14532567|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
14532568|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532569|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14532570|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14255832|NCT00313729|Temozolomide|temozolomide|mesh-list
14255833|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14255834|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
14255835|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255836|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255837|NCT00313781|Prednisone|prednisone|mesh-list
14255838|NCT00313781|Docetaxel|docetaxel|mesh-list
14255839|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255840|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
14255841|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
14255842|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
14255843|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255844|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14255845|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
14255846|NCT00313781|Hormones|hormones|mesh-ancestor
14255847|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14255848|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255849|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14255850|NCT00313820|Pregabalin|pregabalin|mesh-list
14255851|NCT00313820|Analgesics|analgesics|mesh-ancestor
14255852|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
14255853|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255854|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255855|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
14255856|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14255857|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14255858|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255859|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14255860|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14255861|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14255862|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14255863|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14255864|NCT00313846|Buprenorphine|buprenorphine|mesh-list
14255865|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14255866|NCT00313846|Narcotics|narcotics|mesh-ancestor
14255867|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14255868|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255869|NCT00313846|Analgesics|analgesics|mesh-ancestor
14255870|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
14255871|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255872|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14255873|NCT00314106|Aldesleukin|aldesleukin|mesh-list
14255874|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
14255875|NCT00314106|Fludarabine|fludarabine|mesh-list
14255876|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14255877|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
14255878|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255879|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255880|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14255881|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
14255882|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255883|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255884|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14255885|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14255886|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14255887|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
14255888|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255889|NCT00314249|Milnacipran|milnacipran|mesh-list
14255890|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
14255891|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14255892|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14255893|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14255894|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255895|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14255896|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255897|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14255898|NCT00314249|Analgesics|analgesics|mesh-ancestor
14255899|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
14255900|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255901|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
14255902|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14255903|NCT00314262|Celecoxib|celecoxib|mesh-list
14255904|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14255905|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14255906|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14255907|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14255908|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255909|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14255910|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14255911|NCT00314262|Analgesics|analgesics|mesh-ancestor
14255912|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
14255913|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255914|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255915|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14255916|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14255917|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14255918|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14255919|NCT00314340|Acetaminophen|acetaminophen|mesh-list
14255920|NCT00314340|Morphine|morphine|mesh-list
14255921|NCT00314340|Hydrocodone|hydrocodone|mesh-list
14255922|NCT00314340|Phenobarbital|phenobarbital|mesh-list
14255923|NCT00314340|Amphetamine|amphetamine|mesh-list
14255924|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14255925|NCT00314340|Narcotics|narcotics|mesh-ancestor
14255926|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14255927|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255928|NCT00314340|Analgesics|analgesics|mesh-ancestor
14255929|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
14255930|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255931|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14255932|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
14255933|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
14255934|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
14255935|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14255936|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
14255937|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
14255938|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
14255939|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14255940|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255941|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
14255942|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14255943|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14255944|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14255945|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14255946|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
14255947|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14255948|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14255949|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14255950|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
14255951|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
14255952|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14255953|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14255954|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14255955|NCT00314574|Omalizumab|omalizumab|mesh-list
14255956|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14255957|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14255958|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
14255959|NCT00314808|Dronabinol|dronabinol|mesh-list
14255960|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
14255961|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255962|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14255963|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14255964|NCT00314808|Analgesics|analgesics|mesh-ancestor
14255965|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
14255966|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255967|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
14255968|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
14255969|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14255970|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255971|NCT00314808|Hormones|hormones|mesh-ancestor
14255972|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14255973|NCT00314951|Vancomycin|vancomycin|mesh-list
14255974|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
14255975|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14255976|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14255977|NCT00315055|Vaccines|vaccines|mesh-list
14255978|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
14255979|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255980|NCT00315146|Pioglitazone|pioglitazone|mesh-list
14255981|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14255982|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255983|NCT00315302|Atropine|atropine|mesh-list
14255984|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14255985|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14255986|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14255987|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
14255988|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14255989|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14255990|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14255991|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
14255992|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
14255993|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
14255994|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14255995|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14255996|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
14255997|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14255998|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14255999|NCT00315328|Atropine|atropine|mesh-list
14256000|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14256001|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14256002|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14256003|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
14256004|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256005|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256006|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14256007|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
14256008|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
14256009|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
14256010|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14256011|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14256012|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
14256013|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14256014|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256015|NCT00315341|Buprenorphine|buprenorphine|mesh-list
14256016|NCT00315341|Methadone|methadone|mesh-list
14256017|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14256018|NCT00315341|Naloxone|naloxone|mesh-list
14256019|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14256020|NCT00315341|Narcotics|narcotics|mesh-ancestor
14256021|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14256022|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256023|NCT00315341|Analgesics|analgesics|mesh-ancestor
14256024|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
14256025|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256026|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14256027|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
14256028|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
14256029|NCT00315445|Acetaminophen|acetaminophen|mesh-list
15042619|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15042620|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
15042621|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042622|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042623|NCT02045589|Antiviral Agents|antiviral agents|mesh-ancestor
15042624|NCT02045589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042625|NCT02045589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042626|NCT02045589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042627|NCT02045589|Immunologic Factors|immunologic factors|mesh-ancestor
15042628|NCT02045589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042629|NCT02045602|Gemcitabine|gemcitabine|mesh-list
15042630|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15042631|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15042632|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
15042633|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042634|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042635|NCT02045602|Antiviral Agents|antiviral agents|mesh-ancestor
14256030|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
14256031|NCT00315445|Oxycodone|oxycodone|mesh-list
14256032|NCT00315445|Buprenorphine|buprenorphine|mesh-list
14256033|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14256034|NCT00315445|Analgesics|analgesics|mesh-ancestor
14256035|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
14256036|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256037|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256038|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
14256039|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14256040|NCT00315445|Narcotics|narcotics|mesh-ancestor
14256041|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14256042|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14256043|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14256044|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14256045|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14256046|NCT00315458|Buprenorphine|buprenorphine|mesh-list
14256047|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14256048|NCT00315458|Narcotics|narcotics|mesh-ancestor
14256049|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14256050|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256051|NCT00315458|Analgesics|analgesics|mesh-ancestor
14256052|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
14256053|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256054|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14256055|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
14256056|NCT00315705|Etoposide|etoposide|mesh-list
14256057|NCT00315705|Clofarabine|clofarabine|mesh-list
14256058|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256059|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
14256060|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256061|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14256062|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14256063|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
14256064|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256065|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256066|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14256067|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14256068|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14256069|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14256070|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256071|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256072|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
14256073|NCT00316004|Dextrans|dextrans|mesh-list
14256074|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
14256075|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
14256076|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
14256077|NCT00316017|Dextrans|dextrans|mesh-list
14256078|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
14256079|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
14256080|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
14256081|NCT00316082|Metformin|metformin|mesh-list
14256082|NCT00316082|Saxagliptin|saxagliptin|mesh-list
14256083|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14256084|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256085|NCT00316082|Incretins|incretins|mesh-ancestor
14256086|NCT00316082|Hormones|hormones|mesh-ancestor
14256087|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14256088|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14256089|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
14256090|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256091|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256092|NCT00316173|Carboplatin|carboplatin|mesh-list
14256093|NCT00316173|Topotecan|topotecan|mesh-list
14256094|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256095|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14256096|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14256097|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256098|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256099|NCT00316186|Carboplatin|carboplatin|mesh-list
14256100|NCT00316186|Topotecan|topotecan|mesh-list
14256101|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256102|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14256103|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14256104|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256105|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256106|NCT00316199|Gemcitabine|gemcitabine|mesh-list
14256107|NCT00316199|Paclitaxel|paclitaxel|mesh-list
14256108|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14256109|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256110|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
14256111|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
14256112|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
14256113|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256114|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256115|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
14256116|NCT00316199|Antiviral Agents|antiviral agents|mesh-ancestor
14256117|NCT00316199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256118|NCT00316199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256119|NCT00316199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256120|NCT00316199|Immunologic Factors|immunologic factors|mesh-ancestor
14256121|NCT00316199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256122|NCT00316225|Pemetrexed|pemetrexed|mesh-list
14256123|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256124|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256125|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256126|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14256127|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14256128|NCT00316264|Palivizumab|palivizumab|mesh-list
14256129|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
14256130|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256131|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
14256132|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14256133|NCT00316277|Narcotics|narcotics|mesh-ancestor
14256134|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14256135|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256136|NCT00316277|Analgesics|analgesics|mesh-ancestor
14256137|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
14256138|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256139|NCT00316719|Lamivudine|lamivudine|mesh-list
14256140|NCT00316719|Adefovir|adefovir|mesh-list
14256141|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14256142|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14256143|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14256144|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256145|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256146|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
14256147|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256148|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14256149|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14256150|NCT00316862|Irinotecan|irinotecan|mesh-list
14256151|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256152|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14256153|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14256154|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256155|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256156|NCT00316888|Cisplatin|cisplatin|mesh-list
14256157|NCT00316888|Fluorouracil|fluorouracil|mesh-list
14256158|NCT00316888|Cetuximab|cetuximab|mesh-list
14256159|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256160|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
14256161|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256162|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256163|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256164|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
14256165|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256166|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14256167|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
14256168|NCT00316914|Calcium|calcium|mesh-list
14256169|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14256170|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256171|NCT00316914|Analgesics|analgesics|mesh-ancestor
14256172|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
14256173|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256174|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
14256175|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14256176|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14256177|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
14256178|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14256179|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14256180|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256181|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
14256182|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14256183|NCT00317044|Esomeprazole|esomeprazole|mesh-list
14256184|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14532571|NCT02038153|Growth Substances|growth substances|mesh-ancestor
14256185|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14256186|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14256187|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256188|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256189|NCT00317473|Vaccines|vaccines|mesh-list
14256190|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
14256191|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256192|NCT00317642|Cytarabine|cytarabine|mesh-list
14256193|NCT00317642|Clofarabine|clofarabine|mesh-list
14256194|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256195|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
14256196|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256197|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256198|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
14256199|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256200|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256201|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
14256202|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256203|NCT00317720|Trastuzumab|trastuzumab|mesh-list
14256204|NCT00317720|Everolimus|everolimus|mesh-list
14256205|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14256206|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256207|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256208|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
14256209|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256210|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
14256211|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14256212|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
14256213|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256214|NCT00318136|Paclitaxel|paclitaxel|mesh-list
14256215|NCT00318136|Bevacizumab|bevacizumab|mesh-list
14256216|NCT00318136|Carboplatin|carboplatin|mesh-list
14256217|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14256218|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256219|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
14256220|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
14256221|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
14256222|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256223|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14256224|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14256225|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14256226|NCT00318136|Growth Substances|growth substances|mesh-ancestor
14256227|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256228|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
14256229|NCT00318149|Vaccines|vaccines|mesh-list
14256230|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
14256231|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256232|NCT00318292|Epinephrine|epinephrine|mesh-list
14256233|NCT00318292|Bupivacaine|bupivacaine|mesh-list
14256234|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
14256235|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
14256236|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14256237|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256238|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
14256239|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256240|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14256241|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14256242|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
14256243|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14256244|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256245|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14256246|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14256247|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
14256248|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14256249|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
14256250|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
14256251|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
14256252|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14256253|NCT00318370|Farletuzumab|farletuzumab|mesh-list
14256254|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256255|NCT00318409|Bupropion|bupropion|mesh-list
14256256|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14256257|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
14256258|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14256259|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14256260|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14256261|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14256262|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256263|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
14256264|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14256265|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256266|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14256267|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14256268|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256269|NCT00318461|Metformin|metformin|mesh-list
14256270|NCT00318461|Liraglutide|liraglutide|mesh-list
14256271|NCT00318461|Glimepiride|glimepiride|mesh-list
14256272|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14256273|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256274|NCT00318461|Incretins|incretins|mesh-ancestor
14256275|NCT00318461|Hormones|hormones|mesh-ancestor
14256276|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14256277|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14256278|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256279|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
14256280|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
14256281|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
14256282|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
14256283|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14256284|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256285|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14256286|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
14256287|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14256288|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256289|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256290|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
14256291|NCT00318643|Mitomycins|mitomycins|mesh-list
14256292|NCT00318643|Mitomycin|mitomycin|mesh-list
14256293|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14256294|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256295|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
14256296|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256297|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14256298|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256299|NCT00318708|Fluticasone|fluticasone|mesh-list
14256300|NCT00318708|Xhance|xhance|mesh-list
14256301|NCT00318708|Clarithromycin|clarithromycin|mesh-list
14256302|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14256303|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14256304|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
14256305|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256306|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256307|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14256308|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
14256309|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
14256310|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14256311|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14256312|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256313|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14256314|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256315|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256316|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14256317|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14256318|NCT00318812|Iron|iron|mesh-list
14256319|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14256320|NCT00318812|Trace Elements|trace elements|mesh-ancestor
14256321|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
14256322|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256323|NCT00318812|Hematinics|hematinics|mesh-ancestor
14256324|NCT00318929|Valproic Acid|valproic acid|mesh-list
14256325|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
14256326|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256327|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256328|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
14256329|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14256330|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256331|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
14256332|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14256333|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14256334|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14256335|NCT00319020|Bosentan|bosentan|mesh-list
14256336|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14256337|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14256338|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256339|NCT00319046|Miglustat|miglustat|mesh-list
14256340|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256341|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256342|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14256343|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14256344|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
14256345|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256346|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14256347|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14256348|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256349|NCT00319111|Bosentan|bosentan|mesh-list
14256350|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14256351|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14256352|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256353|NCT00319501|Diazepam|diazepam|mesh-list
14256354|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14256355|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
14256356|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
14256357|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
14256358|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256359|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256360|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14256361|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14256362|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14256363|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14256364|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14256365|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14256366|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14256367|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14256368|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14256369|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
14256370|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
14256371|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
14256372|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
14256373|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14256374|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256375|NCT00319592|Vaccines|vaccines|mesh-list
14256376|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
14256377|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256378|NCT00319696|Bosentan|bosentan|mesh-list
14256379|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14256380|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14256381|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256382|NCT00319956|Azithromycin|azithromycin|mesh-list
14256383|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14256384|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256385|NCT00319982|Diltiazem|diltiazem|mesh-list
14256386|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14256387|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14256388|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14256389|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256390|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14256391|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256392|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
14256393|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
14256394|NCT00320190|Dasatinib|dasatinib|mesh-list
14256395|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256396|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14256397|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256398|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256399|NCT00320216|Ustekinumab|ustekinumab|mesh-list
14256400|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
14256401|NCT00320255|Apixaban|apixaban|mesh-list
14256402|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14256403|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
14256404|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14256405|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
14256406|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256407|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256408|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
14256409|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
14256410|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14256411|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14256412|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14256413|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14256414|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256415|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
14256416|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14256417|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256418|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14256419|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532572|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
14532573|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532574|NCT02044302|Morphine|morphine|mesh-list
14532575|NCT02044302|Narcotics|narcotics|mesh-list
14532576|NCT02044302|Analgesics|analgesics|mesh-list
14532577|NCT02044302|Bupivacaine|bupivacaine|mesh-list
14532578|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
14532579|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
14532580|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
14532581|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532582|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532583|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
14532584|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532585|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14532586|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14532587|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14532588|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532589|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
14532590|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532591|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14532592|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14532593|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532594|NCT02048904|Incretins|incretins|mesh-ancestor
14532595|NCT02048904|Hormones|hormones|mesh-ancestor
14532596|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14532597|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14532598|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
14532599|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532600|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532601|NCT02044822|Rituximab|rituximab|mesh-list
14532602|NCT02044822|Idelalisib|idelalisib|mesh-list
14532603|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14532604|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532605|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
14532606|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532607|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14532608|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532609|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532610|NCT02043860|Melphalan|melphalan|mesh-list
14532611|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
14532612|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532613|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14532614|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
14532615|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532616|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532617|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14532618|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532619|NCT02030015|Miglustat|miglustat|mesh-list
14532620|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532621|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532622|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14532623|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14532624|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
14532625|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532626|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
14532627|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14532628|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532629|NCT02015663|Tobramycin|tobramycin|mesh-list
14532630|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14532631|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532632|NCT02029846|Metformin|metformin|mesh-list
14532633|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
14532634|NCT02029846|Incretins|incretins|mesh-list
14532635|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14532636|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532637|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
14256420|NCT00320385|Trastuzumab|trastuzumab|mesh-list
14256421|NCT00320385|Lapatinib|lapatinib|mesh-list
14256422|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14256423|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256424|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14256425|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256426|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256427|NCT00320398|PENTA|penta|mesh-list
14256428|NCT00320398|Fondaparinux|fondaparinux|mesh-list
14256429|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14256430|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
14256431|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14256432|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
14256433|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256434|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256435|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
14256436|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14256437|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14256438|NCT00320411|Lapatinib|lapatinib|mesh-list
14256439|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256440|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14256441|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256442|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256443|NCT00320424|PENTA|penta|mesh-list
14256444|NCT00320424|Fondaparinux|fondaparinux|mesh-list
14256445|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
14256446|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
14256447|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14256448|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
14256449|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256450|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256451|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
14256452|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14256453|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14256454|NCT00320489|Olanzapine|olanzapine|mesh-list
14256455|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
14256456|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
14256457|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256458|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256459|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14256460|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14256461|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14256462|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14256463|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14256464|NCT00320489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14256465|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14256466|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14256467|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256468|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14256469|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
14256470|NCT00320515|Pemetrexed|pemetrexed|mesh-list
14256471|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256472|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256473|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256474|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14256475|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14256476|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14256477|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14256478|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14256479|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14256480|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256481|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
14256482|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14256483|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256484|NCT00320541|Gemcitabine|gemcitabine|mesh-list
14256485|NCT00320541|Paclitaxel|paclitaxel|mesh-list
14256486|NCT00320541|Bevacizumab|bevacizumab|mesh-list
14256487|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14256488|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256489|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
14256490|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
14256491|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
14256492|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256493|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14256494|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14256495|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14256496|NCT00320541|Growth Substances|growth substances|mesh-ancestor
14256497|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256498|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
14256499|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256500|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
14256501|NCT00320541|Antiviral Agents|antiviral agents|mesh-ancestor
14256502|NCT00320541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256503|NCT00320541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256504|NCT00320541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256505|NCT00320541|Immunologic Factors|immunologic factors|mesh-ancestor
14256506|NCT00320671|Risperidone|risperidone|mesh-list
14256507|NCT00320671|Aripiprazole|aripiprazole|mesh-list
14256508|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14256509|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
14256510|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14256511|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256512|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256513|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14256514|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14256515|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14256516|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14256517|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14256518|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
14256519|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
14256520|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
14256521|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14256522|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14256523|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14256524|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14256525|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
14256526|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14256527|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256528|NCT00320749|Gemcitabine|gemcitabine|mesh-list
14256529|NCT00320749|Capecitabine|capecitabine|mesh-list
14256530|NCT00320749|Docetaxel|docetaxel|mesh-list
14256531|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256532|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
14256533|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256534|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256535|NCT00320749|Antiviral Agents|antiviral agents|mesh-ancestor
14256536|NCT00320749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256537|NCT00320749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256538|NCT00320749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256539|NCT00320749|Immunologic Factors|immunologic factors|mesh-ancestor
14256540|NCT00320749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256541|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
14256542|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
14256543|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
14256544|NCT00320788|Aflibercept|aflibercept|mesh-list
14256545|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14256546|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14256547|NCT00320788|Growth Substances|growth substances|mesh-ancestor
14256548|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256549|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
14256550|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256551|NCT00320801|Buprenorphine|buprenorphine|mesh-list
14256552|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14256553|NCT00320801|Narcotics|narcotics|mesh-ancestor
14256554|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14256555|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256556|NCT00320801|Analgesics|analgesics|mesh-ancestor
14256557|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
14256558|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256559|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14256560|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
14256561|NCT00321464|Denosumab|denosumab|mesh-list
14256562|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14256563|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256564|NCT00321555|Immunotoxins|immunotoxins|mesh-list
14256565|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
14256566|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256567|NCT00321594|Belinostat|belinostat|mesh-list
14256568|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256569|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14256570|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256571|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256572|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
14256573|NCT00321620|Denosumab|denosumab|mesh-list
14256574|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14256575|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256576|NCT00321646|Bevacizumab|bevacizumab|mesh-list
14256577|NCT00321646|Docetaxel|docetaxel|mesh-list
14256578|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14256579|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256580|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14256581|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14256582|NCT00321646|Growth Substances|growth substances|mesh-ancestor
14256583|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256584|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
14256585|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
14256586|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
14256587|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
14256588|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256589|NCT00321672|Capsaicin|capsaicin|mesh-list
14256590|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
14256591|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
14256592|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
14256593|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256594|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256595|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
14256596|NCT00321685|Leucovorin|leucovorin|mesh-list
14256597|NCT00321685|Folic Acid|folic acid|mesh-list
14256598|NCT00321685|Bevacizumab|bevacizumab|mesh-list
14256599|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14256600|NCT00321685|Fluorouracil|fluorouracil|mesh-list
14256601|NCT00321685|Capecitabine|capecitabine|mesh-list
14256602|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
14256603|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
14256604|NCT00321685|Antibodies|antibodies|mesh-list
14256605|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
14256606|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14256607|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
14256608|NCT00321685|Calcium|calcium|mesh-list
14256609|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
14256610|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256611|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14256612|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14256613|NCT00321685|Growth Substances|growth substances|mesh-ancestor
14256614|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256615|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
14256616|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
14256617|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14256618|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14256619|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
14256620|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256621|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256622|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256623|NCT00321685|Antidotes|antidotes|mesh-ancestor
14256624|NCT00321685|Protective Agents|protective agents|mesh-ancestor
14256625|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
14256626|NCT00321685|Vitamins|vitamins|mesh-ancestor
14256627|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
14256628|NCT00321685|Hematinics|hematinics|mesh-ancestor
14256629|NCT00321698|Docetaxel|docetaxel|mesh-list
14256630|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256631|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
14256632|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
14256633|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
14256634|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256635|NCT00321711|Azacitidine|azacitidine|mesh-list
14256636|NCT00321711|Decitabine|decitabine|mesh-list
14256637|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256638|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
14256639|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256640|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256641|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256642|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
14256643|NCT00321737|Lansoprazole|lansoprazole|mesh-list
14256644|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14256645|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14256646|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14256647|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532638|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256648|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256649|NCT00321828|Leucovorin|leucovorin|mesh-list
14256650|NCT00321828|Bevacizumab|bevacizumab|mesh-list
14256651|NCT00321828|Fluorouracil|fluorouracil|mesh-list
14256652|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
14256653|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
14256654|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14256655|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256656|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14256657|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14256658|NCT00321828|Growth Substances|growth substances|mesh-ancestor
14256659|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256660|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
14256661|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
14256662|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256663|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256664|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256665|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
14256666|NCT00321828|Antidotes|antidotes|mesh-ancestor
14256667|NCT00321828|Protective Agents|protective agents|mesh-ancestor
14256668|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
14256669|NCT00321828|Vitamins|vitamins|mesh-ancestor
14256670|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
14256671|NCT00321854|Pramipexole|pramipexole|mesh-list
14256672|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
14256673|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256674|NCT00321854|Protective Agents|protective agents|mesh-ancestor
14256675|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256676|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14256677|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14256678|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
14256679|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
14256680|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14256681|NCT00321893|Budesonide|budesonide|mesh-list
14256682|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14256683|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14256684|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
14256685|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256686|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256687|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14256688|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
14256689|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
14256690|NCT00321893|Hormones|hormones|mesh-ancestor
14256691|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14256692|NCT00321906|Sirolimus|sirolimus|mesh-list
14256693|NCT00321906|Azathioprine|azathioprine|mesh-list
14256694|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14256695|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256696|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14256697|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256698|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
14256699|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256700|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
14256701|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256702|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
14256703|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256704|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256705|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14256706|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
14256707|NCT00321919|Hematinics|hematinics|mesh-ancestor
14256708|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
14256709|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
14256710|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
14256711|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
14256712|NCT00321932|Calcium|calcium|mesh-list
14256713|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14256714|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256715|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14256716|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256717|NCT00321932|Vitamins|vitamins|mesh-ancestor
14256718|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
14256719|NCT00321932|Antacids|antacids|mesh-ancestor
14256720|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14256721|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
14256722|NCT00321984|Lansoprazole|lansoprazole|mesh-list
14256723|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14256724|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14256725|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14256726|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256727|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256728|NCT00322049|Vaccines|vaccines|mesh-list
14256729|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
14256730|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256731|NCT00322101|Cyclosporine|cyclosporine|mesh-list
14256732|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
14256733|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
14256734|NCT00322101|Busulfan|busulfan|mesh-list
14256735|NCT00322101|Methotrexate|methotrexate|mesh-list
14256736|NCT00322101|Fludarabine|fludarabine|mesh-list
14256737|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
14256738|NCT00322101|Tacrolimus|tacrolimus|mesh-list
14256739|NCT00322101|Cyclosporins|cyclosporins|mesh-list
14256740|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256741|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
14256742|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256743|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14256744|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14256745|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
14256746|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256747|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256748|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14256749|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14256750|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
14256751|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14256752|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256753|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
14256754|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
14256755|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256756|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14256757|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14256758|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14256759|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
14256760|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256761|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14256762|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14256763|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
14256764|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14256765|NCT00322153|Memantine|memantine|mesh-list
14256766|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14256767|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14256768|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
14256769|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14256770|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256771|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256772|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14256773|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14256774|NCT00322309|Mirtazapine|mirtazapine|mesh-list
14256775|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
14256776|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14256777|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14256778|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
14256779|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
14256780|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14256781|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256782|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256783|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14256784|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14256785|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14256786|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
14256787|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14256788|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14256789|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
14256790|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14256791|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14256792|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
14256793|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14256794|NCT00322335|PENTA|penta|mesh-list
14256795|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
14256796|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14256797|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14256798|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256799|NCT00322348|Goserelin|goserelin|mesh-list
14256800|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14256801|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256802|NCT00322374|Epirubicin|epirubicin|mesh-list
14256803|NCT00322374|Epothilones|epothilones|mesh-list
14256804|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14256805|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256806|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14256807|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14256808|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256809|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256810|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
14256811|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
14256812|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
14256813|NCT00322387|Plerixafor|plerixafor|mesh-list
14256814|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14256815|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14256816|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
14256817|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256818|NCT00322439|Etanercept|etanercept|mesh-list
14256819|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14256820|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14256821|NCT00322439|Analgesics|analgesics|mesh-ancestor
14256822|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
14256823|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256824|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256825|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14256826|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14256827|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14256828|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256829|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
14256830|NCT00322452|Paclitaxel|paclitaxel|mesh-list
14256831|NCT00322452|Carboplatin|carboplatin|mesh-list
14256832|NCT00322452|Gefitinib|gefitinib|mesh-list
14256833|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14256834|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256835|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
14256836|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
14256837|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
14256838|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256839|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14256840|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256841|NCT00322465|Azithromycin|azithromycin|mesh-list
14256842|NCT00322465|Doxycycline|doxycycline|mesh-list
14256843|NCT00322465|Tinidazole|tinidazole|mesh-list
14256844|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14256845|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256846|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
14256847|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14256848|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14256849|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
14256850|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256851|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14256852|NCT00322491|Plerixafor|plerixafor|mesh-list
14256853|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14256854|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14256855|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
14256856|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256857|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
14256858|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14256859|NCT00322556|Antibodies|antibodies|mesh-list
14256860|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
14256861|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256862|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14256863|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14256864|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14256865|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14256866|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256867|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14256868|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256869|NCT00322621|Analgesics|analgesics|mesh-ancestor
14256870|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
14256871|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14256872|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
14256873|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14256874|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
15042636|NCT02045602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256875|NCT00322842|Plerixafor|plerixafor|mesh-list
14256876|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14256877|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14256878|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
14256879|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256880|NCT00322868|Pioglitazone|pioglitazone|mesh-list
14256881|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14256882|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256883|NCT00322881|Paclitaxel|paclitaxel|mesh-list
14256884|NCT00322881|Carboplatin|carboplatin|mesh-list
14256885|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14256886|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256887|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
14256888|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
14256889|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
14256890|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256891|NCT00323063|Gemcitabine|gemcitabine|mesh-list
14256892|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
14256893|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256894|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
14256895|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256896|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256897|NCT00323063|Antiviral Agents|antiviral agents|mesh-ancestor
14256898|NCT00323063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256899|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256900|NCT00323063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256901|NCT00323063|Immunologic Factors|immunologic factors|mesh-ancestor
14256902|NCT00323063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256903|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14256904|NCT00323115|Temozolomide|temozolomide|mesh-list
14256905|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14256906|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
14256907|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256908|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256909|NCT00323297|Bosentan|bosentan|mesh-list
14256910|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
14256911|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256912|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
14256913|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14256914|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14256915|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256916|NCT00323297|Urological Agents|urological agents|mesh-ancestor
14256917|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14256918|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14256919|NCT00323362|Gemcitabine|gemcitabine|mesh-list
14256920|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
14256921|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256922|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
14256923|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256924|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256925|NCT00323362|Antiviral Agents|antiviral agents|mesh-ancestor
14256926|NCT00323362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256927|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256928|NCT00323362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256929|NCT00323362|Immunologic Factors|immunologic factors|mesh-ancestor
14256930|NCT00323362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256931|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14256932|NCT00323479|Anastrozole|anastrozole|mesh-list
14256933|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14256934|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256935|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14256936|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14256937|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256938|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256939|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14256940|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
14256941|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14256942|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256943|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14256944|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14256945|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14256946|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256947|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256948|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
14256949|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256950|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14256951|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14256952|NCT00323557|Molgramostim|molgramostim|mesh-list
14256953|NCT00323557|Sargramostim|sargramostim|mesh-list
14256954|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14256955|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
14256956|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256957|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256958|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
14256959|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
14256960|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
14256961|NCT00323622|Amodiaquine|amodiaquine|mesh-list
14256962|NCT00323622|Vaccines|vaccines|mesh-list
14256963|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
14256964|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256965|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
14256966|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14256967|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14256968|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14256969|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14256970|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14256971|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256972|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14256973|NCT00323622|Renal Agents|renal agents|mesh-ancestor
14256974|NCT00323739|Bevacizumab|bevacizumab|mesh-list
14256975|NCT00323739|Everolimus|everolimus|mesh-list
14256976|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14256977|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256978|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14256979|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14256980|NCT00323739|Growth Substances|growth substances|mesh-ancestor
14256981|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256982|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
14256983|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14256984|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
14256985|NCT00323869|Gemcitabine|gemcitabine|mesh-list
14256986|NCT00323869|Bevacizumab|bevacizumab|mesh-list
14256987|NCT00323869|Carboplatin|carboplatin|mesh-list
14256988|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14256989|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14256990|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14256991|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14256992|NCT00323869|Growth Substances|growth substances|mesh-ancestor
14256993|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14256994|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
14256995|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14256996|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
14256997|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14256998|NCT00323869|Antiviral Agents|antiviral agents|mesh-ancestor
14256999|NCT00323869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257000|NCT00323869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257001|NCT00323869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257002|NCT00323869|Immunologic Factors|immunologic factors|mesh-ancestor
14257003|NCT00323882|Ipilimumab|ipilimumab|mesh-list
14257004|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14257005|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257006|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14257007|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257008|NCT00324038|Acetaminophen|acetaminophen|mesh-list
14257009|NCT00324038|Buprenorphine|buprenorphine|mesh-list
14257010|NCT00324038|Codeine|codeine|mesh-list
14257011|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14257012|NCT00324038|Analgesics|analgesics|mesh-ancestor
14257013|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
14257014|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257015|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257016|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
14257017|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14257018|NCT00324038|Narcotics|narcotics|mesh-ancestor
14257019|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14257020|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14257021|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
14257022|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
14257023|NCT00324155|Ipilimumab|ipilimumab|mesh-list
14257024|NCT00324155|Dacarbazine|dacarbazine|mesh-list
14257025|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14257026|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257027|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14257028|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257029|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14257030|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
14257031|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14257032|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257033|NCT00324259|Estradiol|estradiol|mesh-list
14257034|NCT00324259|Estrogens|estrogens|mesh-ancestor
14257035|NCT00324259|Hormones|hormones|mesh-ancestor
14257036|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14257037|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257038|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14257039|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
14257040|NCT00324272|Coagulants|coagulants|mesh-ancestor
14257041|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
14257042|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
14257043|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257044|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14257045|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14257046|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
14257047|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257048|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257049|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14257050|NCT00324415|Fluorouracil|fluorouracil|mesh-list
14257051|NCT00324415|Cetuximab|cetuximab|mesh-list
14257052|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257053|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
14257054|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257055|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14257056|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257057|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
14257058|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257059|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14257060|NCT00324649|Lamivudine|lamivudine|mesh-list
14257061|NCT00324649|Zidovudine|zidovudine|mesh-list
14257062|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14257063|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14257064|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14257065|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257066|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257067|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
14257068|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257069|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14257070|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14257071|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
14257072|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
14257073|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14257074|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257075|NCT00324740|Vorinostat|vorinostat|mesh-list
14257076|NCT00324740|Isotretinoin|isotretinoin|mesh-list
14257077|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257078|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14257079|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257080|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257081|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
14257082|NCT00324870|Bevacizumab|bevacizumab|mesh-list
14257083|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14257084|NCT00324870|Vorinostat|vorinostat|mesh-list
14257085|NCT00324870|Antibodies|antibodies|mesh-list
14257086|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
14257087|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14257088|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257089|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14257090|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14257091|NCT00324870|Growth Substances|growth substances|mesh-ancestor
14257092|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257093|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
14257094|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
14257095|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14257096|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257097|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257098|NCT00324896|Eszopiclone|eszopiclone|mesh-list
14257099|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14257100|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14257101|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257102|NCT00324961|Adefovir|adefovir|mesh-list
14257103|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14257104|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
14257105|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257106|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14257107|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14257108|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257109|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257110|NCT00324987|Bevacizumab|bevacizumab|mesh-list
14257111|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14257112|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
14257113|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
14257114|NCT00324987|Antibodies|antibodies|mesh-list
14257115|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
14257116|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14257117|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
14257118|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257119|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14257120|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14257121|NCT00324987|Growth Substances|growth substances|mesh-ancestor
14257122|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257123|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
14257124|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
14257125|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14257126|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257127|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532639|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532640|NCT02029846|Hormones|hormones|mesh-ancestor
14532641|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14532642|NCT02027272|Dexamethasone|dexamethasone|mesh-list
14532643|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
14532644|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14532645|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
14532646|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
14532647|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532648|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532649|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14532650|NCT02027272|Hormones|hormones|mesh-ancestor
14532651|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14532652|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14532653|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532654|NCT02017379|Erythromycin|erythromycin|mesh-list
14532655|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
14532656|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
14532657|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
14532658|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14532659|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532660|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14532661|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14532662|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532663|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532664|NCT02008370|Bupivacaine|bupivacaine|mesh-list
14532665|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
14532666|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
14532667|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532668|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532669|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
14532670|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532671|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14532672|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14532673|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532674|NCT02015910|Incretins|incretins|mesh-ancestor
14532675|NCT02015910|Hormones|hormones|mesh-ancestor
14532676|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14532677|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14532678|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
14532679|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532680|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532681|NCT01986751|Clonidine|clonidine|mesh-list
14532682|NCT01986751|Ropivacaine|ropivacaine|mesh-list
14532683|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
14532684|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
14532685|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14257128|NCT00325078|Infliximab|infliximab|mesh-list
14257129|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
14257130|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14257131|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257132|NCT00325143|Edetic Acid|edetic acid|mesh-list
14257133|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
14257134|NCT00325143|Antidotes|antidotes|mesh-ancestor
14257135|NCT00325143|Protective Agents|protective agents|mesh-ancestor
14257136|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257137|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
14257138|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
14257139|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257140|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14257141|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
14257142|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
14257143|NCT00325234|Gemcitabine|gemcitabine|mesh-list
14257144|NCT00325234|Carboplatin|carboplatin|mesh-list
14257145|NCT00325234|Pemetrexed|pemetrexed|mesh-list
14257146|NCT00325234|Vinorelbine|vinorelbine|mesh-list
14257147|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257148|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14257149|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
14257150|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257151|NCT00325234|Antiviral Agents|antiviral agents|mesh-ancestor
14257152|NCT00325234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257153|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257154|NCT00325234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257155|NCT00325234|Immunologic Factors|immunologic factors|mesh-ancestor
14257156|NCT00325234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257157|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14257158|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14257159|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14257160|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
14257161|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
14257162|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
14257163|NCT00325403|Treprostinil|treprostinil|mesh-list
14257164|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14257165|NCT00325416|Melphalan|melphalan|mesh-list
14257166|NCT00325416|Topotecan|topotecan|mesh-list
14257167|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14257168|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
14257169|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257170|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257171|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14257172|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257173|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
14257174|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257175|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14257176|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14257177|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257178|NCT00325442|Treprostinil|treprostinil|mesh-list
14257179|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14257180|NCT00325468|Denosumab|denosumab|mesh-list
14257181|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14257182|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257183|NCT00325780|Pitavastatin|pitavastatin|mesh-list
14257184|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14257185|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14257186|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14257187|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
14257188|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257189|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257190|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14257191|NCT00325819|Acetaminophen|acetaminophen|mesh-list
14257192|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14257193|NCT00325819|Analgesics|analgesics|mesh-ancestor
14257194|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
14257195|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257196|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257197|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
14257198|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14257199|NCT00325897|Azithromycin|azithromycin|mesh-list
14257200|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257201|NCT00326170|Azacitidine|azacitidine|mesh-list
14257202|NCT00326170|Tretinoin|tretinoin|mesh-list
14257203|NCT00326170|Valproic Acid|valproic acid|mesh-list
14257204|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14257205|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
14257206|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257207|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257208|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257209|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
14257210|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
14257211|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
14257212|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
14257213|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14257214|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257215|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
14257216|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14257217|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14257218|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15042637|NCT02045602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042638|NCT02045602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042639|NCT02045602|Immunologic Factors|immunologic factors|mesh-ancestor
15042640|NCT02045602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042641|NCT02045667|Mexiletine|mexiletine|mesh-list
15042642|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15042643|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14257219|NCT00326209|Mesalamine|mesalamine|mesh-list
14257220|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14257221|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14257222|NCT00326209|Analgesics|analgesics|mesh-ancestor
14257223|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
14257224|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257225|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257226|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14257227|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257228|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
14257229|NCT00326417|Fludarabine|fludarabine|mesh-list
14257230|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257231|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
14257232|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257233|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257234|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14257235|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
14257236|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257237|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257238|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14257239|NCT00326495|Cetuximab|cetuximab|mesh-list
14257240|NCT00326495|Sorafenib|sorafenib|mesh-list
14257241|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14257242|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257243|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14257244|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257245|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257246|NCT00326599|Gemcitabine|gemcitabine|mesh-list
14257247|NCT00326599|Carboplatin|carboplatin|mesh-list
14257248|NCT00326599|Cediranib|cediranib|mesh-list
14257249|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257250|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14257251|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
14257252|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257253|NCT00326599|Antiviral Agents|antiviral agents|mesh-ancestor
14257254|NCT00326599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257255|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257256|NCT00326599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257257|NCT00326599|Immunologic Factors|immunologic factors|mesh-ancestor
14257258|NCT00326599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257259|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14257260|NCT00326612|Midazolam|midazolam|mesh-list
14257261|NCT00326612|Diazepam|diazepam|mesh-list
14257262|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14257263|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14257264|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14257265|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257266|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14257267|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14257268|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14257269|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14257270|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
14257271|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
14257272|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
14257273|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
14257274|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14257275|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257276|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
14257277|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
14257278|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
14257279|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257280|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14257281|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
14257282|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14257283|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
14257284|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
14257285|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14257286|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
14257287|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257288|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257289|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257290|NCT00326716|Ritonavir|ritonavir|mesh-list
14257291|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14257292|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
14257293|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14257294|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14257295|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
14257296|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257297|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257298|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14257299|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14257300|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
14257301|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257302|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14257303|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14257304|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14257305|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14257306|NCT00326781|Nicotine|nicotine|mesh-list
14257307|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14257308|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
14257309|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257310|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257311|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14257312|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14257313|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
14257314|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14257315|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257316|NCT00326872|Cediranib|cediranib|mesh-list
14257317|NCT00326872|Maleic acid|maleic acid|mesh-list
14257318|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257319|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257320|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257321|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14257322|NCT00326885|Catumaxomab|catumaxomab|mesh-list
14257323|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14257324|NCT00326911|Gemcitabine|gemcitabine|mesh-list
14257325|NCT00326911|Bevacizumab|bevacizumab|mesh-list
14257326|NCT00326911|Cetuximab|cetuximab|mesh-list
14257327|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14257328|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257329|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14257330|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14257331|NCT00326911|Growth Substances|growth substances|mesh-ancestor
14257332|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257333|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
14257334|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14257335|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
14257336|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257337|NCT00326911|Antiviral Agents|antiviral agents|mesh-ancestor
14257338|NCT00326911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257339|NCT00326911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257340|NCT00326911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257341|NCT00326911|Immunologic Factors|immunologic factors|mesh-ancestor
14257342|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
14257343|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
14257344|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
14257345|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257346|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14257347|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14257348|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
14257349|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257350|NCT00327015|Metformin|metformin|mesh-list
14257351|NCT00327015|Pioglitazone|pioglitazone|mesh-list
14257352|NCT00327015|Saxagliptin|saxagliptin|mesh-list
14257353|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14257354|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257355|NCT00327015|Incretins|incretins|mesh-ancestor
14257356|NCT00327015|Hormones|hormones|mesh-ancestor
14257357|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14257358|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14257359|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
14257360|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257361|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257362|NCT00327171|Aflibercept|aflibercept|mesh-list
14257363|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14257364|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14257365|NCT00327171|Growth Substances|growth substances|mesh-ancestor
14257366|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257367|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
14257368|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257369|NCT00327340|Docetaxel|docetaxel|mesh-list
14257370|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
14257371|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257372|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
14257373|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
14257374|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
14257375|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257376|NCT00327340|Analgesics|analgesics|mesh-ancestor
14257377|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
14257378|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257379|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257380|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14257381|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14257382|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257383|NCT00327392|Fospropofol|fospropofol|mesh-list
14257384|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14257385|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14257386|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257387|NCT00327444|Aflibercept|aflibercept|mesh-list
14257388|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14257389|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14257390|NCT00327444|Growth Substances|growth substances|mesh-ancestor
14257391|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257392|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
14257393|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257394|NCT00327717|Zonisamide|zonisamide|mesh-list
14257395|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
14257396|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14257397|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14257398|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257399|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14257400|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257401|NCT00328094|Insulin|insulin|mesh-list
14257402|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14257403|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14257404|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257405|NCT00328172|Metformin|metformin|mesh-list
14257406|NCT00328172|Linagliptin|linagliptin|mesh-list
14257407|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14257408|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257409|NCT00328172|Incretins|incretins|mesh-ancestor
14257410|NCT00328172|Hormones|hormones|mesh-ancestor
14532686|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257411|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14257412|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14257413|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
14257414|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257415|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257416|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
14257417|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14257418|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257419|NCT00328562|Gefitinib|gefitinib|mesh-list
14257420|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257421|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14257422|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257423|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257424|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
14257425|NCT00328614|Goserelin|goserelin|mesh-list
14257426|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
14257427|NCT00328614|Bicalutamide|bicalutamide|mesh-list
14257428|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
14257429|NCT00328614|Androgens|androgens|mesh-list
14257430|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14257431|NCT00328614|Ethylene|ethylene|mesh-list
14257432|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14257433|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257434|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
14257435|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
14257436|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14257437|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257438|NCT00328614|Hormones|hormones|mesh-ancestor
14257439|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
14257440|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257441|NCT00328614|Protective Agents|protective agents|mesh-ancestor
14257442|NCT00328614|Vitamins|vitamins|mesh-ancestor
14257443|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
14257444|NCT00328614|Estrogens|estrogens|mesh-ancestor
14257445|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
14257446|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
14257447|NCT00328614|Growth Substances|growth substances|mesh-ancestor
14257448|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14257449|NCT00328614|Analgesics|analgesics|mesh-ancestor
14257450|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
14257451|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257452|NCT00328627|Pioglitazone|pioglitazone|mesh-list
14257453|NCT00328627|Alogliptin|alogliptin|mesh-list
14257454|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14257455|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257456|NCT00328627|Incretins|incretins|mesh-ancestor
14257457|NCT00328627|Hormones|hormones|mesh-ancestor
14257458|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14257459|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14257460|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
14257461|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257462|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257463|NCT00328770|Sirolimus|sirolimus|mesh-list
14257464|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14257465|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257466|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14257467|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257468|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
14257469|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257470|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
14257471|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257472|NCT00328861|Aldesleukin|aldesleukin|mesh-list
14257473|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
14257474|NCT00328861|Fludarabine|fludarabine|mesh-list
14257475|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257476|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
14257477|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257478|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257479|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14257480|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
14257481|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257482|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257483|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14257484|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14257485|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14257486|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
14257487|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257488|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
14257489|NCT00328926|Hormones|hormones|mesh-list
14257490|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14257491|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14257492|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257493|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14257494|NCT00329030|Rituximab|rituximab|mesh-list
14257495|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
14257496|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14257497|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257498|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
14257499|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257500|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257501|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14257502|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14257503|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14257504|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
14257505|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257506|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14257507|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14257508|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257509|NCT00329238|Warfarin|warfarin|mesh-list
14257510|NCT00329238|Dabigatran|dabigatran|mesh-list
14257511|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
14257512|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
14257513|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14257514|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
14257515|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257516|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257517|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
14257518|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257519|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
14257520|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257521|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257522|NCT00329407|Topiramate|topiramate|mesh-list
14257523|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
14257524|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14257525|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257526|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
14257527|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257528|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
14257529|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257530|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257531|NCT00329433|Heparin|heparin|mesh-list
14257532|NCT00329433|Desirudin|desirudin|mesh-list
14257533|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
14257534|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14257535|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14257536|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257537|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
14257538|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257539|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
14257540|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257541|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257542|NCT00329602|Ropinirole|ropinirole|mesh-list
14257543|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14257544|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14257545|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
14257546|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
14257547|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14257548|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257549|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257550|NCT00329641|Paclitaxel|paclitaxel|mesh-list
14257551|NCT00329641|Carboplatin|carboplatin|mesh-list
14257552|NCT00329641|Sorafenib|sorafenib|mesh-list
14257553|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14257554|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257555|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
14257556|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
14257557|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
14257558|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257559|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14257560|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257561|NCT00329719|Sirolimus|sirolimus|mesh-list
14257562|NCT00329719|Sorafenib|sorafenib|mesh-list
14257563|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257564|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14257565|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257566|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257567|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14257568|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257569|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14257570|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
14257571|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257572|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
14257573|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257574|NCT00329797|Vitamin D|vitamin d|mesh-list
14257575|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
14257576|NCT00329797|Calcium|calcium|mesh-list
14257577|NCT00329797|Vitamins|vitamins|mesh-ancestor
14257578|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
14257579|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257580|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14257581|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14257582|NCT00329849|Vaccines|vaccines|mesh-list
14257583|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
14257584|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257585|NCT00329901|Vaccines|vaccines|mesh-list
14257586|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
14257587|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257588|NCT00330161|Vorinostat|vorinostat|mesh-list
14257589|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257590|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14257591|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257592|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257593|NCT00330174|Acamprosate|acamprosate|mesh-list
14257594|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14257595|NCT00330187|Bupropion|bupropion|mesh-list
14257596|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14257597|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
14257598|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14257599|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14257600|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14257601|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14257602|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257603|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
14257604|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14257605|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257606|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14257607|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14257608|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257609|NCT00330343|Naloxone|naloxone|mesh-list
14257610|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14257611|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257612|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
14257613|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257614|NCT00330421|Sorafenib|sorafenib|mesh-list
14257615|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257616|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14257617|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257618|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257619|NCT00330460|Denosumab|denosumab|mesh-list
14257620|NCT00330460|Alendronate|alendronate|mesh-list
14257621|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14257622|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257623|NCT00330551|Risperidone|risperidone|mesh-list
14257624|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14257625|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
14257626|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14257627|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257628|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257629|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14257630|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14257631|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14257632|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14257633|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14257634|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
14257635|NCT00330564|Sunitinib|sunitinib|mesh-list
14257636|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257637|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14257638|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14257639|NCT00330564|Growth Substances|growth substances|mesh-ancestor
14257640|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257641|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
14257642|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14257643|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257644|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257645|NCT00330668|Mecasermin|mecasermin|mesh-list
14257646|NCT00330668|Growth Substances|growth substances|mesh-ancestor
14257647|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257648|NCT00330681|Edaravone|edaravone|mesh-list
14257649|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14257650|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
14257651|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257652|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14257653|NCT00330681|Protective Agents|protective agents|mesh-ancestor
14257654|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257655|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14257656|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14257657|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14257658|NCT00330733|Analgesics|analgesics|mesh-ancestor
14257659|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
14257660|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257661|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257662|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14257663|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257664|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
14257665|NCT00330759|Denosumab|denosumab|mesh-list
14257666|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14257667|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257668|NCT00330863|Olanzapine|olanzapine|mesh-list
14257669|NCT00330863|Risperidone|risperidone|mesh-list
14257670|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
14257671|NCT00330863|Aripiprazole|aripiprazole|mesh-list
14257672|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
14257673|NCT00330863|Ziprasidone|ziprasidone|mesh-list
14257674|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14257675|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
15042644|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15042645|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15042646|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042647|NCT02045693|Buprenorphine|buprenorphine|mesh-list
15042648|NCT02045693|Methadone|methadone|mesh-list
15042649|NCT02045693|Naloxone|naloxone|mesh-list
15042650|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15042651|NCT02045693|Narcotics|narcotics|mesh-ancestor
15042652|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15042653|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042654|NCT02045693|Analgesics|analgesics|mesh-ancestor
15042655|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
15042656|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042657|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15042658|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
15042659|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
15042660|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
15042661|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
15042662|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
15042663|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14257676|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14257677|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257678|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257679|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14257680|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14257681|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14257682|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14257683|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14257684|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
14257685|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
14257686|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
14257687|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257688|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14257689|NCT00330863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14257690|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14257691|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14257692|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
14257693|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
14257694|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14257695|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14257696|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14257697|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14257698|NCT00330876|Pitavastatin|pitavastatin|mesh-list
14257699|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14257700|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14257701|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14257702|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
14257703|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257704|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257705|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14257706|NCT00330915|Pemetrexed|pemetrexed|mesh-list
14257707|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257708|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257709|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257710|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14257711|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14257712|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
14257713|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
14257714|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
14257715|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14257716|NCT00331006|Rituximab|rituximab|mesh-list
14257717|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14257718|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257719|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
14257720|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257721|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257722|NCT00331136|Artesunate|artesunate|mesh-list
14257723|NCT00331136|Pyronaridine|pyronaridine|mesh-list
14257724|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
14257725|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14257726|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14257727|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257728|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257729|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
14257730|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
14257731|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
14257732|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
14257733|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
14257734|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14257735|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
14257736|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257737|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257738|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14257739|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257740|NCT00331344|Prednisone|prednisone|mesh-list
14257741|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
14257742|NCT00331344|Epothilone B|epothilone b|mesh-list
14257743|NCT00331344|Epothilones|epothilones|mesh-list
14257744|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14257745|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
14257746|NCT00331344|Hormones|hormones|mesh-ancestor
14257747|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14257748|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257749|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14257750|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257751|NCT00331344|Analgesics|analgesics|mesh-ancestor
14257752|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
14257753|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257754|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14257755|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14257756|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257757|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257758|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
14257759|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
14257760|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
14257761|NCT00331409|Everolimus|everolimus|mesh-list
14257762|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
14257763|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257764|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257765|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
14257766|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257767|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14257768|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257769|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257770|NCT00331422|Paclitaxel|paclitaxel|mesh-list
14257771|NCT00331422|Carboplatin|carboplatin|mesh-list
14257772|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14257773|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257774|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
14257775|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
14257776|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
14257777|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257778|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
14257779|NCT00331552|Doxorubicin|doxorubicin|mesh-list
14257780|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14257781|NCT00331552|Trastuzumab|trastuzumab|mesh-list
14257782|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14257783|NCT00331552|Antibodies|antibodies|mesh-list
14257784|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
14257785|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14257786|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257787|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
14257788|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257789|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257790|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14257791|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
14257792|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257793|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257794|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14257795|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14257796|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14257797|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14257798|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532687|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
14532688|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532689|NCT01986751|Analgesics|analgesics|mesh-ancestor
14532690|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14532691|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
14532692|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
14532693|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14532694|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14532695|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14532696|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
14532697|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532698|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532699|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
14532700|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532701|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
14532702|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14532703|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14532704|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532705|NCT01996852|Urological Agents|urological agents|mesh-ancestor
14532706|NCT01997567|Ropivacaine|ropivacaine|mesh-list
14532707|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
14532708|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
14532709|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532710|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532711|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
14532712|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532713|NCT01977729|Sertraline|sertraline|mesh-list
14532714|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
14532715|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14532716|NCT01977729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14532717|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14532718|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14532719|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532720|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532721|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
14532722|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532723|NCT01973062|Rituximab|rituximab|mesh-list
14532724|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14532725|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14532726|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532727|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
14532728|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532729|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14532730|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
14257799|NCT00331630|Paclitaxel|paclitaxel|mesh-list
14257800|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14257801|NCT00331630|Lapatinib|lapatinib|mesh-list
14257802|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14257803|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257804|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
14257805|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
14257806|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
14257807|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257808|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14257809|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257810|NCT00331682|Docetaxel|docetaxel|mesh-list
14257811|NCT00331682|Alvocidib|alvocidib|mesh-list
14257812|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257813|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
14257814|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
14257815|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
14257816|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257817|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
14257818|NCT00331682|Growth Substances|growth substances|mesh-ancestor
14257819|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257820|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14257821|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257822|NCT00331760|Cisplatin|cisplatin|mesh-list
14257823|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257824|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14257825|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14257826|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14257827|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14257828|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257829|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14257830|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257831|NCT00331799|Analgesics|analgesics|mesh-ancestor
14257832|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
14257833|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257834|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
14257835|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14257836|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
14257837|NCT00331864|Ranibizumab|ranibizumab|mesh-list
14257838|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14257839|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14257840|NCT00331864|Growth Substances|growth substances|mesh-ancestor
14257841|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257842|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
14257843|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257844|NCT00332163|Irinotecan|irinotecan|mesh-list
14257845|NCT00332163|Panitumumab|panitumumab|mesh-list
14257846|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14257847|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14257848|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257849|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257850|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257851|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14257852|NCT00332189|Verapamil|verapamil|mesh-list
14257853|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14257854|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14257855|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14257856|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257857|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14257858|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257859|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
14257860|NCT00332241|Aripiprazole|aripiprazole|mesh-list
14257861|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
14257862|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14257863|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14257864|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14257865|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14257866|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257867|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
14257868|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
14257869|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14257870|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257871|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14257872|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14257873|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
14257874|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14257875|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14257876|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14257877|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14257878|NCT00332332|Etanercept|etanercept|mesh-list
14257879|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14257880|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14257881|NCT00332332|Analgesics|analgesics|mesh-ancestor
14257882|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
14257883|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257884|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257885|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14257886|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257887|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14257888|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257889|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
14257890|NCT00332462|Cyclosporine|cyclosporine|mesh-list
14257891|NCT00332462|Cyclosporins|cyclosporins|mesh-list
14257892|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257893|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257894|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257895|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
14257896|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257897|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
14257898|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257899|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
14257900|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14257901|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14257902|NCT00332488|Insulin|insulin|mesh-list
14257903|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14257904|NCT00332488|Metformin|metformin|mesh-list
14257905|NCT00332488|Secretagogues|secretagogues|mesh-list
14257906|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14257907|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257908|NCT00332579|Naltrexone|naltrexone|mesh-list
14257909|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14257910|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14257911|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257912|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
14257913|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257914|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
14257915|NCT00332605|Naltrexone|naltrexone|mesh-list
14257916|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14257917|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14257918|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14257919|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257920|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
14257921|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257922|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
14257923|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257924|NCT00332605|Expectorants|expectorants|mesh-ancestor
14257925|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
14257926|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14257927|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
14257928|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257929|NCT00332605|Protective Agents|protective agents|mesh-ancestor
14257930|NCT00332605|Antidotes|antidotes|mesh-ancestor
14257931|NCT00332644|Bupropion|bupropion|mesh-list
14257932|NCT00332644|Nicotine|nicotine|mesh-list
14257933|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14257934|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
14257935|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257936|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257937|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14257938|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14257939|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
14257940|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14257941|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257942|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14257943|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
14257944|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14257945|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14257946|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14257947|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14257948|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
14257949|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14257950|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14257951|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257952|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
14257953|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14257954|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14257955|NCT00332696|Prednisolone|prednisolone|mesh-list
14257956|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
14257957|NCT00332696|Octreotide|octreotide|mesh-list
14257958|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14257959|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
14257960|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14257961|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
14257962|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
14257963|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14257964|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257965|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14257966|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
14257967|NCT00332696|Hormones|hormones|mesh-ancestor
14257968|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14257969|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14257970|NCT00332696|Protective Agents|protective agents|mesh-ancestor
14257971|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14257972|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257973|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
14257974|NCT00332709|Letrozole|letrozole|mesh-list
14257975|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14257976|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14257977|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14257978|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257979|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257980|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14257981|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
14257982|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14257983|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257984|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14257985|NCT00332839|Cyclosporine|cyclosporine|mesh-list
14257986|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
14257987|NCT00332839|Everolimus|everolimus|mesh-list
14257988|NCT00332839|Tacrolimus|tacrolimus|mesh-list
14257989|NCT00332839|Cyclosporins|cyclosporins|mesh-list
14257990|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14257991|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
14257992|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14257993|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14257994|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14257995|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14257996|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
14257997|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14257998|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
14257999|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14258000|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258001|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14258002|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14258003|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
14258004|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14258005|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14258006|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14258007|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258008|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258009|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
14258010|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258011|NCT00333177|Risperidone|risperidone|mesh-list
14258012|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14258013|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
14258014|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258015|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258016|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258017|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14258018|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14258019|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14258020|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14258021|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14258022|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
14258023|NCT00333359|Gabapentin|gabapentin|mesh-list
14258024|NCT00333359|Analgesics|analgesics|mesh-ancestor
14258025|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
14258026|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258027|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258028|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
14258029|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14258030|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14258031|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14258032|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14258033|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14258034|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14258035|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258036|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258037|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
14258038|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
14258039|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14258040|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258041|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14258042|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
14258043|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14258044|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258045|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258046|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258047|NCT00333775|Bevacizumab|bevacizumab|mesh-list
14258048|NCT00333775|Docetaxel|docetaxel|mesh-list
14258049|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14258050|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258051|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14258052|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14258053|NCT00333775|Growth Substances|growth substances|mesh-ancestor
14258054|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258055|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
14258056|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
14258057|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
14258058|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
14258059|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258060|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
14258061|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258062|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
14258063|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258064|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14258065|NCT00333814|Dexamethasone|dexamethasone|mesh-list
14258066|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
14258067|NCT00333814|BB 1101|bb 1101|mesh-list
14258068|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14258069|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
14258070|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
14258071|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258072|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258073|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14258074|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
14258075|NCT00333814|Hormones|hormones|mesh-ancestor
14258076|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14258077|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14258078|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258079|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
14258080|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258081|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258082|NCT00333840|Interferons|interferons|mesh-list
14258083|NCT00333840|Cytarabine|cytarabine|mesh-list
14258084|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
14258085|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
14258086|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
14258087|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258088|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
14258089|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258090|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14258091|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
14258092|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258093|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258094|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
14258095|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258096|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14258097|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258098|NCT00333866|Pregabalin|pregabalin|mesh-list
14258099|NCT00333866|Analgesics|analgesics|mesh-ancestor
14258100|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
14258101|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258102|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258103|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
14258104|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14258105|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14258106|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258107|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14258108|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14258109|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14258110|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14258111|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14258112|NCT00334074|Cytarabine|cytarabine|mesh-list
14258113|NCT00334074|Clofarabine|clofarabine|mesh-list
14258114|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14258115|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
14258116|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258117|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258118|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
14258119|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258120|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258121|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
14258122|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258123|NCT00334295|Fulvestrant|fulvestrant|mesh-list
14258124|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14258125|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258126|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14258127|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14258128|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
14258129|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14258130|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258131|NCT00334542|Simvastatin|simvastatin|mesh-list
14258132|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14258133|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14258134|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
14258135|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258136|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14258137|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14258138|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258139|NCT00334633|Metronidazole|metronidazole|mesh-list
14258140|NCT00334633|Tinidazole|tinidazole|mesh-list
14258141|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258142|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14258143|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14258144|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14258145|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
14258146|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258147|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
14258148|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
14258149|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
14258150|NCT00334737|Hematinics|hematinics|mesh-ancestor
14258151|NCT00334802|Gemcitabine|gemcitabine|mesh-list
14258152|NCT00334802|Paclitaxel|paclitaxel|mesh-list
14258153|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14258154|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258155|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
14258156|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
14258157|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
14258158|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258159|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14258160|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
14258161|NCT00334802|Antiviral Agents|antiviral agents|mesh-ancestor
14258162|NCT00334802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258163|NCT00334802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258164|NCT00334802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258165|NCT00334802|Immunologic Factors|immunologic factors|mesh-ancestor
14258166|NCT00334802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258167|NCT00334815|Bevacizumab|bevacizumab|mesh-list
14258168|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14258169|NCT00334815|Cisplatin|cisplatin|mesh-list
14258170|NCT00334815|Docetaxel|docetaxel|mesh-list
14258171|NCT00334815|Etoposide|etoposide|mesh-list
14258172|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
14258173|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
14258174|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
14258175|NCT00334815|Antibodies|antibodies|mesh-list
14258176|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
14258177|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14258178|NCT00334815|Lenograstim|lenograstim|mesh-list
14258179|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
14258180|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258181|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14258182|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14258183|NCT00334815|Growth Substances|growth substances|mesh-ancestor
14258184|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258185|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
14258186|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
14258187|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
14258188|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
14258189|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
14258190|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258191|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14258192|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14258193|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14258194|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258195|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14258196|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
14258197|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
14258198|NCT00334958|Rufinamide|rufinamide|mesh-list
14258199|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
14258200|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14258201|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14258202|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14258203|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258204|NCT00335140|Leucovorin|leucovorin|mesh-list
14258205|NCT00335140|Cytarabine|cytarabine|mesh-list
14258206|NCT00335140|Dexamethasone|dexamethasone|mesh-list
14258207|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
14258208|NCT00335140|Rituximab|rituximab|mesh-list
14258209|NCT00335140|Methotrexate|methotrexate|mesh-list
14258210|NCT00335140|Vincristine|vincristine|mesh-list
14258211|NCT00335140|Procarbazine|procarbazine|mesh-list
14258212|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
14258213|NCT00335140|BB 1101|bb 1101|mesh-list
14258214|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
14258215|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14258216|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
14258217|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
14258218|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258219|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258220|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14258221|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
14258222|NCT00335140|Hormones|hormones|mesh-ancestor
14258223|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14258224|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14258225|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258226|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
14258227|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258228|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258229|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14258230|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
14258231|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14258232|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14258233|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
14258234|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14258235|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14258236|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
14258237|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
14258238|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14258239|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258240|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14258241|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
14258242|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258243|NCT00335140|Antidotes|antidotes|mesh-ancestor
14258244|NCT00335140|Protective Agents|protective agents|mesh-ancestor
14258245|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
14258246|NCT00335140|Vitamins|vitamins|mesh-ancestor
14258247|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
14258248|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14258249|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
14258250|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
14258251|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
14258252|NCT00335153|Levodopa|levodopa|mesh-list
14258253|NCT00335153|Carbidopa|carbidopa|mesh-list
14258254|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14258255|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14258256|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14258257|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
14258258|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258259|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258260|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258261|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14258262|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258263|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14258264|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
14258265|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
14258266|NCT00335283|Lansoprazole|lansoprazole|mesh-list
14258267|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
14258268|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14258269|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14258270|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14258271|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258272|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258273|NCT00335322|Ritonavir|ritonavir|mesh-list
14258274|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14258275|NCT00335322|Tenofovir|tenofovir|mesh-list
14258276|NCT00335322|Zidovudine|zidovudine|mesh-list
14258277|NCT00335322|Emtricitabine|emtricitabine|mesh-list
14258278|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14258279|NCT00335322|Abacavir|abacavir|mesh-list
14258280|NCT00335322|Efavirenz|efavirenz|mesh-list
14258281|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14258282|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14258283|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
14258284|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258285|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258286|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14258287|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14258288|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
14258289|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258290|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14258291|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14258292|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14258293|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14258294|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
14258295|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14258296|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14258297|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14258298|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14258299|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14258300|NCT00335452|Clopidogrel|clopidogrel|mesh-list
14258301|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14258302|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14258303|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14258304|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14258305|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
14258306|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258307|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258308|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258309|NCT00335478|Daptomycin|daptomycin|mesh-list
14258310|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14258311|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258312|NCT00335504|Sulindac|sulindac|mesh-list
14258313|NCT00335504|Atorvastatin|atorvastatin|mesh-list
14258314|NCT00335504|Calcium|calcium|mesh-list
14258315|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14258316|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258317|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14258318|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14258319|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
14258320|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258321|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14258322|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14258323|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258324|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14258325|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14258326|NCT00335504|Analgesics|analgesics|mesh-ancestor
14258327|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
14258328|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258329|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14258330|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14258331|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258332|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14258333|NCT00335556|Dactinomycin|dactinomycin|mesh-list
14258334|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
14258335|NCT00335556|Carboplatin|carboplatin|mesh-list
14258336|NCT00335556|Doxorubicin|doxorubicin|mesh-list
14258337|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14258338|NCT00335556|Irinotecan|irinotecan|mesh-list
14258339|NCT00335556|Etoposide|etoposide|mesh-list
14258340|NCT00335556|Vincristine|vincristine|mesh-list
14258341|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258342|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
14258343|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258344|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14258345|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14258346|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
14258347|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258348|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258349|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14258350|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14258351|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14258352|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14258353|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258354|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14258355|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14258356|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
14258357|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
14258358|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
14258359|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14258360|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258361|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14258362|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14258363|NCT00335725|Hormones|hormones|mesh-list
14258364|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
14258365|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14258366|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258367|NCT00335738|Carboplatin|carboplatin|mesh-list
14258368|NCT00335738|Etoposide|etoposide|mesh-list
14258369|NCT00335738|Vincristine|vincristine|mesh-list
14258370|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
14258371|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258372|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14258373|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14258374|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14258375|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258376|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258377|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
14258378|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
14258379|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
14258380|NCT00335764|Sirolimus|sirolimus|mesh-list
14258381|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14258382|NCT00335764|Sorafenib|sorafenib|mesh-list
14258383|NCT00335764|Tipifarnib|tipifarnib|mesh-list
14258384|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258385|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14258386|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258387|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258388|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14258389|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258390|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14258391|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
14258392|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258393|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
14258394|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258395|NCT00335829|Bevacizumab|bevacizumab|mesh-list
14258396|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14258397|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258398|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14258399|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14258400|NCT00335829|Growth Substances|growth substances|mesh-ancestor
14258401|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258402|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
14258403|NCT00335959|Capecitabine|capecitabine|mesh-list
14258404|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
14258405|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14258406|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
14258407|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258408|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258409|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
14258410|NCT00335972|Remifentanil|remifentanil|mesh-list
14258411|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14258412|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14258413|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258414|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14258415|NCT00335972|Analgesics|analgesics|mesh-ancestor
14258416|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
14258417|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258418|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14258419|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14258420|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14258421|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
14258422|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258423|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258424|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14258425|NCT00335972|Narcotics|narcotics|mesh-ancestor
14258426|NCT00336024|Leucovorin|leucovorin|mesh-list
14258427|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
14258428|NCT00336024|Thiotepa|thiotepa|mesh-list
14258429|NCT00336024|Carboplatin|carboplatin|mesh-list
14258430|NCT00336024|Methotrexate|methotrexate|mesh-list
14258431|NCT00336024|Etoposide|etoposide|mesh-list
14258432|NCT00336024|Vincristine|vincristine|mesh-list
14258433|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
14258434|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
14258435|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258436|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
14258437|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258438|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14258439|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14258440|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
14258441|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258442|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258443|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14258444|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14258445|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
14258446|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14258447|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14258448|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
14258449|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
14258450|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258451|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14258452|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14258453|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14258454|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14258455|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14258456|NCT00336024|Antidotes|antidotes|mesh-ancestor
14258457|NCT00336024|Protective Agents|protective agents|mesh-ancestor
14258458|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
14258459|NCT00336024|Vitamins|vitamins|mesh-ancestor
14258460|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
14258461|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
14258462|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
14258463|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
14258464|NCT00336232|Vitamin K|vitamin k|mesh-list
14258465|NCT00336232|Vitamins|vitamins|mesh-ancestor
14258466|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
14258467|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258468|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
14258469|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14258470|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258471|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
14258472|NCT00336232|Coagulants|coagulants|mesh-ancestor
14258473|NCT00336323|Bevacizumab|bevacizumab|mesh-list
14258474|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14258475|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258476|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14258477|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14258478|NCT00336323|Growth Substances|growth substances|mesh-ancestor
14258479|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258480|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
14258481|NCT00336479|Interferons|interferons|mesh-list
14258482|NCT00336479|Ribavirin|ribavirin|mesh-list
14258483|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
14258484|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
14258485|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14258486|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258487|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
14258488|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258489|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
14258490|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258491|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
14258492|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258493|NCT00336492|Infliximab|infliximab|mesh-list
14258494|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
14258495|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14258496|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14258497|NCT00336505|Clarithromycin|clarithromycin|mesh-list
14258498|NCT00336505|Cethromycin|cethromycin|mesh-list
14258499|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14258500|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258501|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14258502|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258503|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258504|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14258505|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14258506|NCT00336544|Clarithromycin|clarithromycin|mesh-list
14258507|NCT00336544|Cethromycin|cethromycin|mesh-list
14258508|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14258509|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258510|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14258511|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258512|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258513|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14258514|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14258515|NCT00336583|Cytarabine|cytarabine|mesh-list
14258516|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
14258517|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
14258518|NCT00336583|Etoposide|etoposide|mesh-list
14258519|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258520|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14258521|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14258522|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14258523|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258524|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258525|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14258526|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
14258527|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
14258528|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258529|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258530|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
14258531|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258532|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14258533|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
14258534|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
14258535|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258536|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14258537|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
14258538|NCT00336583|Hormones|hormones|mesh-ancestor
14258539|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14258540|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14258541|NCT00336583|Protective Agents|protective agents|mesh-ancestor
14258542|NCT00336700|Gemcitabine|gemcitabine|mesh-list
14258543|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14258544|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14258545|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
14258546|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258547|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258548|NCT00336700|Antiviral Agents|antiviral agents|mesh-ancestor
14258549|NCT00336700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258550|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258551|NCT00336700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258552|NCT00336700|Immunologic Factors|immunologic factors|mesh-ancestor
14258553|NCT00336700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258554|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14258555|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
14258556|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14258557|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258558|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14258559|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
14258560|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14258561|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258562|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258563|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258564|NCT00336856|Irinotecan|irinotecan|mesh-list
14258565|NCT00336856|Cetuximab|cetuximab|mesh-list
14258566|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14258567|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14258568|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258569|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258570|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258571|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14258572|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
14258573|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14258574|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258575|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14258576|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
14258577|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14258578|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258579|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258580|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258581|NCT00337103|Capecitabine|capecitabine|mesh-list
14258582|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14258583|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
14258584|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258585|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258586|NCT00337168|Cytarabine|cytarabine|mesh-list
14258587|NCT00337168|Clofarabine|clofarabine|mesh-list
14258588|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14258589|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
14258590|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258591|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258592|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
14258593|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258594|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258595|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
14258596|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258597|NCT00337194|Gemcitabine|gemcitabine|mesh-list
14258598|NCT00337194|Doxorubicin|doxorubicin|mesh-list
14258599|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14258600|NCT00337194|Vinorelbine|vinorelbine|mesh-list
14258601|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14258602|NCT00337194|Antibodies|antibodies|mesh-list
14258603|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14258604|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
14258605|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258606|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14258607|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
14258608|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258609|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258610|NCT00337194|Antiviral Agents|antiviral agents|mesh-ancestor
14258611|NCT00337194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258612|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258613|NCT00337194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258614|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14258615|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14258616|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14258617|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14258618|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
14258619|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
14258620|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
14258621|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14258622|NCT00337207|Bevacizumab|bevacizumab|mesh-list
14258623|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14258624|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258625|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14258626|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14258627|NCT00337207|Growth Substances|growth substances|mesh-ancestor
14258628|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258629|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
14258630|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14258631|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14258632|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258633|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14258634|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14258635|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14258636|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258637|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
14258638|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258639|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
14258640|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14258641|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258642|NCT00337428|Vaccines|vaccines|mesh-list
14258643|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
14258644|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258645|NCT00337467|Ritonavir|ritonavir|mesh-list
14258646|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14258647|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14258648|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14258649|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
14258650|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258651|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258652|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14258653|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14258654|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
14258655|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258656|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14258657|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14258658|NCT00337571|Aripiprazole|aripiprazole|mesh-list
14258659|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
14258660|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15042664|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042665|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
15042666|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042667|NCT02045849|Itraconazole|itraconazole|mesh-list
15042668|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
15042669|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042670|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15042671|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15042672|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042673|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042674|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15042675|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
15042676|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042677|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042678|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15042679|NCT02045914|Calcium|calcium|mesh-list
15042680|NCT02045914|Ionophores|ionophores|mesh-list
15042681|NCT02045914|Ionomycin|ionomycin|mesh-list
15042682|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
15042683|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15042684|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042685|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15042686|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042687|NCT02045940|GSK2881078|gsk2881078|mesh-list
15042688|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
15042689|NCT02045940|Hormones|hormones|mesh-ancestor
15042690|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042691|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042692|NCT02045953|Albuterol|albuterol|mesh-list
15042693|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15042694|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
15042695|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042696|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042697|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15042698|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
15042699|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
15042700|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15042701|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15042702|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15042703|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15042704|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
15042705|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258661|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14258662|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14258663|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14258664|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258665|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
14258666|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
14258667|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258668|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258669|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14258670|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14258671|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
14258672|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14258673|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14258674|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14258675|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14258676|NCT00337610|Metformin|metformin|mesh-list
14258677|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14258678|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14258679|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258680|NCT00337610|Incretins|incretins|mesh-ancestor
14258681|NCT00337610|Hormones|hormones|mesh-ancestor
14258682|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14258683|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14258684|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
14258685|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258686|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258687|NCT00337662|Olanzapine|olanzapine|mesh-list
14258688|NCT00337662|Risperidone|risperidone|mesh-list
14258689|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14258690|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
14258691|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258692|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258693|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258694|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14258695|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14258696|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14258697|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14258698|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14258699|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
14258700|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
14258701|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
14258702|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258703|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14258704|NCT00337662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14258705|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14258706|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14258707|NCT00337727|Dexamethasone|dexamethasone|mesh-list
14258708|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
14258709|NCT00337727|Ondansetron|ondansetron|mesh-list
14258710|NCT00337727|Aprepitant|aprepitant|mesh-list
14258711|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
14258712|NCT00337727|BB 1101|bb 1101|mesh-list
14258713|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14258714|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
14258715|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
14258716|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258717|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258718|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14258719|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
14258720|NCT00337727|Hormones|hormones|mesh-ancestor
14258721|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14258722|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14258723|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258724|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
14258725|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258726|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258727|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
14258728|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
14258729|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14258730|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
14258731|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258732|NCT00337727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14258733|NCT00337727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14258734|NCT00337727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14258735|NCT00337727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14258736|NCT00337727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14258737|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
14258738|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
14258739|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
14258740|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14258741|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
14258742|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258743|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258744|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14258745|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
14258746|NCT00337935|Hematinics|hematinics|mesh-ancestor
14258747|NCT00337987|Prednisone|prednisone|mesh-list
14258748|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
14258749|NCT00337987|Vincristine|vincristine|mesh-list
14258750|NCT00337987|Doxorubicin|doxorubicin|mesh-list
14258751|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14258752|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
14258753|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258754|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
14258755|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258756|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14258757|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14258758|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
14258759|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258760|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258761|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14258762|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14258763|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
14258764|NCT00337987|Hormones|hormones|mesh-ancestor
14258765|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14258766|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14258767|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14258768|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
14258769|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
14258770|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
14258771|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14258772|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14258773|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14258774|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258775|NCT00338039|Gemcitabine|gemcitabine|mesh-list
14258776|NCT00338039|Capecitabine|capecitabine|mesh-list
14258777|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
14258778|NCT00338039|Cetuximab|cetuximab|mesh-list
14258779|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14258780|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
14258781|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258782|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258783|NCT00338039|Antiviral Agents|antiviral agents|mesh-ancestor
14258784|NCT00338039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258785|NCT00338039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258786|NCT00338039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258787|NCT00338039|Immunologic Factors|immunologic factors|mesh-ancestor
14258788|NCT00338039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258789|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14258790|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
14258791|NCT00338286|Hematinics|hematinics|mesh-ancestor
14532731|NCT01984268|Hormones|hormones|mesh-ancestor
14532732|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14532733|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532734|NCT01974284|Ethanol|ethanol|mesh-list
14532735|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14532736|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532737|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532738|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532739|NCT01971853|Analgesics|analgesics|mesh-list
14532740|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
14532741|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532742|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532743|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
14532744|NCT01980875|Idelalisib|idelalisib|mesh-list
14532745|NCT01980875|Chlorambucil|chlorambucil|mesh-list
14532746|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14532747|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532748|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532749|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532750|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14258792|NCT00338598|Glycine|glycine|mesh-list
14258793|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
14258794|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258795|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258796|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258797|NCT00338728|Letrozole|letrozole|mesh-list
14258798|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
14258799|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258800|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14258801|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14258802|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258803|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258804|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14258805|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
14258806|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14258807|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258808|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14258809|NCT00338884|Sunitinib|sunitinib|mesh-list
14258810|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258811|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14258812|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14258813|NCT00338884|Growth Substances|growth substances|mesh-ancestor
14258814|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258815|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
14258816|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14258817|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258818|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258819|NCT00338949|Olanzapine|olanzapine|mesh-list
14258820|NCT00338949|Risperidone|risperidone|mesh-list
14258821|NCT00338949|Ziprasidone|ziprasidone|mesh-list
14258822|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14258823|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
14258824|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258825|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258826|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258827|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14258828|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14258829|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14258830|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14258831|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14258832|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
14258833|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
14258834|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
14258835|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258836|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14258837|NCT00338949|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14258838|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14258839|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14258840|NCT00338962|Naltrexone|naltrexone|mesh-list
14258841|NCT00338962|Paroxetine|paroxetine|mesh-list
14258842|NCT00338962|Desipramine|desipramine|mesh-list
14258843|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14258844|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14258845|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258846|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
14258847|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258848|NCT00338962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14258849|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14258850|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14258851|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258852|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258853|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
14258854|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14258855|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
14258856|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14258857|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14258858|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14258859|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258860|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
14258861|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14258862|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
14258863|NCT00338988|Capecitabine|capecitabine|mesh-list
14258864|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
14258865|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14258866|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
14258867|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258868|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258869|NCT00339079|Fluoxetine|fluoxetine|mesh-list
14258870|NCT00339079|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14258871|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14258872|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14258873|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258874|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258875|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
14258876|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258877|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14258878|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
14258879|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14258880|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14258881|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14258882|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258883|NCT00339144|Dasatinib|dasatinib|mesh-list
14258884|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258885|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14258886|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258887|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258888|NCT00339183|Panitumumab|panitumumab|mesh-list
14258889|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14258890|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258891|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
14258892|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14258893|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14258894|NCT00339833|Analgesics|analgesics|mesh-ancestor
14258895|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
14258896|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258897|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258898|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14258899|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14258900|NCT00340379|Haloperidol|haloperidol|mesh-list
14258901|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
14258902|NCT00340379|Ziprasidone|ziprasidone|mesh-list
14258903|NCT00340379|Sertraline|sertraline|mesh-list
14258904|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
14258905|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14258906|NCT00340379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14258907|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14258908|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14258909|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258910|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258911|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
14258912|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258913|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
14258914|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
14258915|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258916|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14258917|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14258918|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14258919|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14258920|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14258921|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
14258922|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14258923|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14258924|NCT00340678|Losartan|losartan|mesh-list
14258925|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14258926|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14258927|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14258928|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14258929|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258930|NCT00340704|Tamsulosin|tamsulosin|mesh-list
14258931|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14258932|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14258933|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14258934|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
14258935|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258936|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258937|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258938|NCT00340704|Urological Agents|urological agents|mesh-ancestor
14258939|NCT00340834|Interferons|interferons|mesh-list
14258940|NCT00340834|Interferon-beta|interferon-beta|mesh-list
14258941|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
14258942|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14258943|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258944|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
14258945|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258946|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14258947|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258948|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14258949|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
14258950|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258951|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14258952|NCT00342355|Ritonavir|ritonavir|mesh-list
14258953|NCT00342355|Lopinavir|lopinavir|mesh-list
14258954|NCT00342355|Lamivudine|lamivudine|mesh-list
14258955|NCT00342355|Zidovudine|zidovudine|mesh-list
14258956|NCT00342355|Stavudine|stavudine|mesh-list
14258957|NCT00342355|Didanosine|didanosine|mesh-list
14258958|NCT00342355|Efavirenz|efavirenz|mesh-list
14258959|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14258960|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14258961|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
14258962|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14258963|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258964|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14258965|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14258966|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
14258967|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14258968|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14258969|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14258970|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14258971|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14258972|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
14258973|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14258974|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14258975|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14258976|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14258977|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14258978|NCT00342563|Mecamylamine|mecamylamine|mesh-list
14258979|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14258980|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
14258981|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
14258982|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14258983|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258984|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
14258985|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14258986|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
14258987|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14258988|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14258989|NCT00342628|Vaccines|vaccines|mesh-list
14258990|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
14258991|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14258992|NCT00343044|Bevacizumab|bevacizumab|mesh-list
14258993|NCT00343044|Topotecan|topotecan|mesh-list
14258994|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14258995|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14258996|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14258997|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14258998|NCT00343044|Growth Substances|growth substances|mesh-ancestor
14258999|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259000|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
14259001|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14259002|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14259003|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259004|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259005|NCT00343083|Paclitaxel|paclitaxel|mesh-list
14259006|NCT00343083|Carboplatin|carboplatin|mesh-list
14259007|NCT00343083|Cetuximab|cetuximab|mesh-list
14259008|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14259009|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259010|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
14259011|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
14259012|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
14532751|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
14259013|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259014|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14259015|NCT00343252|Teriparatide|teriparatide|mesh-list
14259016|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
14259017|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
14259018|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14259019|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259020|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14259021|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14259022|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14259023|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259024|NCT00343291|Paclitaxel|paclitaxel|mesh-list
14259025|NCT00343291|Bevacizumab|bevacizumab|mesh-list
14259026|NCT00343291|Carboplatin|carboplatin|mesh-list
14259027|NCT00343291|Cetuximab|cetuximab|mesh-list
14259028|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14259029|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259030|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
14259031|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
14259032|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
14259033|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259034|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14259035|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14259036|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14259037|NCT00343291|Growth Substances|growth substances|mesh-ancestor
14259038|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259039|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
14259040|NCT00343382|Pilocarpine|pilocarpine|mesh-list
14259041|NCT00343382|Miotics|miotics|mesh-ancestor
14259042|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
14259043|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259044|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259045|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
14259046|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14259047|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
14259048|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259049|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259050|NCT00343460|Dexamethasone|dexamethasone|mesh-list
14259051|NCT00343460|Palonosetron|palonosetron|mesh-list
14259052|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14259053|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
14259054|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
14259055|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259056|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259057|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14259058|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
14259059|NCT00343460|Hormones|hormones|mesh-ancestor
14259060|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259061|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14259062|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259063|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14259064|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14259065|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
14259066|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259067|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259068|NCT00343512|Docetaxel|docetaxel|mesh-list
14259069|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259070|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
14259071|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
14259072|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
14259073|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259074|NCT00343785|Cyclosporine|cyclosporine|mesh-list
14259075|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
14259076|NCT00343785|Methotrexate|methotrexate|mesh-list
14259077|NCT00343785|Cyclosporins|cyclosporins|mesh-list
14259078|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
14259079|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14259080|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
14259081|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14259082|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
14259083|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259084|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14259085|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14259086|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
14259087|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259088|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259089|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14259090|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14259091|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
14259092|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14259093|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14259094|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
14259095|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
14259096|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259097|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14259098|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14259099|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
14259100|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259101|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14259102|NCT00343863|Dexamethasone|dexamethasone|mesh-list
14259103|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
14259104|NCT00343863|Doxorubicin|doxorubicin|mesh-list
14259105|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14259106|NCT00343863|Ondansetron|ondansetron|mesh-list
14259107|NCT00343863|Palonosetron|palonosetron|mesh-list
14259108|NCT00343863|Antiemetics|antiemetics|mesh-list
14259109|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14259110|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
14259111|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259112|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14259113|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14259114|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
14259115|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259116|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259117|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14259118|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14259119|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
14259120|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259121|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14259122|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
14259123|NCT00343863|Hormones|hormones|mesh-ancestor
14259124|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259125|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14259126|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14259127|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14259128|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14259129|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259130|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
14259131|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
14259132|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14259133|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
14259134|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259135|NCT00343863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14259136|NCT00343863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14259137|NCT00343863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14259138|NCT00343863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14259139|NCT00343863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14259140|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
14259141|NCT00343889|Vaccines|vaccines|mesh-list
14259142|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
14259143|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259144|NCT00344032|Vaccines|vaccines|mesh-list
14259145|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
14259146|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259147|NCT00344175|Simvastatin|simvastatin|mesh-list
14259148|NCT00344175|Pitavastatin|pitavastatin|mesh-list
14259149|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14259150|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14259151|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
14259152|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259153|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14259154|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14259155|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259156|NCT00344305|Vaccines|vaccines|mesh-list
14259157|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
14259158|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259159|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14259160|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
14259161|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259162|NCT00344370|Atorvastatin|atorvastatin|mesh-list
14259163|NCT00344370|Pitavastatin|pitavastatin|mesh-list
14259164|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14259165|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14259166|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
14259167|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259168|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14259169|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14259170|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259171|NCT00344461|Tenofovir|tenofovir|mesh-list
14259172|NCT00344461|Nevirapine|nevirapine|mesh-list
14259173|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
14259174|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259175|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14259176|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14259177|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259178|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259179|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14259180|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14259181|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14259182|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14259183|NCT00344682|Memantine|memantine|mesh-list
14259184|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14259185|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14259186|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
14259187|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259188|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259189|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259190|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14259191|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14259192|NCT00344773|Gefitinib|gefitinib|mesh-list
14259193|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259194|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14259195|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259196|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259197|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
14259198|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14259199|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
14259200|NCT00344968|Hormones|hormones|mesh-ancestor
14259201|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259202|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259203|NCT00345033|Aripiprazole|aripiprazole|mesh-list
14259204|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
14259205|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14259206|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14259207|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14259208|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14259209|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259210|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
14259211|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
14259212|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259213|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259214|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14259215|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14259216|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
14259217|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14259218|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14259219|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14259220|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14259221|NCT00345046|Prednisolone|prednisolone|mesh-list
14259222|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14259223|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
14259224|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14259225|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
14259226|NCT00345046|Prednisone|prednisone|mesh-list
14259227|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14259228|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
14259229|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14259230|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
14259231|NCT00345046|Hormones|hormones|mesh-ancestor
14259232|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259233|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259234|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14259235|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259236|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
14259237|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
14259238|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259239|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14259240|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14259241|NCT00345046|Protective Agents|protective agents|mesh-ancestor
14259242|NCT00345371|Topiramate|topiramate|mesh-list
14259243|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
14259244|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14259245|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259246|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
14259247|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14259248|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14259249|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259250|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14259251|NCT00345384|Analgesics|analgesics|mesh-ancestor
14259252|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
14259253|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259254|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14259255|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14259256|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14259257|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
14259258|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259259|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259260|NCT00345540|Carboplatin|carboplatin|mesh-list
14259261|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259262|NCT00345579|PENTA|penta|mesh-list
14259263|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
14259264|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14259265|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14259266|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259267|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
14259268|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259269|NCT00345683|Vaccines|vaccines|mesh-list
14259270|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
14259271|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259272|NCT00345839|Cinacalcet|cinacalcet|mesh-list
14259273|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14259274|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259275|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
14259276|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
14259277|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259278|NCT00345865|Cytarabine|cytarabine|mesh-list
14259279|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
14259280|NCT00345865|Carmustine|carmustine|mesh-list
14259281|NCT00345865|Etoposide|etoposide|mesh-list
14259282|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14259283|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
14259284|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259285|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14259286|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14259287|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
14259288|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259289|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259290|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14259291|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14259292|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14259293|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14259294|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259295|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14259296|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
14259297|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
14259298|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259299|NCT00345878|Vaccines|vaccines|mesh-list
14259300|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
14259301|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259302|NCT00345969|Testosterone|testosterone|mesh-list
14259303|NCT00345969|Androgens|androgens|mesh-ancestor
14259304|NCT00345969|Hormones|hormones|mesh-ancestor
14259305|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259306|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259307|NCT00346034|Pregabalin|pregabalin|mesh-list
14259308|NCT00346034|Analgesics|analgesics|mesh-ancestor
14259309|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
14259310|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259311|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259312|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
14259313|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14259314|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14259315|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259316|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14259317|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14259318|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14259319|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14259320|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14259321|NCT00346151|Sirolimus|sirolimus|mesh-list
14259322|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
14259323|NCT00346151|Abatacept|abatacept|mesh-list
14259324|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
14259325|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14259326|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
14259327|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
14259328|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14259329|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259330|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14259331|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259332|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
14259333|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14259334|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
14259335|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259336|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14259337|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
14259338|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
14259339|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259340|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14259341|NCT00346151|Hormones|hormones|mesh-ancestor
14259342|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259343|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14259344|NCT00346151|Protective Agents|protective agents|mesh-ancestor
14259345|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14259346|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259347|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14259359|NCT00346216|Ibuprofen|ibuprofen|mesh-list
14259360|NCT00346216|Celecoxib|celecoxib|mesh-list
14259361|NCT00346216|Naproxen|naproxen|mesh-list
14259362|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14259363|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14259364|NCT00346216|Analgesics|analgesics|mesh-ancestor
14259365|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
14259366|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259367|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259368|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14259369|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14259370|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14259371|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259372|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259373|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14259374|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
14259375|NCT00346268|Parecoxib|parecoxib|mesh-list
14259376|NCT00346268|Morphine|morphine|mesh-list
14259377|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14259378|NCT00346268|Narcotics|narcotics|mesh-ancestor
14259379|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14259380|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259381|NCT00346268|Analgesics|analgesics|mesh-ancestor
14259382|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
14259383|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259384|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14259385|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14259386|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259387|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259388|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14259389|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14259390|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14259391|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14259392|NCT00346775|Beclomethasone|beclomethasone|mesh-list
14259393|NCT00346775|Flunisolide|flunisolide|mesh-list
14259394|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14259395|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
14259396|NCT00346775|Hormones|hormones|mesh-ancestor
14259397|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259398|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259399|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14259400|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
14259401|NCT00347009|Adefovir|adefovir|mesh-list
14259402|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
14259403|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
14259404|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259405|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14259406|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14259407|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259408|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259409|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
14259410|NCT00347360|Carvedilol|carvedilol|mesh-list
14259411|NCT00347360|Lisinopril|lisinopril|mesh-list
14259412|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14259413|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14259414|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
14259415|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259416|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259417|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259418|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14259419|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
14259420|NCT00347360|Protective Agents|protective agents|mesh-ancestor
14259421|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14259422|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14259423|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14259424|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
14259425|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
14259426|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
14259427|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14259428|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
14259429|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259430|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14259431|NCT00347438|Capecitabine|capecitabine|mesh-list
14259432|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14259433|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
14259434|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259435|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259436|NCT00347776|Azithromycin|azithromycin|mesh-list
14259437|NCT00347776|Tetracycline|tetracycline|mesh-list
14259438|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14259439|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259440|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14259441|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259442|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259443|NCT00347919|Lapatinib|lapatinib|mesh-list
14259444|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259445|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14259446|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259447|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259448|NCT00347932|Besifloxacin|besifloxacin|mesh-list
14259449|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14259450|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259451|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14259452|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14259453|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259454|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259455|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259456|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
14259457|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14259458|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259459|NCT00348283|Adalimumab|adalimumab|mesh-list
14259460|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14259461|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14259462|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
14259463|NCT00348309|Donepezil|donepezil|mesh-list
14259464|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14259465|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259466|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259467|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
14259468|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259469|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259470|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
14259471|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14259472|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
14259473|NCT00348348|Besifloxacin|besifloxacin|mesh-list
14259474|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14259475|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259476|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14259477|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14259478|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259479|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259480|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259481|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
14259482|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14259483|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259484|NCT00348595|Lenalidomide|lenalidomide|mesh-list
14259485|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
14259486|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259487|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14259488|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14259489|NCT00348595|Growth Substances|growth substances|mesh-ancestor
14259490|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
14259491|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259492|NCT00348686|Felodipine|felodipine|mesh-list
14259493|NCT00348686|Candesartan|candesartan|mesh-list
14259494|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
14259495|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14259496|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14259497|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14259498|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259499|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14259500|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14259501|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14259502|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14259503|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259504|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
14259505|NCT00348790|Vatalanib|vatalanib|mesh-list
14259506|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14259507|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259508|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259509|NCT00348816|Prednisone|prednisone|mesh-list
14259510|NCT00348816|Docetaxel|docetaxel|mesh-list
14259511|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259512|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
14259513|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
14259514|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
14259515|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259516|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14259517|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
14259518|NCT00348816|Hormones|hormones|mesh-ancestor
14259519|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259520|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259521|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14259522|NCT00348881|Vaccines|vaccines|mesh-list
14259523|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
14259524|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259525|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
14259526|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
14259527|NCT00348933|Betaine|betaine|mesh-list
14259528|NCT00348933|Vitamins|vitamins|mesh-ancestor
14259529|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
14259530|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259531|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
14259532|NCT00348933|Hematinics|hematinics|mesh-ancestor
14259533|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14259534|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
14259535|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14259536|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
14259537|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259538|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14259539|NCT00348946|Androgens|androgens|mesh-list
14259540|NCT00348946|Oxandrolone|oxandrolone|mesh-list
14259541|NCT00348946|Hormones|hormones|mesh-ancestor
14259542|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259543|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259544|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
14532752|NCT01980342|Efavirenz|efavirenz|mesh-list
14532753|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14532754|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14532755|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532756|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532757|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
14532758|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532759|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14532760|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14532761|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14532762|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14532763|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14532764|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14532765|NCT01978535|Iron|iron|mesh-list
14532766|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
14532767|NCT01978535|Trace Elements|trace elements|mesh-ancestor
14532768|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
14532769|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532770|NCT01978535|Hematinics|hematinics|mesh-ancestor
14532771|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14532772|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14532773|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532774|NCT01970462|Incretins|incretins|mesh-ancestor
14532775|NCT01970462|Hormones|hormones|mesh-ancestor
14532776|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14532777|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14532778|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
14532779|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532780|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532781|NCT01969565|Dexamethasone|dexamethasone|mesh-list
14532782|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14532783|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
14532784|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
14532785|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532786|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532787|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14532788|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
14532789|NCT01969565|Hormones|hormones|mesh-ancestor
14532790|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14532791|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14532792|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532793|NCT01962974|Golimumab|golimumab|mesh-list
14532794|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14532795|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14532796|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532797|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
14532798|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532799|NCT01951378|Albuterol|albuterol|mesh-list
14532800|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14532801|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
14532802|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532803|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532804|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14532805|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
14532806|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
14532807|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14532808|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14532809|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14532810|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14532811|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
14532812|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532813|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532814|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
14532815|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
14532816|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14532817|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
14532818|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14259545|NCT00349336|Bevacizumab|bevacizumab|mesh-list
14259546|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14259547|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259548|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14259549|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14259550|NCT00349336|Growth Substances|growth substances|mesh-ancestor
14259551|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259552|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
14259553|NCT00349349|Ofatumumab|ofatumumab|mesh-list
14259554|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259555|NCT00349388|Mesalamine|mesalamine|mesh-list
14259556|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14259557|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14259558|NCT00349388|Analgesics|analgesics|mesh-ancestor
14259559|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
14259560|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259561|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259562|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14259563|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14259564|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
14259565|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14259566|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259567|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
14259568|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14259569|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
14259570|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259571|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14259572|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
14259573|NCT00349778|Melphalan|melphalan|mesh-list
14259574|NCT00349778|Carmustine|carmustine|mesh-list
14259575|NCT00349778|Etoposide|etoposide|mesh-list
14259576|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
14259577|NCT00349778|Lenograstim|lenograstim|mesh-list
14259578|NCT00349778|Sargramostim|sargramostim|mesh-list
14259579|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14259580|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
14259581|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259582|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14259583|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14259584|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
14259585|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259586|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259587|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14259588|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14259589|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14259590|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14259591|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259592|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14259593|NCT00349921|Adenosine|adenosine|mesh-list
14259594|NCT00349921|Clonidine|clonidine|mesh-list
14259595|NCT00349921|Analgesics|analgesics|mesh-ancestor
14259596|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
14259597|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259598|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259599|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14259600|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
14259601|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
14259602|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14259603|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14259604|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14259605|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
14259606|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259607|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259608|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14259609|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
14259610|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
14259611|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
14259612|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
14259613|NCT00349973|Dipyridamole|dipyridamole|mesh-list
14259614|NCT00349973|Olanzapine|olanzapine|mesh-list
14259615|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
14259616|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
14259617|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259618|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259619|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14259620|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14259621|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14259622|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14259623|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14259624|NCT00349973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14259625|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14259626|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14259627|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259628|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259629|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
14259630|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14259631|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259632|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14259633|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
14259634|NCT00350025|Paclitaxel|paclitaxel|mesh-list
14259635|NCT00350025|Cetuximab|cetuximab|mesh-list
14259636|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14259637|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259638|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
14259639|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
14259640|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
14259641|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259642|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14259643|NCT00350142|Gemcitabine|gemcitabine|mesh-list
14259644|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14259645|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
14259646|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259647|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259648|NCT00350142|Antiviral Agents|antiviral agents|mesh-ancestor
14259649|NCT00350142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259650|NCT00350142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259651|NCT00350142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14259652|NCT00350142|Immunologic Factors|immunologic factors|mesh-ancestor
14259653|NCT00350142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259654|NCT00350207|Bromides|bromides|mesh-list
14259655|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
14259656|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14259657|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14259658|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
14259659|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259660|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259661|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14259662|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
14259663|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
14259664|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14259665|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
14259666|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259667|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259668|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14259669|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14259670|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14259671|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
14259672|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
14259673|NCT00350272|Tenofovir|tenofovir|mesh-list
14259674|NCT00350272|Lamivudine|lamivudine|mesh-list
14259675|NCT00350272|Efavirenz|efavirenz|mesh-list
14259676|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
14259677|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
14259678|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259679|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14259680|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14259681|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259682|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259683|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14259684|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14259685|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14259686|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14259687|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14259688|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14259689|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14259690|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14259691|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
14259692|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14259693|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259694|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
14259695|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14259696|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14259697|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14259698|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259699|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259700|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259701|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
14259702|NCT00350519|Hematinics|hematinics|mesh-ancestor
14259703|NCT00350532|Clonidine|clonidine|mesh-list
14259704|NCT00350532|Analgesics|analgesics|mesh-ancestor
14259705|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
14259706|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259707|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259708|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14259709|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
14259710|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
14259711|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14259712|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14259713|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14259714|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
14259715|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259716|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259717|NCT00350545|Cyclosporine|cyclosporine|mesh-list
14259718|NCT00350545|Prednisone|prednisone|mesh-list
14259719|NCT00350545|Rituximab|rituximab|mesh-list
14259720|NCT00350545|Tacrolimus|tacrolimus|mesh-list
14259721|NCT00350545|Cyclosporins|cyclosporins|mesh-list
14259722|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14259723|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259724|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
14259725|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259726|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14259727|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14259728|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
14259729|NCT00350545|Hormones|hormones|mesh-ancestor
14259730|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259731|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14259732|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14259733|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14259734|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259735|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259736|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
14259737|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259738|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
14259739|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
14259740|NCT00350636|Oxybutynin|oxybutynin|mesh-list
14259741|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
14259742|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
14259743|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259744|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259745|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14259746|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14259747|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
14259748|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259749|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259750|NCT00350636|Urological Agents|urological agents|mesh-ancestor
14259751|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14259752|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259753|NCT00350636|Renal Agents|renal agents|mesh-ancestor
14259754|NCT00350727|Lapatinib|lapatinib|mesh-list
14259755|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259756|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14259757|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259758|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259759|NCT00350779|Metformin|metformin|mesh-list
14259760|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
14259761|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
14259762|NCT00350779|Glipizide|glipizide|mesh-list
14259763|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14259764|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259765|NCT00350779|Incretins|incretins|mesh-ancestor
14259766|NCT00350779|Hormones|hormones|mesh-ancestor
14259767|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259768|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14259769|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
14259770|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259771|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259772|NCT00350792|Carboplatin|carboplatin|mesh-list
14259773|NCT00350792|Pemetrexed|pemetrexed|mesh-list
14259774|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259775|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259776|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259777|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14259778|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14259779|NCT00350870|Disulfiram|disulfiram|mesh-list
14259780|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
14259781|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
14259782|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259783|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259784|NCT00351000|Ziprasidone|ziprasidone|mesh-list
14259785|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14259786|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
14259787|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259788|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259789|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259790|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14259791|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14259792|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14259793|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14259794|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14259795|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
14259796|NCT00351039|Bevacizumab|bevacizumab|mesh-list
14259797|NCT00351039|Pemetrexed|pemetrexed|mesh-list
14259798|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14259799|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14259800|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259801|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14259802|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14259803|NCT00351039|Growth Substances|growth substances|mesh-ancestor
14259804|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259805|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
14259806|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259807|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259808|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14259809|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14259810|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14259811|NCT00351273|Azithromycin|azithromycin|mesh-list
14259812|NCT00351273|Doxycycline|doxycycline|mesh-list
14259813|NCT00351273|Rifampin|rifampin|mesh-list
14259814|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14259815|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259816|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
14259817|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14259818|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14259819|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14259820|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
14259821|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
14259822|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14259823|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259824|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259825|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15042706|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259826|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14259827|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15042707|NCT02045992|Caffeine|caffeine|mesh-list
15042708|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15042709|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042710|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15042711|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042712|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042713|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15042714|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15042715|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
15042716|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042717|NCT02046044|Digoxin|digoxin|mesh-list
15042718|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15042719|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15042720|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042721|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259828|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14259829|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14259830|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14259831|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
14259832|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14259833|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14259834|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259835|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14259836|NCT00351299|Analgesics|analgesics|mesh-ancestor
14259837|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
14259838|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259839|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
14259840|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14259841|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14259842|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
14259843|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259844|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259845|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
14259846|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14259847|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259848|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14259849|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
14259850|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14259851|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259852|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259853|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259854|NCT00351416|Letrozole|letrozole|mesh-list
14259855|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
14259856|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
14259857|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259858|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14259859|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259860|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259861|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14259862|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
14259863|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259864|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259865|NCT00351611|Pregabalin|pregabalin|mesh-list
14259866|NCT00351611|Analgesics|analgesics|mesh-ancestor
14259867|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
14259868|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14259869|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259870|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
14259871|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14259872|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14259873|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259874|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14259875|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14259876|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14259877|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14259878|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14259879|NCT00351819|Testosterone|testosterone|mesh-list
14259880|NCT00351819|Androgens|androgens|mesh-ancestor
14259881|NCT00351819|Hormones|hormones|mesh-ancestor
14259882|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259883|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259884|NCT00351936|Aripiprazole|aripiprazole|mesh-list
14259885|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
14259886|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14259887|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14259888|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14259889|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14259890|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259891|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
14259892|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
14259893|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259894|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259895|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14259896|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14259897|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
14259898|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14259899|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14259900|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14259901|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14259902|NCT00352001|Lenalidomide|lenalidomide|mesh-list
14259903|NCT00352001|Azacitidine|azacitidine|mesh-list
14259904|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
14259905|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259906|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14259907|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14259908|NCT00352001|Growth Substances|growth substances|mesh-ancestor
14259909|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
14259910|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259911|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14259912|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
14259913|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259914|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259915|NCT00352027|Prednisone|prednisone|mesh-list
14259916|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
14259917|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
14259918|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
14259919|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
14259920|NCT00352027|Doxorubicin|doxorubicin|mesh-list
14259921|NCT00352027|Etoposide|etoposide|mesh-list
14259922|NCT00352027|Vincristine|vincristine|mesh-list
14259923|NCT00352027|Bleomycin|bleomycin|mesh-list
14259924|NCT00352027|Vinblastine|vinblastine|mesh-list
14259925|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14259926|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
14259927|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259928|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14259929|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14259930|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
14259931|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259932|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259933|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14259934|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14259935|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14259936|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14259937|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259938|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14259939|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
14259940|NCT00352027|Hormones|hormones|mesh-ancestor
14259941|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14259942|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14259943|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14259944|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
14259945|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
14259946|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
14259947|NCT00352053|Tenofovir|tenofovir|mesh-list
14259948|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
14259949|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259950|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14259951|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14259952|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259953|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259954|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14259955|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14259956|NCT00352105|Fluorouracil|fluorouracil|mesh-list
14259957|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259958|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
14259959|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259960|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14259961|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14259962|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
14259963|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259964|NCT00352365|Lenalidomide|lenalidomide|mesh-list
14259965|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
14259966|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259967|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14259968|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14259969|NCT00352365|Growth Substances|growth substances|mesh-ancestor
14259970|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
14259971|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259972|NCT00352417|Atreleuton|atreleuton|mesh-list
14259973|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14259974|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259975|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259976|NCT00352612|Clindamycin|clindamycin|mesh-list
14259977|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
14259978|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
14259979|NCT00352612|Cephalexin|cephalexin|mesh-list
14259980|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14259981|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14259982|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14259983|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259984|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259985|NCT00352664|Donepezil|donepezil|mesh-list
14259986|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14259987|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14259988|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14259989|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
14259990|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14259991|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14259992|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
14259993|NCT00352690|Paclitaxel|paclitaxel|mesh-list
14259994|NCT00352690|Carboplatin|carboplatin|mesh-list
14259995|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
14259996|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14259997|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14259998|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
14259999|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
14260000|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
14260001|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260002|NCT00352755|Leucovorin|leucovorin|mesh-list
14260003|NCT00352755|Fluorouracil|fluorouracil|mesh-list
14260004|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
14260005|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
14260006|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260007|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14260008|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260009|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260010|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
14260011|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260012|NCT00352755|Antidotes|antidotes|mesh-ancestor
14260013|NCT00352755|Protective Agents|protective agents|mesh-ancestor
14260014|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
14260015|NCT00352755|Vitamins|vitamins|mesh-ancestor
14260016|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
14260017|NCT00352781|Nicotine|nicotine|mesh-list
14260018|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14260019|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
14260020|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260021|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260022|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14260023|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14260024|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
14260025|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260026|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260027|NCT00352794|Prednisone|prednisone|mesh-list
14260028|NCT00352794|Lenalidomide|lenalidomide|mesh-list
14260029|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14260030|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
14260031|NCT00352794|Hormones|hormones|mesh-ancestor
14260032|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14260033|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260034|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14260035|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260036|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
14260037|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14260038|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15042722|NCT02046044|Protective Agents|protective agents|mesh-ancestor
15042723|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042724|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
15042725|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15042726|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042727|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
15042728|NCT02046187|Temozolomide|temozolomide|mesh-list
15042729|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15042730|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
15042731|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042732|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042733|NCT02046304|Gemcitabine|gemcitabine|mesh-list
14260039|NCT00352794|Growth Substances|growth substances|mesh-ancestor
14260040|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
14260041|NCT00352846|Vitamin D|vitamin d|mesh-list
14260042|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
14260043|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
14260044|NCT00352846|Calcium|calcium|mesh-list
14260045|NCT00352846|Vitamins|vitamins|mesh-ancestor
14260046|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
14260047|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260048|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14260049|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14260050|NCT00352846|Antacids|antacids|mesh-ancestor
14260051|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260052|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14260053|NCT00352885|Citalopram|citalopram|mesh-list
14260054|NCT00352885|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14260055|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14260056|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14260057|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260058|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260059|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
14260060|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260061|NCT00352885|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14260062|NCT00352885|Antidepressive Agents|antidepressive agents|mesh-ancestor
14260063|NCT00352885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14260064|NCT00352911|Mifepristone|mifepristone|mesh-list
14260065|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
14260066|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
14260067|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14260068|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260069|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14260070|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14260071|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14260072|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
14260073|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14260074|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14260075|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
14260076|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14260077|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
14260078|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14260079|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
14260080|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
14260081|NCT00352976|Sirolimus|sirolimus|mesh-list
14260082|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
14260083|NCT00352976|Fludarabine|fludarabine|mesh-list
14260084|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260085|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
14260086|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260087|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14260088|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14260089|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
14260090|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260091|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260092|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14260093|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14260094|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14260095|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
14260096|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14260097|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260098|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260099|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
14260100|NCT00353119|Etanercept|etanercept|mesh-list
14260101|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14260102|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14260103|NCT00353119|Analgesics|analgesics|mesh-ancestor
14260104|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
14260105|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260106|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260107|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14260108|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14260109|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14260110|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260111|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
14260112|NCT00353262|Capecitabine|capecitabine|mesh-list
14260113|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
14260114|NCT00353262|Bevacizumab|bevacizumab|mesh-list
14260115|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14260116|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
14260117|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260118|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260119|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14260120|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14260121|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14260122|NCT00353262|Growth Substances|growth substances|mesh-ancestor
14260123|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260124|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
14260125|NCT00353301|Sirolimus|sirolimus|mesh-list
14260126|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14260127|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260128|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14260129|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260130|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260131|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14260132|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260133|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14260134|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
14260135|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260136|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
14260137|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260138|NCT00353418|Ribavirin|ribavirin|mesh-list
14260139|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14260140|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
14260141|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260142|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
14260143|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260144|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
14260145|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14260146|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260147|NCT00353496|Lanreotide|lanreotide|mesh-list
14260148|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260149|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
14260150|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14260151|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14260152|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
14260153|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260154|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14260155|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
14260156|NCT00353652|Spironolactone|spironolactone|mesh-list
14260157|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
14260158|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
14260159|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14260160|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260161|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
14260162|NCT00353652|Diuretics|diuretics|mesh-ancestor
14260163|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
14260164|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14260165|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
14260166|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14260167|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260168|NCT00353704|Pregabalin|pregabalin|mesh-list
14260169|NCT00353704|Morphine|morphine|mesh-list
14260170|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14260171|NCT00353704|Narcotics|narcotics|mesh-ancestor
14260172|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14260173|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260174|NCT00353704|Analgesics|analgesics|mesh-ancestor
14260175|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
14260176|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260177|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
14260178|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14260179|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14260180|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260181|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14260182|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14260183|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14260184|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14260185|NCT00353834|Insulin|insulin|mesh-list
14260186|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14260187|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
14260188|NCT00353834|Exenatide|exenatide|mesh-list
14260189|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14260190|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260191|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14260192|NCT00353834|Incretins|incretins|mesh-ancestor
14260193|NCT00353834|Hormones|hormones|mesh-ancestor
14260194|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14260195|NCT00353873|Fluticasone|fluticasone|mesh-list
14260196|NCT00353873|Xhance|xhance|mesh-list
14260197|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14260198|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14260199|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14260200|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
14260201|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260202|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260203|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14260204|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
14260205|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
14260206|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14260207|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14260208|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14260209|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14260210|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
14260211|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260212|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260213|NCT00353977|Vaccines|vaccines|mesh-list
14260214|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
14260215|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260216|NCT00354029|Ketamine|ketamine|mesh-list
14260217|NCT00354029|Analgesics|analgesics|mesh-ancestor
14260218|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
14260219|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260220|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260221|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14260222|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14260223|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
14260224|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
14260225|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14260226|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14260227|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14260228|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260229|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260230|NCT00354107|Cytarabine|cytarabine|mesh-list
14260231|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
14260232|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
14260233|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
14260234|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
14260235|NCT00354107|Carboplatin|carboplatin|mesh-list
14260236|NCT00354107|Methotrexate|methotrexate|mesh-list
14260237|NCT00354107|Etoposide|etoposide|mesh-list
14260238|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
14260239|NCT00354107|Ifosfamide|ifosfamide|mesh-list
14260240|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
14260241|NCT00354107|Antibodies|antibodies|mesh-list
14260242|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14260243|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
14260244|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260245|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260246|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14260247|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
14260248|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14260249|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14260250|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
14260251|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260252|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
14260253|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260254|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14260255|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260256|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14260257|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14260258|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14260259|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14260260|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14260261|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
14260262|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260263|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14260264|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14260265|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
14260266|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14260267|NCT00354172|Cyclosporine|cyclosporine|mesh-list
14260268|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
14260269|NCT00354172|Aldesleukin|aldesleukin|mesh-list
14260270|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
14260271|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14260272|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14260273|NCT00354172|Prednisolone|prednisolone|mesh-list
14260274|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
14260275|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
14260276|NCT00354172|Fludarabine|fludarabine|mesh-list
14260277|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
14260278|NCT00354172|Interleukin-2|interleukin-2|mesh-list
14260279|NCT00354172|Cyclosporins|cyclosporins|mesh-list
14260280|NCT00354172|Lenograstim|lenograstim|mesh-list
14260281|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14260282|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
14260283|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260284|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
14260285|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260286|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14260287|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14260288|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
14260289|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260290|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260291|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14260292|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14260293|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
14260294|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14260295|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260296|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
14260297|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260298|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
15042734|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15042735|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
15042736|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042737|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042738|NCT02046304|Antiviral Agents|antiviral agents|mesh-ancestor
14260299|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14260300|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14260301|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14260302|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
14260303|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14260304|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14260305|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
14260306|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
14260307|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260308|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14260309|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
14260310|NCT00354172|Hormones|hormones|mesh-ancestor
14260311|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14260312|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14260313|NCT00354172|Protective Agents|protective agents|mesh-ancestor
14260314|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14260315|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14260316|NCT00354172|Analgesics|analgesics|mesh-ancestor
14260317|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
14260318|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14260319|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14260320|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
14260321|NCT00354224|Capecitabine|capecitabine|mesh-list
14260322|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
14260323|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14260324|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
14260325|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260326|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260327|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
14260328|NCT00354341|Hematinics|hematinics|mesh-ancestor
14260329|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14260330|NCT00354432|Caseins|caseins|mesh-list
14260331|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14260332|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14260333|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14260334|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260335|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260336|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260337|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14260338|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
14260339|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14260340|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
14260341|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
14260342|NCT00354601|Docetaxel|docetaxel|mesh-list
14260343|NCT00354601|Capecitabine|capecitabine|mesh-list
14260344|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260345|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
14260346|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
14260347|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
14260348|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260349|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14260350|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
14260351|NCT00354640|Anastrozole|anastrozole|mesh-list
14260352|NCT00354640|Simvastatin|simvastatin|mesh-list
14260353|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14260354|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14260355|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
14260356|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260357|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14260358|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14260359|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260360|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14260361|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260362|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14260363|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14260364|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14260365|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
14260366|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14260367|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260368|NCT00354679|Bevacizumab|bevacizumab|mesh-list
14260369|NCT00354679|Irinotecan|irinotecan|mesh-list
14260370|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14260371|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260372|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14260373|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14260374|NCT00354679|Growth Substances|growth substances|mesh-ancestor
14260375|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260376|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
14260377|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14260378|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14260379|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260380|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260381|NCT00354744|Dactinomycin|dactinomycin|mesh-list
14260382|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
14260383|NCT00354744|Ifosfamide|ifosfamide|mesh-list
14260384|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
14260385|NCT00354744|Doxorubicin|doxorubicin|mesh-list
14260386|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14260387|NCT00354744|Irinotecan|irinotecan|mesh-list
14260388|NCT00354744|Etoposide|etoposide|mesh-list
14260389|NCT00354744|Vincristine|vincristine|mesh-list
14260390|NCT00354744|Camptothecin|camptothecin|mesh-list
14260391|NCT00354744|Lenograstim|lenograstim|mesh-list
14260392|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260393|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
14260394|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260395|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14260396|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14260397|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
14260398|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260399|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260400|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14260401|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14260402|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14260403|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14260404|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260405|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14260406|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14260407|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14260408|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
14260409|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
14260410|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
14260411|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14260412|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260413|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14260414|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14260415|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
14260416|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
14260417|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
14260418|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260419|NCT00354770|Expectorants|expectorants|mesh-ancestor
14260420|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
14260421|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14260422|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
14260423|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260424|NCT00354770|Protective Agents|protective agents|mesh-ancestor
14260425|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260426|NCT00354770|Antidotes|antidotes|mesh-ancestor
14260427|NCT00354887|Capecitabine|capecitabine|mesh-list
14260428|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
14260429|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14260430|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
14260431|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260432|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260433|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
14260434|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
14260435|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260436|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14260437|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260438|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260439|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
14260440|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14260441|NCT00354978|Leucovorin|leucovorin|mesh-list
14260442|NCT00354978|Bevacizumab|bevacizumab|mesh-list
14260443|NCT00354978|Fluorouracil|fluorouracil|mesh-list
14260444|NCT00354978|Irinotecan|irinotecan|mesh-list
15042739|NCT02046304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042740|NCT02046304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042741|NCT02046304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042742|NCT02046304|Immunologic Factors|immunologic factors|mesh-ancestor
15042743|NCT02046304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260445|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14260446|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260447|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14260448|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14260449|NCT00354978|Growth Substances|growth substances|mesh-ancestor
14260450|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260451|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
14260452|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
14260453|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260454|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14260455|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260456|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
14260457|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14260458|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14260459|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260460|NCT00354978|Antidotes|antidotes|mesh-ancestor
14260461|NCT00354978|Protective Agents|protective agents|mesh-ancestor
14260462|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
14260463|NCT00354978|Vitamins|vitamins|mesh-ancestor
14260464|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
14260465|NCT00355030|Leuprolide|leuprolide|mesh-list
14260466|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14260467|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
14260468|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14260469|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260470|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14260471|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260472|NCT00355082|Lamotrigine|lamotrigine|mesh-list
14260473|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
14260474|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14260475|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14260476|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260477|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14260478|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260479|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14260480|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14260481|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14260482|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14260483|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14260484|NCT00355121|Vaccines|vaccines|mesh-list
14260485|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
14260486|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260487|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
14260488|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
14260489|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260490|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260491|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
14260492|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260493|NCT00355199|Rituximab|rituximab|mesh-list
14260494|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14260495|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260496|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
14260497|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260498|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14260499|NCT00355342|Fluticasone|fluticasone|mesh-list
14260500|NCT00355342|Xhance|xhance|mesh-list
14260501|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
14260502|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14260503|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14260504|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
14260505|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260506|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260507|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14260508|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
14260509|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
14260510|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14260511|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14260512|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14260513|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14260514|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
14260515|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260516|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260517|NCT00355368|Rocuronium|rocuronium|mesh-list
14260518|NCT00355368|Succinylcholine|succinylcholine|mesh-list
14260519|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
14260520|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
14260521|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14260522|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260523|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260524|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
14260525|NCT00355394|Metoclopramide|metoclopramide|mesh-list
14260526|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
14260527|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
14260528|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260529|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260530|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14260531|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14260532|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14260533|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
14260534|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260535|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260536|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
14260537|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532819|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532820|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
14532821|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14532822|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14532823|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14532824|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14532825|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
14532826|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
14532827|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
14532828|NCT01935947|Gemcitabine|gemcitabine|mesh-list
14532829|NCT01935947|Azacitidine|azacitidine|mesh-list
14532830|NCT01935947|Docetaxel|docetaxel|mesh-list
14532831|NCT01935947|Irinotecan|irinotecan|mesh-list
14532832|NCT01935947|Pemetrexed|pemetrexed|mesh-list
14532833|NCT01935947|Camptothecin|camptothecin|mesh-list
14532834|NCT01935947|Entinostat|entinostat|mesh-list
14532835|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14532836|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14260538|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
14260539|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14260540|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14260541|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
14260542|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260543|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14260544|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14260545|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260546|NCT00355784|Hormones|hormones|mesh-list
14260547|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14260548|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260549|NCT00356031|Bevacizumab|bevacizumab|mesh-list
14260550|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14260551|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260552|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14260553|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14260554|NCT00356031|Growth Substances|growth substances|mesh-ancestor
14260555|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260556|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
14260557|NCT00356122|Bevacizumab|bevacizumab|mesh-list
14260558|NCT00356122|Docetaxel|docetaxel|mesh-list
14260559|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
14260560|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14260561|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260562|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14260563|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14260564|NCT00356122|Growth Substances|growth substances|mesh-ancestor
14260565|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260566|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
14260567|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
14260568|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
14260569|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
14260570|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260571|NCT00356135|Clopidogrel|clopidogrel|mesh-list
14260572|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14260573|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14260574|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14260575|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14260576|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14260577|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
14260578|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260579|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260580|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260581|NCT00356148|Ampicillin|ampicillin|mesh-list
14260582|NCT00356148|Sulbactam|sulbactam|mesh-list
14260583|NCT00356148|Sultamicillin|sultamicillin|mesh-list
14260584|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14260585|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260586|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14260587|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260588|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260589|NCT00356200|Fluphenazine|fluphenazine|mesh-list
14260590|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
14260591|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
14260592|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14260593|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14260594|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14260595|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260596|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14260597|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14260598|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
14260599|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260600|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260601|NCT00356265|Phenylephrine|phenylephrine|mesh-list
14260602|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
14260603|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14260604|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
14260605|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
14260606|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260607|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260608|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
14260609|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14260610|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
14532837|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
15042744|NCT02046421|Gemcitabine|gemcitabine|mesh-list
14260611|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
14260612|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
14260613|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14260614|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14260615|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
14260616|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260617|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260618|NCT00356265|Protective Agents|protective agents|mesh-ancestor
14260619|NCT00356278|Cycloserine|cycloserine|mesh-list
14260620|NCT00356278|Alprazolam|alprazolam|mesh-list
14260621|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14260622|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260623|NCT00356278|Renal Agents|renal agents|mesh-ancestor
14260624|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14260625|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
14260626|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14260627|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
14260628|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260629|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14260630|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14260631|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260632|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14260633|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14260634|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14260635|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
14260636|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
14260637|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260638|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
14260639|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260640|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
14260641|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260642|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14260643|NCT00356525|Gemcitabine|gemcitabine|mesh-list
14260644|NCT00356525|Carboplatin|carboplatin|mesh-list
14260645|NCT00356525|Pemetrexed|pemetrexed|mesh-list
14260646|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260647|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14260648|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
14260649|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260650|NCT00356525|Antiviral Agents|antiviral agents|mesh-ancestor
14260651|NCT00356525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260652|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260653|NCT00356525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260654|NCT00356525|Immunologic Factors|immunologic factors|mesh-ancestor
14260655|NCT00356525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260656|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14260657|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14260658|NCT00356590|Etanercept|etanercept|mesh-list
14260659|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14260660|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14260661|NCT00356590|Analgesics|analgesics|mesh-ancestor
14260662|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
14260663|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260664|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260665|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14260666|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14260667|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14260668|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260669|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
14260670|NCT00356603|Sumatriptan|sumatriptan|mesh-list
14260671|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14260672|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14260673|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14260674|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
14260675|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260676|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260677|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260678|NCT00356759|Warfarin|warfarin|mesh-list
14260679|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
14260680|NCT00356811|Paclitaxel|paclitaxel|mesh-list
14260681|NCT00356811|Lapatinib|lapatinib|mesh-list
14260682|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14260683|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260684|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
14260685|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
14260686|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
14260687|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260688|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14260689|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260690|NCT00356889|Bevacizumab|bevacizumab|mesh-list
14260691|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14260692|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14260693|NCT00356889|Antibodies|antibodies|mesh-list
14260694|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
14260695|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14260696|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260697|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14260698|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14260699|NCT00356889|Growth Substances|growth substances|mesh-ancestor
14260700|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260701|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
14260702|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
14260703|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14260704|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260705|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260706|NCT00356915|Itraconazole|itraconazole|mesh-list
14260707|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
14260708|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
14260709|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260710|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14260711|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14260712|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260713|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260714|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14260715|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
14260716|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14260717|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260718|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14260719|NCT00356993|Nicotine|nicotine|mesh-list
14260720|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14260721|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
14260722|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260723|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260724|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14260725|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14260726|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
14260727|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260728|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260729|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14260730|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14260731|NCT00357006|Estradiol|estradiol|mesh-list
14260732|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14260733|NCT00357006|Estrogens|estrogens|mesh-ancestor
14260734|NCT00357006|Hormones|hormones|mesh-ancestor
14260735|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14260736|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260737|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14260738|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
14260739|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14260740|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14260741|NCT00357032|Belinostat|belinostat|mesh-list
14260742|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260743|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14260744|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260745|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260746|NCT00357097|Ropinirole|ropinirole|mesh-list
14260747|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14260748|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14260749|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
14260750|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
14260751|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260752|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260753|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260754|NCT00357110|Fulvestrant|fulvestrant|mesh-list
14260755|NCT00357110|Anastrozole|anastrozole|mesh-list
14260756|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14260757|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260758|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
14260759|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14260760|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
14260761|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14260762|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260763|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14260764|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14260765|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260766|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260767|NCT00357162|Belinostat|belinostat|mesh-list
14260768|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260769|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14260770|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260771|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260772|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
14260773|NCT00357331|Diuretics|diuretics|mesh-ancestor
14260774|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
14260775|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260776|NCT00357331|Expectorants|expectorants|mesh-ancestor
14260777|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
14260778|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
14260779|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
14260780|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260781|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14260782|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260783|NCT00357396|Melphalan|melphalan|mesh-list
14260784|NCT00357396|Busulfan|busulfan|mesh-list
14260785|NCT00357396|Thiotepa|thiotepa|mesh-list
14260786|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14260787|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
14260788|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260789|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260790|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14260791|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260792|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
14260793|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260794|NCT00357500|Thalidomide|thalidomide|mesh-list
14260795|NCT00357500|Celecoxib|celecoxib|mesh-list
14260796|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
14260797|NCT00357500|Etoposide|etoposide|mesh-list
14260798|NCT00357500|Fenofibrate|fenofibrate|mesh-list
14260799|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260800|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
14260801|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260802|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14260803|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14260804|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
14260805|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260806|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260807|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14260808|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14260809|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14260810|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14260811|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260812|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14260813|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14260814|NCT00357500|Analgesics|analgesics|mesh-ancestor
14260815|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
14260816|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260817|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14260818|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14260819|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14260820|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
14260821|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14260822|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260823|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14260824|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14260825|NCT00357500|Growth Substances|growth substances|mesh-ancestor
14260826|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
14260827|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14260828|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
14260829|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14260830|NCT00357552|Ritonavir|ritonavir|mesh-list
14260831|NCT00357552|Lopinavir|lopinavir|mesh-list
14260832|NCT00357552|Tenofovir|tenofovir|mesh-list
14260833|NCT00357552|Emtricitabine|emtricitabine|mesh-list
14260834|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
14260835|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14260836|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14260837|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
14260838|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260839|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260840|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14260841|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14260842|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
14260843|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260844|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14260845|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14260846|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14260847|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14260848|NCT00357656|Factor VIII|factor viii|mesh-list
15042745|NCT02046421|Carboplatin|carboplatin|mesh-list
15042746|NCT02046421|Mifepristone|mifepristone|mesh-list
15042747|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042748|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15042749|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
15042750|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042751|NCT02046421|Antiviral Agents|antiviral agents|mesh-ancestor
15042752|NCT02046421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042753|NCT02046421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042754|NCT02046421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042755|NCT02046421|Immunologic Factors|immunologic factors|mesh-ancestor
14260849|NCT00357656|Coagulants|coagulants|mesh-ancestor
14260850|NCT00357734|Gefitinib|gefitinib|mesh-list
14260851|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260852|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14260853|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260854|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260855|NCT00357760|Aflibercept|aflibercept|mesh-list
14260856|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
14260857|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14260858|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14260859|NCT00357760|Growth Substances|growth substances|mesh-ancestor
14260860|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260861|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
14260862|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260863|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
14260864|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
14260865|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
14260866|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260867|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
14260868|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
14260869|NCT00357903|Etanercept|etanercept|mesh-list
14260870|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14260871|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14260872|NCT00357903|Analgesics|analgesics|mesh-ancestor
14260873|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
14260874|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260875|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260876|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14260877|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14260878|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14260879|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260880|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
14260881|NCT00357968|Clopidogrel|clopidogrel|mesh-list
14260882|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
14260883|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14260884|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
14260885|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
14260886|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14260887|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
14260888|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260889|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260890|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260891|NCT00357994|Levodopa|levodopa|mesh-list
14260892|NCT00357994|Carbidopa|carbidopa|mesh-list
14260893|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
14260894|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
14260895|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
14260896|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
14260897|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042756|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260898|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260899|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260900|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
14260901|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260902|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14260903|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
14260904|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
14260905|NCT00358150|Eliglustat|eliglustat|mesh-list
14260906|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260907|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260908|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
14260909|NCT00358215|Hematinics|hematinics|mesh-ancestor
14260910|NCT00358436|Bromides|bromides|mesh-list
14260911|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
14260912|NCT00358462|Azithromycin|azithromycin|mesh-list
14260913|NCT00358462|Doxycycline|doxycycline|mesh-list
14260914|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14260915|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260916|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
14260917|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14260918|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14260919|NCT00358501|Defibrotide|defibrotide|mesh-list
14260920|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14260921|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14260922|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260923|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14260924|NCT00358579|Vasopressins|vasopressins|mesh-list
14260925|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
14260926|NCT00358579|Epinephrine|epinephrine|mesh-list
14260927|NCT00358579|Racepinephrine|racepinephrine|mesh-list
14260928|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
14260929|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260930|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14260931|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14260932|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
14260933|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14260934|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260935|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14260936|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14260937|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
14260938|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14260939|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14260940|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
14260941|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
14260942|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
14260943|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14260944|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
14260945|NCT00358579|Coagulants|coagulants|mesh-ancestor
14260946|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
14260947|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
14260948|NCT00358644|Decitabine|decitabine|mesh-list
14260949|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14260950|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
14260951|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260952|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260953|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260954|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
14260955|NCT00358657|Sirolimus|sirolimus|mesh-list
14260956|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
14260957|NCT00358657|Fludarabine|fludarabine|mesh-list
14260958|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
14260959|NCT00358657|Tacrolimus|tacrolimus|mesh-list
14260960|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14260961|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
14260962|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14260963|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14260964|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14260965|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
14260966|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260967|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14260968|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14260969|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14260970|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
14260971|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14260972|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260973|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14260974|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14260975|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
14260976|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14260977|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14260978|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
14260979|NCT00358670|Infliximab|infliximab|mesh-list
14260980|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
14260981|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14260982|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14260983|NCT00358735|Enoxaparin|enoxaparin|mesh-list
14260984|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
14260985|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14260986|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14260987|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260988|NCT00358826|Atreleuton|atreleuton|mesh-list
14260989|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
14260990|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260991|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14260992|NCT00358917|Ritonavir|ritonavir|mesh-list
14260993|NCT00358917|Lopinavir|lopinavir|mesh-list
14260994|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
14260995|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14260996|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14260997|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
14260998|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14260999|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261000|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14261001|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14261002|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
14261003|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14261004|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14261005|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14261006|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14261007|NCT00359021|Etravirine|etravirine|mesh-list
14261008|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14261009|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14261010|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261011|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261012|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
14261013|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14261014|NCT00359073|Montelukast|montelukast|mesh-list
14261015|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14261016|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
14261017|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
14261018|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
14261019|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14261020|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261021|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
14261022|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14261023|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261024|NCT00359281|Niacin|niacin|mesh-list
14261025|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
14261026|NCT00359281|Atorvastatin|atorvastatin|mesh-list
14261027|NCT00359281|Simvastatin|simvastatin|mesh-list
14261028|NCT00359281|Ezetimibe|ezetimibe|mesh-list
14261029|NCT00359281|Fenofibrate|fenofibrate|mesh-list
14261030|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14261031|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14261032|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
14261033|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261034|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14261035|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14261036|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261037|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
14261038|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
14261039|NCT00359281|Vitamins|vitamins|mesh-ancestor
14261040|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
14261041|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261042|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
14261043|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
14261044|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14261045|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14261046|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261047|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14261048|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14261049|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14261050|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261051|NCT00359632|Linezolid|linezolid|mesh-list
14261052|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14261053|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14261054|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14261055|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261056|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261057|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
14261058|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
14261059|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14261060|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14261061|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14261062|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261063|NCT00359736|Urological Agents|urological agents|mesh-ancestor
14261064|NCT00359762|Exenatide|exenatide|mesh-list
14261065|NCT00359762|Glimepiride|glimepiride|mesh-list
14261066|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14261067|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261068|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14261069|NCT00359762|Incretins|incretins|mesh-ancestor
14261070|NCT00359762|Hormones|hormones|mesh-ancestor
14261071|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14261072|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14261073|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14261074|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
14261075|NCT00359788|Albuterol|albuterol|mesh-list
14261076|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
14261077|NCT00359788|Ipratropium|ipratropium|mesh-list
14261078|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14261079|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
14261080|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14261081|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14261082|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14261083|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
14261084|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
14261085|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14261086|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
14261087|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14261088|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14261089|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
14261090|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14261091|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
14261092|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14261093|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14261094|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
14532838|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532839|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532840|NCT01935947|Antiviral Agents|antiviral agents|mesh-ancestor
14532841|NCT01935947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532842|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532843|NCT01935947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532844|NCT01935947|Immunologic Factors|immunologic factors|mesh-ancestor
14532845|NCT01935947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532846|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
14532847|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
14532848|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
14532849|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14532850|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14532851|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14532852|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14532853|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14532854|NCT01938716|Gemcitabine|gemcitabine|mesh-list
14532855|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14532856|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
14532857|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532858|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532859|NCT01938716|Antiviral Agents|antiviral agents|mesh-ancestor
14532860|NCT01938716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532861|NCT01938716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532862|NCT01938716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532863|NCT01938716|Immunologic Factors|immunologic factors|mesh-ancestor
14532864|NCT01938716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532865|NCT01936974|Gemcitabine|gemcitabine|mesh-list
14532866|NCT01936974|Bevacizumab|bevacizumab|mesh-list
14532867|NCT01936974|Carboplatin|carboplatin|mesh-list
14532868|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
14532869|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14532870|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532871|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14532872|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14532873|NCT01936974|Growth Substances|growth substances|mesh-ancestor
14532874|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532875|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
14532876|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14532877|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
14532878|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532879|NCT01936974|Antiviral Agents|antiviral agents|mesh-ancestor
14532880|NCT01936974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14532881|NCT01936974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532882|NCT01936974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532883|NCT01936974|Immunologic Factors|immunologic factors|mesh-ancestor
14532884|NCT01938833|Paclitaxel|paclitaxel|mesh-list
14532885|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14532886|NCT01938833|Romidepsin|romidepsin|mesh-list
14532887|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14532888|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532889|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
14532890|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
14532891|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
14532892|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532893|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15042757|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15042758|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
15042759|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15042760|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15042761|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15042762|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15042763|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
15042764|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15042765|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15042766|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
15042767|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042768|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
15042769|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15042770|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15042771|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
15042772|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15042773|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15042774|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15042775|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15042776|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
15042777|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042778|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042779|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042780|NCT02046460|Aspirin|aspirin|mesh-list
15042781|NCT02046460|Vitamin K|vitamin k|mesh-list
15042782|NCT02046460|Warfarin|warfarin|mesh-list
15042783|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
15042784|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
15042785|NCT02046460|Vitamins|vitamins|mesh-ancestor
15042786|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
15042787|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042788|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
15042789|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15042790|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15042791|NCT02046460|Analgesics|analgesics|mesh-ancestor
15042792|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
15042793|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042794|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15042795|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15042796|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15042797|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15042798|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042799|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15042800|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15042801|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042802|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
15042803|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15042804|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
15042805|NCT02046460|Coagulants|coagulants|mesh-ancestor
14532894|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14532895|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14532896|NCT01928082|Estradiol|estradiol|mesh-list
14532897|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14532898|NCT01928082|Estrogens|estrogens|mesh-ancestor
14532899|NCT01928082|Hormones|hormones|mesh-ancestor
14532900|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14532901|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532902|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14532903|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
14532904|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14532905|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14532906|NCT01928615|Trastuzumab|trastuzumab|mesh-list
14532907|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14532908|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14532909|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14532910|NCT01910389|Tadalafil|tadalafil|mesh-list
14532911|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
14532912|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14532913|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14532914|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532915|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532916|NCT01910389|Urological Agents|urological agents|mesh-ancestor
14532917|NCT01916590|Bupivacaine|bupivacaine|mesh-list
14532918|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
14532919|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
14532920|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532921|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532922|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
14532923|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532924|NCT01913327|Risperidone|risperidone|mesh-list
14532925|NCT01913327|Aripiprazole|aripiprazole|mesh-list
14532926|NCT01913327|Modafinil|modafinil|mesh-list
14532927|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14532928|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
14532929|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532930|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532931|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532932|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14532933|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14532934|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532935|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14532936|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14532937|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
14532938|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
14532939|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
14532940|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14532941|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14532942|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14532943|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14532944|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14532945|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14532946|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14532947|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14532948|NCT01901224|Metformin|metformin|mesh-list
15042806|NCT02046486|Ticagrelor|ticagrelor|mesh-list
15042807|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15042808|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15042809|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15042810|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15042811|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
15042812|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042813|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042814|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042815|NCT02046499|Oxytocin|oxytocin|mesh-list
15042816|NCT02046499|Ergonovine|ergonovine|mesh-list
15042817|NCT02046499|Syntometrine|syntometrine|mesh-list
15042818|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
15042819|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15042820|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042821|NCT02046538|Leucovorin|leucovorin|mesh-list
15042822|NCT02046538|Fluorouracil|fluorouracil|mesh-list
15042823|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
14532949|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14532950|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532951|NCT01910441|Metformin|metformin|mesh-list
14532952|NCT01910441|Glimepiride|glimepiride|mesh-list
14532953|NCT01910441|Vildagliptin|vildagliptin|mesh-list
14532954|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14532955|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532956|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14532957|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14532958|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
14532959|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14532960|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
14532961|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532962|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532963|NCT01902966|Propranolol|propranolol|mesh-list
14532964|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14532965|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14532966|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
14532967|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532968|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532969|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532970|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14532971|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14532972|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
14532973|NCT01901679|Celecoxib|celecoxib|mesh-list
14532974|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14532975|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14532976|NCT01901679|Analgesics|analgesics|mesh-ancestor
14532977|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
14532978|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14532979|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532980|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14532981|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14532982|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14532983|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14532984|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532985|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532986|NCT01900730|Valproic Acid|valproic acid|mesh-list
14532987|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
14532988|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14532989|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14532990|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
14532991|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14532992|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14532993|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
14532994|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14532995|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14532996|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14532997|NCT01877564|Metformin|metformin|mesh-list
14532998|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14532999|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533000|NCT01890694|Tolvaptan|tolvaptan|mesh-list
14533001|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
14533002|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533003|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
14533004|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533005|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
14533006|NCT01890577|Hematinics|hematinics|mesh-ancestor
14533007|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
14533008|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14533009|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
14533010|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533011|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
14533012|NCT01895959|Protective Agents|protective agents|mesh-ancestor
14533013|NCT01889420|Everolimus|everolimus|mesh-list
14533014|NCT01889420|Pomalidomide|pomalidomide|mesh-list
14533015|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533016|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533017|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
14533018|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533019|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14533020|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14533021|NCT01889420|Growth Substances|growth substances|mesh-ancestor
14533022|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
14533023|NCT01881984|Glycerol|glycerol|mesh-list
14533024|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
14533025|NCT01881984|Protective Agents|protective agents|mesh-ancestor
14533026|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533027|NCT01893359|Riboflavin|riboflavin|mesh-list
14533028|NCT01893359|Dextrans|dextrans|mesh-list
14533029|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14533030|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14533031|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
14533032|NCT01893359|Vitamins|vitamins|mesh-ancestor
14533033|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
14533034|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533035|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14533036|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
14533037|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
14533038|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
14533039|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
14533040|NCT01887288|Capecitabine|capecitabine|mesh-list
14533041|NCT01887288|Digoxin|digoxin|mesh-list
14533042|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14533043|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
14533044|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533045|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533046|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14533047|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
14533048|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533049|NCT01887288|Protective Agents|protective agents|mesh-ancestor
14533050|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533051|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
14533052|NCT01878786|Everolimus|everolimus|mesh-list
14533053|NCT01878786|Tacrolimus|tacrolimus|mesh-list
14533054|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533055|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
14533056|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533057|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14533058|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533059|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533060|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533061|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14533062|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14533063|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
14533064|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14533065|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14533066|NCT01861717|Lanreotide|lanreotide|mesh-list
14533067|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533068|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
14533069|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
14533070|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
14533071|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533072|NCT01860040|Gemcitabine|gemcitabine|mesh-list
14533073|NCT01860040|Pemetrexed|pemetrexed|mesh-list
14533074|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533075|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14533076|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
14533077|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533078|NCT01860040|Antiviral Agents|antiviral agents|mesh-ancestor
14533079|NCT01860040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14533080|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533081|NCT01860040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533082|NCT01860040|Immunologic Factors|immunologic factors|mesh-ancestor
14533083|NCT01860040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533084|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14533085|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14533086|NCT01851174|Gemcitabine|gemcitabine|mesh-list
14533087|NCT01851174|Paclitaxel|paclitaxel|mesh-list
14533088|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14533089|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533090|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
14533091|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
14533092|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
14533093|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533094|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14533095|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
14533096|NCT01851174|Antiviral Agents|antiviral agents|mesh-ancestor
14533097|NCT01851174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14533098|NCT01851174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533099|NCT01851174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533100|NCT01851174|Immunologic Factors|immunologic factors|mesh-ancestor
14533101|NCT01851174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533102|NCT01846182|Pregabalin|pregabalin|mesh-list
14533103|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14533104|NCT01846182|Analgesics|analgesics|mesh-ancestor
14533105|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
14533106|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533107|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533108|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
14533109|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14533110|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14533111|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533112|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14533113|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14533114|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14533115|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533116|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14533117|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14533118|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14533119|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533120|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
14533121|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
14533122|NCT01844206|Morphine|morphine|mesh-list
14533123|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14533124|NCT01844206|Narcotics|narcotics|mesh-ancestor
14533125|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533126|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533127|NCT01844206|Analgesics|analgesics|mesh-ancestor
14533128|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
14533129|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533130|NCT01856322|Sulindac|sulindac|mesh-list
14533131|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14533132|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14533133|NCT01856322|Analgesics|analgesics|mesh-ancestor
14533134|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
14533135|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533136|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533137|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14533138|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14533139|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533140|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14533141|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533142|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533143|NCT01853176|Bupivacaine|bupivacaine|mesh-list
14533144|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
14533145|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
14533146|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533147|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533148|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
14533149|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533150|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14533151|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533152|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14533153|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533154|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533155|NCT01856361|Ramipril|ramipril|mesh-list
14533156|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
14533157|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
14533158|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533159|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533160|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14533161|NCT01853982|Tazobactam|tazobactam|mesh-list
14533162|NCT01853982|Piperacillin|piperacillin|mesh-list
14533163|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
14533164|NCT01853982|Ceftolozane|ceftolozane|mesh-list
14533165|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
14533166|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14533167|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14533168|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
14533169|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533170|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533171|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
14533172|NCT01853982|Renal Agents|renal agents|mesh-ancestor
14533173|NCT01841931|Buprenorphine|buprenorphine|mesh-list
14533174|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
14533175|NCT01841931|Naloxone|naloxone|mesh-list
14533176|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14533177|NCT01841931|Narcotics|narcotics|mesh-ancestor
14533178|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533179|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533180|NCT01841931|Analgesics|analgesics|mesh-ancestor
14533181|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
14533182|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533183|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14533184|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
14533185|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
14533186|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533187|NCT01821963|Interferons|interferons|mesh-list
14533188|NCT01821963|Ribavirin|ribavirin|mesh-list
14533189|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
14533190|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
14533191|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14533192|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533193|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
14533194|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14533195|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
14533196|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533197|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
14533198|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533199|NCT01821898|Budesonide|budesonide|mesh-list
14533200|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14533201|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14533202|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
14533203|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533204|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533205|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14533206|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
14533207|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
14533208|NCT01821898|Hormones|hormones|mesh-ancestor
14533209|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14533210|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
14533211|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533212|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
14533213|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14533214|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14533215|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533216|NCT01830790|Urological Agents|urological agents|mesh-ancestor
14533217|NCT01829477|Glimepiride|glimepiride|mesh-list
14533218|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14533219|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14533220|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533221|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533222|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
14533223|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
14533224|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14533225|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14533226|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14533227|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533228|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533229|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533230|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
14533231|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14533232|NCT01821859|Bevacizumab|bevacizumab|mesh-list
14533233|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14533234|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14533235|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533236|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14533237|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14533238|NCT01821859|Growth Substances|growth substances|mesh-ancestor
14533239|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533240|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
14533241|NCT01810302|Nicardipine|nicardipine|mesh-list
14533242|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14533243|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14533244|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14533245|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533246|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14533247|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533248|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
14533249|NCT01804166|Golimumab|golimumab|mesh-list
14533250|NCT01804166|Infliximab|infliximab|mesh-list
14533251|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
14533252|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14533253|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14533254|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
14533255|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14533256|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533257|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
14533258|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533259|NCT01783015|Etanercept|etanercept|mesh-list
14533260|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14533261|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14533262|NCT01783015|Analgesics|analgesics|mesh-ancestor
14533263|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
14533264|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533265|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533266|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14533267|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14533268|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14533269|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533270|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
14533271|NCT01800162|Methotrexate|methotrexate|mesh-list
14533272|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14533273|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
14533274|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14533275|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533276|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14533277|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
14533278|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533279|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533280|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
14533281|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533282|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14533283|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533284|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
14533285|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14533286|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14533287|NCT01797380|Citalopram|citalopram|mesh-list
14533288|NCT01797380|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
14533289|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14533290|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14533291|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533292|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533293|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
14533294|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533295|NCT01797380|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14533296|NCT01797380|Antidepressive Agents|antidepressive agents|mesh-ancestor
14533297|NCT01797380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14533298|NCT01781026|Vemurafenib|vemurafenib|mesh-list
14533299|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533300|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14533301|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533302|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533303|NCT01788475|Dexamethasone|dexamethasone|mesh-list
14533304|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
14533305|NCT01788475|BB 1101|bb 1101|mesh-list
14533306|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14533307|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
14533308|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
14533309|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533310|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533311|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14533312|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
14533313|NCT01788475|Hormones|hormones|mesh-ancestor
14533314|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14533315|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14533316|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533317|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
14533318|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533319|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533320|NCT01784991|Morphine|morphine|mesh-list
14533321|NCT01784991|Hydromorphone|hydromorphone|mesh-list
14533322|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14533323|NCT01784991|Narcotics|narcotics|mesh-ancestor
14533324|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533325|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533326|NCT01784991|Analgesics|analgesics|mesh-ancestor
14533327|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
14533328|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533329|NCT01777854|Omeprazole|omeprazole|mesh-list
14533330|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
14533331|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14533332|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
14533333|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533334|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533335|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14533336|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14533337|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533338|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14533339|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14533340|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14533341|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533342|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
14533343|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533344|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
14533345|NCT01772719|Simvastatin|simvastatin|mesh-list
14533346|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14533347|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14533348|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
14533349|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533350|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14533351|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14533352|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533353|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14533354|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533355|NCT01764997|Adalimumab|adalimumab|mesh-list
14533356|NCT01764997|Etanercept|etanercept|mesh-list
14533357|NCT01764997|Methotrexate|methotrexate|mesh-list
14533358|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
14533359|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
14533360|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14533361|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533362|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14533363|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
14533364|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533365|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533366|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
14533367|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533368|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14533369|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533370|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
14533371|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14533372|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14533373|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14533374|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14533375|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14533376|NCT01764997|Analgesics|analgesics|mesh-ancestor
14533377|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
14533378|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533379|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14533380|NCT01769443|Bortezomib|bortezomib|mesh-list
14533381|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533382|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14533383|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14533384|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533385|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14533386|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14533387|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14533388|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533389|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
14533390|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533391|NCT01749826|Morphine|morphine|mesh-list
14533392|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14533393|NCT01749826|Narcotics|narcotics|mesh-ancestor
14533394|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533395|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533396|NCT01749826|Analgesics|analgesics|mesh-ancestor
14533397|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
14533398|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533399|NCT01756586|Dexamethasone|dexamethasone|mesh-list
14533400|NCT01756586|Bupivacaine|bupivacaine|mesh-list
14533401|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14533402|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
14533403|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
14533404|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533405|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533406|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14533407|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
14533408|NCT01756586|Hormones|hormones|mesh-ancestor
14533409|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14533410|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14533411|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533412|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
14533413|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
14533414|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533415|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
14533416|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
14533417|NCT01754987|Sorafenib|sorafenib|mesh-list
14533418|NCT01754987|Vitamins|vitamins|mesh-ancestor
14533419|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
14533420|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533421|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533422|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14533423|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533424|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533425|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
14533426|NCT01754987|Protective Agents|protective agents|mesh-ancestor
14533427|NCT01756560|Bupivacaine|bupivacaine|mesh-list
14533428|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
14533429|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
14533430|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533431|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533432|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
14533433|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533434|NCT01756573|Bupivacaine|bupivacaine|mesh-list
14533435|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
14533436|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
14533437|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533438|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533439|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
14533440|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533441|NCT01745913|Fludarabine|fludarabine|mesh-list
14533442|NCT01745913|Melphalan|melphalan|mesh-list
14533443|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
14533444|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533445|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533446|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533447|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
14533448|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533449|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14533450|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
14533451|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14533452|NCT01752023|Gemcitabine|gemcitabine|mesh-list
14533453|NCT01752023|Itraconazole|itraconazole|mesh-list
14533454|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
14533455|NCT01752023|Cisplatin|cisplatin|mesh-list
14533456|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533457|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14533458|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
14533459|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533460|NCT01752023|Antiviral Agents|antiviral agents|mesh-ancestor
14533461|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14533462|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533463|NCT01752023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533464|NCT01752023|Immunologic Factors|immunologic factors|mesh-ancestor
14533465|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533466|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
14533467|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14533468|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14533469|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14533470|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
14533471|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14533472|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14533473|NCT01740154|Sunitinib|sunitinib|mesh-list
14533474|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533475|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14533476|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14533477|NCT01740154|Growth Substances|growth substances|mesh-ancestor
14533478|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533479|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
14533480|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14533481|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533482|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533483|NCT01748162|Fluticasone|fluticasone|mesh-list
14533484|NCT01748162|Prednisolone|prednisolone|mesh-list
14533485|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14533486|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14533487|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
14533488|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533489|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533490|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14533491|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
14533492|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
14533493|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14533494|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
14533495|NCT01748162|Hormones|hormones|mesh-ancestor
14533496|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14533497|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14533498|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533499|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
14533500|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14533501|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533502|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14533503|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14533504|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14533505|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533506|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
14533507|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533508|NCT01732926|Rituximab|rituximab|mesh-list
14533509|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14533510|NCT01732926|Idelalisib|idelalisib|mesh-list
14533511|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14533512|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533513|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
14533514|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533515|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14533516|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14533517|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
14533518|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533519|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533520|NCT01732913|Rituximab|rituximab|mesh-list
14533521|NCT01732913|Idelalisib|idelalisib|mesh-list
14533522|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14533523|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533524|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
14533525|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533526|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14533527|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533528|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533529|NCT01716052|Ibuprofen|ibuprofen|mesh-list
14533530|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14533531|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14533532|NCT01716052|Analgesics|analgesics|mesh-ancestor
14533533|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
14533534|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533535|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533536|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14533537|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14533538|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14533539|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533540|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533541|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14533542|NCT01718444|Clomiphene|clomiphene|mesh-list
14533543|NCT01718444|Enclomiphene|enclomiphene|mesh-list
14533544|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
14533545|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
14533546|NCT01718444|Progestins|progestins|mesh-list
14533547|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14533548|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
14533549|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14533550|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533551|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14533552|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
14533553|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14533554|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14533555|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14533556|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14533557|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14533558|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14533559|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
14533560|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14533561|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14533562|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14533563|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14533564|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533565|NCT01718444|Hormones|hormones|mesh-ancestor
14533566|NCT01712854|Budesonide|budesonide|mesh-list
14533567|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
14533568|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14533569|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14533570|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
14533571|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533572|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533573|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14533574|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
14533575|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
14533576|NCT01712854|Hormones|hormones|mesh-ancestor
14533577|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14533578|NCT01717482|Metformin|metformin|mesh-list
14533579|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14533580|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533581|NCT01702896|Interleukin-2|interleukin-2|mesh-list
14533582|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533583|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14533584|NCT01702896|Analgesics|analgesics|mesh-ancestor
14533585|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
14533586|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533587|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533588|NCT01709136|Sirolimus|sirolimus|mesh-list
14533589|NCT01709136|Tacrolimus|tacrolimus|mesh-list
14533590|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533591|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
14533592|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533593|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14533594|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533595|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533596|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14533597|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14533598|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14533599|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533600|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
14533601|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
14533602|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14533603|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
14533604|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533605|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533606|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14533607|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
14533608|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
14533609|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14533610|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
14533611|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533612|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533613|NCT01705106|Celecoxib|celecoxib|mesh-list
14533614|NCT01705106|Capecitabine|capecitabine|mesh-list
14533615|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14533616|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
14533617|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533618|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533619|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14533620|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14533621|NCT01705106|Analgesics|analgesics|mesh-ancestor
14533622|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
14533623|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533624|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533625|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14533626|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14533627|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14533628|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14533629|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533630|NCT01702909|Interleukin-2|interleukin-2|mesh-list
14533631|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533632|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14533633|NCT01702909|Analgesics|analgesics|mesh-ancestor
14533634|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
14533635|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533636|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042824|NCT02046538|Irinotecan|irinotecan|mesh-list
15042825|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
15042826|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042827|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15042828|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042829|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042830|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
15042831|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042832|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15042833|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15042834|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042835|NCT02046538|Antidotes|antidotes|mesh-ancestor
15042836|NCT02046538|Protective Agents|protective agents|mesh-ancestor
15042837|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
15042838|NCT02046538|Vitamins|vitamins|mesh-ancestor
15042839|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
15042840|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15042841|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15042842|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15042843|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15042844|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042845|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
15042846|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042847|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042848|NCT02046577|Vitamin D|vitamin d|mesh-list
15042849|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
15042850|NCT02046577|Vitamins|vitamins|mesh-ancestor
15042851|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
15042852|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042853|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15042854|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15042855|NCT02046590|Propofol|propofol|mesh-list
15042856|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
15042857|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15042858|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042859|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15042860|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15042861|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
15042862|NCT02046629|Teriflunomide|teriflunomide|mesh-list
15042863|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
15042864|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15042865|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15042866|NCT02046629|Analgesics|analgesics|mesh-ancestor
15042867|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
15042868|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042869|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042870|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15042871|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15042872|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042873|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
15042874|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15042875|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15042876|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
15042877|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042878|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15042879|NCT02046668|Spironolactone|spironolactone|mesh-list
15042880|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15042881|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
15042882|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14533637|NCT01701622|Febuxostat|febuxostat|mesh-list
14533638|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
14533639|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14533640|NCT01697800|Tadalafil|tadalafil|mesh-list
14533641|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
14533642|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14533643|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14533644|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533645|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533646|NCT01697800|Urological Agents|urological agents|mesh-ancestor
14533647|NCT01692691|Dacarbazine|dacarbazine|mesh-list
14533648|NCT01692691|Carmustine|carmustine|mesh-list
14533649|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14533650|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
14533651|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533652|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533653|NCT01691079|Bromides|bromides|mesh-list
14533654|NCT01691079|Ipratropium|ipratropium|mesh-list
14533655|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
14533656|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14533657|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
14533658|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533659|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533660|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14533661|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
14533662|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14533663|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
14533664|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533665|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533666|NCT01689974|Ipilimumab|ipilimumab|mesh-list
14533667|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14533668|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533669|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
14533670|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533671|NCT01663285|Gemcitabine|gemcitabine|mesh-list
14533672|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533673|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14533674|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
14533675|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533676|NCT01663285|Antiviral Agents|antiviral agents|mesh-ancestor
14533677|NCT01663285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14533678|NCT01663285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533679|NCT01663285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533680|NCT01663285|Immunologic Factors|immunologic factors|mesh-ancestor
14533681|NCT01663285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533682|NCT01683864|Cisplatin|cisplatin|mesh-list
14533683|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533684|NCT01673061|Lidocaine|lidocaine|mesh-list
14533685|NCT01673061|Epinephrine|epinephrine|mesh-list
14533686|NCT01673061|Norflurane|norflurane|mesh-list
14533687|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
14533688|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
14533689|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533690|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533691|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
14533692|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533693|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14533694|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14533695|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14533696|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14533697|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533698|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
14533699|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14533700|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
14533701|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533702|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14533703|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
14533704|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
14533705|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
14533706|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
14533707|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
14533708|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
14533709|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
14533710|NCT01675960|Gabapentin|gabapentin|mesh-list
14533711|NCT01675960|Analgesics|analgesics|mesh-ancestor
14533712|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
14533713|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533714|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533715|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
14533716|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14533717|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14533718|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533719|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14533720|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14533721|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14533722|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533723|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533724|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
14533725|NCT01668147|Ritonavir|ritonavir|mesh-list
14533726|NCT01668147|Efavirenz|efavirenz|mesh-list
14533727|NCT01668147|Loperamide|loperamide|mesh-list
14533728|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
14533729|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14533730|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14533731|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
14533732|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533733|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533734|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14533735|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14533736|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
14533737|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14533738|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14533739|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14533740|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14533741|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14533742|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14533743|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14533744|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14533745|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14533746|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14533747|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14533748|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14533749|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
14533750|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533751|NCT01662102|Rituximab|rituximab|mesh-list
14533752|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14533753|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533754|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
14533755|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533756|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14533757|NCT01659554|Cisplatin|cisplatin|mesh-list
14533758|NCT01659554|Doxorubicin|doxorubicin|mesh-list
14533759|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
14533760|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533761|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14533762|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14533763|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14533764|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533765|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533766|NCT01658813|Interferons|interferons|mesh-list
14533767|NCT01658813|Fluorouracil|fluorouracil|mesh-list
14533768|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
14533769|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533770|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14533771|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533772|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533773|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
14533774|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533775|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
14533776|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14533777|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
14533778|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
14533779|NCT01649505|Coagulants|coagulants|mesh-ancestor
14533780|NCT01642732|Everolimus|everolimus|mesh-list
14533781|NCT01642732|Leuprolide|leuprolide|mesh-list
14533782|NCT01642732|Bicalutamide|bicalutamide|mesh-list
14533783|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533784|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533785|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
14533786|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533787|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14533788|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
14533789|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14533790|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14533791|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
14533792|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
14533793|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14533794|NCT01645709|Verapamil|verapamil|mesh-list
14533795|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14533796|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14533797|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14533798|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533799|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14533800|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533801|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
14533802|NCT01648270|Buprenorphine|buprenorphine|mesh-list
14533803|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14533804|NCT01648270|Narcotics|narcotics|mesh-ancestor
14533805|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533806|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533807|NCT01648270|Analgesics|analgesics|mesh-ancestor
14533808|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
14533809|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533810|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14533811|NCT01633814|Estradiol|estradiol|mesh-list
14533812|NCT01633814|Estrogens|estrogens|mesh-ancestor
14533813|NCT01633814|Hormones|hormones|mesh-ancestor
14533814|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14533815|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533816|NCT01636466|Everolimus|everolimus|mesh-list
14533817|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533818|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533819|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
14533820|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533821|NCT01629329|Aspirin|aspirin|mesh-list
14533822|NCT01629329|Acetaminophen|acetaminophen|mesh-list
14533823|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
14533824|NCT01629329|Caffeine|caffeine|mesh-list
14533825|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14533826|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14533827|NCT01629329|Analgesics|analgesics|mesh-ancestor
14533828|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
14533829|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533830|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533831|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14533832|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14533833|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14533834|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14533835|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533836|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14533837|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14533838|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533839|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
14533840|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14533841|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14533842|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
14533843|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
14533844|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
14533845|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533846|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
14533847|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
14533848|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14533849|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14533850|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14533851|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533852|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14533853|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14533854|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
14533855|NCT01632020|Metformin|metformin|mesh-list
14533856|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14533857|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533858|NCT01608906|Heparin|heparin|mesh-list
14533859|NCT01608906|Calcium heparin|calcium heparin|mesh-list
14533860|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
14533861|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14533862|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14533863|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533864|NCT01621737|Oxytocin|oxytocin|mesh-list
14533865|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
14533866|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14533867|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533868|NCT01614067|Ganirelix|ganirelix|mesh-list
14533869|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
14533870|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14533871|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533872|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
14533873|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
14533874|NCT01607320|Clomiphene|clomiphene|mesh-list
14533875|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
14533876|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14533877|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
14533878|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14533879|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533880|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14533881|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
14533882|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14533883|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14533884|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14533885|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14533886|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14533887|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
14533888|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14533889|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
14533890|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14533891|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533892|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14533893|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14533894|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14533895|NCT01609231|Irinotecan|irinotecan|mesh-list
14533896|NCT01609231|Cetuximab|cetuximab|mesh-list
14533897|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14533898|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14533899|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533900|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533901|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533902|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14533903|NCT01602198|Rivastigmine|rivastigmine|mesh-list
14533904|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14533905|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533906|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533907|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
14533908|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533909|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533910|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14533911|NCT01602198|Protective Agents|protective agents|mesh-ancestor
14533912|NCT01606150|Lidocaine|lidocaine|mesh-list
14533913|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
14533914|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
14533915|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533916|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533917|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
14533918|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533919|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14533920|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14533921|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14533922|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14533923|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533924|NCT01605370|Metoprolol|metoprolol|mesh-list
14533925|NCT01605370|Nebivolol|nebivolol|mesh-list
14533926|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14533927|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14533928|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
14533929|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
14533930|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533931|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533932|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
14533933|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14533934|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14533935|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
14533936|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533937|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533938|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
14533939|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14533940|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14533941|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14533942|NCT01605617|Fesoterodine|fesoterodine|mesh-list
14533943|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
14533944|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
14533945|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
14533946|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14533947|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533948|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533949|NCT01605617|Urological Agents|urological agents|mesh-ancestor
14533950|NCT01606709|Leuprolide|leuprolide|mesh-list
14533951|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
14533952|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
14533953|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14533954|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533955|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14533956|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533957|NCT01603121|Lisofylline|lisofylline|mesh-list
14533958|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14533959|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
14533960|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533961|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14533962|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14533963|NCT01603121|Analgesics|analgesics|mesh-ancestor
14533964|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
14533965|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533966|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14533967|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14533968|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14533969|NCT01602016|Leucovorin|leucovorin|mesh-list
14533970|NCT01602016|Folic Acid|folic acid|mesh-list
14533971|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
14533972|NCT01602016|Antidotes|antidotes|mesh-ancestor
14533973|NCT01602016|Protective Agents|protective agents|mesh-ancestor
14533974|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533975|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
14533976|NCT01602016|Vitamins|vitamins|mesh-ancestor
14533977|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
14533978|NCT01602016|Hematinics|hematinics|mesh-ancestor
14533979|NCT01603394|Pregabalin|pregabalin|mesh-list
14533980|NCT01603394|Analgesics|analgesics|mesh-ancestor
14533981|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
14533982|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14533983|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14533984|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
14533985|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14533986|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14533987|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533988|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14533989|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14533990|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14533991|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14533992|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14533993|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14533994|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14533995|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14533996|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14533997|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14533998|NCT01598025|Fludarabine|fludarabine|mesh-list
14533999|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
14534000|NCT01598025|Melphalan|melphalan|mesh-list
14534001|NCT01598025|Thiotepa|thiotepa|mesh-list
14534002|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14534003|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534004|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14534005|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
14534006|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534007|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14534008|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
14534009|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534010|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14534011|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
14534012|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14534013|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
14534014|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
14534015|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534016|NCT01587963|Protective Agents|protective agents|mesh-ancestor
14534017|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534018|NCT01587963|Vitamins|vitamins|mesh-ancestor
14534019|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
14534020|NCT01591096|Plasminogen|plasminogen|mesh-list
14534021|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
14534022|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14534023|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14534024|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534025|NCT01576575|Rifampin|rifampin|mesh-list
14534026|NCT01576575|Ketoconazole|ketoconazole|mesh-list
14534027|NCT01576575|Buprenorphine|buprenorphine|mesh-list
14534028|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14534029|NCT01576575|Narcotics|narcotics|mesh-ancestor
14534030|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14534031|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534032|NCT01576575|Analgesics|analgesics|mesh-ancestor
14534033|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
14534034|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534035|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
14534036|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14534037|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
14534038|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14534039|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534040|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
14534041|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14534042|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534043|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534044|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14534045|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14534046|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
14534047|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
14534048|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
14534049|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14534050|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
14534051|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
14534052|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14534053|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14534054|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
14534055|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14534056|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14534057|NCT01583647|Niacin|niacin|mesh-list
14534058|NCT01583647|Niacinamide|niacinamide|mesh-list
14534059|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
14534060|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14534061|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
14534062|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534063|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14534064|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
14534065|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
14534066|NCT01583647|Vitamins|vitamins|mesh-ancestor
14534067|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
14534068|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534069|NCT01575028|Bupivacaine|bupivacaine|mesh-list
14534070|NCT01575028|Ropivacaine|ropivacaine|mesh-list
14534071|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
14534072|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
14534073|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14534074|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534075|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
14534076|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534077|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
14534078|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
14534079|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
14534080|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
14534081|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534082|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14534083|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14534084|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
14534085|NCT01570634|Loperamide|loperamide|mesh-list
14534086|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
14534087|NCT01570634|Calcium|calcium|mesh-list
14534088|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14534089|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534090|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14534091|NCT01566370|Zonisamide|zonisamide|mesh-list
14534092|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
14534093|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14534094|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14534095|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534096|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14534097|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534098|NCT01561989|Vitamin D|vitamin d|mesh-list
14534099|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
14534100|NCT01561989|Vaccines|vaccines|mesh-list
14534101|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
14534102|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534103|NCT01561989|Vitamins|vitamins|mesh-ancestor
14534104|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
14534105|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14534106|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14534107|NCT01560507|Bupropion|bupropion|mesh-list
14534108|NCT01560507|Nicotine|nicotine|mesh-list
14534109|NCT01560507|Varenicline|varenicline|mesh-list
14534110|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
14534111|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
14534112|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534113|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534114|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
14534115|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
14534116|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
14534117|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14534118|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534119|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14534120|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
14534121|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14534122|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14534123|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14534124|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14534125|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
14534126|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14534127|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14534128|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534129|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
14534130|NCT01555489|Vitamins|vitamins|mesh-ancestor
14534131|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
14534132|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534133|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
14534134|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534135|NCT01555489|Protective Agents|protective agents|mesh-ancestor
14534136|NCT01549977|Febuxostat|febuxostat|mesh-list
14534137|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
14534138|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14534139|NCT01558492|Paclitaxel|paclitaxel|mesh-list
14534140|NCT01558492|Carboplatin|carboplatin|mesh-list
14534141|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14534142|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534143|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
14534144|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
14534145|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
14534146|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534147|NCT01555073|Celecoxib|celecoxib|mesh-list
14534148|NCT01555073|Pregabalin|pregabalin|mesh-list
14534149|NCT01555073|Analgesics|analgesics|mesh-ancestor
14534150|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
14534151|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534152|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534153|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
14534154|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
14534155|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14534156|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534157|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14534158|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14534159|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14534160|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14534161|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14534162|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14534163|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14534164|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14534165|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14534166|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14534167|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14534168|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534169|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
14534170|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14534171|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
14534172|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
14534173|NCT01550510|Irinotecan|irinotecan|mesh-list
14534174|NCT01550510|Camptothecin|camptothecin|mesh-list
14534175|NCT01550510|Vitamins|vitamins|mesh-ancestor
14534176|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
14534177|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534178|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14534179|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14534180|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534181|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534182|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534183|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
14534184|NCT01550510|Protective Agents|protective agents|mesh-ancestor
14534185|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14534186|NCT01547728|Antithrombins|antithrombins|mesh-list
14534187|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
14534188|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14534189|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
14534190|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534191|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534192|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
14534193|NCT01548651|Saxagliptin|saxagliptin|mesh-list
14534194|NCT01548651|Incretins|incretins|mesh-ancestor
14534195|NCT01548651|Hormones|hormones|mesh-ancestor
14534196|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14534197|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534198|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
14534199|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
14534200|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534201|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534202|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14534203|NCT01545648|Denosumab|denosumab|mesh-list
14534204|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14534205|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534206|NCT01546883|Dabigatran|dabigatran|mesh-list
14534207|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
14534208|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14534209|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
14534210|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534211|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534212|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
14534213|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
14534214|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
14534215|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534216|NCT01536015|Rotigotine|rotigotine|mesh-list
14534217|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
14534218|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
14534219|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14534220|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534221|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534222|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
14534223|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
14534224|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534225|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
14534226|NCT01533753|Gabapentin|gabapentin|mesh-list
14534227|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
14534228|NCT01533753|Analgesics|analgesics|mesh-ancestor
14534229|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
14534230|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534231|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534232|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
14534233|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
14534234|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14534235|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14534236|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14534237|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14534238|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14534239|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14534240|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534241|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
14534242|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14534243|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14534244|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14534245|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14534246|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
14534247|NCT01534143|Sirolimus|sirolimus|mesh-list
14534248|NCT01534143|Fludarabine|fludarabine|mesh-list
14534249|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
14534250|NCT01534143|Bortezomib|bortezomib|mesh-list
14534251|NCT01534143|Busulfan|busulfan|mesh-list
14534252|NCT01534143|Tacrolimus|tacrolimus|mesh-list
14534253|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
14534254|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14534255|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
14534256|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534257|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14534258|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
14534259|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534260|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14534261|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
14534262|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534263|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14534264|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534265|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14534266|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534267|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14534268|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
14534269|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
14534270|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14534271|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14534272|NCT01530880|Acetaminophen|acetaminophen|mesh-list
14534273|NCT01530880|Ibuprofen|ibuprofen|mesh-list
14534274|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14534275|NCT01530880|Analgesics|analgesics|mesh-ancestor
14534276|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
14534277|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534278|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534279|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
14534280|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14534281|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14534282|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14534283|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14534284|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534285|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042883|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042884|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15042885|NCT02046668|Diuretics|diuretics|mesh-ancestor
15042886|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
15042887|NCT02046694|Allopurinol|allopurinol|mesh-list
15042888|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
15042889|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042890|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042891|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
15042892|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15042893|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15042894|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
15042895|NCT02046694|Protective Agents|protective agents|mesh-ancestor
15042896|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042897|NCT02046720|Propofol|propofol|mesh-list
15042898|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14534286|NCT01527942|Acetaminophen|acetaminophen|mesh-list
14534287|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14534288|NCT01527942|Analgesics|analgesics|mesh-ancestor
14534289|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
14534290|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534291|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534292|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
14534293|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
14534294|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
14534295|NCT01532635|Tacrolimus|tacrolimus|mesh-list
14534296|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14534297|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
14534298|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534299|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14534300|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14534301|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
14534302|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534303|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534304|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14534305|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14534306|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534307|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14534308|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14534309|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
14534310|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14534311|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534312|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
14534313|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534314|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
14534315|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534316|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534317|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14534318|NCT01526408|Famciclovir|famciclovir|mesh-list
14534319|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
14534320|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534321|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14534322|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534323|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534324|NCT01525927|Cisplatin|cisplatin|mesh-list
14534325|NCT01525927|Carboplatin|carboplatin|mesh-list
14534326|NCT01525927|Etoposide|etoposide|mesh-list
14534327|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534328|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14534329|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14534330|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14534331|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534332|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534333|NCT01507233|Morphine|morphine|mesh-list
14534334|NCT01507233|Bupivacaine|bupivacaine|mesh-list
14534335|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
14534336|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
14534337|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14534338|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534339|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
14534340|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534341|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14534342|NCT01507233|Narcotics|narcotics|mesh-ancestor
14534343|NCT01507233|Analgesics|analgesics|mesh-ancestor
14534344|NCT01500772|Ribavirin|ribavirin|mesh-list
14534345|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14534346|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
14534347|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534348|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
14534349|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534350|NCT01517763|Immunoconjugates|immunoconjugates|mesh-list
14534351|NCT01517763|Immunologic Factors|immunologic factors|mesh-ancestor
14534352|NCT01517763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534353|NCT01507584|Bimatoprost|bimatoprost|mesh-list
14534354|NCT01507584|Brinzolamide|brinzolamide|mesh-list
14534355|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14534356|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
14534357|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534358|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534359|NCT01510756|Sorafenib|sorafenib|mesh-list
14534360|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534361|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14534362|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534363|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534364|NCT01500109|Acetaminophen|acetaminophen|mesh-list
14534365|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14534366|NCT01500109|Analgesics|analgesics|mesh-ancestor
14534367|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
14534368|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534369|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534370|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
14534371|NCT01509053|Aripiprazole|aripiprazole|mesh-list
14534372|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
14534373|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14534374|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14534375|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14534376|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14534377|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534378|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
14534379|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
14534380|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14534381|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534382|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
14534383|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
14534384|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
14534385|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
14534386|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
14534387|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14534388|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14534389|NCT01495988|Bevacizumab|bevacizumab|mesh-list
14534390|NCT01495988|Vemurafenib|vemurafenib|mesh-list
14534391|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14534392|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534393|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14534394|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14534395|NCT01495988|Growth Substances|growth substances|mesh-ancestor
14534396|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534397|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
14534398|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14534399|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534400|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534401|NCT01483872|Tigecycline|tigecycline|mesh-list
14534402|NCT01483872|Heparin|heparin|mesh-list
14534403|NCT01483872|Calcium heparin|calcium heparin|mesh-list
14534404|NCT01483872|Anticoagulants|anticoagulants|mesh-list
14534405|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534406|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
14534407|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
14534408|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14534409|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534410|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
14534411|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534412|NCT01487499|Cisplatin|cisplatin|mesh-list
14534413|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534414|NCT01478113|Amphetamine|amphetamine|mesh-list
14534415|NCT01478113|Adderall|adderall|mesh-list
14534416|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
14534417|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14534418|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534419|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
14534420|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
14534421|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534422|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
14534423|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14534424|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534425|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
14534426|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14534427|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14534428|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14534429|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14534430|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
14534431|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14534432|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
14534433|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14534434|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14534435|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534436|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
14534437|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14534438|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534439|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14534440|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534441|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
14534442|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14534443|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
14534444|NCT01473732|Everolimus|everolimus|mesh-list
14534445|NCT01473732|Tacrolimus|tacrolimus|mesh-list
14534446|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14534447|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
14534448|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534449|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14534450|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534451|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534452|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534453|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14534454|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14534455|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
14534456|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14534457|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534458|NCT01472692|Febuxostat|febuxostat|mesh-list
14534459|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
14534460|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14534461|NCT01465230|Lenalidomide|lenalidomide|mesh-list
14534462|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
14534463|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534464|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14534465|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14534466|NCT01465230|Growth Substances|growth substances|mesh-ancestor
14534467|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
14534468|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534469|NCT01464723|Ranibizumab|ranibizumab|mesh-list
14534470|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14534471|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14534472|NCT01464723|Growth Substances|growth substances|mesh-ancestor
14534473|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534474|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
14534475|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534476|NCT01446250|Ribavirin|ribavirin|mesh-list
14534477|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14534478|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
14534479|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534480|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
14534481|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534482|NCT01457053|Torsemide|torsemide|mesh-list
14534483|NCT01457053|Furosemide|furosemide|mesh-list
14534484|NCT01457053|Bumetanide|bumetanide|mesh-list
14534485|NCT01457053|Diuretics|diuretics|mesh-list
14534486|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
14534487|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
14534488|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534489|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14534490|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534491|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14534492|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
14534493|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
14534494|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534495|NCT01451723|Protective Agents|protective agents|mesh-ancestor
14534496|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534497|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
14534498|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
14534499|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534500|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14534501|NCT01440595|Ribavirin|ribavirin|mesh-list
14534502|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14534503|NCT01440595|Grazoprevir|grazoprevir|mesh-list
14534504|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
14534505|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534506|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
14534507|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534508|NCT01443923|Interferons|interferons|mesh-list
14534509|NCT01443923|Ribavirin|ribavirin|mesh-list
14534510|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
14534511|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
14534512|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14534513|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534514|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
14534515|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534516|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
14534517|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534518|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
14534519|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534520|NCT01439347|Vincristine|vincristine|mesh-list
14534521|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14534522|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534523|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
14534524|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
14534525|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
14534526|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534527|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
14534528|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14534529|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534530|NCT01434745|Simvastatin|simvastatin|mesh-list
14534531|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14534532|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14534533|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
14534534|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534535|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14534536|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14534537|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534538|NCT01415986|Temoporfin|temoporfin|mesh-list
14534539|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534540|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
14534541|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
14534542|NCT01410799|Hormones|hormones|mesh-list
14534543|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
14534544|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14534545|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534546|NCT01426113|Timolol|timolol|mesh-list
14534547|NCT01426113|Bimatoprost|bimatoprost|mesh-list
14534548|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14534549|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14534550|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14534551|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14534552|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
14534553|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14534554|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534555|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534556|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14534557|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14534558|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
14534559|NCT01420965|Antibodies|antibodies|mesh-list
14534560|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
14534561|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14534562|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
14534563|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534564|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14534565|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14534566|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
14534567|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534568|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534569|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14534570|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
14534571|NCT01406860|Promethazine|promethazine|mesh-list
14534572|NCT01406860|Droperidol|droperidol|mesh-list
14534573|NCT01406860|Metoclopramide|metoclopramide|mesh-list
14534574|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
14534575|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14534576|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14534577|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534578|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
14534579|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
14534580|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
14534581|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534582|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
14534583|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
14534584|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14534585|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
14534586|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
14534587|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
14534588|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14534589|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534590|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
14534591|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
14534592|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
14534593|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
14534594|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
14534595|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
14534596|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
14534597|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
14534598|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14534599|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14534600|NCT01401049|Lidocaine|lidocaine|mesh-list
14534601|NCT01401049|Propofol|propofol|mesh-list
14534602|NCT01401049|Fospropofol|fospropofol|mesh-list
14534603|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
14534604|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
14534605|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14534606|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534607|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
14534608|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534609|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14534610|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
14534611|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14534612|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14534613|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534614|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
14534615|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14534616|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
14534617|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
14534618|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
14534619|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14534620|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14534621|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534622|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534623|NCT01409031|Urological Agents|urological agents|mesh-ancestor
14534624|NCT01402531|Bevacizumab|bevacizumab|mesh-list
14534625|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14534626|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534627|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14534628|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14534629|NCT01402531|Growth Substances|growth substances|mesh-ancestor
14534630|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534631|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
14534632|NCT01397552|Dexamethasone|dexamethasone|mesh-list
14534633|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
14534634|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14534635|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14534636|NCT01397552|Prednisolone|prednisolone|mesh-list
14534637|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
14534638|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14534639|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
14534640|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14534641|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
14534642|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
14534643|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534644|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534645|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14534646|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
14534647|NCT01397552|Hormones|hormones|mesh-ancestor
14534648|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14534649|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14534650|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534651|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14534652|NCT01397552|Protective Agents|protective agents|mesh-ancestor
14534653|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
14534654|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
14534655|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534656|NCT01397695|Bevacizumab|bevacizumab|mesh-list
14534657|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14534658|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534659|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14534660|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14534661|NCT01397695|Growth Substances|growth substances|mesh-ancestor
14534662|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534663|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
14534664|NCT01390181|Losartan|losartan|mesh-list
14534665|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14534666|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14534667|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
14534668|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
14534669|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534670|NCT01394211|Anastrozole|anastrozole|mesh-list
14534671|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14534672|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534673|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14534674|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14534675|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534676|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534677|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14534678|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
14534679|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14534680|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534681|NCT01377441|Ibuprofen|ibuprofen|mesh-list
14534682|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
14534683|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
14534684|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14534685|NCT01377441|Analgesics|analgesics|mesh-ancestor
14534686|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
14534687|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534688|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534689|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14534690|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14534691|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534692|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534693|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
14534694|NCT01383447|Entinostat|entinostat|mesh-list
14534695|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14534696|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534697|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14534698|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534699|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534700|NCT01372618|Pasireotide|pasireotide|mesh-list
14534701|NCT01372618|Hormones|hormones|mesh-ancestor
14534702|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14534703|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534704|NCT01385280|Exemestane|exemestane|mesh-list
14534705|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
14534706|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
14534707|NCT01385280|Estradiol|estradiol|mesh-list
14534708|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
14534709|NCT01385280|Estrogens|estrogens|mesh-ancestor
14534710|NCT01385280|Hormones|hormones|mesh-ancestor
14534711|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14534712|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534713|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14534714|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
14534715|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14534716|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14534717|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534718|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
14534719|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
14534720|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534721|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534722|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14534723|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
14534724|NCT01379274|Lenalidomide|lenalidomide|mesh-list
14534725|NCT01379274|Azacitidine|azacitidine|mesh-list
14534726|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
14534727|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534728|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14534729|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14534730|NCT01379274|Growth Substances|growth substances|mesh-ancestor
14534731|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
14534732|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534733|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14534734|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
14534735|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534736|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534737|NCT01379469|Carbamazepine|carbamazepine|mesh-list
14534738|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
14534739|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
14534740|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
14534741|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14534742|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534743|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14534744|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14534745|NCT01379469|Analgesics|analgesics|mesh-ancestor
14534746|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
14534747|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534748|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14534749|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14534750|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534751|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14534752|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14534753|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
14534754|NCT01369641|Cisplatin|cisplatin|mesh-list
14534755|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534756|NCT01369641|Antidotes|antidotes|mesh-ancestor
14534757|NCT01369641|Protective Agents|protective agents|mesh-ancestor
14534758|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534759|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
14534760|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534761|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
14534762|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14534763|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534764|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
14534765|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
14534766|NCT01359254|Vidarabine|vidarabine|mesh-list
14534767|NCT01359254|Fludarabine|fludarabine|mesh-list
14534768|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
14534769|NCT01359254|Melphalan|melphalan|mesh-list
14534770|NCT01359254|Busulfan|busulfan|mesh-list
14534771|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
14534772|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534773|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14534774|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
14534775|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534776|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14534777|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
14534778|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534779|NCT01359254|Antiviral Agents|antiviral agents|mesh-ancestor
14534780|NCT01359254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534781|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14534782|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
14534783|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14534784|NCT01347632|Metronidazole|metronidazole|mesh-list
14534785|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534786|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14534787|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
14534788|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
14534789|NCT01350232|Cytarabine|cytarabine|mesh-list
14534790|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
14534791|NCT01350232|Rituximab|rituximab|mesh-list
14534792|NCT01350232|Fludarabine|fludarabine|mesh-list
14534793|NCT01350232|Bortezomib|bortezomib|mesh-list
14534794|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14534795|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
14534796|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534797|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14534798|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14534799|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
14534800|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534801|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534802|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14534803|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14534804|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14534805|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
14534806|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
14534807|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534808|NCT01352416|Ranolazine|ranolazine|mesh-list
14534809|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
14534810|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14534811|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534812|NCT01350258|Vidarabine|vidarabine|mesh-list
14534813|NCT01350258|Fludarabine|fludarabine|mesh-list
14534814|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
14534815|NCT01350258|Melphalan|melphalan|mesh-list
14534816|NCT01350258|Thiotepa|thiotepa|mesh-list
14534817|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534818|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14534819|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
14534820|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534821|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14534822|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
14534823|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534824|NCT01350258|Antiviral Agents|antiviral agents|mesh-ancestor
14534825|NCT01350258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534826|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14534827|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
14534828|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14534829|NCT01349595|Bortezomib|bortezomib|mesh-list
14534830|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534831|NCT01340573|Interferons|interferons|mesh-list
14534832|NCT01340573|Ribavirin|ribavirin|mesh-list
14534833|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
14534834|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534835|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
14534836|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534837|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
14534838|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534839|NCT01335997|Niacin|niacin|mesh-list
14534840|NCT01335997|Niacinamide|niacinamide|mesh-list
14534841|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
14534842|NCT01335997|Simvastatin|simvastatin|mesh-list
14534843|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14534844|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14534845|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
14534846|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534847|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14534848|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14534849|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534850|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
14534851|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
14534852|NCT01335997|Vitamins|vitamins|mesh-ancestor
14534853|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
14534854|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534855|NCT01340885|Rivastigmine|rivastigmine|mesh-list
14534856|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
14534857|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
14534858|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14534859|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14534860|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534861|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
14534862|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14534863|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534864|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
14534865|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534866|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
14534867|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14534868|NCT01340885|Protective Agents|protective agents|mesh-ancestor
14534869|NCT01326923|Cetuximab|cetuximab|mesh-list
14534870|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14534871|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534872|NCT01332799|Allopurinol|allopurinol|mesh-list
14534873|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
14534874|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534875|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534876|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
14534877|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14534878|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
14534879|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
14534880|NCT01332799|Protective Agents|protective agents|mesh-ancestor
14534881|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042899|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15042900|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042901|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15042902|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
15042903|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
14534882|NCT01329549|Carboplatin|carboplatin|mesh-list
14534883|NCT01329549|Nintedanib|nintedanib|mesh-list
14534884|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534885|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14534886|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534887|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534888|NCT01326845|Deferasirox|deferasirox|mesh-list
14534889|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
14534890|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
14534891|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
14534892|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534893|NCT01320683|Leucovorin|leucovorin|mesh-list
14534894|NCT01320683|Bevacizumab|bevacizumab|mesh-list
14534895|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14534896|NCT01320683|Fluorouracil|fluorouracil|mesh-list
14534897|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
14534898|NCT01320683|Irinotecan|irinotecan|mesh-list
14534899|NCT01320683|Antibodies|antibodies|mesh-list
14534900|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
14534901|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14534902|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
14534903|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534904|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14534905|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14534906|NCT01320683|Growth Substances|growth substances|mesh-ancestor
14534907|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534908|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
14534909|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
14534910|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
14534911|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534912|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14534913|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14534914|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14534915|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14534916|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534917|NCT01320683|Antidotes|antidotes|mesh-ancestor
14534918|NCT01320683|Protective Agents|protective agents|mesh-ancestor
14534919|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
14534920|NCT01320683|Vitamins|vitamins|mesh-ancestor
14534921|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
14534922|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
14534923|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
14534924|NCT01313273|Lanreotide|lanreotide|mesh-list
14534925|NCT01313273|Androgens|androgens|mesh-list
14534926|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
14534927|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
14534928|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
14534929|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
14534930|NCT01313273|Hormones|hormones|mesh-ancestor
14534931|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14534932|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534933|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
14534934|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534935|NCT01313273|Protective Agents|protective agents|mesh-ancestor
14534936|NCT01313273|Vitamins|vitamins|mesh-ancestor
14534937|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
14534938|NCT01313273|Estrogens|estrogens|mesh-ancestor
14534939|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14534940|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534941|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
14534942|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
14534943|NCT01321008|Prednisone|prednisone|mesh-list
14534944|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
14534945|NCT01321008|Doxorubicin|doxorubicin|mesh-list
14534946|NCT01321008|Vincristine|vincristine|mesh-list
14534947|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14534948|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
14534949|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534950|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14534951|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14534952|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
14534953|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534954|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534955|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14534956|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14534957|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14534958|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14534959|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534960|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14534961|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
14534962|NCT01321008|Hormones|hormones|mesh-ancestor
14534963|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14534964|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14534965|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14534966|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
14534967|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
14534968|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
14534969|NCT01310803|Valrubicin|valrubicin|mesh-list
14534970|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534971|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
14534972|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14534973|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14534974|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534975|NCT01309581|Ketamine|ketamine|mesh-list
14534976|NCT01309581|Methohexital|methohexital|mesh-list
14534977|NCT01309581|Analgesics|analgesics|mesh-ancestor
14534978|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
14534979|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14534980|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14534981|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
14534982|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
14534983|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
14534984|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
14534985|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14534986|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
14534987|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
14534988|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14534989|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534990|NCT01315873|Bortezomib|bortezomib|mesh-list
14534991|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
14534992|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14534993|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14534994|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
14534995|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14534996|NCT01313923|Sirolimus|sirolimus|mesh-list
14534997|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14534998|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14534999|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14535000|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535001|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
14535002|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535003|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
14535004|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535005|NCT01313416|Gemcitabine|gemcitabine|mesh-list
14535006|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535007|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
14535008|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535009|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535010|NCT01313416|Antiviral Agents|antiviral agents|mesh-ancestor
14535011|NCT01313416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535012|NCT01313416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535013|NCT01313416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535014|NCT01313416|Immunologic Factors|immunologic factors|mesh-ancestor
14535015|NCT01313416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535016|NCT01303003|Dexamethasone|dexamethasone|mesh-list
14535017|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14535018|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
14535019|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
14535020|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535021|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535022|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14535023|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
14535024|NCT01303003|Hormones|hormones|mesh-ancestor
14535025|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14535026|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14535027|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535028|NCT01302444|Tadalafil|tadalafil|mesh-list
14535029|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
14535030|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14535031|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14535032|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535033|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535034|NCT01302444|Urological Agents|urological agents|mesh-ancestor
14535035|NCT01301963|Plerixafor|plerixafor|mesh-list
14535036|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14535037|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14535038|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
14535039|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535040|NCT01292070|Histamine|histamine|mesh-list
14535041|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
14535042|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
14535043|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14535044|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535045|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535046|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
14535047|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535048|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
14535049|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535050|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14535051|NCT01290718|Capecitabine|capecitabine|mesh-list
14535052|NCT01290718|Trastuzumab|trastuzumab|mesh-list
14535053|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535054|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
14535055|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535056|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535057|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14535058|NCT01293123|Tenofovir|tenofovir|mesh-list
14535059|NCT01293123|Emtricitabine|emtricitabine|mesh-list
14535060|NCT01293123|Efavirenz|efavirenz|mesh-list
14535061|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
14535062|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
14535063|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535064|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14535065|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14535066|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535067|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535068|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14535069|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14535070|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14535071|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14535072|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14535073|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14535074|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14535075|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14535076|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
14535077|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
14535078|NCT01280643|Leucovorin|leucovorin|mesh-list
14535079|NCT01280643|Bevacizumab|bevacizumab|mesh-list
14535080|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14535081|NCT01280643|Cetuximab|cetuximab|mesh-list
14535082|NCT01280643|Fluorouracil|fluorouracil|mesh-list
14535083|NCT01280643|Capecitabine|capecitabine|mesh-list
14535084|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
14535085|NCT01280643|Irinotecan|irinotecan|mesh-list
14535086|NCT01280643|Antibodies|antibodies|mesh-list
14535087|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
14535088|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14535089|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
14535090|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535091|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14535092|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14535093|NCT01280643|Growth Substances|growth substances|mesh-ancestor
15042904|NCT02046733|Nivolumab|nivolumab|mesh-list
15042905|NCT02046733|Ipilimumab|ipilimumab|mesh-list
15042906|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15042907|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042908|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15042909|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042910|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15042911|NCT02046850|Rifampin|rifampin|mesh-list
15042912|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15042913|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
15042914|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15042915|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15042916|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
15042917|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15042918|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042919|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042920|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14535094|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535095|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
14535096|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
14535097|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
14535098|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535099|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535100|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535101|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
14535102|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
14535103|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535104|NCT01280643|Antidotes|antidotes|mesh-ancestor
14535105|NCT01280643|Protective Agents|protective agents|mesh-ancestor
14535106|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
14535107|NCT01280643|Vitamins|vitamins|mesh-ancestor
14535108|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
14535109|NCT01281124|Azacitidine|azacitidine|mesh-list
14535110|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535111|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
14535112|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535113|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535114|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535115|NCT01272141|Everolimus|everolimus|mesh-list
14535116|NCT01272141|Lapatinib|lapatinib|mesh-list
14535117|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535118|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535119|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
14535120|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535121|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14535122|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535123|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535124|NCT01282216|Vaccines|vaccines|mesh-list
14535125|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
14535126|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
14535127|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535128|NCT01284504|Celecoxib|celecoxib|mesh-list
14535129|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
14535130|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14535131|NCT01284504|Analgesics|analgesics|mesh-ancestor
14535132|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
14535133|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535134|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535135|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14535136|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14535137|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
14535138|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
14535139|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535140|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535141|NCT01269034|Insulin|insulin|mesh-list
14535142|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
14535143|NCT01269034|Exenatide|exenatide|mesh-list
14535144|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
14535145|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
14535146|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
14535147|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14535148|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535149|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
14535150|NCT01269034|Incretins|incretins|mesh-ancestor
14535151|NCT01269034|Hormones|hormones|mesh-ancestor
14535152|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14535153|NCT01274533|Lenalidomide|lenalidomide|mesh-list
14535154|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
14535155|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535156|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14535157|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14535158|NCT01274533|Growth Substances|growth substances|mesh-ancestor
14535159|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
14535160|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535161|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
14535162|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
14535163|NCT01279616|Busulfan|busulfan|mesh-list
14535164|NCT01279616|Rituximab|rituximab|mesh-list
14535165|NCT01279616|Fludarabine|fludarabine|mesh-list
14535166|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
14535167|NCT01279616|Tacrolimus|tacrolimus|mesh-list
14535168|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
14535169|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535170|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
14535171|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535172|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14535173|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
14535174|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
14535175|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535176|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535177|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
14535178|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14535179|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535180|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
14535181|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
14535182|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535183|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
14535184|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
14535185|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
14535186|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14535187|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535188|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
14535189|NCT01276054|Methylene Blue|methylene blue|mesh-list
14535190|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
14535191|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535192|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535193|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
14535194|NCT01264965|Acetaminophen|acetaminophen|mesh-list
14535195|NCT01264965|Oxycodone|oxycodone|mesh-list
14535196|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
14535197|NCT01264965|Analgesics|analgesics|mesh-ancestor
14535198|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
14535199|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535200|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535201|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
14535202|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
14535203|NCT01264965|Narcotics|narcotics|mesh-ancestor
14535204|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14535205|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
14535206|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
14535207|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
14535208|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
14535209|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
14535210|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14535211|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535212|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
14535213|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535214|NCT01273064|Interferons|interferons|mesh-list
14535215|NCT01273064|Ribavirin|ribavirin|mesh-list
14535216|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535217|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
14535218|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535219|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
14535220|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535221|NCT01274559|Niacin|niacin|mesh-list
14535222|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14535223|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
14535224|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535225|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14535226|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
14535227|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
14535228|NCT01274559|Vitamins|vitamins|mesh-ancestor
14535229|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
14535230|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535231|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
14535232|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
14535233|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
14535234|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14535235|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535236|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
14535237|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14535238|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535239|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
14535240|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535241|NCT01267825|Bupivacaine|bupivacaine|mesh-list
14535242|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
14535243|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
14535244|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
14535245|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535246|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
14535247|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535252|NCT01259284|Atorvastatin|atorvastatin|mesh-list
14535253|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
14535254|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
14535255|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
14535256|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535257|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
14535258|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
14535259|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535260|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
14535261|NCT01263028|Vitamin D|vitamin d|mesh-list
14535262|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14535263|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535264|NCT01263028|Vitamins|vitamins|mesh-ancestor
14535265|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
14535266|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14535267|NCT01253668|Antibodies|antibodies|mesh-list
14535268|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14535269|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
14535270|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535271|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
14535272|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
14535273|NCT01259024|Estrogens|estrogens|mesh-ancestor
14535274|NCT01259024|Hormones|hormones|mesh-ancestor
14535275|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14535276|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535277|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14535278|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535279|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
14535280|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535281|NCT01246011|Warfarin|warfarin|mesh-list
14535282|NCT01246011|Argatroban|argatroban|mesh-list
14535283|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
14535284|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
14535285|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
14535286|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
14535287|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535288|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535289|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
14535290|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
14535291|NCT01244620|Tadalafil|tadalafil|mesh-list
14535292|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
14535293|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
14535294|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
14535295|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
14535296|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535297|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535298|NCT01244620|Urological Agents|urological agents|mesh-ancestor
14535299|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
14535300|NCT01240304|Gemcitabine|gemcitabine|mesh-list
14535301|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535302|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
14535303|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535304|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535305|NCT01240304|Antiviral Agents|antiviral agents|mesh-ancestor
14535306|NCT01240304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535307|NCT01240304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535308|NCT01240304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535309|NCT01240304|Immunologic Factors|immunologic factors|mesh-ancestor
14535310|NCT01240304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535311|NCT01230788|Rituximab|rituximab|mesh-list
14535312|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14535313|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535314|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
14535315|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535316|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14535317|NCT01231750|Capsaicin|capsaicin|mesh-list
14535318|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
14535319|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
14535320|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
14535321|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535322|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535323|NCT01230307|Vitamin D|vitamin d|mesh-list
14535324|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
14535325|NCT01230307|Vitamins|vitamins|mesh-ancestor
14535326|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
14535327|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535328|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14535329|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14535330|NCT01222871|Triamcinolone|triamcinolone|mesh-list
14535331|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14535332|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
14535333|NCT01222871|Hormones|hormones|mesh-ancestor
14535334|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14535335|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535336|NCT01219673|Minocycline|minocycline|mesh-list
14535337|NCT01219673|Modafinil|modafinil|mesh-list
14535338|NCT01219673|Bupropion|bupropion|mesh-list
14535339|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
14535340|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
14535341|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14535342|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
14535343|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14535344|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14535345|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535346|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
14535347|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14535348|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535349|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
14535350|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14535351|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535352|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
14535353|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535354|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14535355|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
14535356|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14535357|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14535358|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
14535359|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
14535360|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
14535361|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
14535362|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535363|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14535364|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535365|NCT01223001|Analgesics|analgesics|mesh-ancestor
14535366|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
14535367|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535368|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
14535369|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
14535370|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
14535371|NCT01217060|Dexamethasone|dexamethasone|mesh-list
14535372|NCT01217060|Docetaxel|docetaxel|mesh-list
14535373|NCT01217060|Fluorouracil|fluorouracil|mesh-list
14535374|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14535375|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
14535376|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
14535377|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535378|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535379|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14535380|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
14535381|NCT01217060|Hormones|hormones|mesh-ancestor
14535382|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14535383|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14535384|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535385|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
14535386|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
14535387|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
14535388|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535389|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
14535390|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535391|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535392|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
14535393|NCT01206101|Liraglutide|liraglutide|mesh-list
14535394|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
14535395|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535396|NCT01206101|Incretins|incretins|mesh-ancestor
14535397|NCT01206101|Hormones|hormones|mesh-ancestor
14535398|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14535399|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
14535400|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
14535401|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
14535402|NCT01216631|Prednisolone|prednisolone|mesh-list
14535403|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
14535404|NCT01216631|Infliximab|infliximab|mesh-list
14535405|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
14535406|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
14535407|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
14535408|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
14535409|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
14535410|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
14535411|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535412|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
14535413|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
14535414|NCT01216631|Hormones|hormones|mesh-ancestor
14535415|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14535416|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
14535417|NCT01216631|Protective Agents|protective agents|mesh-ancestor
14535418|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14535419|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535420|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
14535421|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
14535422|NCT01211756|Oxytocin|oxytocin|mesh-list
14535423|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
14535424|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14535425|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535426|NCT01209520|Paclitaxel|paclitaxel|mesh-list
14535427|NCT01209520|Vinorelbine|vinorelbine|mesh-list
14535428|NCT01209520|Docetaxel|docetaxel|mesh-list
14535429|NCT01209520|Cisplatin|cisplatin|mesh-list
14535430|NCT01209520|Carboplatin|carboplatin|mesh-list
14535431|NCT01209520|Pemetrexed|pemetrexed|mesh-list
14535432|NCT01209520|Azacitidine|azacitidine|mesh-list
14535433|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14535434|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535435|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
14535436|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
14535437|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
14535438|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535439|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535440|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
14535441|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14535442|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535443|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
14535444|NCT01207726|Azacitidine|azacitidine|mesh-list
14535445|NCT01207726|Entinostat|entinostat|mesh-list
14535446|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
14535447|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535448|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
14535449|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535450|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535451|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535452|NCT01206296|Gemcitabine|gemcitabine|mesh-list
14535453|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535454|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
14535455|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535456|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535457|NCT01206296|Antiviral Agents|antiviral agents|mesh-ancestor
14535458|NCT01206296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535459|NCT01206296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535460|NCT01206296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535461|NCT01206296|Immunologic Factors|immunologic factors|mesh-ancestor
14535462|NCT01206296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535463|NCT01207102|Paclitaxel|paclitaxel|mesh-list
14535464|NCT01207102|Carboplatin|carboplatin|mesh-list
14535465|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
14535466|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14535467|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535468|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
14535469|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
14535470|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
14535471|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535472|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
14535473|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
14535474|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535475|NCT01202110|Propranolol|propranolol|mesh-list
14535476|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
14535477|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
14535478|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
14535479|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14535480|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535481|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535482|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
14535483|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14535484|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
14535485|NCT01206439|Nebivolol|nebivolol|mesh-list
14535486|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
14535487|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
14535488|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
14535489|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
14535490|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
14535491|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
14535492|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
14535493|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535494|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535495|NCT01200602|Megestrol|megestrol|mesh-list
14535496|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
14535497|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
14535498|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
14535499|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
14535500|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
14535501|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
14535502|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535503|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
14535504|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
14535505|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14535506|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535507|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
14535508|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
14535509|NCT01198548|Vitamin D|vitamin d|mesh-list
14535510|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
14535511|NCT01198548|Leucovorin|leucovorin|mesh-list
14535512|NCT01198548|Bevacizumab|bevacizumab|mesh-list
14535513|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
14535514|NCT01198548|Fluorouracil|fluorouracil|mesh-list
14535515|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
14535516|NCT01198548|Antibodies|antibodies|mesh-list
14535517|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
14535518|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
14535519|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
14535520|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535521|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
14535522|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
14535523|NCT01198548|Growth Substances|growth substances|mesh-ancestor
14535524|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535525|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
14535526|NCT01198548|Vitamins|vitamins|mesh-ancestor
14535527|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
14535528|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
14535529|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
14535530|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14535531|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
14535532|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535533|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535534|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535535|NCT01198548|Antidotes|antidotes|mesh-ancestor
14535536|NCT01198548|Protective Agents|protective agents|mesh-ancestor
14535537|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
14535538|NCT01194908|Tamoxifen|tamoxifen|mesh-list
14535539|NCT01194908|Decitabine|decitabine|mesh-list
14535540|NCT01194908|Panobinostat|panobinostat|mesh-list
14535541|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535542|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
14535543|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535544|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535545|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535546|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14535547|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
14535548|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14535549|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535550|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14535551|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14535552|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14535553|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14535554|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14535555|NCT01194856|Ritonavir|ritonavir|mesh-list
14535556|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
14535557|NCT01194856|Efavirenz|efavirenz|mesh-list
14535558|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
14535559|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
14535560|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
14535561|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535562|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535563|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
14535564|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
14535565|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
14535566|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
14535567|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
14535568|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
14535569|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
14535570|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
14535571|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
14535572|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
14535573|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
14535574|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
14535575|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
14535576|NCT01194427|Tamoxifen|tamoxifen|mesh-list
14535577|NCT01194427|Vorinostat|vorinostat|mesh-list
14535578|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
14535579|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
14535580|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
14535581|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535582|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
14535583|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535584|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
14535585|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
14535586|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
14535587|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
14535588|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535589|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535590|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
14535591|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535592|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
14535593|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
14535594|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535595|NCT01182610|Paclitaxel|paclitaxel|mesh-list
14535596|NCT01182610|Carboplatin|carboplatin|mesh-list
14535597|NCT01182610|Fluorouracil|fluorouracil|mesh-list
14535598|NCT01182610|Panitumumab|panitumumab|mesh-list
14535599|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
14535600|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
14535601|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
14535602|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
14535603|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
14535604|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
14535605|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
14535606|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
14535607|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
14535608|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
14535609|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
14535610|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15042921|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15042922|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15042923|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15042924|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15042925|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15042926|NCT02046915|Dexamethasone|dexamethasone|mesh-list
15042927|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
15042928|NCT02046915|Pomalidomide|pomalidomide|mesh-list
15042929|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15042930|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
15042931|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042932|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15042933|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15042934|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
15042935|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042936|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042937|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15042938|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15042939|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
15042940|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
15042941|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042942|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15042943|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
15042944|NCT02046915|Hormones|hormones|mesh-ancestor
15042945|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042946|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15042947|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15042948|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15042949|NCT02046915|Growth Substances|growth substances|mesh-ancestor
15042950|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
15042951|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
15042952|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15042953|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
15042954|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15042955|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
15042956|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042957|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042958|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
15042959|NCT02047019|Candesartan|candesartan|mesh-list
15042960|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
15042961|NCT02047019|Nifedipine|nifedipine|mesh-list
15042962|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15042963|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15042964|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15042965|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042966|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15042967|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15042968|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15042969|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042970|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
15042971|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
15042972|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15042973|NCT02047136|Histamine|histamine|mesh-list
15042974|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
15042975|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
15042976|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15042977|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042978|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042979|NCT02047149|Zileuton|zileuton|mesh-list
15042980|NCT02047149|Dasatinib|dasatinib|mesh-list
15042981|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
15042982|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15042983|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15042984|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15042985|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15042986|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15042987|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15042988|NCT02047149|Analgesics|analgesics|mesh-ancestor
15042989|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
15042990|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15042991|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15042992|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15042993|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15042994|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
15042995|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15042996|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
15042997|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15042998|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
15042999|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15043000|NCT02047162|Bismuth|bismuth|mesh-list
15043001|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
15043002|NCT02047162|Antacids|antacids|mesh-ancestor
15043003|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043004|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15043005|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
15043006|NCT02047175|Niacin|niacin|mesh-list
15043007|NCT02047175|Amlodipine|amlodipine|mesh-list
15043008|NCT02047175|Telmisartan|telmisartan|mesh-list
15043009|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15043010|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15043011|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15043012|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15043013|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043014|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15043015|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043016|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
15043017|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15043018|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15043019|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
15043020|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15043021|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15043022|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043023|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15043024|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15043025|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
15043026|NCT02047175|Vitamins|vitamins|mesh-ancestor
15043027|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
15043028|NCT02047201|Docetaxel|docetaxel|mesh-list
15043029|NCT02047201|Fluorouracil|fluorouracil|mesh-list
15043030|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043031|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
15043032|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
15043033|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
15043034|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043035|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
15043036|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15043037|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15043038|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
15043039|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043040|NCT02047292|Tacrine|tacrine|mesh-list
15043041|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15043042|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043043|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043044|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
15043045|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043046|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043047|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15043048|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
15043049|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043050|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
15043051|NCT02047422|Metolazone|metolazone|mesh-list
15043052|NCT02047422|Furosemide|furosemide|mesh-list
15043053|NCT02047422|Spironolactone|spironolactone|mesh-list
15043054|NCT02047422|Diuretics|diuretics|mesh-ancestor
15043055|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
15043056|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043057|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15043058|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15043059|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043060|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15043061|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
15043062|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15043063|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15043064|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15043065|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15043066|NCT02047474|Leucovorin|leucovorin|mesh-list
15043067|NCT02047474|Fluorouracil|fluorouracil|mesh-list
15043068|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
15043069|NCT02047474|Irinotecan|irinotecan|mesh-list
15043070|NCT02047474|Calcium|calcium|mesh-list
15043071|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
15043072|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15043073|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043074|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
15043075|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043076|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15043077|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043078|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15043079|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
15043080|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15043081|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15043082|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043083|NCT02047474|Antidotes|antidotes|mesh-ancestor
15043084|NCT02047474|Protective Agents|protective agents|mesh-ancestor
15043085|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
15043086|NCT02047474|Vitamins|vitamins|mesh-ancestor
15043087|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
15043088|NCT02047539|Aspirin|aspirin|mesh-list
15043089|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15043090|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15043091|NCT02047539|Analgesics|analgesics|mesh-ancestor
15043092|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
15043093|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043094|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043095|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15043096|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15043097|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15043098|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15043099|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043100|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15043101|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15043102|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043103|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
15043104|NCT02047552|Iron|iron|mesh-list
15043105|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
15043106|NCT02047552|Oxandrolone|oxandrolone|mesh-list
15043107|NCT02047552|Trace Elements|trace elements|mesh-ancestor
15043108|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
15043109|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043110|NCT02047552|Hematinics|hematinics|mesh-ancestor
15043111|NCT02047552|Androgens|androgens|mesh-ancestor
15043112|NCT02047552|Hormones|hormones|mesh-ancestor
15043113|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15043114|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
15043115|NCT02047565|Edoxaban|edoxaban|mesh-list
15043116|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15043117|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
15043118|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15043119|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
15043120|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043121|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043122|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
15043123|NCT02047578|Busulfan|busulfan|mesh-list
15043124|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
15043125|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043126|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15043127|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
15043128|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043129|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15043130|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043131|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15043132|NCT02047630|Latanoprost|latanoprost|mesh-list
15043133|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15043134|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15043135|NCT02047773|Meropenem|meropenem|mesh-list
15043136|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15043137|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043138|NCT02047799|Calcitriol|calcitriol|mesh-list
15043139|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15043140|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043141|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15043142|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15043143|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043144|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15043145|NCT02047799|Vitamins|vitamins|mesh-ancestor
15043146|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
15043147|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15043148|NCT02047838|Hormones|hormones|mesh-list
15043149|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15043150|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15043151|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043152|NCT02048007|Azithromycin|azithromycin|mesh-list
15043153|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15043154|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043155|NCT02048020|Paclitaxel|paclitaxel|mesh-list
15043156|NCT02048020|Carboplatin|carboplatin|mesh-list
15043157|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15043158|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043159|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
15043160|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
15043161|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
15043162|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043163|NCT02048085|Clopidogrel|clopidogrel|mesh-list
15043164|NCT02048085|Ticagrelor|ticagrelor|mesh-list
15043165|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15043166|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15043167|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15043168|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15043169|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
15043170|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043171|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043172|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043173|NCT02048098|Misoprostol|misoprostol|mesh-list
15043174|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15043175|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
15043176|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15043177|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043178|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15043179|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15043180|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
15043181|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
15043182|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15043183|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043184|NCT02048215|Ephedrine|ephedrine|mesh-list
15043185|NCT02048215|Caffeine|caffeine|mesh-list
15043186|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15043187|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043188|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15043189|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043190|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043191|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15043192|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15043193|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
15043194|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043195|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
15043196|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
15043197|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043198|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15043199|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
15043200|NCT02048228|Clopidogrel|clopidogrel|mesh-list
15043201|NCT02048228|Ticagrelor|ticagrelor|mesh-list
15043202|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15043203|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15043204|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15043205|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15043206|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
15043207|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043208|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043209|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043210|NCT02048293|Remifentanil|remifentanil|mesh-list
15043211|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15043212|NCT02048293|Narcotics|narcotics|mesh-ancestor
15043213|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043214|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043215|NCT02048293|Analgesics|analgesics|mesh-ancestor
15043216|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
15043217|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043218|NCT02048319|Ethanol|ethanol|mesh-list
15043219|NCT02048319|Pasireotide|pasireotide|mesh-list
15043220|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15043221|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043222|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043223|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043224|NCT02048319|Hormones|hormones|mesh-ancestor
15043225|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15043226|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15043227|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
15043228|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15043229|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15043230|NCT02048358|Prednisolone|prednisolone|mesh-list
15043231|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
15043232|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15043233|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
15043234|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15043235|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
15043236|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
15043237|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043238|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043239|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15043240|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
15043241|NCT02048358|Hormones|hormones|mesh-ancestor
15043242|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15043243|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15043244|NCT02048358|Protective Agents|protective agents|mesh-ancestor
15043245|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15043246|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043247|NCT02048384|Metformin|metformin|mesh-list
15043248|NCT02048384|Sirolimus|sirolimus|mesh-list
15043249|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15043250|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043251|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15043252|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043253|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15043254|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043255|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
15043256|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15043257|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
15043258|NCT02048423|Ketamine|ketamine|mesh-list
15043259|NCT02048423|Analgesics|analgesics|mesh-ancestor
15043260|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
15043261|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043262|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043263|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15043264|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15043265|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
15043266|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
15043267|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043268|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15043269|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15043270|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043271|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043272|NCT02048475|Desflurane|desflurane|mesh-list
15043273|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15043274|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
15043275|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
15043276|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043277|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043278|NCT02048488|Belizatinib|belizatinib|mesh-list
15043279|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15043280|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043281|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043282|NCT02048540|Bevacizumab|bevacizumab|mesh-list
15043283|NCT02048540|Docetaxel|docetaxel|mesh-list
15043284|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
15043285|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15043286|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043287|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15043288|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15043289|NCT02048540|Growth Substances|growth substances|mesh-ancestor
15043290|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043291|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
15043292|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
15043293|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
15043294|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
15043295|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043296|NCT02048644|Beclomethasone|beclomethasone|mesh-list
15043297|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
15043298|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15043299|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
15043300|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043301|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043302|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15043303|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
15043304|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15043305|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15043306|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15043307|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
15043308|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043309|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043310|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15043311|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
15043312|NCT02048644|Hormones|hormones|mesh-ancestor
15043313|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15043314|NCT02048683|Sevoflurane|sevoflurane|mesh-list
15043315|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15043316|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15043317|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
15043318|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
15043319|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043320|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043321|NCT02048761|Metformin|metformin|mesh-list
15043322|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15043323|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043324|NCT02048800|Treosulfan|treosulfan|mesh-list
15043325|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15043326|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
15043327|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043328|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043329|NCT02048852|Menthol|menthol|mesh-list
15043330|NCT02048852|Nicotine|nicotine|mesh-list
15043331|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15043332|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
15043333|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043334|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043335|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15043336|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15043337|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
15043338|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043339|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043340|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
15043341|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
15043342|NCT02048865|Apixaban|apixaban|mesh-list
15043343|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15043344|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
15043345|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15043346|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
15043347|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043348|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043349|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
15043350|NCT02048917|Bupropion|bupropion|mesh-list
15043351|NCT02048917|Varenicline|varenicline|mesh-list
15043352|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15043353|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
15043354|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15043355|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15043356|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15043357|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15043358|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043359|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
15043360|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043361|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043362|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15043363|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15043364|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043365|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15043366|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15043367|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
15043368|NCT02048930|Budesonide|budesonide|mesh-list
15043369|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15043370|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15043371|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
15043372|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043373|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043374|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15043375|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
15043376|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
15043377|NCT02048930|Hormones|hormones|mesh-ancestor
15043378|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15043379|NCT02048943|Gemcitabine|gemcitabine|mesh-list
15043380|NCT02048943|Paclitaxel|paclitaxel|mesh-list
15043381|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15043382|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15043383|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043384|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
15043385|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
15043386|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
15043387|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043388|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15043389|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
15043390|NCT02048943|Antiviral Agents|antiviral agents|mesh-ancestor
15043391|NCT02048943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043392|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043393|NCT02048943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15043394|NCT02048943|Immunologic Factors|immunologic factors|mesh-ancestor
15043395|NCT02048943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043396|NCT02048969|Flumazenil|flumazenil|mesh-list
15043397|NCT02048969|Antidotes|antidotes|mesh-ancestor
15043398|NCT02048969|Protective Agents|protective agents|mesh-ancestor
15043399|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043400|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
15043401|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
15043402|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043403|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043404|NCT02049034|Lixisenatide|lixisenatide|mesh-list
15043405|NCT02049034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15043406|NCT02049034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043407|NCT02049047|Everolimus|everolimus|mesh-list
15043408|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043409|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15043410|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
15043411|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043412|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
15043413|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15043414|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15043415|NCT02049073|Prednisolone|prednisolone|mesh-list
15043416|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
15043417|NCT02049073|Zonisamide|zonisamide|mesh-list
15043418|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15043419|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
15043420|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15043421|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
15043422|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
15043423|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043424|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043425|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15043426|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
15043427|NCT02049073|Hormones|hormones|mesh-ancestor
15043428|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15043429|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15043430|NCT02049073|Protective Agents|protective agents|mesh-ancestor
15043431|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15043432|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043433|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
15043434|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15043435|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15043436|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043437|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15043438|NCT02049138|Upadacitinib|upadacitinib|mesh-list
15043439|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
15043440|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15043441|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043442|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043443|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15043444|NCT02049190|Onapristone|onapristone|mesh-list
15043445|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043446|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15043447|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
15043448|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15043449|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043450|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
15043451|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15043452|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
15043453|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
15043454|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043455|NCT02049229|Everolimus|everolimus|mesh-list
15043456|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043457|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15043458|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
15043459|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043460|NCT02049255|Bupivacaine|bupivacaine|mesh-list
15043461|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
15043462|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
15043463|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
15043464|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043465|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043466|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
15043467|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043468|NCT02049268|Ethanol|ethanol|mesh-list
15043469|NCT02049268|Nicotine|nicotine|mesh-list
15043470|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15043471|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
15043472|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043473|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043474|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15043475|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15043476|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
15043477|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043478|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043479|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15043480|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043481|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043482|NCT02049294|Omalizumab|omalizumab|mesh-list
15043483|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15043484|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15043485|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
15043486|NCT02049320|Remifentanil|remifentanil|mesh-list
15043487|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15043488|NCT02049320|Narcotics|narcotics|mesh-ancestor
15043489|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043490|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043491|NCT02049320|Analgesics|analgesics|mesh-ancestor
15043492|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
15043493|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043494|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
15043495|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
15043496|NCT02049346|Hematinics|hematinics|mesh-ancestor
15043497|NCT02049411|Ketamine|ketamine|mesh-list
15043498|NCT02049411|Analgesics|analgesics|mesh-ancestor
15043499|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
15043500|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043501|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043502|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15043503|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15043504|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
15043505|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
15043506|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043507|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15043508|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15043509|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043510|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043511|NCT02049515|Ofatumumab|ofatumumab|mesh-list
15043512|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043513|NCT02049541|Rituximab|rituximab|mesh-list
15043514|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15043515|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043516|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
15043517|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043518|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15043519|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
15043520|NCT02049580|Thiotepa|thiotepa|mesh-list
15043521|NCT02049580|Fludarabine|fludarabine|mesh-list
15043522|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15043523|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
15043524|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043525|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15043526|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15043527|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
15043528|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043529|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043530|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15043531|NCT02049593|Irinotecan|irinotecan|mesh-list
15043532|NCT02049593|Temozolomide|temozolomide|mesh-list
15043533|NCT02049593|Talazoparib|talazoparib|mesh-list
15043534|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15043535|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15043536|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15043537|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043538|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043539|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043540|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15043541|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
15043542|NCT02049606|Nabumetone|nabumetone|mesh-list
15043543|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15043544|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15043545|NCT02049606|Analgesics|analgesics|mesh-ancestor
15043546|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
15043547|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043548|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043549|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15043550|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15043551|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15043552|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15043553|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043554|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043555|NCT02049671|Hormones|hormones|mesh-list
15043556|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15043557|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043558|NCT02049736|Telbivudine|telbivudine|mesh-list
15043559|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
15043560|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043561|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15043562|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043563|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043564|NCT02049762|Aspirin|aspirin|mesh-list
15043565|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15043566|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15043567|NCT02049762|Analgesics|analgesics|mesh-ancestor
15043568|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
15043569|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043570|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043571|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15043572|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15043573|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15043574|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15043575|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043576|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15043577|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15043578|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043579|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
15043580|NCT02049801|Cytarabine|cytarabine|mesh-list
15043581|NCT02049801|Idarubicin|idarubicin|mesh-list
15043582|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15043583|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
15043584|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043585|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043586|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
15043587|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043588|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15043589|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
15043590|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043591|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15043592|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15043593|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15043594|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043595|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
15043596|NCT02049970|Bupivacaine|bupivacaine|mesh-list
15043597|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
15043598|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
15043599|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043600|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043601|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
15043602|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043603|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15043604|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15043605|NCT02049970|Analgesics|analgesics|mesh-ancestor
15043606|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15043607|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15043608|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15043609|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
15043610|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043611|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043612|NCT02050009|Metformin|metformin|mesh-list
15043613|NCT02050009|Paclitaxel|paclitaxel|mesh-list
15043614|NCT02050009|Carboplatin|carboplatin|mesh-list
15043615|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15043616|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043617|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
15043618|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
15043619|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
15043620|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043621|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15043622|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043623|NCT02050074|Metformin|metformin|mesh-list
15043624|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
15043625|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15043626|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043627|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15043628|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15043629|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
15043630|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043631|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15043632|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
15043633|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15043634|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
15043635|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
15043636|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043637|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043638|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15043639|NCT02050152|Analgesics|analgesics|mesh-ancestor
15043640|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
15043641|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043642|NCT02050178|Gemcitabine|gemcitabine|mesh-list
15043643|NCT02050178|Paclitaxel|paclitaxel|mesh-list
15043644|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15043645|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043646|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
15043647|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
15043648|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
15043649|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043650|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15043651|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
15043652|NCT02050178|Antiviral Agents|antiviral agents|mesh-ancestor
15043653|NCT02050178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043654|NCT02050178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043655|NCT02050178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15043656|NCT02050178|Immunologic Factors|immunologic factors|mesh-ancestor
15043657|NCT02050178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043658|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
15043659|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
15043660|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15043661|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15043662|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043663|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043664|NCT02050360|Urological Agents|urological agents|mesh-ancestor
15043665|NCT02050529|Hydralazine|hydralazine|mesh-list
15043666|NCT02050529|Labetalol|labetalol|mesh-list
15043667|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15043668|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
15043669|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15043670|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15043671|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
15043672|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043673|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043674|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043675|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
15043676|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
15043677|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043678|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15043679|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15043680|NCT02050594|Ipilimumab|ipilimumab|mesh-list
15043681|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15043682|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043683|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15043684|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043685|NCT02050672|Inositol|inositol|mesh-list
15043686|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
15043687|NCT02050672|Vitamins|vitamins|mesh-ancestor
15043688|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
15043689|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043690|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
15043691|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15043692|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043693|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
15043694|NCT02050802|Macitentan|macitentan|mesh-list
15043695|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15043696|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043697|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15043698|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15043699|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043700|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043701|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043702|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
15043703|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15043704|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
15043705|NCT02050893|Midazolam|midazolam|mesh-list
15043706|NCT02050893|Propofol|propofol|mesh-list
15043707|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15043708|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043709|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043710|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15043711|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
15043712|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
15043713|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15043714|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15043715|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15043716|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15043717|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
15043718|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
15043719|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043720|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043721|NCT02050958|Ibuprofen|ibuprofen|mesh-list
15043722|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15043723|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15043724|NCT02050958|Analgesics|analgesics|mesh-ancestor
15043725|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
15043726|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043727|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043728|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15043729|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15043730|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15043731|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043732|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043733|NCT02051023|Fluorometholone|fluorometholone|mesh-list
15043734|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
15043735|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15043736|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15043737|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15043738|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
15043739|NCT02051023|Hormones|hormones|mesh-ancestor
15043740|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15043741|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043742|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15043743|NCT02051153|Modafinil|modafinil|mesh-list
15043744|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15043745|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043746|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15043747|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15043748|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15043749|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043750|NCT02051231|Oxytocin|oxytocin|mesh-list
15043751|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
15043752|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15043753|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043754|NCT02051387|Cannabidiol|cannabidiol|mesh-list
15043755|NCT02051387|Olanzapine|olanzapine|mesh-list
15043756|NCT02051387|Risperidone|risperidone|mesh-list
15043757|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15043758|NCT02051387|Amisulpride|amisulpride|mesh-list
15043759|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15043760|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
15043761|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043762|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043763|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043764|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15043765|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15043766|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043767|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15043768|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15043769|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
15043770|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
15043771|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
15043772|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043773|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15043774|NCT02051387|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15043775|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15043776|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15043777|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
15043778|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
15043779|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15043780|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15043781|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15043782|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15043783|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15043784|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043785|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043786|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043787|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15043788|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
15043789|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15043790|NCT02051530|Tryptophan|tryptophan|mesh-list
15043791|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15043792|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
15043793|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15043794|NCT02051569|Tryptophan|tryptophan|mesh-list
15043795|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15043796|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
15043797|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15043798|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
15043799|NCT02051738|Mebendazole|mebendazole|mesh-list
15043800|NCT02051738|Piperazine|piperazine|mesh-list
15043801|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
15043802|NCT02051738|DMP 777|dmp 777|mesh-list
15043803|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
15043804|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
15043805|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15043806|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043807|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
15043808|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
15043809|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
15043810|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043811|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043812|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043813|NCT02051751|Paclitaxel|paclitaxel|mesh-list
15043814|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15043815|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043816|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
15043817|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
15043818|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
15043819|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043820|NCT02051842|Metadoxine|metadoxine|mesh-list
15043821|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15043822|NCT02051868|Paclitaxel|paclitaxel|mesh-list
15043823|NCT02051868|Carboplatin|carboplatin|mesh-list
15043824|NCT02051868|Fluorouracil|fluorouracil|mesh-list
15043825|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15043826|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043827|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
15043828|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
15043829|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
15043830|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043831|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
15043832|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15043833|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15043834|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
15043835|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043836|NCT02051894|Dobutamine|dobutamine|mesh-list
15043837|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15043838|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
15043839|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
15043840|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043841|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043842|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15043843|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15043844|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15043845|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
15043846|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043847|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043848|NCT02051894|Protective Agents|protective agents|mesh-ancestor
15043849|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
15043850|NCT02051946|Diuretics|diuretics|mesh-ancestor
15043851|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
15043852|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043853|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043854|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043855|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
15043856|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
15043857|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15043858|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15043859|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15043860|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15043861|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043862|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
15043863|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043864|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043865|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15043866|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043867|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15043868|NCT02052128|Onapristone|onapristone|mesh-list
15043869|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043870|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15043871|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
15043872|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15043873|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043874|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
15043875|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15043876|NCT02052154|Vaccines|vaccines|mesh-list
15043877|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
15043878|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043879|NCT02052167|Methotrexate|methotrexate|mesh-list
15043880|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15043881|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
15043882|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15043883|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043884|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15043885|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
15043886|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043887|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043888|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
15043889|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043890|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15043891|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15043892|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
15043893|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15043894|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15043895|NCT02052180|Bupivacaine|bupivacaine|mesh-list
15043896|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
15043897|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
15043898|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15043899|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043900|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
15043901|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043902|NCT02052193|Vemurafenib|vemurafenib|mesh-list
15043903|NCT02052193|Dabrafenib|dabrafenib|mesh-list
15043904|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043905|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15043906|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043907|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043908|NCT02052258|Oxytocin|oxytocin|mesh-list
15043909|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
15043910|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15043911|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043912|NCT02052323|Artesunate|artesunate|mesh-list
15043913|NCT02052323|Mefloquine|mefloquine|mesh-list
15043914|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
15043915|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15043916|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15043917|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043918|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043919|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
15043920|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
15043921|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15043922|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
15043923|NCT02052336|Clarithromycin|clarithromycin|mesh-list
15043924|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15043925|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043926|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15043927|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043928|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043929|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15043930|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15043931|NCT02052388|Daptomycin|daptomycin|mesh-list
15043932|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15043933|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043934|NCT02052492|Vitamin D|vitamin d|mesh-list
15043935|NCT02052492|Vitamins|vitamins|mesh-ancestor
15043936|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
15043937|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043938|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15043939|NCT02052609|Brodalumab|brodalumab|mesh-list
15043940|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
15043941|NCT02052687|Imiquimod|imiquimod|mesh-list
15043942|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15043943|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
15043944|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043945|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15043946|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
15043947|NCT02052713|Tamsulosin|tamsulosin|mesh-list
15043948|NCT02052713|Dutasteride|dutasteride|mesh-list
15043949|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15043950|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15043951|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15043952|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
15043953|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043954|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043955|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043956|NCT02052713|Urological Agents|urological agents|mesh-ancestor
15043957|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15043958|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15043959|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043960|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
15043961|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15043962|NCT02052726|Vaccines|vaccines|mesh-list
15043963|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
15043964|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043965|NCT02052908|Naproxen|naproxen|mesh-list
15043966|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15043967|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15043968|NCT02052908|Analgesics|analgesics|mesh-ancestor
15043969|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
15043970|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15043971|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043972|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15043973|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15043974|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
15043975|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15043976|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043977|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043978|NCT02052934|Vaccines|vaccines|mesh-list
15043979|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
15043980|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043981|NCT02052973|Propolis|propolis|mesh-list
15043982|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043983|NCT02053142|Acyclovir|acyclovir|mesh-list
15043984|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
15043985|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15043986|NCT02053298|Timolol|timolol|mesh-list
15043987|NCT02053298|Dorzolamide|dorzolamide|mesh-list
15043988|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15043989|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15043990|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
15043991|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15043992|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15043993|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15043994|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15043995|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15043996|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15043997|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15043998|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
15043999|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15044000|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15044001|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044002|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
15044003|NCT02053363|Coagulants|coagulants|mesh-ancestor
15044004|NCT02053402|Vitamin D|vitamin d|mesh-list
15044005|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
15044006|NCT02053402|Vitamins|vitamins|mesh-ancestor
15044007|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
15044008|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044009|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15044010|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15044011|NCT02053519|Vitamin D|vitamin d|mesh-list
15044012|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
15044013|NCT02053519|Vitamins|vitamins|mesh-ancestor
15044014|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
15044015|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044016|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15044017|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15044018|NCT02053558|Lidocaine|lidocaine|mesh-list
15044019|NCT02053558|Ropivacaine|ropivacaine|mesh-list
15044020|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
15044021|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
15044022|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15044023|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044024|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
15044025|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044026|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15044027|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15044028|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15044029|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15044030|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044031|NCT02053597|Paclitaxel|paclitaxel|mesh-list
15044032|NCT02053597|Doxorubicin|doxorubicin|mesh-list
15044033|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15044034|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044035|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
15044036|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
15044037|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
15044038|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044039|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15044040|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15044041|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15044042|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044043|NCT02053675|Vasopressins|vasopressins|mesh-list
15044044|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
15044045|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
15044046|NCT02053675|Coagulants|coagulants|mesh-ancestor
15044047|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15044048|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15044049|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
15044050|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044051|NCT02053727|Abatacept|abatacept|mesh-list
15044052|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15044053|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044054|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044055|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15044056|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
15044057|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044058|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15044059|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
15044060|NCT02053766|Propofol|propofol|mesh-list
15044061|NCT02053766|Sevoflurane|sevoflurane|mesh-list
15044062|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15044063|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15044064|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044065|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15044066|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
15044067|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
15044068|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15044069|NCT02053766|Analgesics|analgesics|mesh-ancestor
15044070|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
15044071|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044072|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15044073|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15044074|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15044075|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
15044076|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044077|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044078|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15044079|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15044080|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15044081|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
15044082|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15044083|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
15044084|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15044085|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044086|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15044087|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15044088|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044089|NCT02053818|Sufentanil|sufentanil|mesh-list
15044090|NCT02053818|Remifentanil|remifentanil|mesh-list
15044091|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15044092|NCT02053818|Narcotics|narcotics|mesh-ancestor
15044093|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15044094|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044095|NCT02053818|Analgesics|analgesics|mesh-ancestor
15044096|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
15044097|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044098|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15044099|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15044100|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
15044101|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
15044102|NCT02053857|Amoxicillin|amoxicillin|mesh-list
15044103|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15044104|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044105|NCT02053909|Aspirin|aspirin|mesh-list
15044106|NCT02053909|Ticagrelor|ticagrelor|mesh-list
15044107|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15044108|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15044109|NCT02053909|Analgesics|analgesics|mesh-ancestor
15044110|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
15044111|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044112|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044113|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15044114|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15044115|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15044116|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15044117|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044118|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15044119|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15044120|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044121|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
15044122|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15044123|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15044124|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15044125|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
15044126|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044127|NCT02053922|Misoprostol|misoprostol|mesh-list
15044128|NCT02053922|Oxytocin|oxytocin|mesh-list
15044129|NCT02053922|Carbetocin|carbetocin|mesh-list
15044130|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15044131|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
15044132|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15044133|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044134|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15044135|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15044136|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
15044137|NCT02053935|Dopamine|dopamine|mesh-list
15044138|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15044139|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
15044140|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
15044141|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044142|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044143|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
15044144|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044145|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044146|NCT02053935|Protective Agents|protective agents|mesh-ancestor
15044147|NCT02053974|Spironolactone|spironolactone|mesh-list
15044148|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15044149|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
15044150|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15044151|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044152|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15044153|NCT02053974|Diuretics|diuretics|mesh-ancestor
15044154|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
15044155|NCT02054000|Tirofiban|tirofiban|mesh-list
15044156|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15044157|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15044158|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044159|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15044160|NCT02054052|Bevacizumab|bevacizumab|mesh-list
15044161|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15044162|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044163|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15044164|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15044165|NCT02054052|Growth Substances|growth substances|mesh-ancestor
15044166|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044167|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
15044168|NCT02054078|Bevacizumab|bevacizumab|mesh-list
15044169|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15044170|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044171|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15044172|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15044173|NCT02054078|Growth Substances|growth substances|mesh-ancestor
15044174|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044175|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
15044176|NCT02054143|Sevoflurane|sevoflurane|mesh-list
15044177|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15044178|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15044179|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
15044180|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
15044181|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15044182|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044183|NCT02054182|Vitamin D|vitamin d|mesh-list
15044184|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
15044185|NCT02054182|Vitamins|vitamins|mesh-ancestor
15044186|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
15044187|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044188|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15044189|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15044190|NCT02054299|Thiamine|thiamine|mesh-list
15044191|NCT02054299|Proguanil|proguanil|mesh-list
15044192|NCT02054299|Sumatriptan|sumatriptan|mesh-list
15044193|NCT02054299|Amitriptyline|amitriptyline|mesh-list
15044194|NCT02054299|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15044195|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15044196|NCT02054299|Fenoterol|fenoterol|mesh-list
15044197|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15044198|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15044199|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15044200|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
15044201|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044202|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044203|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044204|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15044205|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
15044206|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15044207|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15044208|NCT02054299|Analgesics|analgesics|mesh-ancestor
15044209|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
15044210|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044211|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15044212|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15044213|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15044214|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
15044215|NCT02054299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15044216|NCT02054299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15044217|NCT02054299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15044218|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15044219|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
15044220|NCT02054299|Vitamins|vitamins|mesh-ancestor
15044221|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
15044222|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
15044223|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15044224|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15044225|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044226|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
15044227|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15044228|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
15044229|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15044230|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
15044231|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
15044232|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
15044233|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15044234|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15044235|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15044236|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15044237|NCT02054429|Insulin|insulin|mesh-list
15044238|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15044239|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15044240|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044241|NCT02054442|Methotrexate|methotrexate|mesh-list
15044242|NCT02054442|Cetuximab|cetuximab|mesh-list
15044243|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15044244|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
15044245|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15044246|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044247|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15044248|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
15044249|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044250|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044251|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
15044252|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044253|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15044254|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15044255|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
15044256|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15044257|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15044258|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15044259|NCT02054468|Remifentanil|remifentanil|mesh-list
15044260|NCT02054468|Propofol|propofol|mesh-list
15044261|NCT02054468|Rocuronium|rocuronium|mesh-list
15044262|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15044263|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15044264|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044265|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15044266|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
15044267|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
15044268|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15044269|NCT02054468|Narcotics|narcotics|mesh-ancestor
15044270|NCT02054468|Analgesics|analgesics|mesh-ancestor
15044271|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
15044272|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044273|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15044274|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15044275|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15044276|NCT02054637|Lanreotide|lanreotide|mesh-list
15044277|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044278|NCT02054663|Clopidogrel|clopidogrel|mesh-list
15044279|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15044280|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15044281|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15044282|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15044283|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
15044284|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044285|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044286|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044287|NCT02054676|Ibuprofen|ibuprofen|mesh-list
15044288|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15044289|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15044290|NCT02054676|Analgesics|analgesics|mesh-ancestor
15044291|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
15044292|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044293|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044294|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15044295|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15044296|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15044297|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044298|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044299|NCT02054793|Itraconazole|itraconazole|mesh-list
15044300|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
15044301|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044302|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15044303|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15044304|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044305|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044306|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15044307|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
15044308|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15044309|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044310|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15044311|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
15044312|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15044313|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044314|NCT02054884|Paclitaxel|paclitaxel|mesh-list
15044315|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15044316|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15044317|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044318|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
15044319|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
15044320|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
15044321|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044322|NCT02054936|Warfarin|warfarin|mesh-list
15044323|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
15044324|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
15044325|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15044326|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
15044327|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15044328|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
15044329|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044330|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044331|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
15044332|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15044333|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
15044334|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044335|NCT02054949|Expectorants|expectorants|mesh-ancestor
15044336|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
15044337|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15044338|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
15044339|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044340|NCT02054949|Protective Agents|protective agents|mesh-ancestor
15044341|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044342|NCT02054949|Antidotes|antidotes|mesh-ancestor
15044343|NCT02054975|Vitamin D|vitamin d|mesh-list
15044344|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
15044345|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
15044346|NCT02054975|Vitamins|vitamins|mesh-list
15044347|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
15044348|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044349|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15044350|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15044351|NCT02054988|Caffeine|caffeine|mesh-list
15044352|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15044353|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044354|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15044355|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044356|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044357|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15044358|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15044359|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
15044360|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044361|NCT02055014|Liraglutide|liraglutide|mesh-list
15044362|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15044363|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044364|NCT02055014|Incretins|incretins|mesh-ancestor
15044365|NCT02055014|Hormones|hormones|mesh-ancestor
15044366|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15044367|NCT02055079|Sirolimus|sirolimus|mesh-list
15044368|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15044369|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044370|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15044371|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044372|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
15044373|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15044374|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
15044375|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044376|NCT02055131|Aspirin|aspirin|mesh-list
15044377|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15044378|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15044379|NCT02055131|Analgesics|analgesics|mesh-ancestor
15044380|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
15044381|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044382|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044383|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15044384|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15044385|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15044386|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15044387|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044388|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15044389|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15044390|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044391|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
15044392|NCT02055170|Finasteride|finasteride|mesh-list
15044393|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15044394|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15044395|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044396|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044397|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
15044398|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15044399|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044400|NCT02055170|Urological Agents|urological agents|mesh-ancestor
15044401|NCT02055183|Antitoxins|antitoxins|mesh-list
15044402|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
15044403|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
15044404|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044405|NCT02055196|Irinotecan|irinotecan|mesh-list
15044406|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15044407|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15044408|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044409|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044410|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044411|NCT02055274|Rotigotine|rotigotine|mesh-list
15044412|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
15044413|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
15044414|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044415|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044416|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044417|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15044418|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15044419|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15044420|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15044421|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044422|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044423|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044424|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
15044425|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15044426|NCT02055378|Atropine|atropine|mesh-list
15044427|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15044428|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15044429|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15044430|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
15044431|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044432|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044433|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15044434|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
15044435|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
15044436|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
15044437|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15044438|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15044439|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
15044440|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044441|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044442|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
15044443|NCT02055456|Nandrolone|nandrolone|mesh-list
15044444|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
15044445|NCT02055456|Androgens|androgens|mesh-ancestor
15044446|NCT02055456|Hormones|hormones|mesh-ancestor
15044447|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15044448|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044449|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
15044450|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15044451|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
15044452|NCT02055482|Hematinics|hematinics|mesh-ancestor
15044453|NCT02055586|Alovudine|alovudine|mesh-list
15044454|NCT02055586|Fluorides|fluorides|mesh-list
15044455|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
15044456|NCT02055586|Protective Agents|protective agents|mesh-ancestor
15044457|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044458|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
15044459|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044460|NCT02055664|Ropivacaine|ropivacaine|mesh-list
15044461|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
15044462|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
15044463|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15044464|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044465|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
15044466|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044467|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
15044468|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15044469|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044470|NCT02055703|Itraconazole|itraconazole|mesh-list
15044471|NCT02055703|Rifampin|rifampin|mesh-list
15044472|NCT02055703|Digoxin|digoxin|mesh-list
15044473|NCT02055703|Donepezil|donepezil|mesh-list
15044474|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15044475|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044476|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044477|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
15044478|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044479|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044480|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
15044481|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
15044482|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044483|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15044484|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15044485|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15044486|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
15044487|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15044488|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15044489|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15044490|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
15044491|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15044492|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
15044493|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15044494|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15044495|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15044496|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15044497|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15044498|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15044499|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15044500|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15044501|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15044502|NCT02055703|Protective Agents|protective agents|mesh-ancestor
15044503|NCT02055716|Sulforaphane|sulforaphane|mesh-list
15044504|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15044505|NCT02055716|Protective Agents|protective agents|mesh-ancestor
15044506|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044507|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044508|NCT02055911|Ranibizumab|ranibizumab|mesh-list
15044509|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15044510|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15044511|NCT02055911|Growth Substances|growth substances|mesh-ancestor
15044512|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044513|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
15044514|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044515|NCT02056041|Liver Extracts|liver extracts|mesh-list
15044516|NCT02056041|Hematinics|hematinics|mesh-ancestor
15044517|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
15044518|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15044519|NCT02056184|Adalimumab|adalimumab|mesh-list
15044520|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15044521|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15044522|NCT02056210|Plerixafor|plerixafor|mesh-list
15044523|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15044524|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15044525|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
15044526|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044527|NCT02056223|Acetaminophen|acetaminophen|mesh-list
15044528|NCT02056223|Ibuprofen|ibuprofen|mesh-list
15044529|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15044530|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15044531|NCT02056223|Analgesics|analgesics|mesh-ancestor
15044532|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
15044533|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044534|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044535|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15044536|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15044537|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15044538|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044539|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044540|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
15044541|NCT02056249|Norepinephrine|norepinephrine|mesh-list
15044542|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15044543|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15044544|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
15044545|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044546|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044547|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044548|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
15044549|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
15044550|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044551|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15044552|NCT02056353|Insulin|insulin|mesh-list
15044553|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15044554|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044555|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
15044556|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
15044557|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044558|NCT02056366|Protective Agents|protective agents|mesh-ancestor
15044559|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044560|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
15044561|NCT02056366|Vitamins|vitamins|mesh-ancestor
15044562|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
15044563|NCT02056379|Dexamethasone|dexamethasone|mesh-list
15044564|NCT02056379|Budesonide|budesonide|mesh-list
15044565|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15044566|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
15044567|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
15044568|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044569|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044570|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15044571|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
15044572|NCT02056379|Hormones|hormones|mesh-ancestor
15044573|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15044574|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15044575|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044576|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15044577|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15044578|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
15044579|NCT02056405|Mosapride|mosapride|mesh-list
15044580|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15044581|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15044582|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
15044583|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044584|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044585|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044586|NCT02056418|Prednisone|prednisone|mesh-list
15044587|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
15044588|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15044589|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
15044590|NCT02056418|Hormones|hormones|mesh-ancestor
15044591|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15044592|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044593|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15044594|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044595|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
15044596|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15044597|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15044598|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044599|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
15044600|NCT02056444|Coagulants|coagulants|mesh-ancestor
15044601|NCT02056587|Everolimus|everolimus|mesh-list
15044602|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044603|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15044604|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
15044605|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044606|NCT02056600|Metformin|metformin|mesh-list
15044607|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15044608|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044609|NCT02056665|Minocycline|minocycline|mesh-list
15044610|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15044611|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044612|NCT02056678|Acetaminophen|acetaminophen|mesh-list
15044613|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15044614|NCT02056678|Analgesics|analgesics|mesh-ancestor
15044615|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
15044616|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044617|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044618|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
15044619|NCT02056717|Dexamethasone|dexamethasone|mesh-list
15044620|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15044621|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
15044622|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
15044623|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044624|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044625|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15044626|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
15044627|NCT02056717|Hormones|hormones|mesh-ancestor
15044628|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15044629|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15044630|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044631|NCT02056730|Calcium|calcium|mesh-list
15044632|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15044633|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044634|NCT02056743|Fexofenadine|fexofenadine|mesh-list
15044635|NCT02056743|Losartan|losartan|mesh-list
15044636|NCT02056743|Midazolam|midazolam|mesh-list
15044637|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
15044638|NCT02056743|Caffeine|caffeine|mesh-list
15044639|NCT02056743|Omeprazole|omeprazole|mesh-list
15044640|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15044641|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15044642|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15044643|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044644|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15044645|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15044646|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15044647|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15044648|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
15044649|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
15044650|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
15044651|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
15044652|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044653|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044654|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15044655|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15044656|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15044657|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15044658|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15044659|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15044660|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15044661|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044662|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15044663|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15044664|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15044665|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15044666|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
15044667|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
15044668|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
15044669|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15044670|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15044671|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15044672|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15044673|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15044674|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
15044675|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
15044676|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
15044677|NCT02056847|Pitavastatin|pitavastatin|mesh-list
15044678|NCT02056847|Calcium|calcium|mesh-list
15044679|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15044680|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044681|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15044682|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15044683|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15044684|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15044685|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
15044686|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044687|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044688|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15044689|NCT02056899|Gabapentin|gabapentin|mesh-list
15044690|NCT02056899|Analgesics|analgesics|mesh-ancestor
15044691|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
15044692|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044693|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044694|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
15044695|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15044696|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15044697|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15044698|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15044699|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15044700|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15044701|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044702|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044703|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
15044704|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15044705|NCT02056938|Basiliximab|basiliximab|mesh-list
15044706|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
15044707|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044708|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15044709|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
15044710|NCT02057003|Grazoprevir|grazoprevir|mesh-list
15044711|NCT02057003|Ledipasvir|ledipasvir|mesh-list
15044712|NCT02057003|Velpatasvir|velpatasvir|mesh-list
15044713|NCT02057003|Simeprevir|simeprevir|mesh-list
15044714|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
15044715|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044716|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
15044717|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044718|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044719|NCT02057094|Caseins|caseins|mesh-list
15044720|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
15044721|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
15044722|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044723|NCT02057107|Docetaxel|docetaxel|mesh-list
15044724|NCT02057107|Cetuximab|cetuximab|mesh-list
15044725|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044726|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
15044727|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
15044728|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
15044729|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044730|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15044731|NCT02057263|Alendronate|alendronate|mesh-list
15044732|NCT02057263|Diphosphonates|diphosphonates|mesh-list
15044733|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15044734|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044735|NCT02057289|Micafungin|micafungin|mesh-list
15044736|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
15044737|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044738|NCT02057328|Telmisartan|telmisartan|mesh-list
15044739|NCT02057328|Nebivolol|nebivolol|mesh-list
15044740|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15044741|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15044742|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15044743|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044744|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
15044745|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15044746|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15044747|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15044748|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
15044749|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044750|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044751|NCT02057367|Bupivacaine|bupivacaine|mesh-list
15044752|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
15044753|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
15044754|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15044755|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044756|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
15044757|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044758|NCT02057484|Tacrolimus|tacrolimus|mesh-list
15044759|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15044760|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
15044761|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044762|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15044763|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044764|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044765|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
15044766|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
15044767|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
15044768|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15044769|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044770|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
15044771|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044772|NCT02057679|Amoxicillin|amoxicillin|mesh-list
15044773|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15044774|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044775|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
15044776|NCT02057770|Busulfan|busulfan|mesh-list
15044777|NCT02057770|Fludarabine|fludarabine|mesh-list
15044778|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
15044779|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15044780|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
15044781|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044782|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15044783|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15044784|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
15044785|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044786|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044787|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15044788|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15044789|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
15044790|NCT02057796|Efavirenz|efavirenz|mesh-list
15044791|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15044792|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15044793|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
15044794|NCT02057796|Rifampin|rifampin|mesh-list
15044795|NCT02057796|Isoniazid|isoniazid|mesh-list
15044796|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
15044797|NCT02057796|Ethambutol|ethambutol|mesh-list
15044798|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15044799|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15044800|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044801|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044802|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
15044803|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044804|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15044805|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15044806|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15044807|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15044808|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15044809|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15044810|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15044811|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15044812|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15044813|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
15044814|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15044815|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
15044816|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15044817|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15044818|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15044819|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15044820|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15044821|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
15044822|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15044823|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15044824|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
15044825|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044826|NCT02057926|Tetracycline|tetracycline|mesh-list
15044827|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15044828|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044829|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15044830|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044831|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044832|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
15044833|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15044834|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15044835|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044836|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
15044837|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
15044838|NCT02058173|Chloroquine|chloroquine|mesh-list
15044839|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15044840|NCT02058173|Amebicides|amebicides|mesh-ancestor
15044841|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15044842|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15044843|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15044844|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
15044845|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15044846|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15044847|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15044848|NCT02058173|Analgesics|analgesics|mesh-ancestor
15044849|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
15044850|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044851|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044852|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15044853|NCT02058173|Filaricides|filaricides|mesh-ancestor
15044854|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
15044855|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
15044856|NCT02058186|Vitamin D|vitamin d|mesh-list
15044857|NCT02058186|Vitamins|vitamins|mesh-ancestor
15044858|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
15044859|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044860|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15044861|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
15044862|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15044863|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
15044864|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15044865|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
15044866|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044867|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044868|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
15044869|NCT02058212|Vitamin E|vitamin e|mesh-list
15044870|NCT02058212|Selenium|selenium|mesh-list
15044871|NCT02058212|Vitamins|vitamins|mesh-ancestor
15044872|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
15044873|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044874|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
15044875|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044876|NCT02058212|Protective Agents|protective agents|mesh-ancestor
15044877|NCT02058212|Trace Elements|trace elements|mesh-ancestor
15044878|NCT02058277|Aprepitant|aprepitant|mesh-list
15044879|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
15044880|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
15044881|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044882|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044883|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15044884|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15044885|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044886|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044887|NCT02058303|Bupivacaine|bupivacaine|mesh-list
15044888|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
15044889|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
15044890|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15044891|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044892|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
15044893|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044894|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15044895|NCT02058433|Paclitaxel|paclitaxel|mesh-list
15044896|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15044897|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15044898|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044899|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
15044900|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
15044901|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
15044902|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044903|NCT02058446|Amlodipine|amlodipine|mesh-list
15044904|NCT02058446|Valsartan|valsartan|mesh-list
15044905|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
15044906|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15044907|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15044908|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15044909|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044910|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15044911|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044912|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
15044913|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15044914|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15044915|NCT02058485|Midazolam|midazolam|mesh-list
15044916|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
15044917|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15044918|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15044919|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044920|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15044921|NCT02058485|Analgesics|analgesics|mesh-ancestor
15044922|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
15044923|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044924|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15044925|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15044926|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15044927|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
15044928|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044929|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044930|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15044931|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15044932|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15044933|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15044934|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15044935|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
15044936|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
15044937|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
15044938|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
15044939|NCT02058576|Tamsulosin|tamsulosin|mesh-list
15044940|NCT02058576|Dutasteride|dutasteride|mesh-list
15044941|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15044942|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15044943|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15044944|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
15044945|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044946|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044947|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044948|NCT02058576|Urological Agents|urological agents|mesh-ancestor
15044949|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15044950|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15044951|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044952|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
15044953|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15044954|NCT02058641|Darapladib|darapladib|mesh-list
15044955|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
15044956|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15044957|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044958|NCT02058667|Paclitaxel|paclitaxel|mesh-list
15044959|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15044960|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044961|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
15044962|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
15044963|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
15044964|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044965|NCT02058693|Amphetamine|amphetamine|mesh-list
15044966|NCT02058693|Adderall|adderall|mesh-list
15044967|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15044968|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044969|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
15044970|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
15044971|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15044972|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
15044973|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15044974|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15044975|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
15044976|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15044977|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15044978|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15044979|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15044980|NCT02058706|Leuprolide|leuprolide|mesh-list
15044981|NCT02058706|Goserelin|goserelin|mesh-list
15044982|NCT02058706|Bicalutamide|bicalutamide|mesh-list
15044983|NCT02058706|Androgens|androgens|mesh-list
15044984|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15044985|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
15044986|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15044987|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15044988|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15044989|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15044990|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
15044991|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
15044992|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15044993|NCT02058706|Hormones|hormones|mesh-ancestor
15044994|NCT02058823|Amlodipine|amlodipine|mesh-list
15044995|NCT02058823|Valsartan|valsartan|mesh-list
15044996|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15044997|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15044998|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15044999|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045000|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15045001|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045002|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
15045003|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15045004|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15045005|NCT02058875|Cyclosporine|cyclosporine|mesh-list
15045006|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
15045007|NCT02058875|Prednisone|prednisone|mesh-list
15045008|NCT02058875|Cyclosporins|cyclosporins|mesh-list
15045009|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15045010|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
15045011|NCT02058875|Hormones|hormones|mesh-ancestor
15045012|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15045013|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045014|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15045015|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045016|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045017|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045018|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15045019|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
15045020|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
15045021|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045022|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
15045023|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15045024|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15045025|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15045026|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15045027|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
15045028|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15045029|NCT02058901|Sunitinib|sunitinib|mesh-list
15045030|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045031|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15045032|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15045033|NCT02058901|Growth Substances|growth substances|mesh-ancestor
15045034|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045035|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
15045036|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15045037|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045038|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045039|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15045040|NCT02058979|Cefazolin|cefazolin|mesh-list
15045041|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045042|NCT02059018|Diclofenac|diclofenac|mesh-list
15045043|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
15045044|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
15045045|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15045046|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15045047|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15045048|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15045049|NCT02059018|Analgesics|analgesics|mesh-ancestor
15045050|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
15045051|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045052|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045053|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15045054|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15045055|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045056|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045057|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
15045058|NCT02059031|Cabotegravir|cabotegravir|mesh-list
15045059|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15045060|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15045061|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045062|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045063|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15045064|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15045065|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
15045066|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045067|NCT02059330|Palbociclib|palbociclib|mesh-list
15045068|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045069|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15045070|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045071|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045072|NCT02059460|Terlipressin|terlipressin|mesh-list
15045073|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15045074|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15045075|NCT02059564|Liraglutide|liraglutide|mesh-list
15045076|NCT02059564|Exenatide|exenatide|mesh-list
15045077|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15045078|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045079|NCT02059564|Incretins|incretins|mesh-ancestor
15045080|NCT02059564|Hormones|hormones|mesh-ancestor
15045081|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15045082|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15045083|NCT02059590|Isavuconazole|isavuconazole|mesh-list
15045084|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
15045085|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045086|NCT02059616|Amlodipine|amlodipine|mesh-list
15045087|NCT02059616|Candesartan|candesartan|mesh-list
15045088|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
15045089|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15045090|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15045091|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15045092|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045093|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15045094|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045095|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
15045096|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15045097|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15045098|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
15045099|NCT02059655|Bimatoprost|bimatoprost|mesh-list
15045100|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15045101|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15045102|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15045103|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15045104|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045105|NCT02059694|Lidocaine|lidocaine|mesh-list
15045106|NCT02059694|Epinephrine|epinephrine|mesh-list
15045107|NCT02059694|Racepinephrine|racepinephrine|mesh-list
15045108|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
15045109|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
15045110|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
15045111|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15045112|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045113|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
15045114|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045115|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15045116|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15045117|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15045118|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15045119|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045120|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15045121|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15045122|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
15045123|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15045124|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15045125|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15045126|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
15045127|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15045128|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
15045129|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
15045130|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
15045131|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15045132|NCT02059759|Aldesleukin|aldesleukin|mesh-list
15045133|NCT02059759|Interleukin-2|interleukin-2|mesh-list
15045134|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045135|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15045136|NCT02059759|Analgesics|analgesics|mesh-ancestor
15045137|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
15045138|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045139|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045140|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15045141|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15045142|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
15045143|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045144|NCT02059772|Ranibizumab|ranibizumab|mesh-list
15045145|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15045146|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15045147|NCT02059772|Growth Substances|growth substances|mesh-ancestor
15045148|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045149|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
15045150|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045151|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
15045152|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15045153|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
15045154|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045155|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15045156|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15045157|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
15045158|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045159|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045160|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15045161|NCT02059876|Paclitaxel|paclitaxel|mesh-list
15045162|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15045163|NCT02059876|Carboplatin|carboplatin|mesh-list
15045164|NCT02059876|Trastuzumab|trastuzumab|mesh-list
15045165|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15045166|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045167|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
15045168|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
15045169|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
15045170|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045171|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15045172|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
15045173|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15045174|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15045175|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045176|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
15045177|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
15045178|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045179|NCT02059915|Oxycodone|oxycodone|mesh-list
15045180|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15045181|NCT02059915|Narcotics|narcotics|mesh-ancestor
15045182|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15045183|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045184|NCT02059915|Analgesics|analgesics|mesh-ancestor
15045185|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
15045186|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045187|NCT02059967|Paclitaxel|paclitaxel|mesh-list
15045188|NCT02059967|Carboplatin|carboplatin|mesh-list
15045189|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15045190|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045191|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
15045192|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
15045193|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
15045194|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045195|NCT02060006|Meloxicam|meloxicam|mesh-list
15045196|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
15045197|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15045198|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15045199|NCT02060006|Analgesics|analgesics|mesh-ancestor
15045200|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
15045201|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045202|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045203|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15045204|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15045205|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15045206|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045207|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045208|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
15045209|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15045210|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15045211|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15045212|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
15045213|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045214|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15045215|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15045216|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045217|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15045218|NCT02060032|Atorvastatin|atorvastatin|mesh-list
15045219|NCT02060032|Simvastatin|simvastatin|mesh-list
15045220|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15045221|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15045222|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
15045223|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045224|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15045225|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15045226|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045227|NCT02060149|Minocycline|minocycline|mesh-list
15045228|NCT02060149|Sulbactam|sulbactam|mesh-list
15045229|NCT02060149|Cefoperazone|cefoperazone|mesh-list
15045230|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15045231|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15045232|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045233|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15045234|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045235|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045236|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
15045237|NCT02060201|Saxagliptin|saxagliptin|mesh-list
15045238|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15045239|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045240|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15045241|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045242|NCT02060201|Incretins|incretins|mesh-ancestor
15045243|NCT02060201|Hormones|hormones|mesh-ancestor
15045244|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15045245|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15045246|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
15045247|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045248|NCT02060253|Paclitaxel|paclitaxel|mesh-list
15045249|NCT02060253|Trastuzumab|trastuzumab|mesh-list
15045250|NCT02060253|Pertuzumab|pertuzumab|mesh-list
15045251|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15045252|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045253|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
15045254|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
15045255|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
15045256|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045257|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15045258|NCT02060279|Carotenoids|carotenoids|mesh-list
15045259|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
15045260|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045261|NCT02060279|Protective Agents|protective agents|mesh-ancestor
15045262|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045263|NCT02060305|Bevacizumab|bevacizumab|mesh-list
15045264|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15045265|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045266|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15045267|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15045268|NCT02060305|Growth Substances|growth substances|mesh-ancestor
15045269|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045270|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
15045271|NCT02060318|Infliximab|infliximab|mesh-list
15045272|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
15045273|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15045274|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15045275|NCT02060396|Aspirin|aspirin|mesh-list
15045276|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15045277|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15045278|NCT02060396|Analgesics|analgesics|mesh-ancestor
15045279|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
15045280|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045281|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045282|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15045283|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15045284|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15045285|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15045286|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045287|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15045288|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15045289|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045290|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
15045291|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
15045292|NCT02060487|Citric Acid|citric acid|mesh-list
15045293|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
15045294|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
15045295|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15045296|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
15045297|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
15045298|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045299|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
15045300|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15045301|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15045302|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045303|NCT02060487|Urological Agents|urological agents|mesh-ancestor
15045304|NCT02060552|Diacetylrhein|diacetylrhein|mesh-list
15045305|NCT02060552|Colchicine|colchicine|mesh-list
15045306|NCT02060552|Febuxostat|febuxostat|mesh-list
15045307|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
15045308|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15045309|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
15045310|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
15045311|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
15045312|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045313|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045314|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15045315|NCT02060591|Bupivacaine|bupivacaine|mesh-list
15045316|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
15045317|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
15045318|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15045319|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045320|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
15045321|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045322|NCT02060604|Ketorolac|ketorolac|mesh-list
15045323|NCT02060604|Ranibizumab|ranibizumab|mesh-list
15045324|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15045325|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15045326|NCT02060604|Growth Substances|growth substances|mesh-ancestor
15045327|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045328|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
15045329|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045330|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15045331|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15045332|NCT02060604|Analgesics|analgesics|mesh-ancestor
15045333|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
15045334|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045335|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15045336|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15045337|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15045338|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045339|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045340|NCT02060656|Gemcitabine|gemcitabine|mesh-list
15045341|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
15045342|NCT02060656|Rituximab|rituximab|mesh-list
15045343|NCT02060656|Lenalidomide|lenalidomide|mesh-list
15045344|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045345|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15045346|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
15045347|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045348|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15045349|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15045350|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
15045351|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045352|NCT02060656|Antiviral Agents|antiviral agents|mesh-ancestor
15045353|NCT02060656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045354|NCT02060656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045355|NCT02060656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15045356|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15045357|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15045358|NCT02060656|Growth Substances|growth substances|mesh-ancestor
15045359|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
15045360|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15045361|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
15045362|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
15045363|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045364|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15045365|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
15045366|NCT02060656|Hormones|hormones|mesh-ancestor
15045367|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15045368|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15045369|NCT02060656|Protective Agents|protective agents|mesh-ancestor
15045370|NCT02060669|Capecitabine|capecitabine|mesh-list
15045371|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15045372|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
15045373|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045374|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045375|NCT02060734|Lidocaine|lidocaine|mesh-list
15045376|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
15045377|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
15045378|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15045379|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045380|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
15045381|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045382|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15045383|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15045384|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15045385|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15045386|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045387|NCT02060786|Clopidogrel|clopidogrel|mesh-list
15045388|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15045389|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15045390|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15045391|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15045392|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
15045393|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15045394|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045395|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045396|NCT02060851|Iron|iron|mesh-list
15045397|NCT02060851|Trace Elements|trace elements|mesh-ancestor
15045398|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
15045399|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045400|NCT02060916|PAZ320|paz320|mesh-list
15045401|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15045402|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045403|NCT02060929|Esketamine|esketamine|mesh-list
15045404|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
15045405|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15045406|NCT02060955|Bevacizumab|bevacizumab|mesh-list
15045407|NCT02060955|Irinotecan|irinotecan|mesh-list
15045408|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15045409|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045410|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15045411|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15045412|NCT02060955|Growth Substances|growth substances|mesh-ancestor
15045413|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045414|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
15045415|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15045416|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15045417|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045418|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045419|NCT02061007|Misonidazole|misonidazole|mesh-list
15045420|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045421|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15045422|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15045423|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045424|NCT02061124|Sevelamer|sevelamer|mesh-list
15045425|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
15045426|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
15045427|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045428|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15045429|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15045430|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045431|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15045432|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
15045433|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045434|NCT02061267|Niacin|niacin|mesh-list
15045435|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
15045436|NCT02061267|Vitamins|vitamins|mesh-ancestor
15045437|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
15045438|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045439|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
15045440|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15045441|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
15045442|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045443|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15045444|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
15045445|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
15045446|NCT02061293|Promethazine|promethazine|mesh-list
15045447|NCT02061293|Psilocybin|psilocybin|mesh-list
15045448|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15045449|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15045450|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15045451|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045452|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
15045453|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
15045454|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
15045455|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045456|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
15045457|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
15045458|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15045459|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15045460|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
15045461|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
15045462|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15045463|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045464|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15045465|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
15045466|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
15045467|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
15045468|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15045469|NCT02061449|Romidepsin|romidepsin|mesh-list
15045470|NCT02061449|Poly ICLC|poly iclc|mesh-list
15045471|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
15045472|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
15045473|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045474|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15045475|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045476|NCT02061475|Lidocaine|lidocaine|mesh-list
15045477|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
15045478|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
15045479|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15045480|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045481|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
15045482|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045483|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15045484|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15045485|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15045486|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15045487|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045488|NCT02061631|Dexamethasone|dexamethasone|mesh-list
15045489|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
15045490|NCT02061631|Docetaxel|docetaxel|mesh-list
15045491|NCT02061631|BB 1101|bb 1101|mesh-list
15045492|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045493|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15045494|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
15045495|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
15045496|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045497|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045498|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15045499|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
15045500|NCT02061631|Hormones|hormones|mesh-ancestor
15045501|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15045502|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15045503|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
15045504|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045505|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045506|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
15045507|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
15045508|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
15045509|NCT02061644|Anesthetics|anesthetics|mesh-list
15045510|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15045511|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045512|NCT02061657|Misoprostol|misoprostol|mesh-list
15045513|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15045514|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
15045515|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15045516|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045517|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15045518|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15045519|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
15045520|NCT02061761|Nivolumab|nivolumab|mesh-list
15045521|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15045522|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045523|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15045524|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045525|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
15045526|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15045527|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
15045528|NCT02061800|Melphalan|melphalan|mesh-list
15045529|NCT02061800|Busulfan|busulfan|mesh-list
15045530|NCT02061800|Thiotepa|thiotepa|mesh-list
15045531|NCT02061800|Fludarabine|fludarabine|mesh-list
15045532|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
15045533|NCT02061800|Tacrolimus|tacrolimus|mesh-list
15045534|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15045535|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
15045536|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045537|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15045538|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15045539|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
15045540|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045541|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045542|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15045543|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15045544|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045545|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15045546|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
15045547|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
15045548|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045549|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15045550|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
15045551|NCT02061800|Hormones|hormones|mesh-ancestor
15045552|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15045553|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15045554|NCT02061800|Protective Agents|protective agents|mesh-ancestor
15045555|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15045556|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15045557|NCT02061878|Bexarotene|bexarotene|mesh-list
15045558|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045559|NCT02061917|Lobeline|lobeline|mesh-list
15045560|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15045561|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
15045562|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045563|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045564|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15045565|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15045566|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
15045567|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15045568|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045569|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
15045570|NCT02062034|Vitamins|vitamins|mesh-list
15045571|NCT02062034|Vitamin E|vitamin e|mesh-list
15045572|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
15045573|NCT02062034|Ubiquinone|ubiquinone|mesh-list
15045574|NCT02062034|Antioxidants|antioxidants|mesh-list
15045575|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
15045576|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045577|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045578|NCT02062034|Protective Agents|protective agents|mesh-ancestor
15045579|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
15045580|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15045581|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045582|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
15045583|NCT02062112|Laxatives|laxatives|mesh-list
15045584|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15045585|NCT02062190|Resveratrol|resveratrol|mesh-list
15045586|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
15045587|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045588|NCT02062190|Protective Agents|protective agents|mesh-ancestor
15045589|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045590|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045591|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15045592|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
15045593|NCT02062203|Glycine|glycine|mesh-list
15045594|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15045595|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045596|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15045597|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15045598|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045599|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045600|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045601|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045602|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
15045603|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15045604|NCT02062255|Aspirin|aspirin|mesh-list
15045605|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15045606|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15045607|NCT02062255|Analgesics|analgesics|mesh-ancestor
15045608|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
15045609|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045610|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045611|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15045612|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15045613|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15045614|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15045615|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045616|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15045617|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15045618|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045619|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
15045620|NCT02062281|Vaccines|vaccines|mesh-list
15045621|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15045622|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
15045623|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045624|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
15045625|NCT02062333|Esmolol|esmolol|mesh-list
15045626|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15045627|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15045628|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045629|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15045630|NCT02062333|Analgesics|analgesics|mesh-ancestor
15045631|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
15045632|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045633|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15045634|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15045635|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15045636|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
15045637|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15045638|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045639|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15045640|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15045641|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15045642|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
15045643|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15045644|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15045645|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045646|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
15045647|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045648|NCT02062892|Sirolimus|sirolimus|mesh-list
15045649|NCT02062892|Everolimus|everolimus|mesh-list
15045650|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045651|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15045652|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
15045653|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045654|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15045655|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045656|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15045657|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
15045658|NCT02062944|Sirolimus|sirolimus|mesh-list
15045659|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
15045660|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15045661|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045662|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15045663|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045664|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
15045665|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
15045666|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045667|NCT02062983|Trastuzumab|trastuzumab|mesh-list
15045668|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15045669|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045670|NCT02062996|Phenylephrine|phenylephrine|mesh-list
15045671|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
15045672|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15045673|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15045674|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
15045675|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15045676|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045677|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045678|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
15045679|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
15045680|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045681|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
15045682|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15045683|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
15045684|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15045685|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
15045686|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15045687|NCT02062996|Protective Agents|protective agents|mesh-ancestor
15045688|NCT02063022|Dactinomycin|dactinomycin|mesh-list
15045689|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
15045690|NCT02063022|Melphalan|melphalan|mesh-list
15045691|NCT02063022|Busulfan|busulfan|mesh-list
15045692|NCT02063022|Ifosfamide|ifosfamide|mesh-list
15045693|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
15045694|NCT02063022|Doxorubicin|doxorubicin|mesh-list
15045695|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15045696|NCT02063022|Etoposide|etoposide|mesh-list
15045697|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
15045698|NCT02063022|Vincristine|vincristine|mesh-list
15045699|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15045700|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
15045701|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045702|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15045703|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15045704|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
15045705|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045706|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045707|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15045708|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15045709|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15045710|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15045711|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045712|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15045713|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
15045714|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
15045715|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
15045716|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15045717|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045718|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15045719|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15045720|NCT02063100|Losartan|losartan|mesh-list
15045721|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15045722|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15045723|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15045724|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15045725|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045726|NCT02063139|Fluticasone|fluticasone|mesh-list
15045727|NCT02063139|Beclomethasone|beclomethasone|mesh-list
15045728|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15045729|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15045730|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
15045731|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045732|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045733|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15045734|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
15045735|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
15045736|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15045737|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
15045738|NCT02063139|Hormones|hormones|mesh-ancestor
15045739|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15045740|NCT02063269|Rivastigmine|rivastigmine|mesh-list
15045741|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15045742|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045743|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045744|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
15045745|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15045746|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045747|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15045748|NCT02063269|Protective Agents|protective agents|mesh-ancestor
15045749|NCT02063334|Vitamin D|vitamin d|mesh-list
15045750|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
15045751|NCT02063334|Vitamins|vitamins|mesh-ancestor
15045752|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
15045753|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045754|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15045755|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15045756|NCT02063360|Ritonavir|ritonavir|mesh-list
15045757|NCT02063360|Darunavir|darunavir|mesh-list
15045758|NCT02063360|Fostemsavir|fostemsavir|mesh-list
15045759|NCT02063360|Etravirine|etravirine|mesh-list
15045760|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15045761|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15045762|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
15045763|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045764|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045765|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15045766|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15045767|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
15045768|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045769|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15045770|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15045771|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15045772|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15045773|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15045774|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15045775|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
15045776|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15045777|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
15045778|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045779|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
15045780|NCT02063373|Protective Agents|protective agents|mesh-ancestor
15045781|NCT02063425|Fluoxetine|fluoxetine|mesh-list
15045782|NCT02063425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15045783|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15045784|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15045785|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045786|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15045787|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
15045788|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045789|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15045790|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
15045791|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15045792|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15045793|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15045794|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045795|NCT02063529|Leucovorin|leucovorin|mesh-list
15045796|NCT02063529|Fluorouracil|fluorouracil|mesh-list
15045797|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
15045798|NCT02063529|Irinotecan|irinotecan|mesh-list
15045799|NCT02063529|Cetuximab|cetuximab|mesh-list
15045800|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
15045801|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
15045802|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045803|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15045804|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045805|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15045806|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
15045807|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045808|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15045809|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15045810|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045811|NCT02063529|Antidotes|antidotes|mesh-ancestor
15045812|NCT02063529|Protective Agents|protective agents|mesh-ancestor
15045813|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
15045814|NCT02063529|Vitamins|vitamins|mesh-ancestor
15045815|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
15045816|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15045817|NCT02063568|Oxytocin|oxytocin|mesh-list
15045818|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
15045819|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15045820|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045821|NCT02063620|Ketamine|ketamine|mesh-list
15045822|NCT02063620|Analgesics|analgesics|mesh-ancestor
15045823|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
15045824|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045825|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045826|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15045827|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15045828|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
15045829|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
15045830|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15045831|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15045832|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15045833|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15045834|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045835|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
15045836|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15045837|NCT02063789|Antibodies|antibodies|mesh-list
15045838|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
15045839|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045840|NCT02063802|Metformin|metformin|mesh-list
15045841|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15045842|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045843|NCT02063841|Bismuth|bismuth|mesh-list
15045844|NCT02063841|Antacids|antacids|mesh-ancestor
15045845|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045846|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15045847|NCT02063945|Risperidone|risperidone|mesh-list
15045848|NCT02063945|Methylphenidate|methylphenidate|mesh-list
15045849|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15045850|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
15045851|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15045852|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045853|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045854|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15045855|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15045856|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15045857|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15045858|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15045859|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
15045860|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15045861|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15045862|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15045863|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15045864|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
15045865|NCT02064010|Acamprosate|acamprosate|mesh-list
15045866|NCT02064010|Calcium|calcium|mesh-list
15045867|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15045868|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045869|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15045870|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15045871|NCT02064023|Insulin|insulin|mesh-list
15045872|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15045873|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15045874|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045875|NCT02064036|Leuprolide|leuprolide|mesh-list
15045876|NCT02064036|Goserelin|goserelin|mesh-list
15045877|NCT02064036|Bicalutamide|bicalutamide|mesh-list
15045878|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15045879|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
15045880|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15045881|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045882|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15045883|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045884|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
15045885|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
15045886|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15045887|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
15045888|NCT02064049|Velpatasvir|velpatasvir|mesh-list
15045889|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
15045890|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045891|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
15045892|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
15045893|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
15045894|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15045895|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045896|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
15045897|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045898|NCT02064140|Rocuronium|rocuronium|mesh-list
15045899|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15045900|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15045901|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15045902|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045903|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045904|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
15045905|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15045906|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
15045907|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
15045908|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15045909|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045910|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15045911|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15045912|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045913|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045914|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045915|NCT02064374|Metformin|metformin|mesh-list
15045916|NCT02064374|Dolutegravir|dolutegravir|mesh-list
15045917|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15045918|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045919|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15045920|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15045921|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045922|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045923|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15045924|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15045925|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
15045926|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15045927|NCT02064465|Lamotrigine|lamotrigine|mesh-list
15045928|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
15045929|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15045930|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15045931|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045932|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15045933|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045934|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15045935|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15045936|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15045937|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15045938|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15045939|NCT02064491|Paclitaxel|paclitaxel|mesh-list
15045940|NCT02064491|Docetaxel|docetaxel|mesh-list
15045941|NCT02064491|Cisplatin|cisplatin|mesh-list
15045942|NCT02064491|Carboplatin|carboplatin|mesh-list
15045943|NCT02064491|Pemetrexed|pemetrexed|mesh-list
15045944|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15045945|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15045946|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15045947|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
15045948|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
15045949|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
15045950|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045951|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15045952|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15045953|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15045954|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15045955|NCT02064504|Fluticasone|fluticasone|mesh-list
15045956|NCT02064504|Xhance|xhance|mesh-list
15045957|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15045958|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15045959|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
15045960|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045961|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045962|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15045963|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
15045964|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
15045965|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15045966|NCT02064517|Calcium|calcium|mesh-list
15045967|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15045968|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045969|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
15045970|NCT02064530|Bupivacaine|bupivacaine|mesh-list
15045971|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
15045972|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
15045973|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15045974|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045975|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
15045976|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15045977|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15045978|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15045979|NCT02064530|Analgesics|analgesics|mesh-ancestor
15045980|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15045981|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15045982|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15045983|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
15045984|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15045985|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045986|NCT02064556|Amlodipine|amlodipine|mesh-list
15045987|NCT02064556|Candesartan|candesartan|mesh-list
15045988|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15045989|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15045990|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15045991|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15045992|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15045993|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15045994|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
15045995|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15045996|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15045997|NCT02064621|Amlodipine|amlodipine|mesh-list
15045998|NCT02064621|Candesartan|candesartan|mesh-list
15045999|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
15046000|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15046001|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15046002|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15046003|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046004|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15046005|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046006|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
15046007|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15046008|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15046009|NCT02064673|Curcumin|curcumin|mesh-list
15046010|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15046011|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15046012|NCT02064673|Analgesics|analgesics|mesh-ancestor
15046013|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
15046014|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046015|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046016|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15046017|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15046018|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046019|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046020|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046021|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
15046022|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
15046023|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
15046024|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046025|NCT02064777|Tacrolimus|tacrolimus|mesh-list
15046026|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15046027|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
15046028|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046029|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15046030|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046031|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046032|NCT02064829|Paclitaxel|paclitaxel|mesh-list
15046033|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15046034|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15046035|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046036|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
15046037|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
15046038|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
15046039|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046040|NCT02064842|Ritonavir|ritonavir|mesh-list
15046041|NCT02064842|Simeprevir|simeprevir|mesh-list
15046042|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15046043|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15046044|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
15046045|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046046|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046047|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15046048|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15046049|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
15046050|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046051|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15046052|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15046053|NCT02064881|Metformin|metformin|mesh-list
15046054|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15046055|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046056|NCT02064946|Vitamin D|vitamin d|mesh-list
15046057|NCT02064946|Vitamins|vitamins|mesh-ancestor
15046058|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
15046059|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046060|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15046061|NCT02065063|Palbociclib|palbociclib|mesh-list
15046062|NCT02065063|Trametinib|trametinib|mesh-list
15046063|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046064|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15046065|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046066|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046067|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
15046068|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
15046069|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
15046070|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046071|NCT02065128|Capsaicin|capsaicin|mesh-list
15046072|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
15046073|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
15046074|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
15046075|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046076|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046077|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
15046078|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15046079|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
15046080|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046081|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15046082|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15046083|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
15046084|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046085|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046086|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15046087|NCT02065219|Bupivacaine|bupivacaine|mesh-list
15046088|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
15046089|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
15046090|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046091|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046092|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
15046093|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046094|NCT02065349|ASP8477|asp8477|mesh-list
15046095|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046096|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046097|NCT02065388|Warfarin|warfarin|mesh-list
15046098|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
15046099|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
15046100|NCT02065401|Antacids|antacids|mesh-ancestor
15046101|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046102|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15046103|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
15046104|NCT02065414|Listerine|listerine|mesh-list
15046105|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15046106|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046107|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
15046108|NCT02065466|Paclitaxel|paclitaxel|mesh-list
15046109|NCT02065466|Bevacizumab|bevacizumab|mesh-list
15046110|NCT02065466|Temozolomide|temozolomide|mesh-list
15046111|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15046112|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046113|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
15046114|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
15046115|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
15046116|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046117|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15046118|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15046119|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15046120|NCT02065466|Growth Substances|growth substances|mesh-ancestor
15046121|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046122|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
15046123|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15046124|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
15046125|NCT02065492|Amlodipine|amlodipine|mesh-list
15046126|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
15046127|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15046128|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046129|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15046130|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15046131|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046132|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
15046133|NCT02065596|Vidarabine|vidarabine|mesh-list
15046134|NCT02065596|Fludarabine|fludarabine|mesh-list
15046135|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
15046136|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046137|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15046138|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
15046139|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046140|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15046141|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
15046142|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046143|NCT02065596|Antiviral Agents|antiviral agents|mesh-ancestor
15046144|NCT02065596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046145|NCT02065609|Trastuzumab|trastuzumab|mesh-list
15046146|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15046147|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046148|NCT02065739|Itraconazole|itraconazole|mesh-list
15046149|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
15046150|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
15046151|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046152|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15046153|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15046154|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046155|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046156|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15046157|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
15046158|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15046159|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046160|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15046161|NCT02065752|Metformin|metformin|mesh-list
15046162|NCT02065752|Canagliflozin|canagliflozin|mesh-list
15046163|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15046164|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046165|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15046166|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046167|NCT02065804|Bupivacaine|bupivacaine|mesh-list
15046168|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
15046169|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
15046170|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046171|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046172|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
15046173|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046174|NCT02065843|Midazolam|midazolam|mesh-list
15046175|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15046176|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15046177|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046178|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046179|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15046180|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15046181|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15046182|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15046183|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
15046184|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
15046185|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
15046186|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
15046187|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046188|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046189|NCT02065947|Lidocaine|lidocaine|mesh-list
15046190|NCT02065947|Epinephrine|epinephrine|mesh-list
15046191|NCT02065947|Racepinephrine|racepinephrine|mesh-list
15046192|NCT02065947|Fentanyl|fentanyl|mesh-list
15046193|NCT02065947|Midazolam|midazolam|mesh-list
15046194|NCT02065947|Ketamine|ketamine|mesh-list
15046195|NCT02065947|Bupivacaine|bupivacaine|mesh-list
15046196|NCT02065947|Propofol|propofol|mesh-list
15046197|NCT02065947|Sevoflurane|sevoflurane|mesh-list
15046198|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
15046199|NCT02065947|Atracurium|atracurium|mesh-list
15046200|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
15046201|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
15046202|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046203|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046204|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
15046205|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046206|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15046207|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15046208|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15046209|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15046210|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046211|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15046212|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15046213|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
15046214|NCT02065947|Analgesics|analgesics|mesh-ancestor
15046215|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15046216|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15046217|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15046218|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046219|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15046220|NCT02065947|Narcotics|narcotics|mesh-ancestor
15046221|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15046222|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15046223|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15046224|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15046225|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
15046226|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
15046227|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15046228|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15046229|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15046230|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15046231|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
15046232|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15046233|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15046234|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
15046235|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15046236|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
15046237|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
15046238|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
15046239|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15046240|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15046241|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15046242|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15046243|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15046244|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15046245|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
15046246|NCT02065986|Tenofovir|tenofovir|mesh-list
15046247|NCT02065986|Emtricitabine|emtricitabine|mesh-list
15046248|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15046249|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
15046250|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046251|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15046252|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15046253|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046254|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046255|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15046256|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15046257|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15046258|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046259|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15046260|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046261|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046262|NCT02066077|Propofol|propofol|mesh-list
15046263|NCT02066077|Etomidate|etomidate|mesh-list
15046264|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15046265|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046266|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046267|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15046268|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
15046269|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
15046270|NCT02066103|Paclitaxel|paclitaxel|mesh-list
15046271|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15046272|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046273|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
15046274|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
15046275|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
15046276|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046277|NCT02066207|Atorvastatin|atorvastatin|mesh-list
15046278|NCT02066207|Fenofibrate|fenofibrate|mesh-list
15046279|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15046280|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15046281|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
15046282|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046283|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15046284|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15046285|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046286|NCT02066350|Pancrelipase|pancrelipase|mesh-list
15046287|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15046288|NCT02066454|Apixaban|apixaban|mesh-list
15046289|NCT02066454|Anticoagulants|anticoagulants|mesh-list
15046290|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15046291|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
15046292|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15046293|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
15046294|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046295|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046296|NCT02066532|Trastuzumab|trastuzumab|mesh-list
15046297|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15046298|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046299|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
15046300|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
15046301|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046302|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
15046303|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046304|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046305|NCT02066571|Droxidopa|droxidopa|mesh-list
15046306|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15046307|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15046308|NCT02066610|Selenium|selenium|mesh-list
15046309|NCT02066610|Selenious Acid|selenious acid|mesh-list
15046310|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
15046311|NCT02066610|Selenic Acid|selenic acid|mesh-list
15046312|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
15046313|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046314|NCT02066610|Protective Agents|protective agents|mesh-ancestor
15046315|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046316|NCT02066610|Trace Elements|trace elements|mesh-ancestor
15046317|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
15046318|NCT02066649|Carvedilol|carvedilol|mesh-list
15046319|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15046320|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15046321|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
15046322|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046323|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046324|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046325|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15046326|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
15046327|NCT02066649|Protective Agents|protective agents|mesh-ancestor
15046328|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15046329|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15046330|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15046331|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
15046332|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15046333|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15046334|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
15046335|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
15046336|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15046337|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
15046338|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15046339|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
15046340|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046341|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046342|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
15046343|NCT02066675|Trabectedin|trabectedin|mesh-list
15046344|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15046345|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
15046346|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046347|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046348|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
15046349|NCT02066688|Vitamin D|vitamin d|mesh-list
15046350|NCT02066688|Folic Acid|folic acid|mesh-list
15046351|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
15046352|NCT02066688|Calcium|calcium|mesh-list
15046353|NCT02066688|Vitamins|vitamins|mesh-ancestor
15046354|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
15046355|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046356|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15046357|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15046358|NCT02066688|Hematinics|hematinics|mesh-ancestor
15046359|NCT02066818|Lidocaine|lidocaine|mesh-list
15046360|NCT02066818|Tetracaine|tetracaine|mesh-list
15046361|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
15046362|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
15046363|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046364|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046365|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
15046366|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046367|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15046368|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15046369|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15046370|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15046371|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046372|NCT02066844|Betamethasone|betamethasone|mesh-list
15046373|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
15046374|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15046375|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
15046376|NCT02066844|Lidocaine|lidocaine|mesh-list
15046377|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15046378|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
15046379|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
15046380|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046381|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046382|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
15046383|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046384|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15046385|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15046386|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15046387|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15046388|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046389|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15046390|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
15046391|NCT02066844|Hormones|hormones|mesh-ancestor
15046392|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15046393|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15046394|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
15046395|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
15046396|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046397|NCT02067013|Ranibizumab|ranibizumab|mesh-list
15046398|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15046399|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15046400|NCT02067013|Growth Substances|growth substances|mesh-ancestor
15046401|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046402|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
15046403|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046404|NCT02067065|Propofol|propofol|mesh-list
15046405|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15046406|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046407|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046408|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15046409|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
15046410|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
15046411|NCT02067078|Dexamethasone|dexamethasone|mesh-list
15046412|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
15046413|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15046414|NCT02067078|Clonidine|clonidine|mesh-list
15046415|NCT02067078|Epinephrine|epinephrine|mesh-list
15046416|NCT02067078|Racepinephrine|racepinephrine|mesh-list
15046417|NCT02067078|Ropivacaine|ropivacaine|mesh-list
15046418|NCT02067078|Bupivacaine|bupivacaine|mesh-list
15046419|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
15046420|NCT02067078|BB 1101|bb 1101|mesh-list
15046421|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15046422|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
15046423|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
15046424|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046425|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046426|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15046427|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
15046428|NCT02067078|Hormones|hormones|mesh-ancestor
15046429|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15046430|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15046431|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046432|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
15046433|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046434|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046435|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
15046436|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
15046437|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046438|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
15046439|NCT02067078|Analgesics|analgesics|mesh-ancestor
15046440|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15046441|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
15046442|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15046443|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15046444|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15046445|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
15046446|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046447|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15046448|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15046449|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15046450|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15046451|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15046452|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15046453|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15046454|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
15046455|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
15046456|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
15046457|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15046458|NCT02067143|Cytarabine|cytarabine|mesh-list
15046459|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15046460|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
15046461|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046462|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046463|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
15046464|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046465|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15046466|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
15046467|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046468|NCT02067182|Dabigatran|dabigatran|mesh-list
15046469|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
15046470|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15046471|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
15046472|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046473|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046474|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
15046475|NCT02067338|Morphine|morphine|mesh-list
15046476|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
15046477|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15046478|NCT02067338|Narcotics|narcotics|mesh-ancestor
15046479|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046480|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046481|NCT02067338|Analgesics|analgesics|mesh-ancestor
15046482|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
15046483|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046484|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
15046485|NCT02067338|Coagulants|coagulants|mesh-ancestor
15046486|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
15046487|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15046488|NCT02067377|Antibodies|antibodies|mesh-list
15046489|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
15046490|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046491|NCT02067416|Paclitaxel|paclitaxel|mesh-list
15046492|NCT02067416|Docetaxel|docetaxel|mesh-list
15046493|NCT02067416|Epirubicin|epirubicin|mesh-list
15046494|NCT02067416|Taxane|taxane|mesh-list
15046495|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15046496|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046497|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
15046498|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
15046499|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
15046500|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046501|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15046502|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15046503|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15046504|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046505|NCT02067442|Acetaminophen|acetaminophen|mesh-list
15046506|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15046507|NCT02067442|Analgesics|analgesics|mesh-ancestor
15046508|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
15046509|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046510|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046511|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
15046512|NCT02067520|Hydromorphone|hydromorphone|mesh-list
15046513|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15046514|NCT02067520|Narcotics|narcotics|mesh-ancestor
15046515|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046516|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046517|NCT02067520|Analgesics|analgesics|mesh-ancestor
15046518|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
15046519|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046520|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
15046521|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15046522|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046523|NCT02067767|Lamivudine|lamivudine|mesh-list
15046524|NCT02067767|Abacavir|abacavir|mesh-list
15046525|NCT02067767|Dolutegravir|dolutegravir|mesh-list
15046526|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15046527|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15046528|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046529|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046530|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
15046531|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046532|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15046533|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15046534|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15046535|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15046536|NCT02067780|Levofloxacin|levofloxacin|mesh-list
15046537|NCT02067780|Ofloxacin|ofloxacin|mesh-list
15046538|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15046539|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046540|NCT02067780|Renal Agents|renal agents|mesh-ancestor
15046541|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15046542|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15046543|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15046544|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046545|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046546|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046547|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15046548|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15046549|NCT02067910|Abatacept|abatacept|mesh-list
15046550|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15046551|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046552|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046553|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15046554|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
15046555|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046556|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15046557|NCT02067936|Remifentanil|remifentanil|mesh-list
15046558|NCT02067936|Propofol|propofol|mesh-list
15046559|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15046560|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046561|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046562|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15046563|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
15046564|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
15046565|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15046566|NCT02067936|Narcotics|narcotics|mesh-ancestor
15046567|NCT02067936|Analgesics|analgesics|mesh-ancestor
15046568|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
15046569|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046570|NCT02067949|Simvastatin|simvastatin|mesh-list
15046571|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15046572|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15046573|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
15046574|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046575|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15046576|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15046577|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046578|NCT02068079|Vemurafenib|vemurafenib|mesh-list
15046579|NCT02068079|Trientine|trientine|mesh-list
15046580|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046581|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15046582|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046583|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046584|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
15046585|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
15046586|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
15046587|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046588|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
15046589|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046590|NCT02068092|Protective Agents|protective agents|mesh-ancestor
15046591|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046592|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15046593|NCT02068131|Capecitabine|capecitabine|mesh-list
15046594|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15046595|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
15046596|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046597|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046598|NCT02068170|Azithromycin|azithromycin|mesh-list
15046599|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
15046600|NCT02068170|Clarithromycin|clarithromycin|mesh-list
15046601|NCT02068170|Levofloxacin|levofloxacin|mesh-list
15046602|NCT02068170|Erythromycin|erythromycin|mesh-list
15046603|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
15046604|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15046605|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
15046606|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15046607|NCT02068170|Itraconazole|itraconazole|mesh-list
15046608|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
15046609|NCT02068170|Fluconazole|fluconazole|mesh-list
15046610|NCT02068170|Ketoconazole|ketoconazole|mesh-list
15046611|NCT02068170|Voriconazole|voriconazole|mesh-list
15046612|NCT02068170|Sunitinib|sunitinib|mesh-list
15046613|NCT02068170|Methadone|methadone|mesh-list
15046614|NCT02068170|Haloperidol|haloperidol|mesh-list
15046615|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
15046616|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15046617|NCT02068170|Tacrolimus|tacrolimus|mesh-list
15046618|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15046619|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
15046620|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046621|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15046622|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046623|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046624|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15046625|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046626|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15046627|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15046628|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046629|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15046630|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
15046631|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15046632|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15046633|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15046634|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15046635|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15046636|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15046637|NCT02068170|Growth Substances|growth substances|mesh-ancestor
15046638|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
15046639|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15046640|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15046641|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15046642|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15046643|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
15046644|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15046645|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15046646|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
15046647|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15046648|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15046649|NCT02068170|Renal Agents|renal agents|mesh-ancestor
15046650|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15046651|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15046652|NCT02068170|Narcotics|narcotics|mesh-ancestor
15046653|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046654|NCT02068170|Analgesics|analgesics|mesh-ancestor
15046655|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
15046656|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046657|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
15046658|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
15046659|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15046660|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15046661|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
15046662|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
15046663|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15046664|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15046665|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15046666|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15046667|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15046668|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
15046669|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046670|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15046671|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
15046672|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15046673|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15046674|NCT02068196|Ipilimumab|ipilimumab|mesh-list
15046675|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15046676|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046677|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15046678|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046679|NCT02068209|Tramadol|tramadol|mesh-list
15046680|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15046681|NCT02068209|Narcotics|narcotics|mesh-ancestor
15046682|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046683|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046684|NCT02068209|Analgesics|analgesics|mesh-ancestor
15046685|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
15046686|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046687|NCT02068235|Ponesimod|ponesimod|mesh-list
15046688|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15046689|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046690|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15046691|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
15046692|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046693|NCT02068287|Esmolol|esmolol|mesh-list
15046694|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15046695|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15046696|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15046697|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
15046698|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046699|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046700|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046701|NCT02068339|Oltipraz|oltipraz|mesh-list
15046702|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
15046703|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046704|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
15046705|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15046706|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
15046707|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15046708|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15046709|NCT02068339|Protective Agents|protective agents|mesh-ancestor
15046710|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046711|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046712|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15046713|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15046714|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046715|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046716|NCT02068404|Nifedipine|nifedipine|mesh-list
15046717|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15046718|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15046719|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046720|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15046721|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046722|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
15046723|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
15046724|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15046725|NCT02068430|Riboflavin|riboflavin|mesh-list
15046726|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
15046727|NCT02068430|Vitamins|vitamins|mesh-ancestor
15046728|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
15046729|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046730|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15046731|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
15046732|NCT02068482|Rifaximin|rifaximin|mesh-list
15046733|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15046734|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046735|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15046736|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
15046737|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
15046738|NCT02068560|Coagulants|coagulants|mesh-ancestor
15046739|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15046740|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
15046741|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046742|NCT02068586|Sunitinib|sunitinib|mesh-list
15046743|NCT02068586|Valproic Acid|valproic acid|mesh-list
15046744|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046745|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15046746|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15046747|NCT02068586|Growth Substances|growth substances|mesh-ancestor
15046748|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046749|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
15046750|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15046751|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046752|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046753|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
15046754|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
15046755|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046756|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
15046757|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15046758|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046759|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15046760|NCT02068625|Rasagiline|rasagiline|mesh-list
15046761|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15046762|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046763|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046764|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15046765|NCT02068625|Protective Agents|protective agents|mesh-ancestor
15046766|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046767|NCT02068690|BI 425809|bi 425809|mesh-list
15046768|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
15046769|NCT02068859|Diclofenac|diclofenac|mesh-list
15046770|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15046771|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15046772|NCT02068859|Analgesics|analgesics|mesh-ancestor
15046773|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
15046774|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046775|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046776|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15046777|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15046778|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15046779|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046780|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046781|NCT02068937|Furosemide|furosemide|mesh-list
15046782|NCT02068937|Diuretics|diuretics|mesh-ancestor
15046783|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
15046784|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046785|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15046786|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15046787|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046788|NCT02069080|Plerixafor|plerixafor|mesh-list
15046789|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15046790|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15046791|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
15046792|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046793|NCT02069132|Warfarin|warfarin|mesh-list
15046794|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
15046795|NCT02069145|Sorafenib|sorafenib|mesh-list
15046796|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
15046797|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046798|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15046799|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046800|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046801|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
15046802|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046803|NCT02069158|Paclitaxel|paclitaxel|mesh-list
15046804|NCT02069158|Carboplatin|carboplatin|mesh-list
15046805|NCT02069158|Gedatolisib|gedatolisib|mesh-list
15046806|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15046807|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046808|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
15046809|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
15046810|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
15046811|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046812|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15046813|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046814|NCT02069197|Orlistat|orlistat|mesh-list
15046815|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046816|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046817|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15046818|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15046819|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
15046820|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15046821|NCT02069301|Fluoxetine|fluoxetine|mesh-list
15046822|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
15046823|NCT02069301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15046824|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15046825|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15046826|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046827|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046828|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
15046829|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046830|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15046831|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15046832|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15046833|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15046834|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046835|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
15046836|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15046837|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046838|NCT02069366|Dronabinol|dronabinol|mesh-list
15046839|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
15046840|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046841|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15046842|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15046843|NCT02069366|Analgesics|analgesics|mesh-ancestor
15046844|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
15046845|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046846|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15046847|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15046848|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046849|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046850|NCT02069366|Hormones|hormones|mesh-ancestor
15046851|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15046852|NCT02069418|Alovudine|alovudine|mesh-list
15046853|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15046854|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15046855|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046856|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
15046857|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046858|NCT02069431|Oxytocin|oxytocin|mesh-list
15046859|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
15046860|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15046861|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046862|NCT02069522|Carotenoids|carotenoids|mesh-list
15046863|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
15046864|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046865|NCT02069522|Protective Agents|protective agents|mesh-ancestor
15046866|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046867|NCT02069665|Ribavirin|ribavirin|mesh-list
15046868|NCT02069665|Ibuprofen|ibuprofen|mesh-list
15046869|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
15046870|NCT02069665|Albuterol|albuterol|mesh-list
15046871|NCT02069665|Guaifenesin|guaifenesin|mesh-list
15046872|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
15046873|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
15046874|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046875|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
15046876|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15046877|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15046878|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15046879|NCT02069665|Analgesics|analgesics|mesh-ancestor
15046880|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
15046881|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046882|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046883|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15046884|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15046885|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15046886|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046887|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15046888|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
15046889|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15046890|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
15046891|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
15046892|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15046893|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15046894|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15046895|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15046896|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
15046897|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046898|NCT02069665|Expectorants|expectorants|mesh-ancestor
15046899|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15046900|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
15046901|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15046902|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
15046903|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
15046904|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15046905|NCT02069808|Leuprolide|leuprolide|mesh-list
15046906|NCT02069808|Menotropins|menotropins|mesh-list
15046907|NCT02069808|Ganirelix|ganirelix|mesh-list
15046908|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15046909|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
15046910|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15046911|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046912|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15046913|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046914|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
15046915|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15046916|NCT02069886|Deferasirox|deferasirox|mesh-list
15046917|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15046918|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
15046919|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
15046920|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046921|NCT02069977|Aripiprazole|aripiprazole|mesh-list
15046922|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
15046923|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15046924|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15046925|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15046926|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046927|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046928|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
15046929|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
15046930|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046931|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046932|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15046933|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15046934|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
15046935|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15046936|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15046937|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15046938|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15046939|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
15046940|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15046941|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046942|NCT02069990|Vitamins|vitamins|mesh-ancestor
15046943|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
15046944|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15046945|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
15046946|NCT02070003|Narcotics|narcotics|mesh-ancestor
15046947|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15046948|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046949|NCT02070003|Analgesics|analgesics|mesh-ancestor
15046950|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
15046951|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15046952|NCT02070120|Mitomycins|mitomycins|mesh-list
15046953|NCT02070120|Mitomycin|mitomycin|mesh-list
15046954|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15046955|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046956|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
15046957|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046958|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15046959|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046960|NCT02070133|Simvastatin|simvastatin|mesh-list
15046961|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15046962|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15046963|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
15046964|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046965|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15046966|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15046967|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15046968|NCT02070159|Clopidogrel|clopidogrel|mesh-list
15046969|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15046970|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15046971|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15046972|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15046973|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15046974|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
15046975|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046976|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046977|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046978|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15046979|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
15046980|NCT02070198|Hormones|hormones|mesh-ancestor
15046981|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15046982|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046983|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
15046984|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15046985|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
15046986|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15046987|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15046988|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15046989|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15046990|NCT02070289|PF-06372865|pf-06372865|mesh-list
15046991|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
15046992|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
15046993|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15046994|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15046995|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15046996|NCT02070406|Aldesleukin|aldesleukin|mesh-list
15046997|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
15046998|NCT02070406|Fludarabine|fludarabine|mesh-list
15046999|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
15047000|NCT02070406|Interleukin-2|interleukin-2|mesh-list
15047001|NCT02070406|Vaccines|vaccines|mesh-list
15047002|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15047003|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15047004|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
15047005|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047006|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15047007|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15047008|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
15047009|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047010|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047011|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15047012|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047013|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
15047014|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15047015|NCT02070406|Analgesics|analgesics|mesh-ancestor
15047016|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
15047017|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047018|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15047019|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15047020|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
15047021|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047022|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15047023|NCT02070458|Cytarabine|cytarabine|mesh-list
15047024|NCT02070458|Etoposide|etoposide|mesh-list
15047025|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
15047026|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
15047027|NCT02070458|Ixazomib|ixazomib|mesh-list
15047028|NCT02070458|Glycine|glycine|mesh-list
15047029|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
15047030|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15047031|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047032|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15047033|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15047034|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047035|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047036|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047037|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
15047038|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
15047039|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047040|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15047041|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
15047042|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047043|NCT02070458|Analgesics|analgesics|mesh-ancestor
15047044|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
15047045|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047046|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
15047047|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
15047048|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047049|NCT02070510|Lisinopril|lisinopril|mesh-list
15047050|NCT02070510|Warfarin|warfarin|mesh-list
15047051|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
15047052|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15047053|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
15047054|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047055|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047056|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15047057|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15047058|NCT02070510|Protective Agents|protective agents|mesh-ancestor
15047059|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047060|NCT02070653|Ticagrelor|ticagrelor|mesh-list
15047061|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15047062|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15047063|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15047064|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15047065|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
15047066|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047067|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047068|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047069|NCT02070679|Vitamin E|vitamin e|mesh-list
15047070|NCT02070679|Tocopherols|tocopherols|mesh-list
15047071|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
15047072|NCT02070679|Vitamins|vitamins|mesh-ancestor
15047073|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
15047074|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047075|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
15047076|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047077|NCT02070679|Protective Agents|protective agents|mesh-ancestor
15047078|NCT02070718|Pentazocine|pentazocine|mesh-list
15047079|NCT02070718|Naloxone|naloxone|mesh-list
15047080|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15047081|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047082|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
15047083|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047084|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15047085|NCT02070718|Narcotics|narcotics|mesh-ancestor
15047086|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15047087|NCT02070718|Analgesics|analgesics|mesh-ancestor
15047088|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15047089|NCT02070796|Rotigotine|rotigotine|mesh-list
15047090|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
15047091|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
15047092|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047093|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047094|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047095|NCT02071004|Aspirin|aspirin|mesh-list
15047096|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15047097|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15047098|NCT02071004|Analgesics|analgesics|mesh-ancestor
15047099|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
15047100|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047101|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047102|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15047103|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15047104|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15047105|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15047106|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047107|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15047108|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15047109|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047110|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
15047111|NCT02071043|Capecitabine|capecitabine|mesh-list
15047112|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
15047113|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047114|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
15047115|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047116|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047117|NCT02071069|Fluorouracil|fluorouracil|mesh-list
15047118|NCT02071069|Irinotecan|irinotecan|mesh-list
15047119|NCT02071069|Cetuximab|cetuximab|mesh-list
15047120|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
15047121|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047122|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047123|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047124|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15047125|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
15047126|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047127|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15047128|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15047129|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047130|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15047131|NCT02071160|Melatonin|melatonin|mesh-list
15047132|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
15047133|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047134|NCT02071160|Protective Agents|protective agents|mesh-ancestor
15047135|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047136|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15047137|NCT02071212|Ticagrelor|ticagrelor|mesh-list
15047138|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15047139|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15047140|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15047141|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15047142|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
15047143|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047144|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047145|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047146|NCT02071303|Celecoxib|celecoxib|mesh-list
15047147|NCT02071303|Tramadol|tramadol|mesh-list
15047148|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15047149|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15047150|NCT02071303|Analgesics|analgesics|mesh-ancestor
15047151|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
15047152|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047153|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047154|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15047155|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15047156|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15047157|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15047158|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047159|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047160|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15047161|NCT02071303|Narcotics|narcotics|mesh-ancestor
15047162|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15047163|NCT02071316|Esomeprazole|esomeprazole|mesh-list
15047164|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
15047165|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15047166|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15047167|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047168|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
15047169|NCT02071316|Coagulants|coagulants|mesh-ancestor
15047170|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15047171|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15047172|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15047173|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047174|NCT02071342|Everolimus|everolimus|mesh-list
15047175|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047176|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15047177|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
15047178|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047179|NCT02071355|Simeprevir|simeprevir|mesh-list
15047180|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
15047181|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047182|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
15047183|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047184|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047185|NCT02071368|Metformin|metformin|mesh-list
15047186|NCT02071368|Canagliflozin|canagliflozin|mesh-list
15047187|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15047188|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047189|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15047190|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047191|NCT02071394|Xenon|xenon|mesh-list
15047192|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15047193|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
15047194|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
15047195|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15047196|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047197|NCT02071407|Midazolam|midazolam|mesh-list
15047198|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15047199|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15047200|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15047201|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047202|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15047203|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15047204|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15047205|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15047206|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
15047207|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
15047208|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
15047209|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
15047210|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047211|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047212|NCT02071433|Iodine|iodine|mesh-list
15047213|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15047214|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047215|NCT02071433|Trace Elements|trace elements|mesh-ancestor
15047216|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
15047217|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047218|NCT02071459|Droxidopa|droxidopa|mesh-list
15047219|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15047220|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15047221|NCT02071537|Gemcitabine|gemcitabine|mesh-list
15047222|NCT02071537|Chloroquine|chloroquine|mesh-list
15047223|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15047224|NCT02071537|Carboplatin|carboplatin|mesh-list
15047225|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047226|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047227|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
15047228|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047229|NCT02071537|Antiviral Agents|antiviral agents|mesh-ancestor
15047230|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047231|NCT02071537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047232|NCT02071537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15047233|NCT02071537|Immunologic Factors|immunologic factors|mesh-ancestor
15047234|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047235|NCT02071537|Amebicides|amebicides|mesh-ancestor
15047236|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15047237|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15047238|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
15047239|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15047240|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15047241|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15047242|NCT02071537|Analgesics|analgesics|mesh-ancestor
15047243|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
15047244|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047245|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15047246|NCT02071537|Filaricides|filaricides|mesh-ancestor
15047247|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
15047248|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
15047249|NCT02071589|Nifedipine|nifedipine|mesh-list
15047250|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15047251|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15047252|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047253|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15047254|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047255|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
15047256|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
15047257|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15047258|NCT02071615|Methylphenidate|methylphenidate|mesh-list
15047259|NCT02071615|Caffeine|caffeine|mesh-list
15047260|NCT02071615|Modafinil|modafinil|mesh-list
15047261|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15047262|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047263|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15047264|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15047265|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15047266|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047267|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
15047268|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047269|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15047270|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047271|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15047272|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15047273|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
15047274|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15047275|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15047276|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15047277|NCT02071641|Sunitinib|sunitinib|mesh-list
15047278|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047279|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15047280|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15047281|NCT02071641|Growth Substances|growth substances|mesh-ancestor
15047282|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047283|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
15047284|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15047285|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047286|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047287|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
15047288|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047289|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047290|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047291|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15047292|NCT02071862|Paclitaxel|paclitaxel|mesh-list
15047293|NCT02071862|Docetaxel|docetaxel|mesh-list
15047294|NCT02071862|Everolimus|everolimus|mesh-list
15047295|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15047296|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047297|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
15047298|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
15047299|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
15047300|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047301|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15047302|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
15047303|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047304|NCT02071888|Dexamethasone|dexamethasone|mesh-list
15047305|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
15047306|NCT02071888|Pomalidomide|pomalidomide|mesh-list
15047307|NCT02071888|BB 1101|bb 1101|mesh-list
15047308|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15047309|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
15047310|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
15047311|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047312|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047313|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15047314|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
15047315|NCT02071888|Hormones|hormones|mesh-ancestor
15047316|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15047317|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15047318|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047319|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
15047320|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047321|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047322|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
15047323|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15047324|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15047325|NCT02071888|Growth Substances|growth substances|mesh-ancestor
15047326|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
15047327|NCT02071927|Azacitidine|azacitidine|mesh-list
15047328|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047329|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
15047330|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047331|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047332|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047333|NCT02071966|Clopidogrel|clopidogrel|mesh-list
15047334|NCT02071966|Ticagrelor|ticagrelor|mesh-list
15047335|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15047336|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15047337|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15047338|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15047339|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
15047340|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047341|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047342|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047343|NCT02072031|Sunitinib|sunitinib|mesh-list
15047344|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047345|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15047346|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15047347|NCT02072031|Growth Substances|growth substances|mesh-ancestor
15047348|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047349|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
15047350|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15047351|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047352|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047353|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
15047354|NCT02072083|Ketamine|ketamine|mesh-list
15047355|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15047356|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15047357|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047358|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15047359|NCT02072083|Analgesics|analgesics|mesh-ancestor
15047360|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
15047361|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047362|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15047363|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15047364|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15047365|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
15047366|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047367|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047368|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15047369|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15047370|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
15047371|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
15047372|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15047373|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15047374|NCT02072135|Bupivacaine|bupivacaine|mesh-list
15047375|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
15047376|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
15047377|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15047378|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047379|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
15047380|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047381|NCT02072213|Tamsulosin|tamsulosin|mesh-list
15047382|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15047383|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15047384|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15047385|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
15047386|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047387|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047388|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047389|NCT02072213|Urological Agents|urological agents|mesh-ancestor
15047390|NCT02072278|Vortioxetine|vortioxetine|mesh-list
15047391|NCT02072278|Citalopram|citalopram|mesh-list
15047392|NCT02072278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15047393|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15047394|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15047395|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047396|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047397|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
15047398|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047399|NCT02072278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15047400|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
15047401|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15047402|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15047403|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15047404|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15047405|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15047406|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15047407|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15047408|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15047409|NCT02072291|Nifedipine|nifedipine|mesh-list
15047410|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15047411|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15047412|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047413|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15047414|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047415|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
15047416|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
15047417|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15047418|NCT02072317|Raltitrexed|raltitrexed|mesh-list
15047419|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047420|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
15047421|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047422|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047423|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15047424|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047425|NCT02072330|Amlodipine|amlodipine|mesh-list
15047426|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15047427|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
15047428|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15047429|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15047430|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15047431|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047432|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15047433|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047434|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
15047435|NCT02072330|Diuretics|diuretics|mesh-ancestor
15047436|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
15047437|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15047438|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15047439|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15047440|NCT02072382|Metformin|metformin|mesh-list
15047441|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15047442|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047443|NCT02072408|Aflibercept|aflibercept|mesh-list
15047444|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15047445|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15047446|NCT02072408|Growth Substances|growth substances|mesh-ancestor
15047447|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047448|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
15047449|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047450|NCT02072486|Sorafenib|sorafenib|mesh-list
15047451|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047452|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15047453|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047454|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047455|NCT02072512|Fulvestrant|fulvestrant|mesh-list
15047456|NCT02072512|Anastrozole|anastrozole|mesh-list
15047457|NCT02072512|Goserelin|goserelin|mesh-list
15047458|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15047459|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047460|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15047461|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15047462|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
15047463|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15047464|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047465|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15047466|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15047467|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047468|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047469|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15047470|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
15047471|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047472|NCT02072720|Bevacizumab|bevacizumab|mesh-list
15047473|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15047474|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047475|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15047476|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15047477|NCT02072720|Growth Substances|growth substances|mesh-ancestor
15047478|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047479|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
15047480|NCT02072746|Zinc|zinc|mesh-list
15047481|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
15047482|NCT02072746|Trace Elements|trace elements|mesh-ancestor
15047483|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
15047484|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047485|NCT02072746|Astringents|astringents|mesh-ancestor
15047486|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
15047487|NCT02072785|Vincristine|vincristine|mesh-list
15047488|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15047489|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047490|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
15047491|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
15047492|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
15047493|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047494|NCT02072798|Cefuroxime|cefuroxime|mesh-list
15047495|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
15047496|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15047497|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047498|NCT02072811|Cytarabine|cytarabine|mesh-list
15047499|NCT02072811|Daunorubicin|daunorubicin|mesh-list
15047500|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
15047501|NCT02072811|Cladribine|cladribine|mesh-list
15047502|NCT02072811|Sargramostim|sargramostim|mesh-list
15047503|NCT02072811|Lenograstim|lenograstim|mesh-list
15047504|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047505|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
15047506|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047507|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047508|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
15047509|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047510|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15047511|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
15047512|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047513|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15047514|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15047515|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15047516|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047517|NCT02072811|Analgesics|analgesics|mesh-ancestor
15047518|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
15047519|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047520|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15047521|NCT02072967|Rituximab|rituximab|mesh-list
15047522|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15047523|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15047524|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047525|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
15047526|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047527|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15047528|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15047529|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
15047530|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047531|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
15047532|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15047533|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047534|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15047535|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15047536|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047537|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047538|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047539|NCT02073149|Iron|iron|mesh-list
15047540|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
15047541|NCT02073149|Trace Elements|trace elements|mesh-ancestor
15047542|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
15047543|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047544|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15047545|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
15047546|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
15047547|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047548|NCT02073227|Metformin|metformin|mesh-list
15047549|NCT02073227|Canagliflozin|canagliflozin|mesh-list
15047550|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15047551|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047552|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15047553|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047554|NCT02073357|Anesthetics|anesthetics|mesh-list
15047555|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15047556|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047557|NCT02073474|Nabiximols|nabiximols|mesh-list
15047558|NCT02073474|Analgesics|analgesics|mesh-ancestor
15047559|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
15047560|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047561|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047562|NCT02073526|Adalimumab|adalimumab|mesh-list
15047563|NCT02073526|Infliximab|infliximab|mesh-list
15047564|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
15047565|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15047566|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15047567|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
15047568|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15047569|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15047570|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
15047571|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047572|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
15047573|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15047574|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
15047575|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047576|NCT02073552|Protective Agents|protective agents|mesh-ancestor
15047577|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047578|NCT02073552|Vitamins|vitamins|mesh-ancestor
15047579|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
15047580|NCT02073552|Laxatives|laxatives|mesh-ancestor
15047581|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15047582|NCT02073669|Interferons|interferons|mesh-list
15047583|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
15047584|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047585|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
15047586|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047587|NCT02073734|Dexamethasone|dexamethasone|mesh-list
15047588|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15047589|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
15047590|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
15047591|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047592|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047593|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15047594|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
15047595|NCT02073734|Hormones|hormones|mesh-ancestor
15047596|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15047597|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15047598|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047599|NCT02073773|Levodopa|levodopa|mesh-list
15047600|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15047601|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15047602|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
15047603|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047604|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047605|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047606|NCT02073838|Ribavirin|ribavirin|mesh-list
15047607|NCT02073838|Decitabine|decitabine|mesh-list
15047608|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
15047609|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047610|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
15047611|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047612|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047613|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047614|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047615|NCT02073916|Paclitaxel|paclitaxel|mesh-list
15047616|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15047617|NCT02073916|Trastuzumab|trastuzumab|mesh-list
15047618|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15047619|NCT02073916|Lapatinib|lapatinib|mesh-list
15047620|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15047621|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047622|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
15047623|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
15047624|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
15047625|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047626|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15047627|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15047628|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047629|NCT02073994|Ivosidenib|ivosidenib|mesh-list
15047630|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047631|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047632|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047633|NCT02074137|Prednisone|prednisone|mesh-list
15047634|NCT02074137|Prednisolone|prednisolone|mesh-list
15047635|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15047636|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
15047637|NCT02074137|Hormones|hormones|mesh-ancestor
15047638|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15047639|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047640|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15047641|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047642|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15047643|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15047644|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15047645|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047646|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047647|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15047648|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15047649|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047650|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
15047651|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047652|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15047653|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15047654|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15047655|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047656|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047657|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15047658|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15047659|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047660|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
15047661|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047662|NCT02074189|Gemcitabine|gemcitabine|mesh-list
15047663|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047664|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047665|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
15047666|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047667|NCT02074189|Antiviral Agents|antiviral agents|mesh-ancestor
15047668|NCT02074189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047669|NCT02074189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047670|NCT02074189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15047671|NCT02074189|Immunologic Factors|immunologic factors|mesh-ancestor
15047672|NCT02074189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047673|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15047674|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15047675|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047676|NCT02074228|Methylphenidate|methylphenidate|mesh-list
15047677|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15047678|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047679|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15047680|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15047681|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15047682|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047683|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
15047684|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047685|NCT02074267|Gabapentin|gabapentin|mesh-list
15047686|NCT02074267|Analgesics|analgesics|mesh-ancestor
15047687|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
15047688|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047689|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047690|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
15047691|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15047692|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15047693|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15047694|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15047695|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15047696|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15047697|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047698|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047699|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
15047700|NCT02074280|Rifaximin|rifaximin|mesh-list
15047701|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15047702|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047703|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15047704|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15047705|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15047706|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15047707|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047708|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047709|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15047710|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15047711|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047712|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
15047713|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047714|NCT02074319|Methotrexate|methotrexate|mesh-list
15047715|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15047716|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
15047717|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15047718|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047719|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047720|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
15047721|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047722|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047723|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
15047724|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047725|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15047726|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15047727|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
15047728|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15047729|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15047730|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
15047731|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15047732|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15047733|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047734|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
15047735|NCT02074436|Coagulants|coagulants|mesh-ancestor
15047736|NCT02074605|Interferons|interferons|mesh-list
15047737|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
15047738|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047739|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
15047740|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047741|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
15047742|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047743|NCT02074800|Siltuximab|siltuximab|mesh-list
15047744|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15047745|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047746|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
15047747|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047748|NCT02074839|Ivosidenib|ivosidenib|mesh-list
15047749|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047750|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047751|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047752|NCT02074878|Sunitinib|sunitinib|mesh-list
15047753|NCT02074878|Crizotinib|crizotinib|mesh-list
15047754|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047755|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15047756|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15047757|NCT02074878|Growth Substances|growth substances|mesh-ancestor
15047758|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047759|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
15047760|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15047761|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047762|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047763|NCT02074891|Tenofovir|tenofovir|mesh-list
15047764|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
15047765|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047766|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15047767|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15047768|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047769|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047770|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15047771|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15047772|NCT02075034|ON 01910|on 01910|mesh-list
15047773|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047774|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15047775|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047776|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047777|NCT02075086|Bevacizumab|bevacizumab|mesh-list
15047778|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15047779|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047780|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15047781|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15047782|NCT02075086|Growth Substances|growth substances|mesh-ancestor
15047783|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047784|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
15047785|NCT02075112|Genistein|genistein|mesh-list
15047786|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047787|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15047788|NCT02075112|Protective Agents|protective agents|mesh-ancestor
15047789|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047790|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15047791|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047792|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047793|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
15047794|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15047795|NCT02075112|Estrogens|estrogens|mesh-ancestor
15047796|NCT02075112|Hormones|hormones|mesh-ancestor
15047797|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15047798|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
15047799|NCT02075242|Tacrolimus|tacrolimus|mesh-list
15047800|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15047801|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
15047802|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047803|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15047804|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047805|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047806|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15047807|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047808|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15047809|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
15047810|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15047811|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047812|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15047813|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15047814|NCT02075294|Entecavir|entecavir|mesh-list
15047815|NCT02075294|Adefovir|adefovir|mesh-list
15047816|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
15047817|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
15047818|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047819|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15047820|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15047821|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047822|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047823|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15047824|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15047825|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15047826|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15047827|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15047828|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047829|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15047830|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15047831|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15047832|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
15047833|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047834|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047835|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15047836|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15047837|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
15047838|NCT02075619|Amlodipine|amlodipine|mesh-list
15047839|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15047840|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15047841|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15047842|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15047843|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047844|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15047845|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047846|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
15047847|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15047848|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15047849|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
15047850|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15047851|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15047852|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047853|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15047854|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15047855|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
15047856|NCT02075749|Triamcinolone|triamcinolone|mesh-list
15047857|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15047858|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15047859|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15047860|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15047861|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
15047862|NCT02075749|Hormones|hormones|mesh-ancestor
15047863|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15047864|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047865|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15047866|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
15047867|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047868|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047869|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
15047870|NCT02075970|Hematinics|hematinics|mesh-ancestor
15047871|NCT02076191|Decitabine|decitabine|mesh-list
15047872|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047873|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
15047874|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047875|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047876|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047877|NCT02076217|Copper|copper|mesh-list
15047878|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
15047879|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
15047880|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
15047881|NCT02076217|Etonogestrel|etonogestrel|mesh-list
15047882|NCT02076217|Desogestrel|desogestrel|mesh-list
15047883|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15047884|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047885|NCT02076217|Trace Elements|trace elements|mesh-ancestor
15047886|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
15047887|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15047888|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15047889|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15047890|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15047891|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15047892|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15047893|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15047894|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047895|NCT02076217|Progestins|progestins|mesh-ancestor
15047896|NCT02076217|Hormones|hormones|mesh-ancestor
15047897|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15047898|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
15047899|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15047900|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
15047901|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047902|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047903|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
15047904|NCT02076373|Hematinics|hematinics|mesh-ancestor
15047905|NCT02076386|Dolutegravir|dolutegravir|mesh-list
15047906|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15047907|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15047908|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047909|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047910|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15047911|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15047912|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
15047913|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047914|NCT02076451|DS-8273a|ds-8273a|mesh-list
15047915|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15047916|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047917|NCT02076477|Docetaxel|docetaxel|mesh-list
15047918|NCT02076477|Pemetrexed|pemetrexed|mesh-list
15047919|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047920|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
15047921|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
15047922|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
15047923|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047924|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047925|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15047926|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15047927|NCT02076529|Ramosetron|ramosetron|mesh-list
15047928|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
15047929|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
15047930|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15047931|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047932|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15047933|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15047934|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
15047935|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047936|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047937|NCT02076594|Docetaxel|docetaxel|mesh-list
15047938|NCT02076594|Capecitabine|capecitabine|mesh-list
15047939|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
15047940|NCT02076594|Epirubicin|epirubicin|mesh-list
15047941|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047942|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
15047943|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
15047944|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
15047945|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047946|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047947|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
15047948|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15047949|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15047950|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15047951|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047952|NCT02076659|Methotrexate|methotrexate|mesh-list
15047953|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15047954|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
15047955|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15047956|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047957|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15047958|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
15047959|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047960|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15047961|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
15047962|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15047963|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15047964|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15047965|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
15047966|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15047967|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15047968|NCT02076685|Isoniazid|isoniazid|mesh-list
15047969|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
15047970|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15047971|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15047972|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15047973|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15047974|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
15047975|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047976|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15047977|NCT02076750|Vitamin D|vitamin d|mesh-list
15047978|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
15047979|NCT02076750|Vitamins|vitamins|mesh-ancestor
15047980|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
15047981|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047982|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15047983|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15047984|NCT02076815|Anagrelide|anagrelide|mesh-list
15047985|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15047986|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15047987|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047988|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15047989|NCT02076828|Zinc|zinc|mesh-list
15047990|NCT02076828|Glycine|glycine|mesh-list
15047991|NCT02076828|Trace Elements|trace elements|mesh-ancestor
15047992|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
15047993|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15047994|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
15047995|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15047996|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15047997|NCT02076841|Interferons|interferons|mesh-list
15047998|NCT02076841|Interferon-beta|interferon-beta|mesh-list
15047999|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
15048000|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048001|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
15048002|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048003|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
15048004|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048005|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15048006|NCT02076893|Ibuprofen|ibuprofen|mesh-list
15048007|NCT02076893|Gabapentin|gabapentin|mesh-list
15048008|NCT02076893|Tramadol|tramadol|mesh-list
15048009|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15048010|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15048011|NCT02076893|Analgesics|analgesics|mesh-ancestor
15048012|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
15048013|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048014|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048015|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15048016|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15048017|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15048018|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048019|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048020|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
15048021|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15048022|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15048023|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048024|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15048025|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15048026|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15048027|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048028|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
15048029|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15048030|NCT02076893|Narcotics|narcotics|mesh-ancestor
15048031|NCT02076945|Lidocaine|lidocaine|mesh-list
15048032|NCT02076945|Bupivacaine|bupivacaine|mesh-list
15048033|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
15048034|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
15048035|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048036|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048037|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
15048038|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048039|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15048040|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15048041|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15048042|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15048043|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048044|NCT02077010|Milrinone|milrinone|mesh-list
15048045|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15048046|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15048047|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
15048048|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15048049|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15048050|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048051|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048052|NCT02077010|Protective Agents|protective agents|mesh-ancestor
15048053|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048054|NCT02077231|Vitamins|vitamins|mesh-list
15048055|NCT02077231|Vitamin A|vitamin a|mesh-list
15048056|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
15048057|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
15048058|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048059|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
15048060|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048061|NCT02077231|Protective Agents|protective agents|mesh-ancestor
15048062|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15048063|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048064|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15048065|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15048066|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15048067|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
15048068|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048069|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15048070|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15048071|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048072|NCT02077309|Linagliptin|linagliptin|mesh-list
15048073|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15048074|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048075|NCT02077309|Incretins|incretins|mesh-ancestor
15048076|NCT02077309|Hormones|hormones|mesh-ancestor
15048077|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15048078|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15048079|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
15048080|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048081|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048082|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
15048083|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
15048084|NCT02077322|Coagulants|coagulants|mesh-ancestor
15048085|NCT02077348|Hormones|hormones|mesh-list
15048086|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048087|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15048088|NCT02077400|Cefazolin|cefazolin|mesh-list
15048089|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15048090|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048091|NCT02077478|Remifentanil|remifentanil|mesh-list
15048092|NCT02077478|Propofol|propofol|mesh-list
15048093|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15048094|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048095|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048096|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15048097|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
15048098|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
15048099|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15048100|NCT02077478|Narcotics|narcotics|mesh-ancestor
15048101|NCT02077478|Analgesics|analgesics|mesh-ancestor
15048102|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
15048103|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048104|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
15048105|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
15048106|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15048107|NCT02077556|Prednisolone|prednisolone|mesh-list
15048108|NCT02077556|Everolimus|everolimus|mesh-list
15048109|NCT02077556|Tacrolimus|tacrolimus|mesh-list
15048110|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15048111|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
15048112|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048113|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15048114|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048115|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048116|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048117|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15048118|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15048119|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
15048120|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15048121|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048122|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15048123|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
15048124|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
15048125|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048126|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15048127|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
15048128|NCT02077556|Hormones|hormones|mesh-ancestor
15048129|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15048130|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15048131|NCT02077556|Protective Agents|protective agents|mesh-ancestor
15048132|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15048133|NCT02077634|Prednisone|prednisone|mesh-list
15048134|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
15048135|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15048136|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
15048137|NCT02077634|Hormones|hormones|mesh-ancestor
15048138|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15048139|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048140|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15048141|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048142|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15048143|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048144|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048145|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
15048146|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15048147|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
15048148|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15048149|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048150|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048151|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15048152|NCT02077712|Analgesics|analgesics|mesh-ancestor
15048153|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
15048154|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048155|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15048156|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15048157|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15048158|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
15048159|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048160|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048161|NCT02077751|Biotin|biotin|mesh-list
15048162|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
15048163|NCT02077751|Vitamins|vitamins|mesh-ancestor
15048164|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
15048165|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048166|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
15048167|NCT02077777|Mesalamine|mesalamine|mesh-list
15048168|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15048169|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15048170|NCT02077777|Analgesics|analgesics|mesh-ancestor
15048171|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
15048172|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048173|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048174|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15048175|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15048176|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
15048177|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15048178|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048179|NCT02077803|Metformin|metformin|mesh-list
15048180|NCT02077803|Canagliflozin|canagliflozin|mesh-list
15048181|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15048182|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048183|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15048184|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048185|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
15048186|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15048187|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048188|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
15048189|NCT02077933|Everolimus|everolimus|mesh-list
15048190|NCT02077933|Exemestane|exemestane|mesh-list
15048191|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048192|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15048193|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
15048194|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048195|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15048196|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15048197|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048198|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048199|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15048200|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
15048201|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15048202|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15048203|NCT02077946|Liraglutide|liraglutide|mesh-list
15048204|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15048205|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048206|NCT02077946|Incretins|incretins|mesh-ancestor
15048207|NCT02077946|Hormones|hormones|mesh-ancestor
15048208|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15048209|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15048210|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
15048211|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048212|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048213|NCT02077959|Lenalidomide|lenalidomide|mesh-list
15048214|NCT02077959|Pidilizumab|pidilizumab|mesh-list
15048215|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
15048216|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048217|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15048218|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15048219|NCT02077959|Growth Substances|growth substances|mesh-ancestor
15048220|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
15048221|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048222|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15048223|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
15048224|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048225|NCT02078063|Mepivacaine|mepivacaine|mesh-list
15048226|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
15048227|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
15048228|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048229|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048230|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
15048231|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048232|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
15048233|NCT02078089|Morphine|morphine|mesh-list
15048234|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15048235|NCT02078089|Narcotics|narcotics|mesh-ancestor
15048236|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048237|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048238|NCT02078089|Analgesics|analgesics|mesh-ancestor
15048239|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
15048240|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048241|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
15048242|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15048243|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15048244|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15048245|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048246|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15048247|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15048248|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
15048249|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
15048250|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048251|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
15048252|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048253|NCT02078167|Policosanol|policosanol|mesh-list
15048254|NCT02078167|Red yeast rice|red yeast rice|mesh-list
15048255|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15048256|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15048257|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15048258|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
15048259|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048260|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048261|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15048262|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15048263|NCT02078232|Pancrelipase|pancrelipase|mesh-list
15048264|NCT02078232|Pancreatin|pancreatin|mesh-list
15048265|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15048266|NCT02078323|Linaclotide|linaclotide|mesh-list
15048267|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
15048268|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
15048269|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048270|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15048271|NCT02078336|Atropine|atropine|mesh-list
15048272|NCT02078336|Midazolam|midazolam|mesh-list
15048273|NCT02078336|Droperidol|droperidol|mesh-list
15048274|NCT02078336|Lorazepam|lorazepam|mesh-list
15048275|NCT02078336|Biperiden|biperiden|mesh-list
15048276|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15048277|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15048278|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048279|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048280|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15048281|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15048282|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15048283|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15048284|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
15048285|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
15048286|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
15048287|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
15048288|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048289|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048290|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15048291|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15048292|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
15048293|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048294|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15048295|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
15048296|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
15048297|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
15048298|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15048299|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15048300|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
15048301|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
15048302|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
15048303|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15048304|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15048305|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15048306|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15048307|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15048308|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15048309|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
15048310|NCT02078388|Doxorubicin|doxorubicin|mesh-list
15048311|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15048312|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048313|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15048314|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15048315|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048316|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048317|NCT02078440|Bromocriptine|bromocriptine|mesh-list
15048318|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15048319|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15048320|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
15048321|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15048322|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048323|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
15048324|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
15048325|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048326|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048327|NCT02078583|Fentanyl|fentanyl|mesh-list
15048328|NCT02078583|Remifentanil|remifentanil|mesh-list
15048329|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15048330|NCT02078583|Narcotics|narcotics|mesh-ancestor
15048331|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048332|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048333|NCT02078583|Analgesics|analgesics|mesh-ancestor
15048334|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
15048335|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048336|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15048337|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15048338|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
15048339|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
15048340|NCT02078596|Valproic Acid|valproic acid|mesh-list
15048341|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
15048342|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048343|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048344|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
15048345|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048346|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048347|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
15048348|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15048349|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048350|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15048351|NCT02078609|Midostaurin|midostaurin|mesh-list
15048352|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048353|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15048354|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048355|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048356|NCT02078648|Poly I-C|poly i-c|mesh-list
15048357|NCT02078648|Bevacizumab|bevacizumab|mesh-list
15048358|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15048359|NCT02078648|Poly ICLC|poly iclc|mesh-list
15048360|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15048361|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048362|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15048363|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15048364|NCT02078648|Growth Substances|growth substances|mesh-ancestor
15048365|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048366|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
15048367|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
15048368|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
15048369|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
15048370|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048371|NCT02078648|Laxatives|laxatives|mesh-ancestor
15048372|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15048373|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15048374|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15048375|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15048376|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048377|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048378|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15048379|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15048380|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048381|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
15048382|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048383|NCT02078869|Progesterone|progesterone|mesh-list
15048384|NCT02078869|Progestins|progestins|mesh-ancestor
15048385|NCT02078869|Hormones|hormones|mesh-ancestor
15048386|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15048387|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048388|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
15048389|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15048390|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15048391|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15048392|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15048393|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048394|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
15048395|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048396|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048397|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15048398|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048399|NCT02078973|Tolvaptan|tolvaptan|mesh-list
15048400|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15048401|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048402|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
15048403|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048404|NCT02079064|Propofol|propofol|mesh-list
15048405|NCT02079064|Desflurane|desflurane|mesh-list
15048406|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15048407|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048408|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048409|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15048410|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
15048411|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
15048412|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15048413|NCT02079181|Fluorides|fluorides|mesh-list
15048414|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
15048415|NCT02079181|Protective Agents|protective agents|mesh-ancestor
15048416|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048417|NCT02079194|Aspirin|aspirin|mesh-list
15048418|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15048419|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15048420|NCT02079194|Analgesics|analgesics|mesh-ancestor
15048421|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
15048422|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048423|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048424|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15048425|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15048426|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15048427|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15048428|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048429|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15048430|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15048431|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048432|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
15048433|NCT02079220|Capecitabine|capecitabine|mesh-list
15048434|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
15048435|NCT02079220|Aflibercept|aflibercept|mesh-list
15048436|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15048437|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
15048438|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048439|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048440|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15048441|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15048442|NCT02079220|Growth Substances|growth substances|mesh-ancestor
15048443|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048444|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
15048445|NCT02079298|Fluconazole|fluconazole|mesh-list
15048446|NCT02079298|Ibuprofen|ibuprofen|mesh-list
15048447|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15048448|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15048449|NCT02079298|Analgesics|analgesics|mesh-ancestor
15048450|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
15048451|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048452|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048453|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15048454|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15048455|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15048456|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048457|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048458|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
15048459|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048460|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15048461|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15048462|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15048463|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
15048464|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15048465|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15048466|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15048467|NCT02079337|Rocuronium|rocuronium|mesh-list
15048468|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15048469|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15048470|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15048471|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048472|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048473|NCT02079350|Polygeline|polygeline|mesh-list
15048474|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
15048475|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
15048476|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
15048477|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15048478|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
15048479|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048480|NCT02079506|Candesartan|candesartan|mesh-list
15048481|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15048482|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15048483|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15048484|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
15048485|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048486|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15048487|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15048488|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048489|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15048490|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15048491|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15048492|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15048493|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
15048494|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048495|NCT02079558|Oxytocin|oxytocin|mesh-list
15048496|NCT02079558|Carbetocin|carbetocin|mesh-list
15048497|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
15048498|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15048499|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048500|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15048501|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
15048502|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048503|NCT02079727|Celecoxib|celecoxib|mesh-list
15048504|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15048505|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15048506|NCT02079727|Analgesics|analgesics|mesh-ancestor
15048507|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
15048508|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048509|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048510|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15048511|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15048512|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15048513|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15048514|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048515|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048516|NCT02079961|Micronutrients|micronutrients|mesh-list
15048517|NCT02079961|Trace Elements|trace elements|mesh-list
15048518|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048519|NCT02079974|Pravastatin|pravastatin|mesh-list
15048520|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15048521|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15048522|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
15048523|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048524|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15048525|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15048526|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048527|NCT02080026|Chloroquine|chloroquine|mesh-list
15048528|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15048529|NCT02080026|Atovaquone|atovaquone|mesh-list
15048530|NCT02080026|Proguanil|proguanil|mesh-list
15048531|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
15048532|NCT02080026|Vaccines|vaccines|mesh-list
15048533|NCT02080026|Amebicides|amebicides|mesh-ancestor
15048534|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15048535|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15048536|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048537|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
15048538|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15048539|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15048540|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15048541|NCT02080026|Analgesics|analgesics|mesh-ancestor
15048542|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
15048543|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048544|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048545|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15048546|NCT02080026|Filaricides|filaricides|mesh-ancestor
15048547|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
15048548|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
15048549|NCT02080026|Immunologic Factors|immunologic factors|mesh-ancestor
15048550|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048551|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048552|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
15048553|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15048554|NCT02080078|Theophylline|theophylline|mesh-list
15048555|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048556|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15048557|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048558|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048559|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15048560|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
15048561|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048562|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048563|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15048564|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
15048565|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15048566|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
15048567|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15048568|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15048569|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
15048570|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048571|NCT02080104|Oxytocin|oxytocin|mesh-list
15048572|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
15048573|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15048574|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048575|NCT02080169|Fentanyl|fentanyl|mesh-list
15048576|NCT02080169|Midazolam|midazolam|mesh-list
15048577|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
15048578|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15048579|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048580|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048581|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15048582|NCT02080169|Analgesics|analgesics|mesh-ancestor
15048583|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
15048584|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048585|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15048586|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15048587|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15048588|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
15048589|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048590|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048591|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15048592|NCT02080169|Narcotics|narcotics|mesh-ancestor
15048593|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15048594|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15048595|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
15048596|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
15048597|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15048598|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15048599|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15048600|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
15048601|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
15048602|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
15048603|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15048604|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
15048605|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048606|NCT02080182|Expectorants|expectorants|mesh-ancestor
15048607|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
15048608|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15048609|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
15048610|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048611|NCT02080182|Protective Agents|protective agents|mesh-ancestor
15048612|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048613|NCT02080182|Antidotes|antidotes|mesh-ancestor
15048614|NCT02080234|Gemcitabine|gemcitabine|mesh-list
15048615|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
15048616|NCT02080234|Asparaginase|asparaginase|mesh-list
15048617|NCT02080234|Pegaspargase|pegaspargase|mesh-list
15048618|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15048619|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
15048620|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048621|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048622|NCT02080234|Antiviral Agents|antiviral agents|mesh-ancestor
15048623|NCT02080234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048624|NCT02080234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048625|NCT02080234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15048626|NCT02080234|Immunologic Factors|immunologic factors|mesh-ancestor
15048627|NCT02080234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048628|NCT02080377|Glyburide|glyburide|mesh-list
15048629|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15048630|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048631|NCT02080416|Nelfinavir|nelfinavir|mesh-list
15048632|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15048633|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15048634|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
15048635|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048636|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048637|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15048638|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15048639|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
15048640|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048641|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
15048642|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15048643|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15048644|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048645|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
15048646|NCT02080494|Coagulants|coagulants|mesh-ancestor
15048647|NCT02080624|Sirolimus|sirolimus|mesh-list
15048648|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15048649|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048650|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15048651|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048652|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
15048653|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15048654|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
15048655|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048656|NCT02080715|Tolcapone|tolcapone|mesh-list
15048657|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15048658|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15048659|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
15048660|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048661|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048662|NCT02080728|Ropivacaine|ropivacaine|mesh-list
15048663|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
15048664|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
15048665|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048666|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048667|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
15048668|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048669|NCT02080845|Theobromine|theobromine|mesh-list
15048670|NCT02080845|Caffeine|caffeine|mesh-list
15048671|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15048672|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048673|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15048674|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048675|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048676|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15048677|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15048678|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
15048679|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048680|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15048681|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
15048682|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048683|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15048684|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
15048685|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
15048686|NCT02080858|Apixaban|apixaban|mesh-list
15048687|NCT02080858|Ticagrelor|ticagrelor|mesh-list
15048688|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15048689|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15048690|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15048691|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15048692|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
15048693|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048694|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048695|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048696|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15048697|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
15048698|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15048699|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
15048700|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048701|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
15048702|NCT02081027|Riluzole|riluzole|mesh-list
15048703|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
15048704|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15048705|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15048706|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048707|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048708|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048709|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15048710|NCT02081027|Protective Agents|protective agents|mesh-ancestor
15048711|NCT02081144|Nicotine|nicotine|mesh-list
15048712|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15048713|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
15048714|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048715|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048716|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15048717|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15048718|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
15048719|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048720|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048721|NCT02081287|Inositol|inositol|mesh-list
15048722|NCT02081287|Lamotrigine|lamotrigine|mesh-list
15048723|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
15048724|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15048725|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15048726|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048727|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15048728|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048729|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15048730|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15048731|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048732|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15048733|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15048734|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
15048735|NCT02081287|Vitamins|vitamins|mesh-ancestor
15048736|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
15048737|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
15048738|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15048739|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
15048740|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048741|NCT02081339|Ranibizumab|ranibizumab|mesh-list
15048742|NCT02081339|Aflibercept|aflibercept|mesh-list
15048743|NCT02081339|Verteporfin|verteporfin|mesh-list
15048744|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15048745|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15048746|NCT02081339|Growth Substances|growth substances|mesh-ancestor
15048747|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048748|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
15048749|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048750|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15048751|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
15048752|NCT02081391|Tapentadol|tapentadol|mesh-list
15048753|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15048754|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15048755|NCT02081391|Narcotics|narcotics|mesh-ancestor
15048756|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048757|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048758|NCT02081391|Analgesics|analgesics|mesh-ancestor
15048759|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
15048760|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048761|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15048762|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15048763|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15048764|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048765|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
15048766|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048767|NCT02081404|Esomeprazole|esomeprazole|mesh-list
15048768|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15048769|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15048770|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15048771|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048772|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048773|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15048774|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15048775|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048776|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15048777|NCT02081495|Doxorubicin|doxorubicin|mesh-list
15048778|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15048779|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048780|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15048781|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15048782|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048783|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048784|NCT02081560|Colistin|colistin|mesh-list
15048785|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15048786|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048787|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
15048788|NCT02081755|Everolimus|everolimus|mesh-list
15048789|NCT02081755|Azathioprine|azathioprine|mesh-list
15048790|NCT02081755|Tacrolimus|tacrolimus|mesh-list
15048791|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15048792|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
15048793|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048794|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15048795|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048796|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048797|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048798|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15048799|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15048800|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
15048801|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15048802|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048803|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
15048804|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15048805|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15048806|NCT02081885|Chitosan|chitosan|mesh-list
15048807|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15048808|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15048809|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
15048810|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048811|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15048812|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
15048813|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
15048814|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
15048815|NCT02081885|Coagulants|coagulants|mesh-ancestor
15048816|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
15048817|NCT02082054|Atropine|atropine|mesh-list
15048818|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
15048819|NCT02082054|Ephedrine|ephedrine|mesh-list
15048820|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15048821|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15048822|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15048823|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
15048824|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048825|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048826|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15048827|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
15048828|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
15048829|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
15048830|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15048831|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15048832|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
15048833|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048834|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048835|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
15048836|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15048837|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15048838|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
15048839|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
15048840|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
15048841|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
15048842|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15048843|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
15048844|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
15048845|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15048846|NCT02082067|Ketorolac|ketorolac|mesh-list
15048847|NCT02082067|Morphine|morphine|mesh-list
15048848|NCT02082067|Anesthetics|anesthetics|mesh-list
15048849|NCT02082067|Ropivacaine|ropivacaine|mesh-list
15048850|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
15048851|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
15048852|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048853|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048854|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15048855|NCT02082067|Narcotics|narcotics|mesh-ancestor
15048856|NCT02082067|Analgesics|analgesics|mesh-ancestor
15048857|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
15048858|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048859|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15048860|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15048861|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15048862|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15048863|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15048864|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048865|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048866|NCT02082236|Sufentanil|sufentanil|mesh-list
15048867|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15048868|NCT02082236|Narcotics|narcotics|mesh-ancestor
15048869|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048870|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048871|NCT02082236|Analgesics|analgesics|mesh-ancestor
15048872|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
15048873|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048874|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15048875|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15048876|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
15048877|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
15048878|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
15048879|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
15048880|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048881|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048882|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048883|NCT02082405|Dexamethasone|dexamethasone|mesh-list
15048884|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
15048885|NCT02082405|Bortezomib|bortezomib|mesh-list
15048886|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15048887|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
15048888|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048889|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15048890|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15048891|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
15048892|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048893|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048894|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15048895|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15048896|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
15048897|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
15048898|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048899|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15048900|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
15048901|NCT02082405|Hormones|hormones|mesh-ancestor
15048902|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15048903|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15048904|NCT02082418|Caseins|caseins|mesh-list
15048905|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
15048906|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
15048907|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048908|NCT02082496|Liraglutide|liraglutide|mesh-list
15048909|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15048910|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048911|NCT02082496|Incretins|incretins|mesh-ancestor
15048912|NCT02082496|Hormones|hormones|mesh-ancestor
15048913|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15048914|NCT02082613|Polidocanol|polidocanol|mesh-list
15048915|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15048916|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15048917|NCT02082652|Etonogestrel|etonogestrel|mesh-list
15048918|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15048919|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
15048920|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15048921|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048922|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15048923|NCT02082665|Dabrafenib|dabrafenib|mesh-list
15048924|NCT02082665|Midazolam|midazolam|mesh-list
15048925|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15048926|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15048927|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15048928|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048929|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048930|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15048931|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15048932|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15048933|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15048934|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
15048935|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
15048936|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
15048937|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
15048938|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048939|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048940|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15048941|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15048942|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
15048943|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15048944|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15048945|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048946|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048947|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15048948|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
15048949|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
15048950|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15048951|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048952|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048953|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15048954|NCT02083055|Analgesics|analgesics|mesh-ancestor
15048955|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
15048956|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048957|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15048958|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15048959|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15048960|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
15048961|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048962|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048963|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
15048964|NCT02083068|Vaccines|vaccines|mesh-list
15048965|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
15048966|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048967|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
15048968|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15048969|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15048970|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
15048971|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15048972|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15048973|NCT02083276|Renal Agents|renal agents|mesh-ancestor
15048974|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15048975|NCT02083315|Morphine|morphine|mesh-list
15048976|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15048977|NCT02083315|Narcotics|narcotics|mesh-ancestor
15048978|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15048979|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048980|NCT02083315|Analgesics|analgesics|mesh-ancestor
15048981|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
15048982|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15048983|NCT02083328|Mannitol|mannitol|mesh-list
15048984|NCT02083328|Caffeine|caffeine|mesh-list
15048985|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15048986|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15048987|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15048988|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15048989|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15048990|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15048991|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15048992|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
15048993|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15048994|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15048995|NCT02083328|Diuretics|diuretics|mesh-ancestor
15048996|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
15048997|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
15048998|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15048999|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049000|NCT02083510|Colchicine|colchicine|mesh-list
15049001|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
15049002|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15049003|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
15049004|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
15049005|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
15049006|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049007|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049008|NCT02083536|Docetaxel|docetaxel|mesh-list
15049009|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049010|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
15049011|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
15049012|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
15049013|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049014|NCT02083575|Vitamins|vitamins|mesh-list
15049015|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
15049016|NCT02083575|Deferiprone|deferiprone|mesh-list
15049017|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
15049018|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049019|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
15049020|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049021|NCT02083575|Protective Agents|protective agents|mesh-ancestor
15049022|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15049023|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
15049024|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
15049025|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
15049026|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15049027|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15049028|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15049029|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
15049030|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049031|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15049032|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15049033|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049034|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15049035|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049036|NCT02083640|Palbociclib|palbociclib|mesh-list
15049037|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049038|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15049039|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049040|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049041|NCT02083692|Metformin|metformin|mesh-list
15049042|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15049043|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049044|NCT02083874|Cannabidiol|cannabidiol|mesh-list
15049045|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
15049046|NCT02083991|Prednisolone|prednisolone|mesh-list
15049047|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
15049048|NCT02083991|Basiliximab|basiliximab|mesh-list
15049049|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15049050|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
15049051|NCT02083991|Hormones|hormones|mesh-ancestor
15049052|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15049053|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049054|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15049055|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049056|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
15049057|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15049058|NCT02084043|Amikacin|amikacin|mesh-list
15049059|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15049060|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049061|NCT02084225|Lidocaine|lidocaine|mesh-list
15049062|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
15049063|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
15049064|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049065|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049066|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
15049067|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049068|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15049069|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15049070|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15049071|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15049072|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049073|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
15049074|NCT02084303|Hematinics|hematinics|mesh-ancestor
15049075|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15049076|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15049077|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
15049078|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
15049079|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15049080|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15049081|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049082|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
15049083|NCT02084342|Coagulants|coagulants|mesh-ancestor
15049084|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15049085|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
15049086|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049087|NCT02084355|Fentanyl|fentanyl|mesh-list
15049088|NCT02084355|Oxycodone|oxycodone|mesh-list
15049089|NCT02084355|Hydromorphone|hydromorphone|mesh-list
15049090|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15049091|NCT02084355|Narcotics|narcotics|mesh-ancestor
15049092|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049093|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049094|NCT02084355|Analgesics|analgesics|mesh-ancestor
15049095|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
15049096|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049097|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15049098|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15049099|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
15049100|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
15049101|NCT02084368|Bupivacaine|bupivacaine|mesh-list
15049102|NCT02084368|Ropivacaine|ropivacaine|mesh-list
15049103|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
15049104|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
15049105|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049106|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049107|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
15049108|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049109|NCT02084420|Pantoprazole|pantoprazole|mesh-list
15049110|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15049111|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15049112|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15049113|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049114|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049115|NCT02084433|Anesthetics|anesthetics|mesh-list
15049116|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049117|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049118|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
15049119|NCT02084446|Prednisone|prednisone|mesh-list
15049120|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
15049121|NCT02084446|Everolimus|everolimus|mesh-list
15049122|NCT02084446|Tacrolimus|tacrolimus|mesh-list
15049123|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
15049124|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15049125|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15049126|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
15049127|NCT02084446|Hormones|hormones|mesh-ancestor
15049128|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15049129|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049130|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15049131|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049132|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15049133|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
15049134|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15049135|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049136|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049137|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15049138|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15049139|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
15049140|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15049141|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049142|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
15049143|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
15049144|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049145|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15049146|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15049147|NCT02084446|Protective Agents|protective agents|mesh-ancestor
15049148|NCT02084472|Petrolatum|petrolatum|mesh-list
15049149|NCT02084472|Mineral Oil|mineral oil|mesh-list
15049150|NCT02084472|Glycerol|glycerol|mesh-list
15049151|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15049152|NCT02084472|Protective Agents|protective agents|mesh-ancestor
15049153|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049154|NCT02084472|Emollients|emollients|mesh-ancestor
15049155|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
15049156|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
15049157|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
15049158|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15049159|NCT02084563|Cytarabine|cytarabine|mesh-list
15049160|NCT02084563|Decitabine|decitabine|mesh-list
15049161|NCT02084563|Daunorubicin|daunorubicin|mesh-list
15049162|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15049163|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
15049164|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049165|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049166|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
15049167|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049168|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15049169|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
15049170|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049171|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049172|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15049173|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15049174|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15049175|NCT02084576|Ketorolac|ketorolac|mesh-list
15049176|NCT02084576|Nepafenac|nepafenac|mesh-list
15049177|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15049178|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15049179|NCT02084576|Analgesics|analgesics|mesh-ancestor
15049180|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
15049181|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049182|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049183|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15049184|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15049185|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15049186|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049187|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049188|NCT02084589|Fentanyl|fentanyl|mesh-list
15049189|NCT02084589|Ropivacaine|ropivacaine|mesh-list
15049190|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
15049191|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
15049192|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049193|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049194|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
15049195|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049196|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15049197|NCT02084589|Narcotics|narcotics|mesh-ancestor
15049198|NCT02084589|Analgesics|analgesics|mesh-ancestor
15049199|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15049200|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15049201|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
15049202|NCT02084602|Artesunate|artesunate|mesh-list
15049203|NCT02084602|Mefloquine|mefloquine|mesh-list
15049204|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
15049205|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15049206|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15049207|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049208|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049209|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
15049210|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
15049211|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15049212|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
15049213|NCT02084615|Aspirin|aspirin|mesh-list
15049214|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15049215|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15049216|NCT02084615|Analgesics|analgesics|mesh-ancestor
15049217|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
15049218|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049219|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049220|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15049221|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15049222|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15049223|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15049224|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049225|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15049226|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15049227|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049228|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
15049229|NCT02084654|Exenatide|exenatide|mesh-list
15049230|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15049231|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049232|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15049233|NCT02084654|Incretins|incretins|mesh-ancestor
15049234|NCT02084654|Hormones|hormones|mesh-ancestor
15049235|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15049236|NCT02084719|Antibodies|antibodies|mesh-list
15049237|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
15049238|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049239|NCT02084732|Sorafenib|sorafenib|mesh-list
15049240|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049241|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15049242|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049243|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049244|NCT02084784|Methylene Blue|methylene blue|mesh-list
15049245|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049246|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049247|NCT02084875|Tofacitinib|tofacitinib|mesh-list
15049248|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15049249|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049250|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049251|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
15049252|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15049253|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049254|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15049255|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15049256|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049257|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049258|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049259|NCT02085005|Capecitabine|capecitabine|mesh-list
15049260|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
15049261|NCT02085005|Aflibercept|aflibercept|mesh-list
15049262|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15049263|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
15049264|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049265|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049266|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15049267|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15049268|NCT02085005|Growth Substances|growth substances|mesh-ancestor
15049269|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049270|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
15049271|NCT02085018|Omeprazole|omeprazole|mesh-list
15049272|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15049273|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15049274|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15049275|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049276|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049277|NCT02085109|Theobromine|theobromine|mesh-list
15049278|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15049279|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
15049280|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049281|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049282|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15049283|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
15049284|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
15049285|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
15049286|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
15049287|NCT02085239|Lidocaine|lidocaine|mesh-list
15049288|NCT02085239|Ropivacaine|ropivacaine|mesh-list
15049289|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
15049290|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
15049291|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049292|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049293|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
15049294|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049295|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15049296|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15049297|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15049298|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15049299|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049300|NCT02085265|Telmisartan|telmisartan|mesh-list
15049301|NCT02085265|Perindopril|perindopril|mesh-list
15049302|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15049303|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15049304|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15049305|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049306|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15049307|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
15049308|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049309|NCT02085291|Norepinephrine|norepinephrine|mesh-list
15049310|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15049311|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15049312|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
15049313|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15049314|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049315|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049316|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
15049317|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
15049318|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049319|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15049320|NCT02085304|Temozolomide|temozolomide|mesh-list
15049321|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15049322|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
15049323|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049324|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049325|NCT02085317|Nitroprusside|nitroprusside|mesh-list
15049326|NCT02085317|Acetylcholine|acetylcholine|mesh-list
15049327|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15049328|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
15049329|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15049330|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049331|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15049332|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
15049333|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15049334|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049335|NCT02085408|Cytarabine|cytarabine|mesh-list
15049336|NCT02085408|Decitabine|decitabine|mesh-list
15049337|NCT02085408|Clofarabine|clofarabine|mesh-list
15049338|NCT02085408|Azacitidine|azacitidine|mesh-list
15049339|NCT02085408|Daunorubicin|daunorubicin|mesh-list
15049340|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15049341|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
15049342|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049343|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049344|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
15049345|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049346|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15049347|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
15049348|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049349|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049350|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15049351|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15049352|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15049353|NCT02085538|Palbociclib|palbociclib|mesh-list
15049354|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049355|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15049356|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049357|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049358|NCT02085577|Acetaminophen|acetaminophen|mesh-list
15049359|NCT02085577|Sufentanil|sufentanil|mesh-list
15049360|NCT02085577|Ketamine|ketamine|mesh-list
15049361|NCT02085577|Morphine|morphine|mesh-list
15049362|NCT02085577|Dsuvia|dsuvia|mesh-list
15049363|NCT02085577|Ondansetron|ondansetron|mesh-list
15049364|NCT02085577|Analgesics|analgesics|mesh-ancestor
15049365|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
15049366|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049367|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049368|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15049369|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15049370|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
15049371|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
15049372|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049373|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15049374|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15049375|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15049376|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049377|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15049378|NCT02085577|Narcotics|narcotics|mesh-ancestor
15049379|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15049380|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
15049381|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
15049382|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
15049383|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15049384|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
15049385|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
15049386|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15049387|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
15049388|NCT02085577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15049389|NCT02085577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15049390|NCT02085577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15049391|NCT02085577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15049392|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15049393|NCT02085590|Vaccines|vaccines|mesh-list
15049394|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
15049395|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
15049396|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049397|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15049398|NCT02085603|Saracatinib|saracatinib|mesh-list
15049399|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049400|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049401|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049402|NCT02085655|Gemcitabine|gemcitabine|mesh-list
15049403|NCT02085655|Thalidomide|thalidomide|mesh-list
15049404|NCT02085655|Dexamethasone|dexamethasone|mesh-list
15049405|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
15049406|NCT02085655|Methotrexate|methotrexate|mesh-list
15049407|NCT02085655|Pegaspargase|pegaspargase|mesh-list
15049408|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15049409|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
15049410|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
15049411|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049412|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049413|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15049414|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
15049415|NCT02085655|Hormones|hormones|mesh-ancestor
15049416|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15049417|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15049418|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049419|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15049420|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
15049421|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049422|NCT02085655|Antiviral Agents|antiviral agents|mesh-ancestor
15049423|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049424|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049425|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15049426|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
15049427|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15049428|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
15049429|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15049430|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
15049431|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15049432|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15049433|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15049434|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
15049435|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15049436|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15049437|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15049438|NCT02085655|Growth Substances|growth substances|mesh-ancestor
15049439|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
15049440|NCT02085824|Enoxaparin|enoxaparin|mesh-list
15049441|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
15049442|NCT02085824|Dabigatran|dabigatran|mesh-list
15049443|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15049444|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
15049445|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15049446|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
15049447|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049448|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049449|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
15049450|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15049451|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15049452|NCT02085902|Ropivacaine|ropivacaine|mesh-list
15049453|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
15049454|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
15049455|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049456|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049457|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
15049458|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049459|NCT02085967|Itraconazole|itraconazole|mesh-list
15049460|NCT02085967|Rifampin|rifampin|mesh-list
15049461|NCT02085967|Midazolam|midazolam|mesh-list
15049462|NCT02085967|Bupropion|bupropion|mesh-list
15049463|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15049464|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15049465|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049466|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049467|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15049468|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15049469|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15049470|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15049471|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
15049472|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
15049473|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
15049474|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
15049475|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15049476|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049477|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15049478|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
15049479|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15049480|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15049481|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15049482|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
15049483|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15049484|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15049485|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049486|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
15049487|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049488|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15049489|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15049490|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
15049491|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15049492|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15049493|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15049494|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
15049495|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15049496|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
15049497|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15049498|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15049499|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15049500|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15049501|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15049502|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15049503|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15049504|NCT02086019|Aspirin|aspirin|mesh-list
15049505|NCT02086019|Ramipril|ramipril|mesh-list
15049506|NCT02086019|Bisoprolol|bisoprolol|mesh-list
15049507|NCT02086019|Heparin|heparin|mesh-list
15049508|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15049509|NCT02086019|Tinzaparin|tinzaparin|mesh-list
15049510|NCT02086019|Dalteparin|dalteparin|mesh-list
15049511|NCT02086019|Clopidogrel|clopidogrel|mesh-list
15049512|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15049513|NCT02086019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15049514|NCT02086019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15049515|NCT02086019|Analgesics|analgesics|mesh-ancestor
15049516|NCT02086019|Sensory System Agents|sensory system agents|mesh-ancestor
15049517|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049518|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049519|NCT02086019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15049520|NCT02086019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15049521|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15049522|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15049523|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049524|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15049525|NCT02086019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15049526|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049527|NCT02086019|Antipyretics|antipyretics|mesh-ancestor
15049528|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15049529|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15049530|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15049531|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
15049532|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15049533|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
15049534|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
15049535|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15049536|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15049537|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15049538|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
15049539|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
15049540|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
15049541|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15049542|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15049543|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15049544|NCT02086032|Estradiol|estradiol|mesh-list
15049545|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15049546|NCT02086032|Estrogens|estrogens|mesh-list
15049547|NCT02086032|Progesterone|progesterone|mesh-list
15049548|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
15049549|NCT02086032|Hormones|hormones|mesh-ancestor
15049550|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15049551|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049552|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15049553|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
15049554|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15049555|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15049556|NCT02086032|Progestins|progestins|mesh-ancestor
15049557|NCT02086097|Ibuprofen|ibuprofen|mesh-list
15049558|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15049559|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15049560|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15049561|NCT02086097|Analgesics|analgesics|mesh-ancestor
15049562|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
15049563|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049564|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049565|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15049566|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15049567|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15049568|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049569|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049570|NCT02086188|Mirabegron|mirabegron|mesh-list
15049571|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15049572|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15049573|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15049574|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
15049575|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15049576|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049577|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049578|NCT02086188|Urological Agents|urological agents|mesh-ancestor
15049579|NCT02086227|Glucagon|glucagon|mesh-list
15049580|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15049581|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15049582|NCT02086227|Hormones|hormones|mesh-ancestor
15049583|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15049584|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049585|NCT02086227|Incretins|incretins|mesh-ancestor
15049586|NCT02086253|BQ 788|bq 788|mesh-list
15049587|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15049588|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15049589|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049590|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
15049591|NCT02086279|Hormones|hormones|mesh-list
15049592|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15049593|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049594|NCT02086292|Lidocaine|lidocaine|mesh-list
15049595|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
15049596|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
15049597|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049598|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049599|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
15049600|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049601|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15049602|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15049603|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15049604|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15049605|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049606|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
15049607|NCT02086409|Vitamin D|vitamin d|mesh-list
15049608|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
15049609|NCT02086409|Vitamins|vitamins|mesh-list
15049610|NCT02086409|Calcium|calcium|mesh-list
15049611|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
15049612|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049613|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15049614|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15049615|NCT02086474|Bupivacaine|bupivacaine|mesh-list
15049616|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
15049617|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
15049618|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
15049619|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049620|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049621|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
15049622|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049623|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15049624|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
15049625|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
15049626|NCT02086474|Protective Agents|protective agents|mesh-ancestor
15049627|NCT02086526|Metformin|metformin|mesh-list
15049628|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15049629|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049630|NCT02086656|Bevacizumab|bevacizumab|mesh-list
15049631|NCT02086656|Capecitabine|capecitabine|mesh-list
15049632|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
15049633|NCT02086656|Irinotecan|irinotecan|mesh-list
15049634|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15049635|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049636|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15049637|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15049638|NCT02086656|Growth Substances|growth substances|mesh-ancestor
15049639|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049640|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
15049641|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15049642|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
15049643|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049644|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15049645|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15049646|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049647|NCT02086747|Acetaminophen|acetaminophen|mesh-list
15049648|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15049649|NCT02086747|Analgesics|analgesics|mesh-ancestor
15049650|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
15049651|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049652|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049653|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
15049654|NCT02086825|Rifaximin|rifaximin|mesh-list
15049655|NCT02086825|Lactulose|lactulose|mesh-list
15049656|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15049657|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049658|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15049659|NCT02086838|Dextrans|dextrans|mesh-list
15049660|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
15049661|NCT02086838|Hematinics|hematinics|mesh-list
15049662|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
15049663|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
15049664|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
15049665|NCT02086903|Clopidogrel|clopidogrel|mesh-list
15049666|NCT02086903|Ticagrelor|ticagrelor|mesh-list
15049667|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15049668|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15049669|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15049670|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15049671|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
15049672|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15049673|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049674|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049675|NCT02086929|Trazodone|trazodone|mesh-list
15049676|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15049677|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15049678|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15049679|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15049680|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049681|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15049682|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049683|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15049684|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
15049685|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15049686|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15049687|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15049688|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049689|NCT02086929|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15049690|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
15049691|NCT02086942|Dexamethasone|dexamethasone|mesh-list
15049692|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
15049693|NCT02086942|Bortezomib|bortezomib|mesh-list
15049694|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15049695|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
15049696|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049697|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15049698|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15049699|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
15049700|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049701|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049702|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15049703|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15049704|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
15049705|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
15049706|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049707|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15049708|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
15049709|NCT02086942|Hormones|hormones|mesh-ancestor
15049710|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15049711|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15049712|NCT02086994|Misoprostol|misoprostol|mesh-list
15049713|NCT02086994|Carbetocin|carbetocin|mesh-list
15049714|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15049715|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
15049716|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15049717|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049718|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15049719|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15049720|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
15049721|NCT02087007|Cilostazol|cilostazol|mesh-list
15049722|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15049723|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
15049724|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049725|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049726|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15049727|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
15049728|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15049729|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15049730|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049731|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15049732|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
15049733|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15049734|NCT02087007|Protective Agents|protective agents|mesh-ancestor
15049735|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15049736|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15049737|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049738|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15049739|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049740|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
15049741|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15049742|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15049743|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
15049744|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15049745|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049746|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049747|NCT02087098|Urological Agents|urological agents|mesh-ancestor
15049748|NCT02087111|Interferons|interferons|mesh-list
15049749|NCT02087111|Ribavirin|ribavirin|mesh-list
15049750|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
15049751|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
15049752|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15049753|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049754|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
15049755|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049756|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
15049757|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049758|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
15049759|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049760|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
15049761|NCT02087202|Ketamine|ketamine|mesh-list
15049762|NCT02087202|Analgesics|analgesics|mesh-ancestor
15049763|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
15049764|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049765|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049766|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15049767|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15049768|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
15049769|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
15049770|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049771|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15049772|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15049773|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15049774|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049775|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15049776|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
15049777|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15049778|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15049779|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15049780|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
15049781|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15049782|NCT02087215|Boron|boron|mesh-list
15049783|NCT02087215|Trace Elements|trace elements|mesh-ancestor
15049784|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
15049785|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049786|NCT02087332|Torsemide|torsemide|mesh-list
15049787|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15049788|NCT02087332|Diuretics|diuretics|mesh-ancestor
15049789|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
15049790|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049791|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15049792|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15049793|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049794|NCT02087384|Vaccines|vaccines|mesh-list
15049795|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
15049796|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049797|NCT02087462|Vitamins|vitamins|mesh-list
15049798|NCT02087462|Thiamine|thiamine|mesh-list
15049799|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
15049800|NCT02087462|Diclofenac|diclofenac|mesh-list
15049801|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
15049802|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049803|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15049804|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15049805|NCT02087462|Analgesics|analgesics|mesh-ancestor
15049806|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
15049807|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049808|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15049809|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15049810|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15049811|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049812|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049813|NCT02087475|Fluorouracil|fluorouracil|mesh-list
15049814|NCT02087475|Irinotecan|irinotecan|mesh-list
15049815|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
15049816|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049817|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15049818|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049819|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15049820|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
15049821|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049822|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15049823|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15049824|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049825|NCT02087488|Eszopiclone|eszopiclone|mesh-list
15049826|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15049827|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049828|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049829|NCT02087527|Dexamethasone|dexamethasone|mesh-list
15049830|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15049831|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
15049832|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
15049833|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049834|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049835|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15049836|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
15049837|NCT02087527|Hormones|hormones|mesh-ancestor
15049838|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15049839|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15049840|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049841|NCT02087540|Telmisartan|telmisartan|mesh-list
15049842|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15049843|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15049844|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15049845|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
15049846|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049847|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15049848|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15049849|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049850|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15049851|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15049852|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15049853|NCT02087566|Linezolid|linezolid|mesh-list
15049854|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15049855|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049856|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15049857|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049858|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049859|NCT02087579|Olanzapine|olanzapine|mesh-list
15049860|NCT02087579|Risperidone|risperidone|mesh-list
15049861|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15049862|NCT02087579|Aripiprazole|aripiprazole|mesh-list
15049863|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15049864|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15049865|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
15049866|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15049867|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049868|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049869|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15049870|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15049871|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049872|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15049873|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15049874|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
15049875|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
15049876|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
15049877|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049878|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15049879|NCT02087579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15049880|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15049881|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15049882|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
15049883|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
15049884|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15049885|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15049886|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15049887|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15049888|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15049889|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
15049890|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15049891|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15049892|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15049893|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049894|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049895|NCT02087683|Vitamin D|vitamin d|mesh-list
15049896|NCT02087683|Vitamins|vitamins|mesh-ancestor
15049897|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
15049898|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049899|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15049900|NCT02087722|Melatonin|melatonin|mesh-list
15049901|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
15049902|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049903|NCT02087722|Protective Agents|protective agents|mesh-ancestor
15049904|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049905|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049906|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
15049907|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15049908|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
15049909|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
15049910|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
15049911|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15049912|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
15049913|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
15049914|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049915|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049916|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15049917|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
15049918|NCT02087813|Hormones|hormones|mesh-ancestor
15049919|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15049920|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15049921|NCT02087813|Protective Agents|protective agents|mesh-ancestor
15049922|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15049923|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049924|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15049925|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15049926|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049927|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049928|NCT02088008|Valsartan|valsartan|mesh-list
15049929|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15049930|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15049931|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15049932|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049933|NCT02088060|Cannabidiol|cannabidiol|mesh-list
15049934|NCT02088060|Olanzapine|olanzapine|mesh-list
15049935|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
15049936|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
15049937|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049938|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049939|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15049940|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15049941|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15049942|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15049943|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15049944|NCT02088060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15049945|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15049946|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15049947|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049948|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15049949|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
15049950|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
15049951|NCT02088398|Ricolinostat|ricolinostat|mesh-list
15049952|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15049953|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15049954|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049955|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049956|NCT02088411|Diclofenac|diclofenac|mesh-list
15049957|NCT02088411|Wobenzym|wobenzym|mesh-list
15049958|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15049959|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15049960|NCT02088411|Analgesics|analgesics|mesh-ancestor
15049961|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
15049962|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049963|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049964|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15049965|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15049966|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15049967|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15049968|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049969|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15049970|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
15049971|NCT02088424|Insulin|insulin|mesh-list
15049972|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15049973|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049974|NCT02088450|Nitrendipine|nitrendipine|mesh-list
15049975|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15049976|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15049977|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15049978|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049979|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15049980|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049981|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
15049982|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
15049983|NCT02088502|Theophylline|theophylline|mesh-list
15049984|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15049985|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
15049986|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15049987|NCT02088502|Expectorants|expectorants|mesh-ancestor
15049988|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
15049989|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15049990|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
15049991|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15049992|NCT02088502|Protective Agents|protective agents|mesh-ancestor
15049993|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15049994|NCT02088502|Antidotes|antidotes|mesh-ancestor
15049995|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15049996|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
15049997|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15049998|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15049999|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15050000|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050001|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
15050002|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15050003|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15050004|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
15050005|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050006|NCT02088515|Docetaxel|docetaxel|mesh-list
15050007|NCT02088515|Nedaplatin|nedaplatin|mesh-list
15050008|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050009|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
15050010|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
15050011|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
15050012|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050013|NCT02088528|Mitomycins|mitomycins|mesh-list
15050014|NCT02088528|Mitomycin|mitomycin|mesh-list
15050015|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15050016|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050017|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
15050018|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050019|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15050020|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050021|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
15050022|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15050023|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15050024|NCT02088671|Propofol|propofol|mesh-list
15050025|NCT02088671|Desflurane|desflurane|mesh-list
15050026|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15050027|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050028|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050029|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15050030|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
15050031|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
15050032|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15050033|NCT02088684|Fulvestrant|fulvestrant|mesh-list
15050034|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15050035|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050036|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15050037|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15050038|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
15050039|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15050040|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050041|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
15050042|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
15050043|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
15050044|NCT02088866|Lidocaine|lidocaine|mesh-list
15050045|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
15050046|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
15050047|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050048|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050049|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
15050050|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050051|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15050052|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15050053|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15050054|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15050055|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050056|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
15050057|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15050058|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
15050059|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050060|NCT02088918|Metformin|metformin|mesh-list
15050061|NCT02088918|Nateglinide|nateglinide|mesh-list
15050062|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15050063|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050064|NCT02088944|Infliximab|infliximab|mesh-list
15050065|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
15050066|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15050067|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15050068|NCT02088970|Riboflavin|riboflavin|mesh-list
15050069|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15050070|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050071|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
15050072|NCT02088970|Vitamins|vitamins|mesh-ancestor
15050073|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
15050074|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050075|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15050076|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
15050077|NCT02088983|Choline|choline|mesh-list
15050078|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
15050079|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
15050080|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15050081|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
15050082|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050083|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15050084|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15050085|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
15050086|NCT02089048|Auranofin|auranofin|mesh-list
15050087|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15050088|NCT02089061|Atorvastatin|atorvastatin|mesh-list
15050089|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15050090|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15050091|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15050092|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
15050093|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050094|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15050095|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15050096|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050097|NCT02089126|Glimepiride|glimepiride|mesh-list
15050098|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15050099|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15050100|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050101|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15050102|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
15050103|NCT02089178|Remifentanil|remifentanil|mesh-list
15050104|NCT02089178|Anesthetics|anesthetics|mesh-list
15050105|NCT02089178|Propofol|propofol|mesh-list
15050106|NCT02089178|Sevoflurane|sevoflurane|mesh-list
15050107|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050108|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050109|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15050110|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15050111|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
15050112|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15050113|NCT02089178|Narcotics|narcotics|mesh-ancestor
15050114|NCT02089178|Analgesics|analgesics|mesh-ancestor
15050115|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
15050116|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050117|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15050118|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15050119|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
15050120|NCT02089204|Fluorides|fluorides|mesh-list
15050121|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
15050122|NCT02089204|Protective Agents|protective agents|mesh-ancestor
15050123|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050124|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
15050125|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050126|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
15050127|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050128|NCT02089256|Liraglutide|liraglutide|mesh-list
15050129|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15050130|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050131|NCT02089256|Incretins|incretins|mesh-ancestor
15050132|NCT02089256|Hormones|hormones|mesh-ancestor
15050133|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15050134|NCT02089295|Oxycodone|oxycodone|mesh-list
15050135|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15050136|NCT02089295|Narcotics|narcotics|mesh-ancestor
15050137|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050138|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050139|NCT02089295|Analgesics|analgesics|mesh-ancestor
15050140|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
15050141|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050142|NCT02089308|Nicotine|nicotine|mesh-list
15050143|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15050144|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
15050145|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050146|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050147|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15050148|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15050149|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
15050150|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050151|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050152|NCT02089386|Tamoxifen|tamoxifen|mesh-list
15050153|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15050154|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
15050155|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15050156|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050157|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15050158|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050159|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15050160|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15050161|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15050162|NCT02089399|Olmesartan|olmesartan|mesh-list
15050163|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15050164|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15050165|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15050166|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
15050167|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050168|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15050169|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15050170|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050171|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15050172|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15050173|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15050174|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15050175|NCT02089438|Vildagliptin|vildagliptin|mesh-list
15050176|NCT02089438|Saxagliptin|saxagliptin|mesh-list
15050177|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15050178|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050179|NCT02089438|Incretins|incretins|mesh-ancestor
15050180|NCT02089438|Hormones|hormones|mesh-ancestor
15050181|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15050182|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15050183|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
15050184|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050185|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050186|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
15050187|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15050188|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050189|NCT02089503|Ranibizumab|ranibizumab|mesh-list
15050190|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15050191|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15050192|NCT02089503|Growth Substances|growth substances|mesh-ancestor
15050193|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050194|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
15050195|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050196|NCT02089529|Ibuprofen|ibuprofen|mesh-list
15050197|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15050198|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15050199|NCT02089529|Analgesics|analgesics|mesh-ancestor
15050200|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
15050201|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050202|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050203|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15050204|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15050205|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15050206|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050207|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050208|NCT02089542|Methylene Blue|methylene blue|mesh-list
15050209|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050210|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050211|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15050212|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15050213|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050214|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15050215|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050216|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050217|NCT02089633|BCT-100|bct-100|mesh-list
15050218|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050219|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
15050220|NCT02089685|Ipilimumab|ipilimumab|mesh-list
15050221|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15050222|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050223|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15050224|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050225|NCT02089763|BCT-100|bct-100|mesh-list
15050226|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050227|NCT02089841|Lumefantrine|lumefantrine|mesh-list
15050228|NCT02089841|Artemether|artemether|mesh-list
15050229|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15050230|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
15050231|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15050232|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15050233|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050234|NCT02089854|Toremifene|toremifene|mesh-list
15050235|NCT02089854|Anastrozole|anastrozole|mesh-list
15050236|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15050237|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050238|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15050239|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15050240|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050241|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050242|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15050243|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
15050244|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15050245|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050246|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15050247|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15050248|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15050249|NCT02089867|Ezetimibe|ezetimibe|mesh-list
15050250|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15050251|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15050252|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
15050253|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050254|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15050255|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
15050256|NCT02089932|Bupivacaine|bupivacaine|mesh-list
15050257|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
15050258|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
15050259|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050260|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050261|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
15050262|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050263|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15050264|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15050265|NCT02089932|Analgesics|analgesics|mesh-ancestor
15050266|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15050267|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15050268|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15050269|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
15050270|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050271|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050272|NCT02090036|Lumefantrine|lumefantrine|mesh-list
15050273|NCT02090036|Artemether|artemether|mesh-list
15050274|NCT02090036|Primaquine|primaquine|mesh-list
15050275|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15050276|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
15050277|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15050278|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15050279|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050280|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15050281|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15050282|NCT02090153|Leucovorin|leucovorin|mesh-list
15050283|NCT02090153|Tegafur|tegafur|mesh-list
15050284|NCT02090153|Antidotes|antidotes|mesh-ancestor
15050285|NCT02090153|Protective Agents|protective agents|mesh-ancestor
15050286|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050287|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
15050288|NCT02090153|Vitamins|vitamins|mesh-ancestor
15050289|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
15050290|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15050291|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
15050292|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050293|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050294|NCT02090244|Teriparatide|teriparatide|mesh-list
15050295|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15050296|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050297|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15050298|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
15050299|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050300|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
15050301|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050302|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050303|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15050304|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
15050305|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15050306|NCT02090322|Bevacizumab|bevacizumab|mesh-list
15050307|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15050308|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050309|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15050310|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15050311|NCT02090322|Growth Substances|growth substances|mesh-ancestor
15050312|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050313|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
15050314|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15050315|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
15050316|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15050317|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
15050318|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050319|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
15050320|NCT02090400|Calcium|calcium|mesh-list
15050321|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15050322|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050323|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15050324|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15050325|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
15050326|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15050327|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15050328|NCT02090439|Silodosin|silodosin|mesh-list
15050329|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15050330|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15050331|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15050332|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
15050333|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050334|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050335|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050336|NCT02090439|Urological Agents|urological agents|mesh-ancestor
15050337|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
15050338|NCT02090504|Oxazepam|oxazepam|mesh-list
15050339|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15050340|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15050341|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
15050342|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
15050343|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050344|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050345|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15050346|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15050347|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15050348|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15050349|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
15050350|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
15050351|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050352|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050353|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
15050354|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
15050355|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15050356|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
15050357|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15050358|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
15050359|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050360|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050361|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
15050362|NCT02090673|Exenatide|exenatide|mesh-list
15050363|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15050364|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050365|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15050366|NCT02090673|Incretins|incretins|mesh-ancestor
15050367|NCT02090673|Hormones|hormones|mesh-ancestor
15050368|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15050369|NCT02090738|Amoxicillin|amoxicillin|mesh-list
15050370|NCT02090738|Clarithromycin|clarithromycin|mesh-list
15050371|NCT02090738|Acetazolamide|acetazolamide|mesh-list
15050372|NCT02090738|Esomeprazole|esomeprazole|mesh-list
15050373|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15050374|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050375|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15050376|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15050377|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15050378|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050379|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050380|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15050381|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15050382|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15050383|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
15050384|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15050385|NCT02090738|Diuretics|diuretics|mesh-ancestor
15050386|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
15050387|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050388|NCT02090790|Dexamethasone|dexamethasone|mesh-list
15050389|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
15050390|NCT02090790|BB 1101|bb 1101|mesh-list
15050391|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15050392|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
15050393|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
15050394|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050395|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050396|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15050397|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
15050398|NCT02090790|Hormones|hormones|mesh-ancestor
15050399|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15050400|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15050401|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050402|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
15050403|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050404|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050405|NCT02090829|Oxytocin|oxytocin|mesh-list
15050406|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
15050407|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15050408|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050409|NCT02090920|Nifedipine|nifedipine|mesh-list
15050410|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15050411|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15050412|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050413|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15050414|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050415|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
15050416|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
15050417|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15050418|NCT02090933|Celecoxib|celecoxib|mesh-list
15050419|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15050420|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15050421|NCT02090933|Analgesics|analgesics|mesh-ancestor
15050422|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
15050423|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050424|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050425|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15050426|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15050427|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15050428|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15050429|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050430|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050431|NCT02091063|Ricolinostat|ricolinostat|mesh-list
15050432|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050433|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15050434|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050435|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050436|NCT02091180|Mannitol|mannitol|mesh-list
15050437|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15050438|NCT02091180|Diuretics|diuretics|mesh-ancestor
15050439|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
15050440|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050441|NCT02091219|Vitamin D|vitamin d|mesh-list
15050442|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
15050443|NCT02091219|Calcifediol|calcifediol|mesh-list
15050444|NCT02091219|Vitamins|vitamins|mesh-ancestor
15050445|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
15050446|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050447|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15050448|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15050449|NCT02091297|Acetaminophen|acetaminophen|mesh-list
15050450|NCT02091297|Morphine|morphine|mesh-list
15050451|NCT02091297|Ropivacaine|ropivacaine|mesh-list
15050452|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15050453|NCT02091297|Narcotics|narcotics|mesh-ancestor
15050454|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050455|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050456|NCT02091297|Analgesics|analgesics|mesh-ancestor
15050457|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
15050458|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050459|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
15050460|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
15050461|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15050462|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
15050463|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
15050464|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15050465|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050466|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15050467|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15050468|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050469|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050470|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050471|NCT02091336|Metformin|metformin|mesh-list
15050472|NCT02091336|Glyburide|glyburide|mesh-list
15050473|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15050474|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050475|NCT02091388|Risperidone|risperidone|mesh-list
15050476|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15050477|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
15050478|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050479|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050480|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050481|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15050482|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15050483|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050484|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15050485|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15050486|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
15050487|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
15050488|NCT02091401|Analgesics|analgesics|mesh-ancestor
15050489|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
15050490|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050491|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050492|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
15050493|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050494|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15050495|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
15050496|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15050497|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15050498|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050499|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15050500|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
15050501|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15050502|NCT02091492|Teriparatide|teriparatide|mesh-list
15050503|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15050504|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050505|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15050506|NCT02091505|Ranibizumab|ranibizumab|mesh-list
15050507|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15050508|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15050509|NCT02091505|Growth Substances|growth substances|mesh-ancestor
15050510|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050511|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
15050512|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050513|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
15050514|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15050515|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
15050516|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050517|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
15050518|NCT02091674|Protective Agents|protective agents|mesh-ancestor
15050519|NCT02091817|Oxytocin|oxytocin|mesh-list
15050520|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
15050521|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15050522|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050523|NCT02091830|Acetaminophen|acetaminophen|mesh-list
15050524|NCT02091830|Cortisone|cortisone|mesh-list
15050525|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15050526|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15050527|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15050528|NCT02091830|Analgesics|analgesics|mesh-ancestor
15050529|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
15050530|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050531|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050532|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
15050533|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15050534|NCT02091908|Lactitol|lactitol|mesh-list
15050535|NCT02091908|Vaccines|vaccines|mesh-list
15050536|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
15050537|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050538|NCT02091908|Cathartics|cathartics|mesh-ancestor
15050539|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15050540|NCT02091973|Everolimus|everolimus|mesh-list
15050541|NCT02091973|Tacrolimus|tacrolimus|mesh-list
15050542|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15050543|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
15050544|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050545|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15050546|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050547|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050548|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050549|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15050550|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
15050551|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15050552|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050553|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050554|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15050555|NCT02092012|Analgesics|analgesics|mesh-ancestor
15050556|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
15050557|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050558|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15050559|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15050560|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15050561|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
15050562|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050563|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050564|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15050565|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15050566|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15050567|NCT02092038|Temozolomide|temozolomide|mesh-list
15050568|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15050569|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
15050570|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050571|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050572|NCT02092142|Vaccines|vaccines|mesh-list
15050573|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
15050574|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050575|NCT02092363|Paclitaxel|paclitaxel|mesh-list
15050576|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15050577|NCT02092363|Carboplatin|carboplatin|mesh-list
15050578|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
15050579|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15050580|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050581|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
15050582|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
15050583|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
15050584|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050585|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
15050586|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050587|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
15050588|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15050589|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050590|NCT02092376|Vitamins|vitamins|mesh-ancestor
15050591|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
15050592|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15050593|NCT02092428|Adenosine|adenosine|mesh-list
15050594|NCT02092428|Regadenoson|regadenoson|mesh-list
15050595|NCT02092428|Analgesics|analgesics|mesh-ancestor
15050596|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
15050597|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050598|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050599|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15050600|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
15050601|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15050602|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
15050603|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
15050604|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050605|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050606|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
15050607|NCT02092506|Amoxicillin|amoxicillin|mesh-list
15050608|NCT02092506|Metronidazole|metronidazole|mesh-list
15050609|NCT02092506|Clarithromycin|clarithromycin|mesh-list
15050610|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15050611|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15050612|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050613|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15050614|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15050615|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15050616|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050617|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050618|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15050619|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15050620|NCT02092532|Aflibercept|aflibercept|mesh-list
15050621|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15050622|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15050623|NCT02092532|Growth Substances|growth substances|mesh-ancestor
15050624|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050625|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
15050626|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050627|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
15050628|NCT02092558|Cephalosporins|cephalosporins|mesh-list
15050629|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15050630|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050631|NCT02092558|Renal Agents|renal agents|mesh-ancestor
15050632|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15050633|NCT02092597|Exenatide|exenatide|mesh-list
15050634|NCT02092597|Linagliptin|linagliptin|mesh-list
15050635|NCT02092597|Gliclazide|gliclazide|mesh-list
15050636|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15050637|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050638|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15050639|NCT02092597|Incretins|incretins|mesh-ancestor
15050640|NCT02092597|Hormones|hormones|mesh-ancestor
15050641|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15050642|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15050643|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
15050644|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050645|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050646|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
15050647|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15050648|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050649|NCT02092701|Vitamins|vitamins|mesh-ancestor
15050650|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
15050651|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15050652|NCT02092766|Artesunate|artesunate|mesh-list
15050653|NCT02092766|Quinine|quinine|mesh-list
15050654|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
15050655|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15050656|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15050657|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050658|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050659|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
15050660|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
15050661|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15050662|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
15050663|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15050664|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050665|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15050666|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050667|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15050668|NCT02092766|Analgesics|analgesics|mesh-ancestor
15050669|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
15050670|NCT02092818|Riociguat|riociguat|mesh-list
15050671|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
15050672|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050673|NCT02092896|Liraglutide|liraglutide|mesh-list
15050674|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15050675|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050676|NCT02092896|Incretins|incretins|mesh-ancestor
15050677|NCT02092896|Hormones|hormones|mesh-ancestor
15050678|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15050679|NCT02092974|Citalopram|citalopram|mesh-list
15050680|NCT02092974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15050681|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15050682|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15050683|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050684|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050685|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
15050686|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050687|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15050688|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
15050689|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15050690|NCT02093000|Bevacizumab|bevacizumab|mesh-list
15050691|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15050692|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050693|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15050694|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15050695|NCT02093000|Growth Substances|growth substances|mesh-ancestor
15050696|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050697|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
15050698|NCT02093091|Vitremer|vitremer|mesh-list
15050699|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
15050700|NCT02093091|Protective Agents|protective agents|mesh-ancestor
15050701|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050702|NCT02093143|Remifentanil|remifentanil|mesh-list
15050703|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15050704|NCT02093143|Narcotics|narcotics|mesh-ancestor
15050705|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050706|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050707|NCT02093143|Analgesics|analgesics|mesh-ancestor
15050708|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
15050709|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050710|NCT02093195|Bosentan|bosentan|mesh-list
15050711|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15050712|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15050713|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
15050714|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15050715|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15050716|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050717|NCT02093299|Clopidogrel|clopidogrel|mesh-list
15050718|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15050719|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15050720|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15050721|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15050722|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
15050723|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050724|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050725|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050726|NCT02093403|Decitabine|decitabine|mesh-list
15050727|NCT02093403|Azacitidine|azacitidine|mesh-list
15050728|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15050729|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
15050730|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050731|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050732|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050733|NCT02093533|Eculizumab|eculizumab|mesh-list
15050734|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15050735|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15050736|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
15050737|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050738|NCT02093585|Tenofovir|tenofovir|mesh-list
15050739|NCT02093585|Abacavir|abacavir|mesh-list
15050740|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
15050741|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050742|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15050743|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15050744|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050745|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050746|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15050747|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15050748|NCT02093598|Sirolimus|sirolimus|mesh-list
15050749|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15050750|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050751|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15050752|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050753|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
15050754|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15050755|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
15050756|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050757|NCT02093728|Itraconazole|itraconazole|mesh-list
15050758|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
15050759|NCT02093728|Fluconazole|fluconazole|mesh-list
15050760|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
15050761|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050762|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15050763|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15050764|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050765|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050766|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15050767|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
15050768|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15050769|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050770|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15050771|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15050772|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15050773|NCT02093741|Factor VIII|factor viii|mesh-list
15050774|NCT02093741|Coagulants|coagulants|mesh-ancestor
15050775|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15050776|NCT02093845|Everolimus|everolimus|mesh-list
15050777|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050778|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15050779|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
15050780|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050781|NCT02093910|Dexamethasone|dexamethasone|mesh-list
15050782|NCT02093910|Bortezomib|bortezomib|mesh-list
15050783|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15050784|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
15050785|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
15050786|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050787|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050788|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15050789|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
15050790|NCT02093910|Hormones|hormones|mesh-ancestor
15050791|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15050792|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15050793|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050794|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15050795|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15050796|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050797|NCT02094053|Donepezil|donepezil|mesh-list
15050798|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15050799|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050800|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050801|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
15050802|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050803|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050804|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
15050805|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
15050806|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15050807|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15050808|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050809|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
15050810|NCT02094066|Coagulants|coagulants|mesh-ancestor
15050811|NCT02094157|Heparin|heparin|mesh-list
15050812|NCT02094157|Calcium heparin|calcium heparin|mesh-list
15050813|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15050814|NCT02094157|Tinzaparin|tinzaparin|mesh-list
15050815|NCT02094157|Dalteparin|dalteparin|mesh-list
15050816|NCT02094157|Warfarin|warfarin|mesh-list
15050817|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
15050818|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15050819|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15050820|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050821|NCT02094196|Ethanol|ethanol|mesh-list
15050822|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15050823|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050824|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050825|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050826|NCT02094222|Glycerol|glycerol|mesh-list
15050827|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15050828|NCT02094222|Protective Agents|protective agents|mesh-ancestor
15050829|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050830|NCT02094274|Fluticasone|fluticasone|mesh-list
15050831|NCT02094274|Xhance|xhance|mesh-list
15050832|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15050833|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15050834|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15050835|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
15050836|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050837|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050838|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15050839|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
15050840|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
15050841|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15050842|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15050843|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15050844|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15050845|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
15050846|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050847|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050848|NCT02094287|Dimethindene|dimethindene|mesh-list
15050849|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
15050850|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
15050851|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15050852|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
15050853|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
15050854|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050855|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050856|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050857|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15050858|NCT02094313|Atorvastatin|atorvastatin|mesh-list
15050859|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
15050860|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15050861|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
15050862|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050863|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15050864|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15050865|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050866|NCT02094339|Analgesics|analgesics|mesh-list
15050867|NCT02094339|Ropivacaine|ropivacaine|mesh-list
15050868|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
15050869|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
15050870|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050871|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050872|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
15050873|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050874|NCT02094378|Esketamine|esketamine|mesh-list
15050875|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
15050876|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15050877|NCT02094391|Ipilimumab|ipilimumab|mesh-list
15050878|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15050879|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050880|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15050881|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050882|NCT02094469|Cilostazol|cilostazol|mesh-list
15050883|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15050884|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
15050885|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050886|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050887|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15050888|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
15050889|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15050890|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15050891|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050892|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15050893|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
15050894|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15050895|NCT02094469|Protective Agents|protective agents|mesh-ancestor
15050896|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15050897|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15050898|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050899|NCT02094599|Dronabinol|dronabinol|mesh-list
15050900|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
15050901|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050902|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15050903|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15050904|NCT02094599|Analgesics|analgesics|mesh-ancestor
15050905|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
15050906|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050907|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15050908|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15050909|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050910|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050911|NCT02094599|Hormones|hormones|mesh-ancestor
15050912|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15050913|NCT02094651|Valproic Acid|valproic acid|mesh-list
15050914|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
15050915|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050916|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050917|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
15050918|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050919|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050920|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
15050921|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15050922|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050923|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15050924|NCT02094703|Levofloxacin|levofloxacin|mesh-list
15050925|NCT02094703|Ofloxacin|ofloxacin|mesh-list
15050926|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
15050927|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15050928|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15050929|NCT02094703|Renal Agents|renal agents|mesh-ancestor
15050930|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15050931|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15050932|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15050933|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050934|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050935|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050936|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15050937|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15050938|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15050939|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15050940|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
15050941|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050942|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050943|NCT02094703|Urological Agents|urological agents|mesh-ancestor
15050944|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
15050945|NCT02094794|Etoposide|etoposide|mesh-list
15050946|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
15050947|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15050948|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
15050949|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050950|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15050951|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15050952|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
15050953|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050954|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15050955|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15050956|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15050957|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15050958|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15050959|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050960|NCT02094807|Acetaminophen|acetaminophen|mesh-list
15050961|NCT02094807|Diclofenac|diclofenac|mesh-list
15050962|NCT02094807|Oxycodone|oxycodone|mesh-list
15050963|NCT02094807|Tramadol|tramadol|mesh-list
15050964|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15050965|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050966|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15050967|NCT02094807|Analgesics|analgesics|mesh-ancestor
15050968|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
15050969|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15050970|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
15050971|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15050972|NCT02094807|Narcotics|narcotics|mesh-ancestor
15050973|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15050974|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15050975|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15050976|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15050977|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15050978|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050979|NCT02094833|Vaccines|vaccines|mesh-list
15050980|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
15050981|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050982|NCT02094924|Candesartan|candesartan|mesh-list
15050983|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
15050984|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15050985|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15050986|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15050987|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050988|NCT02094963|Clopidogrel|clopidogrel|mesh-list
15050989|NCT02094963|Ticagrelor|ticagrelor|mesh-list
15050990|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15050991|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15050992|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15050993|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15050994|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
15050995|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15050996|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15050997|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15050998|NCT02095054|Cetuximab|cetuximab|mesh-list
15050999|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15051000|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051001|NCT02095119|Gemcitabine|gemcitabine|mesh-list
15051002|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
15051003|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051004|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15051005|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
15051006|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051007|NCT02095119|Antiviral Agents|antiviral agents|mesh-ancestor
15051008|NCT02095119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051009|NCT02095119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051010|NCT02095119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15051011|NCT02095119|Immunologic Factors|immunologic factors|mesh-ancestor
15051012|NCT02095119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051013|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15051014|NCT02095132|Irinotecan|irinotecan|mesh-list
15051015|NCT02095132|Camptothecin|camptothecin|mesh-list
15051016|NCT02095132|Adavosertib|adavosertib|mesh-list
15051017|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15051018|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15051019|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051020|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051021|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051022|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15051023|NCT02095184|Letrozole|letrozole|mesh-list
15051024|NCT02095184|Anastrozole|anastrozole|mesh-list
15051025|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051026|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15051027|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15051028|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051029|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051030|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15051031|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
15051032|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15051033|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051034|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15051035|NCT02095314|Vaccines|vaccines|mesh-list
15051036|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
15051037|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051038|NCT02095366|Sufentanil|sufentanil|mesh-list
15051039|NCT02095366|Morphine|morphine|mesh-list
15051040|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15051041|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15051042|NCT02095366|Narcotics|narcotics|mesh-ancestor
15051043|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15051044|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051045|NCT02095366|Analgesics|analgesics|mesh-ancestor
15051046|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
15051047|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051048|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15051049|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15051050|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
15051051|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
15051052|NCT02095405|Caffeine|caffeine|mesh-list
15051053|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15051054|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051055|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15051056|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051057|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051058|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15051059|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15051060|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
15051061|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051062|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
15051063|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15051064|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051065|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15051066|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
15051067|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15051068|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051069|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051070|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051071|NCT02095509|Enoxaparin|enoxaparin|mesh-list
15051072|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
15051073|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15051074|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15051075|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051076|NCT02095522|Colchicine|colchicine|mesh-list
15051077|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
15051078|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15051079|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
15051080|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
15051081|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
15051082|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051083|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051084|NCT02095548|Lorecivivint|lorecivivint|mesh-list
15051085|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15051086|NCT02095574|Venetoclax|venetoclax|mesh-list
15051087|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051088|NCT02095665|Acetaminophen|acetaminophen|mesh-list
15051089|NCT02095665|Tamsulosin|tamsulosin|mesh-list
15051090|NCT02095665|Mirabegron|mirabegron|mesh-list
15051091|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15051092|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15051093|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15051094|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
15051095|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051096|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051097|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051098|NCT02095665|Urological Agents|urological agents|mesh-ancestor
15051099|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15051100|NCT02095665|Analgesics|analgesics|mesh-ancestor
15051101|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
15051102|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051103|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
15051104|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15051105|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15051106|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15051107|NCT02095704|Acetaminophen|acetaminophen|mesh-list
15051108|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15051109|NCT02095704|Analgesics|analgesics|mesh-ancestor
15051110|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
15051111|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051112|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051113|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
15051114|NCT02095717|Curcumin|curcumin|mesh-list
15051115|NCT02095717|Docetaxel|docetaxel|mesh-list
15051116|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051117|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
15051118|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
15051119|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
15051120|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051121|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15051122|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15051123|NCT02095717|Analgesics|analgesics|mesh-ancestor
15051124|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
15051125|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051126|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051127|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15051128|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15051129|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051130|NCT02095730|Vitamins|vitamins|mesh-list
15051131|NCT02095730|Riboflavin|riboflavin|mesh-list
15051132|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
15051133|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
15051134|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051135|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15051136|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
15051137|NCT02095782|Paclitaxel|paclitaxel|mesh-list
15051138|NCT02095782|Carboplatin|carboplatin|mesh-list
15051139|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15051140|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15051141|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051142|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
15051143|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
15051144|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
15051145|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051146|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15051147|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051148|NCT02095834|Dexamethasone|dexamethasone|mesh-list
15051149|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
15051150|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15051151|NCT02095834|Ichthammol|ichthammol|mesh-list
15051152|NCT02095834|BB 1101|bb 1101|mesh-list
15051153|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15051154|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
15051155|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
15051156|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051157|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051158|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15051159|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
15051160|NCT02095834|Hormones|hormones|mesh-ancestor
15051161|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15051162|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15051163|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051164|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15051165|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
15051166|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051167|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
15051168|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051169|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
15051170|NCT02095847|Proflavine|proflavine|mesh-list
15051171|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15051172|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051173|NCT02095886|BMS-955176|bms-955176|mesh-list
15051174|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15051175|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15051176|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
15051177|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051178|NCT02095899|Rufinamide|rufinamide|mesh-list
15051179|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
15051180|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15051181|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15051182|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15051183|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051184|NCT02095938|Amisulpride|amisulpride|mesh-list
15051185|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15051186|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15051187|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15051188|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051189|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15051190|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15051191|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
15051192|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051193|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051194|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15051195|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
15051196|NCT02095990|Hydroquinone|hydroquinone|mesh-list
15051197|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
15051198|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051199|NCT02095990|Protective Agents|protective agents|mesh-ancestor
15051200|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051201|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15051202|NCT02096055|Idarubicin|idarubicin|mesh-list
15051203|NCT02096055|Cladribine|cladribine|mesh-list
15051204|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
15051205|NCT02096055|Guadecitabine|guadecitabine|mesh-list
15051206|NCT02096055|Azacitidine|azacitidine|mesh-list
15051207|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15051208|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051209|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15051210|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15051211|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051212|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051213|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15051214|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
15051215|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051216|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15051217|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
15051218|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
15051219|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15051220|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15051221|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051222|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15051223|NCT02096068|Analgesics|analgesics|mesh-ancestor
15051224|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
15051225|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051226|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15051227|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15051228|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15051229|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
15051230|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051231|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051232|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
15051233|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15051234|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051235|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
15051236|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
15051237|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15051238|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051239|NCT02096133|Vitamins|vitamins|mesh-ancestor
15051240|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
15051241|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15051242|NCT02096224|Sevoflurane|sevoflurane|mesh-list
15051243|NCT02096224|Desflurane|desflurane|mesh-list
15051244|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15051245|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15051246|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
15051247|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
15051248|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15051249|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051250|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
15051251|NCT02096250|Edetic Acid|edetic acid|mesh-list
15051252|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
15051253|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
15051254|NCT02096250|Trace Elements|trace elements|mesh-ancestor
15051255|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
15051256|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051257|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15051258|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
15051259|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
15051260|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051261|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
15051262|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15051263|NCT02096250|Hematinics|hematinics|mesh-ancestor
15051264|NCT02096289|Thioridazine|thioridazine|mesh-list
15051265|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15051266|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15051267|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15051268|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051269|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15051270|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15051271|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
15051272|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051273|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051274|NCT02096315|Murepavadin|murepavadin|mesh-list
15051275|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15051276|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051277|NCT02096328|Murepavadin|murepavadin|mesh-list
15051278|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15051279|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051280|NCT02096354|Irinotecan|irinotecan|mesh-list
15051281|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051282|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15051283|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15051284|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051285|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051286|NCT02096380|Cisplatin|cisplatin|mesh-list
15051287|NCT02096380|Docetaxel|docetaxel|mesh-list
15051288|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051289|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
15051290|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
15051291|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
15051292|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051293|NCT02096419|Clopidogrel|clopidogrel|mesh-list
15051294|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15051295|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15051296|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15051297|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15051298|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
15051299|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051300|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051301|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051302|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
15051303|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15051304|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15051305|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15051306|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15051307|NCT02096536|Vancomycin|vancomycin|mesh-list
15051308|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15051309|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051310|NCT02096601|Levodopa|levodopa|mesh-list
15051311|NCT02096601|Carbidopa|carbidopa|mesh-list
15051312|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15051313|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15051314|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
15051315|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051316|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051317|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051318|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15051319|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051320|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
15051321|NCT02096614|Fludarabine|fludarabine|mesh-list
15051322|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15051323|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
15051324|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051325|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15051326|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15051327|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
15051328|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051329|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051330|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15051331|NCT02096913|Ibuprofen|ibuprofen|mesh-list
15051332|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15051333|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15051334|NCT02096913|Analgesics|analgesics|mesh-ancestor
15051335|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
15051336|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051337|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051338|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15051339|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15051340|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15051341|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051342|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051343|NCT02096926|Ibuprofen|ibuprofen|mesh-list
15051344|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15051345|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15051346|NCT02096926|Analgesics|analgesics|mesh-ancestor
15051347|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
15051348|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051349|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051350|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15051351|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15051352|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15051353|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051354|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051355|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
15051356|NCT02096965|Tolvaptan|tolvaptan|mesh-list
15051357|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15051358|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051359|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
15051360|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051361|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15051362|NCT02097004|Entecavir|entecavir|mesh-list
15051363|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
15051364|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051365|NCT02097017|Lidocaine|lidocaine|mesh-list
15051366|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
15051367|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
15051368|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15051369|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051370|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
15051371|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051372|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15051373|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15051374|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15051375|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15051376|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051377|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
15051378|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15051379|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051380|NCT02097069|Folic Acid|folic acid|mesh-list
15051381|NCT02097069|Inositol|inositol|mesh-list
15051382|NCT02097069|Hematinics|hematinics|mesh-ancestor
15051383|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
15051384|NCT02097069|Vitamins|vitamins|mesh-ancestor
15051385|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
15051386|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051387|NCT02097082|Paclitaxel|paclitaxel|mesh-list
15051388|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15051389|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051390|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
15051391|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
15051392|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
15051393|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051394|NCT02097147|Paroxetine|paroxetine|mesh-list
15051395|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
15051396|NCT02097147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15051397|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15051398|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15051399|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051400|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051401|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
15051402|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051403|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15051404|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
15051405|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15051406|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15051407|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15051408|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051409|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15051410|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15051411|NCT02097160|Vitamin D|vitamin d|mesh-list
15051412|NCT02097160|Vitamins|vitamins|mesh-ancestor
15051413|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
15051414|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051415|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15051416|NCT02097173|Methotrexate|methotrexate|mesh-list
15051417|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15051418|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
15051419|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15051420|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051421|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15051422|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
15051423|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051424|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051425|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
15051426|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051427|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15051428|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15051429|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
15051430|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15051431|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15051432|NCT02097264|Adalimumab|adalimumab|mesh-list
15051433|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15051434|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15051435|NCT02097316|Insulin|insulin|mesh-list
15051436|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15051437|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051438|NCT02097329|Palbociclib|palbociclib|mesh-list
15051439|NCT02097329|Rabeprazole|rabeprazole|mesh-list
15051440|NCT02097329|Famotidine|famotidine|mesh-list
15051441|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
15051442|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
15051443|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15051444|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
15051445|NCT02097329|Antacids|antacids|mesh-list
15051446|NCT02097329|TEMPO|tempo|mesh-list
15051447|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051448|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15051449|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051450|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051451|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15051452|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15051453|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15051454|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
15051455|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
15051456|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051457|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051458|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
15051459|NCT02097329|Protective Agents|protective agents|mesh-ancestor
15051460|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15051461|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
15051462|NCT02097342|Linagliptin|linagliptin|mesh-list
15051463|NCT02097342|Voglibose|voglibose|mesh-list
15051464|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15051465|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051466|NCT02097342|Incretins|incretins|mesh-ancestor
15051467|NCT02097342|Hormones|hormones|mesh-ancestor
15051468|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15051469|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15051470|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
15051471|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051472|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051473|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15051474|NCT02097381|Ritonavir|ritonavir|mesh-list
15051475|NCT02097381|Lopinavir|lopinavir|mesh-list
15051476|NCT02097381|Darunavir|darunavir|mesh-list
15051477|NCT02097381|Tenofovir|tenofovir|mesh-list
15051478|NCT02097381|Emtricitabine|emtricitabine|mesh-list
15051479|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15051480|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15051481|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
15051482|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051483|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051484|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15051485|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15051486|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
15051487|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051488|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15051489|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15051490|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15051491|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15051492|NCT02097394|Pancreatin|pancreatin|mesh-list
15051493|NCT02097394|Pancrelipase|pancrelipase|mesh-list
15051494|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15051495|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
15051496|NCT02097407|Propofol|propofol|mesh-list
15051497|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15051498|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15051499|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051500|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15051501|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
15051502|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
15051503|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15051504|NCT02097407|Analgesics|analgesics|mesh-ancestor
15051505|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
15051506|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051507|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15051508|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15051509|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15051510|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
15051511|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051512|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051513|NCT02097459|Tamoxifen|tamoxifen|mesh-list
15051514|NCT02097459|Toremifene|toremifene|mesh-list
15051515|NCT02097459|Anastrozole|anastrozole|mesh-list
15051516|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15051517|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
15051518|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15051519|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051520|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15051521|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051522|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15051523|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15051524|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15051525|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15051526|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15051527|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051528|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051529|NCT02097511|Metoprolol|metoprolol|mesh-list
15051530|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
15051531|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15051532|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15051533|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
15051534|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
15051535|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051536|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051537|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15051538|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15051539|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15051540|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
15051541|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051542|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051543|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15051544|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15051545|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15051546|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15051547|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
15051548|NCT02097589|Atorvastatin|atorvastatin|mesh-list
15051549|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15051550|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
15051551|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051552|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15051553|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15051554|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
15051555|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051556|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15051557|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15051558|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051559|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
15051560|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15051561|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15051562|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051563|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
15051564|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
15051565|NCT02097810|Entrectinib|entrectinib|mesh-list
15051566|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15051567|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051568|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051569|NCT02097953|Rifampin|rifampin|mesh-list
15051570|NCT02097953|Daptomycin|daptomycin|mesh-list
15051571|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15051572|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
15051573|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15051574|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051575|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
15051576|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15051577|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051578|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051579|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15051580|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15051581|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15051582|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15051583|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15051584|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15051585|NCT02097966|Ribavirin|ribavirin|mesh-list
15051586|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
15051587|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
15051588|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051589|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
15051590|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051591|NCT02098148|Xenon|xenon|mesh-list
15051592|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15051593|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
15051594|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
15051595|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15051596|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051597|NCT02098317|Vitamin D|vitamin d|mesh-list
15051598|NCT02098317|Vitamins|vitamins|mesh-ancestor
15051599|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
15051600|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051601|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15051602|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
15051603|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15051604|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15051605|NCT02098330|Prednisolone|prednisolone|mesh-list
15051606|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
15051607|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15051608|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
15051609|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15051610|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
15051611|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
15051612|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051613|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051614|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15051615|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
15051616|NCT02098330|Hormones|hormones|mesh-ancestor
15051617|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15051618|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15051619|NCT02098330|Protective Agents|protective agents|mesh-ancestor
15051620|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15051621|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051622|NCT02098343|Carboplatin|carboplatin|mesh-list
15051623|NCT02098343|Doxorubicin|doxorubicin|mesh-list
15051624|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15051625|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051626|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15051627|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15051628|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15051629|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051630|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051631|NCT02098421|Oxytocin|oxytocin|mesh-list
15051632|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
15051633|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15051634|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051635|NCT02098460|Cilostazol|cilostazol|mesh-list
15051636|NCT02098460|Atorvastatin|atorvastatin|mesh-list
15051637|NCT02098460|Probucol|probucol|mesh-list
15051638|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15051639|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15051640|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
15051641|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051642|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15051643|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15051644|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051645|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15051646|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
15051647|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051648|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051649|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15051650|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
15051651|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15051652|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15051653|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15051654|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
15051655|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15051656|NCT02098460|Protective Agents|protective agents|mesh-ancestor
15051657|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15051658|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15051659|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
15051660|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
15051661|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
15051662|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15051663|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051664|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15051665|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15051666|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051667|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051668|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051669|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
15051670|NCT02098499|Promethazine|promethazine|mesh-list
15051671|NCT02098499|Haloperidol|haloperidol|mesh-list
15051672|NCT02098499|Metoclopramide|metoclopramide|mesh-list
15051673|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
15051674|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15051675|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15051676|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15051677|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051678|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
15051679|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
15051680|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
15051681|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051682|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
15051683|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
15051684|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15051685|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15051686|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
15051687|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
15051688|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051689|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051690|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15051691|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
15051692|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
15051693|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15051694|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15051695|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15051696|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15051697|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
15051698|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15051699|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15051700|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15051701|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15051702|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051703|NCT02098590|Chloroquine|chloroquine|mesh-list
15051704|NCT02098590|Atovaquone|atovaquone|mesh-list
15051705|NCT02098590|Proguanil|proguanil|mesh-list
15051706|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
15051707|NCT02098590|Vaccines|vaccines|mesh-list
15051708|NCT02098590|Amebicides|amebicides|mesh-ancestor
15051709|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15051710|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15051711|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051712|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
15051713|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15051714|NCT02098590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051715|NCT02098590|Immunologic Factors|immunologic factors|mesh-ancestor
15051716|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051717|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051718|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
15051719|NCT02098616|Asunaprevir|asunaprevir|mesh-list
15051720|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
15051721|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051722|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051723|NCT02098629|Milrinone|milrinone|mesh-list
15051724|NCT02098629|Esmolol|esmolol|mesh-list
15051725|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15051726|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15051727|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15051728|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
15051729|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051730|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051731|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051732|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15051733|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15051734|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
15051735|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15051736|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15051737|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051738|NCT02098629|Protective Agents|protective agents|mesh-ancestor
15051739|NCT02098785|Caffeine|caffeine|mesh-list
15051740|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
15051741|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051742|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15051743|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051744|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15051745|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051746|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15051747|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15051748|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
15051749|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051750|NCT02098824|Methylphenidate|methylphenidate|mesh-list
15051751|NCT02098824|Galantamine|galantamine|mesh-list
15051752|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15051753|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051754|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15051755|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15051756|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15051757|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051758|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
15051759|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051760|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15051761|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051762|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
15051763|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15051764|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
15051765|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051766|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
15051767|NCT02098837|Dolutegravir|dolutegravir|mesh-list
15051768|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15051769|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15051770|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051771|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051772|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15051773|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15051774|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
15051775|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051776|NCT02098889|Scopolamine|scopolamine|mesh-list
15051777|NCT02098889|Bromides|bromides|mesh-list
15051778|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15051779|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
15051780|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15051781|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
15051782|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
15051783|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051784|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051785|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15051786|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
15051787|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15051788|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
15051789|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051790|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051791|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15051792|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
15051793|NCT02098915|Metoclopramide|metoclopramide|mesh-list
15051794|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
15051795|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
15051796|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051797|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051798|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15051799|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15051800|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15051801|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
15051802|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15051803|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051804|NCT02098980|Vitamin D|vitamin d|mesh-list
15051805|NCT02098980|Vitamins|vitamins|mesh-ancestor
15051806|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
15051807|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051808|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15051809|NCT02099123|Atorvastatin|atorvastatin|mesh-list
15051810|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15051811|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15051812|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
15051813|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051814|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15051815|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15051816|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051817|NCT02099136|Celecoxib|celecoxib|mesh-list
15051818|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15051819|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15051820|NCT02099136|Analgesics|analgesics|mesh-ancestor
15051821|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
15051822|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15051823|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051824|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15051825|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15051826|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15051827|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15051828|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051829|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051830|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15051831|NCT02099240|Amoxicillin|amoxicillin|mesh-list
15051832|NCT02099240|Azithromycin|azithromycin|mesh-list
15051833|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
15051834|NCT02099240|Vancomycin|vancomycin|mesh-list
15051835|NCT02099240|Clarithromycin|clarithromycin|mesh-list
15051836|NCT02099240|Doxycycline|doxycycline|mesh-list
15051837|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
15051838|NCT02099240|Levofloxacin|levofloxacin|mesh-list
15051839|NCT02099240|Ofloxacin|ofloxacin|mesh-list
15051840|NCT02099240|Minocycline|minocycline|mesh-list
15051841|NCT02099240|Rifampin|rifampin|mesh-list
15051842|NCT02099240|Clindamycin|clindamycin|mesh-list
15051843|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
15051844|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
15051845|NCT02099240|Gentamicins|gentamicins|mesh-list
15051846|NCT02099240|Isoniazid|isoniazid|mesh-list
15051847|NCT02099240|Meropenem|meropenem|mesh-list
15051848|NCT02099240|Tazobactam|tazobactam|mesh-list
15051849|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
15051850|NCT02099240|Linezolid|linezolid|mesh-list
15051851|NCT02099240|Cycloserine|cycloserine|mesh-list
15051852|NCT02099240|Piperacillin|piperacillin|mesh-list
15051853|NCT02099240|Metronidazole|metronidazole|mesh-list
15051854|NCT02099240|Imipenem|imipenem|mesh-list
15051855|NCT02099240|Penicillins|penicillins|mesh-list
15051856|NCT02099240|Erythromycin|erythromycin|mesh-list
15051857|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
15051858|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15051859|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
15051860|NCT02099240|Amikacin|amikacin|mesh-list
15051861|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
15051862|NCT02099240|Ceftazidime|ceftazidime|mesh-list
15051863|NCT02099240|Colistin|colistin|mesh-list
15051864|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15051865|NCT02099240|Ampicillin|ampicillin|mesh-list
15051866|NCT02099240|Mupirocin|mupirocin|mesh-list
15051867|NCT02099240|Rifabutin|rifabutin|mesh-list
15051868|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
15051869|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
15051870|NCT02099240|Fosfomycin|fosfomycin|mesh-list
15051871|NCT02099240|Rifapentine|rifapentine|mesh-list
15051872|NCT02099240|Cefepime|cefepime|mesh-list
15051873|NCT02099240|Cefuroxime|cefuroxime|mesh-list
15051874|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
15051875|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15051876|NCT02099240|Paromomycin|paromomycin|mesh-list
15051877|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
15051878|NCT02099240|Polymyxins|polymyxins|mesh-list
15051879|NCT02099240|Aztreonam|aztreonam|mesh-list
15051880|NCT02099240|Bacitracin|bacitracin|mesh-list
15051881|NCT02099240|Neomycin|neomycin|mesh-list
15051882|NCT02099240|Sulbactam|sulbactam|mesh-list
15051883|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
15051884|NCT02099240|Cefotaxime|cefotaxime|mesh-list
15051885|NCT02099240|Cefoxitin|cefoxitin|mesh-list
15051886|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
15051887|NCT02099240|Cefixime|cefixime|mesh-list
15051888|NCT02099240|Polymyxin B|polymyxin b|mesh-list
15051889|NCT02099240|Cefdinir|cefdinir|mesh-list
15051890|NCT02099240|Penicillin G|penicillin g|mesh-list
15051891|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
15051892|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
15051893|NCT02099240|Cloxacillin|cloxacillin|mesh-list
15051894|NCT02099240|Norfloxacin|norfloxacin|mesh-list
15051895|NCT02099240|Cefprozil|cefprozil|mesh-list
15051896|NCT02099240|Cephalosporins|cephalosporins|mesh-list
15051897|NCT02099240|Oxacillin|oxacillin|mesh-list
15051898|NCT02099240|Streptomycin|streptomycin|mesh-list
15051899|NCT02099240|Nafcillin|nafcillin|mesh-list
15051900|NCT02099240|Ticarcillin|ticarcillin|mesh-list
15051901|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
15051902|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
15051903|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
15051904|NCT02099240|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
15051905|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
15051906|NCT02099240|Penicillin V|penicillin v|mesh-list
15051907|NCT02099240|Sultamicillin|sultamicillin|mesh-list
15051908|NCT02099240|Kanamycin|kanamycin|mesh-list
15051909|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
15051910|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
15051911|NCT02099240|Cefoperazone|cefoperazone|mesh-list
15051912|NCT02099240|Lincomycin|lincomycin|mesh-list
15051913|NCT02099240|Ethionamide|ethionamide|mesh-list
15051914|NCT02099240|Dirithromycin|dirithromycin|mesh-list
15051915|NCT02099240|Cefotetan|cefotetan|mesh-list
15051916|NCT02099240|Demeclocycline|demeclocycline|mesh-list
15051917|NCT02099240|Cefaclor|cefaclor|mesh-list
15051918|NCT02099240|Ceftibuten|ceftibuten|mesh-list
15051919|NCT02099240|Mafenide|mafenide|mesh-list
15051920|NCT02099240|Capreomycin|capreomycin|mesh-list
15051921|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
15051922|NCT02099240|Netilmicin|netilmicin|mesh-list
15051923|NCT02099240|Tobramycin|tobramycin|mesh-list
15051924|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
15051925|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
15051926|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
15051927|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
15051928|NCT02099240|Virginiamycin|virginiamycin|mesh-list
15051929|NCT02099240|Enoxacin|enoxacin|mesh-list
15051930|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15051931|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
15051932|NCT02099240|Methicillin|methicillin|mesh-list
15051933|NCT02099240|Bacampicillin|bacampicillin|mesh-list
15051934|NCT02099240|Carbenicillin|carbenicillin|mesh-list
15051935|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
15051936|NCT02099240|Mezlocillin|mezlocillin|mesh-list
15051937|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
15051938|NCT02099240|Cefamandole|cefamandole|mesh-list
15051939|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
15051940|NCT02099240|Cefonicid|cefonicid|mesh-list
15051941|NCT02099240|Cefmetazole|cefmetazole|mesh-list
15051942|NCT02099240|Loracarbef|loracarbef|mesh-list
15051943|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
15051944|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
15051945|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
15051946|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
15051947|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
15051948|NCT02099240|Methacycline|methacycline|mesh-list
15051949|NCT02099240|Tetracycline|tetracycline|mesh-list
15051950|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
15051951|NCT02099240|Dalfopristin|dalfopristin|mesh-list
15051952|NCT02099240|Novobiocin|novobiocin|mesh-list
15051953|NCT02099240|Spectinomycin|spectinomycin|mesh-list
15051954|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15051955|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
15051956|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
15051957|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
15051958|NCT02099240|Methenamine|methenamine|mesh-list
15051959|NCT02099240|Sulperazone|sulperazone|mesh-list
15051960|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
15051961|NCT02099240|Cinoxacin|cinoxacin|mesh-list
15051962|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
15051963|NCT02099240|Trimethoprim|trimethoprim|mesh-list
15051964|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
15051965|NCT02099240|Procaine|procaine|mesh-list
15051966|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
15051967|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15051968|NCT02099240|Cilastatin|cilastatin|mesh-list
15051969|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15051970|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
15051971|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15051972|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15051973|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15051974|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15051975|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15051976|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15051977|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
15051978|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15051979|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15051980|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15051981|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15051982|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15051983|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15051984|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15051985|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15051986|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
15051987|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15051988|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15051989|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15051990|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15051991|NCT02099240|Renal Agents|renal agents|mesh-ancestor
15051992|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
15051993|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15051994|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15051995|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15051996|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15051997|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15051998|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15051999|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15052000|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15052001|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15052002|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
15052003|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15052004|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15052005|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15052006|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15052007|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15052008|NCT02099240|Analgesics|analgesics|mesh-ancestor
15052009|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
15052010|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052011|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15052012|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15052013|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
15052014|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15052015|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15052016|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15052017|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
15052018|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
15052019|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
15052020|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052021|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15052022|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15052023|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15052024|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15052025|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
15052026|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
15052027|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15052028|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052029|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052030|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15052031|NCT02099253|Analgesics|analgesics|mesh-ancestor
15052032|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
15052033|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052034|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15052035|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15052036|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15052037|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
15052038|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052039|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052040|NCT02099292|Rituximab|rituximab|mesh-list
15052041|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15052042|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052043|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
15052044|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052045|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15052046|NCT02099331|Melatonin|melatonin|mesh-list
15052047|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
15052048|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052049|NCT02099331|Protective Agents|protective agents|mesh-ancestor
15052050|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052051|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052052|NCT02099357|Vitamin D|vitamin d|mesh-list
15052053|NCT02099357|Vitamins|vitamins|mesh-ancestor
15052054|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
15052055|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052056|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15052057|NCT02099396|Gemcitabine|gemcitabine|mesh-list
15052058|NCT02099396|Docetaxel|docetaxel|mesh-list
15052059|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15052060|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
15052061|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052062|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052063|NCT02099396|Antiviral Agents|antiviral agents|mesh-ancestor
15052064|NCT02099396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15052065|NCT02099396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052066|NCT02099396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15052067|NCT02099396|Immunologic Factors|immunologic factors|mesh-ancestor
15052068|NCT02099396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052069|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
15052070|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
15052071|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
15052072|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
15052073|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15052074|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15052075|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
15052076|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15052077|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15052078|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15052079|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052080|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052081|NCT02099604|Vitamin D|vitamin d|mesh-list
15052082|NCT02099604|Interferons|interferons|mesh-list
15052083|NCT02099604|Ribavirin|ribavirin|mesh-list
15052084|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
15052085|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
15052086|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15052087|NCT02099604|Vitamins|vitamins|mesh-ancestor
15052088|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
15052089|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052090|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15052091|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052092|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
15052093|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15052094|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
15052095|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052096|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
15052097|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
15052098|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15052099|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15052100|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
15052101|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052102|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052103|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052104|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
15052105|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
15052106|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052107|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
15052108|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15052109|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
15052110|NCT02099695|Oxybutynin|oxybutynin|mesh-list
15052111|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
15052112|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
15052113|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052114|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052115|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15052116|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15052117|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
15052118|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052119|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052120|NCT02099695|Urological Agents|urological agents|mesh-ancestor
15052121|NCT02099825|Cycloserine|cycloserine|mesh-list
15052122|NCT02099825|Mifepristone|mifepristone|mesh-list
15052123|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15052124|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
15052125|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15052126|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052127|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15052128|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15052129|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15052130|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
15052131|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15052132|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15052133|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
15052134|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15052135|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
15052136|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15052137|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15052138|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15052139|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15052140|NCT02099825|Renal Agents|renal agents|mesh-ancestor
15052141|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15052142|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
15052143|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15052144|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
15052145|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052146|NCT02099877|Fentanyl|fentanyl|mesh-list
15052147|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15052148|NCT02099877|Narcotics|narcotics|mesh-ancestor
15052149|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052150|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052151|NCT02099877|Analgesics|analgesics|mesh-ancestor
15052152|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
15052153|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052154|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15052155|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15052156|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
15052157|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
15052158|NCT02099890|Curcumin|curcumin|mesh-list
15052159|NCT02099890|Antioxidants|antioxidants|mesh-list
15052160|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15052161|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15052162|NCT02099890|Analgesics|analgesics|mesh-ancestor
15052163|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
15052164|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052165|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052166|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15052167|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15052168|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052169|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052170|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052171|NCT02099890|Protective Agents|protective agents|mesh-ancestor
15052172|NCT02099916|Menotropins|menotropins|mesh-list
15052173|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052174|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15052175|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
15052176|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15052177|NCT02099955|Vitamin D|vitamin d|mesh-list
15052178|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
15052179|NCT02099955|Vitamins|vitamins|mesh-ancestor
15052180|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
15052181|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052182|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15052183|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15052184|NCT02099981|Pimagedine|pimagedine|mesh-list
15052185|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052186|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052187|NCT02100046|Ethosuximide|ethosuximide|mesh-list
15052188|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
15052189|NCT02100176|Dopamine|dopamine|mesh-list
15052190|NCT02100176|Rotigotine|rotigotine|mesh-list
15052191|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
15052192|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
15052193|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052194|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052195|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052196|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15052197|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
15052198|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
15052199|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052200|NCT02100176|Protective Agents|protective agents|mesh-ancestor
15052201|NCT02100202|Turmeric extract|turmeric extract|mesh-list
15052202|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
15052203|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052204|NCT02100202|Protective Agents|protective agents|mesh-ancestor
15052205|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052206|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
15052207|NCT02100267|Miotics|miotics|mesh-ancestor
15052208|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
15052209|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052210|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052211|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15052212|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
15052213|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
15052214|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15052215|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15052216|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
15052217|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052218|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052219|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
15052220|NCT02100293|Analgesics|analgesics|mesh-ancestor
15052221|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
15052222|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052223|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052224|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
15052225|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052226|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15052227|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
15052228|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15052229|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15052230|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052231|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15052232|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
15052233|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15052234|NCT02100423|Vitamin D|vitamin d|mesh-list
15052235|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
15052236|NCT02100423|Curcumin|curcumin|mesh-list
15052237|NCT02100423|Vitamins|vitamins|mesh-ancestor
15052238|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
15052239|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052240|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15052241|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15052242|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15052243|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15052244|NCT02100423|Analgesics|analgesics|mesh-ancestor
15052245|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
15052246|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052247|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15052248|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15052249|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052250|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052251|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052252|NCT02100462|Aspirin|aspirin|mesh-list
15052253|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15052254|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
15052255|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15052256|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15052257|NCT02100462|Analgesics|analgesics|mesh-ancestor
15052258|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
15052259|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052260|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052261|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15052262|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15052263|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15052264|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15052265|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052266|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15052267|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15052268|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052269|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
15052270|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15052271|NCT02100462|Diuretics|diuretics|mesh-ancestor
15052272|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
15052273|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15052274|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15052275|NCT02100488|Insulin|insulin|mesh-list
15052276|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15052277|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15052278|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052279|NCT02100553|Itraconazole|itraconazole|mesh-list
15052280|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
15052281|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
15052282|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15052283|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15052284|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15052285|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052286|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052287|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15052288|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
15052289|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15052290|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052291|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15052292|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
15052293|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
15052294|NCT02100605|Ephedrine|ephedrine|mesh-list
15052295|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15052296|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
15052297|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15052298|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052299|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
15052300|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
15052301|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052302|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
15052303|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052304|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052305|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15052306|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15052307|NCT02100761|Voriconazole|voriconazole|mesh-list
15052308|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
15052309|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15052310|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15052311|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15052312|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052313|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052314|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15052315|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
15052316|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15052317|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052318|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15052319|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15052320|NCT02100787|Laxatives|laxatives|mesh-ancestor
15052321|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15052322|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
15052323|NCT02100852|Chlorambucil|chlorambucil|mesh-list
15052324|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15052325|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052326|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15052327|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
15052328|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052329|NCT02100917|Trastuzumab|trastuzumab|mesh-list
15052330|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15052331|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052332|NCT02101047|Phenylephrine|phenylephrine|mesh-list
15052333|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
15052334|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15052335|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
15052336|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
15052337|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052338|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052339|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
15052340|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15052341|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
15052342|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
15052343|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15052344|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15052345|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15052346|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
15052347|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052348|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052349|NCT02101047|Protective Agents|protective agents|mesh-ancestor
15052350|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15052351|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15052352|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15052353|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
15052354|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052355|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15052356|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15052357|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052358|NCT02101138|Pramipexole|pramipexole|mesh-list
15052359|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
15052360|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052361|NCT02101138|Protective Agents|protective agents|mesh-ancestor
15052362|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052363|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15052364|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15052365|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
15052366|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
15052367|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052368|NCT02101151|Vitamin D|vitamin d|mesh-list
15052369|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
15052370|NCT02101151|Vitamins|vitamins|mesh-ancestor
15052371|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
15052372|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052373|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15052374|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15052375|NCT02101164|Denosumab|denosumab|mesh-list
15052376|NCT02101164|Pamidronate|pamidronate|mesh-list
15052377|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15052378|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052379|NCT02101203|Buspirone|buspirone|mesh-list
15052380|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15052381|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15052382|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052383|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052384|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15052385|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15052386|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
15052387|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052388|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052389|NCT02101216|Abacavir|abacavir|mesh-list
15052390|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
15052391|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15052392|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15052393|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052394|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052395|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
15052396|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15052397|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15052398|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15052399|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
15052400|NCT02101229|Insulin|insulin|mesh-list
15052401|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15052402|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15052403|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052404|NCT02101255|Fluorides|fluorides|mesh-list
15052405|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
15052406|NCT02101255|Protective Agents|protective agents|mesh-ancestor
15052407|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052408|NCT02101476|Acetaminophen|acetaminophen|mesh-list
15052409|NCT02101476|Oxycodone|oxycodone|mesh-list
15052410|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15052411|NCT02101476|Analgesics|analgesics|mesh-ancestor
15052412|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
15052413|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052414|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052415|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
15052416|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15052417|NCT02101476|Narcotics|narcotics|mesh-ancestor
15052418|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052419|NCT02101567|Oxytocin|oxytocin|mesh-list
15052420|NCT02101567|Carbetocin|carbetocin|mesh-list
15052421|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
15052422|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15052423|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052424|NCT02101606|Tenecteplase|tenecteplase|mesh-list
15052425|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15052426|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15052427|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052428|NCT02101632|Petrolatum|petrolatum|mesh-list
15052429|NCT02101632|Emollients|emollients|mesh-ancestor
15052430|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
15052431|NCT02101710|Isosorbide|isosorbide|mesh-list
15052432|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15052433|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15052434|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15052435|NCT02101710|Diuretics|diuretics|mesh-ancestor
15052436|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
15052437|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052438|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
15052439|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15052440|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052441|NCT02101840|Oxycodone|oxycodone|mesh-list
15052442|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15052443|NCT02101840|Narcotics|narcotics|mesh-ancestor
15052444|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052445|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052446|NCT02101840|Analgesics|analgesics|mesh-ancestor
15052447|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
15052448|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052449|NCT02101892|Amitriptyline|amitriptyline|mesh-list
15052450|NCT02101892|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15052451|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15052452|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
15052453|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15052454|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15052455|NCT02101892|Analgesics|analgesics|mesh-ancestor
15052456|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
15052457|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052458|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052459|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15052460|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15052461|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15052462|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052463|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
15052464|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052465|NCT02101892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15052466|NCT02101892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15052467|NCT02101892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052468|NCT02101905|Lapatinib|lapatinib|mesh-list
15052469|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052470|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15052471|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052472|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052473|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15052474|NCT02101931|Levulinic acid|levulinic acid|mesh-list
15052475|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15052476|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
15052477|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052478|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052479|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15052480|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15052481|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15052482|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
15052483|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052484|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052485|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15052486|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15052487|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
15052488|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15052489|NCT02102139|Propofol|propofol|mesh-list
15052490|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15052491|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052492|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052493|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15052494|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
15052495|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
15052496|NCT02102152|Tobramycin|tobramycin|mesh-list
15052497|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15052498|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15052499|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
15052500|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
15052501|NCT02102295|Fluorides|fluorides|mesh-list
15052502|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
15052503|NCT02102295|Protective Agents|protective agents|mesh-ancestor
15052504|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052505|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
15052506|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052507|NCT02102295|Vitamins|vitamins|mesh-ancestor
15052508|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
15052509|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052510|NCT02102321|Albendazole|albendazole|mesh-list
15052511|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
15052512|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15052513|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15052514|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
15052515|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15052516|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15052517|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
15052518|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
15052519|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
15052520|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052521|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052522|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
15052523|NCT02102373|Laxatives|laxatives|mesh-ancestor
15052524|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15052525|NCT02102438|Paclitaxel|paclitaxel|mesh-list
15052526|NCT02102438|Carboplatin|carboplatin|mesh-list
15052527|NCT02102438|Trastuzumab|trastuzumab|mesh-list
15052528|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15052529|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052530|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
15052531|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
15052532|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
15052533|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052534|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15052535|NCT02102516|Ketorolac|ketorolac|mesh-list
15052536|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
15052537|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15052538|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15052539|NCT02102516|Analgesics|analgesics|mesh-ancestor
15052540|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
15052541|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052542|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052543|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15052544|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15052545|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15052546|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052547|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052548|NCT02102555|Acetaminophen|acetaminophen|mesh-list
15052549|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15052550|NCT02102555|Analgesics|analgesics|mesh-ancestor
15052551|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
15052552|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052553|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052554|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
15052555|NCT02102594|Bortezomib|bortezomib|mesh-list
15052556|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052557|NCT02102620|Lidocaine|lidocaine|mesh-list
15052558|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
15052559|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
15052560|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052561|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052562|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
15052563|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052564|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15052565|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15052566|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15052567|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15052568|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052569|NCT02102633|Dabigatran|dabigatran|mesh-list
15052570|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
15052571|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15052572|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
15052573|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052574|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052575|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
15052576|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15052577|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
15052578|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15052579|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
15052580|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15052581|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052582|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15052583|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15052584|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052585|NCT02102672|Trimetazidine|trimetazidine|mesh-list
15052586|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
15052587|NCT02102698|Ecopipam|ecopipam|mesh-list
15052588|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15052589|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15052590|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052591|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052592|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15052593|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15052594|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
15052595|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052596|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052597|NCT02102711|Vitamin A|vitamin a|mesh-list
15052598|NCT02102711|Vitamins|vitamins|mesh-ancestor
15052599|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
15052600|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052601|NCT02102776|Mitomycins|mitomycins|mesh-list
15052602|NCT02102776|Mitomycin|mitomycin|mesh-list
15052603|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15052604|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052605|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
15052606|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052607|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15052608|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052609|NCT02102789|Leucovorin|leucovorin|mesh-list
15052610|NCT02102789|Dexamethasone|dexamethasone|mesh-list
15052611|NCT02102789|Fluorouracil|fluorouracil|mesh-list
15052612|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
15052613|NCT02102789|Floxuridine|floxuridine|mesh-list
15052614|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15052615|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
15052616|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
15052617|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052618|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052619|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15052620|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
15052621|NCT02102789|Hormones|hormones|mesh-ancestor
15052622|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15052623|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15052624|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052625|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052626|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
15052627|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15052628|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15052629|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
15052630|NCT02102789|Antidotes|antidotes|mesh-ancestor
15052631|NCT02102789|Protective Agents|protective agents|mesh-ancestor
15052632|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
15052633|NCT02102789|Vitamins|vitamins|mesh-ancestor
15052634|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
15052635|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15052636|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
15052637|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052638|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15052639|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
15052640|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052641|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052642|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15052643|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15052644|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15052645|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
15052646|NCT02102815|Dexamethasone|dexamethasone|mesh-list
15052647|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15052648|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
15052649|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
15052650|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052651|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052652|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15052653|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
15052654|NCT02102815|Hormones|hormones|mesh-ancestor
15052655|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15052656|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15052657|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052658|NCT02102828|Aspirin|aspirin|mesh-list
15052659|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15052660|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15052661|NCT02102828|Analgesics|analgesics|mesh-ancestor
15052662|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
15052663|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052664|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052665|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15052666|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15052667|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15052668|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15052669|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052670|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15052671|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15052672|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052673|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
15052674|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
15052675|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15052676|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
15052677|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052678|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15052679|NCT02102971|Liver Extracts|liver extracts|mesh-list
15052680|NCT02102971|Hematinics|hematinics|mesh-ancestor
15052681|NCT02103023|Imiquimod|imiquimod|mesh-list
15052682|NCT02103023|Vaccines|vaccines|mesh-list
15052683|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
15052684|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052685|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15052686|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052687|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
15052688|NCT02103049|Ezetimibe|ezetimibe|mesh-list
15052689|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15052690|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15052691|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
15052692|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052693|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15052694|NCT02103166|Scopolamine|scopolamine|mesh-list
15052695|NCT02103166|Bromides|bromides|mesh-list
15052696|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
15052697|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15052698|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
15052699|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
15052700|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052701|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052702|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15052703|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
15052704|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15052705|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
15052706|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052707|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052708|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15052709|NCT02103192|Antioxidants|antioxidants|mesh-list
15052710|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052711|NCT02103192|Protective Agents|protective agents|mesh-ancestor
15052712|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052713|NCT02103205|Iron|iron|mesh-list
15052714|NCT02103205|Lactoferrin|lactoferrin|mesh-list
15052715|NCT02103205|Trace Elements|trace elements|mesh-ancestor
15052716|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
15052717|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052718|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15052719|NCT02103244|Carboplatin|carboplatin|mesh-list
15052720|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052721|NCT02103335|Dexamethasone|dexamethasone|mesh-list
15052722|NCT02103335|Pomalidomide|pomalidomide|mesh-list
15052723|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15052724|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
15052725|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
15052726|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052727|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052728|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15052729|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
15052730|NCT02103335|Hormones|hormones|mesh-ancestor
15052731|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15052732|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15052733|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052734|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
15052735|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15052736|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15052737|NCT02103335|Growth Substances|growth substances|mesh-ancestor
15052738|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
15052739|NCT02103361|Ustekinumab|ustekinumab|mesh-list
15052740|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
15052741|NCT02103374|Terbutaline|terbutaline|mesh-list
15052742|NCT02103374|Ipratropium|ipratropium|mesh-list
15052743|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15052744|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
15052745|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052746|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052747|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15052748|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
15052749|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15052750|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
15052751|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052752|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052753|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
15052754|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
15052755|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15052756|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15052757|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15052758|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15052759|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
15052760|NCT02103465|Rotigotine|rotigotine|mesh-list
15052761|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
15052762|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
15052763|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052764|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052765|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052766|NCT02103556|Mineral Oil|mineral oil|mesh-list
15052767|NCT02103556|Emollients|emollients|mesh-ancestor
15052768|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
15052769|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15052770|NCT02103569|Norethindrone|norethindrone|mesh-list
15052771|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
15052772|NCT02103569|Estradiol|estradiol|mesh-list
15052773|NCT02103569|Asunaprevir|asunaprevir|mesh-list
15052774|NCT02103569|Estrogens|estrogens|mesh-ancestor
15052775|NCT02103569|Hormones|hormones|mesh-ancestor
15052776|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15052777|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052778|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15052779|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
15052780|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15052781|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15052782|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15052783|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15052784|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15052785|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
15052786|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052787|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052788|NCT02103647|Pregabalin|pregabalin|mesh-list
15052789|NCT02103647|Analgesics|analgesics|mesh-ancestor
15052790|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
15052791|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052792|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052793|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
15052794|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15052795|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15052796|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052797|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15052798|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15052799|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15052800|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052801|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15052802|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
15052803|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
15052804|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
15052805|NCT02103660|Progestins|progestins|mesh-list
15052806|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15052807|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052808|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15052809|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15052810|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15052811|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15052812|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15052813|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15052814|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15052815|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052816|NCT02103660|Hormones|hormones|mesh-ancestor
15052817|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15052818|NCT02103686|Pregabalin|pregabalin|mesh-list
15052819|NCT02103686|Analgesics|analgesics|mesh-ancestor
15052820|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
15052821|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052822|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052823|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
15052824|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15052825|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15052826|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052827|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15052828|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15052829|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15052830|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052831|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15052832|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
15052833|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15052834|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15052835|NCT02103725|Analgesics|analgesics|mesh-ancestor
15052836|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
15052837|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052838|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052839|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15052840|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15052841|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
15052842|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15052843|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
15052844|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15052845|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052846|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052847|NCT02103738|Ranibizumab|ranibizumab|mesh-list
15052848|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15052849|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15052850|NCT02103738|Growth Substances|growth substances|mesh-ancestor
15052851|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052852|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
15052853|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052854|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
15052855|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
15052856|NCT02103764|Desogestrel|desogestrel|mesh-list
15052857|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15052858|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15052859|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15052860|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
15052861|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15052862|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052863|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15052864|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15052865|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15052866|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15052867|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052868|NCT02103764|Progestins|progestins|mesh-ancestor
15052869|NCT02103764|Hormones|hormones|mesh-ancestor
15052870|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15052871|NCT02103777|Caffeine|caffeine|mesh-list
15052872|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
15052873|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052874|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15052875|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052876|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15052877|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052878|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15052879|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15052880|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
15052881|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052882|NCT02103881|Ketamine|ketamine|mesh-list
15052883|NCT02103881|Haloperidol|haloperidol|mesh-list
15052884|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
15052885|NCT02103881|Analgesics|analgesics|mesh-ancestor
15052886|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
15052887|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052888|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052889|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15052890|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15052891|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
15052892|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
15052893|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052894|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15052895|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15052896|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052897|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052898|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
15052899|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
15052900|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15052901|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15052902|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15052903|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15052904|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15052905|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
15052906|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15052907|NCT02103998|Iodine|iodine|mesh-list
15052908|NCT02103998|Hormones|hormones|mesh-list
15052909|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15052910|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052911|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15052912|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15052913|NCT02103998|Trace Elements|trace elements|mesh-ancestor
15052914|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
15052915|NCT02104011|Propranolol|propranolol|mesh-list
15052916|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15052917|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15052918|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
15052919|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052920|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052921|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052922|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15052923|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15052924|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
15052925|NCT02104128|Bupropion|bupropion|mesh-list
15052926|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15052927|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
15052928|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15052929|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15052930|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15052931|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15052932|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052933|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
15052934|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052935|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052936|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15052937|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15052938|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052939|NCT02104193|Simvastatin|simvastatin|mesh-list
15052940|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15052941|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15052942|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
15052943|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052944|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15052945|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15052946|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052947|NCT02104284|Mannitol|mannitol|mesh-list
15052948|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
15052949|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15052950|NCT02104284|Diuretics|diuretics|mesh-ancestor
15052951|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
15052952|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052953|NCT02104284|Miotics|miotics|mesh-ancestor
15052954|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
15052955|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052956|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15052957|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
15052958|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
15052959|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15052960|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15052961|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
15052962|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052963|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052964|NCT02104297|Remifentanil|remifentanil|mesh-list
15052965|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15052966|NCT02104297|Narcotics|narcotics|mesh-ancestor
15052967|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15052968|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052969|NCT02104297|Analgesics|analgesics|mesh-ancestor
15052970|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
15052971|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15052972|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
15052973|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052974|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
15052975|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15052976|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15052977|NCT02104323|Endostatins|endostatins|mesh-list
15052978|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15052979|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15052980|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15052981|NCT02104323|Growth Substances|growth substances|mesh-ancestor
15052982|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052983|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
15052984|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
15052985|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15052986|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
15052987|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15052988|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15052989|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15052990|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15052991|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15052992|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
15052993|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15052994|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15052995|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15052996|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15052997|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15052998|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15052999|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053000|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053001|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15053002|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
15053003|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15053004|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053005|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15053006|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15053007|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15053008|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
15053009|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
15053010|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15053011|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15053012|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15053013|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053014|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15053015|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15053016|NCT02104674|Montelukast|montelukast|mesh-list
15053017|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15053018|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
15053019|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15053020|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
15053021|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15053022|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053023|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15053024|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15053025|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053026|NCT02104700|Tenofovir|tenofovir|mesh-list
15053027|NCT02104700|Emtricitabine|emtricitabine|mesh-list
15053028|NCT02104700|Rilpivirine|rilpivirine|mesh-list
15053029|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
15053030|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053031|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15053032|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15053033|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053034|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053035|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15053036|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15053037|NCT02104778|Dexamethasone|dexamethasone|mesh-list
15053038|NCT02104778|Epinephrine|epinephrine|mesh-list
15053039|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15053040|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
15053041|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
15053042|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053043|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053044|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15053045|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
15053046|NCT02104778|Hormones|hormones|mesh-ancestor
15053047|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15053048|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15053049|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053050|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15053051|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15053052|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
15053053|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053054|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053055|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15053056|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15053057|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15053058|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
15053059|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
15053060|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
15053061|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15053062|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15053063|NCT02104843|Asunaprevir|asunaprevir|mesh-list
15053064|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15053065|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15053066|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
15053067|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053068|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15053069|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15053070|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053071|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
15053072|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
15053073|NCT02104986|Cisplatin|cisplatin|mesh-list
15053074|NCT02104986|Ifosfamide|ifosfamide|mesh-list
15053075|NCT02104986|Bleomycin|bleomycin|mesh-list
15053076|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053077|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15053078|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
15053079|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053080|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15053081|NCT02105077|Anesthetics|anesthetics|mesh-list
15053082|NCT02105077|Xenon|xenon|mesh-list
15053083|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053084|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053085|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15053086|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
15053087|NCT02105090|Anesthetics|anesthetics|mesh-list
15053088|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
15053089|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053090|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053091|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053092|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
15053093|NCT02105103|Insulin|insulin|mesh-list
15053094|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15053095|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053096|NCT02105155|Tacrolimus|tacrolimus|mesh-list
15053097|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15053098|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
15053099|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053100|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15053101|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053102|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053103|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
15053104|NCT02105311|Travoprost|travoprost|mesh-list
15053105|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15053106|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15053107|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053108|NCT02105350|Gemcitabine|gemcitabine|mesh-list
15053109|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
15053110|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15053111|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
15053112|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053113|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053114|NCT02105350|Antiviral Agents|antiviral agents|mesh-ancestor
15053115|NCT02105350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053116|NCT02105350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053117|NCT02105350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15053118|NCT02105350|Immunologic Factors|immunologic factors|mesh-ancestor
15053119|NCT02105350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053120|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
15053121|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
15053122|NCT02105610|Sevoflurane|sevoflurane|mesh-list
15053123|NCT02105610|Desflurane|desflurane|mesh-list
15053124|NCT02105610|Isoflurane|isoflurane|mesh-list
15053125|NCT02105610|Anesthetics|anesthetics|mesh-list
15053126|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
15053127|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15053128|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15053129|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
15053130|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053131|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053132|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15053133|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15053134|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15053135|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
15053136|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053137|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15053138|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15053139|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053140|NCT02105675|Docetaxel|docetaxel|mesh-list
15053141|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053142|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
15053143|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
15053144|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
15053145|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053146|NCT02105714|Formaldehyde|formaldehyde|mesh-list
15053147|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
15053148|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053149|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
15053150|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15053151|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053152|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15053153|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053154|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
15053155|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053156|NCT02105870|Abciximab|abciximab|mesh-list
15053157|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
15053158|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15053159|NCT02106104|Glimepiride|glimepiride|mesh-list
15053160|NCT02106104|Linagliptin|linagliptin|mesh-list
15053161|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15053162|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15053163|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053164|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15053165|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
15053166|NCT02106104|Incretins|incretins|mesh-ancestor
15053167|NCT02106104|Hormones|hormones|mesh-ancestor
15053168|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15053169|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15053170|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
15053171|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053172|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053173|NCT02106130|Rebamipide|rebamipide|mesh-list
15053174|NCT02106130|Mosapride|mosapride|mesh-list
15053175|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053176|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15053177|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15053178|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
15053179|NCT02106130|Protective Agents|protective agents|mesh-ancestor
15053180|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053181|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053182|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15053183|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
15053184|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053185|NCT02106182|Silodosin|silodosin|mesh-list
15053186|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15053187|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15053188|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15053189|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
15053190|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053191|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053192|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053193|NCT02106182|Urological Agents|urological agents|mesh-ancestor
15053194|NCT02106286|Bisoprolol|bisoprolol|mesh-list
15053195|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15053196|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
15053197|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
15053198|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053199|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053200|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15053201|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15053202|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15053203|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
15053204|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053205|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053206|NCT02106364|Insulin|insulin|mesh-list
15053207|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15053208|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
15053209|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15053210|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053211|NCT02106468|Prednisone|prednisone|mesh-list
15053212|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15053213|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
15053214|NCT02106468|Hormones|hormones|mesh-ancestor
15053215|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15053216|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053217|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15053218|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053219|NCT02106481|Ropivacaine|ropivacaine|mesh-list
15053220|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
15053221|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
15053222|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053223|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053224|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
15053225|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053226|NCT02106507|Everolimus|everolimus|mesh-list
15053227|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053228|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15053229|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
15053230|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053231|NCT02106520|Bevacizumab|bevacizumab|mesh-list
15053232|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15053233|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053234|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15053235|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15053236|NCT02106520|Growth Substances|growth substances|mesh-ancestor
15053237|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053238|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
15053239|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
15053240|NCT02106559|Trioxsalen|trioxsalen|mesh-list
15053241|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053242|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
15053243|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15053244|NCT02106637|Varenicline|varenicline|mesh-list
15053245|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15053246|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15053247|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
15053248|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053249|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053250|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053251|NCT02106650|Leucovorin|leucovorin|mesh-list
15053252|NCT02106650|Folic Acid|folic acid|mesh-list
15053253|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
15053254|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
15053255|NCT02106650|Vitamins|vitamins|mesh-ancestor
15053256|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
15053257|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053258|NCT02106650|Antidotes|antidotes|mesh-ancestor
15053259|NCT02106650|Protective Agents|protective agents|mesh-ancestor
15053260|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
15053261|NCT02106650|Hematinics|hematinics|mesh-ancestor
15053262|NCT02106767|Rifampin|rifampin|mesh-list
15053263|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15053264|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15053265|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15053266|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
15053267|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053268|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15053269|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15053270|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053271|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15053272|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
15053273|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15053274|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053275|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
15053276|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15053277|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15053278|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15053279|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15053280|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15053281|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15053282|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15053283|NCT02106793|Mitomycins|mitomycins|mesh-list
15053284|NCT02106793|Mitomycin|mitomycin|mesh-list
15053285|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15053286|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053287|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
15053288|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053289|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15053290|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053291|NCT02106806|Zinc|zinc|mesh-list
15053292|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
15053293|NCT02106806|Trace Elements|trace elements|mesh-ancestor
15053294|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
15053295|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053296|NCT02106806|Astringents|astringents|mesh-ancestor
15053297|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
15053298|NCT02106845|Digoxin|digoxin|mesh-list
15053299|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15053300|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15053301|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15053302|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
15053303|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053304|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15053305|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15053306|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053307|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15053308|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15053309|NCT02106845|Protective Agents|protective agents|mesh-ancestor
15053310|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053311|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
15053312|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
15053313|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15053314|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15053315|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053316|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053317|NCT02106871|Urological Agents|urological agents|mesh-ancestor
15053318|NCT02106988|Dexamethasone|dexamethasone|mesh-list
15053319|NCT02106988|Carboplatin|carboplatin|mesh-list
15053320|NCT02106988|Etoposide|etoposide|mesh-list
15053321|NCT02106988|Ifosfamide|ifosfamide|mesh-list
15053322|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
15053323|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15053324|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
15053325|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
15053326|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053327|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053328|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15053329|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
15053330|NCT02106988|Hormones|hormones|mesh-ancestor
15053331|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15053332|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15053333|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053334|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15053335|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15053336|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15053337|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053338|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053339|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15053340|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
15053341|NCT02107079|Melatonin|melatonin|mesh-list
15053342|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
15053343|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053344|NCT02107079|Protective Agents|protective agents|mesh-ancestor
15053345|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053346|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053347|NCT02107118|Complement Factor H|complement factor h|mesh-list
15053348|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15053349|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15053350|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
15053351|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053352|NCT02107144|Trimetazidine|trimetazidine|mesh-list
15053353|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
15053354|NCT02107170|Remifentanil|remifentanil|mesh-list
15053355|NCT02107170|Propofol|propofol|mesh-list
15053356|NCT02107170|Sevoflurane|sevoflurane|mesh-list
15053357|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15053358|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053359|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053360|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15053361|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
15053362|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
15053363|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15053364|NCT02107170|Narcotics|narcotics|mesh-ancestor
15053365|NCT02107170|Analgesics|analgesics|mesh-ancestor
15053366|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
15053367|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053368|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15053369|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15053370|NCT02107235|ON 01910|on 01910|mesh-list
15053371|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053372|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15053373|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053374|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053375|NCT02107365|Interferons|interferons|mesh-list
15053376|NCT02107365|Ribavirin|ribavirin|mesh-list
15053377|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
15053378|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
15053379|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15053380|NCT02107365|Asunaprevir|asunaprevir|mesh-list
15053381|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053382|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
15053383|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053384|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
15053385|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053386|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
15053387|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053388|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
15053389|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053390|NCT02107378|Paclitaxel|paclitaxel|mesh-list
15053391|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15053392|NCT02107378|Doxorubicin|doxorubicin|mesh-list
15053393|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15053394|NCT02107378|Topotecan|topotecan|mesh-list
15053395|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15053396|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053397|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
15053398|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
15053399|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
15053400|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053401|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15053402|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15053403|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15053404|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053405|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15053406|NCT02107391|Leuprolide|leuprolide|mesh-list
15053407|NCT02107391|Goserelin|goserelin|mesh-list
15053408|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15053409|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
15053410|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15053411|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053412|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15053413|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053414|NCT02107690|Lidocaine|lidocaine|mesh-list
15053415|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
15053416|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
15053417|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053418|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053419|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
15053420|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053421|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15053422|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15053423|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15053424|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15053425|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053426|NCT02107716|Lidocaine|lidocaine|mesh-list
15053427|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
15053428|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
15053429|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053430|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053431|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
15053432|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053433|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15053434|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15053435|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15053436|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15053437|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053438|NCT02107729|Lidocaine|lidocaine|mesh-list
15053439|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
15053440|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
15053441|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053442|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053443|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
15053444|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053445|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15053446|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15053447|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15053448|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15053449|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053450|NCT02107742|Lidocaine|lidocaine|mesh-list
15053451|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
15053452|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
15053453|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053454|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053455|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
15053456|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053457|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15053458|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15053459|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15053460|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15053461|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053462|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15053463|NCT02107755|Ipilimumab|ipilimumab|mesh-list
15053464|NCT02107755|Antibodies|antibodies|mesh-list
15053465|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
15053466|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15053467|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
15053468|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053469|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053470|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15053471|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053472|NCT02107807|Lactitol|lactitol|mesh-list
15053473|NCT02107807|Vaccines|vaccines|mesh-list
15053474|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
15053475|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053476|NCT02107807|Cathartics|cathartics|mesh-ancestor
15053477|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15053478|NCT02107924|Vancomycin|vancomycin|mesh-list
15053479|NCT02107924|Tobramycin|tobramycin|mesh-list
15053480|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15053481|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053482|NCT02107937|Paclitaxel|paclitaxel|mesh-list
15053483|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15053484|NCT02107937|Carboplatin|carboplatin|mesh-list
15053485|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15053486|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053487|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
15053488|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
15053489|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
15053490|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053491|NCT02107950|Gemcitabine|gemcitabine|mesh-list
15053492|NCT02107950|Carboplatin|carboplatin|mesh-list
15053493|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053494|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15053495|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
15053496|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053497|NCT02107950|Antiviral Agents|antiviral agents|mesh-ancestor
15053498|NCT02107950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053499|NCT02107950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053500|NCT02107950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15053501|NCT02107950|Immunologic Factors|immunologic factors|mesh-ancestor
15053502|NCT02107950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053503|NCT02108002|Vorinostat|vorinostat|mesh-list
15053504|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053505|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15053506|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053507|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053508|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
15053509|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15053510|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15053511|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15053512|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15053513|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053514|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
15053515|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053516|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053517|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15053518|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053519|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15053520|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15053521|NCT02108301|Cyclosporine|cyclosporine|mesh-list
15053522|NCT02108301|Tacrolimus|tacrolimus|mesh-list
15053523|NCT02108301|Cyclosporins|cyclosporins|mesh-list
15053524|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15053525|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
15053526|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053527|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15053528|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053529|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053530|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
15053531|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053532|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
15053533|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15053534|NCT02108353|Melatonin|melatonin|mesh-list
15053535|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
15053536|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053537|NCT02108353|Protective Agents|protective agents|mesh-ancestor
15053538|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053539|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053540|NCT02108366|Oseltamivir|oseltamivir|mesh-list
15053541|NCT02108366|Celecoxib|celecoxib|mesh-list
15053542|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15053543|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15053544|NCT02108366|Analgesics|analgesics|mesh-ancestor
15053545|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
15053546|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053547|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053548|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15053549|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15053550|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15053551|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15053552|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053553|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053554|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
15053555|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053556|NCT02108483|Dapsone|dapsone|mesh-list
15053557|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053558|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
15053559|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15053560|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15053561|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15053562|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053563|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053564|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
15053565|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15053566|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
15053567|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
15053568|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15053569|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053570|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15053571|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15053572|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
15053573|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15053574|NCT02108548|Naproxen|naproxen|mesh-list
15053575|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15053576|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15053577|NCT02108548|Analgesics|analgesics|mesh-ancestor
15053578|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
15053579|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053580|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053581|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15053582|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15053583|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
15053584|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15053585|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053586|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053587|NCT02108626|Nicotine|nicotine|mesh-list
15053588|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15053589|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
15053590|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053591|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053592|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15053593|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15053594|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
15053595|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053596|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053597|NCT02108639|Asunaprevir|asunaprevir|mesh-list
15053598|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
15053599|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053600|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053601|NCT02108743|Albuterol|albuterol|mesh-list
15053602|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15053603|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
15053604|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053605|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053606|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15053607|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
15053608|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
15053609|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15053610|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15053611|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15053612|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15053613|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
15053614|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053615|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053616|NCT02108756|Pantoprazole|pantoprazole|mesh-list
15053617|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15053618|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15053619|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15053620|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053621|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053622|NCT02108795|Remifentanil|remifentanil|mesh-list
15053623|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15053624|NCT02108795|Narcotics|narcotics|mesh-ancestor
15053625|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053626|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053627|NCT02108795|Analgesics|analgesics|mesh-ancestor
15053628|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
15053629|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053630|NCT02108808|Clopidogrel|clopidogrel|mesh-list
15053631|NCT02108808|Ticagrelor|ticagrelor|mesh-list
15053632|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15053633|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15053634|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15053635|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15053636|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15053637|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
15053638|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053639|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053640|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053641|NCT02108847|Ropivacaine|ropivacaine|mesh-list
15053642|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
15053643|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
15053644|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053645|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053646|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
15053647|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053648|NCT02108860|Abatacept|abatacept|mesh-list
15053649|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15053650|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053651|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053652|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15053653|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
15053654|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053655|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15053656|NCT02108886|Montelukast|montelukast|mesh-list
15053657|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15053658|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
15053659|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15053660|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
15053661|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15053662|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053663|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15053664|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15053665|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053666|NCT02108990|Acetaminophen|acetaminophen|mesh-list
15053667|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15053668|NCT02108990|Analgesics|analgesics|mesh-ancestor
15053669|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
15053670|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053671|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053672|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
15053673|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
15053674|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15053675|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
15053676|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15053677|NCT02109289|Etanercept|etanercept|mesh-list
15053678|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15053679|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15053680|NCT02109289|Analgesics|analgesics|mesh-ancestor
15053681|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
15053682|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053683|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053684|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15053685|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15053686|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15053687|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15053688|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
15053689|NCT02109315|Ascorbic Acid|ascorbic acid|mesh-list
15053690|NCT02109315|Liraglutide|liraglutide|mesh-list
15053691|NCT02109315|Vitamins|vitamins|mesh-ancestor
15053692|NCT02109315|Micronutrients|micronutrients|mesh-ancestor
15053693|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053694|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15053695|NCT02109315|Incretins|incretins|mesh-ancestor
15053696|NCT02109315|Hormones|hormones|mesh-ancestor
15053697|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15053698|NCT02109315|Antioxidants|antioxidants|mesh-ancestor
15053699|NCT02109315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053700|NCT02109315|Protective Agents|protective agents|mesh-ancestor
15053701|NCT02109328|Paclitaxel|paclitaxel|mesh-list
15053702|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15053703|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053704|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
15053705|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
15053706|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
15053707|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053708|NCT02109341|Paclitaxel|paclitaxel|mesh-list
15053709|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15053710|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15053711|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053712|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
15053713|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
15053714|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
15053715|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053716|NCT02109354|Vaccines|vaccines|mesh-list
15053717|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
15053718|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053719|NCT02109510|Lidocaine|lidocaine|mesh-list
15053720|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
15053721|NCT02109510|Ketamine|ketamine|mesh-list
15053722|NCT02109510|Anesthetics|anesthetics|mesh-list
15053723|NCT02109510|Propofol|propofol|mesh-list
15053724|NCT02109510|Sevoflurane|sevoflurane|mesh-list
15053725|NCT02109510|Rocuronium|rocuronium|mesh-list
15053726|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
15053727|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053728|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053729|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
15053730|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053731|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15053732|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15053733|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15053734|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15053735|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053736|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15053737|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15053738|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
15053739|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15053740|NCT02109510|Analgesics|analgesics|mesh-ancestor
15053741|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15053742|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15053743|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15053744|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
15053745|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053746|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15053747|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15053748|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15053749|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15053750|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15053751|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15053752|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15053753|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15053754|NCT02109614|Niacin|niacin|mesh-list
15053755|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15053756|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
15053757|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053758|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15053759|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
15053760|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
15053761|NCT02109614|Vitamins|vitamins|mesh-ancestor
15053762|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
15053763|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053764|NCT02109627|Cytarabine|cytarabine|mesh-list
15053765|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15053766|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
15053767|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053768|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053769|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
15053770|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053771|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15053772|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
15053773|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053774|NCT02109666|Abatacept|abatacept|mesh-list
15053775|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15053776|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053777|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053778|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15053779|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
15053780|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053781|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15053782|NCT02109679|Metformin|metformin|mesh-list
15053783|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15053784|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053785|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
15053786|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
15053787|NCT02109718|Petrolatum|petrolatum|mesh-list
15053788|NCT02109718|Emollients|emollients|mesh-ancestor
15053789|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
15053790|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15053791|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053792|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15053793|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15053794|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
15053795|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15053796|NCT02109783|Caffeine|caffeine|mesh-list
15053797|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15053798|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053799|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15053800|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053801|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053802|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15053803|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15053804|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
15053805|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053806|NCT02109861|Dexamethasone|dexamethasone|mesh-list
15053807|NCT02109861|Bortezomib|bortezomib|mesh-list
15053808|NCT02109861|Melphalan|melphalan|mesh-list
15053809|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15053810|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
15053811|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
15053812|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053813|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053814|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15053815|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
15053816|NCT02109861|Hormones|hormones|mesh-ancestor
15053817|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15053818|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15053819|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053820|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15053821|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
15053822|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053823|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15053824|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15053825|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
15053826|NCT02109900|Progesterone|progesterone|mesh-list
15053827|NCT02109900|Progestins|progestins|mesh-ancestor
15053828|NCT02109900|Hormones|hormones|mesh-ancestor
15053829|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15053830|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053831|NCT02109913|Everolimus|everolimus|mesh-list
15053832|NCT02109913|Exemestane|exemestane|mesh-list
15053833|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053834|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15053835|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
15053836|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053837|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15053838|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15053839|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053840|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053841|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15053842|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
15053843|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15053844|NCT02109965|Midazolam|midazolam|mesh-list
15053845|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
15053846|NCT02109965|Propofol|propofol|mesh-list
15053847|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15053848|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053849|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053850|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15053851|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
15053852|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
15053853|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15053854|NCT02109965|Analgesics|analgesics|mesh-ancestor
15053855|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
15053856|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053857|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15053858|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15053859|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15053860|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
15053861|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053862|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053863|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15053864|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15053865|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15053866|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15053867|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
15053868|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
15053869|NCT02110082|Cetuximab|cetuximab|mesh-list
15053870|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15053871|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053872|NCT02110134|Hydroquinone|hydroquinone|mesh-list
15053873|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
15053874|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053875|NCT02110134|Protective Agents|protective agents|mesh-ancestor
15053876|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053877|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15053878|NCT02110303|Ticagrelor|ticagrelor|mesh-list
15053879|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15053880|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15053881|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15053882|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15053883|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
15053884|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053885|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053886|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053887|NCT02110316|Voriconazole|voriconazole|mesh-list
15053888|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
15053889|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053890|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15053891|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15053892|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053893|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053894|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15053895|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
15053896|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15053897|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053898|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15053899|NCT02110355|Trametinib|trametinib|mesh-list
15053900|NCT02110355|Dabrafenib|dabrafenib|mesh-list
15053901|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053902|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15053903|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053904|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053905|NCT02110394|Rituximab|rituximab|mesh-list
15053906|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15053907|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15053908|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053909|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
15053910|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053911|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15053912|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15053913|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
15053914|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053915|NCT02110459|Murepavadin|murepavadin|mesh-list
15053916|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15053917|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053918|NCT02110524|Paclitaxel|paclitaxel|mesh-list
15053919|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15053920|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053921|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
15053922|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
15053923|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
15053924|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053925|NCT02110537|Flecainide|flecainide|mesh-list
15053926|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15053927|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15053928|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15053929|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15053930|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053931|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
15053932|NCT02110654|Montelukast|montelukast|mesh-list
15053933|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15053934|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
15053935|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15053936|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
15053937|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15053938|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053939|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15053940|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15053941|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053942|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15053943|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
15053944|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15053945|NCT02110719|Acetaminophen|acetaminophen|mesh-list
15053946|NCT02110719|Dexamethasone|dexamethasone|mesh-list
15053947|NCT02110719|Ibuprofen|ibuprofen|mesh-list
15053948|NCT02110719|Celecoxib|celecoxib|mesh-list
15053949|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15053950|NCT02110719|Oxycodone|oxycodone|mesh-list
15053951|NCT02110719|Gabapentin|gabapentin|mesh-list
15053952|NCT02110719|Hydromorphone|hydromorphone|mesh-list
15053953|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15053954|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
15053955|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
15053956|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15053957|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053958|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15053959|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
15053960|NCT02110719|Hormones|hormones|mesh-ancestor
15053961|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15053962|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15053963|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15053964|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15053965|NCT02110719|Analgesics|analgesics|mesh-ancestor
15053966|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
15053967|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
15053968|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15053969|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15053970|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15053971|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15053972|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15053973|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15053974|NCT02110719|Narcotics|narcotics|mesh-ancestor
15053975|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053976|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
15053977|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15053978|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15053979|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15053980|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15053981|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15053982|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15053983|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
15053984|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15053985|NCT02110745|Propofol|propofol|mesh-list
15053986|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15053987|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15053988|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15053989|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15053990|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
15053991|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
15053992|NCT02110784|Piperaquine|piperaquine|mesh-list
15053993|NCT02110784|Artenimol|artenimol|mesh-list
15053994|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
15053995|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15053996|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15053997|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15053998|NCT02110810|Indomethacin|indomethacin|mesh-list
15053999|NCT02110810|Glycerol|glycerol|mesh-list
15054000|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15054001|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15054002|NCT02110810|Analgesics|analgesics|mesh-ancestor
15054003|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
15054004|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054005|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054006|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054007|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15054008|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
15054009|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
15054010|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15054011|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15054012|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054013|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054014|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15054015|NCT02110810|Protective Agents|protective agents|mesh-ancestor
15054016|NCT02110953|Irinotecan|irinotecan|mesh-list
15054017|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15054018|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15054019|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054020|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054021|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054022|NCT02110966|Tramadol|tramadol|mesh-list
15054023|NCT02110966|Mepivacaine|mepivacaine|mesh-list
15054024|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15054025|NCT02110966|Narcotics|narcotics|mesh-ancestor
15054026|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054027|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054028|NCT02110966|Analgesics|analgesics|mesh-ancestor
15054029|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
15054030|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054031|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
15054032|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
15054033|NCT02110992|Docetaxel|docetaxel|mesh-list
15054034|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054035|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
15054036|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
15054037|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
15054038|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054039|NCT02111044|Octreotide|octreotide|mesh-list
15054040|NCT02111044|Somatostatin|somatostatin|mesh-list
15054041|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15054042|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15054043|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054044|NCT02111044|Hormones|hormones|mesh-ancestor
15054045|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054046|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054047|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
15054048|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15054049|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15054050|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
15054051|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
15054052|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054053|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054054|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
15054055|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15054056|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
15054057|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
15054058|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15054059|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
15054060|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054061|NCT02111265|Sufentanil|sufentanil|mesh-list
15054062|NCT02111265|Remifentanil|remifentanil|mesh-list
15054063|NCT02111265|Cisatracurium|cisatracurium|mesh-list
15054064|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15054065|NCT02111265|Narcotics|narcotics|mesh-ancestor
15054066|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054067|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054068|NCT02111265|Analgesics|analgesics|mesh-ancestor
15054069|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
15054070|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054071|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15054072|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15054073|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
15054074|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
15054075|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15054076|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15054077|NCT02111317|Verapamil|verapamil|mesh-list
15054078|NCT02111317|Peficitinib|peficitinib|mesh-list
15054079|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15054080|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15054081|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15054082|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054083|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15054084|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054085|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
15054086|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054087|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15054088|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
15054089|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
15054090|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15054091|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054092|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054093|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15054094|NCT02111421|Analgesics|analgesics|mesh-ancestor
15054095|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
15054096|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054097|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15054098|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15054099|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15054100|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
15054101|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15054102|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054103|NCT02111434|Testosterone|testosterone|mesh-list
15054104|NCT02111434|Androgens|androgens|mesh-ancestor
15054105|NCT02111434|Hormones|hormones|mesh-ancestor
15054106|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054107|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054108|NCT02111473|Testosterone|testosterone|mesh-list
15054109|NCT02111473|Androgens|androgens|mesh-ancestor
15054110|NCT02111473|Hormones|hormones|mesh-ancestor
15054111|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054112|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054113|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
15054114|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15054115|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15054116|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
15054117|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15054118|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054119|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054120|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
15054121|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15054122|NCT02111590|Antibodies|antibodies|mesh-list
15054123|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
15054124|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054125|NCT02111629|Fluconazole|fluconazole|mesh-list
15054126|NCT02111629|Secnidazole|secnidazole|mesh-list
15054127|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
15054128|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054129|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15054130|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15054131|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054132|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054133|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15054134|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
15054135|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054136|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054137|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15054138|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15054139|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15054140|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15054141|NCT02111707|Indomethacin|indomethacin|mesh-list
15054142|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15054143|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15054144|NCT02111707|Analgesics|analgesics|mesh-ancestor
15054145|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
15054146|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054147|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054148|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054149|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15054150|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
15054151|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
15054152|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15054153|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15054154|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054155|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054156|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15054157|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15054158|NCT02111941|Vaccines|vaccines|mesh-list
15054159|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
15054160|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054161|NCT02112006|Bupivacaine|bupivacaine|mesh-list
15054162|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
15054163|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
15054164|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054165|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054166|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
15054167|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054168|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
15054169|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054170|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15054171|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
15054172|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15054173|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054174|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
15054175|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054176|NCT02112097|Etanercept|etanercept|mesh-list
15054177|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15054178|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15054179|NCT02112097|Analgesics|analgesics|mesh-ancestor
15054180|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
15054181|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054182|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054183|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054184|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15054185|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15054186|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15054187|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
15054188|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
15054189|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15054190|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15054191|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054192|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
15054193|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
15054194|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054195|NCT02112175|Lenalidomide|lenalidomide|mesh-list
15054196|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
15054197|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054198|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15054199|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15054200|NCT02112175|Growth Substances|growth substances|mesh-ancestor
15054201|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
15054202|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054203|NCT02112214|Bismuth|bismuth|mesh-list
15054204|NCT02112214|Antacids|antacids|mesh-ancestor
15054205|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054206|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15054207|NCT02112292|Dronabinol|dronabinol|mesh-list
15054208|NCT02112292|Cannabidiol|cannabidiol|mesh-list
15054209|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
15054210|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
15054211|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054212|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15054213|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15054214|NCT02112292|Analgesics|analgesics|mesh-ancestor
15054215|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
15054216|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054217|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
15054218|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
15054219|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15054220|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054221|NCT02112292|Hormones|hormones|mesh-ancestor
15054222|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054223|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
15054224|NCT02112305|Analgesics|analgesics|mesh-ancestor
15054225|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
15054226|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054227|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054228|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
15054229|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054230|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15054231|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
15054232|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15054233|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15054234|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054235|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15054236|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
15054237|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15054238|NCT02112422|Dexamethasone|dexamethasone|mesh-list
15054239|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
15054240|NCT02112422|BB 1101|bb 1101|mesh-list
15054241|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054242|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
15054243|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
15054244|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054245|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054246|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15054247|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
15054248|NCT02112422|Hormones|hormones|mesh-ancestor
15054249|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054250|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15054251|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054252|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
15054253|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054254|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054255|NCT02112487|Macitentan|macitentan|mesh-list
15054256|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
15054257|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15054258|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054259|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
15054260|NCT02112552|Paclitaxel|paclitaxel|mesh-list
15054261|NCT02112552|Carboplatin|carboplatin|mesh-list
15054262|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15054263|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054264|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
15054265|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
15054266|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
15054267|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054268|NCT02112578|Meclizine|meclizine|mesh-list
15054269|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
15054270|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
15054271|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
15054272|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054273|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054274|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15054275|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15054276|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
15054277|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
15054278|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15054279|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054280|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15054281|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15054282|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054283|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054284|NCT02112630|Interferons|interferons|mesh-list
15054285|NCT02112630|Ribavirin|ribavirin|mesh-list
15054286|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
15054287|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
15054288|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15054289|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
15054290|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15054291|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054292|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
15054293|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054294|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
15054295|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054296|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
15054297|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054298|NCT02112643|Selenium|selenium|mesh-list
15054299|NCT02112643|Selenic Acid|selenic acid|mesh-list
15054300|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
15054301|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054302|NCT02112643|Protective Agents|protective agents|mesh-ancestor
15054303|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054304|NCT02112643|Trace Elements|trace elements|mesh-ancestor
15054305|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
15054306|NCT02112695|Diprenorphine|diprenorphine|mesh-list
15054307|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15054308|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054309|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
15054310|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054311|NCT02112721|Vitamin D|vitamin d|mesh-list
15054312|NCT02112721|Vitamins|vitamins|mesh-ancestor
15054313|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
15054314|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054315|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15054316|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15054317|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
15054318|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054319|NCT02112864|Dexamethasone|dexamethasone|mesh-list
15054320|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054321|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
15054322|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
15054323|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054324|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054325|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15054326|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
15054327|NCT02112864|Hormones|hormones|mesh-ancestor
15054328|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054329|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15054330|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054331|NCT02112903|Vortioxetine|vortioxetine|mesh-list
15054332|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
15054333|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15054334|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15054335|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15054336|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054337|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054338|NCT02112903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15054339|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15054340|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15054341|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054342|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15054343|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
15054344|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15054345|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15054346|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15054347|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15054348|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
15054349|NCT02112916|Leucovorin|leucovorin|mesh-list
15054350|NCT02112916|Folic Acid|folic acid|mesh-list
15054351|NCT02112916|Cytarabine|cytarabine|mesh-list
15054352|NCT02112916|Dexamethasone|dexamethasone|mesh-list
15054353|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
15054354|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
15054355|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15054356|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15054357|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15054358|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
15054359|NCT02112916|Ifosfamide|ifosfamide|mesh-list
15054360|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
15054361|NCT02112916|Doxorubicin|doxorubicin|mesh-list
15054362|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15054363|NCT02112916|Methotrexate|methotrexate|mesh-list
15054364|NCT02112916|Etoposide|etoposide|mesh-list
15054365|NCT02112916|Vincristine|vincristine|mesh-list
15054366|NCT02112916|Bortezomib|bortezomib|mesh-list
15054367|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
15054368|NCT02112916|Daunorubicin|daunorubicin|mesh-list
15054369|NCT02112916|Asparaginase|asparaginase|mesh-list
15054370|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
15054371|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
15054372|NCT02112916|Pegaspargase|pegaspargase|mesh-list
15054373|NCT02112916|Thioguanine|thioguanine|mesh-list
15054374|NCT02112916|BB 1101|bb 1101|mesh-list
15054375|NCT02112916|Calcium|calcium|mesh-list
15054376|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
15054377|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
15054378|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15054379|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
15054380|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054381|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15054382|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15054383|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
15054384|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054385|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054386|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15054387|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054388|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
15054389|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
15054390|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054391|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15054392|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
15054393|NCT02112916|Hormones|hormones|mesh-ancestor
15054394|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054395|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15054396|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
15054397|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054398|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15054399|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15054400|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15054401|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15054402|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15054403|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15054404|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
15054405|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15054406|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15054407|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
15054408|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
15054409|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15054410|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15054411|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15054412|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
15054413|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054414|NCT02112916|Antidotes|antidotes|mesh-ancestor
15054415|NCT02112916|Protective Agents|protective agents|mesh-ancestor
15054416|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
15054417|NCT02112916|Vitamins|vitamins|mesh-ancestor
15054418|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
15054419|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
15054420|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
15054421|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
15054422|NCT02112916|Hematinics|hematinics|mesh-ancestor
15054423|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
15054424|NCT02112929|Xenon|xenon|mesh-list
15054425|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15054426|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
15054427|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
15054428|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054429|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054430|NCT02112981|Sirolimus|sirolimus|mesh-list
15054431|NCT02112981|Everolimus|everolimus|mesh-list
15054432|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054433|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15054434|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
15054435|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054436|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15054437|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054438|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15054439|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
15054440|NCT02113072|Beclomethasone|beclomethasone|mesh-list
15054441|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054442|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
15054443|NCT02113072|Hormones|hormones|mesh-ancestor
15054444|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054445|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054446|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15054447|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
15054448|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
15054449|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
15054450|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
15054451|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054452|NCT02113150|Ketamine|ketamine|mesh-list
15054453|NCT02113150|Remifentanil|remifentanil|mesh-list
15054454|NCT02113150|Analgesics|analgesics|mesh-ancestor
15054455|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
15054456|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054457|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054458|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15054459|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15054460|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
15054461|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
15054462|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054463|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15054464|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15054465|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15054466|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054467|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15054468|NCT02113150|Narcotics|narcotics|mesh-ancestor
15054469|NCT02113163|Metformin|metformin|mesh-list
15054470|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
15054471|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15054472|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054473|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15054474|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15054475|NCT02113176|Minocycline|minocycline|mesh-list
15054476|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15054477|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054478|NCT02113202|Bevacizumab|bevacizumab|mesh-list
15054479|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15054480|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054481|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15054482|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15054483|NCT02113202|Growth Substances|growth substances|mesh-ancestor
15054484|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054485|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
15054486|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
15054487|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054488|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
15054489|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15054490|NCT02113319|Dasatinib|dasatinib|mesh-list
15054491|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054492|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15054493|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054494|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054495|NCT02113332|Liraglutide|liraglutide|mesh-list
15054496|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15054497|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054498|NCT02113332|Incretins|incretins|mesh-ancestor
15054499|NCT02113332|Hormones|hormones|mesh-ancestor
15054500|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054501|NCT02113397|Tobramycin|tobramycin|mesh-list
15054502|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15054503|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054504|NCT02113540|Atorvastatin|atorvastatin|mesh-list
15054505|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15054506|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15054507|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
15054508|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054509|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15054510|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15054511|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054512|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15054513|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
15054514|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15054515|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
15054516|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15054517|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054518|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15054519|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15054520|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054521|NCT02113566|Acetaminophen|acetaminophen|mesh-list
15054522|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15054523|NCT02113566|Analgesics|analgesics|mesh-ancestor
15054524|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
15054525|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054526|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054527|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
15054528|NCT02113631|Interferons|interferons|mesh-list
15054529|NCT02113631|Ribavirin|ribavirin|mesh-list
15054530|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
15054531|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
15054532|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15054533|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054534|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
15054535|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054536|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
15054537|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054538|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
15054539|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054540|NCT02113657|Ipilimumab|ipilimumab|mesh-list
15054541|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15054542|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054543|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15054544|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054545|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15054546|NCT02113735|Hormones|hormones|mesh-ancestor
15054547|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054548|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054549|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
15054550|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15054551|NCT02113800|Everolimus|everolimus|mesh-list
15054552|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054553|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15054554|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
15054555|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054556|NCT02113813|Naquotinib|naquotinib|mesh-list
15054557|NCT02113813|Midazolam|midazolam|mesh-list
15054558|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15054559|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15054560|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054561|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054562|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15054563|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15054564|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15054565|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15054566|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
15054567|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
15054568|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
15054569|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
15054570|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15054571|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054572|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054573|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15054574|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054575|NCT02113891|Eculizumab|eculizumab|mesh-list
15054576|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15054577|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15054578|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
15054579|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054580|NCT02113904|Adalimumab|adalimumab|mesh-list
15054581|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054582|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15054583|NCT02113943|Citalopram|citalopram|mesh-list
15054584|NCT02113943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15054585|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15054586|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15054587|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054588|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15054589|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
15054590|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054591|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15054592|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
15054593|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15054594|NCT02114021|Betamethasone|betamethasone|mesh-list
15054595|NCT02114021|Lidocaine|lidocaine|mesh-list
15054596|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
15054597|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
15054598|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054599|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054600|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
15054601|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054602|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15054603|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15054604|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15054605|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15054606|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054607|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054608|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
15054609|NCT02114021|Hormones|hormones|mesh-ancestor
15054610|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054611|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15054612|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
15054613|NCT02114073|Cyclosporine|cyclosporine|mesh-list
15054614|NCT02114073|Betamethasone|betamethasone|mesh-list
15054615|NCT02114073|Cyclosporins|cyclosporins|mesh-list
15054616|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054617|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054618|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15054619|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
15054620|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054621|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
15054622|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054623|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
15054624|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15054625|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15054626|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054627|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
15054628|NCT02114073|Hormones|hormones|mesh-ancestor
15054629|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054630|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15054631|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
15054632|NCT02114099|Atorvastatin|atorvastatin|mesh-list
15054633|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15054634|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15054635|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
15054636|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054637|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15054638|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15054639|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054640|NCT02114333|Vaccines|vaccines|mesh-list
15054641|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
15054642|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054643|NCT02114346|Atorvastatin|atorvastatin|mesh-list
15054644|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15054645|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15054646|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
15054647|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054648|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15054649|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15054650|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054651|NCT02114359|Cisplatin|cisplatin|mesh-list
15054652|NCT02114359|Fluorouracil|fluorouracil|mesh-list
15054653|NCT02114359|Capecitabine|capecitabine|mesh-list
15054654|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
15054655|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054656|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
15054657|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054658|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15054659|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15054660|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
15054661|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054662|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
15054663|NCT02114463|Analgesics|analgesics|mesh-list
15054664|NCT02114463|Ropivacaine|ropivacaine|mesh-list
15054665|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
15054666|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
15054667|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054668|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054669|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
15054670|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054671|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15054672|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15054673|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054674|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15054675|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15054676|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054677|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054678|NCT02114476|Progestins|progestins|mesh-list
15054679|NCT02114476|Hormones|hormones|mesh-ancestor
15054680|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054681|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054682|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
15054683|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15054684|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054685|NCT02114502|Pyridoxine|pyridoxine|mesh-list
15054686|NCT02114502|Gemcitabine|gemcitabine|mesh-list
15054687|NCT02114502|Dexamethasone|dexamethasone|mesh-list
15054688|NCT02114502|Melphalan|melphalan|mesh-list
15054689|NCT02114502|Busulfan|busulfan|mesh-list
15054690|NCT02114502|Vorinostat|vorinostat|mesh-list
15054691|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054692|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
15054693|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
15054694|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054695|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054696|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15054697|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
15054698|NCT02114502|Hormones|hormones|mesh-ancestor
15054699|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054700|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15054701|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054702|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15054703|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
15054704|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054705|NCT02114502|Antiviral Agents|antiviral agents|mesh-ancestor
15054706|NCT02114502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054707|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054708|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15054709|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
15054710|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15054711|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
15054712|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15054713|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15054714|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
15054715|NCT02114502|Vitamins|vitamins|mesh-ancestor
15054716|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
15054717|NCT02114528|Amiodarone|amiodarone|mesh-list
15054718|NCT02114528|Sotalol|sotalol|mesh-list
15054719|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
15054720|NCT02114528|Mexiletine|mexiletine|mesh-list
15054721|NCT02114528|Procainamide|procainamide|mesh-list
15054722|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
15054723|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15054724|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15054725|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054726|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15054727|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15054728|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15054729|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054730|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15054731|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15054732|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15054733|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15054734|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15054735|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
15054736|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15054737|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054738|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
15054739|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
15054740|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054741|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15054742|NCT02114645|Leuprolide|leuprolide|mesh-list
15054743|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15054744|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15054745|NCT02114645|Estradiol|estradiol|mesh-list
15054746|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15054747|NCT02114645|Progesterone|progesterone|mesh-list
15054748|NCT02114645|Estrogens|estrogens|mesh-ancestor
15054749|NCT02114645|Hormones|hormones|mesh-ancestor
15054750|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054751|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054752|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15054753|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
15054754|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15054755|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15054756|NCT02114645|Progestins|progestins|mesh-ancestor
15054757|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15054758|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
15054759|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15054760|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054761|NCT02114658|Sorafenib|sorafenib|mesh-list
15054762|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054763|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15054764|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054765|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054766|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
15054767|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15054768|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054769|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15054770|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15054771|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054772|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054773|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054774|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15054775|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15054776|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15054777|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15054778|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15054779|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
15054780|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054781|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15054782|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15054783|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054784|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
15054785|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054786|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
15054787|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15054788|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15054789|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15054790|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054791|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
15054792|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15054793|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054794|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15054795|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054796|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
15054797|NCT02114775|Hormones|hormones|mesh-list
15054798|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054799|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054800|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
15054801|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15054802|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15054803|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054804|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054805|NCT02114775|Urological Agents|urological agents|mesh-ancestor
15054806|NCT02115035|Vemurafenib|vemurafenib|mesh-list
15054807|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054808|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15054809|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054810|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054811|NCT02115087|Morphine|morphine|mesh-list
15054812|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15054813|NCT02115087|Narcotics|narcotics|mesh-ancestor
15054814|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054815|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054816|NCT02115087|Analgesics|analgesics|mesh-ancestor
15054817|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
15054818|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054819|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
15054820|NCT02115152|Fluorouracil|fluorouracil|mesh-list
15054821|NCT02115152|Capecitabine|capecitabine|mesh-list
15054822|NCT02115152|Epirubicin|epirubicin|mesh-list
15054823|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15054824|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
15054825|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054826|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15054827|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15054828|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
15054829|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054830|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054831|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15054832|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
15054833|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15054834|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15054835|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15054836|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15054837|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054838|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
15054839|NCT02115204|Docetaxel|docetaxel|mesh-list
15054840|NCT02115204|Fluorouracil|fluorouracil|mesh-list
15054841|NCT02115204|Methotrexate|methotrexate|mesh-list
15054842|NCT02115204|Epirubicin|epirubicin|mesh-list
15054843|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15054844|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
15054845|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054846|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15054847|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15054848|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
15054849|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054850|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054851|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15054852|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
15054853|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
15054854|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
15054855|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
15054856|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15054857|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15054858|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
15054859|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15054860|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
15054861|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054862|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15054863|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15054864|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15054865|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15054866|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15054867|NCT02115243|Ipilimumab|ipilimumab|mesh-list
15054868|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15054869|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054870|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15054871|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054872|NCT02115360|Calcitonin|calcitonin|mesh-list
15054873|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
15054874|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
15054875|NCT02115360|Fentanyl|fentanyl|mesh-list
15054876|NCT02115360|Katacalcin|katacalcin|mesh-list
15054877|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15054878|NCT02115360|Narcotics|narcotics|mesh-ancestor
15054879|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054880|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054881|NCT02115360|Analgesics|analgesics|mesh-ancestor
15054882|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
15054883|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054884|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15054885|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15054886|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
15054887|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
15054888|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15054889|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15054890|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
15054891|NCT02115464|Metformin|metformin|mesh-list
15054892|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15054893|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054894|NCT02115490|Diphosphonates|diphosphonates|mesh-list
15054895|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15054896|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054897|NCT02115529|Nabilone|nabilone|mesh-list
15054898|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
15054899|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
15054900|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054901|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054902|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15054903|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15054904|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15054905|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15054906|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15054907|NCT02115594|Fulvestrant|fulvestrant|mesh-list
15054908|NCT02115594|Entinostat|entinostat|mesh-list
15054909|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15054910|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054911|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15054912|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15054913|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
15054914|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15054915|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054916|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15054917|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054918|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054919|NCT02115659|Triptolide|triptolide|mesh-list
15054920|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
15054921|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054922|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15054923|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
15054924|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15054925|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15054926|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
15054927|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15054928|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
15054929|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054930|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054931|NCT02115724|Vitamins|vitamins|mesh-list
15054932|NCT02115724|Vitamin E|vitamin e|mesh-list
15054933|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
15054934|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
15054935|NCT02115724|Antioxidants|antioxidants|mesh-list
15054936|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
15054937|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054938|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054939|NCT02115724|Protective Agents|protective agents|mesh-ancestor
15054940|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
15054941|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
15054942|NCT02115763|Caffeine|caffeine|mesh-list
15054943|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15054944|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054945|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15054946|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054947|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054948|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15054949|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15054950|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
15054951|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15054952|NCT02115776|Amoxicillin|amoxicillin|mesh-list
15054953|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
15054954|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
15054955|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
15054956|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15054957|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054958|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15054959|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
15054960|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15054961|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054962|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054963|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
15054964|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
15054965|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15054966|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15054967|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15054968|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15054969|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
15054970|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15054971|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
15054972|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15054973|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
15054974|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15054975|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
15054976|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15054977|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054978|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
15054979|NCT02116231|Cisplatin|cisplatin|mesh-list
15054980|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15054981|NCT02116257|Propacetamol|propacetamol|mesh-list
15054982|NCT02116257|Analgesics|analgesics|mesh-ancestor
15054983|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
15054984|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15054985|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054986|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15054987|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15054988|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15054989|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15054990|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
15054991|NCT02116348|Mitogens|mitogens|mesh-list
15054992|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
15054993|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15054994|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15054995|NCT02116348|Protective Agents|protective agents|mesh-ancestor
15054996|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15054997|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
15054998|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
15054999|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
15055000|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15055001|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055002|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055003|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
15055004|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15055005|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055006|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055007|NCT02116465|Levodopa|levodopa|mesh-list
15055008|NCT02116465|Carbidopa|carbidopa|mesh-list
15055009|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
15055010|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15055011|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15055012|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
15055013|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055014|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055015|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055016|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15055017|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055018|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15055019|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
15055020|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
15055021|NCT02116556|Rifaximin|rifaximin|mesh-list
15055022|NCT02116556|Prednisone|prednisone|mesh-list
15055023|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15055024|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
15055025|NCT02116556|Hormones|hormones|mesh-ancestor
15055026|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15055027|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055028|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15055029|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055030|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15055031|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055032|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15055033|NCT02116569|Daratumumab|daratumumab|mesh-list
15055034|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055035|NCT02116712|Saracatinib|saracatinib|mesh-list
15055036|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055037|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055038|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055039|NCT02116790|Naproxen|naproxen|mesh-list
15055040|NCT02116790|Levodopa|levodopa|mesh-list
15055041|NCT02116790|Carbidopa|carbidopa|mesh-list
15055042|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
15055043|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15055044|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15055045|NCT02116790|Analgesics|analgesics|mesh-ancestor
15055046|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
15055047|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055048|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055049|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15055050|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15055051|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
15055052|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15055053|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055054|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055055|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15055056|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15055057|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
15055058|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055059|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
15055060|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15055061|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
15055062|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
15055063|NCT02116842|Fentanyl|fentanyl|mesh-list
15055064|NCT02116842|Bupivacaine|bupivacaine|mesh-list
15055065|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
15055066|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
15055067|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055068|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055069|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
15055070|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055071|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15055072|NCT02116842|Narcotics|narcotics|mesh-ancestor
15055073|NCT02116842|Analgesics|analgesics|mesh-ancestor
15055074|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15055075|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15055076|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
15055077|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
15055078|NCT02116868|Nicardipine|nicardipine|mesh-list
15055079|NCT02116868|Urapidil|urapidil|mesh-list
15055080|NCT02116868|Remifentanil|remifentanil|mesh-list
15055081|NCT02116868|Esmolol|esmolol|mesh-list
15055082|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15055083|NCT02116868|Narcotics|narcotics|mesh-ancestor
15055084|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055085|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055086|NCT02116868|Analgesics|analgesics|mesh-ancestor
15055087|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
15055088|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055089|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15055090|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15055091|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15055092|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
15055093|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055094|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055095|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15055096|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15055097|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15055098|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
15055099|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15055100|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
15055101|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15055102|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15055103|NCT02116959|Carboplatin|carboplatin|mesh-list
15055104|NCT02116959|Etoposide|etoposide|mesh-list
15055105|NCT02116959|Vincristine|vincristine|mesh-list
15055106|NCT02116959|Melphalan|melphalan|mesh-list
15055107|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055108|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15055109|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15055110|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15055111|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055112|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055113|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
15055114|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
15055115|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
15055116|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15055117|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
15055118|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15055119|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15055120|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
15055121|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055122|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
15055123|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15055124|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15055125|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055126|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
15055127|NCT02117128|Coagulants|coagulants|mesh-ancestor
15055128|NCT02117141|Hydrocodone|hydrocodone|mesh-list
15055129|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15055130|NCT02117141|Narcotics|narcotics|mesh-ancestor
15055131|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055132|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055133|NCT02117141|Analgesics|analgesics|mesh-ancestor
15055134|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
15055135|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055136|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
15055137|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
15055138|NCT02117167|Pemetrexed|pemetrexed|mesh-list
15055139|NCT02117167|Durvalumab|durvalumab|mesh-list
15055140|NCT02117167|Olaparib|olaparib|mesh-list
15055141|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055142|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055143|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055144|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15055145|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15055146|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15055147|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15055148|NCT02117219|Azacitidine|azacitidine|mesh-list
15055149|NCT02117219|Durvalumab|durvalumab|mesh-list
15055150|NCT02117219|Tremelimumab|tremelimumab|mesh-list
15055151|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15055152|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
15055153|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055154|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055155|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055156|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15055157|NCT02117362|Ipilimumab|ipilimumab|mesh-list
15055158|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15055159|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055160|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15055161|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055162|NCT02117401|Midazolam|midazolam|mesh-list
15055163|NCT02117401|Ketamine|ketamine|mesh-list
15055164|NCT02117401|Remifentanil|remifentanil|mesh-list
15055165|NCT02117401|Propofol|propofol|mesh-list
15055166|NCT02117401|Mivacurium|mivacurium|mesh-list
15055167|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15055168|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055169|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055170|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15055171|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
15055172|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
15055173|NCT02117401|Analgesics|analgesics|mesh-ancestor
15055174|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
15055175|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055176|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15055177|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15055178|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15055179|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055180|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055181|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15055182|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15055183|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15055184|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15055185|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
15055186|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
15055187|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15055188|NCT02117401|Narcotics|narcotics|mesh-ancestor
15055189|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15055190|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15055191|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15055192|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15055193|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15055194|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15055195|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
15055196|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055197|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15055198|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15055199|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055200|NCT02117466|Cetuximab|cetuximab|mesh-list
15055201|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15055202|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055203|NCT02117583|Oxycodone|oxycodone|mesh-list
15055204|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15055205|NCT02117583|Narcotics|narcotics|mesh-ancestor
15055206|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055207|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055208|NCT02117583|Analgesics|analgesics|mesh-ancestor
15055209|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
15055210|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055211|NCT02117596|Sirolimus|sirolimus|mesh-list
15055212|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15055213|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055214|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15055215|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055216|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
15055217|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15055218|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
15055219|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055220|NCT02117622|Insulin|insulin|mesh-list
15055221|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15055222|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055223|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
15055224|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15055225|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
15055226|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055227|NCT02117700|Expectorants|expectorants|mesh-ancestor
15055228|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
15055229|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15055230|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
15055231|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055232|NCT02117700|Protective Agents|protective agents|mesh-ancestor
15055233|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055234|NCT02117700|Antidotes|antidotes|mesh-ancestor
15055235|NCT02117726|Midazolam|midazolam|mesh-list
15055236|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
15055237|NCT02117726|Propofol|propofol|mesh-list
15055238|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15055239|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055240|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055241|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15055242|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
15055243|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
15055244|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15055245|NCT02117726|Analgesics|analgesics|mesh-ancestor
15055246|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
15055247|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055248|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15055249|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15055250|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15055251|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
15055252|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055253|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055254|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15055255|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15055256|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15055257|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15055258|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
15055259|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
15055260|NCT02117739|Dapsone|dapsone|mesh-list
15055261|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055262|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
15055263|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15055264|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15055265|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15055266|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055267|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055268|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
15055269|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15055270|NCT02117752|Dapsone|dapsone|mesh-list
15055271|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055272|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
15055273|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15055274|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15055275|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15055276|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055277|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055278|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
15055279|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15055280|NCT02117765|Ustekinumab|ustekinumab|mesh-list
15055281|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
15055282|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
15055283|NCT02117830|Enclomiphene|enclomiphene|mesh-list
15055284|NCT02117830|Clomiphene|clomiphene|mesh-list
15055285|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
15055286|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15055287|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055288|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15055289|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15055290|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055291|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055292|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055293|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15055294|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055295|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15055296|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
15055297|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15055298|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15055299|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
15055300|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15055301|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15055302|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
15055303|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055304|NCT02117869|Furocoumarins|furocoumarins|mesh-list
15055305|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
15055306|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15055307|NCT02117986|Colistin|colistin|mesh-list
15055308|NCT02117986|Polymyxins|polymyxins|mesh-list
15055309|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15055310|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055311|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15055312|NCT02118051|Progesterone|progesterone|mesh-list
15055313|NCT02118051|Ganirelix|ganirelix|mesh-list
15055314|NCT02118051|Progestins|progestins|mesh-ancestor
15055315|NCT02118051|Hormones|hormones|mesh-ancestor
15055316|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15055317|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055318|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
15055319|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15055320|NCT02118064|Irinotecan|irinotecan|mesh-list
15055321|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15055322|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15055323|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055324|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055325|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055326|NCT02118090|Chloroquine|chloroquine|mesh-list
15055327|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
15055328|NCT02118090|Amebicides|amebicides|mesh-ancestor
15055329|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15055330|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15055331|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055332|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
15055333|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15055334|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15055335|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15055336|NCT02118090|Analgesics|analgesics|mesh-ancestor
15055337|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
15055338|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055339|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055340|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15055341|NCT02118090|Filaricides|filaricides|mesh-ancestor
15055342|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
15055343|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
15055344|NCT02118142|Betaine|betaine|mesh-list
15055345|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15055346|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
15055347|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15055348|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
15055349|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055350|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15055351|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
15055352|NCT02118285|Fludarabine|fludarabine|mesh-list
15055353|NCT02118285|Interleukin-2|interleukin-2|mesh-list
15055354|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15055355|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
15055356|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055357|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15055358|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15055359|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
15055360|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055361|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055362|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15055363|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15055364|NCT02118285|Analgesics|analgesics|mesh-ancestor
15055365|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
15055366|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055367|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
15055368|NCT02118311|Fludarabine|fludarabine|mesh-list
15055369|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15055370|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
15055371|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055372|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15055373|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15055374|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
15055375|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055376|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055377|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15055378|NCT02118376|Exenatide|exenatide|mesh-list
15055379|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15055380|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055381|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15055382|NCT02118376|Incretins|incretins|mesh-ancestor
15055383|NCT02118376|Hormones|hormones|mesh-ancestor
15055384|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15055385|NCT02118467|Phenylephrine|phenylephrine|mesh-list
15055386|NCT02118467|Vasopressins|vasopressins|mesh-list
15055387|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
15055388|NCT02118467|Epinephrine|epinephrine|mesh-list
15055389|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
15055390|NCT02118467|Norepinephrine|norepinephrine|mesh-list
15055391|NCT02118467|Synephrine|synephrine|mesh-list
15055392|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15055393|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15055394|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
15055395|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055396|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055397|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055398|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15055399|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15055400|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
15055401|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055402|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15055403|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
15055404|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
15055405|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
15055406|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15055407|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15055408|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
15055409|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15055410|NCT02118467|Protective Agents|protective agents|mesh-ancestor
15055411|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
15055412|NCT02118467|Coagulants|coagulants|mesh-ancestor
15055413|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15055414|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
15055415|NCT02118532|Paclitaxel|paclitaxel|mesh-list
15055416|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15055417|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055418|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
15055419|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
15055420|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
15055421|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055422|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
15055423|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055424|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15055425|NCT02118675|Protective Agents|protective agents|mesh-ancestor
15055426|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055427|NCT02118688|Risperidone|risperidone|mesh-list
15055428|NCT02118688|Trazodone|trazodone|mesh-list
15055429|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15055430|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
15055431|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055432|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055433|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055434|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15055435|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15055436|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055437|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15055438|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15055439|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
15055440|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15055441|NCT02118688|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15055442|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15055443|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15055444|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15055445|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
15055446|NCT02118727|Memantine|memantine|mesh-list
15055447|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15055448|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15055449|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
15055450|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055451|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055452|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055453|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15055454|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15055455|NCT02118753|Eplerenone|eplerenone|mesh-list
15055456|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15055457|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
15055458|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15055459|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055460|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15055461|NCT02118753|Diuretics|diuretics|mesh-ancestor
15055462|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
15055463|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15055464|NCT02118844|Rocuronium|rocuronium|mesh-list
15055465|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15055466|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15055467|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15055468|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055469|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055470|NCT02118870|Aspirin|aspirin|mesh-list
15055471|NCT02118870|Clopidogrel|clopidogrel|mesh-list
15055472|NCT02118870|Ticagrelor|ticagrelor|mesh-list
15055473|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15055474|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15055475|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15055476|NCT02118870|Analgesics|analgesics|mesh-ancestor
15055477|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
15055478|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055479|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055480|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15055481|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15055482|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15055483|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15055484|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055485|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15055486|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15055487|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055488|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
15055489|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15055490|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15055491|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15055492|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
15055493|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055494|NCT02118909|Itraconazole|itraconazole|mesh-list
15055495|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
15055496|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
15055497|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055498|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15055499|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15055500|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055501|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055502|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15055503|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
15055504|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15055505|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055506|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15055507|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15055508|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15055509|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15055510|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055511|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15055512|NCT02118987|Omalizumab|omalizumab|mesh-list
15055513|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15055514|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15055515|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
15055516|NCT02119000|Bisacodyl|bisacodyl|mesh-list
15055517|NCT02119000|Cathartics|cathartics|mesh-ancestor
15055518|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15055519|NCT02119000|Laxatives|laxatives|mesh-ancestor
15055520|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15055521|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15055522|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
15055523|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15055524|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055525|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15055526|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15055527|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055528|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055529|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055530|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
15055531|NCT02119117|Vitamins|vitamins|mesh-ancestor
15055532|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
15055533|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055534|NCT02119143|Vitamins|vitamins|mesh-list
15055535|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
15055536|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055537|NCT02119234|Beclomethasone|beclomethasone|mesh-list
15055538|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
15055539|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
15055540|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15055541|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
15055542|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055543|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055544|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15055545|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
15055546|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15055547|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15055548|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15055549|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
15055550|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055551|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055552|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15055553|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15055554|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15055555|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
15055556|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15055557|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
15055558|NCT02119234|Hormones|hormones|mesh-ancestor
15055559|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15055560|NCT02119273|Prednisone|prednisone|mesh-list
15055561|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15055562|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
15055563|NCT02119273|Hormones|hormones|mesh-ancestor
15055564|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15055565|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055566|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15055567|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055568|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15055569|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15055570|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
15055571|NCT02119416|Caffeine|caffeine|mesh-list
15055572|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15055573|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055574|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15055575|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055576|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055577|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15055578|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15055579|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
15055580|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055581|NCT02119520|Atorvastatin|atorvastatin|mesh-list
15055582|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15055583|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15055584|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
15055585|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055586|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15055587|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15055588|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055589|NCT02119806|Fentanyl|fentanyl|mesh-list
15055590|NCT02119806|Midazolam|midazolam|mesh-list
15055591|NCT02119806|Propofol|propofol|mesh-list
15055592|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15055593|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055594|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055595|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15055596|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
15055597|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
15055598|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15055599|NCT02119806|Narcotics|narcotics|mesh-ancestor
15055600|NCT02119806|Analgesics|analgesics|mesh-ancestor
15055601|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
15055602|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055603|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15055604|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15055605|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15055606|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15055607|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
15055608|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
15055609|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055610|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055611|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15055612|NCT02119884|Octreotide|octreotide|mesh-list
15055613|NCT02119884|Terlipressin|terlipressin|mesh-list
15055614|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15055615|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15055616|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055617|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15055618|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15055619|NCT02120066|Plasminogen|plasminogen|mesh-list
15055620|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15055621|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15055622|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15055623|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055624|NCT02120092|Clopidogrel|clopidogrel|mesh-list
15055625|NCT02120092|Ticagrelor|ticagrelor|mesh-list
15055626|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15055627|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15055628|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15055629|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15055630|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
15055631|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055632|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055633|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055634|NCT02120118|Docetaxel|docetaxel|mesh-list
15055635|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055636|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
15055637|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
15055638|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
15055639|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055640|NCT02120196|Rifaximin|rifaximin|mesh-list
15055641|NCT02120196|Norfloxacin|norfloxacin|mesh-list
15055642|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15055643|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055644|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15055645|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15055646|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15055647|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055648|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055649|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055650|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15055651|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15055652|NCT02120274|Vitamin D|vitamin d|mesh-list
15055653|NCT02120274|Vitamins|vitamins|mesh-list
15055654|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
15055655|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
15055656|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
15055657|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055658|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15055659|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
15055660|NCT02120274|Hematinics|hematinics|mesh-ancestor
15055661|NCT02120339|Carvedilol|carvedilol|mesh-list
15055662|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15055663|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15055664|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
15055665|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055666|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055667|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055668|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15055669|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
15055670|NCT02120339|Protective Agents|protective agents|mesh-ancestor
15055671|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15055672|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15055673|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15055674|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
15055675|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15055676|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15055677|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
15055678|NCT02120404|Esmolol|esmolol|mesh-list
15055679|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15055680|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15055681|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15055682|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
15055683|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055684|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055685|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055686|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
15055687|NCT02120547|Liver Extracts|liver extracts|mesh-list
15055688|NCT02120547|Hematinics|hematinics|mesh-ancestor
15055689|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15055690|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055691|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15055692|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15055693|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
15055694|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055695|NCT02120599|Folic Acid|folic acid|mesh-list
15055696|NCT02120599|Hematinics|hematinics|mesh-ancestor
15055697|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
15055698|NCT02120599|Vitamins|vitamins|mesh-ancestor
15055699|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
15055700|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055701|NCT02120612|Naloxone|naloxone|mesh-list
15055702|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15055703|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055704|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
15055705|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055706|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
15055707|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
15055708|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15055709|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055710|NCT02120651|Hemostatics|hemostatics|mesh-list
15055711|NCT02120651|Coagulants|coagulants|mesh-ancestor
15055712|NCT02120677|Itraconazole|itraconazole|mesh-list
15055713|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
15055714|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055715|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15055716|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15055717|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055718|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055719|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15055720|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
15055721|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15055722|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055723|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15055724|NCT02120703|Pregabalin|pregabalin|mesh-list
15055725|NCT02120703|Gabapentin|gabapentin|mesh-list
15055726|NCT02120703|Analgesics|analgesics|mesh-ancestor
15055727|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
15055728|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055729|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055730|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
15055731|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15055732|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15055733|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055734|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15055735|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15055736|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15055737|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055738|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15055739|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15055740|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15055741|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055742|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
15055743|NCT02120859|Paclitaxel|paclitaxel|mesh-list
15055744|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15055745|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055746|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
15055747|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
15055748|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
15055749|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055750|NCT02120872|Simvastatin|simvastatin|mesh-list
15055751|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15055752|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15055753|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
15055754|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055755|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15055756|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15055757|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055758|NCT02120911|Trastuzumab|trastuzumab|mesh-list
15055759|NCT02120911|Pertuzumab|pertuzumab|mesh-list
15055760|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15055761|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055762|NCT02121119|Lidocaine|lidocaine|mesh-list
15055763|NCT02121119|Bupivacaine|bupivacaine|mesh-list
15055764|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
15055765|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
15055766|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055767|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055768|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
15055769|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055770|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15055771|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15055772|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15055773|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15055774|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055775|NCT02121197|Dexamethasone|dexamethasone|mesh-list
15055776|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15055777|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
15055778|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
15055779|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055780|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055781|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15055782|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
15055783|NCT02121197|Hormones|hormones|mesh-ancestor
15055784|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15055785|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15055786|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055787|NCT02121288|Clopidogrel|clopidogrel|mesh-list
15055788|NCT02121288|Ticagrelor|ticagrelor|mesh-list
15055789|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15055790|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15055791|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15055792|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15055793|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
15055794|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055795|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055796|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055797|NCT02121353|Ranibizumab|ranibizumab|mesh-list
15055798|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15055799|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15055800|NCT02121353|Growth Substances|growth substances|mesh-ancestor
15055801|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055802|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
15055803|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055804|NCT02121366|Ethanol|ethanol|mesh-list
15055805|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15055806|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055807|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055808|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055809|NCT02121444|Interferons|interferons|mesh-list
15055810|NCT02121444|Interferon-beta|interferon-beta|mesh-list
15055811|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
15055812|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055813|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
15055814|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15055815|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
15055816|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055817|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15055818|NCT02121457|Selenium|selenium|mesh-list
15055819|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
15055820|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055821|NCT02121457|Protective Agents|protective agents|mesh-ancestor
15055822|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055823|NCT02121457|Trace Elements|trace elements|mesh-ancestor
15055824|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
15055825|NCT02121613|Tamsulosin|tamsulosin|mesh-list
15055826|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
15055827|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15055828|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15055829|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15055830|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
15055831|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055832|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055833|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055834|NCT02121613|Urological Agents|urological agents|mesh-ancestor
15055835|NCT02121782|Vaccines|vaccines|mesh-list
15055836|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
15055837|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055838|NCT02121951|Lidocaine|lidocaine|mesh-list
15055839|NCT02121951|Fentanyl|fentanyl|mesh-list
15055840|NCT02121951|Midazolam|midazolam|mesh-list
15055841|NCT02121951|Anesthetics|anesthetics|mesh-list
15055842|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
15055843|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
15055844|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15055845|NCT02121951|Narcotics|narcotics|mesh-ancestor
15055846|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055847|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055848|NCT02121951|Analgesics|analgesics|mesh-ancestor
15055849|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
15055850|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055851|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15055852|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15055853|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
15055854|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15055855|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15055856|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15055857|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15055858|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
15055859|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
15055860|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055861|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055862|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15055863|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15055864|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15055865|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15055866|NCT02121990|Paclitaxel|paclitaxel|mesh-list
15055867|NCT02121990|Bevacizumab|bevacizumab|mesh-list
15055868|NCT02121990|Olaparib|olaparib|mesh-list
15055869|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15055870|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055871|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
15055872|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
15055873|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
15055874|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055875|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15055876|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15055877|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15055878|NCT02121990|Growth Substances|growth substances|mesh-ancestor
15055879|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055880|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
15055881|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15055882|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055883|NCT02122003|Sorafenib|sorafenib|mesh-list
15055884|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055885|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15055886|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055887|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055888|NCT02122055|Fentanyl|fentanyl|mesh-list
15055889|NCT02122055|Midazolam|midazolam|mesh-list
15055890|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
15055891|NCT02122055|Propofol|propofol|mesh-list
15055892|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15055893|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055894|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055895|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15055896|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
15055897|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
15055898|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15055899|NCT02122055|Analgesics|analgesics|mesh-ancestor
15055900|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
15055901|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055902|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15055903|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15055904|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15055905|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
15055906|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055907|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055908|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15055909|NCT02122055|Narcotics|narcotics|mesh-ancestor
15055910|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15055911|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15055912|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15055913|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15055914|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
15055915|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
15055916|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
15055917|NCT02122081|Methotrexate|methotrexate|mesh-list
15055918|NCT02122081|Tacrolimus|tacrolimus|mesh-list
15055919|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
15055920|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15055921|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
15055922|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15055923|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
15055924|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055925|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15055926|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15055927|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
15055928|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055929|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055930|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15055931|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15055932|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
15055933|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15055934|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15055935|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
15055936|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
15055937|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055938|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15055939|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15055940|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15055941|NCT02122172|Afatinib|afatinib|mesh-list
15055942|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055943|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15055944|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15055945|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055946|NCT02122185|Metformin|metformin|mesh-list
15055947|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15055948|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055949|NCT02122211|Betaine|betaine|mesh-list
15055950|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15055951|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
15055952|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15055953|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
15055954|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055955|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15055956|NCT02122393|Sertraline|sertraline|mesh-list
15055957|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
15055958|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15055959|NCT02122393|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15055960|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15055961|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15055962|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055963|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055964|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
15055965|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055966|NCT02122484|Colchicine|colchicine|mesh-list
15055967|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
15055968|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15055969|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
15055970|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
15055971|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
15055972|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055973|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15055974|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
15055975|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15055976|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15055977|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055978|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15055979|NCT02122510|Analgesics|analgesics|mesh-ancestor
15055980|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
15055981|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055982|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15055983|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15055984|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15055985|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
15055986|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055987|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055988|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15055989|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15055990|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15055991|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15055992|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15055993|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15055994|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15055995|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15055996|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15055997|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
15055998|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15055999|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
15056000|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15056001|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
15056002|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056003|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
15056004|NCT02122601|Protective Agents|protective agents|mesh-ancestor
15056005|NCT02122627|Vitamin D|vitamin d|mesh-list
15056006|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
15056007|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
15056008|NCT02122627|Vitamins|vitamins|mesh-list
15056009|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
15056010|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056011|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15056012|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15056013|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
15056014|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15056015|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15056016|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056017|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
15056018|NCT02122679|Coagulants|coagulants|mesh-ancestor
15056019|NCT02122692|Itraconazole|itraconazole|mesh-list
15056020|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
15056021|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
15056022|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056023|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15056024|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15056025|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056026|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056027|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15056028|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
15056029|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15056030|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056031|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15056032|NCT02122705|Remifentanil|remifentanil|mesh-list
15056033|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15056034|NCT02122705|Narcotics|narcotics|mesh-ancestor
15056035|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056036|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056037|NCT02122705|Analgesics|analgesics|mesh-ancestor
15056038|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
15056039|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056040|NCT02122731|Amiloride|amiloride|mesh-list
15056041|NCT02122731|Diuretics|diuretics|mesh-ancestor
15056042|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
15056043|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056044|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
15056045|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15056046|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15056047|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056048|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
15056049|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15056050|NCT02122809|Chiauranib|chiauranib|mesh-list
15056051|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056052|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15056053|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056054|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056055|NCT02122939|Citalopram|citalopram|mesh-list
15056056|NCT02122939|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15056057|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15056058|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15056059|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056060|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056061|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
15056062|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056063|NCT02122939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15056064|NCT02122939|Antidepressive Agents|antidepressive agents|mesh-ancestor
15056065|NCT02122939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15056066|NCT02123004|Clopidogrel|clopidogrel|mesh-list
15056067|NCT02123004|Ticagrelor|ticagrelor|mesh-list
15056068|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15056069|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15056070|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15056071|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15056072|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
15056073|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056074|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056075|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056076|NCT02123056|Metoprolol|metoprolol|mesh-list
15056077|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15056078|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15056079|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
15056080|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
15056081|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056082|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056083|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15056084|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15056085|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15056086|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
15056087|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056088|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056089|NCT02123069|Nitroprusside|nitroprusside|mesh-list
15056090|NCT02123069|Phenylephrine|phenylephrine|mesh-list
15056091|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
15056092|NCT02123069|Norepinephrine|norepinephrine|mesh-list
15056093|NCT02123069|Acetylcholine|acetylcholine|mesh-list
15056094|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15056095|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
15056096|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
15056097|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056098|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056099|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
15056100|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15056101|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
15056102|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
15056103|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15056104|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15056105|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15056106|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
15056107|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056108|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056109|NCT02123069|Protective Agents|protective agents|mesh-ancestor
15056110|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15056111|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
15056112|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15056113|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15056114|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
15056115|NCT02123108|Basiliximab|basiliximab|mesh-list
15056116|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15056117|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
15056118|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056119|NCT02123121|Resveratrol|resveratrol|mesh-list
15056120|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
15056121|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056122|NCT02123121|Protective Agents|protective agents|mesh-ancestor
15056123|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056124|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056125|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15056126|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
15056127|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15056128|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056129|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
15056130|NCT02123355|Remifentanil|remifentanil|mesh-list
15056131|NCT02123355|Sevoflurane|sevoflurane|mesh-list
15056132|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
15056133|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
15056134|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056135|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056136|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15056137|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15056138|NCT02123355|Analgesics|analgesics|mesh-ancestor
15056139|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
15056140|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056141|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15056142|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15056143|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15056144|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
15056145|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056146|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056147|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15056148|NCT02123355|Narcotics|narcotics|mesh-ancestor
15056149|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15056150|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15056151|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
15056152|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15056153|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15056154|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15056155|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15056156|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15056157|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
15056158|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
15056159|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15056160|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
15056161|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056162|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
15056163|NCT02123368|Protective Agents|protective agents|mesh-ancestor
15056164|NCT02123381|Cetuximab|cetuximab|mesh-list
15056165|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15056166|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056167|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15056168|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
15056169|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056170|NCT02123498|Omeprazole|omeprazole|mesh-list
15056171|NCT02123498|Pantoprazole|pantoprazole|mesh-list
15056172|NCT02123498|Ranitidine|ranitidine|mesh-list
15056173|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
15056174|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15056175|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15056176|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15056177|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056178|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056179|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15056180|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
15056181|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
15056182|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056183|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056184|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
15056185|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15056186|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
15056187|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15056188|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
15056189|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056190|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056191|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
15056192|NCT02123563|Listerine|listerine|mesh-list
15056193|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15056194|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056195|NCT02123589|Fentanyl|fentanyl|mesh-list
15056196|NCT02123589|Midazolam|midazolam|mesh-list
15056197|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15056198|NCT02123589|Narcotics|narcotics|mesh-ancestor
15056199|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056200|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056201|NCT02123589|Analgesics|analgesics|mesh-ancestor
15056202|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
15056203|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056204|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15056205|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15056206|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
15056207|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
15056208|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15056209|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15056210|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15056211|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15056212|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
15056213|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
15056214|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056215|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056216|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
15056217|NCT02123615|Antibodies|antibodies|mesh-list
15056218|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
15056219|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15056220|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15056221|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
15056222|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
15056223|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056224|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15056225|NCT02123628|Doxycycline|doxycycline|mesh-list
15056226|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
15056227|NCT02123628|Levofloxacin|levofloxacin|mesh-list
15056228|NCT02123628|Rifampin|rifampin|mesh-list
15056229|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
15056230|NCT02123628|Linezolid|linezolid|mesh-list
15056231|NCT02123628|Cefepime|cefepime|mesh-list
15056232|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
15056233|NCT02123628|Cefotaxime|cefotaxime|mesh-list
15056234|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
15056235|NCT02123628|Trimethoprim|trimethoprim|mesh-list
15056236|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
15056237|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056238|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15056239|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
15056240|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
15056241|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15056242|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15056243|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15056244|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15056245|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056246|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056247|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056248|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15056249|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15056250|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15056251|NCT02123628|Renal Agents|renal agents|mesh-ancestor
15056252|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
15056253|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15056254|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15056255|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15056256|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15056257|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15056258|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15056259|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15056260|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15056261|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15056262|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15056263|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15056264|NCT02123654|Asunaprevir|asunaprevir|mesh-list
15056265|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
15056266|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056267|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056268|NCT02123979|Rotigotine|rotigotine|mesh-list
15056269|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
15056270|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
15056271|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056272|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056273|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056274|NCT02124005|Bupivacaine|bupivacaine|mesh-list
15056275|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
15056276|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
15056277|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056278|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056279|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
15056280|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056281|NCT02124070|Hormones|hormones|mesh-list
15056282|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15056283|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056284|NCT02124148|Leucovorin|leucovorin|mesh-list
15056285|NCT02124148|Fluorouracil|fluorouracil|mesh-list
15056286|NCT02124148|Pemetrexed|pemetrexed|mesh-list
15056287|NCT02124148|Cetuximab|cetuximab|mesh-list
15056288|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056289|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
15056290|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056291|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15056292|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15056293|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
15056294|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056295|NCT02124148|Antidotes|antidotes|mesh-ancestor
15056296|NCT02124148|Protective Agents|protective agents|mesh-ancestor
15056297|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
15056298|NCT02124148|Vitamins|vitamins|mesh-ancestor
15056299|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
15056300|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056301|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15056302|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15056303|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15056304|NCT02124174|Azacitidine|azacitidine|mesh-list
15056305|NCT02124174|Valproic Acid|valproic acid|mesh-list
15056306|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15056307|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
15056308|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056309|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056310|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056311|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
15056312|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
15056313|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056314|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056315|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
15056316|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15056317|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056318|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15056319|NCT02124187|Nicotine|nicotine|mesh-list
15056320|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15056321|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
15056322|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056323|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056324|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15056325|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15056326|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
15056327|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056328|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056329|NCT02124200|Nicotine|nicotine|mesh-list
15056330|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15056331|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
15056332|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056333|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056334|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15056335|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15056336|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
15056337|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056338|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056339|NCT02124226|Methotrexate|methotrexate|mesh-list
15056340|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15056341|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
15056342|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15056343|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056344|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15056345|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
15056346|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056347|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056348|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
15056349|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056350|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15056351|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15056352|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
15056353|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15056354|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15056355|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
15056356|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
15056357|NCT02124317|Paclitaxel|paclitaxel|mesh-list
15056358|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15056359|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15056360|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056361|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
15056362|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
15056363|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
15056364|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056365|NCT02124330|Bentonite|bentonite|mesh-list
15056366|NCT02124330|Antidotes|antidotes|mesh-ancestor
15056367|NCT02124330|Protective Agents|protective agents|mesh-ancestor
15056368|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056369|NCT02124369|Gemcitabine|gemcitabine|mesh-list
15056370|NCT02124369|Paclitaxel|paclitaxel|mesh-list
15056371|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15056372|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15056373|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056374|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
15056375|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
15056376|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
15056377|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056378|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15056379|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
15056380|NCT02124369|Antiviral Agents|antiviral agents|mesh-ancestor
15056381|NCT02124369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056382|NCT02124369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056383|NCT02124369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15056384|NCT02124369|Immunologic Factors|immunologic factors|mesh-ancestor
15056385|NCT02124369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056386|NCT02124421|Paclitaxel|paclitaxel|mesh-list
15056387|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15056388|NCT02124421|Carboplatin|carboplatin|mesh-list
15056389|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15056390|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056391|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
15056392|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
15056393|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
15056394|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056395|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
15056396|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15056397|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
15056398|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056399|NCT02124525|Expectorants|expectorants|mesh-ancestor
15056400|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
15056401|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15056402|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
15056403|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056404|NCT02124525|Protective Agents|protective agents|mesh-ancestor
15056405|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056406|NCT02124525|Antidotes|antidotes|mesh-ancestor
15056407|NCT02124642|Folic Acid|folic acid|mesh-list
15056408|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
15056409|NCT02124642|Hematinics|hematinics|mesh-ancestor
15056410|NCT02124642|Vitamins|vitamins|mesh-ancestor
15056411|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
15056412|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056413|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
15056414|NCT02124655|Listerine|listerine|mesh-list
15056415|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15056416|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056417|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
15056418|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
15056419|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
15056420|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15056421|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15056422|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056423|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056424|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056425|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15056426|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15056427|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15056428|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
15056429|NCT02124850|Nivolumab|nivolumab|mesh-list
15056430|NCT02124850|Cetuximab|cetuximab|mesh-list
15056431|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15056432|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056433|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15056434|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056435|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
15056436|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15056437|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
15056438|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056439|NCT02124941|Expectorants|expectorants|mesh-ancestor
15056440|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
15056441|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15056442|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
15056443|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056444|NCT02124941|Protective Agents|protective agents|mesh-ancestor
15056445|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056446|NCT02124941|Antidotes|antidotes|mesh-ancestor
15056447|NCT02124954|Digoxin|digoxin|mesh-list
15056448|NCT02124954|Midazolam|midazolam|mesh-list
15056449|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15056450|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15056451|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056452|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056453|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15056454|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15056455|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15056456|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15056457|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
15056458|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
15056459|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
15056460|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
15056461|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056462|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056463|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15056464|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15056465|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056466|NCT02124954|Protective Agents|protective agents|mesh-ancestor
15056467|NCT02125084|Everolimus|everolimus|mesh-list
15056468|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056469|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15056470|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
15056471|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056472|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
15056473|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
15056474|NCT02125188|Coagulants|coagulants|mesh-ancestor
15056475|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
15056476|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
15056477|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056478|NCT02125201|Fentanyl|fentanyl|mesh-list
15056479|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15056480|NCT02125201|Narcotics|narcotics|mesh-ancestor
15056481|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056482|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056483|NCT02125201|Analgesics|analgesics|mesh-ancestor
15056484|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
15056485|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056486|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15056487|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15056488|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
15056489|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
15056490|NCT02125227|Metformin|metformin|mesh-list
15056491|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15056492|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15056493|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056494|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15056495|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15056496|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
15056497|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056498|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15056499|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15056500|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056501|NCT02125305|Metformin|metformin|mesh-list
15056502|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15056503|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056504|NCT02125318|Anagrelide|anagrelide|mesh-list
15056505|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15056506|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15056507|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056508|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15056509|NCT02125344|Paclitaxel|paclitaxel|mesh-list
15056510|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
15056511|NCT02125344|Carboplatin|carboplatin|mesh-list
15056512|NCT02125344|Doxorubicin|doxorubicin|mesh-list
15056513|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15056514|NCT02125344|Trastuzumab|trastuzumab|mesh-list
15056515|NCT02125344|Epirubicin|epirubicin|mesh-list
15056516|NCT02125344|Pertuzumab|pertuzumab|mesh-list
15056517|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15056518|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056519|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
15056520|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
15056521|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
15056522|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056523|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15056524|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
15056525|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056526|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15056527|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15056528|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
15056529|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15056530|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15056531|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15056532|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15056533|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056534|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15056535|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
15056536|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056537|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15056538|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056539|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056540|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
15056541|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15056542|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056543|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15056544|NCT02125409|Aspirin|aspirin|mesh-list
15056545|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15056546|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15056547|NCT02125409|Analgesics|analgesics|mesh-ancestor
15056548|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
15056549|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056550|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056551|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15056552|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15056553|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15056554|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15056555|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056556|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15056557|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15056558|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056559|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
15056560|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
15056561|NCT02125500|Ledipasvir|ledipasvir|mesh-list
15056562|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
15056563|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056564|NCT02125513|Paclitaxel|paclitaxel|mesh-list
15056565|NCT02125513|Carboplatin|carboplatin|mesh-list
15056566|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15056567|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056568|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
15056569|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
15056570|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
15056571|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056572|NCT02125565|Lidocaine|lidocaine|mesh-list
15056573|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
15056574|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
15056575|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056576|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056577|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
15056578|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056579|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15056580|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15056581|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15056582|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15056583|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056584|NCT02125578|Interferons|interferons|mesh-list
15056585|NCT02125578|Interferon-beta|interferon-beta|mesh-list
15056586|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
15056587|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056588|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
15056589|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056590|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
15056591|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056592|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15056593|NCT02125617|Prednisolone|prednisolone|mesh-list
15056594|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15056595|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
15056596|NCT02125617|Hormones|hormones|mesh-ancestor
15056597|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15056598|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056599|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15056600|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056601|NCT02125630|Hormones|hormones|mesh-list
15056602|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15056603|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056604|NCT02125643|Caffeine|caffeine|mesh-list
15056605|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15056606|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056607|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15056608|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056609|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056610|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15056611|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15056612|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
15056613|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056614|NCT02125682|Atorvastatin|atorvastatin|mesh-list
15056615|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15056616|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15056617|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
15056618|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056619|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15056620|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15056621|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056622|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15056623|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15056624|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056625|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
15056626|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15056627|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056628|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15056629|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15056630|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056631|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056632|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056633|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
15056634|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15056635|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15056636|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056637|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
15056638|NCT02125890|Coagulants|coagulants|mesh-ancestor
15056639|NCT02125903|Ropivacaine|ropivacaine|mesh-list
15056640|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
15056641|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
15056642|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056643|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056644|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
15056645|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056646|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
15056647|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15056648|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15056649|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
15056650|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056651|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056652|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056653|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
15056654|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
15056655|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056656|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
15056657|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15056658|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
15056659|NCT02126020|Infliximab|infliximab|mesh-list
15056660|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
15056661|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15056662|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15056663|NCT02126137|Ezetimibe|ezetimibe|mesh-list
15056664|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15056665|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15056666|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
15056667|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056668|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15056669|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
15056670|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15056671|NCT02126267|Azithromycin|azithromycin|mesh-list
15056672|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15056673|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056674|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
15056675|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
15056676|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15056677|NCT02126293|Zinc|zinc|mesh-list
15056678|NCT02126293|Trace Elements|trace elements|mesh-ancestor
15056679|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
15056680|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056681|NCT02126332|Acetaminophen|acetaminophen|mesh-list
15056682|NCT02126332|Sufentanil|sufentanil|mesh-list
15056683|NCT02126332|Nefopam|nefopam|mesh-list
15056684|NCT02126332|Tramadol|tramadol|mesh-list
15056685|NCT02126332|Ropivacaine|ropivacaine|mesh-list
15056686|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
15056687|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
15056688|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056689|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056690|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
15056691|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056692|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15056693|NCT02126332|Analgesics|analgesics|mesh-ancestor
15056694|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
15056695|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15056696|NCT02126332|Narcotics|narcotics|mesh-ancestor
15056697|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15056698|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15056699|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
15056700|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15056701|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15056702|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15056703|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
15056704|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056705|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15056706|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15056707|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056708|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15056709|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
15056710|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056711|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15056712|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15056713|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
15056714|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056715|NCT02126462|Antacids|antacids|mesh-ancestor
15056716|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056717|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15056718|NCT02126527|Sirolimus|sirolimus|mesh-list
15056719|NCT02126527|Auranofin|auranofin|mesh-list
15056720|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15056721|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056722|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15056723|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056724|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
15056725|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15056726|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
15056727|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056728|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15056729|NCT02126579|Poly ICLC|poly iclc|mesh-list
15056730|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
15056731|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
15056732|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056733|NCT02126644|Glycolic acid|glycolic acid|mesh-list
15056734|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
15056735|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
15056736|NCT02126657|Glycolic acid|glycolic acid|mesh-list
15056737|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
15056738|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
15056739|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
15056740|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
15056741|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15056742|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15056743|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056744|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056745|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056746|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15056747|NCT02126761|Vaccines|vaccines|mesh-list
15056748|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
15056749|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056750|NCT02126917|Ethanol|ethanol|mesh-list
15056751|NCT02126917|Hydrocodone|hydrocodone|mesh-list
15056752|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15056753|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056754|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056755|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056756|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15056757|NCT02126917|Narcotics|narcotics|mesh-ancestor
15056758|NCT02126917|Analgesics|analgesics|mesh-ancestor
15056759|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
15056760|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056761|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
15056762|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
15056763|NCT02126943|Macitentan|macitentan|mesh-list
15056764|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
15056765|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
15056766|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056767|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
15056768|NCT02126956|Ponesimod|ponesimod|mesh-list
15056769|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15056770|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056771|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15056772|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
15056773|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056774|NCT02126995|Metadoxine|metadoxine|mesh-list
15056775|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15056776|NCT02127034|Digoxin|digoxin|mesh-list
15056777|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
15056778|NCT02127034|Mirabegron|mirabegron|mesh-list
15056779|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15056780|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15056781|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056782|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056783|NCT02127034|Protective Agents|protective agents|mesh-ancestor
15056784|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056785|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15056786|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15056787|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
15056788|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056789|NCT02127034|Urological Agents|urological agents|mesh-ancestor
15056790|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15056791|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15056792|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15056793|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
15056794|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15056795|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15056796|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056797|NCT02127047|Incretins|incretins|mesh-ancestor
15056798|NCT02127047|Hormones|hormones|mesh-ancestor
15056799|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15056800|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15056801|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
15056802|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056803|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056804|NCT02127060|Ascorbic Acid|ascorbic acid|mesh-list
15056805|NCT02127060|Vitamins|vitamins|mesh-ancestor
15056806|NCT02127060|Micronutrients|micronutrients|mesh-ancestor
15056807|NCT02127060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056808|NCT02127060|Antioxidants|antioxidants|mesh-ancestor
15056809|NCT02127060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056810|NCT02127060|Protective Agents|protective agents|mesh-ancestor
15056811|NCT02127073|Oxytocin|oxytocin|mesh-list
15056812|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
15056813|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15056814|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056815|NCT02127138|Sirolimus|sirolimus|mesh-list
15056816|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15056817|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056818|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15056819|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056820|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
15056821|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15056822|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
15056823|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056824|NCT02127151|Talazoparib|talazoparib|mesh-list
15056825|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15056826|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056827|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056828|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056829|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15056830|NCT02127164|Eusol|eusol|mesh-list
15056831|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
15056832|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056833|NCT02127190|CXA-10|cxa-10|mesh-list
15056834|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15056835|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15056836|NCT02127320|Ezetimibe|ezetimibe|mesh-list
15056837|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15056838|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15056839|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
15056840|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056841|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15056842|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15056843|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056844|NCT02127437|Lanreotide|lanreotide|mesh-list
15056845|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056846|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15056847|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15056848|NCT02127489|Bupivacaine|bupivacaine|mesh-list
15056849|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
15056850|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
15056851|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056852|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056853|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
15056854|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056855|NCT02127541|Exenatide|exenatide|mesh-list
15056856|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15056857|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056858|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15056859|NCT02127541|Incretins|incretins|mesh-ancestor
15056860|NCT02127541|Hormones|hormones|mesh-ancestor
15056861|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15056862|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
15056863|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15056864|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15056865|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15056866|NCT02127593|Norgestimate|norgestimate|mesh-list
15056867|NCT02127593|Norgestrel|norgestrel|mesh-list
15056868|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15056869|NCT02127593|Estradiol|estradiol|mesh-list
15056870|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15056871|NCT02127593|Estrogens|estrogens|mesh-ancestor
15056872|NCT02127593|Hormones|hormones|mesh-ancestor
15056873|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15056874|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056875|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15056876|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
15056877|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15056878|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15056879|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15056880|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15056881|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15056882|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15056883|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056884|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15056885|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15056886|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056887|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056888|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056889|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15056890|NCT02127684|Ranibizumab|ranibizumab|mesh-list
15056891|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15056892|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15056893|NCT02127684|Growth Substances|growth substances|mesh-ancestor
15056894|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056895|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
15056896|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056897|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
15056898|NCT02127697|Albuterol|albuterol|mesh-list
15056899|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15056900|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
15056901|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056902|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056903|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15056904|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
15056905|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
15056906|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15056907|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15056908|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15056909|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15056910|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
15056911|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056912|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056913|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15056914|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15056915|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15056916|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
15056917|NCT02127736|Amitriptyline|amitriptyline|mesh-list
15056918|NCT02127736|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15056919|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15056920|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
15056921|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15056922|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15056923|NCT02127736|Analgesics|analgesics|mesh-ancestor
15056924|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
15056925|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056926|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056927|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15056928|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15056929|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15056930|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056931|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
15056932|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056933|NCT02127736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15056934|NCT02127736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15056935|NCT02127736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056936|NCT02127749|Metronidazole|metronidazole|mesh-list
15056937|NCT02127749|Vancomycin|vancomycin|mesh-list
15056938|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
15056939|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056940|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15056941|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15056942|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15056943|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15056944|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15056945|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15056946|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056947|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15056948|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15056949|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15056950|NCT02127775|Lesinurad|lesinurad|mesh-list
15056951|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
15056952|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15056953|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
15056954|NCT02127775|Renal Agents|renal agents|mesh-ancestor
15056955|NCT02127788|Micafungin|micafungin|mesh-list
15056956|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
15056957|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15056958|NCT02127840|Epinephrine|epinephrine|mesh-list
15056959|NCT02127840|Racepinephrine|racepinephrine|mesh-list
15056960|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
15056961|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15056962|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15056963|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
15056964|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056965|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056966|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056967|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15056968|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15056969|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
15056970|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056971|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15056972|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
15056973|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
15056974|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
15056975|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15056976|NCT02127853|Gabapentin|gabapentin|mesh-list
15056977|NCT02127853|Analgesics|analgesics|mesh-ancestor
15056978|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
15056979|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056980|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056981|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
15056982|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15056983|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15056984|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15056985|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15056986|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15056987|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15056988|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15056989|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15056990|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
15056991|NCT02127866|Beclomethasone|beclomethasone|mesh-list
15056992|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
15056993|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
15056994|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15056995|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
15056996|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15056997|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15056998|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15056999|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
15057000|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15057001|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15057002|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15057003|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
15057004|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15057005|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057006|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15057007|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15057008|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15057009|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
15057010|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15057011|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
15057012|NCT02127866|Hormones|hormones|mesh-ancestor
15057013|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057014|NCT02127918|Clobazam|clobazam|mesh-list
15057015|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
15057016|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15057017|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15057018|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15057019|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057020|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15057021|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15057022|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
15057023|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
15057024|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15057025|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057026|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15057027|NCT02127996|Incretins|incretins|mesh-ancestor
15057028|NCT02127996|Hormones|hormones|mesh-ancestor
15057029|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057030|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057031|NCT02128022|Glyburide|glyburide|mesh-list
15057032|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15057033|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057034|NCT02128061|Rituximab|rituximab|mesh-list
15057035|NCT02128061|Lenalidomide|lenalidomide|mesh-list
15057036|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15057037|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057038|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
15057039|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057040|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15057041|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15057042|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15057043|NCT02128061|Growth Substances|growth substances|mesh-ancestor
15057044|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
15057045|NCT02128100|Leucovorin|leucovorin|mesh-list
15057046|NCT02128100|Fluorouracil|fluorouracil|mesh-list
15057047|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
15057048|NCT02128100|Irinotecan|irinotecan|mesh-list
15057049|NCT02128100|Folfirinox|folfirinox|mesh-list
15057050|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
15057051|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057052|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15057053|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057054|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057055|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
15057056|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057057|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15057058|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15057059|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057060|NCT02128100|Antidotes|antidotes|mesh-ancestor
15057061|NCT02128100|Protective Agents|protective agents|mesh-ancestor
15057062|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
15057063|NCT02128100|Vitamins|vitamins|mesh-ancestor
15057064|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
15057065|NCT02128126|Vaccines|vaccines|mesh-list
15057066|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
15057067|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057068|NCT02128178|Enoxaparin|enoxaparin|mesh-list
15057069|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
15057070|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
15057071|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15057072|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15057073|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057074|NCT02128191|Ibuprofen|ibuprofen|mesh-list
15057075|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15057076|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15057077|NCT02128191|Analgesics|analgesics|mesh-ancestor
15057078|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
15057079|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057080|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057081|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15057082|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15057083|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15057084|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057085|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057086|NCT02128204|Lidocaine|lidocaine|mesh-list
15057087|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
15057088|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
15057089|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15057090|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057091|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
15057092|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057093|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15057094|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15057095|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15057096|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15057097|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057098|NCT02128243|Leucovorin|leucovorin|mesh-list
15057099|NCT02128243|Cisplatin|cisplatin|mesh-list
15057100|NCT02128243|Docetaxel|docetaxel|mesh-list
15057101|NCT02128243|Fluorouracil|fluorouracil|mesh-list
15057102|NCT02128243|Capecitabine|capecitabine|mesh-list
15057103|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
15057104|NCT02128243|Epirubicin|epirubicin|mesh-list
15057105|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
15057106|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057107|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
15057108|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
15057109|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
15057110|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057111|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
15057112|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15057113|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057114|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
15057115|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057116|NCT02128243|Antidotes|antidotes|mesh-ancestor
15057117|NCT02128243|Protective Agents|protective agents|mesh-ancestor
15057118|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
15057119|NCT02128243|Vitamins|vitamins|mesh-ancestor
15057120|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
15057121|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15057122|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15057123|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15057124|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057125|NCT02128282|Gemcitabine|gemcitabine|mesh-list
15057126|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057127|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15057128|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
15057129|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057130|NCT02128282|Antiviral Agents|antiviral agents|mesh-ancestor
15057131|NCT02128282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057132|NCT02128282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057133|NCT02128282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057134|NCT02128282|Immunologic Factors|immunologic factors|mesh-ancestor
15057135|NCT02128282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057136|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
15057137|NCT02128308|Levofloxacin|levofloxacin|mesh-list
15057138|NCT02128308|Ofloxacin|ofloxacin|mesh-list
15057139|NCT02128308|Cycloserine|cycloserine|mesh-list
15057140|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
15057141|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
15057142|NCT02128308|Streptomycin|streptomycin|mesh-list
15057143|NCT02128308|Kanamycin|kanamycin|mesh-list
15057144|NCT02128308|Prothionamide|prothionamide|mesh-list
15057145|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15057146|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15057147|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057148|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15057149|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15057150|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057151|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057152|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057153|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15057154|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
15057155|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15057156|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057157|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15057158|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15057159|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15057160|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15057161|NCT02128308|Renal Agents|renal agents|mesh-ancestor
15057162|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15057163|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15057164|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15057165|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
15057166|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
15057167|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15057168|NCT02128321|Repaglinide|repaglinide|mesh-list
15057169|NCT02128321|Isavuconazole|isavuconazole|mesh-list
15057170|NCT02128321|Caffeine|caffeine|mesh-list
15057171|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15057172|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057173|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15057174|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057175|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057176|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15057177|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15057178|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
15057179|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15057180|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15057181|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
15057182|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057183|NCT02128334|Leuprolide|leuprolide|mesh-list
15057184|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15057185|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
15057186|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15057187|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057188|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15057189|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057190|NCT02128360|Letrozole|letrozole|mesh-list
15057191|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057192|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15057193|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15057194|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057195|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057196|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15057197|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
15057198|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057199|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057200|NCT02128425|Leucovorin|leucovorin|mesh-list
15057201|NCT02128425|Fluorouracil|fluorouracil|mesh-list
15057202|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
15057203|NCT02128425|Irinotecan|irinotecan|mesh-list
15057204|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
15057205|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
15057206|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057207|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15057208|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057209|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057210|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
15057211|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057212|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15057213|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15057214|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057215|NCT02128425|Antidotes|antidotes|mesh-ancestor
15057216|NCT02128425|Protective Agents|protective agents|mesh-ancestor
15057217|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
15057218|NCT02128425|Vitamins|vitamins|mesh-ancestor
15057219|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
15057220|NCT02128451|Fentanyl|fentanyl|mesh-list
15057221|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15057222|NCT02128451|Narcotics|narcotics|mesh-ancestor
15057223|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15057224|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057225|NCT02128451|Analgesics|analgesics|mesh-ancestor
15057226|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
15057227|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057228|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15057229|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15057230|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
15057231|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
15057232|NCT02128633|Listerine|listerine|mesh-list
15057233|NCT02128633|Fluorides|fluorides|mesh-list
15057234|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
15057235|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
15057236|NCT02128633|Protective Agents|protective agents|mesh-ancestor
15057237|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057238|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15057239|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057240|NCT02128646|Ketorolac|ketorolac|mesh-list
15057241|NCT02128646|Bupivacaine|bupivacaine|mesh-list
15057242|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
15057243|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
15057244|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15057245|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057246|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
15057247|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057248|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15057249|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15057250|NCT02128646|Analgesics|analgesics|mesh-ancestor
15057251|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15057252|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15057253|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15057254|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057255|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057256|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
15057257|NCT02128685|Progestins|progestins|mesh-ancestor
15057258|NCT02128685|Hormones|hormones|mesh-ancestor
15057259|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057260|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057261|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
15057262|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15057263|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
15057264|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15057265|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
15057266|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057267|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057268|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
15057269|NCT02128893|Isavuconazole|isavuconazole|mesh-list
15057270|NCT02128893|Esomeprazole|esomeprazole|mesh-list
15057271|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15057272|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15057273|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15057274|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057275|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057276|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
15057277|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057278|NCT02128906|Docetaxel|docetaxel|mesh-list
15057279|NCT02128906|Cetuximab|cetuximab|mesh-list
15057280|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057281|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
15057282|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
15057283|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
15057284|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057285|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15057286|NCT02128945|Fludarabine|fludarabine|mesh-list
15057287|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057288|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
15057289|NCT02128971|Trace Elements|trace elements|mesh-ancestor
15057290|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
15057291|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057292|NCT02128984|Antioxidants|antioxidants|mesh-list
15057293|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057294|NCT02128984|Protective Agents|protective agents|mesh-ancestor
15057295|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057296|NCT02129088|Esketamine|esketamine|mesh-list
15057297|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
15057298|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15057299|NCT02129101|Azacitidine|azacitidine|mesh-list
15057300|NCT02129101|Decitabine|decitabine|mesh-list
15057301|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15057302|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
15057303|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057304|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057305|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057306|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15057307|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15057308|NCT02129114|Estradiol|estradiol|mesh-list
15057309|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15057310|NCT02129114|Estrogens|estrogens|mesh-ancestor
15057311|NCT02129114|Hormones|hormones|mesh-ancestor
15057312|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057313|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057314|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15057315|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
15057316|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15057317|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15057318|NCT02129127|Paclitaxel|paclitaxel|mesh-list
15057319|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15057320|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057321|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
15057322|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
15057323|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
15057324|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057325|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
15057326|NCT02129166|Dasatinib|dasatinib|mesh-list
15057327|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057328|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15057329|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057330|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057331|NCT02129179|Glucagon|glucagon|mesh-list
15057332|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15057333|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15057334|NCT02129179|Hormones|hormones|mesh-ancestor
15057335|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057336|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057337|NCT02129179|Incretins|incretins|mesh-ancestor
15057338|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
15057339|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15057340|NCT02129231|Simvastatin|simvastatin|mesh-list
15057341|NCT02129231|Ezetimibe|ezetimibe|mesh-list
15057342|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
15057343|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15057344|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15057345|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
15057346|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057347|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15057348|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15057349|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057350|NCT02129231|Antacids|antacids|mesh-ancestor
15057351|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15057352|NCT02129257|Leucovorin|leucovorin|mesh-list
15057353|NCT02129257|Folic Acid|folic acid|mesh-list
15057354|NCT02129257|Fluorouracil|fluorouracil|mesh-list
15057355|NCT02129257|Irinotecan|irinotecan|mesh-list
15057356|NCT02129257|Aflibercept|aflibercept|mesh-list
15057357|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
15057358|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
15057359|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057360|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15057361|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057362|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057363|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
15057364|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057365|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15057366|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15057367|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057368|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15057369|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15057370|NCT02129257|Growth Substances|growth substances|mesh-ancestor
15057371|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
15057372|NCT02129257|Antidotes|antidotes|mesh-ancestor
15057373|NCT02129257|Protective Agents|protective agents|mesh-ancestor
15057374|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
15057375|NCT02129257|Vitamins|vitamins|mesh-ancestor
15057376|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
15057377|NCT02129257|Hematinics|hematinics|mesh-ancestor
15057378|NCT02129270|Lidocaine|lidocaine|mesh-list
15057379|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
15057380|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
15057381|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15057382|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057383|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
15057384|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057385|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15057386|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15057387|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15057388|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15057389|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057390|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
15057391|NCT02129322|Sorafenib|sorafenib|mesh-list
15057392|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057393|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15057394|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057395|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057396|NCT02129400|Anesthetics|anesthetics|mesh-list
15057397|NCT02129400|Xenon|xenon|mesh-list
15057398|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15057399|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057400|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15057401|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
15057402|NCT02129582|Methotrexate|methotrexate|mesh-list
15057403|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
15057404|NCT02129582|Fludarabine|fludarabine|mesh-list
15057405|NCT02129582|Busulfan|busulfan|mesh-list
15057406|NCT02129582|Tacrolimus|tacrolimus|mesh-list
15057407|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
15057408|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15057409|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
15057410|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15057411|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
15057412|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15057413|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057414|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15057415|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
15057416|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057417|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057418|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
15057419|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057420|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15057421|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057422|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
15057423|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15057424|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15057425|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15057426|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
15057427|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15057428|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15057429|NCT02129595|Resveratrol|resveratrol|mesh-list
15057430|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
15057431|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057432|NCT02129595|Protective Agents|protective agents|mesh-ancestor
15057433|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057434|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057435|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15057436|NCT02129621|Spironolactone|spironolactone|mesh-list
15057437|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15057438|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
15057439|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057440|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057441|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15057442|NCT02129621|Diuretics|diuretics|mesh-ancestor
15057443|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
15057444|NCT02129634|Paclitaxel|paclitaxel|mesh-list
15057445|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15057446|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057447|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
15057448|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
15057449|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
15057450|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057451|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15057452|NCT02129673|Latanoprost|latanoprost|mesh-list
15057453|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15057454|NCT02129699|Denosumab|denosumab|mesh-list
15057455|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15057456|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057457|NCT02129764|Prednisone|prednisone|mesh-list
15057458|NCT02129764|Allopurinol|allopurinol|mesh-list
15057459|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15057460|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
15057461|NCT02129764|Hormones|hormones|mesh-ancestor
15057462|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057463|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057464|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15057465|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057466|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
15057467|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057468|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057469|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
15057470|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15057471|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15057472|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
15057473|NCT02129764|Protective Agents|protective agents|mesh-ancestor
15057474|NCT02129829|Tenofovir|tenofovir|mesh-list
15057475|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
15057476|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057477|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15057478|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15057479|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057480|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057481|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15057482|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15057483|NCT02129933|Bevacizumab|bevacizumab|mesh-list
15057484|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15057485|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057486|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15057487|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15057488|NCT02129933|Growth Substances|growth substances|mesh-ancestor
15057489|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057490|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
15057491|NCT02129985|Metformin|metformin|mesh-list
15057492|NCT02129985|Exenatide|exenatide|mesh-list
15057493|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15057494|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057495|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15057496|NCT02129985|Incretins|incretins|mesh-ancestor
15057497|NCT02129985|Hormones|hormones|mesh-ancestor
15057498|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057499|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15057500|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15057501|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057502|NCT02130167|Atropine|atropine|mesh-list
15057503|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15057504|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15057505|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15057506|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
15057507|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057508|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057509|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15057510|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
15057511|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
15057512|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
15057513|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15057514|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15057515|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
15057516|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15057517|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057518|NCT02130323|Imiquimod|imiquimod|mesh-list
15057519|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15057520|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
15057521|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057522|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057523|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
15057524|NCT02130414|Cyclosporine|cyclosporine|mesh-list
15057525|NCT02130414|Cyclosporins|cyclosporins|mesh-list
15057526|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057527|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057528|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057529|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
15057530|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057531|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
15057532|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057533|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
15057534|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15057535|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15057536|NCT02130440|Resveratrol|resveratrol|mesh-list
15057537|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
15057538|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057539|NCT02130440|Protective Agents|protective agents|mesh-ancestor
15057540|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057541|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057542|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15057543|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
15057544|NCT02130466|Trametinib|trametinib|mesh-list
15057545|NCT02130466|Dabrafenib|dabrafenib|mesh-list
15057546|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15057547|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057548|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15057549|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057550|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057551|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15057552|NCT02130661|Itraconazole|itraconazole|mesh-list
15057553|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
15057554|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057555|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15057556|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15057557|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057558|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057559|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15057560|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
15057561|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057562|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057563|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15057564|NCT02130700|Seviteronel|seviteronel|mesh-list
15057565|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057566|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15057567|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057568|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057569|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
15057570|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15057571|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057572|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15057573|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057574|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057575|NCT02130739|Fentanyl|fentanyl|mesh-list
15057576|NCT02130739|Propofol|propofol|mesh-list
15057577|NCT02130739|Ropivacaine|ropivacaine|mesh-list
15057578|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
15057579|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15057580|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057581|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15057582|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15057583|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
15057584|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
15057585|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
15057586|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057587|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15057588|NCT02130739|Narcotics|narcotics|mesh-ancestor
15057589|NCT02130739|Analgesics|analgesics|mesh-ancestor
15057590|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15057591|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
15057592|NCT02130804|Salicylates|salicylates|mesh-list
15057593|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15057594|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15057595|NCT02130804|Analgesics|analgesics|mesh-ancestor
15057596|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
15057597|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057598|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057599|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15057600|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15057601|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15057602|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057603|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057604|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
15057605|NCT02130817|Dexamethasone|dexamethasone|mesh-list
15057606|NCT02130817|Prednisone|prednisone|mesh-list
15057607|NCT02130817|Abatacept|abatacept|mesh-list
15057608|NCT02130817|Tacrolimus|tacrolimus|mesh-list
15057609|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
15057610|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15057611|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
15057612|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15057613|NCT02130817|Antibodies|antibodies|mesh-list
15057614|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
15057615|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
15057616|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15057617|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15057618|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
15057619|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
15057620|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057621|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057622|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15057623|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
15057624|NCT02130817|Hormones|hormones|mesh-ancestor
15057625|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057626|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15057627|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057628|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057629|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057630|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057631|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
15057632|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15057633|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15057634|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15057635|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
15057636|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15057637|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057638|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15057639|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15057640|NCT02130830|Lidocaine|lidocaine|mesh-list
15057641|NCT02130830|Prilocaine|prilocaine|mesh-list
15057642|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
15057643|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
15057644|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15057645|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057646|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
15057647|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057648|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15057649|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15057650|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15057651|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15057652|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057653|NCT02130869|Cytarabine|cytarabine|mesh-list
15057654|NCT02130869|Aldesleukin|aldesleukin|mesh-list
15057655|NCT02130869|Carboplatin|carboplatin|mesh-list
15057656|NCT02130869|Etoposide|etoposide|mesh-list
15057657|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
15057658|NCT02130869|Melphalan|melphalan|mesh-list
15057659|NCT02130869|Busulfan|busulfan|mesh-list
15057660|NCT02130869|Interleukin-2|interleukin-2|mesh-list
15057661|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15057662|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
15057663|NCT02130869|Sargramostim|sargramostim|mesh-list
15057664|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057665|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15057666|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15057667|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15057668|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057669|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057670|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15057671|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
15057672|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
15057673|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057674|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057675|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
15057676|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057677|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15057678|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
15057679|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15057680|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15057681|NCT02130869|Analgesics|analgesics|mesh-ancestor
15057682|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
15057683|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057684|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15057685|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15057686|NCT02130973|Denosumab|denosumab|mesh-list
15057687|NCT02130973|Teriparatide|teriparatide|mesh-list
15057688|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15057689|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057690|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15057691|NCT02131012|Celecoxib|celecoxib|mesh-list
15057692|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15057693|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15057694|NCT02131012|Analgesics|analgesics|mesh-ancestor
15057695|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
15057696|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057697|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057698|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15057699|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15057700|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15057701|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15057702|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057703|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057704|NCT02131220|Tirofiban|tirofiban|mesh-list
15057705|NCT02131220|Saruplase|saruplase|mesh-list
15057706|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15057707|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15057708|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057709|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15057710|NCT02131246|Insulin|insulin|mesh-list
15057711|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15057712|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
15057713|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
15057714|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15057715|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15057716|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057717|NCT02131298|Itraconazole|itraconazole|mesh-list
15057718|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
15057719|NCT02131298|Palbociclib|palbociclib|mesh-list
15057720|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057721|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15057722|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057723|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057724|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
15057725|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057726|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15057727|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15057728|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15057729|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
15057730|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057731|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057732|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15057733|NCT02131350|Ranibizumab|ranibizumab|mesh-list
15057734|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15057735|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15057736|NCT02131350|Growth Substances|growth substances|mesh-ancestor
15057737|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057738|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
15057739|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057740|NCT02131480|Doxorubicin|doxorubicin|mesh-list
15057741|NCT02131480|Trabectedin|trabectedin|mesh-list
15057742|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15057743|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057744|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15057745|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15057746|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057747|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057748|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15057749|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
15057750|NCT02131506|Lapatinib|lapatinib|mesh-list
15057751|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15057752|NCT02131506|Doxorubicin|doxorubicin|mesh-list
15057753|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057754|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15057755|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057756|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057757|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15057758|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15057759|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15057760|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15057761|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
15057762|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15057763|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15057764|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15057765|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15057766|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057767|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
15057768|NCT02131688|Analgesics|analgesics|mesh-ancestor
15057769|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
15057770|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057771|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057772|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057773|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15057774|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15057775|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057776|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057777|NCT02131753|Cladribine|cladribine|mesh-list
15057778|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057779|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057780|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
15057781|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057782|NCT02131818|Amoxicillin|amoxicillin|mesh-list
15057783|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15057784|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057785|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
15057786|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15057787|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057788|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
15057789|NCT02131948|Insulin|insulin|mesh-list
15057790|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
15057791|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15057792|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057793|NCT02132000|Tamoxifen|tamoxifen|mesh-list
15057794|NCT02132000|Toremifene|toremifene|mesh-list
15057795|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15057796|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
15057797|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057798|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057799|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15057800|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057801|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15057802|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15057803|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15057804|NCT02132026|Denosumab|denosumab|mesh-list
15057805|NCT02132026|Alendronate|alendronate|mesh-list
15057806|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15057807|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057808|NCT02132091|Vitamins|vitamins|mesh-list
15057809|NCT02132091|Ascorbic Acid|ascorbic acid|mesh-list
15057810|NCT02132091|Vitamin E|vitamin e|mesh-list
15057811|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
15057812|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057813|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
15057814|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057815|NCT02132091|Protective Agents|protective agents|mesh-ancestor
15057816|NCT02132104|Hormones|hormones|mesh-list
15057817|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057818|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057819|NCT02132234|Adalimumab|adalimumab|mesh-list
15057820|NCT02132234|Etanercept|etanercept|mesh-list
15057821|NCT02132234|Infliximab|infliximab|mesh-list
15057822|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
15057823|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15057824|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15057825|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
15057826|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15057827|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15057828|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15057829|NCT02132234|Analgesics|analgesics|mesh-ancestor
15057830|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
15057831|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057832|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057833|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057834|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
15057835|NCT02132260|Naftifine|naftifine|mesh-list
15057836|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
15057837|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057838|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15057839|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
15057840|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15057841|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15057842|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15057843|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15057844|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057845|NCT02132390|Toremifene|toremifene|mesh-list
15057846|NCT02132390|Goserelin|goserelin|mesh-list
15057847|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15057848|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057849|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15057850|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15057851|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
15057852|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057853|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057854|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15057855|NCT02132403|Gemcitabine|gemcitabine|mesh-list
15057856|NCT02132403|Milk fat globule|milk fat globule|mesh-list
15057857|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15057858|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
15057859|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057860|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057861|NCT02132403|Antiviral Agents|antiviral agents|mesh-ancestor
15057862|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057863|NCT02132403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057864|NCT02132403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057865|NCT02132403|Immunologic Factors|immunologic factors|mesh-ancestor
15057866|NCT02132403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057867|NCT02132416|Acetaminophen|acetaminophen|mesh-list
15057868|NCT02132416|Ibuprofen|ibuprofen|mesh-list
15057869|NCT02132416|Diclofenac|diclofenac|mesh-list
15057870|NCT02132416|Morphine|morphine|mesh-list
15057871|NCT02132416|Oxycodone|oxycodone|mesh-list
15057872|NCT02132416|Tramadol|tramadol|mesh-list
15057873|NCT02132416|Anesthetics|anesthetics|mesh-list
15057874|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15057875|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057876|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15057877|NCT02132416|Narcotics|narcotics|mesh-ancestor
15057878|NCT02132416|Analgesics|analgesics|mesh-ancestor
15057879|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
15057880|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057881|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15057882|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15057883|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15057884|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15057885|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15057886|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057887|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057888|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
15057889|NCT02132442|Vitamin D|vitamin d|mesh-list
15057890|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
15057891|NCT02132442|Vitamins|vitamins|mesh-ancestor
15057892|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
15057893|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057894|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15057895|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15057896|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
15057897|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15057898|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057899|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
15057900|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
15057901|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15057902|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
15057903|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057904|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15057905|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
15057906|NCT02132689|Heparin|heparin|mesh-list
15057907|NCT02132689|Calcium heparin|calcium heparin|mesh-list
15057908|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15057909|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057910|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
15057911|NCT02132897|Carbamazepine|carbamazepine|mesh-list
15057912|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
15057913|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
15057914|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15057915|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15057916|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057917|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15057918|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15057919|NCT02132897|Analgesics|analgesics|mesh-ancestor
15057920|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
15057921|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057922|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15057923|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15057924|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057925|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15057926|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15057927|NCT02133014|Fluorouracil|fluorouracil|mesh-list
15057928|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
15057929|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057930|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15057931|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057932|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057933|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
15057934|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057935|NCT02133053|Beclomethasone|beclomethasone|mesh-list
15057936|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15057937|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
15057938|NCT02133053|Hormones|hormones|mesh-ancestor
15057939|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15057940|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057941|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15057942|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
15057943|NCT02133079|Vaccines|vaccines|mesh-list
15057944|NCT02133079|Immunologic Factors|immunologic factors|mesh-ancestor
15057945|NCT02133079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057946|NCT02133105|Simendan|simendan|mesh-list
15057947|NCT02133105|Dobutamine|dobutamine|mesh-list
15057948|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15057949|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
15057950|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15057951|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15057952|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057953|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057954|NCT02133105|Protective Agents|protective agents|mesh-ancestor
15057955|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057956|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
15057957|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
15057958|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057959|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
15057960|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15057961|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15057962|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
15057963|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15057964|NCT02133118|Pioglitazone|pioglitazone|mesh-list
15057965|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15057966|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057967|NCT02133287|Sirolimus|sirolimus|mesh-list
15057968|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
15057969|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15057970|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15057971|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15057972|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15057973|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
15057974|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15057975|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
15057976|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057977|NCT02133326|Acetaminophen|acetaminophen|mesh-list
15057978|NCT02133326|Ibuprofen|ibuprofen|mesh-list
15057979|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15057980|NCT02133326|Analgesics|analgesics|mesh-ancestor
15057981|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
15057982|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15057983|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057984|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
15057985|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15057986|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15057987|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15057988|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15057989|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15057990|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15057991|NCT02133378|Hemostatics|hemostatics|mesh-list
15057992|NCT02133378|Coagulants|coagulants|mesh-ancestor
15057993|NCT02133404|Cinacalcet|cinacalcet|mesh-list
15057994|NCT02133404|ASP7991|asp7991|mesh-list
15057995|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15057996|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15057997|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
15057998|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
15057999|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15058000|NCT02133469|Vaccines|vaccines|mesh-list
15058001|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15058002|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
15058003|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058004|NCT02133612|Paclitaxel|paclitaxel|mesh-list
15058005|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15058006|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15058007|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058008|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
15058009|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
15058010|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
15058011|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058012|NCT02133625|Pioglitazone|pioglitazone|mesh-list
15058013|NCT02133625|Carboplatin|carboplatin|mesh-list
15058014|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058015|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15058016|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058017|NCT02133638|Propofol|propofol|mesh-list
15058018|NCT02133638|Sevoflurane|sevoflurane|mesh-list
15058019|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15058020|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058021|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058022|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15058023|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
15058024|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
15058025|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15058026|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15058027|NCT02133677|Temozolomide|temozolomide|mesh-list
15058028|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15058029|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
15058030|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058031|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058032|NCT02133755|Bromocriptine|bromocriptine|mesh-list
15058033|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15058034|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15058035|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
15058036|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15058037|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058038|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
15058039|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
15058040|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058041|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058042|NCT02133820|Analgesics|analgesics|mesh-list
15058043|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
15058044|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058045|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058046|NCT02133885|Minocycline|minocycline|mesh-list
15058047|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15058048|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15058049|NCT02133911|Ranolazine|ranolazine|mesh-list
15058050|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15058051|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15058052|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058053|NCT02133924|Prednisone|prednisone|mesh-list
15058054|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
15058055|NCT02133924|Natalizumab|natalizumab|mesh-list
15058056|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15058057|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
15058058|NCT02133924|Hormones|hormones|mesh-ancestor
15058059|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15058060|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058061|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15058062|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058063|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
15058064|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
15058065|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058066|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15058067|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15058068|NCT02133924|Protective Agents|protective agents|mesh-ancestor
15058069|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
15058070|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15058071|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
15058072|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058073|NCT02133989|Ticlopidine|ticlopidine|mesh-list
15058074|NCT02133989|Clopidogrel|clopidogrel|mesh-list
15058075|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15058076|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15058077|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15058078|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15058079|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
15058080|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058081|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058082|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058083|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15058084|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15058085|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15058086|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15058087|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058088|NCT02134002|Disulfiram|disulfiram|mesh-list
15058089|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15058090|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
15058091|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058092|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058093|NCT02134067|Paclitaxel|paclitaxel|mesh-list
15058094|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15058095|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058096|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
15058097|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
15058098|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
15058099|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058100|NCT02134093|Midazolam|midazolam|mesh-list
15058101|NCT02134093|Sufentanil|sufentanil|mesh-list
15058102|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
15058103|NCT02134093|Remifentanil|remifentanil|mesh-list
15058104|NCT02134093|Anesthetics|anesthetics|mesh-list
15058105|NCT02134093|Propofol|propofol|mesh-list
15058106|NCT02134093|Etomidate|etomidate|mesh-list
15058107|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
15058108|NCT02134093|Rocuronium|rocuronium|mesh-list
15058109|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058110|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058111|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15058112|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15058113|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
15058114|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15058115|NCT02134093|Analgesics|analgesics|mesh-ancestor
15058116|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
15058117|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058118|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15058119|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15058120|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15058121|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
15058122|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058123|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058124|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15058125|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15058126|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15058127|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15058128|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
15058129|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
15058130|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15058131|NCT02134093|Narcotics|narcotics|mesh-ancestor
15058132|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15058133|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15058134|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15058135|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15058136|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15058137|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
15058138|NCT02134106|Polymyxins|polymyxins|mesh-list
15058139|NCT02134106|Doripenem|doripenem|mesh-list
15058140|NCT02134106|Polymyxin B|polymyxin b|mesh-list
15058141|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15058142|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15058143|NCT02134249|Cabergoline|cabergoline|mesh-list
15058144|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15058145|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15058146|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
15058147|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
15058148|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058149|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058150|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058151|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
15058152|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15058153|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15058154|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
15058155|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058156|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15058157|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15058158|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
15058159|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058160|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058161|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15058162|NCT02134288|Everolimus|everolimus|mesh-list
15058163|NCT02134288|Abatacept|abatacept|mesh-list
15058164|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058165|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15058166|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
15058167|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058168|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15058169|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058170|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15058171|NCT02134327|Midazolam|midazolam|mesh-list
15058172|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
15058173|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15058174|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058175|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058176|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15058177|NCT02134327|Analgesics|analgesics|mesh-ancestor
15058178|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
15058179|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058180|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15058181|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15058182|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15058183|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
15058184|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058185|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058186|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15058187|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15058188|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15058189|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15058190|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15058191|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
15058192|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
15058193|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
15058194|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
15058195|NCT02134366|Lorazepam|lorazepam|mesh-list
15058196|NCT02134366|Clonazepam|clonazepam|mesh-list
15058197|NCT02134366|Clobazam|clobazam|mesh-list
15058198|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
15058199|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
15058200|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
15058201|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058202|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058203|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15058204|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15058205|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058206|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15058207|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15058208|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15058209|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
15058210|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
15058211|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058212|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058213|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15058214|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
15058215|NCT02134379|Clotrimazole|clotrimazole|mesh-list
15058216|NCT02134379|Miconazole|miconazole|mesh-list
15058217|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15058218|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15058219|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
15058220|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15058221|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15058222|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058223|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058224|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15058225|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
15058226|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15058227|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058228|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15058229|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15058230|NCT02134405|Esomeprazole|esomeprazole|mesh-list
15058231|NCT02134405|Rebamipide|rebamipide|mesh-list
15058232|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15058233|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15058234|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15058235|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058236|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058237|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
15058238|NCT02134405|Protective Agents|protective agents|mesh-ancestor
15058239|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058240|NCT02134457|Ranibizumab|ranibizumab|mesh-list
15058241|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15058242|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15058243|NCT02134457|Growth Substances|growth substances|mesh-ancestor
15058244|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058245|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
15058246|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058247|NCT02134470|Testosterone|testosterone|mesh-list
15058248|NCT02134470|Androgens|androgens|mesh-ancestor
15058249|NCT02134470|Hormones|hormones|mesh-ancestor
15058250|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15058251|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058252|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
15058253|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15058254|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058255|NCT02134626|Simvastatin|simvastatin|mesh-list
15058256|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15058257|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15058258|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
15058259|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058260|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15058261|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15058262|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058263|NCT02134639|Edotreotide|edotreotide|mesh-list
15058264|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15058265|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058266|NCT02134717|Maraviroc|maraviroc|mesh-list
15058267|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15058268|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15058269|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058270|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15058271|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15058272|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
15058273|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15058274|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15058275|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15058276|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058277|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15058278|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058279|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058280|NCT02134899|Everolimus|everolimus|mesh-list
15058281|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
15058282|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058283|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15058284|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
15058285|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058286|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058287|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058288|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
15058289|NCT02134938|Cathartics|cathartics|mesh-ancestor
15058290|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15058291|NCT02134964|Dapansutrile|dapansutrile|mesh-list
15058292|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15058293|NCT02134990|Docetaxel|docetaxel|mesh-list
15058294|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058295|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
15058296|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
15058297|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
15058298|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058299|NCT02135029|Atorvastatin|atorvastatin|mesh-list
15058300|NCT02135029|Bococizumab|bococizumab|mesh-list
15058301|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15058302|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15058303|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
15058304|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058305|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15058306|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15058307|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058308|NCT02135055|Midazolam|midazolam|mesh-list
15058309|NCT02135055|Morphine|morphine|mesh-list
15058310|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15058311|NCT02135055|Narcotics|narcotics|mesh-ancestor
15058312|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058313|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058314|NCT02135055|Analgesics|analgesics|mesh-ancestor
15058315|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
15058316|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058317|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15058318|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15058319|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15058320|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15058321|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15058322|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15058323|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
15058324|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
15058325|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
15058326|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
15058327|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058328|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058329|NCT02135120|Morphine|morphine|mesh-list
15058330|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058331|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058332|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15058333|NCT02135120|Narcotics|narcotics|mesh-ancestor
15058334|NCT02135120|Analgesics|analgesics|mesh-ancestor
15058335|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
15058336|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058337|NCT02135133|Ofatumumab|ofatumumab|mesh-list
15058338|NCT02135133|Idelalisib|idelalisib|mesh-list
15058339|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058340|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058341|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058342|NCT02135224|Fentanyl|fentanyl|mesh-list
15058343|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15058344|NCT02135224|Narcotics|narcotics|mesh-ancestor
15058345|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058346|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058347|NCT02135224|Analgesics|analgesics|mesh-ancestor
15058348|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
15058349|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058350|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15058351|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15058352|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
15058353|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
15058354|NCT02135263|Enalapril|enalapril|mesh-list
15058355|NCT02135263|Methylphenidate|methylphenidate|mesh-list
15058356|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15058357|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058358|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15058359|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15058360|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15058361|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058362|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
15058363|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058364|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15058365|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
15058366|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058367|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15058368|NCT02135315|Antihypertensive Agents|antihypertensive agents|mesh-list
15058369|NCT02135315|Labetalol|labetalol|mesh-list
15058370|NCT02135315|Nicardipine|nicardipine|mesh-list
15058371|NCT02135315|Isosorbide|isosorbide|mesh-list
15058372|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15058373|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15058374|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15058375|NCT02135315|Diuretics|diuretics|mesh-ancestor
15058376|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
15058377|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058378|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
15058379|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15058380|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058381|NCT02135315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15058382|NCT02135315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15058383|NCT02135315|Adrenergic Agents|adrenergic agents|mesh-ancestor
15058384|NCT02135315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058385|NCT02135315|Sympathomimetics|sympathomimetics|mesh-ancestor
15058386|NCT02135315|Autonomic Agents|autonomic agents|mesh-ancestor
15058387|NCT02135315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058388|NCT02135315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15058389|NCT02135315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15058390|NCT02135315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15058391|NCT02135315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15058392|NCT02135315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15058393|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
15058394|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15058395|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15058396|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15058397|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15058398|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15058399|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058400|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
15058401|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058402|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058403|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15058404|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058405|NCT02135354|Azithromycin|azithromycin|mesh-list
15058406|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15058407|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15058408|NCT02135393|Folic Acid|folic acid|mesh-list
15058409|NCT02135393|Hematinics|hematinics|mesh-ancestor
15058410|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
15058411|NCT02135393|Vitamins|vitamins|mesh-ancestor
15058412|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
15058413|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058414|NCT02135419|Fluorouracil|fluorouracil|mesh-list
15058415|NCT02135419|Imiquimod|imiquimod|mesh-list
15058416|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
15058417|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058418|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15058419|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058420|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15058421|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
15058422|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058423|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15058424|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
15058425|NCT02135510|Palonosetron|palonosetron|mesh-list
15058426|NCT02135510|Metoclopramide|metoclopramide|mesh-list
15058427|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
15058428|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
15058429|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058430|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058431|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15058432|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15058433|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15058434|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
15058435|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058436|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058437|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15058438|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15058439|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
15058440|NCT02135588|Plasminogen|plasminogen|mesh-list
15058441|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15058442|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15058443|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15058444|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058445|NCT02135627|Epinephrine|epinephrine|mesh-list
15058446|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15058447|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15058448|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
15058449|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058450|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058451|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058452|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15058453|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15058454|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
15058455|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058456|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15058457|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
15058458|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
15058459|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
15058460|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15058461|NCT02135640|Denosumab|denosumab|mesh-list
15058462|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15058463|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058464|NCT02135770|Heparin|heparin|mesh-list
15058465|NCT02135770|Calcium heparin|calcium heparin|mesh-list
15058466|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
15058467|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15058468|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15058469|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058470|NCT02135822|Gemcitabine|gemcitabine|mesh-list
15058471|NCT02135822|Paclitaxel|paclitaxel|mesh-list
15058472|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15058473|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15058474|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058475|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
15058476|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
15058477|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
15058478|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058479|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15058480|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
15058481|NCT02135822|Antiviral Agents|antiviral agents|mesh-ancestor
15058482|NCT02135822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15058483|NCT02135822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058484|NCT02135822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15058485|NCT02135822|Immunologic Factors|immunologic factors|mesh-ancestor
15058486|NCT02135822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058487|NCT02135874|Cytarabine|cytarabine|mesh-list
15058488|NCT02135874|Dexamethasone|dexamethasone|mesh-list
15058489|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
15058490|NCT02135874|Rituximab|rituximab|mesh-list
15058491|NCT02135874|Vincristine|vincristine|mesh-list
15058492|NCT02135874|Sorafenib|sorafenib|mesh-list
15058493|NCT02135874|Idarubicin|idarubicin|mesh-list
15058494|NCT02135874|Clofarabine|clofarabine|mesh-list
15058495|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15058496|NCT02135874|Antibodies|antibodies|mesh-list
15058497|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
15058498|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15058499|NCT02135874|BB 1101|bb 1101|mesh-list
15058500|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
15058501|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058502|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15058503|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
15058504|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
15058505|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058506|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15058507|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
15058508|NCT02135874|Hormones|hormones|mesh-ancestor
15058509|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15058510|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15058511|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058512|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
15058513|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058514|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058515|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15058516|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15058517|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
15058518|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
15058519|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15058520|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15058521|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15058522|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
15058523|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
15058524|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
15058525|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15058526|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15058527|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15058528|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15058529|NCT02135887|Leucovorin|leucovorin|mesh-list
15058530|NCT02135887|Folic Acid|folic acid|mesh-list
15058531|NCT02135887|Fluorouracil|fluorouracil|mesh-list
15058532|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
15058533|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
15058534|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
15058535|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058536|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15058537|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058538|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15058539|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
15058540|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058541|NCT02135887|Antidotes|antidotes|mesh-ancestor
15058542|NCT02135887|Protective Agents|protective agents|mesh-ancestor
15058543|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
15058544|NCT02135887|Vitamins|vitamins|mesh-ancestor
15058545|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
15058546|NCT02135887|Hematinics|hematinics|mesh-ancestor
15058547|NCT02135913|Vitamin D|vitamin d|mesh-list
15058548|NCT02135913|Vitamins|vitamins|mesh-ancestor
15058549|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
15058550|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058551|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15058552|NCT02135965|Caffeine|caffeine|mesh-list
15058553|NCT02135965|Albuterol|albuterol|mesh-list
15058554|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15058555|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058556|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15058557|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058558|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058559|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15058560|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15058561|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
15058562|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058563|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15058564|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
15058565|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058566|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15058567|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
15058568|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
15058569|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15058570|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15058571|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15058572|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15058573|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
15058574|NCT02136030|Amphotericin B|amphotericin b|mesh-list
15058575|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
15058576|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
15058577|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
15058578|NCT02136030|Amebicides|amebicides|mesh-ancestor
15058579|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15058580|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15058581|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15058582|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15058583|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
15058584|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15058585|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15058586|NCT02136147|Guanfacine|guanfacine|mesh-list
15058587|NCT02136147|Methylphenidate|methylphenidate|mesh-list
15058588|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15058589|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15058590|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15058591|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058592|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15058593|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15058594|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15058595|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058596|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
15058597|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058598|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15058599|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
15058600|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15058601|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15058602|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15058603|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15058604|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15058605|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
15058606|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
15058607|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15058608|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15058609|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058610|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058611|NCT02136329|Urological Agents|urological agents|mesh-ancestor
15058612|NCT02136511|Rituximab|rituximab|mesh-list
15058613|NCT02136511|Idelalisib|idelalisib|mesh-list
15058614|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15058615|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058616|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
15058617|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058618|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15058619|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058620|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058621|NCT02136589|Diclofenac|diclofenac|mesh-list
15058622|NCT02136589|Travoprost|travoprost|mesh-list
15058623|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15058624|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15058625|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15058626|NCT02136589|Analgesics|analgesics|mesh-ancestor
15058627|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
15058628|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058629|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058630|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15058631|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15058632|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15058633|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058634|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058635|NCT02136641|Fentanyl|fentanyl|mesh-list
15058636|NCT02136641|Midazolam|midazolam|mesh-list
15058637|NCT02136641|Ketamine|ketamine|mesh-list
15058638|NCT02136641|Analgesics|analgesics|mesh-ancestor
15058639|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
15058640|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058641|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058642|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15058643|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15058644|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
15058645|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
15058646|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058647|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15058648|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15058649|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058650|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058651|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15058652|NCT02136641|Narcotics|narcotics|mesh-ancestor
15058653|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15058654|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15058655|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15058656|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15058657|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15058658|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
15058659|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
15058660|NCT02136693|Psyllium|psyllium|mesh-list
15058661|NCT02136693|Cathartics|cathartics|mesh-ancestor
15058662|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15058663|NCT02136771|Vitamin D|vitamin d|mesh-list
15058664|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
15058665|NCT02136771|Vitamins|vitamins|mesh-ancestor
15058666|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
15058667|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058668|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15058669|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15058670|NCT02136784|Morphine|morphine|mesh-list
15058671|NCT02136784|Oxycodone|oxycodone|mesh-list
15058672|NCT02136784|Buprenorphine|buprenorphine|mesh-list
15058673|NCT02136784|Hydromorphone|hydromorphone|mesh-list
15058674|NCT02136784|Hydrocodone|hydrocodone|mesh-list
15058675|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15058676|NCT02136784|Narcotics|narcotics|mesh-ancestor
15058677|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058678|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058679|NCT02136784|Analgesics|analgesics|mesh-ancestor
15058680|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
15058681|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058682|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15058683|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
15058684|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
15058685|NCT02136823|Isradipine|isradipine|mesh-list
15058686|NCT02136823|Riluzole|riluzole|mesh-list
15058687|NCT02136823|Memantine|memantine|mesh-list
15058688|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15058689|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15058690|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
15058691|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058692|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058693|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058694|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15058695|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15058696|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
15058697|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15058698|NCT02136823|Protective Agents|protective agents|mesh-ancestor
15058699|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15058700|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15058701|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15058702|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15058703|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
15058704|NCT02136875|Fluticasone|fluticasone|mesh-list
15058705|NCT02136875|Xhance|xhance|mesh-list
15058706|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15058707|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15058708|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15058709|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
15058710|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058711|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058712|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15058713|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
15058714|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
15058715|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15058716|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15058717|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15058718|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15058719|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
15058720|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058721|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058722|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
15058723|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15058724|NCT02136888|Ponesimod|ponesimod|mesh-list
15058725|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15058726|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15058727|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15058728|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15058729|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058730|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058731|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058732|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15058733|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
15058734|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15058735|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058736|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15058737|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15058738|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15058739|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15058740|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15058741|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
15058742|NCT02136979|Propofol|propofol|mesh-list
15058743|NCT02136979|Sevoflurane|sevoflurane|mesh-list
15058744|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15058745|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058746|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058747|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15058748|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
15058749|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
15058750|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15058751|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15058752|NCT02136992|Pirfenidone|pirfenidone|mesh-list
15058753|NCT02136992|Analgesics|analgesics|mesh-ancestor
15058754|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
15058755|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058756|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058757|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15058758|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15058759|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15058760|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15058761|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058762|NCT02137083|Docetaxel|docetaxel|mesh-list
15058763|NCT02137083|Fulvestrant|fulvestrant|mesh-list
15058764|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058765|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
15058766|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
15058767|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
15058768|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058769|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15058770|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15058771|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15058772|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
15058773|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15058774|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058775|NCT02137109|Natalizumab|natalizumab|mesh-list
15058776|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
15058777|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058778|NCT02137161|Tobramycin|tobramycin|mesh-list
15058779|NCT02137161|Dexamethasone|dexamethasone|mesh-list
15058780|NCT02137161|Bromfenac|bromfenac|mesh-list
15058781|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15058782|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15058783|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
15058784|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
15058785|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058786|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058787|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15058788|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
15058789|NCT02137161|Hormones|hormones|mesh-ancestor
15058790|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15058791|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15058792|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058793|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15058794|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15058795|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15058796|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15058797|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15058798|NCT02137161|Analgesics|analgesics|mesh-ancestor
15058799|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
15058800|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15058801|NCT02137213|Naloxone|naloxone|mesh-list
15058802|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15058803|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058804|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
15058805|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058806|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
15058807|NCT02137239|Prednisone|prednisone|mesh-list
15058808|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
15058809|NCT02137239|Everolimus|everolimus|mesh-list
15058810|NCT02137239|Abatacept|abatacept|mesh-list
15058811|NCT02137239|Tacrolimus|tacrolimus|mesh-list
15058812|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
15058813|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15058814|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
15058815|NCT02137239|Hormones|hormones|mesh-ancestor
15058816|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15058817|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058818|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15058819|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058820|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15058821|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
15058822|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15058823|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058824|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058825|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15058826|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15058827|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
15058828|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15058829|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15058830|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
15058831|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
15058832|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058833|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15058834|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15058835|NCT02137239|Protective Agents|protective agents|mesh-ancestor
15058836|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15058837|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15058838|NCT02137265|Clomiphene|clomiphene|mesh-list
15058839|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15058840|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
15058841|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15058842|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058843|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15058844|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
15058845|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15058846|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15058847|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15058848|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
15058849|NCT02137278|Levodopa|levodopa|mesh-list
15058850|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
15058851|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
15058852|NCT02137278|Diuretics|diuretics|mesh-list
15058853|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15058854|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
15058855|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058856|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
15058857|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058858|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058859|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15058860|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15058861|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15058862|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058863|NCT02137356|Capecitabine|capecitabine|mesh-list
15058864|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15058865|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
15058866|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058867|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058868|NCT02137395|Dexamethasone|dexamethasone|mesh-list
15058869|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15058870|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
15058871|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
15058872|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058873|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058874|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15058875|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
15058876|NCT02137395|Hormones|hormones|mesh-ancestor
15058877|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15058878|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15058879|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058880|NCT02137421|Resveratrol|resveratrol|mesh-list
15058881|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
15058882|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058883|NCT02137421|Protective Agents|protective agents|mesh-ancestor
15058884|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058885|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058886|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15058887|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
15058888|NCT02137434|Calcium|calcium|mesh-list
15058889|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15058890|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058891|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15058892|NCT02137525|Fentanyl|fentanyl|mesh-list
15058893|NCT02137525|Morphine|morphine|mesh-list
15058894|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15058895|NCT02137525|Narcotics|narcotics|mesh-ancestor
15058896|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058897|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058898|NCT02137525|Analgesics|analgesics|mesh-ancestor
15058899|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
15058900|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058901|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15058902|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15058903|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
15058904|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
15058905|NCT02137616|Olanzapine|olanzapine|mesh-list
15058906|NCT02137616|Risperidone|risperidone|mesh-list
15058907|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15058908|NCT02137616|Aripiprazole|aripiprazole|mesh-list
15058909|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15058910|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
15058911|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058912|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058913|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058914|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15058915|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15058916|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058917|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15058918|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15058919|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
15058920|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
15058921|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
15058922|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058923|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15058924|NCT02137616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15058925|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15058926|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15058927|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
15058928|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
15058929|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15058930|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15058931|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15058932|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15058933|NCT02137629|Azacitidine|azacitidine|mesh-list
15058934|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15058935|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
15058936|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058937|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058938|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058939|NCT02137668|Vancomycin|vancomycin|mesh-list
15058940|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15058941|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15058942|NCT02137681|Rituximab|rituximab|mesh-list
15058943|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15058944|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058945|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
15058946|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058947|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15058948|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15058949|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15058950|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058951|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15058952|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
15058953|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058954|NCT02137733|Carvedilol|carvedilol|mesh-list
15058955|NCT02137733|Bisoprolol|bisoprolol|mesh-list
15058956|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15058957|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15058958|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
15058959|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058960|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058961|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058962|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15058963|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
15058964|NCT02137733|Protective Agents|protective agents|mesh-ancestor
15058965|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15058966|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15058967|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15058968|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
15058969|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15058970|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15058971|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
15058972|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
15058973|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058974|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15058975|NCT02137759|Temozolomide|temozolomide|mesh-list
15058976|NCT02137759|Belinostat|belinostat|mesh-list
15058977|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15058978|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
15058979|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058980|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15058981|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15058982|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15058983|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
15058984|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15058985|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15058986|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15058987|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15058988|NCT02137863|Analgesics|analgesics|mesh-ancestor
15058989|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
15058990|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15058991|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15058992|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15058993|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15058994|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
15058995|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15058996|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15058997|NCT02137928|Carboplatin|carboplatin|mesh-list
15058998|NCT02137928|Etoposide|etoposide|mesh-list
15058999|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
15059000|NCT02137928|Vincristine|vincristine|mesh-list
15059001|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059002|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15059003|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15059004|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15059005|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059006|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059007|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
15059008|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
15059009|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
15059010|NCT02137954|Lidocaine|lidocaine|mesh-list
15059011|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
15059012|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
15059013|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059014|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059015|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
15059016|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059017|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15059018|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15059019|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15059020|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15059021|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059022|NCT02137993|Olanzapine|olanzapine|mesh-list
15059023|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
15059024|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
15059025|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059026|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059027|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15059028|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15059029|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15059030|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059031|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15059032|NCT02137993|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15059033|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15059034|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15059035|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059036|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059037|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
15059038|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15059039|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
15059040|NCT02138019|Coagulants|coagulants|mesh-ancestor
15059041|NCT02138045|Liraglutide|liraglutide|mesh-list
15059042|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15059043|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059044|NCT02138045|Incretins|incretins|mesh-ancestor
15059045|NCT02138045|Hormones|hormones|mesh-ancestor
15059046|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15059047|NCT02138058|Topiramate|topiramate|mesh-list
15059048|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
15059049|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15059050|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059051|NCT02138084|Ritonavir|ritonavir|mesh-list
15059052|NCT02138084|Fostemsavir|fostemsavir|mesh-list
15059053|NCT02138084|Rifabutin|rifabutin|mesh-list
15059054|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15059055|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15059056|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
15059057|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059058|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059059|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15059060|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15059061|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
15059062|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15059063|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15059064|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15059065|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15059066|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15059067|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
15059068|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15059069|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15059070|NCT02138292|Trametinib|trametinib|mesh-list
15059071|NCT02138292|Digoxin|digoxin|mesh-list
15059072|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059073|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15059074|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059075|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059076|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15059077|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15059078|NCT02138292|Protective Agents|protective agents|mesh-ancestor
15059079|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059080|NCT02138357|Buprenorphine|buprenorphine|mesh-list
15059081|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15059082|NCT02138357|Narcotics|narcotics|mesh-ancestor
15059083|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059084|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059085|NCT02138357|Analgesics|analgesics|mesh-ancestor
15059086|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
15059087|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059088|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15059089|NCT02138383|Gemcitabine|gemcitabine|mesh-list
15059090|NCT02138383|Paclitaxel|paclitaxel|mesh-list
15059091|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15059092|NCT02138383|Androgens|androgens|mesh-list
15059093|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15059094|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059095|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
15059096|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
15059097|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
15059098|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059099|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15059100|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
15059101|NCT02138383|Antiviral Agents|antiviral agents|mesh-ancestor
15059102|NCT02138383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15059103|NCT02138383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059104|NCT02138383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15059105|NCT02138383|Immunologic Factors|immunologic factors|mesh-ancestor
15059106|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059107|NCT02138383|Hormones|hormones|mesh-ancestor
15059108|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15059109|NCT02138396|Fentanyl|fentanyl|mesh-list
15059110|NCT02138396|Naltrexone|naltrexone|mesh-list
15059111|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15059112|NCT02138396|Narcotics|narcotics|mesh-ancestor
15059113|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059114|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059115|NCT02138396|Analgesics|analgesics|mesh-ancestor
15059116|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
15059117|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059118|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15059119|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15059120|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
15059121|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
15059122|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15059123|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15059124|NCT02138409|Fentanyl|fentanyl|mesh-list
15059125|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15059126|NCT02138409|Narcotics|narcotics|mesh-ancestor
15059127|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059128|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059129|NCT02138409|Analgesics|analgesics|mesh-ancestor
15059130|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
15059131|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059132|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15059133|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15059134|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
15059135|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
15059136|NCT02138500|PF-06372865|pf-06372865|mesh-list
15059137|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
15059138|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
15059139|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059140|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059141|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059142|NCT02138539|Hydroquinone|hydroquinone|mesh-list
15059143|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
15059144|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059145|NCT02138539|Protective Agents|protective agents|mesh-ancestor
15059146|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059147|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15059148|NCT02138552|Octenidine|octenidine|mesh-list
15059149|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15059150|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15059151|NCT02138617|Leucovorin|leucovorin|mesh-list
15059152|NCT02138617|Bevacizumab|bevacizumab|mesh-list
15059153|NCT02138617|Fluorouracil|fluorouracil|mesh-list
15059154|NCT02138617|Irinotecan|irinotecan|mesh-list
15059155|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
15059156|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15059157|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059158|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15059159|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15059160|NCT02138617|Growth Substances|growth substances|mesh-ancestor
15059161|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059162|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
15059163|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
15059164|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059165|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15059166|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15059167|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
15059168|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15059169|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15059170|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059171|NCT02138617|Antidotes|antidotes|mesh-ancestor
15059172|NCT02138617|Protective Agents|protective agents|mesh-ancestor
15059173|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
15059174|NCT02138617|Vitamins|vitamins|mesh-ancestor
15059175|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
15059176|NCT02138630|Capsaicin|capsaicin|mesh-list
15059177|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
15059178|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
15059179|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
15059180|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059181|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059182|NCT02138708|Adenosine|adenosine|mesh-list
15059183|NCT02138708|Acetylcholine|acetylcholine|mesh-list
15059184|NCT02138708|Analgesics|analgesics|mesh-ancestor
15059185|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
15059186|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059187|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059188|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15059189|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
15059190|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15059191|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
15059192|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
15059193|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059194|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059195|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15059196|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
15059197|NCT02138773|Tamsulosin|tamsulosin|mesh-list
15059198|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15059199|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15059200|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15059201|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
15059202|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059203|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059204|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059205|NCT02138773|Urological Agents|urological agents|mesh-ancestor
15059206|NCT02138799|Rifampin|rifampin|mesh-list
15059207|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15059208|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
15059209|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15059210|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15059211|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
15059212|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15059213|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059214|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059215|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15059216|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15059217|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15059218|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15059219|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15059220|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15059221|NCT02138812|Paclitaxel|paclitaxel|mesh-list
15059222|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15059223|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059224|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
15059225|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
15059226|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
15059227|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059228|NCT02138929|Everolimus|everolimus|mesh-list
15059229|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059230|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15059231|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
15059232|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059233|NCT02138955|Curcumin|curcumin|mesh-list
15059234|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15059235|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15059236|NCT02138955|Analgesics|analgesics|mesh-ancestor
15059237|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
15059238|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059239|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059240|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15059241|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15059242|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059243|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059244|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059245|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15059246|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
15059247|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15059248|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15059249|NCT02139098|Amitriptyline|amitriptyline|mesh-list
15059250|NCT02139098|Zolpidem|zolpidem|mesh-list
15059251|NCT02139098|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15059252|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15059253|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15059254|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059255|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059256|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15059257|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
15059258|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
15059259|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059260|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059261|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15059262|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
15059263|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15059264|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15059265|NCT02139098|Analgesics|analgesics|mesh-ancestor
15059266|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
15059267|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059268|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15059269|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15059270|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15059271|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
15059272|NCT02139098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15059273|NCT02139098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15059274|NCT02139241|Ramosetron|ramosetron|mesh-list
15059275|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
15059276|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
15059277|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059278|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059279|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15059280|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15059281|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
15059282|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059283|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059284|NCT02139267|Vaccines|vaccines|mesh-list
15059285|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
15059286|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059287|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
15059288|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15059289|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15059290|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059291|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
15059292|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059293|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059294|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15059295|NCT02139579|Bevacizumab|bevacizumab|mesh-list
15059296|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15059297|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059298|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15059299|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15059300|NCT02139579|Growth Substances|growth substances|mesh-ancestor
15059301|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059302|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
15059303|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15059304|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
15059305|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15059306|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
15059307|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
15059308|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
15059309|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059310|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
15059311|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15059312|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15059313|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15059314|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15059315|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059316|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15059317|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059318|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15059319|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15059320|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059321|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15059322|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15059323|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
15059324|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059325|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
15059326|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15059327|NCT02139761|Analgesics|analgesics|mesh-ancestor
15059328|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
15059329|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059330|NCT02139852|Capsaicin|capsaicin|mesh-list
15059331|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
15059332|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
15059333|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
15059334|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059335|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059336|NCT02139904|Vinorelbine|vinorelbine|mesh-list
15059337|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15059338|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059339|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
15059340|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
15059341|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
15059342|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059343|NCT02139930|Nicotine|nicotine|mesh-list
15059344|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15059345|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
15059346|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059347|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059348|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15059349|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15059350|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
15059351|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059352|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059353|NCT02140047|Vaccines|vaccines|mesh-list
15059354|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
15059355|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059356|NCT02140073|Domperidone|domperidone|mesh-list
15059357|NCT02140073|Omeprazole|omeprazole|mesh-list
15059358|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15059359|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15059360|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15059361|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059362|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059363|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
15059364|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
15059365|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059366|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059367|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15059368|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
15059369|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059370|NCT02140151|Ranibizumab|ranibizumab|mesh-list
15059371|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15059372|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15059373|NCT02140151|Growth Substances|growth substances|mesh-ancestor
15059374|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059375|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
15059376|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059377|NCT02140242|Daunorubicin|daunorubicin|mesh-list
15059378|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15059379|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059380|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15059381|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15059382|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059383|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059384|NCT02140255|Ritonavir|ritonavir|mesh-list
15059385|NCT02140255|Lopinavir|lopinavir|mesh-list
15059386|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
15059387|NCT02140255|Nevirapine|nevirapine|mesh-list
15059388|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
15059389|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15059390|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15059391|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
15059392|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059393|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059394|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15059395|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15059396|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
15059397|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15059398|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15059399|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15059400|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15059401|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15059402|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15059403|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15059404|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15059405|NCT02140268|Midazolam|midazolam|mesh-list
15059406|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15059407|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15059408|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059409|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059410|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15059411|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15059412|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15059413|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15059414|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
15059415|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
15059416|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
15059417|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
15059418|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059419|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059420|NCT02140281|Cefadroxil|cefadroxil|mesh-list
15059421|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15059422|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15059423|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15059424|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059425|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15059426|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059427|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059428|NCT02140437|Fulvestrant|fulvestrant|mesh-list
15059429|NCT02140437|Anastrozole|anastrozole|mesh-list
15059430|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15059431|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059432|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15059433|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15059434|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
15059435|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15059436|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059437|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15059438|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15059439|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059440|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059441|NCT02140450|Timolol|timolol|mesh-list
15059442|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15059443|NCT02140450|Mannitol|mannitol|mesh-list
15059444|NCT02140450|Acetazolamide|acetazolamide|mesh-list
15059445|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15059446|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15059447|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
15059448|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059449|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059450|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059451|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15059452|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15059453|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15059454|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15059455|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15059456|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15059457|NCT02140450|Diuretics|diuretics|mesh-ancestor
15059458|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
15059459|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
15059460|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15059461|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059462|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15059463|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15059464|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15059465|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
15059466|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059467|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15059468|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15059469|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059470|NCT02140515|Hormones|hormones|mesh-list
15059471|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15059472|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15059473|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059474|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
15059475|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
15059476|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
15059477|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15059478|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15059479|NCT02140632|Prednisolone|prednisolone|mesh-list
15059480|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
15059481|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15059482|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
15059483|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15059484|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
15059485|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
15059486|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059487|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059488|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15059489|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
15059490|NCT02140632|Hormones|hormones|mesh-ancestor
15059491|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15059492|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15059493|NCT02140632|Protective Agents|protective agents|mesh-ancestor
15059494|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15059495|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059496|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
15059497|NCT02140736|Hematinics|hematinics|mesh-ancestor
15059498|NCT02140801|Clopidogrel|clopidogrel|mesh-list
15059499|NCT02140801|Ticagrelor|ticagrelor|mesh-list
15059500|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15059501|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15059502|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15059503|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15059504|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
15059505|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059506|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059507|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059508|NCT02140814|Niacinamide|niacinamide|mesh-list
15059509|NCT02140814|Niacin|niacin|mesh-list
15059510|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
15059511|NCT02140814|Vitamins|vitamins|mesh-ancestor
15059512|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
15059513|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059514|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
15059515|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15059516|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
15059517|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059518|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15059519|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
15059520|NCT02140840|Trametinib|trametinib|mesh-list
15059521|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059522|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15059523|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059524|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059525|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
15059526|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15059527|NCT02140983|Liraglutide|liraglutide|mesh-list
15059528|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15059529|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059530|NCT02140983|Incretins|incretins|mesh-ancestor
15059531|NCT02140983|Hormones|hormones|mesh-ancestor
15059532|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15059533|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15059534|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
15059535|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059536|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
15059537|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
15059538|NCT02141035|Vitamins|vitamins|mesh-ancestor
15059539|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
15059540|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059541|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
15059542|NCT02141087|Pirfenidone|pirfenidone|mesh-list
15059543|NCT02141087|Analgesics|analgesics|mesh-ancestor
15059544|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
15059545|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059546|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059547|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15059548|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15059549|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15059550|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15059551|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059552|NCT02141100|Thioguanine|thioguanine|mesh-list
15059553|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15059554|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
15059555|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059556|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059557|NCT02141113|Guanfacine|guanfacine|mesh-list
15059558|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15059559|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15059560|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15059561|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15059562|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
15059563|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059564|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059565|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059566|NCT02141139|Ibuprofen|ibuprofen|mesh-list
15059567|NCT02141139|Ketorolac|ketorolac|mesh-list
15059568|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15059569|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15059570|NCT02141139|Analgesics|analgesics|mesh-ancestor
15059571|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
15059572|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059573|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059574|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15059575|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15059576|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15059577|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059578|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059579|NCT02141178|Bupivacaine|bupivacaine|mesh-list
15059580|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
15059581|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
15059582|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059583|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059584|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
15059585|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059586|NCT02141321|Alprostadil|alprostadil|mesh-list
15059587|NCT02141321|Misoprostol|misoprostol|mesh-list
15059588|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15059589|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
15059590|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15059591|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059592|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15059593|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15059594|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
15059595|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15059596|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
15059597|NCT02141321|Urological Agents|urological agents|mesh-ancestor
15059598|NCT02141347|Durvalumab|durvalumab|mesh-list
15059599|NCT02141347|Tremelimumab|tremelimumab|mesh-list
15059600|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15059601|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059602|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
15059603|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15059604|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059605|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059606|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15059607|NCT02141412|Analgesics|analgesics|mesh-ancestor
15059608|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
15059609|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059610|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15059611|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15059612|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15059613|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
15059614|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059615|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059616|NCT02141425|Peficitinib|peficitinib|mesh-list
15059617|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059618|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059619|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15059620|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
15059621|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059622|NCT02141477|Decitabine|decitabine|mesh-list
15059623|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
15059624|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15059625|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
15059626|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059627|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059628|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059629|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15059630|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15059631|NCT02141698|Esomeprazole|esomeprazole|mesh-list
15059632|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15059633|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15059634|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15059635|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059636|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059637|NCT02141737|Lidocaine|lidocaine|mesh-list
15059638|NCT02141737|Fentanyl|fentanyl|mesh-list
15059639|NCT02141737|Midazolam|midazolam|mesh-list
15059640|NCT02141737|Etomidate|etomidate|mesh-list
15059641|NCT02141737|Rocuronium|rocuronium|mesh-list
15059642|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
15059643|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
15059644|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059645|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059646|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
15059647|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059648|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15059649|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15059650|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15059651|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15059652|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059653|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15059654|NCT02141737|Narcotics|narcotics|mesh-ancestor
15059655|NCT02141737|Analgesics|analgesics|mesh-ancestor
15059656|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15059657|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15059658|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
15059659|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15059660|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15059661|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15059662|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15059663|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
15059664|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
15059665|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059666|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15059667|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15059668|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15059669|NCT02141958|Fenretinide|fenretinide|mesh-list
15059670|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059671|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15059672|NCT02141958|Protective Agents|protective agents|mesh-ancestor
15059673|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059674|NCT02142010|Paclitaxel|paclitaxel|mesh-list
15059675|NCT02142010|Cisplatin|cisplatin|mesh-list
15059676|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15059677|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059678|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
15059679|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
15059680|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
15059681|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059682|NCT02142036|Trastuzumab|trastuzumab|mesh-list
15059683|NCT02142036|Cetuximab|cetuximab|mesh-list
15059684|NCT02142036|Panitumumab|panitumumab|mesh-list
15059685|NCT02142036|Everolimus|everolimus|mesh-list
15059686|NCT02142036|Sunitinib|sunitinib|mesh-list
15059687|NCT02142036|Dasatinib|dasatinib|mesh-list
15059688|NCT02142036|Lapatinib|lapatinib|mesh-list
15059689|NCT02142036|Gefitinib|gefitinib|mesh-list
15059690|NCT02142036|Afatinib|afatinib|mesh-list
15059691|NCT02142036|Vemurafenib|vemurafenib|mesh-list
15059692|NCT02142036|Dabrafenib|dabrafenib|mesh-list
15059693|NCT02142036|Crizotinib|crizotinib|mesh-list
15059694|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15059695|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059696|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15059697|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
15059698|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059699|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15059700|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059701|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059702|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15059703|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15059704|NCT02142036|Growth Substances|growth substances|mesh-ancestor
15059705|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
15059706|NCT02142075|Daptomycin|daptomycin|mesh-list
15059707|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15059708|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15059709|NCT02142140|Methylphenidate|methylphenidate|mesh-list
15059710|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15059711|NCT02142140|Adderall|adderall|mesh-list
15059712|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
15059713|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
15059714|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
15059715|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059716|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15059717|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15059718|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15059719|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059720|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
15059721|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059722|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15059723|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
15059724|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
15059725|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15059726|NCT02142192|Natalizumab|natalizumab|mesh-list
15059727|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
15059728|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059729|NCT02142205|Natalizumab|natalizumab|mesh-list
15059730|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
15059731|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059732|NCT02142218|Nivolumab|nivolumab|mesh-list
15059733|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15059734|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059735|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15059736|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059737|NCT02142296|Aflibercept|aflibercept|mesh-list
15059738|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15059739|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15059740|NCT02142296|Growth Substances|growth substances|mesh-ancestor
15059741|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059742|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
15059743|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059744|NCT02142309|Pioglitazone|pioglitazone|mesh-list
15059745|NCT02142309|Glimepiride|glimepiride|mesh-list
15059746|NCT02142309|Vildagliptin|vildagliptin|mesh-list
15059747|NCT02142309|Canagliflozin|canagliflozin|mesh-list
15059748|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15059749|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059750|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15059751|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15059752|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
15059753|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15059754|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
15059755|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059756|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059757|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15059758|NCT02142335|Rituximab|rituximab|mesh-list
15059759|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15059760|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059761|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
15059762|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059763|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15059764|NCT02142530|Belinostat|belinostat|mesh-list
15059765|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059766|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15059767|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059768|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059769|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
15059770|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
15059771|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
15059772|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15059773|NCT02142543|Protective Agents|protective agents|mesh-ancestor
15059774|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059775|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15059776|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
15059777|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15059778|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15059779|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15059780|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059781|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059782|NCT02142569|Tocotrienols|tocotrienols|mesh-list
15059783|NCT02142569|Vitamin E|vitamin e|mesh-list
15059784|NCT02142569|Tocopherols|tocopherols|mesh-list
15059785|NCT02142569|Red yeast rice|red yeast rice|mesh-list
15059786|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
15059787|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059788|NCT02142569|Protective Agents|protective agents|mesh-ancestor
15059789|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059790|NCT02142569|Vitamins|vitamins|mesh-ancestor
15059791|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
15059792|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15059793|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15059794|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15059795|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
15059796|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059797|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15059798|NCT02142595|Midazolam|midazolam|mesh-list
15059799|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
15059800|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15059801|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059802|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059803|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15059804|NCT02142595|Analgesics|analgesics|mesh-ancestor
15059805|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
15059806|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059807|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15059808|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15059809|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15059810|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
15059811|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059812|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059813|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15059814|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15059815|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15059816|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15059817|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15059818|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
15059819|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
15059820|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
15059821|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
15059822|NCT02142634|Budesonide|budesonide|mesh-list
15059823|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15059824|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15059825|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
15059826|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059827|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059828|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15059829|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
15059830|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
15059831|NCT02142634|Hormones|hormones|mesh-ancestor
15059832|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15059833|NCT02142751|Meropenem|meropenem|mesh-list
15059834|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
15059835|NCT02142751|Fosfomycin|fosfomycin|mesh-list
15059836|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15059837|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15059838|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15059839|NCT02142777|Equol|equol|mesh-list
15059840|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
15059841|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15059842|NCT02142777|Estrogens|estrogens|mesh-ancestor
15059843|NCT02142777|Hormones|hormones|mesh-ancestor
15059844|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15059845|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059846|NCT02142790|Paclitaxel|paclitaxel|mesh-list
15059847|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15059848|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059849|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
15059850|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
15059851|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
15059852|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059853|NCT02142829|Bupivacaine|bupivacaine|mesh-list
15059854|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
15059855|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
15059856|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059857|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059858|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
15059859|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059860|NCT02142868|Letrozole|letrozole|mesh-list
15059861|NCT02142868|Palbociclib|palbociclib|mesh-list
15059862|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059863|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15059864|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15059865|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059866|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059867|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15059868|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
15059869|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15059870|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059871|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15059872|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
15059873|NCT02142920|Gedatolisib|gedatolisib|mesh-list
15059874|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15059875|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059876|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059877|NCT02143050|Metformin|metformin|mesh-list
15059878|NCT02143050|Trametinib|trametinib|mesh-list
15059879|NCT02143050|Dabrafenib|dabrafenib|mesh-list
15059880|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15059881|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059882|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059883|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15059884|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059885|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059886|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
15059887|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15059888|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15059889|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059890|NCT02143219|Leucovorin|leucovorin|mesh-list
15059891|NCT02143219|Folic Acid|folic acid|mesh-list
15059892|NCT02143219|Irinotecan|irinotecan|mesh-list
15059893|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
15059894|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
15059895|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15059896|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15059897|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059898|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059899|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059900|NCT02143219|Antidotes|antidotes|mesh-ancestor
15059901|NCT02143219|Protective Agents|protective agents|mesh-ancestor
15059902|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059903|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
15059904|NCT02143219|Vitamins|vitamins|mesh-ancestor
15059905|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
15059906|NCT02143219|Hematinics|hematinics|mesh-ancestor
15059907|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15059908|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15059909|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15059910|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15059911|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059912|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059913|NCT02143362|Remifentanil|remifentanil|mesh-list
15059914|NCT02143362|Anesthetics|anesthetics|mesh-list
15059915|NCT02143362|Propofol|propofol|mesh-list
15059916|NCT02143362|Cisatracurium|cisatracurium|mesh-list
15059917|NCT02143362|Atracurium|atracurium|mesh-list
15059918|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15059919|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059920|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15059921|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15059922|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
15059923|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15059924|NCT02143362|Narcotics|narcotics|mesh-ancestor
15059925|NCT02143362|Analgesics|analgesics|mesh-ancestor
15059926|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
15059927|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059928|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15059929|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15059930|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15059931|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15059932|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15059933|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
15059934|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15059935|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059936|NCT02143414|Prednisone|prednisone|mesh-list
15059937|NCT02143414|Cortisone|cortisone|mesh-list
15059938|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15059939|NCT02143414|Methotrexate|methotrexate|mesh-list
15059940|NCT02143414|Vincristine|vincristine|mesh-list
15059941|NCT02143414|Dasatinib|dasatinib|mesh-list
15059942|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
15059943|NCT02143414|Blinatumomab|blinatumomab|mesh-list
15059944|NCT02143414|Antibodies|antibodies|mesh-list
15059945|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
15059946|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15059947|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
15059948|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15059949|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
15059950|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059951|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15059952|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15059953|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
15059954|NCT02143414|Hormones|hormones|mesh-ancestor
15059955|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15059956|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15059957|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15059958|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
15059959|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15059960|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15059961|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
15059962|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059963|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
15059964|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059965|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15059966|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15059967|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15059968|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15059969|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15059970|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
15059971|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
15059972|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
15059973|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15059974|NCT02143440|Insulin|insulin|mesh-list
15059975|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15059976|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059977|NCT02143479|Tacrolimus|tacrolimus|mesh-list
15059978|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15059979|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
15059980|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059981|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15059982|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15059983|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059984|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15059985|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
15059986|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15059987|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
15059988|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059989|NCT02143518|Antacids|antacids|mesh-ancestor
15059990|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15059991|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15059992|NCT02143531|Haloperidol|haloperidol|mesh-list
15059993|NCT02143531|Ondansetron|ondansetron|mesh-list
15059994|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
15059995|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
15059996|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
15059997|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15059998|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15059999|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15060000|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
15060001|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
15060002|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15060003|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
15060004|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060005|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060006|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15060007|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15060008|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060009|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15060010|NCT02143531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15060011|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15060012|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
15060013|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15060014|NCT02143570|Darifenacin|darifenacin|mesh-list
15060015|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15060016|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15060017|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
15060018|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060019|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060020|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060021|NCT02143570|Urological Agents|urological agents|mesh-ancestor
15060022|NCT02143622|Cetuximab|cetuximab|mesh-list
15060023|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15060024|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060025|NCT02143687|Sevoflurane|sevoflurane|mesh-list
15060026|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15060027|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15060028|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
15060029|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
15060030|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060031|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060032|NCT02143765|Acarbose|acarbose|mesh-list
15060033|NCT02143765|Mitiglinide|mitiglinide|mesh-list
15060034|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15060035|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060036|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060037|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15060038|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060039|NCT02143804|Molgramostim|molgramostim|mesh-list
15060040|NCT02143804|Sargramostim|sargramostim|mesh-list
15060041|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
15060042|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060043|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060044|NCT02143934|Chloroquine|chloroquine|mesh-list
15060045|NCT02143934|Lumefantrine|lumefantrine|mesh-list
15060046|NCT02143934|Artemether|artemether|mesh-list
15060047|NCT02143934|Primaquine|primaquine|mesh-list
15060048|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15060049|NCT02143934|Amebicides|amebicides|mesh-ancestor
15060050|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15060051|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15060052|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060053|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
15060054|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15060055|NCT02144025|Cyclosporine|cyclosporine|mesh-list
15060056|NCT02144025|Cyclosporins|cyclosporins|mesh-list
15060057|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060058|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060059|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15060060|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
15060061|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060062|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
15060063|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060064|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
15060065|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15060066|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15060067|NCT02144064|Heparin|heparin|mesh-list
15060068|NCT02144064|Calcium heparin|calcium heparin|mesh-list
15060069|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
15060070|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15060071|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15060072|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060073|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
15060074|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15060075|NCT02144194|Docetaxel|docetaxel|mesh-list
15060076|NCT02144194|Vinorelbine|vinorelbine|mesh-list
15060077|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060078|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
15060079|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
15060080|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
15060081|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060082|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15060083|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
15060084|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15060085|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15060086|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15060087|NCT02144246|Norgestimate|norgestimate|mesh-list
15060088|NCT02144246|Norgestrel|norgestrel|mesh-list
15060089|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15060090|NCT02144246|Estradiol|estradiol|mesh-list
15060091|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15060092|NCT02144246|Estrogens|estrogens|mesh-ancestor
15060093|NCT02144246|Hormones|hormones|mesh-ancestor
15060094|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060095|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060096|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15060097|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
15060098|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15060099|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15060100|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15060101|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15060102|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15060103|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15060104|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060105|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15060106|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15060107|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060108|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060109|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060110|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15060111|NCT02144376|Psyllium|psyllium|mesh-list
15060112|NCT02144376|Cathartics|cathartics|mesh-ancestor
15060113|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15060114|NCT02144389|Praziquantel|praziquantel|mesh-list
15060115|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
15060116|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15060117|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060118|NCT02144415|Amphetamine|amphetamine|mesh-list
15060119|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
15060120|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
15060121|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15060122|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060123|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
15060124|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
15060125|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060126|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
15060127|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060128|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060129|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
15060130|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15060131|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15060132|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15060133|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15060134|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
15060135|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15060136|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060137|NCT02144623|Valproic Acid|valproic acid|mesh-list
15060138|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
15060139|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060140|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060141|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
15060142|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060143|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060144|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
15060145|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15060146|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060147|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15060148|NCT02144662|Ranibizumab|ranibizumab|mesh-list
15060149|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15060150|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15060151|NCT02144662|Growth Substances|growth substances|mesh-ancestor
15060152|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060153|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
15060154|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060155|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15060156|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
15060157|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060158|NCT02144753|Psyllium|psyllium|mesh-list
15060159|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
15060160|NCT02144753|Cathartics|cathartics|mesh-ancestor
15060161|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15060162|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
15060163|NCT02144766|Ropivacaine|ropivacaine|mesh-list
15060164|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
15060165|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
15060166|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060167|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060168|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
15060169|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060170|NCT02144792|Verapamil|verapamil|mesh-list
15060171|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15060172|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15060173|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15060174|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060175|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15060176|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060177|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
15060178|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15060179|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
15060180|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15060181|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
15060182|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15060183|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060184|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15060185|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15060186|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060187|NCT02144831|Aspirin|aspirin|mesh-list
15060188|NCT02144831|Clopidogrel|clopidogrel|mesh-list
15060189|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15060190|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15060191|NCT02144831|Analgesics|analgesics|mesh-ancestor
15060192|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
15060193|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060194|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060195|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15060196|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15060197|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15060198|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15060199|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060200|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15060201|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15060202|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060203|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
15060204|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15060205|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15060206|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15060207|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
15060208|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060209|NCT02144922|Pitavastatin|pitavastatin|mesh-list
15060210|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15060211|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15060212|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15060213|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
15060214|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060215|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060216|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15060217|NCT02145065|Paclitaxel|paclitaxel|mesh-list
15060218|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15060219|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060220|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
15060221|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
15060222|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
15060223|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060224|NCT02145091|Psilocybin|psilocybin|mesh-list
15060225|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
15060226|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
15060227|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060228|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15060229|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15060230|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
15060231|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060232|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060233|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15060234|NCT02145104|Valsartan|valsartan|mesh-list
15060235|NCT02145104|Cilnidipine|cilnidipine|mesh-list
15060236|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15060237|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15060238|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15060239|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060240|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15060241|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15060242|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15060243|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060244|NCT02145195|Vitamin D|vitamin d|mesh-list
15060245|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
15060246|NCT02145195|Vitamins|vitamins|mesh-ancestor
15060247|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
15060248|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060249|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15060250|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15060251|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
15060252|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15060253|NCT02145338|Trimethoprim|trimethoprim|mesh-list
15060254|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
15060255|NCT02145338|Cephalexin|cephalexin|mesh-list
15060256|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15060257|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060258|NCT02145338|Renal Agents|renal agents|mesh-ancestor
15060259|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
15060260|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15060261|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15060262|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15060263|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060264|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060265|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15060266|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15060267|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15060268|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15060269|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
15060270|NCT02145520|Analgesics|analgesics|mesh-ancestor
15060271|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
15060272|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060273|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060274|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
15060275|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060276|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15060277|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
15060278|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15060279|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15060280|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060281|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15060282|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
15060283|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15060284|NCT02145546|Amiodarone|amiodarone|mesh-list
15060285|NCT02145546|Sotalol|sotalol|mesh-list
15060286|NCT02145546|Propafenone|propafenone|mesh-list
15060287|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15060288|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
15060289|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15060290|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15060291|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060292|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15060293|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15060294|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15060295|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060296|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15060297|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15060298|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15060299|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15060300|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15060301|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
15060302|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060303|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060304|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
15060305|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
15060306|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060307|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15060308|NCT02145559|Metformin|metformin|mesh-list
15060309|NCT02145559|Sirolimus|sirolimus|mesh-list
15060310|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15060311|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060312|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15060313|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060314|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15060315|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060316|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
15060317|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15060318|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
15060319|NCT02145585|Anesthetics|anesthetics|mesh-list
15060320|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060321|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060322|NCT02145598|Lenalidomide|lenalidomide|mesh-list
15060323|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
15060324|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060325|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15060326|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15060327|NCT02145598|Growth Substances|growth substances|mesh-ancestor
15060328|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
15060329|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060330|NCT02145611|Vildagliptin|vildagliptin|mesh-list
15060331|NCT02145611|Glyburide|glyburide|mesh-list
15060332|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15060333|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060334|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15060335|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
15060336|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060337|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060338|NCT02145624|Vaccines|vaccines|mesh-list
15060339|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
15060340|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060341|NCT02145637|Afatinib|afatinib|mesh-list
15060342|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060343|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15060344|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060345|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060346|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
15060347|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15060348|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15060349|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15060350|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15060351|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060352|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
15060353|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060354|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060355|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15060356|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060357|NCT02145715|Thalidomide|thalidomide|mesh-list
15060358|NCT02145715|Dexamethasone|dexamethasone|mesh-list
15060359|NCT02145715|Bortezomib|bortezomib|mesh-list
15060360|NCT02145715|Panobinostat|panobinostat|mesh-list
15060361|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15060362|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
15060363|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
15060364|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060365|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060366|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15060367|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
15060368|NCT02145715|Hormones|hormones|mesh-ancestor
15060369|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060370|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15060371|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060372|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15060373|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
15060374|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
15060375|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15060376|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060377|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15060378|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15060379|NCT02145715|Growth Substances|growth substances|mesh-ancestor
15060380|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
15060381|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15060382|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060383|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060384|NCT02145767|Progesterone|progesterone|mesh-list
15060385|NCT02145767|Progestins|progestins|mesh-ancestor
15060386|NCT02145767|Hormones|hormones|mesh-ancestor
15060387|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060388|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060389|NCT02145832|Fluconazole|fluconazole|mesh-list
15060390|NCT02145832|Micafungin|micafungin|mesh-list
15060391|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
15060392|NCT02145832|Clotrimazole|clotrimazole|mesh-list
15060393|NCT02145832|Miconazole|miconazole|mesh-list
15060394|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060395|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15060396|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15060397|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060398|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060399|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15060400|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
15060401|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060402|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060403|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15060404|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15060405|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15060406|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15060407|NCT02145884|Timolol|timolol|mesh-list
15060408|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15060409|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15060410|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
15060411|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060412|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060413|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060414|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15060415|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15060416|NCT02145910|Vemurafenib|vemurafenib|mesh-list
15060417|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060418|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15060419|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060420|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060421|NCT02145949|Tryptophan|tryptophan|mesh-list
15060422|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15060423|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
15060424|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15060425|NCT02145975|Fentanyl|fentanyl|mesh-list
15060426|NCT02145975|Morphine|morphine|mesh-list
15060427|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
15060428|NCT02145975|Narcotics|narcotics|mesh-ancestor
15060429|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060430|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060431|NCT02145975|Analgesics|analgesics|mesh-ancestor
15060432|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
15060433|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060434|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15060435|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15060436|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
15060437|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
15060438|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15060439|NCT02146118|Silybin|silybin|mesh-list
15060440|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060441|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15060442|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060443|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060444|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15060445|NCT02146118|Protective Agents|protective agents|mesh-ancestor
15060446|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060447|NCT02146209|Metronidazole|metronidazole|mesh-list
15060448|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060449|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15060450|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15060451|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15060452|NCT02146222|Docetaxel|docetaxel|mesh-list
15060453|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060454|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
15060455|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
15060456|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
15060457|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060458|NCT02146261|Quetmolimab|quetmolimab|mesh-list
15060459|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15060460|NCT02146300|Xylometazoline|xylometazoline|mesh-list
15060461|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
15060462|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15060463|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
15060464|NCT02146391|Enclomiphene|enclomiphene|mesh-list
15060465|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15060466|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
15060467|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060468|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060469|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15060470|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
15060471|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15060472|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15060473|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15060474|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
15060475|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15060476|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15060477|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060478|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
15060479|NCT02146456|Coagulants|coagulants|mesh-ancestor
15060480|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
15060481|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15060482|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15060483|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060484|NCT02146547|Aripiprazole|aripiprazole|mesh-list
15060485|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
15060486|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
15060487|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15060488|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15060489|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15060490|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060491|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060492|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
15060493|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
15060494|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060495|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060496|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15060497|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15060498|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
15060499|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15060500|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15060501|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15060502|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15060503|NCT02146638|Fentanyl|fentanyl|mesh-list
15060504|NCT02146638|Morphine|morphine|mesh-list
15060505|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15060506|NCT02146638|Narcotics|narcotics|mesh-ancestor
15060507|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060508|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060509|NCT02146638|Analgesics|analgesics|mesh-ancestor
15060510|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
15060511|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060512|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15060513|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15060514|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
15060515|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
15060516|NCT02146651|Insulin|insulin|mesh-list
15060517|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15060518|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
15060519|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15060520|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060521|NCT02146703|Gemcitabine|gemcitabine|mesh-list
15060522|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15060523|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
15060524|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060525|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060526|NCT02146703|Antiviral Agents|antiviral agents|mesh-ancestor
15060527|NCT02146703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060528|NCT02146703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060529|NCT02146703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15060530|NCT02146703|Immunologic Factors|immunologic factors|mesh-ancestor
15060531|NCT02146703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060532|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
15060533|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060534|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15060535|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060536|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060537|NCT02146911|Bupropion|bupropion|mesh-list
15060538|NCT02146911|Varenicline|varenicline|mesh-list
15060539|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15060540|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
15060541|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15060542|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15060543|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15060544|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15060545|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060546|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
15060547|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060548|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060549|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15060550|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15060551|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060552|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15060553|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15060554|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
15060555|NCT02146937|Bicalutamide|bicalutamide|mesh-list
15060556|NCT02146937|Finasteride|finasteride|mesh-list
15060557|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
15060558|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
15060559|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060560|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060561|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060562|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15060563|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15060564|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060565|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060566|NCT02146937|Urological Agents|urological agents|mesh-ancestor
15060567|NCT02146976|Propofol|propofol|mesh-list
15060568|NCT02146976|Sevoflurane|sevoflurane|mesh-list
15060569|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15060570|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060571|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060572|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15060573|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
15060574|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
15060575|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15060576|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15060577|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15060578|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
15060579|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
15060580|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
15060581|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
15060582|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060583|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15060584|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
15060585|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
15060586|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060587|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060588|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15060589|NCT02147015|Hormones|hormones|mesh-ancestor
15060590|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060591|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15060592|NCT02147015|Protective Agents|protective agents|mesh-ancestor
15060593|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060594|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060595|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15060596|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
15060597|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
15060598|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060599|NCT02147041|Protective Agents|protective agents|mesh-ancestor
15060600|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060601|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
15060602|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15060603|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060604|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15060605|NCT02147054|Rocuronium|rocuronium|mesh-list
15060606|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15060607|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15060608|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15060609|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060610|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060611|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15060612|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060613|NCT02147262|Doxycycline|doxycycline|mesh-list
15060614|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15060615|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060616|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
15060617|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15060618|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15060619|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
15060620|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15060621|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15060622|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060623|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060624|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15060625|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15060626|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15060627|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15060628|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
15060629|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060630|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060631|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15060632|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15060633|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
15060634|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15060635|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15060636|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
15060637|NCT02147535|Methylphenidate|methylphenidate|mesh-list
15060638|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15060639|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060640|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15060641|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15060642|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15060643|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060644|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
15060645|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060646|NCT02147548|Lorazepam|lorazepam|mesh-list
15060647|NCT02147548|Etifoxine|etifoxine|mesh-list
15060648|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
15060649|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
15060650|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
15060651|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060652|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060653|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15060654|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15060655|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060656|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15060657|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15060658|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15060659|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
15060660|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
15060661|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060662|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060663|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
15060664|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15060665|NCT02147678|Remifentanil|remifentanil|mesh-list
15060666|NCT02147678|Propofol|propofol|mesh-list
15060667|NCT02147678|Etomidate|etomidate|mesh-list
15060668|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
15060669|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060670|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060671|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15060672|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15060673|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
15060674|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15060675|NCT02147678|Narcotics|narcotics|mesh-ancestor
15060676|NCT02147678|Analgesics|analgesics|mesh-ancestor
15060677|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
15060678|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060679|NCT02147730|Anesthetics|anesthetics|mesh-list
15060680|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060681|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060682|NCT02147808|Midazolam|midazolam|mesh-list
15060683|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15060684|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15060685|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060686|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060687|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15060688|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15060689|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15060690|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15060691|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
15060692|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
15060693|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
15060694|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
15060695|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060696|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060697|NCT02147873|Azacitidine|azacitidine|mesh-list
15060698|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15060699|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
15060700|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060701|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060702|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060703|NCT02147925|Metformin|metformin|mesh-list
15060704|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
15060705|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15060706|NCT02147925|Liraglutide|liraglutide|mesh-list
15060707|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15060708|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060709|NCT02147925|Incretins|incretins|mesh-ancestor
15060710|NCT02147925|Hormones|hormones|mesh-ancestor
15060711|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060712|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15060713|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
15060714|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060715|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060716|NCT02147938|Tacrolimus|tacrolimus|mesh-list
15060717|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15060718|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
15060719|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060720|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15060721|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060722|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060723|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
15060724|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15060725|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060726|NCT02147964|Ketoconazole|ketoconazole|mesh-list
15060727|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
15060728|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15060729|NCT02147964|Testosterone|testosterone|mesh-list
15060730|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
15060731|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
15060732|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15060733|NCT02147964|Dutasteride|dutasteride|mesh-list
15060734|NCT02147964|Acyline|acyline|mesh-list
15060735|NCT02147964|Androgens|androgens|mesh-ancestor
15060736|NCT02147964|Hormones|hormones|mesh-ancestor
15060737|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060738|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060739|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15060740|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060741|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
15060742|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
15060743|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060744|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15060745|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15060746|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060747|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060748|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15060749|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
15060750|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15060751|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15060752|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15060753|NCT02148016|Levofloxacin|levofloxacin|mesh-list
15060754|NCT02148016|Ofloxacin|ofloxacin|mesh-list
15060755|NCT02148016|Betamethasone|betamethasone|mesh-list
15060756|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15060757|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060758|NCT02148016|Renal Agents|renal agents|mesh-ancestor
15060759|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15060760|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15060761|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15060762|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060763|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060764|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060765|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15060766|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15060767|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15060768|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
15060769|NCT02148016|Hormones|hormones|mesh-ancestor
15060770|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060771|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060772|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15060773|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
15060774|NCT02148094|Tenofovir|tenofovir|mesh-list
15060775|NCT02148094|Emtricitabine|emtricitabine|mesh-list
15060776|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15060777|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
15060778|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060779|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15060780|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15060781|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060782|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060783|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15060784|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15060785|NCT02148120|Beclomethasone|beclomethasone|mesh-list
15060786|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
15060787|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15060788|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
15060789|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060790|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060791|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15060792|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
15060793|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15060794|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15060795|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15060796|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
15060797|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060798|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060799|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15060800|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
15060801|NCT02148120|Hormones|hormones|mesh-ancestor
15060802|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060803|NCT02148328|Vaccines|vaccines|mesh-list
15060804|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
15060805|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060806|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
15060807|NCT02148367|Hematinics|hematinics|mesh-ancestor
15060808|NCT02148380|Carboplatin|carboplatin|mesh-list
15060809|NCT02148380|Pemetrexed|pemetrexed|mesh-list
15060810|NCT02148380|Gefitinib|gefitinib|mesh-list
15060811|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060812|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060813|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060814|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15060815|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15060816|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15060817|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
15060818|NCT02148393|Estradiol|estradiol|mesh-list
15060819|NCT02148393|Progesterone|progesterone|mesh-list
15060820|NCT02148393|Estrogens|estrogens|mesh-ancestor
15060821|NCT02148393|Hormones|hormones|mesh-ancestor
15060822|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060823|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060824|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15060825|NCT02148393|Progestins|progestins|mesh-ancestor
15060826|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
15060827|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15060828|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060829|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060830|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15060831|NCT02148432|Analgesics|analgesics|mesh-ancestor
15060832|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
15060833|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060834|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15060835|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15060836|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15060837|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
15060838|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060839|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060840|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
15060841|NCT02148549|Irinotecan|irinotecan|mesh-list
15060842|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060843|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15060844|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15060845|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060846|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060847|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15060848|NCT02148601|Vancomycin|vancomycin|mesh-list
15060849|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060850|NCT02148640|Infliximab|infliximab|mesh-list
15060851|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
15060852|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15060853|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15060854|NCT02148783|Methylphenidate|methylphenidate|mesh-list
15060855|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15060856|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060857|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15060858|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15060859|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15060860|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060861|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
15060862|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060863|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
15060864|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15060865|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
15060866|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060867|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
15060868|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15060869|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15060870|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060871|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15060872|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060873|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15060874|NCT02148861|Insulin|insulin|mesh-list
15060875|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15060876|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15060877|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060878|NCT02148913|Melphalan|melphalan|mesh-list
15060879|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15060880|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15060881|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
15060882|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060883|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060884|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15060885|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15060886|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
15060887|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060888|NCT02148978|Saxagliptin|saxagliptin|mesh-list
15060889|NCT02148978|Incretins|incretins|mesh-ancestor
15060890|NCT02148978|Hormones|hormones|mesh-ancestor
15060891|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060892|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060893|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15060894|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
15060895|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060896|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060897|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15060898|NCT02149095|Treprostinil|treprostinil|mesh-list
15060899|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15060900|NCT02149212|Aminaftone|aminaftone|mesh-list
15060901|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
15060902|NCT02149212|Coagulants|coagulants|mesh-ancestor
15060903|NCT02149225|Poly I-C|poly i-c|mesh-list
15060904|NCT02149225|Molgramostim|molgramostim|mesh-list
15060905|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15060906|NCT02149225|Vaccines|vaccines|mesh-list
15060907|NCT02149225|Sargramostim|sargramostim|mesh-list
15060908|NCT02149225|Poly ICLC|poly iclc|mesh-list
15060909|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
15060910|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060911|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060912|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
15060913|NCT02149225|Laxatives|laxatives|mesh-ancestor
15060914|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15060915|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
15060916|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060917|NCT02149329|Meropenem|meropenem|mesh-list
15060918|NCT02149329|Imipenem|imipenem|mesh-list
15060919|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
15060920|NCT02149329|Cilastatin|cilastatin|mesh-list
15060921|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15060922|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060923|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
15060924|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060925|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060926|NCT02149407|Glycerol|glycerol|mesh-list
15060927|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15060928|NCT02149407|Protective Agents|protective agents|mesh-ancestor
15060929|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060930|NCT02149433|Prednisone|prednisone|mesh-list
15060931|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15060932|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
15060933|NCT02149433|Hormones|hormones|mesh-ancestor
15060934|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15060935|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060936|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15060937|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15060938|NCT02149459|Metformin|metformin|mesh-list
15060939|NCT02149459|Biguanides|biguanides|mesh-list
15060940|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15060941|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060942|NCT02149628|Propofol|propofol|mesh-list
15060943|NCT02149628|Desflurane|desflurane|mesh-list
15060944|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15060945|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15060946|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060947|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15060948|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
15060949|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
15060950|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15060951|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
15060952|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15060953|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
15060954|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060955|NCT02149758|Etoricoxib|etoricoxib|mesh-list
15060956|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15060957|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15060958|NCT02149758|Analgesics|analgesics|mesh-ancestor
15060959|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
15060960|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060961|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060962|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15060963|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15060964|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15060965|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15060966|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060967|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060968|NCT02149823|Oxytocin|oxytocin|mesh-list
15060969|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
15060970|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15060971|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060972|NCT02149888|Tenofovir|tenofovir|mesh-list
15060973|NCT02149888|Emtricitabine|emtricitabine|mesh-list
15060974|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
15060975|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15060976|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15060977|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15060978|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15060979|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060980|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15060981|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15060982|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
15060983|NCT02149901|Ephedrine|ephedrine|mesh-list
15060984|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15060985|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
15060986|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15060987|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15060988|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15060989|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
15060990|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
15060991|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15060992|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15060993|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
15060994|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
15060995|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15060996|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15060997|NCT02149914|Rabeprazole|rabeprazole|mesh-list
15060998|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15060999|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15061000|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15061001|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061002|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061003|NCT02149927|Sevoflurane|sevoflurane|mesh-list
15061004|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15061005|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15061006|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
15061007|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
15061008|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061009|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061010|NCT02149953|Glycine|glycine|mesh-list
15061011|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
15061012|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15061013|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061014|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061015|NCT02149992|Inositol|inositol|mesh-list
15061016|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
15061017|NCT02149992|Vitamins|vitamins|mesh-ancestor
15061018|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
15061019|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061020|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
15061021|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15061022|NCT02150031|Lidocaine|lidocaine|mesh-list
15061023|NCT02150031|Epinephrine|epinephrine|mesh-list
15061024|NCT02150031|Racepinephrine|racepinephrine|mesh-list
15061025|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
15061026|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
15061027|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
15061028|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061029|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061030|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
15061031|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061032|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15061033|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15061034|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15061035|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15061036|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061037|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15061038|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061039|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
15061040|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
15061041|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15061042|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15061043|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
15061044|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15061045|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15061046|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15061047|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
15061048|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15061049|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
15061050|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
15061051|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
15061052|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15061053|NCT02150122|Vitamin D|vitamin d|mesh-list
15061054|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
15061055|NCT02150122|Vitamins|vitamins|mesh-ancestor
15061056|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
15061057|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061058|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15061059|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15061060|NCT02150161|Lidocaine|lidocaine|mesh-list
15061061|NCT02150161|Fentanyl|fentanyl|mesh-list
15061062|NCT02150161|Ketamine|ketamine|mesh-list
15061063|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
15061064|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
15061065|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061066|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061067|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
15061068|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061069|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15061070|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15061071|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15061072|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15061073|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061074|NCT02150161|Analgesics|analgesics|mesh-ancestor
15061075|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15061076|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15061077|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
15061078|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15061079|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15061080|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15061081|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15061082|NCT02150161|Narcotics|narcotics|mesh-ancestor
15061083|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15061084|NCT02150291|Folic Acid|folic acid|mesh-list
15061085|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
15061086|NCT02150291|Hematinics|hematinics|mesh-ancestor
15061087|NCT02150291|Vitamins|vitamins|mesh-ancestor
15061088|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
15061089|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061090|NCT02150317|Sorafenib|sorafenib|mesh-list
15061091|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
15061092|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061093|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15061094|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061095|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061096|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15061097|NCT02150317|Estrogens|estrogens|mesh-ancestor
15061098|NCT02150317|Hormones|hormones|mesh-ancestor
15061099|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15061100|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061101|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15061102|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
15061103|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15061104|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
15061105|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061106|NCT02150447|Lansoprazole|lansoprazole|mesh-list
15061107|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15061108|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15061109|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15061110|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061111|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061112|NCT02150473|Adalimumab|adalimumab|mesh-list
15061113|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15061114|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15061115|NCT02150616|Sevoflurane|sevoflurane|mesh-list
15061116|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15061117|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15061118|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
15061119|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
15061120|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061121|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061122|NCT02150707|Liraglutide|liraglutide|mesh-list
15061123|NCT02150707|Exenatide|exenatide|mesh-list
15061124|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15061125|NCT02150707|Glucagon|glucagon|mesh-list
15061126|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15061127|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15061128|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061129|NCT02150707|Incretins|incretins|mesh-ancestor
15061130|NCT02150707|Hormones|hormones|mesh-ancestor
15061131|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15061132|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15061133|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15061134|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
15061135|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061136|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061137|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
15061138|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15061139|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15061140|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15061141|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061142|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
15061143|NCT02150720|Coagulants|coagulants|mesh-ancestor
15061144|NCT02150785|Streptokinase|streptokinase|mesh-list
15061145|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15061146|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15061147|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061148|NCT02150928|Asparaginase|asparaginase|mesh-list
15061149|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061150|NCT02150993|Ritonavir|ritonavir|mesh-list
15061151|NCT02150993|Lopinavir|lopinavir|mesh-list
15061152|NCT02150993|Tenofovir|tenofovir|mesh-list
15061153|NCT02150993|Lamivudine|lamivudine|mesh-list
15061154|NCT02150993|Zidovudine|zidovudine|mesh-list
15061155|NCT02150993|Emtricitabine|emtricitabine|mesh-list
15061156|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
15061157|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
15061158|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15061159|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15061160|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
15061161|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061162|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061163|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15061164|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15061165|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
15061166|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061167|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15061168|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15061169|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15061170|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15061171|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
15061172|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15061173|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15061174|NCT02151084|Gemcitabine|gemcitabine|mesh-list
15061175|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061176|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15061177|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
15061178|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061179|NCT02151084|Antiviral Agents|antiviral agents|mesh-ancestor
15061180|NCT02151084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061181|NCT02151084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061182|NCT02151084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15061183|NCT02151084|Immunologic Factors|immunologic factors|mesh-ancestor
15061184|NCT02151084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061185|NCT02151201|Vaccines|vaccines|mesh-list
15061186|NCT02151201|Immunologic Factors|immunologic factors|mesh-ancestor
15061187|NCT02151201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061188|NCT02151240|Acyclovir|acyclovir|mesh-list
15061189|NCT02151240|Foscarnet|foscarnet|mesh-list
15061190|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
15061191|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
15061192|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061193|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15061194|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15061195|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061196|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061197|NCT02151279|Chitosan|chitosan|mesh-list
15061198|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15061199|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15061200|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
15061201|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061202|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15061203|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
15061204|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
15061205|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
15061206|NCT02151279|Coagulants|coagulants|mesh-ancestor
15061207|NCT02151305|Remifentanil|remifentanil|mesh-list
15061208|NCT02151305|Propofol|propofol|mesh-list
15061209|NCT02151305|Sevoflurane|sevoflurane|mesh-list
15061210|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15061211|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061212|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061213|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15061214|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
15061215|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
15061216|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15061217|NCT02151305|Narcotics|narcotics|mesh-ancestor
15061218|NCT02151305|Analgesics|analgesics|mesh-ancestor
15061219|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
15061220|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061221|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15061222|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15061223|NCT02151344|Vaccines|vaccines|mesh-list
15061224|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
15061225|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061226|NCT02151604|Xenon|xenon|mesh-list
15061227|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15061228|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
15061229|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
15061230|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061231|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061232|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
15061233|NCT02151630|Salicylates|salicylates|mesh-list
15061234|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061235|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
15061236|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
15061237|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
15061238|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15061239|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15061240|NCT02151630|Analgesics|analgesics|mesh-ancestor
15061241|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
15061242|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061243|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061244|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15061245|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15061246|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15061247|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061248|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061249|NCT02151695|Aflibercept|aflibercept|mesh-list
15061250|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15061251|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15061252|NCT02151695|Growth Substances|growth substances|mesh-ancestor
15061253|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061254|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
15061255|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061256|NCT02151721|Gefitinib|gefitinib|mesh-list
15061257|NCT02151721|Vorinostat|vorinostat|mesh-list
15061258|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061259|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15061260|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061261|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061262|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15061263|NCT02151812|Paclitaxel|paclitaxel|mesh-list
15061264|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15061265|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15061266|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061267|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
15061268|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
15061269|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
15061270|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061271|NCT02151916|Fluorides|fluorides|mesh-list
15061272|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
15061273|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
15061274|NCT02151916|Protective Agents|protective agents|mesh-ancestor
15061275|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061276|NCT02151929|Everolimus|everolimus|mesh-list
15061277|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061278|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15061279|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
15061280|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061281|NCT02151968|Anesthetics|anesthetics|mesh-list
15061282|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
15061283|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061284|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061285|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
15061286|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061287|NCT02152059|Nintedanib|nintedanib|mesh-list
15061288|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061289|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15061290|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061291|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061292|NCT02152176|Morphine|morphine|mesh-list
15061293|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15061294|NCT02152176|Narcotics|narcotics|mesh-ancestor
15061295|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061296|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061297|NCT02152176|Analgesics|analgesics|mesh-ancestor
15061298|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
15061299|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061300|NCT02152228|Teriparatide|teriparatide|mesh-list
15061301|NCT02152228|Hormones|hormones|mesh-list
15061302|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
15061303|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15061304|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061305|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15061306|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15061307|NCT02152306|Amlodipine|amlodipine|mesh-list
15061308|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15061309|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15061310|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15061311|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061312|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15061313|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061314|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
15061315|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
15061316|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15061317|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15061318|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061319|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15061320|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15061321|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061322|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061323|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061324|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15061325|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
15061326|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15061327|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061328|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15061329|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15061330|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15061331|NCT02152358|Acyclovir|acyclovir|mesh-list
15061332|NCT02152358|Ganciclovir|ganciclovir|mesh-list
15061333|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
15061334|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
15061335|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061336|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15061337|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061338|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061339|NCT02152410|Morphine|morphine|mesh-list
15061340|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15061341|NCT02152410|Narcotics|narcotics|mesh-ancestor
15061342|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061343|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061344|NCT02152410|Analgesics|analgesics|mesh-ancestor
15061345|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
15061346|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061347|NCT02152423|Enoxaparin|enoxaparin|mesh-list
15061348|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
15061349|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15061350|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15061351|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061352|NCT02152475|Curcumin|curcumin|mesh-list
15061353|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15061354|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15061355|NCT02152475|Analgesics|analgesics|mesh-ancestor
15061356|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
15061357|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061358|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061359|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15061360|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15061361|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061362|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061363|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061364|NCT02152514|Sufentanil|sufentanil|mesh-list
15061365|NCT02152514|Morphine|morphine|mesh-list
15061366|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15061367|NCT02152514|Narcotics|narcotics|mesh-ancestor
15061368|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061369|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061370|NCT02152514|Analgesics|analgesics|mesh-ancestor
15061371|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
15061372|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061373|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15061374|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15061375|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
15061376|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
15061377|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
15061378|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15061379|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15061380|NCT02152579|Isosorbide|isosorbide|mesh-list
15061381|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
15061382|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
15061383|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15061384|NCT02152579|Diuretics|diuretics|mesh-ancestor
15061385|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
15061386|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061387|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
15061388|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15061389|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061390|NCT02152709|Vaccines|vaccines|mesh-list
15061391|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
15061392|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061393|NCT02152787|Propofol|propofol|mesh-list
15061394|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15061395|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061396|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061397|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15061398|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
15061399|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
15061400|NCT02152800|Valacyclovir|valacyclovir|mesh-list
15061401|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
15061402|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061403|NCT02152865|Lupeol|lupeol|mesh-list
15061404|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15061405|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
15061406|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15061407|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15061408|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061409|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
15061410|NCT02152917|Coagulants|coagulants|mesh-ancestor
15061411|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15061412|NCT02152943|Trastuzumab|trastuzumab|mesh-list
15061413|NCT02152943|Everolimus|everolimus|mesh-list
15061414|NCT02152943|Letrozole|letrozole|mesh-list
15061415|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
15061416|NCT02152943|Antibodies|antibodies|mesh-list
15061417|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
15061418|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15061419|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
15061420|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061421|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061422|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15061423|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15061424|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15061425|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061426|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061427|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15061428|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
15061429|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15061430|NCT02152969|Amlodipine|amlodipine|mesh-list
15061431|NCT02152969|Telmisartan|telmisartan|mesh-list
15061432|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
15061433|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15061434|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15061435|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15061436|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061437|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15061438|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061439|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
15061440|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15061441|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15061442|NCT02152969|Diuretics|diuretics|mesh-ancestor
15061443|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
15061444|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15061445|NCT02153060|Dexamethasone|dexamethasone|mesh-list
15061446|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
15061447|NCT02153060|BB 1101|bb 1101|mesh-list
15061448|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15061449|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
15061450|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
15061451|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061452|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061453|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15061454|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
15061455|NCT02153060|Hormones|hormones|mesh-ancestor
15061456|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15061457|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15061458|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061459|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
15061460|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061461|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061462|NCT02153125|Eplerenone|eplerenone|mesh-list
15061463|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15061464|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
15061465|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15061466|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061467|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15061468|NCT02153125|Diuretics|diuretics|mesh-ancestor
15061469|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
15061470|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15061471|NCT02153177|Acetaminophen|acetaminophen|mesh-list
15061472|NCT02153177|Ibuprofen|ibuprofen|mesh-list
15061473|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
15061474|NCT02153177|Hydrocodone|hydrocodone|mesh-list
15061475|NCT02153177|Oxycodone|oxycodone|mesh-list
15061476|NCT02153177|Omeprazole|omeprazole|mesh-list
15061477|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15061478|NCT02153177|Analgesics|analgesics|mesh-ancestor
15061479|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
15061480|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061481|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061482|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
15061483|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15061484|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15061485|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15061486|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15061487|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061488|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061489|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15061490|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15061491|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15061492|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15061493|NCT02153177|Narcotics|narcotics|mesh-ancestor
15061494|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061495|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
15061496|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
15061497|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
15061498|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061499|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
15061500|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15061501|NCT02153281|Phenelzine|phenelzine|mesh-list
15061502|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
15061503|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15061504|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15061505|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061506|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061507|NCT02153424|Apixaban|apixaban|mesh-list
15061508|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15061509|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
15061510|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15061511|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
15061512|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061513|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061514|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
15061515|NCT02153437|Sotalol|sotalol|mesh-list
15061516|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15061517|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15061518|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
15061519|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15061520|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061521|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061522|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15061523|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
15061524|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
15061525|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061526|NCT02153450|Metformin|metformin|mesh-list
15061527|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15061528|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061529|NCT02153541|Antipyrine|antipyrine|mesh-list
15061530|NCT02153541|Benzocaine|benzocaine|mesh-list
15061531|NCT02153541|Mineral Oil|mineral oil|mesh-list
15061532|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
15061533|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
15061534|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061535|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061536|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
15061537|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061538|NCT02153541|Emollients|emollients|mesh-ancestor
15061539|NCT02153541|Dermatologic Agents|dermatologic agents|mesh-ancestor
15061540|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15061541|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15061542|NCT02153541|Analgesics|analgesics|mesh-ancestor
15061543|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15061544|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15061545|NCT02153567|Citalopram|citalopram|mesh-list
15061546|NCT02153567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15061547|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15061548|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15061549|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061550|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15061551|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
15061552|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061553|NCT02153567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15061554|NCT02153567|Antidepressive Agents|antidepressive agents|mesh-ancestor
15061555|NCT02153567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15061556|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
15061557|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15061558|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15061559|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15061560|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061561|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
15061562|NCT02153593|Coagulants|coagulants|mesh-ancestor
15061563|NCT02153606|Glycerol|glycerol|mesh-list
15061564|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15061565|NCT02153606|Protective Agents|protective agents|mesh-ancestor
15061566|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061567|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
15061568|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15061569|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061570|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
15061571|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
15061572|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15061573|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15061574|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15061575|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15061576|NCT02153866|Vaccines|vaccines|mesh-list
15061577|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
15061578|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061579|NCT02153879|Niacin|niacin|mesh-list
15061580|NCT02153879|Fenofibrate|fenofibrate|mesh-list
15061581|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15061582|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
15061583|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061584|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15061585|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
15061586|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
15061587|NCT02153879|Vitamins|vitamins|mesh-ancestor
15061588|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
15061589|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061590|NCT02153944|Propranolol|propranolol|mesh-list
15061591|NCT02153944|Methylphenidate|methylphenidate|mesh-list
15061592|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15061593|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061594|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15061595|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15061596|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15061597|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061598|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
15061599|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15061600|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15061601|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15061602|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
15061603|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15061604|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15061605|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
15061606|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
15061607|NCT02154074|Isoflurane|isoflurane|mesh-list
15061608|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
15061609|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061610|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061611|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15061612|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15061613|NCT02154074|Analgesics|analgesics|mesh-ancestor
15061614|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
15061615|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061616|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15061617|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15061618|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15061619|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
15061620|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15061621|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061622|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15061623|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
15061624|NCT02154217|Timolol|timolol|mesh-list
15061625|NCT02154217|Bimatoprost|bimatoprost|mesh-list
15061626|NCT02154217|Latanoprost|latanoprost|mesh-list
15061627|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15061628|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15061629|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
15061630|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15061631|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061632|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061633|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15061634|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15061635|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15061636|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15061637|NCT02154230|Calcium|calcium|mesh-list
15061638|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15061639|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061640|NCT02154269|Lenograstim|lenograstim|mesh-list
15061641|NCT02154269|Sargramostim|sargramostim|mesh-list
15061642|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15061643|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
15061644|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061645|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
15061646|NCT02154334|Phenylephrine|phenylephrine|mesh-list
15061647|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
15061648|NCT02154334|Esketamine|esketamine|mesh-list
15061649|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15061650|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
15061651|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15061652|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
15061653|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15061654|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15061655|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15061656|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
15061657|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15061658|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061659|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061660|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
15061661|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
15061662|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061663|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
15061664|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15061665|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
15061666|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15061667|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
15061668|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15061669|NCT02154334|Protective Agents|protective agents|mesh-ancestor
15061670|NCT02154360|Aprepitant|aprepitant|mesh-list
15061671|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
15061672|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
15061673|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061674|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061675|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15061676|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15061677|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15061678|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061679|NCT02154438|Ketamine|ketamine|mesh-list
15061680|NCT02154438|Analgesics|analgesics|mesh-ancestor
15061681|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
15061682|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061683|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061684|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15061685|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15061686|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
15061687|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
15061688|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061689|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15061690|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15061691|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15061692|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061693|NCT02154464|Acetaminophen|acetaminophen|mesh-list
15061694|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15061695|NCT02154464|Analgesics|analgesics|mesh-ancestor
15061696|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
15061697|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061698|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061699|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
15061700|NCT02154503|Minoxidil|minoxidil|mesh-list
15061701|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15061702|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
15061703|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
15061704|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15061705|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15061706|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061707|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
15061708|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
15061709|NCT02154646|Gemcitabine|gemcitabine|mesh-list
15061710|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15061711|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
15061712|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061713|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061714|NCT02154646|Antiviral Agents|antiviral agents|mesh-ancestor
15061715|NCT02154646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061716|NCT02154646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061717|NCT02154646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15061718|NCT02154646|Immunologic Factors|immunologic factors|mesh-ancestor
15061719|NCT02154646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061720|NCT02154737|Gemcitabine|gemcitabine|mesh-list
15061721|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15061722|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15061723|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
15061724|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061725|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061726|NCT02154737|Antiviral Agents|antiviral agents|mesh-ancestor
15061727|NCT02154737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061728|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061729|NCT02154737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15061730|NCT02154737|Immunologic Factors|immunologic factors|mesh-ancestor
15061731|NCT02154737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061732|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15061733|NCT02154776|Letrozole|letrozole|mesh-list
15061734|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061735|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15061736|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15061737|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061738|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061739|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15061740|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
15061741|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15061742|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061743|NCT02154789|Polidocanol|polidocanol|mesh-list
15061744|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
15061745|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15061746|NCT02154854|Tacrolimus|tacrolimus|mesh-list
15061747|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15061748|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
15061749|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061750|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15061751|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061752|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061753|NCT02154932|Misoprostol|misoprostol|mesh-list
15061754|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15061755|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
15061756|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15061757|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061758|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15061759|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15061760|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
15061761|NCT02155023|Insulin|insulin|mesh-list
15061762|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15061763|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15061764|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061765|NCT02155049|Bimatoprost|bimatoprost|mesh-list
15061766|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15061767|NCT02155088|Gemcitabine|gemcitabine|mesh-list
15061768|NCT02155088|Paclitaxel|paclitaxel|mesh-list
15061769|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15061770|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061771|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
15061772|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
15061773|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
15061774|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061775|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15061776|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
15061777|NCT02155088|Antiviral Agents|antiviral agents|mesh-ancestor
15061778|NCT02155088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061779|NCT02155088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061780|NCT02155088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15061781|NCT02155088|Immunologic Factors|immunologic factors|mesh-ancestor
15061782|NCT02155088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061783|NCT02155166|Ibuprofen|ibuprofen|mesh-list
15061784|NCT02155166|Lidocaine|lidocaine|mesh-list
15061785|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
15061786|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
15061787|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061788|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061789|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
15061790|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061791|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15061792|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15061793|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15061794|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15061795|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061796|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15061797|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15061798|NCT02155166|Analgesics|analgesics|mesh-ancestor
15061799|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15061800|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15061801|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15061802|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061803|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
15061804|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15061805|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061806|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15061807|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15061808|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061809|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061810|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061811|NCT02155374|Insulin|insulin|mesh-list
15061812|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15061813|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
15061814|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
15061815|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15061816|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061817|NCT02155439|Triamcinolone|triamcinolone|mesh-list
15061818|NCT02155439|Fluorouracil|fluorouracil|mesh-list
15061819|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
15061820|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061821|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15061822|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061823|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15061824|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
15061825|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061826|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15061827|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
15061828|NCT02155439|Hormones|hormones|mesh-ancestor
15061829|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15061830|NCT02155504|Itraconazole|itraconazole|mesh-list
15061831|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
15061832|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061833|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15061834|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15061835|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061836|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061837|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15061838|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
15061839|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15061840|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061841|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15061842|NCT02155517|Propofol|propofol|mesh-list
15061843|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15061844|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061845|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061846|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15061847|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
15061848|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
15061849|NCT02155530|Atorvastatin|atorvastatin|mesh-list
15061850|NCT02155530|Pravastatin|pravastatin|mesh-list
15061851|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15061852|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15061853|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
15061854|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061855|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15061856|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15061857|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061858|NCT02155634|Lenalidomide|lenalidomide|mesh-list
15061859|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
15061860|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061861|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15061862|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15061863|NCT02155634|Growth Substances|growth substances|mesh-ancestor
15061864|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
15061865|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061866|NCT02155777|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
15061867|NCT02155777|Norinyl|norinyl|mesh-list
15061868|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15061869|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15061870|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15061871|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
15061872|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15061873|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061874|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15061875|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15061876|NCT02155777|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
15061877|NCT02155777|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15061878|NCT02155803|Hormones|hormones|mesh-list
15061879|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15061880|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
15061881|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
15061882|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15061883|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061884|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15061885|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061886|NCT02156336|Ranolazine|ranolazine|mesh-list
15061887|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15061888|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15061889|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061890|NCT02156375|Ustekinumab|ustekinumab|mesh-list
15061891|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
15061892|NCT02156570|Ribavirin|ribavirin|mesh-list
15061893|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
15061894|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
15061895|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061896|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
15061897|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15061898|NCT02156596|Ketoprofen|ketoprofen|mesh-list
15061899|NCT02156596|Morphine|morphine|mesh-list
15061900|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15061901|NCT02156596|Narcotics|narcotics|mesh-ancestor
15061902|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15061903|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061904|NCT02156596|Analgesics|analgesics|mesh-ancestor
15061905|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
15061906|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15061907|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15061908|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15061909|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15061910|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15061911|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15061912|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061913|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061914|NCT02156661|Oxytocin|oxytocin|mesh-list
15061915|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
15061916|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15061917|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061918|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
15061919|NCT02156726|Fludarabine|fludarabine|mesh-list
15061920|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15061921|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
15061922|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061923|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15061924|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15061925|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
15061926|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061927|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061928|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15061929|NCT02156739|Edetic Acid|edetic acid|mesh-list
15061930|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
15061931|NCT02156739|Antidotes|antidotes|mesh-ancestor
15061932|NCT02156739|Protective Agents|protective agents|mesh-ancestor
15061933|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061934|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
15061935|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
15061936|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061937|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15061938|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
15061939|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15061940|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
15061941|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
15061942|NCT02156843|Vitamins|vitamins|mesh-ancestor
15061943|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
15061944|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061945|NCT02156960|Denosumab|denosumab|mesh-list
15061946|NCT02156960|Teriparatide|teriparatide|mesh-list
15061947|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15061948|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061949|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15061950|NCT02156999|Vitamin D|vitamin d|mesh-list
15061951|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
15061952|NCT02156999|Vitamins|vitamins|mesh-ancestor
15061953|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
15061954|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061955|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15061956|NCT02157012|Tofacitinib|tofacitinib|mesh-list
15061957|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15061958|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061959|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061960|NCT02157077|Aflibercept|aflibercept|mesh-list
15061961|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15061962|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15061963|NCT02157077|Growth Substances|growth substances|mesh-ancestor
15061964|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061965|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
15061966|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061967|NCT02157181|Rituximab|rituximab|mesh-list
15061968|NCT02157181|Cladribine|cladribine|mesh-list
15061969|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15061970|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15061971|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
15061972|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061973|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15061974|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15061975|NCT02157207|Vitamins|vitamins|mesh-list
15061976|NCT02157207|Vitamin E|vitamin e|mesh-list
15061977|NCT02157207|Antioxidants|antioxidants|mesh-list
15061978|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
15061979|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15061980|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061981|NCT02157207|Protective Agents|protective agents|mesh-ancestor
15061982|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
15061983|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15061984|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
15061985|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15061986|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
15061987|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15061988|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15061989|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
15061990|NCT02157311|Tenofovir|tenofovir|mesh-list
15061991|NCT02157311|Lamivudine|lamivudine|mesh-list
15061992|NCT02157311|Emtricitabine|emtricitabine|mesh-list
15061993|NCT02157311|Efavirenz|efavirenz|mesh-list
15061994|NCT02157311|Lopinavir|lopinavir|mesh-list
15061995|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
15061996|NCT02157311|Darunavir|darunavir|mesh-list
15061997|NCT02157311|Abacavir|abacavir|mesh-list
15061998|NCT02157311|Rilpivirine|rilpivirine|mesh-list
15061999|NCT02157311|Etravirine|etravirine|mesh-list
15062000|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
15062001|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062002|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15062003|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15062004|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062005|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062006|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15062007|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15062008|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15062009|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15062010|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15062011|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15062012|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15062013|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15062014|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15062015|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15062016|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
15062017|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15062018|NCT02157337|Atorvastatin|atorvastatin|mesh-list
15062019|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15062020|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15062021|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
15062022|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062023|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15062024|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15062025|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062026|NCT02157415|Polihexanide|polihexanide|mesh-list
15062027|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
15062028|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062029|NCT02157428|Flumazenil|flumazenil|mesh-list
15062030|NCT02157428|Antidotes|antidotes|mesh-ancestor
15062031|NCT02157428|Protective Agents|protective agents|mesh-ancestor
15062032|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062033|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
15062034|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
15062035|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062036|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062037|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
15062038|NCT02157467|BMS-955176|bms-955176|mesh-list
15062039|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15062040|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15062041|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062042|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15062043|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15062044|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062045|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062046|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062047|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15062048|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
15062049|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15062050|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062051|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15062052|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15062053|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15062054|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15062055|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15062056|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
15062057|NCT02157558|Fexofenadine|fexofenadine|mesh-list
15062058|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15062059|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15062060|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15062061|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
15062062|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
15062063|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062064|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062065|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062066|NCT02157571|Levofloxacin|levofloxacin|mesh-list
15062067|NCT02157571|Ofloxacin|ofloxacin|mesh-list
15062068|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
15062069|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
15062070|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15062071|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062072|NCT02157571|Renal Agents|renal agents|mesh-ancestor
15062073|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15062074|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15062075|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15062076|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062077|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062078|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062079|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15062080|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15062081|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15062082|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
15062083|NCT02157649|Codeine|codeine|mesh-list
15062084|NCT02157649|Guaifenesin|guaifenesin|mesh-list
15062085|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
15062086|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15062087|NCT02157649|Narcotics|narcotics|mesh-ancestor
15062088|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15062089|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062090|NCT02157649|Analgesics|analgesics|mesh-ancestor
15062091|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
15062092|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062093|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
15062094|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
15062095|NCT02157649|Expectorants|expectorants|mesh-ancestor
15062096|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15062097|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15062098|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
15062099|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062100|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062101|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
15062102|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15062103|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
15062104|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
15062105|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
15062106|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15062107|NCT02157792|Gemcitabine|gemcitabine|mesh-list
15062108|NCT02157792|Carboplatin|carboplatin|mesh-list
15062109|NCT02157792|Irinotecan|irinotecan|mesh-list
15062110|NCT02157792|Etoposide|etoposide|mesh-list
15062111|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062112|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15062113|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
15062114|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062115|NCT02157792|Antiviral Agents|antiviral agents|mesh-ancestor
15062116|NCT02157792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062117|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062118|NCT02157792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15062119|NCT02157792|Immunologic Factors|immunologic factors|mesh-ancestor
15062120|NCT02157792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062121|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15062122|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15062123|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15062124|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15062125|NCT02157818|Midazolam|midazolam|mesh-list
15062126|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
15062127|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15062128|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15062129|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062130|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15062131|NCT02157818|Analgesics|analgesics|mesh-ancestor
15062132|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
15062133|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062134|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15062135|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15062136|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15062137|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
15062138|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062139|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062140|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15062141|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15062142|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15062143|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15062144|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15062145|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
15062146|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
15062147|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
15062148|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
15062149|NCT02158013|Diltiazem|diltiazem|mesh-list
15062150|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15062151|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15062152|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15062153|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062154|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15062155|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062156|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
15062157|NCT02158052|Tacrolimus|tacrolimus|mesh-list
15062158|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15062159|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15062160|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
15062161|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062162|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15062163|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062164|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062165|NCT02158078|Insulin|insulin|mesh-list
15062166|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15062167|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062168|NCT02158117|Naloxone|naloxone|mesh-list
15062169|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15062170|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062171|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
15062172|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062173|NCT02158143|Vitamin D|vitamin d|mesh-list
15062174|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
15062175|NCT02158143|Vitamins|vitamins|mesh-ancestor
15062176|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
15062177|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062178|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15062179|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15062180|NCT02158182|Rifaximin|rifaximin|mesh-list
15062181|NCT02158182|Lactulose|lactulose|mesh-list
15062182|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
15062183|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15062184|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062185|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15062186|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
15062187|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15062188|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062189|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062190|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062191|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
15062192|NCT02158221|Growth Substances|growth substances|mesh-ancestor
15062193|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062194|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
15062195|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062196|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062197|NCT02158286|Acetaminophen|acetaminophen|mesh-list
15062198|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15062199|NCT02158286|Analgesics|analgesics|mesh-ancestor
15062200|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
15062201|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062202|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062203|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
15062204|NCT02158481|Carotenoids|carotenoids|mesh-list
15062205|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
15062206|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062207|NCT02158481|Protective Agents|protective agents|mesh-ancestor
15062208|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062209|NCT02158585|Lamotrigine|lamotrigine|mesh-list
15062210|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
15062211|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15062212|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15062213|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062214|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15062215|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062216|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15062217|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15062218|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15062219|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15062220|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15062221|NCT02158598|Vitamin D|vitamin d|mesh-list
15062222|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
15062223|NCT02158598|Vitamins|vitamins|mesh-list
15062224|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
15062225|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062226|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15062227|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15062228|NCT02158624|Ranibizumab|ranibizumab|mesh-list
15062229|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15062230|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15062231|NCT02158624|Growth Substances|growth substances|mesh-ancestor
15062232|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062233|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
15062234|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062235|NCT02158689|Letrozole|letrozole|mesh-list
15062236|NCT02158689|Menotropins|menotropins|mesh-list
15062237|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062238|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15062239|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15062240|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062241|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062242|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15062243|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
15062244|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062245|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062246|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15062247|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
15062248|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15062249|NCT02158702|Dexamethasone|dexamethasone|mesh-list
15062250|NCT02158702|Pomalidomide|pomalidomide|mesh-list
15062251|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062252|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
15062253|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
15062254|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062255|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062256|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15062257|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
15062258|NCT02158702|Hormones|hormones|mesh-ancestor
15062259|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062260|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15062261|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062262|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
15062263|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15062264|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15062265|NCT02158702|Growth Substances|growth substances|mesh-ancestor
15062266|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
15062267|NCT02158845|Leuprolide|leuprolide|mesh-list
15062268|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
15062269|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15062270|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
15062271|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15062272|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062273|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15062274|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062275|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15062276|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
15062277|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15062278|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15062279|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15062280|NCT02158910|Donepezil|donepezil|mesh-list
15062281|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15062282|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062283|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062284|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
15062285|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062286|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062287|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
15062288|NCT02159027|Maraviroc|maraviroc|mesh-list
15062289|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15062290|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15062291|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062292|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15062293|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15062294|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
15062295|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062296|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
15062297|NCT02159066|Infigratinib|infigratinib|mesh-list
15062298|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062299|NCT02159131|Cabotegravir|cabotegravir|mesh-list
15062300|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
15062301|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15062302|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
15062303|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15062304|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062305|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15062306|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15062307|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15062308|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15062309|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15062310|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062311|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062312|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15062313|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15062314|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
15062315|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062316|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
15062317|NCT02159196|Albuterol|albuterol|mesh-list
15062318|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15062319|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
15062320|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062321|NCT02159196|Expectorants|expectorants|mesh-ancestor
15062322|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
15062323|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15062324|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
15062325|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062326|NCT02159196|Protective Agents|protective agents|mesh-ancestor
15062327|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062328|NCT02159196|Antidotes|antidotes|mesh-ancestor
15062329|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15062330|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
15062331|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062332|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15062333|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
15062334|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15062335|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15062336|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15062337|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15062338|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
15062339|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062340|NCT02159248|Gemcitabine|gemcitabine|mesh-list
15062341|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
15062342|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15062343|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
15062344|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062345|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062346|NCT02159248|Antiviral Agents|antiviral agents|mesh-ancestor
15062347|NCT02159248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062348|NCT02159248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062349|NCT02159248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15062350|NCT02159248|Immunologic Factors|immunologic factors|mesh-ancestor
15062351|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062352|NCT02159248|Analgesics|analgesics|mesh-ancestor
15062353|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
15062354|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062355|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15062356|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15062357|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062358|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15062359|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15062360|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15062361|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15062362|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
15062363|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
15062364|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062365|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15062366|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
15062367|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062368|NCT02159287|Heparin|heparin|mesh-list
15062369|NCT02159287|Calcium heparin|calcium heparin|mesh-list
15062370|NCT02159287|Enoxaparin|enoxaparin|mesh-list
15062371|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
15062372|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
15062373|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15062374|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15062375|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062376|NCT02159313|Riociguat|riociguat|mesh-list
15062377|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
15062378|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062379|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
15062380|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
15062381|NCT02159326|Riociguat|riociguat|mesh-list
15062382|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
15062383|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062384|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15062385|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
15062386|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15062387|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062388|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15062389|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15062390|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15062391|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15062392|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15062393|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
15062394|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15062395|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15062396|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15062397|NCT02159573|Natalizumab|natalizumab|mesh-list
15062398|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
15062399|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062400|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
15062401|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15062402|NCT02159599|Ritonavir|ritonavir|mesh-list
15062403|NCT02159599|Darunavir|darunavir|mesh-list
15062404|NCT02159599|Tenofovir|tenofovir|mesh-list
15062405|NCT02159599|Lamivudine|lamivudine|mesh-list
15062406|NCT02159599|Emtricitabine|emtricitabine|mesh-list
15062407|NCT02159599|Abacavir|abacavir|mesh-list
15062408|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15062409|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15062410|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
15062411|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062412|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062413|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15062414|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15062415|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
15062416|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062417|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15062418|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15062419|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15062420|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15062421|NCT02159651|Tacrolimus|tacrolimus|mesh-list
15062422|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15062423|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
15062424|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062425|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15062426|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062427|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062428|NCT02159690|Prednisone|prednisone|mesh-list
15062429|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
15062430|NCT02159690|Dutasteride|dutasteride|mesh-list
15062431|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062432|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
15062433|NCT02159690|Hormones|hormones|mesh-ancestor
15062434|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062435|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062436|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15062437|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062438|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15062439|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062440|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062441|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
15062442|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15062443|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15062444|NCT02159820|Paclitaxel|paclitaxel|mesh-list
15062445|NCT02159820|Carboplatin|carboplatin|mesh-list
15062446|NCT02159820|Decitabine|decitabine|mesh-list
15062447|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15062448|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062449|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
15062450|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
15062451|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
15062452|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062453|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15062454|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
15062455|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062456|NCT02159911|Misoprostol|misoprostol|mesh-list
15062457|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15062458|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
15062459|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15062460|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062461|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15062462|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15062463|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
15062464|NCT02160028|Anesthetics|anesthetics|mesh-list
15062465|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15062466|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062467|NCT02160054|Tacrolimus|tacrolimus|mesh-list
15062468|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15062469|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
15062470|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062471|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15062472|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062473|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062474|NCT02160080|Interferons|interferons|mesh-list
15062475|NCT02160080|Ribavirin|ribavirin|mesh-list
15062476|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
15062477|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062478|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
15062479|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062480|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
15062481|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062482|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
15062483|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062484|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
15062485|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15062486|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15062487|NCT02160132|Prednisolone|prednisolone|mesh-list
15062488|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
15062489|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15062490|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
15062491|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062492|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
15062493|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
15062494|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062495|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062496|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15062497|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
15062498|NCT02160132|Hormones|hormones|mesh-ancestor
15062499|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062500|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15062501|NCT02160132|Protective Agents|protective agents|mesh-ancestor
15062502|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15062503|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062504|NCT02160158|Fesoterodine|fesoterodine|mesh-list
15062505|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15062506|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15062507|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
15062508|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062509|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062510|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062511|NCT02160158|Urological Agents|urological agents|mesh-ancestor
15062512|NCT02160184|Pancrelipase|pancrelipase|mesh-list
15062513|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15062514|NCT02160223|Neostigmine|neostigmine|mesh-list
15062515|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15062516|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062517|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062518|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
15062519|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062520|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062521|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15062522|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
15062523|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062524|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
15062525|NCT02160236|Tenoxicam|tenoxicam|mesh-list
15062526|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15062527|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15062528|NCT02160236|Analgesics|analgesics|mesh-ancestor
15062529|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
15062530|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062531|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062532|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062533|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15062534|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15062535|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062536|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062537|NCT02160275|Insulin|insulin|mesh-list
15062538|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15062539|NCT02160275|Pancrelipase|pancrelipase|mesh-list
15062540|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15062541|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062542|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15062543|NCT02160301|Acetaminophen|acetaminophen|mesh-list
15062544|NCT02160301|Dexamethasone|dexamethasone|mesh-list
15062545|NCT02160301|Celecoxib|celecoxib|mesh-list
15062546|NCT02160301|Oxycodone|oxycodone|mesh-list
15062547|NCT02160301|Gabapentin|gabapentin|mesh-list
15062548|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062549|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
15062550|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
15062551|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062552|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062553|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15062554|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
15062555|NCT02160301|Hormones|hormones|mesh-ancestor
15062556|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062557|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15062558|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062559|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15062560|NCT02160301|Analgesics|analgesics|mesh-ancestor
15062561|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
15062562|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
15062563|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15062564|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15062565|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15062566|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15062567|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062568|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062569|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15062570|NCT02160301|Narcotics|narcotics|mesh-ancestor
15062571|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15062572|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
15062573|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15062574|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15062575|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15062576|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15062577|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15062578|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062579|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
15062580|NCT02160353|Prednisolone|prednisolone|mesh-list
15062581|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
15062582|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062583|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
15062584|NCT02160353|Hormones|hormones|mesh-ancestor
15062585|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062586|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062587|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15062588|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062589|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15062590|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062591|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062592|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
15062593|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15062594|NCT02160548|Atropine|atropine|mesh-list
15062595|NCT02160548|Albuterol|albuterol|mesh-list
15062596|NCT02160548|Pralidoxime|pralidoxime|mesh-list
15062597|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15062598|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
15062599|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062600|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062601|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15062602|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
15062603|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
15062604|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15062605|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15062606|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15062607|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15062608|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
15062609|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062610|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062611|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15062612|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15062613|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
15062614|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
15062615|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15062616|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15062617|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
15062618|NCT02160548|Antidotes|antidotes|mesh-ancestor
15062619|NCT02160548|Protective Agents|protective agents|mesh-ancestor
15062620|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
15062621|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
15062622|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
15062623|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15062624|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15062625|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062626|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
15062627|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
15062628|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
15062629|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15062630|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15062631|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062632|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
15062633|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
15062634|NCT02160704|Enclomiphene|enclomiphene|mesh-list
15062635|NCT02160704|Clomiphene|clomiphene|mesh-list
15062636|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
15062637|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15062638|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
15062639|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062640|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062641|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15062642|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
15062643|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15062644|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15062645|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15062646|NCT02160743|Metformin|metformin|mesh-list
15062647|NCT02160743|Atorvastatin|atorvastatin|mesh-list
15062648|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15062649|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062650|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15062651|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15062652|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
15062653|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062654|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15062655|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15062656|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062657|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
15062658|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15062659|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062660|NCT02161055|Insulin|insulin|mesh-list
15062661|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15062662|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15062663|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062664|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
15062665|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15062666|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15062667|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15062668|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15062669|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062670|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
15062671|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062672|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062673|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15062674|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062675|NCT02161237|Tacrolimus|tacrolimus|mesh-list
15062676|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15062677|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
15062678|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062679|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15062680|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062681|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062682|NCT02161354|Buprenorphine|buprenorphine|mesh-list
15062683|NCT02161354|Naloxone|naloxone|mesh-list
15062684|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15062685|NCT02161354|Narcotics|narcotics|mesh-ancestor
15062686|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15062687|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062688|NCT02161354|Analgesics|analgesics|mesh-ancestor
15062689|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
15062690|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062691|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15062692|NCT02161367|Simethicone|simethicone|mesh-list
15062693|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
15062694|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062695|NCT02161367|Emollients|emollients|mesh-ancestor
15062696|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
15062697|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15062698|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15062699|NCT02161614|Estradiol|estradiol|mesh-list
15062700|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15062701|NCT02161614|Estrogens|estrogens|mesh-ancestor
15062702|NCT02161614|Hormones|hormones|mesh-ancestor
15062703|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062704|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062705|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15062706|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
15062707|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15062708|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15062709|NCT02161653|Pyridoxine|pyridoxine|mesh-list
15062710|NCT02161653|Prednisone|prednisone|mesh-list
15062711|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
15062712|NCT02161653|Metadoxine|metadoxine|mesh-list
15062713|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062714|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
15062715|NCT02161653|Hormones|hormones|mesh-ancestor
15062716|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062717|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062718|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15062719|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062720|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15062721|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062722|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062723|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15062724|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15062725|NCT02161653|Protective Agents|protective agents|mesh-ancestor
15062726|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
15062727|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15062728|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
15062729|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15062730|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
15062731|NCT02161653|Vitamins|vitamins|mesh-ancestor
15062732|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
15062733|NCT02161679|Carboplatin|carboplatin|mesh-list
15062734|NCT02161679|Camptothecin|camptothecin|mesh-list
15062735|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
15062736|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062737|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15062738|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15062739|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15062740|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062741|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062742|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
15062743|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062744|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
15062745|NCT02161692|Carboplatin|carboplatin|mesh-list
15062746|NCT02161692|Etoposide|etoposide|mesh-list
15062747|NCT02161692|Bleomycin|bleomycin|mesh-list
15062748|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15062749|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
15062750|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062751|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15062752|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15062753|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
15062754|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062755|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062756|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15062757|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15062758|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15062759|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15062760|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062761|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15062762|NCT02161770|Osimertinib|osimertinib|mesh-list
15062763|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062764|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15062765|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062766|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062767|NCT02161822|Simvastatin|simvastatin|mesh-list
15062768|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15062769|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15062770|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
15062771|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062772|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15062773|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15062774|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062775|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
15062776|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
15062777|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062778|NCT02161952|Pirfenidone|pirfenidone|mesh-list
15062779|NCT02161952|Analgesics|analgesics|mesh-ancestor
15062780|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
15062781|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062782|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062783|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15062784|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15062785|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062786|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15062787|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062788|NCT02161965|Warfarin|warfarin|mesh-list
15062789|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
15062790|NCT02161965|Fluindione|fluindione|mesh-list
15062791|NCT02161965|Phenindione|phenindione|mesh-list
15062792|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
15062793|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15062794|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
15062795|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15062796|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
15062797|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062798|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062799|NCT02161991|Aprepitant|aprepitant|mesh-list
15062800|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
15062801|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
15062802|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062803|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062804|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15062805|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15062806|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062807|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062808|NCT02162121|Ketorolac|ketorolac|mesh-list
15062809|NCT02162121|Buprenorphine|buprenorphine|mesh-list
15062810|NCT02162121|Anesthetics|anesthetics|mesh-list
15062811|NCT02162121|Ropivacaine|ropivacaine|mesh-list
15062812|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
15062813|NCT02162121|Mepivacaine|mepivacaine|mesh-list
15062814|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
15062815|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15062816|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062817|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
15062818|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062819|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15062820|NCT02162121|Narcotics|narcotics|mesh-ancestor
15062821|NCT02162121|Analgesics|analgesics|mesh-ancestor
15062822|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15062823|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15062824|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15062825|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062826|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15062827|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15062828|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062829|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062830|NCT02162134|Cefuroxime|cefuroxime|mesh-list
15062831|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
15062832|NCT02162134|Ketorolac|ketorolac|mesh-list
15062833|NCT02162134|Midazolam|midazolam|mesh-list
15062834|NCT02162134|Propofol|propofol|mesh-list
15062835|NCT02162134|Sevoflurane|sevoflurane|mesh-list
15062836|NCT02162134|Atracurium|atracurium|mesh-list
15062837|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15062838|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15062839|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062840|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15062841|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
15062842|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
15062843|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15062844|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15062845|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15062846|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15062847|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
15062848|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
15062849|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062850|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062851|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15062852|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15062853|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15062854|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15062855|NCT02162134|Analgesics|analgesics|mesh-ancestor
15062856|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
15062857|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062858|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062859|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15062860|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15062861|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062862|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15062863|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15062864|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15062865|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15062866|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15062867|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15062868|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15062869|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
15062870|NCT02162251|Donepezil|donepezil|mesh-list
15062871|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15062872|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062873|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062874|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
15062875|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062876|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062877|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
15062878|NCT02162264|Donepezil|donepezil|mesh-list
15062879|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15062880|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062881|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062882|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
15062883|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062884|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062885|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
15062886|NCT02162303|Colchicine|colchicine|mesh-list
15062887|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
15062888|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15062889|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
15062890|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
15062891|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
15062892|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062893|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062894|NCT02162381|Methylphenidate|methylphenidate|mesh-list
15062895|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15062896|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062897|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15062898|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15062899|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15062900|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062901|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
15062902|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062903|NCT02162407|Insulin|insulin|mesh-list
15062904|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15062905|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
15062906|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15062907|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062908|NCT02162485|Fluticasone|fluticasone|mesh-list
15062909|NCT02162485|Xhance|xhance|mesh-list
15062910|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15062911|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15062912|NCT02162485|Charcoal|charcoal|mesh-list
15062913|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062914|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15062915|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
15062916|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062917|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062918|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15062919|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
15062920|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
15062921|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15062922|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15062923|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15062924|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15062925|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
15062926|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062927|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062928|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
15062929|NCT02162485|Hormones|hormones|mesh-ancestor
15062930|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062931|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
15062932|NCT02162485|Antidotes|antidotes|mesh-ancestor
15062933|NCT02162485|Protective Agents|protective agents|mesh-ancestor
15062934|NCT02162537|Bevacizumab|bevacizumab|mesh-list
15062935|NCT02162537|Pemetrexed|pemetrexed|mesh-list
15062936|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15062937|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062938|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15062939|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15062940|NCT02162537|Growth Substances|growth substances|mesh-ancestor
15062941|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062942|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
15062943|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15062944|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062945|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15062946|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15062947|NCT02162550|Exenatide|exenatide|mesh-list
15062948|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15062949|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062950|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15062951|NCT02162550|Incretins|incretins|mesh-ancestor
15062952|NCT02162550|Hormones|hormones|mesh-ancestor
15062953|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062954|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
15062955|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15062956|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
15062957|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062958|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
15062959|NCT02162693|Protective Agents|protective agents|mesh-ancestor
15062960|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15062961|NCT02162784|Budesonide|budesonide|mesh-list
15062962|NCT02162784|Albuterol|albuterol|mesh-list
15062963|NCT02162784|Procaterol|procaterol|mesh-list
15062964|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062965|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15062966|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
15062967|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15062968|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062969|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15062970|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
15062971|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
15062972|NCT02162784|Hormones|hormones|mesh-ancestor
15062973|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062974|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
15062975|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15062976|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15062977|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15062978|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15062979|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
15062980|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15062981|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15062982|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
15062983|NCT02162797|Zinc|zinc|mesh-list
15062984|NCT02162797|Trace Elements|trace elements|mesh-ancestor
15062985|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
15062986|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062987|NCT02162810|Prednisolone|prednisolone|mesh-list
15062988|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15062989|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
15062990|NCT02162810|Hormones|hormones|mesh-ancestor
15062991|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15062992|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15062993|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15062994|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15062995|NCT02162849|Nicotine|nicotine|mesh-list
15062996|NCT02162849|Varenicline|varenicline|mesh-list
15062997|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15062998|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
15062999|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063000|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063001|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15063002|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15063003|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
15063004|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063005|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063006|NCT02162875|Praziquantel|praziquantel|mesh-list
15063007|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
15063008|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15063009|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063010|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15063011|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15063012|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
15063013|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063014|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063015|NCT02162966|Colistin|colistin|mesh-list
15063016|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15063017|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063018|NCT02163070|Vitamins|vitamins|mesh-list
15063019|NCT02163070|Vitamin E|vitamin e|mesh-list
15063020|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
15063021|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063022|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
15063023|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063024|NCT02163070|Protective Agents|protective agents|mesh-ancestor
15063025|NCT02163161|Abrocitinib|abrocitinib|mesh-list
15063026|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15063027|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063028|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063029|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
15063030|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15063031|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063032|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063033|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15063034|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15063035|NCT02163174|Protective Agents|protective agents|mesh-ancestor
15063036|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063037|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
15063038|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15063039|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
15063040|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
15063041|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15063042|NCT02163213|Antibodies|antibodies|mesh-list
15063043|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
15063044|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063045|NCT02163291|Paclitaxel|paclitaxel|mesh-list
15063046|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15063047|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063048|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
15063049|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
15063050|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
15063051|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063052|NCT02163330|Acetazolamide|acetazolamide|mesh-list
15063053|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
15063054|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15063055|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063056|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063057|NCT02163330|Diuretics|diuretics|mesh-ancestor
15063058|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
15063059|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063060|NCT02163616|Misoprostol|misoprostol|mesh-list
15063061|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15063062|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
15063063|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15063064|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063065|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15063066|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15063067|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
15063068|NCT02163655|Furosemide|furosemide|mesh-list
15063069|NCT02163655|Diuretics|diuretics|mesh-ancestor
15063070|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
15063071|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063072|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15063073|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15063074|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063075|NCT02163707|Psilocybin|psilocybin|mesh-list
15063076|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
15063077|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063078|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15063079|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15063080|NCT02163720|Doxorubicin|doxorubicin|mesh-list
15063081|NCT02163720|Trabectedin|trabectedin|mesh-list
15063082|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15063083|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063084|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15063085|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15063086|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063087|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063088|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15063089|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
15063090|NCT02163954|Clopidogrel|clopidogrel|mesh-list
15063091|NCT02163954|Ticagrelor|ticagrelor|mesh-list
15063092|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15063093|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15063094|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15063095|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15063096|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
15063097|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063098|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063099|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063100|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
15063101|NCT02163980|Ropivacaine|ropivacaine|mesh-list
15063102|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15063103|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063104|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063105|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15063106|NCT02163980|Analgesics|analgesics|mesh-ancestor
15063107|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
15063108|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063109|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15063110|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15063111|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15063112|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
15063113|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063114|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063115|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
15063116|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
15063117|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15063118|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15063119|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15063120|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063121|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
15063122|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063123|NCT02164032|Insulin|insulin|mesh-list
15063124|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15063125|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15063126|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063127|NCT02164045|Fostemsavir|fostemsavir|mesh-list
15063128|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15063129|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15063130|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
15063131|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063132|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15063133|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15063134|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063135|NCT02164097|Heparin|heparin|mesh-list
15063136|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
15063137|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15063138|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15063139|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063140|NCT02164110|Vaccines|vaccines|mesh-list
15063141|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
15063142|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063143|NCT02164214|Etanercept|etanercept|mesh-list
15063144|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15063145|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15063146|NCT02164214|Analgesics|analgesics|mesh-ancestor
15063147|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
15063148|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063149|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063150|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15063151|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15063152|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15063153|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15063154|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
15063155|NCT02164253|Deferiprone|deferiprone|mesh-list
15063156|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15063157|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
15063158|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
15063159|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063160|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
15063161|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15063162|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063163|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
15063164|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15063165|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063166|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063167|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15063168|NCT02164448|Analgesics|analgesics|mesh-ancestor
15063169|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
15063170|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063171|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15063172|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15063173|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15063174|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
15063175|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063176|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063177|NCT02164552|Vitamin D|vitamin d|mesh-list
15063178|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
15063179|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
15063180|NCT02164552|Vitamins|vitamins|mesh-list
15063181|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
15063182|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063183|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15063184|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15063185|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
15063186|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15063187|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15063188|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063189|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
15063190|NCT02164565|Coagulants|coagulants|mesh-ancestor
15063191|NCT02164578|Aspirin|aspirin|mesh-list
15063192|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
15063193|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15063194|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15063195|NCT02164578|Analgesics|analgesics|mesh-ancestor
15063196|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
15063197|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063198|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063199|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15063200|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15063201|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15063202|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15063203|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063204|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15063205|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15063206|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063207|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
15063208|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15063209|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
15063210|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15063211|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
15063212|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
15063213|NCT02164604|Ranibizumab|ranibizumab|mesh-list
15063214|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15063215|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15063216|NCT02164604|Growth Substances|growth substances|mesh-ancestor
15063217|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063218|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
15063219|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063220|NCT02164734|Remifentanil|remifentanil|mesh-list
15063221|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15063222|NCT02164734|Narcotics|narcotics|mesh-ancestor
15063223|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063224|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063225|NCT02164734|Analgesics|analgesics|mesh-ancestor
15063226|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
15063227|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063228|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
15063229|NCT02164773|Analgesics|analgesics|mesh-ancestor
15063230|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
15063231|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063232|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063233|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
15063234|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063235|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15063236|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
15063237|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15063238|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15063239|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063240|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15063241|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
15063242|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15063243|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
15063244|NCT02164812|Efavirenz|efavirenz|mesh-list
15063245|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15063246|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063247|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15063248|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15063249|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063250|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063251|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063252|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15063253|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15063254|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
15063255|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15063256|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15063257|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15063258|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15063259|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15063260|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15063261|NCT02164825|Morphine|morphine|mesh-list
15063262|NCT02164825|Ropivacaine|ropivacaine|mesh-list
15063263|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15063264|NCT02164825|Narcotics|narcotics|mesh-ancestor
15063265|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063266|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063267|NCT02164825|Analgesics|analgesics|mesh-ancestor
15063268|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
15063269|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063270|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
15063271|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
15063272|NCT02164838|Axitinib|axitinib|mesh-list
15063273|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063274|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15063275|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063276|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063277|NCT02164890|Micafungin|micafungin|mesh-list
15063278|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
15063279|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063280|NCT02164955|Pomalidomide|pomalidomide|mesh-list
15063281|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
15063282|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063283|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15063284|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15063285|NCT02164955|Growth Substances|growth substances|mesh-ancestor
15063286|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
15063287|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063288|NCT02165007|Sirolimus|sirolimus|mesh-list
15063289|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15063290|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063291|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15063292|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063293|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
15063294|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15063295|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
15063296|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063297|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
15063298|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15063299|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
15063300|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063301|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
15063302|NCT02165020|Protective Agents|protective agents|mesh-ancestor
15063303|NCT02165033|Budesonide|budesonide|mesh-list
15063304|NCT02165033|Procaterol|procaterol|mesh-list
15063305|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15063306|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15063307|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
15063308|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063309|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063310|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15063311|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
15063312|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
15063313|NCT02165033|Hormones|hormones|mesh-ancestor
15063314|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15063315|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
15063316|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15063317|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15063318|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15063319|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
15063320|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063321|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063322|NCT02165046|Budesonide|budesonide|mesh-list
15063323|NCT02165046|Procaterol|procaterol|mesh-list
15063324|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15063325|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15063326|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
15063327|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063328|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063329|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15063330|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
15063331|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
15063332|NCT02165046|Hormones|hormones|mesh-ancestor
15063333|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15063334|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
15063335|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15063336|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15063337|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15063338|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
15063339|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063340|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063341|NCT02165098|Cariprazine|cariprazine|mesh-list
15063342|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15063343|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15063344|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063345|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063346|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15063347|NCT02165189|Ribavirin|ribavirin|mesh-list
15063348|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
15063349|NCT02165189|Simeprevir|simeprevir|mesh-list
15063350|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
15063351|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063352|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
15063353|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063354|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
15063355|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063356|NCT02165215|Etrolizumab|etrolizumab|mesh-list
15063357|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15063358|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
15063359|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063360|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
15063361|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15063362|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15063363|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063364|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15063365|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15063366|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063367|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063368|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063369|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15063370|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
15063371|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15063372|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063373|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15063374|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15063375|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15063376|NCT02165449|Ketamine|ketamine|mesh-list
15063377|NCT02165449|Analgesics|analgesics|mesh-ancestor
15063378|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
15063379|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063380|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063381|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15063382|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15063383|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
15063384|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
15063385|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063386|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15063387|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15063388|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063389|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063390|NCT02165475|Loperamide|loperamide|mesh-list
15063391|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
15063392|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15063393|NCT02165566|Insulin|insulin|mesh-list
15063394|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15063395|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
15063396|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15063397|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063398|NCT02165644|Nimodipine|nimodipine|mesh-list
15063399|NCT02165644|Acetazolamide|acetazolamide|mesh-list
15063400|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
15063401|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15063402|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063403|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063404|NCT02165644|Diuretics|diuretics|mesh-ancestor
15063405|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
15063406|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063407|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15063408|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15063409|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15063410|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15063411|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
15063412|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
15063413|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063414|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063415|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
15063416|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15063417|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063418|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
15063419|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15063420|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
15063421|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063422|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
15063423|NCT02165917|Protective Agents|protective agents|mesh-ancestor
15063424|NCT02165930|Naltrexone|naltrexone|mesh-list
15063425|NCT02165930|Oxycodone|oxycodone|mesh-list
15063426|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15063427|NCT02165930|Narcotics|narcotics|mesh-ancestor
15063428|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063429|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063430|NCT02165930|Analgesics|analgesics|mesh-ancestor
15063431|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
15063432|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063433|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15063434|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15063435|NCT02166229|Valproic Acid|valproic acid|mesh-list
15063436|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
15063437|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063438|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063439|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
15063440|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063441|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063442|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
15063443|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15063444|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063445|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15063446|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15063447|NCT02166359|Icodextrin|icodextrin|mesh-list
15063448|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
15063449|NCT02166450|Nystatin|nystatin|mesh-list
15063450|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15063451|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063452|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
15063453|NCT02166450|Ionophores|ionophores|mesh-ancestor
15063454|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15063455|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063456|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
15063457|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15063458|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
15063459|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063460|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
15063461|NCT02166554|Protective Agents|protective agents|mesh-ancestor
15063462|NCT02166593|Atorvastatin|atorvastatin|mesh-list
15063463|NCT02166593|Pravastatin|pravastatin|mesh-list
15063464|NCT02166593|Fenofibrate|fenofibrate|mesh-list
15063465|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15063466|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15063467|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
15063468|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063469|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15063470|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15063471|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063472|NCT02166632|Bupivacaine|bupivacaine|mesh-list
15063473|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
15063474|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
15063475|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063476|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063477|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
15063478|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063479|NCT02166671|Vaccines|vaccines|mesh-list
15063480|NCT02166671|Immunologic Factors|immunologic factors|mesh-ancestor
15063481|NCT02166671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063482|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15063483|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15063484|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15063485|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
15063486|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063487|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15063488|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15063489|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063490|NCT02166853|Midazolam|midazolam|mesh-list
15063491|NCT02166853|Sevoflurane|sevoflurane|mesh-list
15063492|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15063493|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15063494|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063495|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063496|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15063497|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15063498|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15063499|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15063500|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
15063501|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
15063502|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
15063503|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
15063504|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063505|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063506|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15063507|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15063508|NCT02166905|Poly I-C|poly i-c|mesh-list
15063509|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15063510|NCT02166905|Poly ICLC|poly iclc|mesh-list
15063511|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
15063512|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
15063513|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063514|NCT02166905|Laxatives|laxatives|mesh-ancestor
15063515|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15063516|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
15063517|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063518|NCT02166944|Tamoxifen|tamoxifen|mesh-list
15063519|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15063520|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
15063521|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15063522|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063523|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15063524|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063525|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15063526|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15063527|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15063528|NCT02167061|Metformin|metformin|mesh-list
15063529|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15063530|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063531|NCT02167165|Digoxin|digoxin|mesh-list
15063532|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15063533|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15063534|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063535|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063536|NCT02167165|Protective Agents|protective agents|mesh-ancestor
15063537|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063538|NCT02167178|Polygeline|polygeline|mesh-list
15063539|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
15063540|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
15063541|NCT02167321|Leucovorin|leucovorin|mesh-list
15063542|NCT02167321|Fluorouracil|fluorouracil|mesh-list
15063543|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
15063544|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
15063545|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063546|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15063547|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063548|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15063549|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
15063550|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063551|NCT02167321|Antidotes|antidotes|mesh-ancestor
15063552|NCT02167321|Protective Agents|protective agents|mesh-ancestor
15063553|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
15063554|NCT02167321|Vitamins|vitamins|mesh-ancestor
15063555|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
15063556|NCT02167425|Methadone|methadone|mesh-list
15063557|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15063558|NCT02167425|Narcotics|narcotics|mesh-ancestor
15063559|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063560|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063561|NCT02167425|Analgesics|analgesics|mesh-ancestor
15063562|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
15063563|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063564|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
15063565|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
15063566|NCT02167464|Coal Tar|coal tar|mesh-list
15063567|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
15063568|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
15063569|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
15063570|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
15063571|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15063572|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063573|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15063574|NCT02167464|Diuretics|diuretics|mesh-ancestor
15063575|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
15063576|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
15063577|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
15063578|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
15063579|NCT02167620|Metformin|metformin|mesh-list
15063580|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15063581|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063582|NCT02167633|Pantoprazole|pantoprazole|mesh-list
15063583|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15063584|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
15063585|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15063586|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15063587|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063588|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063589|NCT02167633|Hormones|hormones|mesh-ancestor
15063590|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15063591|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063592|NCT02167685|Brincidofovir|brincidofovir|mesh-list
15063593|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
15063594|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063595|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
15063596|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15063597|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15063598|NCT02167698|Prednisolone|prednisolone|mesh-list
15063599|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
15063600|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15063601|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
15063602|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15063603|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
15063604|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
15063605|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063606|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063607|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15063608|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
15063609|NCT02167698|Hormones|hormones|mesh-ancestor
15063610|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15063611|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15063612|NCT02167698|Protective Agents|protective agents|mesh-ancestor
15063613|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15063614|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063615|NCT02167854|Trastuzumab|trastuzumab|mesh-list
15063616|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15063617|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063618|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
15063619|NCT02167958|Fludarabine|fludarabine|mesh-list
15063620|NCT02167958|Tacrolimus|tacrolimus|mesh-list
15063621|NCT02167958|Sargramostim|sargramostim|mesh-list
15063622|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15063623|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
15063624|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063625|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15063626|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15063627|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
15063628|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063629|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063630|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15063631|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15063632|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063633|NCT02168010|Neurotropin|neurotropin|mesh-list
15063634|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15063635|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
15063636|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063637|NCT02168010|Analgesics|analgesics|mesh-ancestor
15063638|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
15063639|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063640|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
15063641|NCT02168075|Mannitol|mannitol|mesh-list
15063642|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15063643|NCT02168075|Diuretics|diuretics|mesh-ancestor
15063644|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
15063645|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063646|NCT02168127|Methylphenidate|methylphenidate|mesh-list
15063647|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15063648|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063649|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15063650|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15063651|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15063652|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063653|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
15063654|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063655|NCT02168205|Pomalidomide|pomalidomide|mesh-list
15063656|NCT02168205|Caffeine|caffeine|mesh-list
15063657|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15063658|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063659|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15063660|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063661|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063662|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15063663|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15063664|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
15063665|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063666|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
15063667|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15063668|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15063669|NCT02168205|Growth Substances|growth substances|mesh-ancestor
15063670|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
15063671|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063672|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
15063673|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15063674|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
15063675|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063676|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
15063677|NCT02168426|Protective Agents|protective agents|mesh-ancestor
15063678|NCT02168543|Alendronate|alendronate|mesh-list
15063679|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15063680|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063681|NCT02168569|Artesunate|artesunate|mesh-list
15063682|NCT02168569|Lumefantrine|lumefantrine|mesh-list
15063683|NCT02168569|Artemether|artemether|mesh-list
15063684|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15063685|NCT02168569|Amodiaquine|amodiaquine|mesh-list
15063686|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
15063687|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15063688|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15063689|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063690|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063691|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
15063692|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
15063693|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15063694|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
15063695|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
15063696|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15063697|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15063698|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063699|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
15063700|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063701|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063702|NCT02168751|Propofol|propofol|mesh-list
15063703|NCT02168751|Sevoflurane|sevoflurane|mesh-list
15063704|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15063705|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063706|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063707|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15063708|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
15063709|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
15063710|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15063711|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15063712|NCT02168881|Misoprostol|misoprostol|mesh-list
15063713|NCT02168881|Dinoprostone|dinoprostone|mesh-list
15063714|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15063715|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
15063716|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15063717|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063718|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15063719|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15063720|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
15063721|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
15063722|NCT02168907|Rituximab|rituximab|mesh-list
15063723|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15063724|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15063725|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063726|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
15063727|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063728|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15063729|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15063730|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
15063731|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063732|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
15063733|NCT02168907|Protective Agents|protective agents|mesh-ancestor
15063734|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
15063735|NCT02168907|Vitamins|vitamins|mesh-ancestor
15063736|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
15063737|NCT02168959|Bupivacaine|bupivacaine|mesh-list
15063738|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
15063739|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
15063740|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063741|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063742|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
15063743|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063744|NCT02169063|Listerine|listerine|mesh-list
15063745|NCT02169063|Fluorides|fluorides|mesh-list
15063746|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
15063747|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
15063748|NCT02169063|Protective Agents|protective agents|mesh-ancestor
15063749|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063750|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15063751|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063752|NCT02169089|Spironolactone|spironolactone|mesh-list
15063753|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15063754|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
15063755|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15063756|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063757|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15063758|NCT02169089|Diuretics|diuretics|mesh-ancestor
15063759|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
15063760|NCT02169154|Diclofenac|diclofenac|mesh-list
15063761|NCT02169154|Menthol|menthol|mesh-list
15063762|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15063763|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15063764|NCT02169154|Analgesics|analgesics|mesh-ancestor
15063765|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
15063766|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063767|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063768|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15063769|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15063770|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15063771|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063772|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063773|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
15063774|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
15063775|NCT02169167|Octenidine|octenidine|mesh-list
15063776|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063777|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15063778|NCT02169544|Abatacept|abatacept|mesh-list
15063779|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15063780|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063781|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063782|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15063783|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
15063784|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063785|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15063786|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
15063787|NCT02169570|Vitamin D|vitamin d|mesh-list
15063788|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
15063789|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
15063790|NCT02169570|Vitamins|vitamins|mesh-list
15063791|NCT02169570|Calcium|calcium|mesh-list
15063792|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
15063793|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063794|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15063795|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15063796|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15063797|NCT02169596|Ticagrelor|ticagrelor|mesh-list
15063798|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15063799|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15063800|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15063801|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15063802|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
15063803|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063804|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063805|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063806|NCT02169609|Interleukin-2|interleukin-2|mesh-list
15063807|NCT02169609|Dinutuximab|dinutuximab|mesh-list
15063808|NCT02169609|Isotretinoin|isotretinoin|mesh-list
15063809|NCT02169609|Sargramostim|sargramostim|mesh-list
15063810|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063811|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15063812|NCT02169609|Analgesics|analgesics|mesh-ancestor
15063813|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
15063814|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063815|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063816|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
15063817|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
15063818|NCT02169648|Ranibizumab|ranibizumab|mesh-list
15063819|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15063820|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15063821|NCT02169648|Growth Substances|growth substances|mesh-ancestor
15063822|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063823|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
15063824|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063825|NCT02169713|Tamsulosin|tamsulosin|mesh-list
15063826|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
15063827|NCT02169713|Mirabegron|mirabegron|mesh-list
15063828|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15063829|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15063830|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15063831|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
15063832|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063833|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063834|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063835|NCT02169713|Urological Agents|urological agents|mesh-ancestor
15063836|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15063837|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15063838|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
15063839|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15063840|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15063841|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15063842|NCT02169752|Ambrisentan|ambrisentan|mesh-list
15063843|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15063844|NCT02169804|Enclomiphene|enclomiphene|mesh-list
15063845|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15063846|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
15063847|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15063848|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063849|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15063850|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
15063851|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15063852|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15063853|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15063854|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
15063855|NCT02169843|Sevoflurane|sevoflurane|mesh-list
15063856|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15063857|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063858|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063859|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15063860|NCT02169843|Analgesics|analgesics|mesh-ancestor
15063861|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
15063862|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063863|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15063864|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15063865|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15063866|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
15063867|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063868|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063869|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15063870|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15063871|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
15063872|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
15063873|NCT02169856|Cefuroxime|cefuroxime|mesh-list
15063874|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
15063875|NCT02169856|Ketorolac|ketorolac|mesh-list
15063876|NCT02169856|Midazolam|midazolam|mesh-list
15063877|NCT02169856|Propofol|propofol|mesh-list
15063878|NCT02169856|Sevoflurane|sevoflurane|mesh-list
15063879|NCT02169856|Atracurium|atracurium|mesh-list
15063880|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15063881|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15063882|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063883|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15063884|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
15063885|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
15063886|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15063887|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15063888|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15063889|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15063890|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
15063891|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
15063892|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15063893|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063894|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15063895|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15063896|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15063897|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15063898|NCT02169856|Analgesics|analgesics|mesh-ancestor
15063899|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
15063900|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063901|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15063902|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15063903|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15063904|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063905|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15063906|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063907|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15063908|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15063909|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15063910|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15063911|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15063912|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
15063913|NCT02169882|Rifampin|rifampin|mesh-list
15063914|NCT02169882|Dexamethasone|dexamethasone|mesh-list
15063915|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15063916|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
15063917|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
15063918|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063919|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063920|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15063921|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
15063922|NCT02169882|Hormones|hormones|mesh-ancestor
15063923|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15063924|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15063925|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063926|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15063927|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
15063928|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15063929|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063930|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
15063931|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15063932|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063933|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063934|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15063935|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15063936|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15063937|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15063938|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15063939|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15063940|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
15063941|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063942|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063943|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
15063944|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
15063945|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15063946|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
15063947|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15063948|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063949|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15063950|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15063951|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15063952|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15063953|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15063954|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
15063955|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15063956|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15063957|NCT02170090|Gemcitabine|gemcitabine|mesh-list
15063958|NCT02170090|Capecitabine|capecitabine|mesh-list
15063959|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15063960|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15063961|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
15063962|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063963|NCT02170090|Antiviral Agents|antiviral agents|mesh-ancestor
15063964|NCT02170090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15063965|NCT02170090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063966|NCT02170090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15063967|NCT02170090|Immunologic Factors|immunologic factors|mesh-ancestor
15063968|NCT02170090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063969|NCT02170116|Dabigatran|dabigatran|mesh-list
15063970|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
15063971|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15063972|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
15063973|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15063974|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063975|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
15063976|NCT02170246|Telmisartan|telmisartan|mesh-list
15063977|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15063978|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15063979|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15063980|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15063981|NCT02170324|Exenatide|exenatide|mesh-list
15063982|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15063983|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063984|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15063985|NCT02170324|Incretins|incretins|mesh-ancestor
15063986|NCT02170324|Hormones|hormones|mesh-ancestor
15063987|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15063988|NCT02170402|Factor VIII|factor viii|mesh-list
15063989|NCT02170402|Coagulants|coagulants|mesh-ancestor
15063990|NCT02170415|Pregabalin|pregabalin|mesh-list
15063991|NCT02170415|Anesthetics|anesthetics|mesh-list
15063992|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
15063993|NCT02170415|Analgesics|analgesics|mesh-ancestor
15063994|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
15063995|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15063996|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15063997|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
15063998|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15063999|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15064000|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064001|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15064002|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15064003|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15064004|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15064005|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15064006|NCT02170571|Dabigatran|dabigatran|mesh-list
15064007|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
15064008|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064009|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064010|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064011|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064012|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
15064013|NCT02170584|Dabigatran|dabigatran|mesh-list
15064014|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
15064015|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064016|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064017|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064018|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064019|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
15064020|NCT02170597|Dabigatran|dabigatran|mesh-list
15064021|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
15064022|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064023|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064024|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064025|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064026|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
15064027|NCT02170610|Pantoprazole|pantoprazole|mesh-list
15064028|NCT02170610|Dabigatran|dabigatran|mesh-list
15064029|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15064030|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15064031|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15064032|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064033|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064034|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
15064035|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064036|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064037|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
15064038|NCT02170623|Pantoprazole|pantoprazole|mesh-list
15064039|NCT02170623|Dabigatran|dabigatran|mesh-list
15064040|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15064041|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15064042|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15064043|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064044|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064045|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
15064046|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064047|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064048|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
15064049|NCT02170636|Pantoprazole|pantoprazole|mesh-list
15064050|NCT02170636|Dabigatran|dabigatran|mesh-list
15064051|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15064052|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15064053|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15064054|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064055|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064056|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
15064057|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064058|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064059|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
15064060|NCT02170675|Ketoconazole|ketoconazole|mesh-list
15064061|NCT02170675|Dabigatran|dabigatran|mesh-list
15064062|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
15064063|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064064|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064065|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064066|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064067|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
15064068|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
15064069|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15064070|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15064071|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15064072|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15064073|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
15064074|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15064075|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064076|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15064077|NCT02170701|Dabigatran|dabigatran|mesh-list
15064078|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
15064079|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064080|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064081|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064082|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064083|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
15064084|NCT02170740|Pantoprazole|pantoprazole|mesh-list
15064085|NCT02170740|Dabigatran|dabigatran|mesh-list
15064086|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15064087|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15064088|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15064089|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064090|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064091|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
15064092|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064093|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064094|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
15064095|NCT02170766|Pantoprazole|pantoprazole|mesh-list
15064096|NCT02170766|Dabigatran|dabigatran|mesh-list
15064097|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15064098|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15064099|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15064100|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064101|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064102|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
15064103|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064104|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064105|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
15064106|NCT02170792|Ranitidine|ranitidine|mesh-list
15064107|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
15064108|NCT02170792|Dabigatran|dabigatran|mesh-list
15064109|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15064110|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15064111|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15064112|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
15064113|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
15064114|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064115|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064116|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064117|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
15064118|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064119|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064120|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064121|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
15064122|NCT02170805|Pantoprazole|pantoprazole|mesh-list
15064123|NCT02170805|Dabigatran|dabigatran|mesh-list
15064124|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15064125|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15064126|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15064127|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064128|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064129|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
15064130|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064131|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064132|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
15064133|NCT02170831|Dabigatran|dabigatran|mesh-list
15064134|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
15064135|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064136|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064137|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064138|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064139|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
15064140|NCT02170844|Dabigatran|dabigatran|mesh-list
15064141|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
15064142|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064143|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064144|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064145|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064146|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
15064147|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
15064148|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15064149|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
15064150|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064151|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
15064152|NCT02170857|Protective Agents|protective agents|mesh-ancestor
15064153|NCT02170896|Pantoprazole|pantoprazole|mesh-list
15064154|NCT02170896|Dabigatran|dabigatran|mesh-list
15064155|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15064156|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15064157|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15064158|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064159|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064160|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
15064161|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064162|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064163|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
15064164|NCT02170909|Dabigatran|dabigatran|mesh-list
15064165|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
15064166|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064167|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064168|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064169|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064170|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
15064171|NCT02170922|Dabigatran|dabigatran|mesh-list
15064172|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
15064173|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064174|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064175|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064176|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064177|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
15064178|NCT02170935|Dabigatran|dabigatran|mesh-list
15064179|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
15064180|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064181|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064182|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064183|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064184|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
15064185|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
15064186|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15064187|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15064188|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064189|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15064190|NCT02170948|Analgesics|analgesics|mesh-ancestor
15064191|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
15064192|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064193|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15064194|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15064195|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15064196|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
15064197|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064198|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064199|NCT02170974|Dabigatran|dabigatran|mesh-list
15064200|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
15064201|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064202|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064203|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064204|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064205|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
15064206|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
15064207|NCT02170987|Dabigatran|dabigatran|mesh-list
15064208|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15064209|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15064210|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15064211|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15064212|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064213|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064214|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064215|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
15064216|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064217|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064218|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
15064219|NCT02171000|Dabigatran|dabigatran|mesh-list
15064220|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
15064221|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064222|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064223|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064224|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064225|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
15064226|NCT02171013|Dabigatran|dabigatran|mesh-list
15064227|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
15064228|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064229|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064230|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064231|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064232|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
15064233|NCT02171026|Amiodarone|amiodarone|mesh-list
15064234|NCT02171026|Dabigatran|dabigatran|mesh-list
15064235|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
15064236|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064237|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064238|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064239|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064240|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
15064241|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15064242|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
15064243|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15064244|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15064245|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15064246|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15064247|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15064248|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15064249|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15064250|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15064251|NCT02171039|Dabigatran|dabigatran|mesh-list
15064252|NCT02171039|Atorvastatin|atorvastatin|mesh-list
15064253|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15064254|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15064255|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
15064256|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064257|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15064258|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15064259|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064260|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
15064261|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064262|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064263|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
15064264|NCT02171052|Digoxin|digoxin|mesh-list
15064265|NCT02171052|Dabigatran|dabigatran|mesh-list
15064266|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
15064267|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064268|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064269|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064270|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064271|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
15064272|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15064273|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15064274|NCT02171052|Protective Agents|protective agents|mesh-ancestor
15064275|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064276|NCT02171156|Nintedanib|nintedanib|mesh-list
15064277|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064278|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15064279|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064280|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064281|NCT02171182|Capsaicin|capsaicin|mesh-list
15064282|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
15064283|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
15064284|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
15064285|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064286|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064287|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15064288|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
15064289|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15064290|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
15064291|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064292|NCT02171221|DFP-11207|dfp-11207|mesh-list
15064293|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15064294|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
15064295|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064296|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064297|NCT02171299|Ropivacaine|ropivacaine|mesh-list
15064298|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
15064299|NCT02171299|Anesthetics|anesthetics|mesh-list
15064300|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15064301|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064302|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
15064303|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064304|NCT02171325|Irinotecan|irinotecan|mesh-list
15064305|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15064306|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15064307|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064308|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064309|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064310|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15064311|NCT02171338|Azithromycin|azithromycin|mesh-list
15064312|NCT02171338|Clarithromycin|clarithromycin|mesh-list
15064313|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
15064314|NCT02171338|Tazobactam|tazobactam|mesh-list
15064315|NCT02171338|Piperacillin|piperacillin|mesh-list
15064316|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15064317|NCT02171338|Penicillin G|penicillin g|mesh-list
15064318|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15064319|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15064320|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064321|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064322|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15064323|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15064324|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15064325|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15064326|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064327|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15064328|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15064329|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
15064330|NCT02171390|Testosterone|testosterone|mesh-list
15064331|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
15064332|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
15064333|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15064334|NCT02171390|Androgens|androgens|mesh-ancestor
15064335|NCT02171390|Hormones|hormones|mesh-ancestor
15064336|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15064337|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064338|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15064339|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064340|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
15064341|NCT02171416|Rilonacept|rilonacept|mesh-list
15064342|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15064343|NCT02171442|Dabigatran|dabigatran|mesh-list
15064344|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
15064345|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064346|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064347|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064348|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064349|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
15064350|NCT02171455|Dabigatran|dabigatran|mesh-list
15064351|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
15064352|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064353|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064354|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064355|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064356|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
15064357|NCT02171468|Dabigatran|dabigatran|mesh-list
15064358|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
15064359|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064360|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064361|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064362|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064363|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
15064364|NCT02171481|Dabigatran|dabigatran|mesh-list
15064365|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
15064366|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064367|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064368|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064369|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064370|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
15064371|NCT02171494|Warfarin|warfarin|mesh-list
15064372|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
15064373|NCT02171507|Diclofenac|diclofenac|mesh-list
15064374|NCT02171507|Dabigatran|dabigatran|mesh-list
15064375|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15064376|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15064377|NCT02171507|Analgesics|analgesics|mesh-ancestor
15064378|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
15064379|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064380|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064381|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15064382|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15064383|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15064384|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064385|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064386|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
15064387|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064388|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064389|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
15064390|NCT02171520|Dabigatran|dabigatran|mesh-list
15064391|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
15064392|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064393|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064394|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064395|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064396|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
15064397|NCT02171533|Verapamil|verapamil|mesh-list
15064398|NCT02171533|Dabigatran|dabigatran|mesh-list
15064399|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
15064400|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064401|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064402|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064403|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064404|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
15064405|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15064406|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15064407|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15064408|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15064409|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064410|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
15064411|NCT02171546|Fexofenadine|fexofenadine|mesh-list
15064412|NCT02171546|Quinidine|quinidine|mesh-list
15064413|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
15064414|NCT02171546|Dabigatran|dabigatran|mesh-list
15064415|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
15064416|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064417|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064418|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064419|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064420|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
15064421|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15064422|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15064423|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15064424|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
15064425|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
15064426|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064427|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064428|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15064429|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15064430|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
15064431|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15064432|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
15064433|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15064434|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15064435|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15064436|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15064437|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064438|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064439|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15064440|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15064441|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15064442|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15064443|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15064444|NCT02171559|Enoxaparin|enoxaparin|mesh-list
15064445|NCT02171559|Dabigatran|dabigatran|mesh-list
15064446|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
15064447|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15064448|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15064449|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064450|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
15064451|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064452|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064453|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064454|NCT02171572|Dabigatran|dabigatran|mesh-list
15064455|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
15064456|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064457|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064458|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064459|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064460|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
15064461|NCT02171585|Clarithromycin|clarithromycin|mesh-list
15064462|NCT02171585|Dabigatran|dabigatran|mesh-list
15064463|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15064464|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15064465|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15064466|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064467|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064468|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15064469|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15064470|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
15064471|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064472|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064473|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
15064474|NCT02171598|Dabigatran|dabigatran|mesh-list
15064475|NCT02171598|Clopidogrel|clopidogrel|mesh-list
15064476|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15064477|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15064478|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15064479|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15064480|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
15064481|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064482|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064483|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064484|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
15064485|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064486|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064487|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064488|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
15064489|NCT02171624|Quinidine|quinidine|mesh-list
15064490|NCT02171624|Dabigatran|dabigatran|mesh-list
15064491|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
15064492|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15064493|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064494|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064495|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064496|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
15064497|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15064498|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15064499|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
15064500|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064501|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064502|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15064503|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
15064504|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15064505|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15064506|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15064507|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15064508|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064509|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064510|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15064511|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15064512|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15064513|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15064514|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15064515|NCT02171637|Afatinib|afatinib|mesh-list
15064516|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064517|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15064518|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064519|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064520|NCT02171650|Afatinib|afatinib|mesh-list
15064521|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064522|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15064523|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064524|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064525|NCT02171663|Afatinib|afatinib|mesh-list
15064526|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064527|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15064528|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064529|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064530|NCT02171676|Docetaxel|docetaxel|mesh-list
15064531|NCT02171676|Afatinib|afatinib|mesh-list
15064532|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064533|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
15064534|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
15064535|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
15064536|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064537|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15064538|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064539|NCT02171689|Afatinib|afatinib|mesh-list
15064540|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064541|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15064542|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064543|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064544|NCT02171702|Afatinib|afatinib|mesh-list
15064545|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064546|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15064547|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064548|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064549|NCT02171715|Afatinib|afatinib|mesh-list
15064550|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064551|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15064552|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064553|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064554|NCT02171728|Afatinib|afatinib|mesh-list
15064555|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064556|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15064557|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064558|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064559|NCT02171741|Docetaxel|docetaxel|mesh-list
15064560|NCT02171741|Afatinib|afatinib|mesh-list
15064561|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064562|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
15064563|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
15064564|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
15064565|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064566|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15064567|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064568|NCT02171754|Ritonavir|ritonavir|mesh-list
15064569|NCT02171754|Afatinib|afatinib|mesh-list
15064570|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15064571|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15064572|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064573|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064574|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064575|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15064576|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15064577|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
15064578|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15064579|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15064580|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15064581|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064582|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15064583|NCT02171767|Afatinib|afatinib|mesh-list
15064584|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064585|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15064586|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064587|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064588|NCT02171780|Olodaterol|olodaterol|mesh-list
15064589|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064590|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
15064591|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064592|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064593|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064594|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064595|NCT02171793|Olodaterol|olodaterol|mesh-list
15064596|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064597|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
15064598|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064599|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064600|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064601|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064602|NCT02171806|Olodaterol|olodaterol|mesh-list
15064603|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064604|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
15064605|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064606|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064607|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064608|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064609|NCT02171832|Olodaterol|olodaterol|mesh-list
15064610|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064611|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
15064612|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064613|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064614|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064615|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064616|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
15064617|NCT02171910|Doxapram|doxapram|mesh-list
15064618|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15064619|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064620|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064621|NCT02171975|Anesthetics|anesthetics|mesh-list
15064622|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15064623|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064624|NCT02171988|Propranolol|propranolol|mesh-list
15064625|NCT02171988|Bisoprolol|bisoprolol|mesh-list
15064626|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
15064627|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15064628|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15064629|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
15064630|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064631|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064632|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064633|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15064634|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15064635|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
15064636|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
15064637|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
15064638|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064639|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15064640|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15064641|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064642|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064643|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
15064644|NCT02172001|Hematinics|hematinics|mesh-ancestor
15064645|NCT02172014|Fentanyl|fentanyl|mesh-list
15064646|NCT02172014|Midazolam|midazolam|mesh-list
15064647|NCT02172014|Citric Acid|citric acid|mesh-list
15064648|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
15064649|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15064650|NCT02172014|Narcotics|narcotics|mesh-ancestor
15064651|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15064652|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064653|NCT02172014|Analgesics|analgesics|mesh-ancestor
15064654|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
15064655|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064656|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15064657|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15064658|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
15064659|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
15064660|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15064661|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15064662|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15064663|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15064664|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
15064665|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
15064666|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064667|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064668|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
15064669|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15064670|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
15064671|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
15064672|NCT02172105|Olodaterol|olodaterol|mesh-list
15064673|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064674|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
15064675|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064676|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064677|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064678|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064679|NCT02172131|Olodaterol|olodaterol|mesh-list
15064680|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064681|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
15064682|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064683|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064684|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064685|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064686|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
15064687|NCT02172144|Olodaterol|olodaterol|mesh-list
15064688|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15064689|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15064690|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15064691|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15064692|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064693|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064694|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15064695|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064696|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064697|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
15064698|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064699|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064700|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064701|NCT02172157|Olodaterol|olodaterol|mesh-list
15064702|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064703|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
15064704|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064705|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064706|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064707|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064708|NCT02172170|Empagliflozin|empagliflozin|mesh-list
15064709|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15064710|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064711|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15064712|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064713|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15064714|NCT02172196|Empagliflozin|empagliflozin|mesh-list
15064715|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15064716|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064717|NCT02172196|Incretins|incretins|mesh-ancestor
15064718|NCT02172196|Hormones|hormones|mesh-ancestor
15064719|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15064720|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15064721|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064722|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064723|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064724|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15064725|NCT02172209|Empagliflozin|empagliflozin|mesh-list
15064726|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15064727|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064728|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15064729|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064730|NCT02172222|Linagliptin|linagliptin|mesh-list
15064731|NCT02172222|Empagliflozin|empagliflozin|mesh-list
15064732|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15064733|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064734|NCT02172222|Incretins|incretins|mesh-ancestor
15064735|NCT02172222|Hormones|hormones|mesh-ancestor
15064736|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15064737|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15064738|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
15064739|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064740|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064741|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15064742|NCT02172235|Pioglitazone|pioglitazone|mesh-list
15064743|NCT02172235|Empagliflozin|empagliflozin|mesh-list
15064744|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15064745|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064746|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15064747|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064748|NCT02172248|Metformin|metformin|mesh-list
15064749|NCT02172248|Empagliflozin|empagliflozin|mesh-list
15064750|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15064751|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064752|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15064753|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064754|NCT02172261|Glimepiride|glimepiride|mesh-list
15064755|NCT02172261|Empagliflozin|empagliflozin|mesh-list
15064756|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15064757|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15064758|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064759|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15064760|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
15064761|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15064762|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064763|NCT02172274|Empagliflozin|empagliflozin|mesh-list
15064764|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15064765|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064766|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15064767|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064768|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
15064769|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15064770|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064771|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
15064772|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064773|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064774|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064775|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064776|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
15064777|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064778|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064779|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064780|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064781|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15064782|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15064783|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15064784|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
15064785|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
15064786|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064787|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
15064788|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064789|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064790|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064791|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064792|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
15064793|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064794|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064795|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064796|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064797|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
15064798|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064799|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
15064800|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064801|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064802|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064803|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064804|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
15064805|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064806|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064807|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064808|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064809|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
15064810|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064811|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
15064812|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064813|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064814|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064815|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064816|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
15064817|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064818|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064819|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064820|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064821|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
15064822|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064823|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
15064824|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064825|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064826|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064827|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064828|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
15064829|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064830|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064831|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064832|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064833|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
15064834|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064835|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
15064836|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064837|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064838|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064839|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064840|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
15064841|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064842|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064843|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064844|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064845|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
15064846|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064847|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
15064848|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064849|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064850|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064851|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064852|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
15064853|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064854|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064855|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064856|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064857|NCT02172404|Ipratropium|ipratropium|mesh-list
15064858|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064859|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
15064860|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064861|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064862|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064863|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064864|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064865|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064866|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064867|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064868|NCT02172417|Ranitidine|ranitidine|mesh-list
15064869|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
15064870|NCT02172417|Cimetidine|cimetidine|mesh-list
15064871|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
15064872|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064873|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
15064874|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064875|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064876|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064877|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064878|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
15064879|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064880|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064881|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064882|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064883|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15064884|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15064885|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15064886|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
15064887|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
15064888|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15064889|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15064890|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15064891|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
15064892|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064893|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
15064894|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064895|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064896|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064897|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064898|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
15064899|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064900|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064901|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064902|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064903|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
15064904|NCT02172443|Ipratropium|ipratropium|mesh-list
15064905|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064906|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
15064907|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064908|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064909|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064910|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064911|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
15064912|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064913|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064914|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064915|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064916|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
15064917|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064918|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
15064919|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064920|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064921|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064922|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064923|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
15064924|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064925|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064926|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064927|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064928|NCT02172469|Bromides|bromides|mesh-list
15064929|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
15064930|NCT02172469|Ipratropium|ipratropium|mesh-list
15064931|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064932|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
15064933|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064934|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064935|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064936|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064937|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
15064938|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064939|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064940|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064941|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064942|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
15064943|NCT02172482|Bromides|bromides|mesh-list
15064944|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
15064945|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064946|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
15064947|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064948|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064949|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064950|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064951|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
15064952|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064953|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064954|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064955|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064956|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
15064957|NCT02172495|Bromides|bromides|mesh-list
15064958|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
15064959|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064960|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
15064961|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064962|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064963|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064964|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064965|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
15064966|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064967|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064968|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064969|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064970|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
15064971|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
15064972|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064973|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
15064974|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064975|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064976|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064977|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064978|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
15064979|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064980|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064981|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064982|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064983|NCT02172521|Bromides|bromides|mesh-list
15064984|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
15064985|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15064986|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
15064987|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15064988|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15064989|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15064990|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
15064991|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
15064992|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15064993|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
15064994|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15064995|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15064996|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
15064997|NCT02172534|Bromides|bromides|mesh-list
15064998|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
15064999|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15065000|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
15065001|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065002|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065003|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15065004|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065005|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
15065006|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15065007|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
15065008|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065009|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065010|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
15065011|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
15065012|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15065013|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
15065014|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065015|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065016|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15065017|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065018|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
15065019|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15065020|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
15065021|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065022|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065023|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
15065024|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15065025|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
15065026|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065027|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065028|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15065029|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065030|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
15065031|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15065032|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
15065033|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065034|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065035|NCT02172573|Pramipexole|pramipexole|mesh-list
15065036|NCT02172573|Bromocriptine|bromocriptine|mesh-list
15065037|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
15065038|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065039|NCT02172573|Protective Agents|protective agents|mesh-ancestor
15065040|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065041|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15065042|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15065043|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
15065044|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
15065045|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065046|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
15065047|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15065048|NCT02172586|Losartan|losartan|mesh-list
15065049|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15065050|NCT02172586|Telmisartan|telmisartan|mesh-list
15065051|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15065052|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15065053|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15065054|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15065055|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065056|NCT02172586|Diuretics|diuretics|mesh-ancestor
15065057|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
15065058|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065059|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15065060|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15065061|NCT02172651|Vitamin D|vitamin d|mesh-list
15065062|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
15065063|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
15065064|NCT02172651|Vitamins|vitamins|mesh-list
15065065|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
15065066|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065067|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15065068|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15065069|NCT02172729|Lidocaine|lidocaine|mesh-list
15065070|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
15065071|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
15065072|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15065073|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065074|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
15065075|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065076|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15065077|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15065078|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15065079|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15065080|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065081|NCT02172768|Micafungin|micafungin|mesh-list
15065082|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
15065083|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065084|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
15065085|NCT02172781|Ipratropium|ipratropium|mesh-list
15065086|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15065087|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
15065088|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065089|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065090|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15065091|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065092|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
15065093|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15065094|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
15065095|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065096|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065097|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
15065098|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15065099|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15065100|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
15065101|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065102|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065103|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15065104|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065105|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
15065106|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15065107|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
15065108|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065109|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065110|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15065111|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15065112|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15065113|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
15065114|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
15065115|NCT02172807|Oxitropium|oxitropium|mesh-list
15065116|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15065117|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
15065118|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065119|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065120|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15065121|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065122|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
15065123|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15065124|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
15065125|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065126|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065127|NCT02172846|Paclitaxel|paclitaxel|mesh-list
15065128|NCT02172846|Carboplatin|carboplatin|mesh-list
15065129|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15065130|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065131|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
15065132|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
15065133|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
15065134|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065135|NCT02172976|Gemcitabine|gemcitabine|mesh-list
15065136|NCT02172976|Fluorouracil|fluorouracil|mesh-list
15065137|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
15065138|NCT02172976|Irinotecan|irinotecan|mesh-list
15065139|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15065140|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
15065141|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065142|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065143|NCT02172976|Antiviral Agents|antiviral agents|mesh-ancestor
15065144|NCT02172976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065145|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065146|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15065147|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
15065148|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065149|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15065150|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15065151|NCT02173093|Aldesleukin|aldesleukin|mesh-list
15065152|NCT02173093|Interleukin-2|interleukin-2|mesh-list
15065153|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065154|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15065155|NCT02173093|Analgesics|analgesics|mesh-ancestor
15065156|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
15065157|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065158|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065159|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15065160|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15065161|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
15065162|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065163|NCT02173106|Cyclosporine|cyclosporine|mesh-list
15065164|NCT02173106|Cyclosporins|cyclosporins|mesh-list
15065165|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065166|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065167|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15065168|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
15065169|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065170|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
15065171|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065172|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
15065173|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15065174|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15065175|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
15065176|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
15065177|NCT02173132|Vitamins|vitamins|mesh-ancestor
15065178|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
15065179|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065180|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
15065181|NCT02173145|Azithromycin|azithromycin|mesh-list
15065182|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15065183|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065184|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
15065185|NCT02173262|Sargramostim|sargramostim|mesh-list
15065186|NCT02173262|Lenograstim|lenograstim|mesh-list
15065187|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
15065188|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065189|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15065190|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065191|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15065192|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15065193|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065194|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065195|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065196|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15065197|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15065198|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15065199|NCT02173288|Furosemide|furosemide|mesh-list
15065200|NCT02173288|Spironolactone|spironolactone|mesh-list
15065201|NCT02173288|Tolvaptan|tolvaptan|mesh-list
15065202|NCT02173288|Midodrine|midodrine|mesh-list
15065203|NCT02173288|Diuretics|diuretics|mesh-ancestor
15065204|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
15065205|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065206|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15065207|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15065208|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065209|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15065210|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
15065211|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15065212|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15065213|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15065214|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
15065215|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
15065216|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065217|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15065218|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15065219|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15065220|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15065221|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
15065222|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065223|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15065224|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15065225|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15065226|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065227|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065228|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15065229|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15065230|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065231|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
15065232|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065233|NCT02173418|Ropivacaine|ropivacaine|mesh-list
15065234|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
15065235|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
15065236|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15065237|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065238|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
15065239|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065240|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15065241|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15065242|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065243|NCT02173457|Incretins|incretins|mesh-ancestor
15065244|NCT02173457|Hormones|hormones|mesh-ancestor
15065245|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15065246|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15065247|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
15065248|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065249|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065250|NCT02173639|Metformin|metformin|mesh-list
15065251|NCT02173639|Linagliptin|linagliptin|mesh-list
15065252|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15065253|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065254|NCT02173639|Incretins|incretins|mesh-ancestor
15065255|NCT02173639|Hormones|hormones|mesh-ancestor
15065256|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15065257|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15065258|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
15065259|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065260|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065261|NCT02173652|Linagliptin|linagliptin|mesh-list
15065262|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15065263|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065264|NCT02173652|Incretins|incretins|mesh-ancestor
15065265|NCT02173652|Hormones|hormones|mesh-ancestor
15065266|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15065267|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15065268|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
15065269|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065270|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065271|NCT02173665|Linagliptin|linagliptin|mesh-list
15065272|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15065273|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065274|NCT02173665|Incretins|incretins|mesh-ancestor
15065275|NCT02173665|Hormones|hormones|mesh-ancestor
15065276|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15065277|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15065278|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
15065279|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065280|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065281|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
15065282|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15065283|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15065284|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
15065285|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065286|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065287|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15065288|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065289|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
15065290|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15065291|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
15065292|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065293|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065294|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15065295|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15065296|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15065297|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
15065298|NCT02173717|Rifampin|rifampin|mesh-list
15065299|NCT02173717|Dabigatran|dabigatran|mesh-list
15065300|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
15065301|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15065302|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
15065303|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065304|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065305|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
15065306|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15065307|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
15065308|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15065309|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065310|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
15065311|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15065312|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15065313|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15065314|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15065315|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15065316|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15065317|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15065318|NCT02173730|Pantoprazole|pantoprazole|mesh-list
15065319|NCT02173730|Dabigatran|dabigatran|mesh-list
15065320|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15065321|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15065322|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15065323|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065324|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065325|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
15065326|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15065327|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
15065328|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
15065329|NCT02173756|Morphine|morphine|mesh-list
15065330|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15065331|NCT02173756|Narcotics|narcotics|mesh-ancestor
15065332|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15065333|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065334|NCT02173756|Analgesics|analgesics|mesh-ancestor
15065335|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
15065336|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065337|NCT02173782|Fenoterol|fenoterol|mesh-list
15065338|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
15065339|NCT02173782|Ipratropium|ipratropium|mesh-list
15065340|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15065341|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
15065342|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065343|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065344|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15065345|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065346|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
15065347|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
15065348|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15065349|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15065350|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15065351|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15065352|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
15065353|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065354|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065355|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15065356|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
15065357|NCT02173795|Fenoterol|fenoterol|mesh-list
15065358|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
15065359|NCT02173795|Ipratropium|ipratropium|mesh-list
15065360|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15065361|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
15065362|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065363|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065364|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15065365|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065366|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
15065367|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
15065368|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15065369|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15065370|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15065371|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15065372|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
15065373|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065374|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065375|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15065376|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
15065377|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
15065378|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
15065379|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15065380|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
15065381|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15065382|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065383|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15065384|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15065385|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15065386|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15065387|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
15065388|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15065389|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15065390|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065391|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065392|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065393|NCT02173873|Aflibercept|aflibercept|mesh-list
15065394|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15065395|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15065396|NCT02173873|Growth Substances|growth substances|mesh-ancestor
15065397|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065398|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
15065399|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065400|NCT02173886|Bupropion|bupropion|mesh-list
15065401|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15065402|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
15065403|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15065404|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15065405|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15065406|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15065407|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065408|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
15065409|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065410|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065411|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15065412|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15065413|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065414|NCT02173912|Amlodipine|amlodipine|mesh-list
15065415|NCT02173912|Candesartan|candesartan|mesh-list
15065416|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
15065417|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15065418|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15065419|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15065420|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065421|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15065422|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065423|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
15065424|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15065425|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15065426|NCT02173951|Deferiprone|deferiprone|mesh-list
15065427|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15065428|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
15065429|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
15065430|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065431|NCT02173964|Pinaverium|pinaverium|mesh-list
15065432|NCT02173964|Bromides|bromides|mesh-list
15065433|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
15065434|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15065435|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15065436|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065437|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15065438|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065439|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
15065440|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
15065441|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065442|NCT02173990|Aflibercept|aflibercept|mesh-list
15065443|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15065444|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15065445|NCT02173990|Growth Substances|growth substances|mesh-ancestor
15065446|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065447|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
15065448|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065449|NCT02174068|Acetaminophen|acetaminophen|mesh-list
15065450|NCT02174068|Nefopam|nefopam|mesh-list
15065451|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15065452|NCT02174068|Analgesics|analgesics|mesh-ancestor
15065453|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
15065454|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065455|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065456|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
15065457|NCT02174094|Clobazam|clobazam|mesh-list
15065458|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
15065459|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15065460|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15065461|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15065462|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065463|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15065464|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15065465|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
15065466|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
15065467|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065468|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065469|NCT02174120|Propofol|propofol|mesh-list
15065470|NCT02174120|Etomidate|etomidate|mesh-list
15065471|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15065472|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15065473|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065474|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15065475|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
15065476|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
15065477|NCT02174172|Interferons|interferons|mesh-list
15065478|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
15065479|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
15065480|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15065481|NCT02174172|Bevacizumab|bevacizumab|mesh-list
15065482|NCT02174172|Ipilimumab|ipilimumab|mesh-list
15065483|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
15065484|NCT02174172|Atezolizumab|atezolizumab|mesh-list
15065485|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15065486|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065487|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15065488|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15065489|NCT02174172|Growth Substances|growth substances|mesh-ancestor
15065490|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065491|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
15065492|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
15065493|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065494|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15065495|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065496|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
15065497|NCT02174211|Ranibizumab|ranibizumab|mesh-list
15065498|NCT02174211|Aflibercept|aflibercept|mesh-list
15065499|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15065500|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15065501|NCT02174211|Growth Substances|growth substances|mesh-ancestor
15065502|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065503|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
15065504|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065505|NCT02174250|Rifampin|rifampin|mesh-list
15065506|NCT02174250|Istradefylline|istradefylline|mesh-list
15065507|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15065508|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
15065509|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15065510|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065511|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
15065512|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15065513|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065514|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065515|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15065516|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15065517|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15065518|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15065519|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15065520|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15065521|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
15065522|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15065523|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15065524|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
15065525|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065526|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065527|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
15065528|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
15065529|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
15065530|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065531|NCT02174328|Aspirin|aspirin|mesh-list
15065532|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15065533|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15065534|NCT02174328|Analgesics|analgesics|mesh-ancestor
15065535|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
15065536|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065537|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065538|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15065539|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15065540|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15065541|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15065542|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065543|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15065544|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15065545|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065546|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
15065547|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
15065548|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065549|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15065550|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065551|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065552|NCT02174549|Tirapazamine|tirapazamine|mesh-list
15065553|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065554|NCT02174575|Sevoflurane|sevoflurane|mesh-list
15065555|NCT02174575|Desflurane|desflurane|mesh-list
15065556|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15065557|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15065558|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
15065559|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
15065560|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15065561|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065562|NCT02174588|Midazolam|midazolam|mesh-list
15065563|NCT02174588|Propofol|propofol|mesh-list
15065564|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15065565|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15065566|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065567|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15065568|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
15065569|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
15065570|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15065571|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15065572|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15065573|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15065574|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
15065575|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
15065576|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065577|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065578|NCT02174666|Vitamin D|vitamin d|mesh-list
15065579|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
15065580|NCT02174666|Vitamins|vitamins|mesh-list
15065581|NCT02174666|Genistein|genistein|mesh-list
15065582|NCT02174666|Biochanin A|biochanin a|mesh-list
15065583|NCT02174666|Daidzein|daidzein|mesh-list
15065584|NCT02174666|Formononetin|formononetin|mesh-list
15065585|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
15065586|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065587|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15065588|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15065589|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15065590|NCT02174666|Protective Agents|protective agents|mesh-ancestor
15065591|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065592|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15065593|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065594|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065595|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
15065596|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
15065597|NCT02174666|Estrogens|estrogens|mesh-ancestor
15065598|NCT02174666|Hormones|hormones|mesh-ancestor
15065599|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15065600|NCT02174718|Vitamin D|vitamin d|mesh-list
15065601|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
15065602|NCT02174718|Vitamins|vitamins|mesh-ancestor
15065603|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
15065604|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065605|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15065606|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15065607|NCT02174757|Doxycycline|doxycycline|mesh-list
15065608|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15065609|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065610|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
15065611|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15065612|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15065613|NCT02174887|Gemcitabine|gemcitabine|mesh-list
15065614|NCT02174887|Paclitaxel|paclitaxel|mesh-list
15065615|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15065616|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065617|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
15065618|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
15065619|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
15065620|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065621|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15065622|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
15065623|NCT02174887|Antiviral Agents|antiviral agents|mesh-ancestor
15065624|NCT02174887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065625|NCT02174887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065626|NCT02174887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15065627|NCT02174887|Immunologic Factors|immunologic factors|mesh-ancestor
15065628|NCT02174887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065629|NCT02174900|Lumefantrine|lumefantrine|mesh-list
15065630|NCT02174900|Artemether|artemether|mesh-list
15065631|NCT02174900|Primaquine|primaquine|mesh-list
15065632|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15065633|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
15065634|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15065635|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15065636|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065637|NCT02174939|Cilostazol|cilostazol|mesh-list
15065638|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15065639|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
15065640|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065641|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065642|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15065643|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065644|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15065645|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15065646|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065647|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15065648|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
15065649|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15065650|NCT02174939|Protective Agents|protective agents|mesh-ancestor
15065651|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15065652|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15065653|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065654|NCT02175017|Nivolumab|nivolumab|mesh-list
15065655|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15065656|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065657|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15065658|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065659|NCT02175030|Copper|copper|mesh-list
15065660|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
15065661|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15065662|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
15065663|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15065664|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065665|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15065666|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15065667|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15065668|NCT02175030|Trace Elements|trace elements|mesh-ancestor
15065669|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
15065670|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15065671|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15065672|NCT02175069|Ropivacaine|ropivacaine|mesh-list
15065673|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
15065674|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
15065675|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15065676|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065677|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
15065678|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065679|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
15065680|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15065681|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
15065682|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065683|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065684|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15065685|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065686|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
15065687|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15065688|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
15065689|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065690|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065691|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15065692|NCT02175355|Telmisartan|telmisartan|mesh-list
15065693|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15065694|NCT02175355|Diuretics|diuretics|mesh-ancestor
15065695|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
15065696|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065697|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15065698|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15065699|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065700|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15065701|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15065702|NCT02175381|Gemcitabine|gemcitabine|mesh-list
15065703|NCT02175381|Carboplatin|carboplatin|mesh-list
15065704|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065705|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15065706|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
15065707|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065708|NCT02175381|Antiviral Agents|antiviral agents|mesh-ancestor
15065709|NCT02175381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065710|NCT02175381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065711|NCT02175381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15065712|NCT02175381|Immunologic Factors|immunologic factors|mesh-ancestor
15065713|NCT02175381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065714|NCT02175394|Linagliptin|linagliptin|mesh-list
15065715|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
15065716|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
15065717|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15065718|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065719|NCT02175394|Incretins|incretins|mesh-ancestor
15065720|NCT02175394|Hormones|hormones|mesh-ancestor
15065721|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15065722|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15065723|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
15065724|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065725|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065726|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15065727|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
15065728|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15065729|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15065730|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15065731|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15065732|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15065733|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15065734|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
15065735|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15065736|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15065737|NCT02175407|Itraconazole|itraconazole|mesh-list
15065738|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
15065739|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065740|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15065741|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15065742|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065743|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065744|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15065745|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
15065746|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15065747|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065748|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15065749|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
15065750|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
15065751|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065752|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15065753|NCT02175446|Bevacizumab|bevacizumab|mesh-list
15065754|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15065755|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065756|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15065757|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15065758|NCT02175446|Growth Substances|growth substances|mesh-ancestor
15065759|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065760|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
15065761|NCT02175485|Fexofenadine|fexofenadine|mesh-list
15065762|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15065763|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15065764|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15065765|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
15065766|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
15065767|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065768|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065769|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065770|NCT02175589|Colchicine|colchicine|mesh-list
15065771|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
15065772|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15065773|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
15065774|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
15065775|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
15065776|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065777|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065778|NCT02175602|Citalopram|citalopram|mesh-list
15065779|NCT02175602|Sertraline|sertraline|mesh-list
15065780|NCT02175602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15065781|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15065782|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15065783|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065784|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065785|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
15065786|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065787|NCT02175602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15065788|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
15065789|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15065790|NCT02175680|Leronlimab|leronlimab|mesh-list
15065791|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15065792|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15065793|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065794|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15065795|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15065796|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
15065797|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065798|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
15065799|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15065800|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065801|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15065802|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065803|NCT02175888|Iron|iron|mesh-list
15065804|NCT02175888|Trace Elements|trace elements|mesh-ancestor
15065805|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
15065806|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065807|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15065808|NCT02175901|Amoxicillin|amoxicillin|mesh-list
15065809|NCT02175901|Metronidazole|metronidazole|mesh-list
15065810|NCT02175901|Clarithromycin|clarithromycin|mesh-list
15065811|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15065812|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
15065813|NCT02175901|Lansoprazole|lansoprazole|mesh-list
15065814|NCT02175901|Bismuth|bismuth|mesh-list
15065815|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15065816|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065817|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065818|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
15065819|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15065820|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15065821|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15065822|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065823|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15065824|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15065825|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15065826|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15065827|NCT02175901|Antacids|antacids|mesh-ancestor
15065828|NCT02175901|Diuretics|diuretics|mesh-ancestor
15065829|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
15065830|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065831|NCT02175901|Expectorants|expectorants|mesh-ancestor
15065832|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065833|NCT02175914|Erythromycin|erythromycin|mesh-list
15065834|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
15065835|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15065836|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
15065837|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15065838|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065839|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15065840|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15065841|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065842|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065843|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15065844|NCT02175927|Amoxicillin|amoxicillin|mesh-list
15065845|NCT02175927|Metronidazole|metronidazole|mesh-list
15065846|NCT02175927|Tetracycline|tetracycline|mesh-list
15065847|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
15065848|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
15065849|NCT02175927|Lansoprazole|lansoprazole|mesh-list
15065850|NCT02175927|Bismuth|bismuth|mesh-list
15065851|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15065852|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065853|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065854|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
15065855|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15065856|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15065857|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15065858|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15065859|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065860|NCT02175927|Antacids|antacids|mesh-ancestor
15065861|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15065862|NCT02175927|Diuretics|diuretics|mesh-ancestor
15065863|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
15065864|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065865|NCT02175927|Expectorants|expectorants|mesh-ancestor
15065866|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065867|NCT02176044|Nitroprusside|nitroprusside|mesh-list
15065868|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15065869|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
15065870|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
15065871|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065872|NCT02176057|Azithromycin|azithromycin|mesh-list
15065873|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15065874|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065875|NCT02176122|Meropenem|meropenem|mesh-list
15065876|NCT02176122|Tazobactam|tazobactam|mesh-list
15065877|NCT02176122|Piperacillin|piperacillin|mesh-list
15065878|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15065879|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15065880|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15065881|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15065882|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15065883|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065884|NCT02176135|Auranofin|auranofin|mesh-list
15065885|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15065886|NCT02176161|Metformin|metformin|mesh-list
15065887|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15065888|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065889|NCT02176187|Fenoterol|fenoterol|mesh-list
15065890|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
15065891|NCT02176187|Ipratropium|ipratropium|mesh-list
15065892|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15065893|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
15065894|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065895|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065896|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15065897|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065898|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
15065899|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
15065900|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15065901|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15065902|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15065903|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15065904|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
15065905|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065906|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065907|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15065908|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
15065909|NCT02176200|Fenoterol|fenoterol|mesh-list
15065910|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
15065911|NCT02176200|Ipratropium|ipratropium|mesh-list
15065912|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15065913|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
15065914|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065915|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065916|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15065917|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
15065918|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
15065919|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
15065920|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15065921|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15065922|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15065923|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15065924|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
15065925|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15065926|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065927|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15065928|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
15065929|NCT02176213|Dexamethasone|dexamethasone|mesh-list
15065930|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
15065931|NCT02176213|Pomalidomide|pomalidomide|mesh-list
15065932|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15065933|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
15065934|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065935|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15065936|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15065937|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
15065938|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065939|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065940|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15065941|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15065942|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
15065943|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
15065944|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065945|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15065946|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
15065947|NCT02176213|Hormones|hormones|mesh-ancestor
15065948|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15065949|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15065950|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15065951|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15065952|NCT02176213|Growth Substances|growth substances|mesh-ancestor
15065953|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
15065954|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15065955|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
15065956|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15065957|NCT02176304|Prednisolone|prednisolone|mesh-list
15065958|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
15065959|NCT02176304|Lidocaine|lidocaine|mesh-list
15065960|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15065961|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
15065962|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
15065963|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
15065964|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15065965|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15065966|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
15065967|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15065968|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15065969|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15065970|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15065971|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15065972|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065973|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15065974|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
15065975|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
15065976|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15065977|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
15065978|NCT02176304|Hormones|hormones|mesh-ancestor
15065979|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15065980|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15065981|NCT02176304|Protective Agents|protective agents|mesh-ancestor
15065982|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15065983|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065984|NCT02176369|Vinorelbine|vinorelbine|mesh-list
15065985|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15065986|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065987|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
15065988|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
15065989|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
15065990|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065991|NCT02176460|Colchicine|colchicine|mesh-list
15065992|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
15065993|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15065994|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
15065995|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
15065996|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
15065997|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15065998|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15065999|NCT02176499|Telmisartan|telmisartan|mesh-list
15066000|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066001|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15066002|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15066003|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066004|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15066005|NCT02176512|Telmisartan|telmisartan|mesh-list
15066006|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066007|NCT02176512|Diuretics|diuretics|mesh-ancestor
15066008|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
15066009|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066010|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15066011|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15066012|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066013|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15066014|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15066015|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
15066016|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
15066017|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066018|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066019|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15066020|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
15066021|NCT02176681|Vildagliptin|vildagliptin|mesh-list
15066022|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15066023|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066024|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15066025|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
15066026|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066027|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066028|NCT02176720|Fluorides|fluorides|mesh-list
15066029|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
15066030|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
15066031|NCT02176720|Protective Agents|protective agents|mesh-ancestor
15066032|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066033|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
15066034|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066035|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066036|NCT02176733|Cyclosporine|cyclosporine|mesh-list
15066037|NCT02176733|Cyclosporins|cyclosporins|mesh-list
15066038|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066039|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066040|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15066041|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
15066042|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066043|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
15066044|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15066045|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
15066046|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15066047|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15066048|NCT02176759|Citric Acid|citric acid|mesh-list
15066049|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
15066050|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
15066051|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15066052|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
15066053|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
15066054|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066055|NCT02176850|Telmisartan|telmisartan|mesh-list
15066056|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066057|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15066058|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15066059|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066060|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15066061|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
15066062|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066063|NCT02177071|Methotrexate|methotrexate|mesh-list
15066064|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
15066065|NCT02177071|Azathioprine|azathioprine|mesh-list
15066066|NCT02177071|Infliximab|infliximab|mesh-list
15066067|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15066068|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
15066069|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15066070|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066071|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15066072|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
15066073|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066074|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066075|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
15066076|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066077|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15066078|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15066079|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
15066080|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15066081|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15066082|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15066083|NCT02177175|Carvedilol|carvedilol|mesh-list
15066084|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15066085|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15066086|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
15066087|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066088|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066089|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066090|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066091|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
15066092|NCT02177175|Protective Agents|protective agents|mesh-ancestor
15066093|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15066094|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15066095|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15066096|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
15066097|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15066098|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15066099|NCT02177253|Bromides|bromides|mesh-list
15066100|NCT02177253|Albuterol|albuterol|mesh-list
15066101|NCT02177253|Ipratropium|ipratropium|mesh-list
15066102|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
15066103|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15066104|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
15066105|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066106|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066107|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15066108|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
15066109|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
15066110|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15066111|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15066112|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15066113|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15066114|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
15066115|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066116|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066117|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15066118|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
15066119|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15066120|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
15066121|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15066122|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
15066123|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066124|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066125|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15066126|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
15066127|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
15066128|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15066129|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
15066130|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066131|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066132|NCT02177318|Bromides|bromides|mesh-list
15066133|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
15066134|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15066135|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
15066136|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066137|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066138|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15066139|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
15066140|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
15066141|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15066142|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
15066143|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066144|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066145|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
15066146|NCT02177331|Lacidipine|lacidipine|mesh-list
15066147|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066148|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15066149|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15066150|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066151|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15066152|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066153|NCT02177344|Bromides|bromides|mesh-list
15066154|NCT02177344|Ipratropium|ipratropium|mesh-list
15066155|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
15066156|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15066157|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
15066158|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066159|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066160|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15066161|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
15066162|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15066163|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
15066164|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066165|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066166|NCT02177357|Pramipexole|pramipexole|mesh-list
15066167|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
15066168|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066169|NCT02177357|Protective Agents|protective agents|mesh-ancestor
15066170|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066171|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15066172|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15066173|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
15066174|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
15066175|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066176|NCT02177370|Fenoterol|fenoterol|mesh-list
15066177|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15066178|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
15066179|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066180|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066181|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15066182|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
15066183|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
15066184|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
15066185|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15066186|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15066187|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15066188|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15066189|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
15066190|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066191|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066192|NCT02177396|Valsartan|valsartan|mesh-list
15066193|NCT02177396|Telmisartan|telmisartan|mesh-list
15066194|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066195|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15066196|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15066197|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066198|NCT02177409|Amlodipine|amlodipine|mesh-list
15066199|NCT02177409|Telmisartan|telmisartan|mesh-list
15066200|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066201|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15066202|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15066203|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066204|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15066205|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066206|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
15066207|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15066208|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15066209|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15066210|NCT02177422|Telmisartan|telmisartan|mesh-list
15066211|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066212|NCT02177422|Diuretics|diuretics|mesh-ancestor
15066213|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
15066214|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066215|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15066216|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15066217|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066218|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15066219|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15066220|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15066221|NCT02177435|Telmisartan|telmisartan|mesh-list
15066222|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
15066223|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066224|NCT02177435|Diuretics|diuretics|mesh-ancestor
15066225|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
15066226|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066227|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15066228|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15066229|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066230|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15066231|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15066232|NCT02177448|Enalapril|enalapril|mesh-list
15066233|NCT02177448|Enalaprilat|enalaprilat|mesh-list
15066234|NCT02177448|Telmisartan|telmisartan|mesh-list
15066235|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15066236|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
15066237|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066238|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066239|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066240|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15066241|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15066242|NCT02177461|Telmisartan|telmisartan|mesh-list
15066243|NCT02177461|Clonidine|clonidine|mesh-list
15066244|NCT02177461|Enalapril|enalapril|mesh-list
15066245|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066246|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15066247|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15066248|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066249|NCT02177461|Analgesics|analgesics|mesh-ancestor
15066250|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
15066251|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066252|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066253|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
15066254|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
15066255|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15066256|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15066257|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15066258|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
15066259|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066260|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15066261|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
15066262|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066263|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15066264|NCT02177487|Telmisartan|telmisartan|mesh-list
15066265|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
15066266|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066267|NCT02177487|Diuretics|diuretics|mesh-ancestor
15066268|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
15066269|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066270|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15066271|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15066272|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066273|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15066274|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15066275|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15066276|NCT02177500|Telmisartan|telmisartan|mesh-list
15066277|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
15066278|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066279|NCT02177500|Diuretics|diuretics|mesh-ancestor
15066280|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
15066281|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066282|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15066283|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15066284|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066285|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15066286|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15066287|NCT02177539|Phenylephrine|phenylephrine|mesh-list
15066288|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
15066289|NCT02177539|Tropicamide|tropicamide|mesh-list
15066290|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
15066291|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15066292|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
15066293|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
15066294|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066295|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066296|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
15066297|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15066298|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
15066299|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
15066300|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15066301|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15066302|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15066303|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
15066304|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066305|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066306|NCT02177539|Protective Agents|protective agents|mesh-ancestor
15066307|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15066308|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15066309|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
15066310|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
15066311|NCT02177552|Carboplatin|carboplatin|mesh-list
15066312|NCT02177552|Docetaxel|docetaxel|mesh-list
15066313|NCT02177552|Capecitabine|capecitabine|mesh-list
15066314|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
15066315|NCT02177552|Epirubicin|epirubicin|mesh-list
15066316|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066317|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
15066318|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
15066319|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
15066320|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066321|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15066322|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
15066323|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15066324|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15066325|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15066326|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066327|NCT02177578|Temozolomide|temozolomide|mesh-list
15066328|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15066329|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
15066330|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066331|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066332|NCT02177643|Diacetylrhein|diacetylrhein|mesh-list
15066333|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15066334|NCT02177734|Vaccines|vaccines|mesh-list
15066335|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
15066336|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066337|NCT02177760|Sirolimus|sirolimus|mesh-list
15066338|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15066339|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15066340|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15066341|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066342|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
15066343|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15066344|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
15066345|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066346|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
15066347|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066348|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15066349|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066350|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066351|NCT02177851|Iron|iron|mesh-list
15066352|NCT02177851|Trace Elements|trace elements|mesh-ancestor
15066353|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
15066354|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066355|NCT02177955|Midazolam|midazolam|mesh-list
15066356|NCT02177955|Diazepam|diazepam|mesh-list
15066357|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15066358|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15066359|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15066360|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066361|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15066362|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15066363|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15066364|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15066365|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
15066366|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
15066367|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
15066368|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
15066369|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066370|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066371|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
15066372|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
15066373|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
15066374|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066375|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15066376|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15066377|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15066378|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
15066379|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15066380|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15066381|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15066382|NCT02178124|Donepezil|donepezil|mesh-list
15066383|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15066384|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066385|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066386|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
15066387|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066388|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066389|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
15066390|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
15066391|NCT02178137|Astringents|astringents|mesh-ancestor
15066392|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066393|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
15066394|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
15066395|NCT02178150|Antacids|antacids|mesh-ancestor
15066396|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066397|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15066398|NCT02178254|Fosfomycin|fosfomycin|mesh-list
15066399|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15066400|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15066401|NCT02178293|Ketoprofen|ketoprofen|mesh-list
15066402|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
15066403|NCT02178293|Benzydamine|benzydamine|mesh-list
15066404|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15066405|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15066406|NCT02178293|Analgesics|analgesics|mesh-ancestor
15066407|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
15066408|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066409|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066410|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15066411|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15066412|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15066413|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066414|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066415|NCT02178306|Telmisartan|telmisartan|mesh-list
15066416|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066417|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15066418|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15066419|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066420|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15066421|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066422|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15066423|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066424|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066425|NCT02178449|Dexamethasone|dexamethasone|mesh-list
15066426|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
15066427|NCT02178449|Ropivacaine|ropivacaine|mesh-list
15066428|NCT02178449|BB 1101|bb 1101|mesh-list
15066429|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15066430|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
15066431|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
15066432|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066433|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066434|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15066435|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
15066436|NCT02178449|Hormones|hormones|mesh-ancestor
15066437|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15066438|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15066439|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066440|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
15066441|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
15066442|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15066443|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
15066444|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
15066445|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066446|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066447|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
15066448|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15066449|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066450|NCT02178488|Vitamins|vitamins|mesh-ancestor
15066451|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
15066452|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15066453|NCT02178644|Capecitabine|capecitabine|mesh-list
15066454|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15066455|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
15066456|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066457|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066458|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
15066459|NCT02178683|Tacrolimus|tacrolimus|mesh-list
15066460|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15066461|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
15066462|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066463|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15066464|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066465|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066466|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15066467|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066468|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15066469|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
15066470|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15066471|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15066472|NCT02178761|Chromium|chromium|mesh-list
15066473|NCT02178761|Everolimus|everolimus|mesh-list
15066474|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066475|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15066476|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
15066477|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066478|NCT02178761|Trace Elements|trace elements|mesh-ancestor
15066479|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
15066480|NCT02178813|Minocycline|minocycline|mesh-list
15066481|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15066482|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15066483|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15066484|NCT02179008|Latanoprost|latanoprost|mesh-list
15066485|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15066486|NCT02179034|Menthol|menthol|mesh-list
15066487|NCT02179034|Nicotine|nicotine|mesh-list
15066488|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15066489|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
15066490|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066491|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066492|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15066493|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15066494|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
15066495|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066496|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066497|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
15066498|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
15066499|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
15066500|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15066501|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15066502|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15066503|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066504|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
15066505|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066506|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066507|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15066508|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066509|NCT02179255|Hormones|hormones|mesh-list
15066510|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15066511|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15066512|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066513|NCT02179268|Sertraline|sertraline|mesh-list
15066514|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15066515|NCT02179268|Citalopram|citalopram|mesh-list
15066516|NCT02179268|Reboxetine|reboxetine|mesh-list
15066517|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
15066518|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15066519|NCT02179268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15066520|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15066521|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15066522|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066523|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066524|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
15066525|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066526|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15066527|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15066528|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15066529|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
15066530|NCT02179294|Meperidine|meperidine|mesh-list
15066531|NCT02179294|Remifentanil|remifentanil|mesh-list
15066532|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15066533|NCT02179294|Narcotics|narcotics|mesh-ancestor
15066534|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15066535|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066536|NCT02179294|Analgesics|analgesics|mesh-ancestor
15066537|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
15066538|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066539|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15066540|NCT02179528|Etoposide|etoposide|mesh-list
15066541|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15066542|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066543|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15066544|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15066545|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066546|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066547|NCT02179567|Bevacizumab|bevacizumab|mesh-list
15066548|NCT02179567|Docetaxel|docetaxel|mesh-list
15066549|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15066550|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066551|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15066552|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15066553|NCT02179567|Growth Substances|growth substances|mesh-ancestor
15066554|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066555|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
15066556|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
15066557|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
15066558|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
15066559|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066560|NCT02179645|Celecoxib|celecoxib|mesh-list
15066561|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15066562|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15066563|NCT02179645|Analgesics|analgesics|mesh-ancestor
15066564|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
15066565|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066566|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066567|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15066568|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15066569|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15066570|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15066571|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066572|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066573|NCT02179658|Vancomycin|vancomycin|mesh-list
15066574|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
15066575|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15066576|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15066577|NCT02179775|Propranolol|propranolol|mesh-list
15066578|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15066579|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15066580|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
15066581|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066582|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066583|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066584|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15066585|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066586|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
15066587|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
15066588|NCT02179814|Promethazine|promethazine|mesh-list
15066589|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
15066590|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15066591|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15066592|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066593|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
15066594|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
15066595|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
15066596|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066597|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
15066598|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
15066599|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15066600|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15066601|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
15066602|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
15066603|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066604|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066605|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15066606|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
15066607|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
15066608|NCT02179931|Flupenthixol|flupenthixol|mesh-list
15066609|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
15066610|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15066611|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15066612|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15066613|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066614|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15066615|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15066616|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
15066617|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066618|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066619|NCT02179970|Plerixafor|plerixafor|mesh-list
15066620|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15066621|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15066622|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
15066623|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15066624|NCT02179996|Vaccines|vaccines|mesh-list
15066625|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
15066626|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066627|NCT02180048|Caffeine|caffeine|mesh-list
15066628|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15066629|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066630|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15066631|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066632|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066633|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15066634|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15066635|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
15066636|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066637|NCT02180087|Ketoprofen|ketoprofen|mesh-list
15066638|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15066639|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15066640|NCT02180087|Analgesics|analgesics|mesh-ancestor
15066641|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
15066642|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066643|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066644|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15066645|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15066646|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15066647|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066648|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066649|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15066650|NCT02180204|Tenecteplase|tenecteplase|mesh-list
15066651|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15066652|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15066653|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066654|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
15066655|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15066656|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15066657|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066658|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
15066659|NCT02180321|Coagulants|coagulants|mesh-ancestor
15066660|NCT02180334|Acetaminophen|acetaminophen|mesh-list
15066661|NCT02180334|Linagliptin|linagliptin|mesh-list
15066662|NCT02180334|Mosapride|mosapride|mesh-list
15066663|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15066664|NCT02180334|Analgesics|analgesics|mesh-ancestor
15066665|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
15066666|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066667|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066668|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
15066669|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066670|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15066671|NCT02180334|Incretins|incretins|mesh-ancestor
15066672|NCT02180334|Hormones|hormones|mesh-ancestor
15066673|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15066674|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15066675|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
15066676|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066677|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15066678|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15066679|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
15066680|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066681|NCT02180425|Adapalene|adapalene|mesh-list
15066682|NCT02180425|Tretinoin|tretinoin|mesh-list
15066683|NCT02180425|Isotretinoin|isotretinoin|mesh-list
15066684|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
15066685|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15066686|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15066687|NCT02180425|Analgesics|analgesics|mesh-ancestor
15066688|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
15066689|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066690|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066691|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15066692|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15066693|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066694|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
15066695|NCT02180503|Linagliptin|linagliptin|mesh-list
15066696|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15066697|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066698|NCT02180503|Incretins|incretins|mesh-ancestor
15066699|NCT02180503|Hormones|hormones|mesh-ancestor
15066700|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15066701|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15066702|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
15066703|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066704|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066705|NCT02180516|Meloxicam|meloxicam|mesh-list
15066706|NCT02180516|Etodolac|etodolac|mesh-list
15066707|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
15066708|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15066709|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15066710|NCT02180516|Analgesics|analgesics|mesh-ancestor
15066711|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
15066712|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066713|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066714|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15066715|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15066716|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15066717|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066718|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066719|NCT02180529|Methylphenidate|methylphenidate|mesh-list
15066720|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15066721|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066722|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15066723|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15066724|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15066725|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066726|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
15066727|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066728|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
15066729|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066730|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
15066731|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15066732|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15066733|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066734|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15066735|NCT02180737|Analgesics|analgesics|mesh-ancestor
15066736|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
15066737|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066738|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15066739|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15066740|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15066741|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
15066742|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066743|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066744|NCT02180789|Tamsulosin|tamsulosin|mesh-list
15066745|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15066746|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15066747|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15066748|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
15066749|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066750|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066751|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066752|NCT02180789|Urological Agents|urological agents|mesh-ancestor
15066753|NCT02180880|Pregabalin|pregabalin|mesh-list
15066754|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
15066755|NCT02180880|Analgesics|analgesics|mesh-ancestor
15066756|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
15066757|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066758|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066759|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
15066760|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15066761|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15066762|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066763|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15066764|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15066765|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15066766|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15066767|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15066768|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15066769|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15066770|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15066771|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15066772|NCT02180997|Tamsulosin|tamsulosin|mesh-list
15066773|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
15066774|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15066775|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15066776|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15066777|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
15066778|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066779|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066780|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066781|NCT02180997|Urological Agents|urological agents|mesh-ancestor
15066782|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15066783|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15066784|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
15066785|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
15066786|NCT02181023|Bromides|bromides|mesh-list
15066787|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
15066788|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15066789|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15066790|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15066791|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
15066792|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066793|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066794|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066795|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
15066796|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15066797|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066798|NCT02181205|Bupivacaine|bupivacaine|mesh-list
15066799|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
15066800|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
15066801|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15066802|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066803|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
15066804|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066805|NCT02181218|Gemcitabine|gemcitabine|mesh-list
15066806|NCT02181218|Dexamethasone|dexamethasone|mesh-list
15066807|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
15066808|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
15066809|NCT02181218|Romidepsin|romidepsin|mesh-list
15066810|NCT02181218|BB 1101|bb 1101|mesh-list
15066811|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15066812|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
15066813|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
15066814|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066815|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066816|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15066817|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
15066818|NCT02181218|Hormones|hormones|mesh-ancestor
15066819|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15066820|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15066821|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066822|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
15066823|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066824|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066825|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15066826|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
15066827|NCT02181218|Antiviral Agents|antiviral agents|mesh-ancestor
15066828|NCT02181218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15066829|NCT02181218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15066830|NCT02181218|Immunologic Factors|immunologic factors|mesh-ancestor
15066831|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15066832|NCT02181309|Meloxicam|meloxicam|mesh-list
15066833|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15066834|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15066835|NCT02181309|Analgesics|analgesics|mesh-ancestor
15066836|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
15066837|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066838|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066839|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15066840|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15066841|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15066842|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15066843|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066844|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066845|NCT02181322|Meloxicam|meloxicam|mesh-list
15066846|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15066847|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15066848|NCT02181322|Analgesics|analgesics|mesh-ancestor
15066849|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
15066850|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066851|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066852|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15066853|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15066854|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15066855|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15066856|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066857|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066858|NCT02181335|Budesonide|budesonide|mesh-list
15066859|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15066860|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15066861|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
15066862|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066863|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066864|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15066865|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
15066866|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
15066867|NCT02181335|Hormones|hormones|mesh-ancestor
15066868|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15066869|NCT02181348|Vitamin E|vitamin e|mesh-list
15066870|NCT02181348|Vitamins|vitamins|mesh-ancestor
15066871|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
15066872|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066873|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
15066874|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066875|NCT02181348|Protective Agents|protective agents|mesh-ancestor
15066876|NCT02181361|Aspirin|aspirin|mesh-list
15066877|NCT02181361|Hirudins|hirudins|mesh-list
15066878|NCT02181361|Warfarin|warfarin|mesh-list
15066879|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15066880|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15066881|NCT02181361|Analgesics|analgesics|mesh-ancestor
15066882|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
15066883|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066884|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066885|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15066886|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15066887|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15066888|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15066889|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066890|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15066891|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15066892|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066893|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
15066894|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
15066895|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
15066896|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15066897|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
15066898|NCT02181478|Cyclosporine|cyclosporine|mesh-list
15066899|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
15066900|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
15066901|NCT02181478|Fludarabine|fludarabine|mesh-list
15066902|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
15066903|NCT02181478|Cyclosporins|cyclosporins|mesh-list
15066904|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15066905|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
15066906|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066907|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15066908|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15066909|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
15066910|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066911|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15066912|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15066913|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15066914|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
15066915|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066916|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
15066917|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15066918|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
15066919|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15066920|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15066921|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15066922|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
15066923|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15066924|NCT02181543|Clonidine|clonidine|mesh-list
15066925|NCT02181543|Analgesics|analgesics|mesh-ancestor
15066926|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
15066927|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066928|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066929|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15066930|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
15066931|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
15066932|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15066933|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15066934|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15066935|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
15066936|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15066937|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066938|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
15066939|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15066940|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15066941|NCT02181920|Dipyrone|dipyrone|mesh-list
15066942|NCT02181920|Diclofenac|diclofenac|mesh-list
15066943|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15066944|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15066945|NCT02181920|Analgesics|analgesics|mesh-ancestor
15066946|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
15066947|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15066948|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066949|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15066950|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15066951|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15066952|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066953|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066954|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
15066955|NCT02181933|Lamivudine|lamivudine|mesh-list
15066956|NCT02181933|Zidovudine|zidovudine|mesh-list
15066957|NCT02181933|Nevirapine|nevirapine|mesh-list
15066958|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15066959|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15066960|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066961|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066962|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
15066963|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15066964|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15066965|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15066966|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
15066967|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15066968|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15066969|NCT02181946|Nevirapine|nevirapine|mesh-list
15066970|NCT02181946|Fluconazole|fluconazole|mesh-list
15066971|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15066972|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15066973|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15066974|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066975|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
15066976|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15066977|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15066978|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15066979|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15066980|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15066981|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
15066982|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15066983|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15066984|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15066985|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
15066986|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15066987|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15066988|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15066989|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15066990|NCT02181985|Heparin|heparin|mesh-list
15066991|NCT02181985|Enoxaparin|enoxaparin|mesh-list
15066992|NCT02181985|Tenecteplase|tenecteplase|mesh-list
15066993|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15066994|NCT02181985|Abciximab|abciximab|mesh-list
15066995|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
15066996|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15066997|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15066998|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15066999|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15067000|NCT02181998|Heparin|heparin|mesh-list
15067001|NCT02181998|Enoxaparin|enoxaparin|mesh-list
15067002|NCT02181998|Tenecteplase|tenecteplase|mesh-list
15067003|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
15067004|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15067005|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15067006|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067007|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15067008|NCT02182011|Tenecteplase|tenecteplase|mesh-list
15067009|NCT02182011|Streptokinase|streptokinase|mesh-list
15067010|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15067011|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15067012|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067013|NCT02182024|Dabigatran|dabigatran|mesh-list
15067014|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
15067015|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15067016|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067017|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067018|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067019|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
15067020|NCT02182050|Nintedanib|nintedanib|mesh-list
15067021|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067022|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15067023|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067024|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067025|NCT02182063|Nintedanib|nintedanib|mesh-list
15067026|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067027|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15067028|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067029|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067030|NCT02182076|Nintedanib|nintedanib|mesh-list
15067031|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067032|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15067033|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067034|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067035|NCT02182102|Pemetrexed|pemetrexed|mesh-list
15067036|NCT02182102|Nintedanib|nintedanib|mesh-list
15067037|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067038|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067039|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067040|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15067041|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15067042|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15067043|NCT02182128|Nintedanib|nintedanib|mesh-list
15067044|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067045|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15067046|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067047|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067048|NCT02182141|Nintedanib|nintedanib|mesh-list
15067049|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067050|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15067051|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067052|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067053|NCT02182154|Nintedanib|nintedanib|mesh-list
15067054|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067055|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15067056|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067057|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067058|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
15067059|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15067060|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
15067061|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15067062|NCT02182167|Expectorants|expectorants|mesh-ancestor
15067063|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
15067064|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15067065|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
15067066|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067067|NCT02182167|Protective Agents|protective agents|mesh-ancestor
15067068|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067069|NCT02182167|Antidotes|antidotes|mesh-ancestor
15067070|NCT02182193|Nintedanib|nintedanib|mesh-list
15067071|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067072|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15067073|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067074|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067075|NCT02182206|Nintedanib|nintedanib|mesh-list
15067076|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067077|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15067078|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067079|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067080|NCT02182219|Nintedanib|nintedanib|mesh-list
15067081|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067082|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15067083|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067084|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067085|NCT02182232|Paclitaxel|paclitaxel|mesh-list
15067086|NCT02182232|Carboplatin|carboplatin|mesh-list
15067087|NCT02182232|Nintedanib|nintedanib|mesh-list
15067088|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15067089|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067090|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
15067091|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
15067092|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
15067093|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067094|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15067095|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067096|NCT02182245|Paclitaxel|paclitaxel|mesh-list
15067097|NCT02182245|Carboplatin|carboplatin|mesh-list
15067098|NCT02182245|Nintedanib|nintedanib|mesh-list
15067099|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15067100|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067101|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
15067102|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
15067103|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
15067104|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067105|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15067106|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067107|NCT02182258|Nintedanib|nintedanib|mesh-list
15067108|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067109|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15067110|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067111|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067112|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
15067113|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15067114|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15067115|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15067116|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15067117|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067118|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067119|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067120|NCT02182336|Vitamin K|vitamin k|mesh-list
15067121|NCT02182336|Digoxin|digoxin|mesh-list
15067122|NCT02182336|Midazolam|midazolam|mesh-list
15067123|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
15067124|NCT02182336|Caffeine|caffeine|mesh-list
15067125|NCT02182336|Omeprazole|omeprazole|mesh-list
15067126|NCT02182336|Warfarin|warfarin|mesh-list
15067127|NCT02182336|Vitamins|vitamins|mesh-ancestor
15067128|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
15067129|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067130|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15067131|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15067132|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15067133|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15067134|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15067135|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15067136|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15067137|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
15067138|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
15067139|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
15067140|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
15067141|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067142|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067143|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
15067144|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15067145|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15067146|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15067147|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067148|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15067149|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15067150|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15067151|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15067152|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
15067153|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15067154|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15067155|NCT02182336|Protective Agents|protective agents|mesh-ancestor
15067156|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15067157|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15067158|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
15067159|NCT02182336|Coagulants|coagulants|mesh-ancestor
15067160|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
15067161|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
15067162|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15067163|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15067164|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
15067165|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15067166|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15067167|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
15067168|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15067169|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15067170|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15067171|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067172|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067173|NCT02182401|Tolbutamide|tolbutamide|mesh-list
15067174|NCT02182401|Midazolam|midazolam|mesh-list
15067175|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15067176|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15067177|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15067178|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067179|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15067180|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15067181|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15067182|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15067183|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
15067184|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
15067185|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
15067186|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
15067187|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067188|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067189|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067190|NCT02182453|Empagliflozin|empagliflozin|mesh-list
15067191|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15067192|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067193|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067194|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067195|NCT02182479|Fenoterol|fenoterol|mesh-list
15067196|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
15067197|NCT02182479|Ipratropium|ipratropium|mesh-list
15067198|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15067199|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
15067200|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067201|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067202|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15067203|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
15067204|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
15067205|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
15067206|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15067207|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15067208|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15067209|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15067210|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
15067211|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067212|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067213|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15067214|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
15067215|NCT02182505|Fenoterol|fenoterol|mesh-list
15067216|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
15067217|NCT02182505|Ipratropium|ipratropium|mesh-list
15067218|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15067219|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
15067220|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067221|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067222|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15067223|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
15067224|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
15067225|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
15067226|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15067227|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15067228|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15067229|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15067230|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
15067231|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067232|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067233|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15067234|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
15067235|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
15067236|NCT02182518|Ephedrine|ephedrine|mesh-list
15067237|NCT02182518|Epinastine|epinastine|mesh-list
15067238|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15067239|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
15067240|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067241|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067242|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15067243|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
15067244|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
15067245|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15067246|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15067247|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
15067248|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
15067249|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067250|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067251|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15067252|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
15067253|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
15067254|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
15067255|NCT02182531|Ephedrine|ephedrine|mesh-list
15067256|NCT02182531|Epinastine|epinastine|mesh-list
15067257|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15067258|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
15067259|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067260|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067261|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15067262|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
15067263|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
15067264|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15067265|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15067266|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
15067267|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
15067268|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067269|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067270|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15067271|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
15067272|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
15067273|NCT02182544|Ketotifen|ketotifen|mesh-list
15067274|NCT02182544|Epinastine|epinastine|mesh-list
15067275|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
15067276|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
15067277|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15067278|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
15067279|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
15067280|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067281|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067282|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067283|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15067284|NCT02182557|Ketotifen|ketotifen|mesh-list
15067285|NCT02182557|Epinastine|epinastine|mesh-list
15067286|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
15067287|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
15067288|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15067289|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
15067290|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
15067291|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067292|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067293|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067294|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15067295|NCT02182570|Epinastine|epinastine|mesh-list
15067296|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15067297|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
15067298|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
15067299|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067300|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067301|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067302|NCT02182583|Oxitropium|oxitropium|mesh-list
15067303|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
15067304|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
15067305|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067306|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067307|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
15067308|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15067309|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067310|NCT02182622|Prednisone|prednisone|mesh-list
15067311|NCT02182622|Docetaxel|docetaxel|mesh-list
15067312|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067313|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
15067314|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
15067315|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
15067316|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067317|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067318|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
15067319|NCT02182622|Hormones|hormones|mesh-ancestor
15067320|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067321|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067322|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15067323|NCT02182635|Oxitropium|oxitropium|mesh-list
15067324|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
15067325|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
15067326|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067327|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067328|NCT02182648|Propofol|propofol|mesh-list
15067329|NCT02182648|Etomidate|etomidate|mesh-list
15067330|NCT02182648|Sevoflurane|sevoflurane|mesh-list
15067331|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15067332|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15067333|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067334|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15067335|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
15067336|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
15067337|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15067338|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15067339|NCT02182661|Oxitropium|oxitropium|mesh-list
15067340|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
15067341|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
15067342|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067343|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067344|NCT02182700|Bromides|bromides|mesh-list
15067345|NCT02182700|Albuterol|albuterol|mesh-list
15067346|NCT02182700|Ipratropium|ipratropium|mesh-list
15067347|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
15067348|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15067349|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
15067350|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067351|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067352|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15067353|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
15067354|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
15067355|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15067356|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15067357|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15067358|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15067359|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
15067360|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067361|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067362|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15067363|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
15067364|NCT02182713|Bromides|bromides|mesh-list
15067365|NCT02182713|Albuterol|albuterol|mesh-list
15067366|NCT02182713|Ipratropium|ipratropium|mesh-list
15067367|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
15067368|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15067369|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
15067370|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067371|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067372|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15067373|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
15067374|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
15067375|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15067376|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15067377|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15067378|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15067379|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
15067380|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067381|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067382|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15067383|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
15067384|NCT02182739|Meloxicam|meloxicam|mesh-list
15067385|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067386|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067387|NCT02182739|Analgesics|analgesics|mesh-ancestor
15067388|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
15067389|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067390|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067391|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067392|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067393|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067394|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067395|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067396|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067397|NCT02182752|Tramadol|tramadol|mesh-list
15067398|NCT02182752|Ropivacaine|ropivacaine|mesh-list
15067399|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
15067400|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
15067401|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15067402|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067403|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
15067404|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067405|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15067406|NCT02182752|Narcotics|narcotics|mesh-ancestor
15067407|NCT02182752|Analgesics|analgesics|mesh-ancestor
15067408|NCT02182765|Nevirapine|nevirapine|mesh-list
15067409|NCT02182765|Abacavir|abacavir|mesh-list
15067410|NCT02182765|Amprenavir|amprenavir|mesh-list
15067411|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15067412|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15067413|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067414|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067415|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
15067416|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15067417|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15067418|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15067419|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15067420|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15067421|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15067422|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
15067423|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15067424|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15067425|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15067426|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067427|NCT02182778|Gemcitabine|gemcitabine|mesh-list
15067428|NCT02182778|Cisplatin|cisplatin|mesh-list
15067429|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067430|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15067431|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
15067432|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067433|NCT02182778|Antiviral Agents|antiviral agents|mesh-ancestor
15067434|NCT02182778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15067435|NCT02182778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067436|NCT02182778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15067437|NCT02182778|Immunologic Factors|immunologic factors|mesh-ancestor
15067438|NCT02182778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067439|NCT02182791|Nevirapine|nevirapine|mesh-list
15067440|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15067441|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15067442|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067443|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067444|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
15067445|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15067446|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15067447|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15067448|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15067449|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15067450|NCT02182856|Bromides|bromides|mesh-list
15067451|NCT02182856|Albuterol|albuterol|mesh-list
15067452|NCT02182856|Ipratropium|ipratropium|mesh-list
15067453|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
15067454|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15067455|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
15067456|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067457|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067458|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15067459|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
15067460|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
15067461|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15067462|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15067463|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15067464|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15067465|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
15067466|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067467|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067468|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15067469|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
15067470|NCT02182960|Ibuprofen|ibuprofen|mesh-list
15067471|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067472|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067473|NCT02182960|Analgesics|analgesics|mesh-ancestor
15067474|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
15067475|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067476|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067477|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067478|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067479|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067480|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067481|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067482|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
15067483|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
15067484|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067485|NCT02183012|Ibuprofen|ibuprofen|mesh-list
15067486|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067487|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067488|NCT02183012|Analgesics|analgesics|mesh-ancestor
15067489|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
15067490|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067491|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067492|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067493|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067494|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067495|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067496|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067497|NCT02183025|Meloxicam|meloxicam|mesh-list
15067498|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
15067499|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067500|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067501|NCT02183025|Analgesics|analgesics|mesh-ancestor
15067502|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
15067503|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067504|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067505|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067506|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067507|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067508|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067509|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067510|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067511|NCT02183038|Naproxen|naproxen|mesh-list
15067512|NCT02183038|Meloxicam|meloxicam|mesh-list
15067513|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067514|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067515|NCT02183038|Analgesics|analgesics|mesh-ancestor
15067516|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
15067517|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067518|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067519|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067520|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067521|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
15067522|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067523|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067524|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067525|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067526|NCT02183051|Ibuprofen|ibuprofen|mesh-list
15067527|NCT02183051|Meloxicam|meloxicam|mesh-list
15067528|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067529|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067530|NCT02183051|Analgesics|analgesics|mesh-ancestor
15067531|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
15067532|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067533|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067534|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067535|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067536|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067537|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067538|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067539|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067540|NCT02183064|Meloxicam|meloxicam|mesh-list
15067541|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067542|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067543|NCT02183064|Analgesics|analgesics|mesh-ancestor
15067544|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
15067545|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067546|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067547|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067548|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067549|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067550|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067551|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067552|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067553|NCT02183077|Meloxicam|meloxicam|mesh-list
15067554|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067555|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067556|NCT02183077|Analgesics|analgesics|mesh-ancestor
15067557|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
15067558|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067559|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067560|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067561|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067562|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067563|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067564|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067565|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067566|NCT02183090|Meloxicam|meloxicam|mesh-list
15067567|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067568|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067569|NCT02183090|Analgesics|analgesics|mesh-ancestor
15067570|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
15067571|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067572|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067573|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067574|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067575|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067576|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067577|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067578|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067579|NCT02183103|Meloxicam|meloxicam|mesh-list
15067580|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067581|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067582|NCT02183103|Analgesics|analgesics|mesh-ancestor
15067583|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
15067584|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067585|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067586|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067587|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067588|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067589|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067590|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067591|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067592|NCT02183116|Meloxicam|meloxicam|mesh-list
15067593|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067594|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067595|NCT02183116|Analgesics|analgesics|mesh-ancestor
15067596|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
15067597|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067598|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067599|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067600|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067601|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067602|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067603|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067604|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067605|NCT02183129|Diclofenac|diclofenac|mesh-list
15067606|NCT02183129|Meloxicam|meloxicam|mesh-list
15067607|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067608|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067609|NCT02183129|Analgesics|analgesics|mesh-ancestor
15067610|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
15067611|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067612|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067613|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067614|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067615|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067616|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067617|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067618|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067619|NCT02183142|Meloxicam|meloxicam|mesh-list
15067620|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067621|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067622|NCT02183142|Analgesics|analgesics|mesh-ancestor
15067623|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
15067624|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067625|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067626|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067627|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067628|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067629|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067630|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067631|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067632|NCT02183155|Indomethacin|indomethacin|mesh-list
15067633|NCT02183155|Meloxicam|meloxicam|mesh-list
15067634|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067635|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067636|NCT02183155|Analgesics|analgesics|mesh-ancestor
15067637|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
15067638|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067639|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067640|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067641|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067642|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
15067643|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
15067644|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15067645|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067646|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067647|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067648|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067649|NCT02183168|Indomethacin|indomethacin|mesh-list
15067650|NCT02183168|Meloxicam|meloxicam|mesh-list
15067651|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067652|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067653|NCT02183168|Analgesics|analgesics|mesh-ancestor
15067654|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
15067655|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067656|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067657|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067658|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067659|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
15067660|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
15067661|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15067662|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067663|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067664|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067665|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067666|NCT02183181|Meloxicam|meloxicam|mesh-list
15067667|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067668|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067669|NCT02183181|Analgesics|analgesics|mesh-ancestor
15067670|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
15067671|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067672|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067673|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067674|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067675|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15067676|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067677|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067678|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067679|NCT02183194|Paclitaxel|paclitaxel|mesh-list
15067680|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15067681|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067682|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
15067683|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
15067684|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
15067685|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067686|NCT02183220|Aspirin|aspirin|mesh-list
15067687|NCT02183220|Dipyrone|dipyrone|mesh-list
15067688|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15067689|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067690|NCT02183220|Analgesics|analgesics|mesh-ancestor
15067691|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
15067692|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067693|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067694|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15067695|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15067696|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15067697|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15067698|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067699|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15067700|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15067701|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067702|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
15067703|NCT02183246|Porfiromycin|porfiromycin|mesh-list
15067704|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15067705|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067706|NCT02183272|Ketamine|ketamine|mesh-list
15067707|NCT02183272|Analgesics|analgesics|mesh-ancestor
15067708|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
15067709|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067710|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067711|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15067712|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15067713|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
15067714|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
15067715|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15067716|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15067717|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15067718|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067719|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067720|NCT02183298|Linagliptin|linagliptin|mesh-list
15067721|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067722|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067723|NCT02183298|Incretins|incretins|mesh-ancestor
15067724|NCT02183298|Hormones|hormones|mesh-ancestor
15067725|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067726|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067727|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067728|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067729|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067730|NCT02183311|Linagliptin|linagliptin|mesh-list
15067731|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067732|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067733|NCT02183311|Incretins|incretins|mesh-ancestor
15067734|NCT02183311|Hormones|hormones|mesh-ancestor
15067735|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067736|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067737|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067738|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067739|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067740|NCT02183324|Linagliptin|linagliptin|mesh-list
15067741|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067742|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067743|NCT02183324|Incretins|incretins|mesh-ancestor
15067744|NCT02183324|Hormones|hormones|mesh-ancestor
15067745|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067746|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067747|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067748|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067749|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067750|NCT02183337|Pioglitazone|pioglitazone|mesh-list
15067751|NCT02183337|Linagliptin|linagliptin|mesh-list
15067752|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067753|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067754|NCT02183337|Incretins|incretins|mesh-ancestor
15067755|NCT02183337|Hormones|hormones|mesh-ancestor
15067756|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067757|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067758|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067759|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067760|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067761|NCT02183350|Linagliptin|linagliptin|mesh-list
15067762|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067763|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067764|NCT02183350|Incretins|incretins|mesh-ancestor
15067765|NCT02183350|Hormones|hormones|mesh-ancestor
15067766|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067767|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067768|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067769|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067770|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067771|NCT02183363|Linagliptin|linagliptin|mesh-list
15067772|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067773|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067774|NCT02183363|Incretins|incretins|mesh-ancestor
15067775|NCT02183363|Hormones|hormones|mesh-ancestor
15067776|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067777|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067778|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067779|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067780|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067781|NCT02183376|Linagliptin|linagliptin|mesh-list
15067782|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067783|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067784|NCT02183376|Incretins|incretins|mesh-ancestor
15067785|NCT02183376|Hormones|hormones|mesh-ancestor
15067786|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067787|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067788|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067789|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067790|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067791|NCT02183389|Linagliptin|linagliptin|mesh-list
15067792|NCT02183389|Warfarin|warfarin|mesh-list
15067793|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
15067794|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067795|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067796|NCT02183389|Incretins|incretins|mesh-ancestor
15067797|NCT02183389|Hormones|hormones|mesh-ancestor
15067798|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067799|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067800|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067801|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067802|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067803|NCT02183402|Linagliptin|linagliptin|mesh-list
15067804|NCT02183402|Digoxin|digoxin|mesh-list
15067805|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15067806|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15067807|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067808|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067809|NCT02183402|Protective Agents|protective agents|mesh-ancestor
15067810|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067811|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067812|NCT02183402|Incretins|incretins|mesh-ancestor
15067813|NCT02183402|Hormones|hormones|mesh-ancestor
15067814|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067815|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067816|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067817|NCT02183415|Linagliptin|linagliptin|mesh-list
15067818|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067819|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067820|NCT02183415|Incretins|incretins|mesh-ancestor
15067821|NCT02183415|Hormones|hormones|mesh-ancestor
15067822|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067823|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067824|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067825|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067826|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067827|NCT02183428|Glyburide|glyburide|mesh-list
15067828|NCT02183428|Linagliptin|linagliptin|mesh-list
15067829|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067830|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067831|NCT02183428|Incretins|incretins|mesh-ancestor
15067832|NCT02183428|Hormones|hormones|mesh-ancestor
15067833|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067834|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067835|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067836|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067837|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067838|NCT02183441|Linagliptin|linagliptin|mesh-list
15067839|NCT02183441|Ritonavir|ritonavir|mesh-list
15067840|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15067841|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15067842|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067843|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067844|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067845|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15067846|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15067847|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
15067848|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15067849|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15067850|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15067851|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067852|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067853|NCT02183441|Incretins|incretins|mesh-ancestor
15067854|NCT02183441|Hormones|hormones|mesh-ancestor
15067855|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067856|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067857|NCT02183467|Linagliptin|linagliptin|mesh-list
15067858|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
15067859|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15067860|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15067861|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15067862|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15067863|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067864|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067865|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15067866|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067867|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067868|NCT02183467|Incretins|incretins|mesh-ancestor
15067869|NCT02183467|Hormones|hormones|mesh-ancestor
15067870|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067871|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067872|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067873|NCT02183480|Linagliptin|linagliptin|mesh-list
15067874|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067875|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067876|NCT02183480|Incretins|incretins|mesh-ancestor
15067877|NCT02183480|Hormones|hormones|mesh-ancestor
15067878|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067879|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067880|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067881|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067882|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067883|NCT02183493|Linagliptin|linagliptin|mesh-list
15067884|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067885|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067886|NCT02183493|Incretins|incretins|mesh-ancestor
15067887|NCT02183493|Hormones|hormones|mesh-ancestor
15067888|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067889|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067890|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067891|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067892|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067893|NCT02183506|Metformin|metformin|mesh-list
15067894|NCT02183506|Linagliptin|linagliptin|mesh-list
15067895|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067896|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067897|NCT02183506|Incretins|incretins|mesh-ancestor
15067898|NCT02183506|Hormones|hormones|mesh-ancestor
15067899|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067900|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067901|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067902|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067903|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067904|NCT02183532|Linagliptin|linagliptin|mesh-list
15067905|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067906|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067907|NCT02183532|Incretins|incretins|mesh-ancestor
15067908|NCT02183532|Hormones|hormones|mesh-ancestor
15067909|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067910|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067911|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067912|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067913|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067914|NCT02183571|Metformin|metformin|mesh-list
15067915|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067916|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067917|NCT02183584|Linagliptin|linagliptin|mesh-list
15067918|NCT02183584|Rifampin|rifampin|mesh-list
15067919|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067920|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067921|NCT02183584|Incretins|incretins|mesh-ancestor
15067922|NCT02183584|Hormones|hormones|mesh-ancestor
15067923|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067924|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067925|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067926|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067927|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067928|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15067929|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
15067930|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15067931|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15067932|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
15067933|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15067934|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15067935|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15067936|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15067937|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15067938|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15067939|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15067940|NCT02183610|Linagliptin|linagliptin|mesh-list
15067941|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15067942|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067943|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067944|NCT02183610|Incretins|incretins|mesh-ancestor
15067945|NCT02183610|Hormones|hormones|mesh-ancestor
15067946|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067947|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067948|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067949|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067950|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067951|NCT02183623|Linagliptin|linagliptin|mesh-list
15067952|NCT02183623|Simvastatin|simvastatin|mesh-list
15067953|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15067954|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15067955|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
15067956|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067957|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15067958|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15067959|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067960|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067961|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067962|NCT02183623|Incretins|incretins|mesh-ancestor
15067963|NCT02183623|Hormones|hormones|mesh-ancestor
15067964|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067965|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067966|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067967|NCT02183636|Pioglitazone|pioglitazone|mesh-list
15067968|NCT02183636|Linagliptin|linagliptin|mesh-list
15067969|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15067970|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067971|NCT02183636|Incretins|incretins|mesh-ancestor
15067972|NCT02183636|Hormones|hormones|mesh-ancestor
15067973|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15067974|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15067975|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
15067976|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067977|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067978|NCT02183649|Carbetapentane|carbetapentane|mesh-list
15067979|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
15067980|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
15067981|NCT02183688|Acetaminophen|acetaminophen|mesh-list
15067982|NCT02183688|Caffeine|caffeine|mesh-list
15067983|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15067984|NCT02183688|Analgesics|analgesics|mesh-ancestor
15067985|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
15067986|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15067987|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15067988|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
15067989|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15067990|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15067991|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15067992|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15067993|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15067994|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15067995|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
15067996|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15067997|NCT02183701|Losartan|losartan|mesh-list
15067998|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15067999|NCT02183701|Telmisartan|telmisartan|mesh-list
15068000|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15068001|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15068002|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15068003|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15068004|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068005|NCT02183701|Diuretics|diuretics|mesh-ancestor
15068006|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
15068007|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068008|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15068009|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15068010|NCT02183779|Fluconazole|fluconazole|mesh-list
15068011|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
15068012|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068013|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15068014|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15068015|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068016|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068017|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15068018|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
15068019|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15068020|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068021|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15068022|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15068023|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
15068024|NCT02183805|Carboplatin|carboplatin|mesh-list
15068025|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15068026|NCT02183805|Paclitaxel|paclitaxel|mesh-list
15068027|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15068028|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
15068029|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068030|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15068031|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15068032|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
15068033|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068034|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068035|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15068036|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15068037|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
15068038|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
15068039|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
15068040|NCT02183870|Crizotinib|crizotinib|mesh-list
15068041|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068042|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15068043|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068044|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068045|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15068046|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15068047|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15068048|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
15068049|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068050|NCT02183948|Oxytocin|oxytocin|mesh-list
15068051|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
15068052|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15068053|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068054|NCT02184052|Meloxicam|meloxicam|mesh-list
15068055|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15068056|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15068057|NCT02184052|Analgesics|analgesics|mesh-ancestor
15068058|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
15068059|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068060|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068061|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15068062|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15068063|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15068064|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15068065|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068066|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068067|NCT02184065|Meloxicam|meloxicam|mesh-list
15068068|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15068069|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15068070|NCT02184065|Analgesics|analgesics|mesh-ancestor
15068071|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
15068072|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068073|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068074|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15068075|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15068076|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15068077|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15068078|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068079|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068080|NCT02184078|Nevirapine|nevirapine|mesh-list
15068081|NCT02184078|Rifabutin|rifabutin|mesh-list
15068082|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15068083|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15068084|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068085|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068086|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
15068087|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068088|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15068089|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15068090|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15068091|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15068092|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15068093|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15068094|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
15068095|NCT02184091|Nevirapine|nevirapine|mesh-list
15068096|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15068097|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15068098|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068099|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068100|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
15068101|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068102|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15068103|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15068104|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15068105|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15068106|NCT02184104|Caffeine|caffeine|mesh-list
15068107|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15068108|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068109|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15068110|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068111|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068112|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15068113|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15068114|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
15068115|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068116|NCT02184117|Adenosine|adenosine|mesh-list
15068117|NCT02184117|Analgesics|analgesics|mesh-ancestor
15068118|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
15068119|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068120|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068121|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15068122|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
15068123|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15068124|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
15068125|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
15068126|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068127|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068128|NCT02184247|Theophylline|theophylline|mesh-list
15068129|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15068130|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
15068131|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068132|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068133|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15068134|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
15068135|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15068136|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068137|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068138|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
15068139|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15068140|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15068141|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
15068142|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068143|NCT02184260|Dipyrone|dipyrone|mesh-list
15068144|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15068145|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15068146|NCT02184260|Analgesics|analgesics|mesh-ancestor
15068147|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
15068148|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068149|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068150|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15068151|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15068152|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
15068153|NCT02184273|Dipyrone|dipyrone|mesh-list
15068154|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15068155|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15068156|NCT02184273|Analgesics|analgesics|mesh-ancestor
15068157|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
15068158|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068159|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068160|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15068161|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15068162|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
15068163|NCT02184286|Nevirapine|nevirapine|mesh-list
15068164|NCT02184286|Saquinavir|saquinavir|mesh-list
15068165|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15068166|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15068167|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068168|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068169|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
15068170|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068171|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15068172|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15068173|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15068174|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15068175|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15068176|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15068177|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
15068178|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15068179|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15068180|NCT02184299|Nevirapine|nevirapine|mesh-list
15068181|NCT02184299|Prednisone|prednisone|mesh-list
15068182|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15068183|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
15068184|NCT02184299|Hormones|hormones|mesh-ancestor
15068185|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15068186|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068187|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15068188|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068189|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15068190|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15068191|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068192|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068193|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
15068194|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068195|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15068196|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15068197|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15068198|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15068199|NCT02184312|Nevirapine|nevirapine|mesh-list
15068200|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15068201|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15068202|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068203|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068204|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
15068205|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068206|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15068207|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15068208|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15068209|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15068210|NCT02184351|Clotrimazole|clotrimazole|mesh-list
15068211|NCT02184351|Miconazole|miconazole|mesh-list
15068212|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15068213|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068214|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
15068215|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15068216|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15068217|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068218|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068219|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15068220|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
15068221|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15068222|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068223|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15068224|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15068225|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15068226|NCT02184364|Estrogens|estrogens|mesh-ancestor
15068227|NCT02184364|Hormones|hormones|mesh-ancestor
15068228|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15068229|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068230|NCT02184429|PF-06669571|pf-06669571|mesh-list
15068231|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
15068232|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
15068233|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068234|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068235|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068236|NCT02184533|Selenious Acid|selenious acid|mesh-list
15068237|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
15068238|NCT02184533|Trace Elements|trace elements|mesh-ancestor
15068239|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
15068240|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068241|NCT02184559|Ropivacaine|ropivacaine|mesh-list
15068242|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
15068243|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
15068244|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068245|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068246|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
15068247|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068248|NCT02184637|Lumefantrine|lumefantrine|mesh-list
15068249|NCT02184637|Artemether|artemether|mesh-list
15068250|NCT02184637|Piperaquine|piperaquine|mesh-list
15068251|NCT02184637|Artenimol|artenimol|mesh-list
15068252|NCT02184637|Tafenoquine|tafenoquine|mesh-list
15068253|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15068254|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
15068255|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15068256|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15068257|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068258|NCT02184819|Riboflavin|riboflavin|mesh-list
15068259|NCT02184819|Simendan|simendan|mesh-list
15068260|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
15068261|NCT02184819|Vitamins|vitamins|mesh-ancestor
15068262|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
15068263|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068264|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15068265|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
15068266|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15068267|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
15068268|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15068269|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15068270|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068271|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068272|NCT02184819|Protective Agents|protective agents|mesh-ancestor
15068273|NCT02184832|Metformin|metformin|mesh-list
15068274|NCT02184832|Tryptophan|tryptophan|mesh-list
15068275|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15068276|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068277|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15068278|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
15068279|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15068280|NCT02184858|Lisinopril|lisinopril|mesh-list
15068281|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15068282|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
15068283|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068284|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068285|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15068286|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15068287|NCT02184858|Protective Agents|protective agents|mesh-ancestor
15068288|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068289|NCT02184897|Lenograstim|lenograstim|mesh-list
15068290|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15068291|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
15068292|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068293|NCT02184910|Gastrins|gastrins|mesh-list
15068294|NCT02184910|Hormones|hormones|mesh-ancestor
15068295|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15068296|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068297|NCT02184975|Hemostatics|hemostatics|mesh-list
15068298|NCT02184975|Coagulants|coagulants|mesh-ancestor
15068299|NCT02185066|Metformin|metformin|mesh-list
15068300|NCT02185066|Atorvastatin|atorvastatin|mesh-list
15068301|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15068302|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068303|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15068304|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15068305|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
15068306|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068307|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15068308|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15068309|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068310|NCT02185118|Sevoflurane|sevoflurane|mesh-list
15068311|NCT02185118|Isoflurane|isoflurane|mesh-list
15068312|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15068313|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15068314|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
15068315|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
15068316|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068317|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068318|NCT02185196|Vitamin D|vitamin d|mesh-list
15068319|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
15068320|NCT02185196|Vitamins|vitamins|mesh-ancestor
15068321|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
15068322|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068323|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15068324|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15068325|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
15068326|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15068327|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068328|NCT02185222|Vitamins|vitamins|mesh-ancestor
15068329|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
15068330|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15068331|NCT02185261|Interferons|interferons|mesh-list
15068332|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
15068333|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
15068334|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068335|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
15068336|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068337|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
15068338|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068339|NCT02185300|Dolutegravir|dolutegravir|mesh-list
15068340|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15068341|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15068342|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068343|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068344|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15068345|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15068346|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
15068347|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068348|NCT02185326|Hormones|hormones|mesh-list
15068349|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15068350|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068351|NCT02185352|Cisplatin|cisplatin|mesh-list
15068352|NCT02185352|Etoposide|etoposide|mesh-list
15068353|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068354|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15068355|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15068356|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15068357|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068358|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068359|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
15068360|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15068361|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068362|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068363|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15068364|NCT02185430|Analgesics|analgesics|mesh-ancestor
15068365|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
15068366|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068367|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15068368|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15068369|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15068370|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
15068371|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068372|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068373|NCT02185456|Metronidazole|metronidazole|mesh-list
15068374|NCT02185456|Miconazole|miconazole|mesh-list
15068375|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068376|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15068377|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15068378|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15068379|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
15068380|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15068381|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15068382|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068383|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068384|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15068385|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
15068386|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15068387|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068388|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15068389|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15068390|NCT02185547|Sertraline|sertraline|mesh-list
15068391|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
15068392|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15068393|NCT02185547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15068394|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15068395|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15068396|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068397|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068398|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
15068399|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068400|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
15068401|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15068402|NCT02185651|Miglustat|miglustat|mesh-list
15068403|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068404|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068405|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15068406|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15068407|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
15068408|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068409|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15068410|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15068411|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068412|NCT02185690|Carboplatin|carboplatin|mesh-list
15068413|NCT02185690|Pemetrexed|pemetrexed|mesh-list
15068414|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068415|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068416|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068417|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15068418|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15068419|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
15068420|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
15068421|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
15068422|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068423|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068424|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
15068425|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068426|NCT02185768|Idarubicin|idarubicin|mesh-list
15068427|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15068428|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068429|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15068430|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15068431|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068432|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068433|NCT02185833|Dirithromycin|dirithromycin|mesh-list
15068434|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15068435|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068436|NCT02185846|Dirithromycin|dirithromycin|mesh-list
15068437|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15068438|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068439|NCT02185859|Lidocaine|lidocaine|mesh-list
15068440|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
15068441|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
15068442|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
15068443|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068444|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068445|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
15068446|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068447|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15068448|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15068449|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15068450|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15068451|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068452|NCT02185859|Analgesics|analgesics|mesh-ancestor
15068453|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
15068454|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15068455|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15068456|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
15068457|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15068458|NCT02185898|Menthol|menthol|mesh-list
15068459|NCT02185898|Nicotine|nicotine|mesh-list
15068460|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15068461|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
15068462|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068463|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068464|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15068465|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15068466|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
15068467|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068468|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068469|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
15068470|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
15068471|NCT02185924|Parecoxib|parecoxib|mesh-list
15068472|NCT02185924|Ropivacaine|ropivacaine|mesh-list
15068473|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
15068474|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
15068475|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068476|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068477|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
15068478|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068479|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15068480|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15068481|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068482|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068483|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15068484|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15068485|NCT02185924|Analgesics|analgesics|mesh-ancestor
15068486|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15068487|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15068488|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15068489|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15068490|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15068491|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
15068492|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068493|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15068494|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15068495|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068496|NCT02186028|Vitamin D|vitamin d|mesh-list
15068497|NCT02186028|Vitamins|vitamins|mesh-ancestor
15068498|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
15068499|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068500|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15068501|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
15068502|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15068503|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068504|NCT02186106|Vitamins|vitamins|mesh-ancestor
15068505|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
15068506|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15068507|NCT02186119|Ranibizumab|ranibizumab|mesh-list
15068508|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15068509|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15068510|NCT02186119|Growth Substances|growth substances|mesh-ancestor
15068511|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068512|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
15068513|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068514|NCT02186132|Atropine|atropine|mesh-list
15068515|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15068516|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15068517|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15068518|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
15068519|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068520|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068521|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15068522|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
15068523|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
15068524|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
15068525|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15068526|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15068527|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
15068528|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068529|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068530|NCT02186145|Metronidazole|metronidazole|mesh-list
15068531|NCT02186145|Nystatin|nystatin|mesh-list
15068532|NCT02186145|Dexamethasone|dexamethasone|mesh-list
15068533|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15068534|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
15068535|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
15068536|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068537|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068538|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15068539|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
15068540|NCT02186145|Hormones|hormones|mesh-ancestor
15068541|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15068542|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15068543|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068544|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068545|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15068546|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15068547|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15068548|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
15068549|NCT02186145|Ionophores|ionophores|mesh-ancestor
15068550|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15068551|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068552|NCT02186158|Ascorbic Acid|ascorbic acid|mesh-list
15068553|NCT02186158|Vitamins|vitamins|mesh-ancestor
15068554|NCT02186158|Micronutrients|micronutrients|mesh-ancestor
15068555|NCT02186158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068556|NCT02186158|Antioxidants|antioxidants|mesh-ancestor
15068557|NCT02186158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068558|NCT02186158|Protective Agents|protective agents|mesh-ancestor
15068559|NCT02186249|Nivolumab|nivolumab|mesh-list
15068560|NCT02186249|Ipilimumab|ipilimumab|mesh-list
15068561|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15068562|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068563|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15068564|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068565|NCT02186275|Vitamin D|vitamin d|mesh-list
15068566|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
15068567|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
15068568|NCT02186275|Vitamins|vitamins|mesh-list
15068569|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
15068570|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068571|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15068572|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15068573|NCT02186366|Buspirone|buspirone|mesh-list
15068574|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15068575|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15068576|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068577|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068578|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15068579|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15068580|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
15068581|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068582|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068583|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15068584|NCT02186457|Polymyxins|polymyxins|mesh-list
15068585|NCT02186457|Polymyxin B|polymyxin b|mesh-list
15068586|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068587|NCT02186483|Metformin|metformin|mesh-list
15068588|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15068589|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15068590|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068591|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15068592|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15068593|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
15068594|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068595|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15068596|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15068597|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068598|NCT02186496|Amlodipine|amlodipine|mesh-list
15068599|NCT02186496|Candesartan|candesartan|mesh-list
15068600|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15068601|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15068602|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15068603|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068604|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15068605|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068606|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
15068607|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15068608|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15068609|NCT02186535|Vitamin D|vitamin d|mesh-list
15068610|NCT02186535|Calcium|calcium|mesh-list
15068611|NCT02186535|Vitamins|vitamins|mesh-ancestor
15068612|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
15068613|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068614|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15068615|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15068616|NCT02186574|Tenofovir|tenofovir|mesh-list
15068617|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
15068618|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068619|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15068620|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15068621|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068622|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068623|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15068624|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15068625|NCT02186600|Vitamin D|vitamin d|mesh-list
15068626|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
15068627|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
15068628|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
15068629|NCT02186600|Calcium|calcium|mesh-list
15068630|NCT02186600|Vitamins|vitamins|mesh-ancestor
15068631|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
15068632|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068633|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15068634|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15068635|NCT02186600|Antacids|antacids|mesh-ancestor
15068636|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068637|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15068638|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15068639|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15068640|NCT02186769|Risperidone|risperidone|mesh-list
15068641|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15068642|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
15068643|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068644|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068645|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068646|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15068647|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15068648|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068649|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15068650|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15068651|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
15068652|NCT02186782|Citric Acid|citric acid|mesh-list
15068653|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
15068654|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15068655|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15068656|NCT02186782|Clomiphene|clomiphene|mesh-list
15068657|NCT02186782|Enclomiphene|enclomiphene|mesh-list
15068658|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
15068659|NCT02186782|Estradiol|estradiol|mesh-list
15068660|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15068661|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
15068662|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15068663|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
15068664|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
15068665|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068666|NCT02186782|Estrogens|estrogens|mesh-ancestor
15068667|NCT02186782|Hormones|hormones|mesh-ancestor
15068668|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15068669|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068670|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15068671|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
15068672|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15068673|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15068674|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15068675|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
15068676|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15068677|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
15068678|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15068679|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15068680|NCT02186886|Golimumab|golimumab|mesh-list
15068681|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15068682|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15068683|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15068684|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
15068685|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068686|NCT02186899|Anesthetics|anesthetics|mesh-list
15068687|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068688|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068689|NCT02186951|Amoxicillin|amoxicillin|mesh-list
15068690|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
15068691|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
15068692|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15068693|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068694|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068695|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068696|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15068697|NCT02186990|Propofol|propofol|mesh-list
15068698|NCT02186990|Etomidate|etomidate|mesh-list
15068699|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15068700|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068701|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068702|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15068703|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
15068704|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
15068705|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
15068706|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15068707|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068708|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068709|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15068710|NCT02187068|Analgesics|analgesics|mesh-ancestor
15068711|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
15068712|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068713|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15068714|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15068715|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15068716|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
15068717|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068718|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068719|NCT02187081|Sorafenib|sorafenib|mesh-list
15068720|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068721|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15068722|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068723|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068724|NCT02187107|Darunavir|darunavir|mesh-list
15068725|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15068726|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15068727|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
15068728|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068729|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068730|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15068731|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15068732|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
15068733|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068734|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
15068735|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15068736|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15068737|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068738|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
15068739|NCT02187120|Coagulants|coagulants|mesh-ancestor
15068740|NCT02187133|Rituximab|rituximab|mesh-list
15068741|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15068742|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15068743|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068744|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
15068745|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068746|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15068747|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15068748|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
15068749|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068750|NCT02187198|Buprenorphine|buprenorphine|mesh-list
15068751|NCT02187198|Naloxone|naloxone|mesh-list
15068752|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15068753|NCT02187198|Narcotics|narcotics|mesh-ancestor
15068754|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068755|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068756|NCT02187198|Analgesics|analgesics|mesh-ancestor
15068757|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
15068758|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068759|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15068760|NCT02187211|Minocycline|minocycline|mesh-list
15068761|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15068762|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068763|NCT02187250|Metformin|metformin|mesh-list
15068764|NCT02187250|Liraglutide|liraglutide|mesh-list
15068765|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15068766|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068767|NCT02187250|Incretins|incretins|mesh-ancestor
15068768|NCT02187250|Hormones|hormones|mesh-ancestor
15068769|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15068770|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
15068771|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068772|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068773|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
15068774|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068775|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068776|NCT02187315|Cisplatin|cisplatin|mesh-list
15068777|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068778|NCT02187354|Blinatumomab|blinatumomab|mesh-list
15068779|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068780|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
15068781|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15068782|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
15068783|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068784|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15068785|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15068786|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
15068787|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068788|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068789|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15068790|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
15068791|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068792|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068793|NCT02187445|Budesonide|budesonide|mesh-list
15068794|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15068795|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15068796|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
15068797|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068798|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068799|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15068800|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
15068801|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
15068802|NCT02187445|Hormones|hormones|mesh-ancestor
15068803|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15068804|NCT02187484|Telmisartan|telmisartan|mesh-list
15068805|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15068806|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15068807|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15068808|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068809|NCT02187497|Telmisartan|telmisartan|mesh-list
15068810|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15068811|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15068812|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15068813|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068814|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15068815|NCT02187523|Telmisartan|telmisartan|mesh-list
15068816|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15068817|NCT02187523|Diuretics|diuretics|mesh-ancestor
15068818|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
15068819|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068820|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15068821|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15068822|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068823|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15068824|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15068825|NCT02187536|Telmisartan|telmisartan|mesh-list
15068826|NCT02187536|Simvastatin|simvastatin|mesh-list
15068827|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15068828|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15068829|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
15068830|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068831|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15068832|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15068833|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068834|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15068835|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15068836|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15068837|NCT02187562|Aspirin|aspirin|mesh-list
15068838|NCT02187562|Meloxicam|meloxicam|mesh-list
15068839|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15068840|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15068841|NCT02187562|Analgesics|analgesics|mesh-ancestor
15068842|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
15068843|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068844|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068845|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15068846|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15068847|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15068848|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15068849|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068850|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15068851|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15068852|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068853|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
15068854|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15068855|NCT02187588|Ibuprofen|ibuprofen|mesh-list
15068856|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15068857|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15068858|NCT02187588|Analgesics|analgesics|mesh-ancestor
15068859|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
15068860|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068861|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068862|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15068863|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15068864|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15068865|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068866|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068867|NCT02187614|Acetaminophen|acetaminophen|mesh-list
15068868|NCT02187614|Diclofenac|diclofenac|mesh-list
15068869|NCT02187614|Morphine|morphine|mesh-list
15068870|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15068871|NCT02187614|Narcotics|narcotics|mesh-ancestor
15068872|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068873|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068874|NCT02187614|Analgesics|analgesics|mesh-ancestor
15068875|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
15068876|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068877|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15068878|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
15068879|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15068880|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15068881|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15068882|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15068883|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068884|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068885|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15068886|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15068887|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15068888|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15068889|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068890|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
15068891|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068892|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068893|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15068894|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068895|NCT02187705|Telmisartan|telmisartan|mesh-list
15068896|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15068897|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15068898|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15068899|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068900|NCT02187718|Anesthetics|anesthetics|mesh-list
15068901|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15068902|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068903|NCT02187822|Taxane|taxane|mesh-list
15068904|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068905|NCT02187874|Oxytocin|oxytocin|mesh-list
15068906|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
15068907|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15068908|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068909|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
15068910|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
15068911|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15068912|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068913|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15068914|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
15068915|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15068916|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15068917|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068918|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068919|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15068920|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15068921|NCT02187900|Protective Agents|protective agents|mesh-ancestor
15068922|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068923|NCT02188121|Losartan|losartan|mesh-list
15068924|NCT02188121|Simvastatin|simvastatin|mesh-list
15068925|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15068926|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15068927|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
15068928|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068929|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15068930|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15068931|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068932|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15068933|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15068934|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15068935|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15068936|NCT02188173|Dexamethasone|dexamethasone|mesh-list
15068937|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15068938|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
15068939|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
15068940|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068941|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068942|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15068943|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
15068944|NCT02188173|Hormones|hormones|mesh-ancestor
15068945|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15068946|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15068947|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068948|NCT02188186|Metformin|metformin|mesh-list
15068949|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15068950|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15068951|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068952|NCT02188186|Incretins|incretins|mesh-ancestor
15068953|NCT02188186|Hormones|hormones|mesh-ancestor
15068954|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15068955|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15068956|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
15068957|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068958|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068959|NCT02188225|Fluoxetine|fluoxetine|mesh-list
15068960|NCT02188225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15068961|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15068962|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15068963|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068964|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068965|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
15068966|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068967|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15068968|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
15068969|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15068970|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15068971|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15068972|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15068973|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
15068974|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15068975|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15068976|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
15068977|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15068978|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15068979|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068980|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
15068981|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15068982|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068983|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15068984|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15068985|NCT02188368|Clarithromycin|clarithromycin|mesh-list
15068986|NCT02188368|Dexamethasone|dexamethasone|mesh-list
15068987|NCT02188368|Prednisone|prednisone|mesh-list
15068988|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
15068989|NCT02188368|Bortezomib|bortezomib|mesh-list
15068990|NCT02188368|Pomalidomide|pomalidomide|mesh-list
15068991|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15068992|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
15068993|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15068994|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15068995|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15068996|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
15068997|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15068998|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15068999|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15069000|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069001|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
15069002|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
15069003|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069004|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15069005|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
15069006|NCT02188368|Hormones|hormones|mesh-ancestor
15069007|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069008|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15069009|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069010|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15069011|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069012|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15069013|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15069014|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15069015|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15069016|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15069017|NCT02188368|Growth Substances|growth substances|mesh-ancestor
15069018|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
15069019|NCT02188394|Bupivacaine|bupivacaine|mesh-list
15069020|NCT02188394|Anesthetics|anesthetics|mesh-list
15069021|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
15069022|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069023|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069024|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
15069025|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069026|NCT02188407|Propofol|propofol|mesh-list
15069027|NCT02188407|Sevoflurane|sevoflurane|mesh-list
15069028|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15069029|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069030|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069031|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15069032|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
15069033|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
15069034|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15069035|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15069036|NCT02188472|Trimethoprim|trimethoprim|mesh-list
15069037|NCT02188472|Penicillins|penicillins|mesh-list
15069038|NCT02188472|Penicillin V|penicillin v|mesh-list
15069039|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15069040|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069041|NCT02188472|Renal Agents|renal agents|mesh-ancestor
15069042|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
15069043|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15069044|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15069045|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15069046|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069047|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069048|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15069049|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15069050|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15069051|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15069052|NCT02188511|Nicotine|nicotine|mesh-list
15069053|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15069054|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
15069055|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069056|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069057|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15069058|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15069059|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
15069060|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069061|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069062|NCT02188537|Nelfinavir|nelfinavir|mesh-list
15069063|NCT02188537|Dexamethasone|dexamethasone|mesh-list
15069064|NCT02188537|Bortezomib|bortezomib|mesh-list
15069065|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069066|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
15069067|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
15069068|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069069|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069070|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15069071|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
15069072|NCT02188537|Hormones|hormones|mesh-ancestor
15069073|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069074|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15069075|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069076|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15069077|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15069078|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
15069079|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069080|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069081|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15069082|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15069083|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
15069084|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069085|NCT02188550|Everolimus|everolimus|mesh-list
15069086|NCT02188550|Letrozole|letrozole|mesh-list
15069087|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069088|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15069089|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
15069090|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069091|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15069092|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15069093|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069094|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069095|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15069096|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
15069097|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069098|NCT02188615|Vinorelbine|vinorelbine|mesh-list
15069099|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069100|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15069101|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
15069102|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
15069103|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
15069104|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069105|NCT02188654|Metformin|metformin|mesh-list
15069106|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15069107|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069108|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
15069109|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15069110|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
15069111|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069112|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
15069113|NCT02188771|Protective Agents|protective agents|mesh-ancestor
15069114|NCT02188810|Vaccines|vaccines|mesh-list
15069115|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
15069116|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069117|NCT02188888|Esmolol|esmolol|mesh-list
15069118|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15069119|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15069120|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15069121|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
15069122|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069123|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069124|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069125|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
15069126|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
15069127|NCT02188953|Calcium|calcium|mesh-list
15069128|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15069129|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069130|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15069131|NCT02188953|Antacids|antacids|mesh-ancestor
15069132|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069133|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15069134|NCT02189304|Budesonide|budesonide|mesh-list
15069135|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
15069136|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
15069137|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
15069138|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069139|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15069140|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
15069141|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069142|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069143|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15069144|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
15069145|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
15069146|NCT02189304|Hormones|hormones|mesh-ancestor
15069147|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069148|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15069149|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15069150|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15069151|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
15069152|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069153|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069154|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15069155|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15069156|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15069157|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
15069158|NCT02189343|Thalidomide|thalidomide|mesh-list
15069159|NCT02189343|Dexamethasone|dexamethasone|mesh-list
15069160|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
15069161|NCT02189343|Pomalidomide|pomalidomide|mesh-list
15069162|NCT02189343|Ricolinostat|ricolinostat|mesh-list
15069163|NCT02189343|BB 1101|bb 1101|mesh-list
15069164|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069165|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
15069166|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
15069167|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069168|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069169|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15069170|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
15069171|NCT02189343|Hormones|hormones|mesh-ancestor
15069172|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069173|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15069174|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069175|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
15069176|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069177|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069178|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
15069179|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15069180|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15069181|NCT02189343|Growth Substances|growth substances|mesh-ancestor
15069182|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
15069183|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15069184|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
15069185|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15069186|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069187|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15069188|NCT02189395|Insulin|insulin|mesh-list
15069189|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
15069190|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15069191|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15069192|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069193|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
15069194|NCT02189577|Bromides|bromides|mesh-list
15069195|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
15069196|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15069197|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15069198|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15069199|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
15069200|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069201|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069202|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069203|NCT02189655|Bupivacaine|bupivacaine|mesh-list
15069204|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
15069205|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
15069206|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069207|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069208|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
15069209|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069210|NCT02189681|Anesthetics|anesthetics|mesh-list
15069211|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069212|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069213|NCT02189694|Hormones|hormones|mesh-list
15069214|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069215|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069216|NCT02189720|Amifampridine|amifampridine|mesh-list
15069217|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15069218|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069219|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069220|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
15069221|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15069222|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069223|NCT02189772|Metadoxine|metadoxine|mesh-list
15069224|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15069225|NCT02190149|Factor VIII|factor viii|mesh-list
15069226|NCT02190149|Coagulants|coagulants|mesh-ancestor
15069227|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
15069228|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
15069229|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069230|NCT02190318|Losartan|losartan|mesh-list
15069231|NCT02190318|Spironolactone|spironolactone|mesh-list
15069232|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15069233|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15069234|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15069235|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15069236|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069237|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15069238|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
15069239|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069240|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069241|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15069242|NCT02190318|Diuretics|diuretics|mesh-ancestor
15069243|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
15069244|NCT02190357|Rifaximin|rifaximin|mesh-list
15069245|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15069246|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069247|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15069248|NCT02190526|Mesalamine|mesalamine|mesh-list
15069249|NCT02190526|Amitriptyline|amitriptyline|mesh-list
15069250|NCT02190526|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15069251|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15069252|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15069253|NCT02190526|Analgesics|analgesics|mesh-ancestor
15069254|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
15069255|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069256|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069257|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069258|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15069259|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15069260|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
15069261|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15069262|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15069263|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15069264|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15069265|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069266|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
15069267|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069268|NCT02190526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15069269|NCT02190526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15069270|NCT02190526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069271|NCT02190695|Carboplatin|carboplatin|mesh-list
15069272|NCT02190695|Decitabine|decitabine|mesh-list
15069273|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
15069274|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069275|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15069276|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
15069277|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069278|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069279|NCT02190708|Midazolam|midazolam|mesh-list
15069280|NCT02190708|Omeprazole|omeprazole|mesh-list
15069281|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
15069282|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15069283|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15069284|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069285|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069286|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15069287|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15069288|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15069289|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15069290|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
15069291|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
15069292|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
15069293|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
15069294|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069295|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069296|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15069297|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15069298|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069299|NCT02190760|Dexamethasone|dexamethasone|mesh-list
15069300|NCT02190760|Bupivacaine|bupivacaine|mesh-list
15069301|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069302|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
15069303|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
15069304|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069305|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069306|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15069307|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
15069308|NCT02190760|Hormones|hormones|mesh-ancestor
15069309|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069310|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15069311|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069312|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
15069313|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
15069314|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069315|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
15069316|NCT02190838|Metformin|metformin|mesh-list
15069317|NCT02190838|Dacarbazine|dacarbazine|mesh-list
15069318|NCT02190838|Melatonin|melatonin|mesh-list
15069319|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15069320|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069321|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
15069322|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069323|NCT02190838|Protective Agents|protective agents|mesh-ancestor
15069324|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069325|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15069326|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
15069327|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069328|NCT02190994|Prednisone|prednisone|mesh-list
15069329|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
15069330|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069331|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
15069332|NCT02190994|Hormones|hormones|mesh-ancestor
15069333|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069334|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069335|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15069336|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069337|NCT02191007|Calcitriol|calcitriol|mesh-list
15069338|NCT02191007|Betamethasone|betamethasone|mesh-list
15069339|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
15069340|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
15069341|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
15069342|NCT02191007|Calcipotriene|calcipotriene|mesh-list
15069343|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
15069344|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069345|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
15069346|NCT02191007|Hormones|hormones|mesh-ancestor
15069347|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069348|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069349|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15069350|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
15069351|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
15069352|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15069353|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
15069354|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15069355|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069356|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15069357|NCT02191007|Vitamins|vitamins|mesh-ancestor
15069358|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
15069359|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15069360|NCT02191020|Acitretin|acitretin|mesh-list
15069361|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
15069362|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
15069363|NCT02191059|Docetaxel|docetaxel|mesh-list
15069364|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069365|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
15069366|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
15069367|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
15069368|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069369|NCT02191072|Omalizumab|omalizumab|mesh-list
15069370|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15069371|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15069372|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
15069373|NCT02191124|Mirtazapine|mirtazapine|mesh-list
15069374|NCT02191124|Paroxetine|paroxetine|mesh-list
15069375|NCT02191124|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15069376|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15069377|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15069378|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069379|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069380|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
15069381|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069382|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15069383|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
15069384|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15069385|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15069386|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15069387|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069388|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15069389|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
15069390|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
15069391|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15069392|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15069393|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069394|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15069395|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15069396|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15069397|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
15069398|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15069399|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15069400|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15069401|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
15069402|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
15069403|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
15069404|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15069405|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15069406|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069407|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069408|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069409|NCT02191189|Nevirapine|nevirapine|mesh-list
15069410|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15069411|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15069412|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069413|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069414|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
15069415|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069416|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15069417|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15069418|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15069419|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15069420|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
15069421|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15069422|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069423|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069424|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
15069425|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069426|NCT02191215|Nevirapine|nevirapine|mesh-list
15069427|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15069428|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15069429|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069430|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069431|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
15069432|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069433|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15069434|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15069435|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15069436|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15069437|NCT02191228|Linagliptin|linagliptin|mesh-list
15069438|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15069439|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069440|NCT02191228|Incretins|incretins|mesh-ancestor
15069441|NCT02191228|Hormones|hormones|mesh-ancestor
15069442|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069443|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15069444|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
15069445|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069446|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069447|NCT02191280|Quercetin|quercetin|mesh-list
15069448|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
15069449|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069450|NCT02191280|Protective Agents|protective agents|mesh-ancestor
15069451|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069452|NCT02191293|Nevirapine|nevirapine|mesh-list
15069453|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15069454|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15069455|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069456|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069457|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
15069458|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069459|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15069460|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15069461|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15069462|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15069463|NCT02191319|Nevirapine|nevirapine|mesh-list
15069464|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15069465|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15069466|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069467|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069468|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
15069469|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069470|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15069471|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15069472|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15069473|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15069474|NCT02191332|Nevirapine|nevirapine|mesh-list
15069475|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15069476|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15069477|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069478|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069479|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
15069480|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069481|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15069482|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15069483|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15069484|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15069485|NCT02191371|Propofol|propofol|mesh-list
15069486|NCT02191371|Desflurane|desflurane|mesh-list
15069487|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15069488|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069489|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069490|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15069491|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
15069492|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
15069493|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15069494|NCT02191423|Oxytocin|oxytocin|mesh-list
15069495|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
15069496|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15069497|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069498|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
15069499|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15069500|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069501|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15069502|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069503|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069504|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15069505|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15069506|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
15069507|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
15069508|NCT02191566|Tegafur|tegafur|mesh-list
15069509|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069510|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15069511|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
15069512|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069513|NCT02191657|Deferiprone|deferiprone|mesh-list
15069514|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15069515|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
15069516|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
15069517|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069518|NCT02191670|Tenecteplase|tenecteplase|mesh-list
15069519|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15069520|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15069521|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069522|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
15069523|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
15069524|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
15069525|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15069526|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15069527|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069528|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069529|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069530|NCT02191748|Triamcinolone|triamcinolone|mesh-list
15069531|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069532|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
15069533|NCT02191748|Hormones|hormones|mesh-ancestor
15069534|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069535|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069536|NCT02191826|Tolcapone|tolcapone|mesh-list
15069537|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15069538|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15069539|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
15069540|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069541|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069542|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
15069543|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
15069544|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
15069545|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15069546|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
15069547|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069548|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069549|NCT02191891|Afatinib|afatinib|mesh-list
15069550|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069551|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15069552|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069553|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069554|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
15069555|NCT02191930|Doxorubicin|doxorubicin|mesh-list
15069556|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15069557|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15069558|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15069559|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
15069560|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069561|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15069562|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15069563|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
15069564|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069565|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069566|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15069567|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15069568|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15069569|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15069570|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069571|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15069572|NCT02191943|Fluorides|fluorides|mesh-list
15069573|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
15069574|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
15069575|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
15069576|NCT02191943|Protective Agents|protective agents|mesh-ancestor
15069577|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069578|NCT02192060|Triclosan|triclosan|mesh-list
15069579|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15069580|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069581|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15069582|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15069583|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
15069584|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069585|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15069586|NCT02192203|Diclofenac|diclofenac|mesh-list
15069587|NCT02192203|Menthol|menthol|mesh-list
15069588|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15069589|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15069590|NCT02192203|Analgesics|analgesics|mesh-ancestor
15069591|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
15069592|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069593|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069594|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069595|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15069596|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15069597|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069598|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069599|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
15069600|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
15069601|NCT02192229|Vitamin D|vitamin d|mesh-list
15069602|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
15069603|NCT02192229|Vitamins|vitamins|mesh-ancestor
15069604|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
15069605|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069606|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15069607|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15069608|NCT02192320|Dexamethasone|dexamethasone|mesh-list
15069609|NCT02192320|Atorvastatin|atorvastatin|mesh-list
15069610|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069611|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
15069612|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
15069613|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069614|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069615|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15069616|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
15069617|NCT02192320|Hormones|hormones|mesh-ancestor
15069618|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069619|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15069620|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069621|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15069622|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15069623|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
15069624|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069625|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15069626|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15069627|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069628|NCT02192411|Lidocaine|lidocaine|mesh-list
15069629|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
15069630|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
15069631|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069632|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069633|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
15069634|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069635|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15069636|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15069637|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15069638|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15069639|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069640|NCT02192424|Insulin|insulin|mesh-list
15069641|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15069642|NCT02192424|Metformin|metformin|mesh-list
15069643|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
15069644|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
15069645|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15069646|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069647|NCT02192450|Insulin|insulin|mesh-list
15069648|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15069649|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
15069650|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
15069651|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
15069652|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15069653|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069654|NCT02192463|Nevirapine|nevirapine|mesh-list
15069655|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15069656|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15069657|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069658|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069659|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
15069660|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069661|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15069662|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15069663|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15069664|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15069665|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
15069666|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15069667|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15069668|NCT02192632|Analgesics|analgesics|mesh-ancestor
15069669|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
15069670|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069671|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069672|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069673|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15069674|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
15069675|NCT02192697|Naquotinib|naquotinib|mesh-list
15069676|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069677|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15069678|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069679|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069680|NCT02192710|Midazolam|midazolam|mesh-list
15069681|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15069682|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15069683|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069684|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069685|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15069686|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15069687|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15069688|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15069689|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
15069690|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
15069691|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
15069692|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
15069693|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069694|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069695|NCT02192723|Olanzapine|olanzapine|mesh-list
15069696|NCT02192723|Risperidone|risperidone|mesh-list
15069697|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
15069698|NCT02192723|Aripiprazole|aripiprazole|mesh-list
15069699|NCT02192723|Ziprasidone|ziprasidone|mesh-list
15069700|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
15069701|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15069702|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
15069703|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069704|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069705|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069706|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15069707|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069708|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15069709|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15069710|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
15069711|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
15069712|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
15069713|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069714|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15069715|NCT02192723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15069716|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15069717|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15069718|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
15069719|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
15069720|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
15069721|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15069722|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15069723|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15069724|NCT02192827|Dexamethasone|dexamethasone|mesh-list
15069725|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
15069726|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
15069727|NCT02192827|BB 1101|bb 1101|mesh-list
15069728|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069729|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
15069730|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
15069731|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069732|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069733|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15069734|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
15069735|NCT02192827|Hormones|hormones|mesh-ancestor
15069736|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069737|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15069738|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069739|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
15069740|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069741|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069742|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15069743|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15069744|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069745|NCT02192853|Incretins|incretins|mesh-ancestor
15069746|NCT02192853|Hormones|hormones|mesh-ancestor
15069747|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069748|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15069749|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
15069750|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069751|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069752|NCT02192944|Chloroquine|chloroquine|mesh-list
15069753|NCT02192944|Piperaquine|piperaquine|mesh-list
15069754|NCT02192944|Artenimol|artenimol|mesh-list
15069755|NCT02192944|Amebicides|amebicides|mesh-ancestor
15069756|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15069757|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15069758|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069759|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
15069760|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15069761|NCT02193022|Miltefosine|miltefosine|mesh-list
15069762|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
15069763|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069764|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069765|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15069766|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15069767|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15069768|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15069769|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069770|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15069771|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
15069772|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069773|NCT02193256|Prazosin|prazosin|mesh-list
15069774|NCT02193256|Varenicline|varenicline|mesh-list
15069775|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15069776|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15069777|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
15069778|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069779|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069780|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069781|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15069782|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15069783|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15069784|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15069785|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
15069786|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15069787|NCT02193269|Minocycline|minocycline|mesh-list
15069788|NCT02193269|Tetracycline|tetracycline|mesh-list
15069789|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069790|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15069791|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069792|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069793|NCT02193308|Amlodipine|amlodipine|mesh-list
15069794|NCT02193308|Telmisartan|telmisartan|mesh-list
15069795|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
15069796|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15069797|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15069798|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15069799|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069800|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15069801|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069802|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
15069803|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15069804|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15069805|NCT02193334|Mitogens|mitogens|mesh-list
15069806|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
15069807|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069808|NCT02193568|Anesthetics|anesthetics|mesh-list
15069809|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069810|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069811|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
15069812|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069813|NCT02193620|Nalbuphine|nalbuphine|mesh-list
15069814|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15069815|NCT02193620|Narcotics|narcotics|mesh-ancestor
15069816|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069817|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069818|NCT02193620|Analgesics|analgesics|mesh-ancestor
15069819|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
15069820|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069821|NCT02193633|Paclitaxel|paclitaxel|mesh-list
15069822|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15069823|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15069824|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069825|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
15069826|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
15069827|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
15069828|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069829|NCT02193698|Dexamethasone|dexamethasone|mesh-list
15069830|NCT02193698|Lenalidomide|lenalidomide|mesh-list
15069831|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15069832|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
15069833|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
15069834|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069835|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069836|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15069837|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
15069838|NCT02193698|Hormones|hormones|mesh-ancestor
15069839|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15069840|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15069841|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069842|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
15069843|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15069844|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15069845|NCT02193698|Growth Substances|growth substances|mesh-ancestor
15069846|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
15069847|NCT02193841|Calcium|calcium|mesh-list
15069848|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15069849|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069850|NCT02193893|Coal Tar|coal tar|mesh-list
15069851|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
15069852|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
15069853|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15069854|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15069855|NCT02194049|Etoposide|etoposide|mesh-list
15069856|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
15069857|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069858|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15069859|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15069860|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15069861|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069862|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069863|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
15069864|NCT02194075|Methylphenidate|methylphenidate|mesh-list
15069865|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15069866|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069867|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15069868|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15069869|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15069870|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069871|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
15069872|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069873|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15069874|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15069875|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069876|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15069877|NCT02194075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15069878|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
15069879|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15069880|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
15069881|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15069882|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15069883|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069884|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15069885|NCT02194153|Tenecteplase|tenecteplase|mesh-list
15069886|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15069887|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15069888|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069889|NCT02194166|Paclitaxel|paclitaxel|mesh-list
15069890|NCT02194166|Docetaxel|docetaxel|mesh-list
15069891|NCT02194166|Trastuzumab|trastuzumab|mesh-list
15069892|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15069893|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069894|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
15069895|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
15069896|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
15069897|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069898|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15069899|NCT02194179|Nevirapine|nevirapine|mesh-list
15069900|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15069901|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15069902|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069903|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069904|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
15069905|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069906|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15069907|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15069908|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15069909|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15069910|NCT02194192|Ephedrine|ephedrine|mesh-list
15069911|NCT02194192|Ondansetron|ondansetron|mesh-list
15069912|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
15069913|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
15069914|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15069915|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069916|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15069917|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
15069918|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
15069919|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15069920|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
15069921|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15069922|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069923|NCT02194192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15069924|NCT02194192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15069925|NCT02194192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15069926|NCT02194192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15069927|NCT02194192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15069928|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15069929|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
15069930|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15069931|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
15069932|NCT02194218|Nevirapine|nevirapine|mesh-list
15069933|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15069934|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15069935|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15069936|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069937|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
15069938|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069939|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15069940|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15069941|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15069942|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15069943|NCT02194231|Trabectedin|trabectedin|mesh-list
15069944|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15069945|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
15069946|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069947|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069948|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15069949|NCT02194257|Ambroxol|ambroxol|mesh-list
15069950|NCT02194257|Expectorants|expectorants|mesh-ancestor
15069951|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
15069952|NCT02194270|Ambroxol|ambroxol|mesh-list
15069953|NCT02194270|Expectorants|expectorants|mesh-ancestor
15069954|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
15069955|NCT02194283|Ambroxol|ambroxol|mesh-list
15069956|NCT02194283|Expectorants|expectorants|mesh-ancestor
15069957|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
15069958|NCT02194296|Ambroxol|ambroxol|mesh-list
15069959|NCT02194296|Expectorants|expectorants|mesh-ancestor
15069960|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
15069961|NCT02194309|Amlodipine|amlodipine|mesh-list
15069962|NCT02194309|Telmisartan|telmisartan|mesh-list
15069963|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15069964|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15069965|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15069966|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069967|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15069968|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069969|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
15069970|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15069971|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15069972|NCT02194374|Vidarabine|vidarabine|mesh-list
15069973|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
15069974|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15069975|NCT02194374|Rituximab|rituximab|mesh-list
15069976|NCT02194374|Fludarabine|fludarabine|mesh-list
15069977|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
15069978|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15069979|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
15069980|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15069981|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15069982|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15069983|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
15069984|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069985|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069986|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15069987|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15069988|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15069989|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
15069990|NCT02194374|Antiviral Agents|antiviral agents|mesh-ancestor
15069991|NCT02194374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15069992|NCT02194452|Octreotide|octreotide|mesh-list
15069993|NCT02194452|Edotreotide|edotreotide|mesh-list
15069994|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15069995|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15069996|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15069997|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15069998|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15069999|NCT02194491|AS2471907|as2471907|mesh-list
15070000|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15070001|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070002|NCT02194556|Gemcitabine|gemcitabine|mesh-list
15070003|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15070004|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
15070005|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070006|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070007|NCT02194556|Antiviral Agents|antiviral agents|mesh-ancestor
15070008|NCT02194556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070009|NCT02194556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070010|NCT02194556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15070011|NCT02194556|Immunologic Factors|immunologic factors|mesh-ancestor
15070012|NCT02194556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070013|NCT02194686|Cilostazol|cilostazol|mesh-list
15070014|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15070015|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
15070016|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070017|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070018|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15070019|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
15070020|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15070021|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15070022|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070023|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15070024|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
15070025|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15070026|NCT02194686|Protective Agents|protective agents|mesh-ancestor
15070027|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15070028|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15070029|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070030|NCT02194764|Naltrexone|naltrexone|mesh-list
15070031|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15070032|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15070033|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070034|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
15070035|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070036|NCT02194829|Gemcitabine|gemcitabine|mesh-list
15070037|NCT02194829|Paclitaxel|paclitaxel|mesh-list
15070038|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15070039|NCT02194829|Adavosertib|adavosertib|mesh-list
15070040|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15070041|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070042|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
15070043|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
15070044|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
15070045|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070046|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15070047|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
15070048|NCT02194829|Antiviral Agents|antiviral agents|mesh-ancestor
15070049|NCT02194829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070050|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070051|NCT02194829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15070052|NCT02194829|Immunologic Factors|immunologic factors|mesh-ancestor
15070053|NCT02194829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070054|NCT02194855|Rocuronium|rocuronium|mesh-list
15070055|NCT02194855|Cisatracurium|cisatracurium|mesh-list
15070056|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15070057|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15070058|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15070059|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070060|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070061|NCT02194881|Ivacaftor|ivacaftor|mesh-list
15070062|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
15070063|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15070064|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070065|NCT02194894|Acetaminophen|acetaminophen|mesh-list
15070066|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15070067|NCT02194894|Analgesics|analgesics|mesh-ancestor
15070068|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
15070069|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070070|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070071|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
15070072|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
15070073|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15070074|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070075|NCT02195089|Vaccines|vaccines|mesh-list
15070076|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
15070077|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070078|NCT02195115|Amitriptyline|amitriptyline|mesh-list
15070079|NCT02195115|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15070080|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15070081|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
15070082|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15070083|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15070084|NCT02195115|Analgesics|analgesics|mesh-ancestor
15070085|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
15070086|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070087|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070088|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15070089|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15070090|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15070091|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070092|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
15070093|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15070094|NCT02195115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15070095|NCT02195115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15070096|NCT02195115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070097|NCT02195180|Leucovorin|leucovorin|mesh-list
15070098|NCT02195180|Gemcitabine|gemcitabine|mesh-list
15070099|NCT02195180|Fluorouracil|fluorouracil|mesh-list
15070100|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
15070101|NCT02195180|Asparaginase|asparaginase|mesh-list
15070102|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15070103|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
15070104|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070105|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070106|NCT02195180|Antiviral Agents|antiviral agents|mesh-ancestor
15070107|NCT02195180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070108|NCT02195180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070109|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15070110|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
15070111|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070112|NCT02195180|Antidotes|antidotes|mesh-ancestor
15070113|NCT02195180|Protective Agents|protective agents|mesh-ancestor
15070114|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
15070115|NCT02195180|Vitamins|vitamins|mesh-ancestor
15070116|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
15070117|NCT02195271|Melatonin|melatonin|mesh-list
15070118|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
15070119|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070120|NCT02195271|Protective Agents|protective agents|mesh-ancestor
15070121|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070122|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070123|NCT02195336|Paclitaxel|paclitaxel|mesh-list
15070124|NCT02195336|Bevacizumab|bevacizumab|mesh-list
15070125|NCT02195336|Carboplatin|carboplatin|mesh-list
15070126|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15070127|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070128|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
15070129|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
15070130|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
15070131|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070132|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15070133|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15070134|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15070135|NCT02195336|Growth Substances|growth substances|mesh-ancestor
15070136|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070137|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
15070138|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15070139|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15070140|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
15070141|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070142|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070143|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15070144|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
15070145|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
15070146|NCT02195375|Hormones|hormones|mesh-ancestor
15070147|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15070148|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
15070149|NCT02195466|Ritonavir|ritonavir|mesh-list
15070150|NCT02195466|Tipranavir|tipranavir|mesh-list
15070151|NCT02195466|Fluconazole|fluconazole|mesh-list
15070152|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15070153|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15070154|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
15070155|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070156|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070157|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15070158|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15070159|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
15070160|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070161|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15070162|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15070163|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
15070164|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15070165|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15070166|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
15070167|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15070168|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070169|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15070170|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15070171|NCT02195492|Hylan|hylan|mesh-list
15070172|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
15070173|NCT02195492|Protective Agents|protective agents|mesh-ancestor
15070174|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070175|NCT02195544|Hylan|hylan|mesh-list
15070176|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
15070177|NCT02195544|Protective Agents|protective agents|mesh-ancestor
15070178|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070179|NCT02195557|Hylan|hylan|mesh-list
15070180|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
15070181|NCT02195557|Protective Agents|protective agents|mesh-ancestor
15070182|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070183|NCT02195635|Octreotide|octreotide|mesh-list
15070184|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15070185|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15070186|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070187|NCT02195661|Melatonin|melatonin|mesh-list
15070188|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
15070189|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
15070190|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070191|NCT02195661|Protective Agents|protective agents|mesh-ancestor
15070192|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070193|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070194|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15070195|NCT02195791|Pioglitazone|pioglitazone|mesh-list
15070196|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15070197|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070198|NCT02195804|Ranitidine|ranitidine|mesh-list
15070199|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
15070200|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15070201|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15070202|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15070203|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
15070204|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
15070205|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15070206|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070207|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070208|NCT02195817|Nalmefene|nalmefene|mesh-list
15070209|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15070210|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070211|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
15070212|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070213|NCT02195908|Antiemetics|antiemetics|mesh-list
15070214|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
15070215|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070216|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070217|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15070218|NCT02195973|Paclitaxel|paclitaxel|mesh-list
15070219|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15070220|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070221|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
15070222|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
15070223|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
15070224|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070225|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
15070226|NCT02196142|Mannitol|mannitol|mesh-list
15070227|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
15070228|NCT02196142|Diuretics|diuretics|mesh-ancestor
15070229|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
15070230|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070231|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15070232|NCT02196155|Cortisone|cortisone|mesh-list
15070233|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
15070234|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15070235|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15070236|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15070237|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15070238|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070239|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
15070240|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15070241|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070242|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15070243|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15070244|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070245|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
15070246|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15070247|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
15070248|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070249|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070250|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15070251|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
15070252|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
15070253|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15070254|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
15070255|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15070256|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070257|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
15070258|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
15070259|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070260|NCT02196285|Vaccines|vaccines|mesh-list
15070261|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
15070262|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070263|NCT02196441|Bupivacaine|bupivacaine|mesh-list
15070264|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
15070265|NCT02196441|Tetracaine|tetracaine|mesh-list
15070266|NCT02196441|Anesthetics|anesthetics|mesh-list
15070267|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070268|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070269|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
15070270|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070271|NCT02196493|Azithromycin|azithromycin|mesh-list
15070272|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15070273|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070274|NCT02196662|Mesalamine|mesalamine|mesh-list
15070275|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15070276|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15070277|NCT02196662|Analgesics|analgesics|mesh-ancestor
15070278|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
15070279|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070280|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070281|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15070282|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15070283|NCT02196740|Metronidazole|metronidazole|mesh-list
15070284|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
15070285|NCT02196740|Clindamycin|clindamycin|mesh-list
15070286|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
15070287|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
15070288|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
15070289|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070290|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15070291|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15070292|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15070293|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15070294|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15070295|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070296|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070297|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070298|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15070299|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15070300|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15070301|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
15070302|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15070303|NCT02196805|Probucol|probucol|mesh-list
15070304|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15070305|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15070306|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
15070307|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070308|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15070309|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
15070310|NCT02196805|Protective Agents|protective agents|mesh-ancestor
15070311|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070312|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
15070313|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15070314|NCT02197000|Protective Agents|protective agents|mesh-ancestor
15070315|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070316|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070317|NCT02197026|Hylan|hylan|mesh-list
15070318|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
15070319|NCT02197026|Protective Agents|protective agents|mesh-ancestor
15070320|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070321|NCT02197039|Esomeprazole|esomeprazole|mesh-list
15070322|NCT02197039|Pantoprazole|pantoprazole|mesh-list
15070323|NCT02197039|Hemostatics|hemostatics|mesh-list
15070324|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15070325|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15070326|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15070327|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070328|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070329|NCT02197039|Coagulants|coagulants|mesh-ancestor
15070330|NCT02197143|Esomeprazole|esomeprazole|mesh-list
15070331|NCT02197143|Ranitidine|ranitidine|mesh-list
15070332|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
15070333|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15070334|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15070335|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15070336|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070337|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070338|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15070339|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
15070340|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
15070341|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15070342|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070343|NCT02197156|Acetaminophen|acetaminophen|mesh-list
15070344|NCT02197156|Hydrocodone|hydrocodone|mesh-list
15070345|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15070346|NCT02197156|Analgesics|analgesics|mesh-ancestor
15070347|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
15070348|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070349|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070350|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
15070351|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15070352|NCT02197156|Narcotics|narcotics|mesh-ancestor
15070353|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070354|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
15070355|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
15070356|NCT02197169|Interferons|interferons|mesh-list
15070357|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
15070358|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070359|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
15070360|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070361|NCT02197182|Copper|copper|mesh-list
15070362|NCT02197182|Metronidazole|metronidazole|mesh-list
15070363|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070364|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15070365|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15070366|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15070367|NCT02197182|Trace Elements|trace elements|mesh-ancestor
15070368|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
15070369|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070370|NCT02197221|Bortezomib|bortezomib|mesh-list
15070371|NCT02197221|Melphalan|melphalan|mesh-list
15070372|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070373|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15070374|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
15070375|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070376|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15070377|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15070378|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
15070379|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070380|NCT02197260|Amoxicillin|amoxicillin|mesh-list
15070381|NCT02197260|Metronidazole|metronidazole|mesh-list
15070382|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15070383|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070384|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15070385|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15070386|NCT02197286|Vitamin D|vitamin d|mesh-list
15070387|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
15070388|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
15070389|NCT02197286|Vitamins|vitamins|mesh-list
15070390|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
15070391|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070392|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15070393|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15070394|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
15070395|NCT02197403|Propofol|propofol|mesh-list
15070396|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15070397|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070398|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070399|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15070400|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
15070401|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
15070402|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15070403|NCT02197403|Analgesics|analgesics|mesh-ancestor
15070404|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
15070405|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070406|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15070407|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15070408|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15070409|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
15070410|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15070411|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070412|NCT02197442|Valsartan|valsartan|mesh-list
15070413|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15070414|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15070415|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15070416|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070417|NCT02197494|Valsartan|valsartan|mesh-list
15070418|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15070419|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15070420|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15070421|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070422|NCT02197598|Nalmefene|nalmefene|mesh-list
15070423|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15070424|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070425|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
15070426|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070427|NCT02197637|Vinorelbine|vinorelbine|mesh-list
15070428|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15070429|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070430|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
15070431|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
15070432|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
15070433|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070434|NCT02197650|Asparaginase|asparaginase|mesh-list
15070435|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070436|NCT02197676|Guadecitabine|guadecitabine|mesh-list
15070437|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070438|NCT02197702|Vitamin D|vitamin d|mesh-list
15070439|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
15070440|NCT02197702|Vitamins|vitamins|mesh-ancestor
15070441|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
15070442|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070443|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15070444|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15070445|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
15070446|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15070447|NCT02197741|Narcotics|narcotics|mesh-ancestor
15070448|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070449|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070450|NCT02197741|Analgesics|analgesics|mesh-ancestor
15070451|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
15070452|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070453|NCT02197884|Clarithromycin|clarithromycin|mesh-list
15070454|NCT02197884|Itraconazole|itraconazole|mesh-list
15070455|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15070456|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070457|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15070458|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070459|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070460|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15070461|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15070462|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
15070463|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15070464|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15070465|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
15070466|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15070467|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070468|NCT02197988|Fentanyl|fentanyl|mesh-list
15070469|NCT02197988|Bupivacaine|bupivacaine|mesh-list
15070470|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
15070471|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
15070472|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070473|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070474|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
15070475|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070476|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15070477|NCT02197988|Narcotics|narcotics|mesh-ancestor
15070478|NCT02197988|Analgesics|analgesics|mesh-ancestor
15070479|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15070480|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15070481|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
15070482|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15070483|NCT02198001|Amoxicillin|amoxicillin|mesh-list
15070484|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
15070485|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
15070486|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15070487|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070488|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15070489|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070490|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070491|NCT02198027|Bupivacaine|bupivacaine|mesh-list
15070492|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
15070493|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
15070494|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070495|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070496|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
15070497|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070498|NCT02198170|Ketoconazole|ketoconazole|mesh-list
15070499|NCT02198170|Lenvatinib|lenvatinib|mesh-list
15070500|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
15070501|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070502|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15070503|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15070504|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070505|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070506|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15070507|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
15070508|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15070509|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070510|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15070511|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070512|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15070513|NCT02198209|Liraglutide|liraglutide|mesh-list
15070514|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15070515|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070516|NCT02198209|Incretins|incretins|mesh-ancestor
15070517|NCT02198209|Hormones|hormones|mesh-ancestor
15070518|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15070519|NCT02198248|Prednisolone|prednisolone|mesh-list
15070520|NCT02198248|Rituximab|rituximab|mesh-list
15070521|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
15070522|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15070523|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070524|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
15070525|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070526|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15070527|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15070528|NCT02198248|Hormones|hormones|mesh-ancestor
15070529|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15070530|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15070531|NCT02198261|Minoxidil|minoxidil|mesh-list
15070532|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15070533|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
15070534|NCT02198300|Clopidogrel|clopidogrel|mesh-list
15070535|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15070536|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15070537|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15070538|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15070539|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
15070540|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15070541|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070542|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070543|NCT02198378|Acetaminophen|acetaminophen|mesh-list
15070544|NCT02198378|Morphine|morphine|mesh-list
15070545|NCT02198378|Entonox|entonox|mesh-list
15070546|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15070547|NCT02198378|Narcotics|narcotics|mesh-ancestor
15070548|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070549|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070550|NCT02198378|Analgesics|analgesics|mesh-ancestor
15070551|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
15070552|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070553|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15070554|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
15070555|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15070556|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
15070557|NCT02198404|Propofol|propofol|mesh-list
15070558|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15070559|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070560|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070561|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15070562|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
15070563|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
15070564|NCT02198417|Metformin|metformin|mesh-list
15070565|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15070566|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070567|NCT02198443|Ritonavir|ritonavir|mesh-list
15070568|NCT02198443|Lopinavir|lopinavir|mesh-list
15070569|NCT02198443|Tenofovir|tenofovir|mesh-list
15070570|NCT02198443|Emtricitabine|emtricitabine|mesh-list
15070571|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15070572|NCT02198443|Cobicistat|cobicistat|mesh-list
15070573|NCT02198443|Elvitegravir|elvitegravir|mesh-list
15070574|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15070575|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15070576|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
15070577|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070578|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070579|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15070580|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15070581|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
15070582|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070583|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15070584|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15070585|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15070586|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15070587|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15070588|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
15070589|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15070590|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
15070591|NCT02198482|Cytarabine|cytarabine|mesh-list
15070592|NCT02198482|Daunorubicin|daunorubicin|mesh-list
15070593|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
15070594|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15070595|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
15070596|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070597|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070598|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
15070599|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070600|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15070601|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
15070602|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070603|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15070604|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15070605|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15070606|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070607|NCT02198482|Analgesics|analgesics|mesh-ancestor
15070608|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
15070609|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070610|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
15070611|NCT02198495|Hematinics|hematinics|mesh-ancestor
15070612|NCT02198508|Deferasirox|deferasirox|mesh-list
15070613|NCT02198508|Deferiprone|deferiprone|mesh-list
15070614|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15070615|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
15070616|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
15070617|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070618|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
15070619|NCT02198547|Ropivacaine|ropivacaine|mesh-list
15070620|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
15070621|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
15070622|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070623|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070624|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
15070625|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070626|NCT02198547|Analgesics|analgesics|mesh-ancestor
15070627|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15070628|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
15070629|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15070630|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15070631|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070632|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15070633|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
15070634|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15070635|NCT02198807|Piperaquine|piperaquine|mesh-list
15070636|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
15070637|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
15070638|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15070639|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15070640|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070641|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15070642|NCT02198820|Anesthetics|anesthetics|mesh-list
15070643|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070644|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070645|NCT02198846|Insulin|insulin|mesh-list
15070646|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15070647|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070648|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
15070649|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
15070650|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15070651|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070652|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070653|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
15070654|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15070655|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070656|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070657|NCT02198924|Celecoxib|celecoxib|mesh-list
15070658|NCT02198924|Parecoxib|parecoxib|mesh-list
15070659|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15070660|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15070661|NCT02198924|Analgesics|analgesics|mesh-ancestor
15070662|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
15070663|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070664|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070665|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15070666|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15070667|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15070668|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15070669|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070670|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070671|NCT02199171|Carboplatin|carboplatin|mesh-list
15070672|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070673|NCT02199184|Prednisone|prednisone|mesh-list
15070674|NCT02199184|Cortisone|cortisone|mesh-list
15070675|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
15070676|NCT02199184|Rituximab|rituximab|mesh-list
15070677|NCT02199184|Doxorubicin|doxorubicin|mesh-list
15070678|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15070679|NCT02199184|Etoposide|etoposide|mesh-list
15070680|NCT02199184|Vincristine|vincristine|mesh-list
15070681|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
15070682|NCT02199184|Ofatumumab|ofatumumab|mesh-list
15070683|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
15070684|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15070685|NCT02199184|Antibodies|antibodies|mesh-list
15070686|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
15070687|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15070688|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15070689|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
15070690|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070691|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15070692|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15070693|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
15070694|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070695|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070696|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15070697|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15070698|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15070699|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15070700|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070701|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15070702|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
15070703|NCT02199184|Hormones|hormones|mesh-ancestor
15070704|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15070705|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15070706|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15070707|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
15070708|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
15070709|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
15070710|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
15070711|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
15070712|NCT02199223|Panitumumab|panitumumab|mesh-list
15070713|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15070714|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070715|NCT02199327|Interferons|interferons|mesh-list
15070716|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
15070717|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
15070718|NCT02199327|Mitomycins|mitomycins|mesh-list
15070719|NCT02199327|Mitomycin|mitomycin|mesh-list
15070720|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070721|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
15070722|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070723|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
15070724|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070725|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15070726|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
15070727|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070728|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15070729|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070730|NCT02199379|Lenvatinib|lenvatinib|mesh-list
15070731|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070732|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15070733|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070734|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070735|NCT02199392|Lenvatinib|lenvatinib|mesh-list
15070736|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070737|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15070738|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070739|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070740|NCT02199418|Paclitaxel|paclitaxel|mesh-list
15070741|NCT02199418|Cisplatin|cisplatin|mesh-list
15070742|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15070743|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070744|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
15070745|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
15070746|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
15070747|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070748|NCT02199431|Itraconazole|itraconazole|mesh-list
15070749|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
15070750|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070751|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15070752|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15070753|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070754|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070755|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15070756|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
15070757|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15070758|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070759|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15070760|NCT02199444|Sevelamer|sevelamer|mesh-list
15070761|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
15070762|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
15070763|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070764|NCT02199522|Propofol|propofol|mesh-list
15070765|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15070766|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070767|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070768|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15070769|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
15070770|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
15070771|NCT02199613|Darunavir|darunavir|mesh-list
15070772|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15070773|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15070774|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
15070775|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070776|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070777|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15070778|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15070779|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
15070780|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070781|NCT02199678|Ketamine|ketamine|mesh-list
15070782|NCT02199678|Analgesics|analgesics|mesh-ancestor
15070783|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
15070784|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070785|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070786|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15070787|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15070788|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
15070789|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
15070790|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070791|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15070792|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15070793|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15070794|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070795|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
15070796|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15070797|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15070798|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
15070799|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070800|NCT02199951|Piperaquine|piperaquine|mesh-list
15070801|NCT02199951|Artenimol|artenimol|mesh-list
15070802|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
15070803|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15070804|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15070805|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070806|NCT02200094|Telmisartan|telmisartan|mesh-list
15070807|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15070808|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15070809|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15070810|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070811|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
15070812|NCT02200146|Prednisone|prednisone|mesh-list
15070813|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15070814|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
15070815|NCT02200146|Hormones|hormones|mesh-ancestor
15070816|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15070817|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070818|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15070819|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070820|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
15070821|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15070822|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15070823|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070824|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070825|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070826|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15070827|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
15070828|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15070829|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070830|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070831|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15070832|NCT02200159|Analgesics|analgesics|mesh-ancestor
15070833|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
15070834|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070835|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15070836|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15070837|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15070838|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
15070839|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15070840|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070841|NCT02200172|Melatonin|melatonin|mesh-list
15070842|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
15070843|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070844|NCT02200172|Protective Agents|protective agents|mesh-ancestor
15070845|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070846|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070847|NCT02200185|Morphine|morphine|mesh-list
15070848|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15070849|NCT02200185|Narcotics|narcotics|mesh-ancestor
15070850|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15070851|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070852|NCT02200185|Analgesics|analgesics|mesh-ancestor
15070853|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
15070854|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070855|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
15070856|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15070857|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
15070858|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070859|NCT02200237|Antacids|antacids|mesh-ancestor
15070860|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070861|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15070862|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
15070863|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15070864|NCT02200354|Bevacizumab|bevacizumab|mesh-list
15070865|NCT02200354|Pemetrexed|pemetrexed|mesh-list
15070866|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15070867|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070868|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15070869|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15070870|NCT02200354|Growth Substances|growth substances|mesh-ancestor
15070871|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070872|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
15070873|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070874|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070875|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15070876|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15070877|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
15070878|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15070879|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15070880|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15070881|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070882|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15070883|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070884|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
15070885|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15070886|NCT02200562|Ipilimumab|ipilimumab|mesh-list
15070887|NCT02200562|Dabrafenib|dabrafenib|mesh-list
15070888|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15070889|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070890|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15070891|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070892|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15070893|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070894|NCT02200575|Telmisartan|telmisartan|mesh-list
15070895|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15070896|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15070897|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15070898|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070899|NCT02200640|Losartan|losartan|mesh-list
15070900|NCT02200640|Telmisartan|telmisartan|mesh-list
15070901|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15070902|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15070903|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15070904|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15070905|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070906|NCT02200653|Losartan|losartan|mesh-list
15070907|NCT02200653|Telmisartan|telmisartan|mesh-list
15070908|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15070909|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15070910|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15070911|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15070912|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070913|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
15070914|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15070915|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
15070916|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070917|NCT02200757|Topotecan|topotecan|mesh-list
15070918|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15070919|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15070920|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070921|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070922|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070923|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15070924|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15070925|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
15070926|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15070927|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070928|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070929|NCT02200848|Rituximab|rituximab|mesh-list
15070930|NCT02200848|Lenalidomide|lenalidomide|mesh-list
15070931|NCT02200848|Glutarimide|glutarimide|mesh-list
15070932|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15070933|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070934|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
15070935|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070936|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15070937|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15070938|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15070939|NCT02200848|Growth Substances|growth substances|mesh-ancestor
15070940|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
15070941|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15070942|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070943|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070944|NCT02200978|Cytarabine|cytarabine|mesh-list
15070945|NCT02200978|Methotrexate|methotrexate|mesh-list
15070946|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
15070947|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
15070948|NCT02200978|Tretinoin|tretinoin|mesh-list
15070949|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
15070950|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15070951|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
15070952|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15070953|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070954|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15070955|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
15070956|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070957|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15070958|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
15070959|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070960|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15070961|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15070962|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
15070963|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15070964|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15070965|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
15070966|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15070967|NCT02200978|Analgesics|analgesics|mesh-ancestor
15070968|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
15070969|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15070970|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15070971|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15070972|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
15070973|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
15070974|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15070975|NCT02200991|Lixisenatide|lixisenatide|mesh-list
15070976|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15070977|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070978|NCT02200991|Incretins|incretins|mesh-ancestor
15070979|NCT02200991|Hormones|hormones|mesh-ancestor
15070980|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15070981|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15070982|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
15070983|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15070984|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070985|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
15070986|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15070987|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070988|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15070989|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15070990|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15070991|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
15070992|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070993|NCT02201043|Thalidomide|thalidomide|mesh-list
15070994|NCT02201043|Tolnaftate|tolnaftate|mesh-list
15070995|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15070996|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
15070997|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15070998|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
15070999|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15071000|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071001|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15071002|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15071003|NCT02201043|Growth Substances|growth substances|mesh-ancestor
15071004|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
15071005|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071006|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
15071007|NCT02201082|Amikacin|amikacin|mesh-list
15071008|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15071009|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071010|NCT02201121|Phenylephrine|phenylephrine|mesh-list
15071011|NCT02201121|Dopamine|dopamine|mesh-list
15071012|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
15071013|NCT02201121|Ephedrine|ephedrine|mesh-list
15071014|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15071015|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
15071016|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
15071017|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071018|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071019|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
15071020|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15071021|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
15071022|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
15071023|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15071024|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15071025|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15071026|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
15071027|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15071028|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071029|NCT02201121|Protective Agents|protective agents|mesh-ancestor
15071030|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15071031|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
15071032|NCT02201134|Sevoflurane|sevoflurane|mesh-list
15071033|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15071034|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15071035|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
15071036|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
15071037|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15071038|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071039|NCT02201199|Insulin|insulin|mesh-list
15071040|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15071041|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
15071042|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15071043|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071044|NCT02201225|Micronutrients|micronutrients|mesh-list
15071045|NCT02201225|Trace Elements|trace elements|mesh-list
15071046|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071047|NCT02201238|Diclofenac|diclofenac|mesh-list
15071048|NCT02201238|Menthol|menthol|mesh-list
15071049|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15071050|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15071051|NCT02201238|Analgesics|analgesics|mesh-ancestor
15071052|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
15071053|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071054|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071055|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15071056|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15071057|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15071058|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071059|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071060|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
15071061|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
15071062|NCT02201316|Mosapride|mosapride|mesh-list
15071063|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071064|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15071065|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15071066|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
15071067|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15071068|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071069|NCT02201342|Udenafil|udenafil|mesh-list
15071070|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15071071|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15071072|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071073|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071074|NCT02201381|Metformin|metformin|mesh-list
15071075|NCT02201381|Doxycycline|doxycycline|mesh-list
15071076|NCT02201381|Mebendazole|mebendazole|mesh-list
15071077|NCT02201381|Atorvastatin|atorvastatin|mesh-list
15071078|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15071079|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071080|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15071081|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15071082|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
15071083|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071084|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15071085|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15071086|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071087|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15071088|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071089|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
15071090|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15071091|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15071092|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
15071093|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
15071094|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
15071095|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
15071096|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
15071097|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071098|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15071099|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
15071100|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071101|NCT02201459|Interferons|interferons|mesh-list
15071102|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
15071103|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
15071104|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15071105|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071106|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
15071107|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071108|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
15071109|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071110|NCT02201563|Minocycline|minocycline|mesh-list
15071111|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15071112|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071113|NCT02201576|Bortezomib|bortezomib|mesh-list
15071114|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
15071115|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15071116|NCT02201576|Antibodies|antibodies|mesh-list
15071117|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
15071118|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15071119|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071120|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
15071121|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071122|NCT02201602|Gliclazide|gliclazide|mesh-list
15071123|NCT02201602|Glyburide|glyburide|mesh-list
15071124|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15071125|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071126|NCT02201641|Calcium|calcium|mesh-list
15071127|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15071128|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071129|NCT02201667|Aspirin|aspirin|mesh-list
15071130|NCT02201667|Clopidogrel|clopidogrel|mesh-list
15071131|NCT02201667|Ticagrelor|ticagrelor|mesh-list
15071132|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15071133|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15071134|NCT02201667|Analgesics|analgesics|mesh-ancestor
15071135|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
15071136|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071137|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071138|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15071139|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15071140|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15071141|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15071142|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071143|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15071144|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15071145|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071146|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
15071147|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15071148|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15071149|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15071150|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
15071151|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15071152|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15071153|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
15071154|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15071155|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
15071156|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071157|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15071158|NCT02201914|Clomiphene|clomiphene|mesh-list
15071159|NCT02201914|Enclomiphene|enclomiphene|mesh-list
15071160|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
15071161|NCT02201914|Cetrorelix|cetrorelix|mesh-list
15071162|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15071163|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
15071164|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15071165|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071166|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15071167|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
15071168|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15071169|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15071170|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15071171|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
15071172|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15071173|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
15071174|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15071175|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15071176|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071177|NCT02201992|Crizotinib|crizotinib|mesh-list
15071178|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071179|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15071180|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071181|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071182|NCT02202005|Nevirapine|nevirapine|mesh-list
15071183|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15071184|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15071185|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071186|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071187|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
15071188|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071189|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15071190|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15071191|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15071192|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15071193|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15071194|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15071195|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15071196|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071197|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071198|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15071199|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15071200|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071201|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
15071202|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15071203|NCT02202200|Palbociclib|palbociclib|mesh-list
15071204|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071205|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15071206|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071207|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071208|NCT02202239|Fentanyl|fentanyl|mesh-list
15071209|NCT02202239|Midazolam|midazolam|mesh-list
15071210|NCT02202239|Remifentanil|remifentanil|mesh-list
15071211|NCT02202239|Propofol|propofol|mesh-list
15071212|NCT02202239|Etomidate|etomidate|mesh-list
15071213|NCT02202239|Sevoflurane|sevoflurane|mesh-list
15071214|NCT02202239|Cisatracurium|cisatracurium|mesh-list
15071215|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15071216|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15071217|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071218|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15071219|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
15071220|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
15071221|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15071222|NCT02202239|Narcotics|narcotics|mesh-ancestor
15071223|NCT02202239|Analgesics|analgesics|mesh-ancestor
15071224|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
15071225|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071226|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15071227|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15071228|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15071229|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15071230|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
15071231|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
15071232|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15071233|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071234|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15071235|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15071236|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15071237|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15071238|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
15071239|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15071240|NCT02202304|Thymol|thymol|mesh-list
15071241|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15071242|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071243|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
15071244|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
15071245|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
15071246|NCT02202473|Lamivudine|lamivudine|mesh-list
15071247|NCT02202473|Oxymatrine|oxymatrine|mesh-list
15071248|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15071249|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15071250|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071251|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071252|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
15071253|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071254|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15071255|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15071256|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15071257|NCT02202512|Naproxen|naproxen|mesh-list
15071258|NCT02202512|Cimetidine|cimetidine|mesh-list
15071259|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15071260|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15071261|NCT02202512|Analgesics|analgesics|mesh-ancestor
15071262|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
15071263|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071264|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071265|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15071266|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15071267|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
15071268|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15071269|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071270|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071271|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15071272|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15071273|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15071274|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
15071275|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
15071276|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15071277|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15071278|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15071279|NCT02202525|Telmisartan|telmisartan|mesh-list
15071280|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15071281|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15071282|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15071283|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071284|NCT02202564|Ganciclovir|ganciclovir|mesh-list
15071285|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
15071286|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
15071287|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071288|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15071289|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071290|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071291|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
15071292|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
15071293|NCT02202577|Povidone|povidone|mesh-list
15071294|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15071295|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071296|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
15071297|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
15071298|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
15071299|NCT02202603|Teriparatide|teriparatide|mesh-list
15071300|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15071301|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071302|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15071303|NCT02202707|Gabapentin|gabapentin|mesh-list
15071304|NCT02202707|Analgesics|analgesics|mesh-ancestor
15071305|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
15071306|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071307|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071308|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
15071309|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15071310|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15071311|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15071312|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15071313|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15071314|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15071315|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15071316|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071317|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
15071318|NCT02202720|Sevoflurane|sevoflurane|mesh-list
15071319|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15071320|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15071321|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
15071322|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
15071323|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15071324|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071325|NCT02202889|Calcium|calcium|mesh-list
15071326|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15071327|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071328|NCT02202967|Misoprostol|misoprostol|mesh-list
15071329|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15071330|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
15071331|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15071332|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071333|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15071334|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15071335|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
15071336|NCT02202993|Mibefradil|mibefradil|mesh-list
15071337|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15071338|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15071339|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15071340|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071341|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15071342|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071343|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
15071344|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15071345|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15071346|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071347|NCT02203097|Propofol|propofol|mesh-list
15071348|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15071349|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15071350|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071351|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15071352|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
15071353|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
15071354|NCT02203175|Fentanyl|fentanyl|mesh-list
15071355|NCT02203175|Propofol|propofol|mesh-list
15071356|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15071357|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15071358|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071359|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15071360|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
15071361|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
15071362|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15071363|NCT02203175|Narcotics|narcotics|mesh-ancestor
15071364|NCT02203175|Analgesics|analgesics|mesh-ancestor
15071365|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
15071366|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071367|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15071368|NCT02203227|Turmeric extract|turmeric extract|mesh-list
15071369|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
15071370|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071371|NCT02203227|Protective Agents|protective agents|mesh-ancestor
15071372|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071373|NCT02203253|Thalidomide|thalidomide|mesh-list
15071374|NCT02203253|Dexamethasone|dexamethasone|mesh-list
15071375|NCT02203253|Palonosetron|palonosetron|mesh-list
15071376|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15071377|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
15071378|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
15071379|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071380|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071381|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15071382|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
15071383|NCT02203253|Hormones|hormones|mesh-ancestor
15071384|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15071385|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15071386|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071387|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15071388|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
15071389|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
15071390|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15071391|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071392|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15071393|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15071394|NCT02203253|Growth Substances|growth substances|mesh-ancestor
15071395|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
15071396|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15071397|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15071398|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
15071399|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15071400|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071401|NCT02203396|Cyclosporine|cyclosporine|mesh-list
15071402|NCT02203396|Levamisole|levamisole|mesh-list
15071403|NCT02203396|Cyclosporins|cyclosporins|mesh-list
15071404|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
15071405|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071406|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071407|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15071408|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
15071409|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071410|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
15071411|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071412|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
15071413|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15071414|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15071415|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15071416|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
15071417|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
15071418|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15071419|NCT02203422|Cyclosporine|cyclosporine|mesh-list
15071420|NCT02203422|Cyclosporins|cyclosporins|mesh-list
15071421|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071422|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071423|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15071424|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
15071425|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071426|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
15071427|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071428|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
15071429|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15071430|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15071431|NCT02203461|Ritonavir|ritonavir|mesh-list
15071432|NCT02203461|Lopinavir|lopinavir|mesh-list
15071433|NCT02203461|Darunavir|darunavir|mesh-list
15071434|NCT02203461|Tenofovir|tenofovir|mesh-list
15071435|NCT02203461|Emtricitabine|emtricitabine|mesh-list
15071436|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15071437|NCT02203461|Cobicistat|cobicistat|mesh-list
15071438|NCT02203461|Elvitegravir|elvitegravir|mesh-list
15071439|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15071440|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15071441|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
15071442|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071443|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071444|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15071445|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15071446|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
15071447|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071448|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15071449|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15071450|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15071451|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15071452|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15071453|NCT02203500|Telmisartan|telmisartan|mesh-list
15071454|NCT02203500|Lacidipine|lacidipine|mesh-list
15071455|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15071456|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15071457|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15071458|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071459|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15071460|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15071461|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15071462|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071463|NCT02203552|Minocycline|minocycline|mesh-list
15071464|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15071465|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071466|NCT02203604|Aldesleukin|aldesleukin|mesh-list
15071467|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15071468|NCT02203604|Ipilimumab|ipilimumab|mesh-list
15071469|NCT02203604|Interleukin-2|interleukin-2|mesh-list
15071470|NCT02203604|Antibodies|antibodies|mesh-list
15071471|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
15071472|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15071473|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
15071474|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071475|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071476|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15071477|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071478|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15071479|NCT02203604|Analgesics|analgesics|mesh-ancestor
15071480|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
15071481|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071482|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15071483|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15071484|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
15071485|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071486|NCT02203643|Dexamethasone|dexamethasone|mesh-list
15071487|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
15071488|NCT02203643|Lenalidomide|lenalidomide|mesh-list
15071489|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15071490|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
15071491|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071492|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15071493|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15071494|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
15071495|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071496|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071497|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15071498|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15071499|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
15071500|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
15071501|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071502|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15071503|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
15071504|NCT02203643|Hormones|hormones|mesh-ancestor
15071505|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15071506|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15071507|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15071508|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15071509|NCT02203643|Growth Substances|growth substances|mesh-ancestor
15071510|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
15071511|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
15071512|NCT02203656|Testosterone|testosterone|mesh-list
15071513|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
15071514|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
15071515|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15071516|NCT02203656|Androgens|androgens|mesh-ancestor
15071517|NCT02203656|Hormones|hormones|mesh-ancestor
15071518|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15071519|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071520|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15071521|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071522|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
15071523|NCT02203760|Gemcitabine|gemcitabine|mesh-list
15071524|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15071525|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
15071526|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071527|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071528|NCT02203760|Antiviral Agents|antiviral agents|mesh-ancestor
15071529|NCT02203760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071530|NCT02203760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071531|NCT02203760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15071532|NCT02203760|Immunologic Factors|immunologic factors|mesh-ancestor
15071533|NCT02203760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071534|NCT02203773|Posaconazole|posaconazole|mesh-list
15071535|NCT02203773|Azacitidine|azacitidine|mesh-list
15071536|NCT02203773|Decitabine|decitabine|mesh-list
15071537|NCT02203773|Venetoclax|venetoclax|mesh-list
15071538|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15071539|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
15071540|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071541|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071542|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071543|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
15071544|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071545|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15071546|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15071547|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15071548|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15071549|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15071550|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15071551|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
15071552|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15071553|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071554|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
15071555|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071556|NCT02204020|Azacitidine|azacitidine|mesh-list
15071557|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15071558|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
15071559|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071560|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071561|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071562|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15071563|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15071564|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071565|NCT02204254|Doxycycline|doxycycline|mesh-list
15071566|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15071567|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071568|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
15071569|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15071570|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15071571|NCT02204397|Ustekinumab|ustekinumab|mesh-list
15071572|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
15071573|NCT02204475|Interferons|interferons|mesh-list
15071574|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15071575|NCT02204475|Grazoprevir|grazoprevir|mesh-list
15071576|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071577|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
15071578|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071579|NCT02204501|Midazolam|midazolam|mesh-list
15071580|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15071581|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15071582|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15071583|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071584|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15071585|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15071586|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15071587|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15071588|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
15071589|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
15071590|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
15071591|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
15071592|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15071593|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071594|NCT02204527|Vitamin D|vitamin d|mesh-list
15071595|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
15071596|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
15071597|NCT02204527|Vitamins|vitamins|mesh-list
15071598|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
15071599|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071600|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15071601|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15071602|NCT02204553|Panobinostat|panobinostat|mesh-list
15071603|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071604|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
15071605|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071606|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071607|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
15071608|NCT02204644|HH-GV-678|hh-gv-678|mesh-list
15071609|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071610|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15071611|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071612|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071613|NCT02204683|Aflibercept|aflibercept|mesh-list
15071614|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15071615|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15071616|NCT02204683|Growth Substances|growth substances|mesh-ancestor
15071617|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071618|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
15071619|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071620|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
15071621|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071622|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15071623|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071624|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071625|NCT02204839|Insulin|insulin|mesh-list
15071626|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
15071627|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
15071628|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15071629|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071630|NCT02204852|Iloprost|iloprost|mesh-list
15071631|NCT02204852|Eptifibatide|eptifibatide|mesh-list
15071632|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15071633|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
15071634|NCT02204878|Parecoxib|parecoxib|mesh-list
15071635|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15071636|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15071637|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071638|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071639|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15071640|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15071641|NCT02204878|Analgesics|analgesics|mesh-ancestor
15071642|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
15071643|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071644|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071645|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15071646|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15071647|NCT02205034|Oxytocin|oxytocin|mesh-list
15071648|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
15071649|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15071650|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071651|NCT02205112|Levofloxacin|levofloxacin|mesh-list
15071652|NCT02205112|Ofloxacin|ofloxacin|mesh-list
15071653|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15071654|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071655|NCT02205112|Renal Agents|renal agents|mesh-ancestor
15071656|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15071657|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15071658|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15071659|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071660|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071661|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071662|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15071663|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15071664|NCT02205151|Amlodipine|amlodipine|mesh-list
15071665|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15071666|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15071667|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15071668|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071669|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15071670|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071671|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
15071672|NCT02205164|Aprepitant|aprepitant|mesh-list
15071673|NCT02205164|Palonosetron|palonosetron|mesh-list
15071674|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
15071675|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
15071676|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071677|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071678|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15071679|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15071680|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15071681|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071682|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15071683|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15071684|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
15071685|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15071686|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15071687|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15071688|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
15071689|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071690|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15071691|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15071692|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071693|NCT02205242|Azithromycin|azithromycin|mesh-list
15071694|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15071695|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071696|NCT02205255|Azithromycin|azithromycin|mesh-list
15071697|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15071698|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071699|NCT02205398|Cetuximab|cetuximab|mesh-list
15071700|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15071701|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071702|NCT02205489|Cetirizine|cetirizine|mesh-list
15071703|NCT02205489|Acyclovir|acyclovir|mesh-list
15071704|NCT02205489|Ibuprofen|ibuprofen|mesh-list
15071705|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
15071706|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15071707|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15071708|NCT02205489|Prednisolone|prednisolone|mesh-list
15071709|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
15071710|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
15071711|NCT02205489|Esomeprazole|esomeprazole|mesh-list
15071712|NCT02205489|Ranitidine|ranitidine|mesh-list
15071713|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15071714|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
15071715|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15071716|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15071717|NCT02205489|Analgesics|analgesics|mesh-ancestor
15071718|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
15071719|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071720|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071721|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15071722|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15071723|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15071724|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071725|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071726|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
15071727|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
15071728|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15071729|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
15071730|NCT02205489|Hormones|hormones|mesh-ancestor
15071731|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15071732|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15071733|NCT02205489|Protective Agents|protective agents|mesh-ancestor
15071734|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15071735|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071736|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15071737|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15071738|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15071739|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
15071740|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071741|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15071742|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15071743|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15071744|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
15071745|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
15071746|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15071747|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15071748|NCT02205502|Lidocaine|lidocaine|mesh-list
15071749|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
15071750|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
15071751|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15071752|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071753|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
15071754|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071755|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15071756|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15071757|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15071758|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15071759|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071760|NCT02205515|Everolimus|everolimus|mesh-list
15071761|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071762|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15071763|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
15071764|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071765|NCT02205541|Eculizumab|eculizumab|mesh-list
15071766|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15071767|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15071768|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
15071769|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071770|NCT02205554|Tramadol|tramadol|mesh-list
15071771|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15071772|NCT02205554|Narcotics|narcotics|mesh-ancestor
15071773|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15071774|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071775|NCT02205554|Analgesics|analgesics|mesh-ancestor
15071776|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
15071777|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071778|NCT02205580|Sufentanil|sufentanil|mesh-list
15071779|NCT02205580|Dsuvia|dsuvia|mesh-list
15071780|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15071781|NCT02205580|Narcotics|narcotics|mesh-ancestor
15071782|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15071783|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071784|NCT02205580|Analgesics|analgesics|mesh-ancestor
15071785|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
15071786|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071787|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15071788|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15071789|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
15071790|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
15071791|NCT02205619|Glycine|glycine|mesh-list
15071792|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
15071793|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15071794|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071795|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071796|NCT02205775|Atorvastatin|atorvastatin|mesh-list
15071797|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15071798|NCT02205775|Ezetimibe|ezetimibe|mesh-list
15071799|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15071800|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15071801|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
15071802|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071803|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15071804|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15071805|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071806|NCT02205879|Pregabalin|pregabalin|mesh-list
15071807|NCT02205879|Analgesics|analgesics|mesh-ancestor
15071808|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
15071809|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071810|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071811|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
15071812|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15071813|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15071814|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071815|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15071816|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15071817|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15071818|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15071819|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15071820|NCT02205892|Lupeol|lupeol|mesh-list
15071821|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15071822|NCT02205931|Topiramate|topiramate|mesh-list
15071823|NCT02205931|Lamotrigine|lamotrigine|mesh-list
15071824|NCT02205931|Zonisamide|zonisamide|mesh-list
15071825|NCT02205931|Carbamazepine|carbamazepine|mesh-list
15071826|NCT02205931|Phenytoin|phenytoin|mesh-list
15071827|NCT02205931|Rufinamide|rufinamide|mesh-list
15071828|NCT02205931|Levetiracetam|levetiracetam|mesh-list
15071829|NCT02205931|Valproic Acid|valproic acid|mesh-list
15071830|NCT02205931|Clonazepam|clonazepam|mesh-list
15071831|NCT02205931|Vigabatrin|vigabatrin|mesh-list
15071832|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
15071833|NCT02205931|Clobazam|clobazam|mesh-list
15071834|NCT02205931|Ethosuximide|ethosuximide|mesh-list
15071835|NCT02205931|Stiripentol|stiripentol|mesh-list
15071836|NCT02205931|Nitrazepam|nitrazepam|mesh-list
15071837|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15071838|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071839|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
15071840|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15071841|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15071842|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071843|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15071844|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15071845|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15071846|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15071847|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15071848|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15071849|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071850|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
15071851|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15071852|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
15071853|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15071854|NCT02205931|Analgesics|analgesics|mesh-ancestor
15071855|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
15071856|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071857|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15071858|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15071859|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15071860|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15071861|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
15071862|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15071863|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
15071864|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
15071865|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15071866|NCT02205996|Insulin|insulin|mesh-list
15071867|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15071868|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15071869|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071870|NCT02206022|Remifentanil|remifentanil|mesh-list
15071871|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15071872|NCT02206022|Narcotics|narcotics|mesh-ancestor
15071873|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15071874|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071875|NCT02206022|Analgesics|analgesics|mesh-ancestor
15071876|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
15071877|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071878|NCT02206035|Methotrexate|methotrexate|mesh-list
15071879|NCT02206035|Tacrolimus|tacrolimus|mesh-list
15071880|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15071881|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
15071882|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15071883|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071884|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15071885|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
15071886|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071887|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071888|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
15071889|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071890|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15071891|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15071892|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
15071893|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15071894|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15071895|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15071896|NCT02206048|Proflavine|proflavine|mesh-list
15071897|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15071898|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071899|NCT02206165|Amlodipine|amlodipine|mesh-list
15071900|NCT02206165|Candesartan|candesartan|mesh-list
15071901|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
15071902|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15071903|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15071904|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15071905|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071906|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15071907|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071908|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
15071909|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15071910|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15071911|NCT02206178|Acetaminophen|acetaminophen|mesh-list
15071912|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
15071913|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15071914|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15071915|NCT02206178|Analgesics|analgesics|mesh-ancestor
15071916|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
15071917|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071918|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071919|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
15071920|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
15071921|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071922|NCT02206178|Expectorants|expectorants|mesh-ancestor
15071923|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
15071924|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15071925|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
15071926|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071927|NCT02206178|Protective Agents|protective agents|mesh-ancestor
15071928|NCT02206178|Antidotes|antidotes|mesh-ancestor
15071929|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
15071930|NCT02206204|Selexipag|selexipag|mesh-list
15071931|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15071932|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15071933|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15071934|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15071935|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15071936|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071937|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071938|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071939|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15071940|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
15071941|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15071942|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071943|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15071944|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15071945|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15071946|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15071947|NCT02206295|Selexipag|selexipag|mesh-list
15071948|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15071949|NCT02206308|Antibodies|antibodies|mesh-list
15071950|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15071951|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
15071952|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071953|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
15071954|NCT02206425|Dexamethasone|dexamethasone|mesh-list
15071955|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
15071956|NCT02206425|Prednisone|prednisone|mesh-list
15071957|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
15071958|NCT02206425|Melphalan|melphalan|mesh-list
15071959|NCT02206425|Doxorubicin|doxorubicin|mesh-list
15071960|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15071961|NCT02206425|Lenalidomide|lenalidomide|mesh-list
15071962|NCT02206425|Pomalidomide|pomalidomide|mesh-list
15071963|NCT02206425|BB 1101|bb 1101|mesh-list
15071964|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15071965|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
15071966|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071967|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15071968|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15071969|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
15071970|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15071971|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15071972|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15071973|NCT02206425|Vitamins|vitamins|mesh-ancestor
15071974|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
15071975|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15071976|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
15071977|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
15071978|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15071979|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15071980|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
15071981|NCT02206425|Hormones|hormones|mesh-ancestor
15071982|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15071983|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15071984|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
15071985|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15071986|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15071987|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15071988|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15071989|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15071990|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15071991|NCT02206425|Growth Substances|growth substances|mesh-ancestor
15071992|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
15071993|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
15071994|NCT02206425|Protective Agents|protective agents|mesh-ancestor
15071995|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
15071996|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15071997|NCT02206477|Protective Agents|protective agents|mesh-ancestor
15071998|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15071999|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15072000|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
15072001|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072002|NCT02206490|Naltrexone|naltrexone|mesh-list
15072003|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
15072004|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15072005|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15072006|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072007|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
15072008|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072009|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
15072010|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
15072011|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15072012|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15072013|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072014|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072015|NCT02206503|Dexamethasone|dexamethasone|mesh-list
15072016|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
15072017|NCT02206503|Lenalidomide|lenalidomide|mesh-list
15072018|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15072019|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
15072020|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072021|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15072022|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15072023|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
15072024|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072025|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072026|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15072027|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15072028|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
15072029|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
15072030|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072031|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15072032|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
15072033|NCT02206503|Hormones|hormones|mesh-ancestor
15072034|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15072035|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15072036|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15072037|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15072038|NCT02206503|Growth Substances|growth substances|mesh-ancestor
15072039|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
15072040|NCT02206555|Tenofovir|tenofovir|mesh-list
15072041|NCT02206555|Emtricitabine|emtricitabine|mesh-list
15072042|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15072043|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
15072044|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072045|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15072046|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15072047|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072048|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072049|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15072050|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15072051|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
15072052|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
15072053|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15072054|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072055|NCT02206646|Tenecteplase|tenecteplase|mesh-list
15072056|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15072057|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15072058|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072059|NCT02206659|Telmisartan|telmisartan|mesh-list
15072060|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15072061|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15072062|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15072063|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072064|NCT02206711|BMS-955176|bms-955176|mesh-list
15072065|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15072066|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15072067|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
15072068|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072069|NCT02206737|Nicotine|nicotine|mesh-list
15072070|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15072071|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
15072072|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072073|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072074|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15072075|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15072076|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
15072077|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072078|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072079|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15072080|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
15072081|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072082|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15072083|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072084|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072085|NCT02206789|Cyclosporine|cyclosporine|mesh-list
15072086|NCT02206789|Prednisolone|prednisolone|mesh-list
15072087|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15072088|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
15072089|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15072090|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
15072091|NCT02206789|Cyclosporins|cyclosporins|mesh-list
15072092|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15072093|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
15072094|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072095|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072096|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15072097|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
15072098|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072099|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
15072100|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072101|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
15072102|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15072103|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15072104|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15072105|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
15072106|NCT02206789|Hormones|hormones|mesh-ancestor
15072107|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15072108|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15072109|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072110|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
15072111|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
15072112|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072113|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15072114|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15072115|NCT02206789|Protective Agents|protective agents|mesh-ancestor
15072116|NCT02206802|Minoxidil|minoxidil|mesh-list
15072117|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15072118|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
15072119|NCT02206815|Aspirin|aspirin|mesh-list
15072120|NCT02206815|Warfarin|warfarin|mesh-list
15072121|NCT02206815|Clopidogrel|clopidogrel|mesh-list
15072122|NCT02206815|Ticagrelor|ticagrelor|mesh-list
15072123|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15072124|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15072125|NCT02206815|Analgesics|analgesics|mesh-ancestor
15072126|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
15072127|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072128|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072129|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15072130|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15072131|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15072132|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15072133|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072134|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15072135|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15072136|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072137|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
15072138|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15072139|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15072140|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15072141|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
15072142|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072143|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
15072144|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
15072145|NCT02206854|Analgesics|analgesics|mesh-ancestor
15072146|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
15072147|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072148|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072149|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15072150|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15072151|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15072152|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15072153|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15072154|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072155|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072156|NCT02206867|Adalimumab|adalimumab|mesh-list
15072157|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15072158|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15072159|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
15072160|NCT02206932|Simeprevir|simeprevir|mesh-list
15072161|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
15072162|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072163|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
15072164|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072165|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072166|NCT02207010|Adavosertib|adavosertib|mesh-list
15072167|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072168|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072169|NCT02207335|Gemcitabine|gemcitabine|mesh-list
15072170|NCT02207335|Carboplatin|carboplatin|mesh-list
15072171|NCT02207335|Capecitabine|capecitabine|mesh-list
15072172|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072173|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15072174|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
15072175|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072176|NCT02207335|Antiviral Agents|antiviral agents|mesh-ancestor
15072177|NCT02207335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072178|NCT02207335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072179|NCT02207335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15072180|NCT02207335|Immunologic Factors|immunologic factors|mesh-ancestor
15072181|NCT02207335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072182|NCT02207348|Liraglutide|liraglutide|mesh-list
15072183|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15072184|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072185|NCT02207348|Incretins|incretins|mesh-ancestor
15072186|NCT02207348|Hormones|hormones|mesh-ancestor
15072187|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15072188|NCT02207361|Paclitaxel|paclitaxel|mesh-list
15072189|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15072190|NCT02207361|Carboplatin|carboplatin|mesh-list
15072191|NCT02207361|Epirubicin|epirubicin|mesh-list
15072192|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15072193|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072194|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
15072195|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
15072196|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
15072197|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072198|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15072199|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15072200|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15072201|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072202|NCT02207387|Rasagiline|rasagiline|mesh-list
15072203|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15072204|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072205|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072206|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15072207|NCT02207387|Protective Agents|protective agents|mesh-ancestor
15072208|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072209|NCT02207426|Tobramycin|tobramycin|mesh-list
15072210|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15072211|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072212|NCT02207439|Nelfinavir|nelfinavir|mesh-list
15072213|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15072214|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15072215|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
15072216|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072217|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072218|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15072219|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15072220|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
15072221|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072222|NCT02207452|Albuterol|albuterol|mesh-list
15072223|NCT02207452|Ipratropium|ipratropium|mesh-list
15072224|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15072225|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
15072226|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072227|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072228|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15072229|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
15072230|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
15072231|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15072232|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15072233|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15072234|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15072235|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
15072236|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072237|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072238|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15072239|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
15072240|NCT02207660|Fluorouracil|fluorouracil|mesh-list
15072241|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072242|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
15072243|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072244|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15072245|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15072246|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
15072247|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072248|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
15072249|NCT02207699|Benzonatate|benzonatate|mesh-list
15072250|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15072251|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072252|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15072253|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15072254|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072255|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072256|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072257|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
15072258|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
15072259|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
15072260|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
15072261|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
15072262|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15072263|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072264|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
15072265|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072266|NCT02207920|Vaccines|vaccines|mesh-list
15072267|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
15072268|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072269|NCT02207959|Proflavine|proflavine|mesh-list
15072270|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15072271|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072272|NCT02208128|Bevacizumab|bevacizumab|mesh-list
15072273|NCT02208128|Sunitinib|sunitinib|mesh-list
15072274|NCT02208128|Everolimus|everolimus|mesh-list
15072275|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15072276|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072277|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15072278|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15072279|NCT02208128|Growth Substances|growth substances|mesh-ancestor
15072280|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072281|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
15072282|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15072283|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
15072284|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15072285|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072286|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072287|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
15072288|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15072289|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15072290|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072291|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
15072292|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
15072293|NCT02208245|Ropivacaine|ropivacaine|mesh-list
15072294|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
15072295|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
15072296|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15072297|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072298|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
15072299|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072300|NCT02208427|Isoniazid|isoniazid|mesh-list
15072301|NCT02208427|Rifapentine|rifapentine|mesh-list
15072302|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
15072303|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15072304|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072305|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15072306|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15072307|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
15072308|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072309|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15072310|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15072311|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
15072312|NCT02208492|Levetiracetam|levetiracetam|mesh-list
15072313|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
15072314|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
15072315|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
15072316|NCT02208505|Remifentanil|remifentanil|mesh-list
15072317|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15072318|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15072319|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072320|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15072321|NCT02208505|Analgesics|analgesics|mesh-ancestor
15072322|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
15072323|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072324|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15072325|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15072326|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15072327|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
15072328|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072329|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072330|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15072331|NCT02208505|Narcotics|narcotics|mesh-ancestor
15072332|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15072333|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15072334|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072335|NCT02208583|Prednisone|prednisone|mesh-list
15072336|NCT02208583|Cisplatin|cisplatin|mesh-list
15072337|NCT02208583|Docetaxel|docetaxel|mesh-list
15072338|NCT02208583|Etoposide|etoposide|mesh-list
15072339|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
15072340|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072341|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
15072342|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
15072343|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
15072344|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072345|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15072346|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
15072347|NCT02208583|Hormones|hormones|mesh-ancestor
15072348|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15072349|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072350|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15072351|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15072352|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15072353|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15072354|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072355|NCT02208596|Pentazocine|pentazocine|mesh-list
15072356|NCT02208596|Propofol|propofol|mesh-list
15072357|NCT02208596|Etomidate|etomidate|mesh-list
15072358|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15072359|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15072360|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072361|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15072362|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
15072363|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
15072364|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15072365|NCT02208596|Narcotics|narcotics|mesh-ancestor
15072366|NCT02208596|Analgesics|analgesics|mesh-ancestor
15072367|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
15072368|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072369|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15072370|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15072371|NCT02208778|Remifentanil|remifentanil|mesh-list
15072372|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15072373|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15072374|NCT02208778|Narcotics|narcotics|mesh-ancestor
15072375|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15072376|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072377|NCT02208778|Analgesics|analgesics|mesh-ancestor
15072378|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
15072379|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072380|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15072381|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15072382|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15072383|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072384|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072385|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
15072386|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15072387|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
15072388|NCT02208791|Sirolimus|sirolimus|mesh-list
15072389|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15072390|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072391|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15072392|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072393|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
15072394|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15072395|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
15072396|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072397|NCT02208882|Midazolam|midazolam|mesh-list
15072398|NCT02208882|BMS-986120|bms-986120|mesh-list
15072399|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15072400|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15072401|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15072402|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072403|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15072404|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15072405|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15072406|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15072407|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
15072408|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
15072409|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
15072410|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
15072411|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072412|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072413|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15072414|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15072415|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
15072416|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15072417|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
15072418|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15072419|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072420|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15072421|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15072422|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072423|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
15072424|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15072425|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
15072426|NCT02209025|Theobromine|theobromine|mesh-list
15072427|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15072428|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
15072429|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072430|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072431|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15072432|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
15072433|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
15072434|NCT02209155|Verapamil|verapamil|mesh-list
15072435|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15072436|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15072437|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15072438|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072439|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15072440|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072441|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
15072442|NCT02209350|Aspirin|aspirin|mesh-list
15072443|NCT02209350|Clopidogrel|clopidogrel|mesh-list
15072444|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15072445|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15072446|NCT02209350|Analgesics|analgesics|mesh-ancestor
15072447|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
15072448|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072449|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072450|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15072451|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15072452|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15072453|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15072454|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072455|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15072456|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15072457|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072458|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
15072459|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15072460|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15072461|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15072462|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
15072463|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072464|NCT02209428|Temozolomide|temozolomide|mesh-list
15072465|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15072466|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
15072467|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072468|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072469|NCT02209441|Sorafenib|sorafenib|mesh-list
15072470|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072471|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15072472|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072473|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072474|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
15072475|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
15072476|NCT02209636|Vitamins|vitamins|mesh-ancestor
15072477|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
15072478|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072479|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
15072480|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072481|NCT02209636|Protective Agents|protective agents|mesh-ancestor
15072482|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
15072483|NCT02209649|Telmisartan|telmisartan|mesh-list
15072484|NCT02209649|Lacidipine|lacidipine|mesh-list
15072485|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15072486|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15072487|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15072488|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072489|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15072490|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15072491|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15072492|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072493|NCT02209701|Porfiromycin|porfiromycin|mesh-list
15072494|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15072495|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072496|NCT02209740|Tenofovir|tenofovir|mesh-list
15072497|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
15072498|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072499|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15072500|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15072501|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072502|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072503|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15072504|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15072505|NCT02209831|Pantoprazole|pantoprazole|mesh-list
15072506|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15072507|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15072508|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15072509|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072510|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072511|NCT02209909|Aspirin|aspirin|mesh-list
15072512|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15072513|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15072514|NCT02209909|Analgesics|analgesics|mesh-ancestor
15072515|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
15072516|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072517|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072518|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15072519|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15072520|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15072521|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15072522|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072523|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15072524|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15072525|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072526|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
15072527|NCT02209974|Fluticasone|fluticasone|mesh-list
15072528|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15072529|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15072530|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
15072531|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072532|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072533|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15072534|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
15072535|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
15072536|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15072537|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15072538|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
15072539|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072540|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
15072541|NCT02210104|Ipilimumab|ipilimumab|mesh-list
15072542|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15072543|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
15072544|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072545|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15072546|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15072547|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
15072548|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072549|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072550|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15072551|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15072552|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15072553|NCT02210117|Bevacizumab|bevacizumab|mesh-list
15072554|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15072555|NCT02210117|Nivolumab|nivolumab|mesh-list
15072556|NCT02210117|Ipilimumab|ipilimumab|mesh-list
15072557|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
15072558|NCT02210117|Antibodies|antibodies|mesh-list
15072559|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
15072560|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15072561|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
15072562|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072563|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15072564|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15072565|NCT02210117|Growth Substances|growth substances|mesh-ancestor
15072566|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072567|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
15072568|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
15072569|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15072570|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072571|NCT02210156|Micronutrients|micronutrients|mesh-list
15072572|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072573|NCT02210169|Vancomycin|vancomycin|mesh-list
15072574|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15072575|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072576|NCT02210182|Pentamidine|pentamidine|mesh-list
15072577|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
15072578|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072579|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15072580|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15072581|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
15072582|NCT02210260|Heroin|heroin|mesh-list
15072583|NCT02210260|Bupivacaine|bupivacaine|mesh-list
15072584|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
15072585|NCT02210260|Anesthetics|anesthetics|mesh-list
15072586|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15072587|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072588|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
15072589|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072590|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15072591|NCT02210260|Narcotics|narcotics|mesh-ancestor
15072592|NCT02210260|Analgesics|analgesics|mesh-ancestor
15072593|NCT02210325|Azithromycin|azithromycin|mesh-list
15072594|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
15072595|NCT02210325|Solithromycin|solithromycin|mesh-list
15072596|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15072597|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072598|NCT02210364|Capecitabine|capecitabine|mesh-list
15072599|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15072600|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
15072601|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072602|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072603|NCT02210559|Gemcitabine|gemcitabine|mesh-list
15072604|NCT02210559|Paclitaxel|paclitaxel|mesh-list
15072605|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15072606|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072607|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
15072608|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
15072609|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
15072610|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072611|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15072612|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
15072613|NCT02210559|Antiviral Agents|antiviral agents|mesh-ancestor
15072614|NCT02210559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072615|NCT02210559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072616|NCT02210559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15072617|NCT02210559|Immunologic Factors|immunologic factors|mesh-ancestor
15072618|NCT02210559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072619|NCT02210598|Oxytocin|oxytocin|mesh-list
15072620|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
15072621|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15072622|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072623|NCT02210663|Veliparib|veliparib|mesh-list
15072624|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15072625|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072626|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072627|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072628|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15072629|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15072630|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15072631|NCT02210702|Norethindrone|norethindrone|mesh-list
15072632|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
15072633|NCT02210702|Estradiol|estradiol|mesh-list
15072634|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15072635|NCT02210702|Estrogens|estrogens|mesh-ancestor
15072636|NCT02210702|Hormones|hormones|mesh-ancestor
15072637|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15072638|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072639|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15072640|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
15072641|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15072642|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15072643|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15072644|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15072645|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15072646|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
15072647|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
15072648|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15072649|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
15072650|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072651|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15072652|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15072653|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072654|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072655|NCT02210728|Methylphenidate|methylphenidate|mesh-list
15072656|NCT02210728|Amphetamine|amphetamine|mesh-list
15072657|NCT02210728|Adderall|adderall|mesh-list
15072658|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
15072659|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15072660|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072661|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15072662|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15072663|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15072664|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072665|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
15072666|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072667|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
15072668|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
15072669|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072670|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
15072671|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15072672|NCT02210754|Menthol|menthol|mesh-list
15072673|NCT02210754|Nicotine|nicotine|mesh-list
15072674|NCT02210754|Glycerol|glycerol|mesh-list
15072675|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15072676|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
15072677|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072678|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072679|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15072680|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15072681|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
15072682|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072683|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072684|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
15072685|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
15072686|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
15072687|NCT02210754|Protective Agents|protective agents|mesh-ancestor
15072688|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
15072689|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15072690|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
15072691|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15072692|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
15072693|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072694|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072695|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
15072696|NCT02210858|Tipifarnib|tipifarnib|mesh-list
15072697|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072698|NCT02210884|Vitamin D|vitamin d|mesh-list
15072699|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
15072700|NCT02210884|Vitamins|vitamins|mesh-list
15072701|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
15072702|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072703|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15072704|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15072705|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
15072706|NCT02210949|Hematinics|hematinics|mesh-ancestor
15072707|NCT02211066|Clopidogrel|clopidogrel|mesh-list
15072708|NCT02211066|Ticagrelor|ticagrelor|mesh-list
15072709|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15072710|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15072711|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15072712|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15072713|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
15072714|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072715|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072716|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072717|NCT02211079|Tolbutamide|tolbutamide|mesh-list
15072718|NCT02211079|Midazolam|midazolam|mesh-list
15072719|NCT02211079|Caffeine|caffeine|mesh-list
15072720|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15072721|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15072722|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15072723|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072724|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15072725|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15072726|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15072727|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15072728|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
15072729|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
15072730|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
15072731|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
15072732|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072733|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072734|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15072735|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15072736|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072737|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15072738|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15072739|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
15072740|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15072741|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
15072742|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15072743|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15072744|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072745|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15072746|NCT02211118|Analgesics|analgesics|mesh-ancestor
15072747|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
15072748|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072749|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15072750|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15072751|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15072752|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
15072753|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072754|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072755|NCT02211222|Lenvatinib|lenvatinib|mesh-list
15072756|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072757|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15072758|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072759|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072760|NCT02211326|Warfarin|warfarin|mesh-list
15072761|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
15072762|NCT02211391|Caseins|caseins|mesh-list
15072763|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
15072764|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
15072765|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072766|NCT02211417|Mineral Oil|mineral oil|mesh-list
15072767|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
15072768|NCT02211417|Emollients|emollients|mesh-ancestor
15072769|NCT02211443|Cetuximab|cetuximab|mesh-list
15072770|NCT02211443|Antibodies|antibodies|mesh-list
15072771|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15072772|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
15072773|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072774|NCT02211443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15072775|NCT02211443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072776|NCT02211482|Lamivudine|lamivudine|mesh-list
15072777|NCT02211482|Dolutegravir|dolutegravir|mesh-list
15072778|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15072779|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15072780|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072781|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072782|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
15072783|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072784|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15072785|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15072786|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15072787|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15072788|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
15072789|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15072790|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
15072791|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072792|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
15072793|NCT02211521|Protective Agents|protective agents|mesh-ancestor
15072794|NCT02211625|Oxycodone|oxycodone|mesh-list
15072795|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15072796|NCT02211625|Narcotics|narcotics|mesh-ancestor
15072797|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15072798|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072799|NCT02211625|Analgesics|analgesics|mesh-ancestor
15072800|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
15072801|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072802|NCT02211690|Tenofovir|tenofovir|mesh-list
15072803|NCT02211690|Emtricitabine|emtricitabine|mesh-list
15072804|NCT02211690|Dolutegravir|dolutegravir|mesh-list
15072805|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
15072806|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072807|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15072808|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15072809|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072810|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072811|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15072812|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15072813|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15072814|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15072815|NCT02211729|Azithromycin|azithromycin|mesh-list
15072816|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
15072817|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
15072818|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
15072819|NCT02211729|Amodiaquine|amodiaquine|mesh-list
15072820|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15072821|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072822|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
15072823|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15072824|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15072825|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15072826|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072827|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072828|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15072829|NCT02211729|Renal Agents|renal agents|mesh-ancestor
15072830|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
15072831|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15072832|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072833|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15072834|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072835|NCT02211833|Pemetrexed|pemetrexed|mesh-list
15072836|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072837|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072838|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072839|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15072840|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15072841|NCT02211846|Mirabegron|mirabegron|mesh-list
15072842|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
15072843|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15072844|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15072845|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
15072846|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072847|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072848|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072849|NCT02211846|Urological Agents|urological agents|mesh-ancestor
15072850|NCT02211911|Bisacodyl|bisacodyl|mesh-list
15072851|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
15072852|NCT02211911|Cathartics|cathartics|mesh-ancestor
15072853|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15072854|NCT02211911|Laxatives|laxatives|mesh-ancestor
15072855|NCT02211950|Acarbose|acarbose|mesh-list
15072856|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
15072857|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072858|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072859|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15072860|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072861|NCT02211976|Bisacodyl|bisacodyl|mesh-list
15072862|NCT02211976|Cathartics|cathartics|mesh-ancestor
15072863|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15072864|NCT02211976|Laxatives|laxatives|mesh-ancestor
15072865|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
15072866|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15072867|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15072868|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072869|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
15072870|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072871|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072872|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
15072873|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15072874|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15072875|NCT02212210|Prednisolone|prednisolone|mesh-list
15072876|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
15072877|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15072878|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
15072879|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15072880|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
15072881|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
15072882|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072883|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072884|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15072885|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
15072886|NCT02212210|Hormones|hormones|mesh-ancestor
15072887|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15072888|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15072889|NCT02212210|Protective Agents|protective agents|mesh-ancestor
15072890|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15072891|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072892|NCT02212223|Vitamin D|vitamin d|mesh-list
15072893|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
15072894|NCT02212223|Vitamins|vitamins|mesh-ancestor
15072895|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
15072896|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072897|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15072898|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15072899|NCT02212340|Remifentanil|remifentanil|mesh-list
15072900|NCT02212340|Desflurane|desflurane|mesh-list
15072901|NCT02212340|Propofol|propofol|mesh-list
15072902|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15072903|NCT02212340|Narcotics|narcotics|mesh-ancestor
15072904|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15072905|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072906|NCT02212340|Analgesics|analgesics|mesh-ancestor
15072907|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
15072908|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15072909|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15072910|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
15072911|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
15072912|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15072913|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15072914|NCT02212392|Meropenem|meropenem|mesh-list
15072915|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15072916|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072917|NCT02212431|Cysteamine|cysteamine|mesh-list
15072918|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
15072919|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072920|NCT02212535|Plerixafor|plerixafor|mesh-list
15072921|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15072922|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15072923|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
15072924|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072925|NCT02212561|Vidarabine|vidarabine|mesh-list
15072926|NCT02212561|Cytarabine|cytarabine|mesh-list
15072927|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
15072928|NCT02212561|Methotrexate|methotrexate|mesh-list
15072929|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
15072930|NCT02212561|Fludarabine|fludarabine|mesh-list
15072931|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15072932|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
15072933|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15072934|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072935|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15072936|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
15072937|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072938|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15072939|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
15072940|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072941|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15072942|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15072943|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
15072944|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15072945|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15072946|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
15072947|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072948|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15072949|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
15072950|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
15072951|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15072952|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072953|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072954|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
15072955|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
15072956|NCT02212639|Digoxin|digoxin|mesh-list
15072957|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15072958|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15072959|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072960|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072961|NCT02212639|Protective Agents|protective agents|mesh-ancestor
15072962|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072963|NCT02212652|Vitamin D|vitamin d|mesh-list
15072964|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
15072965|NCT02212652|Vitamins|vitamins|mesh-list
15072966|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
15072967|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072968|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15072969|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15072970|NCT02212756|Metformin|metformin|mesh-list
15072971|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15072972|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072973|NCT02212769|Losartan|losartan|mesh-list
15072974|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15072975|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15072976|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15072977|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15072978|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072979|NCT02212782|Linagliptin|linagliptin|mesh-list
15072980|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15072981|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15072982|NCT02212782|Incretins|incretins|mesh-ancestor
15072983|NCT02212782|Hormones|hormones|mesh-ancestor
15072984|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15072985|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15072986|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
15072987|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072988|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15072989|NCT02212795|Levofloxacin|levofloxacin|mesh-list
15072990|NCT02212795|Ofloxacin|ofloxacin|mesh-list
15072991|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
15072992|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15072993|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15072994|NCT02212795|Renal Agents|renal agents|mesh-ancestor
15072995|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15072996|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15072997|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15072998|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15072999|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073000|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073001|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15073002|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15073003|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15073004|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
15073005|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15073006|NCT02212821|Erythromycin|erythromycin|mesh-list
15073007|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
15073008|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
15073009|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
15073010|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15073011|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073012|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15073013|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15073014|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073015|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073016|NCT02212990|Acetaminophen|acetaminophen|mesh-list
15073017|NCT02212990|Ibuprofen|ibuprofen|mesh-list
15073018|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15073019|NCT02212990|Analgesics|analgesics|mesh-ancestor
15073020|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
15073021|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073022|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073023|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
15073024|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15073025|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15073026|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15073027|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15073028|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073029|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073030|NCT02213029|Oxytocin|oxytocin|mesh-list
15073031|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
15073032|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15073033|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073034|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
15073035|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15073036|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
15073037|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15073038|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073039|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15073040|NCT02213107|Dutasteride|dutasteride|mesh-list
15073041|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15073042|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15073043|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073044|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073045|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
15073046|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15073047|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073048|NCT02213146|Insulin|insulin|mesh-list
15073049|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
15073050|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15073051|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15073052|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073053|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
15073054|NCT02213159|Morphine|morphine|mesh-list
15073055|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15073056|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15073057|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073058|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15073059|NCT02213159|Analgesics|analgesics|mesh-ancestor
15073060|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
15073061|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073062|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15073063|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15073064|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15073065|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
15073066|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15073067|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073068|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15073069|NCT02213159|Narcotics|narcotics|mesh-ancestor
15073070|NCT02213211|Lumefantrine|lumefantrine|mesh-list
15073071|NCT02213211|Artemether|artemether|mesh-list
15073072|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15073073|NCT02213211|Artemisinins|artemisinins|mesh-list
15073074|NCT02213211|Artemisinin|artemisinin|mesh-list
15073075|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
15073076|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15073077|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15073078|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073079|NCT02213224|Amlodipine|amlodipine|mesh-list
15073080|NCT02213224|Telmisartan|telmisartan|mesh-list
15073081|NCT02213224|Perindopril|perindopril|mesh-list
15073082|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15073083|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15073084|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15073085|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073086|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15073087|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073088|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
15073089|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15073090|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15073091|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15073092|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
15073093|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073094|NCT02213302|Midazolam|midazolam|mesh-list
15073095|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15073096|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15073097|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15073098|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073099|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15073100|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15073101|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15073102|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15073103|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
15073104|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
15073105|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
15073106|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
15073107|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15073108|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073109|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
15073110|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15073111|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15073112|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
15073113|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073114|NCT02213328|Tenofovir|tenofovir|mesh-list
15073115|NCT02213328|Emtricitabine|emtricitabine|mesh-list
15073116|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15073117|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
15073118|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073119|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15073120|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15073121|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073122|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073123|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15073124|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15073125|NCT02213419|Ethanol|ethanol|mesh-list
15073126|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15073127|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073128|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15073129|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073130|NCT02213432|Vaccines|vaccines|mesh-list
15073131|NCT02213432|Immunologic Factors|immunologic factors|mesh-ancestor
15073132|NCT02213432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073133|NCT02213497|Paclitaxel|paclitaxel|mesh-list
15073134|NCT02213497|Carboplatin|carboplatin|mesh-list
15073135|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15073136|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15073137|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073138|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
15073139|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
15073140|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
15073141|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073142|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15073143|NCT02213588|Antioxidants|antioxidants|mesh-list
15073144|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073145|NCT02213588|Protective Agents|protective agents|mesh-ancestor
15073146|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073147|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
15073148|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
15073149|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15073150|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073151|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073152|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
15073153|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15073154|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15073155|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073156|NCT02213627|Menotropins|menotropins|mesh-list
15073157|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15073158|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
15073159|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15073160|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073161|NCT02213653|Iron|iron|mesh-list
15073162|NCT02213653|Trace Elements|trace elements|mesh-ancestor
15073163|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
15073164|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073165|NCT02213718|Sufentanil|sufentanil|mesh-list
15073166|NCT02213718|Propofol|propofol|mesh-list
15073167|NCT02213718|Desflurane|desflurane|mesh-list
15073168|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15073169|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15073170|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073171|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15073172|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
15073173|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
15073174|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15073175|NCT02213718|Narcotics|narcotics|mesh-ancestor
15073176|NCT02213718|Analgesics|analgesics|mesh-ancestor
15073177|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
15073178|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073179|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15073180|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15073181|NCT02213744|Gemcitabine|gemcitabine|mesh-list
15073182|NCT02213744|Capecitabine|capecitabine|mesh-list
15073183|NCT02213744|Trastuzumab|trastuzumab|mesh-list
15073184|NCT02213744|Vinorelbine|vinorelbine|mesh-list
15073185|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15073186|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
15073187|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073188|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073189|NCT02213744|Antiviral Agents|antiviral agents|mesh-ancestor
15073190|NCT02213744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073191|NCT02213744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073192|NCT02213744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15073193|NCT02213744|Immunologic Factors|immunologic factors|mesh-ancestor
15073194|NCT02213744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073195|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15073196|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15073197|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
15073198|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
15073199|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
15073200|NCT02213757|Estrogens|estrogens|mesh-list
15073201|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15073202|NCT02213757|Hormones|hormones|mesh-ancestor
15073203|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15073204|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073205|NCT02213783|Imipenem|imipenem|mesh-list
15073206|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15073207|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073208|NCT02213796|Meropenem|meropenem|mesh-list
15073209|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15073210|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073211|NCT02213848|Calcium|calcium|mesh-list
15073212|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15073213|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073214|NCT02213887|Pantoprazole|pantoprazole|mesh-list
15073215|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15073216|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15073217|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15073218|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073219|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073220|NCT02213913|Prednisone|prednisone|mesh-list
15073221|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
15073222|NCT02213913|Rituximab|rituximab|mesh-list
15073223|NCT02213913|Doxorubicin|doxorubicin|mesh-list
15073224|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15073225|NCT02213913|Etoposide|etoposide|mesh-list
15073226|NCT02213913|Vincristine|vincristine|mesh-list
15073227|NCT02213913|Lenalidomide|lenalidomide|mesh-list
15073228|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
15073229|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15073230|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
15073231|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073232|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15073233|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15073234|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
15073235|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073236|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073237|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15073238|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15073239|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15073240|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15073241|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15073242|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073243|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15073244|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
15073245|NCT02213913|Hormones|hormones|mesh-ancestor
15073246|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15073247|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15073248|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15073249|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
15073250|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
15073251|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
15073252|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15073253|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15073254|NCT02213913|Growth Substances|growth substances|mesh-ancestor
15073255|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
15073256|NCT02214004|Trastuzumab|trastuzumab|mesh-list
15073257|NCT02214004|Letrozole|letrozole|mesh-list
15073258|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15073259|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073260|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15073261|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15073262|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073263|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073264|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15073265|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
15073266|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15073267|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073268|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
15073269|NCT02214368|Propofol|propofol|mesh-list
15073270|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15073271|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15073272|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073273|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15073274|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
15073275|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
15073276|NCT02214381|Paclitaxel|paclitaxel|mesh-list
15073277|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
15073278|NCT02214381|Doxorubicin|doxorubicin|mesh-list
15073279|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15073280|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073281|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
15073282|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
15073283|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
15073284|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073285|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15073286|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
15073287|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073288|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15073289|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15073290|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
15073291|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15073292|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15073293|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15073294|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15073295|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073296|NCT02214433|Pantoprazole|pantoprazole|mesh-list
15073297|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15073298|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15073299|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15073300|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15073301|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073302|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073303|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15073304|NCT02214498|Enalapril|enalapril|mesh-list
15073305|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15073306|NCT02214498|Diuretics|diuretics|mesh-ancestor
15073307|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
15073308|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073309|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15073310|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15073311|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073312|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15073313|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
15073314|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073315|NCT02214563|Vitamin D|vitamin d|mesh-list
15073316|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
15073317|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
15073318|NCT02214563|Vitamins|vitamins|mesh-list
15073319|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
15073320|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073321|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15073322|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15073323|NCT02214602|Doxorubicin|doxorubicin|mesh-list
15073324|NCT02214602|Epirubicin|epirubicin|mesh-list
15073325|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15073326|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073327|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15073328|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15073329|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073330|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073331|NCT02214680|Timolol|timolol|mesh-list
15073332|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
15073333|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
15073334|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15073335|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15073336|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
15073337|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15073338|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073339|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073340|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15073341|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15073342|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15073343|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15073344|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15073345|NCT02214706|Sirolimus|sirolimus|mesh-list
15073346|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15073347|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073348|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15073349|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073350|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
15073351|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15073352|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
15073353|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073354|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
15073355|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15073356|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073357|NCT02214810|Bupivacaine|bupivacaine|mesh-list
15073358|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
15073359|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
15073360|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15073361|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073362|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
15073363|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073364|NCT02214966|Telmisartan|telmisartan|mesh-list
15073365|NCT02214966|Ramipril|ramipril|mesh-list
15073366|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15073367|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15073368|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15073369|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073370|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15073371|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
15073372|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073373|NCT02214979|Telmisartan|telmisartan|mesh-list
15073374|NCT02214979|Ramipril|ramipril|mesh-list
15073375|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15073376|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15073377|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15073378|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073379|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15073380|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
15073381|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073382|NCT02214992|Telmisartan|telmisartan|mesh-list
15073383|NCT02214992|Ramipril|ramipril|mesh-list
15073384|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15073385|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15073386|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15073387|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073388|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15073389|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
15073390|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073391|NCT02215005|Telmisartan|telmisartan|mesh-list
15073392|NCT02215005|Ramipril|ramipril|mesh-list
15073393|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15073394|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15073395|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15073396|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073397|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15073398|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
15073399|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073400|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15073401|NCT02215044|Gemcitabine|gemcitabine|mesh-list
15073402|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15073403|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
15073404|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073405|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073406|NCT02215044|Antiviral Agents|antiviral agents|mesh-ancestor
15073407|NCT02215044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073408|NCT02215044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073409|NCT02215044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15073410|NCT02215044|Immunologic Factors|immunologic factors|mesh-ancestor
15073411|NCT02215044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073412|NCT02215057|Lidocaine|lidocaine|mesh-list
15073413|NCT02215057|Anesthetics|anesthetics|mesh-list
15073414|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
15073415|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15073416|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073417|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
15073418|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073419|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15073420|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15073421|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15073422|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15073423|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073424|NCT02215096|GSK2636771|gsk2636771|mesh-list
15073425|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073426|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15073427|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073428|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073429|NCT02215148|Tolvaptan|tolvaptan|mesh-list
15073430|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
15073431|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073432|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
15073433|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073434|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15073435|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15073436|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15073437|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
15073438|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073439|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15073440|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15073441|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073442|NCT02215213|Vitamin D|vitamin d|mesh-list
15073443|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
15073444|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
15073445|NCT02215213|Vitamins|vitamins|mesh-list
15073446|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
15073447|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073448|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15073449|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15073450|NCT02215265|Cisplatin|cisplatin|mesh-list
15073451|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073452|NCT02215330|Eplerenone|eplerenone|mesh-list
15073453|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
15073454|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
15073455|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15073456|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073457|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15073458|NCT02215330|Diuretics|diuretics|mesh-ancestor
15073459|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
15073460|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15073461|NCT02215382|Atropine|atropine|mesh-list
15073462|NCT02215382|Neostigmine|neostigmine|mesh-list
15073463|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15073464|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15073465|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15073466|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
15073467|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073468|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073469|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15073470|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
15073471|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
15073472|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
15073473|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15073474|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15073475|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
15073476|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15073477|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073478|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15073479|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073480|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15073481|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15073482|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
15073483|NCT02215395|Estradiol|estradiol|mesh-list
15073484|NCT02215395|Estrogens|estrogens|mesh-ancestor
15073485|NCT02215395|Hormones|hormones|mesh-ancestor
15073486|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15073487|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073488|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15073489|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15073490|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15073491|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15073492|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15073493|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
15073494|NCT02215434|Testosterone|testosterone|mesh-list
15073495|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
15073496|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
15073497|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15073498|NCT02215434|Androgens|androgens|mesh-ancestor
15073499|NCT02215434|Hormones|hormones|mesh-ancestor
15073500|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15073501|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073502|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15073503|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073504|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
15073505|NCT02215447|Paclitaxel|paclitaxel|mesh-list
15073506|NCT02215447|Carboplatin|carboplatin|mesh-list
15073507|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15073508|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073509|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
15073510|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
15073511|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
15073512|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073513|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
15073514|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15073515|NCT02215460|Azithromycin|azithromycin|mesh-list
15073516|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15073517|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073518|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
15073519|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
15073520|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15073521|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
15073522|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15073523|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15073524|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073525|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
15073526|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
15073527|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
15073528|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15073529|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15073530|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
15073531|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
15073532|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15073533|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073534|NCT02215538|Methylphenidate|methylphenidate|mesh-list
15073535|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15073536|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073537|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15073538|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15073539|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15073540|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073541|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
15073542|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15073543|NCT02215720|Sirolimus|sirolimus|mesh-list
15073544|NCT02215720|Cetuximab|cetuximab|mesh-list
15073545|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15073546|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073547|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15073548|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073549|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15073550|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
15073551|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15073552|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
15073553|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073554|NCT02215733|Telmisartan|telmisartan|mesh-list
15073555|NCT02215733|Diuretics|diuretics|mesh-list
15073556|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15073557|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15073558|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15073559|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15073560|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073561|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
15073562|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073563|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15073564|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
15073565|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15073566|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15073567|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15073568|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15073569|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15073570|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073571|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15073572|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073573|NCT02215798|Analgesics|analgesics|mesh-ancestor
15073574|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
15073575|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073576|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
15073577|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15073578|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
15073579|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15073580|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
15073581|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073582|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
15073583|NCT02215876|Doxorubicin|doxorubicin|mesh-list
15073584|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15073585|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
15073586|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073587|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15073588|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15073589|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
15073590|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073591|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073592|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15073593|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15073594|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15073595|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15073596|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073597|NCT02215993|Ticagrelor|ticagrelor|mesh-list
15073598|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15073599|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15073600|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15073601|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15073602|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15073603|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
15073604|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15073605|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073606|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073607|NCT02216045|Ribavirin|ribavirin|mesh-list
15073608|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15073609|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
15073610|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
15073611|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073612|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
15073613|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073614|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
15073615|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073616|NCT02216058|Sirolimus|sirolimus|mesh-list
15073617|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15073618|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073619|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15073620|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073621|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
15073622|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15073623|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
15073624|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073625|NCT02216149|Capecitabine|capecitabine|mesh-list
15073626|NCT02216149|Tegafur|tegafur|mesh-list
15073627|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
15073628|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15073629|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
15073630|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073631|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073632|NCT02216227|Iodine|iodine|mesh-list
15073633|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
15073634|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15073635|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
15073636|NCT02216227|Vancomycin|vancomycin|mesh-list
15073637|NCT02216227|Cefazolin|cefazolin|mesh-list
15073638|NCT02216227|Mupirocin|mupirocin|mesh-list
15073639|NCT02216227|Povidone|povidone|mesh-list
15073640|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15073641|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073642|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
15073643|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
15073644|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15073645|NCT02216227|Trace Elements|trace elements|mesh-ancestor
15073646|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
15073647|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073648|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
15073649|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
15073650|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15073651|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073652|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073653|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15073654|NCT02216266|Physostigmine|physostigmine|mesh-list
15073655|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15073656|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073657|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073658|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
15073659|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15073660|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073661|NCT02216266|Miotics|miotics|mesh-ancestor
15073662|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
15073663|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073664|NCT02216331|Rifampin|rifampin|mesh-list
15073665|NCT02216331|Rifapentine|rifapentine|mesh-list
15073666|NCT02216331|Bedaquiline|bedaquiline|mesh-list
15073667|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15073668|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
15073669|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15073670|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073671|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
15073672|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15073673|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073674|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073675|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15073676|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15073677|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
15073678|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
15073679|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
15073680|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15073681|NCT02216383|Oxytocin|oxytocin|mesh-list
15073682|NCT02216383|Carbetocin|carbetocin|mesh-list
15073683|NCT02216383|Syntometrine|syntometrine|mesh-list
15073684|NCT02216383|Ergonovine|ergonovine|mesh-list
15073685|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
15073686|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15073687|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073688|NCT02216409|Magrolimab|magrolimab|mesh-list
15073689|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15073690|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073691|NCT02216487|Irinotecan|irinotecan|mesh-list
15073692|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15073693|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15073694|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073695|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073696|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073697|NCT02216513|Deferoxamine|deferoxamine|mesh-list
15073698|NCT02216513|Siderophores|siderophores|mesh-ancestor
15073699|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15073700|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
15073701|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
15073702|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073703|NCT02216552|Resveratrol|resveratrol|mesh-list
15073704|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
15073705|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073706|NCT02216552|Protective Agents|protective agents|mesh-ancestor
15073707|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073708|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073709|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15073710|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15073711|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15073712|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15073713|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073714|NCT02216617|Docetaxel|docetaxel|mesh-list
15073715|NCT02216617|Afatinib|afatinib|mesh-list
15073716|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073717|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
15073718|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
15073719|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
15073720|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073721|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15073722|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073723|NCT02216656|Cinacalcet|cinacalcet|mesh-list
15073724|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15073725|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073726|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
15073727|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
15073728|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15073729|NCT02216669|Imidazole|imidazole|mesh-list
15073730|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073731|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073732|NCT02216747|Prednisone|prednisone|mesh-list
15073733|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15073734|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
15073735|NCT02216747|Hormones|hormones|mesh-ancestor
15073736|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15073737|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073738|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15073739|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073740|NCT02216786|Everolimus|everolimus|mesh-list
15073741|NCT02216786|Fulvestrant|fulvestrant|mesh-list
15073742|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073743|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15073744|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
15073745|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073746|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15073747|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15073748|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15073749|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
15073750|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15073751|NCT02216799|Insulin|insulin|mesh-list
15073752|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15073753|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
15073754|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15073755|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073756|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
15073757|NCT02216877|Antacids|antacids|mesh-ancestor
15073758|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073759|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15073760|NCT02216994|Mineral Oil|mineral oil|mesh-list
15073761|NCT02216994|Lactulose|lactulose|mesh-list
15073762|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15073763|NCT02216994|Emollients|emollients|mesh-ancestor
15073764|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
15073765|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
15073766|NCT02217007|Acamprosate|acamprosate|mesh-list
15073767|NCT02217007|Calcium|calcium|mesh-list
15073768|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15073769|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073770|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15073771|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
15073772|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
15073773|NCT02217020|Irinotecan|irinotecan|mesh-list
15073774|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073775|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15073776|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15073777|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073778|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073779|NCT02217163|Dexamethasone|dexamethasone|mesh-list
15073780|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
15073781|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15073782|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
15073783|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073784|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15073785|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15073786|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
15073787|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073788|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073789|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15073790|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15073791|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
15073792|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
15073793|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073794|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15073795|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
15073796|NCT02217163|Hormones|hormones|mesh-ancestor
15073797|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15073798|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15073799|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
15073800|NCT02217189|Astringents|astringents|mesh-ancestor
15073801|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073802|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
15073803|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15073804|NCT02217202|Laxatives|laxatives|mesh-ancestor
15073805|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15073806|NCT02217267|Lidocaine|lidocaine|mesh-list
15073807|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
15073808|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
15073809|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15073810|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073811|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
15073812|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073813|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15073814|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15073815|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15073816|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15073817|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073818|NCT02217319|Sevoflurane|sevoflurane|mesh-list
15073819|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15073820|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15073821|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
15073822|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
15073823|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15073824|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073825|NCT02217514|Midazolam|midazolam|mesh-list
15073826|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15073827|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15073828|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15073829|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073830|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15073831|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15073832|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15073833|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15073834|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
15073835|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
15073836|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
15073837|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
15073838|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15073839|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073840|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
15073841|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15073842|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073843|NCT02217553|Vitamins|vitamins|mesh-ancestor
15073844|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
15073845|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15073846|NCT02217631|Prednisolone|prednisolone|mesh-list
15073847|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15073848|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
15073849|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15073850|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
15073851|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15073852|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
15073853|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15073854|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
15073855|NCT02217631|Hormones|hormones|mesh-ancestor
15073856|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15073857|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073858|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15073859|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073860|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
15073861|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
15073862|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073863|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15073864|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15073865|NCT02217631|Protective Agents|protective agents|mesh-ancestor
15073866|NCT02217670|Metformin|metformin|mesh-list
15073867|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15073868|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073869|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
15073870|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15073871|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
15073872|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073873|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073874|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15073875|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
15073876|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15073877|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
15073878|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073879|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15073880|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15073881|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
15073882|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
15073883|NCT02217683|Protective Agents|protective agents|mesh-ancestor
15073884|NCT02217709|Phenelzine|phenelzine|mesh-list
15073885|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
15073886|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15073887|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15073888|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073889|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073890|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15073891|NCT02217722|Amoxicillin|amoxicillin|mesh-list
15073892|NCT02217722|Metronidazole|metronidazole|mesh-list
15073893|NCT02217722|Doxycycline|doxycycline|mesh-list
15073894|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073895|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15073896|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15073897|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
15073898|NCT02217787|PF-06372865|pf-06372865|mesh-list
15073899|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
15073900|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
15073901|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15073902|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073903|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073904|NCT02217826|Octreotide|octreotide|mesh-list
15073905|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15073906|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15073907|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073908|NCT02217839|Octreotide|octreotide|mesh-list
15073909|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15073910|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15073911|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073912|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15073913|NCT02217852|Captopril|captopril|mesh-list
15073914|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
15073915|NCT02217852|Nitrendipine|nitrendipine|mesh-list
15073916|NCT02217852|Diuretics|diuretics|mesh-ancestor
15073917|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
15073918|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073919|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15073920|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15073921|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073922|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15073923|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
15073924|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073925|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15073926|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15073927|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
15073928|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
15073929|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15073930|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073931|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15073932|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15073933|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15073934|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073935|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073936|NCT02217956|Bevacizumab|bevacizumab|mesh-list
15073937|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15073938|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073939|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15073940|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15073941|NCT02217956|Growth Substances|growth substances|mesh-ancestor
15073942|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073943|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
15073944|NCT02218021|Oxycodone|oxycodone|mesh-list
15073945|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15073946|NCT02218021|Narcotics|narcotics|mesh-ancestor
15073947|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15073948|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073949|NCT02218021|Analgesics|analgesics|mesh-ancestor
15073950|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
15073951|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073952|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
15073953|NCT02218034|Tazarotene|tazarotene|mesh-list
15073954|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
15073955|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
15073956|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
15073957|NCT02218034|Vitamins|vitamins|mesh-ancestor
15073958|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
15073959|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073960|NCT02218047|Interferons|interferons|mesh-list
15073961|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
15073962|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
15073963|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073964|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
15073965|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073966|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
15073967|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073968|NCT02218177|Ranibizumab|ranibizumab|mesh-list
15073969|NCT02218177|Aflibercept|aflibercept|mesh-list
15073970|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15073971|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15073972|NCT02218177|Growth Substances|growth substances|mesh-ancestor
15073973|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073974|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
15073975|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15073976|NCT02218359|Amikacin|amikacin|mesh-list
15073977|NCT02218359|Fosfomycin|fosfomycin|mesh-list
15073978|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15073979|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15073980|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15073981|NCT02218398|Albuterol|albuterol|mesh-list
15073982|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15073983|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
15073984|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15073985|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15073986|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15073987|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
15073988|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
15073989|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15073990|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15073991|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15073992|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15073993|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
15073994|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15073995|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15073996|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
15073997|NCT02218476|Vitamins|vitamins|mesh-ancestor
15073998|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
15073999|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074000|NCT02218606|Prednisone|prednisone|mesh-list
15074001|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
15074002|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15074003|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
15074004|NCT02218606|Hormones|hormones|mesh-ancestor
15074005|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074006|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074007|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15074008|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074009|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15074010|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074011|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074012|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
15074013|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15074014|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
15074015|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
15074016|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15074017|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
15074018|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15074019|NCT02218645|Brotizolam|brotizolam|mesh-list
15074020|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15074021|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074022|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074023|NCT02218658|Brotizolam|brotizolam|mesh-list
15074024|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15074025|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074026|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074027|NCT02218671|Brotizolam|brotizolam|mesh-list
15074028|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15074029|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074030|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074031|NCT02218684|Telmisartan|telmisartan|mesh-list
15074032|NCT02218684|Lacidipine|lacidipine|mesh-list
15074033|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15074034|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15074035|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15074036|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074037|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15074038|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15074039|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15074040|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074041|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15074042|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
15074043|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074044|NCT02218762|Fluticasone|fluticasone|mesh-list
15074045|NCT02218762|Xhance|xhance|mesh-list
15074046|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15074047|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
15074048|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15074049|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15074050|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
15074051|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074052|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074053|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15074054|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
15074055|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
15074056|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15074057|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15074058|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15074059|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15074060|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
15074061|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074062|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074063|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
15074064|NCT02218762|Hormones|hormones|mesh-ancestor
15074065|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074066|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
15074067|NCT02218775|Aticaprant|aticaprant|mesh-list
15074068|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15074069|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074070|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
15074071|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074072|NCT02218814|Bupivacaine|bupivacaine|mesh-list
15074073|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
15074074|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
15074075|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074076|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074077|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
15074078|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074079|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
15074080|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15074081|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
15074082|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
15074083|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15074084|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
15074085|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074086|NCT02219100|Mifepristone|mifepristone|mesh-list
15074087|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
15074088|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
15074089|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15074090|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074091|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15074092|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15074093|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15074094|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
15074095|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
15074096|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
15074097|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
15074098|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074099|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
15074100|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15074101|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
15074102|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
15074103|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15074104|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15074105|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074106|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
15074107|NCT02219152|Coagulants|coagulants|mesh-ancestor
15074108|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
15074109|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15074110|NCT02219165|Antibodies|antibodies|mesh-list
15074111|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
15074112|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074113|NCT02219178|Dexamethasone|dexamethasone|mesh-list
15074114|NCT02219178|Lenalidomide|lenalidomide|mesh-list
15074115|NCT02219178|Bortezomib|bortezomib|mesh-list
15074116|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15074117|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
15074118|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
15074119|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074120|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074121|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15074122|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
15074123|NCT02219178|Hormones|hormones|mesh-ancestor
15074124|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074125|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15074126|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074127|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
15074128|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15074129|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15074130|NCT02219178|Growth Substances|growth substances|mesh-ancestor
15074131|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
15074132|NCT02219191|Puerarin|puerarin|mesh-list
15074133|NCT02219191|Atorvastatin|atorvastatin|mesh-list
15074134|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15074135|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15074136|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
15074137|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074138|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15074139|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15074140|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074141|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
15074142|NCT02219217|Dolutegravir|dolutegravir|mesh-list
15074143|NCT02219217|Cobicistat|cobicistat|mesh-list
15074144|NCT02219217|Elvitegravir|elvitegravir|mesh-list
15074145|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15074146|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15074147|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074148|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074149|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15074150|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15074151|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
15074152|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15074153|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15074154|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15074155|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
15074156|NCT02219373|Gabapentin|gabapentin|mesh-list
15074157|NCT02219373|Analgesics|analgesics|mesh-ancestor
15074158|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
15074159|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074160|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074161|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
15074162|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15074163|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15074164|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074165|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15074166|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15074167|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15074168|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074169|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074170|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
15074171|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15074172|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15074173|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15074174|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15074175|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15074176|NCT02219412|Aspirin|aspirin|mesh-list
15074177|NCT02219412|Ticagrelor|ticagrelor|mesh-list
15074178|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15074179|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15074180|NCT02219412|Analgesics|analgesics|mesh-ancestor
15074181|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
15074182|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074183|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074184|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15074185|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15074186|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15074187|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15074188|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074189|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15074190|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15074191|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074192|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
15074193|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15074194|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15074195|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15074196|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
15074197|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074198|NCT02219490|Ribavirin|ribavirin|mesh-list
15074199|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
15074200|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074201|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
15074202|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15074203|NCT02219581|Dexamethasone|dexamethasone|mesh-list
15074204|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
15074205|NCT02219581|BB 1101|bb 1101|mesh-list
15074206|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15074207|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
15074208|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
15074209|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074210|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074211|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15074212|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
15074213|NCT02219581|Hormones|hormones|mesh-ancestor
15074214|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074215|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15074216|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074217|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
15074218|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074219|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074220|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
15074221|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
15074222|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15074223|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15074224|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074225|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074226|NCT02219646|Urological Agents|urological agents|mesh-ancestor
15074227|NCT02219659|Fentanyl|fentanyl|mesh-list
15074228|NCT02219659|Midazolam|midazolam|mesh-list
15074229|NCT02219659|Propofol|propofol|mesh-list
15074230|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15074231|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074232|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074233|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15074234|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
15074235|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
15074236|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15074237|NCT02219659|Narcotics|narcotics|mesh-ancestor
15074238|NCT02219659|Analgesics|analgesics|mesh-ancestor
15074239|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
15074240|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074241|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15074242|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15074243|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15074244|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15074245|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
15074246|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
15074247|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074248|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074249|NCT02219672|Ritonavir|ritonavir|mesh-list
15074250|NCT02219672|Lopinavir|lopinavir|mesh-list
15074251|NCT02219672|Tenofovir|tenofovir|mesh-list
15074252|NCT02219672|Lamivudine|lamivudine|mesh-list
15074253|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
15074254|NCT02219672|Triptolide|triptolide|mesh-list
15074255|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15074256|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15074257|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
15074258|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074259|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074260|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15074261|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15074262|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
15074263|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15074264|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15074265|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15074266|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15074267|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15074268|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15074269|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15074270|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
15074271|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074272|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15074273|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
15074274|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15074275|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15074276|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
15074277|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15074278|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
15074279|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074280|NCT02219698|Acetaminophen|acetaminophen|mesh-list
15074281|NCT02219698|Ibuprofen|ibuprofen|mesh-list
15074282|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15074283|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15074284|NCT02219698|Analgesics|analgesics|mesh-ancestor
15074285|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
15074286|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074287|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074288|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15074289|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15074290|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15074291|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074292|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074293|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
15074294|NCT02219737|Rituximab|rituximab|mesh-list
15074295|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15074296|NCT02219737|Carboplatin|carboplatin|mesh-list
15074297|NCT02219737|Etoposide|etoposide|mesh-list
15074298|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
15074299|NCT02219737|Ifosfamide|ifosfamide|mesh-list
15074300|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
15074301|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
15074302|NCT02219737|Antibodies|antibodies|mesh-list
15074303|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
15074304|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15074305|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
15074306|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074307|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074308|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15074309|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15074310|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15074311|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15074312|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074313|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074314|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15074315|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
15074316|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
15074317|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
15074318|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
15074319|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
15074320|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
15074321|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
15074322|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15074323|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074324|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
15074325|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
15074326|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
15074327|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15074328|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15074329|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
15074330|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
15074331|NCT02219789|Fulvestrant|fulvestrant|mesh-list
15074332|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15074333|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074334|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15074335|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15074336|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
15074337|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074338|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074339|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15074340|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15074341|NCT02219867|Ketamine|ketamine|mesh-list
15074342|NCT02219867|Analgesics|analgesics|mesh-ancestor
15074343|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
15074344|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074345|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074346|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15074347|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15074348|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
15074349|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
15074350|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074351|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15074352|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15074353|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074354|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074355|NCT02219893|Immunotoxins|immunotoxins|mesh-list
15074356|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
15074357|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074358|NCT02219906|Resveratrol|resveratrol|mesh-list
15074359|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
15074360|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074361|NCT02219906|Protective Agents|protective agents|mesh-ancestor
15074362|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074363|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074364|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15074365|NCT02219984|Anticoagulants|anticoagulants|mesh-list
15074366|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
15074367|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15074368|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
15074369|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074370|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074371|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15074372|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
15074373|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15074374|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
15074375|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074376|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074377|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
15074378|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
15074379|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
15074380|NCT02220023|Protective Agents|protective agents|mesh-ancestor
15074381|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
15074382|NCT02220036|Antacids|antacids|mesh-ancestor
15074383|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074384|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15074385|NCT02220049|Bortezomib|bortezomib|mesh-list
15074386|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074387|NCT02220088|Leucovorin|leucovorin|mesh-list
15074388|NCT02220088|Fluorouracil|fluorouracil|mesh-list
15074389|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
15074390|NCT02220088|Sorafenib|sorafenib|mesh-list
15074391|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
15074392|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074393|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15074394|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074395|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15074396|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
15074397|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074398|NCT02220088|Antidotes|antidotes|mesh-ancestor
15074399|NCT02220088|Protective Agents|protective agents|mesh-ancestor
15074400|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
15074401|NCT02220088|Vitamins|vitamins|mesh-ancestor
15074402|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
15074403|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15074404|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074405|NCT02220114|Vigabatrin|vigabatrin|mesh-list
15074406|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
15074407|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074408|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074409|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
15074410|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074411|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074412|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
15074413|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15074414|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
15074415|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074416|NCT02220218|Metformin|metformin|mesh-list
15074417|NCT02220218|Canagliflozin|canagliflozin|mesh-list
15074418|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15074419|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074420|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15074421|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074422|NCT02220296|Insulin|insulin|mesh-list
15074423|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15074424|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
15074425|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15074426|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074427|NCT02220335|Digoxin|digoxin|mesh-list
15074428|NCT02220335|Diuretics|diuretics|mesh-list
15074429|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15074430|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
15074431|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15074432|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15074433|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074434|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074435|NCT02220335|Protective Agents|protective agents|mesh-ancestor
15074436|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074437|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
15074438|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
15074439|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
15074440|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074441|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
15074442|NCT02220348|Linaclotide|linaclotide|mesh-list
15074443|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
15074444|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
15074445|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074446|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15074447|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
15074448|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15074449|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074450|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074451|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15074452|NCT02220361|Analgesics|analgesics|mesh-ancestor
15074453|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
15074454|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074455|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15074456|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15074457|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15074458|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
15074459|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074460|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074461|NCT02220400|Ketamine|ketamine|mesh-list
15074462|NCT02220400|Analgesics|analgesics|mesh-ancestor
15074463|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
15074464|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074465|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074466|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15074467|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15074468|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
15074469|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
15074470|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074471|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15074472|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15074473|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074474|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074475|NCT02220426|Xenon|xenon|mesh-list
15074476|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15074477|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
15074478|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
15074479|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074480|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074481|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
15074482|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15074483|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074484|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074485|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15074486|NCT02220530|Fentanyl|fentanyl|mesh-list
15074487|NCT02220530|Midazolam|midazolam|mesh-list
15074488|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15074489|NCT02220530|Narcotics|narcotics|mesh-ancestor
15074490|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074491|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074492|NCT02220530|Analgesics|analgesics|mesh-ancestor
15074493|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
15074494|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074495|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15074496|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15074497|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
15074498|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
15074499|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15074500|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15074501|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15074502|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15074503|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
15074504|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
15074505|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074506|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074507|NCT02220608|Bortezomib|bortezomib|mesh-list
15074508|NCT02220608|Lenograstim|lenograstim|mesh-list
15074509|NCT02220608|Sargramostim|sargramostim|mesh-list
15074510|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15074511|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
15074512|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074513|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074514|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
15074515|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15074516|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
15074517|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074518|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
15074519|NCT02220621|Protective Agents|protective agents|mesh-ancestor
15074520|NCT02220634|Regadenoson|regadenoson|mesh-list
15074521|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
15074522|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15074523|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
15074524|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
15074525|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074526|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074527|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074528|NCT02220647|Metformin|metformin|mesh-list
15074529|NCT02220647|Linagliptin|linagliptin|mesh-list
15074530|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15074531|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074532|NCT02220647|Incretins|incretins|mesh-ancestor
15074533|NCT02220647|Hormones|hormones|mesh-ancestor
15074534|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074535|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15074536|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
15074537|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074538|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074539|NCT02220660|Olodaterol|olodaterol|mesh-list
15074540|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15074541|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
15074542|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074543|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074544|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15074545|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
15074546|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
15074547|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
15074548|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074549|NCT02220673|Protective Agents|protective agents|mesh-ancestor
15074550|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074551|NCT02220751|Doxycycline|doxycycline|mesh-list
15074552|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15074553|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15074554|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
15074555|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15074556|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15074557|NCT02220777|Omeprazole|omeprazole|mesh-list
15074558|NCT02220777|ASP8477|asp8477|mesh-list
15074559|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15074560|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15074561|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15074562|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074563|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074564|NCT02220803|Acetazolamide|acetazolamide|mesh-list
15074565|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
15074566|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15074567|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074568|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074569|NCT02220803|Diuretics|diuretics|mesh-ancestor
15074570|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
15074571|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074572|NCT02220829|Silodosin|silodosin|mesh-list
15074573|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15074574|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15074575|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15074576|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
15074577|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074578|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074579|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074580|NCT02220829|Urological Agents|urological agents|mesh-ancestor
15074581|NCT02220842|Atezolizumab|atezolizumab|mesh-list
15074582|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
15074583|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074584|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15074585|NCT02220868|Ribavirin|ribavirin|mesh-list
15074586|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
15074587|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15074588|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
15074589|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074590|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
15074591|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15074592|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15074593|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15074594|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15074595|NCT02221063|Thiamine|thiamine|mesh-list
15074596|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
15074597|NCT02221063|Vitamins|vitamins|mesh-ancestor
15074598|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
15074599|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074600|NCT02221102|Aspirin|aspirin|mesh-list
15074601|NCT02221102|Edoxaban|edoxaban|mesh-list
15074602|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15074603|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15074604|NCT02221102|Analgesics|analgesics|mesh-ancestor
15074605|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
15074606|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074607|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074608|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15074609|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15074610|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15074611|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15074612|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074613|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15074614|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15074615|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074616|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
15074617|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15074618|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
15074619|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15074620|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
15074621|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
15074622|NCT02221154|Folic Acid|folic acid|mesh-list
15074623|NCT02221154|Hematinics|hematinics|mesh-ancestor
15074624|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
15074625|NCT02221154|Vitamins|vitamins|mesh-ancestor
15074626|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
15074627|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074628|NCT02221180|Metformin|metformin|mesh-list
15074629|NCT02221180|Canagliflozin|canagliflozin|mesh-list
15074630|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15074631|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074632|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15074633|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074634|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
15074635|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15074636|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074637|NCT02221375|Ciclesonide|ciclesonide|mesh-list
15074638|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
15074639|NCT02221375|Hormones|hormones|mesh-ancestor
15074640|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074641|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074642|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15074643|NCT02221401|Metformin|metformin|mesh-list
15074644|NCT02221401|Linagliptin|linagliptin|mesh-list
15074645|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15074646|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074647|NCT02221401|Incretins|incretins|mesh-ancestor
15074648|NCT02221401|Hormones|hormones|mesh-ancestor
15074649|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074650|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15074651|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
15074652|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074653|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074654|NCT02221414|Metformin|metformin|mesh-list
15074655|NCT02221414|Linagliptin|linagliptin|mesh-list
15074656|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15074657|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074658|NCT02221414|Incretins|incretins|mesh-ancestor
15074659|NCT02221414|Hormones|hormones|mesh-ancestor
15074660|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074661|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15074662|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
15074663|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074664|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074665|NCT02221453|Triamcinolone|triamcinolone|mesh-list
15074666|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
15074667|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
15074668|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
15074669|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15074670|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
15074671|NCT02221453|Hormones|hormones|mesh-ancestor
15074672|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074673|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074674|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15074675|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
15074676|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074677|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074678|NCT02221479|Plerixafor|plerixafor|mesh-list
15074679|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15074680|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15074681|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
15074682|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15074683|NCT02221492|Plerixafor|plerixafor|mesh-list
15074684|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15074685|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15074686|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
15074687|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15074688|NCT02221531|Carbetocin|carbetocin|mesh-list
15074689|NCT02221531|Oxytocin|oxytocin|mesh-list
15074690|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
15074691|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15074692|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074693|NCT02221570|Baclofen|baclofen|mesh-list
15074694|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15074695|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074696|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15074697|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074698|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
15074699|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
15074700|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
15074701|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074702|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074703|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
15074704|NCT02221583|Tacrolimus|tacrolimus|mesh-list
15074705|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15074706|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
15074707|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074708|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15074709|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074710|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074711|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15074712|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074713|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15074714|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
15074715|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15074716|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15074717|NCT02221596|Vitamin D|vitamin d|mesh-list
15074718|NCT02221596|Vitamins|vitamins|mesh-ancestor
15074719|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
15074720|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074721|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15074722|NCT02221622|Pregnanolone|pregnanolone|mesh-list
15074723|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15074724|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
15074725|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074726|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074727|NCT02221635|Risperidone|risperidone|mesh-list
15074728|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15074729|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
15074730|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074731|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074732|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074733|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15074734|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15074735|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074736|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15074737|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15074738|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
15074739|NCT02221752|Folic Acid|folic acid|mesh-list
15074740|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
15074741|NCT02221752|Hematinics|hematinics|mesh-ancestor
15074742|NCT02221752|Vitamins|vitamins|mesh-ancestor
15074743|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
15074744|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074745|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
15074746|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15074747|NCT02221765|Hormones|hormones|mesh-ancestor
15074748|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074749|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074750|NCT02221830|Oxytocin|oxytocin|mesh-list
15074751|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
15074752|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15074753|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074754|NCT02221960|Durvalumab|durvalumab|mesh-list
15074755|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15074756|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074757|NCT02221999|Paclitaxel|paclitaxel|mesh-list
15074758|NCT02221999|Letrozole|letrozole|mesh-list
15074759|NCT02221999|Hormones|hormones|mesh-list
15074760|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15074761|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074762|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
15074763|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
15074764|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
15074765|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074766|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074767|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074768|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15074769|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15074770|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074771|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15074772|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
15074773|NCT02222142|Anesthetics|anesthetics|mesh-list
15074774|NCT02222142|Isoflurane|isoflurane|mesh-list
15074775|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074776|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074777|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15074778|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
15074779|NCT02222168|BI 409306|bi 409306|mesh-list
15074780|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15074781|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074782|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074783|NCT02222220|Metoclopramide|metoclopramide|mesh-list
15074784|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
15074785|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
15074786|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074787|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074788|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15074789|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
15074790|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15074791|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
15074792|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074793|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074794|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
15074795|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15074796|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15074797|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15074798|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15074799|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074800|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074801|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074802|NCT02222350|Firuglipel|firuglipel|mesh-list
15074803|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15074804|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074805|NCT02222376|Pirfenidone|pirfenidone|mesh-list
15074806|NCT02222376|Analgesics|analgesics|mesh-ancestor
15074807|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
15074808|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074809|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074810|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15074811|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15074812|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15074813|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15074814|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074815|NCT02222428|Olodaterol|olodaterol|mesh-list
15074816|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15074817|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
15074818|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074819|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074820|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15074821|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
15074822|NCT02222441|Pioglitazone|pioglitazone|mesh-list
15074823|NCT02222441|Palbociclib|palbociclib|mesh-list
15074824|NCT02222441|Modafinil|modafinil|mesh-list
15074825|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15074826|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074827|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074828|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15074829|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074830|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074831|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15074832|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
15074833|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15074834|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15074835|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15074836|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15074837|NCT02222480|Diuretics|diuretics|mesh-ancestor
15074838|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
15074839|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074840|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15074841|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15074842|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074843|NCT02222519|Bromides|bromides|mesh-list
15074844|NCT02222519|Rocuronium|rocuronium|mesh-list
15074845|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
15074846|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15074847|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15074848|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15074849|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074850|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074851|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
15074852|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15074853|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074854|NCT02222636|Fentanyl|fentanyl|mesh-list
15074855|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
15074856|NCT02222636|Anesthetics|anesthetics|mesh-list
15074857|NCT02222636|Sevoflurane|sevoflurane|mesh-list
15074858|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074859|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074860|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15074861|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15074862|NCT02222636|Analgesics|analgesics|mesh-ancestor
15074863|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
15074864|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074865|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15074866|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15074867|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15074868|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
15074869|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074870|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074871|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15074872|NCT02222636|Narcotics|narcotics|mesh-ancestor
15074873|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15074874|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15074875|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
15074876|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15074877|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15074878|NCT02222649|Vitamin D|vitamin d|mesh-list
15074879|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
15074880|NCT02222649|Vitamins|vitamins|mesh-ancestor
15074881|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
15074882|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074883|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15074884|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15074885|NCT02222727|Donepezil|donepezil|mesh-list
15074886|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15074887|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074888|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074889|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
15074890|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074891|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074892|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
15074893|NCT02222740|Hydrocodone|hydrocodone|mesh-list
15074894|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15074895|NCT02222740|Narcotics|narcotics|mesh-ancestor
15074896|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074897|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074898|NCT02222740|Analgesics|analgesics|mesh-ancestor
15074899|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
15074900|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074901|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
15074902|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
15074903|NCT02222987|Clopidogrel|clopidogrel|mesh-list
15074904|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15074905|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15074906|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15074907|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15074908|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
15074909|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15074910|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074911|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074912|NCT02223026|Metformin|metformin|mesh-list
15074913|NCT02223026|Linagliptin|linagliptin|mesh-list
15074914|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15074915|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074916|NCT02223026|Incretins|incretins|mesh-ancestor
15074917|NCT02223026|Hormones|hormones|mesh-ancestor
15074918|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074919|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15074920|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
15074921|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074922|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074923|NCT02223052|Azacitidine|azacitidine|mesh-list
15074924|NCT02223052|Cc-486|cc-486|mesh-list
15074925|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15074926|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
15074927|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074928|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074929|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074930|NCT02223299|Tryptophan|tryptophan|mesh-list
15074931|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15074932|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
15074933|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15074934|NCT02223377|Morphine|morphine|mesh-list
15074935|NCT02223377|Hydromorphone|hydromorphone|mesh-list
15074936|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15074937|NCT02223377|Narcotics|narcotics|mesh-ancestor
15074938|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074939|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074940|NCT02223377|Analgesics|analgesics|mesh-ancestor
15074941|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
15074942|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074943|NCT02223416|Teriparatide|teriparatide|mesh-list
15074944|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15074945|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074946|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15074947|NCT02223533|Morphine|morphine|mesh-list
15074948|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15074949|NCT02223533|Narcotics|narcotics|mesh-ancestor
15074950|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15074951|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074952|NCT02223533|Analgesics|analgesics|mesh-ancestor
15074953|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
15074954|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074955|NCT02223598|Dexamethasone|dexamethasone|mesh-list
15074956|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15074957|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
15074958|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
15074959|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15074960|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074961|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15074962|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
15074963|NCT02223598|Hormones|hormones|mesh-ancestor
15074964|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15074965|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15074966|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074967|NCT02223611|Cisplatin|cisplatin|mesh-list
15074968|NCT02223611|Vinorelbine|vinorelbine|mesh-list
15074969|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074970|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15074971|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
15074972|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
15074973|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
15074974|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074975|NCT02223819|Crizotinib|crizotinib|mesh-list
15074976|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074977|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15074978|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15074979|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074980|NCT02223832|Ponesimod|ponesimod|mesh-list
15074981|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15074982|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074983|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15074984|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
15074985|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15074986|NCT02223884|Carboplatin|carboplatin|mesh-list
15074987|NCT02223884|Docetaxel|docetaxel|mesh-list
15074988|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15074989|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
15074990|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
15074991|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
15074992|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15074993|NCT02223949|Alprostadil|alprostadil|mesh-list
15074994|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15074995|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
15074996|NCT02223949|Urological Agents|urological agents|mesh-ancestor
15074997|NCT02224014|Brotizolam|brotizolam|mesh-list
15074998|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15074999|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15075000|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075001|NCT02224040|Azithromycin|azithromycin|mesh-list
15075002|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
15075003|NCT02224040|Cefixime|cefixime|mesh-list
15075004|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15075005|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15075006|NCT02224066|Aspirin|aspirin|mesh-list
15075007|NCT02224066|Clopidogrel|clopidogrel|mesh-list
15075008|NCT02224066|Ticagrelor|ticagrelor|mesh-list
15075009|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15075010|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15075011|NCT02224066|Analgesics|analgesics|mesh-ancestor
15075012|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
15075013|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075014|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075015|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15075016|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15075017|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15075018|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15075019|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075020|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15075021|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15075022|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075023|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
15075024|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15075025|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15075026|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15075027|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
15075028|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075029|NCT02224105|Prednisolone|prednisolone|mesh-list
15075030|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15075031|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
15075032|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15075033|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
15075034|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15075035|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
15075036|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15075037|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
15075038|NCT02224105|Hormones|hormones|mesh-ancestor
15075039|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15075040|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075041|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15075042|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075043|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
15075044|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
15075045|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075046|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15075047|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15075048|NCT02224105|Protective Agents|protective agents|mesh-ancestor
15075049|NCT02224131|Aspirin|aspirin|mesh-list
15075050|NCT02224131|Clopidogrel|clopidogrel|mesh-list
15075051|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15075052|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15075053|NCT02224131|Analgesics|analgesics|mesh-ancestor
15075054|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
15075055|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075056|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075057|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15075058|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15075059|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15075060|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15075061|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075062|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15075063|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15075064|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075065|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
15075066|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15075067|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15075068|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15075069|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
15075070|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075071|NCT02224170|Dexamethasone|dexamethasone|mesh-list
15075072|NCT02224170|Lidocaine|lidocaine|mesh-list
15075073|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15075074|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
15075075|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
15075076|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075077|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075078|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15075079|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
15075080|NCT02224170|Hormones|hormones|mesh-ancestor
15075081|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15075082|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15075083|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075084|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
15075085|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
15075086|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15075087|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
15075088|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15075089|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15075090|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15075091|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15075092|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075093|NCT02224391|Nicotine|nicotine|mesh-list
15075094|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15075095|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
15075096|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075097|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075098|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15075099|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15075100|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
15075101|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075102|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075103|NCT02224443|Fentanyl|fentanyl|mesh-list
15075104|NCT02224443|Midazolam|midazolam|mesh-list
15075105|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
15075106|NCT02224443|Remifentanil|remifentanil|mesh-list
15075107|NCT02224443|Propofol|propofol|mesh-list
15075108|NCT02224443|Etomidate|etomidate|mesh-list
15075109|NCT02224443|Sevoflurane|sevoflurane|mesh-list
15075110|NCT02224443|Atracurium|atracurium|mesh-list
15075111|NCT02224443|Cisatracurium|cisatracurium|mesh-list
15075112|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15075113|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15075114|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075115|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15075116|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
15075117|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
15075118|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15075119|NCT02224443|Analgesics|analgesics|mesh-ancestor
15075120|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
15075121|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075122|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15075123|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15075124|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15075125|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
15075126|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075127|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075128|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15075129|NCT02224443|Narcotics|narcotics|mesh-ancestor
15075130|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15075131|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15075132|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15075133|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15075134|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
15075135|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
15075136|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15075137|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15075138|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15075139|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15075140|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15075141|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15075142|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15075143|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
15075144|NCT02224456|Tenofovir|tenofovir|mesh-list
15075145|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
15075146|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15075147|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15075148|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15075149|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075150|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075151|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15075152|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15075153|NCT02224534|Clopidogrel|clopidogrel|mesh-list
15075154|NCT02224534|Ticagrelor|ticagrelor|mesh-list
15075155|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15075156|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15075157|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15075158|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15075159|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
15075160|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075161|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075162|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075163|NCT02224768|Ipilimumab|ipilimumab|mesh-list
15075164|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15075165|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075166|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15075167|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075168|NCT02224937|Melatonin|melatonin|mesh-list
15075169|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
15075170|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075171|NCT02224937|Protective Agents|protective agents|mesh-ancestor
15075172|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075173|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15075174|NCT02224950|Emollients|emollients|mesh-list
15075175|NCT02224950|Chitosan|chitosan|mesh-list
15075176|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15075177|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15075178|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
15075179|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075180|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15075181|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
15075182|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
15075183|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
15075184|NCT02224950|Coagulants|coagulants|mesh-ancestor
15075185|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
15075186|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
15075187|NCT02225054|Ropivacaine|ropivacaine|mesh-list
15075188|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15075189|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15075190|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075191|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15075192|NCT02225054|Analgesics|analgesics|mesh-ancestor
15075193|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
15075194|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075195|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15075196|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15075197|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15075198|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
15075199|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075200|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075201|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
15075202|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
15075203|NCT02225067|Calcium|calcium|mesh-list
15075204|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15075205|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075206|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
15075207|NCT02225093|Caffeine|caffeine|mesh-list
15075208|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15075209|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075210|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15075211|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075212|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075213|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15075214|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15075215|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
15075216|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075217|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
15075218|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
15075219|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15075220|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15075221|NCT02225210|Fentanyl|fentanyl|mesh-list
15075222|NCT02225210|Midazolam|midazolam|mesh-list
15075223|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
15075224|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15075225|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15075226|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075227|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15075228|NCT02225210|Analgesics|analgesics|mesh-ancestor
15075229|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
15075230|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075231|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15075232|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15075233|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15075234|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
15075235|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075236|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075237|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15075238|NCT02225210|Narcotics|narcotics|mesh-ancestor
15075239|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15075240|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15075241|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
15075242|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
15075243|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15075244|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15075245|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15075246|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
15075247|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
15075248|NCT02225275|Lenalidomide|lenalidomide|mesh-list
15075249|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
15075250|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
15075251|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075252|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15075253|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15075254|NCT02225275|Growth Substances|growth substances|mesh-ancestor
15075255|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
15075256|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075257|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15075258|NCT02225418|Ropivacaine|ropivacaine|mesh-list
15075259|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
15075260|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
15075261|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15075262|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075263|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
15075264|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075265|NCT02225470|Vinorelbine|vinorelbine|mesh-list
15075266|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15075267|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075268|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
15075269|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
15075270|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
15075271|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075272|NCT02225548|Tadalafil|tadalafil|mesh-list
15075273|NCT02225548|Selegiline|selegiline|mesh-list
15075274|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
15075275|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15075276|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15075277|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075278|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075279|NCT02225548|Urological Agents|urological agents|mesh-ancestor
15075280|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
15075281|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15075282|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15075283|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15075284|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
15075285|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15075286|NCT02225548|Protective Agents|protective agents|mesh-ancestor
15075287|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075288|NCT02225652|Paclitaxel|paclitaxel|mesh-list
15075289|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
15075290|NCT02225652|Fluorouracil|fluorouracil|mesh-list
15075291|NCT02225652|Epirubicin|epirubicin|mesh-list
15075292|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15075293|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075294|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
15075295|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
15075296|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
15075297|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075298|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15075299|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
15075300|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075301|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15075302|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15075303|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
15075304|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15075305|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
15075306|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15075307|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15075308|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15075309|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15075310|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075311|NCT02225756|Cyclosporine|cyclosporine|mesh-list
15075312|NCT02225756|Cyclosporins|cyclosporins|mesh-list
15075313|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075314|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075315|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15075316|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
15075317|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075318|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
15075319|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15075320|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
15075321|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15075322|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15075323|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15075324|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15075325|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15075326|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075327|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
15075328|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
15075329|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
15075330|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15075331|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
15075332|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075333|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15075334|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15075335|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
15075336|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075337|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075338|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15075339|NCT02225834|Atorvastatin|atorvastatin|mesh-list
15075340|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15075341|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15075342|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
15075343|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075344|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15075345|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15075346|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075347|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
15075348|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
15075349|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075350|NCT02225886|Protective Agents|protective agents|mesh-ancestor
15075351|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075352|NCT02225886|Vitamins|vitamins|mesh-ancestor
15075353|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
15075354|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
15075355|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
15075356|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075357|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15075358|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
15075359|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075360|NCT02226068|Cyclosporine|cyclosporine|mesh-list
15075361|NCT02226068|Cyclosporins|cyclosporins|mesh-list
15075362|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075363|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075364|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15075365|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
15075366|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075367|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
15075368|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15075369|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
15075370|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15075371|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15075372|NCT02226276|Copper|copper|mesh-list
15075373|NCT02226276|Trastuzumab|trastuzumab|mesh-list
15075374|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15075375|NCT02226276|Maytansine|maytansine|mesh-list
15075376|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
15075377|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
15075378|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15075379|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075380|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075381|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15075382|NCT02226276|Trace Elements|trace elements|mesh-ancestor
15075383|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
15075384|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075385|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15075386|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
15075387|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
15075388|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
15075389|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
15075390|NCT02226289|Bevacizumab|bevacizumab|mesh-list
15075391|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15075392|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075393|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15075394|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15075395|NCT02226289|Growth Substances|growth substances|mesh-ancestor
15075396|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075397|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
15075398|NCT02226328|Fentanyl|fentanyl|mesh-list
15075399|NCT02226328|Midazolam|midazolam|mesh-list
15075400|NCT02226328|Propofol|propofol|mesh-list
15075401|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15075402|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15075403|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075404|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15075405|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
15075406|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
15075407|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15075408|NCT02226328|Narcotics|narcotics|mesh-ancestor
15075409|NCT02226328|Analgesics|analgesics|mesh-ancestor
15075410|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
15075411|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075412|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15075413|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15075414|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15075415|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15075416|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
15075417|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
15075418|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075419|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075420|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
15075421|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15075422|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15075423|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075424|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15075425|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
15075426|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15075427|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15075428|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075429|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075430|NCT02226341|Hormones|hormones|mesh-ancestor
15075431|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15075432|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075433|NCT02226367|Prazosin|prazosin|mesh-list
15075434|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15075435|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15075436|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15075437|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15075438|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
15075439|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075440|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075441|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075442|NCT02226484|Quercetin|quercetin|mesh-list
15075443|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
15075444|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075445|NCT02226484|Protective Agents|protective agents|mesh-ancestor
15075446|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075447|NCT02226510|Metformin|metformin|mesh-list
15075448|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15075449|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075450|NCT02226588|Misoprostol|misoprostol|mesh-list
15075451|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15075452|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
15075453|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15075454|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075455|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15075456|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15075457|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
15075458|NCT02226601|Aprepitant|aprepitant|mesh-list
15075459|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
15075460|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
15075461|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075462|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075463|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15075464|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
15075465|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075466|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075467|NCT02226757|Paclitaxel|paclitaxel|mesh-list
15075468|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15075469|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075470|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
15075471|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
15075472|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
15075473|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075474|NCT02226783|Omeprazole|omeprazole|mesh-list
15075475|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15075476|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15075477|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15075478|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075479|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075480|NCT02226913|Lidocaine|lidocaine|mesh-list
15075481|NCT02226913|Epinephrine|epinephrine|mesh-list
15075482|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
15075483|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
15075484|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15075485|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075486|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
15075487|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075488|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15075489|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15075490|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15075491|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15075492|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075493|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15075494|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15075495|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
15075496|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075497|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15075498|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15075499|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
15075500|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15075501|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
15075502|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
15075503|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
15075504|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15075505|NCT02226926|Aspirin|aspirin|mesh-list
15075506|NCT02226926|Dipyridamole|dipyridamole|mesh-list
15075507|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
15075508|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15075509|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15075510|NCT02226926|Analgesics|analgesics|mesh-ancestor
15075511|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
15075512|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075513|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075514|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15075515|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15075516|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15075517|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15075518|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075519|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15075520|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15075521|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075522|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
15075523|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15075524|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
15075525|NCT02226978|Ritonavir|ritonavir|mesh-list
15075526|NCT02226978|Tipranavir|tipranavir|mesh-list
15075527|NCT02226978|Valacyclovir|valacyclovir|mesh-list
15075528|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15075529|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15075530|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
15075531|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075532|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075533|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15075534|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15075535|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
15075536|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15075537|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15075538|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15075539|NCT02226991|Ritonavir|ritonavir|mesh-list
15075540|NCT02226991|Tipranavir|tipranavir|mesh-list
15075541|NCT02226991|Efavirenz|efavirenz|mesh-list
15075542|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15075543|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15075544|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
15075545|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075546|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075547|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15075548|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15075549|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
15075550|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15075551|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15075552|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15075553|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15075554|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15075555|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15075556|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15075557|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15075558|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15075559|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15075560|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15075561|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15075562|NCT02227056|Methylphenidate|methylphenidate|mesh-list
15075563|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15075564|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075565|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15075566|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15075567|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15075568|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075569|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
15075570|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075571|NCT02227082|Olaparib|olaparib|mesh-list
15075572|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15075573|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075574|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075575|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075576|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
15075577|NCT02227173|Digoxin|digoxin|mesh-list
15075578|NCT02227173|Montelukast|montelukast|mesh-list
15075579|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15075580|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
15075581|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
15075582|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
15075583|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15075584|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075585|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
15075586|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15075587|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075588|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15075589|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15075590|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075591|NCT02227173|Protective Agents|protective agents|mesh-ancestor
15075592|NCT02227173|Analgesics|analgesics|mesh-ancestor
15075593|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
15075594|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075595|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15075596|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15075597|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15075598|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15075599|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15075600|NCT02227186|Vaccines|vaccines|mesh-list
15075601|NCT02227186|Immunologic Factors|immunologic factors|mesh-ancestor
15075602|NCT02227186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075603|NCT02227212|Insulin|insulin|mesh-list
15075604|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
15075605|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15075606|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075607|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
15075608|NCT02227264|Cinacalcet|cinacalcet|mesh-list
15075609|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15075610|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075611|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
15075612|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
15075613|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15075614|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
15075615|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
15075616|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
15075617|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15075618|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075619|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15075620|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15075621|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15075622|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15075623|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075624|NCT02227550|Vitamin K|vitamin k|mesh-list
15075625|NCT02227550|Warfarin|warfarin|mesh-list
15075626|NCT02227550|Apixaban|apixaban|mesh-list
15075627|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
15075628|NCT02227550|Fluindione|fluindione|mesh-list
15075629|NCT02227550|Vitamins|vitamins|mesh-ancestor
15075630|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
15075631|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075632|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
15075633|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15075634|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
15075635|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15075636|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
15075637|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075638|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075639|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15075640|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15075641|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
15075642|NCT02227550|Coagulants|coagulants|mesh-ancestor
15075643|NCT02227745|Dorzolamide|dorzolamide|mesh-list
15075644|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
15075645|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15075646|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
15075647|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075648|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
15075649|NCT02227745|Protective Agents|protective agents|mesh-ancestor
15075650|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15075651|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
15075652|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075653|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075654|NCT02227797|Voriconazole|voriconazole|mesh-list
15075655|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
15075656|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15075657|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15075658|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15075659|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075660|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075661|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15075662|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
15075663|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15075664|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075665|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15075666|NCT02227823|Bromides|bromides|mesh-list
15075667|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
15075668|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
15075669|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15075670|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075671|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075672|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
15075673|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075674|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075675|NCT02227901|Temozolomide|temozolomide|mesh-list
15075676|NCT02227901|Tipifarnib|tipifarnib|mesh-list
15075677|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15075678|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
15075679|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075680|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075681|NCT02227914|Sorafenib|sorafenib|mesh-list
15075682|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075683|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15075684|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075685|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075686|NCT02227927|Domperidone|domperidone|mesh-list
15075687|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
15075688|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
15075689|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075690|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075691|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15075692|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15075693|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
15075694|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075695|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075696|NCT02227940|Gemcitabine|gemcitabine|mesh-list
15075697|NCT02227940|Paclitaxel|paclitaxel|mesh-list
15075698|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15075699|NCT02227940|Cisplatin|cisplatin|mesh-list
15075700|NCT02227940|Ceritinib|ceritinib|mesh-list
15075701|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15075702|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075703|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
15075704|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
15075705|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
15075706|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075707|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15075708|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
15075709|NCT02227940|Antiviral Agents|antiviral agents|mesh-ancestor
15075710|NCT02227940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15075711|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075712|NCT02227940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15075713|NCT02227940|Immunologic Factors|immunologic factors|mesh-ancestor
15075714|NCT02227940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075715|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15075716|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
15075717|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
15075718|NCT02227992|Coagulants|coagulants|mesh-ancestor
15075719|NCT02228005|Sertraline|sertraline|mesh-list
15075720|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
15075721|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15075722|NCT02228005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15075723|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15075724|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15075725|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075726|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075727|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
15075728|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075729|NCT02228031|Oxytocin|oxytocin|mesh-list
15075730|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
15075731|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15075732|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075733|NCT02228083|Lidocaine|lidocaine|mesh-list
15075734|NCT02228083|Epinephrine|epinephrine|mesh-list
15075735|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
15075736|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
15075737|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15075738|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075739|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
15075740|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075741|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15075742|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15075743|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15075744|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15075745|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075746|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15075747|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15075748|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
15075749|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075750|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15075751|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15075752|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
15075753|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15075754|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
15075755|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
15075756|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
15075757|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15075758|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
15075759|NCT02228122|Laxatives|laxatives|mesh-ancestor
15075760|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15075761|NCT02228135|Dexamethasone|dexamethasone|mesh-list
15075762|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15075763|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
15075764|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
15075765|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075766|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075767|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15075768|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
15075769|NCT02228135|Hormones|hormones|mesh-ancestor
15075770|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15075771|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15075772|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075773|NCT02228239|Mirtazapine|mirtazapine|mesh-list
15075774|NCT02228239|Esketamine|esketamine|mesh-list
15075775|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
15075776|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15075777|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15075778|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
15075779|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
15075780|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075781|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075782|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075783|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15075784|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15075785|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15075786|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
15075787|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15075788|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15075789|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
15075790|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
15075791|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15075792|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
15075793|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
15075794|NCT02228252|Caseins|caseins|mesh-list
15075795|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
15075796|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
15075797|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075798|NCT02228369|Osimertinib|osimertinib|mesh-list
15075799|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075800|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15075801|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075802|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075803|NCT02228473|Atropine|atropine|mesh-list
15075804|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
15075805|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15075806|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15075807|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15075808|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
15075809|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075810|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075811|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15075812|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
15075813|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
15075814|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
15075815|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15075816|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15075817|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
15075818|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075819|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075820|NCT02228512|Prednisone|prednisone|mesh-list
15075821|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
15075822|NCT02228512|Rituximab|rituximab|mesh-list
15075823|NCT02228512|Doxorubicin|doxorubicin|mesh-list
15075824|NCT02228512|Etoposide|etoposide|mesh-list
15075825|NCT02228512|Vincristine|vincristine|mesh-list
15075826|NCT02228512|Pomalidomide|pomalidomide|mesh-list
15075827|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15075828|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
15075829|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075830|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15075831|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15075832|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
15075833|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075834|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075835|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15075836|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15075837|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15075838|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15075839|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15075840|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075841|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15075842|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
15075843|NCT02228512|Hormones|hormones|mesh-ancestor
15075844|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15075845|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15075846|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15075847|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
15075848|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
15075849|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
15075850|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15075851|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15075852|NCT02228512|Growth Substances|growth substances|mesh-ancestor
15075853|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
15075854|NCT02228616|Lactulose|lactulose|mesh-list
15075855|NCT02228616|Prucalopride|prucalopride|mesh-list
15075856|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15075857|NCT02228616|Laxatives|laxatives|mesh-ancestor
15075858|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
15075859|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
15075860|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
15075861|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075862|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075863|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075864|NCT02228772|Cytarabine|cytarabine|mesh-list
15075865|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
15075866|NCT02228772|Doxorubicin|doxorubicin|mesh-list
15075867|NCT02228772|Methotrexate|methotrexate|mesh-list
15075868|NCT02228772|Vincristine|vincristine|mesh-list
15075869|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
15075870|NCT02228772|Ixazomib|ixazomib|mesh-list
15075871|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15075872|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
15075873|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075874|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15075875|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15075876|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
15075877|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075878|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075879|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15075880|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15075881|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15075882|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15075883|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15075884|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15075885|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
15075886|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15075887|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15075888|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
15075889|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
15075890|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15075891|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15075892|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
15075893|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15075894|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15075895|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
15075896|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
15075897|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
15075898|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
15075899|NCT02228850|Alprostadil|alprostadil|mesh-list
15075900|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15075901|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
15075902|NCT02228850|Urological Agents|urological agents|mesh-ancestor
15075903|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15075904|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15075905|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15075906|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075907|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075908|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15075909|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15075910|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075911|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
15075912|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15075913|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
15075914|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
15075915|NCT02228902|Trace Elements|trace elements|mesh-ancestor
15075916|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
15075917|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075918|NCT02228902|Hematinics|hematinics|mesh-ancestor
15075919|NCT02228928|Capsaicin|capsaicin|mesh-list
15075920|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
15075921|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
15075922|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
15075923|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075924|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075925|NCT02229045|Paclitaxel|paclitaxel|mesh-list
15075926|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15075927|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15075928|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075929|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
15075930|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
15075931|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
15075932|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075933|NCT02229058|Paclitaxel|paclitaxel|mesh-list
15075934|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15075935|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15075936|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075937|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
15075938|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
15075939|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
15075940|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075941|NCT02229123|Levetiracetam|levetiracetam|mesh-list
15075942|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
15075943|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
15075944|NCT02229175|Bevacizumab|bevacizumab|mesh-list
15075945|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15075946|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075947|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15075948|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15075949|NCT02229175|Growth Substances|growth substances|mesh-ancestor
15075950|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075951|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
15075952|NCT02229201|Propofol|propofol|mesh-list
15075953|NCT02229201|Sevoflurane|sevoflurane|mesh-list
15075954|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15075955|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15075956|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075957|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15075958|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
15075959|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
15075960|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15075961|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15075962|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
15075963|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
15075964|NCT02229240|Incretins|incretins|mesh-ancestor
15075965|NCT02229240|Hormones|hormones|mesh-ancestor
15075966|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15075967|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075968|NCT02229266|Cytarabine|cytarabine|mesh-list
15075969|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15075970|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
15075971|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075972|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075973|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
15075974|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15075975|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15075976|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
15075977|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075978|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
15075979|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15075980|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15075981|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075982|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
15075983|NCT02229292|Coagulants|coagulants|mesh-ancestor
15075984|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
15075985|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15075986|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15075987|NCT02229578|Lidocaine|lidocaine|mesh-list
15075988|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
15075989|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
15075990|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15075991|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15075992|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
15075993|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15075994|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15075995|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15075996|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15075997|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15075998|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15075999|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
15076000|NCT02229617|Testosterone|testosterone|mesh-list
15076001|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
15076002|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
15076003|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
15076004|NCT02229617|Androgens|androgens|mesh-ancestor
15076005|NCT02229617|Hormones|hormones|mesh-ancestor
15076006|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15076007|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076008|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15076009|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076010|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
15076011|NCT02229656|Olaparib|olaparib|mesh-list
15076012|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15076013|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076014|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076015|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076016|NCT02229721|Oxytocin|oxytocin|mesh-list
15076017|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
15076018|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15076019|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076020|NCT02229734|Androgens|androgens|mesh-list
15076021|NCT02229734|Hormones|hormones|mesh-ancestor
15076022|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15076023|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076024|NCT02229747|Diclofenac|diclofenac|mesh-list
15076025|NCT02229747|Meloxicam|meloxicam|mesh-list
15076026|NCT02229747|Nimesulide|nimesulide|mesh-list
15076027|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15076028|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15076029|NCT02229747|Analgesics|analgesics|mesh-ancestor
15076030|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
15076031|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076032|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076033|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15076034|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15076035|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15076036|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076037|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076038|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15076039|NCT02229760|Ritonavir|ritonavir|mesh-list
15076040|NCT02229760|Tipranavir|tipranavir|mesh-list
15076041|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15076042|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15076043|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
15076044|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076045|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076046|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15076047|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15076048|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
15076049|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15076050|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15076051|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15076052|NCT02229773|Pravastatin|pravastatin|mesh-list
15076053|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15076054|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15076055|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
15076056|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076057|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15076058|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15076059|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076060|NCT02229786|Acetaminophen|acetaminophen|mesh-list
15076061|NCT02229786|Scopolamine|scopolamine|mesh-list
15076062|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15076063|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15076064|NCT02229786|Analgesics|analgesics|mesh-ancestor
15076065|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
15076066|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076067|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076068|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
15076069|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
15076070|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
15076071|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15076072|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15076073|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
15076074|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076075|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076076|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15076077|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
15076078|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15076079|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
15076080|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15076081|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15076082|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15076083|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076084|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15076085|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15076086|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15076087|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076088|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15076089|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15076090|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15076091|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15076092|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076093|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076094|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076095|NCT02229825|Analgesics|analgesics|mesh-ancestor
15076096|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
15076097|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076098|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
15076099|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15076100|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
15076101|NCT02229877|Omeprazole|omeprazole|mesh-list
15076102|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15076103|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15076104|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15076105|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076106|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076107|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15076108|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15076109|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15076110|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076111|NCT02229942|Rituximab|rituximab|mesh-list
15076112|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15076113|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076114|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
15076115|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076116|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15076117|NCT02229955|Cyclosporine|cyclosporine|mesh-list
15076118|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15076119|NCT02229955|Cyclosporins|cyclosporins|mesh-list
15076120|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076121|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076122|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15076123|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
15076124|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076125|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
15076126|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15076127|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
15076128|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15076129|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15076130|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15076131|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
15076132|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15076133|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15076134|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076135|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
15076136|NCT02229968|Coagulants|coagulants|mesh-ancestor
15076137|NCT02230033|Itraconazole|itraconazole|mesh-list
15076138|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
15076139|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
15076140|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15076141|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15076142|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15076143|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076144|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076145|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15076146|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
15076147|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15076148|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076149|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15076150|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15076151|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
15076152|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15076153|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
15076154|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
15076155|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076156|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15076157|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076158|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076159|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
15076160|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15076161|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076162|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15076163|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
15076164|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15076165|NCT02230163|Antibodies|antibodies|mesh-list
15076166|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
15076167|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076168|NCT02230176|Sunitinib|sunitinib|mesh-list
15076169|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
15076170|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076171|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15076172|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15076173|NCT02230176|Growth Substances|growth substances|mesh-ancestor
15076174|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076175|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
15076176|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15076177|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076178|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076179|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15076180|NCT02230228|Vitamin A|vitamin a|mesh-list
15076181|NCT02230228|Retinol acetate|retinol acetate|mesh-list
15076182|NCT02230228|Vitamins|vitamins|mesh-ancestor
15076183|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
15076184|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076185|NCT02230228|Protective Agents|protective agents|mesh-ancestor
15076186|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15076187|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076188|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15076189|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
15076190|NCT02230319|Paclitaxel|paclitaxel|mesh-list
15076191|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15076192|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076193|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
15076194|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
15076195|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
15076196|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076197|NCT02230358|Anesthetics|anesthetics|mesh-list
15076198|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15076199|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076200|NCT02230371|Granisetron|granisetron|mesh-list
15076201|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
15076202|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
15076203|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076204|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076205|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15076206|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15076207|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
15076208|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076209|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076210|NCT02230553|Lapatinib|lapatinib|mesh-list
15076211|NCT02230553|Trametinib|trametinib|mesh-list
15076212|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076213|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15076214|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076215|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076216|NCT02230618|Insulin|insulin|mesh-list
15076217|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
15076218|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15076219|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076220|NCT02230735|Epinephrine|epinephrine|mesh-list
15076221|NCT02230735|Racepinephrine|racepinephrine|mesh-list
15076222|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
15076223|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15076224|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15076225|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
15076226|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076227|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076228|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076229|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15076230|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15076231|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
15076232|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076233|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15076234|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
15076235|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
15076236|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
15076237|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15076238|NCT02230800|Tocovid|tocovid|mesh-list
15076239|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
15076240|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15076241|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076242|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076243|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15076244|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15076245|NCT02230800|Protective Agents|protective agents|mesh-ancestor
15076246|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076247|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
15076248|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15076249|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
15076250|NCT02230800|Vitamins|vitamins|mesh-ancestor
15076251|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
15076252|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
15076253|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15076254|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15076255|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15076256|NCT02230930|Apomorphine|apomorphine|mesh-list
15076257|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15076258|NCT02230930|Emetics|emetics|mesh-ancestor
15076259|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076260|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
15076261|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076262|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15076263|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
15076264|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
15076265|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076266|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076267|NCT02230982|Nintedanib|nintedanib|mesh-list
15076268|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076269|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15076270|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076271|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076272|NCT02231021|Pioglitazone|pioglitazone|mesh-list
15076273|NCT02231021|Alogliptin|alogliptin|mesh-list
15076274|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15076275|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076276|NCT02231021|Incretins|incretins|mesh-ancestor
15076277|NCT02231021|Hormones|hormones|mesh-ancestor
15076278|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15076279|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15076280|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
15076281|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076282|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076283|NCT02231125|Losartan|losartan|mesh-list
15076284|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15076285|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15076286|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15076287|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15076288|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076289|NCT02231203|Tocopherols|tocopherols|mesh-list
15076290|NCT02231203|Antioxidants|antioxidants|mesh-list
15076291|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076292|NCT02231203|Protective Agents|protective agents|mesh-ancestor
15076293|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076294|NCT02231203|Vitamins|vitamins|mesh-ancestor
15076295|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
15076296|NCT02231255|Pramipexole|pramipexole|mesh-list
15076297|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
15076298|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076299|NCT02231255|Protective Agents|protective agents|mesh-ancestor
15076300|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076301|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15076302|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15076303|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
15076304|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
15076305|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076306|NCT02231281|Ritonavir|ritonavir|mesh-list
15076307|NCT02231281|Lopinavir|lopinavir|mesh-list
15076308|NCT02231281|Tenofovir|tenofovir|mesh-list
15076309|NCT02231281|Lamivudine|lamivudine|mesh-list
15076310|NCT02231281|Zidovudine|zidovudine|mesh-list
15076311|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15076312|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15076313|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
15076314|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076315|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076316|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15076317|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15076318|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
15076319|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15076320|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15076321|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15076322|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15076323|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15076324|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
15076325|NCT02231294|Pramipexole|pramipexole|mesh-list
15076326|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
15076327|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076328|NCT02231294|Protective Agents|protective agents|mesh-ancestor
15076329|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076330|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15076331|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15076332|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
15076333|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
15076334|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076335|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
15076336|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15076337|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
15076338|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076339|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076340|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15076341|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
15076342|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
15076343|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15076344|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076345|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076346|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15076347|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15076348|NCT02231333|Protective Agents|protective agents|mesh-ancestor
15076349|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076350|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
15076351|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15076352|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
15076353|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
15076354|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15076355|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
15076356|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076357|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076358|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15076359|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
15076360|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
15076361|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15076362|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
15076363|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076364|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076365|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15076366|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
15076367|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
15076368|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15076369|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
15076370|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076371|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076372|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15076373|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
15076374|NCT02231385|Acetic Acid|acetic acid|mesh-list
15076375|NCT02231385|Retinol acetate|retinol acetate|mesh-list
15076376|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15076377|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15076378|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15076379|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
15076380|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076381|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15076382|NCT02231385|Protective Agents|protective agents|mesh-ancestor
15076383|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076384|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
15076385|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15076386|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
15076387|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076388|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076389|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15076390|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
15076391|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
15076392|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15076393|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
15076394|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076395|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076396|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15076397|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
15076398|NCT02231606|Methamphetamine|methamphetamine|mesh-list
15076399|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15076400|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076401|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
15076402|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
15076403|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076404|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
15076405|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076406|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076407|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
15076408|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15076409|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15076410|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15076411|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15076412|NCT02231632|Vaccines|vaccines|mesh-list
15076413|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
15076414|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076415|NCT02231658|Liraglutide|liraglutide|mesh-list
15076416|NCT02231658|Lixisenatide|lixisenatide|mesh-list
15076417|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15076418|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076419|NCT02231658|Incretins|incretins|mesh-ancestor
15076420|NCT02231658|Hormones|hormones|mesh-ancestor
15076421|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15076422|NCT02231762|Temozolomide|temozolomide|mesh-list
15076423|NCT02231762|Lanreotide|lanreotide|mesh-list
15076424|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15076425|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
15076426|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076427|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076428|NCT02231775|Trametinib|trametinib|mesh-list
15076429|NCT02231775|Dabrafenib|dabrafenib|mesh-list
15076430|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076431|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15076432|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076433|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076434|NCT02231788|Amlodipine|amlodipine|mesh-list
15076435|NCT02231788|Telmisartan|telmisartan|mesh-list
15076436|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15076437|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15076438|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15076439|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076440|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15076441|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076442|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
15076443|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15076444|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15076445|NCT02231879|Plerixafor|plerixafor|mesh-list
15076446|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15076447|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15076448|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
15076449|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15076450|NCT02231905|Pramipexole|pramipexole|mesh-list
15076451|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
15076452|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076453|NCT02231905|Protective Agents|protective agents|mesh-ancestor
15076454|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076455|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15076456|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15076457|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
15076458|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
15076459|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076460|NCT02231931|Metformin|metformin|mesh-list
15076461|NCT02231931|Digoxin|digoxin|mesh-list
15076462|NCT02231931|Furosemide|furosemide|mesh-list
15076463|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15076464|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15076465|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076466|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15076467|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15076468|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
15076469|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076470|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15076471|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15076472|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076473|NCT02231931|Diuretics|diuretics|mesh-ancestor
15076474|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
15076475|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
15076476|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15076477|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15076478|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15076479|NCT02231931|Protective Agents|protective agents|mesh-ancestor
15076480|NCT02231957|Vaccines|vaccines|mesh-list
15076481|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
15076482|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076483|NCT02232035|Diazepam|diazepam|mesh-list
15076484|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15076485|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
15076486|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
15076487|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
15076488|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076489|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076490|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15076491|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15076492|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15076493|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15076494|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15076495|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15076496|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15076497|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15076498|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15076499|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
15076500|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
15076501|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
15076502|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
15076503|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076504|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076505|NCT02232139|Midazolam|midazolam|mesh-list
15076506|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15076507|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15076508|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15076509|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076510|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15076511|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15076512|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15076513|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15076514|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
15076515|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
15076516|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
15076517|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
15076518|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076519|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076520|NCT02232269|Felodipine|felodipine|mesh-list
15076521|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15076522|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15076523|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15076524|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15076525|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076526|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15076527|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076528|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
15076529|NCT02232308|Lisinopril|lisinopril|mesh-list
15076530|NCT02232308|Nizatidine|nizatidine|mesh-list
15076531|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
15076532|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
15076533|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076534|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076535|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15076536|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15076537|NCT02232308|Protective Agents|protective agents|mesh-ancestor
15076538|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076539|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15076540|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15076541|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
15076542|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
15076543|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
15076544|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076545|NCT02232347|Sufentanil|sufentanil|mesh-list
15076546|NCT02232347|Ketamine|ketamine|mesh-list
15076547|NCT02232347|Analgesics|analgesics|mesh-ancestor
15076548|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
15076549|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076550|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076551|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15076552|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15076553|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
15076554|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
15076555|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15076556|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15076557|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15076558|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076559|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076560|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15076561|NCT02232347|Narcotics|narcotics|mesh-ancestor
15076562|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15076563|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15076564|NCT02232360|Fenofibrate|fenofibrate|mesh-list
15076565|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15076566|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15076567|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
15076568|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076569|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15076570|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15076571|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076572|NCT02232386|Rituximab|rituximab|mesh-list
15076573|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15076574|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076575|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
15076576|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076577|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15076578|NCT02232399|Simendan|simendan|mesh-list
15076579|NCT02232399|Milrinone|milrinone|mesh-list
15076580|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15076581|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
15076582|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15076583|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15076584|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076585|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076586|NCT02232399|Protective Agents|protective agents|mesh-ancestor
15076587|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076588|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15076589|NCT02232516|Lenalidomide|lenalidomide|mesh-list
15076590|NCT02232516|Romidepsin|romidepsin|mesh-list
15076591|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
15076592|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076593|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15076594|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15076595|NCT02232516|Growth Substances|growth substances|mesh-ancestor
15076596|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
15076597|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076598|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15076599|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15076600|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15076601|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15076602|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15076603|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076604|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076605|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076606|NCT02232542|Analgesics|analgesics|mesh-ancestor
15076607|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
15076608|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076609|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
15076610|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15076611|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
15076612|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
15076613|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15076614|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15076615|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15076616|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076617|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076618|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076619|NCT02232555|Analgesics|analgesics|mesh-ancestor
15076620|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
15076621|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076622|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
15076623|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15076624|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
15076625|NCT02232581|Alovudine|alovudine|mesh-list
15076626|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
15076627|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
15076628|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15076629|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
15076630|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076631|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15076632|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15076633|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076634|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
15076635|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15076636|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
15076637|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076638|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076639|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15076640|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
15076641|NCT02232607|Lacidipine|lacidipine|mesh-list
15076642|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15076643|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15076644|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15076645|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076646|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15076647|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076648|NCT02232672|Choline|choline|mesh-list
15076649|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
15076650|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15076651|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
15076652|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076653|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15076654|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15076655|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
15076656|NCT02232685|Choline|choline|mesh-list
15076657|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
15076658|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15076659|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
15076660|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076661|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15076662|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15076663|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
15076664|NCT02232724|Choline|choline|mesh-list
15076665|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
15076666|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15076667|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
15076668|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076669|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15076670|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15076671|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
15076672|NCT02232737|Nicotine|nicotine|mesh-list
15076673|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
15076674|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
15076675|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076676|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076677|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15076678|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15076679|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
15076680|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076681|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076682|NCT02232763|Losartan|losartan|mesh-list
15076683|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15076684|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15076685|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15076686|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15076687|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076688|NCT02232776|Losartan|losartan|mesh-list
15076689|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15076690|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15076691|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15076692|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15076693|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076694|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
15076695|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
15076696|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076697|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15076698|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
15076699|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076700|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076701|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15076702|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15076703|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15076704|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
15076705|NCT02232932|Capecitabine|capecitabine|mesh-list
15076706|NCT02232932|Liver Extracts|liver extracts|mesh-list
15076707|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15076708|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
15076709|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076710|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076711|NCT02232932|Hematinics|hematinics|mesh-ancestor
15076712|NCT02232945|Oseltamivir|oseltamivir|mesh-list
15076713|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
15076714|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15076715|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076716|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076717|NCT02232971|Glucagon|glucagon|mesh-list
15076718|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15076719|NCT02232971|Hormones|hormones|mesh-ancestor
15076720|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15076721|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076722|NCT02233023|Dopamine|dopamine|mesh-list
15076723|NCT02233023|Pramipexole|pramipexole|mesh-list
15076724|NCT02233023|Bromocriptine|bromocriptine|mesh-list
15076725|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
15076726|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
15076727|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076728|NCT02233023|Protective Agents|protective agents|mesh-ancestor
15076729|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076730|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15076731|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15076732|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
15076733|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076734|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15076735|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
15076736|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
15076737|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076738|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
15076739|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15076740|NCT02233049|Everolimus|everolimus|mesh-list
15076741|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15076742|NCT02233049|Dasatinib|dasatinib|mesh-list
15076743|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076744|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15076745|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
15076746|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076747|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15076748|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076749|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076750|NCT02233075|Interferons|interferons|mesh-list
15076751|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
15076752|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
15076753|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
15076754|NCT02233075|REP 2139|rep 2139|mesh-list
15076755|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076756|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
15076757|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15076758|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
15076759|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076760|NCT02233179|Calpastatin|calpastatin|mesh-list
15076761|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
15076762|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
15076763|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076764|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076765|NCT02233205|Gemcitabine|gemcitabine|mesh-list
15076766|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15076767|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
15076768|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076769|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076770|NCT02233205|Antiviral Agents|antiviral agents|mesh-ancestor
15076771|NCT02233205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15076772|NCT02233205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076773|NCT02233205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15076774|NCT02233205|Immunologic Factors|immunologic factors|mesh-ancestor
15076775|NCT02233205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076776|NCT02233218|Amlodipine|amlodipine|mesh-list
15076777|NCT02233218|Telmisartan|telmisartan|mesh-list
15076778|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15076779|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15076780|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15076781|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15076782|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076783|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15076784|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076785|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
15076786|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15076787|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15076788|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
15076789|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15076790|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15076791|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076792|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15076793|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15076794|NCT02233231|Varenicline|varenicline|mesh-list
15076795|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
15076796|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15076797|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
15076798|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076799|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076800|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076801|NCT02233244|Midazolam|midazolam|mesh-list
15076802|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15076803|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15076804|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15076805|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076806|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15076807|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15076808|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15076809|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15076810|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
15076811|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
15076812|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
15076813|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
15076814|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076815|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076816|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
15076817|NCT02233322|Hematinics|hematinics|mesh-ancestor
15076818|NCT02233387|Imidazole|imidazole|mesh-list
15076819|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076820|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076821|NCT02233400|Acetaminophen|acetaminophen|mesh-list
15076822|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15076823|NCT02233400|Analgesics|analgesics|mesh-ancestor
15076824|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
15076825|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076826|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076827|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
15076828|NCT02233439|Galactogogues|galactogogues|mesh-list
15076829|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076830|NCT02233452|Ketamine|ketamine|mesh-list
15076831|NCT02233452|Methadone|methadone|mesh-list
15076832|NCT02233452|Analgesics|analgesics|mesh-ancestor
15076833|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
15076834|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076835|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076836|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15076837|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15076838|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
15076839|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
15076840|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15076841|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15076842|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15076843|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076844|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076845|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15076846|NCT02233452|Narcotics|narcotics|mesh-ancestor
15076847|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
15076848|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
15076849|NCT02233504|Deferasirox|deferasirox|mesh-list
15076850|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15076851|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
15076852|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
15076853|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076854|NCT02233556|Memantine|memantine|mesh-list
15076855|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15076856|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15076857|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
15076858|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076859|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076860|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076861|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15076862|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15076863|NCT02233582|Ibuprofen|ibuprofen|mesh-list
15076864|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15076865|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15076866|NCT02233582|Analgesics|analgesics|mesh-ancestor
15076867|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
15076868|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076869|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076870|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15076871|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15076872|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15076873|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076874|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076875|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
15076876|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
15076877|NCT02233621|Estradiol|estradiol|mesh-list
15076878|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
15076879|NCT02233621|Estrogens|estrogens|mesh-ancestor
15076880|NCT02233621|Hormones|hormones|mesh-ancestor
15076881|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15076882|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076883|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15076884|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
15076885|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15076886|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15076887|NCT02233777|Pregabalin|pregabalin|mesh-list
15076888|NCT02233777|Analgesics|analgesics|mesh-ancestor
15076889|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
15076890|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076891|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076892|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
15076893|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15076894|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15076895|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076896|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15076897|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15076898|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15076899|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15076900|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15076901|NCT02233790|Clopidogrel|clopidogrel|mesh-list
15076902|NCT02233790|Ticagrelor|ticagrelor|mesh-list
15076903|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15076904|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15076905|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15076906|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15076907|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
15076908|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076909|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076910|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076911|NCT02233816|Vaccines|vaccines|mesh-list
15076912|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
15076913|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076914|NCT02233881|Ipratropium|ipratropium|mesh-list
15076915|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15076916|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
15076917|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076918|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076919|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15076920|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
15076921|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15076922|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
15076923|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076924|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076925|NCT02233894|Ipratropium|ipratropium|mesh-list
15076926|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15076927|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
15076928|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076929|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076930|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15076931|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
15076932|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15076933|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
15076934|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076935|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076936|NCT02233907|Oxitropium|oxitropium|mesh-list
15076937|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
15076938|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
15076939|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076940|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076941|NCT02233920|Oxitropium|oxitropium|mesh-list
15076942|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
15076943|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
15076944|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076945|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076946|NCT02233972|Midazolam|midazolam|mesh-list
15076947|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15076948|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15076949|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15076950|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076951|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15076952|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15076953|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15076954|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15076955|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
15076956|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
15076957|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
15076958|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
15076959|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076960|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076961|NCT02234037|Decitabine|decitabine|mesh-list
15076962|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15076963|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
15076964|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076965|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076966|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15076967|NCT02234050|Trabectedin|trabectedin|mesh-list
15076968|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15076969|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
15076970|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076971|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15076972|NCT02234193|Lidocaine|lidocaine|mesh-list
15076973|NCT02234193|Epinephrine|epinephrine|mesh-list
15076974|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
15076975|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
15076976|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15076977|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15076978|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
15076979|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15076980|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15076981|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15076982|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15076983|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15076984|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15076985|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15076986|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15076987|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
15076988|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15076989|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15076990|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15076991|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
15076992|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15076993|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
15076994|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
15076995|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
15076996|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15076997|NCT02234349|Pancrelipase|pancrelipase|mesh-list
15076998|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15076999|NCT02234440|Metformin|metformin|mesh-list
15077000|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15077001|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077002|NCT02234466|Dexamethasone|dexamethasone|mesh-list
15077003|NCT02234466|Ondansetron|ondansetron|mesh-list
15077004|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15077005|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
15077006|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
15077007|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077008|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077009|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15077010|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
15077011|NCT02234466|Hormones|hormones|mesh-ancestor
15077012|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15077013|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15077014|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077015|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
15077016|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
15077017|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15077018|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
15077019|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077020|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077021|NCT02234466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15077022|NCT02234466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15077023|NCT02234466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15077024|NCT02234466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15077025|NCT02234466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15077026|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15077027|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15077028|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15077029|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
15077030|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077031|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15077032|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15077033|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077034|NCT02234544|Vitamin D|vitamin d|mesh-list
15077035|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
15077036|NCT02234544|Ezetimibe|ezetimibe|mesh-list
15077037|NCT02234544|Vitamins|vitamins|mesh-ancestor
15077038|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
15077039|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077040|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15077041|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15077042|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15077043|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15077044|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
15077045|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077046|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15077047|NCT02234739|Voriconazole|voriconazole|mesh-list
15077048|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
15077049|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077050|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15077051|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15077052|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077053|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077054|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15077055|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
15077056|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15077057|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077058|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15077059|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
15077060|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15077061|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
15077062|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15077063|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
15077064|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077065|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077066|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
15077067|NCT02234869|Interferons|interferons|mesh-list
15077068|NCT02234869|Interferon-beta|interferon-beta|mesh-list
15077069|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
15077070|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
15077071|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077072|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
15077073|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077074|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
15077075|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077076|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15077077|NCT02234882|Fostemsavir|fostemsavir|mesh-list
15077078|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
15077079|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15077080|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15077081|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
15077082|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077083|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15077084|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15077085|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077086|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15077087|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15077088|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
15077089|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077090|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
15077091|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
15077092|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
15077093|NCT02234921|Imiquimod|imiquimod|mesh-list
15077094|NCT02234921|Vaccines|vaccines|mesh-list
15077095|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
15077096|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077097|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15077098|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15077099|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15077100|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
15077101|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077102|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077103|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15077104|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15077105|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
15077106|NCT02235012|Ketamine|ketamine|mesh-list
15077107|NCT02235012|Analgesics|analgesics|mesh-ancestor
15077108|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
15077109|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077110|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077111|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15077112|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15077113|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
15077114|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
15077115|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15077116|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15077117|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15077118|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077119|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077120|NCT02235194|Chromium|chromium|mesh-list
15077121|NCT02235194|Picolinic acid|picolinic acid|mesh-list
15077122|NCT02235194|Trace Elements|trace elements|mesh-ancestor
15077123|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
15077124|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077125|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
15077126|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
15077127|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
15077128|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077129|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
15077130|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15077131|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077132|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
15077133|NCT02235246|Analgesics|analgesics|mesh-ancestor
15077134|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
15077135|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077136|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077137|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
15077138|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15077139|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15077140|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
15077141|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15077142|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15077143|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077144|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15077145|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
15077146|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15077147|NCT02235324|Leucovorin|leucovorin|mesh-list
15077148|NCT02235324|Fluorouracil|fluorouracil|mesh-list
15077149|NCT02235324|Aflibercept|aflibercept|mesh-list
15077150|NCT02235324|Calcium|calcium|mesh-list
15077151|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
15077152|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
15077153|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15077154|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077155|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
15077156|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077157|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15077158|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077159|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15077160|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
15077161|NCT02235324|Antidotes|antidotes|mesh-ancestor
15077162|NCT02235324|Protective Agents|protective agents|mesh-ancestor
15077163|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
15077164|NCT02235324|Vitamins|vitamins|mesh-ancestor
15077165|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
15077166|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15077167|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15077168|NCT02235324|Growth Substances|growth substances|mesh-ancestor
15077169|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
15077170|NCT02235337|Riboflavin|riboflavin|mesh-list
15077171|NCT02235337|Vitamins|vitamins|mesh-ancestor
15077172|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
15077173|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077174|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
15077175|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
15077176|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
15077177|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15077178|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15077179|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15077180|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077181|NCT02235402|Lacidipine|lacidipine|mesh-list
15077182|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
15077183|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15077184|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15077185|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15077186|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077187|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15077188|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077189|NCT02235402|Diuretics|diuretics|mesh-ancestor
15077190|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
15077191|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15077192|NCT02235415|Lacidipine|lacidipine|mesh-list
15077193|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15077194|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15077195|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15077196|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077197|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15077198|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077199|NCT02235428|Bromides|bromides|mesh-list
15077200|NCT02235428|Albuterol|albuterol|mesh-list
15077201|NCT02235428|Ipratropium|ipratropium|mesh-list
15077202|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
15077203|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077204|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
15077205|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077206|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077207|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077208|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077209|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
15077210|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15077211|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15077212|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15077213|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15077214|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
15077215|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077216|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077217|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15077218|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
15077219|NCT02235480|Tazarotene|tazarotene|mesh-list
15077220|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
15077221|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
15077222|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
15077223|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15077224|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15077225|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077226|NCT02235532|Fluorides|fluorides|mesh-list
15077227|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
15077228|NCT02235532|Protective Agents|protective agents|mesh-ancestor
15077229|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077230|NCT02235558|Verapamil|verapamil|mesh-list
15077231|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15077232|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15077233|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15077234|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077235|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15077236|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077237|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
15077238|NCT02235584|Dexamethasone|dexamethasone|mesh-list
15077239|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15077240|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
15077241|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
15077242|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077243|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077244|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15077245|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
15077246|NCT02235584|Hormones|hormones|mesh-ancestor
15077247|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15077248|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15077249|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077250|NCT02235662|Tenofovir|tenofovir|mesh-list
15077251|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
15077252|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
15077253|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077254|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15077255|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15077256|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077257|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077258|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15077259|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15077260|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15077261|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
15077262|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15077263|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077264|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15077265|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15077266|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15077267|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
15077268|NCT02235805|Cathartics|cathartics|mesh-ancestor
15077269|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15077270|NCT02235909|Losartan|losartan|mesh-list
15077271|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
15077272|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15077273|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15077274|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15077275|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15077276|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077277|NCT02235948|Folic Acid|folic acid|mesh-list
15077278|NCT02235948|Hematinics|hematinics|mesh-ancestor
15077279|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
15077280|NCT02235948|Vitamins|vitamins|mesh-ancestor
15077281|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
15077282|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077283|NCT02235961|Liraglutide|liraglutide|mesh-list
15077284|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15077285|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077286|NCT02235961|Incretins|incretins|mesh-ancestor
15077287|NCT02235961|Hormones|hormones|mesh-ancestor
15077288|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15077289|NCT02236013|Cytarabine|cytarabine|mesh-list
15077290|NCT02236013|Daunorubicin|daunorubicin|mesh-list
15077291|NCT02236013|Idarubicin|idarubicin|mesh-list
15077292|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15077293|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
15077294|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077295|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077296|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
15077297|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077298|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15077299|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
15077300|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077301|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15077302|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15077303|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15077304|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077305|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
15077306|NCT02236026|ST 1435|st 1435|mesh-list
15077307|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15077308|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077309|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15077310|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15077311|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077312|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077313|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077314|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15077315|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
15077316|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15077317|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077318|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15077319|NCT02236052|Vaccines|vaccines|mesh-list
15077320|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
15077321|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077322|NCT02236065|Lenograstim|lenograstim|mesh-list
15077323|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15077324|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
15077325|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077326|NCT02236078|Isoniazid|isoniazid|mesh-list
15077327|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
15077328|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15077329|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077330|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
15077331|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15077332|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
15077333|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077334|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15077335|NCT02236169|Bromides|bromides|mesh-list
15077336|NCT02236169|Norflurane|norflurane|mesh-list
15077337|NCT02236169|Ipratropium|ipratropium|mesh-list
15077338|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
15077339|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077340|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
15077341|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077342|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077343|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077344|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077345|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15077346|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
15077347|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077348|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077349|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
15077350|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15077351|NCT02236182|Bromides|bromides|mesh-list
15077352|NCT02236182|Ipratropium|ipratropium|mesh-list
15077353|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
15077354|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077355|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
15077356|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077357|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077358|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077359|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077360|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15077361|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
15077362|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077363|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077364|NCT02236260|Lidocaine|lidocaine|mesh-list
15077365|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
15077366|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
15077367|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15077368|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077369|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
15077370|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077371|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15077372|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15077373|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15077374|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15077375|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077376|NCT02236403|Metronidazole|metronidazole|mesh-list
15077377|NCT02236403|Ivermectin|ivermectin|mesh-list
15077378|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077379|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15077380|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15077381|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15077382|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
15077383|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15077384|NCT02236715|Ipratropium|ipratropium|mesh-list
15077385|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077386|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
15077387|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077388|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077389|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077390|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077391|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15077392|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
15077393|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077394|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077395|NCT02236728|Pramipexole|pramipexole|mesh-list
15077396|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
15077397|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077398|NCT02236728|Protective Agents|protective agents|mesh-ancestor
15077399|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077400|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15077401|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15077402|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
15077403|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
15077404|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077405|NCT02236741|Pramipexole|pramipexole|mesh-list
15077406|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
15077407|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077408|NCT02236741|Protective Agents|protective agents|mesh-ancestor
15077409|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077410|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15077411|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15077412|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
15077413|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
15077414|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077415|NCT02236793|Becaplermin|becaplermin|mesh-list
15077416|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
15077417|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
15077418|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15077419|NCT02236793|Growth Substances|growth substances|mesh-ancestor
15077420|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077421|NCT02236936|Cetuximab|cetuximab|mesh-list
15077422|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077423|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15077424|NCT02236962|Pioglitazone|pioglitazone|mesh-list
15077425|NCT02236962|Ephedrine|ephedrine|mesh-list
15077426|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15077427|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077428|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15077429|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
15077430|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
15077431|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077432|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15077433|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
15077434|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077435|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077436|NCT02237027|Tenofovir|tenofovir|mesh-list
15077437|NCT02237027|Emtricitabine|emtricitabine|mesh-list
15077438|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
15077439|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
15077440|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077441|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15077442|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15077443|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077444|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077445|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15077446|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15077447|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15077448|NCT02237053|Octreotide|octreotide|mesh-list
15077449|NCT02237053|Glucagon|glucagon|mesh-list
15077450|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077451|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15077452|NCT02237053|Hormones|hormones|mesh-ancestor
15077453|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15077454|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15077455|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077456|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
15077457|NCT02237079|Estrogens|estrogens|mesh-list
15077458|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
15077459|NCT02237079|Hormones|hormones|mesh-ancestor
15077460|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15077461|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077462|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15077463|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15077464|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
15077465|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15077466|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
15077467|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
15077468|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
15077469|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15077470|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077471|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15077472|NCT02237209|Vaccines|vaccines|mesh-list
15077473|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
15077474|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077475|NCT02237261|Prednisone|prednisone|mesh-list
15077476|NCT02237261|Bortezomib|bortezomib|mesh-list
15077477|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15077478|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15077479|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
15077480|NCT02237261|Hormones|hormones|mesh-ancestor
15077481|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15077482|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077483|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15077484|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077485|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15077486|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
15077487|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077488|NCT02237326|Acetic Acid|acetic acid|mesh-list
15077489|NCT02237326|Retinol acetate|retinol acetate|mesh-list
15077490|NCT02237326|Lugol's solution|lugol's solution|mesh-list
15077491|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15077492|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077493|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15077494|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
15077495|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077496|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15077497|NCT02237326|Protective Agents|protective agents|mesh-ancestor
15077498|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077499|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
15077500|NCT02237326|Coagulants|coagulants|mesh-ancestor
15077501|NCT02237339|Allopurinol|allopurinol|mesh-list
15077502|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
15077503|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077504|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077505|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
15077506|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15077507|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15077508|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
15077509|NCT02237339|Protective Agents|protective agents|mesh-ancestor
15077510|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077511|NCT02237365|Aspirin|aspirin|mesh-list
15077512|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15077513|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15077514|NCT02237365|Analgesics|analgesics|mesh-ancestor
15077515|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
15077516|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077517|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077518|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15077519|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15077520|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15077521|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15077522|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077523|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15077524|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15077525|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077526|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
15077527|NCT02237443|Bromides|bromides|mesh-list
15077528|NCT02237443|Rocuronium|rocuronium|mesh-list
15077529|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
15077530|NCT02237443|Succinylcholine|succinylcholine|mesh-list
15077531|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
15077532|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
15077533|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
15077534|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15077535|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077536|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077537|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
15077538|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
15077539|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15077540|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
15077541|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077542|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077543|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
15077544|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15077545|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15077546|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077547|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15077548|NCT02237495|Analgesics|analgesics|mesh-ancestor
15077549|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
15077550|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077551|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15077552|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15077553|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15077554|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
15077555|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077556|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077557|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
15077558|NCT02237534|Calcium|calcium|mesh-list
15077559|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15077560|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077561|NCT02237534|Antacids|antacids|mesh-ancestor
15077562|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077563|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15077564|NCT02237560|Camphor|camphor|mesh-list
15077565|NCT02237560|Salicylates|salicylates|mesh-list
15077566|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
15077567|NCT02237560|Menthol|menthol|mesh-list
15077568|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15077569|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077570|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
15077571|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
15077572|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15077573|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15077574|NCT02237560|Analgesics|analgesics|mesh-ancestor
15077575|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
15077576|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077577|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077578|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15077579|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15077580|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15077581|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077582|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077583|NCT02237651|Anesthetics|anesthetics|mesh-list
15077584|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15077585|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077586|NCT02237690|Doxorubicin|doxorubicin|mesh-list
15077587|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15077588|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15077589|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077590|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15077591|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15077592|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077593|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077594|NCT02237729|Adalimumab|adalimumab|mesh-list
15077595|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15077596|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15077597|NCT02237755|Citric Acid|citric acid|mesh-list
15077598|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
15077599|NCT02237755|Clomiphene|clomiphene|mesh-list
15077600|NCT02237755|Enclomiphene|enclomiphene|mesh-list
15077601|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
15077602|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
15077603|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
15077604|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
15077605|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
15077606|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077607|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15077608|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
15077609|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15077610|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077611|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15077612|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
15077613|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15077614|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
15077615|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
15077616|NCT02237768|Dirithromycin|dirithromycin|mesh-list
15077617|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15077618|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077619|NCT02237807|Dirithromycin|dirithromycin|mesh-list
15077620|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15077621|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077622|NCT02237820|Dexamethasone|dexamethasone|mesh-list
15077623|NCT02237820|Prednisone|prednisone|mesh-list
15077624|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15077625|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
15077626|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
15077627|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077628|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077629|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15077630|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
15077631|NCT02237820|Hormones|hormones|mesh-ancestor
15077632|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15077633|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15077634|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077635|NCT02237859|Vancomycin|vancomycin|mesh-list
15077636|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15077637|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077638|NCT02237924|Endostar protein|endostar protein|mesh-list
15077639|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15077640|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15077641|NCT02237924|Growth Substances|growth substances|mesh-ancestor
15077642|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077643|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
15077644|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077645|NCT02237937|Amitriptyline|amitriptyline|mesh-list
15077646|NCT02237937|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
15077647|NCT02237937|Citalopram|citalopram|mesh-list
15077648|NCT02237937|Paroxetine|paroxetine|mesh-list
15077649|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
15077650|NCT02237937|Sertraline|sertraline|mesh-list
15077651|NCT02237937|Nortriptyline|nortriptyline|mesh-list
15077652|NCT02237937|Trimipramine|trimipramine|mesh-list
15077653|NCT02237937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15077654|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15077655|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15077656|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077657|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077658|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
15077659|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077660|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15077661|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
15077662|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15077663|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077664|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
15077665|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15077666|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077667|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
15077668|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
15077669|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15077670|NCT02237937|Analgesics|analgesics|mesh-ancestor
15077671|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
15077672|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15077673|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
15077674|NCT02237937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15077675|NCT02237937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15077676|NCT02237937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15077677|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15077678|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077679|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
15077680|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077681|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077682|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077683|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077684|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15077685|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15077686|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15077687|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
15077688|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077689|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077690|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
15077691|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
15077692|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077693|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
15077694|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077695|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077696|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077697|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077698|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15077699|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15077700|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15077701|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
15077702|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077703|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077704|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
15077705|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15077706|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
15077707|NCT02238132|Ipratropium|ipratropium|mesh-list
15077708|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077709|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
15077710|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077711|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077712|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077713|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077714|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15077715|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
15077716|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077717|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077718|NCT02238145|Ipratropium|ipratropium|mesh-list
15077719|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077720|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
15077721|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077722|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077723|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077724|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077725|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15077726|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
15077727|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077728|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077729|NCT02238158|Ipratropium|ipratropium|mesh-list
15077730|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077731|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
15077732|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077733|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077734|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077735|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077736|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15077737|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
15077738|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077739|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077740|NCT02238171|Ipratropium|ipratropium|mesh-list
15077741|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077742|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
15077743|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077744|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077745|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077746|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077747|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15077748|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
15077749|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077750|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077751|NCT02238184|Ipratropium|ipratropium|mesh-list
15077752|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077753|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
15077754|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077755|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077756|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077757|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077758|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15077759|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
15077760|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077761|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077762|NCT02238197|Ipratropium|ipratropium|mesh-list
15077763|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077764|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
15077765|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077766|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077767|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077768|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077769|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15077770|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
15077771|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077772|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077773|NCT02238210|Ipratropium|ipratropium|mesh-list
15077774|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077775|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
15077776|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077777|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077778|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077779|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077780|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15077781|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
15077782|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077783|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077784|NCT02238223|Epinastine|epinastine|mesh-list
15077785|NCT02238223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15077786|NCT02238223|Histamine Antagonists|histamine antagonists|mesh-ancestor
15077787|NCT02238223|Histamine Agents|histamine agents|mesh-ancestor
15077788|NCT02238223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077789|NCT02238223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077790|NCT02238223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077791|NCT02238236|Epinastine|epinastine|mesh-list
15077792|NCT02238236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15077793|NCT02238236|Histamine Antagonists|histamine antagonists|mesh-ancestor
15077794|NCT02238236|Histamine Agents|histamine agents|mesh-ancestor
15077795|NCT02238236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077796|NCT02238236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077797|NCT02238236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077798|NCT02238249|Epinastine|epinastine|mesh-list
15077799|NCT02238249|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15077800|NCT02238249|Histamine Antagonists|histamine antagonists|mesh-ancestor
15077801|NCT02238249|Histamine Agents|histamine agents|mesh-ancestor
15077802|NCT02238249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077803|NCT02238249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077804|NCT02238249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077805|NCT02238262|Telmisartan|telmisartan|mesh-list
15077806|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15077807|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15077808|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15077809|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077810|NCT02238275|Telmisartan|telmisartan|mesh-list
15077811|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15077812|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15077813|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15077814|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077815|NCT02238288|Acetaminophen|acetaminophen|mesh-list
15077816|NCT02238288|Lidocaine|lidocaine|mesh-list
15077817|NCT02238288|Epinephrine|epinephrine|mesh-list
15077818|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
15077819|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
15077820|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
15077821|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15077822|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077823|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
15077824|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077825|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15077826|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15077827|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15077828|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15077829|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077830|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15077831|NCT02238288|Analgesics|analgesics|mesh-ancestor
15077832|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
15077833|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15077834|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15077835|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
15077836|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077837|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15077838|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077839|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
15077840|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077841|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077842|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
15077843|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
15077844|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15077845|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15077846|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15077847|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
15077848|NCT02238288|Coagulants|coagulants|mesh-ancestor
15077849|NCT02238314|Ritonavir|ritonavir|mesh-list
15077850|NCT02238314|Tipranavir|tipranavir|mesh-list
15077851|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
15077852|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15077853|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15077854|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
15077855|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077856|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077857|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15077858|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15077859|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
15077860|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077861|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15077862|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15077863|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15077864|NCT02238340|Ketoprofen|ketoprofen|mesh-list
15077865|NCT02238340|Morphine|morphine|mesh-list
15077866|NCT02238340|Oxycodone|oxycodone|mesh-list
15077867|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15077868|NCT02238340|Narcotics|narcotics|mesh-ancestor
15077869|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15077870|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077871|NCT02238340|Analgesics|analgesics|mesh-ancestor
15077872|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
15077873|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077874|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15077875|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15077876|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15077877|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15077878|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15077879|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077880|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077881|NCT02238353|Fluticasone|fluticasone|mesh-list
15077882|NCT02238353|Azelastine|azelastine|mesh-list
15077883|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15077884|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15077885|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
15077886|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077887|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077888|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15077889|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
15077890|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
15077891|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15077892|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
15077893|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077894|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077895|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
15077896|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15077897|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
15077898|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
15077899|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077900|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15077901|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
15077902|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15077903|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
15077904|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15077905|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077906|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15077907|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15077908|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077909|NCT02238392|Adenosine|adenosine|mesh-list
15077910|NCT02238392|Analgesics|analgesics|mesh-ancestor
15077911|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
15077912|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077913|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077914|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15077915|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
15077916|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
15077917|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
15077918|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
15077919|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15077920|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077921|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
15077922|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15077923|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077924|NCT02238418|Vitamins|vitamins|mesh-ancestor
15077925|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
15077926|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15077927|NCT02238431|Leuprolide|leuprolide|mesh-list
15077928|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
15077929|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
15077930|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15077931|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077932|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15077933|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077934|NCT02238444|Aspirin|aspirin|mesh-list
15077935|NCT02238444|Heparin|heparin|mesh-list
15077936|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15077937|NCT02238444|Tinzaparin|tinzaparin|mesh-list
15077938|NCT02238444|Dalteparin|dalteparin|mesh-list
15077939|NCT02238444|Dipyridamole|dipyridamole|mesh-list
15077940|NCT02238444|Warfarin|warfarin|mesh-list
15077941|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15077942|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15077943|NCT02238444|Analgesics|analgesics|mesh-ancestor
15077944|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
15077945|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15077946|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077947|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15077948|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15077949|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15077950|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15077951|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077952|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15077953|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15077954|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077955|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
15077956|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
15077957|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15077958|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
15077959|NCT02238457|Losartan|losartan|mesh-list
15077960|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15077961|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15077962|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15077963|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15077964|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077965|NCT02238470|Warfarin|warfarin|mesh-list
15077966|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
15077967|NCT02238470|Dabigatran|dabigatran|mesh-list
15077968|NCT02238470|Apixaban|apixaban|mesh-list
15077969|NCT02238470|Anticoagulants|anticoagulants|mesh-list
15077970|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15077971|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
15077972|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15077973|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
15077974|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077975|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077976|NCT02238496|Sirolimus|sirolimus|mesh-list
15077977|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15077978|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15077979|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15077980|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077981|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
15077982|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15077983|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
15077984|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15077985|NCT02238509|Trastuzumab|trastuzumab|mesh-list
15077986|NCT02238509|Lapatinib|lapatinib|mesh-list
15077987|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15077988|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15077989|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15077990|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15077991|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15077992|NCT02238535|Iloprost|iloprost|mesh-list
15077993|NCT02238535|Warfarin|warfarin|mesh-list
15077994|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
15077995|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15077996|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
15077997|NCT02238548|Vaccines|vaccines|mesh-list
15077998|NCT02238548|Immunologic Factors|immunologic factors|mesh-ancestor
15077999|NCT02238548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078000|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
15078001|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15078002|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15078003|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078004|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
15078005|NCT02238639|Coagulants|coagulants|mesh-ancestor
15078006|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
15078007|NCT02238704|Iron|iron|mesh-list
15078008|NCT02238704|Folic Acid|folic acid|mesh-list
15078009|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
15078010|NCT02238704|Calcium|calcium|mesh-list
15078011|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15078012|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078013|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15078014|NCT02238704|Trace Elements|trace elements|mesh-ancestor
15078015|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
15078016|NCT02238704|Hematinics|hematinics|mesh-ancestor
15078017|NCT02238704|Vitamins|vitamins|mesh-ancestor
15078018|NCT02238717|Pregabalin|pregabalin|mesh-list
15078019|NCT02238717|PF-06372865|pf-06372865|mesh-list
15078020|NCT02238717|Analgesics|analgesics|mesh-ancestor
15078021|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
15078022|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078023|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078024|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
15078025|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15078026|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078027|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078028|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15078029|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15078030|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15078031|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078032|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15078033|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
15078034|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
15078035|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078036|NCT02238808|Estradiol|estradiol|mesh-list
15078037|NCT02238808|Estrogens|estrogens|mesh-list
15078038|NCT02238808|Hormones|hormones|mesh-ancestor
15078039|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15078040|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078041|NCT02238860|Tenofovir|tenofovir|mesh-list
15078042|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
15078043|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078044|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15078045|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15078046|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078047|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078048|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15078049|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15078050|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
15078051|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15078052|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
15078053|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078054|NCT02239107|Expectorants|expectorants|mesh-ancestor
15078055|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
15078056|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15078057|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
15078058|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078059|NCT02239107|Protective Agents|protective agents|mesh-ancestor
15078060|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078061|NCT02239107|Antidotes|antidotes|mesh-ancestor
15078062|NCT02239276|Stiripentol|stiripentol|mesh-list
15078063|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
15078064|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
15078065|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
15078066|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15078067|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078068|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078069|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15078070|NCT02239445|Analgesics|analgesics|mesh-ancestor
15078071|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
15078072|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078073|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15078074|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15078075|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15078076|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
15078077|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078078|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078079|NCT02239458|Saxagliptin|saxagliptin|mesh-list
15078080|NCT02239458|Incretins|incretins|mesh-ancestor
15078081|NCT02239458|Hormones|hormones|mesh-ancestor
15078082|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15078083|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078084|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15078085|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
15078086|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078087|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078088|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15078089|NCT02239484|Tadalafil|tadalafil|mesh-list
15078090|NCT02239484|Tamsulosin|tamsulosin|mesh-list
15078091|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
15078092|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15078093|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15078094|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078095|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078096|NCT02239484|Urological Agents|urological agents|mesh-ancestor
15078097|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15078098|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15078099|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15078100|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
15078101|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078102|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078103|NCT02239523|Denosumab|denosumab|mesh-list
15078104|NCT02239523|Teriparatide|teriparatide|mesh-list
15078105|NCT02239523|Diphosphonates|diphosphonates|mesh-list
15078106|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15078107|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078108|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15078109|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
15078110|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
15078111|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
15078112|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078113|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15078114|NCT02239614|Antacids|antacids|mesh-ancestor
15078115|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078116|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15078117|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15078118|NCT02239731|Doxycycline|doxycycline|mesh-list
15078119|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078120|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
15078121|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15078122|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15078123|NCT02239835|Ritonavir|ritonavir|mesh-list
15078124|NCT02239835|Saquinavir|saquinavir|mesh-list
15078125|NCT02239835|Tipranavir|tipranavir|mesh-list
15078126|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15078127|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15078128|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
15078129|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078130|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078131|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15078132|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15078133|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
15078134|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078135|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15078136|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15078137|NCT02239900|Ipilimumab|ipilimumab|mesh-list
15078138|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15078139|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078140|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15078141|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078142|NCT02239913|Topiramate|topiramate|mesh-list
15078143|NCT02239913|Phentermine|phentermine|mesh-list
15078144|NCT02239913|Cocaine|cocaine|mesh-list
15078145|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
15078146|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15078147|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078148|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
15078149|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
15078150|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078151|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
15078152|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078153|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15078154|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15078155|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15078156|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078157|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078158|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
15078159|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078160|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15078161|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
15078162|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15078163|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
15078164|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
15078165|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
15078166|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
15078167|NCT02239952|Sunitinib|sunitinib|mesh-list
15078168|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078169|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15078170|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078171|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078172|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15078173|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15078174|NCT02239952|Growth Substances|growth substances|mesh-ancestor
15078175|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078176|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
15078177|NCT02240017|Gemcitabine|gemcitabine|mesh-list
15078178|NCT02240017|Carboplatin|carboplatin|mesh-list
15078179|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078180|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15078181|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
15078182|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078183|NCT02240017|Antiviral Agents|antiviral agents|mesh-ancestor
15078184|NCT02240017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078185|NCT02240017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078186|NCT02240017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15078187|NCT02240017|Immunologic Factors|immunologic factors|mesh-ancestor
15078188|NCT02240017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078189|NCT02240043|Hormones|hormones|mesh-list
15078190|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15078191|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078192|NCT02240160|Nabiximols|nabiximols|mesh-list
15078193|NCT02240160|Analgesics|analgesics|mesh-ancestor
15078194|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
15078195|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078196|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078197|NCT02240173|Haloperidol|haloperidol|mesh-list
15078198|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
15078199|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
15078200|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
15078201|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078202|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078203|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15078204|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
15078205|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15078206|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078207|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15078208|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
15078209|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
15078210|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078211|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078212|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15078213|NCT02240199|Lidocaine|lidocaine|mesh-list
15078214|NCT02240199|Pregabalin|pregabalin|mesh-list
15078215|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
15078216|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
15078217|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078218|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078219|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
15078220|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078221|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15078222|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15078223|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15078224|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078225|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078226|NCT02240199|Analgesics|analgesics|mesh-ancestor
15078227|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
15078228|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15078229|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15078230|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15078231|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15078232|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15078233|NCT02240212|Paclitaxel|paclitaxel|mesh-list
15078234|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15078235|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078236|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
15078237|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
15078238|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
15078239|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078240|NCT02240238|Gemcitabine|gemcitabine|mesh-list
15078241|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15078242|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
15078243|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078244|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078245|NCT02240238|Antiviral Agents|antiviral agents|mesh-ancestor
15078246|NCT02240238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078247|NCT02240238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078248|NCT02240238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15078249|NCT02240238|Immunologic Factors|immunologic factors|mesh-ancestor
15078250|NCT02240238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078251|NCT02240433|Sorafenib|sorafenib|mesh-list
15078252|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078253|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15078254|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078255|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078256|NCT02240459|Fesoterodine|fesoterodine|mesh-list
15078257|NCT02240459|Oxybutynin|oxybutynin|mesh-list
15078258|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15078259|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15078260|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
15078261|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078262|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078263|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078264|NCT02240459|Urological Agents|urological agents|mesh-ancestor
15078265|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
15078266|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
15078267|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078268|NCT02240537|Sargramostim|sargramostim|mesh-list
15078269|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
15078270|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078271|NCT02240602|Oxycodone|oxycodone|mesh-list
15078272|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15078273|NCT02240602|Narcotics|narcotics|mesh-ancestor
15078274|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078275|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078276|NCT02240602|Analgesics|analgesics|mesh-ancestor
15078277|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
15078278|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078279|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
15078280|NCT02240641|Lacidipine|lacidipine|mesh-list
15078281|NCT02240641|Diuretics|diuretics|mesh-list
15078282|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15078283|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
15078284|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
15078285|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
15078286|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
15078287|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078288|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15078289|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
15078290|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078291|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078292|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
15078293|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15078294|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078295|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15078296|NCT02240719|Everolimus|everolimus|mesh-list
15078297|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15078298|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078299|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15078300|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
15078301|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078302|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15078303|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
15078304|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078305|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
15078306|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
15078307|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078308|NCT02240927|Enoxaparin|enoxaparin|mesh-list
15078309|NCT02240927|Warfarin|warfarin|mesh-list
15078310|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
15078311|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
15078312|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15078313|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15078314|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078315|NCT02240953|Warfarin|warfarin|mesh-list
15078316|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
15078317|NCT02241005|Allantoin|allantoin|mesh-list
15078318|NCT02241005|Dermatologic Agents|dermatologic agents|mesh-ancestor
15078319|NCT02241018|Antibodies|antibodies|mesh-list
15078320|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15078321|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
15078322|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
15078323|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078324|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078325|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078326|NCT02241031|Oprelvekin|oprelvekin|mesh-list
15078327|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078328|NCT02241083|Dopamine|dopamine|mesh-list
15078329|NCT02241083|Norepinephrine|norepinephrine|mesh-list
15078330|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15078331|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15078332|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
15078333|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078334|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078335|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078336|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
15078337|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
15078338|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078339|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15078340|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15078341|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
15078342|NCT02241083|Protective Agents|protective agents|mesh-ancestor
15078343|NCT02241096|Lidocaine|lidocaine|mesh-list
15078344|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
15078345|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
15078346|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078347|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078348|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
15078349|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078350|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15078351|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15078352|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15078353|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078354|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078355|NCT02241148|Acetaminophen|acetaminophen|mesh-list
15078356|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15078357|NCT02241148|Analgesics|analgesics|mesh-ancestor
15078358|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
15078359|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078360|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078361|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
15078362|NCT02241161|Bacteriocins|bacteriocins|mesh-list
15078363|NCT02241161|Antioxidants|antioxidants|mesh-list
15078364|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078365|NCT02241161|Protective Agents|protective agents|mesh-ancestor
15078366|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078367|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15078368|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078369|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
15078370|NCT02241174|Eusol|eusol|mesh-list
15078371|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
15078372|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078373|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
15078374|NCT02241200|Hematinics|hematinics|mesh-ancestor
15078375|NCT02241278|Ketamine|ketamine|mesh-list
15078376|NCT02241278|Analgesics|analgesics|mesh-ancestor
15078377|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
15078378|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078379|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078380|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15078381|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15078382|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
15078383|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
15078384|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078385|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15078386|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15078387|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078388|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078389|NCT02241356|Methamphetamine|methamphetamine|mesh-list
15078390|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15078391|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078392|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
15078393|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
15078394|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078395|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
15078396|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078397|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078398|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
15078399|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
15078400|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15078401|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078402|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15078403|NCT02241421|Amoxicillin|amoxicillin|mesh-list
15078404|NCT02241421|Vancomycin|vancomycin|mesh-list
15078405|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15078406|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078407|NCT02241460|Lidocaine|lidocaine|mesh-list
15078408|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
15078409|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
15078410|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078411|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078412|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
15078413|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078414|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15078415|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15078416|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15078417|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078418|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078419|NCT02241499|Fluorouracil|fluorouracil|mesh-list
15078420|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
15078421|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
15078422|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078423|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15078424|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078425|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15078426|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
15078427|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078428|NCT02241564|Sirolimus|sirolimus|mesh-list
15078429|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
15078430|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078431|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078432|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15078433|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078434|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15078435|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078436|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
15078437|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15078438|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
15078439|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078440|NCT02241590|Entecavir|entecavir|mesh-list
15078441|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
15078442|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078443|NCT02241616|Entecavir|entecavir|mesh-list
15078444|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
15078445|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078446|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
15078447|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15078448|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078449|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15078450|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15078451|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078452|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078453|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078454|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
15078455|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
15078456|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
15078457|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078458|NCT02241876|Expectorants|expectorants|mesh-ancestor
15078459|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
15078460|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
15078461|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
15078462|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078463|NCT02241876|Protective Agents|protective agents|mesh-ancestor
15078464|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078465|NCT02241876|Antidotes|antidotes|mesh-ancestor
15078466|NCT02241941|Daptomycin|daptomycin|mesh-list
15078467|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15078468|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078469|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15078470|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15078471|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
15078472|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15078473|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15078474|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078475|NCT02242149|Diacetylrhein|diacetylrhein|mesh-list
15078476|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15078477|NCT02242214|Misoprostol|misoprostol|mesh-list
15078478|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15078479|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
15078480|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15078481|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078482|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15078483|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15078484|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
15078485|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15078486|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15078487|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
15078488|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078489|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078490|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15078491|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
15078492|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15078493|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15078494|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15078495|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
15078496|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078497|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078498|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
15078499|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
15078500|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15078501|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
15078502|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078503|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078504|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15078505|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
15078506|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15078507|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15078508|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15078509|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
15078510|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078511|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078512|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
15078513|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15078514|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
15078515|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
15078516|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
15078517|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15078518|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
15078519|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078520|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078521|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15078522|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
15078523|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
15078524|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15078525|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
15078526|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078527|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078528|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15078529|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15078530|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15078531|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
15078532|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
15078533|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15078534|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
15078535|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078536|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078537|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15078538|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
15078539|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
15078540|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15078541|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
15078542|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078543|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078544|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
15078545|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15078546|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
15078547|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078548|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078549|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15078550|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
15078551|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
15078552|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15078553|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
15078554|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078555|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078556|NCT02242292|Scopolamine|scopolamine|mesh-list
15078557|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
15078558|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15078559|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
15078560|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
15078561|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078562|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078563|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15078564|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
15078565|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
15078566|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
15078567|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078568|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078569|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
15078570|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
15078571|NCT02242318|Valsartan|valsartan|mesh-list
15078572|NCT02242318|Telmisartan|telmisartan|mesh-list
15078573|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078574|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078575|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15078576|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078577|NCT02242331|Telmisartan|telmisartan|mesh-list
15078578|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078579|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078580|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15078581|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078582|NCT02242344|Telmisartan|telmisartan|mesh-list
15078583|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078584|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078585|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15078586|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078587|NCT02242357|Telmisartan|telmisartan|mesh-list
15078588|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078589|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078590|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15078591|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078592|NCT02242370|Telmisartan|telmisartan|mesh-list
15078593|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078594|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078595|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15078596|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078597|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15078598|NCT02242383|Telmisartan|telmisartan|mesh-list
15078599|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078600|NCT02242383|Diuretics|diuretics|mesh-ancestor
15078601|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
15078602|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078603|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15078604|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078605|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078606|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078607|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15078608|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15078609|NCT02242396|Telmisartan|telmisartan|mesh-list
15078610|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
15078611|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078612|NCT02242396|Diuretics|diuretics|mesh-ancestor
15078613|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
15078614|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078615|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15078616|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078617|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078618|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078619|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15078620|NCT02242409|Gemcitabine|gemcitabine|mesh-list
15078621|NCT02242409|Paclitaxel|paclitaxel|mesh-list
15078622|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15078623|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15078624|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078625|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
15078626|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
15078627|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
15078628|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078629|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15078630|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
15078631|NCT02242409|Antiviral Agents|antiviral agents|mesh-ancestor
15078632|NCT02242409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078633|NCT02242409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078634|NCT02242409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15078635|NCT02242409|Immunologic Factors|immunologic factors|mesh-ancestor
15078636|NCT02242409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078637|NCT02242474|Adalimumab|adalimumab|mesh-list
15078638|NCT02242474|Etanercept|etanercept|mesh-list
15078639|NCT02242474|Golimumab|golimumab|mesh-list
15078640|NCT02242474|Infliximab|infliximab|mesh-list
15078641|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
15078642|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15078643|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15078644|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15078645|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
15078646|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15078647|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15078648|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15078649|NCT02242474|Analgesics|analgesics|mesh-ancestor
15078650|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
15078651|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078652|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078653|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15078654|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
15078655|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
15078656|NCT02242513|Lidocaine|lidocaine|mesh-list
15078657|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
15078658|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
15078659|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078660|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078661|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
15078662|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078663|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15078664|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15078665|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15078666|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078667|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078668|NCT02242591|Ropivacaine|ropivacaine|mesh-list
15078669|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
15078670|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
15078671|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078672|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078673|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
15078674|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078675|NCT02242656|Opium|opium|mesh-list
15078676|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15078677|NCT02242656|Narcotics|narcotics|mesh-ancestor
15078678|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078679|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078680|NCT02242656|Analgesics|analgesics|mesh-ancestor
15078681|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
15078682|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078683|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
15078684|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15078685|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
15078686|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
15078687|NCT02242695|Clotrimazole|clotrimazole|mesh-list
15078688|NCT02242695|Dequalinium|dequalinium|mesh-list
15078689|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15078690|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078691|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
15078692|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15078693|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15078694|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078695|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078696|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15078697|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
15078698|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15078699|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078700|NCT02242734|Hydrocodone|hydrocodone|mesh-list
15078701|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15078702|NCT02242734|Narcotics|narcotics|mesh-ancestor
15078703|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078704|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078705|NCT02242734|Analgesics|analgesics|mesh-ancestor
15078706|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
15078707|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078708|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
15078709|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
15078710|NCT02242799|Artesunate|artesunate|mesh-list
15078711|NCT02242799|Lumefantrine|lumefantrine|mesh-list
15078712|NCT02242799|Artemether|artemether|mesh-list
15078713|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
15078714|NCT02242799|Amodiaquine|amodiaquine|mesh-list
15078715|NCT02242799|Dolutegravir|dolutegravir|mesh-list
15078716|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
15078717|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15078718|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15078719|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078720|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078721|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
15078722|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
15078723|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15078724|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
15078725|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15078726|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15078727|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078728|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078729|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15078730|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15078731|NCT02242812|Metoprolol|metoprolol|mesh-list
15078732|NCT02242812|Telmisartan|telmisartan|mesh-list
15078733|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078734|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078735|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15078736|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078737|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15078738|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
15078739|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
15078740|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078741|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078742|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
15078743|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
15078744|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15078745|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
15078746|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078747|NCT02242825|Telmisartan|telmisartan|mesh-list
15078748|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
15078749|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078750|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078751|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15078752|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078753|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15078754|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078755|NCT02242825|Diuretics|diuretics|mesh-ancestor
15078756|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
15078757|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078758|NCT02242838|Telmisartan|telmisartan|mesh-list
15078759|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078760|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078761|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15078762|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078763|NCT02242851|Telmisartan|telmisartan|mesh-list
15078764|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078765|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078766|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15078767|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078768|NCT02242864|Telmisartan|telmisartan|mesh-list
15078769|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
15078770|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078771|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078772|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15078773|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078774|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15078775|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078776|NCT02242864|Diuretics|diuretics|mesh-ancestor
15078777|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
15078778|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078779|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15078780|NCT02242877|Telmisartan|telmisartan|mesh-list
15078781|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078782|NCT02242877|Diuretics|diuretics|mesh-ancestor
15078783|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
15078784|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078785|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15078786|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078787|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078788|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078789|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15078790|NCT02242929|Imiquimod|imiquimod|mesh-list
15078791|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15078792|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
15078793|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078794|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078795|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
15078796|NCT02242955|Diazepam|diazepam|mesh-list
15078797|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15078798|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
15078799|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
15078800|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
15078801|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078802|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078803|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15078804|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15078805|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078806|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
15078807|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15078808|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15078809|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15078810|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15078811|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15078812|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
15078813|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
15078814|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
15078815|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
15078816|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078817|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078818|NCT02243098|Digoxin|digoxin|mesh-list
15078819|NCT02243098|Atorvastatin|atorvastatin|mesh-list
15078820|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15078821|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15078822|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
15078823|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078824|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15078825|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15078826|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078827|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15078828|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15078829|NCT02243098|Protective Agents|protective agents|mesh-ancestor
15078830|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078831|NCT02243124|Dexamethasone|dexamethasone|mesh-list
15078832|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15078833|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
15078834|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
15078835|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078836|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078837|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15078838|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
15078839|NCT02243124|Hormones|hormones|mesh-ancestor
15078840|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15078841|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15078842|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078843|NCT02243137|Aspirin|aspirin|mesh-list
15078844|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
15078845|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
15078846|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15078847|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15078848|NCT02243137|Analgesics|analgesics|mesh-ancestor
15078849|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
15078850|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078851|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078852|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15078853|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15078854|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15078855|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15078856|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078857|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15078858|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15078859|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078860|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
15078861|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
15078862|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
15078863|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15078864|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078865|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15078866|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15078867|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078868|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078869|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078870|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15078871|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
15078872|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15078873|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078874|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15078875|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15078876|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15078877|NCT02243254|Ibuprofen|ibuprofen|mesh-list
15078878|NCT02243254|Remifentanil|remifentanil|mesh-list
15078879|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15078880|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15078881|NCT02243254|Analgesics|analgesics|mesh-ancestor
15078882|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
15078883|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078884|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078885|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15078886|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15078887|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15078888|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078889|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078890|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15078891|NCT02243254|Narcotics|narcotics|mesh-ancestor
15078892|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078893|NCT02243358|Gemcitabine|gemcitabine|mesh-list
15078894|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15078895|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
15078896|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078897|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078898|NCT02243358|Antiviral Agents|antiviral agents|mesh-ancestor
15078899|NCT02243358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078900|NCT02243358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078901|NCT02243358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15078902|NCT02243358|Immunologic Factors|immunologic factors|mesh-ancestor
15078903|NCT02243358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078904|NCT02243436|Cytarabine|cytarabine|mesh-list
15078905|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
15078906|NCT02243436|Etoposide|etoposide|mesh-list
15078907|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15078908|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15078909|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15078910|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15078911|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15078912|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078913|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078914|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15078915|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
15078916|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
15078917|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078918|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15078919|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
15078920|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078921|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15078922|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
15078923|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
15078924|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15078925|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15078926|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
15078927|NCT02243436|Hormones|hormones|mesh-ancestor
15078928|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15078929|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15078930|NCT02243436|Protective Agents|protective agents|mesh-ancestor
15078931|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15078932|NCT02243553|Vitamin K|vitamin k|mesh-list
15078933|NCT02243553|Ritonavir|ritonavir|mesh-list
15078934|NCT02243553|Tipranavir|tipranavir|mesh-list
15078935|NCT02243553|Digoxin|digoxin|mesh-list
15078936|NCT02243553|Midazolam|midazolam|mesh-list
15078937|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
15078938|NCT02243553|Caffeine|caffeine|mesh-list
15078939|NCT02243553|Omeprazole|omeprazole|mesh-list
15078940|NCT02243553|Warfarin|warfarin|mesh-list
15078941|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15078942|NCT02243553|Vitamins|vitamins|mesh-ancestor
15078943|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
15078944|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078945|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15078946|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15078947|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15078948|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15078949|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15078950|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15078951|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15078952|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
15078953|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
15078954|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
15078955|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
15078956|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15078957|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078958|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15078959|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15078960|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
15078961|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15078962|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15078963|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15078964|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
15078965|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15078966|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15078967|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15078968|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
15078969|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15078970|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15078971|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15078972|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15078973|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15078974|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15078975|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15078976|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
15078977|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15078978|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15078979|NCT02243553|Protective Agents|protective agents|mesh-ancestor
15078980|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
15078981|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15078982|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
15078983|NCT02243553|Coagulants|coagulants|mesh-ancestor
15078984|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
15078985|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
15078986|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15078987|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15078988|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15078989|NCT02243566|Telmisartan|telmisartan|mesh-list
15078990|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
15078991|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15078992|NCT02243566|Diuretics|diuretics|mesh-ancestor
15078993|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
15078994|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15078995|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15078996|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15078997|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15078998|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15078999|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15079000|NCT02243618|Rebamipide|rebamipide|mesh-list
15079001|NCT02243618|Polaprezinc|polaprezinc|mesh-list
15079002|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15079003|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15079004|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
15079005|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079006|NCT02243618|Protective Agents|protective agents|mesh-ancestor
15079007|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079008|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079009|NCT02243631|Probenecid|probenecid|mesh-list
15079010|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
15079011|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
15079012|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15079013|NCT02243631|Renal Agents|renal agents|mesh-ancestor
15079014|NCT02243644|Albendazole|albendazole|mesh-list
15079015|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
15079016|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15079017|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15079018|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
15079019|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15079020|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15079021|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
15079022|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
15079023|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
15079024|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079025|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079026|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
15079027|NCT02243735|Trace Elements|trace elements|mesh-ancestor
15079028|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
15079029|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079030|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
15079031|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15079032|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079033|NCT02243800|Vitamins|vitamins|mesh-ancestor
15079034|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
15079035|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
15079036|NCT02243813|Psilocybin|psilocybin|mesh-list
15079037|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
15079038|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079039|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15079040|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
15079041|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
15079042|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
15079043|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
15079044|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079045|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079046|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15079047|NCT02243826|Analgesics|analgesics|mesh-ancestor
15079048|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
15079049|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079050|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
15079051|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15079052|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079053|NCT02243852|Hormones|hormones|mesh-list
15079054|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15079055|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079056|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
15079057|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15079058|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079059|NCT02244073|Insulin|insulin|mesh-list
15079060|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15079061|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15079062|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079063|NCT02244086|Bupivacaine|bupivacaine|mesh-list
15079064|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
15079065|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
15079066|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079067|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079068|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
15079069|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079070|NCT02244112|Midazolam|midazolam|mesh-list
15079071|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15079072|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15079073|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079074|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079075|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15079076|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15079077|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15079078|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15079079|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
15079080|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
15079081|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
15079082|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
15079083|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079084|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079085|NCT02244125|Dexamethasone|dexamethasone|mesh-list
15079086|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
15079087|NCT02244125|Pomalidomide|pomalidomide|mesh-list
15079088|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15079089|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
15079090|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079091|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15079092|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15079093|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
15079094|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079095|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079096|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15079097|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15079098|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
15079099|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
15079100|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079101|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15079102|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
15079103|NCT02244125|Hormones|hormones|mesh-ancestor
15079104|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15079105|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15079106|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15079107|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15079108|NCT02244125|Growth Substances|growth substances|mesh-ancestor
15079109|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
15079110|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
15079111|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
15079112|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15079113|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
15079114|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15079115|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079116|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15079117|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15079118|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079119|NCT02244164|Liraglutide|liraglutide|mesh-list
15079120|NCT02244164|Exenatide|exenatide|mesh-list
15079121|NCT02244164|Lixisenatide|lixisenatide|mesh-list
15079122|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
15079123|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15079124|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079125|NCT02244164|Incretins|incretins|mesh-ancestor
15079126|NCT02244164|Hormones|hormones|mesh-ancestor
15079127|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15079128|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
15079129|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
15079130|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079131|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079132|NCT02244190|Ritonavir|ritonavir|mesh-list
15079133|NCT02244190|Tipranavir|tipranavir|mesh-list
15079134|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15079135|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15079136|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
15079137|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079138|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079139|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15079140|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15079141|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
15079142|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15079143|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15079144|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15079145|NCT02244216|Fenoterol|fenoterol|mesh-list
15079146|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15079147|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
15079148|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079149|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079150|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15079151|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
15079152|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
15079153|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
15079154|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15079155|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
15079156|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15079157|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15079158|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079159|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079160|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079161|NCT02244229|Tamsulosin|tamsulosin|mesh-list
15079162|NCT02244229|Finasteride|finasteride|mesh-list
15079163|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15079164|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15079165|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15079166|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079167|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079168|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079169|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079170|NCT02244229|Urological Agents|urological agents|mesh-ancestor
15079171|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
15079172|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15079173|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079174|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
15079175|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15079176|NCT02244242|Tamsulosin|tamsulosin|mesh-list
15079177|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15079178|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15079179|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15079180|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079181|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079182|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079183|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079184|NCT02244242|Urological Agents|urological agents|mesh-ancestor
15079185|NCT02244255|Tamsulosin|tamsulosin|mesh-list
15079186|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15079187|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15079188|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15079189|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079190|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079191|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079192|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079193|NCT02244255|Urological Agents|urological agents|mesh-ancestor
15079194|NCT02244268|Tamsulosin|tamsulosin|mesh-list
15079195|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15079196|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15079197|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15079198|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079199|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079200|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079201|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079202|NCT02244268|Urological Agents|urological agents|mesh-ancestor
15079203|NCT02244281|Tamsulosin|tamsulosin|mesh-list
15079204|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15079205|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15079206|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15079207|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079208|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079209|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079210|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079211|NCT02244281|Urological Agents|urological agents|mesh-ancestor
15079212|NCT02244294|Tamsulosin|tamsulosin|mesh-list
15079213|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15079214|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15079215|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15079216|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079217|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079218|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079219|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079220|NCT02244294|Urological Agents|urological agents|mesh-ancestor
15079221|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
15079222|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
15079223|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
15079224|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079225|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079226|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079227|NCT02244320|Tamsulosin|tamsulosin|mesh-list
15079228|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15079229|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15079230|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15079231|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079232|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079233|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079234|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079235|NCT02244320|Urological Agents|urological agents|mesh-ancestor
15079236|NCT02244437|Acetaminophen|acetaminophen|mesh-list
15079237|NCT02244437|Ibuprofen|ibuprofen|mesh-list
15079238|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15079239|NCT02244437|Analgesics|analgesics|mesh-ancestor
15079240|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
15079241|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079242|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079243|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
15079244|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15079245|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15079246|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15079247|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15079248|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079249|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079250|NCT02244489|Capecitabine|capecitabine|mesh-list
15079251|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
15079252|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
15079253|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15079254|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
15079255|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079256|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079257|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15079258|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079259|NCT02244502|Paclitaxel|paclitaxel|mesh-list
15079260|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15079261|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079262|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
15079263|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
15079264|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
15079265|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079266|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
15079267|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15079268|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079269|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079270|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15079271|NCT02244515|Analgesics|analgesics|mesh-ancestor
15079272|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
15079273|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079274|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15079275|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15079276|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15079277|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079278|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079279|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079280|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
15079281|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
15079282|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15079283|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15079284|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079285|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079286|NCT02244528|Urological Agents|urological agents|mesh-ancestor
15079287|NCT02244567|Metformin|metformin|mesh-list
15079288|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079289|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15079290|NCT02244632|Bevacizumab|bevacizumab|mesh-list
15079291|NCT02244632|Fluorouracil|fluorouracil|mesh-list
15079292|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
15079293|NCT02244632|Irinotecan|irinotecan|mesh-list
15079294|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15079295|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079296|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15079297|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15079298|NCT02244632|Growth Substances|growth substances|mesh-ancestor
15079299|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079300|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
15079301|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
15079302|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079303|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15079304|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15079305|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
15079306|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15079307|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15079308|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079309|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
15079310|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15079311|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15079312|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079313|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
15079314|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079315|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079316|NCT02244710|Clopidogrel|clopidogrel|mesh-list
15079317|NCT02244710|Ticagrelor|ticagrelor|mesh-list
15079318|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15079319|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15079320|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15079321|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15079322|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
15079323|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079324|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079325|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079326|NCT02244762|Hydrocodone|hydrocodone|mesh-list
15079327|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15079328|NCT02244762|Narcotics|narcotics|mesh-ancestor
15079329|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079330|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079331|NCT02244762|Analgesics|analgesics|mesh-ancestor
15079332|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
15079333|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079334|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
15079335|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
15079336|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
15079337|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15079338|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15079339|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
15079340|NCT02244866|Hormones|hormones|mesh-ancestor
15079341|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15079342|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079343|NCT02244879|Resveratrol|resveratrol|mesh-list
15079344|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
15079345|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079346|NCT02244879|Protective Agents|protective agents|mesh-ancestor
15079347|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079348|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079349|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15079350|NCT02245022|Tenofovir|tenofovir|mesh-list
15079351|NCT02245022|Lamivudine|lamivudine|mesh-list
15079352|NCT02245022|Efavirenz|efavirenz|mesh-list
15079353|NCT02245022|Dolutegravir|dolutegravir|mesh-list
15079354|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
15079355|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15079356|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15079357|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15079358|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079359|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079360|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15079361|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15079362|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15079363|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15079364|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15079365|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
15079366|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
15079367|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
15079368|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15079369|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15079370|NCT02245087|Atorvastatin|atorvastatin|mesh-list
15079371|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15079372|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15079373|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
15079374|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079375|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15079376|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15079377|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079378|NCT02245126|Lidocaine|lidocaine|mesh-list
15079379|NCT02245126|Bupivacaine|bupivacaine|mesh-list
15079380|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
15079381|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
15079382|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079383|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079384|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
15079385|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079386|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15079387|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15079388|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15079389|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15079390|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079391|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
15079392|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079393|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079394|NCT02245191|Phenylephrine|phenylephrine|mesh-list
15079395|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
15079396|NCT02245191|Ephedrine|ephedrine|mesh-list
15079397|NCT02245191|Metaraminol|metaraminol|mesh-list
15079398|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15079399|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
15079400|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
15079401|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079402|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079403|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
15079404|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15079405|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
15079406|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
15079407|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15079408|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15079409|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15079410|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079411|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079412|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079413|NCT02245191|Protective Agents|protective agents|mesh-ancestor
15079414|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15079415|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
15079416|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15079417|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079418|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079419|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15079420|NCT02245256|Analgesics|analgesics|mesh-ancestor
15079421|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
15079422|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079423|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15079424|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15079425|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15079426|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079427|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079428|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079429|NCT02245269|Ritonavir|ritonavir|mesh-list
15079430|NCT02245269|Tipranavir|tipranavir|mesh-list
15079431|NCT02245269|Atorvastatin|atorvastatin|mesh-list
15079432|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15079433|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15079434|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
15079435|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079436|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15079437|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15079438|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079439|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15079440|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15079441|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
15079442|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15079443|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15079444|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
15079445|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15079446|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15079447|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15079448|NCT02245295|Anesthetics|anesthetics|mesh-list
15079449|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079450|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079451|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
15079452|NCT02245321|Hematinics|hematinics|mesh-ancestor
15079453|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
15079454|NCT02245334|Povidone|povidone|mesh-list
15079455|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
15079456|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
15079457|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15079458|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15079459|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
15079460|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15079461|NCT02245438|Ritonavir|ritonavir|mesh-list
15079462|NCT02245438|Tipranavir|tipranavir|mesh-list
15079463|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
15079464|NCT02245438|Norethindrone|norethindrone|mesh-list
15079465|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
15079466|NCT02245438|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
15079467|NCT02245438|Norinyl|norinyl|mesh-list
15079468|NCT02245438|Estradiol|estradiol|mesh-list
15079469|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15079470|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15079471|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
15079472|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079473|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079474|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15079475|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15079476|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
15079477|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15079478|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15079479|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15079480|NCT02245438|Estrogens|estrogens|mesh-ancestor
15079481|NCT02245438|Hormones|hormones|mesh-ancestor
15079482|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15079483|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079484|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
15079485|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
15079486|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15079487|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15079488|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
15079489|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
15079490|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
15079491|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
15079492|NCT02245438|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
15079493|NCT02245451|Ritonavir|ritonavir|mesh-list
15079494|NCT02245451|Tipranavir|tipranavir|mesh-list
15079495|NCT02245451|Methadone|methadone|mesh-list
15079496|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15079497|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15079498|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
15079499|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079500|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079501|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15079502|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15079503|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
15079504|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15079505|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15079506|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15079507|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15079508|NCT02245451|Narcotics|narcotics|mesh-ancestor
15079509|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079510|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079511|NCT02245451|Analgesics|analgesics|mesh-ancestor
15079512|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
15079513|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079514|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
15079515|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
15079516|NCT02245464|Telmisartan|telmisartan|mesh-list
15079517|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15079518|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15079519|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15079520|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079521|NCT02245477|Mitogens|mitogens|mesh-list
15079522|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
15079523|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
15079524|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079525|NCT02245477|Growth Substances|growth substances|mesh-ancestor
15079526|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079527|NCT02245490|Tamsulosin|tamsulosin|mesh-list
15079528|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15079529|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15079530|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15079531|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079532|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079533|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079534|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079535|NCT02245490|Urological Agents|urological agents|mesh-ancestor
15079536|NCT02245503|Tamsulosin|tamsulosin|mesh-list
15079537|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15079538|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15079539|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15079540|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079541|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079542|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079543|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079544|NCT02245503|Urological Agents|urological agents|mesh-ancestor
15079545|NCT02245529|Tamsulosin|tamsulosin|mesh-list
15079546|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15079547|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15079548|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15079549|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079550|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079551|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079552|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079553|NCT02245529|Urological Agents|urological agents|mesh-ancestor
15079554|NCT02245555|Tamsulosin|tamsulosin|mesh-list
15079555|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15079556|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15079557|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15079558|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079559|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079560|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079561|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079562|NCT02245555|Urological Agents|urological agents|mesh-ancestor
15079563|NCT02245789|Remifentanil|remifentanil|mesh-list
15079564|NCT02245789|Propofol|propofol|mesh-list
15079565|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
15079566|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079567|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079568|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15079569|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15079570|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
15079571|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15079572|NCT02245789|Narcotics|narcotics|mesh-ancestor
15079573|NCT02245789|Analgesics|analgesics|mesh-ancestor
15079574|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
15079575|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079576|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
15079577|NCT02245841|Hormones|hormones|mesh-ancestor
15079578|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15079579|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079580|NCT02245867|Antibodies|antibodies|mesh-list
15079581|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15079582|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
15079583|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079584|NCT02245932|Resveratrol|resveratrol|mesh-list
15079585|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
15079586|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079587|NCT02245932|Protective Agents|protective agents|mesh-ancestor
15079588|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079589|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079590|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15079591|NCT02246023|Propofol|propofol|mesh-list
15079592|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15079593|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079594|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079595|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15079596|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
15079597|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
15079598|NCT02246049|Leucovorin|leucovorin|mesh-list
15079599|NCT02246049|Bevacizumab|bevacizumab|mesh-list
15079600|NCT02246049|Fluorouracil|fluorouracil|mesh-list
15079601|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
15079602|NCT02246049|Irinotecan|irinotecan|mesh-list
15079603|NCT02246049|Calcium|calcium|mesh-list
15079604|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
15079605|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15079606|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079607|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15079608|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15079609|NCT02246049|Growth Substances|growth substances|mesh-ancestor
15079610|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079611|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
15079612|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15079613|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
15079614|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079615|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15079616|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15079617|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
15079618|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15079619|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15079620|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079621|NCT02246049|Antidotes|antidotes|mesh-ancestor
15079622|NCT02246049|Protective Agents|protective agents|mesh-ancestor
15079623|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
15079624|NCT02246049|Vitamins|vitamins|mesh-ancestor
15079625|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
15079626|NCT02246127|Everolimus|everolimus|mesh-list
15079627|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079628|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15079629|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
15079630|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079631|NCT02246179|Lidocaine|lidocaine|mesh-list
15079632|NCT02246179|Epinephrine|epinephrine|mesh-list
15079633|NCT02246179|Prilocaine|prilocaine|mesh-list
15079634|NCT02246179|Carticaine|carticaine|mesh-list
15079635|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
15079636|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
15079637|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
15079638|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079639|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079640|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
15079641|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079642|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15079643|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
15079644|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
15079645|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15079646|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079647|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15079648|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15079649|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079650|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079651|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15079652|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15079653|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
15079654|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15079655|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
15079656|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
15079657|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
15079658|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15079659|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
15079660|NCT02246244|Citalopram|citalopram|mesh-list
15079661|NCT02246244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15079662|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15079663|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15079664|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079665|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079666|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
15079667|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079668|NCT02246244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15079669|NCT02246244|Antidepressive Agents|antidepressive agents|mesh-ancestor
15079670|NCT02246244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15079671|NCT02246257|Metformin|metformin|mesh-list
15079672|NCT02246257|Losartan|losartan|mesh-list
15079673|NCT02246257|Simvastatin|simvastatin|mesh-list
15079674|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15079675|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079676|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
15079677|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15079678|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
15079679|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079680|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15079681|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
15079682|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079683|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
15079684|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15079685|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15079686|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15079687|NCT02246270|Heparin|heparin|mesh-list
15079688|NCT02246270|Calcium heparin|calcium heparin|mesh-list
15079689|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
15079690|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15079691|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15079692|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079693|NCT02246595|Vilobelimab|vilobelimab|mesh-list
15079694|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
15079695|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15079696|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
15079697|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079698|NCT02246621|Letrozole|letrozole|mesh-list
15079699|NCT02246621|Anastrozole|anastrozole|mesh-list
15079700|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079701|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15079702|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15079703|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079704|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079705|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15079706|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
15079707|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15079708|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079709|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15079710|NCT02246712|Tramadol|tramadol|mesh-list
15079711|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15079712|NCT02246712|Narcotics|narcotics|mesh-ancestor
15079713|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079714|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079715|NCT02246712|Analgesics|analgesics|mesh-ancestor
15079716|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
15079717|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079718|NCT02246816|Opium|opium|mesh-list
15079719|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15079720|NCT02246816|Narcotics|narcotics|mesh-ancestor
15079721|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079722|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079723|NCT02246816|Analgesics|analgesics|mesh-ancestor
15079724|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
15079725|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079726|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
15079727|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15079728|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
15079729|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
15079730|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
15079731|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15079732|NCT02246842|Antibodies|antibodies|mesh-list
15079733|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15079734|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
15079735|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
15079736|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079737|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
15079738|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15079739|NCT02246855|Antibodies|antibodies|mesh-list
15079740|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
15079741|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079742|NCT02246868|Factor VIII|factor viii|mesh-list
15079743|NCT02246868|Coagulants|coagulants|mesh-ancestor
15079744|NCT02246881|Factor VIII|factor viii|mesh-list
15079745|NCT02246881|Coagulants|coagulants|mesh-ancestor
15079746|NCT02246894|Factor VIII|factor viii|mesh-list
15079747|NCT02246894|Coagulants|coagulants|mesh-ancestor
15079748|NCT02246920|Fluticasone|fluticasone|mesh-list
15079749|NCT02246920|Xhance|xhance|mesh-list
15079750|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15079751|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15079752|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
15079753|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079754|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079755|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15079756|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
15079757|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
15079758|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15079759|NCT02247128|Aspirin|aspirin|mesh-list
15079760|NCT02247128|Clopidogrel|clopidogrel|mesh-list
15079761|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15079762|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15079763|NCT02247128|Analgesics|analgesics|mesh-ancestor
15079764|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
15079765|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079766|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079767|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15079768|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15079769|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15079770|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15079771|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079772|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15079773|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15079774|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079775|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
15079776|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15079777|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15079778|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15079779|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
15079780|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079781|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
15079782|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15079783|NCT02247141|Antibodies|antibodies|mesh-list
15079784|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
15079785|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079786|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
15079787|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15079788|NCT02247154|Antibodies|antibodies|mesh-list
15079789|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
15079790|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079791|NCT02247258|Azathioprine|azathioprine|mesh-list
15079792|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
15079793|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079794|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15079795|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079796|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15079797|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
15079798|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079799|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15079800|NCT02247310|Interferons|interferons|mesh-list
15079801|NCT02247310|Interferon-beta|interferon-beta|mesh-list
15079802|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
15079803|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079804|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
15079805|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15079806|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
15079807|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079808|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15079809|NCT02247362|Vaccines|vaccines|mesh-list
15079810|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
15079811|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
15079812|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079813|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
15079814|NCT02247414|Aspirin|aspirin|mesh-list
15079815|NCT02247414|Heparin|heparin|mesh-list
15079816|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
15079817|NCT02247414|Tinzaparin|tinzaparin|mesh-list
15079818|NCT02247414|Dalteparin|dalteparin|mesh-list
15079819|NCT02247414|Dipyridamole|dipyridamole|mesh-list
15079820|NCT02247414|Warfarin|warfarin|mesh-list
15079821|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15079822|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15079823|NCT02247414|Analgesics|analgesics|mesh-ancestor
15079824|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
15079825|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079826|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079827|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15079828|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15079829|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15079830|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15079831|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079832|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15079833|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15079834|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079835|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
15079836|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
15079837|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15079838|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
15079839|NCT02247505|Tadalafil|tadalafil|mesh-list
15079840|NCT02247505|Tamsulosin|tamsulosin|mesh-list
15079841|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
15079842|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15079843|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15079844|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079845|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079846|NCT02247505|Urological Agents|urological agents|mesh-ancestor
15079847|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15079848|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15079849|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15079850|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079851|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079852|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079853|NCT02247518|Tadalafil|tadalafil|mesh-list
15079854|NCT02247518|Tamsulosin|tamsulosin|mesh-list
15079855|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
15079856|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
15079857|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15079858|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079859|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079860|NCT02247518|Urological Agents|urological agents|mesh-ancestor
15079861|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
15079862|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
15079863|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15079864|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
15079865|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079866|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079867|NCT02247544|Trabectedin|trabectedin|mesh-list
15079868|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15079869|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
15079870|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079871|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079872|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
15079873|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
15079874|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
15079875|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079876|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079877|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
15079878|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15079879|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079880|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
15079881|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079882|NCT02247596|Resveratrol|resveratrol|mesh-list
15079883|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
15079884|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079885|NCT02247596|Protective Agents|protective agents|mesh-ancestor
15079886|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079887|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079888|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15079889|NCT02247648|Tramadol|tramadol|mesh-list
15079890|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15079891|NCT02247648|Narcotics|narcotics|mesh-ancestor
15079892|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15079893|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079894|NCT02247648|Analgesics|analgesics|mesh-ancestor
15079895|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
15079896|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15079897|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
15079898|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
15079899|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
15079900|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15079901|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15079902|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
15079903|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15079904|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
15079905|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
15079906|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15079907|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079908|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15079909|NCT02247986|Methylphenidate|methylphenidate|mesh-list
15079910|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15079911|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079912|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
15079913|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15079914|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15079915|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079916|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
15079917|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079918|NCT02248012|Everolimus|everolimus|mesh-list
15079919|NCT02248012|Temozolomide|temozolomide|mesh-list
15079920|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15079921|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15079922|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
15079923|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079924|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15079925|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
15079926|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079927|NCT02248051|CXA-10|cxa-10|mesh-list
15079928|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15079929|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
15079930|NCT02248129|Telmisartan|telmisartan|mesh-list
15079931|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15079932|NCT02248129|Diuretics|diuretics|mesh-ancestor
15079933|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
15079934|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079935|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
15079936|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15079937|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079938|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
15079939|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
15079940|NCT02248142|Pramipexole|pramipexole|mesh-list
15079941|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
15079942|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079943|NCT02248142|Protective Agents|protective agents|mesh-ancestor
15079944|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079945|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15079946|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15079947|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
15079948|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
15079949|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079950|NCT02248155|Pramipexole|pramipexole|mesh-list
15079951|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
15079952|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079953|NCT02248155|Protective Agents|protective agents|mesh-ancestor
15079954|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079955|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15079956|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15079957|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
15079958|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
15079959|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079960|NCT02248168|Pramipexole|pramipexole|mesh-list
15079961|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
15079962|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079963|NCT02248168|Protective Agents|protective agents|mesh-ancestor
15079964|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079965|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15079966|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15079967|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
15079968|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
15079969|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079970|NCT02248181|Pramipexole|pramipexole|mesh-list
15079971|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
15079972|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079973|NCT02248181|Protective Agents|protective agents|mesh-ancestor
15079974|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079975|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15079976|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15079977|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
15079978|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
15079979|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079980|NCT02248207|Pramipexole|pramipexole|mesh-list
15079981|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
15079982|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079983|NCT02248207|Protective Agents|protective agents|mesh-ancestor
15079984|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079985|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15079986|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15079987|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
15079988|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
15079989|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15079990|NCT02248220|Pramipexole|pramipexole|mesh-list
15079991|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
15079992|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15079993|NCT02248220|Protective Agents|protective agents|mesh-ancestor
15079994|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15079995|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
15079996|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
15079997|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
15079998|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
15079999|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080000|NCT02248233|Nimodipine|nimodipine|mesh-list
15080001|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
15080002|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
15080003|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15080004|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
15080005|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15080006|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080007|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
15080008|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080009|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
15080010|NCT02248259|Itraconazole|itraconazole|mesh-list
15080011|NCT02248259|BI 409306|bi 409306|mesh-list
15080012|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
15080013|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080014|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15080015|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15080016|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080017|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080018|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15080019|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
15080020|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15080021|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080022|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15080023|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15080024|NCT02248415|Anesthetics|anesthetics|mesh-list
15080025|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15080026|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080027|NCT02248428|Thalidomide|thalidomide|mesh-list
15080028|NCT02248428|Clarithromycin|clarithromycin|mesh-list
15080029|NCT02248428|Dexamethasone|dexamethasone|mesh-list
15080030|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
15080031|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15080032|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
15080033|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080034|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15080035|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15080036|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
15080037|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080038|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080039|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15080040|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15080041|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
15080042|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
15080043|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080044|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15080045|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
15080046|NCT02248428|Hormones|hormones|mesh-ancestor
15080047|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15080048|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15080049|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
15080050|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15080051|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080052|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15080053|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15080054|NCT02248428|Growth Substances|growth substances|mesh-ancestor
15080055|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
15080056|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15080057|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080058|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15080059|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15080060|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
15080061|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15080062|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080063|NCT02248493|Acetaminophen|acetaminophen|mesh-list
15080064|NCT02248493|Ketoprofen|ketoprofen|mesh-list
15080065|NCT02248493|Morphine|morphine|mesh-list
15080066|NCT02248493|Tramadol|tramadol|mesh-list
15080067|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15080068|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15080069|NCT02248493|Narcotics|narcotics|mesh-ancestor
15080070|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15080071|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080072|NCT02248493|Analgesics|analgesics|mesh-ancestor
15080073|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
15080074|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080075|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15080076|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
15080077|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15080078|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15080079|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15080080|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15080081|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080082|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080083|NCT02248506|Clotrimazole|clotrimazole|mesh-list
15080084|NCT02248506|Miconazole|miconazole|mesh-list
15080085|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
15080086|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080087|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
15080088|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
15080089|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15080090|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080091|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080092|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15080093|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
15080094|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15080095|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080096|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
15080097|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15080098|NCT05354778|Hydrocortisone|hydrocortisone|mesh-list
15080099|NCT05354778|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15080100|NCT05354778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15080101|NCT05354700|Carboplatin|carboplatin|mesh-list
15080102|NCT05354700|Etoposide|etoposide|mesh-list
15080103|NCT05354700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080104|NCT05354700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15080105|NCT05354700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15080106|NCT05354700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15080107|NCT05354700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080108|NCT05354700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080109|NCT05354635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
15080110|NCT05354635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080111|NCT05354479|Acetaminophen|acetaminophen|mesh-list
15080112|NCT05354479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15080113|NCT05354479|Analgesics|analgesics|mesh-ancestor
15080114|NCT05354479|Sensory System Agents|sensory system agents|mesh-ancestor
15080115|NCT05354479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080116|NCT05354479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080117|NCT05354479|Antipyretics|antipyretics|mesh-ancestor
15080118|NCT05354466|Neostigmine|neostigmine|mesh-list
15080119|NCT05354466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15080120|NCT05354466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080121|NCT05354466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080122|NCT05354466|Cholinergic Agents|cholinergic agents|mesh-ancestor
15080123|NCT05354466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080124|NCT05354466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080125|NCT05354466|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15080126|NCT05354466|Autonomic Agents|autonomic agents|mesh-ancestor
15080127|NCT05354466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080128|NCT05354453|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
15080129|NCT05354453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080130|NCT05354453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080131|NCT05354453|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
15080132|NCT05354453|Protective Agents|protective agents|mesh-ancestor
15080133|NCT05354453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080134|NCT05354453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080135|NCT05354258|Pyrimethamine|pyrimethamine|mesh-list
15080136|NCT05354258|Sulfadoxine|sulfadoxine|mesh-list
15080137|NCT05354258|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
15080138|NCT05354258|Amodiaquine|amodiaquine|mesh-list
15080139|NCT05354258|Albendazole|albendazole|mesh-list
15080140|NCT05354258|Praziquantel|praziquantel|mesh-list
15080141|NCT05354258|Antimalarials|antimalarials|mesh-ancestor
15080142|NCT05354258|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
15080143|NCT05354258|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15080144|NCT05354258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080145|NCT05354258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15080146|NCT05354258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080147|NCT05354258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080148|NCT05354258|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
15080149|NCT05354258|Renal Agents|renal agents|mesh-ancestor
15080150|NCT05354258|Anthelmintics|anthelmintics|mesh-ancestor
15080151|NCT05354258|Anticestodal Agents|anticestodal agents|mesh-ancestor
15080152|NCT05354258|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15080153|NCT05354258|Tubulin Modulators|tubulin modulators|mesh-ancestor
15080154|NCT05354258|Antimitotic Agents|antimitotic agents|mesh-ancestor
15080155|NCT05354258|Mitosis Modulators|mitosis modulators|mesh-ancestor
15080156|NCT05354258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080157|NCT05354128|Fibrinolytic Agents|fibrinolytic agents|mesh-list
15080158|NCT05354128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15080159|NCT05354128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080160|NCT05354102|Nivolumab|nivolumab|mesh-list
15080161|NCT05354102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15080162|NCT05354102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080163|NCT05354102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15080164|NCT05354102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080165|NCT05354076|Doxorubicin|doxorubicin|mesh-list
15080166|NCT05354076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15080167|NCT05354076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15080168|NCT05354076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080169|NCT05354076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15080170|NCT05354076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15080171|NCT05354076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080172|NCT05354076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080173|NCT05353933|Pantoprazole|pantoprazole|mesh-list
15080174|NCT05353933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
15080175|NCT05353933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15080176|NCT05353933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
15080177|NCT05353933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080178|NCT05353933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080179|NCT05353829|Methotrexate|methotrexate|mesh-list
15080180|NCT05353829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
15080181|NCT05353829|Abortifacient Agents|abortifacient agents|mesh-ancestor
15080182|NCT05353829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15080183|NCT05353829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080184|NCT05353829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15080185|NCT05353829|Antimetabolites|antimetabolites|mesh-ancestor
15080186|NCT05353829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080187|NCT05353829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080188|NCT05353829|Dermatologic Agents|dermatologic agents|mesh-ancestor
15080189|NCT05353829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080190|NCT05353829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15080191|NCT05353829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15080192|NCT05353829|Immunologic Factors|immunologic factors|mesh-ancestor
15080193|NCT05353829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15080194|NCT05353829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15080195|NCT05353816|Heparin|heparin|mesh-list
15080196|NCT05353816|Anticoagulants|anticoagulants|mesh-ancestor
15080197|NCT05353816|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15080198|NCT05353816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15080199|NCT05353816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080200|NCT05353764|Ropivacaine|ropivacaine|mesh-list
15080201|NCT05353764|Anesthetics, Local|anesthetics, local|mesh-ancestor
15080202|NCT05353764|Anesthetics|anesthetics|mesh-ancestor
15080203|NCT05353764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15080204|NCT05353764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080205|NCT05353764|Sensory System Agents|sensory system agents|mesh-ancestor
15080206|NCT05353764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080207|NCT05353673|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
15080208|NCT05353673|Danazol|danazol|mesh-list
15080209|NCT05353673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15080210|NCT05353673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080211|NCT05353673|Incretins|incretins|mesh-ancestor
15080212|NCT05353673|Hormones|hormones|mesh-ancestor
15080213|NCT05353673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15080214|NCT05353673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
15080215|NCT05353673|Protease Inhibitors|protease inhibitors|mesh-ancestor
15080216|NCT05353673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080217|NCT05353673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080218|NCT05353673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15080219|NCT05353673|Hormone Antagonists|hormone antagonists|mesh-ancestor
15080220|NCT05353543|Antidepressive Agents|antidepressive agents|mesh-list
15080221|NCT05353543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15080222|NCT05353439|Pembrolizumab|pembrolizumab|mesh-list
15080223|NCT05353439|Topotecan|topotecan|mesh-list
15080224|NCT05353439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15080225|NCT05353439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080226|NCT05353439|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15080227|NCT05353439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15080228|NCT05353439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080229|NCT05353439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080230|NCT05353374|Fusidic Acid|fusidic acid|mesh-list
15080231|NCT05353374|Petrolatum|petrolatum|mesh-list
15080232|NCT05353374|Emollients|emollients|mesh-ancestor
15080233|NCT05353374|Dermatologic Agents|dermatologic agents|mesh-ancestor
15080234|NCT05353374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15080235|NCT05353374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080236|NCT05353374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15080237|NCT05353374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080238|NCT05353374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080239|NCT05353361|Paclitaxel|paclitaxel|mesh-list
15080240|NCT05353361|Pertuzumab|pertuzumab|mesh-list
15080241|NCT05353361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15080242|NCT05353361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080243|NCT05353361|Tubulin Modulators|tubulin modulators|mesh-ancestor
15080244|NCT05353361|Antimitotic Agents|antimitotic agents|mesh-ancestor
15080245|NCT05353361|Mitosis Modulators|mitosis modulators|mesh-ancestor
15080246|NCT05353361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080247|NCT05353361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15080248|NCT05353348|Vitamins|vitamins|mesh-list
15080249|NCT05353348|Folic Acid|folic acid|mesh-list
15080250|NCT05353348|Hydroxocobalamin|hydroxocobalamin|mesh-list
15080251|NCT05353348|Vitamin B 12|vitamin b 12|mesh-list
15080252|NCT05353348|Vitamin B Complex|vitamin b complex|mesh-list
15080253|NCT05353348|Epoetin Alfa|epoetin alfa|mesh-list
15080254|NCT05353348|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
15080255|NCT05353348|Micronutrients|micronutrients|mesh-ancestor
15080256|NCT05353348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080257|NCT05353348|Hematinics|hematinics|mesh-ancestor
15080258|NCT05353335|Antihypertensive Agents|antihypertensive agents|mesh-list
15080259|NCT05353283|Tenofovir|tenofovir|mesh-list
15080260|NCT05353283|Antiviral Agents|antiviral agents|mesh-ancestor
15080261|NCT05353283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080262|NCT05353283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
15080263|NCT05353283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15080264|NCT05353283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080265|NCT05353283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080266|NCT05353283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15080267|NCT05353283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15080268|NCT05353257|Carboplatin|carboplatin|mesh-list
15080269|NCT05353257|Etoposide|etoposide|mesh-list
15080270|NCT05353257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080271|NCT05353257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15080272|NCT05353257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15080273|NCT05353257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15080274|NCT05353257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080275|NCT05353257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080276|NCT05353205|HH-GV-678|hh-gv-678|mesh-list
15080277|NCT05353205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15080278|NCT05353205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080279|NCT05353205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080280|NCT05353192|Hormones|hormones|mesh-list
15080281|NCT05353192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15080282|NCT05353192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080283|NCT05353140|Aspirin|aspirin|mesh-list
15080284|NCT05353140|Rivaroxaban|rivaroxaban|mesh-list
15080285|NCT05353140|Clopidogrel|clopidogrel|mesh-list
15080286|NCT05353140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15080287|NCT05353140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15080288|NCT05353140|Analgesics|analgesics|mesh-ancestor
15080289|NCT05353140|Sensory System Agents|sensory system agents|mesh-ancestor
15080290|NCT05353140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080291|NCT05353140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080292|NCT05353140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15080293|NCT05353140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15080294|NCT05353140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15080295|NCT05353140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15080296|NCT05353140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080297|NCT05353140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15080298|NCT05353140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15080299|NCT05353140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080300|NCT05353140|Antipyretics|antipyretics|mesh-ancestor
15080301|NCT05353140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
15080302|NCT05353140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15080303|NCT05353140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15080304|NCT05353140|Purinergic Agents|purinergic agents|mesh-ancestor
15080305|NCT05353140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080306|NCT05353140|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
15080307|NCT05353140|Antithrombins|antithrombins|mesh-ancestor
15080308|NCT05353140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
15080309|NCT05353140|Protease Inhibitors|protease inhibitors|mesh-ancestor
15080310|NCT05353140|Anticoagulants|anticoagulants|mesh-ancestor
15080311|NCT05353101|Loteprednol Etabonate|loteprednol etabonate|mesh-list
15080312|NCT05353101|Cyclosporine|cyclosporine|mesh-list
15080313|NCT05353101|Tobramycin|tobramycin|mesh-list
15080314|NCT05353101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15080315|NCT05353101|Cyclosporins|cyclosporins|mesh-list
15080316|NCT05353101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080317|NCT05353101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080318|NCT05353101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15080319|NCT05353101|Immunologic Factors|immunologic factors|mesh-ancestor
15080320|NCT05353101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080321|NCT05353101|Antifungal Agents|antifungal agents|mesh-ancestor
15080322|NCT05353101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080323|NCT05353101|Dermatologic Agents|dermatologic agents|mesh-ancestor
15080324|NCT05353101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15080325|NCT05353101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15080326|NCT05353101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15080327|NCT05353101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15080328|NCT05353101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15080329|NCT05353062|Epinephrine|epinephrine|mesh-list
15080330|NCT05353062|Hemostatics|hemostatics|mesh-list
15080331|NCT05353062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15080332|NCT05353062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15080333|NCT05353062|Adrenergic Agents|adrenergic agents|mesh-ancestor
15080334|NCT05353062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080335|NCT05353062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080336|NCT05353062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080337|NCT05353062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
15080338|NCT05353062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15080339|NCT05353062|Autonomic Agents|autonomic agents|mesh-ancestor
15080340|NCT05353062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080341|NCT05353062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15080342|NCT05353062|Respiratory System Agents|respiratory system agents|mesh-ancestor
15080343|NCT05353062|Mydriatics|mydriatics|mesh-ancestor
15080344|NCT05353062|Sympathomimetics|sympathomimetics|mesh-ancestor
15080345|NCT05353062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15080346|NCT05353062|Coagulants|coagulants|mesh-ancestor
15080347|NCT05353010|Tacrolimus|tacrolimus|mesh-list
15080348|NCT05353010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15080349|NCT05353010|Immunologic Factors|immunologic factors|mesh-ancestor
15080350|NCT05353010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080351|NCT05353010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15080352|NCT05353010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080353|NCT05353010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080354|NCT05352854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15080355|NCT05352854|Pilocarpine|pilocarpine|mesh-list
15080356|NCT05352854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15080357|NCT05352854|Miotics|miotics|mesh-ancestor
15080358|NCT05352854|Autonomic Agents|autonomic agents|mesh-ancestor
15080359|NCT05352854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080360|NCT05352854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080361|NCT05352854|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
15080362|NCT05352854|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
15080363|NCT05352854|Cholinergic Agents|cholinergic agents|mesh-ancestor
15080364|NCT05352854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080365|NCT05352854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080366|NCT05352828|Nivolumab|nivolumab|mesh-list
15080367|NCT05352828|Fludarabine|fludarabine|mesh-list
15080368|NCT05352828|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15080369|NCT05352828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15080370|NCT05352828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080371|NCT05352828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15080372|NCT05352828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080373|NCT05352828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15080374|NCT05352828|Alkylating Agents|alkylating agents|mesh-ancestor
15080375|NCT05352815|Insulin|insulin|mesh-list
15080376|NCT05352815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15080377|NCT05352815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080378|NCT05352685|Propofol|propofol|mesh-list
15080379|NCT05352685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15080380|NCT05352685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15080381|NCT05352685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080382|NCT05352685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15080383|NCT05352685|Anesthetics, General|anesthetics, general|mesh-ancestor
15080384|NCT05352685|Anesthetics|anesthetics|mesh-ancestor
15080385|NCT05352672|Pembrolizumab|pembrolizumab|mesh-list
15080386|NCT05352672|Cemiplimab|cemiplimab|mesh-list
15080387|NCT05352672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15080388|NCT05352672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080389|NCT05351489|Dexmedetomidine|dexmedetomidine|mesh-list
15080390|NCT05351489|Bupivacaine|bupivacaine|mesh-list
15080391|NCT05351489|Anesthetics, Local|anesthetics, local|mesh-ancestor
15080392|NCT05351489|Anesthetics|anesthetics|mesh-ancestor
15080393|NCT05351489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15080394|NCT05351489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080395|NCT05351489|Sensory System Agents|sensory system agents|mesh-ancestor
15080396|NCT05351489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080397|NCT05351489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15080398|NCT05351489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15080399|NCT05351489|Analgesics|analgesics|mesh-ancestor
15080400|NCT05351489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15080401|NCT05351489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15080402|NCT05351489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15080403|NCT05351489|Adrenergic Agents|adrenergic agents|mesh-ancestor
15080404|NCT05351489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080405|NCT05351489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080406|NCT05345002|Tretinoin|tretinoin|mesh-list
15080407|NCT05345002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080408|NCT05345002|Keratolytic Agents|keratolytic agents|mesh-ancestor
15080409|NCT05345002|Dermatologic Agents|dermatologic agents|mesh-ancestor
15080410|NCT05344404|Niacinamide|niacinamide|mesh-list
15080411|NCT05344404|Niacin|niacin|mesh-list
15080412|NCT05344404|Nicotinic Acids|nicotinic acids|mesh-list
15080413|NCT05344404|Vitamin B Complex|vitamin b complex|mesh-ancestor
15080414|NCT05344404|Vitamins|vitamins|mesh-ancestor
15080415|NCT05344404|Micronutrients|micronutrients|mesh-ancestor
15080416|NCT05344404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080417|NCT05344404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
15080418|NCT05344404|Antimetabolites|antimetabolites|mesh-ancestor
15080419|NCT05344404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080420|NCT05344404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
15080421|NCT05344404|Vasodilator Agents|vasodilator agents|mesh-ancestor
15080422|NCT05341609|Ritonavir|ritonavir|mesh-list
15080423|NCT05341609|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
15080424|NCT05341609|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
15080425|NCT05341609|Protease Inhibitors|protease inhibitors|mesh-ancestor
15080426|NCT05341609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080427|NCT05341609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080428|NCT05341609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
15080429|NCT05341609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
15080430|NCT05341609|Antiviral Agents|antiviral agents|mesh-ancestor
15080431|NCT05341609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080432|NCT05341609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15080433|NCT05341609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15080434|NCT05341180|Lactulose|lactulose|mesh-list
15080435|NCT05341180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
15080436|NCT05341180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15080437|NCT05340452|Clarithromycin|clarithromycin|mesh-list
15080438|NCT05340452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15080439|NCT05340452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080440|NCT05340452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
15080441|NCT05340452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080442|NCT05340452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080443|NCT05340452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
15080444|NCT05340452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15080445|NCT05339399|Oxytocin|oxytocin|mesh-list
15080446|NCT05339399|Oxytocics|oxytocics|mesh-ancestor
15080447|NCT05339399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15080448|NCT05339399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080449|NCT05338983|Anesthetics|anesthetics|mesh-list
15080450|NCT05338983|Mepivacaine|mepivacaine|mesh-list
15080451|NCT05338983|Anesthetics, Local|anesthetics, local|mesh-list
15080452|NCT05338983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15080453|NCT05338983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080454|NCT05338983|Sensory System Agents|sensory system agents|mesh-ancestor
15080455|NCT05338983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080456|NCT05338931|Gossypol acetic acid|gossypol acetic acid|mesh-list
15080457|NCT05338931|Gossypol|gossypol|mesh-list
15080458|NCT05338931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15080459|NCT05338931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080460|NCT05338931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
15080461|NCT05338931|Contraceptive Agents|contraceptive agents|mesh-ancestor
15080462|NCT05338931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
15080463|NCT05338931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080464|NCT05338931|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
15080465|NCT05338931|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
15080466|NCT05338931|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
15080467|NCT05337566|Azithromycin|azithromycin|mesh-list
15080468|NCT05337566|Cefuroxime|cefuroxime|mesh-list
15080469|NCT05337566|Cefuroxime axetil|cefuroxime axetil|mesh-list
15080470|NCT05337566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15080471|NCT05337566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080472|NCT05335954|Norepinephrine|norepinephrine|mesh-list
15080473|NCT05335954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15080474|NCT05335954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15080475|NCT05335954|Adrenergic Agents|adrenergic agents|mesh-ancestor
15080476|NCT05335954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080477|NCT05335954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080478|NCT05335954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080479|NCT05335954|Sympathomimetics|sympathomimetics|mesh-ancestor
15080480|NCT05335954|Autonomic Agents|autonomic agents|mesh-ancestor
15080481|NCT05335954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080482|NCT05335954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15080483|NCT05330364|Cladribine|cladribine|mesh-list
15080484|NCT05330364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080485|NCT05330364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15080486|NCT05330364|Immunologic Factors|immunologic factors|mesh-ancestor
15080487|NCT05330364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080488|NCT05328297|JNJ-55308942|jnj-55308942|mesh-list
15080489|NCT05328297|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
15080490|NCT05328297|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
15080491|NCT05328297|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15080492|NCT05328297|Purinergic Agents|purinergic agents|mesh-ancestor
15080493|NCT05328297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080494|NCT05328297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080495|NCT05328297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080496|NCT05327270|Nivolumab|nivolumab|mesh-list
15080497|NCT05327270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15080498|NCT05327270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080499|NCT05327270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15080500|NCT05327270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080501|NCT05324163|Celecoxib|celecoxib|mesh-list
15080502|NCT05324163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15080503|NCT05324163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15080504|NCT05324163|Analgesics|analgesics|mesh-ancestor
15080505|NCT05324163|Sensory System Agents|sensory system agents|mesh-ancestor
15080506|NCT05324163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080507|NCT05324163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080508|NCT05324163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15080509|NCT05324163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15080510|NCT05324163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
15080511|NCT05324163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
15080512|NCT05324163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080513|NCT05324163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080514|NCT05310916|Dapagliflozin|dapagliflozin|mesh-list
15080515|NCT05310916|Hypoglycemic Agents|hypoglycemic agents|mesh-list
15080516|NCT05310916|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15080517|NCT05310916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080518|NCT05310916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080519|NCT05307705|Paclitaxel|paclitaxel|mesh-list
15080520|NCT05307705|Letrozole|letrozole|mesh-list
15080521|NCT05307705|Fulvestrant|fulvestrant|mesh-list
15080522|NCT05307705|Anastrozole|anastrozole|mesh-list
15080523|NCT05307705|Exemestane|exemestane|mesh-list
15080524|NCT05307705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15080525|NCT05307705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080526|NCT05307705|Tubulin Modulators|tubulin modulators|mesh-ancestor
15080527|NCT05307705|Antimitotic Agents|antimitotic agents|mesh-ancestor
15080528|NCT05307705|Mitosis Modulators|mitosis modulators|mesh-ancestor
15080529|NCT05307705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080530|NCT05307705|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
15080531|NCT05307705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15080532|NCT05307705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080533|NCT05307705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15080534|NCT05307705|Hormone Antagonists|hormone antagonists|mesh-ancestor
15080535|NCT05307705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15080536|NCT05307705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080537|NCT05307705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15080538|NCT05307705|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15080539|NCT05299242|Adalimumab|adalimumab|mesh-list
15080540|NCT05299242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15080541|NCT05299242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15080542|NCT05298696|Cilostazol|cilostazol|mesh-list
15080543|NCT05298696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
15080544|NCT05298696|Autonomic Agents|autonomic agents|mesh-ancestor
15080545|NCT05298696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080546|NCT05298696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080547|NCT05298696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
15080548|NCT05298696|Respiratory System Agents|respiratory system agents|mesh-ancestor
15080549|NCT05298696|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
15080550|NCT05298696|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
15080551|NCT05298696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080552|NCT05298696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
15080553|NCT05298696|Vasodilator Agents|vasodilator agents|mesh-ancestor
15080554|NCT05298696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15080555|NCT05298696|Protective Agents|protective agents|mesh-ancestor
15080556|NCT05298696|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
15080557|NCT05298696|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15080558|NCT05298696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080559|NCT05298670|Metformin|metformin|mesh-list
15080560|NCT05298670|Interferons|interferons|mesh-list
15080561|NCT05298670|Interferon-beta|interferon-beta|mesh-list
15080562|NCT05298670|Interferon beta-1a|interferon beta-1a|mesh-list
15080563|NCT05298670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15080564|NCT05298670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080565|NCT05298670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080566|NCT05298670|Antiviral Agents|antiviral agents|mesh-ancestor
15080567|NCT05298670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080568|NCT05298670|Immunologic Factors|immunologic factors|mesh-ancestor
15080569|NCT05298670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15080570|NCT05289323|Neostigmine|neostigmine|mesh-list
15080571|NCT05289323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
15080572|NCT05289323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080573|NCT05289323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080574|NCT05289323|Cholinergic Agents|cholinergic agents|mesh-ancestor
15080575|NCT05289323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080576|NCT05289323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080577|NCT05289323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
15080578|NCT05289323|Autonomic Agents|autonomic agents|mesh-ancestor
15080579|NCT05289323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080580|NCT05268497|Antidepressive Agents|antidepressive agents|mesh-list
15080581|NCT05268497|Esketamine|esketamine|mesh-list
15080582|NCT05268497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15080583|NCT05256537|Mycophenolic Acid|mycophenolic acid|mesh-list
15080584|NCT05256537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15080585|NCT05256537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080586|NCT05256537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
15080587|NCT05256537|Antitubercular Agents|antitubercular agents|mesh-ancestor
15080588|NCT05256537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15080589|NCT05256537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080590|NCT05256537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080591|NCT05256537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080592|NCT05256225|Paclitaxel|paclitaxel|mesh-list
15080593|NCT05256225|Carboplatin|carboplatin|mesh-list
15080594|NCT05256225|Trastuzumab|trastuzumab|mesh-list
15080595|NCT05256225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
15080596|NCT05256225|Pertuzumab|pertuzumab|mesh-list
15080597|NCT05256225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15080598|NCT05256225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080599|NCT05256225|Tubulin Modulators|tubulin modulators|mesh-ancestor
15080600|NCT05256225|Antimitotic Agents|antimitotic agents|mesh-ancestor
15080601|NCT05256225|Mitosis Modulators|mitosis modulators|mesh-ancestor
15080602|NCT05256225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080603|NCT05256225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15080604|NCT05254626|Pioglitazone|pioglitazone|mesh-list
15080605|NCT05254626|Dapagliflozin|dapagliflozin|mesh-list
15080606|NCT05254626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15080607|NCT05254626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080608|NCT05254626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15080609|NCT05254626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080610|NCT05248633|Dexamethasone|dexamethasone|mesh-list
15080611|NCT05248633|Lenalidomide|lenalidomide|mesh-list
15080612|NCT05248633|Bortezomib|bortezomib|mesh-list
15080613|NCT05248633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15080614|NCT05248633|Antiemetics|antiemetics|mesh-ancestor
15080615|NCT05248633|Autonomic Agents|autonomic agents|mesh-ancestor
15080616|NCT05248633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080617|NCT05248633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080618|NCT05248633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15080619|NCT05248633|Glucocorticoids|glucocorticoids|mesh-ancestor
15080620|NCT05248633|Hormones|hormones|mesh-ancestor
15080621|NCT05248633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15080622|NCT05248633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15080623|NCT05248633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080624|NCT05248633|Immunologic Factors|immunologic factors|mesh-ancestor
15080625|NCT05248633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15080626|NCT05248633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15080627|NCT05248633|Growth Substances|growth substances|mesh-ancestor
15080628|NCT05248633|Growth Inhibitors|growth inhibitors|mesh-ancestor
15080629|NCT05239741|Leucovorin|leucovorin|mesh-list
15080630|NCT05239741|Bevacizumab|bevacizumab|mesh-list
15080631|NCT05239741|Pembrolizumab|pembrolizumab|mesh-list
15080632|NCT05239741|Cetuximab|cetuximab|mesh-list
15080633|NCT05239741|Fluorouracil|fluorouracil|mesh-list
15080634|NCT05239741|Oxaliplatin|oxaliplatin|mesh-list
15080635|NCT05239741|Irinotecan|irinotecan|mesh-list
15080636|NCT05239741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15080637|NCT05239741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080638|NCT05239741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15080639|NCT05239741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15080640|NCT05239741|Growth Substances|growth substances|mesh-ancestor
15080641|NCT05239741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080642|NCT05239741|Growth Inhibitors|growth inhibitors|mesh-ancestor
15080643|NCT05239741|Antimetabolites|antimetabolites|mesh-ancestor
15080644|NCT05239741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080645|NCT05239741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15080646|NCT05239741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15080647|NCT05239741|Immunologic Factors|immunologic factors|mesh-ancestor
15080648|NCT05239741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
15080649|NCT05239741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15080650|NCT05239741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080651|NCT05239741|Antidotes|antidotes|mesh-ancestor
15080652|NCT05239741|Protective Agents|protective agents|mesh-ancestor
15080653|NCT05239741|Vitamin B Complex|vitamin b complex|mesh-ancestor
15080654|NCT05239741|Vitamins|vitamins|mesh-ancestor
15080655|NCT05239741|Micronutrients|micronutrients|mesh-ancestor
15080656|NCT05239728|Pembrolizumab|pembrolizumab|mesh-list
15080657|NCT05239728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15080658|NCT05239728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080659|NCT05229965|Acetaminophen|acetaminophen|mesh-list
15080660|NCT05229965|Codeine|codeine|mesh-list
15080661|NCT05229965|Caffeine|caffeine|mesh-list
15080662|NCT05229965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15080663|NCT05229965|Analgesics|analgesics|mesh-ancestor
15080664|NCT05229965|Sensory System Agents|sensory system agents|mesh-ancestor
15080665|NCT05229965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080666|NCT05229965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080667|NCT05229965|Antipyretics|antipyretics|mesh-ancestor
15080668|NCT05229965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
15080669|NCT05229965|Narcotics|narcotics|mesh-ancestor
15080670|NCT05229965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15080671|NCT05229965|Antitussive Agents|antitussive agents|mesh-ancestor
15080672|NCT05229965|Respiratory System Agents|respiratory system agents|mesh-ancestor
15080673|NCT05229965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
15080674|NCT05229965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
15080675|NCT05229965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080676|NCT05229965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080677|NCT05229965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
15080678|NCT05229965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
15080679|NCT05229965|Purinergic Agents|purinergic agents|mesh-ancestor
15080680|NCT05229965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080681|NCT05223582|Prednisone|prednisone|mesh-list
15080682|NCT05223582|Abiraterone Acetate|abiraterone acetate|mesh-list
15080683|NCT05223582|Androgens|androgens|mesh-list
15080684|NCT05223582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15080685|NCT05223582|Glucocorticoids|glucocorticoids|mesh-ancestor
15080686|NCT05223582|Hormones|hormones|mesh-ancestor
15080687|NCT05223582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15080688|NCT05223582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080689|NCT05223582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15080690|NCT05223582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080691|NCT05223582|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15080692|NCT05223582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080693|NCT05223582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080694|NCT05223582|Hormone Antagonists|hormone antagonists|mesh-ancestor
15080695|NCT05223582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15080696|NCT05214287|Nitrox|nitrox|mesh-list
15080697|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
15080698|NCT05214287|Protective Agents|protective agents|mesh-ancestor
15080699|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080700|NCT05212610|Vaccines|vaccines|mesh-list
15080701|NCT05212610|Immunologic Factors|immunologic factors|mesh-ancestor
15080702|NCT05212610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080703|NCT05197062|Aticaprant|aticaprant|mesh-list
15080704|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
15080705|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080706|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
15080707|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080708|NCT05173987|Paclitaxel|paclitaxel|mesh-list
15080709|NCT05173987|Docetaxel|docetaxel|mesh-list
15080710|NCT05173987|Carboplatin|carboplatin|mesh-list
15080711|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
15080712|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15080713|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080714|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
15080715|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
15080716|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
15080717|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080718|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15080719|NCT05172245|Cisplatin|cisplatin|mesh-list
15080720|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080721|NCT05155709|Azacitidine|azacitidine|mesh-list
15080722|NCT05155709|Venetoclax|venetoclax|mesh-list
15080723|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15080724|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
15080725|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080726|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080727|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080728|NCT05153408|Carboplatin|carboplatin|mesh-list
15080729|NCT05153408|Pemetrexed|pemetrexed|mesh-list
15080730|NCT05153408|Osimertinib|osimertinib|mesh-list
15080731|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080732|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080733|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080734|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15080735|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15080736|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15080737|NCT05147233|Dexamethasone|dexamethasone|mesh-list
15080738|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15080739|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
15080740|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
15080741|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080742|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080743|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15080744|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
15080745|NCT05147233|Hormones|hormones|mesh-ancestor
15080746|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15080747|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15080748|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080749|NCT05139017|Gemcitabine|gemcitabine|mesh-list
15080750|NCT05139017|Rituximab|rituximab|mesh-list
15080751|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
15080752|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15080753|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15080754|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080755|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
15080756|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080757|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15080758|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15080759|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
15080760|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080761|NCT05139017|Antiviral Agents|antiviral agents|mesh-ancestor
15080762|NCT05139017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080763|NCT05139017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080764|NCT05139017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15080765|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15080766|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
15080767|NCT05124457|Insulin|insulin|mesh-list
15080768|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
15080769|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
15080770|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
15080771|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
15080772|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
15080773|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15080774|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080775|NCT05113537|177Lu-PSMA-617|177lu-psma-617|mesh-list
15080776|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080777|NCT05113537|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
15080778|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15080779|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15080780|NCT05109234|Brivaracetam|brivaracetam|mesh-list
15080781|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
15080782|NCT05096663|Vitamins|vitamins|mesh-list
15080783|NCT05096663|Folic Acid|folic acid|mesh-list
15080784|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
15080785|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
15080786|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
15080787|NCT05096663|Gemcitabine|gemcitabine|mesh-list
15080788|NCT05096663|Dexamethasone|dexamethasone|mesh-list
15080789|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
15080790|NCT05096663|Docetaxel|docetaxel|mesh-list
15080791|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
15080792|NCT05096663|Pemetrexed|pemetrexed|mesh-list
15080793|NCT05096663|Ramucirumab|ramucirumab|mesh-list
15080794|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15080795|NCT05096663|Antibodies|antibodies|mesh-list
15080796|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
15080797|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15080798|NCT05096663|BB 1101|bb 1101|mesh-list
15080799|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
15080800|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080801|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
15080802|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15080803|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
15080804|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
15080805|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080806|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15080807|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
15080808|NCT05096663|Hormones|hormones|mesh-ancestor
15080809|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15080810|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15080811|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080812|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
15080813|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080814|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080815|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15080816|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
15080817|NCT05096663|Antiviral Agents|antiviral agents|mesh-ancestor
15080818|NCT05096663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080819|NCT05096663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15080820|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
15080821|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
15080822|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
15080823|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
15080824|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15080825|NCT05096663|Hematinics|hematinics|mesh-ancestor
15080826|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
15080827|NCT05087381|Niclosamide|niclosamide|mesh-list
15080828|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
15080829|NCT05087381|Bromhexine|bromhexine|mesh-list
15080830|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080831|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080832|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15080833|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15080834|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15080835|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080836|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15080837|NCT05087381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
15080838|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
15080839|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
15080840|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080841|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
15080842|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
15080843|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
15080844|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
15080845|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
15080846|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
15080847|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
15080848|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
15080849|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
15080850|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
15080851|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080852|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
15080853|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
15080854|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
15080855|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15080856|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
15080857|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
15080858|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
15080859|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
15080860|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
15080861|NCT05087381|Expectorants|expectorants|mesh-ancestor
15080862|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
15080863|NCT05084404|Guanabenz|guanabenz|mesh-list
15080864|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
15080865|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
15080866|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15080867|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15080868|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
15080869|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080870|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080871|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080872|NCT05083182|Ustekinumab|ustekinumab|mesh-list
15080873|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
15080874|NCT05077904|Alprazolam|alprazolam|mesh-list
15080875|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15080876|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15080877|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080878|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15080879|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15080880|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15080881|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
15080882|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
15080883|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080884|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080885|NCT05076617|Alprazolam|alprazolam|mesh-list
15080886|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15080887|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15080888|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080889|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15080890|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15080891|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15080892|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
15080893|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
15080894|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080895|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080896|NCT05063552|Bevacizumab|bevacizumab|mesh-list
15080897|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15080898|NCT05063552|Cetuximab|cetuximab|mesh-list
15080899|NCT05063552|Cisplatin|cisplatin|mesh-list
15080900|NCT05063552|Carboplatin|carboplatin|mesh-list
15080901|NCT05063552|Docetaxel|docetaxel|mesh-list
15080902|NCT05063552|Atezolizumab|atezolizumab|mesh-list
15080903|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
15080904|NCT05063552|Antibodies|antibodies|mesh-list
15080905|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
15080906|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15080907|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
15080908|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080909|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15080910|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15080911|NCT05063552|Growth Substances|growth substances|mesh-ancestor
15080912|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080913|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
15080914|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
15080915|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
15080916|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
15080917|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
15080918|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080919|NCT05062980|Docetaxel|docetaxel|mesh-list
15080920|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
15080921|NCT05062980|Ramucirumab|ramucirumab|mesh-list
15080922|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080923|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
15080924|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
15080925|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
15080926|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080927|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15080928|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
15080929|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
15080930|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
15080931|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
15080932|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
15080933|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080934|NCT05058651|Cisplatin|cisplatin|mesh-list
15080935|NCT05058651|Carboplatin|carboplatin|mesh-list
15080936|NCT05058651|Etoposide|etoposide|mesh-list
15080937|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
15080938|NCT05058651|Atezolizumab|atezolizumab|mesh-list
15080939|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
15080940|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15080941|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080942|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15080943|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15080944|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15080945|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080946|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080947|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
15080948|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080949|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
15080950|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
15080951|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
15080952|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
15080953|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
15080954|NCT05050162|Cisplatin|cisplatin|mesh-list
15080955|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
15080956|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080957|NCT05020327|Amoxicillin|amoxicillin|mesh-list
15080958|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15080959|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15080960|NCT05020236|Dexamethasone|dexamethasone|mesh-list
15080961|NCT05020236|Daratumumab|daratumumab|mesh-list
15080962|NCT05020236|Pomalidomide|pomalidomide|mesh-list
15080963|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15080964|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
15080965|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
15080966|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15080967|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080968|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15080969|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
15080970|NCT05020236|Hormones|hormones|mesh-ancestor
15080971|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15080972|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15080973|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15080974|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
15080975|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
15080976|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
15080977|NCT05020236|Growth Substances|growth substances|mesh-ancestor
15080978|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
15080979|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
15080980|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
15080981|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
15080982|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15080983|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080984|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15080985|NCT05008913|Adavosertib|adavosertib|mesh-list
15080986|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15080987|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15080988|NCT05008224|Prednisone|prednisone|mesh-list
15080989|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
15080990|NCT05008224|Dacarbazine|dacarbazine|mesh-list
15080991|NCT05008224|Doxorubicin|doxorubicin|mesh-list
15080992|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
15080993|NCT05008224|Etoposide|etoposide|mesh-list
15080994|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
15080995|NCT05008224|Vincristine|vincristine|mesh-list
15080996|NCT05008224|Bleomycin|bleomycin|mesh-list
15080997|NCT05008224|Vinblastine|vinblastine|mesh-list
15080998|NCT05008224|Procarbazine|procarbazine|mesh-list
15080999|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15081000|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
15081001|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081002|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15081003|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15081004|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
15081005|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081006|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081007|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15081008|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15081009|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15081010|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15081011|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081012|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081013|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15081014|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
15081015|NCT05008224|Hormones|hormones|mesh-ancestor
15081016|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15081017|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15081018|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15081019|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
15081020|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
15081021|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
15081022|NCT05000736|Fulvestrant|fulvestrant|mesh-list
15081023|NCT05000736|Palbociclib|palbociclib|mesh-list
15081024|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
15081025|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15081026|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081027|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
15081028|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
15081029|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
15081030|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15081031|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081032|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15081033|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081034|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081035|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
15081036|NCT04977986|Cannabidiol|cannabidiol|mesh-list
15081037|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
15081038|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
15081039|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
15081040|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
15081041|NCT04976868|Analgesics|analgesics|mesh-ancestor
15081042|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
15081043|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081044|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081045|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15081046|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15081047|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
15081048|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15081049|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
15081050|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
15081051|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081052|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081053|NCT04941287|Atezolizumab|atezolizumab|mesh-list
15081054|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
15081055|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15081056|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
15081057|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081058|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
15081059|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081060|NCT04929028|Fluorouracil|fluorouracil|mesh-list
15081061|NCT04929028|Capecitabine|capecitabine|mesh-list
15081062|NCT04929028|Nivolumab|nivolumab|mesh-list
15081063|NCT04929028|Mitomycins|mitomycins|mesh-list
15081064|NCT04929028|Mitomycin|mitomycin|mesh-list
15081065|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
15081066|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081067|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15081068|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081069|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15081070|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
15081071|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081072|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081073|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15081074|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15081075|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
15081076|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
15081077|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081078|NCT04928664|Bupivacaine|bupivacaine|mesh-list
15081079|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
15081080|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
15081081|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15081082|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081083|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
15081084|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081085|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
15081086|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
15081087|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15081088|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
15081089|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081090|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15081091|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15081092|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
15081093|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081094|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081095|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15081096|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081097|NCT04910503|Dexamethasone|dexamethasone|mesh-list
15081098|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
15081099|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15081100|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
15081101|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
15081102|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081103|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081104|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15081105|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
15081106|NCT04910503|Hormones|hormones|mesh-ancestor
15081107|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15081108|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15081109|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081110|NCT04893109|Paclitaxel|paclitaxel|mesh-list
15081111|NCT04893109|Maytansine|maytansine|mesh-list
15081112|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
15081113|NCT04893109|Trastuzumab|trastuzumab|mesh-list
15081114|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15081115|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081116|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
15081117|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
15081118|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
15081119|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081120|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081121|NCT04876066|Ketamine|ketamine|mesh-list
15081122|NCT04876066|Analgesics|analgesics|mesh-ancestor
15081123|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
15081124|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081125|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081126|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
15081127|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15081128|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
15081129|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
15081130|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15081131|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
15081132|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
15081133|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15081134|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081135|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
15081136|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15081137|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
15081138|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081139|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
15081140|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15081141|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
15081142|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081143|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
15081144|NCT04866706|Protective Agents|protective agents|mesh-ancestor
15081145|NCT04858334|Olaparib|olaparib|mesh-list
15081146|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
15081147|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081148|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081149|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081150|NCT04856007|Metformin|metformin|mesh-list
15081151|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
15081152|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
15081153|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081154|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
15081155|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081156|NCT04849715|Rituximab|rituximab|mesh-list
15081157|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
15081158|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081159|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081160|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
15081161|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081162|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15081163|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15081164|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
15081165|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081166|NCT04849364|Capecitabine|capecitabine|mesh-list
15081167|NCT04849364|Atezolizumab|atezolizumab|mesh-list
15081168|NCT04849364|Talazoparib|talazoparib|mesh-list
15081169|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15081170|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
15081171|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081172|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081173|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
15081174|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081175|NCT04842045|Midazolam|midazolam|mesh-list
15081176|NCT04842045|Psilocybin|psilocybin|mesh-list
15081177|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
15081178|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
15081179|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
15081180|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081181|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
15081182|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
15081183|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
15081184|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
15081185|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
15081186|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
15081187|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
15081188|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
15081189|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15081190|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081191|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
15081192|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
15081193|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081194|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081195|NCT04797780|Azacitidine|azacitidine|mesh-list
15081196|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
15081197|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
15081198|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081199|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081200|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081201|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
15081202|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081203|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081204|NCT04793958|Cetuximab|cetuximab|mesh-list
15081205|NCT04793958|Adagrasib|adagrasib|mesh-list
15081206|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081207|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081208|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15081209|NCT04792580|Lifitegrast|lifitegrast|mesh-list
15081210|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15081211|NCT04789330|Phenylephrine|phenylephrine|mesh-list
15081212|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
15081213|NCT04789330|Norepinephrine|norepinephrine|mesh-list
15081214|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
15081215|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
15081216|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
15081217|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081218|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081219|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
15081220|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
15081221|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
15081222|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
15081223|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
15081224|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
15081225|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
15081226|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
15081227|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
15081228|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081229|NCT04789330|Protective Agents|protective agents|mesh-ancestor
15081230|NCT04768101|Corticosterone|corticosterone|mesh-list
15081231|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15081232|NCT04759586|Prednisone|prednisone|mesh-list
15081233|NCT04759586|Prednisolone|prednisolone|mesh-list
15081234|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
15081235|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
15081236|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
15081237|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
15081238|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
15081239|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
15081240|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
15081241|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
15081242|NCT04759586|Cortisone|cortisone|mesh-list
15081243|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
15081244|NCT04759586|Rituximab|rituximab|mesh-list
15081245|NCT04759586|Doxorubicin|doxorubicin|mesh-list
15081246|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
15081247|NCT04759586|Nivolumab|nivolumab|mesh-list
15081248|NCT04759586|Etoposide|etoposide|mesh-list
15081249|NCT04759586|Vincristine|vincristine|mesh-list
15081250|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
15081251|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
15081252|NCT04759586|Antibodies|antibodies|mesh-list
15081253|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
15081254|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
15081255|NCT04759586|Lenograstim|lenograstim|mesh-list
15081256|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
15081257|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
15081258|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
15081259|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
15081260|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
15081261|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
15081262|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
15081263|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
15081264|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081265|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081266|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
15081267|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
15081268|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
15081269|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
15081270|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081271|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
15081272|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
15081273|NCT04759586|Hormones|hormones|mesh-ancestor
15081274|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
15081275|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
15081276|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15081277|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
15081278|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
15081279|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
15081280|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
15081281|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
15081282|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
15081283|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
15081284|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
15081285|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
15081286|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
15081287|NCT04759586|Protective Agents|protective agents|mesh-ancestor
15081288|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
15081289|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
15081290|NCT04751370|Nivolumab|nivolumab|mesh-list
15081291|NCT04751370|Ipilimumab|ipilimumab|mesh-list
15081292|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081293|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081294|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
15081295|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081296|NCT04745026|Cannabidiol|cannabidiol|mesh-list
15081297|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
15081298|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
15081299|NCT04740307|Lenvatinib|lenvatinib|mesh-list
15081300|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
15081301|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
15081302|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
15081303|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081304|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
15081305|NCT04736979|Amoxicillin|amoxicillin|mesh-list
15081306|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
15081307|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
15081308|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
15081309|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
15081310|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
15081311|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
15081312|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
15081313|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
